PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	DONNA, E; DANTA, I; KIM, CS; WANNER, A				DONNA, E; DANTA, I; KIM, CS; WANNER, A			RELATIONSHIP BETWEEN DEPOSITION OF AND RESPONSIVENESS TO INHALED METHACHOLINE IN NORMAL AND ASYMPTOMATIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MIAMI,MT SINAI MED CTR,DEPT MED,DIV PULM DIS,4300 ALTON RD,MIAMI BEACH,FL 33140	Mount Sinai Medical Center; University of Miami					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020989] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-20989] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERT RE, 1973, ARCH INTERN MED, V131, P115, DOI 10.1001/archinte.131.1.115; BEAUPRE A, 1982, THORAX, V37, P124, DOI 10.1136/thx.37.2.124; BOUHUYS A, 1969, J CLIN INVEST, V48, P1159, DOI 10.1172/JCI106073; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; CHAN TL, 1980, AM IND HYG ASSOC J, V41, P399, DOI 10.1080/15298668091424942; ENGLAND SJ, 1985, J APPL PHYSIOL, V58, P352, DOI 10.1152/jappl.1985.58.2.352; Ferron G. A., 1977, Journal of Aerosol Science, V8, P251, DOI 10.1016/0021-8502(77)90045-3; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HEYDER J, 1980, J AEROSOL SCI, V11, P505, DOI 10.1016/0021-8502(80)90123-8; Heyder J., 1978, J AEROSOL SCI, V9, P147; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; Kanner R.E., 1975, CLIN PULMONARY FUNCT; KIM CS, 1984, J AEROSOL SCI, V15, P167, DOI 10.1016/0021-8502(84)90034-X; KIM CS, 1983, J APPL PHYSIOL, V55, P154, DOI 10.1152/jappl.1983.55.1.154; LANDAHL H. D., 1950, BULL MATH BIOPHYS, V12, P43, DOI 10.1007/BF02477345; MALO JL, 1985, AM REV RESPIR DIS, V132, P644; RAMSDALE EH, 1984, THORAX, V39, P912, DOI 10.1136/thx.39.12.912; SEKIZAWA K, 1986, AM REV RESPIR DIS, V133, P593; SHINDOH C, 1985, AM REV RESPIR DIS, V132, P671; SVARTENGREN M, 1987, EXP LUNG RES, V12, P265, DOI 10.3109/01902148709062840; WANNER A, 1985, AM REV RESPIR DIS, V131, P3; XU GB, 1984, AEROSOLS SCI TECHNOL, P981	22	11	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1989	83	2	1				456	461		10.1016/0091-6749(89)90133-4	http://dx.doi.org/10.1016/0091-6749(89)90133-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T4489	2645344				2022-12-18	WOS:A1989T448900014
J	SOMMERHOFF, CP; OSBORNE, ML; GOLD, WM; LAZARUS, SC				SOMMERHOFF, CP; OSBORNE, ML; GOLD, WM; LAZARUS, SC			FUNCTIONAL AND MORPHOLOGIC CHARACTERIZATION OF MAST-CELLS RECOVERED BY BRONCHOALVEOLAR LAVAGE FROM BASENJI GREYHOUND AND MONGREL DOGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,BOX 0130,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco					NHLBI NIH HHS [HL-24136] Funding Source: Medline; NIAMS NIH HHS [R01 AR-38928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038928] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BACH MK, 1971, J EXP MED, V1323, P752; BECKER A B, 1987, American Review of Respiratory Disease, V135, pA222; BECKER AB, 1985, ANAT REC, V213, P477, DOI 10.1002/ar.1092130402; BEFUS AD, 1982, J IMMUNOL, V128, P2475; BOUSHEY HA, 1985, AM REV RESPIR DIS, V131, P312; BROSTOFF J, 1985, British Journal of Pharmacology, V85, p205P; CHUNG KF, 1987, J APPL PHYSIOL, V62, P253, DOI 10.1152/jappl.1987.62.1.253; ENERBACK L, 1987, INT ARCH ALLER A IMM, V82, P249, DOI 10.1159/000234199; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P289, DOI 10.1111/apm.1966.66.3.289; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P313, DOI 10.1111/apm.1966.66.3.313; ENNIS M, 1982, AGENTS ACTIONS, V12, P60, DOI 10.1007/BF01965108; FABBRI LM, 1984, AM REV RESPIR DIS, V129, P288; FINDLAY SR, 1980, AM REV RESPIR DIS, V122, P53; FLINT KC, 1985, BRIT MED J, V291, P923, DOI 10.1136/bmj.291.6500.923; FLINT KC, 1985, CLIN SCI, V68, P427, DOI 10.1042/cs0680427; FOREMAN JC, 1973, NATURE, V245, P249, DOI 10.1038/245249a0; GADDY JN, 1986, AM REV RESPIR DIS, V134, P969, DOI 10.1164/arrd.1986.134.5.969; GUERZON GM, 1979, AM REV RESPIR DIS, V119, P59; HIRSHMAN CA, 1986, AM REV RESPIR DIS, V133, pA238; HIRSHMAN CA, 1985, CHEST, V87, pS172, DOI 10.1378/chest.87.5_Supplement.172S; HIRSHMAN CA, 1983, PROSTAGLANDINS, V25, P481, DOI 10.1016/0090-6980(83)90020-5; HIRSHMAN CA, 1986, AM REV RESPIR DIS, V133, P482; HOLTZMAN MJ, 1983, J APPL PHYSIOL, V54, P134, DOI 10.1152/jappl.1983.54.1.134; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; KITAMURA Y, 1986, DEV GROWTH DIFFER, V28, P321; Luna LG, 1968, MANUAL HISTOLOGIC ST; MARONE G, 1985, INT ARCH ALLER A IMM, V76, P70, DOI 10.1159/000233737; MEAD J, 1953, J APPL PHYSIOL, V5, P779, DOI 10.1152/jappl.1953.5.12.779; MORDELETDAMBRINE M, 1984, AM REV RESPIR DIS, V130, P305; MOTA I, 1956, Q J MICROSC SCI, V97, P251; OSBORNE ML, 1987, AM REV RESPIR DIS, V135, P345; OSBORNE ML, 1986, AM REV RESPIR DIS, V133, pA396; PATTERSON R, 1977, J CLIN INVEST, V59, P217, DOI 10.1172/JCI108631; PATTERSON R, 1974, CLIN EXP IMMUNOL, V16, P223; PEARCE FL, 1982, J IMMUNOL, V128, P2481; PETERS SP, 1982, AM REV RESPIR DIS, V126, P1034; REBAR AH, 1980, VET PATHOL, V17, P294, DOI 10.1177/030098588001700303; SCHULMAN ES, 1985, AM REV RESPIR DIS, V131, P230; SCHULMAN ES, 1982, J IMMUNOL, V129, P2662; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; STEVENS RL, 1987, FASEB J, V46, P1915; STROBEL S, 1981, J CLIN PATHOL, V34, P851, DOI 10.1136/jcp.34.8.851; TOMIOKA M, 1984, AM REV RESPIR DIS, V129, P1000; TSAO C, 1976, INT ARCH ALLER A IMM, V52, P315, DOI 10.1159/000231697; TUNG R, 1982, J IMMUNOL, V128, P2067; WARDLAW AJ, 1985, THORAX, V40, P717; WINGREN U, 1983, HISTOCHEM J, V15, P571, DOI 10.1007/BF01954148; WOODBURY RG, 1978, P NATL ACAD SCI USA, V75, P2785, DOI 10.1073/pnas.75.6.2785; WOODBURY RG, 1982, IMMUNOLOGY, V46, P487; Zar J.H, 1999, BIOSTAT ANAL, V4th	50	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1989	83	2	1				441	449		10.1016/0091-6749(89)90131-0	http://dx.doi.org/10.1016/0091-6749(89)90131-0			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T4489	2465334				2022-12-18	WOS:A1989T448900012
J	BOLINGER, AM; YOUNG, KYL; GAMBERTOGLIO, JG; NEWTH, CJL; ZUREIKAT, G; POWELL, M; LEUNG, P; AFFRIME, MB; SYMCHOWICZ, S; PATRICK, JE				BOLINGER, AM; YOUNG, KYL; GAMBERTOGLIO, JG; NEWTH, CJL; ZUREIKAT, G; POWELL, M; LEUNG, P; AFFRIME, MB; SYMCHOWICZ, S; PATRICK, JE			INFLUENCE OF FOOD ON THE ABSORPTION OF ALBUTEROL REPETABS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARM,DIV CLIN PHARM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; SCHERING PLOUGH CORP,BLOOMFIELD,NJ 07003	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck & Company; Schering Plough Corporation								AFFRIME M, 1986, ARCH PHARM TOXICOL S, V59, P228; AHRENS RC, 1984, PHARMACOTHERAPY, V4, P105; NYBERG L, 1984, EUR J RESPIR DIS S, V134, P149; PEDERSEN S, 1984, BR J CLIN PRACT S35, V38, P37; POWELL ML, 1987, BIOPHARM DRUG DISPOS, V8, P461, DOI 10.1002/bdd.2510080506; TABACHNIK E, 1982, J PEDIATR-US, V100, P489, DOI 10.1016/S0022-3476(82)80467-8; WEISBERGER M, 1983, BIOMED MASS SPECTROM, V10, P556, DOI 10.1002/bms.1200101005	7	11	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					123	126		10.1016/0091-6749(89)90486-7	http://dx.doi.org/10.1016/0091-6749(89)90486-7			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419	2913132				2022-12-18	WOS:A1989T041900017
J	MIYAZAWA, H; INOUYE, S; SAKAGUCHI, M; KOIZUMI, K				MIYAZAWA, H; INOUYE, S; SAKAGUCHI, M; KOIZUMI, K			A REVERSE-SANDWICH ELISA FOR IGG ANTIBODY TO A POLLEN ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									INST PUBL HLTH,DEPT MICROBIOL,SHIROKANEDAI 4-6-1,MINATO KU,TOKYO 108,JAPAN; KYORIN UNIV,DEPT MED TECHNOL,MITAKA,TOKYO 181,JAPAN; FURUKAWA MEM HOSP,NIKKO,JAPAN	Kyorin University			Inouye, Sharon/R-7216-2019					BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG HC, 1984, J IMMUNOL METHODS, V72, P401, DOI 10.1016/0022-1759(84)90008-5; CHAPMAN MD, 1978, CLIN EXP IMMUNOL, V34, P126; COCKCROFT A, 1981, LANCET, V1, P827; Inouye S., 1986, IGAKUNO AYUMI, V138, P285; JOHANSSON SGO, 1974, SCAND J IMMUNOL, V3, P881; LONGBOTTOM JL, 1984, CLIN IMMUNOL ALLERGY, V4, P19; MURANAKA M, 1986, J ALLERGY CLIN IMMUN, V77, P616, DOI 10.1016/0091-6749(86)90355-6; NERURKAR LS, 1984, J CLIN MICROBIOL, V20, P109, DOI 10.1128/JCM.20.1.109-114.1984; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V79, P505, DOI 10.1016/0091-6749(87)90369-1; PLATTSMILLS TAE, 1978, J IMMUNOL, V120, P1201; PLATTSMILLS TAE, 1976, J CLIN INVEST, V57, P1041, DOI 10.1172/JCI108346; SAKAGUCHI M, 1986, Japanese Journal of Allergology, V35, P233; SCHUMACHER MJ, 1981, J ALLERGY CLIN IMMUN, V68, P310, DOI 10.1016/0091-6749(81)90157-3; SOOTHILL JF, 1976, CLIN ALLERGY, V6, P305, DOI 10.1111/j.1365-2222.1976.tb01911.x; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X; YUNGINGER JW, 1973, J CLIN INVEST, V52, P1268, DOI 10.1172/JCI107294	17	11	12	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1988	82	3	1				407	413		10.1016/0091-6749(88)90013-9	http://dx.doi.org/10.1016/0091-6749(88)90013-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q3229	3170988				2022-12-18	WOS:A1988Q322900013
J	LOPEZ, LR; NORIEGA, Y; LOSNO, R				LOPEZ, LR; NORIEGA, Y; LOSNO, R			IMMEDIATE SKIN-TEST REACTIVITY TO COMMON AEROALLERGENS IN PATIENTS WITH RESPIRATORY ALLERGIES - A COMPARATIVE-ANALYSIS OF ALLERGEN-INDUCED SKIN REACTIONS AND THEIR HISTAMINE CONTROLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV PERUANA CAYETANO HEREDIA,DEPT MICROBIOL,IMMUNOL SECT,LIMA,PERU	Universidad Peruana Cayetano Heredia								BARBEE RA, 1976, ANN INTERN MED, V84, P129, DOI 10.7326/0003-4819-84-2-129; BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P15, DOI 10.1016/0091-6749(81)90117-2; BARBEE RA, 1987, J ALLERGY CLIN IMMUN, V79, P16, DOI 10.1016/S0091-6749(87)80010-6; CIUFFARDI E, 1977, ALLERGY CLIN IMMUNOL, P316; CURRAN WS, 1965, ANN INTERN MED, V55, P777; GODFREY RC, 1976, CLIN ALLERGY, V6, P79, DOI 10.1111/j.1365-2222.1976.tb01415.x; HAAHTELA T, 1980, ALLERGY, V35, P425, DOI 10.1111/j.1398-9995.1980.tb01789.x; INDRAJANA T, 1971, ANN ALLERGY, V29, P639; PAGGIARO PL, 1986, CLIN ALLERGY, V16, P49, DOI 10.1111/j.1365-2222.1986.tb01953.x; PEPYS J, 1972, P ROY SOC MED, V65, P271, DOI 10.1177/003591577206500320; VANASPEREN PP, 1984, J ALLERGY CLIN IMMUN, V73, P381, DOI 10.1016/0091-6749(84)90412-3; WOOLCOCK AJ, 1978, CLIN ALLERGY, V8, P155, DOI 10.1111/j.1365-2222.1978.tb00460.x	12	11	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1988	81	6					1143	1148		10.1016/0091-6749(88)90882-2	http://dx.doi.org/10.1016/0091-6749(88)90882-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P0023	3379226				2022-12-18	WOS:A1988P002300012
J	FIREMAN, P				FIREMAN, P			NASAL PROVOCATION TESTING - AN OBJECTIVE ASSESSMENT FOR NASAL AND EUSTACHIAN-TUBE OBSTRUCTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV PITTSBURGH,SCH MED,DEPT PEDIAT,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	FIREMAN, P (corresponding author), CHILDRENS HOSP,DEPT ALLERGY & IMMUNOL,125 DE SOTO ST,PITTSBURGH,PA 15213, USA.				PHS HHS [R01 19262] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ACKERMAN MN, 1984, J ALLERGY CLIN IMMUN, V73, P604, DOI 10.1016/0091-6749(84)90519-0; ASHAN G, 1958, ACTA OTO-LARYNGOL, V140, P91; Blackley CH, 1873, EXPT RES CAUSES NATU; DOYLE WJ, 1984, ARCH OTOLARYNGOL, V110, P508; DOYLE WJ, 1985, J ALLERGY CLIN IMMUN, V76, P551, DOI 10.1016/0091-6749(85)90774-2; FRIEDMAN PA, 1983, J ALLERGY CLIN IMMUN, V71, P442; NACLERIO RM, 1984, ARCH OTOLARYNGOL, V110, P25; OKUDA M, 1977, ARCH OTO-RHINO-LARYN, V214, P241, DOI 10.1007/BF00458318; PIERSON WE, 1988, J ALLERGY CLIN IMMUN, V81, P949, DOI 10.1016/0091-6749(88)90158-3; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403; SCHUMACHER MJ, 1987, IMMUNOL ALLERGY CLIN, V7, P15; SKONER DP, 1986, ARCH OTOLARYNGOL, V112, P840; SKONER DP, 1987, J ALLERGY CLIN IMMUN, V79, P27, DOI 10.1016/S0091-6749(87)80012-X; SOLOMON WR, 1983, NASAL PROVOCATIVE TE, V2, P133; STILLWAGON PK, 1987, ANN ALLERGY, V58, P442; WALDEN SM, 1988, J ALLERGY CLIN IMMUN, V81, P940, DOI 10.1016/0091-6749(88)90157-1	16	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	2	S			953	960		10.1016/0091-6749(88)90159-5	http://dx.doi.org/10.1016/0091-6749(88)90159-5			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7037	3131407				2022-12-18	WOS:A1988N703700004
J	IIKURA, Y; NAGAKURA, T; WALSH, GM; AKIMOTO, K; KISIDA, M; KONDOU, T; ODAJIMA, Y; OKUMA, M; AKAZAWA, A; YUKISHITA, T				IIKURA, Y; NAGAKURA, T; WALSH, GM; AKIMOTO, K; KISIDA, M; KONDOU, T; ODAJIMA, Y; OKUMA, M; AKAZAWA, A; YUKISHITA, T			ROLE OF CHEMICAL MEDIATORS AFTER ANTIGEN AND EXERCISE CHALLENGE IN CHILDREN WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL CHILDRENS MED RES CTR,DEPT ALLERGY & IMMUNOL,TOKYO,JAPAN	National Center for Child Health & Development - Japan	IIKURA, Y (corresponding author), NATL CHILDRENS HOSP,DEPT ALLERGY,3-35-31 TAISHIDO,SETAGAYA KU,TOKYO 154,JAPAN.		Walsh, Garry/D-4869-2013	Walsh, Garry/0000-0002-7138-4078				ATKINS PC, 1978, J ALLERGY CLIN IMMUN, V62, P149, DOI 10.1016/0091-6749(78)90099-4; BERGSTRAND H, 1983, AGENTS ACTIONS, V13, P288, DOI 10.1007/BF01971480; BERNSTEIN IL, 1987, J ALLERGY CLIN IMMUN, V79, P320, DOI 10.1016/0091-6749(87)90148-5; CHANYEUNG M, 1986, CHEST, V89, pS500; DURHAM SR, 1984, NEW ENGL J MED, V311, P1398, DOI 10.1056/NEJM198411293112202; IIKURA Y, 1984, JPN J ALLERGOL, V33, P656; IIKURA Y, 1985, ACTA PED JPN, V27, P269; INUI H, 1983, IYAKUNO MON, V23, P93; JUBIZ W, 1982, J BIOL CHEM, V257, P6106; LEE TH, 1983, NEW ENGL J MED, V308, P1502, DOI 10.1056/NEJM198306233082504; METZGER WJ, 1986, J ALLERGY CLIN IMMUN, V78, P282; NACLERIO R, 1986, EAR NOSE THROAT J, V65, P206; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; TERANO T, 1986, PROG LIPID RES, V25, P129, DOI 10.1016/0163-7827(86)90026-3; YAMATODANI A, 1985, J CHROMATOGR, V344, P115, DOI 10.1016/S0378-4347(00)82012-5	15	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	2	S			1050	1055		10.1016/0091-6749(88)90179-0	http://dx.doi.org/10.1016/0091-6749(88)90179-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7037	2967315				2022-12-18	WOS:A1988N703700024
J	BOUSQUET, J; LEBEL, B; CHANAL, I; MOREL, A; MICHEL, FB				BOUSQUET, J; LEBEL, B; CHANAL, I; MOREL, A; MICHEL, FB			ANTI-ALLERGIC ACTIVITY OF LORATADINE AND TERFENADINE ASSESSED BY NASAL CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					228	228		10.1016/0091-6749(88)90476-9	http://dx.doi.org/10.1016/0091-6749(88)90476-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400263
J	BUSSE, W; RANDLEV, B; SEDGWICK, J; SOFIA, RD				BUSSE, W; RANDLEV, B; SEDGWICK, J; SOFIA, RD			THE EFFECT OF AZELASTINE (AZ) ON NEUTROPHIL AND EOSINOPHIL GENERATION OF SUPEROXIDE (O2-)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					212	212						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400198
J	FINNERTY, JP; HOLGATE, ST				FINNERTY, JP; HOLGATE, ST			ROLE OF HISTAMINE AND PROSTAGLANDINS IN EIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					240	240		10.1016/0091-6749(88)90524-6	http://dx.doi.org/10.1016/0091-6749(88)90524-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400311
J	ROSENOW, EC				ROSENOW, EC			DRUG-INDUCED BRONCHOPULMONARY PLEURAL DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											ROSENOW, EC (corresponding author), MAYO CLIN & MAYO FDN,DIV THORAC DIS & INTERNAL MED,200 1ST ST SW,ROCHESTER,MN 55905, USA.							BEIN ME, 1978, J COMPUT ASSIST TOMO, V2, P379, DOI 10.1097/00004728-197809000-00001; BRASHEAR RE, 1980, SEMIN RESPIR MED, V2, P59; CARANASOS GJ, 1974, JAMA-J AM MED ASSOC, V228, P713, DOI 10.1001/jama.228.6.713; CHESTER EH, 1981, CHEST, V79, P540, DOI 10.1378/chest.79.5.540; COCKERILL FR, 1985, ARCH INTERN MED, V145, P1398, DOI 10.1001/archinte.145.8.1398; COOPER JAD, 1986, AM REV RESPIR DIS, V133, P488; COOPER JAD, 1986, AM REV RESPIR DIS, V133, P321; DARCY PF, 1985, DRUG INTEL CLIN PHAR, V19, P540, DOI 10.1177/106002808501900706; DESWARTE RD, 1986, ARCH INTERN MED, V146, P649, DOI 10.1001/archinte.146.4.649; DYKE RW, 1984, NEW ENGL J MED, V310, P389; FRIEDMAN GD, 1971, J AMER MED ASSOC, V217, P567, DOI 10.1001/jama.217.5.567; Gillett D G, 1978, Monogr Pathol, V19, P21; GILSON AJ, 1985, CHEST, V88, P304, DOI 10.1378/chest.88.2.304; GINSBERG SJ, 1982, SEMIN ONCOL, V9, P34; GINSBURG WW, 1980, SEMIN RESPIR MED, V2, P51; HEFFNER JE, 1981, ANN INTERN MED, V95, P405, DOI 10.7326/0003-4819-95-4-405; HOLMBERG L, 1980, AM J MED, V69, P733, DOI 10.1016/0002-9343(80)90443-X; HOLMBERG L, 1981, EUR J RESPIR DIS, V62, P180; KOCHWESER J, 1974, NEW ENGL J MED, V291, P302, DOI 10.1056/NEJM197408082910610; KOCHWESER J, 1971, ARCH INTERN MED, V128, P399, DOI 10.1001/archinte.128.3.399; KONITS PH, 1982, CANCER, V50, P2771, DOI 10.1002/1097-0142(19821215)50:12<2771::AID-CNCR2820501213>3.0.CO;2-T; KUDENCHUK PJ, 1984, CHEST, V86, P541, DOI 10.1378/chest.86.4.541; LIPPMANN M, 1977, MED CLIN N AM, V61, P1353, DOI 10.1016/S0025-7125(16)31266-4; LIU FLW, 1986, THORAX, V41, P100, DOI 10.1136/thx.41.2.100; MARTIN WJ, 1983, AM REV RESPIR DIS, V127, P482, DOI 10.1164/arrd.1983.127.4.482; MILLER RR, 1974, ARCH INTERN MED, V134, P219, DOI 10.1001/archinte.134.2.219; NICKELS J, 1983, ACTA PATH MICRO IM A, V91, P265; NIMROD C, 1984, AM J OBSTET GYNECOL, V148, P625, DOI 10.1016/0002-9378(84)90763-4; PERLOW GM, 1981, ANN INTERN MED, V94, P489, DOI 10.7326/0003-4819-94-4-489; PORTER J, 1977, JAMA-J AM MED ASSOC, V237, P879, DOI 10.1001/jama.237.9.879; PRAKASH UBS, 1980, SEMIN RESPIR MED, V2, P70; RADOW SK, 1983, AM REV RESPIR DIS, V127, P575, DOI 10.1164/arrd.1983.127.5.575; REASOR MJ, 1984, FED PROC, V43, P2578; REYNOLDS RJ, 1982, J RESPIR DIS, V3, P95; ROSENOW EC, 1980, SEMIN RESPIR MED, V2, P89; ROSENOW EC, 1980, SEMIN RESPIR MED, V2, P45; SCHNEIDERMAN H, 1983, JAMA-J AM MED ASSOC, V250, P2340; SCHOEN RT, 1981, AM J MED, V71, P5, DOI 10.1016/0002-9343(81)90250-3; SCHOENE RB, 1984, AM J OPHTHALMOL, V97, P86, DOI 10.1016/0002-9394(84)90450-1; SHAPIRO S, 1971, J AMER MED ASSOC, V216, P467, DOI 10.1001/jama.216.3.467; WANG KK, 1984, MAYO CLIN PROC, V59, P343, DOI 10.1016/S0025-6196(12)61431-1	41	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1987	80	6					780	787		10.1016/S0091-6749(87)80265-8	http://dx.doi.org/10.1016/S0091-6749(87)80265-8			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5020	3320158				2022-12-18	WOS:A1987L502000002
J	DRESKIN, SC; GALLIN, JI				DRESKIN, SC; GALLIN, JI			EVOLUTION OF THE HYPERIMMUNOGLOBULIN-E AND RECURRENT INFECTION (HIE, JOBS) SYNDROME IN A YOUNG GIRL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,CLIN INVEST LAB,BACTERIAL DIS SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								BERGER M, 1980, J IMMUNOL, V125, P2437; BUCKLEY RH, 1981, CLIN IMMUNOLOGY UPDA, P148; CLARK RA, 1973, ANN INTERN MED, V78, P515, DOI 10.7326/0003-4819-78-4-515; DONABEDIAN H, 1983, MEDICINE, V62, P195, DOI 10.1097/00005792-198307000-00001; DONABEDIAN H, 1982, J CLIN INVEST, V69, P1155, DOI 10.1172/JCI110551; DRESKIN SC, 1985, J CLIN INVEST, V75, P26, DOI 10.1172/JCI111683; DRESKIN SC, 1985, CURRENT THERAPY ALLE, P140; FRIEDMAN SJ, 1985, ARCH DERMATOL, V121, P869, DOI 10.1001/archderm.121.7.869; FRIEDMAN SJ, 1984, J IMMUNOL METHODS, V66, P369, DOI 10.1016/0022-1759(84)90350-8; GABRIELSEN T, 1985, ACTA DERM-VENEREOL, V114, P61; GALLIN JI, 1981, REV INFECT DIS, V3, P1196; GEHA RS, 1981, J CLIN INVEST, V68, P783, DOI 10.1172/JCI110315; HANIFIN JM, 1986, J ALLERGY CLIN IMMUN, V78, P563, DOI 10.1016/0091-6749(86)90071-0; HILL HR, 1974, LANCET, V2, P617; HILL HR, 1982, AM J DIS CHILD, V136, P767, DOI 10.1001/archpedi.1982.03970450009001; SCHOPFER K, 1979, NEW ENGL J MED, V300, P835, DOI 10.1056/NEJM197904123001506; VANSCOY RE, 1975, ANN INTERN MED, V82, P766, DOI 10.7326/0003-4819-82-6-766	17	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1987	80	5					746	751		10.1016/0091-6749(87)90297-1	http://dx.doi.org/10.1016/0091-6749(87)90297-1			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K9930	3680819				2022-12-18	WOS:A1987K993000017
J	SIMONS, FER				SIMONS, FER			ANTICHOLINERGIC DRUGS AND THE AIRWAYS - TIME FUTURE CONTAINED IN TIME PAST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											SIMONS, FER (corresponding author), UNIV MANITOBA, DEPT PEDIAT & CHILD HLTH, 840 SHERBROOK ST, WINNIPEG R3A 1S1, MANITOBA, CANADA.							ANGGARD A, 1983, EUR J RESPIR DIS, V64, P143; BANDOUVAKIS J, 1981, BRIT J DIS CHEST, V75, P295, DOI 10.1016/0007-0971(81)90009-7; BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; BAUER R, 1976, ARZNEIMITTEL-FORSCH, V26, P981; BAUER R, 1979, PHARM BIOCH PROPERTI, V2, P489; BECK R, 1985, J PEDIATR-US, V107, P605, DOI 10.1016/S0022-3476(85)80033-0; BENDE M, 1985, ORL J OTO-RHINO-LARY, V47, P303, DOI 10.1159/000275790; BOK HE, 1983, EUR J RESPIR DIS, V64, P486; BORUM P, 1979, ACTA OTO-LARYNGOL, P35; BORUM P, 1981, AM REV RESPIR DIS, V123, P418; BORUT TC, 1977, J ALLERGY CLIN IMMUN, V60, P127, DOI 10.1016/0091-6749(77)90038-0; CHAPMAN KR, 1985, AM REV RESPIR DIS, V132, P845; CLARKE PS, 1982, ANN ALLERGY, V48, P180; COCKCROFT DW, 1978, CLIN ALLERGY, V8, P361, DOI 10.1111/j.1365-2222.1978.tb00471.x; DEVRIES K, 1975, POSTGRAD MED J, V51, P106; DOLOVICH J, 1987, J ALLERGY CLIN IMMUN, V80, P274, DOI 10.1016/0091-6749(87)90031-5; EASTON PA, 1986, NEW ENGL J MED, V315, P735, DOI 10.1056/NEJM198609183151205; ENGELHARDT A, 1975, POSTGRAD MED J, V51, P82; FARROW PR, 1986, HUM TOXICOL, V5, P53, DOI 10.1177/096032718600500111; GANDEVIA B, 1975, POSTGRAD MED J, V51, P13; GROSS NJ, 1984, AM REV RESPIR DIS, V129, P856, DOI 10.1164/arrd.1984.129.5.856; GROTH S, 1983, EUR J RESPIR DIS, V64, P490; HELPRIN GA, 1986, LANCET, V2, P1469; HOWARTH PH, 1985, AM REV RESPIR DIS, V132, P986; KIKIS D, 1982, CLIN CARDIOL, V5, P441, DOI 10.1002/clc.4960050804; KIRKEGAARD J, 1987, J ALLERGY CLIN IMMUN, V79, P585, DOI 10.1016/S0091-6749(87)80153-7; KNIGHT A, 1986, ANN ALLERGY, V57, P348; KUMLIEN J, 1985, CLIN OTOLARYNGOL, V10, P165, DOI 10.1111/j.1365-2273.1985.tb01187.x; LEAHY BC, 1983, BRIT J DIS CHEST, V77, P159, DOI 10.1016/0007-0971(83)90022-0; MALMBERG H, 1983, CLIN OTOLARYNGOL, V8, P273, DOI 10.1111/j.1365-2273.1983.tb01441.x; MANN JS, 1985, BRIT J DIS CHEST, V79, P209; MOLKENBOER JFWM, 1979, SCAND J RESPIR DIS, P154; MYGIND N, 1983, EUR J RESPIR DIS, V64, P167; NIELD J, 1985, BRIT MED J, V290, P674; OSTBERG B, 1987, ARCH OTOLARYNGOL, V113, P160; PAKES GE, 1980, DRUGS, V20, P237, DOI 10.2165/00003495-198020040-00001; POPPIUS H, 1986, EUR J RESPIR DIS, V68, P319; REBUCK AS, 1987, AM J MED, V82, P59, DOI 10.1016/0002-9343(87)90378-0; ROMINGER KL, 1979, SCAND J RESPIR DIS, P116; RUFFIN RE, 1978, CHEST, V73, P501, DOI 10.1378/chest.73.4.501; SACKNER MA, 1977, AM REV RESPIR DIS, V116, P1013; SANTAMARIA J, 1987, CHEST, V91, P86, DOI 10.1378/chest.91.1.86; SANWIKARJA S, 1986, ANN ALLERGY, V56, P162; SJOGREN I, 1984, ALLERGY, V39, P457, DOI 10.1111/j.1398-9995.1984.tb01968.x; TAYLOR RG, 1986, THORAX, V41, P295, DOI 10.1136/thx.41.4.295; VONHAACKE NP, 1983, BRIT MED J, V287, P1258, DOI 10.1136/bmj.287.6401.1258-a; WARD MJ, 1981, BRIT MED J, V282, P598, DOI 10.1136/bmj.282.6264.598; WARD MJ, 1985, BRIT J DIS CHEST, V79, P374, DOI 10.1016/0007-0971(85)90071-3; WATSON WA, 1987, J ALLERGY CLIN IMMUN, V79, P151; WOENNE R, 1978, J ALLERGY CLIN IMMUN, V62, P119, DOI 10.1016/0091-6749(78)90089-1	50	11	12	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	1				239	242		10.1016/0091-6749(87)90025-X	http://dx.doi.org/10.1016/0091-6749(87)90025-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1036	2957415				2022-12-18	WOS:A1987K103600001
J	HARVEY, C; SHAW, RJ; LONGBOTTOM, JL				HARVEY, C; SHAW, RJ; LONGBOTTOM, JL			DIAGNOSTIC SPECIFICITY OF A SANDWICH ELISA FOR ASPERGILLUS-RELATED DISEASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									BROMPTON HOSP,INST CARDIOTHORAC,DEPT ALLERGY & CLIN IMMUNOL,FULHAM RD,LONDON SW3 6HP,ENGLAND	Royal Brompton Hospital								GREENBERGER PA, 1982, J LAB CLIN MED, V99, P288; HARVEY C, 1986, CLIN ALLERGY, V16, P323, DOI 10.1111/j.1365-2222.1986.tb01964.x; HARVEY C, 1986, CLIN EXP IMMUNOL, V65, P206; HEARN VM, 1985, J IMMUNOASSAY, V6, P137, DOI 10.1080/01971528508063026; KAUFFMAN HF, 1983, J ALLERGY CLIN IMMUN, V72, P255, DOI 10.1016/0091-6749(83)90029-5; KHAN ZU, 1984, INT ARCH ALLER A IMM, V73, P205, DOI 10.1159/000233468; KURUP VP, 1984, MYKOSEN, V27, P43; KURUP VP, 1983, INFECT IMMUN, V41, P698, DOI 10.1128/IAI.41.2.698-701.1983; LONGBOTTOM JL, 1983, J ALLERGY CLIN IMMUN, V72, P668, DOI 10.1016/0091-6749(83)90627-9; LONGBOTTOM JL, 1964, J PATHOL BACTERIOL, V88, P141, DOI 10.1002/path.1700880119; MALO JL, 1981, CLIN ALLERGY, V11, P333, DOI 10.1111/j.1365-2222.1981.tb01603.x; MANTYJARVI RA, 1980, CLIN ALLERGY, V10, P187, DOI 10.1111/j.1365-2222.1980.tb02096.x; OJANEN TH, 1980, ALLERGY, V35, P537, DOI 10.1111/j.1398-9995.1980.tb01801.x; PATTERSON R, 1982, ANN INTERN MED, V96, P286, DOI 10.7326/0003-4819-96-3-286; PATTERSON R, 1974, INT ARCH ALLER A IMM, V46, P150, DOI 10.1159/000231119; PHILPOT CM, 1976, J BIOL STAND, V4, P73, DOI 10.1016/0092-1157(76)90015-9; RICHARDSON MD, 1982, J CLIN PATHOL, V35, P1134, DOI 10.1136/jcp.35.10.1134; SCHONHEYDER H, 1985, SABOURAUDIA, V23, P93; SCHONHEYDER H, 1983, INT ARCH ALLER A IMM, V70, P108, DOI 10.1159/000233306; SCHONHEYDER H, 1984, INT ARCH ALLER A IMM, V74, P262, DOI 10.1159/000233555; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x; SHALE DJ, 1985, J IMMUNOL METHODS, V77, P197, DOI 10.1016/0022-1759(85)90032-8; WEINER MH, 1979, J LAB CLIN MED, V93, P111; WEINER MH, 1983, ANN INTERN MED, V99, P777, DOI 10.7326/0003-4819-99-6-777; WILSON EV, 1983, SABOURAUDIA, V21, P195; YARZABAL LA, 1978, SABOURAUDIA, V16, P55	26	11	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1987	79	2					324	330		10.1016/0091-6749(87)90149-7	http://dx.doi.org/10.1016/0091-6749(87)90149-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G1791	3819216				2022-12-18	WOS:A1987G179100004
J	COHEN, JJ				COHEN, JJ			IMMUNITY AND BEHAVIOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO, SCH MED, DEPT MED, DENVER, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	COHEN, JJ (corresponding author), UNIV COLORADO, SCH MED, DEPT MICROBIOL & IMMUNOL, DENVER, CO 80262 USA.			Cohen, J. John/0000-0003-1772-8236				ADER R, 1985, BEHAV BRAIN SCI, V8, P379, DOI 10.1017/S0140525X00000765; BARTROP RW, 1977, LANCET, V1, P834; BESEDOVSKY HO, 1985, J IMMUNOL, V135, pS750; BLACK S, 1963, BMJ-BRIT MED J, P1649; BLALOCK JE, 1985, IMMUNOL TODAY, V6, P115, DOI 10.1016/0167-5699(85)90070-2; Cohen J J, 1985, J Burn Care Rehabil, V6, P167, DOI 10.1097/00004630-198503000-00015; COHEN JJ, 1971, ANN ALLERGY, V29, P358; COHEN JJ, 1972, J IMMUNOL, V108, P841; COHEN JJ, 1984, STRESS IMMUNITY AGIN, P73; CUPPS TR, 1982, IMMUNOL REV, V65, P133, DOI 10.1111/j.1600-065X.1982.tb00431.x; IMBODEN JB, 1985, IMMUNOL TODAY, V6, P328, DOI 10.1016/0167-5699(85)90129-X; JACOBS S, 1977, PSYCHOSOM MED, V39, P344, DOI 10.1097/00006842-197709000-00006; JEMMOTT JB, 1983, LANCET, V1, P1400; KLUGER MJ, 1985, PHYSL METABOLIC IMMU; KOISTINEN J, 1975, VOX SANG, V29, P192, DOI 10.1111/j.1423-0410.1975.tb00494.x; MCCLELLAND DC, 1980, J HUM STRESS, V6, P11, DOI 10.1080/0097840X.1980.9934531; NICOLA NA, 1984, IMMUNOL TODAY, V5, P76, DOI 10.1016/0167-5699(84)90170-1; SCHLEIFER SJ, 1983, JAMA-J AM MED ASSOC, V250, P374, DOI 10.1001/jama.250.3.374; SCHMALE AH, 1971, SOC SCI MED, V5, P95, DOI 10.1016/0037-7856(71)90090-4; SMITH EM, 1981, P NATL ACAD SCI-BIOL, V78, P7530, DOI 10.1073/pnas.78.12.7530; WILLIAMS JM, 1981, BRAIN RES BULL, V6, P83, DOI 10.1016/S0361-9230(81)80072-X; ZURAWSKI G, 1986, SCIENCE, V232, P772, DOI 10.1126/science.2938259	22	11	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					2	5		10.1016/S0091-6749(87)80005-2	http://dx.doi.org/10.1016/S0091-6749(87)80005-2			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810	3805542				2022-12-18	WOS:A1987F881000001
J	FISHER, RH; KAGEYSOBOTKA, A; PROUD, D; ORCHARD, MA; LICHTENSTEIN, LM				FISHER, RH; KAGEYSOBOTKA, A; PROUD, D; ORCHARD, MA; LICHTENSTEIN, LM			PLATELET-BASOPHIL INTERACTIONS - CLINICAL CORRELATES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					196	196						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000310
J	HERBERMAN, RB				HERBERMAN, RB			NATURAL-KILLER-CELLS IN LUNGS AND OTHER TISSUES AND REGULATION OF THEIR ACTIVITY BY SUPPRESSOR CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									UNIV PITTSBURGH,SCH MED,DEPT MED,PITTSBURGH,PA 15213; UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15213	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	HERBERMAN, RB (corresponding author), UNIV PITTSBURGH,SCH MED,PITTSBURGH CANC INST,PITTSBURGH,PA 15213, USA.							ABRUZZO LV, 1983, SCIENCE, V222, P581, DOI 10.1126/science.6685343; ALLAVENA P, 1981, J NATL CANCER I, V67, P319; ARAI S, 1983, J IMMUNOL, V131, P651; BORDIGNON C, 1982, CLIN EXP IMMUNOL, V47, P437; CUDKOWICZ G, 1979, IMMUNOL REV, V44, P13, DOI 10.1111/j.1600-065X.1979.tb00266.x; CUDKOWICZ G, 1979, IMMUNOL REV, V44, P1313; DJEU JY, 1982, J EXP MED, V156, P1222, DOI 10.1084/jem.156.4.1222; DJEU JY, 1982, NK CELLS OTHER NATUR, P669; DOMZIG W, 1982, NK CELLS OTHER NATUR, P409; EREMIN O, 1980, NATURAL CELL MEDIATE, P1011; GERSON JM, 1981, INT J CANCER, V27, P243, DOI 10.1002/ijc.2910270218; GERSON JM, 1980, NATURAL CELL MEDIATE, P1047; GORELIK E, 1982, INT J CANCER, V30, P107, DOI 10.1002/ijc.2910300118; GORELIK E, 1982, CANCER IMMUNOL IMMUN, V12, P105; GORELIK E, 1979, J NATL CANCER I, V63, P1397; HANNA N, 1980, INT J CANCER, V26, P675, DOI 10.1002/ijc.2910260521; HANNA N, 1981, J IMMUNOL, V127, P1754; HANNA N, 1980, J NATL CANCER I, V65, P801, DOI 10.1093/jnci/65.4.801; HANNA N, 1981, J NATL CANCER I, V66, P1183, DOI 10.1093/jnci/66.6.1183; HANNA N, 1983, J IMMUNOL, V130, P974; Herberman R B, 1978, Adv Cancer Res, V27, P305; HERBERMAN RB, 1983, PROGR IMMUNOLOGY, V5, P1157; HERBERMAN RB, 1984, NATURAL KILLER ACTIV, P409; HOCHMAN PS, 1979, J IMMUNOL, V123, P968; HOCHMAN PS, 1981, CELL IMMUNOL, V61, P200, DOI 10.1016/0008-8749(81)90366-X; KASAHARA T, 1983, J IMMUNOL, V131, P2379; LEVENTON GS, 1983, J IMMUNOL METHODS, V63, P35, DOI 10.1016/0022-1759(83)90207-7; MANN DW, 1985, P SOC EXP BIOL MED, V180, P224; MOY PM, 1985, CANCER RES, V45, P57; NAIR MPN, 1981, CELL IMMUNOL, V58, P9, DOI 10.1016/0008-8749(81)90144-1; ORTALDO JR, 1984, ANNU REV IMMUNOL, V2, P359, DOI 10.1146/annurev.iy.02.040184.002043; PITCHENIK AE, 1986, AM REV RESPIR DIS, V133, pA6; POLLACK SB, 1984, 2ND P INT WORKSH NAT; POLLACK SB, 1981, MEDIATION CELLULAR I, P225; PUCCETTI P, 1980, INT J CANCER, V25, P153, DOI 10.1002/ijc.2910250121; RICCARDI C, 1979, J NATL CANCER I, V63, P1041; ROBINSON BWS, 1984, J CLIN INVEST, V74, P942, DOI 10.1172/JCI111513; SANTONI A, 1980, INT J CANCER, V26, P837, DOI 10.1002/ijc.2910260619; SANTONI A, 1982, NK CELLS OTHER NATUR, P527; SANTONI A, 1982, NK CELLS OTHER NATUR, P519; SCALA G, 1984, NATURE, V309, P56, DOI 10.1038/309056a0; SCALA G, IMMUNOBIOLOGY NATURA; SERRATE SA, 1982, NK CELLS OTHER NATUR, P1069; SERRATE SA, 1982, NK CELLS OTHER NATUR, P1055; SUZUKI R, 1983, J IMMUNOL, V130, P987; SUZUKI S, 1984, NATURAL KILLER ACTIV, P296; TAGLIABUE A, 1982, J IMMUNOL, V129, P395; TALMADGE JE, 1980, NATURE, V284, P622, DOI 10.1038/284622a0; TALMADGE JE, UNPUB J IMMUNOL; TIMONEN T, 1982, J IMMUNOL METHODS, V51, P269, DOI 10.1016/0022-1759(82)90393-3; VOSE BM, 1979, INT J CANCER, V24, P579, DOI 10.1002/ijc.2910240510; WARNER JF, 1982, NATURE, V300, P31, DOI 10.1038/300031a0; WILTROUT RH, 1984, J EXP MED, V160, P1431, DOI 10.1084/jem.160.5.1431	53	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	1				566	570		10.1016/0091-6749(86)90072-2	http://dx.doi.org/10.1016/0091-6749(86)90072-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5682	2945854				2022-12-18	WOS:A1986E568200003
J	LEVY, G				LEVY, G			KINETICS OF DRUG-ACTION - AN OVERVIEW	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											LEVY, G (corresponding author), SUNY BUFFALO,DEPT PHARMACEUT,BUFFALO,NY 14260, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM020852] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 20852] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DANHOF M, 1984, J PHARMACOL EXP THER, V229, P44; DAVIES PDO, 1984, BRIT J CLIN PHARMACO, V17, P335, DOI 10.1111/j.1365-2125.1984.tb02350.x; GIBALDI M, 1971, CLIN PHARMACOL THER, V12, P734; GIBALDI M, 1972, ANESTHESIOLOGY, V36, P213, DOI 10.1097/00000542-197203000-00005; GIBALDI M, 1982, PHARMACOKINETICS, P1; GRAINGER SL, 1985, BRIT J CLIN PHARMACO, V19, pS239, DOI 10.1111/j.1365-2125.1985.tb02769.x; HOLFORD NHG, 1981, CLIN PHARMACOKINET, V6, P429, DOI 10.2165/00003088-198106060-00002; JENNE JW, 1984, CLIN CHEST MED, V5, P645; LEVY G, 1966, CLIN PHARMACOL THER, V7, P362; LEVY G, 1970, ANESTHESIOLOGY, V32, P551, DOI 10.1097/00000542-197006000-00018; LEVY G, 1967, J PHARM SCI, V56, P1687, DOI 10.1002/jps.2600561239; LEVY G, 1975, J PEDIATR-US, V86, P789, DOI 10.1016/S0022-3476(75)80374-X; LEVY G, 1985, VARIABILITY DRUG THE, P125; NAGASHIMA R, 1969, CLIN PHARMACOL THER, V10, P22; RAMZAN IM, 1986, J PHARMACOL EXP THER, V236, P708; SHEINER LB, 1979, CLIN PHARMACOL THER, V25, P358; SIMONS FER, 1984, J ALLERGY CLIN IMMUN, V73, P69, DOI 10.1016/0091-6749(84)90486-X; WAGNER JG, 1968, J THEOR BIOL, V20, P173, DOI 10.1016/0022-5193(68)90188-4; WHITING B, 1984, BRIT J CLIN PHARMACO, V17, P1	19	11	11	0	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	2				754	761		10.1016/0091-6749(86)90057-6	http://dx.doi.org/10.1016/0091-6749(86)90057-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5684	3534056				2022-12-18	WOS:A1986E568400015
J	NICKLAS, RA; SHEFFER, AL; ADKINSON, NF				NICKLAS, RA; SHEFFER, AL; ADKINSON, NF			WORKSHOP 3 - STUDY DESIGN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HARVARD UNIV,SCH MED,BOSTON,MA 02115; JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205	Harvard University; Harvard Medical School; Johns Hopkins University	NICKLAS, RA (corresponding author), US FDA,BETHESDA,MD 20014, USA.							GOULD AL, 1980, BIOMETRICS, V36, P721, DOI 10.2307/2556126; HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x; HUDGEL DW, 1982, AM REV RESPIR DIS, V126, P121; JACOBS RL, 1981, J ALLERGY CLIN IMMUN, V68, P125, DOI 10.1016/0091-6749(81)90170-6; KINSMAN RA, 1977, PSYCHOSOM MED, V39, P102, DOI 10.1097/00006842-197703000-00005; MCFADDEN ER, 1973, NEW ENGL J MED, V288, P221, DOI 10.1056/NEJM197302012880501; NICKLAS RA, 1982, 38TH ANN M AM AC ALL; RUBINFELD AR, 1976, LANCET, V1, P882; SHAPIRO GG, 1983, PEDIATRICS, V71, P510; SLAVIN RG, 1982, ANN ALLERGY, V49, P76; STEVENSON DD, 1984, J ALLERGY CLIN IMMUN, V74, P617, DOI 10.1016/0091-6749(84)90115-5; SZCAEKLIK A, 1977, J ALLERGY CLIN IMMUN, V60, P276; WELLIVER RC, 1983, J ALLERGY CLIN IMMUN, V72, P341, DOI 10.1016/0091-6749(83)90497-9; WILSON N, 1982, BRIT MED J, V284, P863, DOI 10.1136/bmj.284.6319.863; 1972, CIRCULATION, V45, P991; 1977, HEW FDA773040 PUBL; 1982, BIOMETRICS, V38, P276; 1975, CHEST, V67, P383; 1977, HEW FDA773041 PUBL	19	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	2				507	517		10.1016/0091-6749(86)90097-7	http://dx.doi.org/10.1016/0091-6749(86)90097-7			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1151		Bronze			2022-12-18	WOS:A1986E115100005
J	FARNAM, J; GRANT, JA; LETTBROWN, MA; LORD, RA; RUSSELL, WL; HENRY, DP				FARNAM, J; GRANT, JA; LETTBROWN, MA; LORD, RA; RUSSELL, WL; HENRY, DP			COMBINED COLD-INDUCED AND HEAT-INDUCED CHOLINERGIC URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT PHARMACOL,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	FARNAM, J (corresponding author), UNIV TEXAS,MED BRANCH,DEPT MED,DIV ALLERGY,CLIN SCI 409,GALVESTON,TX 77550, USA.		Henry, David/AAU-4650-2020	Henry, David/0000-0001-7169-7704	NCRR NIH HHS [RR-73] Funding Source: Medline; NIAID NIH HHS [AI-12621] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOWSHER RR, 1983, J BIOL CHEM, V258, P2215; CASALE TB, 1985, ANN ALLERGY, V55, P334; CZARNETZKI BM, 1984, BRIT J DERMATOL, V110, P587; Duke WW, 1924, J AMER MED ASSOC, V83, P3, DOI 10.1001/jama.1924.02660010007002; EPSTEIN JH, 1966, ANN ALLERGY, V24, P397; GOREVIC PD, 1980, INT J DERMATOL, V19, P417, DOI 10.1111/j.1365-4362.1980.tb05893.x; GRANDEL KE, 1985, NEW ENGL J MED, V313, P405, DOI 10.1056/NEJM198508153130702; GRANT JA, 1985, ANN ALLERGY, V54, P35; GRANT JA, 1981, J ALLERGY CLIN IMMUN, V67, P75, DOI 10.1016/0091-6749(81)90049-X; Grant RT, 1936, CLIN SCI, V2, P253; Hopkins JG, 1938, ARCH DERMATOL SYPH, V38, P679, DOI 10.1001/archderm.1938.01480170003001; KAPLAN AP, 1984, J ALLERGY CLIN IMMUN, V73, P453, DOI 10.1016/0091-6749(84)90354-3; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P319, DOI 10.1016/0091-6749(81)90158-5; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P438; KAPLAN AP, 1983, ALLERGY PRINCIPLES P, P1341; KATAYAMA S, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1196; KIDD JM, 1983, J ALLERGY CLIN IMMUN, V71, P407, DOI 10.1016/0091-6749(83)90070-2; LEWIS J, 1981, J ALLERGY CLIN IMMUN, V68, P432, DOI 10.1016/0091-6749(81)90197-4; MATHEWS KP, 1983, J ALLERGY CLIN IMMUN, V72, P1, DOI 10.1016/0091-6749(83)90042-8; MURPHY GM, 1984, BRIT J DERMATOL, V110, P581; NOVEY HS, 1983, J ALLERGY CLIN IMMUN, V71, P498, DOI 10.1016/0091-6749(83)90468-2; SHEFFER AL, 1985, J ALLERGY CLIN IMMUN, V75, P479, DOI 10.1016/S0091-6749(85)80021-X; SHEFFER AL, 1984, J ALLERGY CLIN IMMUN, V73, P699, DOI 10.1016/0091-6749(84)90309-9; SHEFFER AL, 1980, J ALLERGY CLIN IMMUN, V66, P106, DOI 10.1016/0091-6749(80)90056-1; SHEFFER AL, 1983, J ALLERGY CLIN IMMUN, V71, P311, DOI 10.1016/0091-6749(83)90085-4; SOTER NA, 1980, NEW ENGL J MED, V302, P604, DOI 10.1056/NEJM198003133021104; UDASSIN R, 1981, ARCH INTERN MED, V141, P1029, DOI 10.1001/archinte.1981.00340080069016; VERBURG KM, 1983, LIFE SCI, V32, P2855, DOI 10.1016/0024-3205(83)90322-3; WHINNERY JE, 1983, AVIAT SPACE ENVIR MD, V54, P551	29	11	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1986	78	2					353	357		10.1016/S0091-6749(86)80089-6	http://dx.doi.org/10.1016/S0091-6749(86)80089-6			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D7261	3734288				2022-12-18	WOS:A1986D726100019
J	GREENSPON, LW; WHITE, J; SHIELDS, RL; FUGNER, A; GOLD, WM				GREENSPON, LW; WHITE, J; SHIELDS, RL; FUGNER, A; GOLD, WM			PURIFICATION OF ASCARIS-SUUM ANTIGEN - ITS ALLERGENIC ACTIVITY INVITRO AND INVIVO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,1327-M,SAN FRANCISCO,CA 94143; BOEHRINGER INGELHEIM KG,DEPT PHARMACOL,D-6507 INGELHEIM,FED REP GER; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; Boehringer Ingelheim; University of California System; University of California San Francisco					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-00535, HL-24136, HL-07159] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMBLER J, 1974, INT ARCH ALLER A IMM, V46, P427, DOI 10.1159/000231146; BEAVEN MA, 1972, CLIN CHIM ACTA, V37, P91, DOI 10.1016/0009-8981(72)90419-6; DANDEU JP, 1978, IMMUNOL COMMUN, V7, P393, DOI 10.3109/08820137809047625; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; HERZIG DJ, 1974, J IMMUNOL METHODS, V5, P219, DOI 10.1016/0022-1759(74)90106-9; HOGARTHS.RS, 1967, IMMUNOLOGY, V13, P535; HUSSAIN R, 1973, J IMMUNOL, V111, P260; KESSLER GF, 1974, INT ARCH ALLER A IMM, V47, P313, DOI 10.1159/000231225; KUO CY, 1977, INT ARCH ALLER A IMM, V54, P308, DOI 10.1159/000231842; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWENSTEIN H, 1976, INT ARCH ALLER A IMM, V51, P48, DOI 10.1159/000231578; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MJORNDAL TO, 1983, J ALLERGY CLIN IMMUN, V71, P62, DOI 10.1016/0091-6749(83)90548-1; SILVA MRE, 1946, ARCH SURG-CHICAGO, V52, P523; SNAPPER JR, 1980, AM REV RESPIR DIS, V122, P775, DOI 10.1164/arrd.1980.122.5.775; SPRENT JFA, 1951, J INFECT DIS, V88, P168, DOI 10.1093/infdis/88.2.168; STREJAN G, 1968, J IMMUNOL, V101, P628; THOMPSON AR, 1972, BIOCHIM BIOPHYS ACTA, V261, P245, DOI 10.1016/0304-4165(72)90335-2; UVNAS B, 1967, ACTA PHYSIOL SCAND, V70, P269, DOI 10.1111/j.1748-1716.1967.tb03625.x; VONREDLICH D, 1969, ANAL BIOCHEM, V29, P167, DOI 10.1016/0003-2697(69)90021-9; WEISZER I, 1968, J ALLERGY, V41, P14, DOI 10.1016/0021-8707(68)90004-X	21	11	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1986	77	3					443	451		10.1016/0091-6749(86)90178-8	http://dx.doi.org/10.1016/0091-6749(86)90178-8			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A5367	2419382				2022-12-18	WOS:A1986A536700007
J	MALO, PE; WASSERMAN, M; PARRIS, D; PFEIFFER, D				MALO, PE; WASSERMAN, M; PARRIS, D; PFEIFFER, D			INHIBITION BY AURANOFIN OF PHARMACOLOGICAL AND ANTIGEN-INDUCED CONTRACTIONS OF THE ISOLATED GUINEA-PIG TRACHEA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MALO, PE (corresponding author), SK&F LABS,DEPT PHARMACOL,709 SWEDELAND RD,SWEDELAND,PA 19479, USA.		Pfeiffer, Dirk U/C-5002-2009	Pfeiffer, Dirk U/0000-0001-7000-0530				BERNSTROM K, 1982, METHOD ENZYMOL, V86, P38; CHAKRIN LW, 1973, PHARMACOLOGIST, V15, P220; DIMARTIN.MJ, 1974, FED PROC, V33, P558; HERXHEIMER H, 1971, BRIT J PHARMACOL, V8, P177; HOGABOOM GK, 1983, BIOCHEM BIOPH RES CO, V116, P1136, DOI 10.1016/S0006-291X(83)80261-7; KRELL RD, 1983, PROSTAGLANDINS, V25, P171, DOI 10.1016/0090-6980(83)90102-8; KURAKANE K, 1957, JAP J CLIN MED, V16, P1477; MORRIS HR, 1980, PROSTAG OTH LIPID M, V19, P185, DOI 10.1016/0090-6980(80)90019-2; MURANAKA M, 1978, ANN ALLERGY, V40, P132; MURANAKA M, 1981, J ALLERGY CLIN IMMUN, V67, P350, DOI 10.1016/0091-6749(81)90079-8; NOMURA T, 1974, JAP J THORAC DIS, V12, P522; NORN S, 1971, ACTA PHARM TOXICO S1, V30, P1; SUZUKI S, 1983, J ALLERGY CLIN IMMUN, V72, P469, DOI 10.1016/0091-6749(83)90583-3; TAKAISHI T, 1984, J ALLERGY CLIN IMMUN, V74, P296, DOI 10.1016/0091-6749(84)90261-6; WALZ DT, 1976, J PHARMACOL EXP THER, V197, P142; WANG S, 1985, J ALLERGY CLIN IMMUN, V75, P184; WEICHMAN BM, 1982, J PHARMACOL EXP THER, V222, P202; YAMAUCHI N, 1984, J ALLERGY CLIN IMMUN, V74, P802, DOI 10.1016/0091-6749(84)90182-9; YAMAUCHI N, 1982, JPN J ALLERGOL, V31, P576	19	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1986	77	2					371	376		10.1016/S0091-6749(86)80120-8	http://dx.doi.org/10.1016/S0091-6749(86)80120-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A0899	3080512				2022-12-18	WOS:A1986A089900018
J	BUCKLEY, CE; LARRICK, JW; KAPLAN, JE				BUCKLEY, CE; LARRICK, JW; KAPLAN, JE			POPULATION DIFFERENCES IN CUTANEOUS METHACHOLINE REACTIVITY AND CIRCULATING IGE CONCENTRATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									DUKE UNIV,DEPT MED,DURHAM,NC 27706; DUKE UNIV,DEPT MICROBIOL IMMUNOL,DURHAM,NC 27706; CETUS IMMUNE RES LABS,PALO ALTO,CA; UNIV NEW MEXICO,SCH MED,ALBUQUERQUE,NM 87131	Duke University; Duke University; University of New Mexico					NIGMS NIH HHS [GM-07171] Funding Source: Medline; PHS HHS [LI-000422] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUCKLEY CE, 1982, J ALLERGY CLIN IMMUN, V69, P25, DOI 10.1016/0091-6749(82)90083-5; BUCKLEY CE, 1984, ZINSSER TXB MICROBIO; BUCKLEY RH, 1975, J CLIN INVEST, V55, P157, DOI 10.1172/JCI107906; Di PALMA JOSEPH R., 1942, AMER HEART JOUR, V23, P377, DOI 10.1016/S0002-8703(42)90616-1; FOX RH, 1963, BRIT MED BULL, V19, P110, DOI 10.1093/oxfordjournals.bmb.a070027; GLEICH GJ, 1977, J ALLERGY CLIN IMMUN, V60, P188, DOI 10.1016/0091-6749(77)90123-3; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P261, DOI 10.1016/0091-6749(82)90062-8; HASEGAWA M, 1983, CLIN ALLERGY, V13, P277, DOI 10.1111/j.1365-2222.1983.tb02599.x; ISHIZAKA K, 1967, J IMMUNOL, V99, P1187; KALINER M, 1982, ANN INTERN MED, V96, P349, DOI 10.7326/0003-4819-96-3-349; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P319, DOI 10.1016/0091-6749(81)90158-5; KAPLAN JE, 1980, AM J TROP MED HYG, V29, P1012, DOI 10.4269/ajtmh.1980.29.1012; KAPLAN JE, 1980, AM J TROP MED HYG, V29, P298, DOI 10.4269/ajtmh.1980.29.298; LARRICK JW, 1983, J ALLERGY CLIN IMMUN, V71, P184, DOI 10.1016/0091-6749(83)90097-0; LARRICK JW, 1985, AM J PHYS ANTHROPOL, V66, P445, DOI 10.1002/ajpa.1330660412; LARRICK JW, 1979, MED ANTHR, V3, P174; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P472, DOI 10.1172/JCI107204; LYNCH NR, 1984, J ALLERGY CLIN IMMUN, V73, P229, DOI 10.1016/S0091-6749(84)80012-3; MATHER K, 1947, STATISTICAL ANAL BIO; MERRETT TG, 1976, CLIN ALLERGY, V6, P131, DOI 10.1111/j.1365-2222.1976.tb01890.x; PETRY R, 1984, Journal of Allergy and Clinical Immunology, V73, P184; SMITH CAB, 1969, BIOMATHEMATICS, V2, P451; TAYLORIDE D, 1979, J I MED NEPAL, V1, P135	23	11	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1985	76	6					847	854		10.1016/0091-6749(85)90759-6	http://dx.doi.org/10.1016/0091-6749(85)90759-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AWX93	4067133				2022-12-18	WOS:A1985AWX9300015
J	ADLER, TR; BEALL, GN; HEINER, DC; SABHARWAL, UK; SWANSON, K				ADLER, TR; BEALL, GN; HEINER, DC; SABHARWAL, UK; SWANSON, K			IMMUNOLOGICAL AND CLINICAL CORRELATES OF BRONCHIAL CHALLENGE RESPONSES TO BERMUDA GRASS-POLLEN EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT MED,1000 W CARSON ST,TORRANCE,CA 90509; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,TORRANCE,CA 90509; UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA								AALBERSE RC, 1983, J IMMUNOL, V130, P722; BECK CS, 1981, AM REV RESPIR DIS, V124, P94; BOOTH S, 1965, ARCH ENVIRON HEALTH, V10, P152, DOI 10.1080/00039896.1965.10663974; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; BRUCE CA, 1975, J ALLERGY CLIN IMMUN, V56, P331, DOI 10.1016/0091-6749(75)90126-8; BRYANT D H, 1975, Clinical Allergy, V5, P145, DOI 10.1111/j.1365-2222.1975.tb01847.x; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; COCKCROFT DW, 1979, AM REV RESPIR DIS, V120, P1053; DEVEY ME, 1976, CLIN ALLERGY, V6, P227, DOI 10.1111/j.1365-2222.1976.tb01901.x; GWYNN CM, 1982, LANCET, V1, P254; KLAUSTERMEYER WB, 1980, ANN ALLERGY, V45, P338; LEE WY, 1978, J IMMUNOL METHODS, V20, P185, DOI 10.1016/0022-1759(78)90255-7; NATHAN RA, 1979, J ALLERGY CLIN IMMUN, V64, P491, DOI 10.1016/0091-6749(79)90058-7; NEIJENS HJ, 1979, J ALLERGY CLIN IMMUN, V64, P507, DOI 10.1016/0091-6749(79)90060-5; PLATTSMILLS TAE, 1982, LANCET, V2, P675; SHACKS S, 1982, CLIN RES, V30, P127; SHAKIB F, 1980, RES CLIN LAB, V10, P463, DOI 10.1007/BF02938793; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; VANDERGIESSEN M, 1976, INT ARCH ALLER A IMM, V50, P625, DOI 10.1159/000231566; VANTOORENENBERGEN AW, 1982, INT ARCH ALLER A IMM, V67, P117, DOI 10.1159/000233000; VANTOORENENBERGEN AW, 1981, INT ARCH ALLER A IMM, V65, P432, DOI 10.1159/000232784; VIJAY HM, 1977, INT ARCH ALLER A IMM, V53, P78, DOI 10.1159/000231734	22	11	12	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					31	36		10.1016/0091-6749(85)90008-9	http://dx.doi.org/10.1016/0091-6749(85)90008-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ABF26	3871447				2022-12-18	WOS:A1985ABF2600004
J	ATKINS, PC; ZWEIMAN, B				ATKINS, PC; ZWEIMAN, B			BRONCHIAL-ASTHMA - WHAT ARE THOSE INFLAMMATORY CELLS DOING THERE ANYWAY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									UNIV PENN, MED & NEUROL, PHILADELPHIA, PA 19104 USA	University of Pennsylvania	ATKINS, PC (corresponding author), UNIV PENN, MED, PHILADELPHIA, PA 19104 USA.							ATKINS P, 1973, J ALLERGY CLIN IMMUN, V51, P263, DOI 10.1016/0091-6749(73)90128-0; ATKINS PC, 1979, J ALLERGY CLIN IMMUN, V64, P251, DOI 10.1016/0091-6749(79)90140-4; ATKINS PC, 1978, J ALLERGY CLIN IMMUN, V62, P149, DOI 10.1016/0091-6749(78)90099-4; ATKINS PC, 1980, J ALLERGY CLIN IMMUN, V66, P478, DOI 10.1016/0091-6749(80)90009-3; ATKINS PC, 1977, ANN INTERN MED, V86, P415, DOI 10.7326/0003-4819-86-4-415; ATKINS PC, 1984, J ALLERGY CLIN IMMUN, V73, P341, DOI 10.1016/0091-6749(84)90406-8; BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249; COHEN AB, 1982, AM REV RESPIR DIS, V126, P241; DURHAM SR, 1984, J ALLERGY CLIN IMMUN, V74, P49, DOI 10.1016/0091-6749(84)90086-1; FABBRI LM, 1984, AM REV RESPIR DIS, V129, P288; GALLIN JI, 1984, CLIN RES, V32, P320; JOSEPH M, 1983, J CLIN INVEST, V71, P221, DOI 10.1172/JCI110762; KAY AB, 1979, CLIN EXP IMMUNOL, V38, P294; MELEWICZ FM, 1981, J IMMUNOL, V126, P1592; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; NARASBHAT K, 1976, J ALLERGY CLIN IMMUN, V58, P647, DOI 10.1016/0091-6749(76)90176-7; PAPAGEORGIOU N, 1983, LANCET, V2, P1220; SANDER DN, 1984, J IMMUNOL, V132, P828; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; WARD PA, 1968, J EXP MED, V128, P1201, DOI 10.1084/jem.128.5.1201	20	11	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	2					239	241		10.1016/0091-6749(85)90052-1	http://dx.doi.org/10.1016/0091-6749(85)90052-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ABZ05	3155762				2022-12-18	WOS:A1985ABZ0500002
J	BUCKLEY, CE; SALTZMAN, HA; SIEKER, HO				BUCKLEY, CE; SALTZMAN, HA; SIEKER, HO			THE PREVALENCE AND DEGREE OF SENSITIVITY TO INGESTED SULFITES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					144	144		10.1016/0091-6749(85)90294-5	http://dx.doi.org/10.1016/0091-6749(85)90294-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200159
J	ENANDER, I; AHLSTEDT, S; NYGREN, H				ENANDER, I; AHLSTEDT, S; NYGREN, H			REGIONAL AND SYSTEMIC IMMUNE-RESPONSES TO TRINITROPHENYL DERIVATIVES AFTER INTRANASAL AND SUBCUTANEOUS SENSITIZATION OF MICE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									PHARMACIA DIAGNOST AB,EXPTL ALLERGY RES,BOX 17,S-75103 UPPSALA 1,SWEDEN; GOTHENBURG UNIV,DEPT CLIN IMMUNOL,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT HISTOL,S-41124 GOTHENBURG,SWEDEN	Pfizer; Pharmacia Corporation; University of Gothenburg; University of Gothenburg								AHLSTEDT S, 1983, INT ARCH ALLER A IMM, V71, P293, DOI 10.1159/000233410; AHLSTEDT S, 1983, INT ARCH ALLER A IMM, V72, P71, DOI 10.1159/000234843; AHLSTEDT S, 1978, SCAND J IMMUNOL   S7, V8, P119; BEFUS AD, 1982, PROG ALLERGY, V31, P76; BENACERRAF B, 1959, IMMUNOLOGY, V2, P53; DENBURG JA, 1980, J CLIN INVEST, V65, P390, DOI 10.1172/JCI109682; DIJKMAN JH, 1981, INT ARCH ALLER A IMM, V64, P422, DOI 10.1159/000232722; ENANDER I, 1983, INT ARCH ALLER A IMM, V72, P59, DOI 10.1159/000234841; ENANDER I, 1984, IMMUNOLOGY, V51, P661; HAIG DM, 1982, NATURE, V300, P188, DOI 10.1038/300188a0; JONES R, 1978, LAB INVEST, V39, P41; KAROL MH, 1980, TOXICOL APPL PHARM, V53, P260, DOI 10.1016/0041-008X(80)90425-1; KRAMPS JA, 1981, INT ARCH ALLER A IMM, V64, P428, DOI 10.1159/000232723; MILLER HRP, 1979, INT ARCH ALLER A IMM, V59, P281, DOI 10.1159/000232271; PEPYS J, 1972, Clinical Allergy, V2, P225, DOI 10.1111/j.1365-2222.1972.tb01287.x; SCHATZ M, 1977, J ALLERGY CLIN IMMUN, V60, P27, DOI 10.1016/0091-6749(77)90079-3; THOMAS WR, 1978, IMMUNOLOGY, V35, P673; WATANABE S, 1974, LAB INVEST, V31, P555; WLODARSKI K, 1973, IMMUNOLOGY, V24, P47	19	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					37	43		10.1016/0091-6749(85)90009-0	http://dx.doi.org/10.1016/0091-6749(85)90009-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ABF26	3968326				2022-12-18	WOS:A1985ABF2600005
J	HARTLEY, TF; LIEBERMAN, PL; MELTZER, EO; NOYES, JN; PEARLMAN, DS; TINKELMAN, DG				HARTLEY, TF; LIEBERMAN, PL; MELTZER, EO; NOYES, JN; PEARLMAN, DS; TINKELMAN, DG			EFFICACY AND TOLERANCE OF FLUOCORTIN-BUTYL ADMINISTERED TWICE DAILY IN ADULT PATIENTS WITH PERENNIAL RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		ARBESMAN C, 1983, J ALLERGY CLIN IMMUN, V71, P597, DOI 10.1016/0091-6749(83)90442-6; BHARGAVA AS, 1978, ARZNEIMITTEL-FORSCH, V28-2, P1638; BLAISS MS, 1982, ANN ALLERGY, V48, P210; CHAPLIN MD, 1980, CLIN PHARMACOL THER, V27, P402, DOI 10.1038/clpt.1980.54; CHAPLIN MD, 1980, J ALLERGY CLIN IMMUN, V65, P445, DOI 10.1016/0091-6749(80)90238-9; Gunzel P, 1977, Arzneimittelforschung, V27, P2217; HARRIS DM, 1975, POSTGRAD MED J, V51, P20; HORAK F, 1982, ANN ALLERGY, V48, P305; Kapp J F, 1977, Arzneimittelforschung, V27, P2191; KAPP JF, 1982, N ENGL SOC ALLERGY P, V3, P482; MARTIN LE, 1974, CLIN PHARMACOL THER, V15, P267; MARTIN LE, 1975, POSTGRAD MED J S4, V52, P11; MICHELS MI, 1967, ANN ALLERGY, V25, P569; MILLER RG, 1980, SIMULTANEOUS STATIST, P67; MYGIND N, 1973, ACTA ALLERGOL, V28, P211, DOI 10.1111/j.1398-9995.1973.tb01327.x; NETER J, 1974, APPLIED LINEAR STATI, P685; NORMAN PS, 1967, J ALLERGY, V40, P57, DOI 10.1016/0021-8707(67)90060-3; RHOADES RB, 1980, J ALLERGY CLIN IMMUN, V65, P218; SHERMAN B, 1982, J ALLERGY CLIN IMMUN, V69, P208, DOI 10.1016/0091-6749(82)90101-4; THORN GW, 1948, JAMA-J AM MED ASSOC, V137, P1005, DOI 10.1001/jama.1948.02890460001001; VAZ R, 1982, J PEDIATR-US, V100, P660, DOI 10.1016/S0022-3476(82)80781-6; VLASSES PH, 1981, CLIN PHARMACOL THER, V29, P643, DOI 10.1038/clpt.1981.89; WYATT R, 1978, NEW ENGL J MED, V299, P1387, DOI 10.1056/NEJM197812212992504; 1980, INVESTIGATORS BROCHU	24	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	4					501	507		10.1016/S0091-6749(85)80024-5	http://dx.doi.org/10.1016/S0091-6749(85)80024-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AFY44	3884690				2022-12-18	WOS:A1985AFY4400011
J	LAFORCE, C; DAVIS, V				LAFORCE, C; DAVIS, V			NASAL SEPTAL PERFORATION IN PATIENTS USING INTRANASAL BECLOMETHASONE DEPROPIONATE (BDP)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					186	186		10.1016/0091-6749(85)90461-0	http://dx.doi.org/10.1016/0091-6749(85)90461-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200326
J	GODFREY, S				GODFREY, S			INTERNATIONAL-SYMPOSIUM ON SPECIAL PROBLEMS AND MANAGEMENT OF ALLERGIC ATHLETES - JANUARY 13-14, 1984 - PALM-SPRINGS, CALIFORNIA - INTRODUCTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											GODFREY, S (corresponding author), HADASSAH UNIV HOSP,DEPT PEDIAT,IL-91120 JERUSALEM,ISRAEL.							ANDERSON SD, 1982, EUR J RESPIR DIS, V63, P459; BAROR O, 1977, J ALLERGY CLIN IMMUN, V60, P163, DOI 10.1016/0091-6749(77)90119-1; BARYISHAY E, 1983, AM REV RESPIR DIS, V127, P572, DOI 10.1164/arrd.1983.127.5.572; BENDOV I, 1982, AM REV RESPIR DIS, V125, P530, DOI 10.1164/arrd.1982.125.5.530; BENDOV I, 1983, THORAX, V38, P584, DOI 10.1136/thx.38.8.584; BENDOV I, ISR J MED SCI; CHEN WY, 1977, RESPIRATION, V34, P305, DOI 10.1159/000193842; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; DEAL EC, 1979, J APPL PHYSIOL, V46, P484, DOI 10.1152/jappl.1979.46.3.484; DEAL EC, 1979, J APPL PHYSIOL, V46, P467, DOI 10.1152/jappl.1979.46.3.467; DEAL EC, 1979, J APPL PHYSIOL, V46, P476, DOI 10.1152/jappl.1979.46.3.476; DENDOV I, 1982, THORAX, V37, P730; EDMUNDS AT, 1978, AM REV RESPIR DIS, V117, P247; FITCH KD, 1976, JAMA-J AM MED ASSOC, V236, P152, DOI 10.1001/jama.236.2.152; HENRIKSEN JM, 1981, ALLERGY, V36, P463, DOI 10.1111/j.1398-9995.1981.tb01857.x; LIPIN I, THORAX; SILVERMAN M, 1972, ARCH DIS CHILD, V47, P419, DOI 10.1136/adc.47.253.419; WEINSTEIN RE, 1976, J ALLERGY CLIN IMMUN, V57, P250; WILSON NM, 1982, THORAX, V37, P657, DOI 10.1136/thx.37.9.657	19	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					630	633		10.1016/0091-6749(84)90295-1	http://dx.doi.org/10.1016/0091-6749(84)90295-1			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS046	6715728				2022-12-18	WOS:A1984SS04600002
J	GRAMMER, LC; PATTERSON, R				GRAMMER, LC; PATTERSON, R			PROTEINS - CHYMOPAPAIN AND INSULIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											GRAMMER, LC (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611, USA.			Grammer, Leslie/0000-0001-6860-2014	NIAID NIH HHS [AI 11403] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOOTH BH, 1980, ALLERGIC DISEASES DI, P88; DESWARTE RD, 1980, ALLERGIC DISEASES, P568; DRENTH J, 1968, NATURE, V218, P929, DOI 10.1038/218929a0; FALHOLT K, 1982, 11TH C INT DIAB FED, V11, P58; FINEBERG SE, 1982, DIABETES CARE, V5, P107; FIREMAN P, 1982, DIABETES CARE, V5, P119, DOI 10.2337/diacare.5.2.S119; GALLOWAY JA, 1978, MED CLIN N AM, V62, P663, DOI 10.1016/S0025-7125(16)31764-3; GOODMAN JW, 1980, BASIC CLIN IMMUNOLOG, P44; GRAMMER LC, 1983, J ALLERGY CLIN IMMUN, V71, P250, DOI 10.1016/0091-6749(83)90107-0; GREENBERGER PA, 1981, J ALLERGY CLIN IMMUN, V67, P185, DOI 10.1016/0091-6749(81)90059-2; HENNESSY J, 1983, JAMA, V249, P328; LANCASTER H, 1983, WALL STREET J   0425, P27; MATTSON JR, 1975, ARCH INTERN MED, V135, P818, DOI 10.1001/archinte.135.6.818; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; PATTERSON R, 1969, J IMMUNOL, V103, P1061; REAVES ML, 1982, INSULIN UPDATE, P295; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WILLIS J, 1982, FDA DRUG B, V12, P17	19	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	4					635	640		10.1016/0091-6749(84)90118-0	http://dx.doi.org/10.1016/0091-6749(84)90118-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ163	6386938				2022-12-18	WOS:A1984TQ16300015
J	KRAGBALLE, K; VOORHEES, JJ				KRAGBALLE, K; VOORHEES, JJ			MODULATION OF EPIDERMAL-CELL DIVISION AND GROWTH BY OXYGENATION PRODUCTS OF ARACHIDONIC-ACID	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											KRAGBALLE, K (corresponding author), UNIV MICHIGAN,SCH MED,DEPT DERMATOL,ANN ARBOR,MI 48109, USA.							ALLEN BR, 1982, BRIT MED J, V285, P1241, DOI 10.1136/bmj.285.6350.1241; BARR RM, 1983, J INVEST DERMATOL, V80, P345; BRAIN SD, 1982, J INVEST DERMATOL, V78, P328; BRAIN SD, 1982, LANCET, V2, P762; BRAIN SD, 1984, BRIT J CLIN PHARMACO, V17, pP650; BRAIN SD, BR J CLIN PHARM; CAMP RDR, 1983, PROSTAGLANDINS, V26, P431, DOI 10.1016/0090-6980(83)90178-8; DOWD PM, 1983, BRIT J DERMATOL, V109, P693; EAGLSTEIN WH, 1975, J INVEST DERMATOL, V64, P386, DOI 10.1111/1523-1747.ep12512322; ELLIS CN, 1983, J INVEST DERMATOL, V80, P362; FORSTER, 1983, BRIT J DERMATOL, V108, P103; FURSTENBERGER G, 1981, CANCER LETT, V11, P191, DOI 10.1016/0304-3835(81)90107-5; FURSTENBERGER G, 1979, RES COMMUN CHEM PATH, V24, P533; FURSTENBERGER G, 1980, BIOCHEM BIOPH RES CO, V92, P749, DOI 10.1016/0006-291X(80)90767-6; HAMMARSTROM S, 1975, P NATL ACAD SCI USA, V72, P5130, DOI 10.1073/pnas.72.12.5130; KATAYAMA H, 1981, Journal of Dermatology (Tokyo), V8, P323; KRAGBALLE K, 1984, J INVEST DERMATOL, V82, P398; KRAGBALLE K, 1983, ARCH DERMATOL, V119, P548, DOI 10.1001/archderm.119.7.548; KRAGBALLE K, UNPUB IMPROVEMENT PS; LOWE NJ, 1977, J INVEST DERMATOL, V68, P134, DOI 10.1111/1523-1747.ep12492448; MARKS F, 1981, CANCER RES, V41, P696; MARKS F, 1983, CARCINOGENESIS, V11, P1465; MISCH K, BR J DERMATOL; RESHAD H, 1983, BRIT J DERMATOL, V108, P111; SALARI H, PROSTAGLANDINS LEUKO; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; ZIBOH VA, 1983, J INVEST DERMATOL, V80, P359	27	11	11	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					426	429		10.1016/0091-6749(84)90142-8	http://dx.doi.org/10.1016/0091-6749(84)90142-8			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ633	6432884				2022-12-18	WOS:A1984TQ63300022
J	NAGANO, T; KANAO, K; SUGAI, T				NAGANO, T; KANAO, K; SUGAI, T			ALLERGIC CONTACT URTICARIA CAUSED BY RAW PRAWNS AND SHRIMPS - 3 CASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUMITOMO HOSP,DIV RADIOISOTOPE,OSAKA,JAPAN; OSAKA KAISEI HOSP,DEPT DERMATOL,OSAKA,JAPAN	Sumitomo Hospital	NAGANO, T (corresponding author), NAGANO DERMATOL CLIN,1-2-3 SUEHIRO CHO,TOYONAKA,OSAKA 560,JAPAN.							Hjorth N, 1976, Contact Dermatitis, V2, P28, DOI 10.1111/j.1600-0536.1976.tb02975.x; MAIBACH HI, 1975, ARCH DERMATOL, V111, P726, DOI 10.1001/archderm.111.6.726; Nagano T, 1982, Arerugi, V31, P46; NAGANO T, 1981, SKIN RES HIFU, V23, P544; von Krogh G, 1982, SEMIN DERMATOL, V1, P59; WATANABE K, 1980, SKIN RES HIFU, V22, P293; WIDE L, 1967, LANCET, V2, P1105	7	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	4					489	493		10.1016/0091-6749(84)90383-X	http://dx.doi.org/10.1016/0091-6749(84)90383-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TN620	6491094				2022-12-18	WOS:A1984TN62000005
J	AHMED, T; KING, MM; KRAINSON, JP				AHMED, T; KING, MM; KRAINSON, JP			MODIFICATION OF AIRWAY HISTAMINE-RECEPTOR FUNCTION WITH METHYLPREDNISOLONE SUCCINATE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											AHMED, T (corresponding author), MT SINAI MED CTR,DEPT MED,DIV PULM DIS,MIAMI BEACH,FL 33140, USA.				NHLBI NIH HHS [HL 27798] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHMED T, 1982, J APPL PHYSIOL, V53, P175, DOI 10.1152/jappl.1982.53.1.175; AHMED T, 1980, J APPL PHYSIOL, V49, P826, DOI 10.1152/jappl.1980.49.5.826; AHMED T, UNPUB FUNCTIONAL DEP; ARUNLAKSHANA O, 1954, J PHYSIOL-LONDON, V123, P32, DOI 10.1113/jphysiol.1954.sp005032; ASH ASF, 1966, BRIT J PHARM CHEMOTH, V27, P427, DOI 10.1111/j.1476-5381.1966.tb01674.x; BLACK JW, 1972, NATURE, V236, P385, DOI 10.1038/236385a0; BRIGHAM KL, 1981, J CLIN INVEST, V67, P1103, DOI 10.1172/JCI110123; CLAMAN HN, 1975, J ALLERGY CLIN IMMUN, V55, P145, DOI 10.1016/0091-6749(75)90010-X; EYRE P, 1977, ASTHMA PHYSL IMMUNOP, P169; MILICEMILI JJ, 1964, J APPL PHYSIOL, V19, P201; PARKER CW, 1973, J CLIN INVEST, V52, P1342, DOI 10.1172/JCI107306; RUSSOMARIE F, 1981, CLIN RES PROC, V17, P587; SCHLEIMER RP, 1981, NATURE, V292, P454, DOI 10.1038/292454a0; SCHMUTZLER W, 1975, INT ARCH ALLER A IMM, V49, P209, DOI 10.1159/000231396; TOWNLEY RG, 1970, J ALLERGY, V45, P118	15	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	2					224	229		10.1016/0091-6749(83)90103-3	http://dx.doi.org/10.1016/0091-6749(83)90103-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QC188	6337199				2022-12-18	WOS:A1983QC18800008
J	BERNSTEIN, DI; ZEISS, CR; WOLKONSKY, P; LEVITZ, D; ROBERTS, M; PATTERSON, R				BERNSTEIN, DI; ZEISS, CR; WOLKONSKY, P; LEVITZ, D; ROBERTS, M; PATTERSON, R			THE RELATIONSHIP OF TOTAL SERUM IGE AND BLOCKING ANTIBODY IN TRIMELLITIC ANHYDRIDE INDUCED OCCUPATIONAL ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM LAKESIDE MED CTR,ACOS RES,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611; STAND OIL CO,FORT WAYNE,IN	Northwestern University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMAD D, 1979, LANCET, V2, P326; BERG T, 1969, INT ARCH ALLER A IMM, V36, P219, DOI 10.1159/000230745; BERNSTEIN DI, 1982, J ALLERGY CLIN IMMUN, V69, P311, DOI 10.1016/S0091-6749(82)80009-2; BERNSTEIN IL, 1981, CLIN CHEST MED, V2, P255; CROMWELL O, 1979, CLIN ALLERGY, V9, P109, DOI 10.1111/j.1365-2222.1979.tb01529.x; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; JOHANSSON SGO, 1981, CLIN IMMUNOLOGY UPDA, P123; LIDD D, 1962, J ALLERGY, V33, P45, DOI 10.1016/0021-8707(62)90062-X; PATTERSON R, 1981, INT ARCH ALLER A IMM, V66, P332, DOI 10.1159/000232838; PATTERSON R, 1973, Journal of Immunology, V110, P1135; PATTERSON R, 1979, AM REV RESPIR DIS, V120, P1259; PATTERSON R, 1973, AM J MED, V54, P16, DOI 10.1016/0002-9343(73)90078-8; PATTERSON R, 1978, J CLIN INVEST, V62, P971, DOI 10.1172/JCI109226; SALE SR, 1981, J ALLERGY CLIN IMMUN, V68, P188, DOI 10.1016/0091-6749(81)90182-2; WANG JLF, 1978, AM REV RESPIR DIS, V117, P917; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZEISS CR, 1980, INT ARCH ALLER A IMM, V61, P380; ZEISS CR, 1982, J ALLERGY CLIN IMMUN, V70, P15, DOI 10.1016/0091-6749(82)90195-6	18	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	6					714	719		10.1016/0091-6749(83)90635-8	http://dx.doi.org/10.1016/0091-6749(83)90635-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RW048	6643876				2022-12-18	WOS:A1983RW04800014
J	CREER, TL				CREER, TL			SELF-MANAGEMENT PSYCHOLOGY AND THE TREATMENT OF CHILDHOOD ASTHMA - RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											CREER, TL (corresponding author), OHIO UNIV,DEPT PSYCHOL,ATHENS,OH 45701, USA.							ATKINS CJ, UNPUB BEHAVIORAL PRO; Bandura A., 1977, SOCIAL LEARNING THEO; CHAI H, 1968, J ALLERGY, V41, P23, DOI 10.1016/0021-8707(68)90005-1; CREER TL, ALLERGY PRINCIPLES P; CREER TL, 1982, BEHAVIORAL PEDIATRIC; HARM D, UNPUB IMPROVING ABIL; LUPARELLO T, 1968, PSYCHOSOM MED, V30, P819, DOI 10.1097/00006842-196811000-00002; PATTERSON GR, 1969, BEHAVIOR THERAPY APP; RENNE CM, UNPUB LATENCY SEEKIN; RUBINFELD AR, 1976, LANCET, V1, P882; TAPLIN PS, 1978, J ASTHMA RES, V16, P15, DOI 10.3109/02770907809106608	11	11	11	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	5					607	610		10.1016/0091-6749(83)90488-8	http://dx.doi.org/10.1016/0091-6749(83)90488-8			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	RS163	6643868				2022-12-18	WOS:A1983RS16300014
J	JUNIPER, EF; OCONNOR, J; ROBERTS, RS; HARGREAVE, FE				JUNIPER, EF; OCONNOR, J; ROBERTS, RS; HARGREAVE, FE			A 2 YEAR STUDY OF PEGALGEN (A POLYETHYLENE-GLYCOL MODIFIED RAGWEED EXTRACT) IN RAGWEED RHINOCONJUNCTIVITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					119	119		10.1016/0091-6749(83)90247-6	http://dx.doi.org/10.1016/0091-6749(83)90247-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200124
J	PATTERSON, R; SUSZKO, IM; GRAMMER, LC; SHAUGHNESSY, MA				PATTERSON, R; SUSZKO, IM; GRAMMER, LC; SHAUGHNESSY, MA			POLYMERIZATION OF INDIVIDUAL-SPECIES OF GRASS-POLLEN ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PATTERSON, R (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611, USA.			Grammer, Leslie/0000-0001-6860-2014	NIAID NIH HHS [AI 11403] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BACAL E, 1978, J ALLERGY CLIN IMMUN, V62, P289, DOI 10.1016/0091-6749(78)90160-4; GRAMMER LC, 1982, J ALLERGY CLIN IMMUN, V69, P494, DOI 10.1016/0091-6749(82)90173-7; GRAMMER LC, J ALLERGY CLIN IMMUN; HENDRIX SG, 1980, J ALLERGY CLIN IMMUN, V66, P486, DOI 10.1016/0091-6749(80)90010-X; HENDRIX SG, 1982, J CLIN IMMUNOL, V2, P10, DOI 10.1007/BF00915972; KELLY JF, 1980, J ALLERGY CLIN IMMUN, V65, P50, DOI 10.1016/0091-6749(80)90176-1; PATTERSON R, 1981, INT ARCH ALLER A IMM, V66, P332, DOI 10.1159/000232838; PATTERSON R, 1978, J ALLERGY CLIN IMMUN, V61, P28, DOI 10.1016/0091-6749(78)90470-0; PATTERSON R, 1977, J ALLERGY CLIN IMMUN, V59, P314, DOI 10.1016/0091-6749(77)90053-7; PATTERSON R, 1981, J ALLERGY CLIN IMMUN, V67, P162, DOI 10.1016/0091-6749(81)90013-0; PATTERSON R, 1981, J ALLERGY CLIN IMMUN, V68, P85, DOI 10.1016/0091-6749(81)90163-9; PATTERSON R, 1973, J IMMUNOL, V110, P1413; PATTERSON R, 1972, ALLERGIC DISEASES DI	13	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	2					129	133		10.1016/0091-6749(83)90519-5	http://dx.doi.org/10.1016/0091-6749(83)90519-5			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RD959	6193158				2022-12-18	WOS:A1983RD95900004
J	SCHUBERTH, KC; GRAFT, DF; KAGEYSOBOTKA, A; KWITEROVICH, KA; SZKLO, M; LICHTENSTEIN, LM; VALENTINE, MD				SCHUBERTH, KC; GRAFT, DF; KAGEYSOBOTKA, A; KWITEROVICH, KA; SZKLO, M; LICHTENSTEIN, LM; VALENTINE, MD			DO ALL CHILDREN WITH INSECT ALLERGY NEED VENOM THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					140	140		10.1016/0091-6749(83)90332-9	http://dx.doi.org/10.1016/0091-6749(83)90332-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200209
J	SHERMAN, NA; MORRIS, HG				SHERMAN, NA; MORRIS, HG			ASPIRIN-INDUCED SHIFT IN THE METABOLISM OF ARACHIDONIC-ACID	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NATL JEWISH HOSP & RES CTR,DENVER,CO 80206	National Jewish Health									0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					153	153		10.1016/0091-6749(83)90382-2	http://dx.doi.org/10.1016/0091-6749(83)90382-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200259
J	LEE, ML				LEE, ML			GLUCAGON IN ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											LEE, ML (corresponding author), GEISINGER MED CTR,DEPT ALLERGY IMMUNOL & INFECT DIS,DANVILLE,PA 17821, USA.							ILLINGWORTH RN, 1980, LANCET, V2, P86; JACOBS RL, 1981, J ALLERGY CLIN IMMUN, V68, P125, DOI 10.1016/0091-6749(81)90170-6; KOSINSKI EJ, 1971, NEW ENGL J MED, V285, P1325; KOSINSKI EJ, 1973, ARCH INTERN MED, V132, P840, DOI 10.1001/archinte.132.6.840; PARMLEY WW, 1971, NEW ENGL J MED, V285, P801, DOI 10.1056/NEJM197109302851414	5	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	3					331	331		10.1016/S0091-6749(82)80012-2	http://dx.doi.org/10.1016/S0091-6749(82)80012-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NF697	7061775	Bronze			2022-12-18	WOS:A1982NF69700012
J	NORMAN, PS				NORMAN, PS			QUALITY-CONTROL OF ALLERGEN EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									JOHNS HOPKINS UNIV,DEPT MED,DIV CLIN IMMUNOL,BALTIMORE,MD 21239	Johns Hopkins University	NORMAN, PS (corresponding author), GOOD SAMARITAN HOSP,DEPT MED,DIV CLIN IMMUNOL,BALTIMORE,MD 21239, USA.								0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	1					1	2		10.1016/0091-6749(82)90079-3	http://dx.doi.org/10.1016/0091-6749(82)90079-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ377	7033327				2022-12-18	WOS:A1982MZ37700001
J	BUSSE, WW; ANDERSON, CL				BUSSE, WW; ANDERSON, CL			THE GRANULOCYTE RESPONSE TO THE PHOSPHODIESTERASE INHIBITOR RO 20-1724 IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											BUSSE, WW (corresponding author), UNIV WISCONSIN,CTR CLIN SCI,MADISON,WI 53792, USA.				NIAID NIH HHS [AI 00343, AI 10404, AI 15685] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI010404, R01AI015685] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BROOKS SM, 1979, J ALLERGY CLIN IMMUN, V63, P401, DOI 10.1016/0091-6749(79)90213-6; BROWN BL, 1971, BIOCHEM J, V121, P561, DOI 10.1042/bj1210561; BUSSE WW, 1976, J ALLERGY CLIN IMMUN, V58, P586, DOI 10.1016/0091-6749(76)90205-0; BUSSE WW, 1977, J CLIN INVEST, V59, P1080, DOI 10.1172/JCI108731; BUSSE WW, 1977, AM REV RESPIR DIS, V115, P783; BUSSE WW, 1979, J INVEST DERMATOL, V73, P184, DOI 10.1111/1523-1747.ep12581674; FISHMAN WH, 1967, CLIN CHIM ACTA, V15, P435, DOI 10.1016/0009-8981(67)90008-3; GALANT SP, 1980, J CLIN INVEST, V65, P577, DOI 10.1172/JCI109702; HENSON P, 1974, J IMMUNOL, V107, P1535; IGNARRO LJ, 1973, SCIENCE, V180, P1181, DOI 10.1126/science.180.4091.1181; KARIMAN K, 1977, CLIN RES, V25, pA503; LEE TP, 1977, J ALLERGY CLIN IMMUN, V59, P408, DOI 10.1016/0091-6749(77)90002-1; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; REED CE, 1974, J ALLERGY CLIN IMMUN, V53, P34, DOI 10.1016/0091-6749(74)90097-9; RUOHO AE, 1980, J ALLERGY CLIN IMMUN, V66, P46, DOI 10.1016/0091-6749(80)90137-2; SHEPPARD H, 1973, P235; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; WEISSMANN G, 1971, J EXP MED, V134, pS149; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550; ZURIER RB, 1973, P NATL ACAD SCI USA, V70, P844, DOI 10.1073/pnas.70.3.844	22	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	1					70	74		10.1016/0091-6749(81)90048-8	http://dx.doi.org/10.1016/0091-6749(81)90048-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KZ173	6256424				2022-12-18	WOS:A1981KZ17300013
J	FREEDMAN, PM; AULT, B; ZEISS, CR; TREUHAFT, MW; ROBERTS, RC; EMANUEL, DA; BALDAUF, MC; MARX, JJ				FREEDMAN, PM; AULT, B; ZEISS, CR; TREUHAFT, MW; ROBERTS, RC; EMANUEL, DA; BALDAUF, MC; MARX, JJ			SKIN TESTING IN FARMERS LUNG-DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MARSHFIELD MED FDN INC,DEPT ALLERGY,510 N ST JOSEPH AVE,MARSHFIELD,WI 54449; MARSHFIELD CLIN,DEPT CARDIOL,MARSHFIELD,WI 54449; MARSHFIELD CLIN,DEPT PATHOL,MARSHFIELD,WI 54449; NORTHWESTERN UNIV,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611	Marshfield Clinic; Marshfield Clinic; Northwestern University								AUGUSTIN R, 1978, HDB EXPT IMMUNOLOGY; BICE DE, 1977, INT ARCH ALLER A IMM, V55, P267; BRYANT DH, 1975, J ALLERGY CLIN IMMUN, V56, P417, DOI 10.1016/0091-6749(75)90060-3; BRYANT DH, 1976, ASTHMA PHYSL IMMUNOP, P315; COHEN SH, 1979, AM REV RESPIR DIS, V119, P64; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; EDWARDS J H, 1974, Clinical Allergy, V4, P379, DOI 10.1111/j.1365-2222.1974.tb01399.x; FAUX J A, 1971, Clinical Allergy, V1, P149, DOI 10.1111/j.1365-2222.1971.tb03014.x; FINK JN, 1968, ANN INTERN MED, V68, P1205, DOI 10.7326/0003-4819-68-6-1205; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; HARGREAVE FE, 1972, J ALLERGY CLIN IMMUN, V50, P157, DOI 10.1016/0091-6749(72)90047-4; HENSON PM, 1978, IMMUNOLOGY, V2, P310; KARR RM, 1978, CHEST, V74, P98, DOI 10.1378/chest.74.1.98; MARX JJ, 1978, J ALLERGY CLIN IMMUN, V62, P185, DOI 10.1016/0091-6749(78)90105-7; MARX JJ, 1979, FED PROC, V38, P941; MARX JJ, 1980, INT ARCH ALLER A IMM, V62, P133, DOI 10.1159/000232505; PARISH W E, 1971, Clinical Allergy, V1, P369, DOI 10.1111/j.1365-2222.1971.tb00788.x; PARISH W E, 1971, Clinical Allergy, V1, P433, DOI 10.1111/j.1365-2222.1971.tb00794.x; PARISH WE, 1970, LANCET, V2, P591; PARISH WE, 1973, ASTHMA, P74; PARISH WE, 1973, MECHANISMS ALLERGY R, P197; PATTERSON R, 1976, AM REV RESPIR DIS, V114, P315; PATTERSON R, 1976, AM J MED, V60, P144, DOI 10.1016/0002-9343(76)90543-X; PEPYS J, 1965, THORAX, V20, P21, DOI 10.1136/thx.20.1.21; PEPYS J., 1962, THORAX, V17, P366, DOI 10.1136/thx.17.4.366; PEPYS J, 1968, ALLERGOLOGIE, P221; REID RT, 1970, J IMMUNOL, V104, P935; RICHERSON HB, 1979, J ALLERGY CLIN IMMUN, V64, P67, DOI 10.1016/0091-6749(79)90085-X; RICHTER M, 1957, J IMMUNOL, V79, P13; ROBERTS RC, 1976, J ALLERGY CLIN IMMUN, V57, P518, DOI 10.1016/0091-6749(76)90002-6; SCHORLEMMER HU, 1977, CLIN EXP IMMUNOL, V27, P198; SOLLEY GO, 1976, ASTHMA PHYSL IMMUNOP, P283; Staines F H, 1961, J Coll Gen Pract, V4, P351; TERR AI, 1965, J ALLERGY, V36, P433, DOI 10.1016/0021-8707(65)90137-1; TREUHAFT M, UNPUBLISHED; UDAKA K, 1971, INFLAMMATION IMMUNIT, P390; WALKER H, 1969, ELEMENTARY STATISTIC, P265; WENZEL FJ, 1974, AM REV RESPIR DIS, V109, P464; WILLIAMS J. V., 1963, THORAX, V18, P182, DOI 10.1136/thx.18.2.182	39	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	1					51	58		10.1016/0091-6749(81)90045-2	http://dx.doi.org/10.1016/0091-6749(81)90045-2			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KZ173	7451771	Bronze			2022-12-18	WOS:A1981KZ17300010
J	SCHUYLER, MR; BONDAREVSKY, E; SCHWARTZ, HJ; SCHMITT, D				SCHUYLER, MR; BONDAREVSKY, E; SCHWARTZ, HJ; SCHMITT, D			CORTICOSTEROID-SENSITIVE LYMPHOCYTES ARE NORMAL IN ATOPIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH 44106	Case Western Reserve University								CANONICA GW, 1979, J IMMUNOL, V123, P2669; CHIANG JL, 1980, J ALLERGY CLIN IMMUN, V65, P263, DOI 10.1016/0091-6749(80)90153-0; CLOT J, 1979, CLIN ALLERGY, V91, P245; DISCOMBE G, 1946, LANCET, V1, P195; FAUCI AS, 1976, CLIN EXP IMMUNOL, V24, P54; FAUCI AS, 1975, J CLIN INVEST, V55, P22, DOI 10.1172/JCI107914; FAUCI AS, 1975, BLOOD, V46, P235; FAUCI AS, 1974, J CLIN INVEST, V53, P240, DOI 10.1172/JCI107544; FRANCIS RS, 1976, THORAX, V31, P309, DOI 10.1136/thx.31.3.309; Goldstein A., 1964, BIOSTATISTICS INTRO, P55; GUPTA S, 1975, CLIN EXP IMMUNOL, V22, P438; HAHN BH, 1980, J IMMUNOL, V124, P2812; HAYNES B, 1978, J CLIN INVEST, V61, P704; ISHIZAKA K, 1976, ADV IMMUNOL, V23, P1, DOI 10.1016/S0065-2776(08)60318-1; JUTO P, 1979, J ALLERGY CLIN IMMUN, V64, P38, DOI 10.1016/0091-6749(79)90081-2; KOHN BA, 1979, J ALLERGY CLIN IMMUN, V64, P182, DOI 10.1016/0091-6749(79)90093-9; LANG P, 1978, J ALLERGY CLIN IMMUN, V61, P248, DOI 10.1016/0091-6749(78)90199-9; MCGEADY SJ, 1975, J ALLERGY CLIN IMMUN, V56, P393, DOI 10.1016/0091-6749(75)90133-5; MORETTA L, 1977, J EXP MED, V146, P184, DOI 10.1084/jem.146.1.184; NEIBURGER RG, 1978, J ALLERGY CLIN IMMUN, V61, P88, DOI 10.1016/0091-6749(78)90230-0; NORTH RJ, 1972, CELL IMMUNOL, V3, P501, DOI 10.1016/0008-8749(72)90255-9; RACHELEFSKY GS, 1976, J ALLERGY CLIN IMMUN, V57, P569, DOI 10.1016/0091-6749(76)90008-7; ROITMAN B, 1979, J ALLERGY CLIN IMMUN, V63, P199; SARACLAR Y, 1977, J ALLERGY CLIN IMMUN, V61, P301; SAXON A, 1980, J CLIN INVEST, V65, P1457, DOI 10.1172/JCI109810; SCHUSTER DL, 1980, J IMMUNOL, V124, P1662; SCHWARTZ H, 1978, J ALLERGY CLIN IMMUN, V64, P9; STRANNEGARD IL, 1976, INT ARCH ALLER A IMM, V50, P684, DOI 10.1159/000231547; STRANNEGARD IL, 1977, SCAND J IMMUNOL, V6, P1225; STRANNEGARD O, 1978, IMMUNOL REV, V41, P149, DOI 10.1111/j.1600-065X.1978.tb01463.x; TANIGUCHI N, 1977, J IMMUNOL, V118, P193; UNDERWOOD S, 1979, J ALLERGY CLIN IMMUN, V63, P1971; VERHAEGEN H, 1977, J ALLERGY CLIN IMMUN, V59, P266, DOI 10.1016/0091-6749(77)90161-0; YU D, 1974, J CLIN INVEST, V53, P240; 1974, LANCET, V2, P303	35	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	68	1					72	78		10.1016/0091-6749(81)90126-3	http://dx.doi.org/10.1016/0091-6749(81)90126-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LY101	7240601				2022-12-18	WOS:A1981LY10100012
J	TULINSILVER, J; SCHTEINGART, DE; MATHEWS, KP				TULINSILVER, J; SCHTEINGART, DE; MATHEWS, KP			EFFECT OF THEOPHYLLINE ON CORTISOL SECRETION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MICHIGAN,MED CTR,SCH MED,DEPT MED,ALLERGY SECT,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT ENDOCRINOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NCRR NIH HHS [2-MO1-RR00042] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANGELI A, 1974, B SOC ITAL BIOL SPER, V50, P366; CHANEY AL, 1958, URINARY METHODS CLIN, P79; CHRISTY NP, 1971, HUMAN ADRENAL CORTEX, P407; DASH RJ, 1975, STEROIDS, V26, P647, DOI 10.1016/0039-128X(75)90057-4; EDWARDS AL, 1967, STATISTICAL METHODS, P215; Ellis EF, 1978, ALLERGY PRINCIPLES P, P434; ESPINER EA, 1974, ENDOCRINOLOGY, V95, P838, DOI 10.1210/endo-95-3-838; GRAHAMES.DG, 1967, J BIOL CHEM, V242, P5535; JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349; KSHIRSAJAR AH, 1978, MULTIVARIATE ANAL, P161; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; Peterson RR, 1971, HUMAN ADRENAL CORTEX; PIAFSKY KM, 1975, NEW ENGL J MED, V292, P1218, DOI 10.1056/NEJM197506052922305; SCHTEINGART DE, 1963, METABOLISM, V12, P484; SILBER RH, 1954, J BIOL CHEM, V210, P923; SLOTFELDT ML, 1979, AM J HOSP PHARM, V34, P66; SOKAL RR, 1969, INTRO BIOSTATISTICS, P107; SOKAL RS, 1969, INTRO BIOSTATISTICS, P222; VAGUE PH, 1971, EUR J CLIN BIOL RES, V16, P483; WAGNER JG, 1975, FUNDAMENTALS CLIN PH, P72; WILLIAMS GH, 1977, HARRISONS PRINCIPLES, P524	21	11	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	1					45	50		10.1016/0091-6749(81)90044-0	http://dx.doi.org/10.1016/0091-6749(81)90044-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KZ173	6256423				2022-12-18	WOS:A1981KZ17300009
J	BAHNA, SL; MYHRE, B; HEINER, DC				BAHNA, SL; MYHRE, B; HEINER, DC			IGE ELEVATION AND SUPPRESSION BY TOBACCO SMOKING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	12	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					231	232						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000222
J	CHARPIN, J; CHARPIN, H				CHARPIN, J; CHARPIN, H			PARIETERA-OFFICINALIS L ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											CHARPIN, J (corresponding author), HOP ST MARGUERITE, F-13009 MARSEILLE, FRANCE.							CHARPIN J, 1975, ATLAS EUROPEAN ALLER; PANZANI R, 1956, PRESSE MED, V64, P908; SERAFINI UMBERTO, 1957, ACTA ALLERGOL, V11, P3, DOI 10.1111/j.1398-9995.1957.tb03005.x	3	11	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	1					80	81						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB459	7350207				2022-12-18	WOS:A1980JB45900016
J	FLAHERTY, DK; GELLER, M; SURFUS, JE; LEO, GM; REED, CE; RANKIN, J				FLAHERTY, DK; GELLER, M; SURFUS, JE; LEO, GM; REED, CE; RANKIN, J			HLA-ANTIGEN FREQUENCIES AND NATURAL-HISTORY IN ALTERNARIA-SENSITIVE AND PERENNIAL NON-ALLERGIC ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											FLAHERTY, DK (corresponding author), UNIV WISCONSIN, CTR HLTH SCI, MADISON, WI 53706 USA.				NHLBI NIH HHS [N01-HR-62936] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACH FH, 1976, NEW ENGL J MED, V295, P806, DOI 10.1056/NEJM197610072951504; BACH FH, 1976, NEW ENGL J MED, V295, P872, DOI 10.1056/NEJM197610142951606; BERNSTEIN L, 1978, ALLERGY PRINCIPLES P, V2, P752; BLUMENTHAL MN, 1974, SCIENCE, V184, P1301, DOI 10.1126/science.184.4143.1301; BRODER I, 1974, J ALLERGY CLIN IMMUN, V54, P100, DOI 10.1016/0091-6749(74)90038-4; BRODER I, 1974, J ALLERGY CLIN IMMUN, V53, P127, DOI 10.1016/0091-6749(74)90001-3; DAUSSETT J, 1977, HLA DISEASE; ELGEFORS B, 1974, ACTA ALLERGOL, V29, P327, DOI 10.1111/j.1398-9995.1974.tb01469.x; GOODFRIEND L, 1976, MONOGR ALLERGY, V11; JERSILD C, 1975, TRANSPLANT REV, V22, P148; KATZ DH, 1977, HOSP PRACT, V12, P85, DOI 10.1080/21548331.1977.11707080; KERN RA, 1933, J ALLERGY, V4, P485; KUNKEL H, 1974, J HOPKINS CENTENNIAL; LEVINE BB, 1972, SCIENCE, V178, P1201, DOI 10.1126/science.178.4066.1201; LILLY F, 1970, J NATL CANCER I, V45, P163; MARSH DG, 1973, SCIENCE, V179, P691, DOI 10.1126/science.179.4074.691; MARSH DG, 1976, 33 NOB S MOL BIOL AS; MORRIS RI, 1974, NEW ENGL J MED, V290, P1117, DOI 10.1056/NEJM197405162902004; RACHELEFSKY G, 1976, LANCET, V2, P1042; RAJKA G, 1970, ACTA DERM-VENEREOL, V50, P281; RAY JG, 1971, NIH76545 DHEW NAT I, P23; RITZMANN SE, 1976, JAMA-J AM MED ASSOC, V236, P2305, DOI 10.1001/jama.236.20.2305; ROSENBERG LE, 1977, NEW ENGL J MED, V297, P1060, DOI 10.1056/NEJM197711102971909; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; SCHALLER JG, 1976, J PEDIATR-US, V88, P913, DOI 10.1016/S0022-3476(76)81042-6; SETTIPANE GA, 1974, J ALLERGY CLIN IMMUN, V53, P200, DOI 10.1016/0091-6749(74)90081-5; SMITH JM, 1978, ALLERGY PRINCIPLES P, V2, P644; STOY P, 1979, J ALLERGY CLIN IMMUN, V63, P200; VLADUTIU AO, 1974, IMMUNOGENETICS, V1, P305, DOI 10.1007/BF01564070; YOO TJ, 1976, J ALLERGY CLIN IMMUN, V57, P25, DOI 10.1016/0091-6749(76)90075-0; YUNGINGER JW, 1972, J ALLERGY CLIN IMMUN, V50, P109, DOI 10.1016/0091-6749(72)90006-1	31	11	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	5					408	416		10.1016/0091-6749(80)90121-9	http://dx.doi.org/10.1016/0091-6749(80)90121-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KQ965	7192296				2022-12-18	WOS:A1980KQ96500010
J	MASON, WD; LANMAN, RC; AMICK, EN; ARNOLD, J; MARCH, L				MASON, WD; LANMAN, RC; AMICK, EN; ARNOLD, J; MARCH, L			BIOAVAILABILITY OF THEOPHYLLINE FOLLOWING A RECTALLY ADMINISTERED CONCENTRATED AMINOPHYLLINE SOLUTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MISSOURI,SCH PHARM,PHARMACOKINET LAB,KANSAS CITY,MO 64108	University of Missouri System; University of Missouri Kansas City	MASON, WD (corresponding author), UNIV MISSOURI,SCH MED,KANSAS CITY,MO 64108, USA.							HENDELES L, 1977, AM J HOSP PHARM, V34, P525, DOI 10.1093/ajhp/34.5.525; LILLEHEI JP, 1968, J AMER MED ASSOC, V205, P530, DOI 10.1001/jama.205.7.530; SEGAL MS, 1971, ANN ALLERGY, V29, P135; TRUITT EB, 1950, J PHARMACOL EXP THER, V100, P309	4	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	2					119	122		10.1016/0091-6749(80)90058-5	http://dx.doi.org/10.1016/0091-6749(80)90058-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD119	7400475				2022-12-18	WOS:A1980KD11900005
J	SELCOW, JE; MENDELSON, LM; ROSEN, JP				SELCOW, JE; MENDELSON, LM; ROSEN, JP			ANAPHYLACTIC REACTIONS IN SKIN-TEST - NEGATIVE PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	5					400	400		10.1016/0091-6749(80)90220-1	http://dx.doi.org/10.1016/0091-6749(80)90220-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JV955	7372959	Bronze			2022-12-18	WOS:A1980JV95500014
J	KARR, RM; LEHRER, SB; BUTCHER, BT; WILSON, MR; ANICETTI, V; SALVAGGIO, JE				KARR, RM; LEHRER, SB; BUTCHER, BT; WILSON, MR; ANICETTI, V; SALVAGGIO, JE			ANALYSIS OF ANTIGENIC RELATIONSHIPS AMONG SPECIES OF ASPERGILLUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					213	214						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400271
J	SALVAGGIO, JE				SALVAGGIO, JE			OVERVIEW AND MECHANISMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SALVAGGIO, JE (corresponding author), TULANE UNIV,SCH MED,DEPT MED,NEW ORLEANS,LA 70112, USA.							ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1	1	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					646	649		10.1016/0091-6749(79)90029-0	http://dx.doi.org/10.1016/0091-6749(79)90029-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX843	229143	Bronze			2022-12-18	WOS:A1979HX84300017
J	BECKER, WG; BUCKLEY, RH				BECKER, WG; BUCKLEY, RH			INVITRO STUDIES OF HUMAN IGE BIOSYNTHESIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Buckley, Rebecca/AAB-1578-2019						0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					177	177		10.1016/0091-6749(78)90401-3	http://dx.doi.org/10.1016/0091-6749(78)90401-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300162
J	KATZ, R; RACHELEFSKY, G; GOLDBERG, M; BORIS, G; GYEPES, M; SHAPIRO, M; MICKEY, M; FINEGOLD, S; SIEGEL, S				KATZ, R; RACHELEFSKY, G; GOLDBERG, M; BORIS, G; GYEPES, M; SHAPIRO, M; MICKEY, M; FINEGOLD, S; SIEGEL, S			SINUSITIS IN CHILDREN WITH RESPIRATORY ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					190	190		10.1016/0091-6749(78)90446-3	http://dx.doi.org/10.1016/0091-6749(78)90446-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300207
J	WASSERMAN, SI; SHEFFER, AL; SOTER, NA; AUSTEN, KF; MCFADDEN, ER				WASSERMAN, SI; SHEFFER, AL; SOTER, NA; AUSTEN, KF; MCFADDEN, ER			ASSESSMENT OF MAST-CELL MEDIATORS AND PULMONARY-FUNCTION IN ASPIRIN (ASA)-INDUCED BRONCHOSPASM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					139	139		10.1016/0091-6749(78)90276-2	http://dx.doi.org/10.1016/0091-6749(78)90276-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300037
J	WEBER, RW; MANSFIELD, LE; NELSON, HS				WEBER, RW; MANSFIELD, LE; NELSON, HS			CROSS-REACTIVITY AMONG WEEDS OF AMARANTH AND CHENOPOD FAMILIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					172	172		10.1016/0091-6749(78)90385-8	http://dx.doi.org/10.1016/0091-6749(78)90385-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173		Bronze			2022-12-18	WOS:A1978ES17300146
J	SOHNLE, PG; KIRKPATRICK, CH				SOHNLE, PG; KIRKPATRICK, CH			STUDY OF POSSIBLE MECHANISMS OF BASOPHIL ACCUMULATION IN EXPERIMENTAL CUTANEOUS CANDIDIASIS IN GUINEA-PIGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,CLIN INVEST LAB,BETHESDA,MD 20014	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								ASKENASE PW, 1973, J EXP MED, V138, P1144, DOI 10.1084/jem.138.5.1144; BOETCHER DA, 1973, IMMUNOL COMMUN, V2, P421, DOI 10.3109/08820137309022813; COLVIN RB, 1973, J IMMUNOL, V110, P1279; DVORAK HF, 1974, LAB INVEST, V31, P111; DVORAK HF, 1970, J EXP MED, V132, P558, DOI 10.1084/jem.132.3.558; DVORAK HF, 1972, J EXP MED, V135, P235, DOI 10.1084/jem.135.2.235; HIGUCHI Y, 1975, CELL IMMUNOL, V15, P100, DOI 10.1016/0008-8749(75)90168-9; KATZ SI, 1974, J IMMUNOL, V113, P1073; NISHIURA M, 1974, IMMUNOLOGY, V27, P1023; RAPP HJ, 1970, MOLECULAR BASIS COMP; SOHNLE PG, UNPUBLISHED DATA; SOHNLE PG, 1976, J IMMUNOL, V117, P525; STADECKE.MJ, 1974, J IMMUNOL, V113, P496; WARD PA, 1975, J IMMUNOL, V114, P1523	14	11	12	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	2					171	177		10.1016/0091-6749(77)90221-4	http://dx.doi.org/10.1016/0091-6749(77)90221-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CV622	833382				2022-12-18	WOS:A1977CV62200013
J	ARROYAVE, CM; STEVENSON, DD; BHAT, KN; TAN, EM				ARROYAVE, CM; STEVENSON, DD; BHAT, KN; TAN, EM			ORAL ASPIRIN CHALLENGE IN ASTHMATIC-PATIENTS - STUDY OF PLASMA MEDIATORS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					206	206						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000041
J	KNIGHT, A; UNDERDOWN, BJ; DEMANUELE, F; HARGREAVE, FE				KNIGHT, A; UNDERDOWN, BJ; DEMANUELE, F; HARGREAVE, FE			DISODIUM-CROMOGLYCATE IN RAGWEED-ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV TORONTO,SUNNYBROOK MED CTR,DEPT MED,TORONTO,ONTARIO,CANADA; MCMASTER UNIV,ST JOSEPHS HOSP,DEPT MED,HAMILTON 16,ONTARIO,CANADA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McGill University; McMaster University								BLAIR H, 1975, Clinical Allergy, V5, P139, DOI 10.1111/j.1365-2222.1975.tb01846.x; COX JSG, 1967, NATURE, V216, P1328, DOI 10.1038/2161328a0; GOOSE J, 1969, IMMUNOLOGY, V16, P749; HOLOPAIN.E, 1971, LANCET, V1, P55; KOLOTKIN BM, 1974, J ALLERGY CLIN IMMUN, V53, P288, DOI 10.1016/0091-6749(74)90108-0; PEPYS J, 1968, LANCET, V2, P134; SILVERMAN M, 1972, Clinical Allergy, V2, P137, DOI 10.1111/j.1365-2222.1972.tb01278.x; TAYLOR G, 1971, Clinical Allergy, V1, P189, DOI 10.1111/j.1365-2222.1971.tb03018.x; TAYLOR WA, 1974, INT ARCH ALLER A IMM, V47, P175, DOI 10.1159/000231212; TOOGOOD JH, 1973, J ALLERGY CLIN IMMUN, V52, P334, DOI 10.1016/0091-6749(73)90092-4	10	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	2					278	283		10.1016/0091-6749(76)90132-9	http://dx.doi.org/10.1016/0091-6749(76)90132-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CA661	7585				2022-12-18	WOS:A1976CA66100004
J	PATTERSON, R; SUSZKO, IM				PATTERSON, R; SUSZKO, IM			POLYMERIZED RAGWEED ANTIGEN-E .4. ANALYSIS OF STABILITY OF MOLECULAR-SIZE AND ANTIGENIC REACTIVITY OF POLYMER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									NORTHWESTERN UNIV,MED SCH,DEPT MED,SECT ALLERGY IMMUNOL,305 E CHICAGO AVE,SEARLE BLDG 3-461,CHICAGO,IL 60611	Northwestern University								IRONS JS, IN PRESS; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; Lieberman P, 1974, Adv Intern Med, V19, P391; NORMAN PS, 1968, J ALLERGY, V42, P93, DOI 10.1016/0021-8707(68)90139-1; PATTERSON R, 1973, J IMMUNOL, V110, P1402; PATTERSON R, 1973, J IMMUNOL, V110, P1413; PATTERSON R, 1972, ALLERGIC DISEASES DI, P295; PRUZANSK.JJ, 1965, J IMMUNOL, V95, P48; PRUZANSKY JJ, 1966, J ALLERGY, V38, P315, DOI 10.1016/0021-8707(66)90028-1	9	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	2					168	173		10.1016/0091-6749(76)90036-1	http://dx.doi.org/10.1016/0091-6749(76)90036-1			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BE952	55428	Bronze			2022-12-18	WOS:A1976BE95200009
J	RAPHAEL, SA; NELL, PA; HRYNCHUK, IM; LISCHNER, HW				RAPHAEL, SA; NELL, PA; HRYNCHUK, IM; LISCHNER, HW			POSITIVE LATEX ANTIGLOBULIN-TEST IN ATOPIC PEDIATRIC SUBJECTS RECEIVING HYPOSENSITIZATION THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					231	231						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000103
J	MARX, JJ; FLAHERTY, DK				MARX, JJ; FLAHERTY, DK			ALTERNATE PATHWAY ACTIVATION OF COMPLEMENT BY ANTIGENS ASSOCIATED WITH HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					70	71						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800005
J	NORMAN, PS; MARSH, DG; LICHTENSTEIN, LM; ISHIZAKA, K				NORMAN, PS; MARSH, DG; LICHTENSTEIN, LM; ISHIZAKA, K			IMMUNOLOGICAL AND CLINICAL RESPONSES TO RAGWEED EXTRACT AND ITS ALLERGOID	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					78	78						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800024
J	PATTERSON, R; SCHATZ, M				PATTERSON, R; SCHATZ, M			ADMINISTRATION OF RADIOGRAPHIC CONTRAST-MEDIUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									NORTHWESTERN UNIV,MED SCH,DEPT MED,SECT ALLERGY,CHICAGO,IL 60611	Northwestern University								SCHATZ M, 1975, J ALLERGY CLIN IMMUN, V55, P358, DOI 10.1016/0091-6749(75)90007-X; ZWEIMAN B, 1975, ANN INTERN MED, V83, P159, DOI 10.7326/0003-4819-83-2-159	2	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	4					328	328		10.1016/0091-6749(75)90108-6	http://dx.doi.org/10.1016/0091-6749(75)90108-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AS523					2022-12-18	WOS:A1975AS52300011
J	YUNGINGER, JW; JONES, RT; LEIFERMAN, KM; GLEICH, GJ				YUNGINGER, JW; JONES, RT; LEIFERMAN, KM; GLEICH, GJ			MEASUREMENT OF IGE ANTIBODY TO HONEYBEE COMPONENTS IN BEEKEEPERS AND THEIR FAMILY MEMBERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					74	75						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800015
J	MILLER, R; WHITE, LW; SCHWARTZ, HJ				MILLER, R; WHITE, LW; SCHWARTZ, HJ			CASE OF EPISODIC URTICARIA DUE TO SACCHARIN INGESTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH; UNIV HOSP CLEVELAND,CLEVELAND,OH 44106	Case Western Reserve University; University Hospitals of Cleveland								COLAIZZI JL, 1971, J AM PHARM ASSOC, VNS11, P135; CRIEP LH, 1968, CLINICAL IMMUNOLOGY; DIPALMA JR, 1971, DRILLS PHARMACOLOGY; FEINGOLD BF, 1968, ANN ALLERGY, V26, P309; KUN E, 1947, P SOC EXP BIOL MED, V66, P175; MEYLER L, 1968, SIDE EFFECTS DRUGS S, V6; OSOL A, 1967, US DISPENSATORY PHYS; TAUB SJ, 1972, EYE EAR NOSE THROAT, V51, P405	8	11	12	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	4					240	242		10.1016/0091-6749(74)90086-4	http://dx.doi.org/10.1016/0091-6749(74)90086-4			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S6732	4835735	Bronze			2022-12-18	WOS:A1974S673200007
J	GILLESPIE, E; VALENTINE, MD; LICHTENSTEIN, LM				GILLESPIE, E; VALENTINE, MD; LICHTENSTEIN, LM			BETA-ADRENERGIC BLOCKADE THEORY OF ASTHMA - FACT OR FANTASY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	11	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					93	94		10.1016/S0091-6749(73)80035-1	http://dx.doi.org/10.1016/S0091-6749(73)80035-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300035
J	MILLER, ME				MILLER, ME			USES AND ABUSES OF PLASMA THERAPY IN PATIENT WITH RECURRENT INFECTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHARLES R DREW POSTGRAD MED SCH,DEPT PEDIAT,LOS ANGELES,CA 90059	Charles R. Drew University of Medicine & Science								ALPER CA, 1970, NEW ENGL J MED, V282, P349, DOI 10.1056/NEJM197002122820701; AMER J, 1963, PEDIATRICS, V32, P4; BRUTON OC, 1952, PEDIATRICS, V9, P722; BUSER F, 1968, J PEDIATR-US, V72, P29, DOI 10.1016/S0022-3476(68)80397-X; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; CRAIN JD, 1970, IMMUNOGLOBULINS BIOL, P179; EDSALL G, 1970, IMMUNOGLOBULINS BIOL, P293; FUDENBERG HH, 1970, IMMUNOGLOBULINS, P211; GEWURZ H, 1967, HOSP PRAC, V2, P40; GOOD RA, 1971, IMMUNOBIOLOGY, P3; GRADY GF, 1970, IMMUNOGLOBINS BIOLOG, P247; HEINER DC, 1967, J PEDIATR-US, V70, P820, DOI 10.1016/S0022-3476(67)80341-X; HODES HL, 1963, PEDIATRICS, V32, P1; JACOBS JC, 1972, PEDIATRICS, V49, P225; JANEWAY CA, 1966, NEW ENGL J MED, V275, P826, DOI 10.1056/NEJM196610132751508; JOHNSTON RB, 1972, PEDIATR RES, V6, P121; MANCINI G, 1964, PROTIDES BIOL FLUIDS, V11, P370; MILLER ME, 1970, NEW ENGL J MED, V282, P354, DOI 10.1056/NEJM197002122820702; MILLER ME, 1968, LANCET, V2, P60; MILLER ME, 1972, J PEDIATR-US, V80, P879; MILLER ME, 1970, ANN NY ACAD SCI, V171, P512, DOI 10.1111/j.1749-6632.1970.tb39360.x; MULLEREBERHARD HJ, 1968, TEXTBOOK IMMUNOPATH, P33; RADERMECKER M, 1971, IMMUNOLOGICAL DISEAS, P888; SCHUR PH, 1970, NEW ENGL J MED, V283, P631, DOI 10.1056/NEJM197009172831205; SMITH RT, 1968, BIOL BASIS PEDIATRIC, P495; STIEHM ER, 1966, BLOOD-J HEMATOL, V28, P918, DOI 10.1182/blood.V28.6.918.918; STIEHM ER, 1966, PEDIATRICS, V37, P715; STIEHM ER, IN PRESS; WARD PA, 1969, LANCET, V2, P344; WEST CD, 1968, J PEDIATR-US, V72, P153, DOI 10.1016/S0022-3476(68)80425-1	30	11	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	1					45	56		10.1016/0091-6749(73)90008-0	http://dx.doi.org/10.1016/0091-6749(73)90008-0			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O5651	4118411				2022-12-18	WOS:A1973O565100007
J	PHIPATANAKUL, CS; SLAVIN, RG				PHIPATANAKUL, CS; SLAVIN, RG			USE OF THERMOGRAPHY IN CLINICAL ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BARNES R. BOWLING, 1963, SCIENCE, V140, P870, DOI 10.1126/science.140.3569.870; BRANEMARK PI, 1968, ACTA DERM-VENEREOL, V48, P385; BRUESCHKE E, 1965, AM J MED ELECTRON, V4, P65; BRUESCHKE EE, 1964, ANN NY ACAD SCI, V121, P80, DOI 10.1111/j.1749-6632.1964.tb13687.x; BYSTRYN JC, 1969, J INVEST DERMATOL, V52, P189, DOI 10.1038/jid.1969.29; CHAMPION RH, 1963, BRIT J DERMATOL, V75, P12, DOI 10.1111/j.1365-2133.1963.tb13526.x; EYSTER WH, 1952, J INVEST DERMATOL, V18, P37, DOI 10.1038/jid.1952.5; GERSHONC.J, 1965, RADIOL CLIN N AM, V3, P403; Hardy JD, 1939, AM J PHYSIOL, V127, P454, DOI 10.1152/ajplegacy.1939.127.3.454; JOHNSON LA, 1965, ARCH DERMATOL, V92, P621, DOI 10.1001/archderm.92.6.621; KAUFMAN HS, 1967, J AMER MED ASSOC, V202, P91; KLIOT DA, 1965, AM J OBSTET GYNECOL, V93, P515, DOI 10.1016/0002-9378(65)90509-0; LAWSON RN, 1961, CAN MED ASSOC J, V84, P1129; MLADICK R, 1966, PLAST RECONSTR SURG, V38, P512, DOI 10.1097/00006534-196638060-00003; NORINS AL, 1971, PEDIATR CLIN N AM, V18, P801; RAMSAY C, 1969, BRIT J DERMATOL, V81, P37, DOI 10.1111/j.1365-2133.1969.tb15917.x; WEBER RG, 1955, J INVEST DERMATOL, V24, P19, DOI 10.1038/jid.1955.4	17	11	13	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	50	5					264	+		10.1016/0091-6749(72)90025-5	http://dx.doi.org/10.1016/0091-6749(72)90025-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N9856	5076353				2022-12-18	WOS:A1972N985600002
J	van Leeuwen, LPM; GeurtsvanKessel, CH; Ellerbroek, PM; de Bree, GJ; Potjewijd, J; Rutgers, A; Jolink, H; van de Veerdonk, F; van Gorp, ECM; de Wilt, F; Bogers, S; Gommers, L; Geers, D; Bruns, AHW; Leavis, HL; van Haga, JW; Lemkes, BA; van der Veen, A; de Kruijf-Bazen, SFJ; van Paassen, P; de Leeuw, K; van de Ven, AAJM; Verbeek-Menken, PH; van Wengen, A; Arend, SM; Ruten-Budde, AJ; van der Ent, MW; van Hagen, PM; Sanders, RW; Grobben, M; van der Straten, K; Burger, JA; Poniman, M; Nierkens, S; van Gils, MJ; de Vries, RD; Dalm, VASH				van Leeuwen, Leanne P. M.; GeurtsvanKessel, Corine H.; Ellerbroek, Pauline M.; de Bree, Godelieve J.; Potjewijd, Judith; Rutgers, Abraham; Jolink, Hetty; van de Veerdonk, Frank; van Gorp, Eric C. M.; de Wilt, Faye; Bogers, Susanne; Gommers, Lennert; Geers, Daryl; Bruns, Anke H. W.; Leavis, Helen L.; van Haga, Jelle W.; Lemkes, Bregtje A.; van der Veen, Annelou; de Kruijf-Bazen, S. F. J.; van Paassen, Pieter; de Leeuw, Karina; van de Ven, Annick A. J. M.; Verbeek-Menken, Petra H.; van Wengen, Annelies; Arend, Sandra M.; Ruten-Budde, Anja J.; van der Ent, Marianne W.; van Hagen, P. Martin; Sanders, Rogier W.; Grobben, Marloes; van der Straten, Karlijn; Burger, Judith A.; Poniman, Meliawati; Nierkens, Stefan; van Gils, Marit J.; de Vries, Rory D.; Dalm, Virgil A. S. H.			Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Inborn errors of immunity; primary immunodeficiency disorders; SARS-CoV-2; mRNA-1273 COVID-19 vaccine; immuno-genicity; antibody response; T-cell response; CVID; CID; XLA	PRIMARY IMMUNODEFICIENCY	Background: Patients with inborn errors of immunity (IEI) are at increased risk of severe coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of great importance in this group, but little is known about the immunogenicity of COVID-19 vaccines in these patients. Objectives: We sought to study humoral and cellular immune responses after mRNA-1273 COVID-19 vaccination in adult patients with IEI. Methods: In a prospective, controlled, multicenter study, 505 patients with IEI (common variable immunodeficiency [CVID], isolated or undefined antibody deficiencies, X-linked agammaglobulinemia, combined B- and T-cell immunodeficiency, phagocyte defects) and 192 controls were included. All participants received 2 doses of the mRNA-1273 COVID-19 vaccine. Levels of severe acute respiratory syndrome coronavirus-2-specific binding antibodies, neutralizing antibodies, and T-cell responses were assessed at baseline, 28 days after first vaccination, and 28 days after second vaccination. Results: Seroconversion rates in patients with clinically mild antibody deficiencies and phagocyte defects were similar to those in healthy controls, but seroconversion rates in patients with more severe IEI, such as CVID and combined B- and T-cell immunodeficiency, were lower. Binding antibody titers correlated well to the presence of neutralizing antibodies. T-cell responses were comparable to those in controls in all IEI cohorts, with the exception of patients with CVID. The presence of noninfectious complications and the use of immunosuppressive drugs in patients with CVID were negatively correlated with the antibody response. Conclusions: COVID-19 vaccination with mRNA-1273 was immunogenic in mild antibody deficiencies and phagocyte defects and in most patients with combined B- and T-cell immunodeficiency and CVID. Lowest response was detected in patients with X-linked agammaglobulinemia and in patients with CVID with noninfectious complications. The assessment of longevity of immune responses in these vulnerable patient groups will guide decision making for additional vaccinations.	[van Leeuwen, Leanne P. M.; GeurtsvanKessel, Corine H.; van Gorp, Eric C. M.; de Wilt, Faye; Bogers, Susanne; Gommers, Lennert; Geers, Daryl; de Vries, Rory D.] UMC Utrecht, Dept Virosci, Erasmus MC Univ Med Ctr, Utrecht, Netherlands; [van Leeuwen, Leanne P. M.; van Gorp, Eric C. M.] UMC Utrecht, Erasmus MC Univ Med Ctr Rotterdam, Travel Clin, Utrecht, Netherlands; [Ellerbroek, Pauline M.; Bruns, Anke H. W.; Leavis, Helen L.] UMC Utrecht, Dept Internal Med, Utrecht, Netherlands; [de Bree, Godelieve J.; van Haga, Jelle W.; Lemkes, Bregtje A.; van der Veen, Annelou] Amsterdam UMC, Dept Infect Dis, Amsterdam, Netherlands; [Potjewijd, Judith; de Kruijf-Bazen, S. F. J.; van Paassen, Pieter] Maastricht UMC, Dept Internal Med, Div Nephrol & Clin Immunol, Maastricht, Netherlands; [Rutgers, Abraham; de Leeuw, Karina; van de Ven, Annick A. J. M.] Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Jolink, Hetty; Verbeek-Menken, Petra H.; van Wengen, Annelies; Arend, Sandra M.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [van de Veerdonk, Frank] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Ruten-Budde, Anja J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Biostat, Rotterdam, Netherlands; [van der Ent, Marianne W.; van Hagen, P. Martin; Dalm, Virgil A. S. H.] Erasmus MC Univ Med Ctr Rotterdam, Dept Internal Med, Div Allergy & Clin Immunol, Rotterdam, Netherlands; [van Hagen, P. Martin; Dalm, Virgil A. S. H.] Erasmus MC Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands; [Sanders, Rogier W.; Grobben, Marloes; van der Straten, Karlijn; Burger, Judith A.; Poniman, Meliawati; van Gils, Marit J.] Univ Amsterdam, Amsterdam Inst Infect & Immun, Dept Med Microbiol & Infect Prevent, Amsterdam UMC, Amsterdam, Netherlands; [Nierkens, Stefan] UMC Utrecht, Ctr Translat Immunol, Utrecht, Netherlands; [Nierkens, Stefan] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Utrecht University; Utrecht University Medical Center	Dalm, VASH (corresponding author), Erasmus MC, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	r.dalm@erasmusmc.nl	de Vries, Rory D/L-2264-2015; van Gils, Marit J./H-4791-2019	de Vries, Rory D/0000-0003-2817-0127; van Gils, Marit J./0000-0003-3422-8161; Grobben, Marloes/0000-0002-1559-9592	ZonMw [10430072010006]	ZonMw(Netherlands Organization for Health Research and Development)	This study was funded by ZonMw (grant no. 10430072010006), EudraCT number 2021000515-24.	Amodio D, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.727850; Arroyo-Sanchez D, 2022, J CLIN IMMUNOL, V42, P240, DOI 10.1007/s10875-021-01174-5; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Brouwer PJM, 2021, CELL, V184, P1188, DOI 10.1016/j.cell.2021.01.035; Connolly CM, 2022, ANN RHEUM DIS, V81, P293, DOI 10.1136/annrheumdis-2021-221252; Del Bello A, 2022, AM J TRANSPLANT, V22, P322, DOI 10.1111/ajt.16775; Delmonte OM, 2021, J ALLERGY CLIN IMMUN, V148, P1192, DOI 10.1016/j.jaci.2021.08.016; Gadani SP, 2021, EBIOMEDICINE, V73, DOI 10.1016/j.ebiom.2021.103636; Geers D, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1750; GeurtsvanKessel CH, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abo2202; GeurtsvanKessel CH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17317-y; Goudouris ES, 2021, J CLIN IMMUNOL, V41, P1479, DOI 10.1007/s10875-021-01066-8; Grobben M, 2021, ELIFE, V10, DOI [10.7554/eLife.70330, 10.7554/eLife.70330.sa0, 10.7554/eLife.70330.sa1, 10.7554/eLife.70330.sa2]; Hagin D, 2021, J ALLERGY CLIN IMMUN, V148, P739, DOI 10.1016/j.jaci.2021.05.029; Keuning MW, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00731-21; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Meyts I, 2021, J ALLERGY CLIN IMMUN, V147, P520, DOI 10.1016/j.jaci.2020.09.010; Milito C, 2021, CURR OPIN ALLERGY CL, V21, P535, DOI 10.1097/ACI.0000000000000789; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Moor MB, 2021, LANCET RHEUMATOL, V3, pE789, DOI 10.1016/S2665-9913(21)00251-4; Mykytyn AZ, BIORXIV; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Picard C, 2018, J CLIN IMMUNOL, V38, P96, DOI 10.1007/s10875-017-0464-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pulvirenti F, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10112915; Sablerolles RSG, 2022, NEW ENGL J MED, V386, P951, DOI 10.1056/NEJMoa2116747; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Sanders JSF, 2022, TRANSPLANTATION, V106, P821, DOI 10.1097/TP.0000000000003983; Schmidt F, 2020, J EXP MED, V217, DOI 10.1084/jem.20201181; Shields AM, 2021, J ALLERGY CLIN IMMUN, V147, P870, DOI 10.1016/j.jaci.2020.12.620; Stewart D M, 2001, Curr Allergy Asthma Rep, V1, P558, DOI 10.1007/s11882-001-0065-8; Tangye SG, 2021, J CLIN IMMUNOL, V41, P666, DOI 10.1007/s10875-021-00980-1; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1	35	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					1949	1957		10.1016/j.jaci.2022.04.002	http://dx.doi.org/10.1016/j.jaci.2022.04.002			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35421449	Green Published, hybrid			2022-12-18	WOS:000833525500017
J	Lankester, AC; Neven, B; Mahlaoui, N; Von Asmuth, EGJ; Courteille, V; Alligon, M; Albert, MH; Serra, IB; Bader, P; Balashov, D; Beier, R; Bertrand, Y; Blanche, S; Bordon, V; Bredius, RG; Cant, A; Cavazzana, M; Diaz-De-Heredia, C; Dogu, F; Ehlert, K; Entz-Werle, N; Fasth, A; Ferrua, F; Ferster, A; Formankova, R; Friedrich, W; Gonzalez-Vicent, M; Gozdzik, J; Gungor, T; Hoenig, M; Ikinciogullari, A; Kalwak, K; Kansoy, S; Kupesiz, A; Lanfranchi, A; Lindemans, CA; Meisel, R; Michel, G; Miranda, NAA; Moraleda, J; Moshous, D; Pichler, H; Rao, K; Sedlacek, P; Slatter, M; Soncini, E; Speckmann, C; Sundin, M; Toren, A; Vettenranta, K; Worth, A; Yesilipek, MA; Zecca, M; Porta, F; Schulz, A; Veys, P; Fischer, A; Gennery, AR				Lankester, Arjan C.; Neven, Benedicte; Mahlaoui, Nizar; von Asmuth, Erik G. J.; Courteille, Virginie; Alligon, Mikael; Albert, Michael H.; Serra, Isabelle Badell; Bader, Peter; Balashov, Dmitry; Beier, Rita; Bertrand, Yves; Blanche, Stephane; Bordon, Victoria; Bredius, Robbert G.; Cant, Andrew; Cavazzana, Marina; Diaz-de-Heredia, Cristina; Dogu, Figen; Ehlert, Karoline; Entz-Werle, Natacha; Fasth, Anders; Ferrua, Francesca; Ferster, Alina; Formankova, Renata; Friedrich, Wilhelm; Gonzalez-Vicent, Marta; Gozdzik, Jolanta; Gungor, Tayfun; Hoenig, Manfred; Ikinciogullari, Aydan; Kalwak, Krzysztof; Kansoy, Savas; Kupesiz, Alphan; Lanfranchi, Arnalda; Lindemans, Caroline A.; Meisel, Roland; Michel, Gerard; Miranda, Nuno A. A.; Moraleda, Jose; Moshous, Despina; Pichler, Herbert; Rao, Kanchan; Sedlacek, Petr; Slatter, Mary; Soncini, Elena; Speckmann, Carsten; Sundin, Mikael; Toren, Amos; Vettenranta, Kim; Worth, Austen; Yesilipek, Mehmet A.; Zecca, Marco; Porta, Fulvio; Schulz, Ansgar; Veys, Paul; Fischer, Alain; Gennery, Andrew R.			Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SCID; genetic subgroups; conditioning; pretransplantation infections; immune reconstitution	RECONSTITUTION; OUTCOMES; SURVIVAL	Background: Hematopoietic stem cell transplantation (HSCT) represents a curative treatment for patients with severe combined immunodeficiency (SCID), a group of monogenic immune disorders with an otherwise fatal outcome. Objective: We performed a comprehensive multicenter analysis of genotype-specific HSCT outcome, including detailed analysis of immune reconstitution (IR) and the predictive value for clinical outcome. Methods: HSCT outcome was studied in 338 patients with genetically confirmed SCID who underwent transplantation in 2006-2014 and who were registered in the SCETIDE registry. In a representative subgroup of 152 patients, data on IR and longterm clinical outcome were analyzed. Results: Two-year OS was similar with matched family and unrelated donors and better than mismatched donor HSCT (P <.001). The 2-year event-free survival (EFS) was similar in matched and mismatched unrelated donor and less favorable in mismatched related donor (MMRD) HSCT (P <.001). Genetic subgroups did not differ in 2-year OS (P = .1) and EFS (P = .073). In multivariate analysis, pretransplantation infections and use of MMRDs were associated with less favorable OS and EFS. With a median follow-up of 6.2 years (range, 2.0-11.8 years), 73 of 152 patients in the IR cohort were alive and well without Ig dependency. IL-2 receptor gamma chain/Janus kinase 3/IL-7 receptor-deficient SCID, myeloablative conditioning, matched donor HSCT, and naive CD4 T lymphocytes >0.5 3 10(-3)/mL at 11 year were identified as independent predictors of favorable clinical and immunologic outcome. Conclusion: Recent advances in HSCT in SCID patients have resulted in improved OS and EFS in all genotypes and donor types. To achieve a favorable long-term outcome, treatment strategies should aim for optimal naive CD4 T lymphocyte regeneration.	[Lankester, Arjan C.; von Asmuth, Erik G. J.; Bredius, Robbert G.] Leiden Univ Med Ctr, Willem Alexander Childrens Hosp, Pediat Stem Cell Transplantat Program, Albinusdreef 2, NL-2300 RC Leiden, Netherlands; [Lankester, Arjan C.; von Asmuth, Erik G. J.; Bredius, Robbert G.] Leiden Univ Med Ctr, Willem Alexander Childrens Hosp, Lab Pediat Immunol, Albinusdreef 2, NL-2300 RC Leiden, Netherlands; [Neven, Benedicte; Blanche, Stephane; Moshous, Despina; Fischer, Alain] Hop Univ Necker Enfants Malad, Assistance Publ Hop Paris AP HP, Unite Immunohematol & Rhumatol Pediat, Paris, France; [Neven, Benedicte; Cavazzana, Marina; Moshous, Despina; Fischer, Alain] Univ Paris, Paris, France; [Neven, Benedicte] Inst Imagine, Lab Immunogenet Pediat Autoimmune Dis, INSERM UMR1163, Paris, France; [Mahlaoui, Nizar; Courteille, Virginie; Alligon, Mikael] Hop Univ Necker Enfants Malad, Assistance Publ Hop Paris AP HP, French Natl Reference Ctr Primary Immunodeficienc, Paris, France; [Mahlaoui, Nizar; Courteille, Virginie; Alligon, Mikael] Hop Univ Necker Enfants Malad, Assistance Publ Hop Paris AP HP, European Registry Stem Cell Transplantat Primary, Paris, France; [Albert, Michael H.] Dr von Haunersches Univ Childrens Hosp, Munich, Germany; [Serra, Isabelle Badell] Hosp Clin Barcelona, Bone Marrow Transplantat Unit, St Creu & St Pau Hosp, Barcelona, Spain; [Bader, Peter] Univ Hosp Frankfurt, Dept Children & Adolescents Med, Div Stem Cell Transplantat & Immunol, Frankfurt, Germany; [Balashov, Dmitry] Dmitriy Rogachev Natl Ctr Pediat Hematol Oncol &, Dept Hematopoiet Stem Cell Transplantat, Moscow, Russia; [Beier, Rita] Hannover Med Sch, Klin Padiatr Hamatol & Onkol, Hannover, Germany; [Bertrand, Yves] Hosp Civils Lyon, Inst Hematol & Oncol Pediat, Lyon, France; [Bertrand, Yves] Univ Claude Bernard Lyon 1, Lyon, France; [Bordon, Victoria] Ghent Univ Hosp, Dept Pediat Hematooncol & Stem Cell Transplant, Ghent, Belgium; [Cant, Andrew; Slatter, Mary; Gennery, Andrew R.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Cant, Andrew; Slatter, Mary; Gennery, Andrew R.] Great North Childrens Hosp, Paediat Haematopoiet Stem Cell Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Cavazzana, Marina] Necker Childrens Hosp Assistance, Paris Biotherapy Dept, Paris, France; [Cavazzana, Marina] INSERM, Assistance Publ Hop Paris, Biotherapy Clin Invest Ctr, Paris, France; [Cavazzana, Marina; Moshous, Despina] Inst Imagine, Lab Genom Dynam Immune Syst, INSERM UMR1163, Paris, France; [Diaz-de-Heredia, Cristina] Hosp Univ Vall dHebron, Dept Pediat Oncol & Hematol & Hematopoiet Stem Ce, Barcelona, Spain; [Dogu, Figen; Ikinciogullari, Aydan] Ankara Univ, Dept PIA, Ankara, Turkey; [Dogu, Figen; Ikinciogullari, Aydan] Ankara Univ, BMT Unit, Ankara, Turkey; [Ehlert, Karoline] Univ Klinikum Munster, Dept Pediat Hematol & Oncol, Munster, Germany; [Ehlert, Karoline] Univ Greifswald, Dept Pediat Hematol & Oncol, Greifswald, Germany; [Entz-Werle, Natacha] Univ Hosp Strasbourg, Pediat Oncohematol Dept Pediat 3, Strasbourg, France; [Fasth, Anders] Univ Gothenburg, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden; [Ferrua, Francesca] IRCCS San Raffaele Sci Inst, Pediat Immunohematol & Bone Marrow Transplantat U, Milan, Italy; [Ferrua, Francesca] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy; [Ferster, Alina] Hop Univ Enfants Reine Fabiola, Dept Hematooncol, Brussels, Belgium; [Formankova, Renata; Sedlacek, Petr] Charles Univ Motol, Med Sch 2, Teaching Hosp Motol, Dept Pediat Hematol & Oncol, Prague, Czech Republic; [Friedrich, Wilhelm; Hoenig, Manfred; Schulz, Ansgar] Univ Med Ctr Ulm, Dept Pediat, Ulm, Germany; [Gonzalez-Vicent, Marta] Hosp Infantil Univ Nino Jesus, Hematopoiet Stem Cell Transplantat & Cellular The, Madrid, Spain; [Gozdzik, Jolanta] Jagiellonian Univ Med Coll, Dept Clin Immunol & Transplantat, Krakow, Poland; [Gungor, Tayfun] Univ Childrens Hosp, Dept Hematol Oncol Immunol Gene Therapy & Stem Ce, Zurich, Switzerland; [Gungor, Tayfun] Univ Childrens Hosp, Childrens Res Ctr CRC, Zurich, Switzerland; [Kalwak, Krzysztof] Wroclaw Med Univ, Dept Pediat Hematol Oncol & BMT, Wroclaw, Poland; [Kansoy, Savas] Ege Univ Hosp, Dept Pediat Hematol & Oncol, Izmir, Turkey; [Kupesiz, Alphan] Akdeniz Univ, Sch Med, Dept Pediat Hematol & Oncol, Antalya, Turkey; [Lanfranchi, Arnalda] ASST Spedali Civili, Diagnost Dept, Stem Cell Lab, Sect Hematol & Blood Coagulat,Clin Chem Lab, Brescia, Italy; [Lindemans, Caroline A.] Princess Maxima Ctr Pediat Oncol, Dept Stem Cell Transplantat, Utrecht, Netherlands; [Lindemans, Caroline A.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands; [Meisel, Roland] Heinrich Heine Univ, Div Pediat Stem Cell Therapy, Med Fac, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Michel, Gerard] CHU La Timone, Serv Hematol Immunol Oncol Pediat, Marseille, France; [Miranda, Nuno A. A.] Inst Portugues Oncol Lisboa, BMT Unit, Lisbon, Portugal; [Moraleda, Jose] Hosp Virgen de la Arrixaca IMIB, Dept Hematol & Hemotherapy, Murcia, Spain; [Pichler, Herbert] St Anna Hosp, Childrens Canc Inst, Dept Stem Cell Transplantat, Vienna, Austria; [Rao, Kanchan; Worth, Austen; Veys, Paul] Great Ormond St GOS Hosp Children NHS Fdn Trust, London, England; [Rao, Kanchan; Worth, Austen; Veys, Paul] Univ Coll London GOS Inst Child Hlth, London, England; [Soncini, Elena; Porta, Fulvio] Childrens Hosp Brescia, Pediat Oncohaematol & BMT Unit, Brescia, Italy; [Speckmann, Carsten] Univ Freiburg, Med Ctr, Dept Pediat Hematol & Oncol, Ctr Pediat & Adolescent Med,Fac Med, Freiburg, Germany; [Speckmann, Carsten] Univ Freiburg, Med Ctr, Fac Med, Inst Immunodeficiency,Ctr Chron Immunodeficiency, Freiburg, Germany; [Sundin, Mikael] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Sect Pediat Hematol Immunol & HCT, Stockholm, Sweden; [Sundin, Mikael] Karolinska Inst, CLINTEC, Div Pediat, Stockholm, Sweden; [Toren, Amos] Sheba Med Ctr, Taediatr Hematooncol & BMT, Tel Hashomer, Israel; [Vettenranta, Kim] Univ Helsinki, Helsinki, Finland; [Vettenranta, Kim] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Yesilipek, Mehmet A.] Medicalpk Antalya Hosp, Pediat Hematol Oncol & Pediat Stem Cell Transplan, Antalya, Turkey; [Yesilipek, Mehmet A.] Gortepe Hosp, Pediat Hematol Oncol & Pediat Stem Cell Transplan, Antalya, Turkey; [Zecca, Marco] Fdn IRCCS Policlin San Matteo, Pediat Hematol Oncol, Pavia, Italy	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; University of Barcelona; Hospital Clinic de Barcelona; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Hannover Medical School; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ghent University; Ghent University Hospital; Newcastle University - UK; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Universitari Vall d'Hebron; Ankara University; Ankara University; University of Munster; Ernst Moritz Arndt Universitat Greifswald; CHU Strasbourg; University of Gothenburg; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Charles University Prague; Ulm University; Jagiellonian University; Collegium Medicum Jagiellonian University; University Children's Hospital Zurich; University Children's Hospital Zurich; Wroclaw Medical University; Ege University; Akdeniz University; Antalya Training & Research Hospital; Hospital Spedali Civili Brescia; Utrecht University; Utrecht University Medical Center; Heinrich Heine University Dusseldorf; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Saint Anna Children's Hospital; University of Freiburg; University of Freiburg; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Chaim Sheba Medical Center; University of Helsinki; University of Helsinki; Medical Park Hospitals Group; IRCCS Fondazione San Matteo	Lankester, AC (corresponding author), Leiden Univ Med Ctr, Willem Alexander Childrens Hosp, Pediat Stem Cell Transplantat Program, Albinusdreef 2, NL-2300 RC Leiden, Netherlands.; Lankester, AC (corresponding author), Leiden Univ Med Ctr, Willem Alexander Childrens Hosp, Lab Pediat Immunol, Albinusdreef 2, NL-2300 RC Leiden, Netherlands.	a.lankester@lumc.nl	Ferrua, Francesca/K-4340-2016; Diaz de Heredia, Cristina/G-4016-2016	Ferrua, Francesca/0000-0002-5695-4490; von Asmuth, Erik/0000-0001-6256-7457; Diaz de Heredia, Cristina/0000-0001-8086-296X; Fasth, Anders/0000-0002-0033-740X				Abd Hamid IJ, 2018, J CLIN IMMUNOL, V38, P727, DOI 10.1007/s10875-018-0540-9; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Bakhtiar S, 2021, BLOOD ADV, V5, P262, DOI 10.1182/bloodadvances.2020002185; Borghans JA, 2006, BLOOD, V108, P763, DOI 10.1182/blood-2006-01-009241; Chiesa R, 2020, BLOOD, V136, P1201, DOI 10.1182/blood.2020005590; Czechowicz A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08201-x; DEKONING J, 1969, LANCET, V1, P1223; Delmonte OM, 2022, J ALLERGY CLIN IMMUN, V149, P1113, DOI 10.1016/j.jaci.2021.07.029; Dvorak CC, 2014, J ALLERGY CLIN IMMUN, V134, P935, DOI 10.1016/j.jaci.2014.06.021; Elfeky R, 2019, J ALLERGY CLIN IMMUN, V144, P280, DOI 10.1016/j.jaci.2019.01.030; Fernandes JF, 2020, BIOL BLOOD MARROW TR, V26, P1923, DOI 10.1016/j.bbmt.2020.07.003; Ferrua F, 2019, J ALLERGY CLIN IMMUN, V143, P2238, DOI 10.1016/j.jaci.2018.12.1010; GATTI RA, 1968, LANCET, V2, P1366; Gennery AR, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00381; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Haddad E, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00481; Haddad E, 2018, BLOOD, V132, P1737, DOI 10.1182/blood-2018-03-840702; Hamid IJA, 2017, BLOOD, V129, P2198, DOI 10.1182/blood-2016-11-748616; Heimall J, 2017, BLOOD, V130, P2718, DOI 10.1182/blood-2017-05-781849; Hiwarkar P, 2017, BLOOD ADV, V1, P2206, DOI 10.1182/bloodadvances.2017010827; Kohn DB, 2021, NEW ENGL J MED, V384, P2002, DOI 10.1056/NEJMoa2027675; Laberko A, 2019, BLOOD, V134, P1755, DOI 10.1182/blood.2019001757; Miggelbrink AM, 2018, BLOOD, V131, P2967, DOI 10.1182/blood-2017-10-809822; Neven B, 2019, BIOL BLOOD MARROW TR, V25, P1363, DOI 10.1016/j.bbmt.2019.03.009; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Sarzotti M, 2003, J IMMUNOL, V170, P2711, DOI 10.4049/jimmunol.170.5.2711; Schuetz C, 2014, BLOOD, V123, P281, DOI 10.1182/blood-2013-01-476432; Shah RM, 2018, J ALLERGY CLIN IMMUN, V141, P1417, DOI 10.1016/j.jaci.2017.07.008; Shaw P, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00434; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; van der Burg M, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00373	32	10	10	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1744	+		10.1016/j.jaci.2021.10.017	http://dx.doi.org/10.1016/j.jaci.2021.10.017			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3I4PN	34718043	Green Published, hybrid			2022-12-18	WOS:000832701000006
J	Tsoi, LC; Hacini-Rachinel, F; Fogel, P; Rousseau, F; Xing, XY; Patrick, MT; Billi, AC; Berthier, CC; Kahlenberg, JM; Lazzari, A; Wiegmann, H; Stander, S; Piketty, C; Julia, V; Krishnaswamy, JK; Gudjonsson, JE				Tsoi, Lam C.; Hacini-Rachinel, Feriel; Fogel, Paul; Rousseau, Francois; Xing, Xianying; Patrick, Matthew T.; Billi, Allison C.; Berthier, Celine C.; Kahlenberg, J. Michelle; Lazzari, Anne; Wiegmann, Henning; Stander, Sonja; Piketty, Christophe; Julia, Valerie; Krishnaswamy, Jayendra Kumar; Gudjonsson, Johann E.			Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Prurigo nodularis; nemolizumab; <p>T(H)2</p>; <p>T(H)17</p>; mechanism	SKIN; GROWTH; CELLS	Background: Prurigo nodularis (PN) is a debilitating, difficultto-treat, intensely pruritic, chronic inflammatory skin disease characterized by hyperkeratotic skin nodules. The pathogenesis of PN is not well understood but is believed to involve cross talk between sensory nerve fibers, immune cells, and the epidermis. It is centered around the neuroimmune cytokine IL-31, driving an intractable itch-scratch cycle.& nbsp;Objective: We sought to provide a comprehensive view of the transcriptomic changes in PN skin and characterize the mechanism of action of the anti-IL-31 receptor inhibitor nemolizumab.& nbsp;Method: RNA sequencing of biopsy samples obtained from a cohort of patients treated with the anti-IL-31 receptor inhibitor nemolizumab and taken at baseline and week 12. Generation and integration of patient data with RNA-Seq data generated from reconstructed human epidermis stimulated with IL-31 and other proinflammatory cytokines.& nbsp;Results: Our results demonstrate that nemolizumab effectively decreases IL-31 responses in PN skin, leading to effective suppression of downstream inflammatory responses including T(H)2/IL-13 and T(H)17/IL-17 responses. This is accompanied by decreased keratinocyte proliferation and normalization of epidermal differentiation and function. Furthermore, our results demonstrate how transcriptomic changes associated with nemolizumab treatment correlate with improvement in lesions, pruritus, stabilization of extracellular matrix remodeling, and processes associated with cutaneous nerve function.& nbsp;Conclusion: These data demonstrate a broad response to IL-31 receptor inhibition with nemolizumab and confirm the critical upstream role of IL-31 in PN pathogenesis.& nbsp;	[Tsoi, Lam C.; Xing, Xianying; Patrick, Matthew T.; Billi, Allison C.; Gudjonsson, Johann E.] Univ Michigan, Dept Dermatol, Ann Arbor, MI USA; [Tsoi, Lam C.] Univ Michigan, Dept Biostat, Ann Arbor, MI USA; [Tsoi, Lam C.] Univ Michigan, Dept Computat Med & Bioinformat, Med Sch, Ann Arbor, MI USA; [Berthier, Celine C.] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA; [Hacini-Rachinel, Feriel; Fogel, Paul; Rousseau, Francois; Lazzari, Anne; Piketty, Christophe; Julia, Valerie; Krishnaswamy, Jayendra Kumar] Univ Hosp Munster, Dept Dermatol, Munster, France; [Wiegmann, Henning; Stander, Sonja] Univ Hosp Munster, Ctr Chron Pruritus, Munster, France; [Wiegmann, Henning; Stander, Sonja] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI USA; [Gudjonsson, Johann E.] Univ Michigan, Dept Dermatol, 6427C Med Sci Bldg I,1301 Catherine St, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gudjonsson, JE (corresponding author), Univ Michigan, Dept Dermatol, 6427C Med Sci Bldg I,1301 Catherine St, Ann Arbor, MI 48109 USA.	johanng@umich.edu						Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Belzberg M, J INVEST DERMATOL, V2021; Campion M, 2019, EXP DERMATOL, V28, P1501, DOI 10.1111/exd.14034; Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Galvao J, 2018, INVEST OPHTH VIS SCI, V59, P2736, DOI 10.1167/iovs.17-23319; Hanel KH, 2016, J IMMUNOL, V196, P3233, DOI 10.4049/jimmunol.1402943; Hashimoto T, 2021, EXP DERMATOL, V30, P804, DOI 10.1111/exd.14279; Huang AH, 2020, J AM ACAD DERMATOL, V83, P1559, DOI 10.1016/j.jaad.2020.04.183; Iking A, 2013, J EUR ACAD DERMATOL, V27, P550, DOI 10.1111/j.1468-3083.2012.04481.x; Johansson O, 2002, ARCH DERMATOL RES, V293, P614, DOI 10.1007/s00403-001-0285-8; Johansson O, 2000, ARCH DERMATOL RES, V292, P371, DOI 10.1007/s004030000142; Kasraie S, 2011, ALLERGY, V66, P845, DOI 10.1111/j.1398-9995.2011.02545.x; Kwatra SG, 2020, NEW ENGL J MED, V382, P757, DOI 10.1056/NEJMe1916733; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liang Y, 1998, J CUTAN PATHOL, V25, P189, DOI 10.1111/j.1600-0560.1998.tb01718.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Moore DL, 2011, MOL CELL NEUROSCI, V47, P233, DOI 10.1016/j.mcn.2011.05.005; Rouaud-Tinguely P, 2015, BRIT J DERMATOL, V173, P1006, DOI 10.1111/bjd.14012; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Schuhknecht B, 2011, BRIT J DERMATOL, V165, P85, DOI 10.1111/j.1365-2133.2011.10306.x; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Stander S, 2020, NEW ENGL J MED, V382, P706, DOI 10.1056/NEJMoa1908316; Todberg T, 2020, ACTA DERM-VENEREOL, V100, DOI 10.2340/00015555-3471; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; Wang JB, 2016, J BIOL CHEM, V291, P21422, DOI 10.1074/jbc.A116.732339; Weigelt N, 2010, J CUTAN PATHOL, V37, P578, DOI 10.1111/j.1600-0560.2009.01484.x; Williams KA, 2020, J AM ACAD DERMATOL, V83, P1567, DOI 10.1016/j.jaad.2020.04.182	30	10	10	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1329	1339		10.1016/j.jaci.2021.10.004	http://dx.doi.org/10.1016/j.jaci.2021.10.004			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	0Z8PK	34857395	hybrid			2022-12-18	WOS:000791333500008
J	Shamji, MH; Sharif, H; Layhadi, JA; Zhu, RF; Kishore, U; Renz, H				Shamji, Mohamed H.; Sharif, Hanisah; Layhadi, Janice A.; Zhu, Rongfei; Kishore, Uday; Renz, Harald			Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Allergen immunotherapy; antibody response; innate lymphoid cells	GRASS-POLLEN IMMUNOTHERAPY; INNATE LYMPHOID-CELLS; HELPER T-CELLS; REGULATORY B-CELLS; TERM CLINICAL-EFFICACY; FOLLICULAR HELPER; SUBLINGUAL IMMUNOTHERAPY; DENDRITIC CELLS; IMMUNOGLOBULIN-E; DIFFERENTIAL INDUCTION	Allergen immunotherapy (AIT) is an effective treatment for allergic rhinitis, inducing long-term clinical tolerance to the sensitizing allergen. Clinical tolerance induction can be achieved when AIT is administered for at least 3 years. AIT is associated with the modulation of innate and adaptive immune systems. This comprises inhibition of IgE-dependent activation of mast cells and basophils in the local target organ, suppression of T(H)2 cells, immune deviation toward T(H)1 cells, induction of T and B regulatory cells, and production of allergen-neutralizing antibodies. However, recent developments in their underpinning mechanisms have revealed that AIT, administered subcutaneously or sublingually, induces immune regulation through novel cell targets and molecular mechanisms. This comprehensive review discusses how immune tolerance driven by subcutaneous immunotherapy and sublingual immunotherapy is associated with the induction of a novel regulatory subset of innate lymphoid cells and suppression of proinflammatory T(H)2, allergen-specific T(H)2 (T(H)2A), and T follicular helper cells. Moreover, they are associated with exhaustion of T(H)2A cells and differential expression of nasal and systemic IgA antibodies. Uncovering the underpinning mechanisms of a successful AIT and immune tolerance induction will allow the development of targeted therapeutics for allergic rhinitis with and without asthma.	[Shamji, Mohamed H.; Sharif, Hanisah; Layhadi, Janice A.; Zhu, Rongfei] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Shamji, Mohamed H.; Sharif, Hanisah; Layhadi, Janice A.; Zhu, Rongfei] NIHR Imperial Biomed Res Ctr, London, England; [Zhu, Rongfei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Allergy, Wuhan, Peoples R China; [Kishore, Uday] Brunel Univ London, Coll Hlth Med & Life Sci, Biosci, Uxbridge, Middx, England; [Renz, Harald] Philipps Univ Marburg, Inst Lab Med, Marburg, Germany; [Renz, Harald] German Ctr Lung Res DZL, Marburg, Germany; [Renz, Harald] Univ Giessen & Marburg Lung Ctr, Marburg, Germany	Imperial College London; Huazhong University of Science & Technology; Brunel University; Philipps University Marburg	Shamji, MH (corresponding author), Imperial Coll London, Fac Med, Natl Heart & Lung Inst, Immunomodulat & Tolerance Grp,Allergy & Clin Immu, London SW7 2AZ, England.	m.shamji@imperial.ac.uk		Shamji, Mohamed/0000-0003-3425-3463				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Abebe EC, 2021, J INFLAMM RES, V14, P75, DOI 10.2147/JIR.S286426; Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Angelini F, 2011, WORLD J PEDIATR, V7, P24, DOI 10.1007/s12519-011-0242-3; Ballesteros-Tato A, 2016, IMMUNITY, V44, P259, DOI 10.1016/j.immuni.2015.11.017; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bellinghausen I, 2001, J ALLERGY CLIN IMMUN, V108, P242, DOI 10.1067/mai.2001.117177; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boonpiyathad T, 2021, J ALLERGY CLIN IMMUN, V147, P1507, DOI 10.1016/j.jaci.2020.10.029; Boonpiyathad T, 2019, J ALLERGY CLIN IMMUN, V143, P1077, DOI 10.1016/j.jaci.2018.10.061; Bousquet J, 2001, ANN ALLERG ASTHMA IM, V87, P38, DOI 10.1016/S1081-1206(10)62193-X; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Buelens C, 1995, ADV EXP MED BIOL, V378, P363; Burton BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5741; Buters J, 2015, J ALLERGY CLIN IMMUN, V136, P87, DOI 10.1016/j.jaci.2015.01.049; Calderon MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001936.pub2; Ciepiela O, 2014, PEDIAT ALLER IMM PUL, V27, P17, DOI 10.1089/ped.2014.0328; Cooke RA, 1935, J EXP MED, V62, P733, DOI 10.1084/jem.62.6.733; Craig TJ, 2004, J ALLERGY CLIN IMMUN, V114, pS139, DOI 10.1016/j.jaci.2004.08.044; De Bruyne R, 2015, CLIN EXP ALLERGY, V45, P1060, DOI 10.1111/cea.12514; Dhaeze T, 2015, J IMMUNOL, V195, P832, DOI 10.4049/jimmunol.1500759; Didier A, 2011, J ALLERGY CLIN IMMUN, V128, P559, DOI 10.1016/j.jaci.2011.06.022; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Durham SR, 2010, J ALLERGY CLIN IMMUN, V125, P131, DOI 10.1016/j.jaci.2009.10.035; Ebner C, 1997, CLIN EXP ALLERGY, V27, P1007, DOI 10.1111/j.1365-2222.1997.tb01252.x; Eljaszewicz A, 2021, J ALLERGY CLIN IMMUN, V147, P1865, DOI 10.1016/j.jaci.2020.08.042; Faffe DS, 2003, AM J PHYSIOL-LUNG C, V285, pL907, DOI 10.1152/ajplung.00120.2003; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Francis JN, 2008, J ALLERGY CLIN IMMUN, V121, P1120, DOI 10.1016/j.jaci.2008.01.072; FREEMAN J., 1960, ANN ALLERGY, V18, P427; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; Fukuda T, 1996, AM J RESP CELL MOL, V14, P84, DOI 10.1165/ajrcmb.14.1.8534490; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gevaert P, 2022, J ALLERGY CLIN IMMUN, V149, P189, DOI 10.1016/j.jaci.2021.05.039; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P261, DOI 10.1016/0091-6749(82)90062-8; Golebski K, 2021, IMMUNITY, V54, P291, DOI 10.1016/j.immuni.2020.12.013; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Gueguen C, 2016, J ALLERGY CLIN IMMUN, V137, P545, DOI 10.1016/j.jaci.2015.09.015; Guerra F, 2001, J ALLERGY CLIN IMMUN, V107, P647, DOI 10.1067/mai.2001.112263; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Haczku A, 1999, AM J RESP CRIT CARE, V159, P1638, DOI 10.1164/ajrccm.159.5.9711040; Hamid QA, 1997, J ALLERGY CLIN IMMUN, V99, P254, DOI 10.1016/S0091-6749(97)70106-4; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hua C, 2016, J AUTOIMMUN, V73, P64, DOI 10.1016/j.jaut.2016.06.002; Tabar AI, 2019, J ALLERGY CLIN IMMUN, V144, P216, DOI 10.1016/j.jaci.2019.02.029; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Jin JJ, 2017, J ALLER CL IMM-PRACT, V5, P1, DOI 10.1016/j.jaip.2016.09.027; Jung S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193958; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Karnekura R, 2015, CLIN IMMUNOL, V158, P204, DOI 10.1016/j.clim.2015.02.016; Kobayashi T, 2017, J ALLERGY CLIN IMMUN, V139, P300, DOI 10.1016/j.jaci.2016.04.021; Lao-Araya M, 2014, J ALLERGY CLIN IMMUN, V134, P1193, DOI 10.1016/j.jaci.2014.07.029; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Lilly CM, 1997, J CLIN INVEST, V99, P1767, DOI 10.1172/JCI119341; Lombardi V, 2016, J ALLERGY CLIN IMMUN, V138, P305, DOI 10.1016/j.jaci.2015.12.1325; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Matsuoka T, 2013, ALLERGOL INT, V62, P403, DOI 10.2332/allergolint.13-RAI-0650; Mitthamsiri W, 2018, ALLERGY ASTHMA IMMUN, V10, P662, DOI 10.4168/aair.2018.10.6.662; Mobs C, 2010, J IMMUNOL, V184, P2194, DOI 10.4049/jimmunol.0901379; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Muraro A, 2010, ALLERGY, V65, P681, DOI 10.1111/j.1398-9995.2010.02343.x; Naclerio R, 1999, J ALLERGY CLIN IMMUN, V103, pS382, DOI 10.1016/S0091-6749(99)70216-2; NOON L, 1953, INT ARCH ALLER A IMM, V4, P285, DOI 10.1159/000228032; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Novembre E, 2004, J ALLERGY CLIN IMMUN, V114, P851, DOI 10.1016/j.jaci.2004.07.012; O'Hehir RE, 2009, AM J RESP CRIT CARE, V180, P936, DOI 10.1164/rccm.200905-0686OC; Oefner CM, 2012, J ALLERGY CLIN IMMUN, V129, P1647, DOI 10.1016/j.jaci.2012.02.037; Okano M, 2008, CLIN EXP ALLERGY, V38, P1891, DOI 10.1111/j.1365-2222.2008.03116.x; Passali D, 2018, ASIA PAC ALLERGY, V8, DOI 10.5415/apallergy.2018.8.e7; Pilette C, 2007, J IMMUNOL, V178, P4658, DOI 10.4049/jimmunol.178.7.4658; Plewako H, 2006, INT ARCH ALLERGY IMM, V141, P346, DOI 10.1159/000095461; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Ratner P, 2015, ANN ALLERG ASTHMA IM, V114, P141, DOI 10.1016/j.anai.2014.11.012; Reisinger J, 2005, J ALLERGY CLIN IMMUN, V116, P347, DOI 10.1016/j.jaci.2005.04.003; Renand A, 2018, J ALLERGY CLIN IMMUN, V141, P1750, DOI 10.1016/j.jaci.2017.09.041; Rispens T, 2011, J AM CHEM SOC, V133, P10302, DOI 10.1021/ja203638y; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Rosskopf S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31757-z; Sato K, 2002, CELL IMMUNOL, V215, P186, DOI 10.1016/S0008-8749(02)00021-7; Scadding GW, 2015, ALLERGY, V70, P689, DOI 10.1111/all.12608; Scadding GW, 2010, CLIN EXP ALLERGY, V40, P598, DOI 10.1111/j.1365-2222.2010.03462.x; Scadding GK, 2000, CLIN OTOLARYNGOL, V25, P551, DOI 10.1046/j.1365-2273.2000.00417.x; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040; Schulten V, 2018, J ALLERGY CLIN IMMUN, V141, P775, DOI 10.1016/j.jaci.2017.04.032; Sehra S, 2015, J ALLERGY CLIN IMMUN, V136, P433, DOI 10.1016/j.jaci.2015.01.021; Shamji MH, 2012, ALLERGY, V67, P217, DOI 10.1111/j.1398-9995.2011.02745.x; Shamji MH, 2006, J IMMUNOL METHODS, V317, P71, DOI 10.1016/j.jim.2006.09.004; Shamji MH, 2021, J ALLERGY CLIN IMMUN, V148, P1061, DOI 10.1016/j.jaci.2021.03.030; Shamji MH, 2021, J ALLER CL IMM-PRACT, V9, P1769, DOI 10.1016/j.jaip.2021.03.029; Shamji MH, 2019, J ALLERGY CLIN IMMUN, V143, P1067, DOI 10.1016/j.jaci.2018.09.039; Shamji MH, 2019, J ALLERGY CLIN IMMUN, V143, P1131, DOI 10.1016/j.jaci.2018.06.041; Shamji MH, 2017, J ALLERGY CLIN IMMUN, V140, P1485, DOI 10.1016/j.jaci.2017.10.010; Shamji MH, 2015, J ALLERGY CLIN IMMUN, V135, P913, DOI 10.1016/j.jaci.2014.09.049; Shamji MH, 2013, J ALLERGY CLIN IMMUN, V132, P1003, DOI 10.1016/j.jaci.2013.05.025; Sharif H, 2021, J ALLERGY CLIN IMMUN, V147, P663, DOI 10.1016/j.jaci.2020.10.035; Sharif H, 2019, J ALLERGY CLIN IMMUN, V144, P738, DOI 10.1016/j.jaci.2019.02.023; Shi JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01849; Small Peter, 2011, Allergy Asthma Clin Immunol, V7 Suppl 1, pS3, DOI 10.1186/1710-1492-7-S1-S3; Soderquist B, 1999, CLIN EXP IMMUNOL, V118, P408; Swamy RS, 2012, J ALLERGY CLIN IMMUN, V130, P215, DOI 10.1016/j.jaci.2012.04.021; TAYLOR JA, 1995, MOL CELL BIOL, V15, P4149; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Tran NP, 2011, ALLERGY ASTHMA IMMUN, V3, P148, DOI 10.4168/aair.2011.3.3.148; Tulic MK, 2004, J ALLERGY CLIN IMMUN, V113, P235, DOI 10.1016/j.jaci.2003.11.001; van de Veen W, 2016, J ALLERGY CLIN IMMUN, V138, P654, DOI 10.1016/j.jaci.2016.07.006; van Neerven RJJ, 1999, J IMMUNOL, V163, P2944; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Wachholz PA, 2003, J ALLERGY CLIN IMMUN, V112, P915, DOI 10.1016/S0091-6749(03)02022-0; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Wambre E, 2015, CURR OPIN ALLERGY CL, V15, P581, DOI 10.1097/ACI.0000000000000216; Wambre E, 2014, J ALLERGY CLIN IMMUN, V133, P872, DOI 10.1016/j.jaci.2013.10.054; Wambre E, 2012, CURR OPIN IMMUNOL, V24, P700, DOI 10.1016/j.coi.2012.07.009; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544, DOI 10.1016/j.jaci.2011.08.034; Wang SH, 2021, ALLERGY, V76, P2827, DOI 10.1111/all.14896; WARDLAW AJ, 1994, J ALLERGY CLIN IMMUN, V94, P1163, DOI 10.1016/0091-6749(94)90327-1; Wurtzen PA, 2008, CLIN EXP ALLERGY, V38, P1290, DOI 10.1111/j.1365-2222.2008.03020.x; Yanez A, 2002, ANN ALLERG ASTHMA IM, V89, P479, DOI 10.1016/S1081-1206(10)62085-6; Yao Y, 2019, J ALLERGY CLIN IMMUN, V144, P118, DOI 10.1016/j.jaci.2019.02.008; Yao Y, 2018, J ALLERGY CLIN IMMUN, V142, P321, DOI 10.1016/j.jaci.2018.03.008; Yorgancioglu A, 2008, TUBERK TORAK, V56, P224; Zimmer A, 2012, J ALLERGY CLIN IMMUN, V129, P1020, DOI 10.1016/j.jaci.2012.02.014; Zissler UM, 2018, EBIOMEDICINE, V36, P475, DOI 10.1016/j.ebiom.2018.09.016	132	10	10	7	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					791	801		10.1016/j.jaci.2022.01.016	http://dx.doi.org/10.1016/j.jaci.2022.01.016			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	35093483	Green Published, hybrid			2022-12-18	WOS:000765938100001
J	Ma, C; Schoepfer, AM; Dellon, ES; Bredenoord, AJ; Chehade, M; Collins, MH; Feagan, BG; Furuta, GT; Gupta, SK; Hirano, I; Jairath, V; Katzka, DA; Pai, RK; Rothenberg, ME; Straumann, A; Aceves, SS; Alexander, JA; Arva, NC; Atkins, D; Biedermann, L; Blanchard, C; Cianferoni, A; de los Rios, CC; Clayton, F; Davis, CM; de Bortoli, N; Dias, JA; Falk, GW; Genta, RM; Ghaffari, G; Gonsalves, N; Greuter, T; Hopp, R; Blatman, KSH; Jensen, ET; Johnston, D; Kagalwalla, AF; Larsson, HM; Leung, J; Louis, H; Masterson, JC; Menard-Katcher, C; Menard-Katcher, PA; Moawad, FJ; Muir, AB; Mukkada, VA; Penagini, R; Pesek, RD; Peterson, K; Putnam, PE; Ravelli, A; Savarino, EV; Schlag, C; Schreiner, P; Simon, D; Smyrk, TC; Spergel, JM; Taft, TH; Terreehorst, I; Vanuytsel, T; Venter, C; Vieira, MC; Vieth, M; Vlieg-Boerstra, B; von Arnim, U; Walker, MM; Wechsler, JB; Woodland, P; Woosley, JT; Yang, GY; Zevit, N; Safroneeva, E				Ma, Christopher; Schoepfer, Alain M.; Dellon, Evan S.; Bredenoord, Albert J.; Chehade, Mirna; Collins, Margaret H.; Feagan, Brian G.; Furuta, Glenn T.; Gupta, Sandeep K.; Hirano, Ikuo; Jairath, Vipul; Katzka, David A.; Pai, Rish K.; Rothenberg, Marc E.; Straumann, Alex; Aceves, Seema S.; Alexander, Jeffrey A.; Arva, Nicoleta C.; Atkins, Dan; Biedermann, Luc; Blanchard, Carine; Cianferoni, Antonella; de los Rios, Constanza Ciriza; Clayton, Frederic; Davis, Carla M.; de Bortoli, Nicola; Dias, Jorge A.; Falk, Gary W.; Genta, Robert M.; Ghaffari, Gisoo; Gonsalves, Nirmala; Greuter, Thomas; Hopp, Russell; Blatman, Karen S. Hsu; Jensen, Elizabeth T.; Johnston, Doug; Kagalwalla, Amir F.; Larsson, Helen M.; Leung, John; Louis, Hubert; Masterson, Joanne C.; Menard-Katcher, Calies; Menard-Katcher, Paul A.; Moawad, Fouad J.; Muir, Amanda B.; Mukkada, Vincent A.; Penagini, Roberto; Pesek, Robert D.; Peterson, Kathryn; Putnam, Philip E.; Ravelli, Alberto; Savarino, Edoardo, V; Schlag, Christoph; Schreiner, Philipp; Simon, Dagmar; Smyrk, Thomas C.; Spergel, Jonathan M.; Taft, Tiffany H.; Terreehorst, Ingrid; Vanuytsel, Tim; Venter, Carina; Vieira, Mario C.; Vieth, Michael; Vlieg-Boerstra, Berber; von Arnim, Ulrike; Walker, Marjorie M.; Wechsler, Joshua B.; Woodland, Philip; Woosley, John T.; Yang, Guang-Yu; Zevit, Noam; Safroneeva, Ekaterina			Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophilic esophagitis; outcomes; clinical trials; end points; histology; histopathology; endoscopy; symptoms; patient-reported outcomes; quality of life	BUDESONIDE ORAL SUSPENSION; ENDOSCOPIC REFERENCE SCORE; DIAGNOSIS; ADULTS; GUIDELINES; MANAGEMENT; SYMPTOMS; CHILDREN; FEATURES; PLACEBO	Background: End points used to determine treatment efficacy in eosinophilic esophagitis (EoE) have evolved over time. With multiple novel therapies in development for EoE, harmonization of outcomes measures will facilitate evidence synthesis and appraisal when comparing different treatments. Objective: We sought to develop a core outcome set (COS) for controlled and observational studies of pharmacologic and diet interventions in adult and pediatric patients with EoE. Methods: Candidate outcomes were generated from systematic literature reviews and patient engagement interviews and surveys. Consensus was established using an iterative Delphi process, with items voted on using a 9-point Likert scale and with feedback from other participants to allow score refinement. Consensus meetings were held to ratify the outcome domains of importance and the core outcome measures. Stakeholders were recruited internationally and included adult and pediatric gastroenterologists, allergists, dieticians, pathologists, psychologists, researchers, and methodologists. Results: The COS consists of 4 outcome domains for controlled and observational studies: histopathology, endoscopy, patientreported symptoms, and EoE-specific quality of life. A total of 69 stakeholders (response rate 95.8%) prioritized 42 outcomes in a 2-round Delphi process, and the final ratification meeting generated consensus on 33 outcome measures. These included measurement of the peak eosinophil count, Eosinophilic Esophagitis Histology Scoring System, Eosinophilic Esophagitis Endoscopic Reference Score, and patient-reported measures of dysphagia and quality of life. Conclusions: This interdisciplinary collaboration involving global stakeholders has produced a COS that can be applied to adult and pediatric studies of pharmacologic and diet therapies for EoE and will facilitate meaningful treatment comparisons and improve the quality of data synthesis.	[Ma, Christopher] Univ Calgary, Dept Med, Div Gastroenterol & Hepatol, Calgary, AB, Canada; [Ma, Christopher] Univ Calgary, Dept Community Hlth Sci, Div Gastroenterol & Hepatol, Calgary, AB, Canada; [Ma, Christopher; Feagan, Brian G.; Jairath, Vipul] Alimentiv Inc, London, ON, Canada; [Schoepfer, Alain M.; Greuter, Thomas] Ctr Hosp Univ Vaudois CHUV, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Schoepfer, Alain M.; Greuter, Thomas] Univ Lausanne, Lausanne, Switzerland; [Dellon, Evan S.] Univ N Carolina, Div Gastroenterol & Hepatol, Ctr Esophageal Dis & Swallowing, Sch Med, Chapel Hill, NC USA; [Bredenoord, Albert J.] Amsterdam Univ Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Chehade, Mirna] Icahn Sch Med Mt Sinai, Mt Sinai Ctr Eosinophil Disorders, New York, NY 10029 USA; [Collins, Margaret H.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Feagan, Brian G.; Jairath, Vipul] Western Univ, Dept Med, London, ON, Canada; [Feagan, Brian G.; Jairath, Vipul] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Furuta, Glenn T.; Menard-Katcher, Calies] Univ Colorado, Childrens Hosp Colorado, Digest Hlth Inst, Sect Pediat Gastroenterol,Sch Med, Aurora, CO USA; [Gupta, Sandeep K.] Indiana Univ Sch Med, Riley Hosp Children, Div Pediat Gastroenterol Hepatol & Nutr, Indianapolis, IN 46202 USA; [Hirano, Ikuo; Gonsalves, Nirmala; Taft, Tiffany H.] Northwestern Univ, Div Gastroenterol & Hepatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Katzka, David A.; Alexander, Jeffrey A.] Mayo Clin, Div Gastroenterol, Rochester, NY USA; [Pai, Rish K.] Mayo Clin Arizona, Dept Pathol & Lab Med, Scottsdale, AZ USA; [Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr,Div Allergy & I, Cincinnati, OH USA; [Straumann, Alex; Biedermann, Luc; Greuter, Thomas; Schreiner, Philipp] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Aceves, Seema S.] Univ Calif San Diego, Rady Childrens Hosp, Div Allergy Immunol, San Diego, CA 92103 USA; [Arva, Nicoleta C.] Northwestern Univ, Dept Pathol & Lab Med, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Atkins, Dan; Venter, Carina] Univ Colorado, Sch Med, Sect Allergy & Immunol, Gastrointestinal Eosinophil Dis Program,Childrens, Aurora, CO USA; [Blanchard, Carine] Nestle Res, Soc Prod Nestle, Nestle Inst Hlth Sci, Vevey, Switzerland; [Cianferoni, Antonella; Spergel, Jonathan M.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat,Div Allergy & Immunol, Philadelphia, PA 19104 USA; [de los Rios, Constanza Ciriza] Univ Complutense, Hosp Clin San Carlos, Inst Invest Sanitaria SanCarlos IdISSC, Dept Gastroenterol, Madrid, Spain; [Clayton, Frederic] Univ Utah, Dept Pathol, Huntsman Canc Hosp, Salt Lake City, UT USA; [Davis, Carla M.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Immunol Allergy & Retrovirol Sect, Houston, TX 77030 USA; [de Bortoli, Nicola] Univ Pisa, Cisanello Hosp, Dept Translat Res & New Technol Med & Surg, Div Gastroenterol, Pisa, Italy; [Dias, Jorge A.] Ctr Hosp S Joao, Pediat Gastroenterol, Porto, Portugal; [Falk, Gary W.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Genta, Robert M.] Inform Diagnost, Irving, TX USA; [Genta, Robert M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Ghaffari, Gisoo] Penn State Coll Med, Div Pulm Allergy Crit Care Med, Dept Med, Hershey, PA USA; [Hopp, Russell] Univ Nebraska Med Ctr, Childrens Hosp & Med Ctr, Omaha, NE USA; [Blatman, Karen S. Hsu] Dartmouth Geisel Sch Med, Dartmouth Hitchcock Med Ctr, Sect Allergy & Clin Immunol, Hanover, NH USA; [Jensen, Elizabeth T.] Wake Forest Univ Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Johnston, Doug] Asthma & Allergy Specialists, Charlotte, NC USA; [Kagalwalla, Amir F.; Wechsler, Joshua B.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Chicago, IL 60611 USA; [Kagalwalla, Amir F.] John H Stroger Jr Hosp Cook Cty, Dept Pediat, Div Gastroenterol, Chicago, IL USA; [Larsson, Helen M.] NAL Med Ctr, Dept ENT Head & Neck Surg, Trollhattan, Sweden; [Leung, John] Tufts Med Ctr, Div Gastroenterol, Boston, MA 02111 USA; [Louis, Hubert] Univ Libre Bruxelles, Dept Gastroenterol Hepatopancreatol & Digest Onco, Erasme Hosp, Brussels, Belgium; [Masterson, Joanne C.] Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland; [Menard-Katcher, Paul A.] Univ Colorado, Div Gastroenterol & Hepatol, Anschutz Med Campus, Aurora, CO USA; [Moawad, Fouad J.] Scripps Clin, Div Gastroenterol & Hepatol, La Jolla, CA USA; [Muir, Amanda B.] Univ Penn, Childrens Hosp Philadelphia, Div Gastroenterol & Hepatol & Nutr, Ctr Pediat Eosinophil Dis,Perelman Sch Med, Philadelphia, PA 19104 USA; [Mukkada, Vincent A.; Putnam, Philip E.] Univ Cincinnati, Coll Med, Dept Pediat,Div Gastroenterol Hepatol & Nutr, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Penagini, Roberto] Univ Milan, Dept Patho Physiol & Transplantat, Milan, Italy; [Penagini, Roberto] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Milan, Italy; [Pesek, Robert D.] Univ Arkansas Med Sci, Div Allergy & Immunol, Little Rock, AR 72205 USA; [Pesek, Robert D.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Peterson, Kathryn] Univ Utah, Div Gastroenterol, Salt Lake City, UT USA; [Ravelli, Alberto] Childrens Hosp, Univ Dept Pediat, Spedali Civili, Brescia, Italy; [Savarino, Edoardo, V] Univ Padua, Dept Surg Oncol & Gastroenterol, DiSCOG, Padua, Italy; [Schlag, Christoph] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, Munich, Germany; [Simon, Dagmar] Univ Bern, Bern Univ Hosp, Dept Dermatol, Inselspital, Bern, Switzerland; [Smyrk, Thomas C.] Mayo Clin, Dept Pathol, Rochester, NY USA; [Terreehorst, Ingrid] Amsterdam Univ Med Ctr, Dept ENT, Amsterdam, Netherlands; [Vanuytsel, Tim] Univ Hosp Leuven, Gastroenterol & Hepatol, Leuven, Belgium; [Vanuytsel, Tim] KULeuven, Translat Res Gastrointestinal Disorders, Leuven, Belgium; [Vieira, Mario C.] Pontificia Univ Catolica Parana, Dept Pediat, Curitiba, Parana, Brazil; [Vieira, Mario C.] Hosp Pequeno Principe, Ctr Pediat Gastroenterol, Curitiba, Parana, Brazil; [Vieth, Michael] Friedrich Alexander Univ Erlangen Nuremberg, Inst Pathol, Klinikum Bayreuth, Erlangen, Germany; [Vlieg-Boerstra, Berber] OLVG Hosp, Dept Pediat, Amsterdam, Netherlands; [von Arnim, Ulrike] Univ Hosp, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Walker, Marjorie M.] Univ Newcastle, Ctr Res Excellence Digest Hlth, Newcastle, NSW, Australia; [Woodland, Philip] Queen Mary Univ London, Bark & London Sch Med & Dent, Wingate Inst Neurogastroenterol, London, England; [Woosley, John T.] Univ N Carolina, Dept Pathol & Lab Med, Sch Med, Chapel Hill, NC USA; [Yang, Guang-Yu] Northwestern Univ, Feinberg Sch Med, Div Pathol, Chicago, IL 60611 USA; [Zevit, Noam] Schneider Childrens Med Ctr Israel, Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel; [Zevit, Noam] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Safroneeva, Ekaterina] Univ Bern, Inst Social & Prevent Med, Mittelstr 43, CH-3012 Bern, Switzerland	University of Calgary; University of Calgary; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Icahn School of Medicine at Mount Sinai; Cincinnati Children's Hospital Medical Center; Western University (University of Western Ontario); Western University (University of Western Ontario); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Northwestern University; Feinberg School of Medicine; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Zurich; University Zurich Hospital; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; Nestle SA; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Complutense University of Madrid; Hospital Clinico San Carlos; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Baylor College of Medicine; University of Pisa; Sao Joao Hospital; University of Pennsylvania; Pennsylvania Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Nebraska System; University of Nebraska Medical Center; Dartmouth College; Wake Forest University; Ann & Robert H. Lurie Children's Hospital of Chicago; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tufts Medical Center; Universite Libre de Bruxelles; Maynooth University; University of Colorado System; University of Colorado Anschutz Medical Campus; Scripps Research Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; Utah System of Higher Education; University of Utah; University of Padua; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Bern; University Hospital of Bern; Mayo Clinic; KU Leuven; University Hospital Leuven; KU Leuven; Pontificia Universidade Catolica do Parana; Hospital Pequeno Principe; Klinikum Bayreuth; University of Erlangen Nuremberg; University Hospital Magdeburg; University of Newcastle; University of London; Queen Mary University London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Northwestern University; Feinberg School of Medicine; Tel Aviv University; Sackler Faculty of Medicine; University of Bern	Safroneeva, E (corresponding author), Univ Bern, Inst Social & Prevent Med, Mittelstr 43, CH-3012 Bern, Switzerland.	ina.safroneeva@ispm.unibe.ch	Ma, Christopher/AAH-4886-2021; Vanuytsel, Tim/O-9972-2016	Vanuytsel, Tim/0000-0001-8728-0903	Swiss National Science Foundation [32003B_160115/1, 32473B_185008]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Supported by grants from the Swiss National Science Foundation (32003B_160115/1 to A.M.S. and 32473B_185008 to E.S.), Switzerland.	Aceves SS, 2018, J ALLERGY CLIN IMMUN, V142, P130, DOI 10.1016/j.jaci.2018.05.014; Aceves SS, 2011, J ALLERGY CLIN IMMUN, V128, P1047, DOI 10.1016/j.jaci.2011.09.026; Collins MH, 2017, DIS ESOPHAGUS, V30, DOI 10.1111/dote.12470; Collins MH, 2019, AM J SURG PATHOL, V43, P1501, DOI 10.1097/PAS.0000000000001361; de Rooij WE, 2019, DRUGS, V79, P1419, DOI 10.1007/s40265-019-01173-2; Dellon ES, 2013, ALIMENT PHARM THER, V38, P634, DOI 10.1111/apt.12413; Dellon ES, 2007, AM J GASTROENTEROL, V102, P2300, DOI 10.1111/j.1572-0241.2007.01396.x; Dellon ES, 2020, CLIN GASTROENTEROL H, V18, P1483, DOI 10.1016/j.cgh.2019.08.050; Dellon ES, 2019, GASTROENTEROLOGY, V157, P65, DOI 10.1053/j.gastro.2019.03.014; Dellon ES, 2018, GASTROENTEROLOGY, V155, P1022, DOI 10.1053/j.gastro.2018.07.009; Dellon ES, 2018, GASTROENTEROLOGY, V154, P319, DOI 10.1053/j.gastro.2017.06.067; Dellon ES, 2017, GASTROENTEROLOGY, V152, P776, DOI 10.1053/j.gastro.2016.11.021; Dellon ES, 2016, CLIN GASTROENTEROL H, V14, P31, DOI 10.1016/j.cgh.2015.08.040; Dellon ES, 2014, GASTROINTEST ENDOSC, V79, P577, DOI 10.1016/j.gie.2013.10.027; Dellon ES, 2013, AM J GASTROENTEROL, V108, P679, DOI 10.1038/ajg.2013.71; Dellon ES, 2012, CURR OPIN GASTROEN, V28, P382, DOI 10.1097/MOG.0b013e328352b5ef; Eluri S, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.27; Franciosi JP, 2013, J PEDIATR GASTR NUTR, V57, P57, DOI 10.1097/MPG.0b013e31828f1fd2; Franciosi JP, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-126; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Furuta GT, 2015, NEW ENGL J MED, V373, P1640, DOI 10.1056/NEJMra1502863; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hirano I, 2020, GASTROENTEROLOGY, V158, P1776, DOI 10.1053/j.gastro.2020.02.038; Hirano I, 2019, AM J GASTROENTEROL, V114, pS205, DOI 10.14309/01.ajg.0000590932.88962.0b; Hirano I, 2020, GASTROENTEROLOGY, V158, P111, DOI 10.1053/j.gastro.2019.09.042; Hirano I, 2019, GASTROENTEROLOGY, V156, P592, DOI 10.1053/j.gastro.2018.10.051; Hirano I, 2017, CLIN GASTROENTEROL H, V15, P1173, DOI 10.1016/j.cgh.2017.03.016; Hirano I, 2013, GUT, V62, P489, DOI 10.1136/gutjnl-2011-301817; Hiremath G, 2020, GASTROINTEST ENDOSC, V91, P785, DOI 10.1016/j.gie.2019.11.031; Hudgens S, 2017, J PATIENT-REP OUTCOM, V1, DOI 10.1186/s41687-017-0006-5; Kirkham JJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002447; Kirkham JJ, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0913-9; Klinnert MD, 2019, J PEDIATR GASTR NUTR, V69, P682, DOI 10.1097/MPG.0000000000002479; Lucendo AJ, 2019, GASTROENTEROLOGY, V157, P74, DOI 10.1053/j.gastro.2019.03.025; Lucendo AJ, 2017, UNITED EUR GASTROENT, V5, P335, DOI 10.1177/2050640616689525; Lynch MK, 2018, J PEDIATR PSYCHOL, V43, P464, DOI 10.1093/jpepsy/jsx128; Lyons E, 2019, GASTROENTEROLOGY, V157, P275, DOI 10.1053/j.gastro.2019.04.020; Ma C, 2018, CLIN GASTROENTEROL H, V16, P1714, DOI 10.1016/j.cgh.2018.06.005; Martin LJ, 2015, J ALLERGY CLIN IMMUN, V135, P1519, DOI 10.1016/j.jaci.2015.03.004; Moawad FJ, 2016, CLIN GASTROENTEROL H, V14, P23, DOI 10.1016/j.cgh.2015.08.034; Reed CC, 2018, CLIN GASTROENTEROL H, V16, P226, DOI 10.1016/j.cgh.2017.09.046; Rubin T, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0144-y; Safroneeva E, 2020, AM J GASTROENTEROL, V115, P2098, DOI 10.14309/ajg.0000000000000957; Safroneeva E, 2018, ALIMENT PHARM THER, V48, P1082, DOI 10.1111/apt.15000; Safroneeva E, 2016, GASTROENTEROLOGY, V150, P581, DOI 10.1053/j.gastro.2015.11.004; Schoepfer AM, 2021, INT ARCH ALLERGY IMM, DOI 10.1159/000516898; Schoepfer AM, 2014, GASTROENTEROLOGY, V147, P1255, DOI 10.1053/j.gastro.2014.08.028; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Straumann A, 2020, GASTROENTEROLOGY, V159, P1672, DOI 10.1053/j.gastro.2020.07.039; Taft TH, 2011, ALIMENT PHARM THER, V34, P790, DOI 10.1111/j.1365-2036.2011.04791.x; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; van Rhijn BD, 2014, ENDOSCOPY, V46, P1049, DOI 10.1055/s-0034-1377781; Wang R, 2018, DIGEST DIS SCI, V63, P1756, DOI 10.1007/s10620-018-5045-0; Warners MJ, 2018, ALIMENT PHARM THER, V47, P940, DOI 10.1111/apt.14559; Warners MJ, 2018, AM J GASTROENTEROL, V113, P836, DOI 10.1038/s41395-018-0052-5; Warners MJ, 2017, AM J GASTROENTEROL, V112, P1658, DOI 10.1038/ajg.2017.363; Wechsler JB, 2018, CLIN GASTROENTEROL H, V16, P1056, DOI 10.1016/j.cgh.2017.12.019; Williamson PR, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1978-4	58	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					659	670		10.1016/j.jaci.2021.07.001	http://dx.doi.org/10.1016/j.jaci.2021.07.001			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34242635	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-18	WOS:000752623200024
J	Baxter, SK; Walsh, T; Casadei, S; Eckert, MM; Allenspach, EJ; Hagin, D; Segundo, G; Lee, MK; Gulsuner, S; Shirts, BH; Sullivan, KE; Keller, MD; Torgerson, TR; King, MC				Baxter, Sarah K.; Walsh, Tom; Casadei, Silvia; Eckert, Mary M.; Allenspach, Eric J.; Hagin, David; Segundo, Gesmar; Lee, Ming K.; Gulsuner, Suleyman; Shirts, Brian H.; Sullivan, Kathleen E.; Keller, Michael D.; Torgerson, Troy R.; King, Mary-Claire			Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immune dysregulation; molecular diagnosis; genetics; sequencing; pediatric; precision medicine; autoimmunity; inborn er-rors of immunity; primary immunodeficiency disorders	MICROVILLUS INCLUSION DISEASE; PRIMARY IMMUNODEFICIENCY; MUTATIONS; IRF2BP2; ASSOCIATION; GENETICS; FEATURES; GAIN; IPEX	Background: Most patients with childhood-onset immune dysregulation, polyendocrinopathy, and enteropathy have no genetic diagnosis for their illness. These patients may undergo empirical immunosuppressive treatment with highly variable outcomes. Objective: We sought to determine the genetic basis of disease in patients referred with Immune dysregulation, disease, but with no mutation in FOXP3; then to assess consequences of genetic diagnoses for clinical management. Methods: Genomic DNA was sequenced using a panel of 462 genes implicated in inborn errors of immunity. Candidate mutations were characterized by genomic, transcriptional, and (for some) protein analysis. Results: Of 123 patients with FOXP3-negative IPEX-like disease, 48 (39%) carried damaging germline mutations in 1 of the following 27 genes: AIRE, BACH2, BCL11B, CARD11, CARD14, CTLA4, IRF2BP2, ITCH, JAK1, KMT2D, LRBA, MYO5B, NFKB1, NLRC4, POLA1, POMP, RAG1, SH2D1A, TACI, TOM1, TTC37, and XIAP. Many of these genes had not been previously associated with an IPEX-like diagnosis. For 42 of the 48 patients with genetic diagnoses, knowing the critical gene could have altered therapeutic management, including recommendations for targeted treatments and for or against hematopoietic cell transplantation. Conclusions: Many childhood disorders now bundled as "IPEX-like"disease are caused by individually rare, severe mutations in immune regulation genes. Most genetic diagnoses of these conditions yield clinically actionable findings. Barriers are lack of testing or lack of repeat testing if older technologies failed to provide a diagnosis. (J Allergy Clin Immunol 2022;149:327-39.)	[Baxter, Sarah K.; Allenspach, Eric J.; Torgerson, Troy R.] Univ Washington, Dept Pediat Pediat Rheumatol, Seattle, WA 98195 USA; [Baxter, Sarah K.; Eckert, Mary M.; Allenspach, Eric J.; Hagin, David; Torgerson, Troy R.] Seattle Childrens Hosp & Res Inst, Seattle, WA USA; [Baxter, Sarah K.; Walsh, Tom; Casadei, Silvia; Lee, Ming K.; Gulsuner, Suleyman; King, Mary-Claire] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Baxter, Sarah K.; Walsh, Tom; Casadei, Silvia; Lee, Ming K.; Gulsuner, Suleyman; King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hagin, David] Tel Aviv Univ, Allergy & Clin Immunol Unit, Dept Med, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Hagin, David] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Segundo, Gesmar] Univ Fed Uberlandia, Dept Pediat Allergy & Immunol, Uberlandia, MG, Brazil; [Shirts, Brian H.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA; [Sullivan, Kathleen E.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Keller, Michael D.] Childrens Natl Hosp, Div Allergy & Immunol, Washington, DC USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Universidade Federal de Uberlandia; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's National Health System	King, MC (corresponding author), Univ Washington, Hlth Sci, K-160,1959 NE Pacific St, Seattle, WA 98195 USA.	mcking@uw.edu	Hagin, David/GRS-3442-2022	Shirts, brian/0000-0002-7188-6764	National Institutes of Health; NIH [R35CA197458]; King Lab Gift Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Lab Gift Fund	This study was supported by the National Institutes of Health (grant no. NIH R35CA197458 to M.C.K.) and King Lab Gift Fund.	Abu Rayyan A, 2020, P NATL ACAD SCI USA, V117, P20070, DOI 10.1073/pnas.2009628117; Afzali B, 2017, NAT IMMUNOL, V18, P813, DOI 10.1038/ni.3753; Barzaghi F, 2018, J ALLERGY CLIN IMMUN, V141, P1036, DOI 10.1016/j.jaci.2017.10.041; Baxter SK, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.3435; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Burroughs LM, 2010, J ALLERGY CLIN IMMUN, V126, P1000, DOI 10.1016/j.jaci.2010.05.021; Canna SW, 2020, BLOOD, V135, P1332, DOI 10.1182/blood.2019000936; Canna SW, 2017, J ALLERGY CLIN IMMUN, V139, P1698, DOI 10.1016/j.jaci.2016.10.022; Casadei S, 2019, P NATL ACAD SCI USA, V116, P26798, DOI 10.1073/pnas.1915608116; Chandrasekaran P, 2016, J ALLERGY CLIN IMMUN, V138, P1222, DOI 10.1016/j.jaci.2016.05.007; Chen HH, 2015, CIRC RES, V117, P671, DOI 10.1161/CIRCRESAHA.114.305777; Constantine GM, 2019, IMMUNOL REV, V287, P103, DOI 10.1111/imr.12714; Craiglow BG, 2018, J AM ACAD DERMATOL, V79, P487, DOI 10.1016/j.jaad.2018.02.034; Del Bel KL, 2017, J ALLERGY CLIN IMMUN, V139, P2016, DOI 10.1016/j.jaci.2016.12.957; Delmonte OM, 2020, MED PRIN PRACT, V29, P101, DOI 10.1159/000503997; Fabre A, 2019, J ALLER CL IMM-PRACT, V7, P1958, DOI 10.1016/j.jaip.2019.02.018; Fabre A, 2017, INTRACTABLE RARE DIS, V6, P152, DOI 10.5582/irdr.2017.01040; Fabre A, 2012, AM J HUM GENET, V90, P689, DOI 10.1016/j.ajhg.2012.02.009; Fabre A, 2011, HUM MUTAT, V32, P277, DOI 10.1002/humu.21420; Farmer JR, 2019, J ALLER CL IMM-PRACT, V7, P1970, DOI 10.1016/j.jaip.2019.02.038; Gamez-Diaz L, 2016, J ALLERGY CLIN IMMUN, V137, P223, DOI 10.1016/j.jaci.2015.09.025; Gulsuner S, 2020, SCIENCE, V367, P569, DOI 10.1126/science.aay8833; Habibi S, 2019, J ALLER CL IMM-PRACT, V7, P2379, DOI 10.1016/j.jaip.2019.04.011; Heimall JR, 2018, J CLIN IMMUNOL, V38, P320, DOI 10.1007/s10875-018-0489-8; Kadowaki T, 2018, J ALLERGY CLIN IMMUN, V141, P1485, DOI 10.1016/j.jaci.2017.10.039; Keller MD, 2016, J ALLERGY CLIN IMMUN, V138, P544, DOI 10.1016/j.jaci.2016.01.018; Keskitalo S, 2019, NPJ GENOM MED, V4, DOI 10.1038/s41525-019-0088-5; Leiding JW, 2019, J ALLER CL IMM-PRACT, V7, P761, DOI 10.1016/j.jaip.2018.12.017; Lindsley AW, 2016, J ALLERGY CLIN IMMUN, V137, P179, DOI 10.1016/j.jaci.2015.06.002; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Ono S, 2017, J CLIN IMMUNOL, V37, P85, DOI 10.1007/s10875-016-0348-4; Ramalho-Oliveira R, 2019, J LEUKOCYTE BIOL, V106, P717, DOI 10.1002/JLB.MR1218-507R; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Schwab C, 2018, J ALLERGY CLIN IMMUN, V142, P1932, DOI 10.1016/j.jaci.2018.02.055; Siahanidou T, 2013, EUR J PEDIATR, V172, P1271, DOI 10.1007/s00431-013-1948-0; Starokadomskyy P, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125688; Stray-Pedersen A, 2017, J ALLERGY CLIN IMMUN, V139, P232, DOI 10.1016/j.jaci.2016.05.042; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Tuijnenburg P, 2018, J ALLERGY CLIN IMMUN, V142, P1285, DOI 10.1016/j.jaci.2018.01.039; Wang YR, 2019, WORLD J PEDIATR, V15, P528, DOI 10.1007/s12519-019-00309-4; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	43	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					327	339		10.1016/j.jaci.2021.04.005	http://dx.doi.org/10.1016/j.jaci.2021.04.005			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	33864888				2022-12-18	WOS:000747922700003
J	Johnson, CC; Havstad, SL; Ownby, DR; Joseph, CLM; Sitarik, AR; Myers, JB; Gebretsadik, T; Hartert, TV; Hershey, GKK; Jackson, DJ; Lemanske, RF; Martin, LJ; Zoratti, EM; Visness, CM; Ryan, PH; Gold, DR; Martinez, FD; Miller, RL; Seroogy, CM; Wright, AL; Gern, JE				Johnson, Christine C.; Havstad, Suzanne L.; Ownby, Dennis R.; Joseph, Christine L. M.; Sitarik, Alexandra R.; Myers, Jocelyn Biagini; Gebretsadik, Tebeb; V. Hartert, Tina; Hershey, Gurjit K. Khurana; Jackson, Daniel J.; Lemanske, Robert F., Jr.; Martin, Lisa J.; Zoratti, Edward M.; Visness, Cynthia M.; Ryan, Patrick H.; Gold, Diane R.; Martinez, Fernando D.; Miller, Rachel L.; Seroogy, Christine M.; Wright, Anne L.; Gern, James E.		Children's Resp Environm Workgrp E	Pediatric asthma incidence rates in the United States from 1980 to 2017	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Epidemiology; IRs; pediatric asthma; sex; parental history; time; United States	CHILDHOOD ASTHMA; RISK-FACTORS; RESPIRATORY SYMPTOMS; SURVEILLANCE SYSTEM; ALLERGIC RHINITIS; SCHOOL-CHILDREN; TOTAL COMMUNITY; PUERTO-RICAN; PREVALENCE; EPIDEMIOLOGY	Background: Few studies have examined longitudinal asthma incidence rates (IRs) from a public health surveillance perspective. Objective: Our aim was to calculate descriptive asthma IRs in children over time with consideration for demographics and parental asthma history. Methods: Data from 9 US birth cohorts were pooled into 1 population covering the period from 1980 to 2017. The outcome was earliest parental report of a doctor diagnosis of asthma. IRs per 1,000 person-years were calculated. Results: The racial/ethnic backgrounds of the 6,283 children studied were as follows: 55% European American (EA), 25.5% African American (AA), 9.5% Mexican-Hispanic American (MA) and 8.5% Caribbean-Hispanic American (CA). The average follow-up was 10.4 years (SD = 8.5 years; median = 8.4 years), totaling 65,291 person-years, with 1789 asthma diagnoses yielding a crude IR of 27.5 per 1,000 person-years (95% CI = 26.3-28.8). Age-specific rates were highest among children aged 0 to 4 years, notably from 1995 to 1999, with a decline in EA and MA children in 2000 to 2004 followed by a decline in AA and CA children in 2010 to 2014. Parental asthma history was associated with statistically significantly increased rates. IRs were similar and higher in AA and CA children versus lower but similar in EA and MA children. The differential rates by sex from birth through adolescence principally resulted from a decline in rates among males but relatively stable rates among females. Conclusions: US childhood asthma IRs varied dramatically by age, sex, parental asthma history, race/ethnicity, and calendar year. Higher rates in the 0- to 4-year-olds group, particularly among AA/CA males with a parental history of asthma, as well as changes in rates over time and by demographic factors, suggest that asthma is driven by complex interactions between genetic susceptibility and variation in time-dependent environmental and social factors.	[Johnson, Christine C.; Havstad, Suzanne L.; Joseph, Christine L. M.; Sitarik, Alexandra R.; Zoratti, Edward M.] Henry Ford Hlth Syst, Detroit, MI USA; [Ownby, Dennis R.] Augusta Univ, Div Allergy & Immunol, Augusta, GA USA; [Myers, Jocelyn Biagini; Hershey, Gurjit K. Khurana; Martin, Lisa J.; Ryan, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Gebretsadik, Tebeb; V. Hartert, Tina] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Jackson, Daniel J.; Lemanske, Robert F., Jr.; Seroogy, Christine M.; Gern, James E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA; [Visness, Cynthia M.] Rho Inc, Chapel Hill, NC USA; [Gold, Diane R.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Gold, Diane R.] Harvard Med Sch, Boston, MA 02115 USA; [Gold, Diane R.] Brigham & Womens Hosp, Med Network, Channing Div, 75 Francis St, Boston, MA 02115 USA; [Martinez, Fernando D.; Wright, Anne L.] Univ Arizona, Asthma & Airways Res Ctr, Tucson, AZ USA; [Martinez, Fernando D.; Wright, Anne L.] Univ Arizona, Coll Med, Dept Pediat, Div Pulm & Sleep Med, Tucson, AZ USA; [Miller, Rachel L.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Henry Ford Health System; Henry Ford Hospital; University System of Georgia; Augusta University; Cincinnati Children's Hospital Medical Center; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; Rho; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Arizona; University of Arizona; Icahn School of Medicine at Mount Sinai	Johnson, CC (corresponding author), Henry Ford Hlth Syst, Dept Publ Hlth Sci, 1 Ford Pl,3E, Detroit, MI 48202 USA.	cjohnso1@hfhs.org	Ryan, Patrick/HDO-1133-2022	Sitarik, Alexandra/0000-0001-8957-389X	Children's Respiratory and Environment Workgroup (CREW) consortium, National Institutes of Health (NIH) Environmental Influences on Child Health Outcomes (ECHO); Health and Human Services/NIH [5UG3OD023282]; Columbia University Center for Children's Environmental Health (CCCEH) [P01ES09600, R01 ES008977, P30ES09089, R01 ES013163, R827027]; Tucson Children's Respiratory Study [NHLBI 132523]; Infant Immune Study [AI-61811]; Childhood Origins of Asthma Study [P01 HL070831, U10 HL064305, R01 HL061879]; Urban Environment and Childhood Asthma Study [NO1-AI-25496, NO1-AI-25482, HHSN272200900052C, HHSN272201000052I, 1UM1AI 114271-01, UM2AI117870, NCRR/NIH RR00052, M01RR00533, 1UL1RR025771, M01RR00071, 1UL1RR024156, UL1TR001079, 5UL1RR024992-02, NCATS/NIHUL1TR000040]; Cincinnati Childhood Allergy and Air Pollution Study [R01 ES11170, R01 ES019890]; Epidemiology of Home Allergens and Asthma Study [R01 AI035786]; Wayne County Health, Environment, Allergy and Asthma Longitudinal Study [R01 AI050681, R56 AI050681, R01 AI061774, R21 AI059415, K01 AI070606, R21 AI069271, R01 HL113010, R21 ES022321, P01 AI089473, R21 AI080066, R01 AI110450, R01 HD082147]; Fund for Henry Ford Hospital; Childhood Allergy Study [R01 AI024156, R03 HL067427, R01 AI051598]; Blue Cross Foundation	Children's Respiratory and Environment Workgroup (CREW) consortium, National Institutes of Health (NIH) Environmental Influences on Child Health Outcomes (ECHO)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health and Human Services/NIH; Columbia University Center for Children's Environmental Health (CCCEH); Tucson Children's Respiratory Study; Infant Immune Study; Childhood Origins of Asthma Study; Urban Environment and Childhood Asthma Study; Cincinnati Childhood Allergy and Air Pollution Study; Epidemiology of Home Allergens and Asthma Study; Wayne County Health, Environment, Allergy and Asthma Longitudinal Study; Fund for Henry Ford Hospital; Childhood Allergy Study; Blue Cross Foundation	The research reported in this article was supported by the Children's Respiratory and Environment Workgroup (CREW) consortium, which is part of National Institutes of Health (NIH) Environmental Influences on Child Health Outcomes (ECHO) . CREW is funded by Health and Human Services/NIH grant 5UG3OD023282 (J.E.G.) . Additional support was provided by the individual cohorts' grants and contracts, which are as follows: Columbia University Center for Children's Environmental Health (CCCEH) (grants P01ES09600 [F.P.P.] , R01 ES008977 [F.P.P.] , P30ES09089 [R.S.] , R01 ES013163 [R.L.M.] , and R827027 [F.P.P.] ) ; the Tucson Children's Respiratory Study (grant NHLBI 132523) (F.D.M./A.L.W.) ; the Infant Immune Study (grant AI-61811 [A.L.W.] ) ; the Childhood Origins of Asthma Study (grants P01 HL070831 [R.F.L./D.J.J.] , U10 HL064305 [R.F.L.] , and R01 HL061879 [R.F.L.] ) ; the Urban Environment and Childhood Asthma Study (grants NO1-AI-25496 [W.W.B.] , NO1-AI-25482, HHSN272200900052C [W.W.B.] , HHSN272201000052I, 1UM1AI 114271-01 [W.W.B./D.J.J./J.E.G.] , UM2AI117870, NCRR/NIH RR00052, M01RR00533, 1UL1RR025771 [D.M.C.] , M01RR00071, 1UL1RR024156 [H.N.G.] , UL1TR001079 [D.E.F.] , 5UL1RR024992-02 [K.S.P.] , and NCATS/NIHUL1TR000040 [H.N.G.] ) ; the Cincinnati Childhood Allergy and Air Pollution Study (grants R01 ES11170 [G.K.L./G.K.H.] and R01 ES019890 [P.H.R.] ) ; the Epidemiology of Home Allergens and Asthma Study (grant R01 AI035786) (D.R.G.) ; the Wayne County Health, Environment, Allergy and Asthma Longitudinal Study (grants R01 AI050681 [C.C.J.] , R56 AI050681 [C.C.J.] , R01 AI061774 [L.K.W.] , R21 AI059415 [D.R.O.] , K01 AI070606 [G.R.W.] , R21 AI069271 [G.R.W.] , R01 HL113010 [G.R.W.] , R21 ES022321 [A.C.B.] , P01 AI089473 [C.C.J./D.R.O.] , R21 AI080066 [C.L.M.J.] , R01 AI110450 [G.R.W.] , and R01 HD082147 [A.C.B.] ) and the Fund for Henry Ford Hospital (C.C.J./G.R.W./A.C.B.) ; and the Childhood Allergy Study (grants R01 AI024156 [D.R.O.] ; R03 HL067427 [D.R.O.] , and R01 AI051598 [E.M.Z.] ) ; the Blue Cross Foundation (C.C.J.) ; and the Fund for Henry Ford Hospital (D.R.O./C.C.J./E.M.Z.) .	Akinbami LJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2354; Akinbami Lara J, 2011, Natl Health Stat Report, P1; Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Andersson M, 2013, PEDIATRICS, V132, pE435, DOI 10.1542/peds.2013-0741; Bacharier LB, 2019, AM J RESP CRIT CARE, V199, P71, DOI 10.1164/rccm.201801-0190OC; Bardal S, 2017, J ASTHMA, V54, P308, DOI 10.1080/02770903.2016.1208223; Beasley R, 2015, LANCET, V386, P1075, DOI 10.1016/S0140-6736(15)00156-7; Black MH, 2013, AM J EPIDEMIOL, V178, P1120, DOI 10.1093/aje/kwt093; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed.; BRODER I, 1974, J ALLERGY CLIN IMMUN, V54, P100, DOI 10.1016/0091-6749(74)90038-4; BRODER I, 1974, J ALLERGY CLIN IMMUN, V53, P127, DOI 10.1016/0091-6749(74)90001-3; Broms K, 2012, EUR J EPIDEMIOL, V27, P695, DOI 10.1007/s10654-012-9725-3; Brozek G, 2015, RESP MED, V109, P982, DOI 10.1016/j.rmed.2015.05.010; Carr TF, 2017, J ALLER CL IMM-PRACT, V5, P114, DOI 10.1016/j.jaip.2016.07.001; CARTERPOKRAS OD, 1993, AM J PUBLIC HEALTH, V83, P580, DOI 10.2105/AJPH.83.4.580; Claudio L, 2006, ANN EPIDEMIOL, V16, P332, DOI 10.1016/j.annepidem.2005.06.046; Daya M, 2019, ANN ALLERG ASTHMA IM, V122, P456, DOI 10.1016/j.anai.2019.02.009; de Marco R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-95; de Marco R, 2004, J ALLERGY CLIN IMMUN, V113, P845, DOI 10.1016/j.jaci.2004.01.780; de Sousa JC, 2010, PRIM CARE RESP J, V19, P352, DOI 10.4104/pcrj.2010.00022; Dharmage SC, 2015, CLIN EXP ALLERGY, V45, P6, DOI 10.1111/cea.12424; DODGE RR, 1980, AM REV RESPIR DIS, V122, P567; Donovan BM, 2020, CLIN INFECT DIS, V70, P1658, DOI 10.1093/cid/ciz448; Eagan TML, 2002, EUR RESPIR J, V19, P599, DOI 10.1183/09031936.02.00247302; Engelkes M, 2015, PEDIAT ALLERG IMM-UK, V26, P367, DOI 10.1111/pai.12376; Finkelstein JA, 2003, PEDIATRICS, V112, P620, DOI 10.1542/peds.112.3.620; Gergen PJ, 2015, IMMUNOL ALLERGY CLIN, V35, P101, DOI 10.1016/j.iac.2014.09.006; Gern JE, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1088-9; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Henriksen L, 2015, J ALLERGY CLIN IMMUN, V136, P360, DOI 10.1016/j.jaci.2015.02.003; Hohmann C, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2019-000460; Honkamaki J, 2019, RESP MED, V154, P56, DOI 10.1016/j.rmed.2019.06.003; Huber PJ, 1967, P 5 BERKELEY S MATH, P221; Jajosky R, 2011, J PUBLIC HEALTH MAN, V17, P255, DOI 10.1097/PHH.0b013e318200f8da; Javed A, 2013, J ASTHMA, V50, P472, DOI 10.3109/02770903.2013.787625; Johnson CC, 2005, J ALLERGY CLIN IMMUN, V115, P1218, DOI 10.1016/j.jaci.2005.04.020; Johnson CC, 2021, JAMA PEDIATR, DOI 10.1001/jamapediatrics.2021.0667; Keet CA, 2015, J ALLERGY CLIN IMMUN, V135, P655, DOI 10.1016/j.jaci.2014.11.022; Keller T, 2018, ALLERGY, V73, P602, DOI 10.1111/all.13312; Koutsavlis AT, 2001, J PUBLIC HEALTH POL, V22, P311, DOI 10.2307/3343144; Kravitz-Wirtz N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061114; Lara M, 2006, PEDIATRICS, V117, P43, DOI 10.1542/peds.2004-1714; Lawson JA, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-51; MacMahon B, 1970, EPIDEMIOLOGY PRINCIP; Matsui EC, 2019, J ALLERGY CLIN IMMUN, V143, P2024, DOI 10.1016/j.jaci.2019.03.015; Montinaro F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7596; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; National Institutes of Health National Cancer Institute Surveillance Epidemiology and End Results Program, SEER REG; Patrick DM, 2020, LANCET RESP MED, V8, P1094, DOI 10.1016/S2213-2600(20)30052-7; Vega AP, 2008, ARCH BRONCONEUMOL, V44, P464, DOI 10.1016/S1579-2129(08)60084-1; Pividori M, 2019, LANCET RESP MED, V7, P509, DOI 10.1016/S2213-2600(19)30055-4; Reibman J, 2010, MT SINAI J MED, V77, P140, DOI 10.1002/msj.20171; Ronmark E, 2002, RESP MED, V96, P1006, DOI 10.1053/rmed.2002.1391; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rudd RA, 2007, J ASTHMA, V44, P65, DOI 10.1080/02770900601125896; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Shah R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02997; Simpson CR, 2010, J ROY SOC MED, V103, P98, DOI 10.1258/jrsm.2009.090348; Strachan DP, 1996, BRIT MED J, V312, P1195; To T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-254; Trepka MJ, 2009, PUBLIC HEALTH REP, V124, P267, DOI 10.1177/003335490912400215; Wang AL, 2019, J ALLERGY CLIN IMMUN, V143, P1752, DOI 10.1016/j.jaci.2018.09.038; Wendt JK, 2012, AM J EPIDEMIOL, V176, P744, DOI 10.1093/aje/kws150; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Winer RA, 2012, J ASTHMA, V49, P16, DOI 10.3109/02770903.2011.637594; Yeatts K, 2006, ENVIRON HEALTH PERSP, V114, P634, DOI 10.1289/ehp.8381; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; Zahran HS, 2018, MMWR-MORBID MORTAL W, V67, P149, DOI 10.15585/mmwr.mm6705e1	70	10	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1270	1280		10.1016/j.jaci.2021.04.027	http://dx.doi.org/10.1016/j.jaci.2021.04.027		NOV 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	WV7LX	33964299	Green Accepted			2022-12-18	WOS:000717415000025
J	Luo, YM; Alexander, M; Gadina, M; O'Shea, JJ; Meylan, F; Schwartz, DM				Luo, Yiming; Alexander, Madison; Gadina, Massimo; O'Shea, John J.; Meylan, Francoise; Schwartz, Daniella M.			JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						JAK; STAT; Jakinib; immunodeficiency; immunomodu-lation	SEVERE ATOPIC-DERMATITIS; JANUS KINASE INHIBITOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; DOUBLE-BLIND; PROTEIN-KINASE; MUTATIONS; TOFACITINIB; PLACEBO; DEFICIENCY	Since its discovery, the Janus kinase-signal transduction and activation of transcription (JAK-STAT) pathway has become recognized as a central mediator of widespread and varied human physiological processes. The field of JAK-STAT biology, particularly its clinical relevance, continues to be shaped by 2 important advances. First, the increased use of genomic sequencing has led to the discovery of novel clinical syndromescaused by mutations in JAK and STAT genes. This has provided insights regarding the consequences of aberrant JAK-STAT signaling for immunity, lymphoproliferation, and malignancy. In addition, since the approval of ruxolitinib and tofacitinib, the therapeutic use of JAK inhibitors (jakinibs) has expanded to include a large spectrum of diseases. Efficacy and safety data from over a decade of clinical studies have provided additional mechanistic insights while improving the care of patients with inflammatory and neoplastic conditions. This review discusses major advances in the field, focusing on updates in genetic diseases and in studies of clinical jakinibs in human disease. (J Allergy Clin Immunol 2021;148:911-25.)	[Luo, Yiming] Natl Inst Arthrit Musculoskeletal & Skin Dis, Natl Inst Hlth, Vasculitis Translat Res Program, Autoimmun Branch, Bethesda, MD USA; [Gadina, Massimo; Meylan, Francoise] Natl Inst Arthrit Musculoskeletal & Skin Dis, Natl Inst Hlth, Off Sci & Technol, Bethesda, MD USA; [O'Shea, John J.] Natl Inst Arthrit Musculoskeletal & Skin Dis, Natl Inst Hlth, Mol Immunol & Inflammat Branch, Bethesda, MD USA; [Schwartz, Daniella M.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schwartz, DM (corresponding author), Bldg 10,9000 Rockville Pike, Bethesda, MD 20892 USA.	Daniella.Schwartz@nih.gov		Schwartz, Daniella/0000-0002-1660-8438	National Institute of Arthritis, Musculoskeletal, and Skin Diseases; National Institute of Allergy and Infectious Diseases	National Institute of Arthritis, Musculoskeletal, and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Arthritis, Musculoskeletal, and Skin Diseases and National Institute of Allergy and Infectious Diseases intramural research programs.	Aavikko M, 2015, J INFECT DIS, V211, P1842, DOI 10.1093/infdis/jiu667; Abelson AK, 2009, ANN RHEUM DIS, V68, P1746, DOI 10.1136/ard.2008.097642; Acarli ANO, 2020, NEUROLOGY, V94; Akbari H, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118167; Alsohime F, 2020, NEW ENGL J MED, V382, P256, DOI 10.1056/NEJMoa1905633; Baechler EC, 2007, MOL MED, V13, P59, DOI 10.2119/2006-00085.Baechler; Berenson JR, 2020, CLIN CANCER RES, V26, P2346, DOI 10.1158/1078-0432.CCR-19-1899; Bergerson JRE, 2019, IMMUNOL ALLERGY CLIN, V39, P49, DOI 10.1016/j.iac.2018.08.007; Berghout, 2019, OPEN FORUM INFECT DI, V6, pS77; Bieber T, 2021, NEW ENGL J MED, V384, P1101, DOI 10.1056/NEJMoa2019380; Biehl A, 2019, 183 PHASE 1B 2A TRIA; Boisson-Dupuis S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau8714; Burmester GR, 2018, LANCET, V391, P2503, DOI 10.1016/S0140-6736(18)31115-2; Chen ZW, 2019, NEW ENGL J MED, V381, P291, DOI 10.1056/NEJMc1900045; Choy EH, 2020, NAT REV RHEUMATOL, V16, P335, DOI 10.1038/s41584-020-0419-z; Cohen SB, 2021, ANN RHEUM DIS, V80, P304, DOI [10.1136/annrheumdis-2020-218510., 10.1136/annrheumdis-2020-218510]; Combe B, 2021, ANN RHEUM DIS, V80, P848, DOI 10.1136/annrheumdis-2020-219214; Conaghan PG, 2021, DRUG SAFETY, V44, P515, DOI 10.1007/s40264-020-01036-w; Cornelissen C, 2012, EUR J CELL BIOL, V91, P552, DOI 10.1016/j.ejcb.2011.07.006; Cross NCP, 2019, LEUKEMIA, V33, P415, DOI 10.1038/s41375-018-0342-3; Del Bel KL, 2017, J ALLERGY CLIN IMMUN, V139, P2016, DOI 10.1016/j.jaci.2016.12.957; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Deodhar A, 2021, ANN RHEUM DIS, V80, P1004, DOI 10.1136/annrheumdis-2020-219601; Dhillon S, 2020, DRUGS, V80, P609, DOI 10.1007/s40265-020-01291-2; Diels J, 2020, BRIT J DERMATOL, V183, P276, DOI 10.1111/bjd.18634; Duncan CJA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7501; Eisenberg R, 2021, J ALLER CL IMM-PRACT, V9, P1008, DOI 10.1016/j.jaip.2020.11.050; Eletto D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13992; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Evrot E, 2013, CLIN CANCER RES, V19, P6230, DOI 10.1158/1078-0432.CCR-13-0905; Fabre A, 2019, J ALLER CL IMM-PRACT, V7, P1958, DOI 10.1016/j.jaip.2019.02.018; Fasan A, 2013, LEUKEMIA, V27, P1598, DOI 10.1038/leu.2012.350; Fleischmann R, 2019, ARTHRITIS RHEUMATOL, V71, P1788, DOI 10.1002/art.41032; Fleischmann RM, 2019, ANN RHEUM DIS, V78, P1454, DOI 10.1136/annrheumdis-2019-215764; Fogelman D, 2018, CANCER MED-US, V7, P5382, DOI 10.1002/cam4.1703; Frucht DM, 2001, GENES IMMUN, V2, P422, DOI 10.1038/sj.gene.6363802; Genovese M, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1541-z; Genovese MC, 2019, JAMA-J AM MED ASSOC, V322, P315, DOI 10.1001/jama.2019.9055; Gruber C, 2020, J EXP MED, V217, DOI 10.1084/jem.20192319; Gruber CN, 2020, IMMUNITY, V53, P672, DOI 10.1016/j.immuni.2020.07.006; Guimaraes PO, 2021, NEW ENGL J MED, V385, P406, DOI 10.1056/NEJMoa2101643; Guttman-Yassky E, 2021, LANCET, V397, P2151, DOI 10.1016/S0140-6736(21)00588-2; Hadjadj J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18925-4; Hagberg N, 2018, ANN RHEUM DIS, V77, P1070, DOI 10.1136/annrheumdis-2017-212794; Hambleton S, 2013, P NATL ACAD SCI USA, V110, P3053, DOI 10.1073/pnas.1220098110; Hancock DB, 2012, J ALLERGY CLIN IMMUN, V129, P1673, DOI 10.1016/j.jaci.2012.03.012; Hao X, 2020, INVEST NEW DRUG, V38, P610, DOI 10.1007/s10637-019-00794-4; Hasni SA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23361-z; He H, 2008, GENES IMMUN, V9, P195, DOI 10.1038/gene.2008.2; Hirbe AC, 2017, CANCER-AM CANCER SOC, V123, P1194, DOI 10.1002/cncr.30455; Hu QY, 2020, ANN RHEUM DIS, V79, P842, DOI 10.1136/annrheumdis-2019-216699; Jagpal A, 2018, DRUG SAFETY, V41, P545, DOI 10.1007/s40264-018-0639-1; Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994; Kaplanski G, 2021, AUTOIMMUN REV, V20, DOI 10.1016/j.autrev.2020.102726; Kapralova K, 2016, BLOOD, V128, P1418, DOI 10.1182/blood-2016-02-698951; Khan I, 2013, LEUKEMIA, V27, P1882, DOI 10.1038/leu.2013.167; Kiel MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9470; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kim H, 2021, ANN RHEUM DIS, V80, P406, DOI 10.1136/annrheumdis-2020-218690; Klammt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04521-0; Koppikar P, 2012, NATURE, V489, P155, DOI 10.1038/nature11303; Kremer JM, 2021, ACR OPEN RHEUMATOL, V3, P173, DOI 10.1002/acr2.11232; Lesmana H, 2020, BLOOD, V136, DOI 10.1182/blood-2020-142078; Li Z, 2013, J IMMUNOL, V190, P2335, DOI 10.4049/jimmunol.1203118; Loh CY, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00048; Lupardus PJ, 2014, P NATL ACAD SCI USA, V111, P8025, DOI 10.1073/pnas.1401180111; Ma CA, 2017, BLOOD, V129, P650, DOI 10.1182/blood-2016-09-737817; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Marconi VC, MEDRXIV, V2021; Maruvka YE, 2017, NAT BIOTECHNOL, V35, P951, DOI 10.1038/nbt.3966; McInnes IB, 2021, NEW ENGL J MED, V384, P1227, DOI 10.1056/NEJMoa2022516; McIntosh LA, 2017, ARTHRITIS RHEUMATOL, V69, P2222, DOI 10.1002/art.40216; Mease P, 2017, NEW ENGL J MED, V377, P1537, DOI 10.1056/NEJMoa1615975; Mease P, 2020, ARTHRITIS RHEUMATOL, V72; Mease PJ, 2021, ANN RHEUM DIS, V80, P312, DOI 10.1136/annrheumdis-2020-218870; Mesa RA, 2017, LANCET HAEMATOL, V4, pE225, DOI 10.1016/S2352-3026(17)30027-3; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Moens L, 2017, J ALLERGY CLIN IMMUN, V139, P1995, DOI 10.1016/j.jaci.2016.10.033; Morand EF, 2020, NEW ENGL J MED, V382, P211, DOI 10.1056/NEJMoa1912196; Mucha S, 2020, J ALLERGY CLIN IMMUN, V145, P1208, DOI 10.1016/j.jaci.2019.10.030; Nakagawa H, 2020, J AM ACAD DERMATOL, V82, P823, DOI 10.1016/j.jaad.2019.12.015; National Institutes of Health, NIH CLOS ENR TRIAL C; Nemoto M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25260-8; O'Shaughnessy J, 2018, BREAST CANCER RES TR, V170, P547, DOI 10.1007/s10549-018-4770-6; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Paik JJ, 2021, ARTHRITIS RHEUMATOL, V73, P875, DOI 10.1002/art.41602; Papp K, 2018, NEW ENGL J MED, V379, P1313, DOI 10.1056/NEJMoa1806382; Pardanani A, 2015, JAMA ONCOL, V1, P643, DOI 10.1001/jamaoncol.2015.1590; Peisong G, 2004, GENES IMMUN, V5, P58, DOI 10.1038/sj.gene.6364030; Peterson Danielle M, 2021, JAAD Case Rep, V10, P4, DOI 10.1016/j.jdcr.2021.01.020; Phillips TJ, 2018, BLOOD, V132, P293, DOI 10.1182/blood-2017-10-812701; Reich K, 2021, LANCET, V397, P2169, DOI 10.1016/S0140-6736(21)00589-4; RMD commentary, 2021, RMD OPEN, V7; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Robinson MF, 2020, ARTHRITIS RHEUMATOL, V72, P1621, DOI 10.1002/art.41316; Rubbert-Roth A, 2020, NEW ENGL J MED, V383, P1511, DOI 10.1056/NEJMoa2008250; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814; Sandborn WJ, 2020, J CROHNS COLITIS, V14, P1202, DOI 10.1093/ecco-jcc/jjaa049; Schimke LF, 2017, J INFECT DIS, V216, P1623, DOI 10.1093/infdis/jix522; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Schwartz DM, 2016, NAT REV RHEUMATOL, V12, P25, DOI 10.1038/nrrheum.2015.167; Schwartz DM, 2020, ANN RHEUM DIS, V79, P429, DOI 10.1136/annrheumdis-2019-215918; Shahmarvand N, 2018, CANCER SCI, V109, P926, DOI 10.1111/cas.13525; Shahni R, 2015, BRAIN, V138, P2834, DOI 10.1093/brain/awv182; Sic H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01824; Silverberg JI, 2021, JAMA DERMATOL, V157, P691, DOI 10.1001/jamadermatol.2021.1273; Smolen JS, 2019, LANCET, V393, P2303, DOI 10.1016/S0140-6736(19)30419-2; Solimani F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02847; Spaner DE, 2019, CANCER MED-US, V8, P1540, DOI 10.1002/cam4.2042; Stivala S, 2019, J CLIN INVEST, V129, P1596, DOI 10.1172/JCI98785; Takeuchi T, 2019, ANN RHEUM DIS, V78, P1305, DOI 10.1136/annrheumdis-2019-215164; Talpaz M, 2021, LEUKEMIA, V35, P1, DOI 10.1038/s41375-020-0954-2; Tanaka Y, 2019, ANN RHEUM DIS, V78, P1320, DOI 10.1136/annrheumdis-2019-215163; Taylor PC, 2019, ARTHRITIS RHEUMATOL, V71, P1042, DOI 10.1002/art.40841; Tefferi A, 2011, MAYO CLIN PROC, V86, P1188, DOI 10.4065/mcp.2011.0518; Tiacci E, 2018, BLOOD, V131, P2454, DOI 10.1182/blood-2017-11-814913; Traves PG, 2021, ANN RHEUM DIS, V80, P865, DOI 10.1136/annrheumdis-2020-219012; Turrubiartes-Martinez E, 2020, GENES-BASEL, V11, DOI 10.3390/genes11121434; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; US Food and Drug Administration, COR COVID 19 UPD FDA; Vallurupalli M, 2019, BLOOD, V134, P1783, DOI 10.1182/blood.2019002289; van der Heijde D, 2019, LANCET, V394, P2108, DOI 10.1016/S0140-6736(19)32534-6; van der Heijde D, 2019, ARTHRITIS RHEUMATOL, V71, P878, DOI 10.1002/art.40803; Vanderver A, 2020, NEW ENGL J MED, V383, P986, DOI 10.1056/NEJMc2001362; Vannucchi AM, 2015, NEW ENGL J MED, V372, P426, DOI 10.1056/NEJMoa1409002; Verstovsek S, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0417-z; Villarino AV, 2020, CELL, V181, P1696, DOI 10.1016/j.cell.2020.04.052; Waanders E, 2017, LEUKEMIA, V31, P821, DOI 10.1038/leu.2016.277; Wallace DJ, 2018, LANCET, V392, P222, DOI 10.1016/S0140-6736(18)31363-1; Winter PS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005301; WINTHROP K, 2019, ARTHRITIS RHEUMATOL, V71; Wu PL, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00253; Yates M, 2021, ARTHRITIS RHEUMATOL, V73, P779, DOI 10.1002/art.41580; Yildiz M, 2015, BLOOD, V125, P668, DOI 10.1182/blood-2014-06-582650; You HX, 2019, ANN RHEUM DIS, V78, P1441, DOI 10.1136/annrheumdis-2019-215455; Zeiser R, 2021, NEW ENGL J MED, V385, P228, DOI 10.1056/NEJMoa2033122; Zeiser R, 2020, NEW ENGL J MED, V382, P1800, DOI 10.1056/NEJMoa1917635; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang WJ, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.654406; Zheng J, 2015, EUR J IMMUNOL, V45, P2834, DOI 10.1002/eji.201445344	142	10	11	2	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					911	925		10.1016/j.jaci.2021.08.004	http://dx.doi.org/10.1016/j.jaci.2021.08.004		OCT 2021	15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	34625141	Green Accepted			2022-12-18	WOS:000705023300001
J	Labrosse, R; Barmettler, S; Derfalvi, B; Blincoe, A; Cros, G; Lacombe-Barrios, J; Barsalou, J; Yang, N; Alrumayyan, N; Sinclair, J; Ong, MS; Camargo, CA; Walter, J; Haddad, E				Labrosse, Roxane; Barmettler, Sara; Derfalvi, Beata; Blincoe, Annaliesse; Cros, Guilhem; Lacombe-Barrios, Jonathan; Barsalou, Julie; Yang, Nancy; Alrumayyan, Nora; Sinclair, Jan; Ong, Mei-Sing; Camargo, Carlos A.; Walter, Jolan; Haddad, Elie			Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						B-cell depleting therapy; hypogammaglobulinemia; IgG; immunoglobulin; infection; children; pediatrics; primary immunodeficiency; secondary immunodeficiency; rituximab	PATIENTS RECEIVING RITUXIMAB; MONOCLONAL-ANTIBODY THERAPY; CELL TARGETED THERAPIES; DEPLETION THERAPY; CHILDREN; SAFETY; IMMUNOGLOBULIN; EFFICACY; LYMPHOMA; COMPLICATIONS	Background: Rituximab is a B-cell depleting agent used in B-cell malignancies and autoimmune diseases. A subset of adult patients may develop prolonged and symptomatic hypogammaglobulinemia following rituximab treatment. However, this phenomenon has not been well delineated in the pediatric population. Objectives: This study sought to determine the prevalence, risk factors, and clinical significance of hypogammaglobulinemia following rituximab therapy in children. Methods: This was a multicenter, retrospective cohort study that extracted clinical and immunological data from pediatric patients who received rituximab. Results: The cohort comprised 207 patients (median age, 12.0 years). Compared to baseline values, there was a significant increase in hypogammaglobulinemia post-rituximab therapy, with an increase in prevalence of hypo-IgG (28.7%-42.6%; P = .009), hypo-IgA (11.1%-20.4%; P = .02), and hypo-IgM (20.0%-62.0%; P < .0001). Additionally, low IgG levels at any time post-rituximab therapy were associated with a higher risk of serious infections (34.4% vs 18.9%; odds ratio, 2.3; 95% CI, 1.1-4.8; P = .03). Persistent IgG hypogammaglobulinemia was observed in 27 of 101 evaluable patients (26.7%). Significant risk factors for persistent IgG hypogammaglobulinemia included low IgG and IgA levels pre-rituximab therapy. Nine patients (4.3%) within the study were subsequently diagnosed with a primary immunodeficiency, 7 of which received rituximab for autoimmune cytopenias. Conclusions: Hypogammaglobulinemia post-rituximab treatment is frequently diagnosed within the pediatric population. Low IgG levels are associated with a significant increase in serious infections, and underlying primary immunodeficiencies are relatively common in children receiving rituximab, thus highlighting the importance of immunologic monitoring both before and after rituximab therapy.	[Labrosse, Roxane; Lacombe-Barrios, Jonathan; Barsalou, Julie; Haddad, Elie] Ctr Hosp Univ St Justine, Dept Pediat, Montreal, PQ, Canada; [Haddad, Elie] Ctr Hosp Univ St Justine, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Cros, Guilhem] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Labrosse, Roxane] Boston Childrens Hosp, Dept Pediat, Div Hematol Oncol, Boston, MA USA; [Barmettler, Sara; Yang, Nancy; Camargo, Carlos A.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Allergy & Clin Immunol Unit, Boston, MA 02114 USA; [Camargo, Carlos A.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Walter, Jolan] Massachusetts Gen Hosp, Pediat Allergy & Immunol, Boston, MA 02114 USA; [Derfalvi, Beata; Alrumayyan, Nora] Dalhousie Univ, IWK Hlth Ctr, Dept Pediat, Div Immunol, Halifax, NS, Canada; [Blincoe, Annaliesse; Sinclair, Jan] Starship Childrens Hosp, Dept Paediat Immunol & Allergy, Auckland, New Zealand; [Ong, Mei-Sing] Harvard Med Sch, Harvard Pilgrim Hlth Care, Dept Populat Med, Boston, MA 02115 USA; [Walter, Jolan] Univ S Florida, Johns Hopkins All Childrens Hosp, Dept Pediat, Tampa, FL 33620 USA	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Dalhousie University; Starship Children's Hospital; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; State University System of Florida; University of South Florida	Haddad, E (corresponding author), 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	elie.haddad@umontreal.ca	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; /0000-0001-8012-2697; Derfalvi, Beata/0000-0001-7272-7119				Alshaiki F, 2018, EUR J RHEUMATOL, V5, P118, DOI 10.5152/eurjrheum.2018.17096; Appelgren D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02242; Barmettler S, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.4169; Barmettler S, 2015, J ALLERGY CLIN IMMUN, V136, P1407, DOI 10.1016/j.jaci.2015.06.035; Becerra E, 2015, CLIN EXP IMMUNOL, V179, P414, DOI 10.1111/cei.12472; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonilla FA, 2015, J ALLERGY CLIN IMMUN, V136, P1186, DOI 10.1016/j.jaci.2015.04.049; Cabanillas F, 2006, ANN ONCOL, V17, P1424, DOI 10.1093/annonc/mdl141; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P3612, DOI 10.1002/art.22211; Casulo C, 2013, CL LYMPH MYELOM LEUK, V13, P106, DOI 10.1016/j.clml.2012.11.011; Cohen JI, 2015, CURR TOP MICROBIOL, V390, P241, DOI 10.1007/978-3-319-22822-8_10; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Compagno N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00626; De Angelis F, 2015, LEUKEMIA RES, V39, P1382, DOI 10.1016/j.leukres.2015.10.013; de Souza KJ, 2018, IMMUNOPHARM IMMUNOT, V40, P13, DOI 10.1080/08923973.2017.1392562; Deshayes S, 2019, AM J HEMATOL, V94, P1314, DOI 10.1002/ajh.25632; Duraisingham SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100324; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Romero DSF, 2015, MEDICINA-BUENOS AIRE, V75, P319; Fischer A, 2017, J ALLERGY CLIN IMMUN, V140, P1388, DOI 10.1016/j.jaci.2016.12.978; Frangoul H, 2013, BONE MARROW TRANSPL, V48, P1456, DOI 10.1038/bmt.2013.76; Fujinaga S, 2016, CLIN NEPHROL, V85, P340, DOI 10.5414/CN108835; Garvey B, 2008, BRIT J HAEMATOL, V141, P149, DOI 10.1111/j.1365-2141.2008.07054.x; Gottenberg JE, 2010, ARTHRITIS RHEUM-US, V62, P2625, DOI 10.1002/art.27555; HAMILOS DL, 1992, ANN ALLERGY, V68, P472; HOKLAND P, 1985, J IMMUNOL, V135, P1746; Kavanaugh AF, 2006, J RHEUMATOL, V33, P18; KEHRL JH, 1994, IMMUNOL TODAY, V15, P432, DOI 10.1016/0167-5699(94)90273-9; Keven K, 2003, Transpl Infect Dis, V5, P181, DOI 10.1111/j.1399-3062.2003.00035.x; Khojah AM, 2019, PEDIATR RHEUMATOL, V17, DOI 10.1186/s12969-019-0365-y; Kridin K, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102466; Leandro MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3908; Lim SH, 2005, BONE MARROW TRANSPL, V35, P207, DOI 10.1038/sj.bmt.1704742; Makatsori M, 2014, QJM-INT J MED, V107, P821, DOI 10.1093/qjmed/hcu094; Marco H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-178; Marzuillo P, 2019, WORLD J CLIN CASES, V7, P1021, DOI 10.12998/wjcc.v7.i9.1021; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Mei HE, 2010, BLOOD, V116, P5181, DOI 10.1182/blood-2010-01-266536; Notarangelo LD, 2010, BLOOD, V116, P1189, DOI 10.1182/blood-2010-06-286179; Ottaviano G, 2020, J ALLER CL IMM-PRACT, V8, P273, DOI 10.1016/j.jaip.2019.07.032; Ozaras N, 2012, SEIZURE-EUR J EPILEP, V21, P229, DOI 10.1016/j.seizure.2011.12.013; Parmentier C, 2020, PEDIATR NEPHROL, V35, P455, DOI 10.1007/s00467-019-04398-1; Piro LD, 1999, ANN ONCOL, V10, P655, DOI 10.1023/A:1008389119525; Rao A, 2008, PEDIATR BLOOD CANCER, V50, P822, DOI 10.1002/pbc.21264; Reboursiere E, 2016, INT J HEMATOL, V104, P85, DOI 10.1007/s12185-016-1992-4; Reddy V, 2017, ARTHRIT CARE RES, V69, P857, DOI 10.1002/acr.22993; Roberts DM, 2015, J AUTOIMMUN, V57, P24, DOI 10.1016/j.jaut.2014.11.004; Roberts DM, 2015, J AUTOIMMUN, V57, P60, DOI 10.1016/j.jaut.2014.11.009; Rubin Z, 2018, J ALLER CL IMM-PRACT, V6, P1705, DOI 10.1016/j.jaip.2017.12.002; Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188; Shah S, 2017, CLIN KIDNEY J, V10, P470, DOI 10.1093/ckj/sfx014; Shapiro RS, 2011, AM J HEMATOL, V86, P48, DOI 10.1002/ajh.21903; Stabler S, 2021, CLIN INFECT DIS, V72, P727, DOI 10.1093/cid/ciaa127; Sundin M, 2015, PEDIATR BLOOD CANCER, V62, P890, DOI 10.1002/pbc.25409; Tallantyre EC, 2018, J NEUROL, V265, P1115, DOI 10.1007/s00415-018-8812-0; Thiel J, 2017, J ALLER CL IMM-PRACT, V5, P1556, DOI 10.1016/j.jaip.2017.07.027; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; van Vollenhoven RF, 2010, J RHEUMATOL, V37, P558, DOI 10.3899/jrheum.090856; Walter JE, 2016, J ALLER CL IMM-PRACT, V4, P1089, DOI 10.1016/j.jaip.2016.08.004; Worch J, 2015, CANCERS, V7, P305, DOI 10.3390/cancers7010305; Wu JH, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1729-7; Yusof MYM, 2019, ARTHRITIS RHEUMATOL, V71, P1812, DOI 10.1002/art.40937	62	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					523	+		10.1016/j.jaci.2021.03.041	http://dx.doi.org/10.1016/j.jaci.2021.03.041		AUG 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	33862010				2022-12-18	WOS:000687104900005
J	Busse, WW; Bleecker, ER; FitzGerald, JM; Ferguson, GT; Barker, P; Brooks, L; Olsson, RF; Martin, UJ; Goldman, M				Busse, William W.; Bleecker, Eugene R.; FitzGerald, J. Mark; Ferguson, Gary T.; Barker, Peter; Brooks, Laura; Olsson, Richard F.; Martin, Ubaldo J.; Goldman, Mitchell		BORA Study Investigators	Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 13-16, 2020	ELECTR NETWORK	Amer Acad Allergy, Asthma & Immunol		Asthma; benralizumab; eosinophils; IL-5 receptor	ANTIBODY; RECEPTOR	Background: Adults and adolescents with severe asthma who completed the 48-week SIROCCO and 56-week CALIMA phase III benralizumab trials entered the safety extension study BORA (NCT02258542). The continued safety and efficacy of benralizumab in the first year of BORA (year 2 of treatment) have been reported. Objective: We sought to report outcomes for adolescents during years 2 and 3 of treatment in BORA. Methods: Patients on benralizumab 30 mg every 4 weeks (Q4W) or every 8 weeks (Q8W) in SIROCCO/CALIMA continued their regimens in BORA (Q4W/Q4W and Q8W/Q8W, respectively), whereas placebo patients were rerandomized 1:1 to benralizumab (placebo/Q4W and placebo/Q8W, respectively) for 108 weeks. The primary outcome was safety; secondary outcomes included reduction in annual asthma exacerbation rate and change from baseline in prebronchodilator FEV1. Results: Adolescents (N = 86) were treated with benralizumab Q8W (n = 61) or Q4W (n = 25); 69 completed treatment (Q8W: n = 51; Q4W: n = 18). For Q4W and Q8W regimens, rates of treatment-emergent adverse events were 68% (17 of 25) and 74% (45 of 61), respectively, rates of treatment-emergent adverse events (TEAEs) were 68% (17/25) and 74% (45/61), TEAEs leading to discontinuation were 4% (1/25) and 0%, serious AEs were 8% (2/25) and 7% (4/61), and no deaths occurred. In efficacy analyses, 69% (42 of 61) Q8W patients were exacerbation-free (placebo/Q8W: 62% [18 of 29], Q8W/Q8W: 75% [24 of 32]). Mean +/- SD change in FEV1 at week 108 versus BORA baseline was 0.327 +/- 0.452 L (placebo/Q8W) and 0.323 +/- 0.558 L (Q8W/Q8W). Conclusions: Safety and efficacy profiles in this 2-year extension study (up to 3 years of benralizumab treatment in adolescents) were consistent with previous findings.	[Busse, William W.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53792 USA; [Bleecker, Eugene R.] Univ Arizona, Coll Med, Tucson, AZ USA; [FitzGerald, J. Mark] Vancouver Gen Hosp, Lung Ctr, Vancouver, BC, Canada; [Ferguson, Gary T.] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA; [Barker, Peter; Brooks, Laura; Martin, Ubaldo J.; Goldman, Mitchell] AstraZeneca, Gaithersburg, MD USA; [Olsson, Richard F.] AstraZeneca, Gothenburg, Sweden	University of Wisconsin System; University of Wisconsin Madison; University of Arizona; University of British Columbia; AstraZeneca; AstraZeneca	Busse, WW (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Allergy Pulm & Crit Care Med, Madison, WI 53792 USA.	wwb@medicine.wisc.edu			AstraZeneca; Kyowa Hakko Kirin	AstraZeneca(AstraZeneca); Kyowa Hakko Kirin(Kyowa Kirin Ltd)	This study was funded by AstraZeneca and Kyowa Hakko Kirin.	Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1; Busse WW, 2019, LANCET RESP MED, V7, P46, DOI 10.1016/S2213-2600(18)30406-5; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]; Global Asthma Network, 2018, GLOBAL ASTHMA REPORT; Kolbeck R, 2010, J ALLERGY CLIN IMMUN, V125, P1344, DOI 10.1016/j.jaci.2010.04.004; Price D, 2016, J ASTHMA ALLERGY, V9, P1, DOI 10.2147/JAA.S97973; Talini D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005748; Tan LD, 2016, J ASTHMA ALLERGY, V9, P71, DOI 10.2147/JAA.S78049; Pham TH, 2016, RESP MED, V111, P21, DOI 10.1016/j.rmed.2016.01.003	10	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					266	+		10.1016/j.jaci.2021.02.009	http://dx.doi.org/10.1016/j.jaci.2021.02.009		JUL 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	TE3IW	33609624				2022-12-18	WOS:000669908500010
J	Castillo-Gonzalez, R; Cibrian, D; Sanchez-Madrid, F				Castillo-Gonzalez, Raquel; Cibrian, Danay; Sanchez-Madrid, Francisco			Dissecting the complexity of gamma delta T-cell subsets in skin homeostasis, inflammation, and malignancy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						gamma delta T cells; skin; psoriasis; atopic dermatitis; infection; cancer	INTERFERON-GAMMA; CONTACT HYPERSENSITIVITY; ATOPIC-DERMATITIS; PERIPHERAL-BLOOD; DENDRITIC CELLS; HOST-DEFENSE; NK CELLS; RECEPTOR; TUMOR; RECOGNITION	gamma delta T cells are much less common than ab T cells, accounting for 0.5% to 5% of all T lymphocytes in the peripheral blood and lymphoid tissues in mice and humans. However, they are the most abundant T-lymphocyte subset in some epithelial barriers such as mouse skin. gd T cells are considered innate lymphocytes because of their non-MHC restricted antigen recognition, as well as because of their rapid response to cytokines, invading pathogens, and malignant cells. Exacerbated expansion and activation of gd T cells in the skin is a common feature of acute and chronic skin inflammation such as psoriasis and contact or atopic dermatitis. Different gd T-cell subsets showing differential developmental and functional features are found in mouse and human skin. This review discusses the state of the art of research and future perspectives about the role of the different subsets of gd T-cells detected in the skin in steady-state, psoriasis, dermatitis, infection, and malignant skin diseases. Also, we highlight the differences between human and mouse gd T cells in skin homeostasis and inflammation, as understanding the differential role of each subtype of skin gd T cells will improve the discovery of new therapies. (J Allergy Clin Immunol 2021;147:2030-42.)	[Castillo-Gonzalez, Raquel; Cibrian, Danay; Sanchez-Madrid, Francisco] Univ Autonoma Madrid, Serv Immunol, Hosp Princesa, Inst Invest Sanitaria Princesa, Madrid, Spain; [Cibrian, Danay; Sanchez-Madrid, Francisco] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Cibrian, Danay; Sanchez-Madrid, Francisco] Carlos III Hlth Inst, CIBER Enfermedades Cardiovasc, Madrid, Spain	Autonomous University of Madrid; Hospital de La Princesa; Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Cibrian, D; Sanchez-Madrid, F (corresponding author), Inst Invest Sanitaria Princesa IIS IP, Diego de Leon 62, Madrid 28006, Spain.	danay.cibrian@cnic.es; fsmadrid@salud.madrid.org	; Sanchez-Madrid, Francisco/M-7889-2016	Castillo-Gonzalez, Raquel/0000-0002-9877-2126; Sanchez-Madrid, Francisco/0000-0001-5303-0762	Spanish Ministry of Economy and Competitiveness [SAF2017-82886-R]; Comunidad de Madrid, Ramon Areces Foundation "Ciencias de la Vida y la Salud" (XIX Concurso-2018) [S2017/BMD-3671-INFLAMUNE-CM]; Ayudas Fundacion BBVA a Equipos de Investigacion Cientifica (BIOMEDICINA-2018); "La Caixa" Banking Foundation (HR17-00016)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad de Madrid, Ramon Areces Foundation "Ciencias de la Vida y la Salud" (XIX Concurso-2018); Ayudas Fundacion BBVA a Equipos de Investigacion Cientifica (BIOMEDICINA-2018); "La Caixa" Banking Foundation (HR17-00016)	Supported by grant SAF2017-82886-R from the Spanish Ministry of Economy and Competitiveness, grant S2017/BMD-3671-INFLAMUNE-CM from the Comunidad de Madrid, Ramon Areces Foundation "Ciencias de la Vida y la Salud" (XIX Concurso-2018); a grant from Ayudas Fundacion BBVA a Equipos de Investigacion Cientifica (BIOMEDICINA-2018), and a grant from the "La Caixa" Banking Foundation (HR17-00016).	Abate G, 2005, J INFECT DIS, V192, P1362, DOI 10.1086/444423; Agerholm R, 2019, EMBO REP, V20, DOI 10.15252/embr.201948647; Ando N, 2015, J INVEST DERMATOL, V135, P3001, DOI 10.1038/jid.2015.316; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Baeck M, 2013, CONTACT DERMATITIS, V68, P357, DOI 10.1111/cod.12040; Bains SN, 2019, CLIN REV ALLERG IMMU, V56, P99, DOI 10.1007/s12016-018-8713-0; Benveniste PM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aav4036; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; BUKOWSKI JF, 1994, J IMMUNOL, V153, P5133; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; Cai YH, 2019, CELL REP, V27, P3034, DOI 10.1016/j.celrep.2019.05.019; Cai YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4986; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Cairo C, 2005, CLIN EXP IMMUNOL, V141, P116, DOI 10.1111/j.1365-2249.2005.02813.x; Chan LNC, 2015, INFECT IMMUN, V83, P4427, DOI 10.1128/IAI.01061-15; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Cibrian D, 2020, TRENDS MOL MED; Cibrian D, 2020, J ALLERGY CLIN IMMUN, V145, P199, DOI 10.1016/j.jaci.2019.09.025; Cibrian D, 2016, NAT IMMUNOL, V17, P985, DOI 10.1038/ni.3504; Colpitts SL, 2015, P NATL ACAD SCI USA, V112, P9692, DOI 10.1073/pnas.1420741112; Cooper AJR, 2020, J IMMUNOL, V205, P1039, DOI 10.4049/jimmunol.2000143; Cordova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049878; Correia DV, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22892; Correia DV, 2011, BLOOD, V118, P992, DOI 10.1182/blood-2011-02-339135; Dalessandri T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12080; Davey MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14760; Davis ASW, 2015, J IMMUNOL, V194, P2260, DOI 10.4049/jimmunol.1402438; De Creus A, 2002, J IMMUNOL, V168, P6486, DOI 10.4049/jimmunol.168.12.6486; Dimova T, 2015, P NATL ACAD SCI USA, V112, pE556, DOI 10.1073/pnas.1412058112; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; Donia M, 2012, ONCOIMMUNOLOGY, V1, P1297, DOI 10.4161/onci.21659; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Dyring-Andersen B, 2013, CONTACT DERMATITIS, V68, P339, DOI 10.1111/cod.12043; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Fitzpatrick S, 2019, INVEST OPHTH VIS SCI, V60, P3952, DOI 10.1167/iovs.19-27810; FUJITA M, 1993, ARCH DERMATOL RES, V285, P436, DOI 10.1007/BF00372140; Ganzetti G, 2015, MELANOMA RES, V25, P232, DOI 10.1097/CMR.0000000000000151; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gentek R, 2018, J EXP MED, V215, P2994, DOI 10.1084/jem.20181206; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Girardi M, 2006, J INVEST DERMATOL, V126, P808, DOI 10.1038/sj.jid.5700120; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Greb JE, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.82; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Guan HB, 2002, J INVEST DERMATOL, V119, P137, DOI 10.1046/j.1523-1747.2002.01830.x; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hartwig T, 2015, EUR J IMMUNOL, V45, P3022, DOI 10.1002/eji.201545883; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Ho AW, 2019, NAT REV IMMUNOL, V19, P490, DOI 10.1038/s41577-019-0162-3; Hoeres T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00800; Hoft DF, 1998, J IMMUNOL, V161, P1045; Holtmeier V, 2001, J INVEST DERMATOL, V116, P275, DOI 10.1046/j.1523-1747.2001.01250.x; Hunter S, 2018, J HEPATOL, V69, P654, DOI 10.1016/j.jhep.2018.05.007; Hurabielle C, 2020, P NATL ACAD SCI USA, V117, P16465, DOI 10.1073/pnas.2003022117; Imai Y, 2015, J IMMUNOL, V195, P421, DOI 10.4049/jimmunol.1500448; In TSH, 2004, NAT COMMUN, V8, P2017; Jaiswal AK, 2018, J IMMUNOL, V201, P1651, DOI 10.4049/jimmunol.1800104; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Cabanes FJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003892; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jiang XD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169397; Kadow S, 2011, J IMMUNOL, V187, P3104, DOI 10.4049/jimmunol.1100912; Kamamoto CSL, 2017, DERM-ENDOCRINOL, V9, DOI 10.1080/19381980.2017.1361573; Karunakaran MM, 2020, IMMUNITY, V52, P487, DOI 10.1016/j.immuni.2020.02.014; Kashem SW, 2016, TRENDS IMMUNOL, V37, P440, DOI 10.1016/j.it.2016.04.007; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Katsuta M, 2006, J IMMUNOL, V176, P7736, DOI 10.4049/jimmunol.176.12.7736; Kenna TJ, 2012, ARTHRITIS RHEUM-US, V64, P1420, DOI 10.1002/art.33507; Kimura Y, 2016, CANCER SCI, V107, P1206, DOI 10.1111/cas.13005; Kistowska M, 2008, EUR J IMMUNOL, V38, P2200, DOI 10.1002/eji.200838366; Kitajima M, 2018, J IMMUNOL, V200, P1555, DOI 10.4049/jimmunol.1701389; Kong Y, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1115-3; Kulig P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13466; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Lee HC, 2002, IMMUNOL LETT, V81, P211, DOI 10.1016/S0165-2478(02)00007-X; Leung DYM, 2013, ALLERGOL INT, V62, P151, DOI 10.2332/allergolint.13-RAI-0564; Li YS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01099; Liu HY, 2017, CELL HOST MICROBE, V22, P653, DOI 10.1016/j.chom.2017.10.006; Liu Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05950-5; Lo Presti E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01401; Lo Presti E, 2017, CANCER IMMUNOL RES, V5, P397, DOI 10.1158/2326-6066.CIR-16-0348; LOVESCHIMENTI CD, 1994, J LEUKOCYTE BIOL, V55, P379, DOI 10.1002/jlb.55.3.379; Lu Y, 2015, J IMMUNOL, V195, P4273, DOI 10.4049/jimmunol.1500939; Mabuchi T, 2013, J INVEST DERMATOL, V133, P164, DOI 10.1038/jid.2012.260; Maher CO, 2015, J IMMUNOL, V194, P5953, DOI 10.4049/jimmunol.1403066; Mair F, 2015, ELIFE, V4, DOI 10.7554/eLife.10087; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Malhotra N, 2016, J ALLERGY CLIN IMMUN, V138, P1098, DOI 10.1016/j.jaci.2016.07.001; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Mangan BA, 2013, J IMMUNOL, V191, P30, DOI 10.4049/jimmunol.1300121; Marchitto MC, 2019, P NATL ACAD SCI USA, V116, P10917, DOI 10.1073/pnas.1818256116; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; MCVAY LD, 1991, EMBO J, V10, P83, DOI 10.1002/j.1460-2075.1991.tb07923.x; McVay LD, 1996, J IMMUNOL, V157, P2873; Meeh PF, 2006, CANCER IMMUNOL IMMUN, V55, P1072, DOI 10.1007/s00262-005-0094-6; Merches K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062249; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Munoz-Ruiz M, 2017, TRENDS IMMUNOL, V38, P336, DOI 10.1016/j.it.2017.01.007; Muro R, 2018, J CLIN INVEST, V128, P415, DOI 10.1172/JCI95837; Muschaweckh A, 2017, J IMMUNOL, V199, P2668, DOI 10.4049/jimmunol.1700287; Myles IA, 2013, NAT IMMUNOL, V14, P804, DOI 10.1038/ni.2637; Nakamizo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14292-1; Nakamizo S, 2015, J INVEST DERMATOL, V135, P1007, DOI 10.1038/jid.2014.516; Nasti TH, 2017, J IMMUNOL, V198, P950, DOI 10.4049/jimmunol.1601455; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nielsen MM, 2017, NAT REV IMMUNOL, V17, P733, DOI 10.1038/nri.2017.101; Nielsen MM, 2015, J INVEST DERMATOL, V135, P1311, DOI 10.1038/jid.2015.23; Nielsen MM, 2014, J IMMUNOL, V192, P2975, DOI 10.4049/jimmunol.1301689; Nishimura H, 2004, J VIROL, V78, P4927, DOI 10.1128/JVI.78.9.4927-4930.2004; NORDLIND K, 1995, ARCH DERMATOL RES, V287, P137, DOI 10.1007/BF01262321; Papotto PH, 2017, EMBO REP, V18, P1957, DOI 10.15252/embr.201744200; Paulson KG, 2020, JAMA DERMATOL, V156, P57, DOI 10.1001/jamadermatol.2019.3353; Puttur FK, 2010, J IMMUNOL, V185, P477, DOI 10.4049/jimmunol.0904106; Ramirez-Valle F, 2015, P NATL ACAD SCI USA, V112, P8046, DOI 10.1073/pnas.1508990112; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rigau M, 2020, SCIENCE, V367, P642, DOI 10.1126/science.aay5516; Roark CL, 2013, IMMUNOL RES, V55, P217, DOI 10.1007/s12026-012-8364-9; Roller A, 2012, J IMMUNOL, V189, P4612, DOI 10.4049/jimmunol.1103173; Saito T, 2017, J IMMUNOL, V199, P62, DOI 10.4049/jimmunol.1600848; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; SCHAUER U, 1991, CLIN EXP IMMUNOL, V86, P440; Schwacha MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158993; Sciammas R, 1997, J EXP MED, V185, P1969, DOI 10.1084/jem.185.11.1969; Sebestyen Z, 2020, NAT REV DRUG DISCOV, V19, P169, DOI 10.1038/s41573-019-0038-z; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Shibata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8687; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Sparber F, 2019, CELL HOST MICROBE, V25, P389, DOI 10.1016/j.chom.2019.02.002; Spidale NA, 2020, ELIFE, V9, DOI 10.7554/eLife.51188; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Sulcova J, 2015, EUR J IMMUNOL, V45, P2517, DOI 10.1002/eji.201545675; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sureshbabu SK, 2020, CLIN EXP IMMUNOL, V201, P40, DOI 10.1111/cei.13436; Suwanpradid J, 2017, J INVEST DERMATOL, V137, P288, DOI 10.1016/j.jid.2016.08.013; Tan LK, 2019, CELL REP, V27, P3657, DOI 10.1016/j.celrep.2019.05.064; Tang Q, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/713859; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Tong PL, 2015, J INVEST DERMATOL, V135, P84, DOI 10.1038/jid.2014.289; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Vantourout P, 2018, P NATL ACAD SCI USA, V115, P1039, DOI 10.1073/pnas.1701237115; von Meyenn L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02285; Wakita D, 2010, EUR J IMMUNOL, V40, P1927, DOI 10.1002/eji.200940157; Wang LS, 2001, J CLIN INVEST, V108, P1349, DOI 10.1172/JCI13584; Wragg KM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107773; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Zhang HL, 2019, CELL REP, V29, P391, DOI 10.1016/j.celrep.2019.09.003; Zhang ZZ, 2018, NAT MED, V24, P617, DOI 10.1038/s41591-018-0003-0; Zuberbuehler MK, 2019, NAT IMMUNOL, V20, P73, DOI 10.1038/s41590-018-0274-0; Zufferey C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077334	163	10	10	1	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2030	2042		10.1016/j.jaci.2020.11.023	http://dx.doi.org/10.1016/j.jaci.2020.11.023		JUN 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33259837				2022-12-18	WOS:000657814800005
J	Hsieh, CY; Jung, CR; Lin, CY; Hwang, BF				Hsieh, Chia-Yun; Jung, Chau-Ren; Lin, Chuan-Yao; Hwang, Bing-Fang			Combined exposure to heavy metals in PM2.5 and pediatric asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Heavy metals; asthma; birth cohort; vulnerable time windows; coexposure	GLOBAL BURDEN	Background: Asthma is the most common chronic allergic disease in children; it affects more than 300 million people worldwide. Information on the association between exposure to ambient heavy metals and incidence of pediatric asthma is limited. Objective: We sought to evaluate the effects of heavy metals during pregnancy and infancy periods with asthma and identify a sensitive time window, clarifying the effect of ambient heavy metals on lung development. Methods: A total of 171,281 children, who were born from 2004 to 2011 in Taichung City, were followed until 2014. Concentrations of ambient heavy metals such as arsenic (As), cadmium (Cd), mercury (Hg), and lead (Pb) were obtained from the Weather Research and Forecasting/Chem model, considering the top 75 emission sources in Taiwan. The distributed lag nonlinear model was used to investigate the relationship between combined exposure to heavy metals in 2.5 mm particulate matter and asthma in pregnant women and 1-year-old infants. Results: We identified 31,277 new asthma cases from the birth cohort. After adjustment for socioeconomic status, maternal age, maternal atopy, maternal anemia, and maternal kidney disease, distributed lag nonlinear model results revealed positive associations of asthma with exposure to Pb during gestational weeks 1 to 14 and 21 to 40, and 1 to 3 weeks after birth. Regarding the sensitivity analyses, coexposure to Pb and As, coexposure to Pb and Cd, and coexposure to Pb and Hg were positively associated with asthma onset as well. Conclusions: Our study suggested that combined exposure to Pb with As, Cd, and Hg during early and late gestational weeks was associated with the incidence of pediatric asthma.	[Hsieh, Chia-Yun; Hwang, Bing-Fang] China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, 91 Hsueh Shih Rd, Taichung 40402, Taiwan; [Jung, Chau-Ren] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Jung, Chau-Ren] Natl Inst Environm Studies, Japan Environm & Childrens Study Programme Off, Tsukuba, Ibaraki, Japan; [Lin, Chuan-Yao] Acad Sinica, Res Ctr Environm Changes, 128,Sect 2,Acad Rd, Taipei 11529, Taiwan; [Hwang, Bing-Fang] Asia Univ, Dept Occupat Therapy, Coll Med & Hlth Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; National Institute for Environmental Studies - Japan; Academia Sinica - Taiwan; Asia University Taiwan	Hwang, BF (corresponding author), China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.; Lin, CY (corresponding author), Acad Sinica, Res Ctr Environm Changes, 128,Sect 2,Acad Rd, Taipei 11529, Taiwan.	yao435@rcec.sinica.edu.tw; bfhwang@mail.cmu.edu.tw	Lin, CY/K-6503-2014; lin, chuan/HHD-2571-2022; Hwang, Bing-Fang/O-2709-2015	Lin, CY/0000-0002-0005-7088; Hwang, Bing-Fang/0000-0002-5951-9662; Jung, Chau-Ren/0000-0003-0673-9968	Health and Welfare Data Science Center, Taiwan Ministry of Health andWelfare, Taiwan	Health and Welfare Data Science Center, Taiwan Ministry of Health andWelfare, Taiwan	We appreciate the Health and Welfare Data Science Center, Taiwan Ministry of Health andWelfare, Taiwan for providing health data, and are grateful to Health Data Science Center, China Medical University Hospital, Taiwan for providing administrative, technical, and funding support.	Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P287, DOI 10.1016/j.jaci.2012.04.025; Bartsch H, 2004, CANCER DETECT PREV, V28, P385, DOI 10.1016/j.cdp.2004.07.004; Bortey-Sam N, 2018, ENVIRON POLLUT, V235, P163, DOI 10.1016/j.envpol.2017.12.005; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Chen I-L, 2013, PROJECT DRAFT CONTRO; Ehteshami-Afshar S, 2016, INT J TUBERC LUNG D, V20, P11, DOI 10.5588/ijtld.15.0472; Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-31; Fang GC, 2003, SCI TOTAL ENVIRON, V308, P157, DOI 10.1016/S0048-9697(02)00648-4; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; Gray DL, 2015, REV ENVIRON CONTAM T, V234, P135, DOI 10.1007/978-3-319-10638-0_3; Grell GA, 2005, ATMOS ENVIRON, V39, P6957, DOI 10.1016/j.atmosenv.2005.04.027; Haluza D, 2014, LUNG, V192, P111, DOI 10.1007/s00408-013-9529-6; Hsu CY, 2017, SCI TOTAL ENVIRON, V590, P204, DOI 10.1016/j.scitotenv.2017.02.212; Huang XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155818; Jedrychowski WA, 2010, PEDIAT ALLERG IMM-UK, V21, pE723, DOI 10.1111/j.1399-3038.2010.01034.x; Joseph CLM, 2005, ENVIRON HEALTH PERSP, V113, P900, DOI 10.1289/ehp.7453; Joshi S, 2007, EARLY HUM DEV, V83, P789, DOI 10.1016/j.earlhumdev.2007.09.007; Jung CR, 2019, J ALLERGY CLIN IMMUN, V143, P2254, DOI 10.1016/j.jaci.2019.03.024; Karmaus Wilfried, 2005, Environ Health, V4, P5; Kim KN, 2015, EPIDEMIOLOGY, V26, P733, DOI 10.1097/EDE.0000000000000351; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Lavigne E, 2019, AM J RESP CRIT CARE, V199, P1487, DOI 10.1164/rccm.201810-1976OC; Li C-Y., 2016, TAIWAN GONG GONG WEI, V35, P209, DOI [10.6288/TJPH201635104053, DOI 10.6288/TJPH201635104053]; Lodovici M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/487074; Lutz PM, 1999, TOXICOLOGY, V134, P63, DOI 10.1016/S0300-483X(99)00036-0; Malo JL, 2009, J ALLERGY CLIN IMMUN, V123, P545, DOI 10.1016/j.jaci.2008.09.010; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Min JY, 2008, BIOL TRACE ELEM RES, V123, P41, DOI 10.1007/s12011-008-8099-6; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Povey D, 2010, LEAD POISONING TRUTH, P1; Rokadia HK, 2013, CHEST, V143, P388, DOI 10.1378/chest.12-0595; Sbihi H, 2017, AM J RESP CRIT CARE, V195, P607, DOI 10.1164/rccm.201601-0164OC; Shi HL, 2004, FREE RADICAL BIO MED, V37, P582, DOI 10.1016/j.freeradbiomed.2004.03.012; Stein Renato T, 2004, Paediatr Respir Rev, V5, P155, DOI 10.1016/j.prrv.2004.01.007; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Tsao SM, 2011, J MICROBIOL IMMUNOL, V44, P139, DOI 10.1016/j.jmii.2010.02.005; Wang IJ, 2017, J EXPO SCI ENV EPID, V27, P478, DOI 10.1038/jes.2017.5; Wu KG, 2019, J MICROBIOL IMMUNOL, V52, P352, DOI 10.1016/j.jmii.2018.08.001; Zeng X, 2016, ENVIRON POLLUT, V210, P346, DOI 10.1016/j.envpol.2016.01.025	40	10	11	11	27	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2171	+		10.1016/j.jaci.2020.12.634	http://dx.doi.org/10.1016/j.jaci.2020.12.634		JUN 2021	23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33378689				2022-12-18	WOS:000657814800022
J	Johal, KJ; Chichester, KL; Oliver, ET; Devine, KC; Bieneman, AP; Schroeder, JT; MacGlashan, DW; Saini, SS				Johal, Kirti J.; Chichester, Kristin L.; Oliver, Eric T.; Devine, Kelly C.; Bieneman, Anja P.; Schroeder, John T.; MacGlashan, Donald W., Jr.; Saini, Sarbjit S.			The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Basophil; basophil activation test; chronic spontaneous urticaria; Fc epsilon RI; histamine release; IgE; omalizumab; plasmacytoid dendritic cell	EPSILON-RI EXPRESSION; PLASMACYTOID DENDRITIC CELLS; CHRONIC IDIOPATHIC URTICARIA; HISTAMINE-RELEASE; DISEASE-ACTIVITY; IGE; RESPONSES; SKIN	Background: The mechanisms underlying disease pathogenesis in chronic spontaneous urticaria (CSU) and improvement with omalizumab are incompletely understood. Objectives: This study sought to examine whether the rate of clinical remission is concordant with baseline basophil features or the rate of change of IgE-dependent functions of basophils and/or plasmacytoid dendritic cells during omalizumab therapy. Methods: Adults (n = 18) with refractory CSU were treated with omalizumab 300 mg monthly for 90 days. Subjects recorded daily urticaria activity scores, and clinical assessments with blood sampling occurred at baseline and on days 1, 3, 6, 10, 20, 30, 60, and 90 following omalizumab. At baseline, subjects were categorized by basophil functional phenotypes, determined by in vitro histamine release (HR) responses to anti-IgE antibody, as CSU-responder (CSU-R) or CSU-non-responder (CSU-NR), as well as basopenic (B) or nonbasopenic (NB). Results: CSU-R/NB subjects demonstrated the most rapid and complete symptom improvement. By day 6, CSU-R/NB and CSU-NR/NB had increased anti-IgE-mediated basophil HR relative to baseline, and these shifts did not correlate with symptom improvement. In contrast, CSU-NR/B basophil HR did not change during therapy. The kinetics of the decrease in surface IgE/Fc epsilon RI was similar in all 3 phenotypic groups and independent of the timing of the clinical response. Likewise, plasmacytoid dendritic cells' surface IgE/Fc epsilon RI decline and TLR9-induced IFN-alpha responses did not reflect clinical change. Conclusions: Changes in basophil IgE-based HR, surface IgE, or Fc epsilon RI bear no relationship to the kinetics in the change in clinical symptoms. Baseline basophil count and basophil functional phenotype, as determined by HR, may be predictive of responsiveness to omalizumab.	[Johal, Kirti J.; Chichester, Kristin L.; Oliver, Eric T.; Devine, Kelly C.; Bieneman, Anja P.; Schroeder, John T.; MacGlashan, Donald W., Jr.; Saini, Sarbjit S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Johal, Kirti J.] George Washington Univ, Sch Med & Hlth Sci, Div Allergy & Immunol, Dept Med, Washington, DC 20052 USA	Johns Hopkins University; George Washington University	Saini, SS (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle,2B-71B, Baltimore, MD 21224 USA.	ssaini@jhmi.edu			National Institute of Allergy and Infectious Diseases [AI116658, AI115703, AI116658-S1]; National Institutes of Health; Novartis; Eli Lilly; Regeneron	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Eli Lilly(Eli Lilly); Regeneron(Regeneron)	Supported by National Institute of Allergy and Infectious Diseases grants AI116658, AI115703 (J.T.S., A.P.B.) , and AI116658-S1 (E.T.O.) . Disclosure of potential conflict of interest: S. S. Saini has consulted for Allakos, Celltrion, Eli Lilly, Gbio, Genentech, Medimmune, Novartis, Regeneron, Sanofi, and Pfizer; and has received funding for research from the National Institutes of Health, Novartis, Eli Lilly, and Regeneron. The rest of the authors declare that they have no relevant conflicts of interest.	Aghdam MA, 2020, CLIN EXP ALLERGY, V50, P364, DOI 10.1111/cea.13566; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Bernstein JA, 2014, J ALLERGY CLIN IMMUN, V133, P1270, DOI 10.1016/j.jaci.2014.02.036; Deza G, 2017, ACTA DERM-VENEREOL, V97, P698, DOI 10.2340/00015555-2654; DUNSKY EH, 1979, J ALLERGY CLIN IMMUN, V63, P426, DOI 10.1016/0091-6749(79)90217-3; Eckman JA, 2008, J INVEST DERMATOL, V128, P1956, DOI 10.1038/jid.2008.55; Eckman JA, 2010, J ALLERGY CLIN IMMUN, V125, P889, DOI 10.1016/j.jaci.2009.09.012; Ertas R, 2018, ALLERGY, V73, P705, DOI 10.1111/all.13345; Futata E, 2011, BRIT J DERMATOL, V164, P1271, DOI 10.1111/j.1365-2133.2010.10198.x; Gericke J, 2017, J ALLERGY CLIN IMMUN, V139, P1059, DOI 10.1016/j.jaci.2016.07.047; Grattan CEH, 2003, CLIN EXP ALLERGY, V33, P337, DOI 10.1046/j.1365-2222.2003.01589.x; GREAVES MW, 1974, CLIN ALLERGY, V4, P265, DOI 10.1111/j.1365-2222.1974.tb01384.x; Huang AH, 2020, J ALLER CL IMM-PRACT, V8, P793, DOI 10.1016/j.jaip.2019.08.004; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Kaplan AP, 2017, ALLERGY, V72, P519, DOI 10.1111/all.13083; Kaplan A, 2016, J ALLERGY CLIN IMMUN, V137, P474, DOI 10.1016/j.jaci.2015.08.023; KERN F, 1976, J CLIN INVEST, V57, P1369, DOI 10.1172/JCI108405; MacGlashan D, 2021, J ALLERGY CLIN IMMUN, V147, P2295, DOI 10.1016/j.jaci.2021.02.039; MacGlashan DW, 2017, J ALLERGY CLIN IMMUN, V139, P1680, DOI 10.1016/j.jaci.2016.12.965; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Mathias SD, 2012, ANN ALLERG ASTHMA IM, V108, P20, DOI 10.1016/j.anai.2011.09.008; Metz M, 2017, THERANOSTICS, V7, P1266, DOI 10.7150/thno.18304; Oliver ET, 2015, ALLERGY, V70, P601, DOI 10.1111/all.12578; Palacios T, 2016, J ALLER CL IMM-PRACT, V4, P529, DOI 10.1016/j.jaip.2015.11.025; Paterniti MO, 2014, J INVEST DERMATOL, V134, P1743, DOI 10.1038/jid.2013.541; Rauber MM, 2020, J EUR ACAD DERMATOL, V34, P2078, DOI 10.1111/jdv.16216; Rauber MM, 2017, ALLERGY, V72, P1904, DOI 10.1111/all.13215; RORSMAN H, 1961, ACTA ALLERGOL, V16, P185, DOI 10.1111/j.1398-9995.1961.tb02894.x; Saini SS, 2017, J INVEST DERMATOL, V137, P958, DOI 10.1016/j.jid.2016.11.025; Saini SS, 2014, IMMUNOL ALLERGY CLIN, V34, P33, DOI 10.1016/j.iac.2013.09.012; Saini SS, 2009, CURR ALLERGY ASTHM R, V9, P286, DOI 10.1007/s11882-009-0040-3; Savage JH, 2012, J ALLERGY CLIN IMMUN, V130, P1123, DOI 10.1016/j.jaci.2012.05.039; Schroeder John T, 2016, Curr Protoc Immunol, V112, DOI 10.1002/0471142735.im0724s112; Schroeder JT, 2010, J ALLERGY CLIN IMMUN, V125, P896, DOI 10.1016/j.jaci.2009.10.021; Schroeder JT, 2005, J IMMUNOL, V175, P5724, DOI 10.4049/jimmunol.175.9.5724; Straesser MD, 2018, J ALLER CL IMM-PRACT, V6, P1386, DOI 10.1016/j.jaip.2017.10.030; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; van den Elzen MT, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0141-3; Vonakis BM, 2007, J ALLERGY CLIN IMMUN, V119, P441, DOI 10.1016/j.jaci.2006.09.035; Ying S, 2002, J ALLERGY CLIN IMMUN, V109, P694, DOI 10.1067/mai.2002.123236	40	10	10	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2271	+		10.1016/j.jaci.2021.02.038	http://dx.doi.org/10.1016/j.jaci.2021.02.038		JUN 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7MD	33713769	Green Accepted			2022-12-18	WOS:000657783800007
J	Park, JY; Choi, JH; Lee, SN; Cho, HJ; Ahn, JS; Kim, YB; Park, DY; Park, SC; Kim, SI; Kang, MJ; Jang, AR; Ahn, JH; Lee, TS; Kim, DY; Shin, SJ; Yoon, JH; Park, JH				Park, Ji-Yeon; Choi, Joo-Hee; Lee, Sang-Nam; Cho, Hyung-Ju; Ahn, Ji-Suk; Kim, Yong-Bum; Park, Do-Yong; Park, Sang Chul; Kim, Soo-In; Kang, Min-Jung; Jang, Ah-Ra; Ahn, Jae-Hun; Lee, Tae-Sung; Kim, Dong-Yeon; Shin, Sung Jae; Yoon, Joo-Heon; Park, Jong-Hwan			Protein arginine methyltransferase 1 contributes to the development of allergic rhinitis by promoting the production of epithelial-derived cytokines	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PRMT1; allergic rhinitis (AR); epithelial cytokines; MAPKs; house dust mite (HDM)	ANTIBODY-RESPONSES; PRMT1; METHYLATION; CELLS; EXPRESSION; INFLAMMATION; ACTIVATION; IGE	Background: Arginine methylation is a posttranslational modification mediated by protein arginine methyltransferases (PRMTs). Although previous studies have shown that PRMT1 contributes to the severity of allergic airway inflammation or asthma, the underlying mechanism is poorly understood. Objective: This study aimed to explore the role of PRMT1 and its relevant mechanism in the development of allergic rhinitis (AR). Methods: The expression levels of PRMTs and cytokines were determined by RT-PCR, and the localization of PRMT1 was determined by immunohistochemistry and confocal microscopy. The levels of house dust mite (HDM)-specific immunoglobulins in serum and of cytokines in nasal lavage fluids were determined by ELISA. PRMT1 inhibition was achieved by siRNA and treatment with the pan PRMT inhibitor arginine N-methyltransferase inhibitor-1. Results: PRMT1 expression was significantly increased in the nasal mucosa of patients and mice with AR. The degree of eosinophilic infiltration in the nasal mucosa was reduced in PRMT1(+/-) AR mice compared with wild-type mice. PRMT1 haploinsufficiency reduced the levels of HDM-specific immunoglobulins in serum and those of T(H)2 (IL-4, IL-5, and IL-13) and epithelial (thymic stromal lymphopoietin [TSLP], IL-25, and IL-33) cytokines in the nasal lavage fluids of AR mice. In nasal epithelial cells, HDM and IL-4 cooperate to enhance PRMT1 expression through a mitogen-activated protein kinase-dependent pathway. In addition, PRMT1 was essential for the production of TSLP, IL-25, and IL-33 in response to HDM and IL 4. Arginine N-methyltransferase inhibitor-1 treatment alleviated AR in the mouse model. Conclusions: PRMT1 plays an important role in AR development by regulating epithelial-derived cytokine production and might be a new therapeutic target for AR.	[Park, Ji-Yeon; Choi, Joo-Hee; Kang, Min-Jung; Jang, Ah-Ra; Ahn, Jae-Hun; Lee, Tae-Sung; Kim, Dong-Yeon; Park, Jong-Hwan] Chonnam Natl Univ, Coll Vet Med, Lab Anim Med, 77 Yongbong Ro, Gwangju 61186, South Korea; [Park, Ji-Yeon; Choi, Joo-Hee; Kang, Min-Jung; Jang, Ah-Ra; Ahn, Jae-Hun; Lee, Tae-Sung; Kim, Dong-Yeon; Park, Jong-Hwan] Chonnam Natl Univ, Anim Med Inst, Gwangju, South Korea; [Lee, Sang-Nam; Ahn, Ji-Suk; Yoon, Joo-Heon] Yonsei Univ, Airway Mucus Inst, Coll Med, Seoul, South Korea; [Cho, Hyung-Ju; Park, Sang Chul; Yoon, Joo-Heon] Yonsei Univ, Dept Otorhinolaryngol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Kim, Yong-Bum; Park, Do-Yong] Korea Inst Toxicol, Ctr Nonclin Studies, Daejeon, South Korea; [Kim, Soo-In] Yonsei Univ, Res Ctr Human Nat Ural Def Syst, Coll Med, Seoul, South Korea; [Shin, Sung Jae] Yonsei Univ, Inst Immunol & Immunol Dis, Dept Microbiol, Coll Med, Seoul, South Korea; [Park, Sang Chul] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Chonnam National University; Chonnam National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Institute of Toxicology; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hallym University	Park, JH (corresponding author), Chonnam Natl Univ, Coll Vet Med, Lab Anim Med, 77 Yongbong Ro, Gwangju 61186, South Korea.; Yoon, JH (corresponding author), Yonsei Univ, Dept Otorhinolaryngol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.	jhyoon@yubs.ac; jonpark@jmu.ac.kr		Cho, Hyung-Ju/0000-0002-2851-3225; Shin, Sung Jae/0000-0003-0854-4582	Global Research Lab Program [2016K1A1A2910779]; MidCareer Researcher Program [2018R1A2B3004143]; National Research Foundation of Korea - Ministry of Science and Information and Communication Technologies	Global Research Lab Program; MidCareer Researcher Program; National Research Foundation of Korea - Ministry of Science and Information and Communication Technologies	This research was supported by the Global Research Lab Program (grant no. 2016K1A1A2910779) and the MidCareer Researcher Program (grant no. 2018R1A2B3004143) of the National Research Foundation of Korea funded by the Ministry of Science and Information and Communication Technologies.	Altan B, 2016, GASTRIC CANCER, V19, P789, DOI 10.1007/s10120-015-0551-7; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Brescia G, 2015, ACTA OTO-LARYNGOL, V135, P1200, DOI 10.3109/00016489.2015.1063784; Chen YH, 2009, EXP EYE RES, V89, P1028, DOI 10.1016/j.exer.2009.09.004; Choi JH, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0134-x; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gao YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19874; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hams E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00597; Hata K, 2016, FEBS LETT, V590, P1200, DOI 10.1002/1873-3468.12161; Hata K, 2013, MICROBIOL IMMUNOL, V57, P185, DOI 10.1111/1348-0421.12019; Herrmann F, 2009, GENES CELLS, V14, P309, DOI 10.1111/j.1365-2443.2008.01266.x; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Infantino S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01009-1; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jacquet A, 2011, INT ARCH ALLERGY IMM, V155, P95, DOI 10.1159/000320375; Kang J, 2016, ONCOTARGET, V7, P85472, DOI 10.18632/oncotarget.13403; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Lim SK, 2013, BIOCHEM BIOPH RES CO, V440, P707, DOI 10.1016/j.bbrc.2013.09.136; Lloyd CM, 2009, NAT MED, V15, P366, DOI 10.1038/nm0409-366; Masters SL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001902; Mathioudaki K, 2008, BRIT J CANCER, V99, P2094, DOI 10.1038/sj.bjc.6604807; Mathioudaki K, 2011, TUMOR BIOL, V32, P575, DOI 10.1007/s13277-010-0153-2; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Musiani D, 2020, CELL REP, V30, P1208, DOI 10.1016/j.celrep.2019.12.061; Naqvi M, 2007, J ALLERGY CLIN IMMUN, V120, P137, DOI 10.1016/j.jaci.2007.02.045; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Poulard C, 2016, ONCOTARGET, V7, P67532, DOI 10.18632/oncotarget.11376; Reintjes A, 2016, P NATL ACAD SCI USA, V113, P4326, DOI 10.1073/pnas.1522372113; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shin JH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191115; Shin SH, 2009, CLIN EXP OTORHINOLAR, V2, P175, DOI 10.3342/ceo.2009.2.4.175; Stefanowicz D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044213; Sun QZ, 2017, J ALLERGY CLIN IMMUN, V140, P510, DOI 10.1016/j.jaci.2016.11.013; Sun QZ, 2015, J IMMUNOL, V195, P298, DOI 10.4049/jimmunol.1402465; Sun QZ, 2012, J IMMUNOL, V188, P3506, DOI 10.4049/jimmunol.1102635; Sun XF, 2007, HISTOL HISTOPATHOL, V22, P1387, DOI 10.14670/HH-22.1387; Tamura K, 2017, J PHARMACOL SCI, V135, P89, DOI 10.1016/j.jphs.2017.09.032; Tan Rachel, 2017, Asthma Res Pract, V3, P8, DOI 10.1186/s40733-017-0036-z; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Valizadeh A, 2015, J CLIN DIAGN RES, V9, pCE1, DOI 10.7860/JCDR/2015/12235.5814; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang IV, 2017, AM J RESP CRIT CARE, V195, P829, DOI 10.1164/rccm.201608-1558LE; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zakrzewicz D, 2015, BBA-MOL BASIS DIS, V1852, P2678, DOI 10.1016/j.bbadis.2015.09.008; Zhang X, 2018, ALLERGY ASTHMA IMMUN, V10, P34, DOI 10.4168/aair.2018.10.1.34	53	10	10	7	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1720	1731		10.1016/j.jaci.2020.12.646	http://dx.doi.org/10.1016/j.jaci.2020.12.646		MAY 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33476674	Green Published, hybrid			2022-12-18	WOS:000647680800021
J	Shah, SA; Tibble, H; Pillinger, R; McLean, S; Ryan, D; Critchley, H; Price, D; Hawrylowicz, CM; Simpson, CR; Soyiri, IN; Appiagyei, F; Sheikh, A; Nwaru, BI				Shah, Syed A.; Tibble, Holly; Pillinger, Rebecca; McLean, Susannah; Ryan, Dermot; Critchley, Hilary; Price, David; Hawrylowicz, Catherine M.; Simpson, Colin R.; Soyiri, Ireneous N.; Appiagyei, Francis; Sheikh, Aziz; Nwaru, Bright, I			Hormone replacement therapy and asthma onset in menopausal women: National cohort study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; estrogens; epidemiology; estradiol; progestogen	IL-17A PRODUCTION; ESTROGEN; EXPRESSION; RISK; UK; EPIDEMIOLOGY; ASSOCIATION; POPULATION; DISEASE; ALPHA	Background: There is uncertainty about the role of hormonal replacement therapy (HRT) in the development of asthma. Objective: We investigated whether use of HRT and duration of use was associated with risk of development of asthma in perimenopausal and postmenopausal women. Methods: We constructed a 17-year (from January 1, 2000, to December 31, 2016) open cohort of 353,173 women (aged 46-70 years) from the Optimum Patient Care Database, a longitudinal primary care database from across the United Kingdom. HRT use, subtypes, and duration of use; confounding variables; and asthma onset were defined by using the Read Clinical Classification System. We fitted multilevel Cox regression models to estimate hazard ratios (HRs) with 95% CIs. Results: During the 17-year follow-up (1,340,423 person years), 7,614 new asthma cases occurred, giving an incidence rate of 5.7 (95% CI = 5.5-5.8) per 1,000 person years. Compared with nonuse of HRT, previous use of any (HR = 0.83; 95% CI = 0.76-0.88), estrogen-only (HR = 0.89; 95% CI = 0.84-0.95), or combined estrogen and progestogen (HR = 0.82; 95% CI = 0.76-0.88) HRT was associated with a reduced risk of asthma onset. This was also the case with current use of any (HR = 0.79; 95% CI = 0.74-0.85), estrogen-only (HR = 0.80; 95% CI = 0.73-0.87), and combined estrogen and progestogen (HR = 0.78; 95% CI = 0.70-0.87) HRT. Longer duration of HRT use (1-2 years [HR = 0.93; 95% CI = 0.87-0.99]; 3-4 years [HR = 0.77; 95% CI = 0.70-0.84]; and >= 5 years [HR = 0.71; 95% CI = 0.64-0.78]) was associated with a dose-response reduced risk of asthma onset. Conclusion: We found that HRT was associated with a reduced risk of development of late onset asthma in menopausal women. Further cohort studies are needed to confirm these findings.	[Shah, Syed A.; Tibble, Holly; Pillinger, Rebecca; McLean, Susannah; Ryan, Dermot; Simpson, Colin R.; Soyiri, Ireneous N.; Sheikh, Aziz; Nwaru, Bright, I] Univ Edinburgh, Asthma UK Ctr Appl Res, Ctr Med Informat, Usher Inst, Edinburgh, Midlothian, Scotland; [Ryan, Dermot; Price, David; Appiagyei, Francis] Optimum Patient Care, Cambridge, England; [Critchley, Hilary] Univ Edinburgh, Med Res Council Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Price, David] Univ Aberdeen, Acad Primary Care, Div Appl Hlth Sci, Aberdeen, Scotland; [Price, David] Observat & Pragmat Res Inst, Singapore, Singapore; [Hawrylowicz, Catherine M.] Kings Colle London, Asthma UK Ctr Allerg Mech Asthma, Sch Immunol & Microbial Sci, Guys Hosp, London, England; [Simpson, Colin R.] Victoria Univ Wellington, Wellington Fac Hlth, Sch Hlth, Wellington, New Zealand; [Soyiri, Ireneous N.] Univ Hull, Hull York Med Sch, Inst Clin & Appl Hlth Res, Kingston Upon Hull, N Humberside, England; [Nwaru, Bright, I] Univ Gothenburg, Krefting Res Ctr, Gothenburg, Sweden; [Nwaru, Bright, I] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Inst Med, Gothenburg, Sweden	University of Edinburgh; University of Edinburgh; University of Aberdeen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Victoria University Wellington; University of Hull; University of York - UK; University of Gothenburg; University of Gothenburg	Shah, SA (corresponding author), Univ Edinburgh, Asthma UK Ctr Appl Res, Usher Inst, 9,Bioquarter,Little France Rd, Edinburgh EH16 4UX, Midlothian, Scotland.	ahmar.shah@ed.ac.uk	Simpson, Colin R/L-7180-2014; CRITCHLEY, HILARY OD/C-7575-2013; Hawrylowicz, Catherine/Q-8483-2017	Simpson, Colin R/0000-0002-5194-8083; Mclean, Susannah/0000-0001-8238-5167; Hawrylowicz, Catherine/0000-0002-2337-7463; CRITCHLEY, HILARY/0000-0003-1913-4044	Asthma UK [AUK-IG-2016-346]; Health Data Research UK; Knut and Alice Wallenberg Foundation; Wallenberg Centre for Molecular and Translational Medicine, OPC, OPRI, University of Gothenburg, Sweden; VBG Group Herman Krefting Foundation on Asthma and Allergy	Asthma UK; Health Data Research UK; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Wallenberg Centre for Molecular and Translational Medicine, OPC, OPRI, University of Gothenburg, Sweden; VBG Group Herman Krefting Foundation on Asthma and Allergy	Supported by Asthma UK (grant AUK-IG-2016-346) and Health Data Research UK. B.N. acknowledges support of the Knut and Alice Wallenberg Foundation; the Wallenberg Centre for Molecular and Translational Medicine, OPC, OPRI, University of Gothenburg, Sweden; and the VBG Group Herman Krefting Foundation on Asthma and Allergy. The funders (Asthma UK and Health Data Research UK) had no influence on the design of the study, the interpretation of its findings, or the decision to publish.	Ambhore NS, 2019, AM J RESP CELL MOL, V61, P469, DOI 10.1165/rcmb.2018-0321OC; Aravamudan B, 2017, J CELL PHYSIOL, V232, P1754, DOI 10.1002/jcp.25674; Barr RG, 2004, ARCH INTERN MED, V164, P379, DOI 10.1001/archinte.164.4.379; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bhallamudi S, 2020, AM J PHYSIOL-LUNG C, V318, pL112, DOI 10.1152/ajplung.00206.2019; Bonnelykke K, 2015, J ALLERGY CLIN IMMUN, V135, P813, DOI 10.1016/j.jaci.2014.11.019; Carlson CL, 2001, AM J RESP CRIT CARE, V163, P423, DOI 10.1164/ajrccm.163.2.2003040; Castro-Rodriguez LA, 2001, AM J RESP CRIT CARE, V163, P1344, DOI 10.1164/ajrccm.163.6.2006140; Cevrioglu AS, 2004, MATURITAS, V49, P221, DOI 10.1016/j.maturitas.2004.01.009; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Deas I, 2003, ENVIRON PLANN C, V21, P883, DOI 10.1068/c0240; Fruzzetti F, 1999, AM J OBSTET GYNECOL, V180, pS369, DOI 10.1016/S0002-9378(99)70698-8; Fuseini H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02740; Jarvis D, 2008, ALLERGY, V63, P95, DOI 10.1111/j.1398-9995.2007.01530.x; Jones RCM, 2014, LANCET RESP MED, V2, P267, DOI 10.1016/S2213-2600(14)70008-6; Kalidhindi RSR, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01499; Kos-Kudla B, 2001, GYNECOL ENDOCRINOL, V15, P304, DOI 10.1080/713602889; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Kvaskoff M, 2015, HUM REPROD UPDATE, V21, P500, DOI 10.1093/humupd/dmv013; Lange P, 2001, THORAX, V56, P613, DOI 10.1136/thorax.56.8.613; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; McCleary N, 2018, J ALLERGY CLIN IMMUN, V141, P1510, DOI 10.1016/j.jaci.2017.11.034; Moulton VR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02279; Mueller JE, 2003, RESP MED, V97, P990, DOI 10.1016/S0954-6111(03)00128-8; Newcomb DC, 2015, J ALLERGY CLIN IMMUN, V136, P1025, DOI 10.1016/j.jaci.2015.05.046; Nissen F, 2018, BRIT J GEN PRACT, V68, pE775, DOI 10.3399/bjgp18X699389; Nissen F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017474; Nwaru BI, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020075; Pata O, 2003, MATURITAS, V46, P213, DOI 10.1016/S0378-5122(03)00191-9; Piccinni MP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00642; Price DB, 2015, LANCET RESP MED, V3, P849, DOI 10.1016/S2213-2600(15)00367-7; Real FG, 2006, THORAX, V61, P34, DOI 10.1136/thx.2005.040881; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Romieu I, 2010, THORAX, V65, P292, DOI 10.1136/thx.2009.116079; Simpson CR, 2010, J ROY SOC MED, V103, P98, DOI 10.1258/jrsm.2009.090348; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; TROISI RJ, 1995, AM J RESP CRIT CARE, V152, P1183, DOI 10.1164/ajrccm.152.4.7551368; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911	41	10	10	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1662	1670		10.1016/j.jaci.2020.11.024	http://dx.doi.org/10.1016/j.jaci.2020.11.024		MAY 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33279576	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000647680800016
J	Sun, ZW; Kim, JH; Kim, SH; Kim, HR; Zhang, KL; Pan, YD; Ko, MK; Kim, BM; Chu, H; Lee, HR; Kim, HL; Kim, JH; Fu, XJ; Hyun, YM; Yun, KN; Kim, JY; Lee, DW; Song, SY; Lin, CP; Clark, RA; Lee, KH; Kupper, TS; Park, CO				Sun, ZhengWang; Kim, Ji Hye; Kim, Seo Hyeong; Kim, Hye Ran; Zhang, KeLun; Pan, Youdong; Ko, Min Kyung; Kim, Bo Mi; Chu, Howard; Lee, Hee Ra; Kim, Hye Li; Kim, Ji Hyung; Fu, Xiujun; Hyun, Young-Min; Yun, Ki Na; Kim, Jin Young; Lee, Dong Won; Song, Seung Yong; Lin, Charles P.; Clark, Rachael A.; Lee, Kwang Hoon; Kupper, Thomas S.; Park, Chang Ook			Skin-resident natural killer T cells participate in cutaneous allergic inflammation in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; natural killer T cells; tissue-resident memory T cells; T-RM cells; CXCR4; CXCL12; thymic stromal lymphopoietin	HUMAN EPITHELIAL-CELLS; DENDRITIC CELLS; NKT CELLS; RECEPTOR; EXPRESSION; MECHANISMS; 7-TRANSMEMBRANE; TRAFFICKING; INFECTION; RESPONSES	Background: Natural killer T (NKT) cells are unconventional T cells that bridge innate and adaptive immunity. NKT cells have been implicated in the development of atopic dermatitis (AD). Objective: We aimed to investigate the role of NKT cells in AD development, especially in skin. Methods: Global proteomic and transcriptomic analyses were performed by using skin and blood from human healthy-controls and patients with AD. Levels of CXCR4 and CXCL12 expression in skin NKT cells were analyzed in human AD and mouse AD models. By using parabiosis and intravital imaging, the role of skin CXCR4+ NKT cells was further evaluated in models of mice with AD by using CXCR4-conditionally deficient or CXCL12 transgenic mice. Results: CXCR4 and its cognate ligand CXCL12 were significantly upregulated in the skin of humans with AD by global transcriptomic and proteomic analyses. CXCR4(+) NKT cells were enriched in AD skin, and their levels were consistently elevated in our models of mice with AD. Allergen-induced NKT cells participate in cutaneous allergic inflammation. Similar to tissue-resident memory T cells, the predominant skin NKT cells were CXCR4(+) and CD69(+). Skin-resident NKT cells uniquely expressed CXCR4, unlike NKT cells in the liver, spleen, and lymph nodes. Skin fibroblasts were the main source of CXCL12. CXCR4(+) NKT cells preferentially trafficked to CXCL12-rich areas, forming an enriched CXCR4(+) tissue-resident NKT cells/CXCL12(+) cell cluster that developed in acute and chronic allergic inflammation in our models of mice with AD. Conclusions: CXCR4(+) tissue-resident NKT cells may form a niche that contributes to AD, in which CXCL12 is highly expressed.	[Sun, ZhengWang; Kim, Ji Hye; Kim, Seo Hyeong; Kim, Hye Ran; Zhang, KeLun; Ko, Min Kyung; Kim, Bo Mi; Chu, Howard; Lee, Hee Ra; Kim, Hye Li; Lee, Kwang Hoon; Park, Chang Ook] Yonsei Univ, Dept Dermatol, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea; [Sun, ZhengWang; Kim, Ji Hye; Kim, Seo Hyeong; Kim, Hye Ran; Zhang, KeLun; Ko, Min Kyung; Kim, Bo Mi; Chu, Howard; Lee, Hee Ra; Kim, Hye Li; Lee, Kwang Hoon; Park, Chang Ook] Yonsei Univ, Cutaneous Biol Res Inst, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea; [Kim, Ji Hye; Kim, Seo Hyeong; Zhang, KeLun; Kim, Hye Li; Hyun, Young-Min; Lee, Kwang Hoon; Park, Chang Ook] Yonsei Univ, Coll Med, Grad Sch Med Sci, Brain Korea 21 Project, Seoul, South Korea; [Hyun, Young-Min] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Lee, Dong Won; Song, Seung Yong] Yonsei Univ, Coll Med, Dept Plast & Reconstruct Surg, Inst Human Tissue Restorat, Seoul, South Korea; [Pan, Youdong; Clark, Rachael A.; Kupper, Thomas S.; Park, Chang Ook] Brigham & Womens Hosp, Dept Dermatol, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Pan, Youdong; Clark, Rachael A.; Kupper, Thomas S.; Park, Chang Ook] Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Fu, Xiujun; Lin, Charles P.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02115 USA; [Fu, Xiujun; Lin, Charles P.] Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02115 USA; [Kim, Ji Hyung] Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea; [Yun, Ki Na; Kim, Jin Young] Korea Basic Sci Inst, Biomed Omics Grp, Ochang, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Korea University; Korea Basic Science Institute (KBSI)	Lee, KH; Park, CO (corresponding author), Yonsei Univ, Dept Dermatol, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea.; Lee, KH; Park, CO (corresponding author), Yonsei Univ, Cutaneous Biol Res Inst, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea.; Kupper, TS (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Kupper, TS (corresponding author), Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	wanglee@yuhs.ac; tkupper@bwh.harvard.edu; copark@yuhs.ac	SUN, ZHENGWANG/AAC-6964-2019	SUN, ZHENGWANG/0000-0002-4486-018X; Song, Seung Yong/0000-0002-3145-7463; Lee, Dongwon/0000-0003-0046-3139; Kim, JI HYUNG/0000-0001-6785-2345; Park, Chang Ook/0000-0003-3856-1201; Kim, Ji Hye/0000-0003-2734-1174; Hyun, Young-Min/0000-0002-0567-2039	National Institutes of Health [R01AI041707, R01AI127654, TR01AI097128, R01AR063962]; National Research Foundation of Korea - Korea government (Ministry of Science and ICT) [NRF-2017R1A2B4009568]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI14C1324, HI14C1799]; Dongwha Faculty Research Assistance Program of Yonsei University College of Medicine [6-2016-0129]; Amorepacific grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea - Korea government (Ministry of Science and ICT); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Dongwha Faculty Research Assistance Program of Yonsei University College of Medicine; Amorepacific grant	Supported by National Institutes of Health grants R01AI041707 (to T.S.K.) , R01AI127654 (to T.S.K.) , TR01AI097128 (to T.S.K. and R.A.C.) , and R01AR063962 (to R.A.C.) , the National Research Foundation of Korea grant funded by the Korea government (Ministry of Science and ICT) (No. NRF-2017R1A2B4009568 [to C.O.P.] ) , grants of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant HI14C1324 [to K.H.L and C.O.P.] and grant HI14C1799 [to C.O.P.] ) , the Dongwha Faculty Research Assistance Program of Yonsei University College of Medicine (6-2016-0129 [to C.O.P.] ) , and an Amorepacific grant (2018 [to C.O.P.] ) .	Albacker LA, 2013, NAT MED, V19, P1297, DOI 10.1038/nm.3321; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Chang CH, 2016, STEM CELLS, V34, P1664, DOI 10.1002/stem.2340; Chu H, 2017, ALLERGY ASTHMA IMMUN, V9, P158, DOI 10.4168/aair.2017.9.2.158; Collins N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11514; Fedyk ER, 2001, J IMMUNOL, V166, P5749, DOI 10.4049/jimmunol.166.9.5749; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gros E, 2009, J ALLERGY CLIN IMMUN, V124, P753, DOI 10.1016/j.jaci.2009.07.004; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Hijnen D, 2013, J INVEST DERMATOL, V133, P973, DOI 10.1038/jid.2012.456; Ivins S, 2015, DEV CELL, V33, P455, DOI 10.1016/j.devcel.2015.03.026; Jiang XD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169397; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jin S, 2014, EXP DERMATOL, V23, P938, DOI 10.1111/exd.12563; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kohara H, 2007, BLOOD, V110, P4153, DOI 10.1182/blood-2007-04-084210; Kuksin CA, 2015, BLOOD, V125, P2087, DOI 10.1182/blood-2014-08-594796; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Li Z, 2012, J PROTEOME RES, V11, P1582, DOI 10.1021/pr200748h; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; LOETSCHER M, 1994, J BIOL CHEM, V269, P232; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Matos TR, 2017, J CLIN INVEST, V127, P4031, DOI 10.1172/JCI93396; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Noda M, 2011, BLOOD, V117, P451, DOI 10.1182/blood-2010-04-277897; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Park CO, 2008, EXP DERMATOL, V17, P24, DOI 10.1111/j.1600-0625.2007.00634.x; Park CO, 2018, J ALLERGY CLIN IMMUN, V142, P647, DOI 10.1016/j.jaci.2017.09.042; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Park CO, 2013, EXP DERMATOL, V22, P6, DOI 10.1111/exd.12034; Pitt LA, 2015, CANCER CELL, V27, P755, DOI 10.1016/j.ccell.2015.05.002; Riedel JH, 2012, J AM SOC NEPHROL, V23, P1987, DOI 10.1681/ASN.2012040394; Rochman Y, 2018, SCI SIGNAL, P11; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Schlapbach C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007828; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Shimizuhira C, 2014, J INVEST DERMATOL, V134, P2709, DOI 10.1038/jid.2014.200; Shin JU, 2016, J INVEST DERMATOL, V136, P507, DOI 10.1016/j.jid.2015.11.008; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V135, P1218, DOI 10.1016/j.jaci.2015.03.003; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Wu WH, 2010, J ALLERGY CLIN IMMUN, V126, P290, DOI 10.1016/j.jaci.2010.05.024; Zgraggen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093665	59	10	11	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1764	1777		10.1016/j.jaci.2020.11.049	http://dx.doi.org/10.1016/j.jaci.2020.11.049		MAY 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33516870	Green Accepted			2022-12-18	WOS:000647680800025
J	Lu, MD; Litonjua, AA; O'Connor, GT; Zeiger, RS; Bacharier, L; Schatz, M; Carey, VJ; Weiss, ST; Mirzakhani, H				Lu, Mengdi; Litonjua, Augusto A.; O'Connor, George T.; Zeiger, Robert S.; Bacharier, Leonard; Schatz, Michael; Carey, Vincent J.; Weiss, Scott T.; Mirzakhani, Hooman			Effect of early and late prenatal vitamin D and maternal asthma status on offspring asthma or recurrent wheeze	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Pregnancy; maternal asthma; prenatal; vitamin D; childhood; recurrent wheeze; asthma		Background: Childhood asthma developmental programming is complex. Maternal asthma is a strong risk factor for childhood asthma, whereas vitamin D (VD) has emerged as a modifiable prenatal exposure. Objective: Our aim was to examine the combined effect of early and late prenatal VD status in during pregnancies in women with and without asthma on childhood asthma or recurrent wheeze development. Methods: We conducted a cohort study using prospectively collected data from the Vitamin D Antenatal Asthma Reduction Trial, a randomized, double-blinded, placebo-controlled VD supplementation trial in pregnant women at high risk of offspring asthma (N = 806 mother-offspring pairs). 25-Hydroxyvitamin-D (25(OH)D) level was measured in early and late pregnancy. Our main exposure was an ordered variable representing early and late prenatal VD sufficiency (25(OH)D level >= 30 ng/mL) status during pregnancy in women with and without asthma. The primary outcome was offspring with asthma or recurrent wheeze by age 3 years. We also examined the effect of prenatal VD level on early life asthma or recurrent wheeze progression to active asthma at age 6 years. Results: Among mothers with asthma versus among mothers with early and late prenatal VD insufficiency, those with early or late VD sufficiency (adjusted odds ratio = 0.56; 95% CI = 0.31-1.00) or early and late VD sufficiency (adjusted odds ratio = 0.36; 95% CI = 0.15-0.81) had a lower risk of offspring with asthma or recurrent wheeze by age 3 years (P-for trend = .008). This protective trend was reiterated in asthma or recurrent wheeze progression to active asthma from age 3 to 6 years (P (for trend )= .04). Conclusion: This study implies a protective role for VD sufficiency throughout pregnancy, particularly in attenuating the risk conferred by maternal asthma on childhood asthma or recurrent wheeze development.	[Lu, Mengdi] Massachusetts Gen Hosp, Div Pediat Pulm Med, Boston, MA 02114 USA; [Lu, Mengdi; Carey, Vincent J.; Weiss, Scott T.; Mirzakhani, Hooman] Harvard Med Sch, Boston, MA 02115 USA; [Lu, Mengdi; Carey, Vincent J.; Weiss, Scott T.; Mirzakhani, Hooman] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Litonjua, Augusto A.] Univ Rochester, Med Ctr, Golisano Childrens Hosp, Div Pediat Pulm Med, Rochester, NY 14627 USA; [O'Connor, George T.] Boston Univ, Boston Med Ctr, Dept Med, Ctr Pulm, Boston, MA 02215 USA; [Zeiger, Robert S.] Kaiser Permanente Southern Calif Reg, Dept Allergy & Res & Evaluat, San Diego, CA USA; [Zeiger, Robert S.] Kaiser Permanente Southern Calif Reg, Dept Allergy & Res & Evaluat, Pasadena, CA USA; [Bacharier, Leonard; Schatz, Michael] Washington Univ, Dept Pediat, Div Pediat Allergy Immunol & Pulm Med, St Louis, MO 63130 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Rochester; Boston Medical Center; Boston University; Kaiser Permanente; Kaiser Permanente; Washington University (WUSTL)	Mirzakhani, H (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Dept Med, 181 Longwood, Boston, MA 02115 USA.	hoomi@post.harvard.edu		Zeiger, Robert/0000-0001-5788-5063; Bacharier, Leonard/0000-0003-0432-2704; Mirzakhani, Hooman/0000-0002-2290-4436	National Heart, Lung, and Blood Institute [U01 HL091528, R01 HL091528, T32 HL007427, 2L30 HL129467-02A1, 1 K01HL146977 01A1]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Vitamin D Antenatal Asthma Reduction Trial was funded by the National Heart, Lung, and Blood Institute (grants U01 HL091528 and R01 HL091528 [to S.T.W and A.A.L.]). M.L. has received research support from the National Heart, Lung, and Blood Institute (grant T32 HL007427). H.M. has received research support from the National Heart, Lung, and Blood Institute (grants 2L30 HL129467-02A1, U01 HL091528, and 1 K01HL146977 01A1).	Akinbami LJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2354; Chawes BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099856; Duijts L, 2016, EUR RESPIR J, V47, P510, DOI 10.1183/13993003.00718-2015; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Giles W, 2013, OBSTET MED, V6, P58, DOI 10.1258/om.2012.120008; Grzeskowiak LE, 2016, ERJ OPEN RES, V2; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollams EM, 2017, J ALLERGY CLIN IMMUN, V139, P472, DOI 10.1016/j.jaci.2016.07.032; Hollis BW, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.30; Hornsby E, 2018, J ALLERGY CLIN IMMUN, V141, P269, DOI 10.1016/j.jaci.2017.02.039; Jolliffe DA, 2017, LANCET RESP MED, V5, P881, DOI [10.1016/S2213-2600(17)30306-5, 10.1016/s2213-2600(17)30306-5]; Kho AT, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-47; Lim RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010134; Litonjua AA, 2020, NEW ENGL J MED, V382, P525, DOI 10.1056/NEJMoa1906137; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Litonjua AA, 2014, CONTEMP CLIN TRIALS, V38, P37, DOI 10.1016/j.cct.2014.02.006; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; Martineau AR, 2016, THORAX, V71; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Mirzakhani H, 2019, CLIN EXP ALLERGY, V49, P419, DOI 10.1111/cea.13320; Mirzakhani H, 2019, THORAX, V74, P200, DOI 10.1136/thoraxjnl-2018-211962; Mirzakhani H, 2017, J ALLERGY CLIN IMMUN, V140, P1453, DOI 10.1016/j.jaci.2017.03.053; Mirzakhani H, 2016, J CLIN INVEST, V126, P4702, DOI 10.1172/JCI89031; Nurmagambetov T, 2018, ANN AM THORAC SOC, V15, P348, DOI 10.1513/AnnalsATS.201703-259OC; Ozias MK, 2014, J AM COLL NUTR, V33, P394, DOI 10.1080/07315724.2013.879843; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Sablok A, 2015, CLIN ENDOCRINOL, V83, P536, DOI 10.1111/cen.12751; Sears MR, 2014, CHEST, V145, P219, DOI 10.1378/chest.13-2059; Sordillo JE, 2017, J ALLERGY CLIN IMMUN, V139, P482, DOI 10.1016/j.jaci.2016.08.045; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; von Mutius E, 2020, NEW ENGL J MED, V382, P574, DOI 10.1056/NEJMe1915082; Weiss ST, 2011, J ALLERGY CLIN IMMUN, V127, P1128, DOI 10.1016/j.jaci.2011.02.025; Zahran HS, 2018, MMWR-MORBID MORTAL W, V67, P149, DOI 10.15585/mmwr.mm6705e1; Zhang JY, 2014, BRIT J NUTR, V112, P1081, DOI 10.1017/S0007114514001883; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	35	10	12	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1234	+		10.1016/j.jaci.2020.06.041	http://dx.doi.org/10.1016/j.jaci.2020.06.041		APR 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	32822692	Bronze, Green Accepted			2022-12-18	WOS:000637368900013
J	Do, AN; Chun, Y; Grishina, G; Grishin, A; Rogers, AJ; Raby, BA; Weiss, ST; Vicencio, A; Schadt, EE; Bunyavanich, S				Do, Anh N.; Chun, Yoojin; Grishina, Galina; Grishin, Alexander; Rogers, Angela J.; Raby, Benjamin A.; Weiss, Scott T.; Vicencio, Alfin; Schadt, Eric E.; Bunyavanich, Supinda			Network study of nasal transcriptome profiles reveals master regulator genes of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; nasal; transcriptome; network; gene expression; severe persistent asthma; mild persistent asthma; moderate persistent asthma; master regulator; probabilistic causal network		Background: Nasal transcriptomics can provide an accessible window into asthma pathobiology. Objective: Our goal was to move beyond gene signatures of asthma to identify master regulator genes that causally regulate genes associated with asthma phenotypes. Methods: We recruited 156 children with severe persistent asthma and controls for nasal transcriptome profiling and applied network-based and probabilistic causal methods to identify severe asthma genes and their master regulators. We then took the same approach in an independent cohort of 190 adults with mild/moderate asthma and controls to identify mild/moderate asthma genes and their master regulators. Comparative analysis of the master regulator genes followed by validation testing in independent children with severe asthma (n = 21) and mild/moderate asthma (n = 154) was then performed. Results: Nasal gene signatures for severe persistent asthma and for mild/moderate persistent asthma were identified; both were found to be enriched in coexpression network modules for ciliary function and inflammatory response. By applying probabilistic causal methods to these gene signatures and validation testing in independent cohorts, we identified (1) a master regulator gene common to asthma across severity and ages (FOXJ1); (2) master regulator genes of severe persistent asthma in children (LRRC23, TMEM231, CAPS, PTPRC, and FYB); and (3) master regulator genes of mild/moderate persistent asthma in children and adults (C1orf38 and FMNL1). The identified master regulators were statistically inferred to causally regulate the expression of downstream genes that modulate ciliary function and inflammatory response to influence asthma. Conclusion: The identified master regulator genes of asthma provide a novel path forward to further uncovering asthma mechanisms and therapy.	[Do, Anh N.; Chun, Yoojin; Schadt, Eric E.; Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Do, Anh N.; Chun, Yoojin; Schadt, Eric E.; Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Grishina, Galina; Grishin, Alexander; Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Div Allergy & Immunol, Dept Pediat, New York, NY 10029 USA; [Vicencio, Alfin] Icahn Sch Med Mt Sinai, Div Pulm Med, Dept Pediat, New York, NY 10029 USA; [Rogers, Angela J.] Stanford Univ, Dept Med, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Raby, Benjamin A.] Childrens Hosp Boston, Div Pulm Med, Boston, MA USA; [Weiss, Scott T.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Weiss, Scott T.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bunyavanich, S (corresponding author), Icahn Sch Med Mt Sinai, 1425 Madison Ave,Box 1498, New York, NY 10029 USA.	supinda@post.harvard.edu		Rogers, Angela/0000-0001-6969-6200	US National Institutes of Health [NIH R01 AI 118833]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the US National Institutes of Health NIH R01 AI 118833. Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.	Akhouayri I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002319; Altman MC, 2019, NAT IMMUNOL, V20, P637, DOI 10.1038/s41590-019-0347-8; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2007, 084051 NAT HEART LUN; Basnet S, 2019, AM J RESP CELL MOL, V61, P450, DOI 10.1165/rcmb.2018-0220OC; Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Blue E, 2018, ANN AM THORAC SOC, V15, P440, DOI 10.1513/AnnalsATS.201706-451OC; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Boon M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5418; Bosco A, 2012, J ALLERGY CLIN IMMUN, V129, P88, DOI 10.1016/j.jaci.2011.10.038; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Charney DS, 2018, CHARNEY NESTLERS NEU; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Chun Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133707; Cohain A, 2017, BIOCOMPUT-PAC SYM, P120, DOI 10.1142/9789813207813_0013; Edwards MR, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02448-2016; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Ferreira MAR, 2019, AM J HUM GENET, V104, P665, DOI 10.1016/j.ajhg.2019.02.022; Fitzpatrick AM, 2016, J ALLER CL IMM-PRACT, V4, P11, DOI 10.1016/j.jaip.2015.10.008; Fredriksson K, 2014, J IMMUNOL, V192, P4497, DOI 10.4049/jimmunol.1301234; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Hu JM, 2016, INT REV IMMUNOL, V35, P325, DOI 10.3109/08830185.2014.956360; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirmo AC, 2016, J IMMUNOL, V197, P4219, DOI 10.4049/jimmunol.1601094; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kong Q, 2015, J ASTHMA, V52, P343, DOI 10.3109/02770903.2014.971967; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li CS, 2006, J HUM GENET, V51, P292, DOI 10.1007/s10038-006-0359-8; Li YY, 2014, J ALLERGY CLIN IMMUN, V134, P1282, DOI 10.1016/j.jaci.2014.07.038; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Marioni, 2019, HDB STAT GENOMICS; Mersich AT, 2010, CYTOSKELETON, V67, P573, DOI 10.1002/cm.20468; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Modena BD, 2017, AM J RESP CRIT CARE, V195, P1449, DOI 10.1164/rccm.201607-1407OC; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Nevers Y, 2017, MOL BIOL EVOL, V34, P2016, DOI 10.1093/molbev/msx146; Ooi AT, 2012, AM J TRANSL RES, V4, P219; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Ozerskaya I, 2017, EUR RESPIR J, V50, DOI 10.1183/1393003.congress-2017.PA4498; Pandey G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27189-4; Papaioannou AI, 2017, EUR J PHARMACOL, V808, P14, DOI 10.1016/j.ejphar.2016.09.033; Peirce MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011465; Peters LA, 2017, NAT GENET, V49, P1437, DOI 10.1038/ng.3947; Peters MC, 2019, AM J RESP CRIT CARE, V199, P465, DOI 10.1164/rccm.201807-1291OC; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson D, 2017, CLIN EXP ALLERGY, V47, P161, DOI 10.1111/cea.12880; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szodoray P, 2016, J ALLERGY CLIN IMMUN, V138, P839, DOI 10.1016/j.jaci.2016.01.035; Thomas B, 2010, J ALLERGY CLIN IMMUN, V126, P722, DOI 10.1016/j.jaci.2010.05.046; Tsoucas D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10802-z; Turner J, 2011, AM J RESP CELL MOL, V44, P276, DOI 10.1165/rcmb.2009-0304OC; Wesolowska-Andersen A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1140-8; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Wu YD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09572-5; Yamaguchi A, 2014, J HISTOCHEM CYTOCHEM, V62, P286, DOI 10.1369/0022155413520607; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Yii ACA, 2018, ALLERGY, V73, P1964, DOI 10.1111/all.13496; Zhang B., 2013, P WORLD C ENG, VII, P5; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069; Zhu J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001301	81	10	10	3	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					879	893		10.1016/j.jaci.2020.07.006	http://dx.doi.org/10.1016/j.jaci.2020.07.006		MAR 2021	15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RA9TV	32828590	Green Accepted			2022-12-18	WOS:000631762400011
J	Scurlock, AM; Burks, AW; Sicherer, SH; Leung, DYM; Kim, EH; Henning, AK; Dawson, P; Lindblad, RW; Berin, MC; Cho, CB; Davidson, WF; Plaut, M; Sampson, HA; Wood, RA; Jones, SM				Scurlock, Amy M.; Burks, A. Wesley; Sicherer, Scott H.; Leung, Donald Y. M.; Kim, Edwin H.; Henning, Alice K.; Dawson, Peter; Lindblad, Robert W.; Berin, M. Cecilia; Cho, Christine B.; Davidson, Wendy F.; Plaut, Marshall; Sampson, Hugh A.; Wood, Robert A.; Jones, Stacie M.		Consortium Food Allergy Res CoFAR	Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Peanut allergy; food allergy; epicutaneous immunotherapy; desensitization; &nbsp; IgE; &nbsp; IgG < sub > 4 <; sub >???????; &nbsp; follow-up	CHILDHOOD; CHILDREN; SAFETY; IMPACT	Background: Consortium for Food Allergy Research investigators previously reported 52-week outcomes from a randomized controlled trial of peanut epicutaneous immunotherapy, observing modest and statistically significant induction of desensitization, highest in children ages 4 to 11 years. Objective: We sought to evaluate changes in efficacy, safety, and mechanistic parameters following extended open-label peanut epicutaneous immunotherapy. Methods: Peanut-allergic participants (4-25 years) received 52 weeks of placebo (PLB), Viaskin Peanut 100 mg (VP100) or 250 mg (VP250), and then crossed over to VP250 for PLB (PLBVP250) and VP100 (VP100-VP250) participants and continued treatment for VP250 participants (total 5 130 weeks of active epicutaneous immunotherapy). Efficacy was assessed by double blind, placebo-controlled food challenge (5044 mg peanut protein), and adherence, safety, and mechanistic parameters were evaluated. Results: At week 130, desensitization success was achieved in 1 of 20 (5%) PLB-VP250, 5 of 24 (20.8%) VP100-VP250, and 9 of 25 (36%) VP250 participants, with median successfully consumed dose change from baseline of 11.5 mg, 141.5 mg, and 400 mg, respectively. Median age (years) for week 130 desensitization success was 6.2 years (interquartile range, 5.29.1) versus 9.4 years (interquartile range, 7.6-12.8) for failures (P < .001). Adherence was 96%. Adverse reactions were predominantly local patch-site reactions. Significant increases in peanut-and Ara h2-specific IgG4 observed at week 52 persisted to week 130. By a post hoc analysis, there were no statistically significant increases from week 52 toweek 130 in either desensitization success or successfully consumed dose. Conclusions: Extended treatment with VP250 was well tolerated, and desensitization observed at week 52 persisted between weeks 52 and 130. Treatment success was observed predominantly in younger participants, with younger age at initiation of active therapy an important predictor of success. (J Allergy Clin Immunol 2021;147:992-1003.) <comment>Superscript/Subscript Available</comment	[Scurlock, Amy M.; Jones, Stacie M.] Univ Arkansas Med Sci, Dept Pediat, 13 Childrens Way,Slot 512-13, Little Rock, AR 72202 USA; [Scurlock, Amy M.; Jones, Stacie M.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Burks, A. Wesley; Kim, Edwin H.] Univ N Carolina, UNC Sch Med, Chapel Hill, NC 27515 USA; [Sicherer, Scott H.; Berin, M. Cecilia; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Leung, Donald Y. M.; Cho, Christine B.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Henning, Alice K.; Dawson, Peter; Lindblad, Robert W.] Emmes, Rockville, MD USA; [Davidson, Wendy F.; Plaut, Marshall] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Wood, Robert A.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA	University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Icahn School of Medicine at Mount Sinai; National Jewish Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine	Scurlock, AM (corresponding author), Univ Arkansas Med Sci, Dept Pediat, 13 Childrens Way,Slot 512-13, Little Rock, AR 72202 USA.	ScurlockAmyM@uams.edu		berin, cecilia/0000-0002-9051-9249; Kim, Edwin/0000-0001-6418-1785	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [U19AI066738, U01AI066560, UM2AI130836]; University of Arkansas for Medical Sciences [UL1TR003107]; University of North Carolina [UL1TR001111, UM1AI30936]; Mount Sinai University [UL1TR000067, UM1AI130570]; National Jewish Health [UL1TR002535, UM1AI130780]; Johns Hopkins University School of Medicine [UL1TR000424, UM1AI30838]; NIH-NIAID; National Center for Research Resources (NCRR), a component of the NIH; DBVTechnologies, Inc (Montrouge, France)	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Arkansas for Medical Sciences; University of North Carolina; Mount Sinai University; National Jewish Health; Johns Hopkins University School of Medicine(Johns Hopkins University); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR), a component of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DBVTechnologies, Inc (Montrouge, France)	This study is registered with ClinicalTrials.gov with ID NCT01904604 and was supported by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) (grant nos. U19AI066738, U01AI066560, and UM2AI130836). The project was also supported by the University of Arkansas for Medical Sciences (grant no. UM1AI130781), the University of North Carolina (grant no. UM1AI30936), the Mount Sinai University (grant no. UM1AI130570), National Jewish Health (grant no. UM1AI130780), and Johns Hopkins University School of Medicine (grant no. UM1AI30838), which were supported by the NIH-NIAID, and by the University of Arkansas for Medical Sciences (grant no. UL1TR003107), the University of North Carolina (grant no. UL1TR001111), the Mount Sinai University (grant no. UL1TR000067), National Jewish Health (grant no. UL1TR002535), and Johns Hopkins University School of Medicine (grant no. UL1TR000424), which were supported by the National Center for Research Resources (NCRR), a component of the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NCRR or the NIH. Support for this trial was also provided by DBVTechnologies, Inc (Montrouge, France), through funds provided to the Consortium for Food Allergy Research. Protocol development, study conduct, data analysis, and manuscript development were conducted independently of DBV.	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Baumert JL, 2018, J ALLER CL IMM-PRACT, V6, P457, DOI 10.1016/j.jaip.2017.05.006; Bilaver LA, 2019, ANN ALLERG ASTHMA IM, V122, P373, DOI 10.1016/j.anai.2019.01.014; Bollinger ME, 2006, ANN ALLERG ASTHMA IM, V96, P415, DOI 10.1016/S1081-1206(10)60908-8; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Burks AW, 2015, J ALLERGY CLIN IMMUN, V135, P1240, DOI 10.1016/j.jaci.2014.12.1917; Cho SH, 2001, J ALLERGY CLIN IMMUN, V108, P269, DOI 10.1067/mai.2001.117455; Fleischer DM, 2020, J ALLERGY CLIN IMMUN, V146, P863, DOI 10.1016/j.jaci.2020.06.028; Fleischer DM, 2019, JAMA-J AM MED ASSOC, V321, P946, DOI 10.1001/jama.2019.1113; Fleischer DM, 2013, J ALLERGY CLIN IMMUN, V131, P119, DOI 10.1016/j.jaci.2012.11.011; Gupta R, 2013, JAMA PEDIATR, V167, P1026, DOI 10.1001/jamapediatrics.2013.2376; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Jones SM, 2017, J ALLERGY CLIN IMMUN, V139, P1242, DOI 10.1016/j.jaci.2016.08.017; Jones SM, 2016, J ALLERGY CLIN IMMUN, V137, P1258, DOI 10.1016/j.jaci.2016.01.008; Kim EH, 2019, J ALLERGY CLIN IMMUN, V144, P1320, DOI 10.1016/j.jaci.2019.07.030; Mondoulet L, 2010, CLIN EXP ALLERGY, V40, P659, DOI 10.1111/j.1365-2222.2009.03430.x; Mondoulet Lucie, 2012, Clin Transl Allergy, V2, P22, DOI 10.1186/2045-7022-2-22; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Sampson HA, 2017, JAMA-J AM MED ASSOC, V318, P1798, DOI 10.1001/jama.2017.16591; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Stensgaard A, 2017, CLIN EXP ALLERGY, V47, P530, DOI 10.1111/cea.12849; Vickery BP, 2019, J ALLER CL IMM-PRACT, V7, P357, DOI 10.1016/j.jaip.2018.11.049; Vickery BP, 2018, NEW ENGL J MED, V379, P1991, DOI 10.1056/NEJMoa1812856; Virkud YV, 2017, J ALLERGY CLIN IMMUN, V139, P882, DOI 10.1016/j.jaci.2016.07.030	24	10	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					992	+		10.1016/j.jaci.2020.11.027	http://dx.doi.org/10.1016/j.jaci.2020.11.027		MAR 2021	17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	33290772	Green Accepted			2022-12-18	WOS:000635524300004
J	Yanase, Y; Matsuo, Y; Takahagi, S; Kawaguchi, T; Uchida, K; Ishii, K; Tanaka, A; Matsubara, D; Ozawa, K; Hide, M				Yanase, Yuhki; Matsuo, Yoshimi; Takahagi, Shunsuke; Kawaguchi, Tomoko; Uchida, Kazue; Ishii, Kaori; Tanaka, Akio; Matsubara, Daiki; Ozawa, Koichiro; Hide, Michihiro			Coagulation factors induce human skin mast cell and basophil degranula-tion via activation of complement 5 and the C5a receptor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; NASOPHARYNGEAL MICROBIOME; INFECTION		[Yanase, Yuhki; Ozawa, Koichiro] Hiroshima Univ, Dept Pharmacotherapy, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Yanase, Yuhki; Matsuo, Yoshimi; Takahagi, Shunsuke; Kawaguchi, Tomoko; Uchida, Kazue; Ishii, Kaori; Tanaka, Akio; Matsubara, Daiki; Hide, Michihiro] Hiroshima Univ, Dept Dermatol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University	Yanase, Y (corresponding author), Hiroshima Univ, Dept Pharmacotherapy, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.; Yanase, Y (corresponding author), Hiroshima Univ, Dept Dermatol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	ed1h-w1de-road@hiroshima-u.ac.jp			Takeda Science Foundation; Japanese Society of Allergology Clinical Research Support Program	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society of Allergology Clinical Research Support Program	Partially funded by a grant from the Takeda Science Foundation 2018 (to Y.Y.), the Japanese Society of Allergology Clinical Research Support Program (to Y.Y.) and Grant-in-Aid for Scientific Research (to M.H. and Y.Y.).	Baker R, 2008, ANTIVIR RES, V80, P102, DOI 10.1016/j.antiviral.2008.07.003; Bansal CJ, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-019-0372-z; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759; Freitas TAK, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv180; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kimberlin DW, RED BOOK 2018 REPORT, V31st; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Kolkhir P, 2020, ANN ALLERG ASTHMA IM, V124, P2, DOI 10.1016/j.anai.2019.08.014; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin EK, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0040-0; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Maurer M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00689; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Min TK, 2019, ALLERGY ASTHMA IMMUN, V11, P470, DOI 10.4168/aair.2019.11.4.470; Moormann C, 2006, J INVEST DERMATOL, V126, P746, DOI 10.1038/sj.jid.5700169; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rosas-Salazar C, 2018, J ALLERGY CLIN IMMUN, V142, P1447, DOI 10.1016/j.jaci.2017.10.049; Rosas-Salazar C, 2016, J INFECT DIS, V214, P1924, DOI 10.1093/infdis/jiw456; Rosas-Salazar C, 2016, AM J RESP CRIT CARE, V193, P1180, DOI 10.1164/rccm.201512-2350LE; Saito R, 2020, ALLERGY, V75, P971, DOI 10.1111/all.14110; Shilts MH, 2016, MICROB ECOL, V71, P233, DOI 10.1007/s00248-015-0663-y; Takahagi S, 2010, ALLERGY, V65, P649, DOI 10.1111/j.1398-9995.2009.02222.x; Turi KN, 2018, AM J RESP CRIT CARE, V198, P1064, DOI 10.1164/rccm.201711-2348OC; Wingett Steven W, 2018, F1000Res, V7, P1338, DOI 10.12688/f1000research.15931.2; Won JH, 2012, P NATL ACAD SCI USA, V109, P2848, DOI 10.1073/pnas.1112599109; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Yanase Y, 2018, ALLERGOL INT, V67, P191, DOI 10.1016/j.alit.2017.09.003; Yanase Y, 2018, J ALLERGY CLIN IMMUN, V141, P1115, DOI 10.1016/j.jaci.2017.07.026	32	10	11	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1101	+		10.1016/j.jaci.2020.08.018	http://dx.doi.org/10.1016/j.jaci.2020.08.018		MAR 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	32888945	Bronze			2022-12-18	WOS:000635524300017
J	Bisgaard, H; Norgaard, S; Sevelsted, A; Chawes, BL; Stokholm, J; Mortensen, EL; Ulrik, CS; Bonnelykke, K				Bisgaard, Hans; Norgaard, Sarah; Sevelsted, Astrid; Chawes, Bo Lund; Stokholm, Jakob; Mortensen, Erik Lykke; Ulrik, Charlotte Suppli; Bonnelykke, Klaus			Asthma-like symptoms in young children increase the risk of COPD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; COPD; cohort study	OBSTRUCTIVE PULMONARY-DISEASE; ADULT LUNG-FUNCTION; CHILDHOOD; INFANCY; COHORT; AGE; ASSOCIATION; EXPOSURE; WEIGHT; LIFE	Background: Chronic obstructive pulmonary disease (COPD) may originate in early life and share disease mechanisms with asthma-like symptoms in early childhood. This possibility remains unexplored on account of the lack of long-term prospective studies from infancy to the onset of COPD. Objective: We aimed to investigate the relationship between asthma-like symptoms in young children and development of COPD. Methods: In a population-based cohort of women who gave birth at the central hospital in Copenhagen during period from 1959 to 1961, we investigated data from 3290 mother-child pairs who attended examinations during pregnancy and when the children were aged 1, 3, and 6 years. COPD was assessed from the Danish national registries on hospitalizations and prescription medication since 1994. A subgroup of 930 individuals underwent spirometry testing at age 50 years. Results: Of the 3290 children, 1 in 4 had a history of asthma-like symptoms in early childhood. The adjusted hazard ratio for hospitalization for COPD was 1.88 (95% CI 5 1.32-2.68), and the odds ratio for prescription of long-acting muscarinic antagonists was 2.27 (95% CI 5 1.38-3.70). Asthma-like symptoms in early childhood were also associated with a reduced FEV1 percent predicted and an FEV1-to-forced vital capacity ratio at age 50 years (-3.36% [95% CI 5 -5.47 to -1.24] and -1.28 [95% CI 5 -2.17 to -0.38], respectively) and with COPD defined according to Global Initiative for Chronic Obstructive Lung Disease stage higher than 1 (odds ratio 5 1.96 [95% CI 5 1.13-3.34]). Conclusion: This 60-year prospective follow-up of a motherchild cohort demonstrated a doubled risk for COPD from childhood asthma-like symptoms.	[Bisgaard, Hans; Norgaard, Sarah; Sevelsted, Astrid; Chawes, Bo Lund; Stokholm, Jakob; Bonnelykke, Klaus] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, Ledreborg Alle 34, DK-2820 Gentofte, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Ulrik, Charlotte Suppli] Univ Copenhagen, Hvidovre Hosp, Dept Resp Med, Resp Res Unit Hvidovre, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Bisgaard, H (corresponding author), Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, Ledreborg Alle 34, DK-2820 Gentofte, Denmark.	bisgaard@copsac.com	Bisgaard, Hans/N-4761-2016	Bisgaard, Hans/0000-0003-4131-7592; Bonnelykke, Klaus/0000-0003-2003-1018; Stokholm, Jakob/0000-0003-4989-9769	Lundbeck Foundation [R16-A1694]; Ministry of Health [903516]; Danish Council for Strategic Research [0603-00280B]; Capital Region Research Foundation; Helsefonden [19-B0044]; Kong Christian den Tiendes Fond	Lundbeck Foundation(Lundbeckfonden); Ministry of Health; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region Research Foundation; Helsefonden; Kong Christian den Tiendes Fond	All funding received by Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, is listed on www.copsac.com.The Lundbeck Foundation (grant R16-A1694), the Ministry of Health (grant 903516), the Danish Council for Strategic Research (grant 0603-00280B), and the Capital Region Research Foundation have provided core support to the COPSAC research center. Helsefonden (grant 19-B0044) and Kong Christian den Tiendes Fond provided funding for this study. No funding sources had any involvement in this study.	Agusti A, 2017, LANCET RESP MED, V5, P935, DOI 10.1016/S2213-2600(17)30434-4; ALLERGY J., 2021, CLIN IMMUNOL; [Anonymous], 2014, SINGL INH STRAT STEP; Avlund K, 2014, J AGING HEALTH, V26, P5, DOI 10.1177/0898264313509277; Baarnes CB, 2017, INT J CHRONIC OBSTR, V12, DOI 10.2147/COPD.S123167; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; Belgrave DCM, 2018, LANCET RESP MED, V6, P526, DOI 10.1016/S2213-2600(18)30099-7; BISGAARD H, 1987, ACTA PAEDIATR SCAND, V76, P719, DOI 10.1111/j.1651-2227.1987.tb10555.x; Bisgaard H, 2012, AM J RESP CRIT CARE, V185, P1183, DOI 10.1164/rccm.201110-1922OC; Brostrom EB, 2013, EUR J EPIDEMIOL, V28, P79, DOI 10.1007/s10654-013-9761-7; Bui DS, 2018, LANCET RESP MED, V6, P535, DOI 10.1016/S2213-2600(18)30100-0; Chawes BLK, 2015, J ALLERGY CLIN IMMUN, V135, P1450, DOI 10.1016/j.jaci.2014.11.020; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Hallas HW, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002722; Hayden LP, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0273-8; Johannessen A, 2012, RESPIROLOGY, V17, P499, DOI 10.1111/j.1440-1843.2012.02129.x; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lange P, 2015, NEW ENGL J MED, V373, P1575, DOI 10.1056/NEJMc1510089; Lund R, 2016, INT J EPIDEMIOL, V45, P1044, DOI 10.1093/ije/dyv149; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marossy AE, 2007, AM J RESP CRIT CARE, V175, P355, DOI 10.1164/rccm.200607-1023OC; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Perret JL, 2016, RESPIROLOGY, V21, P911, DOI 10.1111/resp.12750; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; REINISCH JM, 1995, JAMA-J AM MED ASSOC, V274, P1518, DOI 10.1001/jama.274.19.1518; Savran O, 2018, INT J CHRONIC OBSTR, V13, P683, DOI 10.2147/COPD.S153555; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; SLUITER HJ, 1991, EUR RESPIR J, V4, P479; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; Villumsen, 1970, ENV FACTORS CONGENIT; Woodruff PG, 2017, AM J RESP CRIT CARE, V196, P375, DOI 10.1164/rccm.201705-0973WS; Zachau-Christiansen B., 1972, DEV 1 YEAR LIFE; Zachau-Christiansen B., 1975, BABIES STUDY HUMAN D	37	10	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					569	+		10.1016/j.jaci.2020.05.043	http://dx.doi.org/10.1016/j.jaci.2020.05.043		FEB 2021	17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32535134	Bronze			2022-12-18	WOS:000616665800019
J	Kaplan, AP; Ghebrehiwet, B				Kaplan, Allen P.; Ghebrehiwet, Berhane			Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Bradykinin; kallikrein; edema; COVID			[Kaplan, Allen P.] Med Univ South Carolina, Pulm & Crit Care Div, Charleston, SC 29425 USA; [Ghebrehiwet, Berhane] SUNY Stony Brook, Div Rheumatol Allergy & Clin Immunol, Stony Brook, NY 11794 USA	Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaplan, AP (corresponding author), Med Univ South Carolina, Dept Med, Pulm Crit Care Div, 96 Jonathan Lucas St, Charleston, SC 29425 USA.	kaplana@musc.edu						Busse PJ, 2020, NEW ENGL J MED, V382, P1136, DOI 10.1056/NEJMra1808012; Franco R, 2020, J IMMUNOL, V205, P1198, DOI 10.4049/jimmunol.2000642; Garvin MR, 2020, ELIFE, V9, DOI 10.7554/eLife.59177; Ghebrehiwet B, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00058; Ghebrehiwet B, 2014, J IMMUNOL, V192, P377, DOI 10.4049/jimmunol.1302031; John ALS, 2020, J IMMUNOL, V205, P555, DOI 10.4049/jimmunol.2000526; Kaplan AP, 2010, MOL IMMUNOL, V47, P2161, DOI 10.1016/j.molimm.2010.05.010; Manjili RH, 2020, J IMMUNOL, V205, P12, DOI 10.4049/jimmunol.2000413; van de Veerdonk FL, 2020, ELIFE, V9, DOI 10.7554/eLife.57555; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	10	10	10	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					507	509		10.1016/j.jaci.2020.10.025	http://dx.doi.org/10.1016/j.jaci.2020.10.025		FEB 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	33129885	Bronze, Green Published			2022-12-18	WOS:000616665800011
J	Leonard, SA; Laubach, S; Wang, JL				Leonard, Stephanie A.; Laubach, Susan; Wang, Julie			Integrating oral immunotherapy into clinical practice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Oral immunotherapy; food allergy treatment; sublingual immunotherapy; epicutaneous immunotherapy	QUALITY-OF-LIFE; FOOD ALLERGY; DOUBLE-BLIND; SUSTAINED UNRESPONSIVENESS; PEANUT IMMUNOTHERAPY; ANAPHYLAXIS; EPINEPHRINE; SAFETY; ASSOCIATION; GUIDELINES	In 2020, the first food allergy treatment, an oral immunotherapy (OIT) product for peanut allergy, was approved by the Food and Drug Administration, and a peanut epicutaneous immunotherapy patch was under review. As food allergy therapies become available and widespread, allergy offices will need to adjust practices to be able to offer their patients these new treatments. OIT is an intensive therapy that requires commitment from patients and their families, and open communication with the practice is paramount. OIT may not be the right therapy for every patient, and although identifying good candidates is still an area rich for research opportunity, experience from cohorts and clinical trials provides some insight. It is important to understand the scope of practice for each member of the OIT team based on state regulations for a particular location. Staffing and space will likely dictate how many patients at an individual office could be on active OIT at one time. Emergency medications, supplies, and protocols must be in place. Screening, scheduling, visit procedures, monitoring, home dosing, dose modifications, safety precautions, adverse reactions, and maintenance will be addressed in this article. Finally, adjunct therapies under investigation will be reviewed.	[Leonard, Stephanie A.; Laubach, Susan] Univ Calif San Diego, Div Pediat Allergy & Immunol, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA; [Wang, Julie] Mt Sinai Sch Med, Jaffe Food Allergy Inst, Div Pediat Allergy, New York, NY USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai	Leonard, SA (corresponding author), Univ Calif San Diego, Rady Childrens Hosp, 3020 Childrens Way,MC 5114, San Diego, CA 92123 USA.	saleonard@health.ucsd.edu						Afinogenova Y, 2020, J ALLER CL IMM-PRACT, V8, P2727, DOI 10.1016/j.jaip.2020.03.016; Anagnostou K, 2014, LANCET, V383, P1297, DOI 10.1016/S0140-6736(13)62301-6; Andorf S, 2019, ECLINICALMEDICINE, V7, P27, DOI 10.1016/j.eclinm.2018.12.006; Begin P, 2020, ALLERGY ASTHMA CL IM, V16, DOI 10.1186/s13223-020-0413-7; Begin P, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-1; Bird JA, 2020, J ALLER CL IMM-PRACT, V8, P75, DOI 10.1016/j.jaip.2019.09.029; Bird JA, 2018, J ALLER CL IMM-PRACT, V6, P476, DOI 10.1016/j.jaip.2017.09.016; Bird JA, 2017, J ALLER CL IMM-PRACT, V5, P301, DOI 10.1016/j.jaip.2016.07.019; Blom WM, 2018, J ALLERGY CLIN IMMUN, V142, P865, DOI 10.1016/j.jaci.2018.04.041; Blumchen K, 2019, J ALLER CL IMM-PRACT, V7, P479, DOI 10.1016/j.jaip.2018.10.048; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Casale TB, 2020, J ALLER CL IMM-PRACT, V8, P1795, DOI 10.1016/j.jaip.2020.04.022; Chinthrajah RS, 2019, LANCET, V394, P1437, DOI 10.1016/S0140-6736(19)31793-3; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; Cook Q, 2020, J ALLER CL IMM-PRACT, V8, P2805, DOI 10.1016/j.jaip.2020.04.021; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Dantzer JA, 2020, J ALLER CL IMM-PRACT, V8, P1753, DOI 10.1016/j.jaip.2019.12.036; Dantzer JA, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0839-5; De Schryver S, 2019, J ALLER CL IMM-PRACT, V7, P1912, DOI 10.1016/j.jaip.2019.02.007; Dunlop JH, 2019, J ALLER CL IMM-PRACT, V7, P662, DOI 10.1016/j.jaip.2018.05.035; Eiwegger T, 2020, J ALLERGY CLIN IMMUN, V145, P1153, DOI 10.1016/j.jaci.2019.10.021; Eiwegger T, 2019, ANN ALLERG ASTHMA IM, V123, P430, DOI 10.1016/j.anai.2019.09.001; Elegbede CF, 2019, CLIN EXP ALLERGY, V49, P677, DOI 10.1111/cea.13348; Epstein-Rigbi N, 2020, ALLERGY, V75, P2623, DOI 10.1111/all.14350; Filep S, 2018, J ALLERGY CLIN IMMUN, V141, P626, DOI 10.1016/j.jaci.2017.05.049; Fiocchi A, 2019, J ALLER CL IMM-PRACT, V7, P1901, DOI 10.1016/j.jaip.2019.01.023; Fiocchi A, 2017, CURR OPIN ALLERGY CL, V17, P232, DOI 10.1097/ACI.0000000000000357; Fleischer DM, 2012, PEDIATRICS, V130, pE25, DOI 10.1542/peds.2011-1762; Martin-Munoz MF, 2019, PEDIAT ALLERG IMM-UK, V30, P214, DOI 10.1111/pai.13002; Goldberg MR, 2020, J ALLER CL IMM-PRACT, V8, P125, DOI 10.1016/j.jaip.2019.07.034; Gupta RS, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1235; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hindley JP, 2018, J ALLERGY CLIN IMMUN, V141, P780, DOI 10.1016/j.jaci.2017.05.050; Hsiao KC, 2017, LANCET CHILD ADOLESC, V1, P97, DOI 10.1016/S2352-4642(17)30041-X; Jones SM, 2016, J ALLERGY CLIN IMMUN, V137, P1117, DOI 10.1016/j.jaci.2015.12.1316; Katz AL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1485; Kauppila TK, 2019, PEDIAT ALLERG IMM-UK, V30, P356, DOI 10.1111/pai.13025; Kawamoto N, 2020, ALLERGY, V75, P197, DOI 10.1111/all.13965; Keet CA, 2013, J ALLERGY CLIN IMMUN, V132, P737, DOI 10.1016/j.jaci.2013.05.006; Kelso JM, 2006, J ALLERGY CLIN IMMUN, V117, P464, DOI 10.1016/j.jaci.2005.11.015; Kim EH, 2020, J ALLERGY CLIN IMMUN, V146, P851, DOI 10.1016/j.jaci.2020.05.040; Kim EH, 2020, ALLERGY, V75, P1337, DOI 10.1111/all.14220; Kim EH, 2020, J ALLERGY CLIN IMMUN, V145, P1292, DOI 10.1016/j.jaci.2019.11.045; Langlois A, 2020, ALLERGY ASTHMA CL IM, V16, DOI 10.1186/s13223-020-00419-z; Lieberman P, 2015, ANN ALLERG ASTHMA IM, V115, P341, DOI 10.1016/j.anai.2015.07.019; Lucendo AJ, 2014, ALIMENT PHARM THER, V40, P422, DOI 10.1111/apt.12859; MacGinnitie AJ, 2017, J ALLERGY CLIN IMMUN, V139, P873, DOI 10.1016/j.jaci.2016.08.010; Moraly T, 2020, J ALLER CL IMM-PRACT, V8, P704, DOI 10.1016/j.jaip.2019.10.045; Mota I, 2018, ASIA PAC ALLERGY, V8, DOI 10.5415/apallergy.2018.8.e28; Nachshon L, 2019, J ALLER CL IMM-PRACT, V7, P2775, DOI 10.1016/j.jaip.2019.05.031; Nachshon L, 2018, PEDIAT ALLERG IMM-UK, V29, P519, DOI 10.1111/pai.12914; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Niggemann B, 2014, ALLERGY, V69, P1582, DOI 10.1111/all.12532; Nowak-Wegrzyn A, 2019, J ALLERGY CLIN IMMUN, V143, P651, DOI 10.1016/j.jaci.2018.08.041; Nurmatov U, 2017, ALLERGY, V72, P1133, DOI 10.1111/all.13124; Pajno GB, 2018, ALLERGY, V73, P799, DOI 10.1111/all.13319; Park JH, 2011, J ALLERGY CLIN IMMUN, V128, P1127, DOI 10.1016/j.jaci.2011.08.026; Pepper AN, 2020, J ALLERGY CLIN IMMUN, V146, P244, DOI 10.1016/j.jaci.2020.05.027; Petroni D, 2018, ANN ALLERG ASTHMA IM, V120, P237, DOI 10.1016/j.anai.2017.11.016; Purington N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02057; Sampath V, 2018, ANN ALLERG ASTHMA IM, V120, P254, DOI 10.1016/j.anai.2018.01.004; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013; Simons FER, 2001, J ALLERGY CLIN IMMUN, V108, P1040, DOI 10.1067/mai.2001.119916; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Smith M, 2014, LANCET, V384, P2019, DOI 10.1016/S0140-6736(14)62327-8; Soller L, 2019, J ALLER CL IMM-PRACT, V7, P2759, DOI 10.1016/j.jaip.2019.04.010; Staden U, 2007, ALLERGY, V62, P1261, DOI 10.1111/j.1398-9995.2007.01501.x; Stensgaard A, 2017, CLIN EXP ALLERGY, V47, P530, DOI 10.1111/cea.12849; Tao B, 2017, CLIN EXP ALLERGY, V47, P1501, DOI 10.1111/cea.13024; Trendelenburg V, 2020, J ALLER CL IMM-PRACT, V8, P2437, DOI 10.1016/j.jaip.2020.03.043; Tsai M, 2020, J ALLERGY CLIN IMMUN, V145, P885, DOI 10.1016/j.jaci.2019.10.038; van der Kleij HPM, 2019, ALLERGY, V74, P986, DOI 10.1111/all.13687; Varshney P, 2009, J ALLERGY CLIN IMMUN, V124, P1351, DOI 10.1016/j.jaci.2009.09.042; Vickery BP, 2018, NEW ENGL J MED, V379, P1991, DOI 10.1056/NEJMoa1812856; Vickery BP, 2017, J ALLERGY CLIN IMMUN, V139, P173, DOI 10.1016/j.jaci.2016.05.027; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; Vogelberg C, 2020, PATIENT PREFER ADHER, V14, P817, DOI 10.2147/PPA.S242957; Wasserman RL, 2019, J ALLER CL IMM-PRACT, V7, P418, DOI 10.1016/j.jaip.2018.05.023; Wasserman RL, 2014, J ALLER CL IMM-PRACT, V2, P91, DOI 10.1016/j.jaip.2013.10.001; Wood RA, 2016, J ALLERGY CLIN IMMUN, V137, P1103, DOI 10.1016/j.jaci.2015.10.005; Wright BL, 2021, CLIN GASTROENTEROL H, V19, P1151, DOI 10.1016/j.cgh.2020.05.019; Wright BL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02624; Yee CSK, 2019, J ALLER CL IMM-PRACT, V7, P451, DOI 10.1016/j.jaip.2018.09.015	83	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					1	13		10.1016/j.jaci.2020.11.011	http://dx.doi.org/10.1016/j.jaci.2020.11.011		JAN 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA7UA	33436161				2022-12-18	WOS:000613645900001
J	Cazzola, M; Rogliani, P; Matera, MG				Cazzola, Mario; Rogliani, Paola; Matera, Maria Gabriella			The latest on the role of LAMAs in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; LAMAs; parasympathetic nerves; treatable traits	TIOTROPIUM		[Cazzola, Mario; Rogliani, Paola] Univ Roma Tor Vergata, Dept Expt Med, Unit Resp Med, Rome, Italy; [Matera, Maria Gabriella] Univ Campania Luigi Vanvitelli, Dept Expt Med, Unit Pharmacol, Naples, Italy	University of Rome Tor Vergata; Universita della Campania Vanvitelli	Cazzola, M (corresponding author), Univ Roma Tor Vergata, Dipartimento Med Sperimentale, Via Montpellier 1, I-00131 Rome, Italy.	mario.cazzola@uniroma2.it	Cazzola, Mario/ABD-9998-2021; Rogliani, Paola/AIB-0300-2022	Cazzola, Mario/0000-0003-4895-9707; Rogliani, Paola/0000-0001-7801-5040	Almirall; AstraZeneca; Biofutura; Boehringer Ingelheim; Chiesi Farmaceutici; Cipla; Edmond Pharma; GlaxoSmithKline; Lallemand; Menarini Group; Mundipharma; Novartis; Pfizer; Teva; Verona Pharma; Zambon	Almirall(Almirall); AstraZeneca(AstraZeneca); Biofutura; Boehringer Ingelheim(Boehringer Ingelheim); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Cipla; Edmond Pharma; GlaxoSmithKline(GlaxoSmithKline); Lallemand(Lallemand - France); Menarini Group(Menarini Group); Mundipharma; Novartis(Novartis); Pfizer(Pfizer); Teva(Teva Pharmaceutical Industries); Verona Pharma; Zambon	Disclosure of potential conflict of interest: M. Cazzola has participated as a faculty member and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi Farmaceutici, Cipla, Edmond Pharma, GlaxoSmithKline, Lallemand, Menarini Group, Mundipharma, Novartis, Pfizer, Teva, Verona Pharma, and Zambon and is or has been a consultant to ABC Farmaceutici, AstraZeneca, Chiesi Farmaceutici, Edmond Pharma, Lallemand, Novartis, Ockham Biotech, Verona Pharma, and Zambon, and his department was funded by Almirall. P. Rogliani participated as a faculty member and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi Farmaceutici, Edmond Pharma, GlaxoSmithKline, Menarini Group, Mundipharma, and Novartis, and her department was funded by Almirall, Boehringer Ingelheim, Chiesi Farmaceutici Novartis, and Zambon. M. G. Matera has participated as a faculty member and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, and Novartis, has been a consultant to ABC Farmaceutici and Chiesi Farmaceutici, and her department was funded by Novartis, Boehringer Ingelheim, Novartis, and Zambon.	Averell CM, 2019, J ASTHMA ALLERGY, V12, P309, DOI 10.2147/JAA.S216932; Buhl R, 2018, RESP MED, V143, P82, DOI 10.1016/j.rmed.2018.08.014; Casale TB, 2018, J ALLER CL IMM-PRACT, V6, P923, DOI 10.1016/j.jaip.2017.08.037; Dusser D, 2019, THER ADV RESPIR DIS, V13, DOI 10.1177/1753466618824010; Gosens R, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01247-2017; Kistemaker LEM, 2019, PHYSIOLOGY, V34, P283, DOI 10.1152/physiol.00050.2018; Matera MG, 2020, PHARMACOL REV, V72, P218, DOI 10.1124/pr.119.018150; McDonald VM, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01509-2019; Rogliani P, 2020, BRIT J PHARMACOL, V177, P1150, DOI 10.1111/bph.14909; Virchow JC, 2019, LANCET, V394, P1737, DOI 10.1016/S0140-6736(19)32215-9	10	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1288	1291		10.1016/j.jaci.2020.06.014	http://dx.doi.org/10.1016/j.jaci.2020.06.014			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32603663	Bronze			2022-12-18	WOS:000596937900008
J	Gokkaya, M; Damialis, A; Nussbaumer, T; Beck, I; Bounas-Pyrros, N; Bezold, S; Amisi, MM; Kolek, F; Todorova, A; Chaker, A; Aglas, L; Ferreira, F; Redegeld, FA; Brunner, JO; Neumann, AU; Traidl-Hoffmann, C; Gilles, S				Goekkaya, Mehmet; Damialis, Athanasios; Nussbaumer, Thomas; Beck, Isabelle; Bounas-Pyrros, Nikolaos; Bezold, Sebastian; Amisi, Marie M.; Kolek, Franziska; Todorova, Antonia; Chaker, Adam; Aglas, Lorenz; Ferreira, Fatima; Redegeld, Frank A.; Brunner, Jens O.; Neumann, Avidan U.; Traidl-Hoffmann, Claudia; Gilles, Stefanie			Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposure	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergic rhinitis; biomarkers; chemokines; cytokines; immunoglobulins; nasal symptoms; pollen	SENSITIZATION PROFILES; NASAL; IMMUNOTHERAPY; RHINITIS; ASSOCIATION; MECHANISMS; ANTIBODIES; RESPONSES; TRENDS	Background: Pollen exposure induces local and systemic allergic immune responses in sensitized individuals, but nonsensitized individuals also are exposed to pollen. The kinetics of symptom expression under natural pollen exposure have never been systematically studied, especially in subjects without allergy. Objective: We monitored the humoral immune response under natural pollen exposure to potentially uncover nasal biomarkers for in-season symptom severity and identify protective factors. Methods: We compared humoral immune response kinetics in a panel study of subjects with seasonal allergic rhinitis (SAR) and subjects without allergy and tested for cross-sectional and interseasonal differences in levels of serum and nasal, total, and Betula verrucosa 1-specific immunoglobulin isotypes; immunoglobulin free light chains; cytokines; and chemokines. Nonsupervised principal component analysis was performed for all nasal immune variables, and single immune variables were correlated with in-season symptom severity by Spearman test. Results: Symptoms followed airborne pollen concentrations in subjects with SAR, with a time lag between 0 and 13 days depending on the pollen type. Of the 7 subjects with nonallergy, 4 also exhibited in-season symptoms whereas 3 did not. Cumulative symptoms in those without allergy were lower than in those with SAR but followed the pollen exposure with similar kinetics. Nasal eotaxin-2, CCL22/MDC, and monocyte chemoattactant protein-1 (MCP-1) levels were higher in subjects with SAR, whereas IL-8 levels were higher in subjects without allergy. Principal component analysis and Spearman correlations identified nasal levels of IL-8, IL-33, and Betula verrucosa 1-specific IgG 4 (sIgG 4) and Betula verrucosa 1-specific IgE (sIgE) antibodies as predictive for seasonal symptom severity. Conclusions: Nasal pollen-specific IgA and IgG isotypes are potentially protective within the humoral compartment. Nasal levels of IL-8, IL-33, sIgG 4 and sIgE could be predictive biomarkers for pollen-specific symptom expression, irrespective of atopy.	[Goekkaya, Mehmet; Damialis, Athanasios; Nussbaumer, Thomas; Beck, Isabelle; Bounas-Pyrros, Nikolaos; Bezold, Sebastian; Amisi, Marie M.; Kolek, Franziska; Todorova, Antonia; Neumann, Avidan U.; Traidl-Hoffmann, Claudia; Gilles, Stefanie] Tech Univ Munich, Chair & Inst Environm Med, UNIKA T, Neusasser Str 47, D-86156 Augsburg, Germany; [Goekkaya, Mehmet; Damialis, Athanasios; Nussbaumer, Thomas; Beck, Isabelle; Bounas-Pyrros, Nikolaos; Bezold, Sebastian; Amisi, Marie M.; Kolek, Franziska; Todorova, Antonia; Neumann, Avidan U.; Traidl-Hoffmann, Claudia; Gilles, Stefanie] German Res Ctr Environm, Helmholtz Zentrum Munchen, Augsburg, Germany; [Bounas-Pyrros, Nikolaos; Bezold, Sebastian; Todorova, Antonia; Traidl-Hoffmann, Claudia] Univ Clin Augsburg, Dept Dermatol, Augsburg, Germany; [Chaker, Adam] Tech Univ Munich, ENT Dept, Klinikum Rechts Isar, Munich, Germany; [Aglas, Lorenz; Ferreira, Fatima] Univ Salzburg, Dept Mol Biol, Salzburg, Austria; [Redegeld, Frank A.] Univ Utrecht, Div Pharmacol, Dept Pharmaceut Sci, Utrecht, Netherlands; [Brunner, Jens O.] Univ Augsburg, Chair Hlth Care Operat Hlth Informat Management, UNIKA, Augsburg, Germany; [Traidl-Hoffmann, Claudia] Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Salzburg University; Utrecht University; University of Augsburg	Gilles, S (corresponding author), HelmholtzZentrum Munchen, Neusasser Str 47, D-86156 Augsburg, Germany.	stefanie.gilles@tum.de	Aglas, Lorenz/L-3996-2015; Ferreira, Fatima/AAB-4321-2019; Gilles-Stein, Stefanie/AAA-3741-2021; Damialis, Athanasios/P-9072-2018; Brunner, Jens O./ACB-5245-2022	Aglas, Lorenz/0000-0002-1236-5934; Ferreira, Fatima/0000-0003-0989-2335; Gilles-Stein, Stefanie/0000-0002-5159-2558; Damialis, Athanasios/0000-0003-2917-5667; Brunner, Jens O./0000-0002-2700-4795; Chaker, Adam/0000-0002-5117-4073; Kolek, Franziska/0000-0001-8703-1894	Christine Kuhne - Center for Allergy Research and Education (CK-CARE); Initiative and Networking Fund of the Helmholtz Association (Immunology Inflammation)	Christine Kuhne - Center for Allergy Research and Education (CK-CARE); Initiative and Networking Fund of the Helmholtz Association (Immunology Inflammation)	Supported by the Christine Kuhne - Center for Allergy Research and Education (CK-CARE); The Initiative and Networking Fund of the Helmholtz Association (Immunology & Inflammation).	Aghayan-Ugurluoglu R, 2000, J ALLERGY CLIN IMMUN, V105, P803, DOI 10.1067/mai.2000.104782; Aglas L, 2018, J ALLERGY CLIN IMMUN, V142, P984, DOI 10.1016/j.jaci.2018.05.004; Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Baumann R, 2013, CLIN EXP ALLERGY, V43, P1134, DOI 10.1111/cea.12148; Benson M, 2003, ALLERGY, V58, P386, DOI 10.1034/j.1398-9995.2003.00113.x; Bergmann Karl-Christian, 2016, Allergo J Int, V25, P6; Biedermann T, 2019, ALLERGY, V74, P1237, DOI 10.1111/all.13758; Bousquet J, 2017, ALLERGY, V72, P1475, DOI 10.1111/all.13177; Chae SC, 2005, IMMUNOGENETICS, V56, P760, DOI 10.1007/s00251-004-0746-2; Damialis A, 2016, 6 EUR AER S LYON FRA, P65; Damialis A, 2019, CLIMATE CHANGE POLLE; Damialis A, 2007, ATMOS ENVIRON, V41, P7011, DOI 10.1016/j.atmosenv.2007.05.009; De Corso E, 2011, RHINOLOGY, V49, P174, DOI 10.4193/Rhino10.133; De Knop KJ, 2011, PEDIAT ALLERG IMM-UK, V22, pe139, DOI 10.1111/j.1399-3038.2011.01112.x; Eckl-Dorna J, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03131; Gadermaier E, 2011, ALLERGY, V66, P1174, DOI 10.1111/j.1398-9995.2011.02592.x; Garcia-Mozo H, 2017, ALLERGY, V72, P1849, DOI 10.1111/all.13210; Gilles S, 2020, ALLERGY, V75, P576, DOI 10.1111/all.14047; Gilles-Stein S, 2016, CLIN EXP ALLERGY, V46, P1355, DOI 10.1111/cea.12739; Henriquez KM, 2015, J MED VIROL, V87, P330, DOI 10.1002/jmv.24042; Holgado A, 2019, J ALLERGY CLIN IMMUN; Huber S, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0226-7; Joenvaara S, 2009, J ALLERGY CLIN IMMUN, V124, P135, DOI 10.1016/j.jaci.2008.11.048; Keen C, 2005, PEDIAT ALLERG IMM-UK, V16, P209, DOI 10.1111/j.1399-3038.2005.00264.x; Konig K, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0093-x; Kramer MF, 2006, AM J OTOLARYNG, V27, P190, DOI 10.1016/j.amjoto.2005.09.013; Li Y, 2018, J IMMUNOL, V200, P2253, DOI 10.4049/jimmunol.1701455; Mattila P, 2010, ALLERGY, V65, P175, DOI 10.1111/j.1398-9995.2009.02181.x; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Oteros J, 2015, INT ARCH ALLERGY IMM, V167, P158, DOI 10.1159/000436968; Panzner P, 2014, INT ARCH ALLERGY IMM, V164, P74, DOI 10.1159/000362760; Peric A, 2016, INT FORUM ALLERGY RH, V6, P392, DOI 10.1002/alr.21684; Powe DG, 2010, J ALLERGY CLIN IMMUN, V125, P139, DOI 10.1016/j.jaci.2009.07.025; Reisinger J, 2005, J ALLERGY CLIN IMMUN, V116, P347, DOI 10.1016/j.jaci.2005.04.003; Rondon C, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0821-7; Shamji MH, 2011, CLIN EXP ALLERGY, V41, P1235, DOI 10.1111/j.1365-2222.2011.03804.x; Stemeseder T, 2017, ALLERGY, V72, P754, DOI 10.1111/all.13071; Wachholz PA, 2004, CURR OPIN ALLERGY CL, V4, P313, DOI 10.1097/01.all.0000136753.35948.c0	38	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2020	146	3					583	+		10.1016/j.jaci.2020.02.037	http://dx.doi.org/10.1016/j.jaci.2020.02.037			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NO0HS	32272131	Bronze			2022-12-18	WOS:000569168900011
J	Lum, SH; Selvarajah, S; Deya-Martinez, A; McNaughton, P; Sobh, A; Waugh, S; Burton-Fanning, S; Newton, L; Gandy, J; Nademi, Z; Owens, S; Williams, E; Emonts, M; Flood, T; Cant, A; Abinun, M; Hambleton, S; Gennery, AR; Slatter, M				Lum, Su Han; Selvarajah, Sabeena; Deya-Martinez, Angela; McNaughton, Peter; Sobh, Ali; Waugh, Sheila; Burton-Fanning, Shirelle; Newton, Lisa; Gandy, Julie; Nademi, Zohreh; Owens, Stephen; Williams, Eleri; Emonts, Marieke; Flood, Terry; Cant, Andrew; Abinun, Mario; Hambleton, Sophie; R. Gennery, Andrew; Slatter, Mary			Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						primary immunodeficiency; posttransplant autoimmune cytopenia; pediatrics	HEMOLYTIC-ANEMIA; DISEASES; INFECTION; RECIPIENTS; CHILDREN; SERUM	Background: Post hematopoietic cell transplantation (HCT) autoimmune cytopenia (AIC) is a potentially life-threatening complication, but studies focusing on large cohorts of patients transplanted for primary immunodeficiency are lacking. Objectives: This study sought to determine the incidence, risk factors, and outcomes of post-HCT AIC and B-lymphocyte function following rituximab. Methods: We retrospectively studied 502 children with primary immunodeficiency who were transplanted at our center between 1987 and 2018. Results: Thirty-six patients (9%) developed post-HCT AIC, with a median onset of 6.5 months post-HCT. On univariate analysis, pre-HCT AIC, mismatched donor, alemtuzumab, anti-thymocyte antiglobulin, and acute and chronic graft versus host disease were significantly associated with post-HCT AIC. After multivariate analysis, alemtuzumab (subdistribution hazard ratio, 9.0; 95% CI, 1.50-54.0; P =.02) was independently associated with post-HCT AIC. Corticosteroid and high-dose intravenous immunoglobulin achieved remission in 50% (n = 18), additional rituximab led to remission in 25% (n = 9), and the remaining 25% were treated with a combination of various modalities including sirolimus (n = 5), bortezomib (n = 3), mycophenolate mofetil (n = 2), splenectomy (n = 2), and second HCT (n = 3). The mortality of post-HCT AIC reduced from 25% (4 of 16) prior to 2011 to 5% (1 of 20) after 2011. The median follow-up of 5.8 years (range, 0.4 to 29.1 years) showed that 26 of 30 survivors (87%) were in complete remission, and 4 were in remission with ongoing sirolimus and low-dose steroids. Of the 17 who received rituximab, 7 had B-lymphocyte recovery, 5 had persistent low B-lymphocyte count and remained on intravenous immunoglobulin replacement, 2 had second HCT, and 3 died. Conclusions: The frequency of post HCT AIC in our cohort was 9%, and the most significant risk factors for its occurrence were the presence of graft versus host disease and the use of alemtuzumab.	[Lum, Su Han; Selvarajah, Sabeena; Deya-Martinez, Angela; McNaughton, Peter; Sobh, Ali; Nademi, Zohreh; Owens, Stephen; Williams, Eleri; Emonts, Marieke; Flood, Terry; Cant, Andrew; Abinun, Mario; Hambleton, Sophie; R. Gennery, Andrew; Slatter, Mary] Great North Childrens Hosp, Childrens Haematopoiet Stem Cell Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Waugh, Sheila; Newton, Lisa; Gandy, Julie; Abinun, Mario] Newcastle Upon Tyne Hosp Natl Hlth Syst Fdn Trust, Microbiol & Virol, Newcastle Upon Tyne, Tyne & Wear, England; [Nademi, Zohreh; Emonts, Marieke; Cant, Andrew; Hambleton, Sophie; R. Gennery, Andrew; Slatter, Mary] Newcastle Upon Tyne Hosp Natl Hlth Syst Fdn Trust, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Lum, Su Han; Burton-Fanning, Shirelle] Leiden Univ, Dept Paediat, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lum, SH (corresponding author), Great North Childrens Hosp, Clin Resource Bldg,Floor 4,Block 2, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	s.lum@nhs.net	Sobh, Ali/Q-6160-2016	Sobh, Ali/0000-0001-7047-076X; Deya-Martinez, Angela/0000-0002-8026-7674; Williams, Eleri/0000-0001-5898-993X; McNaughton, Peter/0000-0002-4600-8839; Lum, Su Han/0000-0002-5471-029X				Ahmed I, 2015, PEDIATR TRANSPLANT, V19, P391, DOI 10.1111/petr.12455; Boleto G, 2018, SEMIN ARTHRITIS RHEU, V48, P149, DOI 10.1016/j.semarthrit.2018.02.010; Chang TY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005396; Cherif H, 2006, VACCINE, V24, P75, DOI 10.1016/j.vaccine.2005.07.054; Dasanu Constantin A, 2011, J Oncol Pharm Pract, V17, P233, DOI 10.1177/1078155210374240; De La Torre I, 2012, RHEUMATOLOGY, V51, P833, DOI 10.1093/rheumatology/ker417; Dvorak CC, 2019, BIOL BLOOD MARROW TR, V25, P1355, DOI 10.1016/j.bbmt.2019.03.008; Faraci M, 2014, BIOL BLOOD MARROW TR, V20, P272, DOI 10.1016/j.bbmt.2013.11.014; Hebart H, 1996, BRIT J HAEMATOL, V95, P138, DOI 10.1046/j.1365-2141.1996.7592380.x; Heusele M, 2014, CLIN RHEUMATOL, V33, P799, DOI 10.1007/s10067-014-2509-2; Holbro A, 2012, BRIT J HAEMATOL, V157, P281, DOI 10.1111/j.1365-2141.2012.09070.x; Horn B, 1999, BONE MARROW TRANSPL, V24, P1009, DOI 10.1038/sj.bmt.1702011; Hosoba S, 2015, TRANSFUSION, V55, P259, DOI 10.1111/trf.12815; Hwang-Bo S, 2017, BLOOD RES, V52, P119, DOI 10.5045/br.2017.52.2.119; Kaplan B, 2019, IMMUNOL ALLERGY CLIN, V39, P31, DOI 10.1016/j.iac.2018.08.005; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Kruizinga MD, 2018, BIOL BLOOD MARROW TR, V24, P772, DOI 10.1016/j.bbmt.2017.12.782; Li XF, 2019, J INT MED RES, V47, P3320, DOI 10.1177/0300060519855593; Minamimura K, 2006, J IMMUNOL, V176, P4125, DOI 10.4049/jimmunol.176.7.4125; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; O'Brien TA, 2004, BRIT J HAEMATOL, V127, P67, DOI 10.1111/j.1365-2141.2004.05138.x; Page KM, 2008, BIOL BLOOD MARROW TR, V14, P1108, DOI 10.1016/j.bbmt.2008.07.006; Park JA, 2016, TRANSFUS MED REV, V30, P6, DOI 10.1016/j.tmrv.2015.09.001; Reddy V, 2017, ARTHRIT CARE RES, V69, P857, DOI 10.1002/acr.22993; Sanz J, 2007, BONE MARROW TRANSPL, V39, P555, DOI 10.1038/sj.bmt.1705641; Schmidt-Hieber M, 2010, INT J HEMATOL, V91, P877, DOI 10.1007/s12185-010-0597-6; Schuetz C, 2018, BLOOD ADV, V2, P2550, DOI 10.1182/bloodadvances.2018020883; Sherer Y, 1998, BONE MARROW TRANSPL, V22, P873, DOI 10.1038/sj.bmt.1701437; Teachey DT, 2009, BRIT J HAEMATOL, V145, P101, DOI 10.1111/j.1365-2141.2009.07595.x; Theilacker C, 2016, CLIN INFECT DIS, V62, P871, DOI 10.1093/cid/civ1195; Varani S, 2002, J MED VIROL, V66, P56, DOI 10.1002/jmv.2111; Wang M, 2015, BIOL BLOOD MARROW TR, V21, P60, DOI 10.1016/j.bbmt.2014.09.009; Willemsen L, 2015, BIOL BLOOD MARROW TR, V21, P473, DOI 10.1016/j.bbmt.2014.11.674	33	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					406	416		10.1016/j.jaci.2020.04.053	http://dx.doi.org/10.1016/j.jaci.2020.04.053			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32442647	Bronze			2022-12-18	WOS:000558835000030
J	Pai, SY; Thrasher, AJ				Pai, Sung-Yun; Thrasher, Adrian J.			Gene therapy for X-linked severe combined immunodeficiency: Historical outcomes and current status	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Severe combined immunodeficiency; gene therapy; T cell; B cell			[Pai, Sung-Yun] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Pai, Sung-Yun] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Thrasher, Adrian J.] UCL, Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England; [Thrasher, Adrian J.] Great Ormond St Hosp Children NHS Fdn Trust, London, England	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Thrasher, AJ (corresponding author), UCL, Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	a.thrasher@ucl.ac.uk			Wellcome Trust [217112/Z/19/Z]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric)	A.J.T. is supported by funding from TheWellcome Trust (grant no. 217112/Z/19/Z AJT) and the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London.	De Ravin SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8856; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Haddad E, 2018, BLOOD, V132, P1737, DOI 10.1182/blood-2018-03-840702; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Mamcarz E, 2019, NEW ENGL J MED, V380, P1525, DOI 10.1056/NEJMoa1815408; Miggelbrink AM, 2018, BLOOD, V131, P2967, DOI 10.1182/blood-2017-10-809822; Schiroli G, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0820; Wu Chuanfeng, 2011, Front Med, V5, P356, DOI 10.1007/s11684-011-0159-1	10	10	10	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					258	261		10.1016/j.jaci.2020.05.055	http://dx.doi.org/10.1016/j.jaci.2020.05.055			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32561390	Green Published			2022-12-18	WOS:000558835000004
J	Han, YY; Rosser, F; Forno, E; Celedon, JC				Han, Yueh-Ying; Rosser, Franziska; Forno, Erick; Celedon, Juan C.			Electronic vapor products, marijuana use, smoking, and asthma in US adolescents	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Han, Yueh-Ying; Rosser, Franziska; Forno, Erick; Celedon, Juan C.] Univ Pittsburgh, Div Pediat Pulm Med, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Celedon, JC (corresponding author), Univ Pittsburgh, Div Pediat Pulm Med, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA.	juan.celedon@chp.edu	Forno, Erick/I-1476-2019	Forno, Erick/0000-0001-6497-9885	US National Institutes of Health (NIH) [MD011764]; NIH [MD011764, KL2TR001856, HL125666, HL117191, HL119952]	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Y.-Y. Han was supported by grant MD011764 from the US National Institutes of Health (NIH). F. Rosser was supported by grant KL2TR001856 from the NIH. E. Forno was supported by grant HL125666 from the NIH. J. C. Celedon was supported by grants HL117191, HL119952, and MD011764 from the NIH.	Berry KM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7794; Bramness JG, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0814-x; Clapp PW, 2019, AM J PHYSIOL-LUNG C, V316, pL470, DOI 10.1152/ajplung.00304.2018; Gentzke AS, 2019, MMWR-MORBID MORTAL W, V68, P157, DOI 10.15585/mmwr.mm6806e1; Ghosh A, 2018, AM J RESP CRIT CARE, V198, P67, DOI 10.1164/rccm.201710-2033OC; Kann L, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6506a1; Kim SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17682-7; Reid KM, 2018, MMWR-MORBID MORTAL W, V67, P599, DOI 10.15585/mmwr.mm6721a2; Schweitzer RJ, 2017, PREV MED, V105, P226, DOI 10.1016/j.ypmed.2017.09.023	9	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					1025	+		10.1016/j.jaci.2019.12.001	http://dx.doi.org/10.1016/j.jaci.2019.12.001			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31830488	Green Accepted, Bronze			2022-12-18	WOS:000518756700043
J	Khodoun, MV; Morris, SC; Angerman, E; Potter, C; Schuman, R; Wunderlich, M; Maciag, JJ; Locker, KCS; Mulloy, JC; Herr, AB; Finkelman, FD				Khodoun, Marat V.; Morris, Suzanne C.; Angerman, Elizabeth; Potter, Crystal; Schuman, Richard; Wunderlich, Mark; Maciag, Joseph J.; Locker, Kathryn C. Sullivan; Mulloy, James C.; Herr, Andrew B.; Finkelman, Fred D.			Rapid desensitization of humanized mice with anti-human Fc epsilon RI alpha monoclonal antibodies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Anaphylaxis; antibody; IgE; mouse	MAST-CELL; IGE ANTIBODY; ANAPHYLAXIS; OMALIZUMAB; EXPRESSION; RECEPTOR; ALLERGY; IL-4; EPIDEMIOLOGY; EOSINOPHILS	Background: Anaphylaxis is classically mediated by allergen cross-linking of IgE bound to the alpha chain of Fc epsilon RI, the mast cell/basophil high affinity IgE receptor. Allergen cross-linking of the IgE/Fc epsilon RI complex activates these cells, inducing release of disease-causing mediators, cytokines, and enzymes. We previously demonstrated that IgE-mediated anaphylaxis could be safely prevented in wild-type BALB/c mice by rapid desensitization with anti-mouse Fc epsilon RI alpha mAb. Objective: This study sought to use humanized mice to extend these results to humans. Methods: We actively immunized huFc epsilon RI alpha/F709 mice, which express human (hu) instead of mouse Fc epsilon RI alpha and a mutant IL-4 receptor that lacks inhibitory function. We passively immunized huFc epsilon RI alpha mice, as well as human cord blood-reconstituted reNSGS mice, which are immune-deficient, produce mast cell-stimulating human cytokines, and develop numerous human mast cells. For desensitization, we used anti-huFc epsilon RI alpha mAbs that bind Fc epsilon RI alpha regardless of its association with IgE (noncompeting mAbs), and/or mAbs that compete with IgE for huFc epsilon RI alpha binding (competing mAbs). Anaphylaxis was induced by intravenous injection of antigen or anti-huIgE mAb. Results: Anti-huFc epsilon RI alpha mAb rapid desensitization was safer and more effective than allergen rapid desensitization and suppressed anaphylaxis more rapidly than omalizumab or ligelizumab. Rapid desensitization of naive, IgE-sensitized huFc epsilon RI alpha mice and huFc epsilon RI alpha/F709 mice that were egg-allergic with anti-Fc epsilon RI alpha mAbs safely removed >98% of IgE from peritoneal mast cells and completely suppressed IgE-mediated anaphylaxis. Rapid desensitization of reNSGS mice with anti-Fc epsilon RI alpha mAbs also safely removed similar to 98% of mast cell IgE and prevented IgE-mediated anaphylaxis. Conclusions: Rapid desensitization with anti-Fc epsilon RI alpha mAbs may be a safe, effective, and practical way to prevent IgE-mediated anaphylaxis.	[Khodoun, Marat V.; Morris, Suzanne C.; Potter, Crystal; Finkelman, Fred D.] Univ Cincinnati, Coll Med, Div Allergy Immunol & Rheumatol, Dept Internal Med, Cincinnati, OH 45221 USA; [Angerman, Elizabeth; Maciag, Joseph J.; Locker, Kathryn C. Sullivan; Herr, Andrew B.; Finkelman, Fred D.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Schuman, Richard] Antibody & Immunoassay Consultants LLC, Rockville, MD USA; [Wunderlich, Mark; Mulloy, James C.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Finkelman, FD (corresponding author), Apartment 79,26 Sderot Nitza, IL-4226259 Netanya, Israel.	finkelfd@ucmail.uc.edu	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399	National Institutes of Health (NIH) [R01AI113162, R50CA211404]; Food Allergy Research and Education, Inc, United States; Cincinnati Center for Clinical and Translational Science and Training; Cincinnati Digestive Health Center	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Research and Education, Inc, United States; Cincinnati Center for Clinical and Translational Science and Training; Cincinnati Digestive Health Center	This study was funded by the National Institutes of Health (NIH) grant R01AI113162, NIH grant R50CA211404, a grant from Food Allergy Research and Education, Inc, United States, the Cincinnati Center for Clinical and Translational Science and Training, and the Cincinnati Digestive Health Center.	ALTMAN LC, 1981, MED CLIN N AM, V65, P941, DOI 10.1016/S0025-7125(16)31482-1; Ang WXG, 2016, J CLIN INVEST, V126, P4103, DOI 10.1172/JCI87492; Arm JP, 2014, CLIN EXP ALLERGY, V44, P1371, DOI 10.1111/cea.12400; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; BECKMANN MP, 1990, J IMMUNOL, V144, P4212; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Cernadas JR, 2010, ALLERGY, V65, P1357, DOI 10.1111/j.1398-9995.2010.02441.x; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Clark S, 2007, IMMUNOL ALLERGY CLIN, V27, P145, DOI 10.1016/j.iac.2007.03.002; Clay CD, 2018, J ALLERGY CLIN IMMUN, V141, P1373, DOI 10.1016/j.jaci.2017.05.027; Corren J, 2003, J ALLERGY CLIN IMMUN, V111, P87, DOI 10.1067/mai.2003.49; Cox L, 2007, J ALLERGY CLIN IMMUN, V120, P1373, DOI 10.1016/j.jaci.2007.09.032; Dombrowicz D, 1996, J IMMUNOL, V157, P1645; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; DVORAK AM, 1994, AM J PATHOL, V144, P160; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; Finn A, 2003, J ALLERGY CLIN IMMUN, V111, P278, DOI 10.1067/mai.2003.54; Godfraind C, 1998, J IMMUNOL, V160, P3989; Golden David B K, 2004, Novartis Found Symp, V257, P101; Gomes MM, 2008, BIOCHEMISTRY-US, V47, P11285, DOI 10.1021/bi801185b; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9; Holgate ST, 2005, CLIN EXP ALLERGY, V35, P408, DOI 10.1111/j.1365-2222.2005.02191.x; Iikura M, 2001, INT ARCH ALLERGY IMM, V124, P470, DOI 10.1159/000053782; Incorvaia C, 2014, DRUG DES DEV THER, V8, P197, DOI 10.2147/DDDT.S49409; Ito R, 2013, J IMMUNOL, V191, P2890, DOI 10.4049/jimmunol.1203543; Jin YN, 2017, INT ARCH ALLERGY IMM, V174, P7, DOI 10.1159/000479386; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Khodoun MV, 2013, J ALLERGY CLIN IMMUN, V131, P1555, DOI 10.1016/j.jaci.2013.02.043; Kopp MV, 2011, CURR ALLERGY ASTHM R, V11, P101, DOI 10.1007/s11882-010-0173-4; Lee JJ, 2007, BLOOD, V109, P859, DOI 10.1182/blood-2006-06-027490; Leung DYM, 2003, NEW ENGL J MED, V348, P986, DOI 10.1056/NEJMoa022613; Lewis A, 2017, CLIN EXP ALLERGY, V47, P1022, DOI 10.1111/cea.12912; Liu FT, 2011, CLIN REV ALLERG IMMU, V41, P298, DOI 10.1007/s12016-011-8252-4; MacGlashan D, 2012, CLIN EXP ALLERGY, V42, P1060, DOI 10.1111/j.1365-2222.2012.04013.x; Macglashan Donald Jr., 1998, Frontiers in Bioscience, V3, pD746; MacGlashan D, 2009, J LEUKOCYTE BIOL, V85, P627, DOI 10.1189/jlb.1008668; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Matasar MJ, 2003, CURR ALLERGY ASTHM R, V3, P30, DOI 10.1007/s11882-003-0007-8; Mathias CB, 2011, J ALLERGY CLIN IMMUN, V127, P795, DOI 10.1016/j.jaci.2010.11.009; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; ODONOVAN WJ, 1946, LANCET, V251, P444; Oka T, 2012, LAB INVEST, V92, P1472, DOI 10.1038/labinvest.2012.116; Posgai MT, 2018, P NATL ACAD SCI USA, V115, pE8882, DOI 10.1073/pnas.1807478115; Rafi A, 2010, ALLERGY ASTHMA PROC, V31, P76, DOI 10.2500/aap.2010.31.3304; RISKE F, 1991, J BIOL CHEM, V266, P11245; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sancho-Serra MD, 2011, EUR J IMMUNOL, V41, P1004, DOI 10.1002/eji.201040810; Schafer T, 2001, ALLERGY, V56, P1172, DOI 10.1034/j.1398-9995.2001.00196.x; Sibilano R, 2014, EUR J IMMUNOL, V44, P2558, DOI 10.1002/eji.201444546; Sloane D, 2016, J ALLER CL IMM-PRACT, V4, P497, DOI 10.1016/j.jaip.2015.12.019; Snapper Clifford M., 1993, P837; Strait RT, 2003, J IMMUNOL, V170, P3835, DOI 10.4049/jimmunol.170.7.3835; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; SULLIVAN TJ, 1982, J ALLERGY CLIN IMMUN, V69, P500, DOI 10.1016/0091-6749(82)90174-9; Takai T, 2000, BIOSCI BIOTECH BIOCH, V64, P1856, DOI 10.1271/bbb.64.1856; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Wood RA, 2014, J ALLERGY CLIN IMMUN, V133, P461, DOI 10.1016/j.jaci.2013.08.016; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Wunderlich M, 2014, BLOOD, V123, pE134, DOI 10.1182/blood-2014-02-556340	63	10	10	2	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					907	+		10.1016/j.jaci.2019.12.003	http://dx.doi.org/10.1016/j.jaci.2019.12.003			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31836406	Green Accepted, Bronze			2022-12-18	WOS:000518756700028
J	Wei, Y; Zhang, J; Wu, XM; Sun, W; Wei, FQ; Liu, WD; Lu, T; Ji, WD; Li, HB; Wen, WP				Wei, Yi; Zhang, Jia; Wu, Xingmei; Sun, Wei; Wei, Fanqin; Liu, Wendong; Lu, Tong; Ji, Weidong; Li, Huabin; Wen, Weiping			Activated pyrin domain containing 3 (NLRP3) inflammasome in neutrophilic chronic rhinosinusitis with nasal polyps (CRSwNP)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Wei, Yi; Wu, Xingmei; Sun, Wei; Wei, Fanqin; Liu, Wendong; Lu, Tong; Wen, Weiping] Sun Yat Sen Univ, Dept Otorhinolarygol Hosp, Affiliated Hosp 1, Guangzhou, Peoples R China; [Wei, Yi; Wu, Xingmei; Sun, Wei; Wei, Fanqin; Liu, Wendong; Lu, Tong; Wen, Weiping] Sun Yat Sen Univ, Otorhinolaryngol Inst, Guangzhou, Peoples R China; [Wei, Yi; Wu, Xingmei; Sun, Wei; Wei, Fanqin; Liu, Wendong; Lu, Tong; Wen, Weiping] Guangzhou Key Lab Otorhinolaryngol, Guangzhou, Peoples R China; [Zhang, Jia; Li, Huabin] Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai, Peoples R China; [Ji, Weidong] Sun Yat Sen Univ, Translat Med Ctr, Affiliated Hosp 1, Guangzhou, Peoples R China; [Wen, Weiping] Sun Yat Sen Univ, Dept Otolaryngol, Affiliated Hosp 6, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Fudan University; Sun Yat Sen University; Sun Yat Sen University	Ji, WD (corresponding author), Sun Yat Sen Univ, Translat Med Ctr, Affiliated Hosp 1, Guangzhou, Peoples R China.	wdji2008@126.com; allergyli@163.com; wenwp@mail.sysu.edu.cn	温, 家琦/GYV-3177-2022; ji, weidong/AAX-7397-2020					Barac A, 2015, EUR ARCH OTO-RHINO-L, V272, P3727, DOI 10.1007/s00405-015-3511-2; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; Gurung P, 2015, J CLIN INVEST, V125, P1329, DOI 10.1172/JCI79526; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Hong HY, 2018, ALLERGY, V73, P459, DOI 10.1111/all.13267; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; Lin H, 2016, INFLAMMATION, V39, P2045, DOI 10.1007/s10753-016-0442-z; Niebuhr M, 2014, ALLERGY, V69, P1058, DOI 10.1111/all.12428; Ting JPY, 2015, NAT IMMUNOL, V16, P794, DOI 10.1038/ni.3223; Wei Y, 2014, J ALLERGY CLIN IMMUN, V133, P420, DOI 10.1016/j.jaci.2013.09.052; Wen WP, 2012, J ALLERGY CLIN IMMUN, V129, P1522, DOI 10.1016/j.jaci.2012.01.079; Zhang Y, 2017, J ALLERGY CLIN IMMUN, V140, P1230, DOI 10.1016/j.jaci.2017.09.009; Zhao QY, 2011, EUR J IMMUNOL, V41, P2314, DOI 10.1002/eji.201041282	13	10	10	2	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					1002	+		10.1016/j.jaci.2020.01.009	http://dx.doi.org/10.1016/j.jaci.2020.01.009			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31981626	Bronze			2022-12-18	WOS:000518756700036
J	Kansen, HM; Le, TM; Knulst, AC; Gorissen, DMW; van der Ent, CK; Meijer, Y; van Erp, FC				Kansen, Hannah M.; Le, Thuy-My; Knulst, Andre C.; Gorissen, Diana M. W.; van der Ent, Cornelis K.; Meijer, Yolanda; van Erp, Francine C.			Three-year follow-up after peanut food challenges: Accidental reactions in allergic children and introduction failure in tolerant children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							OF-LIFE QUESTIONNAIRE; ANAPHYLAXIS; VALIDATION		[Kansen, Hannah M.; van der Ent, Cornelis K.; Meijer, Yolanda] Univ Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol & Allergol, Utrecht, Netherlands; [Kansen, Hannah M.; Le, Thuy-My; Knulst, Andre C.; van Erp, Francine C.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Dermatol Allergol, Utrecht, Netherlands; [Gorissen, Diana M. W.] Deventer Hosp, Dept Pediat, Deventer, Netherlands	Utrecht University; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Deventer Hospital	Kansen, HM (corresponding author), Univ Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol & Allergol, Utrecht, Netherlands.; Kansen, HM (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Dermatol Allergol, Utrecht, Netherlands.	h.m.kansen-2@umcutrecht.nl		Knulst, Andre/0000-0002-1056-3179; Van der Ent, Cornelis/0000-0002-2501-4121				Blok BMJF, 2008, J ALLERGY CLIN IMMUN, V122, P139, DOI 10.1016/j.jaci.2008.05.008; DunnGalvin A, 2008, CLIN EXP ALLERGY, V38, P977, DOI 10.1111/j.1365-2222.2008.02978.x; Eigenmann PA, 2006, PEDIATR ALLERGY IMMU, V17, P601, DOI 10.1111/j.1399-3038.2006.00455.x; Flokstra-de Blok BMJ, 2009, CLIN EXP ALLERGY, V39, P127, DOI [10.1111/j.1365-2222.2008.03120.x, 10.1111/j.1365-2222.2009.03376.x]; Grabenhenrich LB, 2018, J ALLER CL IMM-PRACT, V6, P1898, DOI 10.1016/j.jaip.2018.02.026; Kansen HM, 2018, PEDIAT ALLERG IMM-UK, V29, P527, DOI 10.1111/pai.12905; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Nha UNL, 2012, PEDIAT ALLERG IMM-UK, V23, P134, DOI 10.1111/j.1399-3038.2011.01235.x; Sampson HA, 2003, PEDIATRICS, V111, P1601; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Skypala IJ, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0218-7; van Erp FC, 2017, J ALLERGY CLIN IMMUN, V139, P358, DOI 10.1016/j.jaci.2016.06.041	12	10	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					705	+		10.1016/j.jaci.2019.09.011	http://dx.doi.org/10.1016/j.jaci.2019.09.011			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31568797	Bronze			2022-12-18	WOS:000512887400032
J	Bernstock, JD; Totten, AH; Elkahloun, AG; Johnson, KR; Hurst, AC; Goldman, F; Groves, AK; Mikhail, FM; Atkinson, TP				Bernstock, Joshua D.; Totten, Arthur H.; Elkahloun, Abdel G.; Johnson, Kory R.; Hurst, Anna C.; Goldman, Frederick; Groves, Andrew K.; Mikhail, Fady M.; Atkinson, T. Prescott			Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Thymus; T-cell receptor excision circles; DiGeorge syndrome; knockout mice; immunodeficiency; FOXI3	TRANSCRIPTION FACTORS; FOXI3; TBX1; EXPRESSION; ARTERY; CELLS	Background: Thymic hypoplasia/aplasia occurs as a part of DiGeorge syndrome, which has several known genetic causes, and with loss-of-function mutations in forkhead box N1 (FOXN1). Objective: We sought to determine the cause of selective T-cell lymphopenia with inverted kappa/lambda ratio in several kindreds. Methods: Patients were identified through newborn screening for severe combined immunodeficiency using the T-cell receptor excision circle assay. Those found to have selective T-cell lymphopenia underwent testing with chromosomal microarray analysis. Three-week-old mice heterozygous for a loss-offunction mutation in forkhead box I3 (FOXI3), a candidate gene within the common deleted region found in patients, were compared with wild-type littermates. Assessments included body and organ weights, flow cytometric analysis of thymocytes and splenocytes, and histologic/transcriptomic analyses of thymic tissue. Results: Five kindreds with similar immunophenotypes that included selective T-cell lymphopenia had overlapping microdeletions at chromosome 2p11.2 that spanned FOXI3 and, in most cases, the immunoglobulin kappa light chain locus. Studies in a mouse knockout strain for FOXI3 revealed smaller body weights and relatively lower thymus weights in heterozygous compared with wild-type animals. Histology and flow cytometry on spleens and thymi from 3-week-old pups for T- and B-cell subsets and epithelial cells did not show any significant qualitative or quantitative differences. Transcriptomic analysis of thymic RNA revealed divergence in global transcriptomic signatures, and Ingenuity Pathway Analysis revealed predicted dysfunction in epithelial adherens junctions. Conclusions: Microdeletions at chromosome 2p11.2 are associated with T-cell lymphopenia and probable thymic hypoplasia in human subjects, and haploinsufficiency for FOXI3, a candidate gene within the deleted region, is the likely underlying cause.	[Bernstock, Joshua D.; Totten, Arthur H.; Goldman, Frederick; Atkinson, T. Prescott] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Hurst, Anna C.; Mikhail, Fady M.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Elkahloun, Abdel G.] NHGRI, NIH, Bethesda, MD 20892 USA; [Johnson, Kory R.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Groves, Andrew K.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Groves, Andrew K.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bernstock, Joshua D.] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Bernstock, Joshua D.] Boston Childrens Hosp, Boston, MA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Baylor College of Medicine; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Atkinson, TP (corresponding author), UAB Div Pediat Allergy & Immunol, Childrens Pk Pl M220,1601 4th Ave S, Birmingham, AL 35233 USA.	patkinson@peds.uab.edu	Totten, Arthur H/AAD-6643-2019; Hurst, Anna CE/AAL-2889-2021	Totten, Arthur H/0000-0002-2979-7522; Hurst, Anna CE/0000-0002-9765-9703; Atkinson, Thomas/0000-0003-2528-6976; Groves, Andrew/0000-0002-0784-7998; Bernstock, Joshua/0000-0002-7814-3867	UAB Departments of Pediatrics and Genetics [RO1 DC013072]	UAB Departments of Pediatrics and Genetics	This work was supported by internal funding from the UAB Departments of Pediatrics and Genetics, and the mouse studies were supported by RO1 DC013072 (to A.K.G.).	Baldini A, 2017, CURR TOP DEV BIOL, V122, P223, DOI 10.1016/bs.ctdb.2016.08.002; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Birol O, 2016, DEV BIOL, V409, P139, DOI 10.1016/j.ydbio.2015.09.022; Bosticardo M, 2019, AM J HUM GENET, V105, P549, DOI 10.1016/j.ajhg.2019.07.014; Bousfiha A, 2015, J CLIN IMMUNOL, V7, P7; Broers AEC, 2002, EXP HEMATOL, V30, P745, DOI 10.1016/S0301-472X(02)00825-1; Calmont A, 2009, DEVELOPMENT, V136, P3173, DOI 10.1242/dev.028902; Cohen JL, 2018, AM J MED GENET A, V176, P2203, DOI 10.1002/ajmg.a.40494; Deneys V, 2001, J IMMUNOL METHODS, V253, P23, DOI 10.1016/S0022-1759(01)00338-6; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Edlund RK, 2014, DEV BIOL, V390, P1, DOI 10.1016/j.ydbio.2014.03.004; FUKUTA K, 1991, EXP ANIM TOKYO, V40, P69, DOI 10.1538/expanim1978.40.1_69; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Gottlieb S, 1998, AM J HUM GENET, V62, P495, DOI 10.1086/301718; Hasten E, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008301; Kupczik K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05764-5; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; Larsen BM, 2019, J IMMUNOL, V203, P686, DOI 10.4049/jimmunol.1801540; Liu N, 2018, HUM MOL GENET, V27, P2454, DOI 10.1093/hmg/ddy146; Luan R, 2019, DIFFERENTIATION, V107, P42, DOI 10.1016/j.diff.2019.06.002; Markert ML, 2010, CLIN IMMUNOL, V135, P236, DOI 10.1016/j.clim.2010.02.007; Sanka M, 2007, J ALLERGY CLIN IMMUN, V120, P952, DOI 10.1016/j.jaci.2007.08.013; Schmalstieg FC, 2002, MOL GENET METAB, V76, P163, DOI 10.1016/S1096-7192(02)00042-2; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Shirokova V, 2016, STEM CELLS, V34, P1896, DOI 10.1002/stem.2363; Tassano E, 2015, AM J MED GENET A, V167, P537, DOI 10.1002/ajmg.a.36895; Vaidya HJ, 2016, EUR J IMMUNOL, V46, P1826, DOI 10.1002/eji.201545814; van Bueren KL, 2010, DEV BIOL, V340, P369, DOI 10.1016/j.ydbio.2010.01.020; Wiener DJ, 2013, VET DERMATOL, V24, P274, DOI 10.1111/vde.12008; Xing Y., 2014, JOVE-J VIS EXP, V90; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6	31	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					358	+		10.1016/j.jaci.2019.09.020	http://dx.doi.org/10.1016/j.jaci.2019.09.020			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31600545	Green Accepted, Bronze			2022-12-18	WOS:000505590800039
J	Flayer, CH; Larson, ED; Joseph, A; Kao, S; Qu, WX; Van Haren, A; Royer, CM; Miller, LA; Capitanio, JP; Sielecki, T; Christofidou-Solomidou, M; Haczku, A				Flayer, Cameron H.; Larson, Erik D.; Joseph, Anjali; Kao, Sean; Qu, Wenxiu; Van Haren, Austin; Royer, Christopher M.; Miller, Lisa A.; Capitanio, John P.; Sielecki, Thais; Christofidou-Solomidou, Melpo; Haczku, Angela			Ozone-induced enhancement of airway hyperreactivity in rhesus macaques: Effects of antioxidant treatment	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; airway inflammation; air pollution; therapies (investigational); nonhuman primate	SURFACTANT PROTEIN-D; TRACHEOBRONCHIAL EPITHELIAL INJURY; DENDRITIC CELLS; LUNG-FUNCTION; INFLAMMATION; ALLERGEN; ASTHMA; HYPERRESPONSIVENESS; RESPONSIVENESS; EXPOSURE	Background: Ozone (O-3) inhalation elicits airway inflammation and impairs treatment responsiveness in asthmatic patients. The underlying immune mechanisms have been difficult to study because of the lack of relevant experimental models. Rhesus macaques spontaneously have asthma and have a similar immune system to human subjects. Objectives: We sought to investigate mucosal immune changes after O-3 inhalation in a clinically relevant nonhuman primate asthma model and to study the effects of an antioxidant synthetic lignan (synthetic secoisolariciresinol diglucoside [LGM2605]). Methods: A cohort of macaques (n = 17) previously characterized with airway hyperreactivity (AHR) to methacholine was assessed (day 1). Macaques were treated (orally) with LGM2605 (25 mg/kg) or placebo twice per day for 7 days, exposed to 0.3 ppm O-3 or air for 6 hours (on day 7), and studied 12 hours later (day 8). Lung function, blood and bronchoalveolar lavage (BAL) fluid immune cell profile, and bronchial brushing and blood cell mRNA expression were assessed. Results: O-3 induced significant BAL fluid neutrophilia and eosinophilia and increased AHR and expression of IL6 and IL25 mRNA in the airway epithelium together with increased BAL fluid group 2 innate lymphoid cell (ILC2s), CD1c(+) myeloid dendritic cell, and CD4(+) T-cell counts and diminished surfactant protein D expression. Although LGM2605 attenuated some of the immune and inflammatory changes, it completely abolished O-3 -induced AHR. Conclusion: ILC2s, CD1c(+) myeloid dendritic cells, and CD4(+) T cells are selectively involved in O-3 -induced asthma exacerbation. The inflammatory changes were partially prevented by antioxidant pretreatment with LGM2605, which had an unexpectedly disproportionate protective effect on AHR.	[Flayer, Cameron H.; Larson, Erik D.; Joseph, Anjali; Kao, Sean; Qu, Wenxiu; Van Haren, Austin; Haczku, Angela] UC Davis Sch Med, Dept Med, Pulm Crit Care & Sleep Div, Davis, CA USA; [Qu, Wenxiu] China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Liaoning, Peoples R China; [Royer, Christopher M.; Miller, Lisa A.; Capitanio, John P.] UC Davis Calif Natl Primate Res Ctr, Davis, CA USA; [Sielecki, Thais] LignaMed, Philadelphia, PA USA; [Christofidou-Solomidou, Melpo] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	University of California System; University of California Davis; China Medical University; University of Pennsylvania	Haczku, A (corresponding author), Univ Calif Davis, Dept Med, Pulm Crit Care & Sleep Div, 6510 GBSF,One Shields Ave, Davis, CA 95616 USA.	haczku@ucdavis.edu			California National Primate Research Center Base Operating Grant National Institutes of Health, United States [P51OD011107];  [T32ES007059];  [T32HL007013];  [P30ES023513];  [R21AI116121];  [1R41AI132012-01];  [H12.01-8754];  [R24OD010962]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010962] Funding Source: NIH RePORTER	California National Primate Research Center Base Operating Grant National Institutes of Health, United States; ; ; ; ; ; ; ; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by T32ES007059 and T32HL007013 (to C.H.F), a P30ES023513 pilot grant and R21AI116121 (to A.H.), 1R41AI132012-01 (to A.H. and T.S.), H12.01-8754 (to T.S. and M.C.-S), R24OD010962 (J.C.), and California National Primate Research Center Base Operating Grant P51OD011107 National Institutes of Health, United States.	Bailey MT, 2009, J IMMUNOL, V182, P7888, DOI 10.4049/jimmunol.0800891; Brand JD, 2012, AM J PHYSIOL-LUNG C, V303, pL1079, DOI 10.1152/ajplung.00185.2012; Capitanio JP, 2011, PSYCHOSOM MED, V73, P288, DOI 10.1097/PSY.0b013e3182155c83; Chen LL, 2004, CHEST, V125, P2328, DOI 10.1378/chest.125.6.2328; CHEN XL, 1995, AM J RESP CELL MOL, V12, P396, DOI 10.1165/ajrcmb.12.4.7695918; Chou DL, 2011, TOXICOL APPL PHARM, V257, P309, DOI 10.1016/j.taap.2011.09.001; Chun K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071575; Crowley CM, 2017, TOXICOL APPL PHARM, V328, P60, DOI 10.1016/j.taap.2017.05.006; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fajt ML, 2015, J ALLERGY CLIN IMMUN, V135, P299, DOI 10.1016/j.jaci.2014.12.1871; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Ge MQ, 2016, J IMMUNOL, V196, P553, DOI 10.4049/jimmunol.1403042; Golub MS, 2006, NEUROTOXICOL TERATOL, V28, P3, DOI 10.1016/j.ntt.2005.10.005; GUNDEL RH, 1991, J CLIN INVEST, V87, P1470, DOI 10.1172/JCI115155; Haczku A, 2001, AM J RESP CELL MOL, V25, P45, DOI 10.1165/ajrcmb.25.1.4391; Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014; Haczku A, 2010, J ALLERGY CLIN IMMUN, V125, P550, DOI 10.1016/j.jaci.2009.11.005; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; HARGREAVE FE, 1986, J ALLERGY CLIN IMMUN, V78, P825, DOI 10.1016/0091-6749(86)90226-5; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Herring MJ, 2015, TOXICOL APPL PHARM, V283, P35, DOI 10.1016/j.taap.2014.12.006; Hortobagyi L, 2008, J ALLERGY CLIN IMMUN, V122, P521, DOI 10.1016/j.jaci.2008.05.002; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Hyde DM, 1999, AM J PHYSIOL-LUNG C, V277, pL1190, DOI 10.1152/ajplung.1999.277.6.L1190; HYDE DM, 1992, AM J RESP CELL MOL, V6, P481, DOI 10.1165/ajrcmb/6.5.481; Islam T, 2009, THORAX, V64, P197, DOI 10.1136/thx.2008.099366; JAKAB GJ, 1995, ENVIRON HEALTH PERSP, V103, P77, DOI 10.2307/3432454; Kierstein S, 2008, ALLERGY, V63, P438, DOI 10.1111/j.1398-9995.2007.01587.x; Kierstein S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-85; Kierstein S, 2005, AM J RESP CRIT CARE, V171, pA483; KOREN HS, 1989, AM REV RESPIR DIS, V139, P407, DOI 10.1164/ajrccm/139.2.407; Koziol-White C, 2010, AM J RESP CRIT CARE, V181; KREIT JW, 1989, J APPL PHYSIOL, V66, P217, DOI 10.1152/jappl.1989.66.1.217; Krishna MT, 1998, EUR RESPIR J, V11, P1294, DOI 10.1183/09031936.98.11061294; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; McDonnell WF, 2012, INHAL TOXICOL, V24, P619, DOI 10.3109/08958378.2012.705919; MILLER BD, 1994, J AM ACAD CHILD PSY, V33, P1236, DOI 10.1097/00004583-199411000-00004; Mishra OP, 2018, BBA-GEN SUBJECTS, V1862, P1364, DOI 10.1016/j.bbagen.2018.03.003; Moore BD, 2012, RESPIRATION, V83, P529, DOI 10.1159/000336835; PATTERSON R, 1992, INT ARCH ALLERGY IMM, V97, P154, DOI 10.1159/000236111; Peden DB, 2011, IMMUNOL REV, V242, P91, DOI 10.1111/j.1600-065X.2011.01035.x; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Pietrofesa RA, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7030038; Pietrofesa RA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7395238; Pietrofesa RA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030322; Pietrofesa RA, 2016, CARCINOGENESIS, V37, P177, DOI 10.1093/carcin/bgv174; Plopper CG, 1998, AM J RESP CELL MOL, V19, P387, DOI 10.1165/ajrcmb.19.3.3183; Sahiner UM, 2018, PEDIAT ALLERG IMM-UK, V29, P789, DOI 10.1111/pai.12965; Schelegle ES, 2003, TOXICOL APPL PHARM, V191, P74, DOI 10.1016/S0041-008X(03)00218-7; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Starosta V, 2006, FREE RADICAL RES, V40, P419, DOI 10.1080/10715760600571248; Stokes JR, 2016, ANN ALLERG ASTHMA IM, V117, P121, DOI 10.1016/j.anai.2016.05.016; Tjota MY, 2014, J ALLERGY CLIN IMMUN, V134, P706, DOI 10.1016/j.jaci.2014.06.013; Torres A, 1997, AM J RESP CRIT CARE, V156, P728, DOI 10.1164/ajrccm.156.3.9601054; Uno Y, 2018, CHEM RES TOXICOL, V31, P1086, DOI 10.1021/acs.chemrestox.8b00198; Velalopoulou A., 2015, INT J MOL SCI, V17; Velalopoulou A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122525; Wang T, 2017, SCI TOTAL ENVIRON, V575, P1582, DOI 10.1016/j.scitotenv.2016.10.081; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright RJ, 2011, AM J RESP CRIT CARE, V184, P752, DOI 10.1164/rccm.201106-1139ED; Yang Q, 2016, J ALLERGY CLIN IMMUN, V137, P571, DOI 10.1016/j.jaci.2015.06.037; Yousefi S, 2018, J LEUKOCYTE BIOL, V104, P205, DOI 10.1002/JLB.3AB1117-455R	64	10	11	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					312	323		10.1016/j.jaci.2019.08.034	http://dx.doi.org/10.1016/j.jaci.2019.08.034			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31627909	Green Accepted, Bronze			2022-12-18	WOS:000505590800035
J	Le Coz, C; Bengsch, B; Khanna, C; Trofa, M; Ohtani, T; Nolan, BE; Henrickson, SE; Lambert, MP; Kim, TO; Despotovic, JM; Feldman, S; Fadugba, OO; Takach, P; Ruffner, M; Jyonouchi, S; Heimall, J; Sullivan, KE; Wherry, EJ; Romberg, N				Le Coz, Carole; Bengsch, Bertram; Khanna, Caroline; Trofa, Melissa; Ohtani, Takuya; Nolan, Brian E.; Henrickson, Sarah E.; Lambert, Michele P.; Kim, Taylor Olmsted; Despotovic, Jenny M.; Feldman, Scott; Fadugba, Olajumoke O.; Takach, Patricia; Ruffner, Melanie; Jyonouchi, Soma; Heimall, Jennifer; Sullivan, Kathleen E.; Wherry, E. John; Romberg, Neil			Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Common variable immunodeficiency; autoimmune cytopenias; activin A; endotoxin; follicular helper T cell; regulatory T cell; recent thymic emigrant; time-of-flight cytometry	CXC CHEMOKINE RECEPTOR-5; HUMAN DENDRITIC CELLS; B-CELLS; IMMUNE DYSREGULATION; GERMLINE MUTATIONS; THYMIC OUTPUT; HELPER-CELLS; ACTIVIN-A; DEFICIENCY; EXPRESSION	Background: Although chiefly a B-lymphocyte disorder, several research groups have identified common variable immunodeficiency (CVID) subjects with numeric and/or functional TH cell alterations. The causes, interrelationships, and consequences of CVID-associated CD4(+) T-cell derangements to hypogammaglobulinemia, autoantibody production, or both remain unclear. Objective: We sought to determine how circulating CD4(+) T cells are altered in CVID subjects with autoimmune cytopenias (AICs; CVID+AIC) and the causes of these derangements. Methods: Using hypothesis-generating, high-dimensional single-cell analyses, we created comprehensive phenotypic maps of circulating CD4(+) T cells. Differences between subject groups were confirmed in a large and genetically diverse cohort of CVID subjects (n = 69) by using flow cytometry, transcriptional profiling, multiplex cytokine/chemokine detection, and a suite of in vitro functional assays measuring naive T-cell differentiation, B-cell/T-cell cocultures, and regulatory T-cell suppression. Results: Although CD4(+) T-H cell profiles from healthy donors and CVID subjects without AICs were virtually indistinguishable, T cells from CVID+AIC subjects exhibited follicular features as early as thymic egress. Follicular skewing correlated with IgA deficiency-associated endotoxemia and endotoxin-induced expression of activin A and inducible T-cell costimulator ligand. The resulting enlarged circulating follicular helper T-cell population from CVID+AIC subjects provided efficient help to receptive healthy donor B cells but not unresponsive CVID B cells. Despite this, circulating follicular helper T cells from CVID+AIC subjects exhibited aberrant transcriptional profiles and altered chemokine/cytokine receptor expression patterns that interfered with regulatory T-cell suppression assays and were associated with autoantibody production. Conclusions: Endotoxemia is associated with early commitment to the follicular T-cell lineage in IgA-deficient CVID subjects, particularly those with AICs.	[Le Coz, Carole; Khanna, Caroline; Trofa, Melissa; Henrickson, Sarah E.; Ruffner, Melanie; Jyonouchi, Soma; Heimall, Jennifer; Sullivan, Kathleen E.; Romberg, Neil] Childrens Hosp Philadelphia, Div Immunol & Allergy, Philadelphia, PA USA; [Lambert, Michele P.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA USA; [Nolan, Brian E.] Childrens Hosp Philadelphia, Div Rheumatol, Philadelphia, PA USA; [Henrickson, Sarah E.; Lambert, Michele P.; Jyonouchi, Soma; Heimall, Jennifer; Sullivan, Kathleen E.; Romberg, Neil] Univ Penn, Dept Pediat, Philadelphia, PA USA; [Feldman, Scott; Fadugba, Olajumoke O.; Takach, Patricia] Univ Penn, Dept Med, Div Allergy & Immunol, Philadelphia, PA USA; [Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA USA; [Ohtani, Takuya; Henrickson, Sarah E.; Sullivan, Kathleen E.; Wherry, E. John; Romberg, Neil] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA USA; [Bengsch, Bertram] Univ Med Ctr Freiburg, Dept Med 2, Freiburg, Germany; [Kim, Taylor Olmsted; Despotovic, Jenny M.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Freiburg; Baylor College of Medicine	Romberg, N (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Rm 1216C, Philadelphia, PA 19104 USA.	rombergn@email.chop.edu	Kim, Taylor/ABG-6778-2021; Wherry, John/ABI-1280-2020; Khanna, Caroline/GWU-8745-2022; Lambert, Michele P./AAB-9225-2021; Bengsch, Bertram/ABF-2142-2020	Lambert, Michele P./0000-0003-0439-402X; Bengsch, Bertram/0000-0003-2552-740X; Le Coz, Carole/0000-0002-9228-5896; Romberg, Neil/0000-0002-1881-5318; Khanna, Caroline/0000-0002-4356-3933; Henrickson, Sarah/0000-0001-5569-4132; Kim, Taylor/0000-0002-2875-6948; Ruffner, Melanie/0000-0002-2943-9944	National Institutes of Health/National Institute of Allergy and Infectious Diseases [K23AI115001, AI146026, AI105343, AI108545, AI117950]; National Institutes of Health/National Cancer Institute [CA210944]; National Institutes of Health/National Institute of Child Health and Human Development [K12HD043245]; American Association of Allergy, Asthma AMP; Immunology Foundation; David and Hallee Adelman Immunotherapy Research Fund; Parker Institute for Cancer Immunotherapy Bridge Scholar Award; Jeffrey Modell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043245] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA210944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117950, P01AI108545, R01AI146026, R01AI105343, K23AI115001] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Association of Allergy, Asthma AMP; Immunology Foundation; David and Hallee Adelman Immunotherapy Research Fund; Parker Institute for Cancer Immunotherapy Bridge Scholar Award; Jeffrey Modell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grant numbers K23AI115001 (to N.R.), AI146026 (to N.R.), AI105343 (to E.J.W.), AI108545 (to E.J.W.), and AI117950 (to E.J.W.) from the National Institutes of Health/National Institute of Allergy and Infectious Diseases; grant CA210944 from the National Institutes of Health/National Cancer Institute (to E.J.W.); grant number K12HD043245 from the National Institutes of Health/National Institute of Child Health and Human Development (to S.E.H.); the American Association of Allergy, Asthma & Immunology Foundation (to S.E.H.); the David and Hallee Adelman Immunotherapy Research Fund (to E.J.W.); the Parker Institute for Cancer Immunotherapy Bridge Scholar Award to (E.J.W.); and the Jeffrey Modell Foundation (to N.R.).	Aladjidi N, 2011, HAEMATOL-HEMATOL J, V96, P655, DOI 10.3324/haematol.2010.036053; Alkhairy OK, 2015, J ALLERGY CLIN IMMUN, V136, P703, DOI 10.1016/j.jaci.2015.02.022; ANDERSSON J, 1973, J EXP MED, V137, P943, DOI 10.1084/jem.137.4.943; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Almejun MB, 2017, J ALLERGY CLIN IMMUN, V139, P913, DOI 10.1016/j.jaci.2016.08.030; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Bousfiha A, 2018, J CLIN IMMUNOL, V38, P129, DOI 10.1007/s10875-017-0465-8; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Canete PF, 2019, J EXP MED, V216, P1843, DOI 10.1084/jem.20190493; Castigli E, 2006, J ALLERGY CLIN IMMUN, V117, P740, DOI 10.1016/j.jaci.2006.01.038; Charbonnier LM, 2015, J ALLERGY CLIN IMMUN, V135, P217, DOI 10.1016/j.jaci.2014.10.019; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; CONDIE RM, 1955, P SOC EXP BIOL MED, V90, P355, DOI 10.3181/00379727-90-22032; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Cunningham-Rundles C, 2012, HEMATOL-AM SOC HEMAT, P301, DOI 10.1182/asheducation-2012.1.301; de Valles-Ibanez G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00636; De Vera MJ, 2004, ANN ALLERG ASTHMA IM, V93, P478, DOI 10.1016/S1081-1206(10)61416-0; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fliegauf M, 2015, AM J HUM GENET, V97, P389, DOI 10.1016/j.ajhg.2015.07.008; Fonseca VR, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan1487; Guazzi V, 2002, CLIN EXP IMMUNOL, V129, P346, DOI 10.1046/j.1365-2249.2002.01893.x; Hedl M, 2014, IMMUNITY, V40, P734, DOI 10.1016/j.immuni.2014.04.011; Herzig DS, 2014, CRIT CARE, V18, DOI 10.1186/cc13902; Herzig DS, 2012, AM J RESP CRIT CARE, V185, P291, DOI 10.1164/rccm.201108-1560OC; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Isgro A, 2005, J IMMUNOL, V174, P5074, DOI 10.4049/jimmunol.174.8.5074; Jacquemin C, 2015, IMMUNITY, V42, P1159, DOI 10.1016/j.immuni.2015.05.012; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kuehn HS, 2016, NEW ENGL J MED, V374, P1032, DOI 10.1056/NEJMoa1512234; Kuehn HS, 2017, BLOOD, V130, P1553, DOI 10.1182/blood-2017-05-782177; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lambert MP, 2017, BLOOD, V129, P2829, DOI 10.1182/blood-2017-03-754119; Lang S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169100; Le Coz C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01715; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Loos T, 2006, LAB INVEST, V86, P902, DOI 10.1038/labinvest.3700453; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; Ma CS, 2015, J ALLERGY CLIN IMMUN, V136, P993, DOI 10.1016/j.jaci.2015.05.036; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Michel M, 2009, BLOOD, V114, P3167, DOI 10.1182/blood-2009-04-215368; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Ochtrop MLG, 2011, BLOOD, V118, P309, DOI 10.1182/blood-2010-11-321695; Park J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074893; Perreau M, 2014, J EXP MED, V211, P2033, DOI 10.1084/jem.20140039; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Romberg N, 2019, J ALLERGY CLIN IMMUN, V143, P258, DOI 10.1016/j.jaci.2018.06.012; Romberg N, 2013, J CLIN INVEST, V123, P4283, DOI 10.1172/JCI69854; Romberg N, 2011, BLOOD, V118, P5977, DOI 10.1182/blood-2011-09-373969; Roskin KM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1216; Salzer E, 2014, J ALLERGY CLIN IMMUN, V133, P1651, DOI 10.1016/j.jaci.2014.02.034; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Simchoni N, 2015, J IMMUNOL, V194, P3035, DOI 10.4049/jimmunol.1402690; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Unger S, 2018, J ALLERGY CLIN IMMUN, V141, P730, DOI 10.1016/j.jaci.2017.04.041; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Widney DP, 2000, J IMMUNOL, V164, P6322, DOI 10.4049/jimmunol.164.12.6322; Yu GP, 2009, CLIN IMMUNOL, V131, P240, DOI 10.1016/j.clim.2008.12.006; Yu JE, 2009, J ALLERGY CLIN IMMUN, V124, P349, DOI 10.1016/j.jaci.2009.05.019	74	10	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1660	1673		10.1016/j.jaci.2019.08.007	http://dx.doi.org/10.1016/j.jaci.2019.08.007			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31445098	Green Accepted, Bronze			2022-12-18	WOS:000500694900023
J	Netea, SA; Messina, NL; Curtis, N				Netea, Stejara A.; Messina, Nicole L.; Curtis, Nigel			Early-life antibiotic exposure and childhood food allergy: A systematic review	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CLASSIFICATION CRITERIA; DIAGNOSIS; BIRTH		[Netea, Stejara A.; Messina, Nicole L.; Curtis, Nigel] Murdoch Childrens Res Inst, Infect Dis Res Grp, Parkville, Vic, Australia; [Messina, Nicole L.; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne	Curtis, N (corresponding author), Murdoch Childrens Res Inst, Infect Dis Res Grp, Parkville, Vic, Australia.; Curtis, N (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic, Australia.; Curtis, N (corresponding author), Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic, Australia.	nigel.curtis@rch.org.au		Messina, Nicole/0000-0001-8404-4462				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alduraywish SA, 2016, ALLERGY, V71, P77, DOI 10.1111/all.12784; Eggesbo M, 2003, J ALLERGY CLIN IMMUN, V112, P420, DOI 10.1067/mai.2003.1610; Federici S, 2015, ANN RHEUM DIS, V74, P799, DOI 10.1136/annrheumdis-2014-206580; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Hirsch AG, 2017, CLIN EXP ALLERGY, V47, P236, DOI 10.1111/cea.12807; Karpa KD, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-87; Kuemmerle-Deschner JB, 2017, ANN RHEUM DIS, V76, P942, DOI 10.1136/annrheumdis-2016-209686; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li MH, 2019, J ALLER CL IMM-PRACT, V7, P492, DOI 10.1016/j.jaip.2018.09.036; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Love BL, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0148-7; Marsh RA, 2010, PEDIATR BLOOD CANCER, V55, P134, DOI 10.1002/pbc.22499; Obiakor CV, 2018, EXPERT REV CLIN IMMU, V14, P841, DOI 10.1080/1744666X.2018.1521271; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Ravelli A, 2016, ANN RHEUM DIS, V75, P481, DOI 10.1136/annrheumdis-2015-208982; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Vanoni F, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0101-9; Yalcinkaya F, 2009, RHEUMATOLOGY, V48, P395, DOI 10.1093/rheumatology/ken509	22	10	10	7	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1445	+		10.1016/j.jaci.2019.08.001	http://dx.doi.org/10.1016/j.jaci.2019.08.001			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31415783	Bronze			2022-12-18	WOS:000495004700042
J	Wen, T; Rothenberg, ME				Wen, Ting; Rothenberg, Marc E.			Cell-by-cell deciphering of T cells in allergic inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						T(H)2 cells; eosinophilic esophagitis; scRNA-seq; T(H)2 cytokine; food allergy	CHAIN FATTY-ACIDS; EXPRESSION PROFILE; GENE-EXPRESSION; SUBPOPULATION; DEFINES	Technical advances in single-cell RNA sequencing (scRNA-seq) render it possible to examine the transcriptomes of single cells in patients with allergic inflammation with high resolution in the context of their specific microenvironment, treatment, and disease status. Using a recently published scRNA-seq study of tissue T cells as an example, we introduce the major pipeline steps, illustrate the options of scRNA-seq platforms, summarize new knowledge gained from this study, and provide directions for future research. The presented scRNA-seq study elucidated the T-cell heterogeneity present in an allergic inflammatory tissue focused on eosinophilic esophagitis, a prototypic, chronic, allergic disease, which provided a unique opportunity to probe the pathogenesis of allergic inflammation at the tissue level through readily available endoscopically procured biopsy specimens. scRNA-seq analysis identified 8 populations of CD3(+) T cells and defined 2 disease-specific populations of CD3(+) CD4(+) T cells, including a markedly activated type 2 cytokine- producing pathogenic cell population distinguished by expression of the short-chain fatty acid receptor free fatty acid receptor 3 and a population of regulatory T cells. In addition to presenting and interpreting new findings within the prior literature, we postulate about future single-cell next-generation sequencing platforms in this burgeoning field.	Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45221 USA; Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave,MLC 7028, Cincinnati, OH 45229 USA.	Rothenberg@cchmc.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235, R01AI045898, R01AI130033, U19AI066738, R37AI045898, R01AI124355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI070235, R01 AI130033, R01 AI053479, R01 AI083450, R37 AI045898, R01 AI045898, U19 AI066738, R01 AI124355] Funding Source: Medline; NIDDK NIH HHS [R01 DK076893, P30 DK078392] Funding Source: Medline; FDA HHS [R01 FD002396] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FDA HHS		Abdel-Gadir A, 2019, NAT MED, V25, P1164, DOI 10.1038/s41591-019-0461-z; Begin P, 2015, J ALLERGY CLIN IMMUN, V135, P1636, DOI 10.1016/j.jaci.2015.03.010; Bel EH, 2017, CHEST, V152, P1276, DOI 10.1016/j.chest.2017.05.019; Benitez AJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0085-6; Berin MC, 2018, J ALLERGY CLIN IMMUN, V142, P149, DOI 10.1016/j.jaci.2018.01.044; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Bullock JZ, 2007, J PEDIATR GASTR NUTR, V45, P22, DOI 10.1097/MPG.0b013e318043c097; Dakhama A, 2013, ALLERGY, V68, P666, DOI 10.1111/all.12135; Halpern KB, 2018, NAT BIOTECHNOL, V36, P962, DOI 10.1038/nbt.4231; Harris JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128346; Hill DA, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-015-0592-3; Holt RA, 2017, NAT BIOTECHNOL, V35, P829, DOI 10.1038/nbt.3957; Kamada T, 2019, P NATL ACAD SCI USA, V116, P9999, DOI 10.1073/pnas.1822001116; Leng N, 2015, NAT METHODS, V12, P947, DOI [10.1038/NMETH.3549, 10.1038/nmeth.3549]; Lexmond WS, 2014, AM J GASTROENTEROL, V109, P646, DOI 10.1038/ajg.2014.12; Lord JD, 2015, WORLD J GASTROENTERO, V21, P11236, DOI 10.3748/wjg.v21.i40.11236; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; McKenzie Andrew N J, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS263, DOI 10.1513/AnnalsATS.201403-097AW; Mitson-Salazar A, 2016, J ALLERGY CLIN IMMUN, V137, P907, DOI 10.1016/j.jaci.2015.08.007; Nobel YR, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0067-7; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; O'Shea KM, 2018, GASTROENTEROLOGY, V154, P333, DOI 10.1053/j.gastro.2017.06.065; Oh SA, 2017, P NATL ACAD SCI USA, V114, pE7536, DOI 10.1073/pnas.1706356114; Riemondy KA, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky1204; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Upadhyaya B, 2011, J IMMUNOL, V187, P3111, DOI 10.4049/jimmunol.1101283; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Wen T, 2019, J CLIN INVEST, V129, P2014, DOI 10.1172/JCI125917; Wen T, 2017, J ALLERGY CLIN IMMUN, V140, P1736, DOI 10.1016/j.jaci.2017.07.022; Xin YR, 2016, P NATL ACAD SCI USA, V113, P3293, DOI 10.1073/pnas.1602306113	37	10	10	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1143	1149		10.1016/j.jaci.2019.10.001	http://dx.doi.org/10.1016/j.jaci.2019.10.001			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31703761	Green Accepted, Bronze			2022-12-18	WOS:000495004700001
J	Li, JY; Jiao, J; Wang, M; Gao, YB; Li, Y; Wang, Y; Zhang, Y; Wang, XD; Zhang, L				Li, Jingyun; Jiao, Jian; Wang, Ming; Gao, Yunbo; Li, Ying; Wang, Yang; Zhang, Yuan; Wang, Xiangdong; Zhang, Luo			Hypomethylation of the IL8 promoter in nasal epithelial cells of patients with chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis; DNA methylation; Han Chinese; human nasal epithelial cells; IL-8 proximal promoter; nuclear factor kappa B; Octamer-binding transcription factor 1	NF-KAPPA-B; DNA METHYLATION STATUS; PROTEIN EXPRESSION; GENE-EXPRESSION; INTERLEUKIN-8; TRANSCRIPTION; OCT-1; ACTIVATION; BINDING; INFLAMMATION	Background: IL-8 is an important chemokine implicated in the pathogenesis of chronic rhinosinusitis (CRS), but little is known about epigenetic regulation of IL8 in the pathogenesis of CRS. Objective: We sought to investigate the relationship between the DNA methylation level in the IL8 proximal promoter and CRS in Han Chinese subjects. Methods: Patients with chronic rhinosinusitis with nasal polyps (CRSwNP; n = 187), patients with chronic rhinosinusitis without nasal polyps (CRSsNP; n = 89), and control subjects (n = 57) were enrolled in 2 independent cohorts. Purified human nasal epithelial cells from each participant were assessed for percentage DNA methylation of CpG sites in the IL8 proximal promoter by using bisulfite pyrosequencing and for functional aspects of methylation status by using in vitro assays. Results: DNA methylation of CpG sites 1, 2, and 3, respectively, in the IL8 proximal promoter was significantly decreased in human nasal epithelial cells of patients with CRSwNP compared with that in patients with CRSsNP (P < .001) and control subjects (P < .001). Percentage of DNA methylation of the CpG3 site was correlated negatively with both tissue eosinophilic cationic protein (P < .01) and myeloperoxidase (P < .05) levels. IL-1 beta (P < .001) and TNF-alpha (P < .01) significantly increased IL8 expression accompanied by a reduction in methylation at the CpG3 site (P < .001). Electrophoretic mobility shift assays demonstrated that methylation status of CpG3 changed the binding of octamer-binding transcription factor 1 and nuclear factor kappa B. Conclusion: Decreased DNA methylation of particularly CpG sites in the IL8 proximal promoter might play a role in the pathogenesis of CRSwNP.	[Li, Jingyun; Jiao, Jian; Wang, Ming; Gao, Yunbo; Li, Ying; Wang, Yang; Zhang, Yuan; Wang, Xiangdong; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Zhang, Yuan; Wang, Xiangdong; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Allergy, Beijing, Peoples R China; [Li, Jingyun; Jiao, Jian; Wang, Ming; Gao, Yunbo; Li, Ying; Wang, Yang; Zhang, Yuan; Wang, Xiangdong; Zhang, Luo] Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhang, Y; Wang, XD; Zhang, L (corresponding author), Beijing Inst Otolaryngol, 17 HouGouHuTong, Beijing 100005, Peoples R China.	summer_zhang1211@126.com; entwxd@vip.sina.com; dr.luozhang@139.com	Wang, Xiangdong/AAF-9148-2020; Li, Jing/GYU-5036-2022	Zhang, Luo/0000-0002-0910-9884	Beijing Natural Science Foundation [7182034, 7172054, 7172053]; National Key R&D Program of China [2016YFC20160905200]; Program for the Changjiang Scholars and Innovative Research Team [IRT13082]; National Natural Science Foundation of China [81420108009, 81630023, 81400447, 81570894, 81570895]; Beijing Municipal Administration of Hospitals' Mission Plan [SML20150203]; Beijing Advanced Innovation Center for Food Nutrition and Human Health (Beijing Technology and Business University) [20181045]; Beijing Health Bureau Program for High Level Talents [2014-3-018]; Cross-disciplinary Collaborative Program of Beijing Nova program [xxjc201712]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Key R&D Program of China; Program for the Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals' Mission Plan; Beijing Advanced Innovation Center for Food Nutrition and Human Health (Beijing Technology and Business University); Beijing Health Bureau Program for High Level Talents; Cross-disciplinary Collaborative Program of Beijing Nova program	Supported by grants to the Beijing Natural Science Foundation (7182034), the National Key R&D Program of China (2016YFC20160905200), the Program for the Changjiang Scholars and Innovative Research Team (IRT13082), the National Natural Science Foundation of China (81420108009, 81630023, 81400447, 81570894, and 81570895), the Beijing Natural Science Foundation (7172054 and 7172053), the Beijing Municipal Administration of Hospitals' Mission Plan (SML20150203), and the Beijing Advanced Innovation Center for Food Nutrition and Human Health (Beijing Technology and Business University, 20181045), the Beijing Health Bureau Program for High Level Talents (2014-3-018), and the Cross-disciplinary Collaborative Program of Beijing Nova program (xxjc201712).	Andia DC, 2010, J PERIODONTOL, V81, P1336, DOI 10.1902/jop.2010.100082; Bachert C, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-25; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Caradonna F, 2018, INFLAMM RES, V67, P327, DOI 10.1007/s00011-017-1124-5; Cheong HS, 2011, ALLERGY, V66, P637, DOI 10.1111/j.1398-9995.2010.02514.x; Clifford RL, 2015, AM J PHYSIOL-LUNG C, V308, pL962, DOI 10.1152/ajplung.00021.2015; Dimberg J, 2012, INT J COLORECTAL DIS, V27, P709, DOI 10.1007/s00384-011-1367-5; Ek A, 2013, ALLERGY, V68, P1314, DOI 10.1111/all.12222; ERGER RA, 1995, AM J PHYSIOL-LUNG C, V268, pL117, DOI 10.1152/ajplung.1995.268.1.L117; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Jeong SH, 2014, TUMOR BIOL, V35, P5501, DOI 10.1007/s13277-014-1724-4; Jiao J, 2016, CLIN EXP ALLERGY, V46, P449, DOI 10.1111/cea.12644; Jundi K, 2015, BIOMOLECULES, V5, P1386, DOI 10.3390/biom5031386; Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952; Kikuchi I, 2006, AM J RESP CELL MOL, V34, P760, DOI 10.1165/rcmb.2005-0303OC; Kim YM, 1999, MOL CELLS, V9, P99; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Liao B, 2018, ALLERGY, V73, P1459, DOI 10.1111/all.13411; Lin RK, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-46; Martino D, 2014, J REPROD IMMUNOL, V104, P43, DOI 10.1016/j.jri.2014.05.003; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Oliveira NFP, 2009, J CLIN PERIODONTOL, V36, P719, DOI 10.1111/j.1600-051X.2009.01446.x; Pance A, 2016, BBA-GENE REGUL MECH, V1859, P820, DOI 10.1016/j.bbagrm.2016.04.003; Poghosyan A, 2016, BIOCHEM BIOPH RES CO, V476, P431, DOI 10.1016/j.bbrc.2016.05.140; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rudack C, 2007, CLIN EXP ALLERGY, V37, P1009, DOI 10.1111/j.1365-2222.2007.02686.x; Shi JB, 2015, ALLERGY, V70, P533, DOI 10.1111/all.12577; Takahashi A, 2015, OSTEOARTHR CARTILAGE, V23, P1946, DOI 10.1016/j.joca.2015.02.168; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; ULLMAN KS, 1991, SCIENCE, V254, P558, DOI 10.1126/science.1683003; Van Crombruggen K, 2012, J ALLERGY CLIN IMMUN, V129, P1515, DOI 10.1016/j.jaci.2012.02.021; van Drunen CM, 2009, IMMUNOL ALLERGY CLIN, V29, P621, DOI 10.1016/j.iac.2009.07.003; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Vazquez-Arreguin K, 2016, BBA-GENE REGUL MECH, V1859, P792, DOI 10.1016/j.bbagrm.2016.02.007; Vince N, 2016, AM J HUM GENET, V99, P1353, DOI 10.1016/j.ajhg.2016.09.023; Wang XD, 2016, ALLERGY, V71, P1170, DOI 10.1111/all.12874; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Wen WP, 2012, J ALLERGY CLIN IMMUN, V129, P1522, DOI 10.1016/j.jaci.2012.01.079; Zhang HQ, 1999, CELL GROWTH DIFFER, V10, P457; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zheng YB, 2015, RHINOLOGY, V53, P345, DOI [10.4193/Rhin14.086, 10.4193/Rhino14.086]	42	10	12	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					993	+		10.1016/j.jaci.2019.06.042	http://dx.doi.org/10.1016/j.jaci.2019.06.042			23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31330222	Bronze			2022-12-18	WOS:000488803900015
J	Lin, L; Moran, TP; Peng, B; Yang, JS; Culton, DA; Che, HL; Jiang, SS; Liu, Z; Geng, SM; Zhang, YZ; Diaz, LA; Qian, Y				Lin, Lan; Moran, Timothy P.; Peng, Bin; Yang, Jinsheng; Culton, Donna A.; Che, Huilian; Jiang, Songsong; Liu, Zhi; Geng, Songmei; Zhang, Yuzhu; Diaz, Luis A.; Qian, Ye			Walnut antigens can trigger autoantibody development in patients with pemphigus vulgaris through a "hit-and-run" mechanism	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Walnut; allergen; pemphigus vulgaris; autoimmune disease; autoantibody; monoclonal antibody; revertant or germline antibody; environmental factor; hit-and-run	PATHOGENIC AUTOANTIBODIES; ENVIRONMENTAL ANTIGENS; SOMATIC MUTATIONS; DNA ANTIBODIES; T-CELLS; LUPUS; RESPONSES; IDENTIFICATION; EPIDEMIOLOGY; AUTOIMMUNITY	Background: Environmental factors, as well as genetic predisposition, are known to be critical for the development of autoimmunity. However, the environmental agents that trigger autoimmune responses have remained elusive. One possible explanation is the "hit-and-run" mechanism in which the inciting antigens that initiate autoimmune responses are not present at the time of overt autoimmune disease. Objective: After our previous findings that some allergens can incite autoimmune responses, we investigated the potential role of environmental allergens in triggering autoantibody development in patients with an autoimmune skin disease, pemphigus vulgaris (PV). Methods: Revertantlgermline mAbs (with mutations on variable regions of heavy and light chains reverted to germline forms) of 8 anti clesmoglein (Dsg) 3 pathogenic mAbs from patients with PV were tested for reactivity against a panel of possible allergens, including insects, pollens, epithelia, fungi, and food antigens. Results: All the PV germline mAbs were reactive to antigens from walnut, including the well-known allergen Jug r 2 and an uncharacterized 85-kDa protein component. Sera from patients with PV contained significantly greater levels of anti-Dsg3 autoantibodies than walnut-specific antibodies, suggesting that the autoreactive B-cell response in patients with PV might be initially triggered by walnut antigens but is subsequently driven by Dsg3. Conclusion: Our findings suggest that walnut antigens/allergens can initiate autoantibody development in patients with PV through a "hit-and-run" mechanism. The revertant/germline mAb approach might provide a paradigm for the etiological study of other allergic and autoimmune diseases.	[Lin, Lan; Peng, Bin; Yang, Jinsheng; Culton, Donna A.; Liu, Zhi; Diaz, Luis A.; Qian, Ye] Univ N Carolina, Dept Dermatol, 2354 Genom Sci Bldg,250 Bell Tower Dr,CB 7287, Chapel Hill, NC 27599 USA; [Moran, Timothy P.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27515 USA; [Peng, Bin; Geng, Songmei] Xi An Jiao Tong Univ, Dept Dermatol, Northwest Hosp, Xian, Shaanxi, Peoples R China; [Che, Huilian; Jiang, Songsong; Zhang, Yuzhu] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Che, Huilian; Jiang, Songsong] USDA, Western Reg Res Ctr, Albany, NY USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Xi'an Jiaotong University; China Agricultural University; United States Department of Agriculture (USDA)	Qian, Y (corresponding author), Univ N Carolina, Dept Dermatol, 2354 Genom Sci Bldg,250 Bell Tower Dr,CB 7287, Chapel Hill, NC 27599 USA.	ye_qian@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022	Moran, Timothy/0000-0002-6832-9772; Che, Huilian/0000-0002-1632-5729	National Institutes of Health [R01 AR067315, R01 AR32599, AI07924, AI40768]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067315, R01AR032599, R01AR072694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES029118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by grants from the National Institutes of Health (R01 AR067315 to Y.Q., R01 AR32599 to L.A.D., and AI07924 and AI40768 to Z.L.).	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Assarehzadegan MA, 2011, MOL BIOL REP, V38, P65, DOI 10.1007/s11033-010-0078-2; Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452; Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Basten A, 2010, CURR OPIN IMMUNOL, V22, P566, DOI 10.1016/j.coi.2010.08.001; BHOL K, 1995, P NATL ACAD SCI USA, V92, P5239, DOI 10.1073/pnas.92.11.5239; Cardones ARG, 2011, DERMATOL CLIN, V29, P469, DOI 10.1016/j.det.2011.03.005; Chen J, 2017, CELL REP, V18, P237, DOI 10.1016/j.celrep.2016.12.013; Cho MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5167; Christen U, 2005, J IMMUNOL, V174, P7481, DOI 10.4049/jimmunol.174.12.7481; Cooper GS, 2008, ENVIRON HEALTH PERSP, V116, P695, DOI 10.1289/ehp.11092; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Costa J, 2014, CLIN EXP ALLERGY, V44, P319, DOI 10.1111/cea.12267; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; Fedeles F, 2010, CLIN DERMATOL, V28, P627, DOI 10.1016/j.clindermatol.2010.03.036; Fierabracci A, 2009, CURR MOL MED, V9, P1024, DOI 10.2174/156652409789839134; Germolec D, 2012, J AUTOIMMUN, V39, P285, DOI 10.1016/j.jaut.2012.05.020; Gourley M, 2007, NAT CLIN PRACT RHEUM, V3, P172, DOI 10.1038/ncprheum0435; Green PHR, 2015, J ALLERGY CLIN IMMUN, V135, P1099, DOI 10.1016/j.jaci.2015.01.044; Leech S, 1998, ARCH DIS CHILD, V79, P448, DOI 10.1136/adc.79.5.448; Lever WF, 1965, PEMPHIGUS PEMPHIGOID; Lin MS, 1997, J CLIN INVEST, V99, P31, DOI 10.1172/JCI119130; Ludwig RJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00603; MANHEIMERLORY A, 1991, J EXP MED, V174, P1639, DOI 10.1084/jem.174.6.1639; Miller FW, 2012, J AUTOIMMUN, V39, P259, DOI 10.1016/j.jaut.2012.05.002; Miller FW, 2011, ADV EXP MED BIOL, V711, P61; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nagel A, 2010, CLIN IMMUNOL, V134, P320, DOI 10.1016/j.clim.2009.11.006; PAUL E, 1992, J IMMUNOL, V149, P3588; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Plotnikova Natalia, 2013, Skin Therapy Lett, V18, P1; Qian Y, 2016, AUTOIMMUN REV, V15, P923, DOI 10.1016/j.autrev.2016.07.005; Qian Y, 2016, J IMMUNOL, V196, P2041, DOI 10.4049/jimmunol.1502233; Qian Y, 2015, J INVEST DERMATOL, V135, P913, DOI 10.1038/jid.2014.430; Qian Y, 2012, J IMMUNOL, V189, P1535, DOI 10.4049/jimmunol.1200842; Rahman A, 2002, LUPUS, V11, P807, DOI 10.1191/0961203302lu302rr; Ray SK, 1996, P NATL ACAD SCI USA, V93, P2019, DOI 10.1073/pnas.93.5.2019; Rizzo C, 2005, CLIN EXP DERMATOL, V30, P535, DOI 10.1111/j.1365-2230.2005.01836.x; Rottem Menachem, 2002, Dev Immunol, V9, P161, DOI 10.1080/1044667031000137638; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sagi L, 2008, AUTOIMMUN REV, V8, P33, DOI 10.1016/j.autrev.2008.07.021; Song YW, 1998, RHEUMATOL INT, V17, P223, DOI 10.1007/s002960050038; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Teuber SS, 1999, J ALLERGY CLIN IMMUN, V104, P1311, DOI 10.1016/S0091-6749(99)70029-1; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; VANES JH, 1991, J EXP MED, V173, P461, DOI 10.1084/jem.173.2.461; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wellmann U, 2005, P NATL ACAD SCI USA, V102, P9258, DOI 10.1073/pnas.0500132102; WINKLER TH, 1992, EUR J IMMUNOL, V22, P1719, DOI 10.1002/eji.1830220709; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yeh SW, 2006, CLIN IMMUNOL, V120, P68, DOI 10.1016/j.clim.2006.03.006; Yuan H, 2017, J INVEST DERMATOL, V137, pS7, DOI 10.1016/j.jid.2017.05.032; Zhang J, 2008, MOL MED, V14, P675, DOI 10.2119/2008-00066.Zhang; Zhang YZ, 2017, MOL BIOTECHNOL, V59, P159, DOI 10.1007/s12033-017-9998-6	56	10	10	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					720	+		10.1016/j.jaci.2019.04.020	http://dx.doi.org/10.1016/j.jaci.2019.04.020			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IW8CV	31071340	Green Accepted, Bronze			2022-12-18	WOS:000485222300017
J	Alosaimi, MF; Shendi, H; Beano, A; Stafstrom, K; El Hawary, R; Meshaal, S; Galal, N; Pai, SY; El-Marsafy, A; Geha, RS; Chou, J				Alosaimi, Mohammed F.; Shendi, Hiba; Beano, Abdallah; Stafstrom, Kelsey; El Hawary, Rabab; Meshaal, Safa; Galal, Nermeen; Pai, Sung-Yun; El-Marsafy, Aisha; Geha, Raif S.; Chou, Janet			T-cell mitochondrial dysfunction and lymphopenia in DOCK2-deficient patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DOCK2 DEFICIENCY; ACTIVATION		[Alosaimi, Mohammed F.; Beano, Abdallah; Stafstrom, Kelsey; Geha, Raif S.; Chou, Janet] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Alosaimi, Mohammed F.; Beano, Abdallah; Stafstrom, Kelsey; Pai, Sung-Yun; Geha, Raif S.; Chou, Janet] Harvard Med Sch, Boston, MA 02115 USA; [Alosaimi, Mohammed F.] King Saud Univ, Div Allergy Immunol, Dept Pediat, Riyadh, Saudi Arabia; [Shendi, Hiba] Tawam Hosp, Dept Pediat, Div Allergy Immunol, Al Ain, U Arab Emirates; [Shendi, Hiba] Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [El Hawary, Rabab; Meshaal, Safa] Cairo Univ, Fac Med, Clin & Chem Pathol Dept, Cairo, Egypt; [Galal, Nermeen; El-Marsafy, Aisha] Cairo Univ, Dept Pediat, Cairo, Egypt; [Pai, Sung-Yun] Boston Childrens Hosp, Div Hematol Oncol, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; King Saud University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Chou, J (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Chou, J (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	Janet.Chou@childrens.harvard.edu	Elhawary, Rabab/AAQ-9135-2020; Alosaimi, Mohammed F/AAY-5814-2021; Pai, Sung-Yun/AAH-7762-2019	Alosaimi, Mohammed F/0000-0002-8025-3491; Pai, Sung-Yun/0000-0002-0158-8147; Meshaal, Safa/0000-0003-0370-3820; El Hawary, Rabab/0000-0001-6244-0288	National Institute of Allergy and Infectious Diseases (NIAID) [1R01AI139633-01]; Perkin Fund; NIAID [5K08AI116979-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI116979, R01AI139633] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Perkin Fund; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institute of Allergy and Infectious Diseases (NIAID) grant 1R01AI139633-01 (to R.S.G.), the Perkin Fund (to R.S.G.), and NIAID grant 5K08AI116979-03 (to J.C.).	Alizadeh Z, 2018, J CLIN IMMUNOL, V38, P10, DOI 10.1007/s10875-017-0468-5; Capala ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128585; Dobbs K, 2015, NEW ENGL J MED, V372, P2409, DOI 10.1056/NEJMoa1413462; McFadden K, 2016, P NATL ACAD SCI USA, V113, pE782, DOI 10.1073/pnas.1517141113; Nishihara H, 2002, BIOCHEM BIOPH RES CO, V296, P716, DOI 10.1016/S0006-291X(02)00931-2; Rissone A, 2015, J EXP MED, V212, P1185, DOI 10.1084/jem.20141286; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; van Haaften-Visser DY, 2017, J BIOL CHEM, V292, P7904, DOI 10.1074/jbc.M116.772038; Zhang Q, 2014, J EXP MED, V211, P2549, DOI 10.1084/jem.20141307	9	10	10	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					306	+		10.1016/j.jaci.2019.02.020	http://dx.doi.org/10.1016/j.jaci.2019.02.020			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	30826364	Green Accepted, Bronze			2022-12-18	WOS:000473432800032
J	Schroeder, JT; Adeosun, AA; Do, D; Bieneman, AP				Schroeder, John T.; Adeosun, Abiodun A.; Do, Danh; Bieneman, Anja P.			Galectin-3 is essential for IgE-dependent activation of human basophils by A549 lung epithelial cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Schroeder, John T.; Adeosun, Abiodun A.; Do, Danh; Bieneman, Anja P.] Johns Hopkins Univ, Dept Med, Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD 21224 USA; [Adeosun, Abiodun A.] Baylor Coll Sch Med, Dept Pharmacol, Houston, TX USA	Johns Hopkins University; Johns Hopkins Medicine	Schroeder, JT (corresponding author), Johns Hopkins Univ, Dept Med, Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD 21224 USA.	schray@jhmi.edu	C, Danh/I-1527-2019	C, Danh/0000-0002-1065-7140	National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States [AI115703, R21AI121766]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI141486, R01AI115703, R21AI121766] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by Public Health Services Research Grants AI115703 and R21AI121766 to J.T.S. from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States.	Augusto JF, 2018, AUTOIMMUN REV, V17, P361, DOI 10.1016/j.autrev.2017.11.027; De Monte L, 2016, CANCER RES, V76, P1792, DOI 10.1158/0008-5472.CAN-15-1801-T; LIU FT, 1985, P NATL ACAD SCI USA, V82, P4100, DOI 10.1073/pnas.82.12.4100; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Schroeder JT, 2017, J IMMUNOL, V199, P855, DOI 10.4049/jimmunol.1700055; Schroeder M, 2018, MOL VIS, V24, P1; Sciacchitano S, 2018, INT J MOL SCI, V19; Wang AL, 2018, STROKE, V49, P211, DOI 10.1161/STROKEAHA.117.019084	8	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					312	+		10.1016/j.jaci.2019.03.001	http://dx.doi.org/10.1016/j.jaci.2019.03.001			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	30857982	Green Accepted, Bronze			2022-12-18	WOS:000473432800034
J	White, SR; Laxman, B; Naureckas, ET; Hogarth, DK; Solway, J; Sperling, AI; Ober, C				White, Steven R.; Laxman, Bharathi; Naureckas, Edward T.; Hogarth, D. Kyle; Solway, Julian; Sperling, Anne I.; Ober, Carole			Evidence for an IL-6-high asthma phenotype in asthmatic patients of African ancestry	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							OBESITY		[White, Steven R.; Laxman, Bharathi; Naureckas, Edward T.; Hogarth, D. Kyle; Solway, Julian; Sperling, Anne I.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	White, SR (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	swhite@bsd.uchicago.edu	Sperling, Anne/ACZ-2351-2022	Ober, Carole/0000-0003-4626-9809; Sperling, Anne I./0000-0002-4265-9212	National Institute of Allergy and Infectious Diseases [U19-AI-095230]; Office of Research on Women's Health [U19-AI-095230]; National Center for Advancing Translational Sciences [UL1TR000430]; Institute for Translational Medicine of the University of Chicago; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UG1HL139125, T32HL007605] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Institute for Translational Medicine of the University of Chicago; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grant U19-AI-095230 cofunded by the National Institute of Allergy and Infectious Diseases and the Office of Research on Women's Health, by UL1TR000430 from the National Center for Advancing Translational Sciences, and by the Institute for Translational Medicine of the University of Chicago.	Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Croteau-Chonka DC, 2018, OBESITY, V26, P1938, DOI 10.1002/oby.22341; Croteau-Chonka DC, 2017, AM J RESP CRIT CARE, V195, P179, DOI 10.1164/rccm.201601-0107OC; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Kothari PH, 2018, J ALLERGY CLIN IMMUN, V141, P2282, DOI 10.1016/j.jaci.2017.11.057; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Muc M, 2016, NUTR RES REV, V29, P194, DOI 10.1017/S0954422416000111; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nicodemus-Johnson J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90151; Nicodemus-Johnson J, 2013, J ALLERGY CLIN IMMUN, V131, P1496, DOI 10.1016/j.jaci.2013.01.037; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Sharma S, 2014, J ALLERGY CLIN IMMUN, V134, P1153, DOI 10.1016/j.jaci.2014.04.011; Stepanikova I, 2017, AM J PREV MED, V52, pS63, DOI 10.1016/j.amepre.2016.09.026; White SR, 2017, J ALLERGY CLIN IMMUN, V140, P857, DOI 10.1016/j.jaci.2017.02.031	16	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					304	+		10.1016/j.jaci.2019.04.007	http://dx.doi.org/10.1016/j.jaci.2019.04.007			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	31029772	Green Accepted, Bronze			2022-12-18	WOS:000473432800031
J	Barnett, DJM; Mommers, M; Penders, J; Arts, ICW; Thijs, C				Barnett, David J. M.; Mommers, Monique; Penders, John; Arts, Ilja C. W.; Thijs, Carel			Intestinal archaea inversely associated with childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Barnett, David J. M.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Mommers, Monique; Thijs, Carel] Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Dept Epidemiol, Maastricht, Netherlands; [Penders, John] Maastricht Univ, Dept Med Microbiol, Sch Nutr & Translat Res Metab NUTRIM, Care & Publ Hlth Res Inst CAPHRI,Med Ctr, Maastricht, Netherlands; [Arts, Ilja C. W.] Maastricht Univ, Dept Epidemiol, Maastricht Ctr Syst Biol MaCSBio, CARIM Sch Cardiovasc Dis,Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Barnett, DJM (corresponding author), Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands.	david.barnett@maastrichtuniversity.nl	Penders, John/A-1280-2011; Barnett, David J M/AAH-3605-2019; Arts, Ilja CW/C-6946-2008	Penders, John/0000-0001-9146-5919; Barnett, David J M/0000-0003-1961-7206; Arts, Ilja CW/0000-0001-6462-6692; Thijs, Carel/0000-0001-6646-5458	TI Food and Nutrition; Netherlands Organisation for Health Research and Development [2100.0090]; Netherland-America Foundation [3.2.03.48, 3.2.07.022]; Netherlands Heart Foundation [2008B112]; FrieslandCampina; Netherlands Sugar Foundation; Netherlands Ministry of Economic Affairs; Stichting Astma Bestrijding	TI Food and Nutrition; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherland-America Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); FrieslandCampina; Netherlands Sugar Foundation; Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Stichting Astma Bestrijding	The microbiological analysis was partly supported by TI Food and Nutrition. Funding for data collection was received from the Netherlands Organisation for Health Research and Development (grant 2100.0090), the Netherland-America Foundation (grants 3.2.03.48, 3.2.07.022), Stichting Astma Bestrijding, Netherlands Heart Foundation (grant 2008B112), Royal Friesland Foods (currently FrieslandCampina), the Netherlands Sugar Foundation, and the Netherlands Ministry of Economic Affairs.	Bang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099411; Bernatchez E, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13163; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Lecours PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023326; Lurie-Weinberger MN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004833; Mbakwa CA, 2015, OBESITY, V23, P2508, DOI 10.1002/oby.21266; Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09; Poole JA, 2012, ANN ALLERG ASTHMA IM, V109, P93, DOI 10.1016/j.anai.2011.12.014; Stokholm J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02573-2	9	10	10	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2305	+		10.1016/j.jaci.2019.02.009	http://dx.doi.org/10.1016/j.jaci.2019.02.009			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30796982	Green Published, Bronze			2022-12-18	WOS:000470113200040
J	Inoue, H; Hattori, T; Zhou, XX; Etling, EB; Modena, BD; Trudeau, JB; Holguin, F; Wenzel, SE				Inoue, Hideki; Hattori, Takeshi; Zhou, Xiuxia; Etling, Emily B.; Modena, Brian D.; Trudeau, John B.; Holguin, Fernando; Wenzel, Sally E.			Dysfunctional ErbB2, an EGF receptor family member, hinders repair of airway epithelial cells from asthmatic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; epidermal growth factor receptor; erythroblastosis oncogene B2; epithelial cell; wound repair; airway inflammation; cell proliferation; cyclin D1; air-liquid interface culture	GENOME-WIDE ASSOCIATION; GROWTH-FACTOR RECEPTOR; DYSREGULATED REPAIR; KINASE INHIBITOR; IN-VITRO; MECHANISMS; EXPRESSION; CANCER; ACTIVATION; PATHWAY	Background: Genetic and genomic data increasingly point to the airway epithelium as critical to asthma pathogenesis. Epithelial growth factor (EGF) family members play a fundamental role in epithelial differentiation, proliferation, and repair. Although expression of erythroblastosis oncogene B2 (ErbB2) mRNA, an EGF family receptor, was reported to be lower in asthmatic patients, little is understood about its functional role. Objective: We sought to determine whether decreased ErbB2 activation in freshly isolated human airway epithelial cells (HAECs) from asthmatic patients associated with impaired wound closure in vitro. Methods: An in vitro scratch-wound model of air-liquid interface cultured and freshly isolated HAECs were compared between HAECs from healthy control subjects (HCs) and asthmatic patients in relation to ErbB2. Results: Freshly brushed HAECs from asthmatic patients had impaired ErbB2 activation compared with those from HCs. In an in vitro scratch-wound model, HAECs from asthmatic patients showed delayed wound closure compared with HAECs from HCs. Cell proliferation, as assessed based on [H-3] thymidine incorporation after wounding, and expression or activation of ErbB2 and cyclin D1 at the leading edge of the wound were lower in HAECs from asthmatic patients and HCs. A selective ErbB2 tyrosine kinase inhibitor, mubritinib, impaired wound closure and decreased cyclin D1 expression in healthy HAECs, with less effect on cells from asthmatic patients, supporting diminished activity in asthmatic patients. Conclusion: These results implicate a primary defect in the ErbB2 pathway as constraining epithelial repair processes in asthmatic patients. Restoration of homeostatic ErbB2 function should be considered a novel asthma therapeutic target.	[Inoue, Hideki; Hattori, Takeshi; Zhou, Xiuxia; Etling, Emily B.; Trudeau, John B.; Wenzel, Sally E.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15260 USA; [Inoue, Hideki] Showa Univ, Dept Med, Div Pulm & Allergy Med, Sch Med, Tokyo, Japan; [Modena, Brian D.] Scripps Res Inst, Mol & Expt Med, La Jolla, CA USA; [Modena, Brian D.] Scripps Hlth, Dept Allergy Asthma & Immunol, San Diego, CA USA; [Holguin, Fernando] Univ Colorado, Sch Med, Div Med Pulm Sci & Crit Care, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Showa University; Scripps Research Institute; University of Colorado System; University of Colorado Anschutz Medical Campus	Wenzel, SE (corresponding author), 130 Desoto St,4127 Publ Hlth, Pittsburgh, PA 15213 USA.	SWENZEL@pitt.edu		Modena, Brian D/0000-0002-4406-8336; Zhou, Xiuxia/0000-0003-1562-103X; Inoue, Hideki/0000-0002-8624-6524; Wenzel, Sally/0000-0002-4242-0164	National Institutes of Health (NIH) [HL069174, HL064937, AI40600, PO1 AI106684, RR024153]; National Heart, Lung, and Blood Institute (NHLBI) [5U10 HL109152-05]; Japanese Society of Allergology Fellowship; Banyu Fellowship; Sanjyukai Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL144418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106684] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Japanese Society of Allergology Fellowship; Banyu Fellowship; Sanjyukai Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institutes of Health (NIH; HL069174, HL064937, AI40600, PO1 AI106684, and RR024153 to S.E.W.), the National Heart, Lung, and Blood Institute (NHLBI; 5U10 HL109152-05 to S.E.W.), a generous donation from the Dellenback Family (to S.E.W.), the Japanese Society of Allergology Fellowship (to H.I.), a Sanjyukai Fellowship (to H.I.), and a Banyu Fellowship (to T.H.).	[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Booth BW, 2001, AM J RESP CELL MOL, V25, P739, DOI 10.1165/ajrcmb.25.6.4659; Chibana K, 2008, CLIN EXP ALLERGY, V38, P936, DOI 10.1111/j.1365-2222.2008.02969.x; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; DEJONG PM, 1993, IN VITRO CELL DEV-AN, V29A, P379, DOI 10.1007/BF02633985; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Gon Y, 2011, EXP CELL RES, V317, P1947, DOI 10.1016/j.yexcr.2011.05.010; Grainge CL, 2013, CHEST, V144, P1906, DOI 10.1378/chest.12-1944; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jones AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19837-6; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Koziczak M, 2004, J BIOL CHEM, V279, P50004, DOI 10.1074/jbc.M404252200; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu JB, 2002, AM J RESP CELL MOL, V27, P306, DOI 10.1165/rcmb.4850; Maruyama IN, 2014, CELLS-BASEL, V3, P304, DOI 10.3390/cells3020304; Modena BD, 2017, AM J RESP CRIT CARE, V195, P1449, DOI 10.1164/rccm.201607-1407OC; Modena BD, 2014, AM J RESP CRIT CARE, V190, P1363, DOI 10.1164/rccm.201406-1099OC; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nagasawa J, 2006, INT J UROL, V13, P587, DOI 10.1111/j.1442-2042.2006.01342.x; Nicodemus-Johnson J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90151; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Park JA, 2015, NAT MATER, V14, P1040, DOI [10.1038/nmat4357, 10.1038/NMAT4357]; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Puddicombe SM, 2003, AM J RESP CELL MOL, V28, P61, DOI 10.1165/rcmb.4715; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Ramsauer VP, 2006, MOL BIOL CELL, V17, P2931, DOI 10.1091/mbc.E05-09-0895; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Solberg OD, 2012, AM J RESP CRIT CARE, V186, P965, DOI 10.1164/rccm.201201-0027OC; Song GG, 2013, HUM IMMUNOL, V74, P256, DOI 10.1016/j.humimm.2012.11.003; Stevens PT, 2008, CLIN EXP ALLERGY, V38, P1901, DOI 10.1111/j.1365-2222.2008.03093.x; Trudeau J, 2006, J ALLERGY CLIN IMMUN, V117, P1446, DOI 10.1016/j.jaci.2006.01.049; Tyner JW, 2006, J CLIN INVEST, V116, P309, DOI 10.1172/JCI25167; Vermeer PD, 2006, AM J PHYSIOL-LUNG C, V291, pL175, DOI 10.1152/ajplung.00547.2005; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yang IV, 2012, J ALLERGY CLIN IMMUN, V130, P1243, DOI 10.1016/j.jaci.2012.07.052; Yarden Y, 2001, EUR J CANCER, V37, pS3	48	10	11	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2075	+		10.1016/j.jaci.2018.11.046	http://dx.doi.org/10.1016/j.jaci.2018.11.046			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30639343	Green Accepted, Bronze			2022-12-18	WOS:000470113200013
J	Schreiber, J; Broker, BM; Ehmann, R; Bachert, C				Schreiber, Jens; Broeker, Barbara M.; Ehmann, Rainer; Bachert, Claus			Nonatopic severe asthma might still be atopic: Sensitization toward Staphylococcus aureus enterotoxins	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IGE; PROTEINS; DUST		[Schreiber, Jens] Otto Von Guericke Univ, Dept Pneumol, Magdeburg, Germany; [Broeker, Barbara M.] Univ Med Greifswald, Dept Immunol, Inst Immunol & Transfus Med, Greifswald, Germany; [Ehmann, Rainer] Outpatient Pneumol Allergy Ctr BAG, Severe Asthma Ctr, Stuttgart, Germany; [Ehmann, Rainer; Bachert, Claus] Univ Ghent, Upper Airways Res Lab, Ghent, Belgium; [Ehmann, Rainer; Bachert, Claus] Univ Ghent, Dept Otorhinolaryngol, Ghent, Belgium; [Ehmann, Rainer; Bachert, Claus] Ghent Univ Hosp, Ghent, Belgium; [Bachert, Claus] Univ Stockholm, Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden	Otto von Guericke University; Greifswald Medical School; Ghent University; Ghent University; Ghent University; Ghent University Hospital; Karolinska Institutet; Stockholm University	Bachert, C (corresponding author), Univ Ghent, Upper Airways Res Lab, Ghent, Belgium.; Bachert, C (corresponding author), Univ Ghent, Dept Otorhinolaryngol, Ghent, Belgium.; Bachert, C (corresponding author), Ghent Univ Hosp, Ghent, Belgium.; Bachert, C (corresponding author), Univ Stockholm, Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden.	Claus.Bachert@ugent.be	Bröker, Barbara M/O-4850-2015; Bachert, Claus/J-8825-2012	Bröker, Barbara M/0000-0002-5020-8542; 	Novartis Pharma GmbH - Novartis Pharma GmbH	Novartis Pharma GmbH - Novartis Pharma GmbH	The study was supported and funded by Novartis Pharma GmbH, Dr Claudia Mailander. Medical writing services from Dr Maren Klug, employee of KW medipoint, were also funded by Novartis Pharma GmbH.	Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Dzoro S, 2018, ALLERGY, V73, P115, DOI 10.1111/all.13260; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Ludwig S, 2017, SCI TOTAL ENVIRON, V581, P750, DOI 10.1016/j.scitotenv.2017.01.003; Schmidt F, 2017, J PROTEOMICS, V155, P31, DOI 10.1016/j.jprot.2017.01.008; Sorensen M, 2017, ALLERGY, V72, P1548, DOI 10.1111/all.13175; Stentzel S, 2017, J ALLERGY CLIN IMMUN, V139, P492, DOI 10.1016/j.jaci.2016.03.045; Tomassen P, 2013, ALLERGY, V68, P1289, DOI 10.1111/all.12230	9	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2279	+		10.1016/j.jaci.2019.01.018	http://dx.doi.org/10.1016/j.jaci.2019.01.018			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30707972	Bronze			2022-12-18	WOS:000470113200031
J	Bruzzese, JM; Kattan, M				Bruzzese, Jean-Marie; Kattan, Meyer			School-based interventions: Where do we go from here?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; school-based programs; asthma education; case management	COST-EFFECTIVENESS; THERAPY		[Bruzzese, Jean-Marie] Columbia Univ, Sch Nursing, Off Scholarship & Res, New York, NY 10032 USA; [Kattan, Meyer] Columbia Univ, Med Ctr, Dept Pediat, 3959 Broadway,CHC7-701, New York, NY 10032 USA	Columbia University; Columbia University	Kattan, M (corresponding author), Columbia Univ, Med Ctr, Dept Pediat, 3959 Broadway,CHC7-701, New York, NY 10032 USA.	mk2833@cumc.columbia.edu	Bruzzese, Jean-Marie/AAN-1061-2021	Bruzzese, Jean-Marie/0000-0002-1866-488X				Bruzzese JM, 2011, AM J RESP CRIT CARE, V183, P998, DOI 10.1164/rccm.201003-0429OC; Bruzzese JM, 2009, J ALLERGY CLIN IMMUN, V124, P195, DOI 10.1016/j.jaci.2009.05.040; Esty B, 2018, ANN ALLERG ASTHMA IM, V120, P482, DOI 10.1016/j.anai.2018.01.028; Gerald JK, 2019, J ALLERGY CLIN IMMUN, V143, P755, DOI 10.1016/j.jaci.2018.06.048; Gerald JK, 2010, J ALLERGY CLIN IMMUN, V125, P643, DOI 10.1016/j.jaci.2009.12.984; Gerald LB, 2009, PEDIATRICS, V123, P466, DOI 10.1542/peds.2008-0499; Knopf JA, 2016, AM J PREV MED, V51, P114, DOI 10.1016/j.amepre.2016.01.009; Noyes K, 2013, PEDIATRICS, V131, pE709, DOI 10.1542/peds.2012-1883; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Szefler SJ, 2019, J ALLERGY CLIN IMMUN, V143, P746, DOI 10.1016/j.jaci.2018.05.041	10	10	10	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					550	551		10.1016/j.jaci.2018.10.031	http://dx.doi.org/10.1016/j.jaci.2018.10.031			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30395889	Bronze			2022-12-18	WOS:000457718700011
J	Farkas, AM; Baranyi, U; Bohmig, GA; Unger, L; Hopf, S; Wahrmann, M; Regele, H; Mahr, B; Schwarz, C; Hock, K; Pilat, N; Kristo, I; Mraz, J; Lupinek, C; Thalhamer, J; Bond, G; Kuessel, L; Wlodek, E; Martin, J; Clatworthy, M; Pettigrew, G; Valenta, R; Wekerle, T				Farkas, Andreas M.; Baranyi, Ulrike; Boehmig, Georg A.; Unger, Lukas; Hopf, Stefan; Wahrmann, Markus; Regele, Heinz; Mahr, Benedikt; Schwarz, Christoph; Hock, Karin; Pilat, Nina; Kristo, Ivan; Mraz, Jasmin; Lupinek, Christian; Thalhamer, Josef; Bond, Gregor; Kuessel, Lorenz; Wlodek, Elizabeth; Martin, Jack; Clatworthy, Menna; Pettigrew, Gavin; Valenta, Rudolf; Wekerle, Thomas			Allograft rejection is associated with development of functional IgE specific for donor MHC antigens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Transplantation; immunology; alloreactivity; humoral rejection; IgE; donor-specific antibodies	ANTIBODY-MEDIATED REJECTION; BIRCH POLLEN ALLERGEN; FC-EPSILON-RI; HLA ANTIBODIES; RENAL-TRANSPLANTATION; TH2 RESPONSES; MAST-CELLS; KIDNEY; COMPLEMENT; HEART	Background: Donor-specific antibodies of the IgG isotype are measured routinely for diagnostic purposes in renal transplant recipients and are associated with antibody-mediated rejection and long-term graft loss. Objective: This study aimed to investigate whether MHC-specific antibodies of the IgE isotype are induced during allograft rejection. Methods: Anti-MHC/HLA IgE levels were measured in sera of mice grafted with skin or heart transplants from various donor strains and in sera of kidney transplant patients with high levels of HLA IgG. Mediator release was triggered in vitro by stimulating basophils that were coated with murine or human IgE-positive serum, respectively, with specific recombinant MHC/HLA antigens. Kidney tissue samples obtained from organ donors were analyzed by using flow cytometry for cells expressing the high-affinity receptor for IgE (Fc epsilon RI). Results: Donor MHC class I-and MHC class II-specific IgE was found on acute rejection of skin and heart grafts in several murine strain combinations, as well as during chronic antibody-mediated heart graft rejection. Anti-HLA IgE, including donor HLA class I and II specificities, was identified in a group of sensitized transplant recipients. Murine and human anti-MHC/HLA IgE triggered mediator release in coated basophils on stimulation with specific MHC/HLA antigens. HLA-specific IgE was not linked to atopy, and allergen-specific IgE present in allergic patients did not cross-react with HLA antigens. FceRI(+) cells were found in the human renal cortex and medulla and provide targets for HLA-specific IgE. Conclusion: These results demonstrate that MHC/HLA-specific IgE develops during an alloresponse and is functional in mediating effector mechanisms.	[Farkas, Andreas M.; Baranyi, Ulrike; Unger, Lukas; Hopf, Stefan; Mahr, Benedikt; Schwarz, Christoph; Hock, Karin; Pilat, Nina; Kristo, Ivan; Mraz, Jasmin; Wekerle, Thomas] Med Univ Vienna, Dept Surg, Sect Transplantat Immunol, Waehringer Guertel 18, A-1090 Vienna, Austria; [Baranyi, Ulrike] Med Univ Vienna, Cardiac Surg Lab, Vienna, Austria; [Boehmig, Georg A.; Wahrmann, Markus; Bond, Gregor] Med Univ Vienna, Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria; [Regele, Heinz] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Lupinek, Christian; Valenta, Rudolf] Med Univ Vienna, Ctr Physiol & Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Kuessel, Lorenz] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Thalhamer, Josef] Univ Salzburg, Dept Mol Biol, Salzburg, Austria; [Wlodek, Elizabeth; Martin, Jack; Pettigrew, Gavin] Univ Cambridge, Dept Surg, Cambridge, England; [Clatworthy, Menna] Univ Cambridge, Dept Med, Cambridge, England	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Salzburg University; University of Cambridge; University of Cambridge	Wekerle, T (corresponding author), Med Univ Vienna, Dept Surg, Sect Transplantat Immunol, Waehringer Guertel 18, A-1090 Vienna, Austria.	Thomas.Wekerle@meduniwien.ac.at	Pilat, Nina/H-7940-2019; Thalhamer, Josef/E-5787-2011; Unger, Lukas/I-8768-2019; Lupinek, Christian/I-3311-2019	Pilat, Nina/0000-0003-4071-9397; Thalhamer, Josef/0000-0003-2285-6400; Unger, Lukas/0000-0002-8423-2268; Lupinek, Christian/0000-0002-8612-8245; bond, gregor/0000-0003-0440-3053; Kristo, Ivan/0000-0001-7999-1625; Wahrmann, Markus/0000-0002-1301-8694; Valenta, Rudolf/0000-0001-5944-3365; Schwarz, Christoph/0000-0002-7676-2779; Hopf, Stefan/0000-0001-7930-9526; Baranyi, Ulrike/0000-0002-6327-3052	Austrian Science Fund (FWF) [TRP151-B19, W1212, P21989-B11, F4605]; Medical Scientific Fund of the Mayor of the City of Vienna [13051]; Government of the Russian Federation [14.W03.31.0024]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Scientific Fund of the Mayor of the City of Vienna; Government of the Russian Federation	Supported by the Austrian Science Fund (FWF; projects TRP151-B19 and W1212 to T.W., project P21989-B11 to U.B, and project F4605 to R.V.) and the Medical Scientific Fund of the Mayor of the City of Vienna (project 13051 to T.W.). R.V. is recipient of a Megagrant of the Government of the Russian Federation (grant no. 14.W03.31.0024).	Ali JM, 2016, CELL REP, V14, P1232, DOI 10.1016/j.celrep.2015.12.099; Aubert O, 2017, J AM SOC NEPHROL, V28, P1912, DOI 10.1681/ASN.2016070797; Bartel G, 2013, TRANSPL INT, V26, P121, DOI 10.1111/tri.12000; Brandacher G, 1998, EUR SURG RES, V30, P52; Caillard S, 2017, TRANSPL INT, V30, P29, DOI 10.1111/tri.12864; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Conlon TM, 2012, J IMMUNOL, V188, P2643, DOI 10.4049/jimmunol.1102830; DEMEULEMESTER C, 1986, IMMUNOLOGY, V57, P617; Dijke EI, 2016, J HEART LUNG TRANSPL, V35, P704, DOI 10.1016/j.healun.2016.01.1232; Doran TJ, 1999, TRANSPLANTATION, V67, P309, DOI 10.1097/00007890-199901270-00022; El-Refaie AMA, 2005, HISTOPATHOLOGY, V47, P375, DOI 10.1111/j.1365-2559.2005.02239.x; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Goldman M, 2001, TRENDS IMMUNOL, V22, P247, DOI 10.1016/S1471-4906(01)01893-2; Guidicelli G, 2016, J AM SOC NEPHROL, V27, P615, DOI 10.1681/ASN.2014040326; Haeryfar SMM, 2008, TRANSPLANTATION, V86, P460, DOI 10.1097/TP.0b013e3181806b72; Harper IG, 2016, CELL REP, V15, P1214, DOI 10.1016/j.celrep.2016.04.009; Hartl A, 2004, ALLERGY, V59, P65, DOI 10.1046/j.1398-9995.2003.00335.x; Henault J, 2016, NAT IMMUNOL, V17, P196, DOI 10.1038/ni.3326; Hickey MJ, 2016, FRONT IMMUNOL, V7; Ishida T, 2005, CLIN TRANSPLANT, V19, P817, DOI 10.1111/j.1399-0012.2005.00427.x; Khovanova N, 2015, TRANSPL INT, V28, P1405, DOI 10.1111/tri.12648; Kishimoto K, 2000, J CLIN INVEST, V106, P63, DOI 10.1172/JCI9586; Kussel L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13275-6; Laffer S, 2001, J ALLERGY CLIN IMMUN, V108, P409, DOI 10.1067/mai.2001.117593; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lefaucheur C, 2016, J AM SOC NEPHROL, V27, P293, DOI 10.1681/ASN.2014111120; Lefaucheur C, 2013, LANCET, V381, P313, DOI 10.1016/S0140-6736(12)61265-3; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Levine DJ, 2016, J HEART LUNG TRANSPL, V35, P397, DOI 10.1016/j.healun.2016.01.1223; Liu Q, 2016, J CLIN INVEST, V126, P2805, DOI 10.1172/JCI84577; Lomago J, 2010, HUM IMMUNOL, V71, P176, DOI 10.1016/j.humimm.2009.11.013; Loupy A, 2016, AM J TRANSPLANT, V16, P111, DOI 10.1111/ajt.13529; Loupy A, 2013, NEW ENGL J MED, V369, P1215, DOI 10.1056/NEJMoa1302506; Loupy A, 2012, NAT REV NEPHROL, V8, P348, DOI 10.1038/nrneph.2012.81; Loveless MH, 1943, J IMMUNOL, V47, P165; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Lupinek C, 2009, J IMMUNOL, V182, P4817, DOI 10.4049/jimmunol.0800726; Marino J, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8759; Marrari M, 2010, TRANSPLANTATION, V90, P1468, DOI 10.1097/TP.0b013e3182007b74; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; O'Leary JG, 2014, AM J TRANSPLANT, V14, P779, DOI 10.1111/ajt.12667; PROUVOSTDANON A, 1977, IMMUNOCHEMISTRY, V14, P81, DOI 10.1016/0019-2791(77)90284-1; PROUVOSTDANON A, 1980, MOL IMMUNOL, V17, P247, DOI 10.1016/0161-5890(80)90077-2; Rauter I, 2006, FASEB J, V20, P967, DOI 10.1096/fj.05-3999fje; Richter R, 2016, TRANSPL INT, V29, P988, DOI 10.1111/tri.12786; Sadeghi M, 2003, CLIN TRANSPLANT, V17, P151, DOI 10.1034/j.1399-0012.2003.00037.x; Schwaiger E, 2014, TRANSPLANTATION, V97, P1279, DOI 10.1097/01.TP.0000441091.47464.c6; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Shiu KY, 2017, KIDNEY INT, V91, P477, DOI 10.1016/j.kint.2016.10.009; Sicard A, 2015, J AM SOC NEPHROL, V26, P457, DOI 10.1681/ASN.2013101144; Smith JD, 2011, AM J TRANSPLANT, V11, P312, DOI 10.1111/j.1600-6143.2010.03383.x; Stegall MD, 2012, NAT REV NEPHROL, V8, P670, DOI 10.1038/nrneph.2012.212; Surquin M, 2005, TRANSPLANTATION, V80, P1485, DOI 10.1097/01.tp.0000176486.01697.3f; Surquin M, 2002, J IMMUNOL, V169, P500, DOI 10.4049/jimmunol.169.1.500; Tay SS, 2009, CURR OPIN ORGAN TRAN, V14, P16, DOI 10.1097/MOT.0b013e32831ebdf5; Theoharides TC, 2015, NEW ENGL J MED, V373, P163, DOI 10.1056/NEJMra1409760; Tsiantoulas D, 2017, CIRC RES, V120, P78, DOI 10.1161/CIRCRESAHA.116.309606; Valenta R, 2009, TRENDS IMMUNOL, V30, P109, DOI 10.1016/j.it.2008.12.004; Valenzuela NM, 2017, J CLIN INVEST, V127, P2492, DOI 10.1172/JCI90597; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; VRTALA S, 1993, J IMMUNOL, V151, P4773; Wade JA, 2007, BLOOD, V109, P4064, DOI 10.1182/blood-2006-06-032193; Wang H, 2003, J IMMUNOL, V171, P3823, DOI 10.4049/jimmunol.171.7.3823; Wekerle T, 2017, LANCET, V389, P2152, DOI 10.1016/S0140-6736(17)31283-7; Wiebe C, 2015, AM J TRANSPLANT, V15, P2921, DOI 10.1111/ajt.13347; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Wu LC, 2014, NAT REV IMMUNOL, V14, P247, DOI 10.1038/nri3632; YOUSEM SA, 1992, HUM PATHOL, V23, P1172, DOI 10.1016/0046-8177(92)90036-3	69	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					335	+		10.1016/j.jaci.2018.06.034	http://dx.doi.org/10.1016/j.jaci.2018.06.034			23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30009843	Green Published, hybrid			2022-12-18	WOS:000454918300037
J	Mauger, D; Apter, AJ				Mauger, David; Apter, Andrea J.			Indirect treatment comparisons and biologics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; biologic; monoclonal antibody; benralizumab; reslizumab; systematic analysis	ASTHMA		[Mauger, David] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Apter, Andrea J.] Univ Penn, Perelman Sch Med, Div Pulm Allergy Crit Care Med, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; Pennsylvania Medicine	Apter, AJ (corresponding author), 829 Gates HUP,3600 Spruce St, Philadelphia, PA 19104 USA.	andrea.apter@uphs.upenn.edu						Busse W, 2019, J ALLERGY CLIN IMMUN, V143, P190, DOI 10.1016/j.jaci.2018.08.031; Busse WW, 2012, J ALLERGY CLIN IMMUN, V129, pS1, DOI 10.1016/j.jaci.2011.12.985; Casale TB, 2019, J ALLER CL IMM-PRACT, V7, P122, DOI 10.1016/j.jaip.2018.08.036; Chu EK, 2005, AM J RESP CRIT CARE, V171, P1202, DOI 10.1164/rccm.200502-257OE; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Manka LA, 2018, ANN ALLERG ASTHMA IM, V121, P406, DOI 10.1016/j.anai.2018.07.033; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Rouse B, 2017, INTERN EMERG MED, V12, P103, DOI 10.1007/s11739-016-1583-7	9	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					84	86		10.1016/j.jaci.2018.11.005	http://dx.doi.org/10.1016/j.jaci.2018.11.005			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30612667	Bronze			2022-12-18	WOS:000454918300010
J	Toivonen, L; Forsstrom, V; Waris, M; Peltola, V				Toivonen, Laura; Forsstrom, Ville; Waris, Matti; Peltola, Ville			Acute respiratory infections in early childhood and risk of asthma at age 7 years	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EARLY-LIFE; SCHOOL-AGE; COHORT		[Toivonen, Laura; Forsstrom, Ville; Peltola, Ville] Turku Univ Hosp, Dept Paediat & Adolescent Med, Turku, Finland; [Toivonen, Laura; Forsstrom, Ville; Peltola, Ville] Univ Turku, Turku, Finland; [Waris, Matti] Univ Turku, Dept Virol, Turku, Finland	University of Turku; University of Turku; University of Turku	Toivonen, L (corresponding author), Turku Univ Hosp, Dept Paediat & Adolescent Med, Turku, Finland.; Toivonen, L (corresponding author), Univ Turku, Turku, Finland.	laura.toivonen@utu.fi	Waris, Matti E/A-6418-2008		University of Turku; Abo Akademi University; Turku University Hospital; Academy of Finland [123571, 140251, 277535]; Foundation for Pediatric Research; University of Turku Graduate School; Finnish Cultural Foundation; Finnish Medical Foundation; Paivikki and Sakari Sohlberg Foundation; Hospital District of Southwest Finland; Research Foundation of the Pulmonary Diseases; Orion Research Foundation sr; Tampere Tuberculosis Foundation; Foundation of the Finnish Anti-Tuberculosis Association; Turunmaa Duodecim Society	University of Turku; Abo Akademi University; Turku University Hospital; Academy of Finland(Academy of Finland); Foundation for Pediatric Research; University of Turku Graduate School; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Medical Foundation; Paivikki and Sakari Sohlberg Foundation; Hospital District of Southwest Finland; Research Foundation of the Pulmonary Diseases; Orion Research Foundation sr; Tampere Tuberculosis Foundation; Foundation of the Finnish Anti-Tuberculosis Association; Turunmaa Duodecim Society	This work was supported by the University of Turku, the Abo Akademi University, the Turku University Hospital, the Academy of Finland (grant nos. 123571, 140251, and 277535), the Foundation for Pediatric Research, the University of Turku Graduate School, the Finnish Cultural Foundation, the Finnish Medical Foundation, Paivikki and Sakari Sohlberg Foundation, research funds from specified government transfers, Hospital District of Southwest Finland, the Research Foundation of the Pulmonary Diseases, Orion Research Foundation sr, Tampere Tuberculosis Foundation, Foundation of the Finnish Anti-Tuberculosis Association, and Turunmaa Duodecim Society. The funding sources had no involvement in the conduct of the research or the preparation of the article.	Bonnelykke K, 2015, J ALLERGY CLIN IMMUN, V136, P81, DOI 10.1016/j.jaci.2015.02.024; Feldman AS, 2015, AM J RESP CRIT CARE, V191, P34, DOI 10.1164/rccm.201405-0901PP; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Jokela P, 2015, J CLIN VIROL, V70, P72, DOI 10.1016/j.jcv.2015.07.294; Kusel MMH, 2012, EUR RESPIR J, V39, P876, DOI 10.1183/09031936.00193310; Lagstrom H, 2013, INT J EPIDEMIOL, V42, P1273, DOI 10.1093/ije/dys150; Nafstad P, 2005, PEDIATRICS, V116, pE255, DOI 10.1542/peds.2004-2785; Osterback R, 2013, J CLIN MICROBIOL, V51, P3960, DOI 10.1128/JCM.01646-13; Rantala AK, 2015, AM J EPIDEMIOL, V182, P615, DOI 10.1093/aje/kwv093; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Toivonen L, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1309; Toivonen L, 2015, J CLIN VIROL, V62, P8, DOI 10.1016/j.jcv.2014.11.018; van Meel ER, 2018, THORAX, V73, P167, DOI 10.1136/thoraxjnl-2017-210149; Waris M, 2013, J CLIN VIROL, V58, P200, DOI 10.1016/j.jcv.2013.06.002	14	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					407	+		10.1016/j.jaci.2018.08.025	http://dx.doi.org/10.1016/j.jaci.2018.08.025			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30194991	Bronze			2022-12-18	WOS:000454918300046
J	Weston, CA; Rana, BMJ; Cousins, DJ				Weston, Cathryn A.; Rana, Batika M. J.; Cousins, David J.			Differential expression of functional chemokine receptors on human blood and lung group 2 innate lymphoid cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Weston, Cathryn A.; Cousins, David J.] Univ Leicester, Dept Infect Immun & Inflammat, NIHR Leicester Biomed Res Ctr Resp, Leicester Inst Lung Hlth, Leicester, Leics, England; [Rana, Batika M. J.; Cousins, David J.] Kings Coll London, MRC & Asthma UK Ctr Allerg Mech Asthma, London, England; [Rana, Batika M. J.] MRC Lab Mol Biol, Cambridge, England	University of Leicester; University of London; King's College London; MRC Laboratory Molecular Biology	Cousins, DJ (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, NIHR Leicester Biomed Res Ctr Resp, Leicester Inst Lung Hlth, Leicester, Leics, England.; Cousins, DJ (corresponding author), Kings Coll London, MRC & Asthma UK Ctr Allerg Mech Asthma, London, England.	dc282@leicester.ac.uk		Cousins, David/0000-0003-3821-9596				D'Ambrosio D, 2001, AM J RESP CRIT CARE, V164, P1266, DOI 10.1164/ajrccm.164.7.2103011; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pilette C, 2004, EUR RESPIR J, V23, P876, DOI 10.1183/09031936.04.00102504; Slack RJ, 2012, BRIT J PHARMACOL, V166, P1774, DOI 10.1111/j.1476-5381.2012.01901.x; Smith SG, 2016, J ALLERGY CLIN IMMUN, V137, P75, DOI 10.1016/j.jaci.2015.05.037; Soriani A, 2018, CYTOKINE GROWTH F R, V42, P47, DOI 10.1016/j.cytogfr.2018.02.003; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365	11	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					410	+		10.1016/j.jaci.2018.08.030	http://dx.doi.org/10.1016/j.jaci.2018.08.030			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30205185	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000454918300047
J	de Sio, FRS; Passerini, L; Restelli, S; Valente, MM; Pramov, A; Maccari, ME; Sanvito, F; Roncarolo, MG; Porteus, M; Bacchetta, R				de Sio, Francesca R. Santoni; Passerini, Laura; Restelli, Silvia; Valente, Maria Maddalena; Pramov, Aleksandar; Maccari, Maria Elena; Sanvito, Francesca; Roncarolo, Maria Grazia; Porteus, Matthew; Bacchetta, Rosa			Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Forkhead box P3; effector T cells; regulatory T cells; immune tolerance; humanized mice; T-cell differentiation; immune dysregulation; polyendocrinopathy; enteropathy; X-linked syndrome; autoimmunity	GENOME-WIDE IDENTIFICATION; LINKED SYNDROME IPEX; HUMAN FOXP3; IMMUNE DYSREGULATION; ENTEROPATHY; POLYENDOCRINOPATHY; BLOOD; PROLIFERATION; AUTOIMMUNITY; TRANSDUCTION	Background: Forkhead box P3 (FOXP3) is a key transcription factor in regulatory T (Treg) cell function. FOXP3 gene mutations cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, a fatal autoimmune syndrome. FOXP3 has also been proposed to act in effector T (Teff) cells, but to date, this role has not been confirmed. Objective: We sought to evaluate the effect of reduced FOXP3 expression on human Treg and Teff cell development and correlate it with IPEX syndrome immune pathology. Methods: We developed a model of humanized mice (huMice) in which the human hematopoietic system is stably knocked down or knocked out for the FOXP3 gene (knockdown [KD]/knockout [KO] huMice). Results: Because FOXP3-KD/KO was not 100% effective, residual FOXP3 expression in hematopoietic stem progenitor cells was sufficient to give rise to Treg cells with normal expression of FOXP3. However, numerous defects appeared in the Teff cell compartment. Compared with control mice, FOXP3-KD/KO huMice showed altered thymocyte differentiation, with KD/KO thymocytes displaying significantly reduced T-cell receptor (TCR) signaling strength and increased TCR repertoire diversity. Peripheral KD/KO Teff cells were expanded and showed signs of homeostatic proliferation, such as a significantly contracted TCR repertoire, a severely reduced naive compartment, decreased telomeric repeat-binding factor 2 expression, and a skew toward a T(H)2 profile, resembling an aged immune system. Consistent with results in FOXP3-KD/KO huMice, analysis of patients with IPEX syndrome provided evidence of defects in the Teff cell compartment at both the thymic and peripheral levels. Conclusions: These findings support an intrinsic role for human FOXP3 in controlling thymocyte maturation and peripheral expansion of Teff cells and reveal a previously undescribed pathogenic mechanism through an altered Teff cell compartment in patients with IPEX syndrome.	[de Sio, Francesca R. Santoni; Passerini, Laura; Restelli, Silvia; Valente, Maria Maddalena; Bacchetta, Rosa] San Raffaele Telethon Inst Gene Therapy, Milan, Italy; [Pramov, Aleksandar] IRCCS San Raffaele Sci Inst, Div Pathol, Milan, Italy; [Maccari, Maria Elena] San Raffaele Vita Salute Univ, Univ Ctr Stat Biomed Sci CUSSB, Milan, Italy; [Sanvito, Francesca] San Raffaele Vita Salute Univ, Sch Med, Milan, Italy; [Roncarolo, Maria Grazia; Porteus, Matthew; Bacchetta, Rosa] Stanford Sch Med, Dept Pediat, Div Stem Cell Transplantat & Regenerat Med, Stanford, CA USA; [Roncarolo, Maria Grazia; Porteus, Matthew] Stanford Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; Stanford University; Stanford University	de Sio, FRS (corresponding author), Via Olgettina 58, I-20132 Milan, Italy.; Bacchetta, R (corresponding author), Dept Pediat, Div Stem Cell Transplantat & Regenerat Med, 265 Campus Dr,Lokey Stem Cell Bldg,G3015, Stanford, CA 94305 USA.	santonidesio.francesca@hsr.it; rosab@stanford.edu	Passerini, Laura/J-7791-2016; Valente, Maria maddalena/AAN-2934-2020; de Sio, Francesca Santoni/AAF-3432-2020	Passerini, Laura/0000-0002-4020-7386; Santoni de Sio, Francesca Romana/0000-0002-6522-0499; Sanvito, Francesca/0000-0002-4046-8420; Maccari, Maria Elena/0000-0001-6488-7622	Telethon [Tele10-A4]; Seventh Framework Project of the European Community (CellPID); NIH-R21 [AI123896-01A1]; Italian Ministry of Health [GR-2010-2317550]	Telethon(Fondazione Telethon); Seventh Framework Project of the European Community (CellPID); NIH-R21(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Health(Ministry of Health, Italy)	Supported by Telethon (Tele10-A4 to R.B.), Seventh Framework Project of the European Community (CellPID to R.B.), NIH-R21 (AI123896-01A1 to R.B.), and the Italian Ministry of Health (GR-2010-2317550 to F.R.S.d.S.).	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Alroqi FJ, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0606-9; Amendola M, 2009, MOL THER, V17, P1039, DOI 10.1038/mt.2009.48; Moro-Garcia MA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00107; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bacchetta R, 2018, ANN NY ACAD SCI, V1417, P5, DOI 10.1111/nyas.13011; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brombin C., 2013, PERMUTATION TESTS SH; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; De Palma M, 2002, METHOD ENZYMOL, V346, P514; Dean J, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0238-z; Delacher M, 2014, CURR TOP MICROBIOL, V381, P83, DOI 10.1007/82_2014_373; Di Nunzio S, 2009, BLOOD, V114, P4138, DOI 10.1182/blood-2009-04-214593; Diotti R, 2011, NUCLEUS-PHILA, V2, P119, DOI 10.4161/nucl.2.2.15135; Duff MO, 2015, NATURE, V521, P376, DOI 10.1038/nature14475; Fleskens V, 2016, ONCOGENE, V35, P4141, DOI 10.1038/onc.2015.481; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Frattini V, 2012, ONCOTARGET, V3, P1146; Fu G, 2014, TRENDS IMMUNOL, V35, P311, DOI 10.1016/j.it.2014.05.003; Fulop T, 2003, ARTHRITIS RES THER, V5, P290, DOI 10.1186/ar1019; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Goronzy JJ, 2012, CELL MOL LIFE SCI, V69, P1615, DOI 10.1007/s00018-012-0970-0; Grimbacher Bodo, 2016, J Allergy Clin Immunol, V137, P3, DOI 10.1016/j.jaci.2015.11.004; Guazzi V, 2002, CLIN EXP IMMUNOL, V129, P346, DOI 10.1046/j.1365-2249.2002.01893.x; Halkias J, 2015, IMMUNOL CELL BIOL, V93, P716, DOI 10.1038/icb.2015.38; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Lampasona V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078664; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Long SA, 2011, J IMMUNOL, V187, P3511, DOI 10.4049/jimmunol.1003880; Martin F, 2010, ONCOGENE, V29, P4121, DOI 10.1038/onc.2010.174; McMurchy AN, 2013, BLOOD, V121, P1265, DOI 10.1182/blood-2012-05-431023; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nieves DS, 2004, ARCH DERMATOL, V140, P466, DOI 10.1001/archderm.140.4.466; Passerini L, 2011, J ALLERGY CLIN IMMUN, V128, P1376, DOI 10.1016/j.jaci.2011.09.010; Pinheiro J., 2000, MIXED EFFECTS MODELS; R Development Core Team, 2011, R LANG ENV STAT COMP; Reis M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00500; Sadlon TJ, 2010, J IMMUNOL, V185, P1071, DOI 10.4049/jimmunol.1000082; Salmaso L, 2005, NPC TEST 2 0 STAT SO; de Sio FRS, 2008, STEM CELLS, V26, P2142, DOI 10.1634/stemcells.2007-0705; Seidel MG, 2009, BLOOD, V113, P5689, DOI 10.1182/blood-2009-02-206359; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Singh N, 2007, BLOOD, V110, P1199, DOI 10.1182/blood-2006-10-054585; Stewart JJ, 1997, MOL IMMUNOL, V34, P1067, DOI 10.1016/S0161-5890(97)00130-2; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tubo NJ, 2014, TRENDS IMMUNOL, V35, P591, DOI 10.1016/j.it.2014.09.008; Tuovinen H, 2008, IMMUNOL CELL BIOL, V86, P523, DOI 10.1038/icb.2008.36; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zama D, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0068-4; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	58	10	11	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1909	+		10.1016/j.jaci.2018.03.015	http://dx.doi.org/10.1016/j.jaci.2018.03.015			22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	29705245	Bronze			2022-12-18	WOS:000452315800024
J	Kelly, SM; Karsh, J; Marcelo, J; Boeckh, D; Stepner, N; Santone, B; Yang, J; Yang, WH				Kelly, Suzanne M.; Karsh, Jacob; Marcelo, Jennifer; Boeckh, Douglas; Stepner, Nate; Santone, Bryan; Yang, Jimmy; Yang, William H.			Fel d 1 and Fel d 4 levels in cat fur, saliva, and urine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IMMUNOLOGICAL CHARACTERIZATION; LIPOCALIN; ALLERGENS; CLONING		[Kelly, Suzanne M.; Karsh, Jacob; Marcelo, Jennifer; Stepner, Nate; Santone, Bryan; Yang, Jimmy; Yang, William H.] Red Maple Trials, Ottawa, ON, Canada; [Boeckh, Douglas] Merivale Cat Hosp, Ottawa, ON, Canada		Kelly, SM (corresponding author), Red Maple Trials, Ottawa, ON, Canada.	skelly@redmapletrials.com			Red Maple Trials	Red Maple Trials	This research was funded by Red Maple Trials.	ANDERSON MC, 1985, J ALLERGY CLIN IMMUN, V76, P563, DOI 10.1016/0091-6749(85)90776-6; Konieczny A, 1997, IMMUNOLOGY, V92, P577, DOI 10.1046/j.1365-2567.1997.00386.x; Peters S, 2001, J ALLERGY CLIN IMMUN, V108, P652, DOI 10.1067/mai.2001.118788; Smith W, 2004, CLIN EXP ALLERGY, V34, P1732, DOI 10.1111/j.1365-2222.2004.02090.x; Thavathiru E, 1999, EUR J BIOCHEM, V266, P467, DOI 10.1046/j.1432-1327.1999.00884.x; Torres JA, 2014, J BIOL CHEM, V289, P23382, DOI 10.1074/jbc.M114.579060; Ukleja-Sokolowska N, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0167-4; Virtanen T, 2012, CLIN EXP ALLERGY, V42, P494, DOI 10.1111/j.1365-2222.2011.03903.x; Zahradnik E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00076	9	10	11	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1990	+		10.1016/j.jaci.2018.07.033	http://dx.doi.org/10.1016/j.jaci.2018.07.033			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30176277	Bronze			2022-12-18	WOS:000452315800037
J	Marsh, RA; Hebert, KM; Keesler, D; Boelens, JJ; Dvorak, CC; Eckrich, MJ; Kapoor, N; Parikh, S; Eapen, M				Marsh, Rebecca A.; Hebert, Kyle M.; Keesler, Daniel; Boelens, Jaap J.; Dvorak, Christopher C.; Eckrich, Michael J.; Kapoor, Neena; Parikh, Suhag; Eapen, Mary			Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RECONSTITUTION; SURVIVAL		[Marsh, Rebecca A.] Cincinnati Childrens Hosp, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Hebert, Kyle M.; Keesler, Daniel; Eapen, Mary] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Boelens, Jaap J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, SCT & Cellular Therapy Program, 1275 York Ave, New York, NY 10021 USA; [Dvorak, Christopher C.] Univ Calif San Francisco, Div Pediat Allergy Immunol & Bone Marrow Transpla, Benioff Childrens Hosp, San Francisco, CA 94143 USA; [Eckrich, Michael J.] Texas Transplant Inst, Pediat Blood & Marrow Stem Cell Transplantat Prog, San Antonio, TX USA; [Kapoor, Neena] Childrens Hosp Los Angeles, Blood & Marrow Transplant Lab, Los Angeles, CA 90027 USA; [Parikh, Suhag] Duke Univ, Med Ctr, Div Pediat Blood & Marrow Transplantat, Durham, NC USA	Cincinnati Children's Hospital Medical Center; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; Children's Hospital Los Angeles; Duke University	Marsh, RA (corresponding author), Cincinnati Childrens Hosp, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA.	Rebecca.Marsh@cchmc.org	Dvorak, Christopher C/AAX-1630-2020	Dvorak, Christopher C/0000-0002-6146-3952; Parikh, Suhag/0000-0002-6066-9852; Eapen, Mary/0000-0001-6193-4243	Public Health Service Grant from the National Cancer Institute (NCI) [5U24-CA076518]; National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases; NHLBI [5U10HL0692940]; NCI [5U10HL0692940]; Health Resources and Services Administration (HRSA/Department of Health and Human Services) [HHSH250201200016C]; Office of Naval Research [N00014-15-1-0848, N00014-16-1-2020]; NATIONAL CANCER INSTITUTE [U24CA076518] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL069294] Funding Source: NIH RePORTER	Public Health Service Grant from the National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Health Resources and Services Administration (HRSA/Department of Health and Human Services); Office of Naval Research(Office of Naval Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The CIBMTR is supported primarily by Public Health Service Grant 5U24-CA076518 from the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases; by the NHLBI and NCI (grant no. 5U10HL0692940); a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/Department of Health and Human Services); and the Office of Naval Research (grant nos. N00014-15-1-0848 and N00014-16-1-2020). The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration, or any other agency of the US government.	Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; BACH FH, 1968, LANCET, V2, P1364; GATTI RA, 1968, LANCET, V2, P1366; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Heimall J, 2017, BLOOD, V130, P2718, DOI 10.1182/blood-2017-05-781849; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Moratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Schuetz C, 2014, BLOOD, V123, P281, DOI 10.1182/blood-2013-01-476432	9	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					2004	2007		10.1016/j.jaci.2018.08.010	http://dx.doi.org/10.1016/j.jaci.2018.08.010			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30170121	Green Accepted, Bronze			2022-12-18	WOS:000452315800043
J	Mathiesen, CBK; Carlsson, MC; Brand, S; Moller, SR; Idorn, M; Straten, PT; Pedersen, AE; Dabelsteen, S; Halim, A; Wurtzen, PA; Brimnes, J; Ipsen, H; Petersen, BL; Wandall, HH				Mathiesen, Caroline B. K.; Carlsson, Michael C.; Brand, Stephanie; Moller, Svenning Rune; Idorn, Manja; Straten, Per Thor; Pedersen, Anders E.; Dabelsteen, Sally; Halim, Adnan; Wurtzen, Peter Adler; Brimnes, Jens; Ipsen, Henrik; Petersen, Bent L.; Wandall, Hans H.			Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DENDRITIC CELLS; STRATEGY		[Mathiesen, Caroline B. K.; Carlsson, Michael C.; Dabelsteen, Sally; Halim, Adnan; Wandall, Hans H.] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Copenhagen, Denmark; [Mathiesen, Caroline B. K.; Carlsson, Michael C.; Dabelsteen, Sally; Halim, Adnan; Wandall, Hans H.] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Moller, Svenning Rune; Petersen, Bent L.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Biol, Glyco sect, Copenhagen, Denmark; [Straten, Per Thor; Pedersen, Anders E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Copenhagen, Denmark; [Straten, Per Thor; Pedersen, Anders E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Copenhagen, Denmark; [Brand, Stephanie; Wurtzen, Peter Adler; Brimnes, Jens; Ipsen, Henrik] ALK Abello, Global Res, Horsholm, Denmark; [Idorn, Manja; Straten, Per Thor] Herlev Gentofte Hosp, Dept Hematol, Ctr Canc Immune Therapy, Herlev, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; ALK-Abello AS	Wandall, HH (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Copenhagen, Denmark.; Wandall, HH (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark.	hhw@sund.ku.dk	Idorn, Manja/AAY-6260-2021; Mathiesen, Caroline B K/AAM-7156-2020; Petersen, Bent Larsen/H-9437-2014; moller, svenning rune/O-9048-2016	Idorn, Manja/0000-0002-6769-9165; Wandall, Hans H./0000-0003-0240-9232; Petersen, Bent Larsen/0000-0002-2004-9077; Dabelsteen, Sally/0000-0002-4279-8060; moller, svenning rune/0000-0003-0392-4631; thor Straten, Per/0000-0002-4731-4969; Halim, Adnan/0000-0003-1629-187X	Danish Research Councils [1331-00133B]; University of Copenhagen [CDO2016: 2016CDO04210]; Danish National Research Foundation [DNRF107]; Carl Emil Friis og hustru Olga Doris Friis Foundation; Lundbeck Foundation; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Kirsten og Freddy Johansen Fonden; Mizutani Foundation; Novo Nordisk Foundation	Danish Research Councils(Det Frie Forskningsrad (DFF)); University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Carl Emil Friis og hustru Olga Doris Friis Foundation; Lundbeck Foundation(Lundbeckfonden); A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Kirsten og Freddy Johansen Fonden; Mizutani Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Supported in part by the Danish Research Councils (1331-00133B); a program of excellence 2016 (CDO2016: 2016CDO04210) from the University of Copenhagen; the Danish National Research Foundation (DNRF107); the Carl Emil Friis og hustru Olga Doris Friis Foundation; the Lundbeck Foundation; the A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal, Kirsten og Freddy Johansen Fonden, Mizutani Foundation; and the Novo Nordisk Foundation.	Halim A, 2015, MOL CELL PROTEOMICS, V14, P191, DOI 10.1074/mcp.M114.042614; Jutel M, 2016, ALLERGY ASTHMA IMMUN, V8, P191, DOI 10.4168/aair.2016.8.3.191; Kitzmuller C, 2018, J ALLERGY CLIN IMMUN, V141, P293, DOI 10.1016/j.jaci.2017.02.044; Lo-Man R, 2001, J IMMUNOL, V166, P2849, DOI 10.4049/jimmunol.166.4.2849; Macri C, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.6; Sirvent S, 2016, J ALLERGY CLIN IMMUN, V138, P558, DOI 10.1016/j.jaci.2016.02.029; Unger WWJ, 2011, CURR OPIN IMMUNOL, V23, P131, DOI 10.1016/j.coi.2010.11.011; van Die I, 2010, GLYCOBIOLOGY, V20, P2, DOI 10.1093/glycob/cwp140; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280	9	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1983	1987		10.1016/j.jaci.2018.07.030	http://dx.doi.org/10.1016/j.jaci.2018.07.030			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30125661	Bronze			2022-12-18	WOS:000452315800034
J	Dalloul, Z; Chenuet, P; Dalloul, I; Boyer, FCO; Aldigier, JC; Laffleur, B; El Makhour, Y; Ryffel, B; Quesniaux, VFJ; Togbe, D; Mergny, JL; Cook-Moreau, J; Cogne, M				Dalloul, Zeinab; Chenuet, Pauline; Dalloul, Iman; Boyer, Francois; Aldigier, Jean-Claude; Laffleur, Brice; El Makhour, Yolla; Ryffel, Bernhard; Quesniaux, Valerie F. J.; Togbe, Dieudonnee; Mergny, Jean-Louis; Cook-Moreau, Jeanne; Cogne, Michel			G-quadruplex DNA targeting alters class-switch recombination in B cells and attenuates allergic inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NEUROPATHIC PAIN; AID		[Dalloul, Zeinab; Dalloul, Iman; Boyer, Francois; Aldigier, Jean-Claude; Laffleur, Brice; Cook-Moreau, Jeanne; Cogne, Michel] Limoges Univ, Limoges, France; [Chenuet, Pauline; Ryffel, Bernhard; Quesniaux, Valerie F. J.; Togbe, Dieudonnee] CNRS, UMR7355, INEM, Orleans, France; [El Makhour, Yolla] Immunol Unit MICSU, Beirut, Lebanon; [El Makhour, Yolla] Lebanese Univ, Fac Sci, Beirut, Lebanon; [Mergny, Jean-Louis] Bordeaux Univ, Pessac, France; [Mergny, Jean-Louis] CAS, Inst Biophys, Brno, Czech Republic	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Lebanese University; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Cogne, M (corresponding author), Limoges Univ, Limoges, France.	cogne@unilim.fr	Mergny, Jean-Louis/E-2860-2013; cogné, michel/D-7370-2015; Togbe, Dieudonnee/AAE-1135-2020; Moreau, Jeanne/O-8522-2016	Mergny, Jean-Louis/0000-0003-3043-8401; cogné, michel/0000-0002-8519-4427; Togbe, Dieudonnee/0000-0001-6658-414X; Moreau, Jeanne/0000-0003-3590-1602	Association pour la Recherche sur le Cancer [PGA120150202338]; Agence Nationale de la Recherche [16-CE15-0019-01]; Institut National du Cancer [9363]; European FEDER [2016-00110366]; SYMBIT Region Nouvelle Aquitaine [CZ.02.1.01/0.0/0.0/15_003/0000477]; Fondation Francaise pour la Recherche contre le Myelome et les Gammapathies monoclonales (F.F.R.M.G.); ERDF; Ligue Nationale contre le Cancer; Biotarget Region Centre	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); European FEDER(European Commission); SYMBIT Region Nouvelle Aquitaine; Fondation Francaise pour la Recherche contre le Myelome et les Gammapathies monoclonales (F.F.R.M.G.); ERDF(European Commission); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Biotarget Region Centre	This work was supported by grants from Association pour la Recherche sur le Cancer (grant no. PGA120150202338), Agence Nationale de la Recherche (grant no. 16-CE15-0019-01), Institut National du Cancer (grant no. 9363), Ligue Nationale contre le Cancer, European FEDER no2016-00110366, Biotarget Region Centre, SYMBIT Region Nouvelle Aquitaine (CZ.02.1.01/0.0/0.0/15_003/0000477), and ERDF. Z.D. was supported by a fellowship from Fondation Francaise pour la Recherche contre le Myelome et les Gammapathies monoclonales (F.F.R.M.G.).	Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Berta T, 2014, J CLIN INVEST, V124, P1173, DOI 10.1172/JCI72230; Chen G, 2015, J CLIN INVEST, V125, P3226, DOI 10.1172/JCI80883; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Jang JH, 2010, PAIN, V148, P343, DOI 10.1016/j.pain.2009.11.021; Kim YH, 2009, J NEUROSCI, V29, P10000, DOI 10.1523/JNEUROSCI.5030-08.2009; Le Noir S, 2017, NUCLEIC ACIDS RES, V45, P5829, DOI 10.1093/nar/gkx203; Lee SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117316; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Morita T, 2015, NEURON, V87, P124, DOI 10.1016/j.neuron.2015.05.044; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; Qiao Q, 2017, MOL CELL, V67, P361, DOI 10.1016/j.molcel.2017.06.034; Riccio A, 2014, J NEUROSCI, V34, P3653, DOI 10.1523/JNEUROSCI.2274-13.2014; Saintamand A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8084; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Vallur AC, 2008, P NATL ACAD SCI USA, V105, P16508, DOI 10.1073/pnas.0805327105; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978; Zheng SM, 2015, CELL, V161, P762, DOI 10.1016/j.cell.2015.03.020; Zimmermann K, 2009, NAT PROTOC, V4, P174, DOI 10.1038/nprot.2008.223	23	10	11	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1352	+		10.1016/j.jaci.2018.06.011	http://dx.doi.org/10.1016/j.jaci.2018.06.011			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29935221	Bronze			2022-12-18	WOS:000446327300037
J	Fazekas-Singer, J; Singer, J; Ilieva, KM; Matz, M; Herrmann, I; Spillner, E; Karagiannis, SN; Jensen-Jarolim, E				Fazekas-Singer, Judit; Singer, Josef; Ilieva, Kristina M.; Matz, Miroslawa; Herrmann, Ina; Spillner, Edzard; Karagiannis, Sophia N.; Jensen-Jarolim, Erika			AllergoOncology: Generating a canine anticancer IgE against the epidermal growth factor receptor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							B-CELL SUBPOPULATIONS; REFERENCE VALUES; LYMPHOCYTE IMMUNOPHENOTYPE; IMMUNOTHERAPY; ANTIBODY; SUBSETS; DONORS		[Fazekas-Singer, Judit; Singer, Josef; Herrmann, Ina; Jensen-Jarolim, Erika] Med Univ Vienna, Univ Vet Med Vienna, Interuniv Messerli Res Inst, Comparat Med, Vienna, Austria; [Fazekas-Singer, Judit; Singer, Josef; Herrmann, Ina; Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria; [Fazekas-Singer, Judit; Singer, Josef; Matz, Miroslawa; Jensen-Jarolim, Erika] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Pathophysiol & Allergy Res, Vienna, Austria; [Singer, Josef] Karl Landsteiner Univ Hlth Sci, Univ Hosp Krems, Dept Internal Med 2, Krems, Austria; [Ilieva, Kristina M.; Karagiannis, Sophia N.] Kings Coll London, Sch Basic & Med Biosci, St Johns Inst Dermatol, London, England; [Ilieva, Kristina M.; Karagiannis, Sophia N.] Kings Coll London, Guys & St Thomas Hosp, NIHR Biomed Res Ctr, London, England; [Ilieva, Kristina M.; Karagiannis, Sophia N.] Kings Coll London, Guys Hosp, London, England; [Ilieva, Kristina M.] Kings Coll London, Guys Canc Ctr, Sch Canc & Pharmaceut Sci, Breast Canc Now Unit, London, England; [Herrmann, Ina] Univ Vet Med, Dept Compan Anim & Horses, Small Anim Clin, Internal Med, Vienna, Austria; [Spillner, Edzard] Aarhus Univ, Dept Engn, Immunol Engn, Aarhus, Denmark	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Medical University of Vienna; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of Veterinary Medicine Vienna; Aarhus University	Jensen-Jarolim, E (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Interuniv Messerli Res Inst, Comparat Med, Vienna, Austria.; Jensen-Jarolim, E (corresponding author), Univ Vienna, Vienna, Austria.; Jensen-Jarolim, E (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Pathophysiol & Allergy Res, Vienna, Austria.	erika.jensen-jarolim@meduniwien.ac.at	Karagiannis, Sophia/H-1097-2011; Fazekas-Singer, Judit/R-4349-2017	Karagiannis, Sophia/0000-0002-4100-7810; Fazekas-Singer, Judit/0000-0002-8777-3502; spillner, edzard/0000-0003-0999-5254	Austrian Science Fund (FWF) [P23398-B11, W1205-B09, SFB F4606-B28]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service Foundation Trust and King's College London [IS-BRC-1215-20006]; Breast Cancer Now working in partnership with Walk the Walk [147]; Medical Research Council [MR/L023091/1]; Cancer Research UK [C30122/A11527, C30122/A15774]; CR UK/NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre [C10355/A15587]; MRC [MR/L023091/1] Funding Source: UKRI	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service Foundation Trust and King's College London; Breast Cancer Now working in partnership with Walk the Walk; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); CR UK/NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Austrian Science Fund (FWF) grants P23398-B11, W1205-B09, and SFB F4606-B28. The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service Foundation Trust and King's College London (grant no. IS-BRC-1215-20006). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The authors acknowledge support by Breast Cancer Now (147) working in partnership with Walk the Walk; the Medical Research Council (grant no. MR/L023091/1); Cancer Research UK (grant nos. C30122/A11527 and C30122/A15774); and CR UK/NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre (grant no. C10355/A15587).	Amatya R, 2004, CLIN IMMUNOL, V112, P290, DOI 10.1016/j.clim.2004.04.008; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; Duchamp M, 2014, IMMUN INFLAMM DIS, V2, P131, DOI 10.1002/iid3.26; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; Fulkerson CM, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/6589529; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Ilieva KM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01112; Jensen-Jarolim E, 2017, ALLERGY, V72, P866, DOI 10.1111/all.13119; Karagiannis P, 2009, CANCER IMMUNOL IMMUN, V58, P915, DOI 10.1007/s00262-008-0607-1; Mantovani FB, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0707-7; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Piatosa B, 2010, CYTOM PART B-CLIN CY, V78B, P372, DOI 10.1002/cyto.b.20536; Pozzi C, 2016, NAT MED, V22, P624, DOI 10.1038/nm.4078; Reimann KA, 2000, CLIN DIAGN LAB IMMUN, V7, P352, DOI 10.1128/CDLI.7.3.352-359.2000; Rovati B, 2014, CLIN EXP MED, V14, P249, DOI 10.1007/s10238-013-0239-4; Singer J, 2014, ALLERGY, V69, P137, DOI 10.1111/all.12276; Singer J, 2014, MOL CANCER THER, V13, P1777, DOI 10.1158/1535-7163.MCT-13-0288; Torres AJL, 2009, BRAZ J INFECT DIS, V13, P221, DOI 10.1590/S1413-86702009000300013	18	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					973	+		10.1016/j.jaci.2018.04.021	http://dx.doi.org/10.1016/j.jaci.2018.04.021			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29746883	Green Published, hybrid			2022-12-18	WOS:000443726500029
J	Chiang, SCC; Vergamini, SM; Husami, A; Neumeier, L; Quinn, K; Ellerhorst, T; Sheppard, L; Gifford, C; Buchbinder, D; Joshi, A; Ifversen, M; Kleiner, GI; Bussel, JB; Chandrakasan, S; Pesek, RD; Pozos, TC; Rose, MJ; Scurlock, AM; Zhang, KJ; Bryceson, YT; Bleesing, J; Marsh, RA				Chiang, Samuel C. C.; Vergamini, Sue M.; Husami, Ammar; Neumeier, Lisa; Quinn, Kathryn; Ellerhorst, Teresa; Sheppard, Linda; Gifford, Carrie; Buchbinder, David; Joshi, Avni; Ifversen, Marianne; Kleiner, Gary I.; Bussel, James B.; Chandrakasan, Shanmuganathan; Pesek, Robert D.; Pozos, Tamara C.; Rose, Melissa J.; Scurlock, Amy M.; Zhang, Kejian; Bryceson, Yenan T.; Bleesing, Jack; Marsh, Rebecca A.			Screening for Wiskott-Aldrich syndrome by flow cytometry	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SYNDROME PROTEIN; MUTATIONS		[Chiang, Samuel C. C.; Vergamini, Sue M.; Neumeier, Lisa; Quinn, Kathryn; Ellerhorst, Teresa; Sheppard, Linda; Gifford, Carrie; Bleesing, Jack; Marsh, Rebecca A.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Husami, Ammar; Zhang, Kejian] Cincinnati Childrens Hosp Med Ctr, Dept Human Genet, Cincinnati, OH 45229 USA; [Buchbinder, David] CHOC Childrens Hosp, Orange, CA USA; [Joshi, Avni] Mayo Clin, Childrens Ctr, Div Pediat Allergy & Immunol, Rochester, MN USA; [Buchbinder, David] Copenhagen Univ Hosp, Rigshosp, Dept Pediat & Adolescent Med, Copenhagen, Denmark; [Kleiner, Gary I.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Bussel, James B.] Weill Cornell Med Coll, New York, NY USA; [Chandrakasan, Shanmuganathan] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Div Bone Marrow Transplant,Aflac Canc & Blood Dis, Atlanta, GA USA; [Pesek, Robert D.; Scurlock, Amy M.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Pesek, Robert D.; Scurlock, Amy M.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Pozos, Tamara C.] Childrens Minnesota, Pediat Infect Dis & Immunol, Minneapolis, MN USA; [Pozos, Tamara C.] Childrens Minnesota, Pediat Infect Dis & Immunol, St Paul, MN USA; [Rose, Melissa J.] Nationwide Childrens Hosp, Columbus, OH USA; [Rose, Melissa J.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Zhang, Kejian] Coyote Biosci, Campbell, CA USA; [Bryceson, Yenan T.] Karolinska Inst, Karolinska Univ Hos Huddinge, Dept Med, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Bryceson, Yenan T.] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Mayo Clinic; Rigshospitalet; University of Copenhagen; University of Miami; Cornell University; Children's Healthcare of Atlanta (CHOA); Emory University; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Children's Hospitals & Clinics of Minnesota; Children's Hospitals & Clinics of Minnesota; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Karolinska Institutet; University of Bergen	Chiang, SCC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA.	sam.chiang@cchmc.org	Chiang, Samuel CC/O-5960-2019; Ifversen, Marianne/AAN-4016-2021; Husami, Ammar/K-7777-2012; Chandrakasan, Shanmuganathan/AAM-3430-2020; zhang, ke/AAH-8217-2019; Bryceson, Yenan/D-2121-2018	Chiang, Samuel CC/0000-0001-6597-6117; Ifversen, Marianne/0000-0002-2558-1935; Husami, Ammar/0000-0002-4287-2857; Bryceson, Yenan/0000-0002-7783-9934	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD072245] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Buchbinder D, 2014, APPL CLIN GENET, V7, P55, DOI 10.2147/TACG.S58444; Candotti F, 2018, J CLIN IMMUNOL, V38, P13, DOI 10.1007/s10875-017-0453-z; Houmadi R, 2018, CELL REP, V22, P979, DOI 10.1016/j.celrep.2017.12.088; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Kawai S, 2002, J IMMUNOL METHODS, V260, P195, DOI 10.1016/S0022-1759(01)00549-X; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Quan LJ, 2016, BIOINFORMATICS, V32, P2936, DOI 10.1093/bioinformatics/btw361; ZHU QL, 1995, BLOOD, V86, P3797, DOI 10.1182/blood.V86.10.3797.bloodjournal86103797	9	10	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					333	335		10.1016/j.jaci.2018.04.017	http://dx.doi.org/10.1016/j.jaci.2018.04.017			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29729304	Bronze			2022-12-18	WOS:000437837500047
J	Wang, P; Su, HT; Zhang, LJ; Chen, H; Hu, XL; Yang, F; Lv, J; Zhang, LF; Zhao, Y				Wang, Peng; Su, Huiting; Zhang, Lianjun; Chen, Hui; Hu, Xuelian; Yang, Fan; Lv, Jun; Zhang, Lianfeng; Zhao, Yong			Phosphatase wild-type p53-induced phosphatase 1 controls the development of T(H)9 cells and allergic airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; Wip1; T(H)9 cell development; IL-9; phosphatase	IL-9-PRODUCING T-CELLS; WIP1 PHOSPHATASE; P53-DEPENDENT MANNER; LUNG INFLAMMATION; INDUCED ASTHMA; TH9 CELLS; MICE; EXPRESSION; CYTOKINE; DISEASE	Background: Allergic asthma is one of the most common diseases worldwide, resulting in a burden of diseases. No available therapeutic regimens can cure asthma thus far. Objective: We sought to identify new molecular targets for T(H)9 cell-mediated allergic airway inflammation. Methods: Wild-type p53-induced phosphatase 1 (Wip1) gene knockout mice, Wip1 inhibitor-treated mice, and ovalbumininduced allergic airway inflammation mouse models were used to characterize the roles of Wip1 in allergic airway inflammation. The induction of T-H cell subsets in vitro, real-time PCR, immunoblots, luciferase assays, and chromatin immunoprecipitation assays were used to determine the regulatory pathways of Wip1 in T(H)9 differentiation. Results: Here we demonstrate that Wip1-deficient mice are less prone to allergic airway inflammation, as indicated by the decreased pathologic alterations in lungs. Short-term treatment with a Wip1-specific inhibitor significantly ameliorates allergic inflammation progression. Intriguingly, Wip1 selectively impaired T(H)9 but not T(H)1, T(H)2, and T(H)17 cell differentiation. Biochemical assays show that Wip1 deficiency increases c-Jun/c-Fos activity in a c-Jun N-terminal kinase-dependent manner and that c-Jun/c-Fos directly binds to Il9 promoter and inhibits Il9 transcription. Conclusion: Wip1 controls T(H)9 cell development through regulating c-Jun/c-Fos activity on the Il9 promoter and is important for the pathogenesis of allergic airway inflammation. These findings shed light on the previously unrecognized roles of Wip1 in TH9 cell differentiation. The inhibitory effects of a Wip1 inhibitor on the pathogenesis of allergic airway inflammation can have important implications for clinical application of Wip1 inhibitors in allergy therapies.	[Wang, Peng; Su, Huiting; Zhang, Lianjun; Chen, Hui; Hu, Xuelian; Yang, Fan; Zhao, Yong] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China; [Wang, Peng; Su, Huiting] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lv, Jun] Capital Med Univ, Beijing YouAn Hosp, Hepatol & Canc Biotherapy Ward, Beijing 100069, Peoples R China; [Zhang, Lianfeng] Minist Hlth, Key Lab Human Dis Comparat Med, Pan Jia Yuan Nan Li 5, Beijing 100021, Peoples R China; [Zhang, Lianfeng] Minist Hlth, Key Lab Human Dis Comparat Med, Inst Lab Anim Sci, Beijing, Peoples R China; [Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Pan Jia Yuan Nan Li 5, Beijing 100021, Peoples R China; [Zhang, Lianfeng] Peking Union Med Coll, Pan Jia Yuan Nan Li 5, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lv, J (corresponding author), Capital Med Univ, Beijing YouAn Hosp, Hepatol & Canc Biotherapy Ward, Beijing 100069, Peoples R China.; Zhang, LF (corresponding author), Minist Hlth, Key Lab Human Dis Comparat Med, Pan Jia Yuan Nan Li 5, Beijing 100021, Peoples R China.; Zhang, LF (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Pan Jia Yuan Nan Li 5, Beijing 100021, Peoples R China.; Zhang, LF (corresponding author), Peking Union Med Coll, Pan Jia Yuan Nan Li 5, Beijing 100021, Peoples R China.; Zhao, Y (corresponding author), Chinese Acad Sci, Transplantat Biol Res Div, State Key Lab Membrane Biol, Inst Zool, Beichen West Rd 1-5, Beijing 100101, Peoples R China.	lujun98@ccmu.edu.cn; zhanglf@cnilas.org; zhaoy@ioz.ac.cn	Coll, Lluis Fajas/C-8567-2014; Zhang, Lianjun/AAE-6795-2020	wang, peng/0000-0003-1845-7589	National Natural Science Foundation [81130055, 81530049, 31470860]; National Basic Research Program of China [2014ZX10002002-001-002]; Knowledge Innovation Program of Chinese Academy of Sciences [XDA04020202-19]; CAS China Manned Space Flight Engineering Project of Life Science Experiments; CAS/SAFEA International Partnership Program for Creative Research Teams; "215'' high-level health technology project	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); CAS China Manned Space Flight Engineering Project of Life Science Experiments; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); "215'' high-level health technology project	Supported by grants from the National Natural Science Foundation for General and Key Programs (81130055, 81530049, and 31470860 to Y.Z.), the National Basic Research Program of China (2014ZX10002002-001-002 to J.L. and Y.Z.), the Knowledge Innovation Program of Chinese Academy of Sciences (XDA04020202-19 to Y.Z.), CAS China Manned Space Flight Engineering Project of Life Science Experiments, the CAS/SAFEA International Partnership Program for Creative Research Teams (to Y.Z.), and the "215'' high-level health technology project (2011 to J.L.).	Abreu SC, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt496; Barnes PJ, 2015, J ALLERGY CLIN IMMUN, V136, P531, DOI 10.1016/j.jaci.2015.05.052; Bassil R, 2014, J IMMUNOL, V193, P198, DOI 10.4049/jimmunol.1303184; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Buss MC, 2015, ONCOGENE, V34, P1126, DOI 10.1038/onc.2014.37; Buss MC, 2012, NEURO-ONCOLOGY, V14, P440, DOI 10.1093/neuonc/nos001; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Chung KF, 2015, LANCET, V386, P1086, DOI 10.1016/S0140-6736(15)00157-9; Claudio E, 2015, J IMMUNOL, V195, P3525, DOI 10.4049/jimmunol.1500436; Du J, 2015, CURR MOL MED, V15, P100, DOI 10.2174/1566524015666150114122929; Emelyanov A, 2015, ONCOGENE, V34, P4429, DOI 10.1038/onc.2014.375; Erpenbeck VJ, 2003, J ALLERGY CLIN IMMUN, V111, P1319, DOI 10.1067/mai.2003.1485; Esfandiari A, 2016, MOL CANCER THER, V15, P379, DOI 10.1158/1535-7163.MCT-15-0651; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/NCHEMBIO.1427, 10.1038/nchembio.1427]; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Groneberg DA, 2002, RESP MED, V96, P81, DOI 10.1053/rmed.2001.1221; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hou YZ, 2014, J IMMUNOL, V193, P130, DOI 10.4049/jimmunol.1302700; Hou YZ, 2013, ARTHRITIS RHEUM-US, V65, P2835, DOI 10.1002/art.38124; Hu XL, 2016, INFLAMM BOWEL DIS, V22, P1316, DOI 10.1097/MIB.0000000000000751; Huang XF, 2014, IMMUNOBIOLOGY, V219, P565, DOI 10.1016/j.imbio.2014.03.005; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Khaitov MR, 2014, HUM GENE THER, V25, P642, DOI 10.1089/hum.2013.142; Le Guezennec X, 2010, TRENDS BIOCHEM SCI, V35, P109, DOI 10.1016/j.tibs.2009.09.005; Liu GW, 2013, BLOOD, V121, P519, DOI 10.1182/blood-2012-05-432674; Mazzarella G, 2000, ALLERGY, V55, P6, DOI 10.1034/j.1398-9995.2000.00511.x; McMillan S, 2002, J EXP MED, V195, P51, DOI 10.1084/jem.20011732; Niedbala W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5575; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Perumal NB, 2011, TRENDS IMMUNOL, V32, P146, DOI 10.1016/j.it.2011.01.006; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Schito ML, 2006, J IMMUNOL, V176, P4818, DOI 10.4049/jimmunol.176.8.4818; Schmitt E, 2014, TRENDS IMMUNOL, V35, P61, DOI 10.1016/j.it.2013.10.004; Schuijs MJ, 2013, CURR OPIN PHARMACOL, V13, P351, DOI 10.1016/j.coph.2013.03.013; Sehra S, 2015, J ALLERGY CLIN IMMUN, V136, P433, DOI 10.1016/j.jaci.2015.01.021; Seumois G, 2016, J IMMUNOL, V197, P655, DOI 10.4049/jimmunol.1600397; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Simpson LJ, 2014, NAT IMMUNOL, V15, P1162, DOI 10.1038/ni.3026; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Sun B, 2014, J IMMUNOL, V192, P1184, DOI 10.4049/jimmunol.1300656; Sun LN, 2013, J IMMUNOL, V191, P3210, DOI 10.4049/jimmunol.1300363; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Wen J, 2016, ONCOGENE, V35, P5552, DOI 10.1038/onc.2016.96; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wu TT, 2012, J IMMUNOL, V189, P4989, DOI 10.4049/jimmunol.1200068; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yi WW, 2015, BLOOD, V126, P620, DOI 10.1182/blood-2015-02-624114; Yin S, 2016, ONCOTARGET, V7, P29359, DOI 10.18632/oncotarget.8833; Zhang LL, 2015, HEPATOLOGY, V61, P2030, DOI 10.1002/hep.27755; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	63	10	12	3	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2168	2181		10.1016/j.jaci.2017.06.026	http://dx.doi.org/10.1016/j.jaci.2017.06.026			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	28732646	Bronze			2022-12-18	WOS:000434701600022
J	Heine, G; Hollstein, T; Treptow, S; Radbruch, A; Worm, M				Heine, Guido; Hollstein, Tim; Treptow, Sandra; Radbruch, Andreas; Worm, Margitta			9-cis retinoic acid modulates the type I allergic immune response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; B cell; IgE; 9-cis retinoic acid; vitamin A	CHRONIC HAND ECZEMA; A-DEFICIENT MICE; HUMAN B-CELLS; VITAMIN-A; IGE-PRODUCTION; TGF-BETA; SECRETING PLASMABLASTS; DENDRITIC CELLS; D-3 PROMOTES; EXPRESSION	Background: Vitamin A is a potent regulator of adaptive immunity. The effect of the endogenous metabolite 9-cis retinoic acid (9cRA) on allergic sensitization is unknown. Objective: We sought to investigate whether and to what extent 9cRA modulates the humoral immune response. Methods: BALB/c mice were sensitized and challenged with ovalbumin (OVA). 9cRA was applied repeatedly together with the antigen. Immunoglobulin production and cellular analysis were performed by using ELISA, ELISpot, and flow cytometry. Human CD19(+) B cells were activated in vitro in the presence or absence of 9cRA and activation markers, and proliferation and secreted immunoglobulin levels were analyzed by using flow cytometry and ELISA. Results: 9cRA applied together with repeated OVA challenge transiently increased specific serum IgA, IgE, and IgG(1) serum levels (2.0- and 8.9-fold). After OVA recall, specific IgE concentrations were reduced by a mean of 57% after adding 9cRA, whereas IgA was strongly induced (20-fold), and IgG(1) levels remained unchanged. Correspondingly, less specific IgE- and more IgA-secreting cells resided in the spleen in the 9cRA groups. Additionally, 9cRA promoted the migration of specific B cells to the mesenteric but not draining lymph nodes. In purified stimulated human B cells, 9cRA markedly reduced IgE production and enhanced IgA production. B-cell activation was modulated by 9cRA, reducing the expression of CD86 and promoting IL-10. Conclusions: Our data indicate that 9cRA modulates the allergic immune response by reducing the IgE response but promoting the IgA response. Thus 9cRA can modulate the allergic immune response toward a non-IgE condition.	[Heine, Guido; Hollstein, Tim; Treptow, Sandra; Worm, Margitta] Charite Univ Med Berlin, Klin Dermatol & Allergol, Allergie Ctr Charite, Berlin, Germany; [Heine, Guido; Radbruch, Andreas; Worm, Margitta] Deutsch Rheuma Forschungszentrum Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ)	Worm, M (corresponding author), Charite Univ Med Berlin, Klin Dermatol Venerol & Allergol, Allergie Ctr Charite, CCM, Charitepl 1, D-10117 Berlin, Germany.	margitta.worm@charite.de	Hollstein, Tim/X-6758-2019; Heine, Guido/G-1656-2018	Hollstein, Tim/0000-0002-4048-2978; Heine, Guido/0000-0003-1467-9862; Worm, Margitta/0000-0002-3449-1245; Radbruch, Andreas/0000-0001-5753-0000	Deutsche Forschungsgemeinschaft [DFG-SFB650-TP5, DFG-TRR130-P19]; Charite-Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum Berlin; DFG [TRR130-TP19]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Charite-Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum Berlin; DFG(German Research Foundation (DFG))	Supported by grants awarded by grants to M.W., A.R., and G.H. of the Deutsche Forschungsgemeinschaft (DFG-SFB650-TP5 and DFG-TRR130-P19) and by Charite-Universitatsmedizin Berlin. T.H. was supported by a student grant awarded by Deutsches Rheuma-Forschungszentrum Berlin. S.T. is currently financed by the DFG (TRR130-TP19).	Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen Q, 2007, CELL IMMUNOL, V249, P37, DOI 10.1016/j.cellimm.2007.11.001; CHUN TY, 1992, J NUTR, V122, P1062, DOI 10.1093/jn/122.5.1062; den Hartog G, 2013, INT ARCH ALLERGY IMM, V162, P225, DOI 10.1159/000353243; Diepgen TL, 2012, ACTA DERM-VENEREOL, V92, P251, DOI 10.2340/00015555-1256; DRACH J, 1994, CANCER RES, V54, P1746; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Ertesvag A, 2007, BLOOD, V109, P3865, DOI 10.1182/blood-2006-09-046748; Geldmeyer-Hilt K, 2011, BIOCHEM BIOPH RES CO, V407, P699, DOI 10.1016/j.bbrc.2011.03.078; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hammerschmidt SI, 2011, J CLIN INVEST, V121, P3051, DOI 10.1172/JCI44262; Heine G, 2002, EUR J IMMUNOL, V32, P3395, DOI 10.1002/1521-4141(2002012)32:12<3395::AID-IMMU3395>3.0.CO;2-I; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Heine G, 2014, J IMMUNOL, V193, P1017, DOI 10.4049/jimmunol.1301656; Heine G, 2014, EUR J IMMUNOL, V44, P1615, DOI 10.1002/eji.201343822; Heine G, 2009, J IMMUNOL, V182, P5276, DOI 10.4049/jimmunol.0801804; Luger EO, 2009, J ALLERGY CLIN IMMUN, V124, P819, DOI 10.1016/j.jaci.2009.06.047; Milovanovic M, 2009, CLIN EXP ALLERGY, V39, P671, DOI 10.1111/j.1365-2222.2009.03233.x; Milovanovic M, 2010, J ALLERGY CLIN IMMUN, V126, P1016, DOI 10.1016/j.jaci.2010.08.020; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; REICHLING J, 2016, HEILPFLANZENKUNDE VE; Ross AC, 2007, VITAM HORM, V75, P197, DOI 10.1016/S0083-6729(06)75008-7; Ruhl R, 2003, J INVEST DERMATOL, V121, P757, DOI 10.1046/j.1523-1747.2003.12493.x; Scheffel F, 2005, INFLAMM RES, V54, P113, DOI 10.1007/s00011-004-1331-8; Schindler M, 2014, INT ARCH ALLERGY IMM, V165, P18, DOI 10.1159/000365659; SMITH SM, 1987, P NATL ACAD SCI USA, V84, P5878, DOI 10.1073/pnas.84.16.5878; Sudfeld CR, 2010, INT J EPIDEMIOL, V39, P48, DOI 10.1093/ije/dyq021; Surman SL, 2012, VIRAL IMMUNOL, V25, P341, DOI 10.1089/vim.2012.0023; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; TOKUYAMA H, 1995, CELL IMMUNOL, V162, P153, DOI 10.1006/cimm.1995.1063; TOKUYAMA H, 1995, CELL IMMUNOL, V166, P247, DOI 10.1006/cimm.1995.9973; Tokuyama H, 1997, CELL IMMUNOL, V176, P14, DOI 10.1006/cimm.1996.1069; Weise C, 2011, EXP DERMATOL, V20, P805, DOI 10.1111/j.1600-0625.2011.01326.x; Worm M, 2001, INT ARCH ALLERGY IMM, V124, P233, DOI 10.1159/000053721; Worm M, 1998, BLOOD, V92, P1713, DOI 10.1182/blood.V92.5.1713.417k20_1713_1720; Zan H, 1998, J IMMUNOL, V161, P5217; Zhan XX, 2013, IMMUNOLOGY, V138, P333, DOI 10.1111/imm.12040	41	10	10	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					650	+		10.1016/j.jaci.2017.03.046	http://dx.doi.org/10.1016/j.jaci.2017.03.046			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28526622	Bronze			2022-12-18	WOS:000424410800022
J	Wilson, JM; Workman, L; Schuyler, AJ; Rifas-Shiman, SL; McGowan, EC; Oken, E; Gold, DR; Hamilton, RG; Platts-Mills, TAE				Wilson, Jeffrey M.; Workman, Lisa; Schuyler, Alexander J.; Rifas-Shiman, Sheryl L.; McGowan, Emily C.; Oken, Emily; Gold, Diane R.; Hamilton, Robert G.; Platts-Mills, Thomas A. E.			Allergen sensitization in a birth cohort at midchildhood: Focus on food component IgE and IgG(4) responses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MICE; ANTIBODIES; MILK		[Wilson, Jeffrey M.; Workman, Lisa; Schuyler, Alexander J.; McGowan, Emily C.; Platts-Mills, Thomas A. E.] Univ Virginia, Div Allergy & Immunol, Charlottesville, VA 22904 USA; [Rifas-Shiman, Sheryl L.; Oken, Emily] Harvard Med Sch, Div Chron Dis Res Lifecourse, Dept Populat Med, Boston, MA USA; [Rifas-Shiman, Sheryl L.; Oken, Emily] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Gold, Diane R.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Gold, Diane R.] Harvard Med Sch, Boston, MA USA; [Gold, Diane R.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Hamilton, Robert G.] Johns Hopkins Univ, Sch Med, Dermatol Allergy & Clin Immunol Lab, Baltimore, MD USA	University of Virginia; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University	Platts-Mills, TAE (corresponding author), Univ Virginia, Div Allergy & Immunol, Charlottesville, VA 22904 USA.	tap2z@virginia.edu	Wilson, JM/AAD-6421-2020	Wilson, JM/0000-0002-5975-1760; Platts-Mills, Thomas/0000-0002-1263-329X	National Institutes of Health; National Institutes of Health/National Institutes of Allergy and Infectious Disease [1K23AI123596]; Phadia/Thermo Fisher; National Institutes of Health [RO1-AI-20565]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102960, R01AI020565, R37AI020565, K23AI123596] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institutes of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Phadia/Thermo Fisher; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S. L. Rifas-Shirman, E. Oken, D. R. Gold, and R. G. Hamilton have received grants from the National Institutes of Health. E. C. McGowan has received a grant from the National Institutes of Health/National Institutes of Allergy and Infectious Disease (grant no. 1K23AI123596). T. A. E. Platts-Mills has received grants from Phadia/Thermo Fisher and the National Institutes of Health (grant no. RO1-AI-20565). The rest of the authors declare that they have no relevant conflicts of interest.	Bunyavanich S, 2014, J ALLERGY CLIN IMMUN, V133, P1373, DOI 10.1016/j.jaci.2013.11.040; CALKHOVEN PG, 1991, CLIN EXP ALLERGY, V21, P91, DOI 10.1111/j.1365-2222.1991.tb00809.x; Erwin EA, 2016, J ALLERGY CLIN IMMUN, V138, P625, DOI 10.1016/j.jaci.2016.01.048; Erwin EA, 2015, J ALLER CL IMM-PRACT, V3, P896, DOI 10.1016/j.jaip.2015.05.015; Ewart SL, 1996, AM J RESP CELL MOL, V14, P627, DOI 10.1165/ajrcmb.14.6.8652191; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kattan JD, 2013, CURR ALLERGY ASTHM R, V13, P58, DOI 10.1007/s11882-012-0311-2; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Sastre J, 2010, CLIN EXP ALLERGY, V40, P1442, DOI 10.1111/j.1365-2222.2010.03585.x; Schwarz A, 2016, J ALLERGY CLIN IMMUN, V138, P1426, DOI 10.1016/j.jaci.2016.01.057; Skrindo I, 2015, PEDIAT ALLERG IMM-UK, V26, P239, DOI 10.1111/pai.12366; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Stabenow D, 2010, HEPATOLOGY, V51, P1430, DOI 10.1002/hep.23575; Tittel AP, 2012, NAT METHODS, V9, P385, DOI [10.1038/NMETH.1905, 10.1038/nmeth.1905]; TOWNSEND D, 1981, J EXP ZOOL, V216, P113, DOI 10.1002/jez.1402160112; Zhang L, 2009, BLOOD, V114, P1545, DOI 10.1182/blood-2009-03-206672	18	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2018	141	1					419	+		10.1016/j.jaci.2017.07.029	http://dx.doi.org/10.1016/j.jaci.2017.07.029			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR8GH	28867458	Bronze, Green Accepted			2022-12-18	WOS:000419312200052
J	Bal, E; Laplantine, E; Hamel, Y; Dubosclard, V; Boisson, B; Pescatore, A; Picard, C; Hadj-Rabia, S; Royer, G; Steffann, J; Bonnefont, JP; Ursini, VM; Vabres, P; Munnich, A; Casanova, JL; Bodemer, C; Weil, R; Agou, F; Smahi, A				Bal, Elodie; Laplantine, Emmanuel; Hamel, Yamina; Dubosclard, Virginie; Boisson, Bertrand; Pescatore, Alessandra; Picard, Capucine; Hadj-Rabia, Smail; Royer, Ghislaine; Steffann, Julie; Bonnefont, Jean-Paul; Ursini, Valeria M.; Vabres, Pierre; Munnich, Arnold; Casanova, Jean-Laurent; Bodemer, Christine; Weil, Robert; Agou, Fabrice; Smahi, Asma			Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-kappa B activation and leads to incontinentia pigmenti	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Incontinentia pigmenti; IKBKG; NF-kappa B essential modulator; nuclear factor kappa B; linear ubiquitin assembly complex; linear ubiquitination; SHANK-associated RH domain-interacting protein	ANHIDROTIC ECTODERMAL DYSPLASIA; ESSENTIAL MODULATOR MUTATION; X-CHROMOSOME INACTIVATION; IKK-GAMMA GENE; IMMUNE-RESPONSES; LUBAC DEFICIENCY; BEHCETS-DISEASE; LIGASE COMPLEX; COILED COILS; IMMUNODEFICIENCY	Background: Incontinentia pigmenti (IP; MIM308300) is a severe, male-lethal, X-linked, dominant genodermatosis resulting from loss-of-function mutations in the IKBKG gene encoding nuclear factor kappa B (NF-kappa B) essential modulator (NEMO; the regulatory subunit of the I kappa B kinase [IKK] complex). In 80% of cases of IP, the deletion of exons 4 to 10 leads to the absence of NEMO and total inhibition of NF-kappa B signaling. Here we describe a new IKBKG mutation responsible for IP resulting in an inactive truncated form of NEMO. Objectives: We sought to identify the mechanism or mechanisms by which the truncated NEMO protein inhibits the NF-kappa B signaling pathway. Methods: We sequenced the IKBKG gene in patients with IP and performed complementation and transactivation assays in NEMO-deficient cells. We also used immunoprecipitation assays, immunoblotting, and an in situ proximity ligation assay to characterize the truncated NEMO protein interactions with IKK-alpha, IKK-beta, TNF receptor-associated factor 6, TNF receptor-associated factor 2, receptor-interacting protein 1, Hemo-oxidized iron regulatory protein 2 ligase 1 (HOIL-1), HOIL-1-interacting protein, and SHANK-associated RH domain-interacting protein. Lastly, we assessed NEMO linear ubiquitination using immunoblotting and investigated the formation of NEMO-containing structures (using immunostaining and confocal microscopy) after cell stimulation with IL-1 beta. Results: We identified a novel splice mutation in IKBKG (c.518 + 2T > G, resulting in an in-frame deletion: p.DelQ134_ R256). The mutant NEMO lacked part of the CC1 coiled-coil and HLX2 helical domain. The p.DelQ134_R256 mutation caused inhibition of NF-kappa B signaling, although the truncated NEMO protein interacted with proteins involved in activation of NF-kappa B signaling. The IL-1 beta-induced formation of NEMO-containing structures was impaired in fibroblasts from patients with IP carrying the truncated NEMO form (as also observed in HOIL-1(-/-) cells). The truncated NEMO interaction with SHANK-associated RH domain-interacting protein was impaired in a male fetus with IP, leading to defective linear ubiquitination. Conclusion: We identified a hitherto unreported disease mechanism (defective linear ubiquitination) in patients with IP.	[Bal, Elodie; Hamel, Yamina; Hadj-Rabia, Smail; Royer, Ghislaine; Steffann, Julie; Bonnefont, Jean-Paul; Munnich, Arnold; Bodemer, Christine; Smahi, Asma] Paris Descartes Univ, INSERM U1163, Sorbonne Paris Cite, IMAGINE Inst,Necker Hosp Enfants Malad, 24 Blvd Montparnasse, Paris, France; [Laplantine, Emmanuel; Weil, Robert] CNRS UMR 3691, Lab Signaling & Pathogenesis, Paris, France; [Dubosclard, Virginie; Agou, Fabrice] Pasteur Inst, Dept Cell Biol, Paris, France; [Dubosclard, Virginie; Agou, Fabrice] Pasteur Inst, Dept Infect, Paris, France; [Dubosclard, Virginie; Agou, Fabrice] Pasteur Inst, Dept Struct Biol & Chem, URA 2185, Paris, France; [Boisson, Bertrand; Picard, Capucine; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Boisson, Bertrand; Picard, Capucine; Casanova, Jean-Laurent] Paris Descartes Univ, Lab Human Genet Infect Dis, Necker Hosp Enfants Malad, Necker Branch,UMR 1163,Sorbonne Paris Cite,IMAGIN, Paris, France; [Pescatore, Alessandra; Ursini, Valeria M.] Inst Genet & Biophys Adriano Buzzati Traverso CNR, Naples, Italy; [Picard, Capucine] Necker Childrens Hosp, Immunodeficiency Study Ctr, Paris, France; [Casanova, Jean-Laurent] Necker Childrens Hosp, Pediat Hematol Immunol & Rheumatol Unit, Paris, France; [Hadj-Rabia, Smail; Bodemer, Christine] Necker Enfants Malades Hosp, AP HP, Dept Dermatol, Referral Ctr Genodermatoses MAGEC,Imagine Inst, Paris, France; [Vabres, Pierre] Dijon CHU, Dept Dermatol, Med Fac, Dijon, France; [Vabres, Pierre] Bourgogne Univ, Genet Dev Abonomalies EA427, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Smahi, A (corresponding author), Paris Descartes Univ, INSERM U1163, Sorbonne Paris Cite, IMAGINE Inst,Necker Hosp Enfants Malad, 24 Blvd Montparnasse, Paris, France.	asma.smahi@inserm.fr	Steffann, Julie/I-2820-2017; Casanova, Jean-Laurent/I-3418-2017; Boisson, Bertrand/AAC-6058-2019; Boisson, Bertrand/I-2485-2017; Vabres, Pierre/D-3906-2011; Vabres, Pierre/V-3850-2019; , AGOU/GXA-2760-2022; pescatore, alessandra/J-3037-2018; SMAHI, ASMA/J-4184-2017	Steffann, Julie/0000-0001-9493-3239; Boisson, Bertrand/0000-0001-5240-3555; Boisson, Bertrand/0000-0001-5240-3555; Vabres, Pierre/0000-0001-8693-3183; Vabres, Pierre/0000-0001-8693-3183; pescatore, alessandra/0000-0001-8453-8198; Hadj-Rabia, Smail/0000-0001-6801-7106; Casanova, Jean-Laurent/0000-0002-7782-4169; BONNEFONT, Jean-Paul/0000-0002-4235-1197; SMAHI, ASMA/0000-0002-6002-0981; Weil, Robert/0000-0001-5235-0932	Societe Francaise de Dermatologie; Association Incontinentia Pigmenti France	Societe Francaise de Dermatologie; Association Incontinentia Pigmenti France	Supported by Societe Francaise de Dermatologie and Association Incontinentia Pigmenti France.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Aradhya S, 2001, HUM MOL GENET, V10, P2171, DOI 10.1093/hmg/10.19.2171; Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dupuis-Girod S, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e97; Elton L, 2015, IMMUNOL REV, V266, P208, DOI 10.1111/imr.12307; Fusco F, 2007, J AM ACAD DERMATOL, V56, P264, DOI 10.1016/j.jaad.2006.09.019; Fusco F, 2012, HUM MOL GENET, V21, P1260, DOI 10.1093/hmg/ddr556; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hadj-Rabia S, 2011, J AM ACAD DERMATOL, V64, P508, DOI 10.1016/j.jaad.2010.01.045; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; HogenEsch H, 1999, PATHOBIOLOGY, V67, P45, DOI 10.1159/000028050; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Juan CK, 2015, J DTSCH DERMATOL GES, V13, P154, DOI 10.1111/ddg.12452; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Ku CL, 2005, PEDIATRICS, V115, pE615, DOI 10.1542/peds.2004-1754; LANDY SJ, 1993, J MED GENET, V30, P53, DOI 10.1136/jmg.30.1.53; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin HK, 2010, J CHIN MED ASSOC, V73, P275, DOI 10.1016/S1726-4901(10)70060-5; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Matsumoto ML, 2012, J MOL BIOL, V418, P134, DOI 10.1016/j.jmb.2011.12.053; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Minic S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-25; Mooster JL, 2010, J ALLERGY CLIN IMMUN, V126, P127, DOI 10.1016/j.jaci.2010.04.026; Orange JS, 2004, J ALLERGY CLIN IMMUN, V114, P650, DOI 10.1016/j.jaci.2004.06.052; Orstavik KH, 2006, AM J MED GENET A, V140A, P31, DOI 10.1002/ajmg.a.31026; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Smahi A, 2000, NATURE, V405, P466; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Takada H, 2010, CLIN GENET, V78, P575, DOI 10.1111/j.1399-0004.2010.01432.x; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Tokunaga F, 2012, ENDOCR J, V59, P641, DOI 10.1507/endocrj.EJ12-0148; Tokunaga F, 2012, MICROBES INFECT, V14, P563, DOI 10.1016/j.micinf.2012.01.011; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Walshaw J, 2001, BIOCHEM SOC SYMP, V68, P111; Wang Z, 2012, J CELL MOL MED, V16, P2271, DOI 10.1111/j.1582-4934.2012.01574.x; Wood CW, 2014, BIOINFORMATICS, V30, P3029, DOI 10.1093/bioinformatics/btu502; Zak DE, 2011, P NATL ACAD SCI USA, V108, P11536, DOI 10.1073/pnas.1107577108; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P10127, DOI 10.1073/pnas.1612594113; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	51	10	11	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1671	+		10.1016/j.jaci.2016.11.056	http://dx.doi.org/10.1016/j.jaci.2016.11.056			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28249776	Bronze			2022-12-18	WOS:000417206000022
J	Markevych, I; Standl, M; Lehmann, I; von Berg, A; Heinrich, J				Markevych, Iana; Standl, Marie; Lehmann, Irina; von Berg, Andrea; Heinrich, Joachim			Food diversity during the first year of life and allergic diseases until 15 years	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PROSPECTIVE BIRTH COHORT; SENSITIZATION; PREVENTION; INFANTS; ASTHMA		[Markevych, Iana; Heinrich, Joachim] LMU, Univ Hosp, Inst & Clin Occupat Social & Environm Med, Munich, Germany; [Markevych, Iana; Standl, Marie; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Lehmann, Irina] UFZ Helmholtz Ctr Environm Res, Dept Environm Immunol Core Facil Studies, Leipzig, Germany; [von Berg, Andrea] Marien Hosp Wesel, Dept Pediat, Res Inst, Wesel, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); St. Marien Hospital	Markevych, I (corresponding author), LMU, Univ Hosp, Inst & Clin Occupat Social & Environm Med, Munich, Germany.; Markevych, I (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany.	iana.markevych@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Markevych, Iana/AAQ-3332-2020	Heinrich, Joachim/0000-0002-9620-1629; Markevych, Iana/0000-0002-5214-0748; Standl, Marie/0000-0002-5345-2049; Lehmann, Irina/0000-0001-8875-5587	Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Helmholtz Centre for Environmental Research-UFZ, Leipzig; Marien-Hospital Wesel; Pediatric Practice, Bad Honnef; Federal Ministry for Environment (IUF) [FKZ 20462296]; Commission of the European Communities; 7th Framework Program (Mechanisms of the Development of Allergy [MeDALL] project)	Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Helmholtz Centre for Environmental Research-UFZ, Leipzig; Marien-Hospital Wesel; Pediatric Practice, Bad Honnef; Federal Ministry for Environment (IUF); Commission of the European Communities(European Commission); 7th Framework Program (Mechanisms of the Development of Allergy [MeDALL] project)	The LISAplus study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and in addition from Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research-UFZ, Leipzig, Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, for the first 2 years. The 4year, 6year, and 10year follow-up examinations of the LISAplus study were covered from the respective budgets of the involved partners (Helmholtz Zentrum Munich [former GSF], Helmholtz Centre for Environmental Research-UFZ, Leipzig, Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, IUF-Leibniz-Research Institute for Environmental Medicine) and in addition by a grant from the Federal Ministry for Environment (IUF, FKZ 20462296). The recent 15year followup examination of the LISAplus study was supported by the Commission of the European Communities, the 7th Framework Program (Mechanisms of the Development of Allergy [MeDALL] project). The aforementioned funding sources had no involvement in the design of the study, collection, analysis, and interpretation of data, writing of the report, and decision to submit the manuscript for publication.	Abrams EM, 2017, J PEDIATR-US, V184, P13, DOI 10.1016/j.jpeds.2017.01.053; Baumbach C., 2016, MANYREGS R PACKAGE; Fiocchi A, 2006, ANN ALLERG ASTHMA IM, V97, P10, DOI 10.1016/S1081-1206(10)61364-6; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Heinrich J, 2014, EXPERT REV CLIN IMMU, V10, P701, DOI 10.1586/1744666X.2014.917049; Johansson EK, 2017, J ALLERGY CLIN IMMUN; Larson K, 2017, MCN-AM J MATERN-CHIL, V42, P72, DOI 10.1097/NMC.0000000000000313; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Nwaru BI, 2014, J ALLERGY CLIN IMMUN, V133, P1084, DOI 10.1016/j.jaci.2013.12.1069; R_Core_Team, 2012, R LANG ENV STAT COMP; Roduit C, 2014, J ALLERGY CLIN IMMUN, V133, P1056, DOI 10.1016/j.jaci.2013.12.1044; Zutavern A, 2006, PEDIATRICS, V117, P401, DOI 10.1542/peds.2004-2521; Zutavern A, 2008, PEDIATRICS, V121, pE44, DOI 10.1542/peds.2006-3553	13	10	10	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1751	+		10.1016/j.jaci.2017.08.011	http://dx.doi.org/10.1016/j.jaci.2017.08.011			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28870462	Bronze			2022-12-18	WOS:000417206000044
J	Long, X; Daya, M; Zhao, JP; Rafaels, N; Liang, HF; Potee, J; Campbell, M; Zhang, BX; Araujo, MI; Oliveira, RR; Mathias, RA; Gao, L; Ruczinski, I; Georas, SN; Vercelli, D; Beaty, TH; Barnes, KC; Chen, XP; Chen, Q				Long, Xin; Daya, Michelle; Zhao, Jianping; Rafaels, Nicholas; Liang, Huifang; Potee, Joseph; Campbell, Monica; Zhang, Bixiang; Araujo, Maria Ilma; Oliveira, Ricardo R.; Mathias, Rasika A.; Gao, Li; Ruczinski, Ingo; Georas, Steve N.; Vercelli, Donata; Beaty, Terri H.; Barnes, Kathleen C.; Chen, Xiaoping; Chen, Qian			The role of ST2 and ST2 genetic variants in schistosomiasis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						sST2; ST2; Schistosoma japonicum; liver cirrhosis immunohistochemistry	MANSONI INFECTION INTENSITY; ASTHMA; FIBROSIS; IMMUNE; IL-33; MICE; TH2; INTERLEUKIN-33; POLYMORPHISMS; ASSOCIATION	Background: Chronic schistosomiasis and its severe complication, periportal fibrosis, are characterized by a predominant T(H)2 response. To date, specific single nucleotide polymorphisms in ST2 have been some of the most consistently associated genetic variants for asthma. Objective: We investigated the role of ST2 (a receptor for the T(H)2 cytokine IL-33) in chronic and late-stage schistosomiasis caused by Schistosoma japonicum and the potential effect of ST2 genetic variants on stage of disease and ST2 expression. Methods: We recruited 947 adult participants (339 with end-stage schistosomiasis and liver cirrhosis, 307 with chronic infections without liver fibrosis, and 301 health controls) from a S japonicum-endemic area (Hubei, China). Six ST2 single nucleotide polymorphisms were genotyped. Serum soluble ST2 (sST2) was measured by ELISA, and ST2 expression in normal liver tissues, Hepatitis B virus-induced fibrotic liver tissues, and S japonicum-induced fibrotic liver tissues was measured by immunohistochemistry. Results: We found sST2 levels were significantly higher in the end-stage group (36.04 [95% CI, 33.85-38.37]) compared with chronic cases and controls (22.7 [95% CI, 22.0-23.4], P < 1E-10). In addition, S japonicum-induced fibrotic liver tissues showed increased ST2 staining compared with normal liver tissues (P = .0001). Markers rs12712135, rs1420101, and rs6543119 were strongly associated with sST2 levels (P = 2E-10, 5E-05, and 6E-05, respectively), and these results were replicated in an independent cohort from Brazil living in a S mansoni endemic region. Conclusions: We demonstrate for the first time that end-stage schistosomiasis is associated with elevated sST2 levels and show that ST2 genetic variants are associated with sST2 levels in patients with schistosomiasis.	[Long, Xin; Zhao, Jianping; Liang, Huifang; Zhang, Bixiang; Chen, Xiaoping] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Long, Xin; Zhao, Jianping; Liang, Huifang; Zhang, Bixiang; Chen, Xiaoping] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Clin Study Ctr Liver Surg Hubei Prov, Wuhan, Hubei, Peoples R China; [Chen, Qian] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Gastroenterol & Hepatol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Long, Xin; Rafaels, Nicholas; Potee, Joseph; Campbell, Monica; Mathias, Rasika A.; Gao, Li; Barnes, Kathleen C.] Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Ruczinski, Ingo; Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Daya, Michelle] Univ Colorado, Sch Med, Biomed Informat & Personalized Med, 12700 East 19th Ave,Mail Stop 8617,Res Ctr Two, Aurora, CO 80045 USA; [Vercelli, Donata] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Georas, Steve N.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Araujo, Maria Ilma] Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil; [Oliveira, Ricardo R.] Fundacao Oswaldo Cruz Bahia, Inst Goncalo Moniz, Salvador, BA, Brazil	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Arizona; University of Rochester	Chen, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.; Chen, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Gastroenterol & Hepatol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.; Barnes, KC (corresponding author), Univ Colorado, Sch Med, Biomed Informat & Personalized Med, 12700 East 19th Ave,Mail Stop 8617,Res Ctr Two, Aurora, CO 80045 USA.	Kathleen.Barnes@UCDenver.edu; chenxp@medmail.com.cn; chenqian201579@yahoo.com	; Oliveira, Ricardo Riccio/E-7707-2017	Long, Xin/0000-0002-9817-5858; Zhao, Jianping/0000-0003-3057-5617; Oliveira, Ricardo Riccio/0000-0001-9586-2313	National Institutes of Health [R01HL112088]; Mary Beryl Patch Turnbull Scholar Program; Major and Special Program of National Science and Technology in Twelfth Five-year Plan of China [2012ZX10002016-004]; National Natural Science Foundation of China [81471612]; State Key Project on Infection Disease of China [2012ZX10002016-004, 2012ZX10002010-001004]; Natural Science Foundation of Hubei Province, China [2011BCB035]; Hepatic Surgery Clinical Study Center of Hubei Province, China [2014BKB089, 2013BCB026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Beryl Patch Turnbull Scholar Program; Major and Special Program of National Science and Technology in Twelfth Five-year Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Project on Infection Disease of China; Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province); Hepatic Surgery Clinical Study Center of Hubei Province, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health (grant R01HL112088), the Mary Beryl Patch Turnbull Scholar Program, the Major and Special Program of National Science and Technology in Twelfth Five-year Plan of China (grant 2012ZX10002016-004), the National Natural Science Foundation of China (grant 81471612), State Key Project on Infection Disease of China (grants 2012ZX10002016-004 and 2012ZX10002010-001004), the Natural Science Foundation of Hubei Province, China (grant 2011BCB035), and the Hepatic Surgery Clinical Study Center of Hubei Province, China (grants 2014BKB089 and 2013BCB026).	Akhabir L, 2010, CURR GENOMICS, V11, P591, DOI 10.2174/138920210793360907; Ali M, 2009, TISSUE ANTIGENS, V73, P206, DOI 10.1111/j.1399-0039.2008.01185.x; Amatucci A, 2007, J LEUKOCYTE BIOL, V82, P124, DOI 10.1189/jlb.1006625; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Co DO, 2004, IMMUNOL LETT, V92, P135, DOI 10.1016/j.imlet.2003.11.023; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Fairfax K, 2012, SEMIN IMMUNOPATHOL, V34, P863, DOI 10.1007/s00281-012-0354-4; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grant AV, 2011, GENES IMMUN, V12, P46, DOI 10.1038/gene.2010.50; Grant AV, 2008, J INFECT DIS, V198, P1227, DOI 10.1086/591946; Grant AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035863; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hong XC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002122; Jones LA, 2010, EUR J IMMUNOL, V40, P426, DOI 10.1002/eji.200939705; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Long X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135360; Lopetuso LR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-18; Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007; Marvie P, 2010, J CELL MOL MED, V14, P1726, DOI 10.1111/j.1582-4934.2009.00801.x; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Nishida A, 2010, GUT, V59, P531, DOI 10.1136/gut.2009.193599; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Reijmerink NE, 2008, J ALLERGY CLIN IMMUN, V122, P651, DOI 10.1016/j.jaci.2008.06.030; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Roussel L, 2013, J ALLERGY CLIN IMMUN, V131, P913, DOI 10.1016/j.jaci.2012.10.019; Sattler S, 2013, ARCH IMMUNOL THER EX, V61, P107, DOI 10.1007/s00005-012-0208-8; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Silas S, 2014, INT J PARASITOL, V44, P381, DOI 10.1016/j.ijpara.2014.02.004; Tajima S, 2007, EXP LUNG RES, V33, P81, DOI 10.1080/01902140701198583; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007; Wu W, 2015, PARASITOL RES, V114, P17, DOI 10.1007/s00436-014-4225-x; Yanaba K, 2011, CLIN RHEUMATOL, V30, P825, DOI 10.1007/s10067-011-1686-5; Zhao L, 2013, CYTOKINE, V64, P22, DOI 10.1016/j.cyto.2013.07.006; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423	43	10	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1416	+		10.1016/j.jaci.2016.12.969	http://dx.doi.org/10.1016/j.jaci.2016.12.969			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28189770	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000414304300021
J	Oue, S; Ramezanpour, M; Paramasivan, S; Miljkovic, D; Cooksley, CM; Bassiouni, A; Ou, J; Psaltis, AJ; Wormald, PJ; Vreugde, S				Oue, Sakiko; Ramezanpour, Mahnaz; Paramasivan, Sathish; Miljkovic, Dijana; Cooksley, Clare M.; Bassiouni, Ahmed; Ou, Judy; Psaltis, Alkis J.; Wormald, Peter-John; Vreugde, Sarah			Increased IL-13 expression is independently associated with neo-osteogenesis in patients with chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BONE-RESORPTION; OSTEITIC BONE; OSTEOBLASTS; PATHWAY; MARKER		[Oue, Sakiko; Ramezanpour, Mahnaz; Paramasivan, Sathish; Miljkovic, Dijana; Cooksley, Clare M.; Bassiouni, Ahmed; Ou, Judy; Psaltis, Alkis J.; Wormald, Peter-John; Vreugde, Sarah] Univ Adelaide, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia	University of Adelaide	Vreugde, S (corresponding author), Univ Adelaide, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia.	sarah.vreugde@adelaide.edu.au		Ou, Judy/0000-0002-3085-5814; Bassiouni, Ahmed/0000-0002-5545-0194; Psaltis, Alkis/0000-0003-2967-1855	Garnett Passe and Rodney Williams Memorial Foundation	Garnett Passe and Rodney Williams Memorial Foundation	Supported by a Conjoint Grant from the Garnett Passe and Rodney Williams Memorial Foundation (to P.-J.W. and S.V.).	Bassiouni A, 2016, INT FORUM ALLERGY RH, V6, P248, DOI 10.1002/alr.21661; Georgalas C, 2010, CLIN OTOLARYNGOL, V35, P455, DOI 10.1111/j.1749-4486.2010.02218.x; Kahai S, 2004, MATRIX BIOL, V23, P445, DOI 10.1016/j.matbio.2004.09.004; Lam K, 2016, INT FORUM ALLERGY RH, V6, P935, DOI 10.1002/alr.21780; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Onoe Y, 1996, J IMMUNOL, V156, P758; Palmqvist P, 2006, J BIOL CHEM, V281, P2414, DOI 10.1074/jbc.M510160200; Perloff JR, 2000, LARYNGOSCOPE, V110, P2095, DOI 10.1097/00005537-200012000-00023; Ramezanpour M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9798206; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Snidvongs K, 2012, RHINOLOGY, V50, P299, DOI [10.4193/Rhin12.022, 10.4193/Rhino12.022]; Tuszynska A, 2010, RHINOLOGY, V48, P415, DOI 10.4193/Rhino09.087; Videler WJM, 2011, RHINOLOGY, V49, P139, DOI 10.4193/Rhino10.158; Wheeler B, 2010, LMPERM PERMUTATIONAL	14	10	10	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1444	+		10.1016/j.jaci.2017.05.021	http://dx.doi.org/10.1016/j.jaci.2017.05.021			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28601687				2022-12-18	WOS:000414304300028
J	Tschudy, MM; Sharfstein, J; Matsui, E; Barnes, CS; Chacker, S; Codina, R; Cohn, JR; Sandel, M; Wedner, HJ				Tschudy, Megan M.; Sharfstein, Joshua; Matsui, Elizabeth; Barnes, Charles S.; Chacker, Stacey; Codina, Rosa; Cohn, John R.; Sandel, Megan; Wedner, H. James			Something new in the air: Paying for community-based environmental approaches to asthma prevention and control	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; environmental interventions; health care payment	RANDOMIZED CONTROLLED-TRIAL; SECONDHAND SMOKE EXPOSURE; INNER-CITY CHILDREN; PRACTICE PARAMETER; RESPIRATORY SYMPTOMS; CLINICAL-TRIAL; INTERVENTION; MANAGEMENT; REDUCTION; CLEANERS	Despite the recommendation in national asthma guidelines to target indoor environmental exposures, most insurers generally have not covered the outreach, education, environmental assessments, or durable goods integral to home environmental interventions. However, emerging payment approaches offer new potential for coverage of home-based environmental intervention costs. These opportunities are becoming available as public and private insurers shift reimbursement to reward better health outcomes, and their key characteristic is a focus on the value rather than the volume of services. These new payment models for environmental interventions can be divided into 2 categories: enhanced fee-for-service reimbursement and set payments per patient that cover asthma-related costs. Several pilot programs across the United States are underway, and as they prove their value and as payment increasingly becomes aligned with better outcomes at lower cost, these efforts should have a bright future. Physicians should be aware that these new possibilities are emerging for payment of the goods and services needed for indoor environmental interventions for their patients with asthma.	[Tschudy, Megan M.] Johns Hopkins Sch Med, Dept Pediat, Div Gen Pediat & Adolescent Med, Baltimore, MD USA; [Matsui, Elizabeth] Johns Hopkins Sch Med, Div Pediat Allergy Immunol, Baltimore, MD USA; [Sharfstein, Joshua] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Barnes, Charles S.] Childrens Mercy Hosp, Allergy Immunol Div, Kansas City, MO 64108 USA; [Chacker, Stacey] Asthma Reg Council New England, Hlth Resources Act, Boston, MA USA; [Codina, Rosa] Allergen Sci & Consulting, Lenoir, NC USA; [Cohn, John R.] Jefferson Univ, Philadelphia, PA USA; [Sandel, Megan] Boston Univ, Pediat & Publ Hlth, Natl Ctr Med Legal Partnership, Boston, MA 02215 USA; [Wedner, H. James] Washington Univ, Sch Med, St Louis, MO USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Children's Mercy Hospital; Jefferson University; Boston University; Washington University (WUSTL)	Matsui, E (corresponding author), Johns Hopkins Univ, Pediat, 600 North Wolfe St,CMSC 1102, Baltimore, MD 21287 USA.	ematsui@jhmi.edu		Matsui, Elizabeth/0000-0001-8134-5593	Environmental Protection Agency; Department of Housing and Urban Development; National Institutes of Health (NIH); Church and Dwight; Shire; Genentech; Stallergenes; Merck; CSL Behring	Environmental Protection Agency(United States Environmental Protection Agency); Department of Housing and Urban Development; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Church and Dwight; Shire; Genentech(Roche HoldingGenentech); Stallergenes; Merck(Merck & Company); CSL Behring	E. Matsui has consultant arrangements with the Environmental Defense Fund and Church and Dwight, has received payment for lectures from Indoor Biotechnologies and Thermo Fisher, and has contracts from Thermo Fisher and Inspirotec for research projects. C. S. Barnes has consultant arrangements with Clorox Corporation; is employed by Children's Mercy Hospital; has received grants from the Environmental Protection Agency, the Department of Housing and Urban Development, the National Institutes of Health (NIH), and Church and Dwight; and has received payment for lectures and travel support from the American Academy of Allergy, Asthma & Immunology (AAAAI). H. J. Wedner has provided expert testimony for Appotex Pharmaceuticals; has received grants from Shire, Genentech, Stallergenes, and Merck; and has received payment for lectures from Shire, CSL Behring, and Genentech. The rest of the authors declare that they have no relevant conflicts of interest.	Amr S, 2003, ANN ALLERG ASTHMA IM, V90, P34, DOI 10.1016/S1081-1206(10)63611-3; [Anonymous], 2013, SECT; Asthma Community Network, ASTHM CHANG PACK; Belanger K, 2006, AM J RESP CRIT CARE, V173, P297, DOI 10.1164/rccm.200408-1123OC; Brush R., 2013, COMMUN DEV INVEST RE, V9, P115; Burton A, 2013, MEDICAID FUNDING COM; Butz AM, 2011, ARCH PEDIAT ADOL MED, V165, P741, DOI 10.1001/archpediatrics.2011.111; CDC, COMM GUID ASTHM CONT; CDC National Asthma Control Program, 2013, ASTHM SELF MAN ED EN; Center for Healthcare Quality and Payment Reform, GUID PHYS FOC ALT PA; Cohn JR, 2011, ENT-EAR NOSE THROAT, V90, P244, DOI 10.1177/014556131109000601; DiMango E, 2016, J ALLER CL IMM-PRACT, V4, P671, DOI 10.1016/j.jaip.2016.01.016; Eakin MN, 2014, AM J RESP CRIT CARE, V189, P1530, DOI 10.1164/rccm.201404-0618OC; Eggleston PA, 2005, ANN ALLERG ASTHMA IM, V95, P518, DOI 10.1016/S1081-1206(10)61012-5; Emmons KM, 2001, PEDIATRICS, V108, P18, DOI 10.1542/peds.108.1.18; Environmental Protection Agency, 402K01001 EPA; Environmental Protection Agency, IND AIR QUAL TOOLS S; Eyster L, 2013, PROMISING APPROACHES; Hansel NN, 2008, ENVIRON HEALTH PERSP, V116, P1428, DOI 10.1289/ehp.11349; Hernandez M, SOCAL IMPACT BONDS C; Krieger J, 2009, ARCH PEDIAT ADOL MED, V163, P141, DOI 10.1001/archpediatrics.2008.532; Krieger JW, 2011, AM J PREV MED, V41, pS48, DOI 10.1016/j.amepre.2011.05.010; Krieger JW, 2005, AM J PUBLIC HEALTH, V95, P652, DOI 10.2105/AJPH.2004.042994; Lanphear BP, 2011, PEDIATRICS, V127, P93, DOI 10.1542/peds.2009-2312; Margellos-Anast H, 2012, J ASTHMA, V49, P380, DOI 10.3109/02770903.2012.660295; Matsui EC, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2589; McCormack MC, 2011, ANN ALLERG ASTHMA IM, V106, P308, DOI 10.1016/j.anai.2011.01.015; Miller H.D., 2015, BUILDING BLOCKS SUCC; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; National Heart Lung and Blood Institute (NHLBI), 2019, NHLBI WHO WORKSH REP; Nemours and Trust for America's Health, MED REIMB COMM BAS P; Patel K, HLTH AFFAIRS BLOG; Permaul P, 2013, ANN ALLERG ASTHMA IM, V111, P299, DOI 10.1016/j.anai.2013.07.028; Phipatanakul W, 2012, ANN ALLERG ASTHMA IM, V109, P375, DOI 10.1016/j.anai.2012.09.019; Portnoy J, 2013, J ALLERGY CLIN IMMUN, V132, pe1; Portnoy J, 2013, ANN ALLERG ASTHMA IM, V111, P465, DOI 10.1016/j.anai.2013.09.018; Portnoy J, 2013, J ALLERGY CLIN IMMUN, V132, P802, DOI 10.1016/j.jaci.2013.04.061; US Environmental Protection Agency, OPT HLTH ASTHM MAN P; Yamaya M, 2001, CLIN EXP ALLERGY, V31, P417, DOI 10.1046/j.1365-2222.2001.01013.x	39	10	10	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1244	1249		10.1016/j.jaci.2016.12.975	http://dx.doi.org/10.1016/j.jaci.2016.12.975			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28192148	Bronze, Green Published			2022-12-18	WOS:000414304300004
J	Hamid, F; Versteeg, SA; Wiria, AE; Wammes, LJ; Wahyuni, S; Supali, T; Sartono, E; van Ree, R; Yazdanbakhsh, M				Hamid, Firdaus; Versteeg, Serge A.; Wiria, Aprilianto E.; Wammes, Linda J.; Wahyuni, Sitti; Supali, Taniawati; Sartono, Erliyani; van Ree, Ronald; Yazdanbakhsh, Maria			Molecular diagnostics and lack of clinical allergy in helminth-endemic areas in Indonesia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IGE ANTIBODIES		[Hamid, Firdaus] Hasanuddin Univ, Fac Med, Dept Microbiol, Makassar, Indonesia; [Hamid, Firdaus; Wiria, Aprilianto E.; Wammes, Linda J.; Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Versteeg, Serge A.; van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Wiria, Aprilianto E.] Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia; [Wahyuni, Sitti] Hasanuddin Univ, Fac Med, Dept Parasitol, Makassar, Indonesia; [van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Amsterdam, Netherlands; [Wammes, Linda J.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Universitas Hasanuddin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Indonesia; Universitas Hasanuddin; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Yazdanbakhsh, M (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands.; van Ree, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands.	r.vanree@amc.uva.nl; m.yazdanbakhsh@lumc.nl	Yazdanbakhsh, Maria/AAI-3996-2020; Wiria, Aprilianto Eddy/AAZ-2419-2021; hamid, firdaus/M-6862-2017	Yazdanbakhsh, Maria/0000-0002-7666-1441; Wiria, Aprilianto Eddy/0000-0002-6482-424X; hamid, firdaus/0000-0003-1788-0836	Royal Netherlands Academy of Arts and Science (Koninklijke Nederlandse Akademie van Wetenschappen [KNAW]) [KNAW-05-PP-35]; European Commission [INCO-CT-2006-031714, INCO-CT-2006-032436]; European Academy of Allergy and Clinical Immunology; Directorate General of Higher Education (DIKTI, Pendidikan Tinggi) Ministry of Education Culture of the Republic of Indonesia	Royal Netherlands Academy of Arts and Science (Koninklijke Nederlandse Akademie van Wetenschappen [KNAW]); European Commission(European CommissionEuropean Commission Joint Research Centre); European Academy of Allergy and Clinical Immunology; Directorate General of Higher Education (DIKTI, Pendidikan Tinggi) Ministry of Education Culture of the Republic of Indonesia	This study was funded by the Royal Netherlands Academy of Arts and Science (Koninklijke Nederlandse Akademie van Wetenschappen [KNAW], Ref. KNAW-05-PP-35) and European Commission contracts (INCO-CT-2006-031714 and INCO-CT-2006-032436). F.H. has received the European Academy of Allergy and Clinical Immunology Exchange Research Fellowship 2012 and a scholarship from the Directorate General of Higher Education (DIKTI, Pendidikan Tinggi) 2013 of the Ministry of Education Culture of the Republic of Indonesia.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Amoah AS, 2013, J ALLERGY CLIN IMMUN, V132, P639, DOI 10.1016/j.jaci.2013.04.023; Cabauatan CR, 2014, J ALLERGY CLIN IMMUN, V133, P910, DOI 10.1016/j.jaci.2013.10.004; Hamid F, 2015, CURR TOP MICROBIOL, V388, P91, DOI 10.1007/978-3-319-13725-4_5; Hamid F, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-83; Mari A, 2008, ALLERGY, V63, P891, DOI 10.1111/j.1398-9995.2008.01703.x; Passalacqua G, 2013, ALLERGY, V68, P1029, DOI 10.1111/all.12194; Wammes LJ, 2014, LANCET INFECT DIS, V14, P1150, DOI 10.1016/S1473-3099(14)70771-6; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	10	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					1196	+		10.1016/j.jaci.2017.04.040	http://dx.doi.org/10.1016/j.jaci.2017.04.040			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28550987	Bronze			2022-12-18	WOS:000412172900044
J	Archila, LD; Khan, FS; Bhatnagar, N; Robinson, D; Farrington, ML; Kwok, WW				Archila, L. Diego; Khan, Fatima S.; Bhatnagar, Nupur; Robinson, David; Farrington, Mary L.; Kwok, William W.			alpha(S1)-Casein elucidate major T-cell responses in cow's milk allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NATURAL-HISTORY; DIAGNOSIS; EPITOPES; ANTIGEN		[Archila, L. Diego; Khan, Fatima S.; Bhatnagar, Nupur; Kwok, William W.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Robinson, David; Farrington, Mary L.] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Khan, Fatima S.; Kwok, William W.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Kwok, WW (corresponding author), Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA.; Kwok, WW (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	bkwok@benaroyaresearch.org			National Institutes of Health [HHSN272200700046c]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health (contract no. HHSN272200700046c).	Archila LD, 2015, J ALLERGY CLIN IMMUN, V136, P983, DOI 10.1016/j.jaci.2015.01.029; Elsayed S, 2004, MOL IMMUNOL, V41, P1225, DOI 10.1016/j.molimm.2004.05.010; Fiocchi A, 2011, CURR OPIN ALLERGY CL, V11, P216, DOI 10.1097/ACI.0b013e32834694ef; Kwok WW, 2010, J ALLERGY CLIN IMMUN, V125, P1407, DOI 10.1016/j.jaci.2010.03.037; Kwok WW, 2000, J IMMUNOL, V164, P4244, DOI 10.4049/jimmunol.164.8.4244; Mackenzie KJ, 2014, P NATL ACAD SCI USA, V111, pE784, DOI 10.1073/pnas.1316178111; Michaud B, 2014, ALLERGY, V69, P1473, DOI 10.1111/all.12484; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Novak EJ, 2001, J IMMUNOL, V166, P6665, DOI 10.4049/jimmunol.166.11.6665; Skripak JM, 2007, J ALLERGY CLIN IMMUN, V120, P1172, DOI 10.1016/j.jaci.2007.08.023; Spergel JM, 2013, J ALLERGY CLIN IMMUN, V131, P813, DOI 10.1016/j.jaci.2013.01.027; Vila L, 2001, CLIN EXP ALLERGY, V31, P1599, DOI 10.1046/j.1365-2222.2001.01218.x; Wal JM, 1998, ALLERGY, V53, P1013, DOI 10.1111/j.1398-9995.1998.tb03811.x	13	10	12	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2017	140	3					854	+		10.1016/j.jaci.2017.02.028	http://dx.doi.org/10.1016/j.jaci.2017.02.028			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FF8CA	28343843	Green Accepted, Bronze			2022-12-18	WOS:000409241500024
J	Feng, J; Luo, JL; Mack, MR; Yang, P; Zhang, F; Wang, G; Gong, X; Cai, T; Mei, ZN; Kim, BS; Yin, SJ; Hu, HZ				Feng, Jing; Luo, Jialie; Mack, Madison R.; Yang, Pu; Zhang, Feng; Wang, Guan; Gong, Xuan; Cai, Tao; Mei, Zhinan; Kim, Brian S.; Yin, Shijin; Hu, Hongzhen			The antimicrobial peptide human beta-defensin 2 promotes itch through Toll-like receptor 4 signaling in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ACTIVATION; PAIN		[Feng, Jing; Luo, Jialie; Yang, Pu; Hu, Hongzhen] Washington Univ, Sch Med, Dept Anesthesiol, Ctr Study Itch, St Louis, MO 63110 USA; [Mack, Madison R.; Kim, Brian S.] Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA; [Zhang, Feng; Wang, Guan; Gong, Xuan; Mei, Zhinan; Yin, Shijin] South Cent Univ Nationalities, Coll Pharm, Wuhan, Hubei, Peoples R China; [Cai, Tao] Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); South Central Minzu University; Chongqing Medical University	Yin, SJ (corresponding author), South Cent Univ Nationalities, Coll Pharm, Wuhan, Hubei, Peoples R China.	yinshijinyf@163.com; hongzhen.hu@wustl.edu	Feng, Jing/C-1729-2018; Kim, Brian/GZK-6649-2022	Feng, Jing/0000-0001-6726-7912; Kim, Brian/0000-0002-8100-7161; Hu, Hongzhen/0000-0002-8967-7522; Mei, Zhinan/0000-0002-2354-8787	National Institutes of Health [R01GM101218, R01DK103901]; Center for the Study of Itch of the Department of Anesthesiology at Washington University School of Medicine; National Natural Science Foundation of China [81373379]; Natural Science Fund of Hubei Province [2015CFB491]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR065577, R01AR070116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK103901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for the Study of Itch of the Department of Anesthesiology at Washington University School of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Hubei Province; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported partly by grants from the National Institutes of Health (grant nos. R01GM101218 and R01DK103901 to H.H.), the Center for the Study of Itch of the Department of Anesthesiology at Washington University School of Medicine (to H.H.), the National Natural Science Foundation of China (grant no. 81373379 to S.Y.), and the Natural Science Fund of Hubei Province (grant no. 2015CFB491 to S.Y.).	Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Broggi A, 2016, JOVE-J VIS EXP, DOI 10.3791/52589; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; Jansen PAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004725; Liu S, 2016, INT J ANTENN PROPAG, V2016, DOI 10.1155/2016/8109013; Luo JL, 2015, CELL MOL LIFE SCI, V72, P3201, DOI 10.1007/s00018-015-1904-4; Reich A, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/64727; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Suarez-Carmona M, 2015, CYTOKINE GROWTH F R, V26, P361, DOI 10.1016/j.cytogfr.2014.12.005; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yin SJ, 2014, BRIT J PHARMACOL, V171, P1510, DOI 10.1111/bph.12543; Yin SJ, 2013, J CLIN INVEST, V123, P3941, DOI 10.1172/JCI66413; Yosipovitch G, 2000, BRIT J DERMATOL, V143, P969, DOI 10.1046/j.1365-2133.2000.03829.x	14	10	11	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2017	140	3					885	+		10.1016/j.jaci.2017.03.035	http://dx.doi.org/10.1016/j.jaci.2017.03.035			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FF8CA	28442325	Green Accepted, Bronze			2022-12-18	WOS:000409241500036
J	White, SR; Nicodemus-Johnson, J; Laxman, B; Denner, DR; Naureckas, ET; Hogarth, DK; Stern, R; Minc, A; Solway, J; Sperling, A; Ober, C				White, Steven R.; Nicodemus-Johnson, Jessie; Laxman, Bharathi; Denner, Darcy R.; Naureckas, Edward T.; Hogarth, D. Kyle; Stern, Randi; Minc, Alexa; Solway, Julian; Sperling, Anne; Ober, Carole			Elevated levels of soluble human leukocyte antigen-G in the airways are a marker for a low-inflammatory endotype of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HLA-G; GENE		[White, Steven R.; Laxman, Bharathi; Denner, Darcy R.; Naureckas, Edward T.; Hogarth, D. Kyle; Stern, Randi; Minc, Alexa; Solway, Julian; Sperling, Anne] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Nicodemus-Johnson, Jessie; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Nicodemus-Johnson, Jessie] USANA Hlth Sci, Salt Lake City, UT USA	University of Chicago; University of Chicago	White, SR (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	swhite@bsd.uchicago.edu	Sperling, Anne/ACZ-2351-2022	Sperling, Anne I./0000-0002-4265-9212; Ober, Carole/0000-0003-4626-9809	National Institute for Allergy and Infectious Diseases [U19 AI095230]; National Heart, Lung and Blood Institute [T32 HL007605]; National Center for Advancing Translational Sciences [UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL096383, T32HL007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095230] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute for Allergy and Infectious Diseases (grant no. U19 AI095230), the National Heart, Lung and Blood Institute (grant no. T32 HL007605), and the National Center for Advancing Translational Sciences (grant no. UL1 TR000430 to the Institute for Translational Medicine of the University of Chicago).	FUJII T, 1994, J IMMUNOL, V153, P5516; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; Nicodemus-Johnson J, 2013, J ALLERGY CLIN IMMUN, V131, P1496, DOI 10.1016/j.jaci.2013.01.037; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Rouas-Freiss N, 2007, TRANSPLANTATION, V84, pS21, DOI 10.1097/01.tp.0000269117.32179.1c; Tahan F, 2006, INT ARCH ALLERGY IMM, V141, P213, DOI 10.1159/000095290; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; White SR, 2010, EUR RESPIR J, V35, P925, DOI 10.1183/09031936.00164809; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	10	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2017	140	3					857	860		10.1016/j.jaci.2017.02.031	http://dx.doi.org/10.1016/j.jaci.2017.02.031			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FF8CA	28363527	Bronze, Green Accepted			2022-12-18	WOS:000409241500025
J	Krug, N; Hohlfeld, JM; Buhl, R; Renz, J; Garn, H; Renz, H				Krug, Norbert; Hohlfeld, Jens M.; Buhl, Roland; Renz, Jonas; Garn, Holger; Renz, Harald			Blood eosinophils predict therapeutic effects of a GATA3-specific DNAzyme in asthma patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GATA-3-SPECIFIC DNAZYME; RESPONSES; EXPOSURE; INNATE; HGD40		[Krug, Norbert; Hohlfeld, Jens M.] Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany; [Buhl, Roland] Univ Hosp Mainz, Pulm Dept, Med Ctr 3, Mainz, Germany; [Renz, Jonas] Sterna Biol GmbH & Co KG, Marburg, Germany; [Garn, Holger; Renz, Harald] Philipps Univ Marburg, Inst Lab Med, Marburg, Germany	Fraunhofer Gesellschaft; University Hospital Mainz; Philipps University Marburg	Renz, H (corresponding author), Philipps Univ Marburg, Inst Lab Med, Marburg, Germany.	harald.renz@uk-gm.de		Garn, Holger/0000-0002-5178-4023	Sterna Biologicals GmbH & Co. KG (Marburg, Germany)	Sterna Biologicals GmbH & Co. KG (Marburg, Germany)	The study was funded by Sterna Biologicals GmbH & Co. KG (Marburg, Germany).	Brusselle GG, 2013, NAT MED, V19, P977, DOI 10.1038/nm.3300; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Dicke T, 2012, NUCLEIC ACID THER, V22, P117, DOI 10.1089/nat.2011.0294; Fuhst R, 2013, PULM PHARMACOL THER, V26, P281, DOI 10.1016/j.pupt.2012.12.005; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Sel S, 2008, J ALLERGY CLIN IMMUN, V121, P910, DOI 10.1016/j.jaci.2007.12.1175; Turowska A, 2013, TOXICOL APPL PHARM, V272, P365, DOI 10.1016/j.taap.2013.06.020	9	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2017	140	2					625	+		10.1016/j.jaci.2017.02.024	http://dx.doi.org/10.1016/j.jaci.2017.02.024			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC5BK	28342914	Bronze			2022-12-18	WOS:000406855500048
J	Oliveria, JP; Salter, BM; Phan, S; Obminski, CD; Munoz, CE; Smith, SG; Scime, T; Watson, RM; Sehmi, R; Gauvreau, GM				Oliveria, John-Paul; Salter, Brittany M.; Phan, Stephanie; Obminski, Caitlin D.; Munoz, Caroline E.; Smith, Steven G.; Scime, Tara; Watson, Rick M.; Sehmi, Roma; Gauvreau, Gail M.			Asthmatic subjects with allergy have elevated levels of IgE plus B cells in the airways	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PLASMA-CELLS; REPRODUCIBILITY; SPUTUM; CHALLENGE; RHINITIS; TESTS		[Oliveria, John-Paul; Salter, Brittany M.; Phan, Stephanie; Obminski, Caitlin D.; Munoz, Caroline E.; Smith, Steven G.; Scime, Tara; Watson, Rick M.; Sehmi, Roma; Gauvreau, Gail M.] McMaster Univ, Div Respirol, Dept Med, Hamilton, ON, Canada	McMaster University	Gauvreau, GM (corresponding author), McMaster Univ, Div Respirol, Dept Med, Hamilton, ON, Canada.	gauvreau@mcmaster.ca	Oliveria, John-Paul/AAH-8080-2020	Oliveria, John-Paul/0000-0002-7192-7634; Smith, Steven/0000-0001-9928-117X; Gauvreau, Gail/0000-0002-6187-2385				Bousquet J, 2007, ALLERGY, V62, P102, DOI 10.1111/j.1398-9995.2006.01305.x; CLARKE CW, 1982, CLIN ALLERGY, V12, P1, DOI 10.1111/j.1365-2222.1982.tb03120.x; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Gauvreau GM, 2015, EUR RESPIR J, V46, DOI [10.1183/13993003.congress-2015.PA5091, 10.1183/13993003.00536-2015]; Gauvreau GM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008961; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; HENDRICK DJ, 1975, THORAX, V30, P2, DOI 10.1136/thx.30.1.2; Horst A, 2002, CLIN EXP IMMUNOL, V130, P370, DOI 10.1046/j.1365-2249.2002.02025.x; Kidney JC, 1996, AM J RESP CRIT CARE, V153, P540, DOI 10.1164/ajrccm.153.2.8564094; KleinJan A, 2000, EUR RESPIR J, V15, P491, DOI 10.1034/j.1399-3003.2000.15.11.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; PEPYS J, 1975, NEW ENGL J MED, V293, P758; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Samitas K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161161; Sohani ZN, 2011, J ASTHMA, V48, P952, DOI 10.3109/02770903.2011.617477; Wilson DR, 2002, AM J RESP CRIT CARE, V165, P22, DOI 10.1164/ajrccm.165.1.2010112; Wong KJ, 2015, ALLERGY, V70, P420, DOI 10.1111/all.12563; Zurcher AW, 1996, INT ARCH ALLERGY IMM, V111, P77, DOI 10.1159/000237349	18	10	12	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2017	140	2					590	+		10.1016/j.jaci.2016.12.981	http://dx.doi.org/10.1016/j.jaci.2016.12.981			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC5BK	28213181	Bronze			2022-12-18	WOS:000406855500034
J	Zieglmayer, P; Lemell, P; Chen, KW; Schmutz, R; Zieglmayer, R; Pfaar, O; Horak, F; Vrtala, S				Zieglmayer, Petra; Lemell, Patrick; Chen, Kuan Wei; Schmutz, Rene; Zieglmayer, Rene; Pfaar, Oliver; Horak, Friedrich; Vrtala, Susanne			Clinical validation of a house dust mite environmental challenge chamber model	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGEN IMMUNOTHERAPY TRIALS; EXPOSURE; RHINITIS; ASTHMA		[Zieglmayer, Petra; Lemell, Patrick; Schmutz, Rene; Zieglmayer, Rene; Horak, Friedrich] Allergy Ctr Vienna West, Vienna Challenge Chamber, Vienna, Austria; [Chen, Kuan Wei; Vrtala, Susanne] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Pfaar, Oliver] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany; [Pfaar, Oliver] Ctr Rhinol & Allergol, Wiesbaden, Germany	Medical University of Vienna; Ruprecht Karls University Heidelberg	Zieglmayer, P (corresponding author), Allergy Ctr Vienna West, Vienna Challenge Chamber, Vienna, Austria.	petra@zieglmayer.at	Zieglmayer, Petra/AAG-1006-2020	Chen, Kuan-Wei/0000-0001-5899-5766; Vrtala, Susanne/0000-0003-4250-8243; Lemell, Patrick/0000-0003-0262-4047; Schmutz, Rene/0000-0003-2019-3906	Austrian Science Fund (FWF) [F4602]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF; grant no. F4602).	Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Casset A, 2007, J AEROSOL MED, V20, P509, DOI 10.1089/jam.2007.0591; Hohlfeld JM, 2010, CLIN EXP ALLERGY, V40, P998, DOI 10.1111/j.1365-2222.2010.03498.x; Lueer K, 2016, ALLERGY, V71, P1693, DOI 10.1111/all.12947; North ML, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0514-4; Pfaar O, 2014, ALLERGY, V69, P854, DOI 10.1111/all.12383; Rosner-Friese K, 2015, J ALLERGY CLIN IMMUN, V135, P636, DOI 10.1016/j.jaci.2014.10.045; Sander I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052981; Schulze J, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-78; Stubner P, 2004, CURR MED RES OPIN, V20, P891, DOI 10.1185/030079904125003700	10	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					266	+		10.1016/j.jaci.2016.12.986	http://dx.doi.org/10.1016/j.jaci.2016.12.986			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	28238743	Bronze			2022-12-18	WOS:000404542000027
J	Doherty, TA; Broide, DH				Doherty, Taylor A.; Broide, David H.			Pathways to limit group 2 innate lymphoid cell activation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Group 2 innate lymphoid cell; activation	AIRWAY HYPERREACTIVITY; CYTOKINE PRODUCTION; RESPONSIVENESS; HOMEOSTASIS; RESPONSES; DISEASE		[Doherty, Taylor A.; Broide, David H.] Univ Calif San Diego, Dept Med, Biomed Sci Bldg,Rm 5090,9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Broide, DH (corresponding author), Univ Calif San Diego, Dept Med, Biomed Sci Bldg,Rm 5090,9500 Gilman Dr, La Jolla, CA 92093 USA.	tdoherty@ucsd.edu; dbroide@ucsd.edu		Broide, David/0000-0001-8405-9090; Doherty, Taylor/0000-0003-3256-0398	National Institutes of Health; Janssen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114585, U19AI070535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T. A. Doherty and D. H. Broide receive research support from the National Institutes of Health and Janssen (D.H.B.).	Almeida FF, 2016, MUCOSAL IMMUNOL, V9, P1103, DOI 10.1038/mi.2016.64; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Chang JE, 2014, J ALLERGY CLIN IMMUN, V133, P899, DOI 10.1016/j.jaci.2013.09.020; Doherty TA, 2015, J LEUKOCYTE BIOL, V97, P455, DOI 10.1189/jlb.5BT0814-374R; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Galle-Treger L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13202; Kudo F, 2016, IMMUNOLOGY, V147, P21, DOI 10.1111/imm.12537; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Mchedlidze T, 2016, MUCOSAL IMMUNOL, V9, P1384, DOI 10.1038/mi.2016.20; Miyazaki M, 2014, NAT IMMUNOL, V15, P767, DOI 10.1038/ni.2928; Rigas D, 2017, J ALLERGY CLIN IMMUN, V139, P1468, DOI 10.1016/j.jaci.2016.08.034; Toki S, 2016, THORAX, V71, P633, DOI 10.1136/thoraxjnl-2015-207728; Walford HH, 2014, CLIN IMMUNOL, V155, P126, DOI 10.1016/j.clim.2014.09.007; Zhou WS, 2016, AM J RESP CRIT CARE, V193, P31, DOI 10.1164/rccm.201410-1793OC	14	10	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1465	1467		10.1016/j.jaci.2016.12.003	http://dx.doi.org/10.1016/j.jaci.2016.12.003			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28087226	Green Accepted, Bronze			2022-12-18	WOS:000400465300006
J	Marild, K; Vistnes, M; Tapia, G; Midttun, O; Ueland, PM; Viken, MK; Magnus, P; Berg, JP; Stene, LC; Stordal, K				Marild, Karl; Vistnes, Maria; Tapia, German; Midttun, Oivind; Ueland, Per M.; Viken, Marte K.; Magnus, Per; Berg, Jens P.; Stene, Lars C.; Stordal, Ketil			Midpregnancy and cord blood immunologic biomarkers, HLA genotype, and pediatric celiac disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NORWEGIAN MOTHER; CHILD COHORT; PLASMA		[Marild, Karl; Vistnes, Maria; Tapia, German; Magnus, Per; Stene, Lars C.; Stordal, Ketil] Norwegian Inst Publ Hlth, Oslo, Norway; [Vistnes, Maria] Diakonhjemmet Hosp, Dept Internal Med, Oslo, Norway; [Midttun, Oivind] Bevital AS, Bergen, Norway; [Ueland, Per M.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Ueland, Per M.] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway; [Viken, Marte K.] Oslo Univ Hosp, Rikshosp, Dept Immunol, Oslo, Norway; [Berg, Jens P.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Berg, Jens P.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Stordal, Ketil] Ostfold Hosp Trust, Dept Pediat, Gralum, Norway	Norwegian Institute of Public Health (NIPH); Diakonhjemmet Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Marild, K (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.	karlmarild@gmail.com	Ueland, Per M/C-7340-2013; Berg, Jens P/G-1455-2012; Tapia, German/AAS-8467-2020	Berg, Jens P/0000-0003-0157-5888; Tapia, German/0000-0002-1770-1183; Ueland, Per Magne/0000-0002-1903-0571; Viken, Marte Kathrine/0000-0002-3917-9269; Vistnes, Maria/0000-0002-6243-0626	Norwegian Ministry of Health and Care Services; Ministry of Education and Research; National Institutes of Health (NIH)/National Institute of Environmental Health Sciences (NIEHS) [N01-ES-75558]; NIH/National Institute of Neurological Disorders and Stroke (NINDS) [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; Norwegian Research Council [221909/F20]; Helse Sor-Ost; Oak Foundation, Geneva, Switzerland	Norwegian Ministry of Health and Care Services; Ministry of Education and Research; National Institutes of Health (NIH)/National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Helse Sor-Ost; Oak Foundation, Geneva, Switzerland	The Norwegian Mother and Child Cohort Study (MoBa) was supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, National Institutes of Health (NIH)/National Institute of Environmental Health Sciences (NIEHS) (contract no. N01-ES-75558), NIH/National Institute of Neurological Disorders and Stroke (NINDS) (grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1). This subproject within MoBa is supported by the Norwegian Research Council (grant no. 221909/F20). The genotyping service for this study was financed by Helse Sor-Ost. K.S. was funded through an unrestricted grant from Oak Foundation, Geneva, Switzerland. The funding sources did not influence the design, conduct, and reporting of the present study.	Green PHR, 2015, J ALLERGY CLIN IMMUN, V135, P1099, DOI 10.1016/j.jaci.2015.01.044; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Lindehammer SR, 2011, AUTOIMMUNITY, V44, P445, DOI 10.3109/08916934.2010.549530; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; Marild K, 2016, ACTA PAEDIATR, V105, P366, DOI 10.1111/apa.13150; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Radunovic N, 1999, AM J OBSTET GYNECOL, V181, P170, DOI 10.1016/S0002-9378(99)70455-2; Skevaki C, 2016, J ALLERGY CLIN IMMUN, V137, P1302, DOI 10.1016/j.jaci.2016.03.012; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998	9	10	10	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1696	1698		10.1016/j.jaci.2016.10.016	http://dx.doi.org/10.1016/j.jaci.2016.10.016			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	27865861	Bronze			2022-12-18	WOS:000400465300036
J	Forno, E				Forno, Erick			Childhood obesity and asthma: To BMI or not to BMI?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Childhood asthma; obese asthma; exhaled nitric oxide	VISCERAL FAT; CHILDREN; ADOLESCENTS		[Forno, Erick] Univ Pittsburgh, Sch Med, Div Pulm Med, Pittsburgh, PA USA; [Forno, Erick] Childrens Hosp Pittsburgh UPMC, Univ Pittsburgh, Sch Med, Div Pulm Med Allergy & Immunol, 4401 Penn Ave, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Forno, E (corresponding author), Childrens Hosp Pittsburgh UPMC, Univ Pittsburgh, Sch Med, Div Pulm Med Allergy & Immunol, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	erick.forno@chp.edu	Forno, Erick/I-1476-2019	Forno, Erick/0000-0001-6497-9885	National Institutes of Health [HL125666]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL125666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health grant no. HL125666.	Bruske I, 2014, CURR OPIN ALLERGY CL, V14, P155, DOI 10.1097/ACI.0000000000000035; Carpio C, 2016, J ALLERGY CLIN IMMUN, V137, P718, DOI 10.1016/j.jaci.2015.11.010; Celedon JC, 2014, NAT MED, V20, P20, DOI 10.1038/nm.3433; Chen YC, 2014, AM J RESP CRIT CARE, V189, P1194, DOI 10.1164/rccm.201401-0097OC; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; den Dekker HT, 2017, J ALLERGY CLIN IMMUN, V139, P810, DOI 10.1016/j.jaci.2016.06.022; Forno E, 2014, J ALLERGY CLIN IMMUN, V133, pe1; Forno E, 2015, J ALLERGY CLIN IMMUN, V136, P304, DOI 10.1016/j.jaci.2015.01.010; Forno E, 2014, J ALLERGY CLIN IMMUN, V133, P1308, DOI 10.1016/j.jaci.2013.09.041; Hacihamdioglu B, 2014, ULTRASOUND MED BIOL, V40, P871, DOI 10.1016/j.ultrasmedbio.2013.11.014; Keys A, 2014, INT J EPIDEMIOL, V43, P655, DOI 10.1093/ije/dyu058; Lang JE, 2015, J ALLERGY CLIN IMMUN, V135, P886, DOI 10.1016/j.jaci.2014.08.029; National Institutes of Health, 1985, HLTH IMPL OB, P1; Onitsuka Y, 2014, INTERNAL MED, V53, P545, DOI 10.2169/internalmedicine.53.1294; Quetelet Adolphe, 2013, TREATISE MAN DEV HIS; Shore SA., 1985, J APPL PHYSIOL, V2007, P516; Tadokoro N, 2010, J ATHEROSCLER THROMB, V17, P546, DOI 10.5551/jat.3251; Tamura A, 2000, PEDIATR INT, V42, P155, DOI 10.1046/j.1442-200x.2000.01197.x; Vijayakanthi N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-0812; Zhang ZM, 2010, J ALLERGY CLIN IMMUN, V126, P1157, DOI 10.1016/j.jaci.2010.09.011	20	10	11	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					767	768		10.1016/j.jaci.2016.08.020	http://dx.doi.org/10.1016/j.jaci.2016.08.020			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	27658759	Green Accepted, Bronze			2022-12-18	WOS:000397295800006
J	Kostjukovits, S; Klemetti, P; Fohr, A; Kajosaari, M; Valta, H; Taskinen, M; Toiviainen-Salo, S; Makitie, O				Kostjukovits, Svetlana; Klemetti, Paula; Fohr, Anna; Kajosaari, Merja; Valta, Helena; Taskinen, Mervi; Toiviainen-Salo, Sanna; Makitie, Outi			High prevalence of bronchiectasis in patients with cartilage-hair hypoplasia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDREN		[Kostjukovits, Svetlana; Klemetti, Paula; Kajosaari, Merja; Valta, Helena; Taskinen, Mervi; Makitie, Outi] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Kostjukovits, Svetlana; Klemetti, Paula; Kajosaari, Merja; Valta, Helena; Taskinen, Mervi; Makitie, Outi] Helsinki Univ Hosp, Helsinki, Finland; [Kostjukovits, Svetlana; Makitie, Outi] Folkhalsan Res Ctr, Helsinki, Finland; [Fohr, Anna; Toiviainen-Salo, Sanna] Univ Helsinki, Cent Hosp, HUS Med Imaging Ctr, Radiol, Helsinki, Finland; [Makitie, Outi] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Makitie, Outi] Karolinska Univ Hosp, Clin Genet, Stockholm, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Makitie, O (corresponding author), Univ Helsinki, Childrens Hosp, Helsinki, Finland.; Makitie, O (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Makitie, O (corresponding author), Folkhalsan Res Ctr, Helsinki, Finland.; Makitie, O (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.; Makitie, O (corresponding author), Karolinska Univ Hosp, Clin Genet, Stockholm, Sweden.	outi.makitie@helsinki.fi	Toiviainen-Salo, Sanna/HGB-7213-2022; Vakkilainen, Svetlana/O-1768-2014	Toiviainen-Salo, Sanna/0000-0003-1176-8165; Vakkilainen, Svetlana/0000-0002-4573-3297	Sigrid Juselius Foundation; Academy of Finland; Folkhalsan Research Foundation; Helsinki University Hospital Research Funds; Swedish Childhood Cancer Foundation; Foundation for Pediatric Research; Novo Nordisk Fonden [NNF16OC0021322] Funding Source: researchfish	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Folkhalsan Research Foundation; Helsinki University Hospital Research Funds; Swedish Childhood Cancer Foundation(European Commission); Foundation for Pediatric Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded by grants to O.M. from the Sigrid Juselius Foundation, the Academy of Finland, the Folkhalsan Research Foundation, the Helsinki University Hospital Research Funds, and the Swedish Childhood Cancer Foundation, as well as to M.T. from the Helsinki University Hospital Research Funds and the Foundation for Pediatric Research.	Cunningham-Rundles C, 2014, STIEHM IMMUNE DEFICI, p[357, 413]; Daheshia M, 2012, PULM MED, V2012, DOI 10.1155/2012/280528; de la Fuente MA, 2011, J ALLERGY CLIN IMMUN, V128, P139, DOI 10.1016/j.jaci.2011.03.042; Driessen GJ, 2011, BLOOD, V118, P6814, DOI 10.1182/blood-2011-06-361881; Horn J, 2010, HUM IMMUNOL, V71, P916, DOI 10.1016/j.humimm.2010.06.002; Kim HY, 2011, ALLERGY ASTHMA IMMUN, V3, P39, DOI 10.4168/aair.2011.3.1.39; Kotaniemi JT, 2002, J ASTHMA, V39, P649, DOI 10.1081/JAS-120014930; Kwak HJ, 2010, TOHOKU J EXP MED, V222, P237, DOI 10.1620/tjem.222.237; Makitie O, 2000, J PEDIATR-US, V137, P487, DOI 10.1067/mpd.2000.108102; Makitie O, 1998, EUR J PEDIATR, V157, P816, DOI 10.1007/s004310050943; Remes ST, 1998, ALLERGY, V53, P682, DOI 10.1111/j.1398-9995.1998.tb03954.x; Routes JM, 2016, MURRAY NADELS TXB RE, P1631; Schatorje EJH, 2012, SCAND J IMMUNOL, V75, P436, DOI 10.1111/j.1365-3083.2012.02671.x; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Toiviainen-Salo S, 2008, J PEDIATR, V152, P422, DOI 10.1016/j.jpeds.2007.11.040	15	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2017	139	1					375	+		10.1016/j.jaci.2016.07.023	http://dx.doi.org/10.1016/j.jaci.2016.07.023			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EK5WM	27568079	Green Published, Bronze			2022-12-18	WOS:000393996800045
J	Marin, AV; Enez-Reinoso, AJ; Briones, AC; Munoz-Ruiz, M; Aydogmus, C; Pasick, LJ; Couso, J; Mazariegos, MS; Alvarez-Prado, AF; Blazquez-Moreno, A; Cipe, FE; Haskologlu, S; Dogu, F; Morin, M; Moreno-Pelayo, MA; Garcia-Sanchez, F; Gil-Herrera, J; Fernandez-Malave, E; Reyburn, HT; Ramiro, AR; Ikinciogullari, A; Recio, MJ; Regueiro, JR; Garcillan, B				Marin, Ana V.; Enez-Reinoso, Anais Jim; Briones, Alejandro C.; Munoz-Ruiz, Miguel; Aydogmus, Cigdem; Pasick, Luke J.; Couso, Jorge; Mazariegos, Marina S.; Alvarez-Prado, Angel F.; Blazquez-Moreno, Alfonso; Cipe, Funda E.; Haskologlu, Sule; Dogu, Figen; Morin, Matias; Moreno-Pelayo, Miguel A.; Garcia-Sanchez, Felix; Gil-Herrera, Juana; Fernandez-Malave, Edgar; Reyburn, Hugh T.; Ramiro, Almudena R.; Ikinciogullari, Aydan; Recio, Maria J.; Regueiro, Jose R.; Garcillan, Beatriz			Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTIGEN RECEPTOR COMPLEX; REFERENCE VALUES; DEFICIENCY; CHILDREN; PATIENT		[Marin, Ana V.; Enez-Reinoso, Anais Jim; Briones, Alejandro C.; Munoz-Ruiz, Miguel; Pasick, Luke J.; Couso, Jorge; Mazariegos, Marina S.; Fernandez-Malave, Edgar; Recio, Maria J.; Regueiro, Jose R.; Garcillan, Beatriz] Univ Complutense Madrid, Sch Med, Dept Immunol, Madrid, Spain; [Marin, Ana V.; Enez-Reinoso, Anais Jim; Briones, Alejandro C.; Munoz-Ruiz, Miguel; Pasick, Luke J.; Couso, Jorge; Mazariegos, Marina S.; Fernandez-Malave, Edgar; Recio, Maria J.; Regueiro, Jose R.; Garcillan, Beatriz] Hosp 12 Octubre, Hlth Res Inst, Madrid, Spain; [Aydogmus, Cigdem; Cipe, Funda E.] Istanbul Kanuni Sultan Suleyman Hosp, Dept Pediat Immunol, Istanbul, Turkey; [Alvarez-Prado, Angel F.; Ramiro, Almudena R.] Fdn Ctr Nacl Invest Cardiovasc, Cell Biol Lab B, Madrid, Spain; [Blazquez-Moreno, Alfonso; Reyburn, Hugh T.] CSIC, Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain; [Haskologlu, Sule; Dogu, Figen; Ikinciogullari, Aydan] Ankara Univ, Sch Med, Dept Pediat Immunol Allergy, Ankara, Turkey; [Morin, Matias; Moreno-Pelayo, Miguel A.] Ramon y Cajal Univ Hosp, IRYCIS, Madrid, Spain; [Morin, Matias; Moreno-Pelayo, Miguel A.] CIBERER, Madrid, Spain; [Garcia-Sanchez, Felix] Reg Transfus Ctr, Lab Histocompatibil, Madrid, Spain; [Gil-Herrera, Juana] Hosp Gen Univ, Div Immunol, Madrid, Spain; [Gil-Herrera, Juana] Hlth Res Inst Gregorio Maranon, Madrid, Spain; [Garcillan, Beatriz] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia	Complutense University of Madrid; Hospital Universitario 12 de Octubre; Istanbul Kanuni Sultan Suleyman Training & Research Hospital; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); Ankara University; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Melbourne	Regueiro, JR (corresponding author), Univ Complutense Madrid, Sch Med, Dept Immunol, Madrid, Spain.; Regueiro, JR (corresponding author), Hosp 12 Octubre, Hlth Res Inst, Madrid, Spain.	regueiro@ucm.es	Briones, Alejandro/K-3171-2014; Recio, Maria/E-7256-2012; MORIN, MATIAS/H-5411-2011; Álvarez-Prado, Ángel F/AAV-6753-2020; Jiménez Reinoso, Anaïs/K-2453-2014; Regueiro, José R./B-5499-2014; İkinciogullari, Aydan/AAQ-3841-2020; Marin, Ana V./K-2446-2014; Muñoz-Ruiz, Miguel/AAC-3549-2021; Dogu, Figen/AAI-1316-2020; Mazariegos, Marina/ABF-9669-2020; Ramiro, Almudena R/H-6037-2015	Briones, Alejandro/0000-0003-4016-1848; Recio, Maria/0000-0002-6461-1586; MORIN, MATIAS/0000-0002-7985-592X; Álvarez-Prado, Ángel F/0000-0003-0622-2993; Jiménez Reinoso, Anaïs/0000-0001-8229-1881; Regueiro, José R./0000-0001-8442-7762; İkinciogullari, Aydan/0000-0003-1145-0843; Marin, Ana V./0000-0002-7541-3729; Muñoz-Ruiz, Miguel/0000-0001-7986-3527; Dogu, Figen/0000-0002-7869-4941; Pasick, Luke/0000-0003-1776-1730; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098; Mazariegos, Marina/0000-0002-3298-9461; Ramiro, Almudena R/0000-0002-7539-3844; Garcillan, Beatriz/0000-0002-4748-8280	Ministerio de Economia y Competitividad (MINECO) [SAF2011 24235, SAF2012 32293, SAF2014 58752 R, SAF2014 54708-R]; Instituto de Salud Carlos III [RD08-0075-0002, PI11/00298, PI11/02198, PI12/02761, CIBERER_ER16P5AC7282]; Fundacion Lair [2012/0070]; Comunidad de Madrid [S2010/BMD-2316/2326]; Complutense University [CT45/15-CT46/15]; MINECO [BES-2012-055054, SVP2014-068263]; Complutense University; Ministerio de Educacion, Cultura y Deporte	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Lair; Comunidad de Madrid(Comunidad de Madrid); Complutense University; MINECO(Spanish Government); Complutense University; Ministerio de Educacion, Cultura y Deporte(Spanish Government)	This study was supported by Ministerio de Economia y Competitividad (MINECO) (grant nos. SAF2011 24235, SAF2012 32293, SAF2014 58752 R, and SAF2014 54708-R); Instituto de Salud Carlos III (grant nos. RD08-0075-0002 [RIER], PI11/00298, PI11/02198, PI12/02761, and CIBERER_ER16P5AC7282); and Fundacion Lair (grant no. 2012/0070). A.V.M. was supported by Comunidad de Madrid (S2010/BMD-2316/2326) and Complutense University (CT45/15-CT46/15), A.J.-R. by MINECO (grant no. BES-2012-055054), A.B.-M. by MINECO (grant no. SVP2014-068263), M.M.-R. by Complutense University, and B.G. by Ministerio de Educacion, Cultura y Deporte.	Aksu G, 2006, TURKISH J PEDIATR, V48, P19; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Garcillan B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00020; Gil J, 2011, J CLIN INVEST, V121, P3872, DOI 10.1172/JCI44254; Ikinciogullari A, 2004, TURKISH J PEDIATR, V46, P125; Jose ES, 1998, EUR J IMMUNOL, V28, P12; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Marin A.V.M., 2015, LYMPHOSIGN J, V2, P3, DOI [10.14785/lpsn-2014-0012, DOI 10.14785/LPSN-2014-0012]; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Recio MJ, 2007, J IMMUNOL, V178, P2556, DOI 10.4049/jimmunol.178.4.2556; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Roberts JL, 2007, BLOOD, V109, P3198, DOI 10.1182/blood-2006-08-043166; Schatorje EJH, 2012, SCAND J IMMUNOL, V75, P436, DOI 10.1111/j.1365-3083.2012.02671.x; Vales-Gomez M, 2016, J ALLERGY CLIN IMMUN, V137, P942, DOI 10.1016/j.jaci.2015.07.051	14	10	10	1	22	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2017	139	1					347	+		10.1016/j.jaci.2016.06.020	http://dx.doi.org/10.1016/j.jaci.2016.06.020			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EK5WM	27555457	Green Accepted, Bronze			2022-12-18	WOS:000393996800035
J	Perez, L; Morales, KH; Klusaritz, H; Han, XY; Huang, JR; Rogers, M; Bennett, IM; Rand, CS; Ndicu, G; Apter, AJ				Perez, Luzmercy; Morales, Knashawn H.; Klusaritz, Heather; Han, Xiaoyan; Huang, Jingru; Rogers, Marisa; Bennett, Ian M.; Rand, Cynthia S.; Ndicu, Grace; Apter, Andrea J.			A health care navigation tool assesses asthma self-management and health literacy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Adults; asthma; health disparities; health literacy; inhaled corticosteroids; minority groups; numeracy; print literacy; self-management	PATIENT NAVIGATION; INHALED STEROIDS; VALIDATION; ADHERENCE; NUMERACY; ADULTS; QUESTIONNAIRE; BARRIERS; OUTCOMES; SHAME	Background: Self-management of moderate-to-severe asthma depends on the patient's ability to (1) navigate (access health care to obtain diagnoses and treatment), (2) use inhaled corticosteroids (ICSs) properly, and (3) understand ICS function. Objective: We sought to test whether navigation skills (medication recall, knowledge of copay requirements, and ability to provide information needed for a medical visit about a persistent cough unresponsive to medication) are related to other self-management skills and health literacy. Methods: A 21-item Navigating Ability (NAV2) questionnaire was developed, validated, and then read to adults with moderate-to-severe asthma. ICS technique was evaluated by using scales derived from instructions in national guidelines; knowledge of ICS function was evaluated by using a validated 10-item questionnaire. Spearman correlation was computed between NAV2 score and these questionnaires and with numeracy (Asthma Numeracy Questionnaire) and print literacy (Short Test of Functional Health Literacy in Adults). Results: Two hundred fifty adults participated: age, 51 +/- 13 years; 72% female; 65% African American; 10% Latino; 50% with household income of less than $30,000/y; 47% with no more than a 12th-grade education; and 29% experienced hospitalizations for asthma in the prior year. A higher NAV2 score was associated with correct ICS technique (rho = 0.24, P = .0002), knowledge of ICSs (rho = 0.35, P < .001), better print literacy (rho = 0.44, P < .001), and numeracy (rho = 0.41, P < .001). Conclusions: Patients with poor navigational ability are likely to have poor inhaler technique and limited understanding of ICS function, as well as limited numeracy and print literacy. Clinicians should consider these elements of self-management for their effect on asthma care and as a marker of more general health literacy deficits.	[Perez, Luzmercy; Huang, Jingru; Ndicu, Grace; Apter, Andrea J.] Univ Penn, Div Pulm Allergy Crit Care Med, Philadelphia, PA 19104 USA; [Perez, Luzmercy; Morales, Knashawn H.; Klusaritz, Heather; Han, Xiaoyan; Huang, Jingru; Rogers, Marisa; Ndicu, Grace; Apter, Andrea J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Morales, Knashawn H.; Han, Xiaoyan] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Klusaritz, Heather] Univ Penn, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA; [Rogers, Marisa] Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Bennett, Ian M.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Bennett, Ian M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rand, Cynthia S.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Medicine	Apter, AJ (corresponding author), Hosp Univ Penn, 829 Gates Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	apter@mail.med.upenn.edu	han, xiao/HDN-9782-2022; Bennett, Ian/AAH-6133-2019	Perez, Luzmercy/0000-0002-1423-7901	National Institutes of Health/National Heart, Lung, and Blood Institute [R18 HL116285]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R18HL116285] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health/National Heart, Lung, and Blood Institute grant R18 HL116285.	Akinbami Lara J, 2011, Natl Health Stat Report, P1; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2007, 3 NAT I HLTH NAT HEA; Apter AJ, 1998, AM J RESP CRIT CARE, V157, P1810, DOI 10.1164/ajrccm.157.6.9712007; Apter AJ, 2003, J ALLERGY CLIN IMMUN, V111, P1219, DOI 10.1067/mai.2003.1479; Apter AJ, 2006, J ASTHMA, V43, P705, DOI 10.1080/02770900600925585; Apter AJ, 2013, J ASTHMA, V50, P850, DOI 10.3109/02770903.2013.812655; Apter AJ, 2013, J ALLERGY CLIN IMMUN, V132, P321, DOI 10.1016/j.jaci.2013.02.014; Apter AJ, 2009, PATIENT EDUC COUNS, V75, P386, DOI 10.1016/j.pec.2009.01.003; Apter AJ, 2008, J GEN INTERN MED, V23, P2117, DOI 10.1007/s11606-008-0803-x; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Black HL, 2010, J ASTHMA, V47, P913, DOI 10.3109/02770903.2010.506681; Collingridge D, 2015, VALIDATING QUESTIONN; Davis TC, 2002, CA-CANCER J CLIN, V52, P134, DOI 10.3322/canjclin.52.3.134; Diaz-Linhart Y, 2016, SOC WORK PUBLIC HLTH, V31, P504, DOI 10.1080/19371918.2016.1160341; Freeman HP, 2006, J CANCER EDUC, V21, pS11, DOI 10.1207/s15430154jce2101s_4; Freeman HP, 2012, CANCER EPIDEM BIOMAR, V21, P1614, DOI 10.1158/1055-9965.EPI-12-0982; Healthy People, 2010, HLTH PEOPLE 2010 HLT; Juniper EF, 2000, AM J RESP CRIT CARE, V162, P1330, DOI 10.1164/ajrccm.162.4.9912138; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Juniper EF, 2001, RESP MED, V95, P319, DOI 10.1053/rmed.2001.1034; Ko NY, 2016, CANCER-AM CANCER SOC, V122, P2715, DOI 10.1002/cncr.30109; Kutner M, 2006, 2006483 NCES; Loerbroks A, 2016, J ASTHMA, V53, P427, DOI 10.3109/02770903.2015.1099664; Loskutova NY, 2016, J AM BOARD FAM MED, V29, P78, DOI 10.3122/jabfm.2016.01.150048; Matsuoka S, 2016, PATIENT EDUC COUNS, V99, P1026, DOI 10.1016/j.pec.2016.01.003; McKinley RK, 1997, BMJ-BRIT MED J, V314, P193, DOI 10.1136/bmj.314.7075.193; Montori VM, 2005, J GEN INTERN MED, V20, P1071, DOI 10.1111/j.1525-1497.2005.051498.x; Nielsen-Bohlman L, 2003, HLTH LITERACY PRESCR; Nurss JR, 1995, TEST FUNCTIONAL HLTH; O'Conor R, 2015, CHEST, V147, P1307, DOI 10.1378/chest.14-0914; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Parikh NS, 1996, PATIENT EDUC COUNS, V27, P33, DOI 10.1016/0738-3991(95)00787-3; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Rudd RE, 2007, REV ADULT LEARNING L, V7, P175; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Streiner D, 1996, HLTH MEASUREMENT SCA; Wang Monica L, 2015, Prev Med Rep, V2, P664, DOI 10.1016/j.pmedr.2015.08.002; Wolf MS, 2007, J HEALTH COMMUN, V12, P721, DOI 10.1080/10810730701672173	43	10	10	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1593	+		10.1016/j.jaci.2016.08.043	http://dx.doi.org/10.1016/j.jaci.2016.08.043			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	EF0MK	27744030	Green Accepted, Bronze			2022-12-18	WOS:000390019300015
J	Truck, J; Kelly, DF; Taylor, JM; Kienzler, AK; Lester, T; Seller, A; Pollard, AJ; Patel, SY				Truck, Johannes; Kelly, Dominic F.; Taylor, John M.; Kienzler, Anne Kathrin; Lester, Tracy; Seller, Anneke; Pollard, Andrew J.; Patel, Smita Y.			Variable phenotype and discrete alterations of immune phenotypes in CTP synthase 1 deficiency: Report of 2 siblings	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HEALTHY-CHILDREN; REFERENCE VALUES; SUBSETS		[Truck, Johannes; Kelly, Dominic F.; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford, England; [Truck, Johannes; Kelly, Dominic F.; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Taylor, John M.; Lester, Tracy; Seller, Anneke] Oxford Univ Hosp NHS Trust, Churchill Hosp, Oxford Med Genet Labs, Oxford, England; [Kienzler, Anne Kathrin; Patel, Smita Y.] Oxford NIHR Biomed Res Ctr, Clin Immunol Grp, Oxford, England	University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Truck, J (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.; Truck, J (corresponding author), NIHR Oxford Biomed Res Ctr, Oxford, England.	johannes.trueck@kispi.uzh.ch	Trück, Johannes/E-3459-2012	Trück, Johannes/0000-0002-0418-7381; Patel, Smita/0000-0002-6207-2208; Kelly, Dominic/0000-0002-6063-8896; Kienzler, Anne-Kathrin/0000-0002-3082-9210				Bonilla FA, 2015, J ALLERGY CLIN IMMUN, V136, pe1; Bonilla FA, 2015, J ALLERGY CLIN IMMUN, V136, P1186, DOI 10.1016/j.jaci.2015.04.049; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Martin E, 2014, NATURE, V510, P288, DOI 10.1038/nature13386; McAnulty C, PRACTICE GUIDELINES; Piatosa B, 2010, CYTOM PART B-CLIN CY, V78B, P372, DOI 10.1002/cyto.b.20536; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Schatorje EJH, 2012, SCAND J IMMUNOL, V75, P436, DOI 10.1111/j.1365-3083.2012.02671.x; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Taylor GS, 2015, ANNU REV IMMUNOL, V33, P787, DOI 10.1146/annurev-immunol-032414-112326; Truck J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091413	12	10	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1722	+		10.1016/j.jaci.2016.04.059	http://dx.doi.org/10.1016/j.jaci.2016.04.059			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27543071	Bronze, Green Accepted			2022-12-18	WOS:000390019300033
J	Bush, RK				Bush, Robert K.			Advances in allergen immunotherapy in 2015	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergen immunotherapy; clinical trials; immunotherapy	HOUSE-DUST MITE; PEANUT ORAL IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; FOOD ALLERGY; DOUBLE-BLIND; EFFICACY; CELLS; SENSITIZATION; RECOMBINANT; MECHANISMS	The year 2015 saw a significant number of advances in allergen immunotherapy (AIT), and several of these are reviewed in this report. Although AIT has been used for more than 100 years, investigations into optimal treatment approaches and mechanisms are ongoing. Among the highlights was a report by an international group of experts who reviewed AIT guidelines from the major specialty societies and addressed potential unmet needs. Herein, advances in the effectiveness, safety, and mechanisms of sublingual and oral immunotherapy are reviewed. Development of hypoallergenic vaccines to enhance safety, newer routes and regimens to improve efficacy, and biomarkers to monitor immunotherapy are also discussed.	[Bush, Robert K.] Univ Wisconsin, Div Allergy Pulm Crit Care & Sleep Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Bush, RK (corresponding author), Univ Wisconsin, Div Allergy Pulm Crit Care & Sleep Med, Madison, WI USA.; Bush, RK (corresponding author), 600 Highland Ave,K4-9 CSC 9988, Madison, WI 53792 USA.	rkb@medicine.wisc.edu						Akdis CA, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0063-2; Bachert C, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0078-8; Begin P, 2015, J ALLERGY CLIN IMMUN, V135, P1636, DOI 10.1016/j.jaci.2015.03.010; Bohm L, 2015, J IMMUNOL, V194, P887, DOI 10.4049/jimmunol.1401612; Bouchaud G, 2015, J ALLERGY CLIN IMMUN, V136, P197, DOI 10.1016/j.jaci.2014.12.1938; Burks AW, 2015, J ALLERGY CLIN IMMUN, V135, P1240, DOI 10.1016/j.jaci.2014.12.1917; Calderon MA, 2015, J ALLER CL IMM-PRACT, V3, P843, DOI 10.1016/j.jaip.2015.06.019; Caminiti L, 2015, J ALLER CL IMM-PRACT, V3, P532, DOI 10.1016/j.jaip.2015.01.017; Chien CH, 2015, J ALLERGY CLIN IMMUN, V136, P1110, DOI 10.1016/j.jaci.2015.04.018; Couroux P, 2015, CLIN EXP ALLERGY, V45, P974, DOI 10.1111/cea.12488; Di Bona D, 2015, JAMA INTERN MED, V175, P1301, DOI 10.1001/jamainternmed.2015.2840; Dodev TS, 2015, ALLERGY, V70, P720, DOI 10.1111/all.12607; Douladiris N, 2015, J ALLERGY CLIN IMMUN, V136, P493, DOI 10.1016/j.jaci.2015.01.015; Focke-Tejkl M, 2015, J ALLERGY CLIN IMMUN, V135, P1207, DOI 10.1016/j.jaci.2014.09.012; Fox EM, 2015, J ALLERGY CLIN IMMUN, V135, P1341, DOI 10.1016/j.jaci.2014.07.052; Goldberg MR, 2015, J ALLERGY CLIN IMMUN, V136, P1601, DOI 10.1016/j.jaci.2015.05.040; Gomez E, 2015, CLIN EXP ALLERGY, V45, P1542, DOI 10.1111/cea.12578; Gorelik M, 2015, J ALLERGY CLIN IMMUN, V135, P1283, DOI 10.1016/j.jaci.2014.11.010; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Kuitunen M, 2015, ALLERGY, V70, P955, DOI 10.1111/all.12647; Liao W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000701; Linhart B, 2015, J IMMUNOL, V194, P4008, DOI 10.4049/jimmunol.1400402; Maloney J, 2015, ALLERGY, V70, P302, DOI 10.1111/all.12560; Martinez-Botas J, 2015, CLIN EXP ALLERGY, V45, P1071, DOI 10.1111/cea.12528; Mascarell L, 2015, ALLERGY, V70, P408, DOI 10.1111/all.12576; Mondoulet L, 2015, J ALLERGY CLIN IMMUN, V135, P1546, DOI 10.1016/j.jaci.2014.11.028; Moreno Benitez F, 2015, ALLERGY, V70, P1413; Nagai Y, 2015, CLIN EXP ALLERGY, V45, P677, DOI 10.1111/cea.12329; Narisety SD, 2015, J ALLERGY CLIN IMMUN, V135, P1275, DOI 10.1016/j.jaci.2014.11.005; Nelson H, 2015, J ALLER CL IMM-PRACT, V3, P256, DOI 10.1016/j.jaip.2014.09.018; Niederberger V, 2015, J ALLERGY CLIN IMMUN, V136, P1101, DOI 10.1016/j.jaci.2015.03.034; Nolte H, 2015, J ALLERGY CLIN IMMUN, V135, P1494, DOI 10.1016/j.jaci.2014.12.1911; Nony E, 2015, ALLERGY, V70, P795, DOI 10.1111/all.12622; Nowak-Wegrzyn A, 2015, CLIN EXP ALLERGY, V45, P368, DOI 10.1111/cea.12382; Patil SU, 2015, J ALLERGY CLIN IMMUN, V136, P125, DOI 10.1016/j.jaci.2015.03.026; Pitsios C, 2015, ALLERGY, V70, P897, DOI 10.1111/all.12638; Prickett SR, 2015, CLIN EXP ALLERGY, V45, P1015, DOI 10.1111/cea.12554; Rosner-Friese K, 2015, J ALLERGY CLIN IMMUN, V135, P636, DOI 10.1016/j.jaci.2014.10.045; Sastre J, 2015, ALLERGY, V70, P598, DOI 10.1111/all.12575; Sato S, 2015, J ALLERGY CLIN IMMUN, V136, P1131, DOI 10.1016/j.jaci.2015.07.019; Scadding GW, 2015, ALLERGY, V70, P689, DOI 10.1111/all.12608; Schmitt J, 2015, J ALLERGY CLIN IMMUN, V136, P1511, DOI 10.1016/j.jaci.2015.07.038; Senti G, 2015, ALLERGY, V70, P707, DOI 10.1111/all.12600; Senti G, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-014-0047-7; Shamji MH, 2015, J ALLERGY CLIN IMMUN, V135, P913, DOI 10.1016/j.jaci.2014.09.049; Siebeneicher S, 2015, ALLERGY, V70, P1559, DOI 10.1111/all.12732; Subbarayal B, 2015, J ALLERGY CLIN IMMUN, V136, P1680, DOI 10.1016/j.jaci.2015.05.025; Tabatabaian F, 2015, ALLERGY ASTHMA PROC, V36, P100, DOI 10.2500/aap.2015.36.3830; Tang MLK, 2015, J ALLERGY CLIN IMMUN, V135, P737, DOI 10.1016/j.jaci.2014.11.034; Werfel T, 2015, ALLERGY, V70, P1079, DOI 10.1111/all.12666; Wisniewski JA, 2015, CLIN EXP ALLERGY, V45, P1201, DOI 10.1111/cea.12537; Wollmann E, 2015, J ALLERGY CLIN IMMUN, V136, P806, DOI 10.1016/j.jaci.2015.02.034; Worm M, 2015, EXPERT REV CLIN IMMU, V11, P1173, DOI 10.1586/1744666X.2015.1066673; Zidarn M, 2015, ALLERGY, V70, P547, DOI 10.1111/all.12581; Zolkipli Z, 2015, J ALLERGY CLIN IMMUN, V136, P1541, DOI 10.1016/j.jaci.2015.04.045	55	10	10	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1284	1291		10.1016/j.jaci.2016.09.007	http://dx.doi.org/10.1016/j.jaci.2016.09.007			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27817799	Bronze			2022-12-18	WOS:000389542700005
J	Travers, J; Rochman, M; Miracle, CE; Cohen, JP; Rothenberg, ME				Travers, Jared; Rochman, Mark; Miracle, Cora E.; Cohen, Jared P.; Rothenberg, Marc E.			Linking impaired skin barrier function to esophageal allergic inflammation via IL-33	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Cytokines; food allergy; basophils; eosinophils; innate Immunity; barrier function	THYMIC STROMAL LYMPHOPOIETIN; EXPERIMENTAL EOSINOPHILIC ESOPHAGITIS; IN-VIVO; RECEPTOR; MICE; CELL; DIFFERENTIATION; INTERLEUKIN-33; EXPRESSION; ASSOCIATE		[Travers, Jared; Rochman, Mark; Miracle, Cora E.; Cohen, Jared P.; Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave,MLC 7028, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave,MLC 7028, Cincinnati, OH 45229 USA.	Marc.Rothenberg@cchmc.org		Rochman, Mark/0000-0002-0818-927X; Miracle, Cora/0000-0002-8730-6779; Travers, Jared/0000-0003-4786-604X	NIAID NIH HHS [U19 AI070235, R01 AI124355, R37 AI045898] Funding Source: Medline; NIGMS NIH HHS [T32 GM063483] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124355, U19AI070235, R37AI045898] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aceves SS, 2014, CURR OPIN GASTROEN, V30, P391, DOI 10.1097/MOG.0000000000000088; Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Akei HS, 2005, GASTROENTEROLOGY, V129, P985, DOI 10.1053/j.gastro.2005.06.027; Almansa C, 2009, AM J GASTROENTEROL, V104, P828, DOI 10.1038/ajg.2008.169; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Bouffi C, 2013, J IMMUNOL, V191, P4317, DOI 10.4049/jimmunol.1301465; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Davis BP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86355; Davis BP, 2016, ANNU REV PATHOL-MECH, V11, P365, DOI 10.1146/annurev-pathol-012615-044241; Davis BP, 2013, EXPERT REV CLIN IMMU, V9, P285, DOI [10.1586/eci.13.15, 10.1586/ECI.13.15]; Judd LM, 2016, AM J PHYSIOL-GASTR L, V310, pG13, DOI 10.1152/ajpgi.00290.2015; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Lee HY, 2014, EXP LUNG RES, V40, P66, DOI 10.3109/01902148.2013.870261; Mishra A, 2007, J LEUKOCYTE BIOL, V81, P916, DOI 10.1189/jlb.1106653; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Peine M, 2016, TRENDS IMMUNOL, V37, P321, DOI 10.1016/j.it.2016.03.007; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Saluja R, 2015, MOL IMMUNOL, V63, P80, DOI 10.1016/j.molimm.2014.06.018; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Simon D, 2015, ALLERGY, V70, P443, DOI 10.1111/all.12570; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Venturelli N, 2016, J ALLERGY CLIN IMMUN, V138, P1367, DOI 10.1016/j.jaci.2016.02.034; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4; Zoltowska AM, 2016, CLIN EXP ALLERGY, V46, P479, DOI 10.1111/cea.12683	31	10	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1381	1383		10.1016/j.jaci.2016.09.001	http://dx.doi.org/10.1016/j.jaci.2016.09.001			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27664378	Green Accepted, Bronze			2022-12-18	WOS:000389542700017
J	Lovell, JP; Foruraghi, L; Freeman, AF; Uzel, G; Zerbe, CS; Su, H; Hsu, AP; Holland, SM				Lovell, Jana P.; Foruraghi, Ladan; Freeman, Alexandra F.; Uzel, Gulbu; Zerbe, Christa S.; Su, Helen; Hsu, Amy P.; Holland, Steven M.			Persistent nodal histoplasmosis in nuclear factor kappa B essential modulator deficiency: Report of a case and review of infection in primary immunodeficiencies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Lovell, Jana P.; Foruraghi, Ladan; Freeman, Alexandra F.; Uzel, Gulbu; Zerbe, Christa S.; Hsu, Amy P.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Su, Helen] NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Holland, SM (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	smh@nih.gov	Su, Helen C/H-9541-2015	Su, Helen C/0000-0002-5582-9110; Hsu, Amy/0000-0001-6841-2122	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, ZIAAI001059, ZIAAI000647] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000647-16] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Braue J, 2015, MEDITERR J HEMATOL I, V7, DOI 10.4084/MJHID.2015.010; Courtois G, 2011, CURR TOP MICROBIOL, V349, P73, DOI 10.1007/82_2010_98; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Kauffman CA, 2009, CLIN CHEST MED, V30, P217, DOI 10.1016/j.ccm.2009.02.002; Mihu Mircea Radu, 2012, Int J Microbiol, V2012, P268123, DOI 10.1155/2012/268123; Orange JS, 2004, J ALLERGY CLIN IMMUN, V113, P725, DOI 10.1016/j.jaci.2004.01.762; RHEW DC, 1995, CLIN INFECT DIS, V21, P702, DOI 10.1093/clinids/21.3.702; Vignesh KS, 2013, IMMUNITY, V39, P697, DOI 10.1016/j.immuni.2013.09.006	9	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					903	905		10.1016/j.jaci.2016.02.040	http://dx.doi.org/10.1016/j.jaci.2016.02.040			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27266944	Bronze, Green Accepted			2022-12-18	WOS:000385496000030
J	Osada, T; Harada, T; Asaka, N; Haruma, T; Kino, K; Sasaki, E; Okano, M; Yamada, A; Utsugi, T				Osada, Toshihiro; Harada, Takafumi; Asaka, Naomasa; Haruma, Tomonori; Kino, Kohsuke; Sasaki, Eiji; Okano, Mitsuhiro; Yamada, Akira; Utsugi, Teruhiro			Identification and gene cloning of a new major allergen Cha o 3 from Chamaecyparis obtusa (Japanese cypress) pollen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GENOME-WIDE ASSOCIATION; MOLECULAR-CLONING; GESTATIONAL-AGE; PEANUT ALLERGY; PURIFICATION; SENSITIZATION; PACKAGE		[Osada, Toshihiro; Harada, Takafumi; Asaka, Naomasa; Haruma, Tomonori; Kino, Kohsuke; Sasaki, Eiji; Utsugi, Teruhiro] Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan; [Osada, Toshihiro; Yamada, Akira] Kurume Univ, Res Ctr Innovat Canc Therapy, Canc Vaccine Dev Div, Fukuoka, Japan; [Okano, Mitsuhiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Okayama, Japan	Taiho Pharmaceutical; Kurume University; Okayama University	Osada, T (corresponding author), Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan.; Osada, T (corresponding author), Kurume Univ, Res Ctr Innovat Canc Therapy, Canc Vaccine Dev Div, Fukuoka, Japan.	toshi-osada@taiho.co.jp		Osada, Toshihiro/0000-0001-8331-9655				Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Cruickshank MN, 2013, GENOME MED, V5, DOI 10.1186/gm500; Di Felice G, 2001, INT ARCH ALLERGY IMM, V125, P280, DOI 10.1159/000053828; Halachev K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r96; Hong X, 2012, ALLERGY, V67, P1538, DOI 10.1111/all.12047; Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304; Hong XM, 2011, J ALLERGY CLIN IMMUN, V128, P374, DOI 10.1016/j.jaci.2011.05.007; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Ito Hirotaka, 1996, Allergology International, V45, P181, DOI 10.2332/allergolint.45.181; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Lee H, 2012, INT J EPIDEMIOL, V41, P188, DOI 10.1093/ije/dyr237; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Midoro-Horiuti T, 1999, J ALLERGY CLIN IMMUN, V104, P613, DOI 10.1016/S0091-6749(99)70332-5; Midoro-Horiuti T, 2001, CLIN EXP ALLERGY, V31, P771, DOI 10.1046/j.1365-2222.2001.01079.x; Mori T, 1999, BIOCHEM BIOPH RES CO, V263, P166, DOI 10.1006/bbrc.1999.1261; Okano Mitsuhiro, 2012, Clinical and Experimental Allergy Reviews, V12, P1, DOI 10.1111/j.1472-9733.2011.01156.x; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; SEXTON R, 1990, PLANT SCI, V67, P169, DOI 10.1016/0168-9452(90)90240-O; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sone T, 2005, CLIN EXP ALLERGY, V35, P664, DOI 10.1111/j.1365-2222.2005.02221.x; Suzuki M, 1996, MOL IMMUNOL, V33, P451, DOI 10.1016/0161-5890(95)00147-6; Tsai HJ, 2009, CLIN EXP ALLERGY, V39, P101, DOI 10.1111/j.1365-2222.2008.03111.x; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439	26	10	11	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					911	+		10.1016/j.jaci.2016.03.026	http://dx.doi.org/10.1016/j.jaci.2016.03.026			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27237746	Bronze			2022-12-18	WOS:000385496000033
J	Fleming, L; Koo, M; Bossley, CJ; Nagakumar, P; Bush, A; Saglani, S				Fleming, Louise; Koo, Maria; Bossley, Cara J.; Nagakumar, Prasad; Bush, Andrew; Saglani, Sejal			The utility of a multidomain assessment of steroid response for predicting clinical response to omalizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA		[Fleming, Louise; Koo, Maria; Bossley, Cara J.; Nagakumar, Prasad; Bush, Andrew; Saglani, Sejal] Royal Brompton Hosp, Resp Paediat, London, England; [Fleming, Louise; Nagakumar, Prasad; Bush, Andrew; Saglani, Sejal] Imperial Coll London, Natl Heart & Lung Inst, Inflammat Repair & Dev, London, England; [Bossley, Cara J.] Kings Coll Hosp London, Resp Paediat, London, England	Royal Brompton Hospital; Imperial College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Fleming, L (corresponding author), Royal Brompton Hosp, Resp Paediat, London, England.; Fleming, L (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Inflammat Repair & Dev, London, England.	l.fleming@imperial.ac.uk	Saglani, Sejal/AAE-5072-2019; Fleming, Louise/ABD-7452-2020	Koo, Nahyun Maria/0000-0003-0576-7270; Fleming, Louise/0000-0002-7268-7433	Asthma UK [AUK-AC-2012-01, 10/058, 10/045] Funding Source: researchfish	Asthma UK		[Anonymous], 2014, THORAX, V69, P1; Bossley CJ, 2009, EUR RESPIR J, V34, P1052, DOI 10.1183/09031936.00186508; Bossley CJ, 2012, J ALLERGY CLIN IMMUN, V129, P974, DOI 10.1016/j.jaci.2012.01.059; Bracken M, 2009, ARCH DIS CHILD, V94, P780, DOI 10.1136/adc.2008.152140; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Ducharme FM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004699; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Jing H, 2014, J ALLERGY CLIN IMMUN, V133, P1667, DOI 10.1016/j.jaci.2014.03.025; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Normansell R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003559.pub4; Sun X, 2002, J PEDIATR-US, V140, P724, DOI 10.1067/mpd.2002.123879	12	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					292	294		10.1016/j.jaci.2015.12.1317	http://dx.doi.org/10.1016/j.jaci.2015.12.1317			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	26924468	Bronze			2022-12-18	WOS:000379659100035
J	Giacomelli, M; Kumar, R; Soresina, A; Tamassia, N; Lorenzini, T; Moratto, D; Gasperini, S; Cassatella, M; Plebani, A; Lougaris, V; Badolato, R				Giacomelli, Mauro; Kumar, Rajesh; Soresina, Annarosa; Tamassia, Nicola; Lorenzini, Tiziana; Moratto, Daniele; Gasperini, Sara; Cassatella, Marco; Plebani, Alessandro; Lougaris, Vassilios; Badolato, Raffaele			Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CRKL; DiGeorge syndrome; c-Fos; proliferation; T-cell receptor activation; IL-2; signal transducer and activator of transcription 5	NONOBESE DIABETIC MICE; 22Q11 DELETION SYNDROMES; CYCLIN D1 EXPRESSION; ADAPTER PROTEIN; HEMATOPOIETIC-CELLS; VELOCARDIOFACIAL SYNDROME; SIGNALING COMPLEX; GENE-EXPRESSION; IL-2 RECEPTOR; NEURAL CREST	Background: Partial DiGeorge syndrome (pDGS) is caused by deletion of the 22q11.2 region. Within this region lies CrK-like (CRKL), a gene encoding an adapter protein belonging to the Crk family that is involved in the signaling cascade of IL-2, stromal cell-derived factor 1 alpha, and type I interferon. Although recurrent infections can be observed in patients with deletion of chromosome 22 syndrome, the immune pathogenesis of this condition is yet not fully understood. Objective: We aimed to investigate the role of CRKL in T-cell functional responses in patients affected with pDGS. Methods: Protein expression levels and phosphorylation of CRKL were evaluated in patients with pDGS. T-cell functional assays in vitro and gene-silencing experiments were also performed. Results: CRKL protein expression, as well as its phosphorylation, were reduced in all patients with pDGS, especially on IL-2 stimulation. Moreover, T cells presented impaired proliferation and reduced IL-2 production on anti-CD3/CD28 stimulation and decreased c-Fos expression. Finally, CRKL silencing in Jurkat T cells resulted in impaired T-cell proliferation and reduced c-Fos expression. Conclusions: The impaired T-cell proliferation and reduction of CRKL, phosphorylated CRKL, and c-Fos levels suggest a possible role of CRKL in functional deficiencies of T cells in patients with pDGS.	[Giacomelli, Mauro; Kumar, Rajesh; Soresina, Annarosa; Lorenzini, Tiziana; Moratto, Daniele; Plebani, Alessandro; Lougaris, Vassilios; Badolato, Raffaele] Univ Brescia, Inst Mol Med Angelo Nocivelli, Dept Pediat, Brescia, Italy; [Giacomelli, Mauro; Kumar, Rajesh] Univ Trieste, Scuola Dottorato Sci Riprod & Sviluppo, Trieste, Italy; [Tamassia, Nicola; Gasperini, Sara; Cassatella, Marco] Univ Verona, Dept Pathol, Verona, Italy	University of Brescia; University of Trieste; University of Verona	Badolato, R (corresponding author), Univ Brescia, Inst Mol Med Angelo Nocivelli, I-25123 Brescia, Italy.	raffaele.badolato@unibs.it	Tamassia, Nicola/J-8621-2016; Cassatella, M A/B-8037-2013; Badolato, Raffaele/A-8081-2010; Giacomelli, Mauro/AGX-9755-2022	Tamassia, Nicola/0000-0003-2990-3003; Cassatella, M A/0000-0001-7824-1806; Badolato, Raffaele/0000-0001-7375-5410; 	Associazione Malattie Rare Azzurra O.N.L.U.S.	Associazione Malattie Rare Azzurra O.N.L.U.S.	M.G. received a fellowship from "Associazione Malattie Rare Azzurra O.N.L.U.S.''	Abate C, 1990, Semin Cancer Biol, V1, P19; Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Bell Emily S, 2012, Genes Cancer, V3, P341, DOI 10.1177/1947601912459951; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Cancrini C, 2014, J PEDIATR-US, V164, P1475, DOI 10.1016/j.jpeds.2014.01.056; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Fish EN, 1999, J BIOL CHEM, V274, P571, DOI 10.1074/jbc.274.2.571; Fu L, 2015, MOL CARCINOGEN, V54, pE35, DOI 10.1002/mc.22148; Fu L, 2015, TUMOR BIOL, V36, P1015, DOI 10.1007/s13277-014-2706-2; Gadina M, 1999, J IMMUNOL, V162, P2081; Gelkop S, 1999, J BIOL CHEM, V274, P21519, DOI 10.1074/jbc.274.31.21519; Gelkop S, 2001, J BIOL CHEM, V276, P36174, DOI 10.1074/jbc.M100731200; GILMOUR KC, 1995, P NATL ACAD SCI USA, V92, P10772, DOI 10.1073/pnas.92.23.10772; GRANELLIPIPERNO A, 1991, J IMMUNOL, V147, P2734; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Guller M, 2008, WORLD J GASTROENTERO, V14, P6339, DOI 10.3748/wjg.14.6339; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Kar B, 2007, BIOCHEMISTRY-US, V46, P10828, DOI 10.1021/bi700537e; Keyte A, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.005; Laloraya M, 2006, DIABETES, V55, P734, DOI 10.2337/diabetes.55.03.06.db05-1059; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lord JD, 1998, J IMMUNOL, V161, P4627; Magne S, 2003, MOL CELL BIOL, V23, P8934, DOI 10.1128/MCB.23.24.8934-8945.2003; Markert ML, 1998, J PEDIATR-US, V132, P15, DOI 10.1016/S0022-3476(98)70478-0; Martino A, 2001, J IMMUNOL, V166, P1723, DOI 10.4049/jimmunol.166.3.1723; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Moon AM, 2006, DEV CELL, V10, P71, DOI 10.1016/j.devcel.2005.12.003; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; MULLER W, 1989, EUR J PEDIATR, V149, P96, DOI 10.1007/BF01995856; Newbern J, 2008, P NATL ACAD SCI USA, V105, P17115, DOI 10.1073/pnas.0805239105; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Nosaka Y, 1999, J BIOL CHEM, V274, P30154, DOI 10.1074/jbc.274.42.30154; Oda A, 2000, BIOCHEM BIOPH RES CO, V278, P299, DOI 10.1006/bbrc.2000.3803; PAI SR, 1994, ANTICANCER RES, V14, P985; Pandey MK, 2012, INT J CANCER, V130, P213, DOI 10.1002/ijc.25997; Parrales A, 2010, J CELL PHYSIOL, V222, P302, DOI 10.1002/jcp.21951; Pierdominici M, 2000, CLIN EXP IMMUNOL, V121, P127, DOI 10.1046/j.1365-2249.2000.01247.x; RAPOPORT MJ, 1993, J EXP MED, V177, P1221, DOI 10.1084/jem.177.4.1221; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; RAVICHANDRAN KS, 1994, J BIOL CHEM, V269, P1599; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Smith JJ, 2002, MOL CELL BIOL, V22, P1412, DOI 10.1128/MCB.22.5.1412-1423.2002; Smith JJ, 2000, J CELL BIOL, V151, P1391, DOI 10.1083/jcb.151.7.1391; Sullivan KE, 1998, CLIN IMMUNOL IMMUNOP, V86, P141, DOI 10.1006/clin.1997.4463; Wang LH, 1999, J IMMUNOL, V162, P3897; Wang Y, 2013, MOL CARCINOGEN, V52, P890, DOI 10.1002/mc.21935; Yamagishi H, 2003, TRENDS MOL MED, V9, P383, DOI 10.1016/S1471-4914(03)00141-2; Yeung CL, 2013, ONCOGENE, V32, P5429, DOI 10.1038/onc.2012.590; Zemble R, 2010, CLIN IMMUNOL, V136, P409, DOI 10.1016/j.clim.2010.04.011; Zhao TT, 2013, TUMOR BIOL, V34, P2891, DOI 10.1007/s13277-013-0851-7; Zheng PL, 2015, J ALLERGY CLIN IMMUN, V135, P1293, DOI 10.1016/j.jaci.2015.01.011; Zimmermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7061; ZIPRIS D, 1991, J IMMUNOL, V146, P3763	61	10	11	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					229	+		10.1016/j.jaci.2015.10.051	http://dx.doi.org/10.1016/j.jaci.2015.10.051			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	26875746	Bronze			2022-12-18	WOS:000379659100025
J	Kamijo, S; Nunomura, S; Ra, C; Kanaguchi, Y; Suzuki, Y; Ogawa, H; Okumura, K; Takai, T				Kamijo, Seiji; Nunomura, Satoshi; Ra, Chisei; Kanaguchi, Yasuhiko; Suzuki, Yusuke; Ogawa, Hideoki; Okumura, Ko; Takai, Toshiro			Innate basophil IL-4 responses against allergens, endotoxin, and cytokines require the Fc receptor gamma-chain	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PROTEASE ALLERGEN; REFRACTORY GOUT; CONTRIBUTE; CELLS		[Kamijo, Seiji; Ogawa, Hideoki; Okumura, Ko; Takai, Toshiro] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan; [Nunomura, Satoshi; Ra, Chisei] Nihon Univ, Sch Med, Allergy & Immunol Grp, Res Inst Med Sci, Tokyo, Japan; [Nunomura, Satoshi] Nihon Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Ra, Chisei] Nihon Univ, Sch Med, Dept Microbiol, Tokyo, Japan; [Ra, Chisei] Asahi Gen Hosp, Dept Clin Lab, Chiba, Japan; [Kanaguchi, Yasuhiko; Suzuki, Yusuke] Juntendo Univ, Grad Sch Med, Dept Internal Med, Div Nephrol, Tokyo, Japan	Juntendo University; Nihon University; Nihon University; Nihon University; Juntendo University	Takai, T (corresponding author), Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan.	t-takai@juntendo.ac.jp	Takai, Toshiro/K-5690-2013; Nunomura, Satoshi/Q-4249-2017	Takai, Toshiro/0000-0001-8363-0355; Nunomura, Satoshi/0000-0002-9315-4185	Grants-in-Aid for Scientific Research [25461711, 26860759] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Hershfield MS, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4500; Hida S, 2009, NAT IMMUNOL, V10, P214, DOI 10.1038/ni.1686; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Nishikado H, 2015, BIOCHEM BIOPH RES CO, V460, P261, DOI 10.1016/j.bbrc.2015.03.022; Rosenstein RK, 2014, P NATL ACAD SCI USA, V111, pE4963, DOI 10.1073/pnas.1418959111; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; Schroeder JT, 2011, IMMUNOL REV, V242, P144, DOI 10.1111/j.1600-065X.2011.01023.x; Siraganian RP, 2010, FEBS LETT, V584, P4933, DOI 10.1016/j.febslet.2010.08.006; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Sundy JS, 2007, ARTHRITIS RHEUM-US, V56, P1021, DOI 10.1002/art.22403; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	14	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1613	1615		10.1016/j.jaci.2015.10.037	http://dx.doi.org/10.1016/j.jaci.2015.10.037			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	26703455	Bronze			2022-12-18	WOS:000376180200045
J	Arebro, J; Tengroth, L; Razavi, R; Georen, SK; Winqvist, O; Cardell, LO				Arebro, Julia; Tengroth, Lotta; Razavi, Ronia; Georen, Susanna Kumlien; Winqvist, Ola; Cardell, Lars-Olaf			Antigen-presenting epithelial cells can play a pivotal role in airway allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HLA-DR; STIM1; EXPRESSION; DISCOVERY; FRAMEWORK; MUTATION		[Arebro, Julia; Tengroth, Lotta; Razavi, Ronia; Georen, Susanna Kumlien; Cardell, Lars-Olaf] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div ENT Dis, Stockholm, Sweden; [Winqvist, Ola] Karolinska Inst, Dept Med, Unit Translat Immunol, Stockholm, Sweden; [Arebro, Julia; Cardell, Lars-Olaf] Karolinska Univ Hosp, Dept ENT Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Cardell, LO (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div ENT Dis, Stockholm, Sweden.; Cardell, LO (corresponding author), Karolinska Univ Hosp, Dept ENT Dis, Stockholm, Sweden.	lars-olaf.cardell@ki.se		winqvist, Ola/0000-0003-0842-4441; Kumlien Georen, Susanna/0000-0001-7292-9255; Arebro, Julia/0000-0002-2584-0941				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bohm J, 2013, AM J HUM GENET, V92, P271, DOI 10.1016/j.ajhg.2012.12.007; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, P15; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dotan I, 2007, AM J PHYSIOL-GASTR L, V292, P8; Fuchs S, 2012, J IMMUNOL, V188, P1523, DOI 10.4049/jimmunol.1102507; Goldwich A, 2013, J AM SOC NEPHROL, V24, P906, DOI 10.1681/ASN.2012020133; Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Markello T, 2015, MOL GENET METAB, V114, P474, DOI 10.1016/j.ymgme.2014.12.307; MCDONALD GB, 1987, J CLIN PATHOL, V40, P312, DOI 10.1136/jcp.40.3.312; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morin G, 2014, HUM MUTAT, V35, P1221, DOI 10.1002/humu.22621; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Renkonen J, 2009, ALLERGY, V64, P868, DOI 10.1111/j.1398-9995.2008.01919.x; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Schaballie H, 2015, J ALLERGY CLIN IMMUN, V136, P816, DOI 10.1016/j.jaci.2015.03.009; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Takizawa R, 2007, CLIN EXP ALLERGY, V37, P420, DOI 10.1111/j.1365-2222.2007.02672.x; Thelemann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086844; Wang S, 2014, J DENT RES, V93, P94, DOI 10.1177/0022034514527971	24	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					957	960		10.1016/j.jaci.2015.08.053	http://dx.doi.org/10.1016/j.jaci.2015.08.053			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26560042	Green Published, Bronze			2022-12-18	WOS:000371897500050
J	Kataoka, S; Muramatsu, H; Okuno, Y; Hayashi, Y; Mizoguchi, Y; Tsumura, M; Okada, S; Kobayashi, M; Sano, C; Sato, H; Oh-iwa, I; Ito, M; Kojima, D; Hama, A; Takahashi, Y; Kojima, S				Kataoka, Shinsuke; Muramatsu, Hideki; Okuno, Yusuke; Hayashi, Yuta; Mizoguchi, Yoko; Tsumura, Miyuki; Okada, Satoshi; Kobayashi, Masao; Sano, Chiaki; Sato, Haruki; Oh-iwa, Ichiro; Ito, Masahumi; Kojima, Daiei; Hama, Asahito; Takahashi, Yoshiyuki; Kojima, Seiji			Extrapulmonary tuberculosis mimicking Mendelian susceptibility to mycobacterial disease in a patient with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHRONIC MUCOCUTANEOUS CANDIDIASIS		[Kataoka, Shinsuke; Muramatsu, Hideki; Okuno, Yusuke; Kojima, Daiei; Hama, Asahito; Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Hayashi, Yuta] Higashi Nagoya Natl Hosp, Natl Hosp Org, Dept Resp Med, Nagoya, Aichi, Japan; [Mizoguchi, Yoko; Tsumura, Miyuki; Okada, Satoshi; Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima, Japan; [Sano, Chiaki] Shimane Univ, Fac Med, Dept Microbiol & Immunol, Izumo, Shimane, Japan; [Sato, Haruki; Oh-iwa, Ichiro] Japanese Red Cross Nagoya Daiichi Hosp, Dept Oral & Maxillofacial Surg, Nagoya, Aichi, Japan; [Ito, Masahumi] Japanese Red Cross Nagoya Daiichi Hosp, Dept Pathol, Nagoya, Aichi, Japan	Nagoya University; Hiroshima University; Shimane University; Red Cross Nagoya Daiichi Hospital; Red Cross Nagoya Daiichi Hospital	Kojima, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan.	kojimas@med.nagoya-u.ac.jp	Okada, Satoshi/B-8901-2011; Muramatsu, Hideki/ABA-3376-2021; Muramatsu, Hideki/I-3763-2012; Mizoguchi, Yoko/AAS-6191-2020; Okuno, Yusuke/C-9082-2009	Okada, Satoshi/0000-0002-4622-5657; Muramatsu, Hideki/0000-0002-8801-0021; Okuno, Yusuke/0000-0003-3139-9272; Mizoguchi, Yoko/0000-0003-3686-9915; Sano, Chiaki/0000-0002-9796-5161				Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Delsing CE, 2012, MED MYCOL CASE REP, V1, P5, DOI 10.1016/j.mmcr.2012.02.003; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Mizoguchi Y, 2014, J LEUKOCYTE BIOL, V95, P667, DOI 10.1189/jlb.0513250; Sampaio EP, 2013, J ALLERGY CLIN IMMUN, V131, P1624, DOI 10.1016/j.jaci.2013.01.052; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	10	10	11	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2016	137	2					619	622		10.1016/j.jaci.2015.06.028	http://dx.doi.org/10.1016/j.jaci.2015.06.028			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DC5BN	26242301	Bronze			2022-12-18	WOS:000369235500035
J	Romao, S; Puente, ET; Nytko, KJ; Siler, U; Munz, C; Reichenbach, J				Romao, Susana; Puente, Emilio Tejera; Nytko, Katarzyna J.; Siler, Ulrich; Muenz, Christian; Reichenbach, Janine			Defective nuclear entry of hydrolases prevents neutrophil extracellular trap formation in patients with chronic granulomatous disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NET FORMATION; AUTOPHAGY		[Romao, Susana; Muenz, Christian] Univ Zurich, Viral Immunobiol Inst Expt Immunol, Zurich, Switzerland; [Romao, Susana; Puente, Emilio Tejera; Nytko, Katarzyna J.; Siler, Ulrich; Reichenbach, Janine] Univ Childrens Hosp Zurich, Div Immunol, Zurich, Switzerland; [Romao, Susana; Puente, Emilio Tejera; Nytko, Katarzyna J.; Siler, Ulrich; Reichenbach, Janine] Childrens Res Ctr, Zurich, Switzerland	University of Zurich; University Children's Hospital Zurich	Romao, S (corresponding author), Univ Zurich, Viral Immunobiol Inst Expt Immunol, Zurich, Switzerland.	janine.reichenbach@kispi.uzh.ch	Reichenbach, Janine/U-2171-2018; Münz, Christian/W-4881-2017	Reichenbach, Janine/0000-0002-9008-1312; Munz, Christian/0000-0001-6419-1940; Siler, Ulrich/0000-0002-2458-2629				Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Cheng ML, 2013, FREE RADICAL RES, V47, P699, DOI 10.3109/10715762.2013.816420; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Itakura A, 2013, AM J PHYSIOL-CELL PH, V305, pC348, DOI 10.1152/ajpcell.00108.2013; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; Mitroulis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029318; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Tang S, 2015, CLIN EXP IMMUNOL, V180, P408, DOI 10.1111/cei.12589	9	10	10	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1703	U453		10.1016/j.jaci.2015.09.007	http://dx.doi.org/10.1016/j.jaci.2015.09.007			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26521040	Green Accepted			2022-12-18	WOS:000366044300040
J	Park, HW; Ge, B; Tse, S; Grundberg, E; Pastinen, T; Kelly, HW; Tantisira, KG				Park, Heung-Woo; Ge, Bing; Tse, Szeman; Grundberg, Elin; Pastinen, Tomi; Kelly, H. William; Tantisira, Kelan G.			Genetic risk factors for decreased bone mineral accretion in children with asthma receiving multiple oral corticosteroid bursts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; bone mineral density; child; corticosteroids	GAMMA-TUBULIN; MANAGEMENT; PROTEIN; EXACERBATIONS; DEXAMETHASONE; MICROTUBULES; OSTEOBLASTS; PREDNISONE; APOPTOSIS; CORTISOL	Background: Long-term intermittent oral corticosteroid (OCS) use in children with asthma leads to significant decreases in bone mineral accretion (BMA). Objective: We aimed to identify genetic factors influencing OCS dose effects on BMA in children with asthma. Methods: We first performed a gene-by-OCS interaction genome-wide association study (GWAS) of BMA in 489 white participants in the Childhood Asthma Management Program trial who took short-term oral prednisone bursts when they experienced acute asthma exacerbations. We selected the top-ranked 2000 single nucleotide polymorphisms (SNPs) in the GWAS and determined whether these SNPs also had cisregulatory effects on dexamethasone-induced gene expression in osteoblasts. Results: We identified 2 SNPs (rs9896933 and rs2074439) associated with decreased BMA and related to the tubulin gamma pathway. The rs9896933 variant met the criteria for genome-wide significance (P = 3.15 x 10(-8) in the GWAS) and is located on the intron of tubulin folding cofactor D (TBCD) gene. The rs2074439 variant (P = 2.74 x 10(-4) in the GWAS) showed strong cis-regulatory effects on dexamethasone-induced tubulin gamma gene expression in osteoblasts (P = 8.64 x 10(-4)). Interestingly, we found that BMA worsened with increasing prednisone dose as the number of mutant alleles of the 2 SNPs increased. Conclusions: We have identified 2 novel tubulin g pathway SNPs, rs9896933 and rs2074439, showing independent interactive effects with cumulative corticosteroid dose on BMA in children with asthma receiving multiple OCS bursts.	[Park, Heung-Woo; Tse, Szeman; Tantisira, Kelan G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Div Network Med, Boston, MA 02115 USA; [Tantisira, Kelan G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Park, Heung-Woo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Ge, Bing; Pastinen, Tomi] McGill Univ, Montreal, PQ, Canada; [Ge, Bing; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Tse, Szeman] Univ Montreal, St Justine Univ, Ctr Hlth, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Grundberg, Elin; Pastinen, Tomi] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Pastinen, Tomi] McGill Univ, Dept Med Genet, Montreal, PQ, Canada; [Kelly, H. William] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Albuquerque, NM 87131 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Seoul National University (SNU); McGill University; Universite de Montreal; McGill University; McGill University; University of New Mexico; University of New Mexico's Health Sciences Center	Tantisira, KG (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.	kelan.tantisira@channing.harvard.edu	Park, Heung-Woo/AAW-7690-2020	Park, Heung-Woo/0000-0002-6970-3228	National Heart, Lung, and Blood Institute [NO1-HR-16044, NO1-HR-16045, NO1-HR-16046, NO1-HR-16047, NO1-HR-16048, NO1-HR-16049, NO1-HR-16050, NO1-HR-16051, NO1-HR-16052]; General Clinical Research Center from the National Center for Research Resources [M01RR00051, M01RR0099718-24, M01RR02719-14, RR00036];  [U01 HL65899];  [R01 HL092197];  [R01 NR013391]; DIVISION OF LUNG DISEASES [N01HR016052, N01HR016050, N01HR016047, N01HR016048, N01HR016046, N01HR016049, N01HR016051, N01HR016044, N01HR016045] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051, M01RR002719] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092197, U01HL065899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013391] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); General Clinical Research Center from the National Center for Research Resources; ; ; ; DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Supported by grants U01 HL65899, R01 HL092197, and R01 NR013391. The Childhood Asthma Management Program is supported by contracts NO1-HR-16044, 16045, 16046, 16047, 16048, 16049, 16050, 16051, and 16052 with the National Heart, Lung, and Blood Institute and General Clinical Research Center grants M01RR00051, M01RR0099718-24, M01RR02719-14, and RR00036 from the National Center for Research Resources.	British Thoracic Society Scottish Intercollegiate Guidelines Network, BRIT GUID MAN ASTHM; Brown JJ, 2005, J PAEDIATR CHILD H, V41, P553, DOI 10.1111/j.1440-1754.2005.00718.x; Canalis E, 2004, BONE, V34, P593, DOI 10.1016/j.bone.2003.11.026; Chan WH, 2007, J CELL BIOCHEM, V100, P1056, DOI 10.1002/jcb.21114; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Colello D, 2010, J CELL SCI, V123, P2093, DOI 10.1242/jcs.057505; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; Dahlin A, 2012, PHARMACOGENOMICS, V13, P1387, DOI [10.2217/pgs.12.126, 10.2217/PGS.12.126]; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; DELANY AM, 1995, J CELL BIOCHEM, V57, P488, DOI 10.1002/jcb.240570314; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gauderman W., QUANTO 1 2 4 COMPUTE; Greenberg RA, 2008, CLIN PEDIATR, V47, P817, DOI 10.1177/0009922808316988; Grundberg E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001279; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Huang YT, 2009, ENVIRON TOXICOL, V24, P343, DOI 10.1002/tox.20434; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kaufman JM, 2008, J CLIN ENDOCR METAB, V93, P3755, DOI 10.1210/jc.2008-0678; Kelly HW, 2008, PEDIATRICS, V122, pE53, DOI 10.1542/peds.2007-3381; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Moudjou M, 1996, J CELL SCI, V109, P875; Murakami K, 2000, P NATL ACAD SCI USA, V97, P3579, DOI 10.1073/pnas.97.7.3579; Pereira RC, 2002, BONE, V30, P685, DOI 10.1016/S8756-3282(02)00687-7; Potter PC, 2010, ALLERGY ASTHMA IMMUN, V2, P1, DOI 10.4168/aair.2010.2.1.1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu WL, 2014, HUM MOL GENET, V23, P5017, DOI 10.1093/hmg/ddu191; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Shefrin AE, 2009, CAN FAM PHYSICIAN, V55, P704; Szefler S, 2000, NEW ENGL J MED, V343, P1054; The Global Initiative for Asthma (GINA), GUID ASTHM MAN PREV; The National Asthma Education and Prevention Program (NAEPP), NAT ASTHM ED PREV PR; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tse SM, 2012, J ALLERGY CLIN IMMUN, V130, P53, DOI 10.1016/j.jaci.2012.04.005; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Zhao M, 2009, MOL CELL BIOL, V29, P1291, DOI 10.1128/MCB.01566-08; Zoorob RJ, 1998, AM FAM PHYSICIAN, V58, P443; Zou WG, 2013, J EXP MED, V210, P1793, DOI 10.1084/jem.20111790	43	10	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2015	136	5					1240	+		10.1016/j.jaci.2015.04.014	http://dx.doi.org/10.1016/j.jaci.2015.04.014			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CW1YE	26025128	Green Accepted, Bronze			2022-12-18	WOS:000364787200012
J	Chien, CH; Yu, HH; Chiang, BL				Chien, Chien-Hui; Yu, Hsin-Hui; Chiang, Bor-Luen			Single allergen-induced oral tolerance inhibits airway inflammation in conjugated allergen immunized mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							REGULATORY T-CELLS; HYPERSENSITIVITY; INDUCTION; MECHANISM		[Chien, Chien-Hui; Chiang, Bor-Luen] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Yu, Hsin-Hui; Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chien, CH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	gicmbor@ntu.edu.tw	Yu, Hsin-Hui/AAV-2068-2020	Yu, Hsin-Hui/0000-0003-2611-5175; CHIANG, BOR-LUEN/0000-0002-6705-0286				Chu KH, 2012, AM J RESP CELL MOL, V46, P651, DOI 10.1165/rcmb.2011-0246OC; Gonnella PA, 2001, J IMMUNOL, V166, P4456, DOI 10.4049/jimmunol.166.7.4456; Gutgemann I, 2002, IMMUNOLOGY, V107, P420, DOI 10.1046/j.1365-2567.2002.01527.x; Hsu LH, 2014, AM J RESP CELL MOL B; Karlsson MR, 2010, ALLERGY, V65, P561, DOI 10.1111/j.1398-9995.2009.02225.x; Reichardt P, 2007, BLOOD, V110, P1519, DOI 10.1182/blood-2006-10-053793; Suzuki K, 2011, PLANT BIOTECHNOL J, V9, P982, DOI 10.1111/j.1467-7652.2011.00613.x; Yasue M, 1997, CELL IMMUNOL, V181, P30, DOI 10.1006/cimm.1997.1184	8	10	11	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					1110	1113		10.1016/j.jaci.2015.04.018	http://dx.doi.org/10.1016/j.jaci.2015.04.018			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CT7EJ	26025127				2022-12-18	WOS:000362976300036
J	Lai, PS; Liang, LM; Cibas, ES; Liu, AH; Gold, DR; Baccarelli, A; Phipatanakul, W				Lai, Peggy S.; Liang, Liming; Cibas, Edmund S.; Liu, Andrew H.; Gold, Diane R.; Baccarelli, Andrea; Phipatanakul, Wanda			Alternate methods of nasal epithelial cell sampling for airway genomic studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GENE-EXPRESSION		[Lai, Peggy S.] Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA; [Lai, Peggy S.; Gold, Diane R.; Baccarelli, Andrea] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lai, Peggy S.; Cibas, Edmund S.; Gold, Diane R.; Phipatanakul, Wanda] Harvard Univ, Boston, MA USA; [Cibas, Edmund S.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gold, Diane R.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Liu, Andrew H.] Natl Jewish Hlth, Pediat Allergy & Immunol, Denver, CO USA; [Liu, Andrew H.] Univ Colorado, Sch Med, Denver, CO USA; [Phipatanakul, Wanda] Boston Childrens Hosp, Allergy & Immunol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Harvard University; Boston Children's Hospital	Lai, PS (corresponding author), Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA.	wanda.phipatanakul@childrens.harvard.edu		Baccarelli, Andrea/0000-0002-3436-0640; Lai, Peggy/0000-0001-9501-8606	NCATS NIH HHS [UL1 TR001102] Funding Source: Medline; NHLBI NIH HHS [U10HL098102, U10 HL098102] Funding Source: Medline; NIAID NIH HHS [R01 AI 073964, R01 AI073964, K24 AI106822, U01 AI110397, K24 AI 106822] Funding Source: Medline; NIEHS NIH HHS [K23ES023700, P30ES000002, P01ES018181, P30 ES000002, K23 ES023700] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI110397, K24AI106822, R01AI073964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181, K23ES023700, P30ES000002] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Erbas B, 2012, J BIOMET BIOSTAT, pS7; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Navidi W, 2002, EPIDEMIOLOGY, V13, P100, DOI 10.1097/00001648-200201000-00016; PIPKORN U, 1988, EUR RESPIR J, V1, P856; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Stokes AB, 2014, EXP LUNG RES, V40, P327, DOI 10.3109/01902148.2014.925987; Zhang XL, 2010, PHYSIOL GENOMICS, V41, P1, DOI 10.1152/physiolgenomics.00167.2009	8	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					1120	1123		10.1016/j.jaci.2015.04.032	http://dx.doi.org/10.1016/j.jaci.2015.04.032			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CT7EJ	26037550	Green Accepted, Bronze			2022-12-18	WOS:000362976300041
J	Abuabara, K; Hoffstad, O; Troxel, A; Gelfand, JM; Margolis, DJ				Abuabara, Katrina; Hoffstad, Ole; Troxel, Andrea; Gelfand, Joel M.; Margolis, David J.			Atopic dermatitis disease control and age: A cohort study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDREN		[Abuabara, Katrina; Gelfand, Joel M.; Margolis, David J.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Hoffstad, Ole; Troxel, Andrea; Gelfand, Joel M.; Margolis, David J.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Abuabara, K (corresponding author), Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA.	Katrina.abuabara@uphs.upenn.edu		Gelfand, Joel/0000-0003-3480-2661; Abuabara, Katrina/0000-0002-7736-6946; Troxel, Andrea/0000-0002-1393-3075	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007465, K24AR064310, R01AR056755] Funding Source: NIH RePORTER; NIAMS NIH HHS [T32-AR-0007465-3, T32 AR007465, K24-AR064310, AR056755, K24 AR064310] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abuabara K, 2013, J ALLERGY CLIN IMMUN, V132, P1139, DOI 10.1016/j.jaci.2013.08.028; Bieber T, 2012, ALLERGY, V67, P1475, DOI 10.1111/all.12049; Hanifin JM, 2004, J AM ACAD DERMATOL, V50, P391, DOI 10.1016/j.jaad.2003.08.003; Kapoor R, 2009, PEDIATR DERMATOL, V26, P682, DOI 10.1111/j.1525-1470.2009.01013.x; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Manthripragada AD, 2013, PEDIATRICS, V132, pE1327, DOI 10.1542/peds.2013-0931; Margolis JS, 2014, JAMA DERMATOL, V150, P593, DOI 10.1001/jamadermatol.2013.10271	7	10	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2015	136	1					190	192		10.1016/j.jaci.2015.03.028	http://dx.doi.org/10.1016/j.jaci.2015.03.028			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CM2WE	25935107	Green Accepted, Bronze			2022-12-18	WOS:000357542200022
J	Khalil, S; McBride, D; Gimenez-Arnau, A; Grattan, C; Balp, MM; Stull, DE				Khalil, Sam; McBride, Doreen; Gimenez-Arnau, Ana; Grattan, Clive; Balp, Maria-Magdalena; Stull, Donald E.			Weekly Urticaria Activity Score (UAS7) and Dermatology Life Quality Index (DLQI) in Validation of Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU) Health States	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 20-24, 2015	Houston, TX	Amer Acad Allergy, Asthma & Immunol					[Khalil, Sam] Novartis Pharmaceut, Basel, Switzerland; [McBride, Doreen; Stull, Donald E.] RTI Hlth Solut, Manchester, Lancs, England; [Gimenez-Arnau, Ana] Univ Autonoma Barcelona, Hosp del Mar, Dept Dermatol, E-08193 Barcelona, Spain; [Grattan, Clive] Norfolk & Norwich Univ Hosp, Dept Dermatol, Norwich, Norfolk, England; [Balp, Maria-Magdalena] Novartis Pharma AG, Basel, Switzerland	Novartis; Research Triangle Institute; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Novartis									0	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2		S		423	AB131	AB131		10.1016/j.jaci.2014.12.1362	http://dx.doi.org/10.1016/j.jaci.2014.12.1362			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	CR2BN					2022-12-18	WOS:000361129600423
J	Smits, HH; Akdis, CA				Smits, Hermelijn H.; Akdis, Cezmi A.			In utero priming by worms protects against respiratory allergies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Respiratory allergies; asthma; worms; in utero priming; immune responses	MECHANISMS		[Smits, Hermelijn H.] Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 ZA Leiden, Netherlands; [Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res, CH-8006 Zurich, Switzerland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Swiss Institute of Allergy & Asthma Research; University of Zurich	Smits, HH (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 ZA Leiden, Netherlands.	H.H.Smits@lumc.nl	Smits, Hermelijn/V-4216-2018; Akdis, Cezmi/AAV-4844-2020	Smits, Hermelijn/0000-0001-9279-2890; Akdis, Cezmi/0000-0001-8020-019X				Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Brown M, 2004, HUM IMMUNOL, V65, P1336, DOI 10.1016/j.humimm.2004.08.176; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Hussaarts L, 2011, J ALLERGY CLIN IMMUN, V128, P733, DOI 10.1016/j.jaci.2011.05.012; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Mpairwe H, 2011, PEDIAT ALLERG IMM-UK, V22, P305, DOI 10.1111/j.1399-3038.2010.01122.x; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Straubinger K, 2014, J ALLERGY CLIN IMMUN, V134, P1271, DOI 10.1016/j.jaci.2014.05.034; Thornton CA, 2010, CURR ALLERGY ASTHM R, V10, P444, DOI 10.1007/s11882-010-0148-5; Wammes LJ, 2014, LANCET INFECT DIS	10	10	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2014	134	6					1280	1281		10.1016/j.jaci.2014.08.051	http://dx.doi.org/10.1016/j.jaci.2014.08.051			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW1UG	25441298	Bronze			2022-12-18	WOS:000346075400009
J	McSharry, C; Spears, M; Chaudhuri, R; Cameron, EJ; Husi, H; Thomson, NC				McSharry, Charles; Spears, Mark; Chaudhuri, Rekha; Cameron, Euan J.; Husi, Holger; Thomson, Neil C.			Increased sputum endotoxin levels are associated with an impaired lung function response to oral steroids in asthmatic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; asthma control; endotoxin; oral steroids; smokers; sputum cytokines	HIGH-FAT DIET; METABOLIC ENDOTOXEMIA; INHALED ENDOTOXIN; CIGARETTE-SMOKING; AIRWAY INFLAMMATION; GUT MICROBIOTA; LIPOPOLYSACCHARIDE; ACTIVATION; RESISTANCE; CORTICOSTEROIDS	Background: Airway endotoxin might contribute to corticosteroid insensitivity in asthmatic patients. Objective: Because cigarette smoke contains endotoxin, we tested the hypothesis that sputum endotoxin concentrations are increased in cigarette smokers and that endotoxin concentrations are associated with corticosteroid insensitivity in asthmatic patients. Methods: Sixty-nine asthmatic patients (never smokers, smokers, and exsmokers) and 20 healthy subjects (never smokers and smokers) were recruited. Fifty-three asthmatic patients received a 2-week course of oral dexamethasone. Serum and induced sputum endotoxin and cytokine concentrations were quantified by using an enzyme immunoassay. Results: Median (interquartile range [IQR]) sputum endotoxin concentration were not significantly different between asthmatic never smokers (184 endotoxin units [EU]/mL; IQR, 91-310 EU/mL), exsmokers (123 EU/mL; IQR, 39-207 EU/mL), and smokers (177 EU/mL; IQR, 41-772 EU/mL; P = .703) and healthy subjects (164 EU/mL; IQR, 106-373 EU/mL). The lung function response to oral corticosteroids decreased with increasing sputum endotoxin concentrations in the never smokers (linear regression alpha = .05, Spearman r = -0.503, P = .009) but not in smokers (alpha = .587, r = -0.282, P = .257), as confirmed by using multiple regression analysis. Asthmatic smokers had higher concentrations of serum endotoxin than asthmatic nonsmokers (0.25 EU/mL [IQR, 0.09-0.39 EU/mL] vs 0.08 EU/mL [IQR, 0.05-0.19 EU/mL], P = .042) unrelated to steroid insensitivity or serum cytokine concentrations. In the asthmatic group sputum endotoxin concentrations correlated with sputum IL-1 receptor antagonist concentrations (r = 0.510, P < .001), and serum endotoxin concentrations significantly correlated with sputum IL-6, IL-8, and chemokine motif ligand 2 concentrations. Conclusion: Asthmatic smokers have similar sputum endotoxin concentrations compared with those of asthmatic never smokers. The association between higher sputum endotoxin levels and an impaired lung function response to oral corticosteroids, particularly in asthmatic never smokers, suggests that airway endotoxin might contribute to corticosteroid insensitivity in asthmatic patients.	[McSharry, Charles; Spears, Mark; Chaudhuri, Rekha; Cameron, Euan J.; Thomson, Neil C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Husi, Holger] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	McSharry, C (corresponding author), Univ Glasgow, Room B4-30,Sir Graeme Davies Bldg,120 Univ Pl, Glasgow, Lanark, Scotland.	charles.mcsharry@glasgow.ac.uk		Spears, Mark/0000-0003-4381-5819; McSharry, Charles/0000-0003-4758-9038	Greater GlasgowHealth Board endowment [GEN13-10]; Chief Scientist Office [CAF/06/07]	Greater GlasgowHealth Board endowment; Chief Scientist Office	Supported by the Greater GlasgowHealth Board endowment (grant no. GEN13-10). M.S. was supported by the Chief Scientist Office (grant no. CAF/06/07).	Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Beckman MJ, 2000, VET IMMUNOL IMMUNOP, V77, P221, DOI 10.1016/S0165-2427(00)00242-7; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; CASTELLAN RM, 1987, NEW ENGL J MED, V317, P605, DOI 10.1056/NEJM198709033171005; Chalmers GW, 2002, THORAX, V57, P226, DOI 10.1136/thorax.57.3.226; Chaudhuri R, 2003, AM J RESP CRIT CARE, V168, P1308, DOI 10.1164/rccm.200304-503OC; Doreswamy V, 2011, CLIN EXP ALLERGY, V41, P9, DOI 10.1111/j.1365-2222.2010.03628.x; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Hauk PJ, 2008, PEDIATR PULM, V43, P916, DOI 10.1002/ppul.20880; Hernandez M, 2012, J ALLERGY CLIN IMMUN, V129, P259, DOI 10.1016/j.jaci.2011.11.007; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hirasawa N, 2009, LIFE SCI, V85, P578, DOI 10.1016/j.lfs.2009.08.012; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Ilowite J, 1988, AM REV RESPIR DIS, V139, P1139; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; KENNEDY SM, 1984, AM REV RESPIR DIS, V129, P143; Kline JN, 1999, AM J RESP CRIT CARE, V160, P297, DOI 10.1164/ajrccm.160.1.9808144; Komlosi ZI, 2006, CLIN EXP ALLERGY, V36, P951, DOI 10.1111/j.1365-2222.2006.02514.x; Larsson L, 2004, INDOOR AIR, V14, P421, DOI 10.1111/j.1600-0668.2004.00290.x; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Loke TK, 2006, J ALLERGY CLIN IMMUN, V118, P368, DOI 10.1016/j.jaci.2006.04.055; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; MICHEL O, 1989, J APPL PHYSIOL, V66, P1059, DOI 10.1152/jappl.1989.66.3.1059; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nightingale JA, 1998, THORAX, V53, P563, DOI 10.1136/thx.53.7.563; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Sebastian A, 2006, J ENVIRON MONITOR, V8, P519, DOI 10.1039/b600706f; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Spears M, 2009, EUR RESPIR J, V33, P1010, DOI 10.1183/09031936.00158208; Spears M, 2006, CURR RESPIR MED REV, V2, P197, DOI 10.2174/157339806776843102; Spears M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071460; Spears M, 2010, EXPERT REV CLIN IMMU, V6, P257, DOI 10.1586/ECI.09.85; Thorne PS, 2009, ENVIRON HEALTH PERSP, V117, P763, DOI 10.1289/ehp.11759; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wood LG, 2011, J ALLERGY CLIN IMMUN, V127, P1133, DOI 10.1016/j.jaci.2011.01.036; Yang M, 2009, J IMMUNOL, V182, P5107, DOI 10.4049/jimmunol.0803468	45	10	10	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2014	134	5					1068	1075		10.1016/j.jaci.2014.08.022	http://dx.doi.org/10.1016/j.jaci.2014.08.022			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AT4UN	25262463				2022-12-18	WOS:000344938900011
J	Buckner, CM; Moir, S; Kardava, L; Ho, J; Santich, BH; Kim, LJY; Funk, EK; Nelson, AK; Winckler, B; Chairez, CL; Theobald-Whiting, NL; Anaya-O'Brien, S; Alimchandani, M; Quezado, MM; Yao, MD; Kovacs, JA; Chun, TW; Fauci, AS; Malech, HL; De Ravin, SS				Buckner, Clarisa M.; Moir, Susan; Kardava, Lela; Ho, Jason; Santich, Brian H.; Kim, Leo Jin Young; Funk, Emily K.; Nelson, Amy K.; Winckler, Britanny; Chairez, Cheryl L.; Theobald-Whiting, Narda L.; Anaya-O'Brien, Sandra; Alimchandani, Meghna; Quezado, Martha M.; Yao, Michael D.; Kovacs, Joseph A.; Chun, Tae-Wook; Fauci, Anthony S.; Malech, Harry L.; De Ravin, Suk See			CXCR4/IgG-expressing plasma cells are associated with human gastrointestinal tissue inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Plasma cells; primary and infectious immunodeficiencies; gastrointestinal inflammation; inflammatory bowel disease; homing receptors	IMMUNOGLOBULIN-A; MONOCLONAL-ANTIBODIES; ULCERATIVE-COLITIS; CROHNS-DISEASE; MUCOSAL; EXPRESSION; BLOOD; HOMEOSTASIS; GENERATION; INFECTION	Background: We previously reported abnormalities in circulating B cells in patients with chronic granulomatous disease (CGD) and those with HIV infection. Gastrointestinal complications are common to both diseases and likely involve perturbation of immune cells, including plasma cells (PCs). IgA is the most abundant immunoglobulin in the human body, with roles in protection and maintenance of intestinal homeostasis. IgA is produced primarily by PCs residing in mucosal tissues that are also thought to circulate in the blood. Objective: We sought to characterize and compare PCs in patients with infectious (HIV) and noninfectious (CGD and Crohn disease) diseases that have been associated with intestinal inflammation. Methods: Phenotypic and transcriptional analyses were performed on cells isolated from the blood and colon. Results: IgA-secreting CCR10-expressing PCs predominated in the guts of healthy subjects, whereas in patients with HIV, CGD, and Crohn disease, there was a significant increase in the proportion of IgG-secreting PCs. Where intestinal inflammation was present, IgG-secreting PCs expressed reduced levels of CCR10 and increased levels of CXCR4. The intensity of CXCR4 expression correlated with the frequency of IgG-expressing PCs and the frequency of CXCR4(+)/IgG(+) PCs was associated with the severity of intestinal inflammatory disease yet distinct from PCs and plasmablasts circulating in the blood. Conclusions: These findings suggest that regardless of the underlying disease, the presence of CXCR4(+)/IgG(+) PCs in the gut is a strong yet localized indicator of intestinal inflammation. Furthermore, our findings suggest that CXCR4(+)/IgG(+) PCs might play a role in immune cell homeostasis during inflammatory processes of the gut.	[Buckner, Clarisa M.; Moir, Susan; Kardava, Lela; Ho, Jason; Santich, Brian H.; Kim, Leo Jin Young; Funk, Emily K.; Nelson, Amy K.; Chairez, Cheryl L.; Chun, Tae-Wook; Fauci, Anthony S.] NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA; [Winckler, Britanny; Theobald-Whiting, Narda L.; Anaya-O'Brien, Sandra; Yao, Michael D.; Malech, Harry L.; De Ravin, Suk See] NIAID, Host Def Lab, Bethesda, MD 20892 USA; [Alimchandani, Meghna; Quezado, Martha M.] NCI, Pathol Lab, Bethesda, MD 20892 USA; [Kovacs, Joseph A.] NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Moir, S (corresponding author), NIAID, Immunoregulat Lab, NIH, 10 Ctr Dr,6A02, Bethesda, MD 20892 USA.	smoir@niaid.nih.gov; sderavin@niaid.nih.gov	Chun, Tae-Wook/AAC-3101-2020; Kovacs, Joseph/AAU-6105-2021; Moir, Susan/AAC-3676-2020; Chun, Tae-Wook/W-9187-2019	Kovacs, Joseph/0000-0002-5191-9880; Chun, Tae-Wook/0000-0001-5153-7340; Nelson, Amy/0000-0001-9028-1894; De Ravin, Suk See/0000-0002-9800-774X; Malech, Harry/0000-0001-5874-5775; Kim, Leo/0000-0002-1790-9136	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, ZIAAI000644, ZIAAI000988, ZIAAI000851, ZIAAI000645] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL008075] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Bakema JE, 2011, MUCOSAL IMMUNOL, V4, P612, DOI 10.1038/mi.2011.36; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Brandtzaeg P, 2010, CURR OPIN GASTROEN, V26, P554, DOI 10.1097/MOG.0b013e32833dccf8; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Buckner CM, 2013, J VIROL, V87, P5800, DOI 10.1128/JVI.00094-13; Cerutti A, 2011, ANN NY ACAD SCI, V1238, P132, DOI 10.1111/j.1749-6632.2011.06266.x; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Di Niro R, 2010, J IMMUNOL, V185, P5377, DOI 10.4049/jimmunol.1001587; DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Guilliano MJ, 2001, J IMMUNOL, V166, P2179, DOI 10.4049/jimmunol.166.4.2179; Hart AL, 2010, INFLAMM BOWEL DIS, V16, P1969, DOI 10.1002/ibd.21304; HARVEY RF, 1980, LANCET, V1, P514; Hosomi S, 2011, CLIN EXP IMMUNOL, V163, P215, DOI 10.1111/j.1365-2249.2010.04290.x; Kang EM, 2011, J ALLERGY CLIN IMMUN, V127, P1319, DOI 10.1016/j.jaci.2011.03.028; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Latiff AHA, 2007, ANN CLIN BIOCHEM, V44, P131, DOI 10.1258/000456307780117993; Lebreton C, 2012, GASTROENTEROLOGY, V143, P698, DOI 10.1053/j.gastro.2012.05.051; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Mei HE, 2009, BLOOD, V113, P2461, DOI 10.1182/blood-2008-04-153544; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Nilssen DE, 2004, GUT, V53, P487, DOI 10.1136/gut.2003.027854; Olsson J, 2000, J INFECT DIS, V182, P1625, DOI 10.1086/317625; Scamurra RW, 2002, J IMMUNOL, V169, P4008, DOI 10.4049/jimmunol.169.7.4008; Schneider T, 1998, GUT, V42, P357, DOI 10.1136/gut.42.3.357; Smith AJ, 2010, JAIDS-J ACQ IMM DEF, V55, P306, DOI 10.1097/QAI.0b013e3181ecfeca; Soucy G, 2012, MODERN PATHOL, V25, P295, DOI 10.1038/modpathol.2011.120; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Uo M, 2013, GUT, V62, P1734, DOI 10.1136/gutjnl-2012-303063; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722	32	10	13	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2014	133	6					1676	+		10.1016/j.jaci.2013.10.050	http://dx.doi.org/10.1016/j.jaci.2013.10.050			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AI2FI	24373354	Green Accepted			2022-12-18	WOS:000336672500021
J	Noh, S; Park, CO; Bae, JM; Lee, J; Shin, JU; Hong, CS; Lee, KH				Noh, Seongmin; Park, Chang Ook; Bae, Jung Min; Lee, Jungsoo; Shin, Jung U.; Hong, Chein-Soo; Lee, Kwang Hoon			Lower vitamin D status is closely correlated with eczema of the head and neck	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ATOPIC-DERMATITIS; MAJOR ALLERGEN; MUSTARD SEEDS; FEATURES; SIN		[Noh, Seongmin; Park, Chang Ook; Lee, Jungsoo; Shin, Jung U.; Lee, Kwang Hoon] Severance Hosp, Dept Dermatol, Seoul, South Korea; [Noh, Seongmin; Park, Chang Ook; Lee, Jungsoo; Shin, Jung U.; Lee, Kwang Hoon] Severance Hosp, Cutaneous Biol Res Inst, Seoul, South Korea; [Hong, Chein-Soo] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Hong, Chein-Soo] Yonsei Univ, Coll Med, Inst Allergy, Seoul, South Korea; [Bae, Jung Min] Catholic Univ Korea, Coll Med, Dept Dermatol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Catholic University of Korea	Noh, S (corresponding author), Severance Hosp, Dept Dermatol, Seoul, South Korea.	kwanglee@yuhs.ac		Shin, Jung U/0000-0001-5259-6879; Bae, Jung Min/0000-0001-5975-8519; Park, Chang Ook/0000-0003-3856-1201				Chiu YE, 2013, J AM ACAD DERMATOL, V69, P40, DOI 10.1016/j.jaad.2013.01.010; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gisondi P, 2012, BRIT J DERMATOL, V166, P505, DOI 10.1111/j.1365-2133.2011.10699.x; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hata TR, 2013, J EUR ACAD DERMATOL; Kanda N, 2012, ALLERGY, V67, P804, DOI 10.1111/j.1398-9995.2012.02824.x; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malling HJ, 1997, SKIN PRICK TESTING B, P157; MENENDEZARIAS L, 1988, EUR J BIOCHEM, V177, P159, DOI 10.1111/j.1432-1033.1988.tb14357.x; Palomares O, 2005, INT ARCH ALLERGY IMM, V137, P18, DOI 10.1159/000084609; Palomares O, 2005, ANN ALLERG ASTHMA IM, V94, P586, DOI 10.1016/S1081-1206(10)61138-6; Searing DA, 2010, J ALLERGY CLIN IMMUN, V125, P995, DOI 10.1016/j.jaci.2010.03.008; Sharief S, 2011, J ALLERGY CLIN IMMUN, V127, P1195, DOI 10.1016/j.jaci.2011.01.017; Sirvent S, 2009, CLIN EXP ALLERGY, V39, P1929, DOI 10.1111/j.1365-2222.2009.03382.x; Webb AR, 2010, BRIT J DERMATOL, V163, P1050, DOI 10.1111/j.1365-2133.2010.09975.x; Yamanaka KI, 2008, J ALLERGY CLIN IMMUN, V121, P148, DOI 10.1016/j.jaci.2007.08.014	18	10	10	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2014	133	6					1767	1770		10.1016/j.jaci.2014.02.038	http://dx.doi.org/10.1016/j.jaci.2014.02.038			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AI2FI	24709375				2022-12-18	WOS:000336672500036
J	Kamemura, N; Kawamoto, N; Nakamura, R; Teshima, R; Fukao, T; Kido, H				Kamemura, Norio; Kawamoto, Norio; Nakamura, Ryosuke; Teshima, Reiko; Fukao, Toshiyuki; Kido, Hiroshi			Low-affinity allergen-specific IgE in cord blood and affinity maturation after birth	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SENSITIZATION; ANTIBODIES; MICROARRAY		[Kamemura, Norio; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan; [Kawamoto, Norio; Fukao, Toshiyuki] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan; [Nakamura, Ryosuke; Teshima, Reiko] Natl Inst Hlth Sci, Div Novel Foods & Immunochem, Tokyo, Japan	Tokushima University; Gifu University; National Institute of Health Sciences - Japan	Kamemura, N (corresponding author), Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan.	kido@ier.tokushima-u.ac.jp	Kawamoto, Norio/AAN-5302-2021	Kawamoto, Norio/0000-0002-3482-7781				Bernstein IL, 2008, ANN ALLERG ASTHMA IM, V100, pS1, DOI 10.1016/S1081-1206(10)60305-5; DEVEY ME, 1988, J IMMUNOL METHODS, V106, P119, DOI 10.1016/0022-1759(88)90279-7; Grayson MH, 2007, J IMMUNOL, V179, P1438, DOI 10.4049/jimmunol.179.3.1438; Kamemura N, 2012, J ALLERGY CLIN IMMUN, V130, P113, DOI 10.1016/j.jaci.2012.02.023; Kawamoto N, 2012, J INVEST ALLERG CLIN, V22, P116; Loibichler C., 2002, Clinical and Experimental Allergy, V32, P1546, DOI 10.1046/j.1365-2222.2002.01479.x; Nakamura R, 2012, ALLERGOL INT, V61, P431, DOI 10.2332/allergolint.11-OA-0407; Ridings J, 1997, CLIN EXP IMMUNOL, V108, P366, DOI 10.1046/j.1365-2249.1997.3631264.x; Suzuki K, 2011, ANAL CHIM ACTA, V706, P321, DOI 10.1016/j.aca.2011.08.034; TERSTAPPEN LWMM, 1990, J LEUKOCYTE BIOL, V48, P138, DOI 10.1002/jlb.48.2.138; Warner JA, 2000, BRIT MED BULL, V56, P883, DOI 10.1258/0007142001903571; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941	12	10	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2014	133	3					904	+		10.1016/j.jaci.2013.09.034	http://dx.doi.org/10.1016/j.jaci.2013.09.034			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EK	24231285				2022-12-18	WOS:000332397600042
J	Schieck, M; Michel, S; Suttner, K; Illig, T; Zeilinger, S; Franke, A; Vogelberg, C; von Berg, A; Bufe, A; Heinzmann, A; Laub, O; Rietschel, E; Simma, B; Frischer, T; Genuneit, J; Kerzel, S; Kabesch, M				Schieck, Maximilian; Michel, Sven; Suttner, Kathrin; Illig, Thomas; Zeilinger, Sonja; Franke, Andre; Vogelberg, Christian; von Berg, Andrea; Bufe, Albrecht; Heinzmann, Andrea; Laub, Otto; Rietschel, Ernst; Simma, Burkhard; Frischer, Thomas; Genuneit, Jon; Kerzel, Sebastian; Kabesch, Michael			Genetic variation in T(H)17 pathway genes, childhood asthma, and total serum IgE levels	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELLS		[Schieck, Maximilian; Michel, Sven; Kerzel, Sebastian; Kabesch, Michael] Univ Childrens Hosp Regensburg KUNO, Dept Pediat Pneumol & Allergy, Regensburg, Germany; [Schieck, Maximilian; Michel, Sven; Suttner, Kathrin; Kabesch, Michael] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany; [Suttner, Kathrin] Tech Univ Munich, ZAUM Ctr Allergy & Environm, D-80290 Munich, Germany; [Suttner, Kathrin] Helmholtz Ctr Munich, Munich, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Illig, Thomas; Zeilinger, Sonja] Helmholtz Ctr Munich, Res Unit Mol Epidemiol, Neuherberg, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Vogelberg, Christian] Tech Univ Dresden, Univ Childrens Hosp, D-01062 Dresden, Germany; [von Berg, Andrea] Marien Hosp, Childrens Dept, Res Inst Prevent Allerg Dis, Wesel, Germany; [Bufe, Albrecht] Ruhr Univ Bochum, Dept Expt Pneumol, Bochum, Germany; [Heinzmann, Andrea] Univ Freiburg, Univ Childrens Hosp, D-79106 Freiburg, Germany; [Laub, Otto] Kinder & Jugendarztpraxis Laub, Rosenheim, Germany; [Rietschel, Ernst] Univ Cologne, Univ Childrens Hosp, D-50931 Cologne, Germany; [Simma, Burkhard] Landeskrankenhaus Feldkirch, Univ Teaching Hosp, Childrens Dept, Feldkirch, Austria; [Frischer, Thomas] Univ Childrens Hosp Vienna, Vienna, Austria; [Genuneit, Jon] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Suttner, Kathrin; Kabesch, Michael] German Lung Res Ctr DZL, Heidelberg, Germany	Hannover Medical School; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; St. Marien Hospital; Ruhr University Bochum; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University Hospital Vienna; Ulm University	Schieck, M (corresponding author), Univ Childrens Hosp Regensburg KUNO, Dept Pediat Pneumol & Allergy, Regensburg, Germany.	michael.kabesch@ukr.de	Genuneit, Jon/I-9323-2012; Schieck, Maximilian/D-4121-2013; Kabesch, Michael/GZM-1583-2022; Kabesch, Michael/AAB-5701-2020; Franke, Andre/B-2151-2010	Genuneit, Jon/0000-0001-5764-1528; Schieck, Maximilian/0000-0001-5878-0546; Franke, Andre/0000-0003-1530-5811; Michel, Sven/0000-0003-3604-3187; Bufe, Albrecht/0000-0001-7335-9362; Kunze, Sonja/0000-0002-9685-2675				Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen JH, 2010, J CLIN IMMUNOL, V30, P539, DOI 10.1007/s10875-010-9391-8; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kawaguchi M, 2006, J ALLERGY CLIN IMMUN, V117, P795, DOI 10.1016/j.jaci.2005.12.1346; Kerzel S, 2012, J PEDIATR-US, V161, P1172, DOI 10.1016/j.jpeds.2012.07.051; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133, P864, DOI 10.1016/j.jaci.2013.09.030; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; Pandey RC, 2013, J ALLERGY CLIN IMMUN, V131, P602, DOI 10.1016/j.jaci.2012.10.061; Silverpil E, 2012, EXPERT REV RESP MED, V6, P173, DOI [10.1586/ERS.12.12, 10.1586/ers.12.12]	10	10	37	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2014	133	3					888	891		10.1016/j.jaci.2013.08.048	http://dx.doi.org/10.1016/j.jaci.2013.08.048			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EK	24184148				2022-12-18	WOS:000332397600036
J	Hafner, R; Couroux, P; Armstrong, K; Salapatek, A; Patel, D; Larche, M				Hafner, Rod; Couroux, Peter; Armstrong, Kristen; Salapatek, AnneMarie; Patel, Deepen; Larche, Mark			Persistent Treatment Effect Achieved At One Year After Four Doses Of Der p Derived Synthetic Peptide Immuno-Regulatory Epitopes In An Exposure Chamber Model Of House Dust Mite Allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Hafner, Rod] Circassia Ltd, Oxford, England; [Couroux, Peter; Patel, Deepen] Topstone Res, Toronto, ON, Canada; [Armstrong, Kristen] Adiga Life Sci Inc, Hamilton, ON, Canada; [Salapatek, AnneMarie] Inflamax Res, Mississauga, ON, Canada; [Larche, Mark] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada	McMaster University				Larche, Mark/0000-0002-1439-7593					0	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		998	AB289	AB289		10.1016/j.jaci.2013.12.1023	http://dx.doi.org/10.1016/j.jaci.2013.12.1023			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO		Bronze			2022-12-18	WOS:000330241301313
J	Keet, CA; Shreffler, WG; Peng, RD; Matsui, W; Matsui, EC				Keet, Corinne A.; Shreffler, Wayne G.; Peng, Roger D.; Matsui, William; Matsui, Elizabeth C.			Associations between serum folate and vitamin D levels and incident mouse sensitization in adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Folate; folic acid; vitamin D; allergy; mouse allergy; sensitization	FOLIC-ACID; 25-HYDROXYVITAMIN D; CHILDHOOD ASTHMA; D INSUFFICIENCY; LUNG-FUNCTION; FOOD ALLERGY; BIRTH COHORT; ATOPY; PREGNANCY; CHILDREN	Background: Although both folic acid intake and vitamin D levels are hypothesized to be contributors to the increased incidence of allergic diseases, prospective studies of these relationships have not been done in adults. Objectives: We sought to determine whether serum folate or vitamin D levels are associated with incident mouse sensitization among new workers at a mouse facility. Methods: Subjects started employment at the Jackson Laboratory between June 2004 and July 2007. Skin testing to mouse and other allergens and collection of questionnaire data were performed at baseline and every 6 months. Serum folate and vitamin D levels were assessed on baseline samples stored at -80 degrees C. Folate was categorized into tertiles (2.5-10.5, 10.5-16.2, and 16.2-78.4 ng/mL, respectively). Vitamin D was categorized as less than 20 ng/mL, 20 to 29 ng/mL, or 30 ng/mL or greater. This was a nested case-control study in which 5 control subjects were matched to each case on baseline atopy and type of employment. Multivariate analyses controlled for age, sex, education, smoking, season, personal mouse exposure, and serum folate and vitamin D levels. Results: Thirty-five cases and 47 control subjects were included. The odds of incident mouse sensitization were higher in the intermediate and highest tertiles of serum folate compared with the lowest tertile of serum folate (odds ratio of 10.5 [95% CI, 1.8-61.5; P=.009] and odds ratio of 5.6 [95% CI, 1.8-31.3; P=.049], respectively, in the multivariate model). Serum vitamin D levels were not associated with incident mouse sensitization. Conclusions: These findings support a role for higher serum folate levels in increased risk of incident allergic disease, even during adulthood.	[Keet, Corinne A.; Matsui, Elizabeth C.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD USA; [Keet, Corinne A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shreffler, Wayne G.] Massachusetts Gen Hosp, Food Allergy Ctr, Div Allergy & Immunol, Boston, MA 02114 USA; [Shreffler, Wayne G.] Dept Pediat, Boston, MA USA; [Peng, Roger D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Matsui, William] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Keet, CA (corresponding author), Johns Hopkins Univ Hosp, CMSC 1102,600 N Wolfe St, Baltimore, MD 21202 USA.	ckeet1@jhmi.edu		Matsui, William/0000-0002-3088-0964; Keet, Corinne/0000-0002-6585-239X; Matsui, Elizabeth/0000-0001-8134-5593	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) [1K23AI103187]; NIAID/NIH [R01AI081845]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081845, K23AI103187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) grant no. 1K23AI103187 (to C.A.K.) and NIAID/NIH grant no. R01AI081845 (to E.C.M.).	Allen KJ, 2013, J ALLERGY CLIN IMMUN, V131, P1109, DOI 10.1016/j.jaci.2013.01.017; Bekkers MBM, 2012, EUR RESPIR J, V39, P1468, DOI 10.1183/09031936.00094511; Bener A, 2012, INT ARCH ALLERGY IMM, V157, P168, DOI 10.1159/000323941; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Ginde AA, 2009, CURR ALLERGY ASTHM R, V9, P81, DOI 10.1007/s11882-009-0012-7; Haberg SE, 2011, J ALLERGY CLIN IMMUN, V127, P262, DOI 10.1016/j.jaci.2010.10.004; Hollams EM, 2011, EUR RESPIR J, V38, P1320, DOI 10.1183/09031936.00029011; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jones AP, 2012, PEDIATRICS, V130, pE1128, DOI 10.1542/peds.2012-1172; Junod SW, FOLIC ACID FORTIFICA; Keet CA, 2011, J ALLERGY CLIN IMMUN, V128, P414, DOI 10.1016/j.jaci.2011.06.011; Kiefte-de Jong JC, 2012, J NUTR, V142, P731, DOI 10.3945/jn.111.154948; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Lin JH, 2013, J ALLERGY CLIN IMMUN, V131, P918, DOI 10.1016/j.jaci.2012.10.046; Magdelijns FJH, 2011, PEDIATRICS, V128, pE135, DOI 10.1542/peds.2010-1690; Martinussen MP, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.033; Matsui EC, 2009, J ALLERGY CLIN IMMUN, V123, P1253, DOI 10.1016/j.jaci.2009.03.007; Mullins RJ, 2012, ANN ALLERG ASTHMA IM, V109, P324, DOI 10.1016/j.anai.2012.07.009; Okupa AY, 2013, J ALLERGY CLIN IMMUN, V131, DOI 10.1016/j.jaci.2012.08.015; Peng RD, 2011, J ALLERGY CLIN IMMUN, V128, P390, DOI 10.1016/j.jaci.2011.04.050; Pfeiffer CM, 2012, J NUTR, V142, P886, DOI 10.3945/jn.111.156919; Pike KC, 2012, THORAX, V67, P950, DOI 10.1136/thoraxjnl-2012-201888; Rothers J, 2011, J ALLERGY CLIN IMMUN, V128, pe1, DOI DOI 10.1016/J.JACI.2011.07.015; Rothers J, 2011, J ALLERGY CLIN IMMUN, V128, P1093, DOI 10.1016/j.jaci.2011.07.015; Sharief S, 2011, J ALLERGY CLIN IMMUN, V127, P1195, DOI 10.1016/j.jaci.2011.01.017; Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567; Thuesen BH, 2010, ALLERGY, V65, P1446, DOI 10.1111/j.1398-9995.2010.02378.x; van Oeffelen AAM, 2011, PEDIAT ALLERG IMM-UK, V22, P784, DOI 10.1111/j.1399-3038.2011.01190.x; Weisse K, 2013, ALLERGY, V68, P220, DOI 10.1111/all.12081; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; Zahran Hatice S., 2011, Morbidity and Mortality Weekly Report, V60, P547	32	10	10	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2					399	404		10.1016/j.jaci.2013.09.042	http://dx.doi.org/10.1016/j.jaci.2013.09.042			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EF	24290285	Green Accepted			2022-12-18	WOS:000332397100014
J	Wickner, PG; Commins, SP				Wickner, Paige G.; Commins, Scott P.			The First 4 Central American Cases Of Delayed Meat Allergy With Galactose-Alpha-1,3-Galactose Positivity Clustered Among Field Biologists In Panama	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Wickner, Paige G.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Chestnut Hill, MA USA; [Commins, Scott P.] Univ Virginia Hlth Syst, Charlottesville, VA USA	Harvard University; Brigham & Women's Hospital; University of Virginia									0	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		736	AB212	AB212		10.1016/j.jaci.2013.12.760	http://dx.doi.org/10.1016/j.jaci.2013.12.760			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO					2022-12-18	WOS:000330241301052
J	Bacharier, LB				Bacharier, Leonard B.			Vitamin D status at birth: An important and potentially modifiable determinant of atopic disease in childhood?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Vitamin D; atopic disease; wheeze; rhinitis; atopic dermatitis; vitamin deficiency	RESPIRATORY-INFECTION; 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; ALLERGIC DISEASE; RANDOMIZED-TRIAL; D DEFICIENCY; PREGNANCY; ASTHMA; RISK; CHILDREN		[Bacharier, Leonard B.] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Bacharier, Leonard B.] St Louis Childrens Hosp, St Louis, MO USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Bacharier, LB (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis Childrens Hosp, 1 Childrens Pl, St Louis, MO 63110 USA.	bacharier_L@kids.wustl.edu		Bacharier, Leonard/0000-0003-0432-2704				Allen KJ, 2013, J ALLERGY CLIN IMMUN, V131, P1109, DOI 10.1016/j.jaci.2013.01.017; Baiz N, 2014, J ALLERGY CLIN IMMUN, V133, P147, DOI 10.1016/j.jaci.2013.05.017; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Erkkola M, 2009, CLIN EXP ALLERGY, V39, P875, DOI 10.1111/j.1365-2222.2009.03234.x; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Jones AP, 2012, PEDIATRICS, V130, pE1128, DOI 10.1542/peds.2012-1172; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Maguire JL, 2013, PEDIATRICS, V131, pE144, DOI 10.1542/peds.2012-1793; Miyake Y, 2010, EUR RESPIR J, V35, P1228, DOI 10.1183/09031936.00100609; Morales E, 2012, EPIDEMIOLOGY, V23, P64, DOI 10.1097/EDE.0b013e31823a44d3; Muehleisen B, 2013, J ALLERGY CLIN IMMUN, V131, P324, DOI 10.1016/j.jaci.2012.12.1562; Pike KC, 2012, THORAX, V67, P950, DOI 10.1136/thoraxjnl-2012-201888; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862	17	10	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					154	155		10.1016/j.jaci.2013.07.034	http://dx.doi.org/10.1016/j.jaci.2013.07.034			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	24001801				2022-12-18	WOS:000329105700021
J	Hennig, C; Ilginus, C; Boztug, K; Skokowa, J; Marodi, L; Szaflarska, A; Sass, M; Pignata, C; Kilic, SS; Caragol, I; Baumann, U; Klein, C; Welte, K; Hansen, G				Hennig, Christian; Ilginus, Claudia; Boztug, Kaan; Skokowa, Julia; Marodi, Laszlo; Szaflarska, Anna; Sass, Mareike; Pignata, Claudio; Kilic, Sara Sebnem; Caragol, Isabel; Baumann, Ulrich; Klein, Christoph; Welte, Karl; Hansen, Gesine			High-content cytometry and transcriptomic biomarker profiling of human B-cell activation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Primary immunodeficiency; primary antibody deficiency; B-cell immunology; chip cytometry	AUTOSOMAL RECESSIVE FORM; ATAXIA-TELANGIECTASIA; DEFICIENCY; IMMUNODEFICIENCIES; EXPRESSION; MUTATIONS; PATHWAY; AID; ATM	Background: Primary antibody deficiencies represent the most prevalent, although very heterogeneous, group of inborn immunodeficiencies, with a puzzling complexity of cellular and molecular processes involved in disease pathogenesis. Objective: We aimed to study in detail the kinetics of CD40 ligand/IL-21-induced B-cell differentiation to define new biomarker sets for further research into primary antibody deficiencies. Methods: We applied high-content screening methods to monitor B-cell activation on the cellular (chip cytometry) and transcriptomic (RNA microarray) levels. Results: The complete activation process, including stepwise changes in protein and RNA expression patterns, entry into the cell cycle, proliferation and expression of activation-induced cytidine deaminase (AID), DNA repair enzymes, and post-class-switch expression of IgA and IgG, was successfully monitored during in vitro differentiation. We identified a number of unknown pathways engaged during B-cell activation, such as CXCL9/CXCL10 secretion by B cells. Finally, we evaluated a deduced set of biomarkers on a group of 18 patients with putative or proved intrinsic B-cell defects recruited from the European Society for Immunodeficiencies database and successfully predicted 2 AID defects and 1 DNA repair defect. Complete absence of class-switched B cells was a sensitive predictor of AID deficiency and should be further evaluated as a diagnostic biomarker. Conclusion: The biomarkers found in this study could be used to further study the complex process of B-cell activation and to understand conditions that lead to the development of primary antibody deficiencies.	[Hennig, Christian; Ilginus, Claudia; Baumann, Ulrich; Hansen, Gesine] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, D-30625 Hannover, Germany; [Boztug, Kaan; Sass, Mareike; Klein, Christoph] Hannover Med Sch, Dept Pediat Oncol & Hematol, D-30625 Hannover, Germany; [Skokowa, Julia; Welte, Karl] Hannover Med Sch, Dept Pediat & Mol Hematopoiesis, D-30625 Hannover, Germany; [Boztug, Kaan] Austrian Acad Sci, Res Ctr Mol Med CeMM, A-1010 Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Marodi, Laszlo] Univ Debrecen, Debrecen, Hungary; [Marodi, Laszlo] Med & Hlth Sci Ctr, Dept Infect & Pediat Immunol, Debrecen, Hungary; [Szaflarska, Anna] Jagiellonian Univ, Polish Amer Inst Pediat, Dept Clin Immunol, Coll Med, Krakow, Poland; [Pignata, Claudio] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Kilic, Sara Sebnem] Uludag Univ, Fac Med, Dept Pediat, Bursa, Turkey; [Caragol, Isabel] Vall dHebron Hosp, Pediat Infect Dis & Immunodeficiencies Unit, Barcelona, Spain; [Klein, Christoph] Univ Munich, Dept Pediat, Munich, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of Debrecen; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Naples Federico II; Uludag University; Hospital Universitari Vall d'Hebron; University of Munich	Hennig, C (corresponding author), Hannover Med Sch, OE6710,I10 E02 R7370,Carl Neuberg Str 1, D-30625 Hannover, Germany.	hennig.christian@mh-hannover.de	Pignata, Claudio/O-2466-2013; Boztug, Kaan/AAM-4161-2021; Marodi, Laszlo/AAU-9915-2020; Kilic, Sara Sebnem/AAH-1658-2021; Skokowa, Julia/AAU-3622-2021	Pignata, Claudio/0000-0003-1568-9843; Boztug, Kaan/0000-0001-8387-9185; Skokowa, Julia/0000-0002-4399-2324; kilic, sara sebnem/0000-0001-8571-2581				Aalhotra RK, 2008, ARCH PATHOL LAB MED, V132, P847, DOI 10.1043/1543-2165(2008)132[847:PDGNCA]2.0.CO;2; [Anonymous], 2011, OMIM ONLINE MENDELIA; Avanzini MA, 2010, INT J IMMUNOPATH PH, V23, P247, DOI 10.1177/039463201002300122; Borte S, 2009, BLOOD, V114, P4089, DOI 10.1182/blood-2009-02-207423; Burdin N, 1996, J IMMUNOL, V156, P4107; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Chistiakov DA, 2009, EUR J MED GENET, V52, P373, DOI 10.1016/j.ejmg.2009.05.009; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; Distel L, 2003, MED PEDIATR ONCOL, V41, P44, DOI 10.1002/mpo.10275; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; Gathmann B, 2009, CLIN EXP IMMUNOL, V157, P3, DOI 10.1111/j.1365-2249.2009.03954.x; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Hennig C, 2010, BRIT J HAEMATOL, V148, P445, DOI 10.1111/j.1365-2141.2009.07987.x; Hennig C, 2009, CYTOM PART A, V75A, P362, DOI 10.1002/cyto.a.20668; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huck K, 2009, CLIN IMMUNOL, V131, P50, DOI 10.1016/j.clim.2008.11.008; Kato A, 2004, BIOCHEM BIOPH RES CO, V320, P1139, DOI 10.1016/j.bbrc.2004.06.059; Kracker S, 2010, CLIN IMMUNOL, V135, P193, DOI 10.1016/j.clim.2010.01.012; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; Mouillot G, 2010, J CLIN IMMUNOL, V30, P746, DOI 10.1007/s10875-010-9424-3; Neron S, 2011, ARCH IMMUNOL THER EX, V59, P25, DOI 10.1007/s00005-010-0108-8; Noordzij JG, 2009, ARCH DIS CHILD, V94, P448, DOI 10.1136/adc.2008.149351; Notarangelo LD, 2008, J ALLERGY CLIN IMMUN, V122, P1069, DOI 10.1016/j.jaci.2008.08.038; Ohtani H, 2009, J PATHOL, V217, P21, DOI 10.1002/path.2448; Pietrucha Barbara Maria, 2010, J Pediatr Hematol Oncol, V32, pe28, DOI 10.1097/MPH.0b013e3181bfd3d9; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Urschel S, 2009, J PEDIATR-US, V154, P888, DOI 10.1016/j.jpeds.2008.12.020; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744	38	10	10	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					172	+		10.1016/j.jaci.2013.06.047	http://dx.doi.org/10.1016/j.jaci.2013.06.047			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	24012209				2022-12-18	WOS:000329105700024
J	Castro-Rodriguez, JA				Castro-Rodriguez, Jose A.			The necessity of having asthma predictive scores in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Recurrent wheezing; asthma; diagnosis; asthma predictive index	RISK		[Castro-Rodriguez, Jose A.] Pontificia Univ Catolica Chile, Sch Med, Dept Pediat, Santiago, Chile; [Castro-Rodriguez, Jose A.] Pontificia Univ Catolica Chile, Sch Med, Dept Publ Hlth Family Med, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Castro-Rodriguez, JA (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Dept Pediat, Lira 44,1Er Piso,Casilla 114-D, Santiago, Chile.	jacastro17@hotmail.com	Castro-Rodriguez, Jose A./ABA-2760-2021; Castro-Rodriguez, Jose A./ABA-6591-2021	Castro-Rodriguez, Jose A./0000-0002-0708-4281				Bisgaard H., 1997, PEDIAT PULMONOL, V15, pS27; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2012, EUR RESPIR MONOGR, P10, DOI 10.1183/1025448x.10000212; Castro-Rodriguez JA, 2010, J ALLERGY CLIN IMMUN, V126, P212, DOI 10.1016/j.jaci.2010.06.032; Caudri D, 2009, J ALLERGY CLIN IMMUN, V124, P903, DOI 10.1016/j.jaci.2009.06.045; Hafkamp-de Groen E, 2013, J ALLERGY CLIN IMMUN, V132, P1303, DOI 10.1016/j.jaci.2013.07.007; Klaassen EMM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/162571; Kurukulaaratchy RJ, 2003, EUR RESPIR J, V22, P767, DOI 10.1183/09031936.03.00005903; Leonardi NA, 2011, J ALLERGY CLIN IMMUN, V127, P1466, DOI 10.1016/j.jaci.2011.03.001; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Pescatore AM, 2013, J ALLERGY CLIN IMMUN; Rodriguez-Martinez CE, 2011, PEDIATR PULM, V46, P1175, DOI 10.1002/ppul.21493; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	15	10	12	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2013	132	6					1311	1313		10.1016/j.jaci.2013.09.006	http://dx.doi.org/10.1016/j.jaci.2013.09.006			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	259PG	24172768				2022-12-18	WOS:000327538200010
J	Yoon, SY; Baek, SH; Kim, S; Lee, YS; Lee, T; Bae, YJ; Kwon, HS; Huh, JW; Hong, SB; Cho, YS; Chun, S; Lim, CM; Koh, Y; Moon, HB; Kim, TB				Yoon, Sun-Young; Baek, Seung Hee; Kim, Sujeong; Lee, Yoon Su; Lee, Taehoon; Bae, Yun-Jeong; Kwon, Hyouk-Soo; Huh, Jin Won; Hong, Sang-Bum; Cho, You Sook; Chun, Sail; Lim, Chae-Man; Koh, Younsuck; Moon, Hee-Bom; Kim, Tae-Bum			Serum procalcitonin as a biomarker differentiating delayed-type drug hypersensitivity from systemic bacterial infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AUTOIMMUNE-DISEASES; SEPSIS		[Yoon, Sun-Young; Kim, Sujeong; Lee, Yoon Su; Lee, Taehoon; Kwon, Hyouk-Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum] Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Seoul, South Korea; [Baek, Seung Hee] Univ Ulsan, Coll Med, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Bae, Yun-Jeong] Univ Ulsan, Coll Med, Hlth Screening & Promot Ctr, Seoul, South Korea; [Huh, Jin Won; Hong, Sang-Bum; Lim, Chae-Man; Koh, Younsuck] Univ Ulsan, Coll Med, Dept Pulm & Crit Care Med, Asan Med Ctr, Seoul, South Korea; [Chun, Sail] Univ Ulsan, Coll Med, Dept Lab Med, Asan Med Ctr, Seoul, South Korea	University of Ulsan; University of Ulsan; University of Ulsan; University of Ulsan; University of Ulsan	Yoon, SY (corresponding author), Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Seoul, South Korea.	allergy@medimail.co.kr	Lee, Taehoon/AHA-1437-2022	Lee, Taehoon/0000-0002-9224-0866; Cho, You Sook/0000-0001-8767-2667				Cakir E, 2005, CLIN BIOCHEM, V38, P234, DOI 10.1016/j.clinbiochem.2004.11.008; Joo K, 2011, J KOREAN MED SCI, V26, P1147, DOI 10.3346/jkms.2011.26.9.1147; Mitaka C, 2005, CLIN CHIM ACTA, V351, P17, DOI 10.1016/j.cccn.2004.08.018; Muller B, 2002, J LEUKOCYTE BIOL, V72, P643; Oshita H, 2010, J MICROBIOL IMMUNOL, V43, P222, DOI 10.1016/S1684-1182(10)60035-7; Prat C, 2006, J INFECTION, V52, P169, DOI 10.1016/j.jinf.2005.05.019; Rinaldi S, 2006, CRIT CARE MED, V34, P2334, DOI 10.1097/01.CCM.0000233872.04706.BB; Schneider HG, 2007, PATHOLOGY, V39, P383, DOI 10.1080/00313020701444564; Tamaki K, 2008, J RHEUMATOL, V35, P114	9	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2013	132	4					981	+		10.1016/j.jaci.2013.04.038	http://dx.doi.org/10.1016/j.jaci.2013.04.038			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	227FR	23768571	Bronze			2022-12-18	WOS:000325096500030
J	Alsina, L; Gonzalez-Roca, E; Giner, MT; Piquer, M; Puga, I; Pascal, M; Ruiz-Ortiz, E; Badell, I; Martin-Mateos, MA; Cerutti, A; Juan, M; Yague, J; Plaza, AM; Arostegui, JI				Alsina, Laia; Gonzalez-Roca, Eva; Teresa Giner, Maria; Piquer, Monica; Puga, Irene; Pascal, Mariona; Ruiz-Ortiz, Estibaliz; Badell, Isabel; Anunciacion Martin-Mateos, Maria; Cerutti, Andrea; Juan, Manel; Yaguee, Jordi; Plaza, Ana M.; Arostegui, Juan I.			Massively parallel sequencing reveals maternal somatic IL2RG mosaicism in an X-linked severe combined immunodeficiency family	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Alsina, Laia; Teresa Giner, Maria; Piquer, Monica; Anunciacion Martin-Mateos, Maria; Plaza, Ana M.] Univ Barcelona, Pediat Allergy & Clin Immunol Dept, Hosp St Joan de Deu, Barcelona, Spain; [Gonzalez-Roca, Eva; Pascal, Mariona; Ruiz-Ortiz, Estibaliz; Juan, Manel; Yaguee, Jordi; Arostegui, Juan I.] Univ Barcelona, IDIBAPS, Hosp Clin, Dept Immunol, Barcelona, Spain; [Puga, Irene; Cerutti, Andrea] Hosp del Mar, Inst Municipal Invest Med, Barcelona, Spain; [Badell, Isabel] Univ Autonoma Barcelona, Dept Pediat, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau	Alsina, L (corresponding author), Univ Barcelona, Pediat Allergy & Clin Immunol Dept, Hosp St Joan de Deu, Barcelona, Spain.	jiaroste@clinic.ub.es	Juan, Manel/Q-2931-2019; Badell, Isabel/AAG-5133-2019; Pascal, Mariona/HCG-9380-2022; Alsina, Laia/AID-4372-2022; Alsina, Laia/GQI-3516-2022	Badell, Isabel/0000-0001-6546-2175; Juan, Manel/0000-0002-3064-1648; Gonzalez-Roca, Eva/0000-0002-1126-0321; RUIZ-ORTIZ, ESTIBALIZ/0000-0002-3003-934X; YAGUE, JORDI/0000-0001-8210-1929; Cerutti, Andrea/0000-0003-3026-4704; Arostegui, Juan Ignacio/0000-0003-4757-504X; Puga, Irene/0000-0003-2208-3196; Alsina, Laia/0000-0002-3559-0018				CONLEY ME, 1990, J CLIN INVEST, V85, P1548, DOI 10.1172/JCI114603; Giron-Michel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031624; Holzelova E, 2004, NEW ENGL J MED, V351, P1409, DOI 10.1056/NEJMoa040036; OMarcaigh AS, 1997, J CLIN IMMUNOL, V17, P29, DOI 10.1023/A:1027332327827; PEPPER AE, 1995, AM J HUM GENET, V57, P564; Puck J M, 2007, PRIMARY IMMUNODEFICI, P123; PUCK JM, 1995, J CLIN INVEST, V95, P895, DOI 10.1172/JCI117740; Puck JM, 1997, BLOOD, V89, P1968; Tanaka N, 2011, ARTHRITIS RHEUM-US, V63, P3625, DOI 10.1002/art.30512	9	10	11	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2013	132	3					741	743		10.1016/j.jaci.2013.03.038	http://dx.doi.org/10.1016/j.jaci.2013.03.038			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	207OS	23683512				2022-12-18	WOS:000323612000029
J	Farrell, J; Lichtenfels, M; Sullivan, A; Elliott, EC; Alfirevic, A; Stachulski, AV; Pirmohamed, M; Naisbitt, DJ; Park, BK				Farrell, John; Lichtenfels, Maike; Sullivan, Andrew; Elliott, Emma C.; Alfirevic, Ana; Stachulski, Andrew V.; Pirmohamed, Munir; Naisbitt, Dean J.; Park, B. Kevin			Activation of carbamazepine-responsive T-cell clones with metabolically inert halogenated derivatives	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							STEVENS-JOHNSON-SYNDROME; HYPERSENSITIVITY; REACTIVITY		[Farrell, John; Lichtenfels, Maike; Sullivan, Andrew; Alfirevic, Ana; Pirmohamed, Munir; Naisbitt, Dean J.; Park, B. Kevin] Univ Liverpool, Dept Pharmacol, MRC, Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England; [Elliott, Emma C.; Stachulski, Andrew V.] Univ Liverpool, Dept Chem, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Farrell, J (corresponding author), Univ Liverpool, Dept Pharmacol, MRC, Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England.	dnes@liv.ac.uk	Pirmohamed, Munir/H-6004-2011	Pirmohamed, Munir/0000-0002-7534-7266; Naisbitt, Dean/0000-0003-4107-7832; Farrell, John/0000-0002-8726-5997	National Institute for Health Research [NF-SI-0512-10064] Funding Source: researchfish; Epilepsy Research UK [P1105] Funding Source: researchfish; MRC [G0700654] Funding Source: UKRI; Medical Research Council [G0700654] Funding Source: Medline; Department of Health Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Epilepsy Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Adam J, 2012, EUR J IMMUNOL, V42, P1706, DOI 10.1002/eji.201142159; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Elliott EC, 2012, J MED CHEM, V55, P9773, DOI 10.1021/jm301013n; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Pearce RE, 2002, DRUG METAB DISPOS, V30, P1170, DOI 10.1124/dmd.30.11.1170; Wei CY, 2012, J ALLERGY CLIN IMMUN, V129, P1562, DOI 10.1016/j.jaci.2011.12.990; Whitaker P, 2011, J IMMUNOL, V187, P200, DOI 10.4049/jimmunol.1100647; Yang CWO, 2007, J ALLERGY CLIN IMMUN, V120, P870, DOI 10.1016/j.jaci.2007.06.017	9	10	10	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2013	132	2					493	495		10.1016/j.jaci.2013.02.045	http://dx.doi.org/10.1016/j.jaci.2013.02.045			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	194KL	23672781				2022-12-18	WOS:000322631700035
J	Fili, L; Vultaggio, A; Cardilicchia, E; Manuelli, C; Casini, A; Nencini, F; Maggi, L; Pratesi, S; Petroni, G; Boscaro, F; Guarna, A; Occhiato, EG; Romagnani, S; Maggi, E; Parronchi, P				Fili, Lucia; Vultaggio, Alessandra; Cardilicchia, Elisa; Manuelli, Cinzia; Casini, Andrea; Nencini, Francesca; Maggi, Laura; Pratesi, Sara; Petroni, Giulia; Boscaro, Francesca; Guarna, Antonio; Occhiato, Ernesto G.; Romagnani, Sergio; Maggi, Enrico; Parronchi, Paola			A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Adjuvants; immunotherapy; allergy; vaccines; Toll-like receptors; adenine derivatives; T-H cells	T-CELL RESPONSES; IMMUNOLOGICAL MECHANISMS; IMMUNOSTIMULATORY DNA; VACCINE ADJUVANTS; MODIFIED ADENINE; INNATE IMMUNITY; TH2 RESPONSES; ASTHMA; AMB; TOLL-LIKE-RECEPTOR-7	Background: Several approaches to find a better adjuvant, focus immunomodulation, and reduce allergenicity are under investigation to improve the efficacy and safety of specific immunotherapy. Objective: We performed an investigation of the in vitro and in vivo effects of a purified allergen chemically conjugated to a novel 8-OH modified adenine as an adjuvant. Methods: Purified group 2 major allergen from house dust mite chemically conjugated to 4-(6-amino-9-benzyl-8-hydroxy-9H-purin-2-ylsulfanyl)-butyric acid succinimidyl ester was analyzed by using mass spectrometry. The adduct (nDer p 2-Conj) was assayed for Toll-like receptor activation on transfected HEK293 cells, stimulation of innate cells, and effects on the functional phenotype of specific T-cell lines and clones by means of flow cytometry, real-time PCR, and expression of T-H-related transcription factors. Lung cells and sera of nDer p 2-Conj-sensitized C57Bl/6 mice were studied by means of cytology, histology, real-time PCR, and ELISA. Results: nDer p 2-Conj stimulated IL-12 and IFN-alpha production from monocytes and plasmacytoid dendritic cells, respectively, retaining the ability to trigger Toll-like receptor 7 exclusively, and expanded human allergen-specific lymphocytes with reduced ability to produce T(H)2-related cytokines and increased IFN-gamma levels, as based on GATA-3/T-bet expression. In vivo adduct-sensitized mice exhibited reduced eosinophil infiltration and IL-13 expression in the airways, IFN-gamma upregulation together with IgE downregulation, and an increase in allergen-specific IgG(2a) levels in sera. The conjugate exhibited reduced ability to activate human FceRI(+) cells without inducing T(H)17 cells or autoantibodies. Conclusions: The codelivery of an allergen with a modified adenine as a conjugate inducing modulatory cytokines from innate cells redirects in vitro and in vivo pathogenic T(H)2 responses without eliciting harmful effects.	[Fili, Lucia; Vultaggio, Alessandra; Cardilicchia, Elisa; Manuelli, Cinzia; Nencini, Francesca; Maggi, Laura; Pratesi, Sara; Petroni, Giulia; Romagnani, Sergio; Maggi, Enrico; Parronchi, Paola] Univ Florence, Ctr Res Transfer & High Educ DENOTHE, Dept Expt & Clin Med, I-50121 Florence, Italy; [Casini, Andrea; Guarna, Antonio; Occhiato, Ernesto G.] Univ Florence, Dept Chem U Schiff, I-50121 Florence, Italy; [Boscaro, Francesca] Univ Florence, Mass Spectrometry Ctr CISM, I-50121 Florence, Italy	University of Florence; University of Florence; University of Florence	Parronchi, P (corresponding author), Immunol Lab, Viale Pieraccini 6, I-50134 Florence, Italy.	paola.parronchi@unifi.it	Alessandra, Vultaggio/K-3201-2014; Parronchi, Paola/AAE-5422-2022; Petroni, Giulia/AAR-7219-2020; Pratesi, Sara/O-3718-2019; Maggi, Enrico/AAA-8045-2019; Pratesi, Sara/K-8135-2016; Maggi, Laura/B-6693-2013	Parronchi, Paola/0000-0002-9184-5089; Petroni, Giulia/0000-0002-0558-5322; Pratesi, Sara/0000-0003-3550-1959; Maggi, Enrico/0000-0002-1824-3583; Pratesi, Sara/0000-0003-3550-1959; Maggi, Laura/0000-0003-2862-9591; Occhiato, Ernesto Giovanni/0000-0003-2187-2409; Boscaro, Francesca/0000-0003-2845-9182	Regione Toscana (Regional Health Research Program); Ente Cassa di Risparmio di Firenze; FP6 European Union project SENS.IT.IV [LSHB-CT-2006-018861]; FP6 European Union project INNOCHEM [FP6-LSHB-CT-2005-518167]	Regione Toscana (Regional Health Research Program)(Regione Toscana); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); FP6 European Union project SENS.IT.IV(European Commission); FP6 European Union project INNOCHEM	Supported by grants from Regione Toscana (Regional Health Research Program 2009), Ente Cassa di Risparmio di Firenze, and in part from the FP6 European Union projects SENS.IT.IV (grant LSHB-CT-2006-018861) and INNOCHEM (FP6-LSHB-CT-2005-518167).	Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Brand S, 2012, J ALLERGY CLIN IMMUN, V129, P1602, DOI 10.1016/j.jaci.2011.12.963; Brand S, 2011, J ALLERGY CLIN IMMUN, V128, P618, DOI 10.1016/j.jaci.2011.04.035; Brewer JM, 1999, J IMMUNOL, V163, P6448; Broide DH, 2009, ANNU REV MED, V60, P279, DOI 10.1146/annurev.med.60.041807.123524; Brugnolo F, 2003, J ALLERGY CLIN IMMUN, V111, P380, DOI 10.1067/mai.2003.102; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Dai JH, 2009, BLOOD, V113, P5829, DOI 10.1182/blood-2008-09-179507; De Gregorio E, 2008, EUR J IMMUNOL, V38, P2068, DOI 10.1002/eji.200838648; Eifan AO, 2011, CURR OPIN ALLERGY CL, V11, P586, DOI 10.1097/ACI.0b013e32834cb994; Ewald SE, 2011, CURR OPIN IMMUNOL, V23, P3, DOI 10.1016/j.coi.2010.11.006; Fili L, 2006, J ALLERGY CLIN IMMUN, V118, P511, DOI 10.1016/j.jaci.2006.05.027; Frew AJ, 2011, CLIN EXP ALLERGY, V41, P1221, DOI 10.1111/j.1365-2222.2011.03768.x; Hackl D, 2011, EUR J IMMUNOL, V41, P1334, DOI 10.1002/eji.201041014; Hirota K, 2003, ORG BIOMOL CHEM, V1, P1354, DOI 10.1039/b300557g; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Kastenmuller K, 2011, J CLIN INVEST, V121, P1782, DOI 10.1172/JCI45416; Kurimoto A, 2004, BIOORGAN MED CHEM, V12, P1091, DOI 10.1016/j.bmc.2003.12.008; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Linhart B, 2012, VACCINE, V30, P4328, DOI 10.1016/j.vaccine.2011.11.011; Maggi E, 2012, CURR OPIN ALLERGY CL, V12, P1, DOI 10.1097/ACI.0b013e32834ecc9a; Musmuca I, 2009, J CHEM INF MODEL, V49, P1777, DOI 10.1021/ci900065a; Oh JZ, 2010, J IMMUNOL, V185, P4602, DOI 10.4049/jimmunol.1001892; Pfaar O, 2011, INT ARCH ALLERGY IMM, V154, P336, DOI 10.1159/000321826; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Romagnani S, 2001, CURR OPIN ALLERGY CL, V1, P73, DOI 10.1097/01.all.0000010988.60715.c8; Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105; Simons FER, 2004, J ALLERGY CLIN IMMUN, V113, P1144, DOI 10.1016/j.jaci.2004.03.003; Tagliabue A, 2008, HUM VACCINES, V4, P347, DOI 10.4161/hv.4.5.6438; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; Trombone APF, 2002, CLIN EXP ALLERGY, V32, P1323, DOI 10.1046/j.1365-2745.2002.01455.x; Tulic MK, 2004, J ALLERGY CLIN IMMUN, V113, P235, DOI 10.1016/j.jaci.2003.11.001; Vultaggio A, 2011, J IMMUNOL, V186, P4707, DOI 10.4049/jimmunol.1002398; Vultaggio A, 2009, J IMMUNOL, V182, P880, DOI 10.4049/jimmunol.182.2.880; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	42	10	10	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2013	132	1					84	U168		10.1016/j.jaci.2013.01.030	http://dx.doi.org/10.1016/j.jaci.2013.01.030			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	173BF	23498597				2022-12-18	WOS:000321052300011
J	Kim, VHD; Murguia, L; Schechter, T; Grunebaum, E; Roifman, CM				Kim, Vy Hong-Diep; Murguia, Luis; Schechter, Tal; Grunebaum, Eyal; Roifman, Chaim M.			Emergency treatment for zeta chain-associated protein of 70 kDa (ZAP70) deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SEVERE COMBINED IMMUNODEFICIENCY; TYROSINE KINASE; ZAP-70; TRANSPLANTATION; RECEPTOR		[Kim, Vy Hong-Diep; Murguia, Luis; Grunebaum, Eyal; Roifman, Chaim M.] Jeffrey Modell Res Lab Diag Primary Immunodeficie, Div Immunol & Allergy, Toronto, ON, Canada; [Schechter, Tal] Jeffrey Modell Res Lab Diag Primary Immunodeficie, Toronto, ON, Canada; [Roifman, Chaim M.] Jeffrey Modell Res Lab Diag Primary Immunodeficie, Canadian Ctr Primary Immunodeficiency, Toronto, ON, Canada; [Kim, Vy Hong-Diep; Murguia, Luis; Schechter, Tal; Grunebaum, Eyal; Roifman, Chaim M.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Kim, Vy Hong-Diep; Murguia, Luis; Schechter, Tal; Grunebaum, Eyal; Roifman, Chaim M.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Kim, VHD (corresponding author), Jeffrey Modell Res Lab Diag Primary Immunodeficie, Div Immunol & Allergy, Toronto, ON, Canada.	chaim.roifman@sickkids.ca						ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Dalal I, 2000, BONE MARROW TRANSPL, V25, P613, DOI 10.1038/sj.bmt.1702215; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Fagioli F, 2003, BONE MARROW TRANSPL, V31, P133, DOI 10.1038/sj.bmt.1703800; JIN YJ, 1990, J IMMUNOL, V144, P647; Newell A, 2011, J ALLERGY CLIN IMMUN, V127, P517, DOI 10.1016/j.jaci.2010.09.016; Parry DE, 1996, J ALLERGY CLIN IMMUN, V97, P830; ROIFMAN CM, 1989, J EXP MED, V170, P2177, DOI 10.1084/jem.170.6.2177; Sharfe N, 2007, LYMPHOCYTE ACTIVATIO; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; WANGE RL, 1992, J BIOL CHEM, V267, P11685	12	10	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1233	1235		10.1016/j.jaci.2012.09.020	http://dx.doi.org/10.1016/j.jaci.2012.09.020			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23141738				2022-12-18	WOS:000317187200036
J	de Diego, RP; Mulvey, C; Crawford, M; Trotter, MWB; Lorenzo, L; Sancho-Shimizu, V; Abel, L; Zhang, SY; Casanova, JL; Godovac-Zimmermann, J				Perez de Diego, Rebeca; Mulvey, Claire; Crawford, Mark; Trotter, Matthew W. B.; Lorenzo, Lazaro; Sancho-Shimizu, Vanessa; Abel, Laurent; Zhang, Shen-Ying; Casanova, Jean-Laurent; Godovac-Zimmermann, Jasminka			The proteome of Toll-like receptor 3-stimulated human immortalized fibroblasts: Implications for susceptibility to herpes simplex virus encephalitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Herpes simplex virus encephalitis (HSE); SILAC; proteomics; mass spectrometry; fibroblast; herpes simplex virus 1 (HSV-1); TLR3; IFN	MITOCHONDRIAL PERMEABILITY TRANSITION; QUANTITATIVE PROTEOMICS; SUPEROXIDE-DISMUTASE; NEURONAL DEATH; CELL-DEATH; IN-VITRO; DEFICIENCY; ACTIVATION; TLR3; EXPRESSION	Background: Inborn errors in Toll-like receptor 3 (TLR3)-IFN type I and III pathways have been implicated in susceptibility to herpes simplex virus encephalitis (HSE) in children, but most patients studied do not carry mutations in any of the genes presently associated with HSE susceptibility. Moreover, many patients do not display any TLR3-IFN-related fibroblastic phenotype. Objective: To study other signaling pathways downstream of TLR3 and/or other independent pathways that may contribute to HSE susceptibility. Methods: We used the stable isotope labeling of amino acids in cell culture proteomics methodology to measure changes in the human immortalized fibroblast proteome after TLR3 activation. Results: Cells from healthy controls were compared with cells from a patient with a known genetic etiology of HSE (UNC-93B(-/-)) and also to cells from an HSE patient with an unknown gene defect. Consistent with known variation in susceptibility of individuals to viral infections, substantial variation in the response level of different healthy controls was observed, but common functional networks could be identified, including upregulation of superoxide dismutase 2. The 2 patients with HSE studied show clear differences in functional response networks when compared with healthy controls and also when compared with each other. Conclusions: The present study delineates a number of novel proteins, TLR3-related pathways, and cellular phenotypes that may help elucidate the genetic basis of childhood HSE. Furthermore, our results reveal superoxide dismutase 2 as a potential therapeutic target for amelioration of the neurologic sequelae caused by HSE. (J Allergy Clin Immunol 2013;131:1157-66.)	[Perez de Diego, Rebeca; Lorenzo, Lazaro; Sancho-Shimizu, Vanessa; Abel, Laurent; Zhang, Shen-Ying; Casanova, Jean-Laurent] Necker Med Sch, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Perez de Diego, Rebeca; Lorenzo, Lazaro; Sancho-Shimizu, Vanessa; Abel, Laurent; Zhang, Shen-Ying; Casanova, Jean-Laurent] Univ Paris 05, Paris, France; [Perez de Diego, Rebeca; Lorenzo, Lazaro; Sancho-Shimizu, Vanessa; Abel, Laurent; Zhang, Shen-Ying; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Perez de Diego, Rebeca] La Paz Univ Hosp, IdiPAZ Inst Hlth Res, Immunol Unit, Madrid 28046, Spain; [Mulvey, Claire; Crawford, Mark; Godovac-Zimmermann, Jasminka] UCL, Div Med, London, England; [Trotter, Matthew W. B.] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England; [Trotter, Matthew W. B.] Univ Cambridge, Dept Surg, Cambridge, England; [Casanova, Jean-Laurent] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Dept Pediat, Riyadh 11461, Saudi Arabia; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Hospital Universitario La Paz; University of London; University College London; University of Cambridge; University of Cambridge; King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	de Diego, RP (corresponding author), La Paz Univ Hosp, IdiPAZ Inst Hlth Res, Immunol Unit, 261 P Castellana, Madrid 28046, Spain.	rebeca.perez@idipaz.es	Zhang, Shen-Ying/I-2685-2017; Abel, Laurent/H-8888-2017; Lorenzo, Lazaro/H-7902-2017; Casanova, Jean-Laurent/I-3418-2017	Zhang, Shen-Ying/0000-0002-9449-3672; Abel, Laurent/0000-0001-7016-6493; Lorenzo, Lazaro/0000-0001-6648-8684; Casanova, Jean-Laurent/0000-0002-7782-4169; Trotter, Matthew/0000-0003-3702-915X; Mulvey, Claire/0000-0002-2989-2052; Perez de Diego, Rebeca/0000-0001-8426-8765	AXA Research Fund; Groupement d'Interet Scientifique Maladies Rares; Action Concertee Incitative de Microbiologie; March of Dimes; Agence Nationale pour la Recherche; Eppley Foundation; National Institute of Allergy and Infectious Diseases [R01AI088364]; Thrasher Research Fund; Jeffrey Modell Foundation; Talecris Biotherapeutics; St Giles Foundation; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [8UL1TR000043]; Rockefeller University; European Union; Wellcome Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088364] Funding Source: NIH RePORTER	AXA Research Fund(AXA Research Fund); Groupement d'Interet Scientifique Maladies Rares; Action Concertee Incitative de Microbiologie; March of Dimes(March of Dimes); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Eppley Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Thrasher Research Fund; Jeffrey Modell Foundation; Talecris Biotherapeutics; St Giles Foundation; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Rockefeller University; European Union(European Commission); Wellcome Trust(Wellcome Trust); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the AXA Research Fund, Groupement d'Interet Scientifique Maladies Rares, Action Concertee Incitative de Microbiologie, the March of Dimes, Agence Nationale pour la Recherche, the Eppley Foundation, the National Institute of Allergy and Infectious Diseases (grant no. R01AI088364), the Thrasher Research Fund, the Jeffrey Modell Foundation, Talecris Biotherapeutics, the St Giles Foundation, the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) (grant no. 8UL1TR000043), and the Rockefeller University.; R. P. de Diego is supported by a European Union FP6 grant. J.-L. Casanova was an international scholar of the Howard Hughes Medical Institute until 2008. J. Godovac-Zimmermann was supported by a Wellcome Trust Grant. Since initial involvement in the work, M. W. B. Trotter has become an employee of Celgene Research SLU, part of Celgene Corporation, and declares no conflicts of interest. The rest of the authors declare that they have no relevant conflicts of interest.	Abel L, 2010, J PEDIAT, V157; Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; BRANKIN B, 1995, J NEUROIMMUNOL, V56, P1, DOI 10.1016/0165-5728(94)00110-A; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; De Tiege X, 2008, EUR J PAEDIATR NEURO, V12, P72, DOI 10.1016/j.ejpn.2007.07.007; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Gillis PA, 2009, J VIROL, V83, P1767, DOI 10.1128/JVI.01944-08; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Hill JM, 2001, VIRUS GENES, V23, P273, DOI 10.1023/A:1012517221937; Jiang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-12; Li L, 2007, BRAIN RES, V1159, P8, DOI 10.1016/j.brainres.2007.04.066; Li V, 2009, EXP NEUROL, V218, P171, DOI 10.1016/j.expneurol.2009.02.007; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mulvey C, 2010, J PROTEOME RES, V9, P5445, DOI 10.1021/pr100678k; Noisakran S, 2001, VIROLOGY, V283, P69, DOI 10.1006/viro.2001.0858; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Parry C, 2005, J GEN VIROL, V86, P7, DOI 10.1099/vir.0.80567-0; Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175; Rakkola R, 2007, PROTEOMICS, V7, P378, DOI 10.1002/pmic.200600582; Rydberg C, 2009, IMMUNOLOGY, V128, pe600, DOI 10.1111/j.1365-2567.2008.03041.x; Saha RN, 2007, FREE RADICAL BIO MED, V42, P1866, DOI 10.1016/j.freeradbiomed.2007.03.022; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Starace D, 2008, BIOL REPROD, V79, P766, DOI 10.1095/biolreprod.108.068619; Swarup V, 2007, NEUROSCI LETT, V420, P144, DOI 10.1016/j.neulet.2007.04.071; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	38	10	11	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1157	1166		10.1016/j.jaci.2013.01.008	http://dx.doi.org/10.1016/j.jaci.2013.01.008			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23434283	Green Accepted			2022-12-18	WOS:000317187200026
J	Lajunen, TK; Jaakkola, JJK; Jaakkola, MS				Lajunen, Taina K.; Jaakkola, Jouni J. K.; Jaakkola, Maritta S.			Influence of heredity on asthma continues to adulthood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INCIDENT CASE-CONTROL; PARENTAL ATOPY; ONSET ASTHMA; PHENOTYPES		[Lajunen, Taina K.; Jaakkola, Jouni J. K.; Jaakkola, Maritta S.] Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jaakkola, Maritta S.] Univ Oulu, Resp Med Unit, Inst Clin Sci, Oulu, Finland; [Jaakkola, Maritta S.] Oulu Univ Hosp, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Lajunen, TK (corresponding author), Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland.	Maritta.Jaakkola@oulu.fi	Lajunen, Taina/J-7337-2013	Lajunen, Taina/0000-0001-8012-457X; Jaakkola, Jouni/0000-0003-4168-4683; Jaakkola, Maritta S./0000-0003-1373-7784				Bel EH, 2004, CURR OPIN PULM MED, V10, P44, DOI 10.1097/00063198-200401000-00008; Jaakkola JJK, 2002, J ALLERGY CLIN IMMUN, V109, P784, DOI 10.1067/mai.2002.123870; Jaakkola JJK, 2003, AM J EPIDEMIOL, V158, P981, DOI 10.1093/aje/kwg238; Jaakkola MS, 2003, AM J PUBLIC HEALTH, V93, P2055, DOI 10.2105/AJPH.93.12.2055; Jaakkola MS, 2002, ENVIRON HEALTH PERSP, V110, P543, DOI 10.1289/ehp.02110543; Lee YL, 2006, CHEST, V129, P300, DOI 10.1378/chest.129.2.300; Lim RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010134; Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041; Piipari R, 2004, EUR RESPIR J, V24, P734, DOI 10.1183/09031936.04.00116903	9	10	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2013	131	3					916	918		10.1016/j.jaci.2012.10.035	http://dx.doi.org/10.1016/j.jaci.2012.10.035			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	098ZM	23246021	Bronze			2022-12-18	WOS:000315587800041
J	Lin, JH; Matsui, W; Aloe, C; Peng, RD; Diette, GB; Breysse, PN; Matsui, EC				Lin, Jenny H.; Matsui, William; Aloe, Charles; Peng, Roger D.; Diette, Gregory B.; Breysse, Patrick N.; Matsui, Elizabeth C.			Relationships between folate and inflammatory features of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FOLIC-ACID; ATOPY		[Lin, Jenny H.] Johns Hopkins Sch Med, Div Pediat Pulmonol, Baltimore, MD 21218 USA; [Matsui, William] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Aloe, Charles; Matsui, Elizabeth C.] Johns Hopkins Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD USA; [Diette, Gregory B.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Peng, Roger D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Breysse, Patrick N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lin, JH (corresponding author), Johns Hopkins Sch Med, Div Pediat Pulmonol, Baltimore, MD 21218 USA.	ematsui@jhmi.edu		Matsui, Elizabeth/0000-0001-8134-5593; Matsui, William/0000-0002-3088-0964	NCRR NIH HHS [M01-RR00052] Funding Source: Medline; NHLBI NIH HHS [T32 HL072748] Funding Source: Medline; NIAID NIH HHS [R01AI070630, R01 AI070630] Funding Source: Medline; NIEHS NIH HHS [P01ES018176, K24 ES021098, P01 ES018176, P50ES015903, P50 ES015903] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K24ES021098, P01ES018176, P50ES015903] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bailey RL, 2010, AM J CLIN NUTR, V91, P231, DOI 10.3945/ajcn.2009.28427; Bekkers MBM, 2012, EUR RESPIR J, V39, P1468, DOI 10.1183/09031936.00094511; Courtemanche C, 2004, J IMMUNOL, V173, P3186, DOI 10.4049/jimmunol.173.5.3186; Farres MN, 2011, INTERNAL MED, V50, P205, DOI 10.2169/internalmedicine.50.4424; Haberg SE, 2011, J ALLERGY CLIN IMMUN, V127, P262, DOI 10.1016/j.jaci.2010.10.004; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; King MR, 2006, J IMMUNOL, V176, P2765, DOI 10.4049/jimmunol.176.5.2765; Mangoni AA, 2006, CLIN CHIM ACTA, V367, P11, DOI 10.1016/j.cca.2005.11.016; Mannino David M, 2002, MMWR Surveill Summ, V51, P1; Matsui EC, 2009, J ALLERGY CLIN IMMUN, V123, P1253, DOI 10.1016/j.jaci.2009.03.007; Thuesen BH, 2010, ALLERGY, V65, P1446, DOI 10.1111/j.1398-9995.2010.02378.x; Zahran Hatice S., 2011, Morbidity and Mortality Weekly Report, V60, P547	12	10	11	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2013	131	3					918	920		10.1016/j.jaci.2012.10.046	http://dx.doi.org/10.1016/j.jaci.2012.10.046			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	098ZM	23237419	Green Accepted			2022-12-18	WOS:000315587800043
J	Shimizu, M; Kanegane, H; Wada, T; Motoyoshi, Y; Morio, T; Candotti, F; Yachie, A				Shimizu, Masaki; Kanegane, Hirokazu; Wada, Taizo; Motoyoshi, Yaeko; Morio, Tomohiro; Candotti, Fabio; Yachie, Akihiro			Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SYNDROME PROTEIN; NEPHROPATHY; DEFICIENT		[Shimizu, Masaki; Wada, Taizo; Yachie, Akihiro] Kanazawa Univ, Sch Med, Dept Pediat, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 920, Japan; [Kanegane, Hirokazu] Toyama Univ, Sch Med & Pharmaceut Sci, Dept Pediat, Toyama 930, Japan; [Motoyoshi, Yaeko; Morio, Tomohiro] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Candotti, Fabio] NHGRI, Disorders Immun Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA	Kanazawa University; University of Toyama; Tokyo Medical & Dental University (TMDU); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Shimizu, M (corresponding author), Kanazawa Univ, Sch Med, Dept Pediat, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 920, Japan.	shimizum@staff.kanazawa-u.ac.jp	Yachie, Akihiro/C-4660-2015	Candotti, Fabio/0000-0001-6399-6042; Morio, Tomohiro/0000-0002-9259-1025	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000122, ZIAHG000121, Z01HG000122] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG000122-11, Z01 HG000122-10] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; HIGGINS EA, 1991, J BIOL CHEM, V266, P6280; Lasseur C, 1997, AM J KIDNEY DIS, V29, P285, DOI 10.1016/S0272-6386(97)90043-3; Liu CH, 2012, INT UROL NEPHROL; Matsukura H, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2003.11.016; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Nguyen DD, 2007, GASTROENTEROLOGY, V133, P1188, DOI 10.1053/j.gastro.2007.07.010; Shimizu M, 2012, CLIN IMMUNOL, V142, P160, DOI 10.1016/j.clim.2011.10.001; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535	9	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					587	590		10.1016/j.jaci.2012.08.040	http://dx.doi.org/10.1016/j.jaci.2012.08.040			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23107152	Green Accepted			2022-12-18	WOS:000314661500042
J	DunnGalvin, A; Segal, LM; Clarke, A; Alizadehfar, R; Hourihane, JO				DunnGalvin, Audrey; Segal, L. M.; Clarke, Ann; Alizadehfar, Reza; Hourihane, Jonathan O'B.			Validation of the Cork-Southampton Food Challenge Outcome Calculator in a Canadian sample	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[DunnGalvin, Audrey; Hourihane, Jonathan O'B.] Natl Univ Ireland Univ Coll Cork, Cork, Ireland; [Segal, L. M.; Alizadehfar, Reza] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Clarke, Ann] McGill Univ, Dept Med, Montreal, PQ, Canada	University College Cork; McGill University; McGill University	DunnGalvin, A (corresponding author), Natl Univ Ireland Univ Coll Cork, Cork, Ireland.	a.dunngalvin@ucc.ie	DunnGalvin, Audrey/G-1741-2012					DunnGalvin A, 2011, J ALLERGY CLIN IMMUN, V127, pe1; DunnGalvin A, 2011, J ALLERGY CLIN IMMUN, V127, P633, DOI 10.1016/j.jaci.2010.12.004	2	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2013	131	1					230	232		10.1016/j.jaci.2012.08.051	http://dx.doi.org/10.1016/j.jaci.2012.08.051			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	062YR	23141739	Bronze			2022-12-18	WOS:000312961200034
J	Polosa, R; Caponnetto, P; Sands, MF				Polosa, Riccardo; Caponnetto, Pasquale; Sands, Mark F.			Caring for the smoking asthmatic patient	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; smoking; smoking cessation	CIGARETTE-SMOKING; LUNG-FUNCTION; CESSATION; REDUCTION; SMOKERS; ADULTS; PREDICTORS		[Polosa, Riccardo] Univ Catania, Inst Internal Med & Clin Immunol, AOU Policlin Vittorio Emanuele, I-95100 Catania, Italy; [Polosa, Riccardo; Caponnetto, Pasquale] Univ Catania, CPCT, AOU Policlin Vittorio Emanuele, I-95100 Catania, Italy; [Sands, Mark F.] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Sands, Mark F.] Vet Adm Healthcare Syst Western New York, Buffalo, NY USA	Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Polosa, R (corresponding author), Univ Catania, Ist Med Interna & Immunol Clin, Policlin Univ, I-95100 Catania, Italy.	polosa@unict.it						Caponnetto P, 2008, RESP MED, V102, P1182, DOI 10.1016/j.rmed.2008.02.017; Chaudhuri R, 2006, AM J RESP CRIT CARE, V174, P127, DOI 10.1164/rccm.200510-1589OC; Clearie KL, 2012, CHEST, V141, P330, DOI 10.1378/chest.11-0392; CUMMINGS KM, 1985, ADDICT BEHAV, V10, P373, DOI 10.1016/0306-4603(85)90034-6; Eisner MD, 2007, NICOTINE TOB RES, V9, P53, DOI 10.1080/14622200601078293; Eisner MD, 2000, AM J PUBLIC HEALTH, V90, P1307, DOI 10.2105/AJPH.90.8.1307; Fiore MC, 2008, TREATING TOBACCO USE; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Pedersen SE, 2007, J ALLERGY CLIN IMMUN, V120, P1036, DOI 10.1016/j.jaci.2007.07.016; Piccillo G, 2008, RESP MED, V102, P256, DOI 10.1016/j.rmed.2007.09.004; Pietinalho A, 2009, ALLERGY, V64, P1722, DOI 10.1111/j.1398-9995.2009.02208.x; Polosa R, 2008, J ALLERGY CLIN IMMUN, V121, P1428, DOI 10.1016/j.jaci.2008.02.041; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; Polosa R, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-16; Polosa R, 2011, TRENDS PHARMACOL SCI, V32, P281, DOI 10.1016/j.tips.2010.12.008; Rodu B, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-19; Spears M, 2009, EUR RESPIR J, V33, P1010, DOI 10.1183/09031936.00158208; Thomson NC, 2009, CURR OPIN PULM MED, V15, P39, DOI 10.1097/MCP.0b013e32831da894; Tonnesen P, 2005, NICOTINE TOB RES, V7, P139, DOI 10.1080/14622200412331328411; WAKEFIELD M, 1995, AUST NZ J MED, V25, P12, DOI 10.1111/j.1445-5994.1995.tb00572.x	22	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2012	130	5					1221	1224		10.1016/j.jaci.2012.04.015	http://dx.doi.org/10.1016/j.jaci.2012.04.015			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	030LE	22608574				2022-12-18	WOS:000310571400034
J	Mertz, TL; Jacobs, SB; Craig, TJ; Ishmael, FT				Mertz, Thomas L.; Jacobs, Steven B.; Craig, Timothy J.; Ishmael, Faoud T.			The brown marmorated stinkbug as a new aeroallergen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASIAN LADY BEETLE; HARMONIA-AXYRIDIS; HYPERSENSITIVITY; ASTHMA; POLYMORPHISMS; INFERENCE; BURDEN; RACE		[Mertz, Thomas L.; Craig, Timothy J.; Ishmael, Faoud T.] Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Sect Allergy & Immunol, Hershey, PA 17033 USA; [Jacobs, Steven B.] Penn State Univ, Coll Agr Sci, Dept Entomol, State Coll, PA USA; [Ishmael, Faoud T.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mertz, TL (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Sect Allergy & Immunol, Hershey, PA 17033 USA.	fishmael@hmc.psu.edu						Albright DD, 2006, ANN ALLERG ASTHMA IM, V97, P521, DOI 10.1016/S1081-1206(10)60944-1; [Center for Invasive Species and Ecosystem Health The Bugwood Network USDA Forest Service USDA APHIS PPQ], BROWN MARM STINKB; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Jacobs Steve, STINKBUG FACT SHEET; KAGEN SL, 1990, CLIN REV ALLERG, V8, P99; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Lopez-Souza N, 2003, IN VITRO CELL DEV-AN, V39, P266; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nakazawa T, 2007, J ALLERGY CLIN IMMUN, V119, P421, DOI 10.1016/j.jaci.2006.11.633; Pritchard JK, 2000, GENETICS, V155, P945; Ray JN, 2004, ALLERGY ASTHMA PROC, V25, P133; Reed JL, 2009, J INFECT DIS, V199, P1128, DOI 10.1086/597386; Shalowitz MU, 2007, AMBUL PEDIATR, V7, P271, DOI 10.1016/j.ambp.2007.03.004; Sharma K, 2006, ANN ALLERG ASTHMA IM, V97, P528, DOI 10.1016/S1081-1206(10)60945-3; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tsai HJ, 2006, HUM GENET, V119, P547, DOI 10.1007/s00439-006-0169-2; Weiss KB, 2009, CONTEMP CLIN TRIALS, V30, P246, DOI 10.1016/j.cct.2009.01.006; Wu BL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-317; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Yang JJ, 2008, J ALLERGY CLIN IMMUN, V122, P820, DOI 10.1016/j.jaci.2008.07.044; Yarbrough JA, 1999, J ALLERGY CLIN IMMUN, V104, P704, DOI 10.1016/S0091-6749(99)70347-7	25	10	13	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2012	130	4					999	1001		10.1016/j.jaci.2012.06.016	http://dx.doi.org/10.1016/j.jaci.2012.06.016			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017MT	22835402				2022-12-18	WOS:000309594800027
J	Palmer, DJ; Metcalfe, J; Prescott, SL				Palmer, Debra J.; Metcalfe, Jessica; Prescott, Susan L.			Preventing disease in the 21st century: The importance of maternal and early infant diet and nutrition	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Infant feeding; allergic disease; peanuts; allergen avoidance; pregnancy; developmental origins of health and disease; noncommunicable diseases; obesity; disease prevention	FOOD-CONSUMPTION; ALLERGIC DISEASE; PREGNANCY; ASTHMA; SENSITIZATION; CHILDHOOD; PEANUT		[Palmer, Debra J.; Metcalfe, Jessica; Prescott, Susan L.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia	University of Western Australia	Prescott, SL (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	susan.prescott@uwa.edu	Palmer, Debra J/L-8554-2013; Palmer, Debra/AAH-6160-2019; Prescott, Susan/H-5665-2014	Palmer, Debra J/0000-0003-2498-8343; 				Allan K, 2011, J AM DIET ASSOC, V111, P258, DOI 10.1016/j.jada.2010.10.048; Chatzi L, 2008, THORAX, V63, P507, DOI 10.1136/thx.2007.081745; Erkkola M, 2012, PEDIAT ALLERG IMM-UK, V23, P186, DOI 10.1111/j.1399-3038.2012.01272.x; Frank L, 1999, PEDIATR ALLERGY IMMU, V10, P27, DOI 10.1034/j.1399-3038.1999.101010.x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Maslova E, 2012, J ALLERGY CLIN IMMUN, V130, P724, DOI 10.1016/j.jaci.2012.05.014; Nurmatov U, 2011, J ALLERGY CLIN IMMUN, V127, P724, DOI 10.1016/j.jaci.2010.11.001; Patelarou E, 2011, NUTR REV, V69, P627, DOI 10.1111/j.1753-4887.2011.00445.x; Sausenthaler S, 2007, AM J CLIN NUTR, V85, P530; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V126, P1191, DOI 10.1016/j.jaci.2010.08.036; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Willers SM, 2007, THORAX, V62, P773, DOI 10.1136/thx.2006.074187; Willers SM, 2008, AM J RESP CRIT CARE, V178, P124, DOI 10.1164/rccm.200710-1544OC	13	10	10	0	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2012	130	3					733	734		10.1016/j.jaci.2012.06.038	http://dx.doi.org/10.1016/j.jaci.2012.06.038			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	001LZ	22857793				2022-12-18	WOS:000308463500023
J	Wegienka, G; Joseph, CLM; Havstad, S; Zoratti, E; Ownby, D; Johnson, CC				Wegienka, Ganesa; Joseph, Christine L. M.; Havstad, Suzanne; Zoratti, Edward; Ownby, Dennis; Johnson, Christine Cole			Sensitization and allergic histories differ between black and white pregnant women	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Pregnancy; IgE; atopy; asthma; eczema; allergic rhinitis; race; ethnicity	NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; REGULATORY T-CELLS; UNITED-STATES; VITAMIN-D; CHILDHOOD ASTHMA; RACIAL DISPARITIES; PRESCRIPTIONS; PREVALENCE; AUSTRALIA	Background: Racial differences in allergic diseases have been reported, with black subjects suffering disproportionately compared with white subjects, although such studies have been more commonly done in pediatric populations. Objective: We sought to determine whether there are differences in rates of allergic sensitization or prior diagnoses of asthma, hay fever, or eczema in black and white pregnant women. Methods: Women were recruited during pregnancy (regardless of allergic history) as part of a birth cohort study in the Detroit metropolitan area and were interviewed about prior doctors' diagnoses of asthma, hay fever/nasal allergies/allergic rhinitis, and eczema. Blood samples were collected, total IgE levels were determined, and specific IgE levels were measured for Alternaria alternata, cat, cockroach, dog, Dermatophagoides farinae, short ragweed, timothy grass, and egg. Results: Black women (n = 563) were more likely than white women (n = 219) to have had at least 1 specific IgE level of 0.35 IU/mL or greater (62.5% vs 40.2%, P < .001). Black women had higher total IgE levels (geometric mean, 47.8 IU/mL [95% CI, 42.5-53.8 IU/mL] vs 20.0 IU/mL [95% CI, 16.2-24.6 IU/mL]; P < .001, Wilcoxon rank sum test). Black women were more likely to have had a prior doctor's diagnosis of asthma (22.7% vs 16.0%, P = .04) and eczema (21.9% vs 14.8%) but not hay fever (white women: 17.5% vs black women: 15.7%, P = .55). Associations persisted for total IgE levels, having 1 or more positive allergen-specific IgE levels, and eczema after adjusting for common socioeconomic or environmental variables. Conclusions: Racial differences in allergic sensitization and diagnoses were present, even after controlling for various factors. Future research should focus on prevention to ameliorate these disparities. (J Allergy Clin Immunol 2012;130:657-62.)	[Wegienka, Ganesa; Joseph, Christine L. M.; Havstad, Suzanne; Johnson, Christine Cole] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Zoratti, Edward] Henry Ford Hosp, Div Allergy & Clin Immunol, Detroit, MI 48202 USA; [Ownby, Dennis] Georgia Hlth Sci Univ, Dept Pediat, Augusta, GA USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University System of Georgia; Augusta University	Wegienka, G (corresponding author), 1 Ford Pl,3E, Detroit, MI 48202 USA.	gwegien1@hfhs.org		Johnson, Christine Cole/0000-0002-6864-6604	National Institute of Allergy and Infectious Diseases; Fund for Henry Ford Hospital; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050681, R56AI050681, K01AI070606] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fund for Henry Ford Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institute of Allergy and Infectious Diseases and the Fund for Henry Ford Hospital.; G. Wegienka, D. Ownby, and C. Cole Johnson have received 1 or more grants from the National Institutes of Health. E. Zoratti is a funded investigator with the National Institute of Allergy and Infectious Diseases. The rest of the authors declare that they have no relevant conflicts of interest.	Akinbami Lara J, 2011, Natl Health Stat Report, P1; Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Camargo CA, 2007, J ALLERGY CLIN IMMUN, V120, P131, DOI 10.1016/j.jaci.2007.03.049; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Janumpally SR, 2002, ARCH DERMATOL, V138, P634, DOI 10.1001/archderm.138.5.634; Joseph CLM, 2006, J ALLERGY CLIN IMMUN, V117, P233, DOI 10.1016/j.jaci.2005.11.004; Lange NE, 2009, EXPERT REV CLIN IMMU, V5, P693, DOI 10.1586/ECI.09.53; Litonjua AA, 2005, J ALLERGY CLIN IMMUN, V115, P751, DOI 10.1016/j.jaci.2004.12.1138; Litonjua AA, 2009, CURR OPIN ALLERGY CL, V9, P202, DOI 10.1097/ACI.0b013e32832b36cd; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; McDaniel M, 2006, PEDIATRICS, V117, pE868, DOI 10.1542/peds.2005-1721; McHugh MK, 2009, J ASTHMA, V46, P759, DOI 10.3109/02770900903067895; Mullins RJ, 2009, ANN ALLERG ASTHMA IM, V103, P488, DOI 10.1016/S1081-1206(10)60265-7; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Ownby DR, 2010, PEDIAT ALLERG IMM-UK, V21, P533, DOI 10.1111/j.1399-3038.2009.00918.x; Rudders SA, 2010, ANN ALLERG ASTHMA IM, V104, P413, DOI 10.1016/j.anai.2010.01.022; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Staples JA, 2003, ENVIRON HEALTH PERSP, V111, P518, DOI 10.1289/ehp.5941; Stevenson LA, 2001, J ALLERGY CLIN IMMUN, V108, P747, DOI 10.1067/mai.2001.119410; Wegienka G, 2011, J REPROD IMMUNOL, V88, P58, DOI 10.1016/j.jri.2010.06.157; Wegienka G, 2009, J REPROD IMMUNOL, V81, P74, DOI 10.1016/j.jri.2009.03.001; Weiss ST, 2011, J ALLERGY CLIN IMMUN, V127, P1128, DOI 10.1016/j.jaci.2011.02.025; Yang JJ, 2008, J ALLERGY CLIN IMMUN, V122, P820, DOI 10.1016/j.jaci.2008.07.044; Zahran Hatice S., 2011, Morbidity and Mortality Weekly Report, V60, P547	27	10	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2012	130	3					657	+		10.1016/j.jaci.2012.06.024	http://dx.doi.org/10.1016/j.jaci.2012.06.024			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	001LZ	22857795	Green Accepted			2022-12-18	WOS:000308463500014
J	Li, JH; Ewart, G; Kraft, M; Finn, PW				Li, Jinghong; Ewart, Gary; Kraft, Monica; Finn, Patricia W.			The public health benefits of air pollution control	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Air pollution; public health; Environmental Protection Agency; Clean Air Act; mercury and air toxics standard	EMERGENCY-DEPARTMENT VISITS; CASE-CROSSOVER; RESPIRATORY HEALTH; ASTHMA; CHILDREN; CANADA; JOBS		[Li, Jinghong; Finn, Patricia W.] Univ Calif San Diego, Dept Med, Div Pulm & Crit Care Med, La Jolla, CA 92093 USA; [Ewart, Gary] Govt Relat, Amer Thorac Soc, Washington, DC USA; [Kraft, Monica] Duke Univ, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA	University of California System; University of California San Diego; Duke University	Finn, PW (corresponding author), Univ Illinois, Dept Med, MC 787,840 S Wood St, Chicago, IL 60612 USA.	pwfinn@uic.edu		Li, Jinghong/0000-0003-2497-9295				Avol EL, 2001, AM J RESP CRIT CARE, V164, P2067, DOI 10.1164/ajrccm.164.11.2102005; Barnett AG, 2005, AM J RESP CRIT CARE, V171, P1272, DOI 10.1164/rccm.200411-1586OC; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Bezdek RH, 2008, J ENVIRON MANAGE, V86, P63, DOI 10.1016/j.jenvman.2006.11.028; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Eckl-Dorna J, 2010, J ALLERGY CLIN IMMUN, V126, P1315, DOI 10.1016/j.jaci.2010.06.012; EPA, 2006, US EPA PUBL; *EPA, 2004, US EPA PUBL; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Jalaludin B, 2008, INT ARCH OCC ENV HEA, V81, P967, DOI 10.1007/s00420-007-0290-0; Moore K, 2008, ENVIRON HEALTH PERSP, V116, P1063, DOI 10.1289/ehp.10497; Morgenstern RD, 2002, J ENVIRON ECON MANAG, V43, P412, DOI 10.1006/jeem.2001.1191; O'Connor GT, 2008, J ALLERGY CLIN IMMUN, V121, P1133, DOI 10.1016/j.jaci.2008.02.020; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; Rago J, 2011, WALL STREET J; Strickland MJ, 2010, AM J RESP CRIT CARE, V182, P307, DOI 10.1164/rccm.200908-1201OC; Szyszkowicz M, 2008, INT J OCCUP MED ENV, V21, P295, DOI 10.2478/v10001-008-0029-5; Villeneuve PJ, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-40; World Health Organisation, 2004, HLTH ASP AIR POLL RE; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108	20	10	10	0	20	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2012	130	1					22	23		10.1016/j.jaci.2012.02.047	http://dx.doi.org/10.1016/j.jaci.2012.02.047			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	977GN	22521246	Bronze			2022-12-18	WOS:000306644800003
J	Hoyte, FCL; Weber, RW; Katial, RK				Hoyte, Flavia C. L.; Weber, Richard W.; Katial, Rohit K.			Pancreatitis as a novel complication of aspirin therapy in patients with aspirin-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RHINOSINUSITIS-ASTHMA; DESENSITIZATION; CERULEIN		[Hoyte, Flavia C. L.; Weber, Richard W.; Katial, Rohit K.] Natl Jewish Hlth, Allergy & Immunol Clin, Denver, CO USA	National Jewish Health	Hoyte, FCL (corresponding author), Natl Jewish Hlth, Allergy & Immunol Clin, Denver, CO USA.	katialr@njhealth.org						Antonopoulos S, 2005, J PANCREAS, V6, P264; Berges-Gimeno MP, 2003, J ALLERGY CLIN IMMUN, V111, P180, DOI 10.1067/mai.2003.7; Cuzzocrea S, 2003, IMMUNOLOGY, V110, P120, DOI 10.1046/j.1365-2567.2003.01715.x; Folch E, 1998, INFLAMMATION, V22, P83, DOI 10.1023/A:1022399824880; Hirano T, 1997, SCAND J GASTROENTERO, V32, P84, DOI 10.3109/00365529709025068; Leong RWL, 2006, EXPERT OPIN DRUG SAF, V5, P585, DOI 10.1517/14740338.5.4.585; SAMTER M, 1967, J ALLERGY, V40, P281, DOI 10.1016/0021-8707(67)90076-7; Stevenson DD, 1996, J ALLERGY CLIN IMMUN, V98, P751, DOI 10.1016/S0091-6749(96)70123-9; SWEET JM, 1990, J ALLERGY CLIN IMMUN, V85, P59, DOI 10.1016/0091-6749(90)90222-P; Trivedi CD, 2005, J CLIN GASTROENTEROL, V39, P709, DOI 10.1097/01.mcg.0000173929.60115.b4; Widal FAP., 1922, PRESSE MED, V30, P189	11	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2012	129	6					1684	1686		10.1016/j.jaci.2011.12.003	http://dx.doi.org/10.1016/j.jaci.2011.12.003			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	952BL	22236727	Bronze			2022-12-18	WOS:000304764600038
J	Uygungil, B; Bonilla, F; Lederman, H				Uygungil, Burcin; Bonilla, Francisco; Lederman, Howard			Evaluation of a patient with hyper-IgM syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Ataxia-telangiectasia; hyper-IgM; lymphoid hypertrophy; opportunistic infection; CD40 ligand deficiency; CD40 deficiency; activation-induced cytidine deaminase; uracyl DNA glycosylase; ectodermal dysplasia	IMMUNOGLOBULIN-M-SYNDROMES; IMMUNOLOGICAL FEATURES; ATAXIA-TELANGIECTASIA; IMMUNODEFICIENCY; DEFICIENCY		[Uygungil, Burcin; Lederman, Howard] Johns Hopkins Med Ctr, Div Pediat Allergy & Immunol, Baltimore, MD USA; [Bonilla, Francisco] Childrens Hosp Boston, Dept Allergy, Boston, MA USA; [Bonilla, Francisco] Childrens Hosp Boston, Dept Immunol & Lab Med, Boston, MA USA	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Uygungil, B (corresponding author), 600 N Wolfe St,CMSC-1102, Baltimore, MD 21287 USA.	buygung1@jhmi.edu			A-T Children's Project; Atlantic Research Group; UpToDate	A-T Children's Project; Atlantic Research Group; UpToDate	F. Bonilla has consultant arrangements with CSL Behring and Prescription Solutions, receives fees for participation in review activities from the Atlantic Research Group, and receives royalties from UpToDate. H. Lederman receives research support from the A-T Children's Project. B. Uygungil declares no relevant conflicts of interest. J. T. Li has consulted for Abbott.	Davies EG, 2010, BRIT J HAEMATOL, V149, P167, DOI 10.1111/j.1365-2141.2010.08077.x; Dehkordy SF, 2012, J CLIN IMMUNOL, V32, P1, DOI 10.1007/s10875-011-9593-8; Durandy A, 2005, IMMUNOL REV, V203, P67, DOI 10.1111/j.0105-2896.2005.00222.x; Etzioni A, 2004, PEDIATR RES, V56, P1; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; Micol R, 2011, J ALLERGY CLIN IMMUN, V128, P382, DOI 10.1016/j.jaci.2011.03.052; Nowak-Wegrzyn A, 2004, J PEDIATR-US, V144, P505, DOI 10.1016/j.jpeds.2003.12.046; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Winkelstein JA, 2003, MEDICINE, V82, P373, DOI 10.1097/01.md.0000100046.06009.b0	10	10	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2012	129	6					1692	+		10.1016/j.jaci.2012.03.043	http://dx.doi.org/10.1016/j.jaci.2012.03.043			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	952BL	22657410				2022-12-18	WOS:000304764600045
J	Schnyder, B; Pichler, WJ				Schnyder, Benno; Pichler, Werner J.			Nonimmediate drug allergy: Diagnostic benefit of skin testing and practical approach	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Adverse drug reaction; drug allergy			[Schnyder, Benno; Pichler, Werner J.] Univ Hosp Bern, Dept Rheumatol Clin Immunol & Allergol, Inselspital, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Pichler, WJ (corresponding author), Univ Hosp Bern, Dept Rheumatol Clin Immunol & Allergol, Inselspital, CH-3010 Bern, Switzerland.	werner.pichler@insel.ch		Pichler, Werner J./0000-0002-8117-359X				Blanca-Lopez N, 2009, ALLERGY, V64, P229, DOI 10.1111/j.1398-9995.2008.01903.x; Borch JE, 2011, INT ARCH ALLERGY IMM, V155, P271, DOI 10.1159/000320384; Romano A, 1997, ARCH DIS CHILD, V76, P513, DOI 10.1136/adc.76.6.513; Romano A, 2012, J ALLERGY CLIN IMMUN, V129, P1166, DOI 10.1016/j.jaci.2011.12.995; Torres MJ, 2003, ALLERGY, V58, P961, DOI 10.1034/j.1398-9995.2003.00280.x	5	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2012	129	4					1170	1171		10.1016/j.jaci.2012.02.029	http://dx.doi.org/10.1016/j.jaci.2012.02.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	917AP	22464676				2022-12-18	WOS:000302144600043
J	Niesvaara, DC; Rondon, C; Quintana, LA; Correa, A; Sainz, RC; Melendez, L; Diaz, TC; Blanca, M				Cruz Niesvaara, D.; Rondon, C.; Almeida Quintana, L.; Correa, A.; Castillo Sainz, R.; Melendez, L.; Carrilo Diaz, T.; Blanca, M.			Evidence of Local Allergic Rhinitis in Areas with High and Permanent Aeroallergens Exposure	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Cruz Niesvaara, D.; Almeida Quintana, L.; Castillo Sainz, R.; Carrilo Diaz, T.] Dr Negrin Univ Hosp, Allergy Serv, Gran Canaria, Spain; [Rondon, C.; Blanca, M.] Carlos Haya Hosp, Allergy Serv, Malaga, Spain; [Correa, A.; Melendez, L.] Carlos Haya Hosp Fdn IMABIS, Res Lab, Malaga, Spain	Hospital Carlos Haya; Hospital Carlos Haya									0	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB111	AB111						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133400425
J	Malyukova, I; Gendel, SM; Luccioli, S				Malyukova, I.; Gendel, S. M.; Luccioli, S.			Milk Is The Predominant Undeclared Allergen In Us Food Product Recalls	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Malyukova, I.; Gendel, S. M.; Luccioli, S.] US FDA, Off Food Addit Safety, Ctr Food Safety & Appl Nutr, College Pk, MD USA	US Food & Drug Administration (FDA)			Gendel, Steven/HHM-4437-2022						0	10	10	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB234	AB234		10.1016/j.jaci.2011.12.160	http://dx.doi.org/10.1016/j.jaci.2011.12.160			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133401050
J	Knutsen, AP; Baker, MW; Markert, ML				Knutsen, Alan P.; Baker, Mei W.; Markert, M. Louise			Interpreting low T-cell receptor excision circles in newborns with DiGeorge anomaly: Importance of assessing naive T-cell markers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							THYMUS TRANSPLANTATION		[Knutsen, Alan P.] St Louis Univ, Dept Pediat Allergy & Immunol, St Louis, MO 63103 USA; [Baker, Mei W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA; [Baker, Mei W.] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA; [Markert, M. Louise] Duke Med Ctr, Dept Pediat, Durham, NC USA; [Markert, M. Louise] Duke Med Ctr, Dept Immunol, Durham, NC USA	Saint Louis University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University	Knutsen, AP (corresponding author), St Louis Univ, Dept Pediat Allergy & Immunol, St Louis, MO 63103 USA.	knutsenm@slu.edu						Chinen J, 2003, J ALLERGY CLIN IMMUN, V111, P573, DOI 10.1067/mai.2003.165; Markert ML, 2007, BLOOD, V109, P4539, DOI 10.1182/blood-2006-10-048652; Markert ML, 2010, CLIN IMMUNOL, V135, P236, DOI 10.1016/j.clim.2010.02.007; Markert ML, 2003, BLOOD, V102, P1121, DOI 10.1182/blood-2002-08-2545; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; OCHS HD, 2004, IMMUNOLOGIC DISORDER, P505; Rope AF, 2009, J PEDIATR-US, V155, P560, DOI 10.1016/j.jpeds.2009.04.010; Routes JM, 2009, JAMA-J AM MED ASSOC, V302, P2465, DOI 10.1001/jama.2009.1806; Zemble R, 2010, CLIN IMMUNOL, V136, P409, DOI 10.1016/j.clim.2010.04.011	9	10	10	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2011	128	6					1375	1376		10.1016/j.jaci.2011.08.019	http://dx.doi.org/10.1016/j.jaci.2011.08.019			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	865WX	22018899	Bronze			2022-12-18	WOS:000298342700039
J	Szefler, SJ				Szefler, Stanley J.			Is it time to revise the asthma guidelines?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; asthma control; asthma guidelines; asthma impairment; asthma risk; asthma severity; biomarkers; genetics; inhaled corticosteroids	STEP-UP THERAPY; CHILDREN; CARE		[Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Szefler, SJ (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Rm J304 Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njhealth.org		Szefler, Stanley/0000-0002-6911-3199	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL064288, U10HL051834, U10HL098075, U01HL075416, R21HL087811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025780-02, 1 UL1 RR025780, UL1 RR025780] Funding Source: Medline; NHLBI NIH HHS [U01 HL075416, U10 HL098075, R21 HL087811, U10 HL064288, U01 HL075416-08, HL-98075, HL-87811, HL-51834, HL-75416, R21 HL087811-01A2, U10 HL098075-02, U10 HL064288-10, HL-64288, U10 HL051834, U10 HL051834-08] Funding Source: Medline; NIAID NIH HHS [AI-90052, N01 AI025496] Funding Source: Medline; NIEHS NIH HHS [P01 ES018181, ES-18181, P01 ES018181-03] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; Busse WW, 2011, J ALLERGY CLIN IMMUN, V128, P740, DOI 10.1016/j.jaci.2011.08.014; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Cookson W, 2011, J ALLERGY CLIN IMMUN, V128, P266, DOI 10.1016/j.jaci.2011.06.026; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V126, P200, DOI 10.1016/j.jaci.2010.06.006; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Lodge CJ, 2011, J ALLERGY CLIN IMMUN, V128, P782, DOI 10.1016/j.jaci.2011.06.038; Marks GB, 2011, J ALLERGY CLIN IMMUN, V128, P789, DOI 10.1016/j.jaci.2011.08.020; Martinez FD, 2011, LANCET, V377, P650, DOI 10.1016/S0140-6736(10)62145-9; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; National Institutes of Health, 2007, NIH PUBL, V02-3659; O'Byrne PM, 2011, J ALLERGY CLIN IMMUN, V128, P257, DOI 10.1016/j.jaci.2011.03.035; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Rabinovitch N, 2010, J ALLERGY CLIN IMMUN, V126, P545, DOI 10.1016/j.jaci.2010.07.008; Schatz M, 2011, J ALLERGY CLIN IMMUN, V128, P273, DOI 10.1016/j.jaci.2011.03.027; Searing DA, 2010, J ALLERGY CLIN IMMUN, V125, P995, DOI 10.1016/j.jaci.2010.03.008; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V128, P485, DOI 10.1016/j.jaci.2011.07.010; Taylor DR, 2011, J ALLERGY CLIN IMMUN, V128, P927, DOI 10.1016/j.jaci.2011.03.051; Thomas A, 2011, J ALLERGY CLIN IMMUN, V128, P915, DOI 10.1016/j.jaci.2011.07.014; Yang IV, 2011, AM J RESP CRIT CARE, V183, P1295, DOI 10.1164/rccm.201010-1579PP	24	10	10	2	24	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2011	128	5					937	938		10.1016/j.jaci.2011.09.004	http://dx.doi.org/10.1016/j.jaci.2011.09.004			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	842FJ	21943941	Bronze, Green Accepted			2022-12-18	WOS:000296578200003
J	Schneider, E; Machavoine, F; Bricard-Rignault, R; Levasseur, M; Petit-Bertron, AF; Gautron, S; Ribeil, JA; Launay, JM; Mecheri, S; Cote, F; Dy, M				Schneider, Elke; Machavoine, Francois; Bricard-Rignault, Rachel; Levasseur, Melanie; Petit-Bertron, Anne France; Gautron, Sophie; Ribeil, Jean-Antoine; Launay, Jean-Marie; Mecheri, Salah; Cote, Francine; Dy, Michel			Downregulation of basophil-derived IL-4 and in vivo T(H)2 IgE responses by serotonin and other organic cation transporter 3 ligands	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Basophils; IL-4; T(H)2-type immune response; organic cation transporter 3	HISTIDINE-DECARBOXYLASE; DENDRITIC CELLS; T-CELLS; HISTAMINE; ROLES; MODULATION; EXPRESSION; SIGNAL	Background: Murine basophils can contribute to the T(H)2 polarization of the immune response by providing rapidly large amounts of IL-4, which suggests that pharmacologic downregulation of this cytokine might provide a strategy to attenuate pathologies associated with excessive production. Objective: We examined a number of physiological and pharmacologic ligands of the organic cation transporter 3 (OCT3), a membrane carrier of biogenic amines, for their inhibitory effect on IL-4 production by basophils, selecting the most efficient compounds for in vivo evaluation in basophil-dependent experimental models. Methods: IL-4 production by basophils isolated ex vivo or from bone marrow cultures was assessed in response to various stimuli with or without biogenic monoamines or pharmacologic analogs. Selected compounds were administered in vivo to examine their effect on levels of circulating IgE generated during a basophil-dependent T(H)2 response and on basophil activation in mice receiving IL-33. Results: We found a drastic decrease in IL-4 production by stimulated basophils on exposure to serotonin (5-hydroxytryptamine [5-HT]) that is taken up by basophils through the specific high-affinity transporters serotonin transporter and the polyspecific, high-capacity organic cation transporter 3 (OCT3; or Slc22a3) but inhibits their function exclusively through the latter. This downregulation is likewise observed in vivo in response to 5-HT and other OCT3 ligands, as well as in human basophils sorted from PMBCs of nonatopic donors. Conclusions: We provide evidence for a new means of downregulating IL-4 production by basophils, both in vitro and in vivo, through OCT3 targeted by 5-HT and pharmacologic ligands. (J Allergy Clin Immunol 2011;128:864-71.)	[Schneider, Elke; Machavoine, Francois; Bricard-Rignault, Rachel; Levasseur, Melanie; Petit-Bertron, Anne France; Ribeil, Jean-Antoine; Cote, Francine; Dy, Michel] Univ Paris 05, Hop Necker, CNRS UMR 8147, Fac Med, F-75015 Paris, France; [Gautron, Sophie] Univ Paris 06, UPMC, CNRS, INSERM U952,UMR 7224, F-75252 Paris 05, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Schneider, E (corresponding author), Univ Paris 05, Hop Necker, CNRS UMR 8147, Fac Med, 161 Rue Sevres, F-75015 Paris, France.	elke.schneider@parisdescartes.fr	Mecheri, Salah/M-8315-2013; Ribeil, Jean-Antoine/F-7896-2017; Gautron, Sophie L/O-3216-2017; Ribeil, Jean-Antoine/AAK-7979-2020	Ribeil, Jean-Antoine/0000-0002-5733-9123; Gautron, Sophie L/0000-0002-4510-7640; Ribeil, Jean-Antoine/0000-0002-4549-4783	CNRS; Universite Paris Descartes; "Agence National pour la Recherche" (ANR) [05-BLAN-0155-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; "Agence National pour la Recherche" (ANR)(French National Research Agency (ANR))	Supported by the CNRS, Universite Paris Descartes, and a grant from the "Agence National pour la Recherche" (ANR 05-BLAN-0155-01).	Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Boehme SA, 2004, J IMMUNOL, V173, P3599, DOI 10.4049/jimmunol.173.6.3599; Chen YH, 2003, J ALLERGY CLIN IMMUN, V112, P944, DOI 10.1016/j.jaci.2003.08.027; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Devouassoux G, 1999, J ALLERGY CLIN IMMUN, V104, P811, DOI 10.1016/S0091-6749(99)70292-7; Dy M, 2001, INT CONGR SER, V1224, P319; DY M, 1991, EXP HEMATOL, V19, P934; Fox MA, 2007, PSYCHOPHARMACOLOGY, V195, P147, DOI 10.1007/s00213-007-0910-0; Gordon J, 2003, TRENDS IMMUNOL, V24, P438, DOI 10.1016/S1471-4906(03)00176-5; Grundemann D, 1999, MOL PHARMACOL, V56, P1, DOI 10.1124/mol.56.1.1; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; Kepley CL, 2001, AM J RESP CRIT CARE, V164, P1053, DOI 10.1164/ajrccm.164.6.2102025; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; Kim S, 2009, J IMMUNOL, V183, P3033, DOI 10.4049/jimmunol.0900332; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; LaBella FS, 2000, SEMIN CANCER BIOL, V10, P47, DOI 10.1006/scbi.2000.0307; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; LUTTON JD, 1991, P SOC EXP BIOL MED, V196, P260; Meredith EJ, 2005, IMMUNOLOGY, V115, P289, DOI 10.1111/j.1365-2567.2005.02166.x; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; Mitre E, 2004, J IMMUNOL, V172, P2439, DOI 10.4049/jimmunol.172.4.2439; Moore ML, 2009, J IMMUNOL, V183, P2016, DOI 10.4049/jimmunol.0803167; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Mukai Kaori, 2009, Allergology International, V58, P11, DOI 10.2332/allergolint.08-RAI-0059; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Pal D, 2006, J NEUROIMMUNE PHARM, V1, P323, DOI 10.1007/s11481-006-9034-2; PARKER CW, 1995, CELL IMMUNOL, V160, P278, DOI 10.1016/0008-8749(95)80039-L; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rudd ML, 2005, J NEUROIMMUNOL, V159, P113, DOI 10.1016/j.jneuroim.2004.10.013; SALACHAS F, 1994, BLOOD, V84, P1098; Sasaki M, 2004, AM J PHYSIOL-CELL PH, V286, pC931, DOI 10.1152/ajpcell.00351.2003; Schneider E, 2005, J EXP MED, V202, P387, DOI 10.1084/jem.20050195; Schneider E, 1999, EXP HEMATOL, V27, P1010, DOI 10.1016/S0301-472X(99)00039-9; Schneider E, 2008, J IMMUNOL, V183, P3591; Schneider E, 2010, EUR CYTOKINE NETW, V21, P142, DOI 10.1684/ecn.2010.0197; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; VANLOVEREN H, 1985, J IMMUNOL, V134, P1292; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zwart R, 2001, MOL CELL BIOL, V21, P4188, DOI 10.1128/MCB.21.13.4188-4196.2001	47	10	12	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2011	128	4					864	U282		10.1016/j.jaci.2011.04.043	http://dx.doi.org/10.1016/j.jaci.2011.04.043			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	841UA	21636115				2022-12-18	WOS:000296538100025
J	Albrecht, M; Chen, HC; Preston-Hurlburt, P; Ranney, P; Hoymann, HG; Maxeiner, J; Staudt, V; Taube, C; Bottomly, HK; Dittrich, AM				Albrecht, Melanie; Chen, Hui-Chen; Preston-Hurlburt, Paula; Ranney, Patricia; Hoymann, Heinz-Gerd; Maxeiner, Joachim; Staudt, Valerie; Taube, Christian; Bottomly, H. Kim; Dittrich, Anna-Maria			T(H)17 cells mediate pulmonary collateral priming	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; IL-17A; T-H cell; polysensitization	T-HELPER TYPE-1; TH17 CELLS; AIRWAY HYPERRESPONSIVENESS; INTERFERON-GAMMA; INFECTIOUS-DISEASES; ASTHMA SEVERITY; IL-17 CYTOKINE; LUNG-FUNCTION; RISK-FACTOR; TH2 CELLS	Background: Our laboratory has shown that inhalational sensitization to new antigens is facilitated through an ongoing T(H)2-polarized inflammation of the lung, a phenomenon we call "collateral priming." Objective: We were interested to analyze whether a T(H)1-polarized pulmonary inflammation also facilitates priming toward new antigens and which cytokine or cytokines are involved. Methods: T(H)1-polarized T cells were generated in vitro and transferred into congenic mice. Mice were challenged initially with cognate antigen and an unrelated antigen; consecutively, they received cognate antigen or the secondary antigen. Airway inflammation, antigen-specific IgG2a levels, and airway hyperresponsiveness were assessed to determine the inflammatory phenotype, with antibody blocking studies used to determine cytokine requirements for T(H)1 collateral priming. Results: Our experiments revealed that ongoing inflammation of the lung induced by the transfer of T(H)1-polarized cells also facilitates priming toward new antigens, which results in lymphocytic inflammation of the lung. Interestingly, blocking studies identified IL-17A as a major contributor to this pathology. Accordingly, we could demonstrate for the first time that T(H)17-polarized cells alone can facilitate priming toward new antigens, inducing lymphocytic airway inflammation and strong airway hyperresponsiveness. Flow cytometric analysis revealed priming of endogenous T cells for IL-17A secretion with a distinct memory/effector phenotype compared to T(H)1 cells, thus presenting an exciting model to further elucidate differentiation of T(H)17 cells. Conclusions: We show that airway inflammation mediated by T(H)17 cells facilitates sensitization to new antigens and confers increased airway responsiveness in a murine model of polysensitization, suggesting a mechanism involving IL-17A behind the increased risk for allergic sensitization in polysensitized subjects. (J Allergy Clin Immunol 2011; 128: 168-77.)	[Albrecht, Melanie; Dittrich, Anna-Maria] Hannover Med Sch, Jr Res Grp SFB 587, D-30625 Hannover, Germany; [Chen, Hui-Chen; Preston-Hurlburt, Paula; Ranney, Patricia; Bottomly, H. Kim] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Chen, Hui-Chen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Hoymann, Heinz-Gerd] Fraunhofer ITEM, Hannover, Germany; [Staudt, Valerie] Johannes Gutenberg Univ Mainz, Inst Immunol, D-6500 Mainz, Germany; [Maxeiner, Joachim; Taube, Christian] Johannes Gutenberg Univ Mainz, Med Clin 3, D-6500 Mainz, Germany; [Bottomly, H. Kim] Wellesley Coll, Presidents Off, Wellesley, MA 02181 USA	Hannover Medical School; Yale University; China Medical University Taiwan; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Wellesley College	Dittrich, AM (corresponding author), Hannover Med Sch, Jr Res Grp SFB 587, Carl Neubergstr 1, D-30625 Hannover, Germany.	dittrich.anna-maria@mh-hannover.de	Dittrich, Anna Maria/M-5640-2013; Chen, Hui-Chen/L-8149-2013; Dittrich, Anna/GRY-6738-2022	Chen, Hui-Chen/0000-0001-9751-5729; 	National Institutes of Health [RO1 HL54450-09]; Deutsche Forschungsgemeinschaft [DI 1224/1-1, SFB 587, Teilprojekt N01]; Forschungszentrum Immunologie Mainz;  [Ta 275/4-1];  [Ta 275/5-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum Immunologie Mainz; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health (grant RO1 HL54450-09 [H.K.B.]) and the Deutsche Forschungsgemeinschaft ("DI 1224/1-1" and "SFB 587, Teilprojekt N01" [A.-M.D.]), as well as Ta 275/4-1 and Ta 275/5-1 and Forschungszentrum Immunologie Mainz (C.T.).	Akerman M, 2003, J ASTHMA, V40, P55, DOI 10.1081/JAS-120017207; Ashino S, 2010, INT IMMUNOL, V22, P503, DOI 10.1093/intimm/dxq034; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; Dittrich AM, 2008, J IMMUNOL, V181, P7307, DOI 10.4049/jimmunol.181.10.7307; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Egan PJ, 2008, ARTHRITIS RHEUM-US, V58, P3720, DOI 10.1002/art.24075; Eisenbarth SC, 2004, J IMMUNOL, V172, P4527, DOI 10.4049/jimmunol.172.7.4527; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Glaab T, 2004, J APPL PHYSIOL, V97, P1104, DOI 10.1152/japplphysiol.01182.2003; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hessel EM, 1997, AM J RESP CELL MOL, V16, P325, DOI 10.1165/ajrcmb.16.3.9070618; Hoymann HG, 2006, EXP TOXICOL PATHOL, V57, P5, DOI 10.1016/j.etp.2006.02.011; Hurst SD, 2001, J IMMUNOL, V166, P4922, DOI 10.4049/jimmunol.166.8.4922; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kim YS, 2010, EXP MOL MED, V42, P533, DOI 10.3858/emm.2010.42.8.054; Kjellman B, 2002, RESP MED, V96, P716, DOI 10.1053/rmed.2002.1337; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Laan M, 1999, J IMMUNOL, V162, P2347; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Mallia P, 2006, CHEST, V130, P1203, DOI 10.1378/chest.130.4.1203; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; POLLART SM, 1989, J ALLERGY CLIN IMMUN, V83, P875, DOI 10.1016/0091-6749(89)90100-0; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; ten Hacken NHT, 1998, EUR RESPIR J, V11, P312, DOI 10.1183/09031936.98.11020312; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Wang YH, 2008, CURR OPIN IMMUNOL, V20, P697, DOI 10.1016/j.coi.2008.09.004; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Wohlleben G, 2003, J IMMUNOL, V170, P4601, DOI 10.4049/jimmunol.170.9.4601; WRIGHT AL, 1989, AM J EPIDEMIOL, V129, P1232, DOI 10.1093/oxfordjournals.aje.a115243; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438	55	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					168	U269		10.1016/j.jaci.2011.01.067	http://dx.doi.org/10.1016/j.jaci.2011.01.067			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	785RE	21459426	Green Accepted			2022-12-18	WOS:000292245600022
J	Sato, T; Liu, XD; Basma, H; Togo, S; Sugiura, H; Nelson, A; Nakanishi, M; Kanaji, N; Wang, XQ; Kim, M; Li, YJ; Michalski, J; Farid, M; Sharp, JG; Rennard, SI				Sato, Tadashi; Liu, Xiangde; Basma, Hesham; Togo, Shinsaku; Sugiura, Hisatoshi; Nelson, Amy; Nakanishi, Masanori; Kanaji, Nobuhiro; Wang, Xingqi; Kim, Miok; Li, Yingji; Michalski, Joel; Farid, Maha; Sharp, John G.; Rennard, Stephen I.			IL-4 induces differentiation of human embryonic stem cells into fibrogenic fibroblast-like cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Embryonic stem cells; fibroblasts; IL-4; fibrosis; asthma; microRNA; miR-155; chemotaxis; collagen gel contraction; TGF-beta	OBSTRUCTIVE PULMONARY-DISEASE; GROWTH-FACTOR-BETA; LUNG FIBROBLASTS; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; EMPHYSEMA SHOW; MICRORNA-155; MYOFIBROBLAST; TISSUE; PHENOTYPE	Background: Fibroblast heterogeneity is recognized, and fibroblasts from diseased tissues, including those of asthmatic subjects, have functional phenotypes that differ from normal tissue. However, progenitor-progeny relationships and the factors that control fibroblast differentiation are poorly defined. Objective: We sought to determine whether IL-4 could alter the functional phenotype of fibroblasts during their differentiation from stem/progenitor cells. Methods: Using a 3-dimensional collagen gel system, we obtained embryoid bodies derived from human embryonic stem cells and recovered spindle-shaped cells consistent with fibroblasts that had differentiated in the presence or absence of IL-4. Results: IL-4-induced fibroblast-like cells were more active in contraction of collagen gels, migration, and production of fibronectin than control (without IL-4) cells. IL-4-induced cells demonstrated less expression of miR-155, which modulated contraction, migration, and fibronectin production. These differences persisted in culture without further addition of IL-4, suggesting the differentiated phenotype might be a permanent alteration. Conclusion: The current study demonstrates that IL-4 induces differentiation of stem/precursor cells into fibroblast-like cells that demonstrate a more fibrogenic phenotype, which is due to reduced expression of miR-155. These findings provide a novel mechanism for the persistent abnormalities in IL-4-related diseases and a novel target to regulate tissue remodeling by fibroblasts. (J Allergy Clin Immunol 2011;127:1595-603.)	[Sato, Tadashi; Liu, Xiangde; Basma, Hesham; Nelson, Amy; Nakanishi, Masanori; Kanaji, Nobuhiro; Wang, Xingqi; Kim, Miok; Li, Yingji; Michalski, Joel; Farid, Maha; Rennard, Stephen I.] Univ Nebraska Med Ctr, Dept Internal Med Pulm Crit Care Sleep & Allergy, Omaha, NE 68198 USA; [Sharp, John G.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Sato, Tadashi; Togo, Shinsaku] Juntendo Univ, Sch Med, Dept Resp Med, Tokyo 113, Japan; [Sugiura, Hisatoshi; Nakanishi, Masanori] Wakayama Med Univ, Sch Med, Dept Internal Med 3, Wakayama, Japan	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Juntendo University; Wakayama Medical University	Rennard, SI (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med Pulm Crit Care Sleep & Allergy, 985910 Nebraska Med Ctr, Omaha, NE 68198 USA.	srennard@unmc.edu	Farid, Maha Mohamed AlAzab Hassan/HDO-0741-2022	Farid, Maha Mohamed AlAzab Hassan/0000-0002-7692-1661	National Heart, Lung, and Blood Institute [RO1-064088]; Pulmonary Section, Department of Internal Medicine; Chancellor's office; Larson Endowment of the University of Nebraska Medical Center (UNMC); Uehara Memorial Foundation; Japanese Respiratory Research Foundation; Pfizer; National Institutes of Health of the National Center for Research Resources [P20 RR016469]; American Academy of Allergy, Asthma Immunology; American College of Osteopathic Family Physicians; Asan Medical Center; ATS; AstraZeneca; California Society of Allergy; Convergent Health Solutions for Reviews and Trends in COPD; COPD Foundation; Creative Educational Concepts/Houston; Dey; Duke; France Foundation; Network for Continuing Education (CHARM); Novartis (Horsham); Nycomed; Otsuka; Sarasota Memorial Hospital; Spanish Thoracic Society; University of Washington; University of Alabama at Birmingham; University of Pittsburgh; University of British Columbia; University of California Davis; VA Sioux Falls; Biomark; Centocor; GlaxoSmithKline; Mpex; National Lung Health Education; National Heart, Lung, and Blood Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064088] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pulmonary Section, Department of Internal Medicine; Chancellor's office; Larson Endowment of the University of Nebraska Medical Center (UNMC); Uehara Memorial Foundation(Uehara Memorial Foundation); Japanese Respiratory Research Foundation; Pfizer(Pfizer); National Institutes of Health of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Academy of Allergy, Asthma Immunology; American College of Osteopathic Family Physicians; Asan Medical Center; ATS; AstraZeneca(AstraZeneca); California Society of Allergy; Convergent Health Solutions for Reviews and Trends in COPD; COPD Foundation; Creative Educational Concepts/Houston; Dey; Duke; France Foundation; Network for Continuing Education (CHARM); Novartis (Horsham); Nycomed; Otsuka(Otsuka Pharmaceutical); Sarasota Memorial Hospital; Spanish Thoracic Society; University of Washington(University of Washington); University of Alabama at Birmingham; University of Pittsburgh(University of Pittsburgh); University of British Columbia; University of California Davis(University of California System); VA Sioux Falls; Biomark; Centocor; GlaxoSmithKline(GlaxoSmithKline); Mpex; National Lung Health Education; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Heart, Lung, and Blood Institute RO1-064088; the Pulmonary Section, Department of Internal Medicine, the Chancellor's office, and the Larson Endowment of the University of Nebraska Medical Center (UNMC; to S. I. R.); the Uehara Memorial Foundation and the Japanese Respiratory Research Foundation and the Pfizer Fellowship (to T. S.). The UNMC Microarray Core receives partial support from National Institutes of Health grant P20 RR016469 from the INBRE Program of the National Center for Research Resources.; S. I. Rennard is a consultant or on the advisory boards for ABIM, Able Association, Adelphil Research, Almirall, APT, Aradigm, Argenta, Astra, BI (ACCP), Biostrategies, BoomCom, Britnali and Nicolini, Capital Research, Chiesi, CommonHealth, Complete Medical Group, Consult Complete, COPDForum, DataMonitor, Decision Resources, Defined Health, Dey, Dunn Group, Easton Associates, Enterprise Analysis, Equinox, Forest, Fulcrum, Gerson Lehman, GlaxoSmithKline, Leerink Swan, M Pankove, MDRxFinancial, MedaCorp, MedImmune, Mpex, Novartis, Nycomed, Oriel, Otsuka, Pearl, Pennside Partners, Pfizer, PharmaVentures, Pharmaxis, Pick Research, Prescott, Price Waterhouse, Propagate, Pulmatrix, Pulmonary Reviews, Quadrant, J. Reckner Associates, Recruiting Resource, Reviews and Trends in COPD/Convergent Health Solutions, Roche, Sacoor, Schering Schlesinger Medical Scimed, Smith Research, Guidepoint, Hoffmann-LaRoche, IMS, Informed, Inspire, Insyght, KOL Connection, Sudler and Hennessey Talecris, Theradvance, UBC, Uptake Medical, and Vantage Point; has received lecture fees from the American Academy of Allergy, Asthma & Immunology, American College of Osteopathic Family Physicians, the Asan Medical Center, ATS, AstraZeneca, California Society of Allergy, Convergent Health Solutions for Reviews and Trends in COPD, COPD Foundation, Creative Educational Concepts/Houston, Dey, Duke, France Foundation, Network for Continuing Education (CHARM), Novartis (Horsham), Nycomed, Otsuka, Pfizer, Sarasota Memorial Hospital, the Spanish Thoracic Society, the University of Washington, the University of Alabama at Birmingham, the University of Pittsburgh, the University of British Columbia, the University of California Davis, and VA Sioux Falls; has received grants from AstraZeneca, Biomark, Centocor, GlaxoSmithKline, and Mpex; is a volunteer for the COPD Foundation, the National Lung Health Education Program, and the National Heart, Lung, and Blood Institute; and is in test preparation for the ABIM. The rest of the authors have declared that they have no conflict of interest.	Abe S, 2004, AM J RESP CRIT CARE, V170, P1158, DOI 10.1164/rccm.200307-908OC; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Christen T, 2001, CIRCULATION, V103, P882, DOI 10.1161/01.CIR.103.6.882; DESMOULIERE A, 1994, CELL MOTIL CYTOSKEL, V29, P195, DOI 10.1002/cm.970290302; Doucet C, 1998, INT IMMUNOL, V10, P1421, DOI 10.1093/intimm/10.10.1421; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; FRIES KM, 1994, CLIN IMMUNOL IMMUNOP, V72, P283, DOI 10.1006/clin.1994.1144; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Hashimoto S, 2001, J ALLERGY CLIN IMMUN, V107, P1001, DOI 10.1067/mai.2001.114702; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; KAHARI VM, 1993, ANN MED, V25, P511; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kotaru C, 2006, AM J RESP CRIT CARE, V173, P1208, DOI 10.1164/rccm.200508-1218OC; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Lewis CC, 2005, J ALLERGY CLIN IMMUN, V115, P534, DOI 10.1016/j.jaci.2004.11.051; Li YJ, 2011, AM J RESP CELL MOL, V44, P99, DOI 10.1165/rcmb.2009-0163OC; LI YJ, 2010, AM J RESP C IN PRESS; Liu XD, 2002, AM J PHYSIOL-LUNG C, V282, pL1049, DOI 10.1152/ajplung.00321.2001; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Mio T, 1996, IN VITRO CELL DEV-AN, V32, P427; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Muller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32; Nana-Sinkam SP, 2009, AM J RESP CRIT CARE, V179, P4, DOI 10.1164/rccm.200807-1042PP; Ohnishi K, 1998, LAB INVEST, V78, P1077; Phan Sem H, 2008, Proc Am Thorac Soc, V5, P334, DOI 10.1513/pats.200708-146DR; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; POSTLETHWAITE AE, 1992, J CLIN INVEST, V90, P1479, DOI 10.1172/JCI116015; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; RAGHOW R, 1994, FASEB J, V8, P823, DOI 10.1096/fasebj.8.11.8070631; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; RENNARD SI, 1981, P NATL ACAD SCI-BIOL, V78, P7147, DOI 10.1073/pnas.78.11.7147; RENNARD SI, 1981, BIOCHEM GENET, V19, P551, DOI 10.1007/BF00484626; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Sugiura H, 2007, AM J RESP CELL MOL, V37, P424, DOI 10.1165/rcmb.2007-0089OC; Sugiura H, 2009, PULM PHARMACOL THER, V22, P487, DOI 10.1016/j.pupt.2009.04.002; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; ZHANG K, 1994, AM J PATHOL, V145, P114	60	10	10	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1595	U432		10.1016/j.jaci.2011.01.049	http://dx.doi.org/10.1016/j.jaci.2011.01.049			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21388667	Green Accepted			2022-12-18	WOS:000291048500042
J	Selleri, S; Brigida, I; Casiraghi, M; Scaramuzza, S; Cappelli, B; Cassani, B; Ferrua, F; Aker, M; Slavin, S; Scarselli, A; Cancrini, C; Marktel, S; Roncarolo, MG; Aiuti, A				Selleri, Silvia; Brigida, Immacolata; Casiraghi, Miriam; Scaramuzza, Samantha; Cappelli, Barbara; Cassani, Barbara; Ferrua, Francesca; Aker, Memet; Slavin, Shimon; Scarselli, Alessia; Cancrini, Caterina; Marktel, Sarah; Roncarolo, Maria Grazia; Aiuti, Alessandro			In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Gene therapy; ADA-SCID; senescence; cell cycle; immune reconstitution	SEVERE COMBINED IMMUNODEFICIENCY; RECEPTOR EXCISION CIRCLE; BONE-MARROW; THYMIC OUTPUT; PERIPHERAL-BLOOD; TRANSPLANTATION; LYMPHOCYTES; MATURATION; RECIPIENTS; SUBSETS	Background: Gene therapy (GT) with hematopoietic stem cells is a promising treatment for inherited immunodeficiencies. Objectives: Limited information is available on the relative contribution of de novo thymopoiesis and peripheral expansion to T-cell reconstitution after GT as well as on the potential effects of gene transfer on hematopoietic stem cells and lymphocyte replicative lifespan. We studied these issues in patients affected by adenosine deaminase severe combined immune deficiency after low-intensity conditioning and reinfusion of retrovirally transduced autologous CD34(+) cells. Methods: Immunophenotype, proliferative status, telomere length, and T-cell receptor excision circles were investigated at early and late time points (up to 9 years) after GT treatment. Control groups consisted of pediatric healthy donors and patients undergoing allogeneic bone marrow transplantation (BMT). Results: We observed no telomere shortening in the bone marrow compartment and in granulocytes, whereas peripheral blood naive T cells from both GT and BMT patients showed a significant reduction in telomere length compared with healthy controls. This was in agreement with the presence of a high fraction of actively cycling naive and memory T cells and lower T-cell receptor excision circles. Conclusion: These data indicate that T-cell homeostatic expansion contributes substantially to immune reconstitution, like BMT, and is not associated with senescence in the stem cell compartment. (J Allergy Clin Immunol 2011;127:1368-75.)	[Selleri, Silvia; Brigida, Immacolata; Casiraghi, Miriam; Scaramuzza, Samantha; Cassani, Barbara; Roncarolo, Maria Grazia; Aiuti, Alessandro] San Raffaele Telethon Inst Gene Therapy, Milan, Italy; [Casiraghi, Miriam; Cappelli, Barbara; Ferrua, Francesca; Marktel, Sarah; Roncarolo, Maria Grazia; Aiuti, Alessandro] Ist Sci San Raffaele, Pediat Immunohematol & Bone Marrow Transplantat U, I-20132 Milan, Italy; [Scaramuzza, Samantha; Cassani, Barbara] Ist Clin Humanitas, Milan, Italy; [Scarselli, Alessia; Cancrini, Caterina; Aiuti, Alessandro] Univ Roma Tor Vergata, Dept Pediat, Childrens Hosp Bambino Gesu, Rome, Italy; [Aker, Memet; Slavin, Shimon] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Humanitas Research Hospital; IRCCS Bambino Gesu; University of Rome Tor Vergata; Hebrew University of Jerusalem	Aiuti, A (corresponding author), HSR TIGET, Via Olgettina 58, I-20132 Milan, Italy.	aiuti.alessandro@hsr.it	scarselli, alessia/AAB-5815-2020; Scaramuzza, Samantha/AAN-2204-2020; marktel, sarah/ABH-5549-2020; Cassani, Barbara/K-3871-2016; AIUTI, ALESSANDRO/K-3918-2016; Ferrua, Francesca/K-4340-2016	Scaramuzza, Samantha/0000-0003-2903-3650; Cassani, Barbara/0000-0002-4115-8109; AIUTI, ALESSANDRO/0000-0002-5398-1717; Ferrua, Francesca/0000-0002-5695-4490; RONCAROLO, Maria Grazia/0000-0002-2193-9186; marktel, sarah/0000-0002-3768-4288; cancrini, caterina/0000-0001-8410-9617; Brigida, Immacolata/0000-0002-0338-2230	Fondazione Telethon; Italian Medicines Agency (AIFA) [FARM5JRXRM]; European Commission [CLINIGENE LSHB-CT2006-018933, CEL-PID HEALTH-F5-2010-261387]; Italian Ministero della Salute; European Community	Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Medicines Agency (AIFA); European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministero della Salute(Ministry of Health, Italy); European Community(European Commission)	Supported by Fondazione Telethon and grants from the independent drug research program of the Italian Medicines Agency (AIFA; FARM5JRXRM; to A.A.), the European Commission (CLINIGENE LSHB-CT2006-018933 and CEL-PID HEALTH-F5-2010-261387 to A.A.), and the Italian Ministero della Salute (to C.C.); Disclosure of potential conflict of interest: S. Selleri, M. Casiraghi, S. Scaramuzza, B. Cappelli, B. Cassani, F. Ferrua, A. Scarselli, C. Cancrini, S. Marktel, M. Grazia Roncarolo, and A. Aiuti have received research support from the Fondazione Telethon and the European Community. The rest of the authors have declared that they have no conflict of interest.	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Akiyama M, 1998, BONE MARROW TRANSPL, V21, P167, DOI 10.1038/sj.bmt.1701060; Akiyama M, 2000, BONE MARROW TRANSPL, V25, P441, DOI 10.1038/sj.bmt.1702144; Awaya N, 2002, BIOL BLOOD MARROW TR, V8, P597, DOI 10.1053/bbmt.2002.v8.abbmt080597; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Biasco L, 2011, EMBO MOL MED, V3, P89, DOI 10.1002/emmm.201000108; Bubanovic IV, 2003, MED HYPOTHESES, V61, P235, DOI 10.1016/S0306-9877(03)00151-8; Cassani B, 2009, BLOOD, V114, P3546, DOI 10.1182/blood-2009-02-202085; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chiesa R, 2010, BIOL BLOOD MARROW TR, V16, P622, DOI 10.1016/j.bbmt.2009.11.024; Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; de Pauw ESD, 2002, BRIT J HAEMATOL, V116, P491, DOI 10.1046/j.0007-1048.2001.03283.x; De Rosa SC, 2004, J IMMUNOL, V172, P1637, DOI 10.4049/jimmunol.172.3.1637; de Vries E, 2000, BONE MARROW TRANSPL, V25, P267, DOI 10.1038/sj.bmt.1702141; Eyrich M, 2005, BIOL BLOOD MARROW TR, V11, P194, DOI 10.1016/j.bbmt.2004.12.001; Eyrich M, 2003, BONE MARROW TRANSPL, V32, P379, DOI 10.1038/sj.bmt.1704158; Gaspar HB, 2006, MOL THER, V14, P505, DOI 10.1016/j.ymthe.2006.06.007; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; GERDES J, 1984, J IMMUNOL, V133, P1710; Ghia P, 2007, BRIT J HAEMATOL, V139, P780, DOI 10.1111/j.1365-2141.2007.06867.x; Guazzi V, 2002, CLIN EXP IMMUNOL, V129, P346, DOI 10.1046/j.1365-2249.2002.01893.x; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Hayday A, 2008, MUCOSAL IMMUNOL, V1, P172, DOI 10.1038/mi.2008.8; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hazenberg MD, 2002, BLOOD, V99, P3449, DOI 10.1182/blood.V99.9.3449; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Junge S, 2007, EUR J IMMUNOL, V37, P3270, DOI 10.1002/eji.200636976; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; Lucarelli G, 2008, BLOOD REV, V22, P53, DOI 10.1016/j.blre.2007.10.001; Mackall CL, 2001, BLOOD, V97, P1491, DOI 10.1182/blood.V97.5.1491; Min B, 2005, SEMIN IMMUNOL, V17, P201, DOI 10.1016/j.smim.2005.02.005; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Qasim W, 2009, GENE THER, V16, P1285, DOI 10.1038/gt.2009.127; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sarzotti-Kelsoe M, 2009, BLOOD, V114, P1445, DOI 10.1182/blood-2009-01-199323; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Torfadottir H, 2006, CLIN EXP IMMUNOL, V145, P407, DOI 10.1111/j.1365-2249.2006.03139.x; Williams KA, 2007, SEMIN IMMUNOL, V19, P318, DOI 10.1016/j.smim.2007.10.004; Wynn R, 1999, BRIT J HAEMATOL, V105, P997, DOI 10.1046/j.1365-2141.1999.01450.x	46	10	12	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1368	U95		10.1016/j.jaci.2011.03.004	http://dx.doi.org/10.1016/j.jaci.2011.03.004			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21477850	Green Submitted			2022-12-18	WOS:000291048500007
J	von Mutius, E				von Mutius, Erika			Trajectories of childhood wheeze	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Wheeze; epidemiology; childhood	1ST 6 YEARS; ASTHMA; LIFE		Univ Munich, Dr Von Haunerschen Kinderspital, Dept Asthma & Allergy, D-80337 Munich, Germany	University of Munich	von Mutius, E (corresponding author), Univ Munich, Dr Von Haunerschen Kinderspital, Dept Asthma & Allergy, Lindwurmstr 4, D-80337 Munich, Germany.	Erika.Von.Mutius@med.uni-muenchen.de		von Mutius, Erika/0000-0002-8893-4515				Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002	4	10	12	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1513	1514		10.1016/j.jaci.2011.04.026	http://dx.doi.org/10.1016/j.jaci.2011.04.026			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21536323				2022-12-18	WOS:000291048500030
J	Ayuso, R; Grishina, G; Pascal, M; Sanchez-Garcia, S; Towle, D; Smith, C; Ibanez, M; Sampson, HA				Ayuso, R.; Grishina, G.; Pascal, M.; Sanchez-Garcia, S.; Towle, D.; Smith, C.; Ibanez, M.; Sampson, H. A.			Hemocyanin, Troponin C and Fatty Acid-binding Protein (FABP) May be Cross-reactive Allergens Between Crustaceans, Cockroach and Dust Mites	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Ayuso, R.; Grishina, G.; Sampson, H. A.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Pascal, M.] Hosp Clin Barcelona, Barcelona, Spain; [Sanchez-Garcia, S.; Ibanez, M.] Hosp Univ Nino Jesus, Madrid, Spain; [Towle, D.; Smith, C.] MDI Biol Lab, Salsbury Cove, ME USA	Icahn School of Medicine at Mount Sinai; University of Barcelona; Hospital Clinic de Barcelona									0	10	11	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB235	AB235		10.1016/j.jaci.2010.12.934	http://dx.doi.org/10.1016/j.jaci.2010.12.934			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846401049
J	Campo, P; Antunez, C; Rondon, C; Mayorga, C; Garcia, R; Ruiz, M; Melendez, L; Rodriguez-Bada, J; Blanca, M				Campo, P.; Antunez, C.; Rondon, C.; Mayorga, C.; Garcia, R.; Ruiz, M.; Melendez, L.; Rodriguez-Bada, J.; Blanca, M.			Positive Bronchial Challenges To D. Pteronyssinus In Asthmatic Subjects In Absence Of Systemic Atopy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Campo, P.; Rondon, C.; Garcia, R.; Ruiz, M.; Blanca, M.] Hosp Carlos Haya, Malaga, Spain; [Antunez, C.; Mayorga, C.; Melendez, L.; Rodriguez-Bada, J.] IMABIS Fdn, Malaga, Spain	Hospital Carlos Haya; FIMABIS			Mayorga, Lina/FBO-7730-2022; Mayorga, Cristobalina/D-7167-2018	Mayorga, Cristobalina/0000-0001-8852-8077					0	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB6	AB6		10.1016/j.jaci.2010.12.038	http://dx.doi.org/10.1016/j.jaci.2010.12.038			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI		Bronze			2022-12-18	WOS:000295846400022
J	Reyes, SOL; Suarez, F; Herbigneaux, RM; Pacquement, H; Reguerre, Y; Riviere, JP; de Suremain, M; Rose, Y; Feinberg, J; Malahoui, N; Fischer, A; Blanche, S; Casanova, JL; Picard, C; Bustamante, J				Reyes, Saul Oswaldo Lugo; Suarez, Felipe; Herbigneaux, Rose-Marie; Pacquement, Helene; Reguerre, Yves; Riviere, Jean-Pierre; de Suremain, Maylis; Rose, Yoann; Feinberg, Jacqueline; Malahoui, Nizar; Fischer, Alain; Blanche, Stephane; Casanova, Jean-Laurent; Picard, Capucine; Bustamante, Jacinta			Hodgkin lymphoma in 2 children with chronic granulomatous disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NADPH OXIDASE; B-CELLS; APOPTOSIS; PATIENT; ACTIVATION; LEUKEMIA		[Reyes, Saul Oswaldo Lugo; de Suremain, Maylis; Rose, Yoann; Feinberg, Jacqueline; Casanova, Jean-Laurent; Picard, Capucine; Bustamante, Jacinta] INSERM, Necker Branch, Lab Human Genet Infect Dis, U980, Paris, France; [Reyes, Saul Oswaldo Lugo; Suarez, Felipe; de Suremain, Maylis; Rose, Yoann; Feinberg, Jacqueline; Casanova, Jean-Laurent; Picard, Capucine; Bustamante, Jacinta] Paris Descartes Univ, Necker Med Sch, Paris, France; [Suarez, Felipe] Necker Enfants Malades Hosp, Dept Hematol, Paris, France; [Herbigneaux, Rose-Marie] Reunion CHU, Hematol Oncol Unit, St Denis, Reunion, France; [Riviere, Jean-Pierre] Reunion CHU, Dept Pathol, St Denis, Reunion, France; [Pacquement, Helene] Inst Curie, Dept Med Oncol, Paris, France; [Reguerre, Yves] CHU Angers, Hematol Oncol Unit, Angers, France; [Malahoui, Nizar; Fischer, Alain; Blanche, Stephane; Casanova, Jean-Laurent; Picard, Capucine; Bustamante, Jacinta] Hop Necker Enfants Malad, AP HP, Pediat Hematol Immunol Unit, Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France; [Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Reunion; CHU Reunion; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University	Reyes, SOL (corresponding author), INSERM, Necker Branch, Lab Human Genet Infect Dis, U980, Paris, France.	jacinta.bustamante@inserm.fr	Casanova, Jean-Laurent/I-3418-2017; Reyes, Saul O Lugo/AAS-7621-2021; Reyes, Saul O Lugo/AAP-7951-2021; Picard, Capucine/H-3914-2017; Lugo Reyes, Saul Oswaldo/N-6594-2013; Bustamante, Jacinta/H-7877-2017	Reyes, Saul O Lugo/0000-0002-3730-4150; Reyes, Saul O Lugo/0000-0002-3730-4150; Picard, Capucine/0000-0001-8788-5056; Lugo Reyes, Saul Oswaldo/0000-0002-3730-4150; Bustamante, Jacinta/0000-0002-3439-2482; Casanova, Jean-Laurent/0000-0002-7782-4169	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR024143, UL1 RR024143-03, 5UL1RR024143-03] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Aguilera DG, 2009, J PEDIAT HEMATOL ONC, V31, P965, DOI 10.1097/MPH.0b013e3181b84751; CLARK RA, 1981, J IMMUNOL, V126, P1295; CLARK RA, 1977, J IMMUNOL, V119, P1413; Geramizadeh B, 2010, IRAN RED CRESCENT ME, V12, P319; Hasui M, 1999, PEDIATR INT, V41, P589; Hiraoka W, 1998, J CLIN INVEST, V102, P1961, DOI 10.1172/JCI3437; Jabado N, 1998, CLIN INFECT DIS, V27, P1437, DOI 10.1086/515015; Kim YS, 2008, J IMMUNOL, V181, P6158, DOI 10.4049/jimmunol.181.9.6158; Kindzelskii AL, 1999, J IMMUNOL, V162, P3188; Lan Q, 2007, HUM GENET, V121, P161, DOI 10.1007/s00439-006-0288-9; Nakazato T, 2005, CLIN CANCER RES, V11, P6040, DOI 10.1158/1078-0432.CCR-04-2273; Paclet MH, 2001, EUR J BIOCHEM, V268, P5197, DOI 10.1046/j.0014-2956.2001.02455.x; ROBISON LL, 1987, AM J PEDIAT HEMATOL, V9, P189; Salavoura K, 2008, ANTICANCER RES, V28, P1263; Tran H, 2008, BLOOD REV, V22, P261, DOI 10.1016/j.blre.2008.03.009; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Vene R, 2010, ANTIOXID REDOX SIGN, V13, P1145, DOI 10.1089/ars.2009.3078; Weel EAM, 1996, EUR J CANCER, V32A, P734, DOI 10.1016/0959-8049(95)00627-3; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Wolach B, 2005, AM J HEMATOL, V80, P50, DOI 10.1002/ajh.20424	20	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2					543	544		10.1016/j.jaci.2010.10.049	http://dx.doi.org/10.1016/j.jaci.2010.10.049			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	714KH	21168906	Green Accepted			2022-12-18	WOS:000286808000038
J	Marquis, A; Strippoli, MPF; Spycher, BD; Rebholz, CE; von der Weid, NX; Kuehni, CE				Marquis, Adine; Strippoli, Marie-Pierre F.; Spycher, Ben D.; Rebholz, Cornelia E.; von der Weid, Nicolas X.; Kuehni, Claudia E.		Swiss Pediat Oncology Grp	Paracetamol, nonsteroidal anti-inflammatory drugs, and risk of asthma in adult survivors of childhood cancer	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ACETAMINOPHEN USE; IBUPROFEN; CHILDREN; ASSOCIATION; POPULATION; SEVERITY; ECZEMA		[Marquis, Adine; Strippoli, Marie-Pierre F.; Spycher, Ben D.; Rebholz, Cornelia E.; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [von der Weid, Nicolas X.] CHU Vaudois, Serv Pediat, Lausanne, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Marquis, A (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	kuehni@ispm.unibe.ch	Strippoli, Marie-Pierre F/K-8164-2013; Spycher, Ben D/B-3308-2008	Strippoli, Marie-Pierre F/0000-0003-3053-484X; Spycher, Ben D/0000-0002-1430-5695; Kuehni, Claudia E./0000-0001-8957-2002				Bayer-Oglesby L, 2005, ENVIRON HEALTH PERSP, V113, P1632, DOI 10.1289/ehp.8159; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Etminan M, 2009, CHEST, V136, P1316, DOI 10.1378/chest.09-0865; Farquhar H, 2010, CLIN EXP ALLERGY, V40, P32, DOI 10.1111/j.1365-2222.2009.03378.x; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hijnen DJ, 2007, J EUR ACAD DERMATOL, V21, P85, DOI 10.1111/j.1468-3083.2006.01877.x; Kanabar D, 2007, CLIN THER, V29, P2716, DOI 10.1016/j.clinthera.2007.12.021; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; McKeever TM, 2005, AM J RESP CRIT CARE, V171, P966, DOI 10.1164/rccm.200409-1269OC; Michel G, 2010, J CLIN ONCOL, V28, P1740, DOI 10.1200/JCO.2009.23.4534; Prosser R, 2010, CHRONIC DIS CAN, V30, P46; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Simon D, 2008, J ALLERGY CLIN IMMUN, V121, P122, DOI 10.1016/j.jaci.2007.11.016; Thomsen SF, 2009, CLIN RESPIR J, V3, P82, DOI 10.1111/j.1752-699X.2008.00113.x	17	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2011	127	1					270	272		10.1016/j.jaci.2010.08.044	http://dx.doi.org/10.1016/j.jaci.2010.08.044			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	702SY	21093027				2022-12-18	WOS:000285917300041
J	McFadden, ER				McFadden, E. R., Jr.			Resurrection men and the FEF25-75	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							SMALL AIRWAY DISEASE; ASTHMA; OBSTRUCTION; RESISTANCE		[McFadden, E. R., Jr.] Case Western Reserve Univ, Metrohlth Med Ctr, Div Pulm Crit Care & Sleep Med, Sch Med, Cleveland, OH 44109 USA; [McFadden, E. R., Jr.] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Med, Sch Med, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System	McFadden, ER (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Div Pulm Crit Care & Sleep Med, Sch Med, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	Erm2@case.edu						Bailey James Blake, 1896, DIARY RESURRECTIONIS; BOULET LP, 1994, CHEST, V105, P1024, DOI 10.1378/chest.105.4.1024; Cirillo I, 2006, ANN ALLERG ASTHMA IM, V96, P692, DOI 10.1016/S1081-1206(10)61067-8; FERGUSON AC, 1988, J ALLERGY CLIN IMMUN, V82, P19, DOI 10.1016/0091-6749(88)90045-0; HORSFIEL.K, 1971, J APPL PHYSIOL, V31, P207, DOI 10.1152/jappl.1971.31.2.207; MACKLEM PT, 1967, J APPL PHYSIOL, V22, P395, DOI 10.1152/jappl.1967.22.3.395; MCFADDEN ER, 1973, NEW ENGL J MED, V288, P221, DOI 10.1056/NEJM197302012880501; MCFADDEN ER, 1972, AM J MED, V52, P725, DOI 10.1016/0002-9343(72)90078-2; MCFADDEN ER, 1974, AM J MED, V57, P171, DOI 10.1016/0002-9343(74)90441-0; OTIS AB, 1956, J APPL PHYSIOL, V8, P427, DOI 10.1152/jappl.1956.8.4.427; Sharma S, 2008, J ALLERGY CLIN IMMUN, V122, P921, DOI 10.1016/j.jaci.2008.09.004; Simon MR, 2010, J ALLERGY CLIN IMMUN, V126, P527, DOI 10.1016/j.jaci.2010.05.016; WAGNER EM, 1990, AM REV RESPIR DIS, V141, P584, DOI 10.1164/ajrccm/141.3.584; WOOLCOCK AJ, 1969, J CLIN INVEST, V48, P1097, DOI 10.1172/JCI106066	14	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2010	126	3					535	536		10.1016/j.jaci.2010.06.035	http://dx.doi.org/10.1016/j.jaci.2010.06.035			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	646CF	20673986	Bronze			2022-12-18	WOS:000281512500019
J	Imoto, Y; Enomoto, H; Fujieda, S; Okamoto, M; Sakashita, M; Susuki, D; Okada, M; Hirota, T; Tamari, M; Ebe, K; Arinami, T; Noguchi, E				Imoto, Yoshimasa; Enomoto, Hisako; Fujieda, Shigeharu; Okamoto, Masayuki; Sakashita, Masafumi; Susuki, Dai; Okada, Masafumi; Hirota, Tomomitsu; Tamari, Mayumi; Ebe, Kouji; Arinami, Tadao; Noguchi, Emiko			S2554X mutation in the filaggrin gene is associated with allergen sensitization in the Japanese population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ICHTHYOSIS VULGARIS; ATOPIC-DERMATITIS; ECZEMA		[Imoto, Yoshimasa; Enomoto, Hisako; Arinami, Tadao; Noguchi, Emiko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Med Genet, Tsukuba, Ibaraki 305, Japan; [Enomoto, Hisako] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Dermatol, Tsukuba, Ibaraki 305, Japan; [Okada, Masafumi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Epidemiol, Tsukuba, Ibaraki 305, Japan; [Imoto, Yoshimasa; Fujieda, Shigeharu; Okamoto, Masayuki; Sakashita, Masafumi; Susuki, Dai] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol, Fukui, Japan; [Imoto, Yoshimasa; Fujieda, Shigeharu; Okamoto, Masayuki; Sakashita, Masafumi; Susuki, Dai] Univ Fukui, Fac Med Sci, Dept Immunol, Fukui, Japan; [Hirota, Tomomitsu; Tamari, Mayumi] RIKEN, Single Nucleotide Polymorphism Res Ctr, Lab Genet Lung Dis, Yokohama, Kanagawa, Japan; [Ebe, Kouji] Takao Hosp, Kyoto, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Fukui; University of Fukui; RIKEN	Imoto, Y (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Med Genet, Tsukuba, Ibaraki 305, Japan.	enoguchi@md.tsukuba.ac.jp	Tamari, Mayumi/N-5378-2015					BABA K, 2009, GUIDELINE NASAL ALLE; Enomoto H, 2008, J HUM GENET, V53, P615, DOI 10.1007/s10038-008-0293-z; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Linneberg A, 2008, CLIN EXP ALLERGY, V38, P1419, DOI 10.1111/j.1365-2222.2008.03063.x; Nomura T, 2008, J INVEST DERMATOL, V128, P1436, DOI 10.1038/sj.jid.5701205; Nomura T, 2007, J ALLERGY CLIN IMMUN, V119, P434, DOI 10.1016/j.jaci.2006.12.646; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020	9	10	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2					498	500		10.1016/j.jaci.2009.10.062	http://dx.doi.org/10.1016/j.jaci.2009.10.062			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	558RU	20159264				2022-12-18	WOS:000274764000034
J	Kazani, S; Israel, E				Kazani, Shamsah; Israel, Elliot			Long-acting beta-agonists and inhaled corticosteroids: Is the whole greater than the sum of its parts?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; inhaled corticosteroids; long-acting beta-agonists; synergism	SMOOTH-MUSCLE-CELLS; ASTHMA; INHIBITION; SALMETEROL; GLUCOCORTICOIDS; MECHANISMS; TRIAL		[Kazani, Shamsah; Israel, Elliot] Harvard Univ, Div Pulm & Crit Care, Sch Med, Brigham & Womens Hosp,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Israel, E (corresponding author), Harvard Univ, Div Pulm & Crit Care, Sch Med, Brigham & Womens Hosp,Dept Med, 75 Francis St, Boston, MA 02115 USA.	eisrael@partners.org						Broadley KJ, 2006, EUR J PHARMACOL, V533, P15, DOI 10.1016/j.ejphar.2005.12.060; Chong LK, 1998, BRIT J PHARMACOL, V123, P1009, DOI 10.1038/sj.bjp.0701703; Goulet S, 2007, J CELL PHYSIOL, V210, P167, DOI 10.1002/jcp.20836; Johnson M, 2006, J ALLERGY CLIN IMMUN, V117, P18, DOI 10.1016/j.jaci.2005.11.012; Kelly MM, 2010, J ALLERGY CLIN IMMUN, V125, P349, DOI 10.1016/j.jaci.2009.09.011; Li X, 1999, AM J RESP CRIT CARE, V160, P1493, DOI 10.1164/ajrccm.160.5.9811052; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Nie M, 2005, J IMMUNOL, V175, P478, DOI 10.4049/jimmunol.175.1.478; Oliver MN, 2007, AM J RESP CELL MOL, V37, P264, DOI 10.1165/rcmb.2006-0418OC; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; TOMLINSON PR, 1994, BRIT J PHARMACOL, V111, P641, DOI 10.1111/j.1476-5381.1994.tb14784.x; *US FDA, 2008, STAT BRIEF PACK LONG; Usmani OS, 2005, AM J RESP CRIT CARE, V172, P704, DOI 10.1164/rccm.200408-1041OC; Wechsler ME, 2009, LANCET, V374, P1754, DOI 10.1016/S0140-6736(09)61492-6	15	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2					357	358		10.1016/j.jaci.2009.12.021	http://dx.doi.org/10.1016/j.jaci.2009.12.021			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	558RU	20159244	Bronze			2022-12-18	WOS:000274764000011
J	Gruenberg, DA; Anover-Sombke, S; Gern, JE; Holland, SM; Rosenzweig, SD; Torgerson, TR; Seroogy, CM				Gruenberg, David A.; Anover-Sombke, Stephanie; Gern, James E.; Holland, Steven M.; Rosenzweig, Sergio D.; Torgerson, Troy R.; Seroogy, Christine M.			Atypical presentation of IL-12 receptor beta 1 deficiency with pneumococcal sepsis and disseminated nontuberculous mycobacterial infection in a 19-month-old girl born to nonconsanguineous US residents	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Gruenberg, David A.; Gern, James E.; Seroogy, Christine M.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Anover-Sombke, Stephanie; Torgerson, Troy R.] Univ Washington, Seattle, WA 98195 USA; [Anover-Sombke, Stephanie; Torgerson, Troy R.] Seattle Childrens Res Inst, Seattle, WA USA; [Holland, Steven M.; Rosenzweig, Sergio D.] NIH, Bethesda, MD 20892 USA	University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; Seattle Children's Hospital; National Institutes of Health (NIH) - USA	Gruenberg, DA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.	cmseroogy@wisc.edu			Intramural NIH HHS [Z99 AI999999] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000647, ZIAAI001122] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Fleisher TA, 1999, CLIN IMMUNOL, V90, P425, DOI 10.1006/clim.1998.4654; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; Rosenzweig SD, 2004, J ALLERGY CLIN IMMUN, V113, P620, DOI 10.1016/j.jaci.2004.02.001; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; Uzel G, 2001, CLIN IMMUNOL, V100, P270, DOI 10.1006/clim.2001.5078; Yancoski J, 2009, INFECT GENET EVOL, V9, P574, DOI 10.1016/j.meegid.2009.02.010	7	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2010	125	1					264	265		10.1016/j.jaci.2009.07.061	http://dx.doi.org/10.1016/j.jaci.2009.07.061			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	544MG	19910038	Green Accepted			2022-12-18	WOS:000273660500033
J	Szefler, SJ				Szefler, Stanley J.			Advances in pediatric asthma in 2009: Gaining control of childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; asthma control; asthma impairment; asthma risk; asthma severity; early intervention in asthma; biomarkers; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting beta-adrenergic agonists; omalizumab; therapeutics	GENE-ENVIRONMENT INTERACTIONS; HEALTH DISPARITIES; LUNG-FUNCTION; ALLERGIC SENSITIZATION; CLINICAL-TRIALS; CHILDREN; EXACERBATIONS; SYMPTOMS; AIRWAY; RISK	This year's summary will focus on recent advances in pediatric asthma as reported in Journal of Allergy and Clinical Immunology publications in 2009. New National Asthma Education and Prevention Program asthma guidelines were released in 2007, with a particular emphasis on asthma control. Now that we have worked with the principals of the guidelines for 2 years, new insights are reported on how to implement the guidelines into clinical practice. This year's report will focus on gaps in management that need to be addressed, including health disparities, methods to improve asthma management through opportunities available in school-based asthma programs, and more information on the development of asthma in childhood. This information brings us closer to the point of managing children with controllable asthma and understanding reasons why asthma is not controlled in the remaining children. If we can close these gaps through better communication, improvements in the health care system, and new insights into treatment, we will move closer to better methods to intervene early in the course of the disease and induce clinical remission as quickly as possible in most children. (J Allergy Clin Immunol 2010;125:69-78.)	[Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA; [Szefler, Stanley J.] Univ Colorado Denver, Sch Med, Denver, CO USA	National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Szefler, SJ (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Rm J304,Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njhealth.org			Public Health Services [HR-16048, HL64288, HL51834, AI-25496, HL081335, HL075416]; Colorado Cancer, Cardiovascular, and Pulmonary Disease Program; National Institutes of Health [1 UL1 RR025780]; National Center for Research Resources; National Heart, Lung, and Blood institute; National Institute of Allergy and Infectious Diseases; GlaxoSmithKline; DIVISION OF LUNG DISEASES [N01HR016048] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL081335, U01HL075416, U10HL064288, U10HL051834] Funding Source: NIH RePORTER	Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); Colorado Cancer, Cardiovascular, and Pulmonary Disease Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline(GlaxoSmithKline); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by Public Health Services research grants HR-16048, HL64288, HL51834, AI-25496. HL081335, and HL075416 and the Colorado Cancer, Cardiovascular, and Pulmonary Disease Program. Supported in part by Colorado CTSA grant 1 UL1 RR025780 from the National Institutes of Health and the National Center for Research Resources.; Disclosure of potential conflict of interest: S. J. Szefler has consulted for GlaxoSmithKline. Genentech. Merck, and Boehringer-lngelheim and has received research support from the National Institutes of Health; the National Heart, Lung, and Blood institute; the National Institute of Allergy and Infectious Diseases; and GlaxoSmithKline.	Apter AJ, 2009, J ALLERGY CLIN IMMUN, V123, P1237, DOI 10.1016/j.jaci.2009.04.028; Bacharier LB, 2009, J ALLERGY CLIN IMMUN, V123, P1077, DOI 10.1016/j.jaci.2008.12.1120; Barton SJ, 2009, J ALLERGY CLIN IMMUN, V123, P1391, DOI 10.1016/j.jaci.2009.03.014; Basu K, 2009, J ALLERGY CLIN IMMUN, V124, P1188, DOI 10.1016/j.jaci.2009.07.043; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P651, DOI 10.1016/j.jaci.2008.11.036; Bruzzese JM, 2009, J ALLERGY CLIN IMMUN, V124, P195, DOI 10.1016/j.jaci.2009.05.040; Bryant-Stephens T, 2009, J ALLERGY CLIN IMMUN, V123, P1199, DOI 10.1016/j.jaci.2009.04.030; Bush A, 2009, NEW ENGL J MED, V360, P409, DOI 10.1056/NEJMe0808951; Camargo CA, 2009, J ALLERGY CLIN IMMUN, V124, pS5, DOI 10.1016/j.jaci.2009.05.010; Canino G, 2009, J ALLERGY CLIN IMMUN, V123, P1209, DOI 10.1016/j.jaci.2009.02.043; Carroll KN, 2009, J ALLERGY CLIN IMMUN, V123, P1055, DOI 10.1016/j.jaci.2009.02.021; Caudri D, 2009, J ALLERGY CLIN IMMUN, V124, P903, DOI 10.1016/j.jaci.2009.06.045; Cicutto L, 2009, J ALLERGY CLIN IMMUN, V124, P390, DOI 10.1016/j.jaci.2009.04.042; Clerisme-Beaty E, 2009, J ALLERGY CLIN IMMUN, V123, P96, DOI 10.1016/j.jaci.2008.11.003; Coogan PF, 2009, J ALLERGY CLIN IMMUN, V123, P89, DOI 10.1016/j.jaci.2008.09.040; Cookson H, 2009, J ALLERGY CLIN IMMUN, V123, P847, DOI 10.1016/j.jaci.2009.01.042; Dakhama A, 2009, J ALLERGY CLIN IMMUN, V123, P138, DOI 10.1016/j.jaci.2008.10.012; Dolhnikoff M, 2009, J ALLERGY CLIN IMMUN, V123, P1090, DOI 10.1016/j.jaci.2009.02.032; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Esteba CA, 2009, J ALLERGY CLIN IMMUN, V124, P238, DOI 10.1016/j.jaci.2009.05.014; Farquhar H, 2009, J ALLERGY CLIN IMMUN, V124, P649, DOI 10.1016/j.jaci.2009.07.037; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V124, P990, DOI 10.1016/j.jaci.2009.08.039; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V123, P146, DOI 10.1016/j.jaci.2008.10.047; Flory JH, 2009, J ALLERGY CLIN IMMUN, V124, P605, DOI 10.1016/j.jaci.2009.05.047; Foliaki S, 2009, J ALLERGY CLIN IMMUN, V124, P982, DOI 10.1016/j.jaci.2009.08.017; Gergen PJ, 2009, J ALLERGY CLIN IMMUN, V124, P447, DOI 10.1016/j.jaci.2009.06.011; Gern JE, 2009, J ALLERGY CLIN IMMUN, V123, P105, DOI 10.1016/j.jaci.2008.11.029; Glezen WP, 2009, J ALLERGY CLIN IMMUN, V123, P404, DOI 10.1016/j.jaci.2008.11.033; Gruchalla RS, 2009, J ALLERGY CLIN IMMUN, V124, P213, DOI 10.1016/j.jaci.2009.05.036; Gupta RS, 2009, J ALLERGY CLIN IMMUN, V123, P1297, DOI 10.1016/j.jaci.2009.03.039; Haselkorn T, 2009, J ALLERGY CLIN IMMUN, V124, P921, DOI 10.1016/j.jaci.2009.09.006; Haselkorn T, 2009, J ALLERGY CLIN IMMUN, V124, P895, DOI 10.1016/j.jaci.2009.07.035; He JQ, 2009, J ALLERGY CLIN IMMUN, V124, P222, DOI 10.1016/j.jaci.2009.04.018; Hollams EM, 2009, J ALLERGY CLIN IMMUN, V124, P463, DOI 10.1016/j.jaci.2009.06.019; Jackson DJ, 2009, J ALLERGY CLIN IMMUN, V124, P949, DOI 10.1016/j.jaci.2009.07.024; Juntti H, 2009, J ALLERGY CLIN IMMUN, V124, P52, DOI 10.1016/j.jaci.2009.04.014; Kelly H. William, 2009, Pediatric Asthma Allergy & Immunology, V22, P75, DOI 10.1089/pai.2009.2202.ph; Kelsay K, 2009, J ALLERGY CLIN IMMUN, V124, P697, DOI 10.1016/j.jaci.2009.09.001; Keski-Nisula L, 2009, J ALLERGY CLIN IMMUN, V123, P1305, DOI 10.1016/j.jaci.2009.03.021; Khan FI, 2009, J ALLERGY CLIN IMMUN, V123, P660, DOI 10.1016/j.jaci.2008.12.018; Knuffman JE, 2009, J ALLERGY CLIN IMMUN, V123, P411, DOI 10.1016/j.jaci.2008.11.016; Kruzick T, 2009, J ALLERGY CLIN IMMUN, V124, P381, DOI 10.1016/j.jaci.2009.05.048; Lanier B, 2009, J ALLERGY CLIN IMMUN, V124, P1210, DOI 10.1016/j.jaci.2009.09.021; Larsen GL, 2009, J ALLERGY CLIN IMMUN, V123, P861, DOI 10.1016/j.jaci.2008.10.036; Lee TH, 2009, J ALLERGY CLIN IMMUN, V124, P417, DOI 10.1016/j.jaci.2009.04.020; Marenholz I, 2009, J ALLERGY CLIN IMMUN, V123, P911, DOI 10.1016/j.jaci.2009.01.051; Miller BD, 2009, J ALLERGY CLIN IMMUN, V124, P66, DOI 10.1016/j.jaci.2009.04.038; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Miller GE, 2009, J ALLERGY CLIN IMMUN, V123, P824, DOI 10.1016/j.jaci.2008.12.019; Murphy KR, 2009, J ALLERGY CLIN IMMUN, V123, P833, DOI 10.1016/j.jaci.2009.01.058; Musaad SMA, 2009, J ALLERGY CLIN IMMUN, V123, P1321, DOI 10.1016/j.jaci.2009.03.023; Naimi DR, 2009, J ALLERGY CLIN IMMUN, V123, P1335, DOI 10.1016/j.jaci.2009.02.022; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nativel C, 2007, SEIZ SIECLE, V3, P7; O'Byrne PM, 2009, J ALLERGY CLIN IMMUN, V124, P397, DOI 10.1016/j.jaci.2009.05.029; Pali-Scholl I, 2009, J ALLERGY CLIN IMMUN, V123, P1012, DOI 10.1016/j.jaci.2009.01.045; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, P699, DOI 10.1016/j.jaci.2009.08.011; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, P691, DOI 10.1016/j.jaci.2009.08.010; Ronmark E, 2009, J ALLERGY CLIN IMMUN, V124, P357, DOI 10.1016/j.jaci.2009.05.011; Salam MT, 2009, J ALLERGY CLIN IMMUN, V123, P596, DOI 10.1016/j.jaci.2008.12.020; Salo PM, 2009, J ALLERGY CLIN IMMUN, V124, P185, DOI 10.1016/j.jaci.2009.05.012; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, pS1, DOI 10.1016/j.jaci.2009.05.001; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Scholtens S, 2009, J ALLERGY CLIN IMMUN, V123, P1312, DOI 10.1016/j.jaci.2009.02.029; Schwartzstein RM, 2009, J ALLERGY CLIN IMMUN, V123, P1319, DOI 10.1016/j.jaci.2009.04.034; Smith AD, 2009, J ALLERGY CLIN IMMUN, V124, P714, DOI 10.1016/j.jaci.2009.07.020; Spahn J, 2009, J ALLERGY CLIN IMMUN, V124, P1197, DOI 10.1016/j.jaci.2009.08.042; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P398, DOI 10.1016/j.jaci.2008.10.043; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P131, DOI 10.1016/j.jaci.2008.10.042; Su RC, 2009, J ALLERGY CLIN IMMUN, V124, P1116, DOI 10.1016/j.jaci.2009.08.033; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Suttner K, 2009, J ALLERGY CLIN IMMUN, V123, P82, DOI 10.1016/j.jaci.2008.09.047; Suttner K, 2009, J ALLERGY CLIN IMMUN, V123, P1179, DOI 10.1016/j.jaci.2009.02.008; Suttner K, 2009, J ALLERGY CLIN IMMUN, V123, P1062, DOI 10.1016/j.jaci.2009.02.025; Szefler SJ, 2009, J ALLERGY CLIN IMMUN, V124, P201, DOI 10.1016/j.jaci.2009.05.045; Szefler SJ, 2009, J ALLERGY CLIN IMMUN, V123, P28, DOI 10.1016/j.jaci.2008.11.002; Tantisira KG, 2009, J ALLERGY CLIN IMMUN, V124, P422, DOI 10.1016/j.jaci.2009.06.035; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Upham JW, 2009, J ALLERGY CLIN IMMUN, V124, P707, DOI 10.1016/j.jaci.2009.07.009; Valet RS, 2009, J ALLERGY CLIN IMMUN, V123, P1220, DOI 10.1016/j.jaci.2008.12.1131; Vercelli D, 2009, J ALLERGY CLIN IMMUN, V123, P26, DOI 10.1016/j.jaci.2008.11.031; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Wichmann FA, 2009, J ALLERGY CLIN IMMUN, V123, P632, DOI 10.1016/j.jaci.2008.09.052; Wright RJ, 2009, J ALLERGY CLIN IMMUN, V123, P831, DOI 10.1016/j.jaci.2009.02.017; Wu AC, 2009, J ALLERGY CLIN IMMUN, V123, P385, DOI 10.1016/j.jaci.2008.10.015; Yemen S, 2009, J ALLERGY CLIN IMMUN, V123, P658, DOI 10.1016/j.jaci.2009.01.063; Zeiger RS, 2009, J ALLERGY CLIN IMMUN, V124, P1106, DOI 10.1016/j.jaci.2009.07.052	89	10	10	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2010	125	1					69	78		10.1016/j.jaci.2009.11.006	http://dx.doi.org/10.1016/j.jaci.2009.11.006			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	544MG	20109738				2022-12-18	WOS:000273660500007
J	James, LK; Durham, SR				James, Louisa K.; Durham, Stephen R.			Rhinitis with negative skin tests and absent serum allergen-specific IgE: More evidence for local IgE?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Rhinitis; IgE	EPSILON-HEAVY-CHAIN; NASAL-MUCOSA; IDIOPATHIC RHINITIS; NONATOPIC PATIENTS; GENE TRANSCRIPTS; EXPRESSION; RNA		[James, Louisa K.; Durham, Stephen R.] Univ London Imperial Coll Sci Technol & Med, NHLI, Sect Allergy & Clin Immunol, London SW3 6LY, England	Imperial College London	Durham, SR (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI, Sect Allergy & Clin Immunol, Dovehouse St, London SW3 6LY, England.	s.durham@imperial.ac.uk	James, Louisa/C-9831-2010	James, Louisa/0000-0002-2252-4636	Medical Research Council [G9805965] Funding Source: Medline; MRC [G9805965] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berger G, 1997, AM J RHINOL, V11, P63, DOI 10.2500/105065897781446775; Bousquet J, 2008, ALLERGY, V63, P842, DOI 10.1111/j.1398-9995.2008.01715.x; Carney AS, 2002, CLIN EXP ALLERGY, V32, P1436, DOI 10.1046/j.1365-2745.2002.01465.x; Durham SR, 1997, EUR J IMMUNOL, V27, P2899, DOI 10.1002/eji.1830271123; Fahy JV, 1999, AM J RESP CRIT CARE, V160, P1023, DOI 10.1164/ajrccm.160.3.9810012; Ghaffar O, 1998, AM J RESP CELL MOL, V18, P706, DOI 10.1165/ajrcmb.18.5.3030; HUGGINS KG, 1975, LANCET, V2, P618; Hunt J, 2008, J BIOL CHEM, V283, P29882, DOI 10.1074/jbc.M804742200; KleinJan A, 1997, J ALLERGY CLIN IMMUN, V99, P515, DOI 10.1016/S0091-6749(97)70079-4; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Powe DG, 2004, ALLERGY, V59, P204, DOI 10.1046/j.1398-9995.2003.00315.x; Powe DG, 2003, CLIN EXP ALLERGY, V33, P1374, DOI 10.1046/j.1365-2222.2003.01737.x; Powe DG, 2001, CLIN EXP ALLERGY, V31, P864, DOI 10.1046/j.1365-2222.2001.01106.x; Rondon C, 2008, ALLERGY, V63, P1352, DOI 10.1111/j.1398-9995.2008.01695.x; Rondon C, 2007, J ALLERGY CLIN IMMUN, V119, P899, DOI 10.1016/j.jaci.2007.01.006; Rondon C, 2009, J ALLERGY CLIN IMMUN, V124, P1005, DOI 10.1016/j.jaci.2009.07.018; Smurthwaite L, 2001, EUR J IMMUNOL, V31, P3422, DOI 10.1002/1521-4141(200112)31:12<3422::AID-IMMU3422>3.0.CO;2-T; Takhar P, 2005, J IMMUNOL, V174, P5024, DOI 10.4049/jimmunol.174.8.5024; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Wilson DR, 2002, AM J RESP CRIT CARE, V165, P22, DOI 10.1164/ajrccm.165.1.2010112; Ying S, 2001, J ALLERGY CLIN IMMUN, V107, P686, DOI 10.1067/mai.2001.114339	22	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2009	124	5					1012	1013		10.1016/j.jaci.2009.09.029	http://dx.doi.org/10.1016/j.jaci.2009.09.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	523XI	19895989				2022-12-18	WOS:000272108000021
J	Duroudier, NP; Strachan, DP; Blakey, JD; Hall, IP				Duroudier, Nathalie P.; Strachan, David P.; Blakey, John D.; Hall, Ian P.			Association of the cysteinyl leukotriene receptor 1 gene with atopy in the British 1958 birth cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopy; asthma; British 1958 birth cohort; cysteinyl leukotriene receptor 1; genetics; leukotriene receptor	REGULATORY POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; MOLECULAR-CLONING; INTOLERANT ASTHMA; CYSLTR1 GENE; IDENTIFICATION; NOMENCLATURE; POPULATIONS; EXPRESSION; CHILDHOOD	Background: Cysteinyl leukotrienes (CysLTs) play an important role in the pathophysiology of many allergic inflammatory disorders. However, data on the contribution of genetic variability of the cysteinyl leukotriene receptor 1 gene (CYSLTR1) in asthma and atopy remain conflicting. Objective: We investigated the association of polymorphisms of interest located at this locus and allergic disease prevalence in a national population with an established DNA archive, the British 1958 birth cohort. Methods: The British 1958 birth cohort comprises all persons born in Britain during 1 week in 1958. Asthma, wheezy bronchitis, and wheezing were ascertained by interview at ages 7, 11, 16, 23, 33, and 42 years. At age 44 to 45 years, serum total circulating IgE levels were measured and atopy was defined as a serum total IgE level of greater than 30 kU/L and specific IgE levels to 1 or more of dust mite, cat fur, and mixed grass of greater than 0.3 kU/L. DNA samples from 8018 participants were genotyped for 2 variants of the CYSLTR1 promoter (Xq13-Xq21). Results: The rare polymorphism C > T (rs7066737) was not associated with any of the phenotypes studied. The common promoter polymorphism A > G (rs2806489) was not associated with total IgE levels or the prevalence or age of onset of asthma, wheezy bronchitis, or wheeze. However, the wild-type allele A was significantly associated with atopy in female subjects (chi(2) = 8.30, P = .004), although not in male subjects (P = .841). Conclusions: These data suggest that a CYSLTR1 polymorphism previously shown to affect the gene transcription in vitro might influence the risk of atopy in the female white population with suggestive evidence of heterozygote vigor. (J Allergy Clin Immunol 2009;124:566-72.)	[Duroudier, Nathalie P.] Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2UH, England; [Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London, England	University of Nottingham; St Georges University London	Duroudier, NP (corresponding author), Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, D Floor,S Block, Nottingham NG7 2UH, England.	nathalie.duroudier@hotmail.fr		Hall, Ian/0000-0001-9933-3216	Asthma UK [05/055]; Medical Research Council [G0000934]; MRC [G0000934] Funding Source: UKRI	Asthma UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported in part by Asthma UK (grant 05/055). The 2002-2004 biomedical survey and the directly extracted DNA collection used here were funded by the Medical Research Council (grant G0000934).	Arriba-Mendez S, 2006, PEDIAT ALLERG IMM-UK, V17, P323, DOI 10.1111/j.1399-3038.2006.00416.x; BISGAARD H, 1985, BRIT MED J, V290, P1468, DOI 10.1136/bmj.290.6480.1468; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Buckland PR, 2006, BBA-MOL BASIS DIS, V1762, P17, DOI 10.1016/j.bbadis.2005.10.004; Butland BK, 2007, ANN ALLERG ASTHMA IM, V98, P337, DOI 10.1016/S1081-1206(10)60879-4; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; Denham S, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-38; Duroudier NP, 2007, CELL BIOCHEM BIOPHYS, V47, P119, DOI 10.1385/CBB:47:1:119; Gauderman W, QUANTO 1 1 COMPUTER; Hall IP, 2006, LANCET, V368, P771, DOI 10.1016/S0140-6736(06)69287-8; Hao L, 2006, CLIN EXP ALLERGY, V36, P735, DOI 10.1111/j.1365-2222.2006.02511.x; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hoogendoorn B, 2003, HUM MOL GENET, V12, P2249, DOI 10.1093/hmg/ddg246; Kim SH, 2007, J CLIN IMMUNOL, V27, P613, DOI 10.1007/s10875-007-9115-x; Kim SH, 2006, CLIN EXP ALLERGY, V36, P433, DOI 10.1111/j.1365-2222.2006.02457.x; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Laan M, 2005, EUR J HUM GENET, V13, P452, DOI 10.1038/sj.ejhg.5201340; Lee JK, 2002, BIOCHEM BIOPH RES CO, V295, P771, DOI 10.1016/S0006-291X(02)00679-4; Lipsick JS, 1996, ONCOGENE, V13, P223; Lynch KR, 1999, NATURE, V399, P789; Nicosia S, 2001, PULM PHARMACOL THER, V14, P3, DOI 10.1006/pupt.2000.0262; Nothacker HP, 2000, MOL PHARMACOL, V58, P1601, DOI 10.1124/mol.58.6.1601; Peters-Golden M, 2005, ANN ALLERG ASTHMA IM, V94, P609, DOI 10.1016/S1081-1206(10)61317-8; Postma DS, 2000, AM J RESP CRIT CARE, V162, pS118, DOI 10.1164/ajrccm.162.supplement_2.ras-13; SAMUELSSON B, 1979, PROSTAGLANDINS, V17, P785, DOI 10.1016/0090-6980(79)90052-2; Sanz C, 2006, J INVEST ALLERG CLIN, V16, P331; Sarau HM, 1999, MOL PHARMACOL, V56, P657, DOI 10.1124/mol.56.3.657; Shirasaki H, 2002, CLIN EXP ALLERGY, V32, P1007, DOI 10.1046/j.1365-2222.2002.01425.x; Strachan DP, 2007, INT J EPIDEMIOL, V36, P522, DOI 10.1093/ije/dyl309; Takasaki J, 2000, BIOCHEM BIOPH RES CO, V274, P316, DOI 10.1006/bbrc.2000.3140; Thompson MD, 2007, PHARMACOGENET GENOM, V17, P539, DOI 10.1097/FPC.0b013e328012d0bf; Woszczek G, 2005, J IMMUNOL, V175, P5152, DOI 10.4049/jimmunol.175.8.5152; Zhang J, 2006, PEDIAT ALLERG IMM-UK, V17, P242, DOI 10.1111/j.1399-3038.2005.00347.x; Zhao JH, 2004, BIOINFORMATICS, V20, P1325, DOI 10.1093/bioinformatics/bth071	36	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2009	124	3					566	U250		10.1016/j.jaci.2009.06.004	http://dx.doi.org/10.1016/j.jaci.2009.06.004			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	552TG	19733299				2022-12-18	WOS:000274315900024
J	Orihara, K; Morita, H; Yagami, A; Kajiwara, N; Nakae, S; Matsumoto, K; Nagasaki, H; Saito, Y; Saito, H; Matsuda, A				Orihara, Kanami; Morita, Hideaki; Yagami, Akiko; Kajiwara, Naoki; Nakae, Susumu; Matsumoto, Kenji; Nagasaki, Hiroshi; Saito, Yumiko; Saito, Hirohisa; Matsuda, Akio			T(H)2 cytokines potently induce an appetite-stimulating peptide, melanin-concentrating hormone, in human vascular endothelial cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA		[Orihara, Kanami; Morita, Hideaki; Yagami, Akiko; Kajiwara, Naoki; Nakae, Susumu; Matsumoto, Kenji; Saito, Hirohisa; Matsuda, Akio] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Morita, Hideaki] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Yagami, Akiko] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 47011, Japan; [Nakae, Susumu] Univ Tokyo, Frontier Res Initiat, Inst Med Sci, Tokyo 1138654, Japan; [Nagasaki, Hiroshi] Nagoya Univ, Sch Med, Dept Metab Med, Nagoya, Aichi 466, Japan; [Saito, Yumiko] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima, Japan	National Center for Child Health & Development - Japan; Keio University; Fujita Health University; University of Tokyo; Nagoya University; Hiroshima University	Orihara, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan.	amatsuda@nch.go.jp	Morita, Hideaki/ADL-2008-2022; Morita, Hideaki/S-2214-2016	Morita, Hideaki/0000-0003-0928-8322; Orihara, Kanami/0000-0002-2652-4529; Saito, Hirohisa/0000-0002-6630-8337	PHS HHS [ID05-24, ID05-41] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Barnes KC, 1999, J ALLERGY CLIN IMMUN, V104, P485, DOI 10.1016/S0091-6749(99)70398-2; Burdyga G, 2006, NEUROSCIENCE, V137, P1405, DOI 10.1016/j.neuroscience.2005.10.057; Kato Atsushi, 2003, BMC Immunol, V4, P8, DOI 10.1186/1471-2172-4-8; Matsuda A, 2008, AM J RESP CELL MOL, V38, P168, DOI 10.1165/rcmb.2007-0162OC; PEDEUTOUR F, 1994, GENOMICS, V19, P31, DOI 10.1006/geno.1994.1008; Saito Yumiko, 2008, V46, P159, DOI 10.1007/400_2007_052; Sandig H, 2007, P NATL ACAD SCI USA, V104, P12440, DOI 10.1073/pnas.0705457104; Waters SM, 2005, J CLIN ENDOCR METAB, V90, P6337, DOI 10.1210/jc.2005-1367; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455	9	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2009	124	3					612	U328		10.1016/j.jaci.2009.04.039	http://dx.doi.org/10.1016/j.jaci.2009.04.039			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	552TG	19541358				2022-12-18	WOS:000274315900036
J	Bin, LH; Howell, MD; Kim, BE; Hall, CF; Streib, JE; Leung, DYM				Bin, Lianghua; Howell, Michael D.; Kim, Byung Eui; Hall, Clifton F.; Streib, Joanne E.; Leung, Donald Y. M.			Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						S100A11; atopic dermatitis; vaccinia virus; IL-10 receptor; IFN-lambda; IL-29	INNATE IMMUNE-RESPONSE; ATOPIC-DERMATITIS SKIN; CYTOKINE MILIEU; VIRAL-INFECTION; HOST-DEFENSE; ST2; ASTHMA; INTERLEUKIN-22; DEFICIENCY; IL-22	Background: The mechanism that predisposes patients with atopic dermatitis (AD) to disseminated vaccinia viral (VV) skin infection after smallpox vaccination is unknown. We have demonstrated that expression of S100A11, a calcium-binding protein involved in keratinocyte differentiation, is downregulated in AD. Objective: We investigated whether inhibiting expression of S100A11 increased VV replication in human keratinocytes and the mechanism by which S100A11 affects the innate immune response of keratinocytes. Methods: Small interfering RNA duplexes were used to reduce gene expression of S100A11 in keratinocytes. VV replication was evaluated by real-time PCR and viral plaque assay. VV cytopathic effect was assessed by crystal violet staining. Affymetrix GeneChip assay was used to compare gene expression profiles. Real time PCR, Western blotting, and immunohistochemistry staining assay were used to evaluate gene expression in keratinocytes and AD skin biopsies. Results: Keratinocytes with deficient S100A11 expression supported increased VV replication and manifested augmented VV cytopathic effects. Gene microarray analysis revealed that the IL-10 receptor 2 chain (IL-10R2), which binds IFN-lambda s, was downregulated by 2.26-fold in S100A11-silenced keratinocytes. IL-10R2 expression was found to be decreased in skin biopsies from patients with acute AD (mean, 25.21 +/- 5.25; n = 20) compared with skin from normal healthy subjects (mean, 137.1 +/- 34.46; n = 19; P < .01). Furthermore, deficient S100A11 gene expression significantly impaired IL-29 (IFN-lambda 1) responsiveness (2'5'-oligoadenylate synthetase and Myxovirus [influenza virus] resistance induction) and its anti-VV effects in keratinocytes. Conclusions: Inhibition of S100A11 gene expression impairs the ability of keratinocytes to control VV replication via downregulation of IFN-lambda receptor IL-10R2. (J Allergy Clin Immunol 2009;124:270-7.)	[Bin, Lianghua; Howell, Michael D.; Kim, Byung Eui; Hall, Clifton F.; Streib, Joanne E.; Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Howell, Michael D.; Leung, Donald Y. M.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leung, DYM (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St,Room K926i, Denver, CO 80206 USA.	leungd@njhealth.org		Kim, Byung Eui/0000-0003-4923-1814	National Institutes of Health/National Institute of Allergy and Infectious Diseases [N01 At 40029, N01 AI40030, AR41256]; National Jewish Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041256] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Jewish Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases contracts N01 At 40029, N01 AI40030. and AR41256. Dr. Bin's salary was supported in part by The Eugene F. and Easton M. Crawford Pediatric Research Fellowship Fund at National Jewish Health.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; COLOTTA F, 1994, J BIOL CHEM, V269, P12403; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Dambacher J, 2008, CYTOKINE, V41, P209, DOI 10.1016/j.cyto.2007.11.016; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Hennings H, 1980, Curr Probl Dermatol, V10, P3; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Howell MD, 2006, J ALLERGY CLIN IMMUN, V117, P836, DOI 10.1016/j.jaci.2005.12.1345; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Howell MD, 2008, J INVEST DERMATOL, V128, P2248, DOI 10.1038/jid.2008.74; Kim BE, 2007, J ALLERGY CLIN IMMUN, V119, P457, DOI 10.1016/j.jaci.2006.10.005; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Martinez J, 2008, J IMMUNOL, V180, P1592, DOI 10.4049/jimmunol.180.3.1592; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sakaguchi M, 2003, J CELL BIOL, V163, P825, DOI 10.1083/jcb.200304017; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stanford MM, 2005, TRENDS IMMUNOL, V26, P339, DOI 10.1016/j.it.2005.04.001; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	37	10	13	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2009	124	2					270	277		10.1016/j.jaci.2009.05.002	http://dx.doi.org/10.1016/j.jaci.2009.05.002			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	482CD	19577285				2022-12-18	WOS:000268860400013
J	Apter, AJ; Casillas, AM				Apter, Andrea J.; Casillas, Adrian M.			Eliminating health disparities: What have we done and what do we do next?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Health disparities; asthma; workforce diversity	ASTHMA CARE; PHYSICIANS; ENGAGEMENT; CHILDREN		[Apter, Andrea J.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA; [Casillas, Adrian M.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Sect Allergy & Immunol, Shreveport, LA 71105 USA	University of Pennsylvania; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Apter, AJ (corresponding author), Hosp Univ Penn, 829 Gates Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	apter@mail.med.upenn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073932, K02HL088469] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL073932-03, R01 HL073932-04, K02 HL088469, HL088469, R01 HL073932, K02 HL088469-02, K02 HL088469-03, HL 073932] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander GC, 2008, HEALTH SERV RES, V43, P773, DOI 10.1111/j.1475-6773.2007.00780.x; Baker RB, 2008, JAMA-J AM MED ASSOC, V300, P306, DOI 10.1001/jama.300.3.306; BERKMAN LF, 2009, ANN REV PUBLIC HLTH; Bryant-Stephens T, 2009, J ALLERGY CLIN IMMUN, V123, P1199, DOI 10.1016/j.jaci.2009.04.030; Canino G, 2009, J ALLERGY CLIN IMMUN, V123, P1209, DOI 10.1016/j.jaci.2009.02.043; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Cohen SG, 2009, J ALLERGY CLIN IMMUN, V123, P265, DOI 10.1016/j.jaci.2008.07.038; Davis RM, 2008, JAMA-J AM MED ASSOC, V300, P323, DOI 10.1001/jama.300.3.323; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; GOLD DR, 1993, AM REV RESPIR DIS, V148, P10, DOI 10.1164/ajrccm/148.1.10; *I MED, 2003, UN TREATM CONFR RAC; Marmot MG, 2009, JAMA-J AM MED ASSOC, V301, P1169, DOI 10.1001/jama.2009.363; Obama Barack, 1995, DREAMS MY FATHER STO; Obama Barack., 2006, AUDACITY HOPE THOUGH; Rand CS, 2008, J ALLERGY CLIN IMMUN, V122, P319, DOI 10.1016/j.jaci.2008.07.004; Smedley BD, 2008, HEALTH AFFAIR, V27, P447, DOI 10.1377/hlthaff.27.2.447; Stingone JA, 2008, J ALLERGY CLIN IMMUN, V122, P748, DOI 10.1016/j.jaci.2008.08.001; Valet RS, 2009, J ALLERGY CLIN IMMUN, V123, P1220, DOI 10.1016/j.jaci.2008.12.1131; Vanderbilt SK, 2007, J NATL MED ASSOC, V99, P1315	19	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2009	123	6					1237	1239		10.1016/j.jaci.2009.04.028	http://dx.doi.org/10.1016/j.jaci.2009.04.028			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	455WO	19501231	Green Accepted			2022-12-18	WOS:000266799100011
J	Wagner, LA; Speckart, S; Cutter, B; Gleich, GJ				Wagner, Lori A.; Speckart, Stephen; Cutter, Bruce; Gleich, Gerald J.			Treatment of FIP1L1/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMATINIB		[Wagner, Lori A.; Gleich, Gerald J.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84112 USA; [Gleich, Gerald J.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Speckart, Stephen; Cutter, Bruce] Montana Oncol, Missoula, MT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Wagner, LA (corresponding author), Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84112 USA.	lori.wagner@hsc.utah.edu						Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Dumont F J, 2001, Curr Opin Investig Drugs, V2, P139; Elsner J, 1996, BLOOD, V88, P4684, DOI 10.1182/blood.V88.12.4684.bloodjournal88124684; Gleich GJ, 2002, LANCET, V359, P1577, DOI 10.1016/S0140-6736(02)08505-7; Klion AD, 2006, J ALLERGY CLIN IMMUN, V117, P1292, DOI 10.1016/j.jaci.2006.02.042; Pitini Vincenzo, 2004, Br J Haematol, V127, P477, DOI 10.1111/j.1365-2141.2004.05206.x; Rothenberg ME, 2008, NEW ENGL J MED, V358, P1215, DOI 10.1056/NEJMoa070812; Roufosse F, 2003, ANNU REV MED, V54, P169, DOI 10.1146/annurev.med.54.101601.152431; Sefcick A, 2004, BRIT J HAEMATOL, V124, P558, DOI 10.1046/j.1365-2141.2003.04801.x	9	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2009	123	6					1407	1408		10.1016/j.jaci.2009.01.069	http://dx.doi.org/10.1016/j.jaci.2009.01.069			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	455WO	19342084				2022-12-18	WOS:000266799100036
J	Bloom, KA; Huang, FR; Bencharitiwong, R; Nowak-Wegrzyn, A; Sampson, HA				Bloom, K. A.; Huang, F. R.; Bencharitiwong, R.; Nowak-Wegrzyn, A.; Sampson, H. A.			Effect of Heating on Cow's Milk and Differences in Immunoblot Reactivity to Incrementally Heated Milk Among Cow's Milk-Allergic Children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Bloom, K. A.; Huang, F. R.; Bencharitiwong, R.; Nowak-Wegrzyn, A.; Sampson, H. A.] Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai									0	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				696	S182	S182		10.1016/j.jaci.2008.12.688	http://dx.doi.org/10.1016/j.jaci.2008.12.688			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR		Bronze			2022-12-18	WOS:000263596301169
J	Burks, AW				Burks, A. Wesley			Early peanut consumption: Postpone or promote?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Peanut allergy; environmental exposure; oral consumption	TREE NUT ALLERGY; ANAPHYLACTIC REACTIONS; CHILDREN; PREVALENCE; FOOD; FATALITIES; FORMULAS; INFANTS; ECZEMA; ISRAEL		Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA	Duke University	Burks, AW (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA.	wesley.barks@duke.edu						Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Baker SS, 2000, PEDIATRICS, V106, P346; Bock SA, 2007, J ALLERGY CLIN IMMUN, V119, P1016, DOI 10.1016/j.jaci.2006.12.622; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; *COMM TOX, 1998, COT REP PEAN ALL; Dalal I, 2002, ALLERGY, V57, P362, DOI 10.1034/j.1398-9995.2002.1s3412.x; DUTOIT G, 2009, J ALLERGY C IN PRESS; Filipiak B, 2007, J PEDIATR-US, V151, P352, DOI 10.1016/j.jpeds.2007.05.018; Fox AT, 2009, J ALLERGY CLIN IMMUN, V123, P417, DOI 10.1016/j.jaci.2008.12.014; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Hourihane JO, 2007, J ALLERGY CLIN IMMUN, V119, P1197, DOI 10.1016/j.jaci.2006.12.670; *IMM TOL NETW, 2006, LEAP STUD; Kopper RA, 2005, INT ARCH ALLERGY IMM, V136, P16, DOI 10.1159/000082580; Levy Y, 2003, ALLERGY, V58, P1206, DOI 10.1046/j.1398-9995.2003.00307.x; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; Zutavern A, 2004, ARCH DIS CHILD, V89, P303, DOI 10.1136/adc.2002.025353	18	10	13	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2					424	425		10.1016/j.jaci.2008.12.015	http://dx.doi.org/10.1016/j.jaci.2008.12.015			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	409GU	19203661				2022-12-18	WOS:000263495000021
J	Boyle, RJ; Leonardi-Bee, J; Bath-Hextall, FJ; Tang, MLK				Boyle, Robert J.; Leonardi-Bee, Jo; Bath-Hextall, Fiona J.; Tang, Mimi L. K.			Probiotics for the treatment or prevention of eczema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ATOPIC-DERMATITIS		[Boyle, Robert J.] Imperial Coll, Dept Paediat Allergy, London, England; [Boyle, Robert J.; Tang, Mimi L. K.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bath-Hextall, Fiona J.] Univ Nottingham, Sch Nursing, Fac Med & Hlth Sci, Nottingham NG7 2RD, England; [Leonardi-Bee, Jo; Bath-Hextall, Fiona J.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Tang, Mimi L. K.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Imperial College London; Murdoch Children's Research Institute; University of Melbourne; University of Nottingham; University of Nottingham; University of Melbourne	Boyle, RJ (corresponding author), Imperial Coll, Dept Paediat Allergy, London, England.		Bath-Hextall, Fiona/B-8722-2008; Tang, Mimi/ABD-8350-2020	Tang, Mimi/0000-0002-3839-5293; Leonardi-Bee, Jo/0000-0003-0893-6068; Boyle, Robert/0000-0002-4913-7580; Bath-Hextall, Fiona/0000-0001-6583-029X	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BOYLE RJ, 2008, COCHRANE DA IN PRESS; Boyle RJ, 2006, AM J CLIN NUTR, V83, P1256, DOI 10.1093/ajcn/83.6.1256; Folster-Holst R, 2006, BRIT J DERMATOL, V155, P1256, DOI 10.1111/j.1365-2133.2006.07558.x; Hattori Kazuhiro, 2003, Arerugi, V52, P20; Lee J, 2008, J ALLERGY CLIN IMMUN, V121, P116, DOI 10.1016/j.jaci.2007.10.043; Passeron T, 2006, ALLERGY, V61, P431, DOI 10.1111/j.1398-9995.2005.00956.x; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10	7	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					266	267		10.1016/j.jaci.2008.07.042	http://dx.doi.org/10.1016/j.jaci.2008.07.042			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	399IP	18804270				2022-12-18	WOS:000262793900045
J	Clerisme-Beaty, E; Rand, CS				Clerisme-Beaty, Emmanuelle; Rand, Cynthia S.			The effect of obesity on asthma incidence: Moving past the epidemiologic evidence	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Obesity; asthma incidence; African American women	BODY-MASS INDEX; UNITED-STATES; RISK; ASSOCIATION; MEN; DISPARITIES; PREVALENCE; OVERWEIGHT; TRENDS		[Rand, Cynthia S.] Johns Hopkins Sch Med, JHAAC, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Rand, CS (corresponding author), Johns Hopkins Sch Med, JHAAC, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	crand@mail.jhmi.edu			NHLBI NIH HHS [HL072455] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072455] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Brisbon N, 2005, J ALLERGY CLIN IMMUN, V115, P1024, DOI 10.1016/j.jaci.2005.02.020; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P145; Chen Y, 2002, AM J EPIDEMIOL, V155, P191, DOI 10.1093/aje/155.3.191; Coogan PF, 2009, J ALLERGY CLIN IMMUN, V123, P89, DOI 10.1016/j.jaci.2008.09.040; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2004, EUR RESPIR J, V24, P740, DOI 10.1183/09031936.04.00088003; Ford ES, 2005, J ALLERGY CLIN IMMUN, V115, P897, DOI 10.1016/j.jaci.2004.11.050; Galuska D. A., 2008, Morbidity and Mortality Weekly Report, V57, P765; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Huovinen E, 2003, RESP MED, V97, P273, DOI 10.1053/rmed.2003.1419; Kopp HP, 2003, ARTERIOSCL THROM VAS, V23, P1042, DOI 10.1161/01.ATV.0000073313.16135.21; Litonjua AA, 2002, THORAX, V57, P581, DOI 10.1136/thorax.57.7.581; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Nystad W, 2004, AM J EPIDEMIOL, V160, P969, DOI 10.1093/aje/kwh303; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Romieu I, 2003, AM J EPIDEMIOL, V158, P165, DOI 10.1093/aje/kwg131; Sin DD, 2002, ARCH INTERN MED, V162, P1477, DOI 10.1001/archinte.162.13.1477; Strunk Robert C., 2002, Journal of Allergy and Clinical Immunology, V109, P229, DOI 10.1067/mai.2002.120950; Tantisira KG, 2003, THORAX, V58, P1036, DOI 10.1136/thorax.58.12.1036	22	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					96	97		10.1016/j.jaci.2008.11.003	http://dx.doi.org/10.1016/j.jaci.2008.11.003			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	399IP	19130929				2022-12-18	WOS:000262793900014
J	Vandenplas, O; Sohy, C; D'Alpaos, V; Nootens, C; Thimpont, J; Weigand, D; Scheurer, S				Vandenplas, Olivier; Sohy, Carine; D'Alpaos, Vinciane; Nootens, Carine; Thimpont, Joel; Weigand, Daniela; Scheurer, Stephan			Tomato-induced occupational asthma in a greenhouse worker	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGENIC POTENCY		[Vandenplas, Olivier; Sohy, Carine; D'Alpaos, Vinciane] Univ Catholique Louvain, Mont Godinne Hosp, Dept Chest Med, Yvoir, Belgium; [Nootens, Carine] Moliere Lonchamps Hosp, Allergol Unit, Brussels, Belgium; [Vandenplas, Olivier; Thimpont, Joel] Fonds Malad Profess, Brussels, Belgium; [Weigand, Daniela; Scheurer, Stephan] Paul Ehrlich Inst, Div Allergol, D-6070 Langen, Germany	Universite Catholique Louvain; Universite Catholique Louvain Hospital; Paul Ehrlich Institute	Vandenplas, O (corresponding author), Univ Catholique Louvain, Mont Godinne Hosp, Dept Chest Med, Yvoir, Belgium.	vandenplas@uclouvain.be	Scheurer, Stephan/A-6509-2019	Scheurer, Stephan/0000-0002-2859-562X				Larramendi CH, 2008, CLIN EXP ALLERGY, V38, P169, DOI 10.1111/j.1365-2222.2007.02865.x; Lorenz Y, 2006, J ALLERGY CLIN IMMUN, V118, P711, DOI 10.1016/j.jaci.2006.05.014; van Toorenenbergen AW, 2000, INT ARCH ALLERGY IMM, V122, P246, DOI 10.1159/000024405; Westphal S, 2003, EUR J BIOCHEM, V270, P1327, DOI 10.1046/j.1432-1033.2003.03503.x; Westphal S, 2004, ALLERGY, V59, P526, DOI 10.1046/j.1398-9995.2003.00413.x	5	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2008	122	6					1229	1231		10.1016/j.jaci.2008.07.035	http://dx.doi.org/10.1016/j.jaci.2008.07.035			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	383ZA	18790524				2022-12-18	WOS:000261711800028
J	Wallace, DV; Dykewicz, MS; Bernstein, DI; Bernstein, IL; Blessing-Moore, J; Cox, L; Khan, DA; Lang, DM; Nicklas, RA; Oppenheimer, J; Portnoy, JM; Randolph, CC; Schuller, D; Spector, SL; Tilles, SA; May, KR; Miller, TA; Druce, HM; Baroody, FM; Bernstein, JA; Craig, TJ; Georgitis, JW; Pawankar, R; Rachelefsky, GS; Settipane, RA; Skoner, DP; Stoloff, SW				Wallace, D., V; Dykewicz, M. S.; Bernstein, D., I; Bernstein, I. L.; Blessing-Moore, J.; Cox, L.; Khan, D. A.; Lang, D. M.; Nicklas, R. A.; Oppenheimer, J.; Portnoy, J. M.; Randolph, C. C.; Schuller, D.; Spector, S. L.; Tilles, S. A.; May, K. R.; Miller, T. A.; Druce, H. M.; Baroody, F. M.; Bernstein, J. A.; Craig, T. J.; Georgitis, J. W.; Pawankar, R.; Rachelefsky, G. S.; Settipane, R. A.; Skoner, D. P.; Stoloff, S. W.			The Diagnosis and Management of Rhinitis: An Updated Practice Parameter (vol 122, pg S1, 2008)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction													Cox, Linda/AAP-1697-2021	Cox, Linda/0000-0002-5258-6870				Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003	1	10	10	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2008	122	6					1237	1237						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	383ZA					2022-12-18	WOS:000261711800033
J	Cohen, SG				Cohen, Sheldon G.			Food allergens: Landmarks along a historic trail	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									NIAID, Natl Lib Med, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Library of Medicine (NLM)	Cohen, SG (corresponding author), NIAID, Natl Lib Med, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							BOWMAN K, 1931, ASTHMA HAY FEVER THE, P368; COCA AF, 1931, ASTHMA HAY FEVER THE, P93; COHEN SG, REPORTS AM ACAD ALLE; Donnally HH, 1930, J IMMUNOL, V19, P15; *GT PUTN SONS, 1931, HIPP ANC MED, pR20; JUDD W, 2002, PLANT SYSTEMATICS PH, P121; LAROCHE G, 1930, ALIMENTARY ANAPHYLAX; Schloss OM, 1912, AM J DIS CHILD, V3, P341; VAUGHAN WT, 1930, J ALLERGY, V1, P385	9	10	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2008	121	6					1521	1524		10.1016/j.jaci.2008.04.027	http://dx.doi.org/10.1016/j.jaci.2008.04.027			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	313WW	18539201				2022-12-18	WOS:000256771700040
J	Loza, MJ; Foster, S; Peters, SP; Penn, RB				Loza, Matthew J.; Foster, Susan; Peters, Stephen P.; Penn, Raymond B.			Interactive effects of steroids and beta-agonists on accumulation of type 2 T cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						human; T cells; beta-adrenergic receptor; beta-agonist; asthma; IL-13; glucocorticosteroid; steroid; IL-2	INHALED CORTICOSTEROIDS; ASTHMA EXACERBATIONS; PERSISTENT ASTHMA; SALMETEROL; INFLAMMATION; SALBUTAMOL; RESPONSES; TRIAL; METAANALYSIS; BUDESONIDE	Background: Airway inflammation associated with asthma has been reported to be either unaffected or slightly increased by inhaled beta-agonist monotherapy, and concerns regarding disease exacerbations with continuous long-acting beta-agonist monotherapy have prompted the recommendation of concomitant steroid treatment. Objectives: Using peripheral blood lymphocytes from asthmatic subjects, we aimed to determine (1) whether short- or long-acting beta-agonists increase IL-13-producing (IL-13(+)) or IFN-gamma-producing (IFN-gamma(+)) T-cell numbers and (2) the ability of the corticosteroid budesonide to reverse these effects. Methods: Peripheral blood lymphocytes from asthmatic subjects were cultured 6 days ex vivo with IL-2 and various concentrations of albuterol, formoterol, and budesonide. Numbers of IL-13(+) and IFN-gamma(+) T cells were determined by means of flow cytometric analysis. Results: Both albuterol and formoterol increased IL-2-stimulated accumulation of IL-13(+) T cells, and this increase was highest at concentrations approximating the dissociation constant of each beta-agonist for the beta(2)-adrenergic receptor. Budesonide at greater than 1 nmol/L reversed the augmenting effects of beta-agonists on IL-13(+) T-cell accumulation, and budesonide at greater than 10 nmol/L inhibited increases in IL-13(+) T cells stimulated by IL-2. Budesonide decreased, whereas beta-agonist did not affect, numbers of total and IFN-gamma(+) T cells in IL-2-stimulated cultures. Conclusion: beta-Agonists at physiologically and clinically relevant concentrations stimulate increased antigen-independent, cytokine-stimulated accumulation, specifically of type 2 T cells from asthmatic subjects. The corticosteroid budesonide potently reverses this effect.	[Loza, Matthew J.; Foster, Susan; Peters, Stephen P.; Penn, Raymond B.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Dept Internal Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	Penn, RB (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	rpenn@wfubmc.edu		Loza, Matthew/0000-0002-8609-118X				Aldridge RE, 2000, AM J RESP CRIT CARE, V161, P1459, DOI 10.1164/ajrccm.161.5.9906052; BAMES PJ, 1999, J ALLERGY CLIN IMMUN, V104, P10; Billington CK, 2003, RESP RES, V4; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Deykin A, 2007, AM J RESP CRIT CARE, V175, P228, DOI 10.1164/rccm.200601-112OC; GARDINER PV, 1994, AM J RESP CRIT CARE, V150, P1006, DOI 10.1164/ajrccm.150.4.7921429; Gauvreau GM, 1997, AM J RESP CRIT CARE, V156, P1738, DOI 10.1164/ajrccm.156.6.96-08042; Gordon JR, 2003, EUR RESPIR J, V22, P118, DOI 10.1183/09031936.03.00031102; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Holtzman MJ, 2002, PHYSIOL REV, V82, P19, DOI 10.1152/physrev.00020.2001; Jackson CM, 2004, DRUG SAFETY, V27, P243, DOI 10.2165/00002018-200427040-00003; Kraft M, 2003, CHEST, V124, P42, DOI 10.1378/chest.124.1.42; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lester LA, 2001, J ALLERGY CLIN IMMUN, V108, P357, DOI 10.1067/mai.2001.117796; Loza M, 2003, MOL BIOTECHNOL, V23, P245, DOI 10.1385/MB:23:3:245; Loza MJ, 2007, J ALLERGY CLIN IMMUN, V119, P235, DOI 10.1016/j.jaci.2006.09.019; Loza MJ, 2005, CLIN EXP ALLERGY, V35, P8, DOI 10.1111/j.1365-2222.2004.02148.x; Loza MJ, 2003, EUR J IMMUNOL, V33, P939, DOI 10.1002/eji.200323643; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; Loza MJ, 2006, BLOOD, V107, P2052, DOI 10.1182/blood-2005-08-3265; MANOLITSAS ND, 1995, AM J RESP CRIT CARE, V151, P1925, DOI 10.1164/ajrccm.151.6.7767541; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Perussia Bice, 2005, Methods Mol Med, V107, P147; Remington TL, 2005, CURR OPIN PULM MED, V11, P74, DOI 10.1097/01.mcp.0000146784.56834.ff; Roberts JA, 1999, EUR RESPIR J, V14, P275, DOI 10.1034/j.1399-3003.1999.14b07.x; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SHAVER JR, 1995, AM J RESP CRIT CARE, V152, P1189, DOI 10.1164/ajrccm.152.4.7551369; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Stelmach I, 2002, CLIN EXP ALLERGY, V32, P264, DOI 10.1046/j.1365-2222.2002.01286.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Swystun VA, 2000, J ALLERGY CLIN IMMUN, V106, P57; Tattersfield AE, 2006, CLIN REV ALLERG IMMU, V31, P107, DOI 10.1385/CRIAI:31:2:107; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Taylor DR, 1998, THORAX, V53, P744, DOI 10.1136/thx.53.9.744; Turner M O, 1998, Can Respir J, V5, P261	38	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3					750	755		10.1016/j.jaci.2007.10.036	http://dx.doi.org/10.1016/j.jaci.2007.10.036			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR		Bronze			2022-12-18	WOS:000253918900033
J	Bluth, MH; Fu, SL; Fu, A; Stanek, A; Smith-Norowitz, TA; Wallner, SR; Gross, RA; Nowakowski, M; Zenilman, ME				Bluth, M. H.; Fu, S. L.; Fu, A.; Stanek, A.; Smith-Norowitz, T. A.; Wallner, S. R.; Gross, R. A.; Nowakowski, M.; Zenilman, M. E.			Sophorolipids decrease asthma severity and ova-specific IgE production in a mouse asthma model	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Bluth, M. H.; Fu, S. L.; Fu, A.; Stanek, A.; Smith-Norowitz, T. A.; Nowakowski, M.; Zenilman, M. E.] SUNY Downstate Med Ctr, Brooklyn, NY USA; [Wallner, S. R.; Gross, R. A.] Polytech Univ, Brooklyn, NY 11201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University; Polytechnic University Puerto Rico									0	10	10	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		6	S2	S2		10.1016/j.jaci.2007.12.011	http://dx.doi.org/10.1016/j.jaci.2007.12.011			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ		Bronze			2022-12-18	WOS:000253426400007
J	Bufe, A; Eberle, P; Franke-Beckmann, E; Funck, J; Klimek, L; Stephan, V; Weisshaar, C; Tholstrup, B				Bufe, A.; Eberle, P.; Franke-Beckmann, E.; Funck, J.; Klimek, L.; Stephan, V.; Weisshaar, C.; Tholstrup, B.			Phase III trial with grass allergen tablet for sublingual immunotherapy in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Bufe, A.] Ruhr Univ Bochum, Bochum, Germany; [Klimek, L.] Zentrum Rhinol Allergol, Wiesbaden, Germany; [Stephan, V.] Klin Kinder & Jugendmed, Bochum, Germany; [Tholstrup, B.] ALK Abello, Horsholm, Denmark	Ruhr University Bochum; Ruhr University Bochum; ALK-Abello AS									0	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		492	S127	S127		10.1016/j.jaci.2007.12.507	http://dx.doi.org/10.1016/j.jaci.2007.12.507			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ		Bronze			2022-12-18	WOS:000253426400493
J	Koterba, AP; Akin, C				Koterba, A. P.; Akin, C.			Differences in the clinical presentation of anaphylaxis in patients with indolent systemic mastocytosis (ISM) versus idiopathic anaphylaxis (IA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Koterba, A. P.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Akin, C.] Univ Michigan, Dept Med, Div Allergy & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan									0	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		263	S68	S69		10.1016/j.jaci.2007.12.273	http://dx.doi.org/10.1016/j.jaci.2007.12.273			2	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400264
J	Greenberger, PA; Ballow, M; Casale, TB; Platts-Mills, TAE; Sampson, HA				Greenberger, Paul A.; Ballow, Mark; Casale, Thomas B.; Platts-Mills, Thomas A. E.; Sampson, Hugh A.			Sublingual immunotherapy and subcutaneous immunotherapy: Issues in the United States	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RANDOMIZED CONTROLLED-TRIAL; HOUSE-DUST MITE; ALLERGIC RHINITIS		[Greenberger, Paul A.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA; [Ballow, Mark] SUNY Buffalo, Dept Pediat, Div Allergy Immunol, Buffalo, NY USA; [Ballow, Mark] Womens & Childrens Hosp, Buffalo, NY USA; [Casale, Thomas B.] Creighton Univ, Dept Med, Omaha, NE 68178 USA; [Platts-Mills, Thomas A. E.] Univ VA Med Ctr, Asthma & Allergy Dis Ctr, Dept Med, Div Allergy Immunol, Charlottesville, VA USA; [Sampson, Hugh A.] Mt Sinai Sch Med, Jaffe Food Allergy Inst, New York, NY USA	Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo; Creighton University; Icahn School of Medicine at Mount Sinai	Greenberger, PA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA.	p-greenberger@northwestem.edu	Greenberger, Paul/L-2770-2019; Casale, Thomas B/K-4334-2013	Greenberger, Paul/0000-0003-3882-8498; Casale, Thomas B/0000-0002-3149-7377; Platts-Mills, Thomas/0000-0002-1263-329X				*AM MED ASS, 2007, CURR PROC TERM CPT, P402; Bousquet J, 2006, ALLERGY, V61, P5, DOI 10.1111/j.1398-9995.2006.01183.x; Canonica GW, 2006, ALLERGY, V61, P20, DOI 10.1111/j.1398-9995.2006.01161.x; Cox LS, 2006, J ALLERGY CLIN IMMUN, V117, P1021, DOI 10.1016/j.jaci.2006.02.040; Di Rienzo V, 2003, CLIN EXP ALLERGY, V33, P206, DOI 10.1046/j.1365-2222.2003.01587.x; Dunsky EH, 2006, ALLERGY, V61, P1235, DOI 10.1111/j.1398-9995.2006.01137.x; Durham SR, 2006, J ALLERGY CLIN IMMUN, V117, P802, DOI 10.1016/j.jaci.2005.12.1358; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; EIGAN AO, 2007, ALLERGY, V62, P567; Li JT, 2003, ANN ALLERG ASTHMA IM, V90, P1, DOI 10.1016/S1081-1206(10)63600-9; Mallik MAB, 2001, ALLELOPATHY J, V8, P1; Marogna M, 2005, J ALLERGY CLIN IMMUN, V115, P1184, DOI 10.1016/j.jaci.2005.02.031; NELSON HS, 1993, J ALLERGY CLIN IMMUN, V92, P380, DOI 10.1016/0091-6749(93)90116-W; SCADDING GK, 1986, CLIN ALLERGY, V16, P483, DOI 10.1111/j.1365-2222.1986.tb01983.x; Smith H, 2004, J ALLERGY CLIN IMMUN, V114, P831, DOI 10.1016/j.jaci.2004.06.058	15	10	12	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2007	120	6					1466	1468		10.1016/j.jaci.2007.08.055	http://dx.doi.org/10.1016/j.jaci.2007.08.055			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241JX	17936891				2022-12-18	WOS:000251653800035
J	Chinen, J; Anmuth, D; Franklin, ARK; Shearer, WT				Chinen, Javier; Anmuth, David; Franklin, Anna R. K.; Shearer, William T.			Long-term follow-up of patients with primary immunodeficiencies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						primary immunodeficiency; Wiskott-Aldrich syndrome; B-cell lymphoma		As an example of the need for long-term follow-up by specialty health care to adequately manage immunodeficient patients, we report the case of a patient with Wiskott-Aldrich syndrome who was lost to follow-up for 4 years to the immunology clinic and came back with a neck mass that was diagnosed as B-cell lymphoma. Patients with immunodeficiency are at high risk for the development of malignancy and autoimmune diseases and should be evaluated by a trained specialist with a frequency of not less than every 6 months.	Texas Childrens Hosp, Baylor Coll Med, Allergy & Immunol Sect, Dept Pediat, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Childrens Canc Hosp, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Chinen, J (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Allergy & Immunol Sect, Dept Pediat, 1102 Bates St, Houston, TX 77030 USA.	jxchinen@texaschildrenshospital.org	Franklin, Anna/AAI-2830-2021	Shearer, William/0000-0002-2483-2130	NCRR NIH HHS [RR0188] Funding Source: Medline; NHLBI NIH HHS [HL72705] Funding Source: Medline; NIAID NIH HHS [AI275551, AI36211, AI69441] Funding Source: Medline; NICHD NIH HHS [HD079533, HD41983, HD78522] Funding Source: Medline; PHS HHS [RAT003084A] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041983] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069441, P30AI036211] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ballow M, 2002, J ALLERGY CLIN IMMUN, V109, P581, DOI 10.1067/mai.2002.122466; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Jawad AF, 2001, J PEDIATR-US, V139, P715, DOI 10.1067/mpd.2001.118534; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005	4	10	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					795	797		10.1016/j.jaci.2007.07.044	http://dx.doi.org/10.1016/j.jaci.2007.07.044			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	220LH	17854877				2022-12-18	WOS:000250157700011
J	Kino, T; Boos, TL; Sulima, A; Siegel, EM; Gold, PW; Rice, KC; Chrousos, GP				Kino, Tomoshige; Boos, Terrence L.; Sulima, Agnieszka; Siegel, Elise M.; Gold, Philip W.; Rice, Kenner C.; Chrousos, George P.			3-O-Formyl-20R,21-epoxyresibufogenin suppresses IL-6-type cytokine actions by targeting the glycoprotein 130 subunit: Potential clinical implications	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IL-6 receptor; glycoprotein 130; hepatic acute phase proteins; signal transducer and activator of transcription 3	LEUKEMIA INHIBITORY FACTOR; ACUTE-PHASE RESPONSE; TRANSCRIPTIONAL ACTIVITY; GLUCOCORTICOID-RECEPTOR; NONPEPTIDE ANTAGONIST; TRANSDUCING RECEPTOR; AUTOIMMUNE-DISEASE; IL-6 RECEPTOR; INTERLEUKIN-6; GP130	Background: The multifunctional inflammatory cytokine IL-6 regulates the acute phase reaction and plays central roles in the pathogenesis of chronic inflammatory disorders. Objectives: Two small chemical compounds, 3-O-formyl-20R,21-epoxyresibufogenin (TB-2-081) and 3-O-formyl-20S, 21-epoxyresibufogenin (TB-2-082), known isolates from the Chinese toad skin extract drug Ch'an So, were synthesized and tested on the IL-6-induced hepatic acute-phase reaction. Methods: HepG2 cells or rat primary hepatocytes were incubated with the compounds, and the effects on IL-6-induced expression of acute-phase molecules were tested. Results: TB-2-081, and to a lesser extent TB-2-082, suppressed IL-6-induced oil-antichymotrypsin (AACT) mRNA expression in HepG2 cells, whereas TB-2-081 failed to influence the mRNA expression of the TNF-alpha-induced mRNA expression of the methionine adenosyltransferase 2A gene in these cells. TB-2-081 suppressed IL-6-induced mRNA expression of alpha 1-acid glycoprotein, alpha 2-macroglobulin, and beta-fibrinogen in and secretion of the C-reactive protein by rat primary hepatocytes. TB-2-081 shifted the IL-6 dose-response curve of the AACT mRNA expression right and downward and inhibited IL-6-induced phosphorylation of signal transducer and activator of transcription 3. In addition to IL-6, TB-2-081 inhibited IL-11-stimulated and oncostatin M-stimulated AACT mRNA expression independently of the IL-6 receptor subunit. The soluble glycoprotein 130, but not the soluble IL-6 receptor, antagonized TB-2-081-induced suppression of IL-6-stimulated AACT mRNA expression. Conclusion: TB-2-081 inhibits IL-6-type cytokine action by attenuating the function of the common receptor subunit glycoprotein 130. Clinical implications: This class of compounds may be beneficial for the treatment of diseases in which excessive circulation/production/action of IL-6-type cytokines play pathologic roles.	NICHHD, NIH, Reprod Biol & Med Branch, Clin Res Ctr,Pediat Endocrinol Sect, Bethesda, MD 20892 USA; NIDA, Chem Biol Res Branch, Bethesda, MD USA; NIMH, NIH, Clin Neuroendocrinol Branch, Bethesda, MD USA; Univ Athens, Dept Pediat 1, GR-10679 Athens, Greece	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National & Kapodistrian University of Athens	Kino, T (corresponding author), NICHHD, NIH, Reprod Biol & Med Branch, Clin Res Ctr,Pediat Endocrinol Sect, Bldg 10,Rm 1-3140,10 Ctr Dr MSC 1109, Bethesda, MD 20892 USA.	kinot@inaii.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000615] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002659, ZIAMH002659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000520] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akabane H, 2004, BIOL PHARM BULL, V27, P1218, DOI 10.1248/bpb.27.1218; Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; BAUMANN H, 1988, J BIOL CHEM, V263, P17390; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Enomoto A, 2004, J NAT PROD, V67, P2070, DOI 10.1021/np049950e; Enomoto A, 2004, BIOCHEM BIOPH RES CO, V323, P1096, DOI 10.1016/j.bbrc.2004.08.196; Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127; Haraoui B, 2005, J RHEUMATOL, V32, P46; Hayashi M, 2002, P NATL ACAD SCI USA, V99, P14728, DOI 10.1073/pnas.232562799; Hayashi M, 2002, J PHARMACOL EXP THER, V303, P104, DOI 10.1124/jpet.102.036137; Heim MH, 1996, EUR J CLIN INVEST, V26, P1, DOI 10.1046/j.1365-2362.1996.103248.x; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Horton AR, 1996, PERSPECT DEV NEUROBI, V4, P35; Ichijo T, 2005, J BIOL CHEM, V280, P42067, DOI 10.1074/jbc.M509338200; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Kamano Y, 2002, J NAT PROD, V65, P1001, DOI 10.1021/np0200360; Kimber SJ, 2005, REPRODUCTION, V130, P131, DOI 10.1530/rep.1.00304; Kino T, 2007, EUR J CLIN INVEST, V37, P425, DOI 10.1111/j.1365-2362.2007.01796.x; Kino T, 2005, J CELL BIOL, V169, P885, DOI 10.1083/jcb.200409150; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Latchman DS, 2000, PHARMACOL THERAPEUT, V85, P29, DOI 10.1016/S0163-7258(99)00049-2; Manolagas SC, 1998, ANN NY ACAD SCI, V840, P194, DOI 10.1111/j.1749-6632.1998.tb09563.x; McClung Michael R, 2006, Curr Osteoporos Rep, V4, P28, DOI 10.1007/s11914-006-0012-7; Mihara M, 2005, EXPERT OPIN BIOL TH, V5, P683, DOI 10.1517/14712598.5.5.683; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Nishimoto N, 2004, CURR OPIN PHARMACOL, V4, P386, DOI 10.1016/j.coph.2004.03.005; Nishimoto N, 2006, CURR OPIN RHEUMATOL, V18, P277, DOI 10.1097/01.bor.0000218949.19860.d1; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; SAITO T, 1991, J IMMUNOL, V147, P168; Sobota R, 2000, BIOCHEM BIOPH RES CO, V267, P329, DOI 10.1006/bbrc.1999.1948; Spronk Henri Mh, 2004, Thromb J, V2, P12, DOI 10.1186/1477-9560-2-12; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Yang HP, 2003, J BIOL CHEM, V278, P50887, DOI 10.1074/jbc.M307600200; Yang ZH, 2005, MOL IMMUNOL, V42, P1015, DOI 10.1016/j.molimm.2004.09.033	35	10	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2007	120	2					437	444		10.1016/j.jaci.2007.03.018	http://dx.doi.org/10.1016/j.jaci.2007.03.018			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	198VF	17451794				2022-12-18	WOS:000248654900033
J	Gaber, F; James, A; Delin, I; Wetterholm, A; Sampson, AP; Dahlen, B; Dahlen, SE; Kumlin, M				Gaber, Flora; James, Anna; Delin, Ingrid; Wetterholm, Anders; Sampson, Anthony P.; Dahlen, Barbro; Dahlen, Sven-Erik; Kumlin, Maria			Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B-4 in saliva: Effects of treatment with zileuton	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Karolinska Univ Hosp Huddinge, Dept Med Biochem & Biophys, Div Chem 2, Stockholm, Sweden; Karolinska Univ Hosp Huddinge, Dept Med, Div Resp Med & Allergy, Stockholm, Sweden; Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; Univ Southampton, Div Infect Inflammat & Repair, Sch Med, Southampton, Hants, England	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Southampton		Flora.Gaber@ki.se	James, Anna/AAY-9937-2021; Sampson, Anthony/C-1112-2011	Delin, Ingrid/0000-0003-3716-4589				Chu SJ, 2000, J IMMUNOL, V165, P4640, DOI 10.4049/jimmunol.165.8.4640; Dahlen SE, 2006, EUR J PHARMACOL, V533, P40, DOI 10.1016/j.ejphar.2005.12.070; Gyllfors P, 2005, THORAX, V60, P902, DOI 10.1136/thx.2005.041913; HUGHES H, 1989, ANAL BIOCHEM, V179, P304, DOI 10.1016/0003-2697(89)90133-4; HUI KP, 1991, THORAX, V46, P184, DOI 10.1136/thx.46.3.184; MALONE JP, 1994, ORAL SURG ORAL MED O, V77, P636, DOI 10.1016/0030-4220(94)90326-3; Mozalevsky A. F., 1997, Ukrainskii Biokhimicheskii Zhurnal, V69, P162; Rudberg PC, 2002, J BIOL CHEM, V277, P1398, DOI 10.1074/jbc.M106577200; Serio KJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1329, DOI 10.1152/ajpcell.1997.272.4.C1329	9	10	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2007	119	5					1267	1268		10.1016/j.jaci.2006.12.650	http://dx.doi.org/10.1016/j.jaci.2006.12.650			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	167CB	17258303				2022-12-18	WOS:000246427200031
J	Durham, SR				Durham, Stephen R.			Tradition and innovation: Finding the right balance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						allergen immunotherapy; subcutaneous; sublingual; peptide; recombinant allergens; T-regulatory cells	GRASS ALLERGEN TABLETS; SUBLINGUAL IMMUNOTHERAPY; CONTROLLED-TRIAL; CELLS; SENSITIZATIONS; PREVENTION; SYMPTOMS; EFFICACY; EXTRACT; VACCINE		Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, MRC, London SW3 6LY, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Asthma UK Ctr Allerg Mech Asthma, Allergy & Clin Immunol Sect, London SW3 6LY, England; Royal Brompton Hosp, London, England	Imperial College London; Imperial College London; University of London; King's College London; Royal Brompton Hospital	Durham, SR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, MRC, Dovehouse St, London SW3 6LY, England.	s.durham@imperial.ac.uk			MRC [G9805965] Funding Source: UKRI; Medical Research Council [G9805965] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramson MJ, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001186; Adkinson NF, 1997, NEW ENGL J MED, V336, P324, DOI 10.1056/NEJM199701303360502; Akdis M, 2007, J ALLERGY CLIN IMMUN, V119, P780, DOI 10.1016/j.jaci.2007.01.022; Calderon MA, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001936.PUB2; Canonica GW, 2003, J ALLERGY CLIN IMMUN, V111, P437, DOI 10.1067/mai.2003.129; Casale TB, 2006, J ALLERGY CLIN IMMUN, V117, P134, DOI 10.1016/j.jaci.2005.09.036; Cox LS, 2006, J ALLERGY CLIN IMMUN, V117, P1021, DOI 10.1016/j.jaci.2006.02.040; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P450, DOI 10.1016/S0091-6749(97)70069-1; Drachenberg KJ, 2001, ALLERGY, V56, P498, DOI 10.1034/j.1398-9995.2001.056006498.x; Durham SR, 2006, J ALLERGY CLIN IMMUN, V117, P802, DOI 10.1016/j.jaci.2005.12.1358; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; Francis JN, 2004, CURR OPIN ALLERGY CL, V4, P543, DOI 10.1097/00130832-200412000-00012; Francis JN, 2003, J ALLERGY CLIN IMMUN, V111, P1255, DOI 10.1067/mai.2003.1570; FRANKLAND AW, 1954, LANCET, V1, P1055; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Klimek L, 1999, CLIN EXP ALLERGY, V29, P1326; Larche M, 2007, J ALLERGY CLIN IMMUN, V119, P906, DOI 10.1016/j.jaci.2007.02.015; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; LOWELL FC, 1965, NEW ENGL J MED, V273, P675, DOI 10.1056/NEJM196509232731302; Macaubas C, 2006, J IMMUNOL, V176, P5069, DOI 10.4049/jimmunol.176.8.5069; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Nelson HS, 2007, J ALLERGY CLIN IMMUN, V119, P769, DOI 10.1016/j.jaci.2007.01.036; Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101; Noon L, 1911, LANCET, V1, P1572; Norman PS, 1996, AM J RESP CRIT CARE, V154, P1623, DOI 10.1164/ajrccm.154.6.8970345; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; Pajno GB, 2001, CLIN EXP ALLERGY, V31, P1392, DOI 10.1046/j.1365-2222.2001.01161.x; Pajno GB, 2007, J ALLERGY CLIN IMMUN, V119, P796, DOI 10.1016/j.jaci.2007.01.009; Purello-D'Ambrosio F, 2001, CLIN EXP ALLERGY, V31, P1295, DOI 10.1046/j.1365-2222.2001.01027.x; Ree R, 2004, ALLERGY, V59, P571, DOI 10.1111/j.1398-9995.2004.00499.x; Robinson DS, 2004, J CLIN INVEST, V114, P1389, DOI 10.1172/JCI200423595; Till SJ, 2004, J ALLERGY CLIN IMMUN, V113, P1025, DOI 10.1016/j.jaci.2004.03.024; Valenta R, 2007, J ALLERGY CLIN IMMUN, V119, P826, DOI 10.1016/j.jaci.2007.01.025; Verhoef A, 2005, PLOS MED, V2, P253, DOI 10.1371/journal.pmed.0020078; Wachholz PA, 2003, J ALLERGY CLIN IMMUN, V112, P915, DOI 10.1016/S0091-6749(03)02022-0; *WHO, 1998, ALLERGY, V53, P44; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x	44	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2007	119	4					792	795		10.1016/j.jaci.2007.02.034	http://dx.doi.org/10.1016/j.jaci.2007.02.034			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	157OK	17418659				2022-12-18	WOS:000245729500003
J	Chaplin, DD; Zindl, CL; Duffy, LB; Atkinson, TP; Lai, J				Chaplin, D. D.; Zindl, C. L.; Duffy, L. B.; Atkinson, T. P.; Lai, J.			Clearance of Mycoplasma pneumoniae is impaired in mice with established allergic airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Chaplin, D. D.; Zindl, C. L.; Duffy, L. B.; Atkinson, T. P.; Lai, J.] Univ Alabama, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham									0	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		522	S132	S132		10.1016/j.jaci.2006.11.647	http://dx.doi.org/10.1016/j.jaci.2006.11.647			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400521
J	Cac, NN; Ballas, ZK				Cac, Natalie N.; Ballas, Zuhair K.			Recalcitrant warts, associated with natural killer cell dysfunction, treated with systemic IFN-alpha	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NK-CELL; INFECTION		Univ Iowa Hosp & Clin, Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa Hosp & Clin, Div Allergy Immunol, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Iowa City VA Med Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Cac, NN (corresponding author), Univ Iowa Hosp & Clin, Carver Coll Med, Iowa City, IA 52242 USA.			Knaack, Aaron/0000-0001-7712-1415; Ballas, Zuhair/0000-0001-5569-1230				BALLAS ZK, 1990, J ALLERGY CLIN IMMUN, V85, P453, DOI 10.1016/0091-6749(90)90155-W; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Heusel JW, 2003, CURR OPIN PEDIATR, V15, P586, DOI 10.1097/00008480-200312000-00008; MALEJCZYK J, 1993, INT J CANCER, V54, P917, DOI 10.1002/ijc.2910540608; Masterson BJ, 1996, J REPROD MED, V41, P562; Mossman KL, 2005, VIRAL IMMUNOL, V18, P267, DOI 10.1089/vim.2005.18.267; Orange JS, 2006, CLIN IMMUNOL, V118, P1, DOI 10.1016/j.clim.2005.10.011; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2	10	10	10	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2006	118	2					526	528		10.1016/j.jaci.2006.04.023	http://dx.doi.org/10.1016/j.jaci.2006.04.023			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	075IH	16890785				2022-12-18	WOS:000239877700036
J	Chinen, J; Finkelman, F; Shearer, WT				Chinen, Javier; Finkelman, Fred; Shearer, William T.			Advances in basic and clinical immunology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						immunology; immunodeficiency; innate immunity; regulatory T cell; astilbin; epigallocatechin; transmembrane activator and calcium modulator and cyclophilin ligand interactor; abacavir; HIV; severe combined immunodeficiency	COMMON VARIABLE IMMUNODEFICIENCY; T-REGULATORY-CELLS; HIV-INFECTED CHILDREN; DENDRITIC CELLS; IMMUNE-RESPONSES; NUCLEAR-FACTOR; B-CELLS; RECEPTOR; DISEASE; KINASE	This review comments on basic and clinical immunology articles that were published in 2005, with a focus on those that appeared in the Journal of Allergy and Clinical Immunology. In the area of basic immunology, mechanisms of the innate immune system and its interaction with the adaptive immune system were described, with special consideration to applications in biodefense strategies. T regulatory cells were further characterized in their role for the control of allergic, autoimmune, and neoplastic disorders. The function of the thymus Hassall's corpuscles was reported to be the generation of T regulatory cells. Flavonoid molecules obtained from medicinal herbs, including astilbin and epigallocatechin gallate, were discovered to have immunomodulatory properties. Advances in clinical immunology resulted from efforts to develop a newborn screening test for severe combined immunodeficiency and the elucidation of the crystal structure of the IL-2 receptor 7 chain. Mutations in the membrane receptor transmembrane activator and calcium modulator and cyclophilin ligand interactor were found in patients with common variable immunodeficiency. New therapeutic options are described, such as the use of infliximab for granulomas and GM-CSF for chronic ulcers in patients with common variable immunodeficiency. The importance of mucosal immunity in acute HIV infection is cited, as is the role of CD8(+) T-cell activation in HIV disease progression in children.	Baylor Coll Med, Dept Pediat, Allergy & Immunol Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Univ Cincinnati, Coll Med, Dept Med, Childrens Hosp,Med Ctr, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Dept Pediat, Childrens Hosp,Med Ctr, Cincinnati, OH USA; Cincinnati Vet Author Med Ctr, Cincinnati, OH USA; Texas Childrens Hosp, Dept Allergy & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Baylor College of Medicine	Chinen, J (corresponding author), Baylor Coll Med, Dept Pediat, Allergy & Immunol Sect, 6621 Fannin St MC,FC330, Houston, TX 77030 USA.	jchinen@bcm.edu		Shearer, William/0000-0002-2483-2130				Akdis M, 2005, J ALLERGY CLIN IMMUN, V116, P961, DOI 10.1016/j.jaci.2005.09.004; Amlie-Lefond C, 2005, J ALLERGY CLIN IMMUN, V116, P1334, DOI 10.1016/j.jaci.2005.08.048; Boasen J, 2005, J ALLERGY CLIN IMMUN, V116, P185, DOI 10.1016/j.jaci.2005.03.015; Bonilla FA, 2005, J ALLERGY CLIN IMMUN, V116, P423, DOI 10.1016/j.jaci.2005.05.026; Bossuyt X, 2005, J ALLERGY CLIN IMMUN, V115, P872, DOI 10.1016/j.jaci.2005.01.039; Carsetti R, 2005, J ALLERGY CLIN IMMUN, V115, P412, DOI 10.1016/j.jaci.2004.10.048; Casanova JL, 2005, J ALLERGY CLIN IMMUN, V116, P426, DOI 10.1016/j.jaci.2005.03.053; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Cianferoni A, 2005, J ALLERGY CLIN IMMUN, V116, P1364, DOI 10.1016/j.jaci.2005.09.006; Cunningham-Rundles S, 2005, J ALLERGY CLIN IMMUN, V115, P1119, DOI 10.1016/j.jaci.2005.04.036; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Faith A, 2005, J ALLERGY CLIN IMMUN, V116, P1136, DOI 10.1016/j.jaci.2005.08.002; Fei MJ, 2005, J ALLERGY CLIN IMMUN, V116, P1350, DOI 10.1016/j.jaci.2005.08.032; Goleva E, 2005, J ALLERGY CLIN IMMUN, V116, P1094, DOI 10.1016/j.jaci.2005.08.051; Hatab AZ, 2005, J ALLERGY CLIN IMMUN, V116, P460, DOI 10.1016/j.jaci.2005.04.008; Hatab AZ, 2005, J ALLERGY CLIN IMMUN, V116, P1161, DOI 10.1016/j.jaci.2005.08.041; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Jabara HH, 2005, J ALLERGY CLIN IMMUN, V115, P856, DOI 10.1016/j.jaci.2005.01.020; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kaur S, 2005, J ALLERGY CLIN IMMUN, V116, P1381, DOI 10.1016/j.jaci.2005.08.028; Kawai K, 2005, J ALLERGY CLIN IMMUN, V116, P192, DOI 10.1016/j.jaci.2005.03.021; Kawai K, 2005, J ALLERGY CLIN IMMUN, V115, P186, DOI 10.1016/j.jaci.2004.10.005; King D, 2005, J ALLERGY CLIN IMMUN, V115, P1081, DOI 10.1016/j.jaci.2004.12.1140; Knight AK, 2005, CLIN EXP IMMUNOL, V141, P333, DOI 10.1111/j.1365-2249.2005.02837.x; Kroczek R, 2005, J ALLERGY CLIN IMMUN, V116, P906, DOI 10.1016/j.jaci.2005.07.005; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Liossis SNC, 2005, J ALLERGY CLIN IMMUN, V116, P721, DOI 10.1016/j.jaci.2005.06.035; Lopez-Granados E, 2005, J ALLERGY CLIN IMMUN, V116, P690, DOI 10.1016/j.jaci.2005.04.043; Majde JA, 2005, J ALLERGY CLIN IMMUN, V116, P1188, DOI 10.1016/j.jaci.2005.08.005; Mehandru S, 2005, J ALLERGY CLIN IMMUN, V116, P419, DOI 10.1016/j.jaci.2005.05.040; Menge T, 2005, J ALLERGY CLIN IMMUN, V116, P453, DOI 10.1016/j.jaci.2005.03.023; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Park EJ, 2005, J ALLERGY CLIN IMMUN, V116, P1151, DOI 10.1016/j.jaci.2005.07.024; Paul ME, 2005, J ALLERGY CLIN IMMUN, V115, P848, DOI 10.1016/j.jaci.2004.11.054; Presta LG, 2005, J ALLERGY CLIN IMMUN, V116, P731, DOI 10.1016/j.jaci.2005.08.003; Radhakrishnan S, 2005, J ALLERGY CLIN IMMUN, V116, P668, DOI 10.1016/j.jaci.2005.04.038; Romagnani P, 2005, J ALLERGY CLIN IMMUN, V116, P1372, DOI 10.1016/j.jaci.2005.09.035; Ryan KR, 2005, J ALLERGY CLIN IMMUN, V116, P1158, DOI 10.1016/j.jaci.2005.08.036; Saadane A, 2005, J ALLERGY CLIN IMMUN, V115, P405, DOI 10.1016/j.jaci.2004.10.044; Saitoh A, 2006, J ALLERGY CLIN IMMUN, V117, P909, DOI 10.1016/j.jaci.2006.01.013; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Seroogy CM, 2005, J ALLERGY CLIN IMMUN, V116, P996, DOI 10.1016/j.jaci.2005.07.015; Shearer WT, 2005, J ALLERGY CLIN IMMUN, V115, P1297, DOI 10.1016/j.jaci.2005.03.003; Shibuya H, 2005, J ALLERGY CLIN IMMUN, V116, P205, DOI 10.1016/j.jaci.2005.03.016; Stocker M, 2005, J ALLERGY CLIN IMMUN, V116, P910, DOI 10.1016/j.jaci.2005.07.022; Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Weerkamp F, 2005, J ALLERGY CLIN IMMUN, V115, P834, DOI 10.1016/j.jaci.2004.10.031; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954	55	10	13	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2006	118	2					489	495		10.1016/j.jaci.2006.05.021	http://dx.doi.org/10.1016/j.jaci.2006.05.021			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	075IH	16890776				2022-12-18	WOS:000239877700027
J	Leung, DYM				Leung, Donald Y. M.			New insights into the complex gene-environment interactions evolving into atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						atopic dermatitis; eczema; genetics; skin barrier; chemokines	T-CELLS; ASSOCIATION; ECZEMA; IL-31		Natl Jewish Med & Res Ctr, Div Pediat Allergy & Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Boulder, CO 80309 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder	Leung, DYM (corresponding author), Natl Jewish Med & Res Ctr, Div Pediat Allergy & Immunol, 1400 Jackson St,K926i, Denver, CO 80206 USA.	leungd@njc.org						Ahmad-Nejad P, 2004, J ALLERGY CLIN IMMUN, V113, P565, DOI 10.1016/j.jaci.2003.12.583; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Boguniewicz M, 2006, J ALLERGY CLIN IMMUN, V117, pS475, DOI 10.1016/j.jaci.2005.10.018; Boguniewicz M, 2006, J ALLERGY CLIN IMMUN, V118, P40, DOI 10.1016/j.jaci.2006.04.044; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Fiset PO, 2006, J ALLERGY CLIN IMMUN, V118, P287, DOI 10.1016/j.jaci.2006.03.046; Graves PE, 2005, J ALLERGY CLIN IMMUN, V116, P650, DOI 10.1016/j.jaci.2005.05.004; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Howell MD, 2006, J ALLERGY CLIN IMMUN, V117, P836, DOI 10.1016/j.jaci.2005.12.1345; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Kelsay K, 2006, J ALLERGY CLIN IMMUN, V118, P198, DOI 10.1016/j.jaci.2006.04.038; McGirt LY, 2006, J ALLERGY CLIN IMMUN, V118, P202, DOI 10.1016/j.jaci.2006.04.033; Morar N, 2006, J ALLERGY CLIN IMMUN, V118, P24, DOI 10.1016/j.jaci.2006.03.037; Ou LS, 2004, J ALLERGY CLIN IMMUN, V113, P756, DOI 10.1016/j.jaci.2004.01.772; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Steinhoff M, 2006, J ALLERGY CLIN IMMUN, V118, P190, DOI 10.1016/j.jaci.2006.04.025; Taieb Alain, 2006, J Allergy Clin Immunol, V117, P378, DOI 10.1016/j.jaci.2005.11.038; Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036; WAHN U, 2006, J ALLERGY CLIN IMMUN, V118, P152; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043; Zuberbier T, 2006, J ALLERGY CLIN IMMUN, V118, P226, DOI 10.1016/j.jaci.2006.02.031	22	10	11	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2006	118	1					37	39		10.1016/j.jaci.2006.04.045	http://dx.doi.org/10.1016/j.jaci.2006.04.045			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	065UH					2022-12-18	WOS:000239184800003
J	Berglund, LJ; Jones, GJ; Murali, R; Fulcher, DA				Berglund, LJ; Jones, GJ; Murali, R; Fulcher, DA			TACI mutation with invasive polyclonal CD8(+) T-cell lymphoproliferation in a patient with common variable immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						transmembrane activator and calcium-modulator and cyclophilin ligand interactor; common variable immunodeficiency; CD8; lymphoproliferation	DISEASE GENE SH2D1A; IGA DEFICIENCY; B-CELLS; CANCER; HYPOGAMMAGLOBULINEMIA; IDENTIFICATION; EXPRESSION; DIAGNOSIS; FEATURES; RECEPTOR	Mutations of the gene encoding the TNF receptor family member transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI), TNFSRF13B, have recently been described in patients with common variable immunodeficiency (CVID). We report the case of a man with CVID in association with a heterozygous TACI gene mutation (C104R) who had a highly unusual, invasive, polyclonal CD8(+) T-cell lymphoproliferation resulting in massive hepatosplenomegaly and causing renal impairment because of infiltration. Although lymphoproliferation is well described in CVID, the key features in this patient included the T-cell origin of the lymphoproliferation, its polyclonal nature, its infiltration into multiple organs, and the presence of the TACI gene mutation.	Westmead Hosp, Immunol Unit, Westmead, NSW 2145, Australia; Westmead Hosp, Dept Tissue Pathol, Inst Clin Pathol & Med Res, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney	Fulcher, DA (corresponding author), Westmead Hosp, Immunol Unit, ICPMR Level 2, Sydney, NSW 2145, Australia.	davidf@westgate.wh.usyd.edu.au	Berglund, Lucinda/S-7921-2019; MURALI, RAJMOHAN/A-7960-2008	MURALI, RAJMOHAN/0000-0001-6988-4295; Berglund, Lucinda/0000-0002-6595-9947				Aghamohammadi A, 2003, INT J HEMATOL, V78, P45, DOI 10.1007/BF02983239; BISELLI R, 1992, SCAND J IMMUNOL, V35, P439, DOI 10.1111/j.1365-3083.1992.tb02879.x; Castano D, 2005, CLIN IMMUNOL, V115, pS29; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; CUNNINGHAMRUNDLES C, 1987, J CLIN IMMUNOL, V7, P294, DOI 10.1007/BF00915550; Eastwood D, 2004, CLIN EXP IMMUNOL, V137, P584, DOI 10.1111/j.1365-2249.2004.02581.x; Gilmour KC, 2000, EUR J IMMUNOL, V30, P1691, DOI 10.1002/1521-4141(200006)30:6<1691::AID-IMMU1691>3.0.CO;2-K; Gottesman SRS, 1999, LEUKEMIA LYMPHOMA, V32, P589, DOI 10.3109/10428199909058418; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Grimbacher B, 2003, CURR OPIN ALLERGY CL, V3, P409, DOI 10.1097/01.all.0000104458.09202.24; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; Kanegane H, 2000, CLIN EXP IMMUNOL, V120, P512, DOI 10.1046/j.1365-2249.2000.01244.x; KINLEN LJ, 1985, LANCET, V1, P263; Mellemkjaer L, 2002, CLIN EXP IMMUNOL, V130, P495, DOI 10.1046/j.1365-2249.2002.02004.x; Morra M, 2001, BLOOD, V98, P1321, DOI 10.1182/blood.V98.5.1321; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Nistala K, 2001, CLIN EXP IMMUNOL, V126, P126, DOI 10.1046/j.1365-2249.2001.01599.x; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Salzer U, 2004, CLIN IMMUNOL, V113, P234, DOI 10.1016/j.clim.2004.07.002; SANDER CA, 1992, AM J SURG PATHOL, V16, P1170, DOI 10.1097/00000478-199212000-00004; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Sneller MC, 2001, AM J MED SCI, V321, P42, DOI 10.1097/00000441-200101000-00007; Soresina A, 2002, EUR J PEDIATR, V161, P656, DOI 10.1007/s00431-002-1083-9; Spickett GP, 2001, CLIN EXP ALLERGY, V31, P536, DOI 10.1046/j.1365-2222.2001.01117.x; Viget N, 1999, Rev Med Interne, V20 Suppl 2, p299s, DOI 10.1016/S0248-8663(99)80473-1; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Warnatz K, 2005, CLIN IMMUNOL, V115, pS20; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Weston SA, 2001, CLIN EXP IMMUNOL, V124, P465, DOI 10.1046/j.1365-2249.2001.01556.x; WRIGHT JJ, 1990, BLOOD, V76, P2046	32	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2006	117	4					870	877		10.1016/j.jaci.2006.01.004	http://dx.doi.org/10.1016/j.jaci.2006.01.004			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	033QB	16630947				2022-12-18	WOS:000236862800023
J	Puck, JM; Malech, HL				Puck, JM; Malech, HL			Gene therapy for immune disorders: Good news tempered by bad news	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	61st Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 18-22, 2005	San Antonio, TX	Amer Acad Allergy Asthma & Immunol		gene therapy; retrovirus; severe combined immunodeficiency; insertional mutagenesis; leukemia; IL2RG; adenosine deaminase	SEVERE COMBINED IMMUNODEFICIENCY; STEM-CELL TRANSPLANTATION; HUMAN GENOME; BONE-MARROW; INTEGRATION; TRANSCRIPTION; RETROVIRUS; SURVIVAL	After a dozen years of human gene therapy trials characterized by minimal gene correction and disappointing clinical impact, the field of gene therapy received some good news in 2000. Infants with X-linked severe combined immunodeficiency who received retroviral gene addition to cells from their bone marrow developed impressive immune reconstitution. During the following 2 years, additional patients were treated and the news was even better-babies receiving gene therapy had sustained T-cell production and in several cases developed better cell function than most patients treated with standard bone marrow transplants. Unfortunately, bad news followed. Three of the patients experienced leukemic T-cell expansions, found to be associated with retroviral insertions into genomic DNA. Where does the field stand today?	NHGRI, NIH, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; NIAID, Host Def Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Puck, JM (corresponding author), NHGRI, NIH, Genet & Mol Biol Branch, NIH Bldg 49,Rm 4A14, Bethesda, MD 20892 USA.	jpuck@mail.nih.gov		Malech, Harry/0000-0001-5874-5775	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000644, ZIAAI000644, Z01AI000992, ZIAAI000992, ZIAAI000645, Z01AI000645] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; Brenner S, 2003, BBA-MOL CELL RES, V1640, P1, DOI 10.1016/S0167-4889(03)00024-7; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Buckley RH, 2004, J ALLERGY CLIN IMMUN, V113, P793, DOI 10.1016/j.jaci.2004.01.764; Buckley RH, 2002, IMMUNOL REV, V185, P206, DOI 10.1034/j.1600-065X.2002.18517.x; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Dave UP, 2004, SCIENCE, V303, P333, DOI 10.1126/science.1091667; DONAHUE RE, 1992, J EXP MED, V176, P1125, DOI 10.1084/jem.176.4.1125; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Hacein-Bey-Abina S, 2005, BLOOD, V106, p60A, DOI 10.1182/blood.V106.11.195.195; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; HAY BN, 2002, AM SOC HEM ANN M PHI; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; May C, 2002, BLOOD, V99, P1902, DOI 10.1182/blood.V99.6.1902; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; Puck JM, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P99; Rabbitts TH, 1999, CANCER RES, V59, p1794S; Rivella S, 2000, J VIROL, V74, P4679, DOI 10.1128/JVI.74.10.4679-4687.2000; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Smogorzewska Elzbieta M., 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P111; Tomaske M, 2003, BRIT J HAEMATOL, V121, P886, DOI 10.1046/j.1365-2141.2003.04390.x; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vandendriessche Thierry, 2005, IDrugs, V8, P629; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	31	10	12	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2006	117	4					865	869		10.1016/j.jaci.2006.01.041	http://dx.doi.org/10.1016/j.jaci.2006.01.041			5	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	033QB	16630946				2022-12-18	WOS:000236862800022
J	Shearer, WT; Fischer, A				Shearer, WT; Fischer, A			The last 80 years in primary immunodeficiency: How far have we come, how far need we go?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						primary immunodeficiency; history and future prospects; molecular defects; intravenous immunoglobulin treatment; bone marrow stem cell transplantation; gene therapy	COMMON VARIABLE IMMUNODEFICIENCY; INNATE IMMUNE-RESPONSES; T-REGULATORY-CELLS; GENE-THERAPY; DEFICIENCY LEADS; RNA COMPONENT; HUMAN-DISEASE; IN-VITRO; MUTATIONS; DEFECTS		Baylor Coll Med, Dept Pediat, Sect Allergy & Immunol, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Texas Childrens Hosp, Dept Allergy & Immunol, Houston, TX 77030 USA; Necker Univ Hosp, Paris, France	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Shearer, WT (corresponding author), Baylor Coll Med, Dept Pediat, Sect Allergy & Immunol, 6621 Fannin St,MC FC330-01, Houston, TX 77030 USA.	wtsheare@TexasChildrensHospital.org		Shearer, William/0000-0002-2483-2130	NCRR NIH HHS [RR0188] Funding Source: Medline; NHLBI NIH HHS [HL72705] Funding Source: Medline; NIAID NIH HHS [AI36211, AI27551] Funding Source: Medline; NICHD NIH HHS [HD79533, HD41983, HD78522] Funding Source: Medline; PHS HHS [202PICL05] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079533] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041983] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027551, P30AI036211] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Akdis M, 2005, J ALLERGY CLIN IMMUN, V116, P961, DOI 10.1016/j.jaci.2005.09.004; Aleman K, 2001, EUR J PEDIATR, V160, P718, DOI 10.1007/s004310100816; Antas PRZ, 2006, J ALLERGY CLIN IMMUN, V117, P916, DOI 10.1016/j.jaci.2006.01.042; Berglund LJ, 2006, J ALLERGY CLIN IMMUN, V117, P870, DOI 10.1016/j.jaci.2006.01.004; Bonilla FA, 2005, J ALLERGY CLIN IMMUN, V116, P423, DOI 10.1016/j.jaci.2005.05.026; Buckley RH, 2006, J ALLERGY CLIN IMMUN, V117, P756, DOI 10.1016/j.jaci.2006.01.008; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Casanova JL, 2005, J ALLERGY CLIN IMMUN, V116, P426, DOI 10.1016/j.jaci.2005.03.053; Castigli E, 2006, J ALLERGY CLIN IMMUN, V117, P740, DOI 10.1016/j.jaci.2006.01.038; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Charrier S, 2005, GENE THER, V12, P597, DOI 10.1038/sj.gt.3302440; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chinen J, 2004, J ALLERGY CLIN IMMUN, V113, P595, DOI 10.1016/j.jaci.2004.01.765; Cohen SG, 2005, J ALLERGY CLIN IMMUN, V116, P1170, DOI 10.1016/j.jaci.2005.03.033; COMEO B, 2001, BLOOD, V97, P2772; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; de Noronha S, 2005, BLOOD, V105, P1590, DOI 10.1182/blood-2004-06-2332; Dworetzky M, 2004, J ALLERGY CLIN IMMUN, V113, P1231, DOI 10.1016/j.jaci.2004.03.041; Ege M, 2005, BLOOD, V105, P4179, DOI 10.1182/blood-2004-12-4861; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Fleisher TA, 2004, J ALLERGY CLIN IMMUN, V114, P227, DOI 10.1016/j.jaci.2004.06.001; GALLEGO MD, 2006, IN PRESS INT IMMUNOL; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Geha RS, 2005, J ALLERGY CLIN IMMUN, V116, P937, DOI 10.1016/j.jaci.2005.07.025; Goleva E, 2005, J ALLERGY CLIN IMMUN, V116, P1094, DOI 10.1016/j.jaci.2005.08.051; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hamilton RG, 2004, J ALLERGY CLIN IMMUN, V114, P213, DOI 10.1016/j.jaci.2004.06.046; Kirkpatrick CH, 2006, J ALLERGY CLIN IMMUN, V117, P960, DOI 10.1016/j.jaci.2005.11.033; Kroczek R, 2005, J ALLERGY CLIN IMMUN, V116, P906, DOI 10.1016/j.jaci.2005.07.005; Lee SJ, 2005, J ALLERGY CLIN IMMUN, V116, P900, DOI 10.1016/j.jaci.2005.03.028; Levi M, 2006, J ALLERGY CLIN IMMUN, V117, P904, DOI 10.1016/j.jaci.2006.01.002; Lin JH, 2006, J ALLERGY CLIN IMMUN, V117, P878, DOI 10.1016/j.jaci.2006.01.034; Liossis SNC, 2005, J ALLERGY CLIN IMMUN, V116, P721, DOI 10.1016/j.jaci.2005.06.035; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mazer BD, 2005, J ALLERGY CLIN IMMUN, V116, P941, DOI 10.1016/j.jaci.2005.07.021; Mehandru S, 2005, J ALLERGY CLIN IMMUN, V116, P419, DOI 10.1016/j.jaci.2005.05.040; Notarangelo L, 2006, J ALLERGY CLIN IMMUN, V117, P883, DOI 10.1016/j.jaci.2005.12.1347; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Presta LG, 2005, J ALLERGY CLIN IMMUN, V116, P731, DOI 10.1016/j.jaci.2005.08.003; Puck JM, 2006, J ALLERGY CLIN IMMUN, V117, P865, DOI 10.1016/j.jaci.2006.01.041; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Roifman CM, 2006, J ALLERGY CLIN IMMUN, V117, P897, DOI 10.1016/j.jaci.2006.01.003; Rosenzweig SD, 2004, J ALLERGY CLIN IMMUN, V113, P620, DOI 10.1016/j.jaci.2004.02.001; Saitoh A, 2006, J ALLERGY CLIN IMMUN, V117, P909, DOI 10.1016/j.jaci.2006.01.013; Saitoh A, 2002, J INFECT DIS, V185, P1409, DOI 10.1086/340614; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; SCHOFER O, 1991, J PEDIATR-US, V118, P86, DOI 10.1016/S0022-3476(05)81853-0; Seroogy CM, 2005, J ALLERGY CLIN IMMUN, V116, P996, DOI 10.1016/j.jaci.2005.07.015; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Stiehm ER, 2005, PEDIATR RES, V57, P458, DOI 10.1203/01.PDR.0000151692.05422.4C; Syllaba L, 1926, REV NEUROL-FRANCE, V45, P541; Thorley-Lawson DA, 2005, J ALLERGY CLIN IMMUN, V116, P251, DOI 10.1016/j.jaci.2005.05.038; Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Wen L, 2004, J ALLERGY CLIN IMMUN, V113, P585, DOI 10.1016/j.jaci.2004.02.003; Westerberg L, 2005, BLOOD, V105, P1144, DOI 10.1182/blood-2004-03-1003	66	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2006	117	4					748	752		10.1016/j.jaci.2006.02.029	http://dx.doi.org/10.1016/j.jaci.2006.02.029			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	033QB	16630928	Bronze			2022-12-18	WOS:000236862800003
J	Beck, TR; Baird, LG				Beck, TR; Baird, LG			Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema - Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Dyax Corp, Business & Prod Dev, Cambridge, MA 02139 USA; Dyax Corp, Dev, Cambridge, MA 02139 USA		Beck, TR (corresponding author), Dyax Corp, Business & Prod Dev, 300 Technol Sq, Cambridge, MA 02139 USA.							Caballero T, 2006, J ALLERGY CLIN IMMUN, V117, P476, DOI 10.1016/j.jaci.2005.10.045; WILLIAMS T, 2005, J ALLERGY CLIN IMMUN, V115, pS181	2	10	10	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2					477	477		10.1016/j.jaci.2005.10.044	http://dx.doi.org/10.1016/j.jaci.2005.10.044			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IM		Bronze			2022-12-18	WOS:000235687300043
J	Kober, A; Perborn, H				Kober, A; Perborn, H			Quantitation of mouse-human chimeric allergen specific IgE antibodies with ImmunoCAP (TM) technology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Pharmacia Diagnost AB, Uppsala, Sweden	Pfizer; Pharmacia Corporation									0	10	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		845	S219	S219		10.1016/j.jaci.2005.12.865	http://dx.doi.org/10.1016/j.jaci.2005.12.865			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865301342
J	Lumry, W; Ritchie, B; Beck, T; Morrison, J				Lumry, W; Ritchie, B; Beck, T; Morrison, J			Interim results of EDEMA2, a multicenter, open-label, repeat-dosing study of intravenous and subcutaneous administration of ecallantide (DX-88) in hereditary angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Allergy & Asthma Specialists, Dallas, TX USA; Univ Alberta, Edmonton, AB, Canada; Dyax Corp, Cambridge, MA USA	University of Alberta									0	10	18	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		699	S179	S179		10.1016/j.jaci.2005.12.715	http://dx.doi.org/10.1016/j.jaci.2005.12.715			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865301196
J	van Toorenenbergen, AW; van Daele, PLA; Boonstra, JG				van Toorenenbergen, AW; van Daele, PLA; Boonstra, JG			False-elevated serum tryptase assay result caused by heterophilic antibodies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Erasmus Univ, Med Ctr, Dept Clin Chem, NL-3015 GD Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Toorenenbergen, AW (corresponding author), Erasmus Univ, Med Ctr, Dept Clin Chem, NL-3015 GD Rotterdam, Netherlands.							Andersen DC, 2004, J IMMUNOASS IMMUNOCH, V25, P17, DOI 10.1081/IAS-120027223; Bjerner J, 2005, CLIN CHEM, V51, P9, DOI 10.1373/clinchem.2004.042994; Kaplan IV, 1999, CLIN CHEM, V45, P616; Kricka LJ, 1999, CLIN CHEM, V45, P942; Valent P, 2004, J ALLERGY CLIN IMMUN, V114, P3, DOI 10.1016/j.jaci.2004.02.045	5	10	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2005	116	5					1159	1160		10.1016/j.jaci.2005.07.023	http://dx.doi.org/10.1016/j.jaci.2005.07.023			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IG	16275392				2022-12-18	WOS:000235686700033
J	Stevenson, DD; Mehra, PK; White, AA; Gupta, S; Woessner, KM; Simon, RA				Stevenson, DD; Mehra, PK; White, AA; Gupta, S; Woessner, KM; Simon, RA			Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; aspirin; tacrolimus; aspirin desensitization	URINARY LEUKOTRIENE-E4; ASTHMATIC-PATIENTS; DESENSITIZATION; EXCRETION; CHALLENGES; INHALATION	Background: In patients with aspirin-exacerbated respiratory disease (AERD), pretreatment with asthma controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of aspirin-induced asthmatic reactions. Objective: A recent study showed that pretreatment with tacrolimus completely prevented aspirin-induced respiratory reactions and might allow silent aspirin desensitization. Methods: Ten patients with rhinosinusitis, nasal polyps, and asthma had a history of asthma attacks after ingesting aspirin and nonsteroidal anti-inflammatory drugs. All underwent baseline oral aspirin challenges and had typical respiratory reactions. They were then randomized to receive tacrolimus (0.1 mg/kg weight; 8 patients) or placebo (2 patients) in a double-blind protocol before rechallenge with aspirin using the previous provoking dose of aspirin. In addition, respiratory reactions sustained by 50 consecutive patients with AERD during 2004 were recorded, analyzed, and compared with the tacrolimus/placebo-treated patients to determine whether there were any differences. Results: Tacrolimus pretreatment failed to block respiratory reactions to provoking doses of aspirin in 5 of 8 patients with AERD, and in the other 3 patients did not block higher doses of aspirin. The results of oral aspirin challenges in the control population of 50 patients were compared with either the baseline or postchallenge data from the tacrolimus-pretreated or placebo-pretreated patients with AERD, and there were no significant differences. Conclusions: Use of tacrolimus as add-on pretreatment to prevent reactions to aspirin in patients with AERD or to achieve the goal of silent aspirin desensitization could not be accomplished.	Scripps Clin, Div Allergy Asthma & Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA; Scripps Clin, Green Hosp, Gen Clin Res Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Stevenson, DD (corresponding author), Scripps Clin, Div Allergy Asthma & Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dstevemd@aol.com			NCRR NIH HHS [M01-RR00833] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Berges-Gimeno MP, 2003, J ALLERGY CLIN IMMUN, V111, P180, DOI 10.1067/mai.2003.7; Berges-Gimeno MP, 2002, CLIN EXP ALLERGY, V32, P1491, DOI 10.1046/j.1365-2745.2002.01501.x; CHRISTIE PE, 1992, AM REV RESPIR DIS, V146, P1531, DOI 10.1164/ajrccm/146.6.1531; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; Daffern PJ, 1999, J ALLERGY CLIN IMMUN, V104, P559, DOI 10.1016/S0091-6749(99)70324-6; Dahlen B, 1998, RESP MED, V92, P378, DOI 10.1016/S0954-6111(98)90279-7; Fung JJ, 2004, TRANSPLANTATION, V77, pS41, DOI 10.1097/01.TP.0000126926.61434.A5; ISRAEL E, 1993, AM REV RESPIR DIS, V148, P1447, DOI 10.1164/ajrccm/148.6_Pt_1.1447; Kawano T, 2004, J ALLERGY CLIN IMMUN, V114, P1278, DOI 10.1016/j.jaci.2004.09.003; Mardiney M, 2001, ARCH OTOLARYNGOL, V127, P1287; Matsuo N, 2001, ANN ALLERG ASTHMA IM, V86, P671, DOI 10.1016/S1081-1206(10)62297-1; NIZANKOWSKA E, 1989, ANN ALLERGY, V63, P159; Pauls JD, 2000, ANN ALLERG ASTHMA IM, V85, P40, DOI 10.1016/S1081-1206(10)62432-5; Stevenson DD, 2000, ANN ALLERG ASTHMA IM, V85, P477, DOI 10.1016/S1081-1206(10)62575-6; STEVENSON DD, 1984, J ALLERGY CLIN IMMUN, V73, P500, DOI 10.1016/0091-6749(84)90361-0; Stevenson DD, 1996, J ALLERGY CLIN IMMUN, V98, P751, DOI 10.1016/S0091-6749(96)70123-9; Stevenson DD, 2003, CLIN REV ALLERG IMMU, V24, P159, DOI 10.1385/CRIAI:24:2:159; SWEET JM, 1990, J ALLERGY CLIN IMMUN, V85, P59, DOI 10.1016/0091-6749(90)90222-P; SZCZEKLIK A, 1979, THORAX, V34, P654, DOI 10.1136/thx.34.5.654; Szczeklik A, 1998, AM J RESP CRIT CARE, V158, P1168, DOI 10.1164/ajrccm.158.4.9710043; WESTCOTT JY, 1991, AM REV RESPIR DIS, V143, P1322, DOI 10.1164/ajrccm/143.6.1322; Yoshida S, 1998, ANN ALLERG ASTHMA IM, V80, P171, DOI 10.1016/S1081-1206(10)62951-1	22	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2005	116	4					755	760		10.1016/j.jaci.2005.05.020	http://dx.doi.org/10.1016/j.jaci.2005.05.020			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IF	16210047				2022-12-18	WOS:000235686600006
J	Pacheco, SE; Gottschalk, SM; Gresik, MV; Dishop, MK; Okmaura, T; McCormick, TG				Pacheco, SE; Gottschalk, SM; Gresik, MV; Dishop, MK; Okmaura, T; McCormick, TG			Chronic active Epstein-Barr virus infection of natural killer cells presenting as severe skin reaction to mosquito bites	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									Texas Childrens Hosp, Pediat Allergy & Immunol Serv, Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	McCormick, TG (corresponding author), Texas Childrens Hosp, Pediat Allergy & Immunol Serv, Baylor Coll Med, 6621 Fannin St,FC330-01, Houston, TX 77030 USA.	Tgmccorm@texaschildrenshospital.org	Gottschalk, Stephen/M-9343-2018	Gottschalk, Stephen/0000-0003-3991-7468				Fujii N, 2000, BONE MARROW TRANSPL, V26, P805, DOI 10.1038/sj.bmt.1702600; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Miyazato H, 2004, AM J HEMATOL, V76, P230, DOI 10.1002/ajh.20091; Ohga S, 2002, CRIT REV ONCOL HEMAT, V44, P203, DOI 10.1016/S1040-8428(02)00112-9; Tokura Y, 2001, J AM ACAD DERMATOL, V45, P569, DOI 10.1067/mjd.2001.114751	5	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2005	116	2					470	472		10.1016/j.jaci.2005.04.044	http://dx.doi.org/10.1016/j.jaci.2005.04.044			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017ID	16083813	Bronze			2022-12-18	WOS:000235686400041
J	Onder, RF				Onder, RF			The ethics of placebo-controlled trials: The case of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						placebo-controlled trial; research ethics; asthma; validity; assay sensitivity	CLINICAL-TRIALS; INHALED CORTICOSTEROIDS; ORTHODOXY	Some have argued that placebo-controlled trials (PCTs) are unnecessary and unethical in conditions such as asthma for which there is standard therapy. This article, by using asthma clinical trials as an example, examines the ethics of PCTs. There remain several scientifically sound reasons to conduct PCTs: (1) ensuring scientific validity of the trial, (2) evaluating new therapies less effective than the gold standard, (3) minimizing the number of patients exposed to potentially inefficacious or dangerous therapy, (4) studying clinical situations in which withdrawal of therapy might be considered, and (5) determining the true incidence of side effects. Opponents of PCTs err by conflating clinical research with clinical practice and ignoring the fact that all clinical research involves some sacrifice on the part of the subject for the ends of the research and the good of future patients. PCTs do not per se violate major ethical codes. Properly conducted, PCTs remain a valuable and ethical tool in the armamentarium of modern scientific medicine.	Washington Univ, Sch Med, St Louis, MO 63141 USA	Washington University (WUSTL)	Onder, RF (corresponding author), Washington Univ, Sch Med, 711 Old Ballas Rd,Suite 100, St Louis, MO 63141 USA.	rfonder@centurytel.net	Roncada, Cristian/O-2772-2013					Botkin JR, 2001, JAMA-J AM MED ASSOC, V286, P3075, DOI 10.1001/jama.286.24.3075; Carter ER, 2002, CHEST, V122, P2267, DOI 10.1378/chest.122.6.2267; Cockcroft DW, 1997, ANN ALLERG ASTHMA IM, V79, P226, DOI 10.1016/S1081-1206(10)63006-2; *COUNC INT ORG MED, 1993, INT ETH GUID BIOM RE; *DHHS, 1998, DHHS REG PROT HUM SU, P2773; Dubus JC, 2003, PEDIATR ALLERGY IMMU, V14, P4, DOI 10.1034/j.1399-3038.2003.01042.x; Ducharme FM, 2003, BMJ-BRIT MED J, V326, P621, DOI 10.1136/bmj.326.7390.621; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Freedman B, 1996, J LAW MED ETHICS, V24, P243, DOI 10.1111/j.1748-720X.1996.tb01859.x; Freedman B, 1996, J LAW MED ETHICS, V24, P252, DOI 10.1111/j.1748-720X.1996.tb01860.x; Galant SP, 1997, ANN ALLERG ASTHMA IM, V79, P173, DOI 10.1016/S1081-1206(10)63000-1; HELLMAN S, 1991, NEW ENGL J MED, V324, P1585, DOI 10.1056/NEJM199105303242208; *INT C HARM STEER, 2003, ICH TOP E9 STAT PRIN; KELLERMAN D, 1997, ANN ALLERG ASTHMA IM, V79, P173; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; LAZARUS SC, 2001, JAMA-J AM MED ASSOC, V285, P3077; Leon AC, 2001, CLIN THER, V23, P596, DOI 10.1016/S0149-2918(01)80063-1; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Miller FG, 2002, ARCH INTERN MED, V162, P1673, DOI 10.1001/archinte.162.15.1673; Miller FG, 2002, CHEST, V121, P1337, DOI 10.1378/chest.121.4.1337; Miller Franklin G., 2002, American Journal of Bioethics, V2, P3, DOI 10.1162/152651602317533523; *NATL COMM PROT HU, 1998, ENCY BIOETHICS, P2767; PASSAMANI E, 1991, NEW ENGL J MED, V324, P1589, DOI 10.1056/NEJM199105303242209; REICH WT, 1995, ENCY BIOETHICS, P2763; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Vastag B, 2000, JAMA-J AM MED ASSOC, V284, P2983, DOI 10.1001/jama.284.23.2983; Weijer C, 2002, CAN MED ASSOC J, V166, P603; Weijer C, 2002, NEW ENGL J MED, V346, P382; Weijer Charles, 2002, American Journal of Bioethics, V2, P10, DOI 10.1162/152651602317533532; *WORLD MED ASS, 2000, DELCL HELS; 2000, INT C HARM STEER COM, P18	33	10	10	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2005	115	6					1228	1234		10.1016/j.jaci.2005.01.059	http://dx.doi.org/10.1016/j.jaci.2005.01.059			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	935WZ	15940139				2022-12-18	WOS:000229815400019
J	King, D; Tomkins, S; Waters, A; Easterbrook, PJ; Thurmond, LM; Thorborn, DE; Raffi, F; Kemeny, DM; Vyakarnam, A				King, D; Tomkins, S; Waters, A; Easterbrook, PJ; Thurmond, LM; Thorborn, DE; Raffi, F; Kemeny, DM; Vyakarnam, A			Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						hypersensitivity; HIV; adverse drug reactions; cytokines; IFN-gamma; IL-4; flow cytometry; antidrug antibodies	INTERFERON-GAMMA; T-CELLS; LYMPHOCYTES; RECHALLENGE; EXPRESSION; INDUCE; TYPE-1	Background: The clinical treatment of patients with HIV and adverse drug events may be enhanced by an understanding of the underlying mechanisms. About 4% of patients with HIV receiving the potent antiretroviral drug abacavir develop a hypersensitivity reaction. This idiosyncratic reaction appears to have an immunologic component that has yet to be defined. Given that the T-cell type 2 cytokine IL-4 may be overproduced by patients with allergy or other immunologic dysiregulation, an index cytokine profile could help elucidate the character of a drug-specific hypersensitivity reaction. Objective: Quantitation of the production of the type 2 IL-4 and the counterregulatory type 1 cytokine IFN-gamma in patients with abacavir-related hypersensitivity. Methods: Intracellular cytokines were enumerated in blood T cells by How cytometry. Subjects were grouped for evaluation as patients with a hypersensitive response after abacavir treatment, patients initiating abacavir who also were evaluated again after 1 month on abacavir, patients on abacavir for 6 months without hypersensitivity, and HIV-naive control individuals. Results: There was a significant association between increased IL-4 production by CD4 and CD8 T lymphocytes and hypersensitivity reactions to abacavir. Lymphocytes from hypersensitive subjects expressed CD28 and the anti-HIV chemokine macrophage inflammatory protein to with a frequency comparable with HIV-naive control cells, suggesting the possibility that the activated T cells from patients with hypersensitivity are functional. Conclusion: The expansion of type 0 and type 2 T cells phenotyped by IL-4 production may correlate with abacavir-associated hypersensitivity. The data suggest a cytokine bias that may facilitate B-cell differentiation and downregulate T-cell cytotoxic responses.	Kings Coll London, Dept Immunol, London SE9 1RT, England; Kings Coll London, Dept HIV Genitourinary Med, London SE9 1RT, England; GlaxoSmithKline, Res Triangle Pk, NC USA; GlaxoSmithKline, Greenford, Middx, England; Hop Hotel Dieu, Nantes, France	University of London; King's College London; University of London; King's College London; GlaxoSmithKline; GlaxoSmithKline; Nantes Universite; CHU de Nantes	Vyakarnam, A (corresponding author), Kings Coll London, St Thomas Sch Med, Dept Infect Dis, Guys Campus,2nd Floor,New Guys House, London SE9 1RT, England.	anna.vyakarnam@kcl.ac.uk	Easterbrook, Philippa J/A-3937-2009	Easterbrook, Philippa/0000-0002-2603-5418				Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Easterbrook P J, 2003, HIV Med, V4, P321, DOI 10.1046/j.1468-1293.2003.00166.x; Empson M, 1999, J ALLERGY CLIN IMMUN, V103, P833, DOI 10.1016/S0091-6749(99)70427-6; Escaut L, 1999, AIDS, V13, P1419, DOI 10.1097/00002030-199907300-00026; Eylar EH, 2001, J CLIN IMMUNOL, V21, P135, DOI 10.1023/A:1011055805869; Fakoya A, 1997, AIDS, V11, P1445, DOI 10.1097/00002030-199712000-00008; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; Galli G, 1998, EUR J IMMUNOL, V28, P3280, DOI 10.1002/(SICI)1521-4141(199810)28:10<3280::AID-IMMU3280>3.0.CO;2-M; Girolomoni G, 2001, CURR OPIN IMMUNOL, V13, P733, DOI 10.1016/S0952-7915(01)00287-4; Hess DA, 1997, ANN PHARMACOTHER, V31, P1378, DOI 10.1177/106002809703101116; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; MAGGI E, 1994, SCIENCE, V265, P244, DOI 10.1126/science.8023142; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Ohsaki M, 1999, J ALLERGY CLIN IMMUN, V103, P276, DOI 10.1016/S0091-6749(99)70502-6; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Saag MS, 1998, AIDS, V12, pF203, DOI 10.1097/00002030-199816000-00002; Shinbara M, 1996, ANN ALLERG ASTHMA IM, V77, P60, DOI 10.1016/S1081-1206(10)63481-3; Sousa AE, 1998, CLIN EXP IMMUNOL, V112, P294; Staszewski S, 1998, AIDS, V12, pF197, DOI 10.1097/00002030-199816000-00001; VYAKARNAM A, 1995, IMMUNOLOGY, V86, P85; Walensky RP, 1999, AIDS, V13, P999, DOI 10.1097/00002030-199905280-00022; Walsh JS, 2002, CHEM-BIOL INTERACT, V142, P135, DOI 10.1016/S0009-2797(02)00059-5; Woodfolk JA, 2001, J IMMUNOL, V167, P5412, DOI 10.4049/jimmunol.167.9.5412; Yawalkar N, 2000, J INVEST DERMATOL, V115, P647, DOI 10.1046/j.1523-1747.2000.00105.x; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3857, DOI 10.1073/pnas.95.7.3857; Zanni MP, 1998, J CLIN INVEST, V102, P1591, DOI 10.1172/JCI3544	27	10	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2005	115	5					1081	1087		10.1016/j.jaci.2004.12.1140	http://dx.doi.org/10.1016/j.jaci.2004.12.1140			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	925LR	15867870				2022-12-18	WOS:000229055100028
J	Talhari, C; Lauceviciute, I; Enderlein, E; Ruzicka, T; Homey, B				Talhari, C; Lauceviciute, I; Enderlein, E; Ruzicka, T; Homey, B			COX-2-selective inhibitor valdecoxib induces severe allergic skin reactions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELECOXIB; ROFECOXIB; INTOLERANCE		Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Talhari, C (corresponding author), Univ Dusseldorf, Dept Dermatol, Moorenstr 5, D-40225 Dusseldorf, Germany.							Alonso JCM, 2004, CONTACT DERMATITIS, V50, P48, DOI 10.1111/j.0105-1873.2004.00271i.x; Chavez ML, 2003, CLIN THER, V25, P817, DOI 10.1016/S0149-2918(03)80110-8; Dieppe PA, 2004, BRIT MED J, V329, P867, DOI 10.1136/bmj.329.7471.867; Goeschke B, 2004, DERMATOLOGY, V209, P53, DOI 10.1159/000078588; Grob M, 2000, DERMATOLOGY, V201, P383, DOI 10.1159/000051569; Kruse R, 2003, ACTA DERM-VENEREOL, V83, P183, DOI 10.1080/00015550310007175; Munoz-Bellido FJ, 2003, ALLERGY, V58, P1072, DOI 10.1034/j.1398-9995.2003.00166.x; Stevenson DD, 2001, ANN ALLERG ASTHMA IM, V87, P177, DOI 10.1016/S1081-1206(10)62221-1; Szczeklik A, 2003, J ALLERGY CLIN IMMUN, V111, P913, DOI 10.1067/mai.2003.1487; WILKINSON DS, 1970, ACTA DERM-VENEREOL, V50, P287	10	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2005	115	5					1089	1090		10.1016/j.jaci.2004.12.1135	http://dx.doi.org/10.1016/j.jaci.2004.12.1135			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	925LR	15867872	Bronze			2022-12-18	WOS:000229055100030
J	Alday, E; Gomez, M; Ojeda, P; Caballero, ML; Moneo, I				Alday, E; Gomez, M; Ojeda, P; Caballero, ML; Moneo, I			IgE-mediated asthma associated with a unique allergen from Angelim pedra (Hymenolobium petraeum) wood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							TRIPLOCHITON-SCLEROXYLON		Inst Nacl Seguridad & Higiene Trabajo, Unidad Neumol & Alergia Laboral, Ctr Nacl Neuvas Tecnol, Madrid 28027, Spain; Hosp Carlos III, Madrid, Spain	Instituto Nacional Seguridad Salud Trabajo (INSST); Hospital Carlos III	Alday, E (corresponding author), Inst Nacl Seguridad & Higiene Trabajo, Unidad Neumol & Alergia Laboral, Ctr Nacl Neuvas Tecnol, C Torrelaguna,73, Madrid 28027, Spain.							*EUR BIOINF I, PROGR FASTA; HINOJOSA M, 1990, ANN ALLERGY, V64, P476; HINOJOSA M, 1984, J ALLERGY CLIN IMMUN, V74, P782, DOI 10.1016/0091-6749(84)90179-9; Moneo I, 2000, J ALLERGY CLIN IMMUN, V106, P177, DOI 10.1067/mai.2000.106732; *NET BUR COM, ANG PEDR; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; *SWISS I BIOINF, SWISS PROT DAT	7	10	10	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2005	115	3					634	636		10.1016/j.jaci.2004.10.052	http://dx.doi.org/10.1016/j.jaci.2004.10.052			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	907AN	15753918	Bronze			2022-12-18	WOS:000227687000033
J	Sicherer, SH; Leung, DYM				Sicherer, SH; Leung, DYM			Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insect stings	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						dermatology; skin disease; anaphylaxis; allergy; hypersensitivity disorders; food; drug; insect venom	ATOPIC-DERMATITIS; PEANUT ALLERGY; FOLLOW-UP; CHILDREN; CELLS; PREVALENCE; PENICILLIN; EXPRESSION; PROTEINS; MODEL	This review highlights some of the research advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insect venom that were reported primarily in the Journal of Allergy and Clinical Immunology from 2002 through 2003. Among the topics highlighted are new insights into the pathogenesis of atopic dermatitis and potential strategies for more effective treatment of the atopic march. Patients should remain supine with raised legs during anaphylactic shock because upper body elevation could result in sudden death from loss of venous return to the heart. A major advance in food allergy was that humanized, monoclonal anti-IgE antibody showed protection against peanut-induced anaphylaxis. In addition to studies elucidating mechanisms of drug hypersensitivity, a clinical study showed patients with a history of prior penicillin allergy with negative penicillin allergy test results are unlikely to experience reactions or resensitization on subsequent oral courses of penicillin. Lastly, there are new recommendations for patients with convincing insect sting reaction histories but negative skin test responses to venom.	Mt Sinai Sch Med, Dept Pediat, Div Allergy & Immunol, Elliot & Roslyn Jaffe Food Allergy Inst, New York, NY USA; Univ Colorado, Hlth Sci Ctr, Div Pediat Allergy Immunol, Dept Pediat,Natl Jewish Med & Res Ctr, Denver, CO 80202 USA	Icahn School of Medicine at Mount Sinai; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Sicherer, SH (corresponding author), Mt Sinai Hosp, Div Allergy Immunol, Box 1198,1 Gustave L Levy Pl, New York, NY 10029 USA.	scott.sicherer@mssm.edu						Asero R, 2003, J ALLERGY CLIN IMMUN, V112, P427, DOI 10.1067/mai.2003.1611; Bender BG, 2003, J ALLERGY CLIN IMMUN, V111, P598, DOI 10.1067/mai.2003.174; Beyer KB, 2001, J ALLERGY CLIN IMMUN, V107, P1077, DOI 10.1067/mai.2001.115480; Boguniewicz Mark, 2003, Journal of Allergy and Clinical Immunology, V112, pS140, DOI 10.1016/j.jaci.2003.09.031; Davis MDP, 2003, J ALLERGY CLIN IMMUN, V112, P988, DOI 10.1016/j.jaci.2003.08.028; Diaz-Perales A, 2003, J ALLERGY CLIN IMMUN, V112, P1002, DOI 10.1016/j.jaci.2003.07.006; Empedrad R, 2003, J ALLERGY CLIN IMMUN, V112, P629, DOI 10.1067/mai.2003.1690; Fleischer DM, 2003, J ALLERGY CLIN IMMUN, V112, P183, DOI 10.1067/mai.2003.1517; Foetisch K, 2003, J ALLERGY CLIN IMMUN, V111, P889, DOI 10.1067/mai.2003.173; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Golden DBK, 2003, J ALLERGY CLIN IMMUN, V112, P495, DOI [10.1067/mai.2003.1606, 10.1016/S0091-6749(03)01537-9]; Groneberg DA, 2003, J ALLERGY CLIN IMMUN, V111, P1099, DOI 10.1067/mai.2003.1477; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Gyllfors P, 2003, J ALLERGY CLIN IMMUN, V111, P1116, DOI 10.1067/mai.2003.1450; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; Kagan RS, 2003, J ALLERGY CLIN IMMUN, V112, P1223, DOI 10.1016/j.jaci.2003.09.026; Kakinuma T, 2003, J ALLERGY CLIN IMMUN, V111, P592, DOI 10.1067/mai.2003.114; Kerschenlohr K, 2003, J ALLERGY CLIN IMMUN, V111, P869, DOI 10.1067/mai.2003.1347; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Laouini D, 2003, J ALLERGY CLIN IMMUN, V112, P981, DOI 10.1016/j.jaci.2003.07.007; Leung DYM, 2003, NEW ENGL J MED, V348, P986, DOI 10.1056/NEJMoa022613; Li XM, 2003, J ALLERGY CLIN IMMUN, V112, P159, DOI 10.1067/mai.2003.1622; Ma SH, 2003, J ALLERGY CLIN IMMUN, V112, P784, DOI 10.1016/S0091-6749(03)02008-6; Macy E, 2003, J ALLERGY CLIN IMMUN, V111, P1111, DOI 10.1067/mai.2003.1385; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; Maleki SJ, 2003, J ALLERGY CLIN IMMUN, V112, P190, DOI 10.1067/mai.2003.1551; Naisbitt DJ, 2003, J ALLERGY CLIN IMMUN, V111, P1393, DOI 10.1067/mai.2003.1507; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Novak N, 2003, J ALLERGY CLIN IMMUN, V112, pS128, DOI DOI 10.1016/j.jaci.2003.09.032; Palosuo K, 2003, J ALLERGY CLIN IMMUN, V111, P1386, DOI 10.1067/mai.2003.1498; Pichichero ME, 1998, J PEDIATR-US, V132, P137, DOI 10.1016/S0022-3476(98)70499-8; Pomes A, 2003, J ALLERGY CLIN IMMUN, V111, P640, DOI 10.1067/mai.2003.118; Pumphrey RSH, 2003, J ALLERGY CLIN IMMUN, V112, P451, DOI 10.1067/mai.2003.1614; Reich K, 2003, J ALLERGY CLIN IMMUN, V112, P1191, DOI 10.1016/j.jaci.2003.09.012; Rodriguez-Perez R, 2003, J ALLERGY CLIN IMMUN, V111, P634, DOI 10.1067/mai.2003.74; Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025; Rosenfeldt V, 2003, J ALLERGY CLIN IMMUN, V111, P389, DOI 10.1067/mai.2003.389; Sampson HA, 2002, NEW ENGL J MED, V346, P1294, DOI 10.1056/NEJMcp012667; Sato E, 2003, J ALLERGY CLIN IMMUN, V111, P143, DOI 10.1067/mai.2003.9; Semper AE, 2003, J ALLERGY CLIN IMMUN, V112, P411, DOI 10.1067/mai.2003.1626; Sicherer Scott H., 2003, Journal of Allergy and Clinical Immunology, V111, pS829, DOI 10.1067/mai.2003.152; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Simons FER, 2002, J ALLERGY CLIN IMMUN, V110, P647, DOI 10.1067/mai.2002.127860; Simonte SJ, 2003, J ALLERGY CLIN IMMUN, V112, P180, DOI 10.1067/mai.2003.1486; Solensky R, 2002, ARCH INTERN MED, V162, P822, DOI 10.1001/archinte.162.7.822; Strom BL, 2003, NEW ENGL J MED, V349, P1628, DOI 10.1056/NEJMoa022963; Teraki Y, 2003, J ALLERGY CLIN IMMUN, V112, P609, DOI 10.1037/mai.2003.1653; Teuber SS, 2002, J ALLERGY CLIN IMMUN, V110, P921, DOI 10.1067/mai.2002.130056; Toda M, 2003, J ALLERGY CLIN IMMUN, V111, P875, DOI 10.1067/mai.2003.1414; Untersmayr E, 2003, J ALLERGY CLIN IMMUN, V112, P616, DOI [10.1016/S0091-6749(03)01719-6, 10.1016/mai.2003.1681]; Vadas P, 2003, J ALLERGY CLIN IMMUN, V112, P175, DOI 10.1067/mai.2003.1480; Watanabe S, 2003, J ALLERGY CLIN IMMUN, V111, P587, DOI 10.1067/mai.2003.105; Wensing M, 2002, J ALLERGY CLIN IMMUN, V110, P915, DOI 10.1067/mai.2002.129235	53	10	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2004	114	1					118	124		10.1016/j.jaci.2004.03.056	http://dx.doi.org/10.1016/j.jaci.2004.03.056			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	836DA	15241353				2022-12-18	WOS:000222534300017
J	Ye, YL; Lee, YL; Chuang, ZJ; Lai, HJ; Chen, CC; Tao, MH; Chiang, BL				Ye, YL; Lee, YL; Chuang, ZJ; Lai, HJ; Chen, CC; Tao, MH; Chiang, BL			Dendritic cells modulated by cytokine-expressing adenoviruses alleviate eosinophilia and airway hyperresponsiveness in an animal model of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma animal model; cytokine expressing adenovirus; dendritic cell	GENE-TRANSFER; IFN-GAMMA; ANTIGEN PRESENTATION; ALLERGIC RESPONSE; TH2 RESPONSES; MOUSE AIRWAYS; IN-VIVO; CPG DNA; INTERLEUKIN-12; INFLAMMATION	Background: It has been found that T(H)1-related cytokines can decrease the accumulation of eosinophils in lung tissue and relieve airway constriction. Objective: Dendritic cells (DCs) have been found to prime naive T-helper cells efficiently. In this study, DCs infected with T(H)1 cytokine-expressing adenovirus can be used to induce antigen-specific T(H)1 cells for treatment in an animal model of asthma. Methods: Cytokine gene-modulated DCs pulsed with ovalbumin antigen (OVA) were injected intravenously into naive mice 1 week before sensitization with OVA antigen. The mice were then monitored for OVA-specific IgE, airway inflammatory cell infiltration, and airway hyperresponsiveness in the study. Results: Significant levels of IL-12 or IL-18 were expressed by Ad-IL-12 or Ad-IL-18 infected, bone marrow-derived DCs. Ad-IL-12 and Ad-IL-18 co-infected DCs effectively, decreasing sera anti-OVA IgE antibody levels, lung eosinophilia, and airway hyperresponsiveness. Conclusion: We concluded that DCs modulated by T(H)1-prone cytokine-expressing adenoviruses can alleviate T(H)2-type airway inflammation in a murine model and can provide possible therapeutic application for DCs in asthma.	Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan; Chung Hwa Coll Med Technol, Dept Med Technol, Tainan, Taiwan; Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan	Chiang, BL (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 7 Chung Shan S Rd, Taipei, Taiwan.	gicmbor@ha.mc.ntu.edu.tw	Tao, Mi-Hua/S-7020-2018	Tao, Mi-Hua/0000-0002-4307-5729; CHIANG, BOR-LUEN/0000-0002-6705-0286				Brusselle GG, 1997, AM J RESP CELL MOL, V17, P767, DOI 10.1165/ajrcmb.17.6.2820; Campbell E, 2000, J IMMUNOL, V164, P1096, DOI 10.4049/jimmunol.164.2.1096; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Chiang DJ, 2003, AM J RESP CRIT CARE, V168, P575, DOI 10.1164/rccm.2205005; Cieslewicz G, 1999, J CLIN INVEST, V104, P301, DOI 10.1172/JCI7010; Dow SW, 1999, HUM GENE THER, V10, P1905, DOI 10.1089/10430349950017266; FREVERT CW, 1995, J IMMUNOL, V154, P335; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; GRIFFITHSJOHNSON DA, 1993, BIOCHEM BIOPH RES CO, V197, P1167, DOI 10.1006/bbrc.1993.2599; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hansen G, 2000, J IMMUNOL, V164, P223, DOI 10.4049/jimmunol.164.1.223; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Hofstra CL, 1998, J IMMUNOL, V161, P5054; Hogan SP, 1998, EUR J IMMUNOL, V28, P413; Hopfenspirger MT, 2002, J IMMUNOL, V168, P2516, DOI 10.4049/jimmunol.168.5.2516; Iwamoto I, 1996, AM J RESP CRIT CARE, V154, P1257, DOI 10.1164/ajrccm.154.5.8912732; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kay AB, 2003, CURR OPIN PHARMACOL, V3, P220, DOI 10.1016/S1471-4892(03)00038-9; Korst RJ, 2002, MOL THER, V5, P307, DOI 10.1006/mthe.2002.0538; Kumano K, 1999, AM J RESP CRIT CARE, V160, P873, DOI 10.1164/ajrccm.160.3.9805026; Lambrecht BN, 2001, CLIN EXP ALLERGY, V31, P206, DOI 10.1046/j.1365-2222.2001.01061.x; LEE J, 1995, J IMMUNOL, V155, P2158; Lee YL, 1999, IMMUNOLOGY, V97, P232, DOI 10.1046/j.1365-2567.1999.00768.x; Lee YL, 1998, HUM GENE THER, V9, P457, DOI 10.1089/hum.1998.9.4-457; Lee YL, 2001, HUM GENE THER, V12, P2065, DOI 10.1089/10430340152677412; Li XM, 1996, J IMMUNOL, V157, P3216; LIRA SA, 1994, J EXP MED, V180, P2039, DOI 10.1084/jem.180.6.2039; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Meeusen ENT, 1996, IMMUNOL TODAY, V17, P421, DOI 10.1016/0167-5699(96)10055-4; Mercier S, 2002, J VIROL, V76, P2899, DOI 10.1128/JVI.76.6.2899-2911.2002; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Rea D, 1999, J VIROL, V73, P10245, DOI 10.1128/JVI.73.12.10245-10253.1999; Schwarze J, 1998, J ALLERGY CLIN IMMUN, V102, P86, DOI 10.1016/S0091-6749(98)70058-2; Stampfli MR, 1999, AM J RESP CELL MOL, V21, P317; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Walter DM, 2001, J IMMUNOL, V166, P6392, DOI 10.4049/jimmunol.166.10.6392; Wang CC, 1998, IMMUNOLOGY, V93, P307; Yang X, 2002, IMMUNOLOGY, V105, P336, DOI 10.1046/j.0019-2805.2002.01377.x; Ye YL, 2002, CYTOKINE, V19, P76, DOI 10.1006/cyto.2002.1950; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Yoshimura S, 2001, INT IMMUNOL, V13, P675, DOI 10.1093/intimm/13.5.675; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	43	10	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2004	114	1					88	96		10.1016/j.jaci.2004.03.010	http://dx.doi.org/10.1016/j.jaci.2004.03.010			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	836DA	15241349				2022-12-18	WOS:000222534300013
J	Lee, SH; Kiss, A; Xu, M; Qian, YP; Bashoura, L; Kheradmand, F; Corry, DB				Lee, SH; Kiss, A; Xu, M; Qian, YP; Bashoura, L; Kheradmand, F; Corry, DB			Airway glycoprotein secretion parallels production and predicts airway obstruction in pulmonary allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; glycoprotein; jacalin; IL-13; allergen; airway hyperresponsiveness	GOBLET CELL HYPERPLASIA; MURINE MODEL; MUCUS PRODUCTION; ATOPIC ASTHMA; LUNG-DISEASE; HYPERREACTIVITY; INFLAMMATION; LECTIN; MICE; INTERLEUKIN-4	Background: Airway obstruction, perhaps the most relevant clinical feature of asthma, is typically assessed in allergic asthma models as airway hyperresponsiveness. Excess secretion of airway glycoproteins also contributes to airway obstruction in asthma but is not measured as part of most experimental models. Objective: The purposes of this study were to develop a reliable, quantitative assay for detecting secreted airway glycoproteins and to assess the secretion of airway glycoproteins in comparison with other markers of airway obstruction resulting from allergic lung inflammation. Methods: Two microtiter plate-based glycoprotein-detecting methods were developed, one using an antiglycoprotein antibody and the other using the glycoprotein-binding plant lectin, jacalin. Both methods were used to assess airway glycoprotein secretion in response to 2 defined agonists given intranasally, IL-13 and an allergen derived from Aspergillus fumigatus. Glycoprotein secretion was assessed concomitant with another measure of airway obstruction, airway hyperresponsiveness provoked by acetylcholine challenge, and a histologic method for quantitating glycoprotein production. Results: Both assays were sufficient for quantitating airway glycoproteins over the full range of values encountered from murine bronchoalveolar lavage and yielded highly reproducible data. Secretion of airway glycoproteins increased commensurate with the detection of both airway hyperresponsiveness and airway glycoprotein production induced by IL-13 and allergen. Conclusion: Airway glycoprotein secretion is a consistent feature of the allergic lung phenotype and likely contributes to airway obstruction induced by allergen in both humans and rodents.	Baylor Coll Med, Dept Immunol, Biol Inflammat Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Biol Inflammat Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Corry, DB (corresponding author), Baylor Coll Med, Dept Immunol, Biol Inflammat Ctr, 1 Baylor Plaza,Suite 520B, Houston, TX 77030 USA.		Lee, Seung-Hyo/B-9922-2015	Lee, Seung-Hyo/0000-0003-0010-4072; Bashoura, Lara/0000-0003-1126-4039	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064061, R01HL069585] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL69585, HL64061] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agusti C, 1998, AM J RESP CRIT CARE, V158, P1253, DOI 10.1164/ajrccm.158.4.9801041; AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Blyth DI, 1998, AM J RESP CELL MOL, V19, P38, DOI 10.1165/ajrcmb.19.1.2930; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; Cohn L, 1999, J IMMUNOL, V162, P6178; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Corry DB, 1998, MOL MED, V4, P344, DOI 10.1007/BF03401741; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; CULLINA MJ, 1993, CLIN CHIM ACTA, V216, P23, DOI 10.1016/0009-8981(93)90136-R; FLORA GS, 1991, ALLERGY PROC, V12, P169, DOI 10.2500/108854191778879476; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Jackson A, 2002, NOVART FDN SYMP, V248, P94; JACKSON A, 2002, NOVART FDN SYMP, V248, P6; JACKSON A, 2002, NOVART FDN SYMP, V248, P277; Kabir S, 1998, J IMMUNOL METHODS, V212, P193, DOI 10.1016/S0022-1759(98)00021-0; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Krinzman SJ, 1996, AM J PHYSIOL-LUNG C, V271, pL476, DOI 10.1152/ajplung.1996.271.3.L476; LANGE P, 1990, THORAX, V45, P579, DOI 10.1136/thx.45.8.579; LEWIS JF, 1967, SOUTHERN MED J, V60, P549, DOI 10.1097/00007611-196705000-00022; McMillan S, 2002, J EXP MED, V195, P51, DOI 10.1084/jem.20011732; PON DJ, 1994, AM J RESP CELL MOL, V10, P625, DOI 10.1165/ajrcmb.10.6.7516172; Rao M, 1991, J Assoc Acad Minor Phys, V2, P127; SHEEHAN JK, 1995, AM J RESP CELL MOL, V13, P748, DOI 10.1165/ajrcmb.13.6.7576713; Shim JJ, 2001, AM J PHYSIOL-LUNG C, V280, pL134, DOI 10.1152/ajplung.2001.280.1.L134; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; STGEORGE JA, 1985, AM REV RESPIR DIS, V132, P556; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wu AM, 1997, INDIAN J BIOCHEM BIO, V34, P61; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3	33	10	11	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2004	113	1					72	78		10.1016/j.jaci.2003.09.039	http://dx.doi.org/10.1016/j.jaci.2003.09.039			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	760MP	14713910				2022-12-18	WOS:000187837900009
J	Gijzen, M; Gonzalez, R; Barber, D; Polo, F				Gijzen, M; Gonzalez, R; Barber, D; Polo, F			Levels of airborne Gly m 1 in regions of soybean cultivation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HYDROPHOBIC PROTEIN; DUST		Agr & Agri Food Canada, London, ON, Canada; ALK Abello SA, Madrid, Spain	Agriculture & Agri Food Canada; ALK-Abello AS	Gijzen, M (corresponding author), Agr & Agri Food Canada, London, ON, Canada.		Gijzen, Mark/C-6284-2011; Barber, Domingo/Y-9516-2019	Gijzen, Mark/0000-0002-3715-6389; Barber, Domingo/0000-0002-5488-5700				ACEVES M, 1991, J ALLERGY CLIN IMMUN, V88, P124, DOI 10.1016/0091-6749(91)90309-C; ANTO JM, 1989, NEW ENGL J MED, V320, P1097, DOI 10.1056/NEJM198904273201701; Burge HA, 2000, ENVIRON HEALTH PERSP, V108, P653, DOI 10.2307/3454401; Gijzen M, 1999, PLANT PHYSIOL, V120, P951, DOI 10.1104/pp.120.4.951; GONZALEZ R, 1995, LANCET, V346, P48, DOI 10.1016/S0140-6736(95)92676-3; Gonzalez R, 2000, ALLERGY, V55, P59, DOI 10.1034/j.1398-9995.2000.00366.x	6	10	10	0	4	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2003	112	4					803	805		10.1016/S0091-6749(03)01884-0	http://dx.doi.org/10.1016/S0091-6749(03)01884-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	730LA	14564369				2022-12-18	WOS:000185831200026
J	Hochreiter, R; Ferreira, F; Thalhamer, J; Hammerl, P				Hochreiter, R; Ferreira, F; Thalhamer, J; Hammerl, P			T(H)1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: No evidence for the synthesis of nonanaphylactic IgG1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergy; anaphylaxis; mouse; nonanaphylactic IgG1; T(H)1; T(H)2; genetic immunization; birch pollen; celery	FC-GAMMA-RIIB; DEFICIENT MICE; GENETIC IMMUNIZATION; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; MAJOR ALLERGEN; IGE SYNTHESIS; BIRCH POLLEN; IN-VIVO; INTERLEUKIN-4	Background: In mouse, IgG1 has been reported to make up 2 functionally distinct phenotypes that also differ in their induction requirements. One of these phenotypes lacks anaphylactic activity. Objective: We hypothesized that nonanaphylactic IgG1 could modulate allergic reactions and investigated whether such antibodies are induced by DNA immunization. Methods: Mice were immunized with allergen-encoding plasmid DNA or with recombinant allergens and alum. Sera were analyzed for IgG subclasses by ELISA for anaphylactic IgE by rat basophil degranulation, and after beat inactivation of IgE for anaphylactic IgG by passive cutaneous anaphylaxis assay. IFN-gamma and IL-5 from in-vitro restimulated spleen cells were quantitated by ELISA. Results: After protein immunization, mice produced IgG1 and IgE, whereas DNA immunization elicited IgG1 and IgG2a but no IgE. However, all sera were positive for non-IgE-mediated passive cutaneous anaphylaxis. In the presence of anaphylactic IgG1, the additional occurrence of nonanaphylactic IgG1 cannot be strictly ruled out. To circumvent this problem, we immunized IL-4 receptor-deficient mice against Bet v la, because anaphylactic but not nonanaphylactic IgG1 has been reported to depend on IL-4. These animals produced only low amounts of IgG1, but sera were again positive for non-IgE-mediated anaphylactic activity. Conclusions: Our results revealed no evidence for the production of nonanaphylactic IgG1. Furthermore, our data indicate that the development of non-IgE-mediated anaphylaxis does not require IL-4 receptor signaling.	Salzburg Univ, Inst Chem & Biochem, A-5020 Salzburg, Austria; Salzburg Univ, Inst Genet, A-5020 Salzburg, Austria	Salzburg University; Salzburg University	Hammerl, P (corresponding author), Salzburg Univ, Inst Chem & Biochem, Hellbrunnerstr 34, A-5020 Salzburg, Austria.		Ferreira, Fatima/E-4889-2011; Thalhamer, Josef/E-5787-2011; Ferreira, Fatima/AAB-4321-2019	Ferreira, Fatima/0000-0003-0989-2335; Thalhamer, Josef/0000-0003-2285-6400; Ferreira, Fatima/0000-0003-0989-2335				Adel-Patient K, 2001, INT ARCH ALLERGY IMM, V126, P59, DOI 10.1159/000049495; ALBER G, 1992, J IMMUNOL, V149, P2428; Broide D, 2000, SPRINGER SEMIN IMMUN, V22, P117, DOI 10.1007/s002810050021; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; de Vries JE, 1999, J ALLERGY CLIN IMMUN, V103, pS492, DOI 10.1016/S0091-6749(99)70166-1; DELPRETE GF, 1993, EUR J IMMUNOL, V23, P1445, DOI 10.1002/eji.1830230707; EY PL, 1979, NATURE, V281, P492, DOI 10.1038/281492a0; Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572; Faquim-Mauro EL, 2000, INT IMMUNOL, V12, P1733, DOI 10.1093/intimm/12.12.1733; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Hartl A, 1999, J ALLERGY CLIN IMMUN, V103, P107, DOI 10.1016/S0091-6749(99)70533-6; Hartl A, 1999, INT ARCH ALLERGY IMM, V120, P17, DOI 10.1159/000024216; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Hoffmann A, 1997, J ALLERGY CLIN IMMUN, V99, P227, DOI 10.1016/S0091-6749(97)70101-5; Horner AA, 2000, J ALLERGY CLIN IMMUN, V106, P349, DOI 10.1067/mai.2000.107933; Hsu CH, 1996, NAT MED, V2, P540, DOI 10.1038/nm0596-540; Jilek S, 2001, J IMMUNOL, V166, P3612, DOI 10.4049/jimmunol.166.5.3612; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lesourne R, 2001, J BIOL CHEM, V276, P6327, DOI 10.1074/jbc.M006537200; Li XM, 1999, J IMMUNOL, V162, P3045; MOON HB, 1989, SCAND J IMMUNOL, V30, P355, DOI 10.1111/j.1365-3083.1989.tb01221.x; MOTA I, 1982, IMMUNOL LETT, V5, P107, DOI 10.1016/0165-2478(82)90042-6; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Oettgen HC, 2001, J ALLERGY CLIN IMMUN, V107, P429, DOI 10.1067/mai.2001.113759; Parronchi P, 1999, CURR TOP MICROBIOL, V238, P27; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; Peng HJ, 2002, VACCINE, V20, P1761, DOI 10.1016/S0264-410X(02)00029-4; Piccinni MP, 2000, ANN NY ACAD SCI, V917, P844; Raz E, 1996, P NATL ACAD SCI USA, V93, P5141, DOI 10.1073/pnas.93.10.5141; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; SEGAL DM, 1981, J IMMUNOL, V126, P138; Singh VK, 1999, IMMUNOL RES, V20, P147, DOI 10.1007/BF02786470; Slater JE, 1998, J ALLERGY CLIN IMMUN, V102, P469, DOI 10.1016/S0091-6749(98)70137-X; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; WIERENGA EA, 1990, J IMMUNOL, V144, P4651	38	10	10	0	5	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2003	112	3					579	584		10.1067/mai.2003.1652	http://dx.doi.org/10.1067/mai.2003.1652			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	719XW	13679818				2022-12-18	WOS:000185231200018
J	Miller, RL; Cheng, M; DiMango, EA; Geromanos, K; Rothman, PB				Miller, RL; Cheng, M; DiMango, EA; Geromanos, K; Rothman, PB		Am Lung Ass	T-cell responses and hypersensitivity to influenza and egg antigens among adults with asthma immunized with the influenza vaccine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						influenza vaccine; egg hypersensitivity; asthma triggers	CHILDREN; VIRUS	Background: The American Lung Association Asthma Clinical Research Centers (ALA-ACRC) reported that the inactivated influenza vaccine is safe for patients with asthma and recommended its use to reduce the morbidity associated with infection. Objective: Because the ALA-ACRC's recommendation would include vaccination of all patients with asthma, including those with severe asthma and first-time vaccinces, we conducted a parallel study to address whether patients with asthma who report bronchospasm after vaccination might be demonstrating a hypersensitivity response to the vaccine. Methods: Thirty-two adult patients with asthma from the ALA-ACRC cohort were recruited. Subjects were randomly assigned to receive influenza vaccine or placebo and then recorded asthma symptoms and peak expiratory flow rates for 14 days. On day 14, influenza vaccine and egg antigen-induced mononuclear cell proliferation and IFN-gamma, IL-5, and IL-4 production were measured and compared with symptoms. Results: Increased influenza but not egg antigen-induced mononuclear cell proliferation was present among vaccinated subjects. These responses were unrelated to asthma exacerbations after vaccine. There were no differences in cytokine production in response to either influenza or egg antigen in association with asthma exacerbations. Conclusions: Episodes of bronchospasm after influenza vaccination do not seem related to hypersensitivity to the vaccine.	Columbia Univ Coll Phys & Surg, Dept Med, Div Pulm Allergy Crit Care, New York, NY 10032 USA	Columbia University	Rothman, PB (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Div Pulm Allergy Crit Care, 630 W 168th St, New York, NY 10032 USA.							BELL TD, 1978, CHEST, V73, P140, DOI 10.1378/chest.73.2.140; BERNHISELBROADBENT J, 1994, J ALLERGY CLIN IMMUN, V93, P1047, DOI 10.1016/S0091-6749(94)70054-0; Bernstein ED, 1998, VACCINE, V16, P1722, DOI 10.1016/S0264-410X(98)00140-6; Castro M, 2001, NEW ENGL J MED, V345, P1529, DOI 10.1056/NEJMoa011961; Miller RL, 2001, AM J RESP CRIT CARE, V164, P995, DOI 10.1164/ajrccm.164.6.2011107; Nicholson KG, 1998, LANCET, V351, P326, DOI 10.1016/S0140-6736(97)07468-0; Powers DC, 1997, J INFECT DIS, V175, P342, DOI 10.1093/infdis/175.2.342; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; 2000, FLUOZONE PRODUCT INS	9	10	10	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2003	112	3					606	608		10.1067/mai.2003.1645	http://dx.doi.org/10.1067/mai.2003.1645			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	719XW	13679822				2022-12-18	WOS:000185231200022
J	Peake, HL; Currie, AJ; Stewart, GA; McWilliam, AS				Peake, HL; Currie, AJ; Stewart, GA; McWilliam, AS			Nitric oxide production by alveolar macrophages in response to house dust mite fecal pellets and the mite allergens, Der p 1 and Der p 2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						house dust mitefiecal pellets; nitric oxide; inducible nitric oxide synthase; macrophages; mite allergens; Der p 1	DER-P-I; MAJOR ALLERGEN; EXHALED AIR; DERMATOPHAGOIDES; SYNTHASE; ASTHMA; EXPRESSION; EXPOSURE; RELEASE	Background: Allergens are frequently found within or attached to particulate material. For example, house dust mite fecal pellets (HDMFP) contain the major mite allergens, exposure to which have been implicated in the development of asthma. Although several studies have examined the ability of purified allergens to generate inflammatory responses, few studies have investigated whether HDMFP per se, are biologically active. Objective: Our objective was to examine the ability of whole HDMFP to stimulate nitric oxide (NO) release from alveolar macrophages. Methods: The rat alveolar macrophage cell line, NR8383, was exposed to HDMFP, Der p 1, or Der p 2, and nitrite levels in the culture supernatants were measured with the Griess reagent. NO synthase mRNA expression was determined by RT-PCR. Results: HDMFP stimulated the production of NO in a dose-dependent and time-dependent manner, with maximum NO levels measured after 48 hours of exposure. Inclusion of polymyxin B did not influence NO production, suggesting that LPS was not responsible for NO production. HDMFP-mediated NO release was down-modulated after treatment with N-G-nitro-L-arginine methyl ester (L-NAME), dexamethasone, EDTA, and cysteine, but not heat treatment. Inducible nitric oxide synthase mRNA was observed 3 hours after HDMFP exposure, with maximum levels after 48 hours. Both purified Der p I and Der p 2 induced NO production, and inhibition of the cysteine protease activity of Der p I had little effect on NO production. Conclusions: HDMFP, Der p I and Der p 2 are potent inducers of NO. Neither LPS nor the enzymatic activity of Der p 1 was responsible for NO production observed.	Curtin Univ Technol, Sch Pharm, Perth, WA 6845, Australia; Univ Western Australia, Sch Biomed & Chem Sci, Dept Microbiol, Nedlands, WA 6009, Australia; British Columbia Res Inst, Vancouver, BC, Canada	Curtin University; University of Western Australia	McWilliam, AS (corresponding author), Curtin Univ Technol, Sch Pharm, GPO Box U1987, Perth, WA 6845, Australia.		Currie, Andrew/C-2778-2015	Currie, Andrew/0000-0002-5193-3404				ALVING K, 1993, EUR RESPIR J, V6, P1368; BARNES PJ, 1993, THORAX, V48, P1034, DOI 10.1136/thx.48.10.1034; Boland S, 1999, AM J PHYSIOL-LUNG C, V276, pL604, DOI 10.1152/ajplung.1999.276.4.L604; COOK HT, 1994, CLIN EXP IMMUNOL, V97, P315; Currie AJ, 2000, J IMMUNOL, V164, P3878, DOI 10.4049/jimmunol.164.7.3878; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Greenberg SS, 1998, NITRIC OXIDE-BIOL CH, V2, P203, DOI 10.1006/niox.1998.0176; HAMID Q, 1993, LANCET, V342, P1510, DOI 10.1016/S0140-6736(05)80083-2; HERBERT CA, 1995, AM J RESP CELL MOL, V12, P369, DOI 10.1165/ajrcmb.12.4.7695916; HEWITT CRA, 1995, J EXP MED, V182, P1537, DOI 10.1084/jem.182.5.1537; Hogg JC, 1999, APPL ENVIRON MICROB, V65, P4227; KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8; King C, 1998, J IMMUNOL, V161, P3645; Knox RB, 1997, CLIN EXP ALLERGY, V27, P246; LOMBARDERO M, 1990, J IMMUNOL, V144, P1353; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Oh H., 1986, Japanese Journal of Sanitary Zoology, V37, P229; PlattsMills TAE, 1997, NEW ENGL J MED, V336, P1382, DOI 10.1056/NEJM199705083361909; PLATTSMILLS TAE, 1982, LANCET, V2, P675; Prime G, 2000, DEV BRAIN RES, V119, P111, DOI 10.1016/S0165-3806(99)00132-7; ROBBINS RA, 1994, BIOCHEM BIOPH RES CO, V203, P209, DOI 10.1006/bbrc.1994.2169; SCHULZ O, 1995, EUR J IMMUNOL, V25, P3191, DOI 10.1002/eji.1830251131; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Schulz O, 1998, J CLIN PATHOL-MOL PA, V51, P222, DOI 10.1136/mp.51.4.222; Shahan TA, 1998, AM J RESP CELL MOL, V18, P435, DOI 10.1165/ajrcmb.18.3.2856; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; SRIVIVASAN A, 2000, P 17 INT C ALL CLIN, P176; Thomas M C, 2000, BMC Nephrol, V1, P1, DOI 10.1186/1471-2369-1-1; TONNEL AB, 1983, LANCET, V1, P1406; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; WHARTON GW, 1972, J PARASITOL, V58, P801, DOI 10.2307/3278321; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210	32	10	12	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2003	112	3					531	537		10.1067/mai.2003.1655	http://dx.doi.org/10.1067/mai.2003.1655			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	719XW	13679812				2022-12-18	WOS:000185231200012
J	Kaul, S; Scheurer, S; Danz, N; Schicktanz, S; Vieths, S; Hoffmann, A				Kaul, S; Scheurer, S; Danz, N; Schicktanz, S; Vieths, S; Hoffmann, A			Monoclonal IgE antibodies against birch pollen allergens: Novel tools for biological characterization and standardization of allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergen standardization; monoclonal IgE antibodies; RBL cells; birch pollen allergens; mediator release	DNP SPECIFICITY; CELL-LINES; MURINE; HYBRIDOMAS; EPITOPE; PROTEINS; BET-V-1; RELEASE; CLONING; DER-F-2	Background: IgE antibodies are key players in immediate hypersensitivity reactions. Allergen characterization and standardization is usually based on the sera of allergic patients, whereas monoclonal IgE antibodies specific for clinically relevant allergens are very rare. Objective: The aim of this study was to establish IgE mAbs specific for birch pollen allergens, because these are important inhalant allergens. Methods: IgE-producing hybridomas were identified by using the highly sensitive rat basophilic leukemia cell mediator release assay with enhanced allergen stimulation by additional cross-linking with birch pollen-specific IgG antibodies. The obtained IgE mAbs were characterized by immunologic methods and by cDNA sequencing. Results: Seven IgE mAbs specific for the birch pollen allergens Bet v 1 or Bet v 6 were obtained and were all biologically active in mast cell-based assays. Mediator release experiments with mAb combinations indicated that 2 different epitope regions were recognized on Bet v 1, whereas the 2 Bet v 6-specific mAbs bound to the same epitope region. After sensitization of rat basophilic leukemia cells with IgE mAbs, different amounts of Bet v 1 or Bet v 6 were detected in commercial diagnostic allergen reagents, whereas sensitization with polyclonal IgE resulted in similar allergenic potency of all products. Conclusions: IgE mAbs represent promising novel tools for allergen characterization and component-resolved standardization of allergen extracts.	Paul Ehrlich Inst, Div Allergol, D-63225 Langen, Germany	Paul Ehrlich Institute	Kaul, S (corresponding author), Paul Ehrlich Inst, Div Allergol, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.		Scheurer, Stephan/A-6509-2019	Scheurer, Stephan/0000-0002-2859-562X				BOHN A, 1982, IMMUNOLOGY, V47, P297; BOTTCHER I, 1980, INT ARCH ALLER A IMM, V61, P248, DOI 10.1159/000232441; BOTTCHER I, 1978, NATURE, V275, P761, DOI 10.1038/275761a0; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; CABILLY S, 1985, GENE, V40, P157, DOI 10.1016/0378-1119(85)90037-X; CARROLL WL, 1988, MOL IMMUNOL, V25, P991, DOI 10.1016/0161-5890(88)90005-3; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Elsayed S, 1991, Scand J Clin Lab Invest Suppl, V204, P17; Engel H, 1999, EUR J IMMUNOL, V29, P2167, DOI 10.1002/(SICI)1521-4141(199907)29:07<2167::AID-IMMU2167>3.3.CO;2-8; ESHHAR Z, 1980, J IMMUNOL, V124, P775; Ferreira F, 1997, INT ARCH ALLERGY IMM, V113, P125, DOI 10.1159/000237524; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Ganglberger E, 2000, FASEB J, V14, P2177, DOI 10.1096/fj.99-1000com; Gu H, 1986, Shi Yan Sheng Wu Xue Bao, V19, P109; Hoffmann A, 1997, J ALLERGY CLIN IMMUN, V99, P227, DOI 10.1016/S0091-6749(97)70101-5; Hoffmann A, 1999, ALLERGY, V54, P446, DOI 10.1034/j.1398-9995.1999.00917.x; Karamloo F, 2001, EUR J BIOCHEM, V268, P5310, DOI 10.1046/j.0014-2956.2001.02463.x; Karamloo F, 1999, J ALLERGY CLIN IMMUN, V104, P991, DOI 10.1016/S0091-6749(99)70080-1; Kaul S, 2001, ALTEX-ALTERN TIEREXP, V18, P55; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; LIU FT, 1984, HYBRIDOMA, V3, P277, DOI 10.1089/hyb.1984.3.277; LIU FT, 1980, J IMMUNOL, V124, P2728; LOWENSTEIN H, 1994, ARB PEI GSH, V87, P49; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; NICHOLLS PJ, 1993, J IMMUNOL METHODS, V165, P81, DOI 10.1016/0022-1759(93)90109-K; Nishiyama C, 1999, MOL IMMUNOL, V36, P53, DOI 10.1016/S0161-5890(98)00112-6; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Peters JH, 1990, MONOKLONALE ANTIKORP; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Smith AM, 1997, CLIN EXP ALLERGY, V27, P593, DOI 10.1111/j.1365-2222.1997.tb00750.x; Takai T, 1997, MOL IMMUNOL, V34, P255, DOI 10.1016/S0161-5890(97)00020-5; van Kampen V, 2001, ALLERGY, V56, P118, DOI 10.1034/j.1398-9995.2001.056002118.x; Wellhausen A, 1996, Z ERNAHRUNGSWISS, V35, P348, DOI 10.1007/BF01610553	34	10	12	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2003	111	6					1262	1268		10.1067/mai.2003.1510	http://dx.doi.org/10.1067/mai.2003.1510			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	688FZ	12789227				2022-12-18	WOS:000183424700015
J	Cohen, SG				Cohen, SG			Noon and Freeman on prophylactic inoculation against hey fever	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									NIAID, Natl Lib Med, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Library of Medicine (NLM)	Cohen, SG (corresponding author), NIAID, Natl Lib Med, NIH, Bethesda, MD USA.							BEHRING EA, 1913, DEUT MED WOCHENSCHR, V39, P875; Behring EV., 1890, DEUT MED WOCHENSCHR, V49, P1113; Blackley CH., 1873, EXPT RES CAUSES NATU; Cohen SG, 2002, J ALLERGY CLIN IMMUN, V110, P674; COHEN SG, 1983, N ENGL REG ALLERGY P, V4, P316; COHEN SG, 1983, N ENGL REG ALLERGY P, V4, P329; Colebrook L., 1954, A WRIGHT PROVOCATIVE, P61; Ehrlich P., 1891, DEUT MED WOCHENSCHR, V17, P979, DOI [10.1055/s-0029-1206682, DOI 10.1055/S-0029-1206682]; Freeman J, 1911, LANCET, V2, P814; KOLMER JA, 1943, CLIN IMMUNOLOGY BIOT, P491; Noon L, 1911, LANCET, V1, P1572; Roux E., 1888, ANN I PASTEUR PARIS, V2, P629; SAUNDERS JF, 1988, J IMMUNOL, V141, pS37; WEICHARDTERLANG.W, 1906, BERL KLIN WOCHENSCHR, V43, P1184; 1913, J HYGIENE, V13, P145	15	10	12	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2003	111	5					1142	1144		10.1016/S0091-6749(03)80153-7	http://dx.doi.org/10.1016/S0091-6749(03)80153-7			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	679DA	12743591	Bronze			2022-12-18	WOS:000182904500041
J	Jacobs, RL				Jacobs, RL			Hypersensitivity pneumonia: UIP/IPF histopathologic presentation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DISEASE; LUNG		Biogen Res Inst, San Antonio, TX 78229 USA		Jacobs, RL (corresponding author), Biogen Res Inst, 8229 Fredericksburg Rd, San Antonio, TX 78229 USA.			Jacobs, Robert/0000-0002-2831-9086				*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; GREENBERGER PA, 1989, AM J MED, V86, P119, DOI 10.1016/0002-9343(89)90243-X; HAMMAR S, 1988, PATHOL ANNU, V23, P195; Jacobs RL, 2002, ANN ALLERG ASTHMA IM, V88, P30, DOI 10.1016/S1081-1206(10)63590-9; LYNCH DA, 1995, AM J ROENTGENOL, V165, P807, DOI 10.2214/ajr.165.4.7676971; PEREZPADILLA R, 1993, AM REV RESPIR DIS, V148, P49, DOI 10.1164/ajrccm/148.1.49	6	10	12	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2002	110	3					532	533		10.1067/mai.2002.126657	http://dx.doi.org/10.1067/mai.2002.126657			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	592KM	12209109				2022-12-18	WOS:000177936900032
J	Reiter, JE				Reiter, JE			Latex sensitivity: An industrial hygiene perspective	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on Natural Rubber Latex Sensitivity	FEB 09-10, 2001	SAN FRANCISCO, CA	Malaysian Rubber Res Inst		latex; allergen; sensitization; industrial hygiene; remediation		As a result of the increase in latex product manufacturing and use during the last 10 to 13 years, latex sensitivity has become an important health issue. Requests for evaluation and control of potential exposure to latex allergens have prompted questions about how to best sample surfaces and the air for the presence and concentration of latex allergens, a search for reasonable occupational exposure limits, and means and methods of control or remediation. In this article, evaluation of latex allergens on surfaces, in residual dust, and in the air is discussed. Interpretation and application of reasonable suggested occupational exposure limits and the need for additional research in this area are also discussed. Suggestions for control and remediation are based on successful programs and projects resulting in elimination of latex and residual latex allergens in health care settings. Measurement of latex allergens on surfaces and in the air and comparison with suggested occupational exposure limits are viable means of risk analysis, and control and remediation can be successful, permitting sensitized individuals to return to the workplace.	Kisco Inc, Menomonee Falls, WI 53051 USA		Reiter, JE (corresponding author), Kisco Inc, N80 W 14038 St George Ct, Menomonee Falls, WI 53051 USA.							*AM C GOV IND HYG, 1991, DOC THRESH LIM VAL B, V3, P1581; *AM C GOV IND HYG, 1991, DOC THRESH LIM VAL B, pR3; *ASTM, 2001, E197399 ASTM; Cassinelli M.E., 1994, NIOSH MANUAL ANAL ME; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P443; CHAROUS BL, 1995, ANN ALLERG ASTHMA IM, V75, P19; Dinardi SR, 1997, OCCUPATIONAL ENV ITS; Korniewicz D M, 1995, AORN J, V61, P1037, DOI 10.1016/S0001-2092(06)63807-6; McCormack B, 1995, AAOHN J, V43, P190; *NAT I OCC SAF HLT, 1994, REC EXP LIM RELS; *OCC SAF HLTH ADM, 1999, OCC SAF HLTH ADM TEC; *OCC SAF HLTH ADM, 1993, FED REGISTER, V58, P35338; Reed CE, 1999, ASTHMA WORKPLACE, P249; Swanson MC, 1996, NATO ASI 2, V11, P257; *TASK FORC ALL REA, 1993, J ALLERGY CLIN IMMUN, V92, P16; TOMAZIC VJ, 1994, J ALLERGY CLIN IMMUN, V93, P751, DOI 10.1016/0091-6749(94)90255-0; *US DEP HHS, 1997, NAT I OCC SAF HLTH A; VANDENPLAS O, 1995, AM J RESP CRIT CARE, V151, P887; WOODARD ED, 1988, JAMA-J AM MED ASSOC, V259, P1965, DOI 10.1001/jama.259.13.1965	19	10	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2002	110	2		S			S121	S128		10.1067/mai.2002.125595	http://dx.doi.org/10.1067/mai.2002.125595			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	586ET	12170253				2022-12-18	WOS:000177572200018
J	Chowdhury, BA; Meyer, RJ				Chowdhury, BA; Meyer, RJ			Intramuscular versus subcutaneous injection of epinephrine in the treatment of anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									US FDA, Ctr Drug Evaluat & Res, Div Pulm & Allergy Drug Prod, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Chowdhury, BA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Pulm & Allergy Drug Prod, Rockville, MD 20857 USA.							AUSTEN KF, 2001, HARRISONS PRINCIPLES, P1915; Estelle F, 2001, J ALLERGY CLIN IMMUN, V108, P871, DOI 10.1067/mai.2001.119409; *MED EC CO, 2002, PHYS DESK REF; THOW JC, 1992, DIABETIC MED, V9, P915, DOI 10.1111/j.1464-5491.1992.tb01731.x	4	10	10	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2002	109	4					720	720		10.1067/mai.2002.123252	http://dx.doi.org/10.1067/mai.2002.123252			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	543YZ	11941328				2022-12-18	WOS:000175132600027
J	Iikura, M; Yamaguchi, M; Hirai, K; Suenaga, A; Fujiwara, T; Fujii, T; Taketani, Y; Yamamoto, K				Iikura, M; Yamaguchi, M; Hirai, K; Suenaga, A; Fujiwara, T; Fujii, T; Taketani, Y; Yamamoto, K			Case report: Streptomycin-induced anaphylactic shock during oocyte retrieval procedures for in vitro fertilization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RELEASABILITY; BASOPHILS		Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Bioregulatory Funct, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Iikura, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.			IIKURA, MOTOYASU/0000-0001-5148-0612				ABECK D, 1994, ALLERGY, V49, P388, DOI 10.1111/j.1398-9995.1994.tb02288.x; CASOLARO V, 1989, AM REV RESPIR DIS, V139, P1375, DOI 10.1164/ajrccm/139.6.1375; KELLER H, 1984, MEYLERS SIDE EFFECTS, P492; Kepley CL, 1999, J ALLERGY CLIN IMMUN, V104, P279, DOI 10.1016/S0091-6749(99)70367-2; LICHTENSTEIN LM, 1986, J ALLERGY CLIN IMMUN, V77, P291, DOI 10.1016/S0091-6749(86)80106-3; MIDTVEDT T, 1993, SIDE EFFECTS DRUGS A, P303; ROSEN FL, 1948, JAMA-J AM MED ASSOC, V137, P1128, DOI 10.1001/jama.1948.82890470001006; Yamaguchi M, 1996, J ALLERGY CLIN IMMUN, V97, P1279, DOI 10.1016/S0091-6749(96)70196-3	8	10	11	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2002	109	3					571	572		10.1067/mai.2002.121533	http://dx.doi.org/10.1067/mai.2002.121533			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	534KW	11898008				2022-12-18	WOS:000174586400028
J	Asero, R; Mistrello, G; Roncarolo, D; Amato, S				Asero, R; Mistrello, G; Roncarolo, D; Amato, S			A case of allergy to airborne, heat-labile shrimp allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							TROPOMYOSIN; IDENTIFICATION		Osped Caduti Bollatesi, Ambulatorio Allergol, Bollate, MI, Italy; Lofarma SpA, Milan, Italy		Asero, R (corresponding author), Osped Caduti Bollatesi, Ambulatorio Allergol, Bollate, MI, Italy.		Amato, Sandra/AAH-4430-2021	Amato, Sandra/0000-0002-3277-0662				Bahna SL, 2001, ANN ALLERG ASTHMA IM, V86, P414, DOI 10.1016/S1081-1206(10)62487-8; Griffin P, 2001, CLIN EXP ALLERGY, V31, P928, DOI 10.1046/j.1365-2222.2001.01100.x; HOFFMAN DR, 1981, ANN ALLERGY, V47, P17; LEUNG PSC, 1994, J ALLERGY CLIN IMMUN, V94, P882, DOI 10.1016/0091-6749(94)90156-2; LIN RY, 1993, J ALLERGY CLIN IMMUN, V92, P837, DOI 10.1016/0091-6749(93)90061-J; MUSMAND JJ, 1993, CLIN EXP ALLERGY, V23, P722, DOI 10.1111/j.1365-2222.1993.tb00359.x; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; SHANTI KN, 1993, J IMMUNOL, V151, P5354; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	9	10	11	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2002	109	2					371	372		10.1067/mai.2002.121311	http://dx.doi.org/10.1067/mai.2002.121311			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	528EZ	11842314	Bronze			2022-12-18	WOS:000174232600029
J	Shiota, Y; Arikita, H; Horita, N; Hiyama, J; Ono, T; Yamakido, M				Shiota, Y; Arikita, H; Horita, N; Hiyama, J; Ono, T; Yamakido, M			Intracellular IL-5 and T-lymphocyte subsets in atopic and nonatopic bronchial asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CD8(+) T cell; IL-5; nonatopic asthma; flow cytometry	CELLS; INTERLEUKIN-5; ACTIVATION; CD4	Background: Allergen-stimulated IL-5 production by CD4+ T cells is the key issue in atopic asthma. On the other hand, virus-specific CD8+ T cells produce IL-5 and might play an important role in the pathogenesis of nonatopic asthma. Objectives: We sought to compare the IL-5-producing T-lymphocyte subsets in the peripheral blood of atopic and nonatopic asthmatic subjects, especially the contribution of IL-5-producing CD8(+) T cells in nonatopic asthma. Methods: Heparinized blood samples were obtained from subjects with atopic asthma (n = 10), subjects with nonatopic asthma (n = 10), and healthy subjects (n = 10) and stimulated with ionomycin and phorbol myristate acetate in the presence of brefeldin A. Two-color flow cytometric analysis with mAbs to cell-surface antigens and intracellular IL-5 was used to detect the IL-5-producing T-cell subsets. Results: A higher percentage of IL-5-producing CD3+ T cells was detected in subjects with atopic and nonatopic asthma than that seen in the healthy subjects. The percentage of IL-5-producing CD4(+) T cells was significantly higher in subjects with atopic asthma than in the healthy subjects. The percentage of IL-5-producing CD8(+) T cells was significantly higher in subjects with nonatopic asthma than in the healthy subjects. The percentage of IL-5-producing CD8(+) T cells was higher in subjects with nonatopic asthma than in those with atopic asthma, but the difference was not statistically significant. Conclusions: CD4(+) T cells are the major source of IL-5 among CD3(+) lymphocytes in subjects with atopic asthma. On the other hand, increased IL-5 production by CD8(+) T cells, as well as by CD4(+) T cells, is a characteristic feature of nonatopic asthma.	Kure Kyosai Hosp, Dept Clin Res, Kure 7378505, Japan; Kure Kyosai Hosp, Dept Internal Med, Kure 7378505, Japan		Shiota, Y (corresponding author), Kure Kyosai Hosp, Dept Clin Res, 2-3-38 Nishichuo, Kure 7378505, Japan.							[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Bardin PG, 2000, EUR RESPIR J, V16, P980, DOI 10.1183/09031936.00.16598000; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; CORRIGAN CJ, 1995, AM J RESP CELL MOL, V12, P567, DOI 10.1165/ajrcmb.12.5.7742019; COYLE AJ, 1995, J EXP MED, V181, P1229, DOI 10.1084/jem.181.3.1229; HUANG SK, 1993, J IMMUNOL, V150, pA138; Huang TJ, 1999, IMMUNOLOGY, V96, P416; JOHNSTON SL, 1998, PEDIATR PULM, V18, P141; MORI A, 1995, INT IMMUNOL, V7, P449, DOI 10.1093/intimm/7.3.449; NAKAJIMA H, 1992, AM REV RESPIR DIS, V146, P374, DOI 10.1164/ajrccm/146.2.374; RENZ H, 1994, J IMMUNOL, V152, P351; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; Schwarze J, 1999, J IMMUNOL, V163, P5729; STEPHEN T, 1997, J ALLERGY CLIN IMMUN, V99, P563; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; YING S, 1995, AM J RESP CELL MOL, V12, P477, DOI 10.1165/ajrcmb.12.5.7742012	18	10	13	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2002	109	2					294	298		10.1067/mai.2002.120757	http://dx.doi.org/10.1067/mai.2002.120757			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	528EZ	11842300	Bronze			2022-12-18	WOS:000174232600015
J	Ayuso, R; Reese, G; Arruda, LK; Chapman, MD; Lehrer, SB				Ayuso, R; Reese, G; Arruda, LK; Chapman, MD; Lehrer, SB			Identification of IgE-binding epitopes in allergenic invertebrate tropomyosins Per a 7, Pen a 1 and Der p 10 with cockroach and shrimp-allergic sera	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									St Johns Episcopal Hosp, Far Rockaway, NY USA; Paul Ehrlich Inst, D-6070 Langen, Germany; Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil; INDOOR Biotechnol Inc, Charlottesville, VA USA; Tulane Univ, New Orleans, LA 70118 USA	Paul Ehrlich Institute; Universidade de Sao Paulo; INDOOR Biotechnologies; Tulane University			Arruda, L. Karla/D-5845-2013	Arruda, L. Karla/0000-0002-7505-210X					0	10	10	1	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		247	S94	S94		10.1016/S0091-6749(02)81383-5	http://dx.doi.org/10.1016/S0091-6749(02)81383-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800246
J	Cyr, MM; Baatjes, AJ; Hayes, LM; Crawford, L; Denburg, JA				Cyr, MM; Baatjes, AJ; Hayes, LM; Crawford, L; Denburg, JA			The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: A placebo-controlled randomized study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									McMaster Univ, Hamilton, ON L8S 4L8, Canada	McMaster University									0	10	11	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		329	S117	S117		10.1016/S0091-6749(02)81465-8	http://dx.doi.org/10.1016/S0091-6749(02)81465-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800328
J	Fuchs, HC; Hoffmann-Sommergruber, K; Wagner, B; Krebitz, M; Scheiner, O; Breiteneder, H				Fuchs, HC; Hoffmann-Sommergruber, K; Wagner, B; Krebitz, M; Scheiner, O; Breiteneder, H			Heterologous expression in Nicotiana benthamiana of Cap a 1, a thaumatin-like protein and major allergen from bell pepper (Capsicum annuum)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Vienna, A-1010 Vienna, Austria	University of Vienna									0	10	10	1	5	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		390	S134	S135		10.1016/S0091-6749(02)81526-3	http://dx.doi.org/10.1016/S0091-6749(02)81526-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800389
J	Modlin, RL				Modlin, RL			Activation of toll-like receptors by microbial lipoproteins: Role in host defense	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	IVIG Advisory Meeting	OCT 26-29, 2000	SANTA BARBARA, CA	Bayer Biol		toll; innate immunity; tuberculosis; IL-12	MYCOBACTERIUM-TUBERCULOSIS INFECTION; SYNTHETIC LIPOPEPTIDE ANALOGS; BACTERIAL LIPOPROTEIN; TREPONEMA-PALLIDUM; LEISHMANIA-MAJOR; MYD88-DEFICIENT MICE; SIGNALING PATHWAY; ESCHERICHIA-COLI; DROSOPHILA TOLL; CUTTING EDGE	Conserved throughout evolution, mammalian toll-like receptors (TLRs) participate in innate immune response to microbial pathogens. The TLRs mediate activation by microbial ligands, resulting in cytokine activation as well as other host defense mechanisms. Activation of TLRs also can result in tissue injury including manifestations of septic shock and host cell apoptosis. In this manner, the activation of mammalian TLRs in the context of infectious disease can contribute to host defense and immunopathology.	Univ Calif Los Angeles, Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Modlin, RL (corresponding author), Univ Calif Los Angeles, Sch Med, Div Dermatol, Dept Med, 52-121 CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.		Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X				AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; ANDERSON GW, 1980, INFECT IMMUN, V28, P132, DOI 10.1128/IAI.28.1.132-136.1980; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; BESSLER WG, 1977, BIOCHEM BIOPH RES CO, V76, P239, DOI 10.1016/0006-291X(77)90717-3; BESSLER WG, 1985, J IMMUNOL, V135, P1900; BIESERT L, 1987, EUR J BIOCHEM, V162, P651, DOI 10.1111/j.1432-1033.1987.tb10687.x; BRAUN V, 1974, ANNU REV BIOCHEM, V43, P89, DOI 10.1146/annurev.bi.43.070174.000513; BRICKER TM, 1988, INFECT IMMUN, V56, P295, DOI 10.1128/IAI.56.2.295-301.1988; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; CHAMBERLAIN NR, 1989, INFECT IMMUN, V57, P2872, DOI 10.1128/IAI.57.9.2872-2877.1989; COOPER AM, 1995, IMMUNOLOGY, V84, P423; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; de Jong R, 1998, SCIENCE, V280, P1435; FLYNN JL, 1995, J IMMUNOL, V155, P2515; HAUSCHILDT S, 1990, EUR J IMMUNOL, V20, P63, DOI 10.1002/eji.1830200110; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HOFFMANN P, 1988, IMMUNOBIOLOGY, V177, P158, DOI 10.1016/S0171-2985(88)80036-6; Hou L, 2000, INFECT IMMUN, V68, P4681, DOI 10.1128/IAI.68.8.4681-4687.2000; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; MAILLARD J, 1972, J EXP MED, V136, P185, DOI 10.1084/jem.136.1.185; Medina E, 1998, IMMUNOLOGY, V93, P270, DOI 10.1046/j.1365-2567.1998.00419.x; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MELCHERS F, 1975, J EXP MED, V142, P473, DOI 10.1084/jem.142.2.473; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; RADOLF JD, 1995, J IMMUNOL, V154, P2866; RADOLF JD, 1988, INFECT IMMUN, V56, P490, DOI 10.1128/IAI.56.2.490-498.1988; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; WEINSTEIN DL, 1986, CELL IMMUNOL, V102, P68, DOI 10.1016/0008-8749(86)90326-6; WEIS JJ, 1994, INFECT IMMUN, V62, P4632, DOI 10.1128/IAI.62.10.4632-4636.1994; Yang RB, 1999, J IMMUNOL, V163, P639; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; ZHANG M, 1994, J CLIN INVEST, V93, P1733, DOI 10.1172/JCI117157	48	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2001	108	4		S			S104	S106		10.1067/mai.2001.118299	http://dx.doi.org/10.1067/mai.2001.118299			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	487KL	11586275				2022-12-18	WOS:000171874200005
J	Pelta, R; Quirce, S; Diaz, FJ				Pelta, R; Quirce, S; Diaz, FJ			Allergenic cross-reactivity between nickel and chromium salts in electroplating-induced asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							OCCUPATIONAL ASTHMA		Univ Autonoma Madrid, Fdn Jimenez Diaz, Dept Allergy, Madrid, Spain; CBF LETI SA, Res Labs, Madrid, Spain	Autonomous University of Madrid	Pelta, R (corresponding author), Univ Autonoma Madrid, Fdn Jimenez Diaz, Dept Allergy, Madrid, Spain.		s, q/AAD-7171-2020					Bright P, 1997, THORAX, V52, P28, DOI 10.1136/thx.52.1.28; CHANYEUNG M, 1990, CLIN REV ALLERG, V8, P147; DOLOVICH J, 1984, BRIT J IND MED, V41, P51; MALO JL, 1982, J ALLERGY CLIN IMMUN, V69, P55, DOI 10.1016/0091-6749(82)90088-4; NOVEY HS, 1983, J ALLERGY CLIN IMMUN, V72, P407, DOI 10.1016/0091-6749(83)90507-9; OLAGUIBEL JM, 1989, ALLERGOL IMMUNOPATH, V17, P173; PARK HS, 1994, CLIN EXP ALLERGY, V24, P676, DOI 10.1111/j.1365-2222.1994.tb00972.x	7	10	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2001	108	4					650	651						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	485NK	11590397				2022-12-18	WOS:000171760300030
J	Quan, A; McCall, MN; Sewell, WA				Quan, A; McCall, MN; Sewell, WA			Dexamethasone inhibits the binding of nuclear factors to the IL-5 promoter in human CD4(+)T cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						gene expression; glucocorticoids; electrophoretic mobility shift assay; interleukin; T(H)2 cells	INTERLEUKIN-5 GENE PROMOTER; TRANSCRIPTION FACTOR; ATOPIC ASTHMA; T-CELLS; IMMUNOSUPPRESSIVE AGENTS; GLUCOCORTICOID RECEPTOR; TH2 CELLS; EXPRESSION; GATA-3; ELEMENTS	Background: IL-5 is produced by the T(H)2 subset of CD4+ T lymphocytes and is necessary for the eosinophilia typical of allergic conditions. Glucocorticoids such as dexamethasone are highly effective inhibitors of eosinophilic inflammation, and one of their effects is inhibition of IL-5 gene expression. Objective: We wished to examine the effect of dexamethasone on the binding of nuclear factors from primary human CD4+ T lymphocytes to the RF-I and RE-II positively acting regulatory elements of the IL-5 promoter. Methods: CD4(+) T cells, purified from PBMCs by magnetic bead separation, were activated with anti-CD3 antibody and phorbol myristate acetate. Nuclear extracts were tested in electrophoretic mobility shift assays with probes based on RE-I and RE-II. Results: In extracts from activated cells, the RE-II region of the promoter formed a complex that was shown by supershift assay to contain NFATc. This complex was abolished by treatment of the cells with dexamethasone before activation and was weak or absent in unactivated cells. By contrast, binding to the RE-I region and to the GATA-3 site within RE-I was observed in resting cells and was not affected by activation or treatment with dexamethasone. Conclusion: Dexamethasone inhibits the inducible binding of factors to the RE-II region but does not affect the constitutive binding to the RE-I region. Characterization of such molecular effects of glucocorticoids could enable the development of specific inhibitors of IL-5 expression that lack the side effects of glucocorticolds.	St Vincents Hosp, Ctr Immunol, Darlinghurst, NSW 2010, Australia; Univ New S Wales, Kensington, NSW 2033, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney	Sewell, WA (corresponding author), St Vincents Hosp, Ctr Immunol, Darlinghurst, NSW 2010, Australia.							Agarwal S, 1999, J ALLERGY CLIN IMMUN, V103, P990, DOI 10.1016/S0091-6749(99)70168-5; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V102, P531, DOI 10.1016/S0091-6749(98)70268-4; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GRUARTGOUILLEUX V, 1995, EUR J IMMUNOL, V25, P1431, DOI 10.1002/eji.1830250544; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; JUNG T, 1995, EUR J IMMUNOL, V25, P2413, DOI 10.1002/eji.1830250843; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Lantelme E, 2001, IMMUNOLOGY, V102, P123, DOI 10.1046/j.1365-2567.2001.01168.x; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; LEE HJ, 1995, J BIOL CHEM, V270, P17541, DOI 10.1074/jbc.270.29.17196; MIYATAKE S, 1991, MOL CELL BIOL, V11, P5894, DOI 10.1128/MCB.11.12.5894; Mori A, 1997, BLOOD, V89, P2891, DOI 10.1182/blood.V89.8.2891; Nakamura Y, 1999, J ALLERGY CLIN IMMUN, V103, P215, DOI 10.1016/S0091-6749(99)70493-8; NORTHROP JP, 1992, J EXP MED, V175, P1235, DOI 10.1084/jem.175.5.1235; PALIOGIANNI F, 1993, J CLIN INVEST, V91, P1481, DOI 10.1172/JCI116353; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Powell N, 2001, CLIN EXP ALLERGY, V31, P69, DOI 10.1046/j.1365-2222.2001.01002.x; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; ROBINSON DS, 1993, J ALLERGY CLIN IMMUN, V92, P397, DOI 10.1016/0091-6749(93)90118-Y; ROLFE FG, 1992, IMMUNOLOGY, V77, P494; Shi HZ, 1997, AM J RESP CELL MOL, V16, P220, DOI 10.1165/ajrcmb.16.3.9070605; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Stranick KS, 1997, J BIOL CHEM, V272, P16453, DOI 10.1074/jbc.272.26.16453; Thomas MA, 1999, EUR J BIOCHEM, V265, P300, DOI 10.1046/j.1432-1327.1999.00732.x; VACCA A, 1992, J EXP MED, V175, P637, DOI 10.1084/jem.175.3.637; Valentine JE, 1997, INT IMMUNOL, V9, P975, DOI 10.1093/intimm/9.7.975; Viola JPB, 1998, BLOOD, V91, P2223, DOI 10.1182/blood.V91.7.2223.2223_2223_2230; Ying S, 1997, J IMMUNOL, V158, P3539; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597	35	10	12	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2001	108	3					340	348						9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	476FK	11544451				2022-12-18	WOS:000171215400003
J	Lamblin, C; Desreumaux, P; Colombel, JF; Tonnel, AB; Wallaert, B				Lamblin, C; Desreumaux, P; Colombel, JF; Tonnel, AB; Wallaert, B			Overexpression of IL-10 mRNA in gut mucosa of patients with allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; IL-10; IL-4; gut	EXPRESSION; DISEASE	Because an airway-like inflammation has been reported in the gut of asthmatic patients, we sought to examine the expression of immunoregulatory cytokines like IL-4, IL-10, and IL-13 by gut mucosa, To establish this, we initiated this study to examine mRNA expressions of IL-4, IL-10, and IL-13 in duodenal mucosa from patients with asthma. Duodenal biopsy specimens were obtained from 20 asthmatic patients (10 allergic, 10 nonallergic) and 8 healthy controls. Cytokine mRNA was quantified with reverse transcriptase-competitive PCR, and results were expressed in proportion to the number of p-actin mRNA in the same sample. IL-10 and IL-4 mRNA were detectable in all patients, whereas no IL-13 mRNA was detected. IL-IO mRNA concentrations were significantly higher in allergic subjects with asthma than in control subjects and nonallergic subjects with asthma, No significant difference was observed for IL-4. IL-IO mRNA expression was not related to asthma severity, FEV,, blood eosinophilia, or IgE levels. Our results support the hypothesis that IL-10 overexpression may counterbalance the effects of proinflammatory cytokines and mitigate the inflammatory reaction found in gut mucosa of subjects with asthma.	Hop Calmette, Clin Malad Resp, F-59037 Lille, France; Lab Rech Malad Inflammatoires Intestinales EMIU01, Lille, France; Inst Pasteur, INSERM U416, F-59019 Lille, France	Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Wallaert, B (corresponding author), Hop Calmette, Clin Malad Resp, Blvd Pr J Leclerc, F-59037 Lille, France.		Desreumaux, Pierre F/R-6877-2018	Desreumaux, Pierre F/0000-0002-6127-5281				Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Borish L, 1998, J ALLERGY CLIN IMMUN, V101, P293, DOI 10.1016/S0091-6749(98)70238-6; Desreumaux P, 1997, GASTROENTEROLOGY, V113, P118, DOI 10.1016/S0016-5085(97)70116-1; Leach MW, 1999, TOXICOL PATHOL, V27, P123, DOI 10.1177/019262339902700124; Legoux P, 1992, Eur Cytokine Netw, V3, P553; Lim S, 1998, LANCET, V352, P113, DOI 10.1016/S0140-6736(98)85018-6; *NAT HEART LUNG BL, 1995, NATL HEART LUNG BLOO; Robinson DS, 1996, AM J RESP CELL MOL, V14, P113, DOI 10.1165/ajrcmb.14.2.8630259; WALLAERT B, 1995, J EXP MED, V182, P1897, DOI 10.1084/jem.182.6.1897; Zou WP, 1995, EUR CYTOKINE NETW, V6, P257	10	10	11	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2001	107	4					739	741						3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	423RG	11295668				2022-12-18	WOS:000168190100031
J	Dubuske, LM				Dubuske, LM		Desloratadine Study Grp	Once-daily desloratadine reduces the symptoms of perennial allergic rhinitis for at least 4 weeks	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Immunol Res Inst New England, Boston, MA USA; Desloratadine Study Grp, Boston, MA USA				DuBuske, Lawrence/AAV-3402-2020						0	10	10	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		525	S159	S159						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300523
J	Lis, K; Malmstrom, K; Nayak, AS; Philip, G; Malice, MP; Reiss, TF				Lis, K; Malmstrom, K; Nayak, AS; Philip, G; Malice, MP; Reiss, TF		Montelukast Fall Rhinitis Investig	Treatment of fall allergic rhinitis with montelukast alone or in combination with loratadine in a multicenter, double-blind, randomized, placebo-controlled study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Merck & Co Inc, Rahway, NJ 07065 USA; Clin Studies Bloomington Normal, Normal, IL USA	Merck & Company									0	10	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		520	S158	S158						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300518
J	Shames, RS; Vexler, V; Lane, NM; McClellan, M; Shi, J; Keller, S; Young, DY; Nieman, RB; Hart, T				Shames, RS; Vexler, V; Lane, NM; McClellan, M; Shi, J; Keller, S; Young, DY; Nieman, RB; Hart, T			The safety and pharmacokinetics of SB240683 anti-Il-4 humanized monoclonal antibody) in patients with mild to moderate asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Prot Design Labs, Fremont, CA USA; SmithKline Beecham Pharmaceut, Collegeville, PA USA	GlaxoSmithKline									0	10	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		1030	S316	S316						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172301026
J	Asero, R				Asero, R			Perennial rhinitis induced by benzoate intolerance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							TARTRAZINE; CHALLENGE; ASTHMA		Osped Caduti Bollatesi, Ambulatorio Allergol, I-20021 Bollate, MI, Italy		Asero, R (corresponding author), Osped Caduti Bollatesi, Ambulatorio Allergol, Via Piave 20, I-20021 Bollate, MI, Italy.							Bush R.K., 1998, ALLERGY PRINCIPLES P, VII, P1183; FREEDMAN BJ, 1977, CLIN ALLERGY, V7, P407, DOI 10.1111/j.1365-2222.1977.tb01471.x; ROSENHALL L, 1982, EUR J RESPIR DIS, V63, P410; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; Simon RA, 1993, ALLERGY PRINCIPLES P, P1687; TARLO SM, 1982, CLIN ALLERGY, V12, P303, DOI 10.1111/j.1365-2222.1982.tb02532.x	6	10	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2001	107	1					197	197		10.1067/mai.2001.112132	http://dx.doi.org/10.1067/mai.2001.112132			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	394PW	11150014	Bronze			2022-12-18	WOS:000166533300034
J	Sonnenfeld, G				Sonnenfeld, G			Extreme environments and the immune system: Effects of spaceflight on immune responses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							SPACE-FLIGHT		Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Sonnenfeld, G (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, 720 Westview Dr SW, Atlanta, GA 30310 USA.							COGOLI A, 1993, J LEUKOCYTE BIOL, V54, P259, DOI 10.1002/jlb.54.3.259; *COMM SPAC BIOL ME, 1998, STRAT RES SPAC BIOL; GMUNDER FK, 1994, AVIAT SPACE ENVIR MD, V65, P419; Lesnyak A, 1996, J APPL PHYSIOL, V81, P178, DOI 10.1152/jappl.1996.81.1.178; Sonnenfeld G, 1998, INT J SPORTS MED, V19, pS195, DOI 10.1055/s-2007-971992; Taylor G R, 1997, Adv Space Biol Med, V6, P1, DOI 10.1016/S1569-2574(08)60076-3; TAYLOR GR, 1992, J LEUKOCYTE BIOL, V51, P129, DOI 10.1002/jlb.51.2.129	7	10	10	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2001	107	1					19	20		10.1067/mai.2001.112034	http://dx.doi.org/10.1067/mai.2001.112034			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	394PW	11149984	Bronze			2022-12-18	WOS:000166533300003
J	Baur, X; Gahnz, G; Chen, ZP				Baur, X; Gahnz, G; Chen, ZP			Extrinsic allergic alveolitis caused by cabreuva wood dust	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter						extrinsic allergic alveolitis (hypersensitivity pneumonitis); cabreuva wood dust; inhalation challenge test	ASTHMA		Univ Hamburg, Ordinariat Arbeitsmed, Zent Inst Arbeitsmed, D-22083 Hamburg, Germany	University of Hamburg	Baur, X (corresponding author), Univ Hamburg, Ordinariat Arbeitsmed, Zent Inst Arbeitsmed, Adolph Schonfelder Str 5, D-22083 Hamburg, Germany.							BELIN L, 1987, INT ARCH ALLER A IMM, V82, P440, DOI 10.1159/000234248; CHANYEUNG M, 1992, AM REV RESPIR DIS, V146, P1606, DOI 10.1164/ajrccm/146.6.1606; HALPIN DMG, 1994, OCCUP ENVIRON MED, V51, P160, DOI 10.1136/oem.51.3.160; Innocenti A, 1991, Med Lav, V82, P446; TEWKSBURY D A, 1968, Clinical and Experimental Immunology, V3, P857	5	10	10	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2000	106	4					780	781		10.1067/mai.2000.109616	http://dx.doi.org/10.1067/mai.2000.109616			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	365ZP	11031353				2022-12-18	WOS:000089980600026
J	McNairy, MM; Gastmeyer, J; Pantera, B; Hoffman, DR				McNairy, MM; Gastmeyer, J; Pantera, B; Hoffman, DR			Isolation of paper wasp venom proteases by affinity chromatography.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									E Carolina Univ, Sch Med, Greenville, NC USA; Univ Florence, Florence, Italy	University of North Carolina; East Carolina University; University of Florence									0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		171	S57	S57		10.1016/S0091-6749(00)90602-X	http://dx.doi.org/10.1016/S0091-6749(00)90602-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530100170
J	Lie, WJ; Knol, EF; Mul, FPJ; Jansen, HM; Roos, D; van der Zee, JS				Lie, WJ; Knol, EF; Mul, FPJ; Jansen, HM; Roos, D; van der Zee, JS			Basophils from patients with allergic asthma show a primed phenotype	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergy; asthma; basophils; histamine release; priming; cytokines	COLONY-STIMULATING FACTOR; MONOCYTE CHEMOTACTIC PROTEIN-3; CHEMOKINE RECEPTOR CCR3; HUMAN IGE SYNTHESIS; HISTAMINE-RELEASE; BLOOD BASOPHILS; MAST-CELLS; B-CELLS; EOSINOPHIL CHEMOTAXIS; ATOPIC-DERMATITIS	Background: IL-3, IL-5, and GM-CSF are not able to induce histamine release in purified basophils of nonallergic donors. However, He have recently found that preincubation Kith 2 mu mol/L thapsigargin, which induces a rise in intracellular free calcium ions, renders human basophils extremely sensitive for IL-3, 1L-5, or GM-CSF, leading to enhanced histamine release. Histamine release was also induced in the reverse order (first cytokine and then thapsigargin). Objective: Because these cytokines are supposed to be increased in allergic inflammation, we examined whether basophils of patients with allergic asthma showed an enhanced response to thapsigargin. Methods: We measured the histamine release induced by thapsigargin in a group of allergic asthmatic subjects (n = 24) and compared this response with those of 3 control groups. The control groups consisted of healthy control subjects (group 1, n = 21); patients with a nonallergic, nonasthmatic lung disease (group 2, n = 22); and patients with nonallergic asthma (group 3, n = 9). Results: There was no difference in spontaneous histamine release. Also, no significant difference in histamine release nas found when anti-IgE or formyl-methionyl-leucyl-phenylalanine was used as a stimulus, Histamine release induced by IL-3 alone or a combination of IL-3 and thapsigargin also did not differ. In contrast, basophils from the group with allergic asthma showed a significantly higher percentage of histamine release induced by thapsigargin (38.2% +/- 13.2%) than did basophils from the 3 control groups (healthy control subjects, 22.5% +/- 6.9%; subjects Kith Lung disease, 24.9% +/- 8.9%;subjects dth nonallergic asthma 15.0% +/- 3.0%; all mean +/- SD). Conclusion: These data indicate that basophils in peripheral blood of subjects dth allergic asthma have a primed phenotype and that thapsigargin-induced histamine release is a practical tool to study this phenomenon.	Netherlands Red Cross, Blood Transfus Serv, Cent Lab, NL-1066 CX Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Expt & Clin Immunol Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Roos, D (corresponding author), Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.		van der Zee, Jaring S/M-8462-2013; van der Zee, Jaring/AAQ-6669-2021; van der Zee, Jaring/HGU-9235-2022	van der Zee, Jaring S/0000-0002-8698-6039; Mul, FPJ/0000-0002-8234-9972; Knol, Edward/0000-0001-7368-9820				ALAM R, 1994, J IMMUNOL, V153, P3155; BISCHOFF SC, 1990, J EXP MED, V172, P1577, DOI 10.1084/jem.172.6.1577; BISCHOFF SC, 1993, EUR J IMMUNOL, V23, P761, DOI 10.1002/eji.1830230329; BRUNNER T, 1991, J IMMUNOL, V147, P237; BRUNNER T, 1993, J EXP MED, V177, P605, DOI 10.1084/jem.177.3.605; CHANYEUNG M, 1993, AM REV RESPIR DIS, V147, P1056; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; DEBOER M, 1986, J IMMUNOL, V136, P3447; DEGENHART HJ, 1988, J ALLERGY CLIN IMMUN, V82, P455, DOI 10.1016/0091-6749(88)90019-X; Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Gibbs BF, 1996, EUR J IMMUNOL, V26, P2493, DOI 10.1002/eji.1830261033; GILBERT HS, 1975, BLOOD, V46, P279; GILLESPIE E, 1972, P SOC EXP BIOL MED, V140, P1228; GUO CB, 1994, AM J RESP CELL MOL, V10, P384, DOI 10.1165/ajrcmb.10.4.7510984; HAAKFRENDSCHO M, 1988, J CLIN INVEST, V82, P17, DOI 10.1172/JCI113567; HIRAI K, 1988, J IMMUNOL, V141, P3958; Humbert M, 1997, AM J RESP CELL MOL, V16, P1; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; JAMES JM, 1993, J ALLERGY CLIN IMMUN, V91, P1155, DOI 10.1016/0091-6749(93)90318-A; KATO M, 1992, LYMPHOKINE CYTOK RES, V11, P287; KNOL E F, 1991, Journal of Allergy and Clinical Immunology, V87, P242, DOI 10.1016/0091-6749(91)91694-O; KNOL EF, 1991, EUR J IMMUNOL, V21, P881, DOI 10.1002/eji.1830210404; KOSHINO T, 1993, CLIN EXP ALLERGY, V23, P919, DOI 10.1111/j.1365-2222.1993.tb00276.x; KRIEGER M, 1992, EUR J IMMUNOL, V22, P2907, DOI 10.1002/eji.1830221123; Li HM, 1996, J IMMUNOL, V156, P4833; Lie WJH, 1998, J ALLERGY CLIN IMMUN, V101, P683, DOI 10.1016/S0091-6749(98)70178-2; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; MACGLASHAN D, 1994, J IMMUNOL, V152, P3006; MARUYAMA N, 1994, AM J RESP CRIT CARE, V150, P1086, DOI 10.1164/ajrccm.150.4.7921441; MASSEY W, 1993, J IMMUNOL, V150, P1084; MUL FPJ, 1992, J IMMUNOL METHODS, V149, P207, DOI 10.1016/0022-1759(92)90252-O; Pawankar R, 1997, J CLIN INVEST, V99, P1492, DOI 10.1172/JCI119311; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SAMPSON HA, 1989, NEW ENGL J MED, V321, P228, DOI 10.1056/NEJM198907273210405; Sanchez-Guerrero I, 1997, Allergol Immunopathol (Madr), V25, P98; SCHLEIMER RP, 1981, J IMMUNOL, V126, P570; SCHROEDER JT, 1995, INT ARCH ALLERGY IMM, V107, P79, DOI 10.1159/000236937; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; SIRAGANIAN RP, 1975, J IMMUNOL METHODS, V7, P283, DOI 10.1016/0022-1759(75)90025-3; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; VANVEEN MJ, 1999, CLIN EXP ALLERGY, V29, P217; WARNER JA, 1987, J IMMUNOL, V139, P161; WARRINGA RAJ, 1992, BLOOD, V79, P1836; WARRINGA RAJ, 1993, J ALLERGY CLIN IMMUN, V91, P1198, DOI 10.1016/0091-6749(93)90323-8; Yanagihara Y, 1997, CLIN EXP IMMUNOL, V108, P295, DOI 10.1046/j.1365-2249.1997.d01-1001.x	47	10	10	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1999	104	5					1000	1007		10.1016/S0091-6749(99)70081-3	http://dx.doi.org/10.1016/S0091-6749(99)70081-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	257JH	10550745				2022-12-18	WOS:000083778400023
J	Kato, C; Sato, K; Eishi, Y; Nakamura, K				Kato, C; Sato, K; Eishi, Y; Nakamura, K			The influence of initial exposure timing to beta-lactoglobulin on oral tolerance induction	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						beta-lactoglobulin; oral tolerance; IgG; subclasses of IgG; IgE; intestinal mucosal lymphocytes; Peyer's patches; enzyme-linked immunospot assay; cytokine production	T-CELL; IMMUNOLOGICAL-TOLERANCE; LAMINA PROPRIA; CHOLERA-TOXIN; B-SUBUNIT; RESPONSES; MICE; ANTIBODY; OVALBUMIN; DETERMINANTS	Background: Although a number of studies have investigated the induction of oral tolerance to several proteins, relatively little is known about the induction of oral tolerance to beta-lactoglobulin, one of the major antigenic proteins in milk. Objective: We investigated the influence of the timing of the initial beta-lactoglobulin exposure on oral tolerance induction and examined some characteristics of the tolerogenic immune response. Methods: BALB/c mice were given beta-lactoglobulin prenatally or from the third or fifth postnatal week, bred for 17 weeks, and compared with unexposed control mice. Specific plasma anti-beta-lactoglobulin antibodies (total IgG, IgG subclasses, IgM, and IgE), antigen-specific splenocyte responses, frequencies of antibody-producing cells, and cytokine production by splenocytes, intestinal mucosal lymphocytes, and Peyer's patches were analyzed. Results: Differences were observed among the 4 groups of mice in changes of plasma anti-beta-lactoglobulin antibody titers, antigen-specific T-cell proliferation, and Frequencies of antibody-producing splenocytes, intestinal mucosal lymphocytes, and Peyer's patch cells after the first exposure to beta-lactoglobulin, The onset and duration of the immunologic responses were found to be dependent on the timing of antigen exposure. Prenatal exposure to antigen facilitated the induction of oral tolerance to beta-lactoglobulin, whereas delayed antigen exposure retarded tolerance. The induction of oral tolerance was associated with increased IL-4 and/or IL-10 production and decreased IL-12 production. Conclusion: Our results suggest that the timing of initial antigen exposure greatly influences the induction of oral tolerance to beta-lactoglobulin and that altered secretion of regulatory cytokines may be responsible for the differences in antibody production and oral tolerance induction.	Japan Womens Univ, Div Clin Nutr, Dept Food & Nutr, Bunkyo Ku, Tokyo 1128681, Japan; Tokyo Med & Dent Univ, Dept Pathol, Tokyo 113, Japan	Japan Womens University; Tokyo Medical & Dental University (TMDU)	Kato, C (corresponding author), Japan Womens Univ, Div Clin Nutr, Dept Food & Nutr, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.		Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670				Borel Y, 1996, ANN NY ACAD SCI, V778, P80, DOI 10.1111/j.1749-6632.1996.tb21117.x; CUMMINS AG, 1994, J CLIN IMMUNOL, V14, P107, DOI 10.1007/BF01541343; DAVIES MDJ, 1981, GUT, V22, P481, DOI 10.1136/gut.22.6.481; ELSON CO, 1995, J IMMUNOL, V154, P1032; Fritsche R, 1997, J ALLERGY CLIN IMMUN, V100, P266, DOI 10.1016/S0091-6749(97)70235-5; HACHIMURA S, 1994, INT IMMUNOL, V6, P1791, DOI 10.1093/intimm/6.11.1791; Harper HM, 1996, IMMUNOLOGY, V89, P449, DOI 10.1046/j.1365-2567.1996.d01-760.x; HIRAHARA K, 1995, J IMMUNOL, V154, P6238; JAMES JM, 1992, J PEDIATR-US, V121, P371, DOI 10.1016/S0022-3476(05)81788-3; Kaneko T, 1998, INT ARCH ALLERGY IMM, V116, P81, DOI 10.1159/000023929; KIM SM, 1993, INT ARCH ALLERGY IMM, V101, P260, DOI 10.1159/000236455; LAMONT AG, 1989, IMMUNOLOGY, V66, P595; Louis E, 1996, INT ARCH ALLERGY IMM, V109, P21, DOI 10.1159/000237227; Lundin BS, 1996, SCAND J IMMUNOL, V43, P56, DOI 10.1046/j.1365-3083.1996.d01-15.x; MOFFATT MF, 1992, CLIN EXP ALLERGY, V22, P1046, DOI 10.1111/j.1365-2222.1992.tb00128.x; MOSMANN TR, 1987, IMMUNOL TODAY, V8, P223, DOI 10.1016/0167-5699(87)90171-X; Nakao A, 1998, INT IMMUNOL, V10, P387, DOI 10.1093/intimm/10.4.387; PENG HJ, 1995, SCAND J IMMUNOL, V42, P297, DOI 10.1111/j.1365-3083.1995.tb03659.x; SAALMAN R, 1995, SCAND J IMMUNOL, V42, P140, DOI 10.1111/j.1365-3083.1995.tb03637.x; SEDGWICK JD, 1983, J IMMUNOL METHODS, V57, P301, DOI 10.1016/0022-1759(83)90091-1; STERN M, 1984, PEDIATR RES, V18, P1252, DOI 10.1203/00006450-198412000-00005; SUN JB, 1994, P NATL ACAD SCI USA, V91, P10795, DOI 10.1073/pnas.91.23.10795; TELEMO E, 1995, ADV EXP MED BIOL, V371, P517; WHARY MT, 1995, CELL IMMUNOL, V163, P215, DOI 10.1006/cimm.1995.1119; Wolvers DAW, 1997, IMMUNOLOGY, V92, P328, DOI 10.1046/j.1365-2567.1997.00356.x	25	10	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1999	104	4	1				870	878		10.1016/S0091-6749(99)70301-5	http://dx.doi.org/10.1016/S0091-6749(99)70301-5			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	248NG	10518835				2022-12-18	WOS:000083281200022
J	Renzi, PM; Xu, LJ; Yang, XX; Powell, WS; Martin, JG				Renzi, PM; Xu, LJ; Yang, XX; Powell, WS; Martin, JG			IL-2 enhances allergic airway responses in rats by increased inflammation but not through increased synthesis of cysteinyl leukotrienes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IL-2; Brown Norway rat; leukotrienes; antigen challenge	GUINEA-PIG MODEL; ANTIGEN CHALLENGE; LYMPHOCYTE-T; BRONCHOALVEOLAR LAVAGE; PERIPHERAL-BLOOD; INTERLEUKIN-2; ASTHMA; HYPERRESPONSIVENESS; RESPONSIVENESS; HETEROGENEITY	Background: IL-2 has been shown to increase allergic airway responses in rats. Objective: The purpose of this study was to investigate whether induction of inflammation and enhancement of cysteinyl-leukotriene (cys-LT) synthesis were involved in the augmentation of airway responses caused by IL-2. Methods: Brown Norway rats received human recombinant IL-2 or saline subcutaneously twice a day from day 9 to day 14 after sensitization to ovalbumin (OVA). On day 14, rats underwent either lung lavage or were challenged with an aerosol spray of OVA, the airway responses and biliary excretion of cys-LTs were measured for a period of 8 hours after challenge, and the lung leukocyte numbers were determined after enzymatic digestion of lung tissues. Results: The early response after OVA increased from 184.2% +/- 13.5% in the animals receiving saline (n = 10) to 309% +/- 51% (baseline lung resistance) in IL-2-pretreated animals (n = 17; P < .05). The late response also increased from 19.6 +/- 4.5 (area under the curve of baseline lung resistance vs time) in the animals receiving saline to 37 +/- 5.4 after administration of IL-2 (P < .05). However, IL-2-treated animals had lower levels of biliary cys-LTs during the late response than saline-treated animals but similar levels during the early response. This difference could not be attributed to an increase in LT metabolism, which we assessed by the recovery of H-3-LTC4 instilled intratracheally in challenged or unchallenged rats, When compared with control animals, pretreatment with IL-2 increased all cell types retrieved from lung lavage fluid before OVA challenge (P < .05). After OVA challenge, the total cell yield from lung lavage fluid was also increased, mostly because of an increase in neutrophils (P < .05). Eosinophils and lymphocytes were greater in the lungs of IL-2-treated than vehicle-treated and OVA-challenged rats (P < .01), and IL-2-treated rats had a lower CD4(+)/CD8(+) ratio in the blood after challenge (P < .001). Conclusion: In conclusion, IL-2 increases early and late responses in rats, and it induces lung inflammation. Altered airway responses are not attributable to an increase in cys-LT production.	McGill Univ, Meakins Christie Labs, Royal Victoria Hosp, Montreal, PQ H2X 2P2, Canada; Univ Montreal Hosp, Res Ctr, Montreal, PQ, Canada	McGill University; Royal Victoria Hospital; Universite de Montreal	Renzi, PM (corresponding author), McGill Univ, Meakins Christie Labs, Royal Victoria Hosp, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.		Powell, William/AAE-9000-2020	Powell, William/0000-0002-8507-4038; Martin, James/0000-0001-7574-5363				ARIMA M, 1995, CHEST, V108, P529, DOI 10.1378/chest.108.2.529; BRIDEAU RJ, 1980, EUR J IMMUNOL, V10, P609, DOI 10.1002/eji.1830100807; EIDELMAN DH, 1988, AM REV RESPIR DIS, V137, P1033, DOI 10.1164/ajrccm/137.5.1033; FOSTER A, 1988, J IMMUNOL, V141, P3544; FRIEDMAN BS, 1993, AM REV RESPIR DIS, V147, P839, DOI 10.1164/ajrccm/147.4.839; GERBLICH AA, 1991, AM REV RESPIR DIS, V143, P533, DOI 10.1164/ajrccm/143.3.533; HAGMANN W, 1986, PROSTAGLANDINS, V31, P239, DOI 10.1016/0090-6980(86)90050-X; MARTIN JG, 1993, AM REV RESPIR DIS, V147, P104, DOI 10.1164/ajrccm/147.1.104; MAUSER PJ, 1993, AM REV RESPIR DIS, V148, P1623, DOI 10.1164/ajrccm/148.6_Pt_1.1623; MILNE AAY, 1995, INT ARCH ALLERGY IMM, V108, P60, DOI 10.1159/000237119; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; OLIVENSTEIN R, 1994, AM J RESP CRIT CARE, V149, pA528; PISANI CV, 1991, BLOOD, V78, P1538, DOI 10.1182/blood.V78.6.1538.1538; RENZI P, 1987, J IMMUNOL METHODS, V98, P53, DOI 10.1016/0022-1759(87)90434-0; RENZI PM, 1993, AM REV RESPIR DIS, V148, P932, DOI 10.1164/ajrccm/148.4_Pt_1.932; RENZI PM, 1991, AM REV RESPIR DIS, V143, P375, DOI 10.1164/ajrccm/143.2.375; RENZI PM, 1991, AM REV RESPIR DIS, V143, P380, DOI 10.1164/ajrccm/143.2.380; RENZI PM, 1992, AM REV RESPIR DIS, V146, P163, DOI 10.1164/ajrccm/146.1.163; RENZI PM, 1993, AM REV RESPIR DIS, V147, P967, DOI 10.1164/ajrccm/147.4.967; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SAPIENZA S, 1990, AM REV RESPIR DIS, V142, P353, DOI 10.1164/ajrccm/142.2.353; SOLER M, 1990, Pulmonary Pharmacology, V3, P9, DOI 10.1016/0952-0600(90)90003-2; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; WATANABE A, 1995, AM J RESP CRIT CARE, V152, P64, DOI 10.1164/ajrccm.152.1.7599864; WATANABE A, 1995, J CLIN INVEST, V96, P1303, DOI 10.1172/JCI118165; WEGNER CD, 1993, J ALLERGY CLIN IMMUN, V91, P917, DOI 10.1016/0091-6749(93)90350-O; WHITE RAH, 1978, J EXP MED, V148, P664, DOI 10.1084/jem.148.3.664; WOOLLETT GR, 1985, EUR J IMMUNOL, V15, P168, DOI 10.1002/eji.1830150211; YANG JP, 1993, J ALLERGY CLIN IMMUN, V91, P792, DOI 10.1016/0091-6749(93)90199-P	29	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1999	104	1					145	152		10.1016/S0091-6749(99)70126-0	http://dx.doi.org/10.1016/S0091-6749(99)70126-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	221QZ	10400852				2022-12-18	WOS:000081738900021
J	Tashkin, DP				Tashkin, DP			Microelectronic adherence monitors for metered-dose inhalers: Who monitors the monitors?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							CLINICAL-TRIAL; NEBULIZER CHRONOLOG; ASTHMA; MEDICATION; USAGE		Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tashkin, DP (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA.							[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; BENDER B, 1997, AM J RESP CRIT CARE, V155, pA259; Brueckner JW, 1997, J ALLERGY CLIN IMMUN, V100, P488, DOI 10.1016/S0091-6749(97)70140-4; COUTTS JAP, 1992, ARCH DIS CHILD, V67, P332, DOI 10.1136/adc.67.3.332; CRAMER JA, 1993, CHEST, V104, P333, DOI 10.1378/chest.104.2.333; GONG H, 1988, J ALLERGY CLIN IMMUN, V82, P5, DOI 10.1016/0091-6749(88)90043-7; MAWHINNEY H, 1991, ANN ALLERGY, V66, P294; MAWHINNEY H, 1993, J ASTHMA, V30, P61, DOI 10.3109/02770909309066381; Milgrom H, 1996, J ALLERGY CLIN IMMUN, V98, P1051, DOI 10.1016/S0091-6749(96)80190-4; *NAT ASTHM ED PREV, 1997, NIH PUBL; NIDES MA, 1993, CHEST, V104, P501, DOI 10.1378/chest.104.2.501; RAND CS, 1992, AM REV RESPIR DIS, V146, P1559, DOI 10.1164/ajrccm/146.6.1559; Simmons MS, 1996, CHEST, V109, P963, DOI 10.1378/chest.109.4.963; SPECTOR SL, 1986, J ALLERGY CLIN IMMUN, V77, P65, DOI 10.1016/0091-6749(86)90325-8; TASHKIN DP, 1991, AM J MED, V91, P335; Wamboldt FS, 1999, J ALLERGY CLIN IMMUN, V104, P53, DOI 10.1016/S0091-6749(99)70113-2; WEEKS K, 1997, AM J RESP CRIT CARE, V155, pA259	17	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1999	104	1					22	24		10.1016/S0091-6749(99)70108-9	http://dx.doi.org/10.1016/S0091-6749(99)70108-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	221QZ	10400834	Bronze			2022-12-18	WOS:000081738900003
J	Yoshida, S; Sakamoto, H; Mikami, H; Onuma, K; Shoji, T; Nakagawa, H; Hasegawa, H; Amayasu, H				Yoshida, S; Sakamoto, H; Mikami, H; Onuma, K; Shoji, T; Nakagawa, H; Hasegawa, H; Amayasu, H			Palladium allergy exacerbating bronchial asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NICKEL		AOKI Int Med Ctr, Dept Med, Div Dent Allergy Res, Yokohama, Kanagawa 224, Japan; Fujita Hlth Univ, Sch Med, Inst Comprehens Med Sci, Toyoake, Aichi 47011, Japan; Hokkaido Univ, Sch Dent, Dent Off Liberty, Sapporo, Hokkaido 060, Japan	Fujita Health University; Hokkaido University	Yoshida, S (corresponding author), AOKI Int Med Ctr, Dept Med, Div Dent Allergy Res, 6-56 Kuzugaya Tsuzuki, Yokohama, Kanagawa 224, Japan.							Cederbrant K, 1997, INT ARCH ALLERGY IMM, V112, P212, DOI 10.1159/000237456; DAVIES JE, 1986, J SOC OCCUP MED, V36, P29; ESTLANDER T, 1993, CLIN EXP ALLERGY, V23, P306, DOI 10.1111/j.1365-2222.1993.tb00327.x; Kanerva L, 1996, CONTACT DERMATITIS, V34, P39, DOI 10.1111/j.1600-0536.1996.tb02110.x; KANRVA L, 1991, EXOGENOUS DERMATOSES, P103	5	10	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1999	103	6					1211	1212		10.1016/S0091-6749(99)70201-0	http://dx.doi.org/10.1016/S0091-6749(99)70201-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	207GT	10359908	Bronze			2022-12-18	WOS:000080929500035
J	Brito, FF; Martinez, A; Palacios, R; Mur, P; Gomez, E; Galindo, PA; Borja, J; Martinez, J				Brito, FF; Martinez, A; Palacios, R; Mur, P; Gomez, E; Galindo, PA; Borja, J; Martinez, J			Rhinoconjunctivitis and asthma caused by vine pollen: A case report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Vitis vinifera; vine pollen allergy; pollen counts; pollen extracts; provocation tests	ALLERGY	Background: The vine (Vitis vinifera) is a cultivated plant that is found in some European and American countries. Its pollen gathers in small quantities during a short pollination period in the months of May and June. Allergy to vine pollen has not been previously documented. Objective: We sought to describe a case report of allergy to vine pollen documented on the basis of anamnesis, cutaneous, provocation, and specific IgE determination tests. Methods: An allergenic extract mas obtained from collected V vinifera pollens by aqueous standard procedures. Pollen counts and pollination periods of this and other common pollens in the area where the patient became symptomatic were studied. Cutaneous tests and the presence of specific IgE to the pollen extracts were performed by prick, CAP, and RAST techniques. Bronchial and conjunctival tests with the involved pollen extracts were also carried out to identify the sensitizing allergens. Five healthy subjects and 5 pollinic patients were used as control subjects and underwent the same tests. Results: Skin prick test responses with vine pollen at different concentrations mere positive for the studied patient and negative for the control subjects. Patient serum revealed a total IgE titer of 334 IU/mL and a specific IgE value of 1.3 PRU/mL (RAST class 2) to vine pollen. Bronchial and conjunctival provocation test responses mere also positive when the patient was challenged with V vinifera extract. Conclusion: Exposure to the pollen of the vineyard plants (V vinifera) can induce immunologic sensitization and rhinoconjunctivitis/asthma.	Complejo Hosp, Sect Allergy, Ciudad Real 13002, Spain; BIAL ARISTEGUI, Dept Res & Dev, Bilbao, Spain; Hosp Santa Barbara, Allergy Unit, Puertollano, Spain		Brito, FF (corresponding author), Complejo Hosp, Sect Allergy, Ronda del Carmen S-N, Ciudad Real 13002, Spain.			MARTINEZ, JORGE/0000-0001-7002-0056; Feo-Brito, Francisco/0000-0003-1886-9620				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRITO FF, 1998, REV ESP ALERGOL INMU, V13, P79; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1021, DOI 10.1016/0019-2791(72)90112-7; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHATHAM M, 1982, CHEST, V82, P15, DOI 10.1378/chest.82.1.15; DREBORG S, 1999, ALLERGY S, V10, P22; GALAN C, 1989, ANN ALLERGY, V63, P435; GARCIAORTEGA P, 1989, CLIN EXP ALLERGY, V19, P529, DOI 10.1111/j.1365-2222.1989.tb02428.x; GUERRA F, 1986, REV ESP ALERGOL IMMU, V1, P68; JAGGER S, 1991, ALLERGENIC POLLEN PO, P49; JIMENEZ A, 1994, INT ARCH ALLERGY IMM, V105, P297, DOI 10.1159/000236772; MORAL A, 1998, REV ESP ALERGOL IMMU, V13, P126; ROMANO MLG, 1992, J INVEST ALLERG CLIN, V2, P323; SALINAS A, 1996, VID VINO CASTILLA MA, P29; SUBIZA J, 1995, J ALLERGY CLIN IMMUN, V96, P15, DOI 10.1016/S0091-6749(95)70028-5; WIDE L, 1967, LANCET, V2, P1105; ZELLWEGER JP, 1977, SCHWEIZ MED WSCHR, V107, P195	17	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1999	103	2	1				262	266		10.1016/S0091-6749(99)70500-2	http://dx.doi.org/10.1016/S0091-6749(99)70500-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	167JW	9949317				2022-12-18	WOS:000078630100013
J	White, AD; Andrews, EB				White, AD; Andrews, EB			The pregnancy registry program at Glaxo Wellcome Company	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article								Registries can be used to provide an early warning system for potential teratogenic effects associated with the use of specific medications during pregnancy. Glaxo Wellcome has developed 5 international registries: (1) the Acyclovir Pregnancy Registry, (2) the Antiretroviral Pregnancy Registry, (3) the Lamotrigine Pregnancy Registry, (4) the Sumatriptan Pregnancy Registry, and (5) the Bupropion Pregnancy Registry. The purpose of these registries is to gain more information about the potential teratogenicity of these drugs during pregnancy, Two potential limitations of such registry data are recognized: (1) the utility of the data collected depends on the size of the sample; and (2) the registered patients may not be representative of all patients using the medication. However, these types of registry reports can be a valuable and cost-effective way to collect data regarding the use of medications during pregnancy when conventional methods (eg, cohort studies) are not appropriate or feasible.	Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA; World Wide Epidemiol Dept, Res Triangle Pk, NC USA	GlaxoSmithKline	White, AD (corresponding author), Glaxo Wellcome Inc, POB 13398,5 Moore Dr, Res Triangle Pk, NC 27709 USA.			Andrews, Elizabeth B./0000-0003-1131-5983					0	10	10	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1999	103	2	2	S			S362	S363		10.1016/S0091-6749(99)70265-4	http://dx.doi.org/10.1016/S0091-6749(99)70265-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	171KA	9949340				2022-12-18	WOS:000078861500009
J	Hoontrakoon, R; Kailey, JM; Bratton, DL				Hoontrakoon, R; Kailey, JM; Bratton, DL			IL-4 and TNF alpha synergize to enhance eosinophil survival.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Natl Jewish Med & Res Ctr, Denver, CO USA	National Jewish Health									0	10	10	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		921	S239	S239						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000923
J	Nayak, A; LaForce, C; Rowe, M; Watrous, M; Fick, R; McAlary, M; Gupta, N; Fowler-Taylor, A; Rohane, P				Nayak, A; LaForce, C; Rowe, M; Watrous, M; Fick, R; McAlary, M; Gupta, N; Fowler-Taylor, A; Rohane, P			rhuMAb-E25 improves quality of life in patients with seasonal allergic rhinitis (SAR).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		185	S49	S49						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000192
J	Skoner, DP; Welch, M; Tinkleman, D; Bagchi, P; Raudenbush, MA; Banerji, D				Skoner, DP; Welch, M; Tinkleman, D; Bagchi, P; Raudenbush, MA; Banerji, D			Inhaled corticosteroid-induced growth retardation in asthmatic children in a "real world" setting.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Childrens Hosp, San Diego, CA USA; Childrens Hosp, Denver, CO 80218 USA; Childrens Hosp, Collegeville, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Los Angeles; Children's Hospital Colorado									0	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		232	S61	S61						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000239
J	Thomas, P; Holz, T; Messer, G; Przybilla, B				Thomas, P; Holz, T; Messer, G; Przybilla, B			Nickel allergic patients with or without reactions upon oral nickel challenge: Lymphocyte reactivity and cytokine pattern.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Munich, Dept Dermatol, D-8000 Munich, Germany	University of Munich									0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		323	S85	S85						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000329
J	Cartier, A				Cartier, A			Occupational asthma: What have we learned?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Festschrift Meeting in Honor of Jerry Dolovich	MAY   24, 1997	HAMILTON, CANADA	McMaster Univ, Fac Hlth Sci, Astra Canada			PEAK EXPIRATORY FLOW; WESTERN RED CEDAR; CRAB-PROCESSING WORKERS; BRONCHIAL RESPONSIVENESS; INHALATION CHALLENGES; SENSITIZING AGENTS; IGE SENSITIZATION; EXPOSURE SYSTEM; DIAGNOSIS; RATES	Occupational asthma is one of the most frequent work-related diseases and may represent between 2% and 6% of all cases of asthma. It is defined as asthma causally and specifically related to exposure to airborne dusts, gases, vapors, or fumes in the working environment. Because it may cause long-lasting disability, it is important to properly identify affected workers and to withdraw them from exposure to the sensitizing agent as soon as possible. Although the history is the clue to the diagnosis, it is not sensitive or specific. The diagnosis should be confirmed by objective means, essentially by monitoring of peak expiratory flow and nonallergic bronchial responsiveness or by specific inhalation challenges. In this article the author reviews the investigation of occupational asthma.	Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Cartier, A (corresponding author), Hop Sacre Coeur, Div Resp, 5400 Blvd Gouin Ouest, Montreal, PQ H4J 1C5, Canada.							BARDY JD, 1987, AM REV RESPIR DIS, V135, P1033; Bernstein IL, 1993, ASTHMA WORKPLACE; BERUBE D, 1991, CHEST, V99, P831, DOI 10.1378/chest.99.4.831; BRIGHT P, 1997, AM J RESP CRIT CAR 2, V155, pA137; BURGE PS, 1979, THORAX, V34, P317, DOI 10.1136/thx.34.3.317; BUTCHER BT, 1977, AM REV RESPIR DIS, V116, P411, DOI 10.1164/arrd.1977.116.3.411; CARTIER A, 1984, J ALLERGY CLIN IMMUN, V74, P261, DOI 10.1016/0091-6749(84)90256-2; CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P507, DOI 10.1016/0091-6749(89)90364-3; CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P823, DOI 10.1016/0091-6749(89)90346-1; CARTIER A, 1986, J ALLERGY CLIN IMMUN, V78, P344, DOI 10.1016/S0091-6749(86)80087-2; CARTIER A, 1984, CLIN ALLERGY, V14, P173; Chan-Yeung Moira, 1993, P299; Chan-Yeung Moira, 1993, P189; CHANYEUNG M, 1992, AM REV RESPIR DIS, V146, P1606, DOI 10.1164/ajrccm/146.6.1606; CHANYEUNG M, 1994, EUR RESPIR J, V7, P346, DOI 10.1183/09031936.94.07020346; CLOUTIER Y, 1992, EUR RESPIR J, V5, P887; CLOUTIER Y, 1989, EUR RESPIR J, V2, P769; CLOUTIER Y, 1992, CHEST, V102, P402, DOI 10.1378/chest.102.2.402; COCKCROFT DW, 1979, CAN MED ASSOC J, V121, P602; COCKCROFT DW, 1984, CLIN ALLERGY, V14, P61, DOI 10.1111/j.1365-2222.1984.tb02191.x; COTE J, 1993, THORAX, V48, P48, DOI 10.1136/thx.48.1.48; COTE J, 1990, J ALLERGY CLIN IMMUN, V85, P592, DOI 10.1016/0091-6749(90)90098-O; GAUTRIN D, 1994, CHEST, V106, P1419, DOI 10.1378/chest.106.5.1419; HARGREAVE FE, 1984, AM REV RESPIR DIS, V130, P513; Lemiere C, 1996, AM J RESP CRIT CARE, V154, P329, DOI 10.1164/ajrccm.154.2.8756802; Lemiere C., 1997, Journal of Allergy and Clinical Immunology, V99, pS80; LEROYER C, 1997, AM J RESP CRIT CAR 2, V155, pA137; LISS GM, 1991, CHEST, V100, P63, DOI 10.1378/chest.100.1.63; MALO JL, 1990, J ALLERGY CLIN IMMUN, V85, P834, DOI 10.1016/0091-6749(90)90065-C; MALO JL, 1995, J ALLERGY CLIN IMMUN, V96, P601, DOI 10.1016/S0091-6749(95)70258-X; MALO JL, 1991, AM REV RESPIR DIS, V143, P528, DOI 10.1164/ajrccm/143.3.528; MALO JL, 1990, CHEST, V98, pS236, DOI 10.1378/chest.98.5.236S; MALO JL, 1993, THORAX, V48, P1211, DOI 10.1136/thx.48.12.1211; MALO JL, 1992, J ALLERGY CLIN IMMUN, V90, P937, DOI 10.1016/0091-6749(92)90466-F; Meredith S, 1996, THORAX, V51, P435, DOI 10.1136/thx.51.4.435; Moscato G, 1993, Monaldi Arch Chest Dis, V48, P23; MOSEATO G, 1995, J ALLERGY CLIN IMMUN, V96, P295; NEWMANTAYLOR AJ, 1980, THORAX, V35, P241, DOI 10.1136/thx.35.4.241; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; PERRIN B, 1991, J ALLERGY CLIN IMMUN, V87, P630, DOI 10.1016/0091-6749(91)90381-W; PERRIN B, 1992, EUR RESPIR J, V5, P40; QUIRCE S, 1995, AM J RESP CRIT CARE, V152, P1100, DOI 10.1164/ajrccm.152.3.7663790; Seligman Paul J., 1993, P323; TSE KS, 1982, CLIN ALLERGY, V12, P249, DOI 10.1111/j.1365-2222.1982.tb02525.x; Vandenplas O, 1996, THORAX, V51, P472, DOI 10.1136/thx.51.5.472	45	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1998	102	5					S90	S95		10.1016/S0091-6749(98)70037-5	http://dx.doi.org/10.1016/S0091-6749(98)70037-5			6	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	139MR	9819315				2022-12-18	WOS:000077033400033
J	Knowles, SR; Weber, E				Knowles, SR; Weber, E			Dextromethorphan anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Sunnybrook Hlth Sci Ctr, Glaxo Wellcome Sunnybrook Drug Safety Clin, Dept Pharm & Med, Toronto, ON M4N 3M5, Canada; Sunnybrook Hlth Sci Ctr, Div Clin Pharmacol, Toronto, ON M4N 3M5, Canada; Univ Toronto, Toronto, ON, Canada	GlaxoSmithKline; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Weber, E (corresponding author), Sunnybrook Hlth Sci Ctr, Glaxo Wellcome Sunnybrook Drug Safety Clin, Dept Pharm & Med, UG06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.							BEM JL, 1992, DRUG SAFETY, V7, P190, DOI 10.2165/00002018-199207030-00004; KARTTUNEN P, 1987, RESPIRATION, V52, P49, DOI 10.1159/000195303; LEVY JH, 1989, ANESTHESIOLOGY, V70, P756, DOI 10.1097/00000542-198905000-00008; ZUCKERPINCHOFF B, 1989, ANESTHESIOLOGY, V71, P599, DOI 10.1097/00000542-198910000-00020	4	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1998	102	2					316	317		10.1016/S0091-6749(98)70101-0	http://dx.doi.org/10.1016/S0091-6749(98)70101-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	113EH	9723677				2022-12-18	WOS:000075537100026
J	Ramadour, M; Birnbaum, J; Magalon, C; Lanteaume, A; Charpin, D; Vervloet, D				Ramadour, M; Birnbaum, J; Magalon, C; Lanteaume, A; Charpin, D; Vervloet, D			Cat sex differences in major allergen production (Fel d 1)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Hop St Marguerite, Serv Pneumoallergol, F-13274 Marseille 9, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Birnbaum, J (corresponding author), Hop St Marguerite, Serv Pneumoallergol, 270 Bd St Marguerite, F-13274 Marseille 9, France.							BROWN PR, 1984, INT ARCH ALLER A IMM, V74, P367; DABROWSKI AJ, 1990, J ALLERGY CLIN IMMUN, V86, P462, DOI 10.1016/S0091-6749(05)80200-3; JalilColome J, 1996, J ALLERGY CLIN IMMUN, V98, P165, DOI 10.1016/S0091-6749(96)70238-5; MILLER JD, 1995, CLIN EXP ALLERGY, V25, P574; WENTZ PE, 1990, J ALLERGY CLIN IMMUN, V85, P94, DOI 10.1016/0091-6749(90)90228-V	5	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	1				282	284		10.1016/S0091-6749(98)70411-7	http://dx.doi.org/10.1016/S0091-6749(98)70411-7			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YZ342	9500764				2022-12-18	WOS:000072244800020
J	Costa, JJ				Costa, JJ			The therapeutic use of hematopoietic growth factors	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; BLOOD PROGENITOR CELLS; HEALTHY-VOLUNTEERS; GRANULOCYTE; MOBILIZATION; CHEMOTHERAPY; CSF; ACTIVATION; APHERESIS; TOXICITY		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Allergy & Inflammat, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Expt Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Costa, JJ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Allergy & Inflammat, Res N,330 Brookline Ave, Boston, MA 02215 USA.							Anderlini P, 1996, TRANSFUSION, V36, P590, DOI 10.1046/j.1537-2995.1996.36796323057.x; [Anonymous], 1994, J CLIN ONCOL, V12, P2471; Bociek RG, 1996, CA-CANCER J CLIN, V46, P165, DOI 10.3322/canjclin.46.3.165; Costa JJ, 1996, J EXP MED, V183, P2681, DOI 10.1084/jem.183.6.2681; COSTA JJ, 1996, PRINCIPLES PRACTICE, P408; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; Croockewit AJ, 1996, CLIN PHARMACOL THER, V59, P1, DOI 10.1016/S0009-9236(96)90016-8; DENZLINGER C, 1993, BLOOD, V81, P2007; Fraser JK, 1996, SEMIN ONCOL, V23, P2; Ganser Arnold, 1996, Current Opinion in Oncology, V8, P265; Glaspy J, 1996, Curr Opin Hematol, V3, P223; Glaspy J, 1996, CANCER CHEMOTH PHARM, V38, pS53, DOI 10.1007/s002800051039; Gough A, 1997, LANCET, V350, P855, DOI 10.1016/S0140-6736(97)04495-4; GRIBBEN JG, 1990, LANCET, V335, P434, DOI 10.1016/0140-6736(90)90665-R; Hoglund M, 1995, BLOOD, V86, P1842; JAIYESIMI I, 1991, NEW ENGL J MED, V325, P587; LIESCHKE GJ, 1990, CANCER RES, V50, P606; Lifton R, 1996, HEMATOL ONCOL CLIN N, V10, P825, DOI 10.1016/S0889-8588(05)70371-3; Moskowitz CH, 1997, BLOOD, V89, P3136; SHPALL EJ, 1997, IN PRESS BLOOD; Waller CF, 1996, BONE MARROW TRANSPL, V18, P279; Weaver A, 1996, BLOOD, V88, P3323, DOI 10.1182/blood.V88.9.3323.bloodjournal8893323	22	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	1				1	6		10.1016/S0091-6749(98)70185-X	http://dx.doi.org/10.1016/S0091-6749(98)70185-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR872	9449493				2022-12-18	WOS:000071539800001
J	Iacono, G; Cavataio, F; Montalto, G; Carroccio, A				Iacono, G; Cavataio, F; Montalto, G; Carroccio, A			Cow's milk-protein allergy as a cause of anal fistula and fissures: A case report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INFANTS		Osped G Di Cristina, Div Pediat 2, Palermo, Italy; Univ Palermo, Cattedra Med Interna, Palermo, Italy	University of Palermo	Carroccio, A (corresponding author), Via Coffaro 25, I-90124 Palermo, Italy.		Carroccio, Antonio/K-4484-2016	Carroccio, Antonio/0000-0001-8913-7916; MONTALTO, Giuseppe/0000-0002-8731-8577				IACONO G, 1995, J PEDIATR-US, V126, P34, DOI 10.1016/S0022-3476(95)70496-5; Iacono G, 1996, J ALLERGY CLIN IMMUN, V97, P822, DOI 10.1016/S0091-6749(96)80160-6; SAVILAHTI E, 1981, ALLERGY, V36, P73, DOI 10.1111/j.1398-9995.1981.tb04101.x; SCHRANDER JJP, 1993, EUR J PEDIATR, V152, P640, DOI 10.1007/BF01955238; WOOD CBS, 1986, ACTA PAEDIATR SCAND, P76	5	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	1				125	127		10.1016/S0091-6749(98)70204-0	http://dx.doi.org/10.1016/S0091-6749(98)70204-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR872	9449512	Bronze			2022-12-18	WOS:000071539800020
J	Nishikawa, S				Nishikawa, S			Embryonic stem cells as a source of hematopoietic and vascular endothelial cells in vitro	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Conference on New Trends in Immunopharmacology	JUL   06, 1996	TOKYO, JAPAN	Novartis Pharma KK, Tokyo, Japan			CULTURE; MOUSE		Kyoto Univ, Fac Med, Dept Mol Genet, Sakyo Ku, Kyoto, Japan	Kyoto University	Nishikawa, S (corresponding author), Kyoto Univ, Fac Med, Dept Mol Genet, Sakyo Ku, Shogoinkawaharacho 53, Kyoto, Japan.							Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; PARDANAUD L, 1989, DEVELOPMENT, V100, P339; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAM PPL, 1989, DEVELOPMENT, V107, P55; WILES MV, 1991, DEVELOPMENT, V111, P259	7	10	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1997	100	6	2	S			S102	S104		10.1016/S0091-6749(97)70014-9	http://dx.doi.org/10.1016/S0091-6749(97)70014-9			3	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR026	9440554	Bronze			2022-12-18	WOS:000071449600014
J	Helbling, A; Reimers, A; Walti, M; Borgts, R; Brander, KA				Helbling, A; Reimers, A; Walti, M; Borgts, R; Brander, KA			Food allergy to Belgian endive (chicory)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 15-20, 1996	NEW ORLEANS, LA	Amer Acad Allergy Asthma & Immunol			LETTUCE; CARROT		UNIV HOSP BERN,DEPT MED,POLICLIN MED,CH-3010 BERN,SWITZERLAND; IMMUNOL ALLERGOL ANALYT AG,ALLERGIE LAB,ZURICH,SWITZERLAND	University of Bern; University Hospital of Bern	Helbling, A (corresponding author), UNIV HOSP BERN,INST IMMUNOL & ALLERGOL,CH-3010 BERN,SWITZERLAND.							BOCCAFOGLI A, 1994, ANN ALLERGY, V73, P301; Cadot P, 1996, CLIN EXP ALLERGY, V26, P940, DOI 10.1111/j.1365-2222.1996.tb00630.x; EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X; HELBLING A, 1994, ALLERGY PROC, V15, P33, DOI 10.2500/108854194778816652; SCHWARTZ HJ, 1995, ANN ALLERG ASTHMA IM, V74, P152; Valenta R, 1996, J ALLERGY CLIN IMMUN, V97, P893, DOI 10.1016/S0091-6749(96)80062-5	6	10	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1997	99	6	1				854	856						3	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XH193	9215258				2022-12-18	WOS:A1997XH19300023
J	Douglas, R; Spelman, D; Czarny, D; OHehir, R				Douglas, R; Spelman, D; Czarny, D; OHehir, R			Desensitization to itraconazole	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									ALFRED HOSP,DEPT MICROBIOL & INFECT DIS,PRAHRAN,VIC 3181,AUSTRALIA	Florey Institute of Neuroscience & Mental Health	Douglas, R (corresponding author), ALFRED HOSP,DEPT ALLERGY & CLIN IMMUNOL,COMMERCIAL RD,PRAHRAN,VIC 3181,AUSTRALIA.		O'Hehir, Robyn E/H-3627-2011	O'Hehir, Robyn E/0000-0002-3489-7595				BITTLEMAN, 1994, J ALLERGY CLIN IMMUN, V92, P270	1	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1997	99	2					269	269						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH831	9042060				2022-12-18	WOS:A1997WH83100023
J	Dicpinigaitis, PV; Thomas, SA; Sherman, MB; Gayle, YE; Rosenstreich, DL				Dicpinigaitis, PV; Thomas, SA; Sherman, MB; Gayle, YE; Rosenstreich, DL			Losartan-induced bronchospasm	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ANGIOTENSIN-II RECEPTORS		ALBERT EINSTEIN COLL MED,JACK D WEILER HOSP,DEPT PHARM,BRONX,NY	Yeshiva University; Albert Einstein College of Medicine	Dicpinigaitis, PV (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,1825 EASTCHESTER RD,BRONX,NY 10461, USA.							ACKER CG, 1995, NEW ENGL J MED, V333, P1572, DOI 10.1056/NEJM199512073332316; Dicpinigaitis PV, 1996, J CLIN PHARMACOL, V36, P361, DOI 10.1002/j.1552-4604.1996.tb04213.x; ENTZEROTH M, 1991, EUR J PHARM-MOLEC PH, V206, P237, DOI 10.1016/S0922-4106(05)80024-0; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; MILLAR E, 1995, EUR RESPIR J, V8, P1838, DOI 10.1183/09031936.95.08111838; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205	6	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	1				1128	1130		10.1016/S0091-6749(96)80205-3	http://dx.doi.org/10.1016/S0091-6749(96)80205-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WB378	8977519	Bronze			2022-12-18	WOS:A1996WB37800023
J	Gengo, FM				Gengo, FM			Reduction of the central nervous system adverse effects associated with antihistamines in the management of allergic disorders: Strategies and progress	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						antihistamines; side effects; risk management	THEOPHYLLINE; CETIRIZINE; ANTAGONISTS; RECEPTOR; MOOD	To reduce the risks associated with the treatment of allergic disorders, physicians should understand the benefits and risks of drugs in the antihistamine class. The risk of central nervous system adverse effects associated with antihistamine use is significant with the use of first-generation antihistamines, which show pharmacologic activity in serotonergic, alpha-adrenergic, dopaminergic, and muscarinic-cholinergic pathways. Adverse effects reported with the use of first-generation antihistamines most often include drowsiness, fatigue, and an inability to concentrate; these effects may result in decreased compliance with therapy. The second-generation antihistamines have the property of low lipid solubility, which slows access across the blood-brain barrier. The low sedative profile of these new drugs may also be linked to a more pronounced binding to peripheral rather than brain histamine H-1-receptors. The use of antihistamines with lower lipid solubility and greater specificity can provide an effective alternative for the relief of allergic symptoms, can improve compliance, and can reduce neurologic side effects. Because of the differences now recognized in the side effects of drugs of this class, an individualized approach to selection of antihistamine therapy is required.	SUNY BUFFALO,SCH MED,DEPT NEUROL & PHARM,BUFFALO,NY 14260; SUNY BUFFALO,SCH PHARM,DEPT NEUROL & PHARM,BUFFALO,NY 14260; DENT NEUROL INST,NEUORPHARMACOL DIV,BUFFALO,NY	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								ARRANG JM, 1994, CELL MOL BIOL, V40, P273; FISCHER SM, 1990, CARCINOGENESIS, V11, P991, DOI 10.1093/carcin/11.6.991; GENGO FM, 1987, CLIN PHARMACOL THER, V42, P265, DOI 10.1038/clpt.1987.145; HENDELES L, 1983, PHARMACOTHERAPY, V3, P2; HILL SJ, 1990, PHARMACOL REV, V42, P45; HINDMARCH I, 1978, ARZNEIMITTEL-FORSCH, V28-1, P483; JENNE JW, 1986, J ALLERGY CLIN IMMUN, V78, P727, DOI 10.1016/0091-6749(86)90053-9; JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349; JUNIPER EF, 1993, ANN ALLERGY, V70, P225; JUSCKO WJ, 1979, J PHARM SCI, V68, P1358; LESKO LJ, 1986, J ALLERGY CLIN IMMUN, V78, P723, DOI 10.1016/0091-6749(86)90052-7; MANNING C, 1992, J CLIN PHARMACOL, V32, P996, DOI 10.1002/j.1552-4604.1992.tb03801.x; MARSHALL PS, 1993, ANN ALLERGY, V71, P251; NICHOLSON AN, 1985, NEUROPHARMACOLOGY, V24, P245, DOI 10.1016/0028-3908(85)90081-4; OFFENLOCH K, 1992, ARZNEIMITTEL-FORSCH, V42-1, P864; PECHADRE JC, 1991, J INT MED RES, V19, P289, DOI 10.1177/030006059101900401; RICE VJ, 1993, AVIAT SPACE ENVIR MD, V64, P717; ROTH T, 1987, J ALLERGY CLIN IMMUN, V80, P94, DOI 10.1016/S0091-6749(87)80197-5; ROVNER BW, 1988, AM J PSYCHIAT, V145, P107; SIMONS FER, 1994, J PEDIATR-US, V124, P979; SIMONS FER, 1993, ALLERGY PRINCIPLES P; SMITH SJ, 1994, OTOLARYNG HEAD NECK, V111, P348, DOI 10.1177/01945998941113P203; SNYDER SH, 1987, ANN ALLERGY, V59, P4; SPENCER CM, 1993, DRUGS, V46, P1055, DOI 10.2165/00003495-199346060-00008; SUNDERLAND T, 1987, ARCH GEN PSYCHIAT, V44, P418; TIMMERMAN H, 1992, THERAPEUTIC INDEX AN, P19; VOLKERTS ER, 1992, HUM PSYCHOPHARM CLIN, V7, P227, DOI 10.1002/hup.470070402; VUUURMAN EFP, 1993, ANN ALLERGY, V10, P249; WEICH NL, 1982, ARZNEIMITTEL-FORSCH, V32, P1167; WEINBERGER M, 1983, NEW ENGL J MED, V308, P760, DOI 10.1056/NEJM198303313081306; ZANGANEH KE, 1993, SOLID MECH APPL, V28, P165	31	10	14	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	3	S			S319	S325		10.1016/S0091-6749(96)70059-3	http://dx.doi.org/10.1016/S0091-6749(96)70059-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WC448	8977543				2022-12-18	WOS:A1996WC44800005
J	Kuwata, S; Yanagisawa, M; Nakagawa, H; Saeki, H; Etoh, T; Miyamoto, M; Juji, T				Kuwata, S; Yanagisawa, M; Nakagawa, H; Saeki, H; Etoh, T; Miyamoto, M; Juji, T			HLA-DM gene polymorphisms in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HLA; HLA-DM; PCR; PCR-RFLP; atopic dermatitis; haplotype; linkage disequilibrium; Japanese population	COMPLEX CLASS-II; PCR-RFLP METHOD; PEPTIDE; MHC; AMPLIFICATION; PATHOGENESIS; HLA-DRB1; ALLELES; CLIP	HLA-DM molecules are involved in the antigen-processing pathway of HLA class II-restricted antigen presentation. We investigated polymorphisms of HLA-DM genes in atopic dermatitis by using the polymerase chain reaction-restriction-fragment length polymorphism method to examine a possible contribution of these genes to the pathogenesis of atopic dermatitis. Genomic DNA was extracted from 37 Japanese patients with atopic dermatitis and 52 control subjects. After polymerase chain reaction amplification of the polymorphic third exon of DMA and DMB genes, amplified products were digested with restriction endonucleases to determine HLA-DM alleles. FokI, HinfI, AciI and SfaNI were used for DMA; HhaI, BsrI, ApaLI, and Bsp1286I for the DMB gene. We identified three DMA alleles and also three DMB alleles. One of 37 patients possessed the DMA*0103 allele, which has been reported as a rare allele in Caucasian populations. Any DMA and DMB alleles were not increased in the patients. The DMA*0102 allele was estimated to constitute a haplotype with DRB1*1201/DQB1*0301 and DRB1*0901/DQB1*0301 in a Japanese population. HLA-DM genes are not considered to contribute primarily to the susceptibility of atopic dermatitis. Further investigation of the functional roles of HLA-DM gene polymorphisms will be useful for a better understanding of susceptibility loci in HLA class II-associated disease.	UNIV TOKYO,FAC MED,DEPT DERMATOL,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,DEPT TRANSFUS MED & IMMUNOHEMATOL,TOKYO 113,JAPAN; JAPANESE RED CROSS,CENT BLOOD CTR,TOKYO,JAPAN	University of Tokyo; University of Tokyo; Japanese Red Cross Medical Center								BODMER JG, 1995, TISSUE ANTIGENS, V46, P1; BOS JD, 1994, LANCET, V343, P1338, DOI 10.1016/S0140-6736(94)92473-2; CARRINGTON M, 1993, IMMUNOGENETICS, V38, P446; CARRINGTON M, 1994, IMMUNOGENETICS, V40, P165; CHO SG, 1991, NATURE, V353, P573, DOI 10.1038/353573a0; COOPER KD, 1994, J INVEST DERMATOL, V102, P128, DOI 10.1111/1523-1747.ep12371746; CRESSWELL P, 1994, CURR BIOL, V4, P541, DOI 10.1016/S0960-9822(00)00119-6; Imanish T, 1992, HLA 1991, V1, P1065; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; Kuwata S, 1995, J ALLERGY CLIN IMMUN, V96, P1051, DOI 10.1016/S0091-6749(95)70190-7; KUWATA S, 1994, J ALLERGY CLIN IMMUN, V94, P565, DOI 10.1016/0091-6749(94)90132-5; MITSUNAGA S, 1992, HUM IMMUNOL, V34, P203, DOI 10.1016/0198-8859(92)90113-2; MITSUNAGA S, 1995, EUR J IMMUNOGENET, V22, P371, DOI 10.1111/j.1744-313X.1995.tb00252.x; MITSUNAGA S, 1995, HUM IMMUNOL, V42, P307, DOI 10.1016/0198-8859(94)00118-A; MITTAL KK, 1976, VOX SANG, V31, P161, DOI 10.1111/j.1423-0410.1976.tb02206.x; MONJI T, 1994, J IMMUNOL, V153, P4468; NAEDA M, 1989, TISSUE ANTIGENS, V34, P290; OTA M, 1992, TISSUE ANTIGENS, V39, P187, DOI 10.1111/j.1399-0039.1992.tb01935.x; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; Saeki H, 1995, J ALLERGY CLIN IMMUN, V96, P1061, DOI 10.1016/S0091-6749(95)70191-5; SAEKI H, 1994, J ALLERGY CLIN IMMUN, V94, P575, DOI 10.1016/0091-6749(94)90133-3; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMID SL, 1994, NATURE, V369, P103, DOI 10.1038/369103a0; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SVEJGAARD A, 1983, IMMUNOL REV, V70, P193, DOI 10.1111/j.1600-065X.1983.tb00715.x; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0	26	10	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	2	S			S192	S200		10.1016/S0091-6749(96)70066-0	http://dx.doi.org/10.1016/S0091-6749(96)70066-0			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WC447	8977527				2022-12-18	WOS:A1996WC44700004
J	Calhoun, WJ; Jarjour, NN; Gleich, GJ; Schwartz, LB; Busse, WW				Calhoun, WJ; Jarjour, NN; Gleich, GJ; Schwartz, LB; Busse, WW			Effect of nedocromil sodium pretreatment on the immediate and late responses of the airway to segmental antigen challenge	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						bronchoalveolar lavage; eosinophil; eosinophil granule proteins; histamine; nedocromil sodium; segmental allergen challenge; tryptase	ALLERGEN CHALLENGE; INFLAMMATION; ASTHMA; EOSINOPHIL; INHIBITION; HISTAMINE	In many patients with asthma, exposure to allergen results in worsening symptoms, pulmonary dysfunction, and increased airway inflammation. In this study, segmental allergen challenge and bronchoalveolar lavage were used to evaluate the airway responses at 5 minutes and 48 hours and to study the extent of inhibition of the response by pretreatment with nedocromil sodium in eight subjects with allergic asthma in a double-blind, placebo-controlled trial. At 5 minutes after challenge, nedocromil sodium pretreatment significantly reduced histamine concentrations, with a trend toward a concomitant reduction in tryptase levels. Nedocromil sodium did not affect the increase in total protein, fetal cell counts, or cell concentrations that occurred 48 hours after challenge but it did significantly reduce eosinophil recruitment. Eosinophil activation assessed as release of granule proteins, was unaffected. A significant positive correlation was shown between the degree of histamine reduction at 5 minutes and the degree of reduction of eosinophil influx at 48 hours, raising the possibility that eosinophil influx into the airway may depend on mediators or cytokines released during the immediate response to allergen.	UNIV WISCONSIN, DIV PULM & CRIT CARE MED, MADISON, WI USA; MAYO CLIN, DEPT IMMUNOL, ROCHESTER, MN USA; VIRGINIA COMMONWEALTH UNIV, DIV RHEUMATOL ALLERGY & IMMUNOL, RICHMOND, VA 23284 USA; UNIV WISCONSIN, DIV ALLERGY & CLIN IMMUNOL, MADISON, WI USA	University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Virginia Commonwealth University; University of Wisconsin System; University of Wisconsin Madison	Calhoun, WJ (corresponding author), UNIV PITTSBURGH, DIV PULM ALLERGY & CRIT CARE MED, 440 SCAIFE HALL, PITTSBURGH, PA 15261 USA.			Calhoun, William/0000-0001-7075-712X				[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; ARMITAGE P, 1989, STAT METHODS MED RES, P408; BOWSHER RR, 1983, J BIOL CHEM, V258, P2215; BROIDE DH, 1991, J CLIN INVEST, V88, P1048, DOI 10.1172/JCI115366; CALHOUN WJ, 1993, AM REV RESPIR DIS, V147, P1465, DOI 10.1164/ajrccm/147.6_Pt_1.1465; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; CALHOUN WJ, 1992, AM REV RESPIR DIS, V145, P317, DOI 10.1164/ajrccm/145.2_Pt_1.317; CHERNIACK R M, 1990, Chest, V97, P1299; DEJONG JW, 1994, AM J RESP CRIT CARE, V149, P91, DOI 10.1164/ajrccm.149.1.8111606; GLANTZ SA, 1992, PRIMER BIOSTATISTICS, P32; HUTSON PA, 1988, BRIT J PHARMACOL, V94, P6, DOI 10.1111/j.1476-5381.1988.tb11493.x; JARJOUR NN, 1990, AM REV RESPIR DIS, V142, P100, DOI 10.1164/ajrccm/142.1.100; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; OHNISHI T, 1993, AM REV RESPIR DIS, V147, P901, DOI 10.1164/ajrccm/147.4.901; PELIKAN Z, 1993, J ALLERGY CLIN IMMUN, V92, P19, DOI 10.1016/0091-6749(93)90032-B; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; The BAL Cooperative Group Steering Committee, 1990, AM REV RESPIR DIS, V141, pS169; WASSERMAN SI, 1993, J ALLERGY CLIN IMMUN, V92, P210, DOI 10.1016/0091-6749(93)90111-R; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002	19	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S46	S50		10.1016/S0091-6749(96)80128-X	http://dx.doi.org/10.1016/S0091-6749(96)80128-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939176				2022-12-18	WOS:A1996VW14000009
J	Vrugt, B; Djukanovic, R; Bron, A; Aalbers, R				Vrugt, B; Djukanovic, R; Bron, A; Aalbers, R			New insights into the pathogenesis of severe corticosteroid-dependent asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						endobronchial biopsy; interleukin-8; severe asthma; T cell	ACTIVATED T-CELLS; GLUCOCORTICOID RESISTANCE; BRONCHOALVEOLAR LAVAGES; BRONCHIAL BIOPSIES; INFLAMMATORY CELLS; LYMPHOCYTES-T; ATOPIC ASTHMA; INTERLEUKIN-5; EXPRESSION; EOSINOPHILIA	Severe asthma is characterized by persistent T-cell activation, as demonstrated in both peripheral blood and bronchial mucosa. Endobronchial biopsy specimens of patients with severe, corticosteroid-dependent asthma revealed increased expression of CD25+ on mucosal T cells. Increased immunoreactivity, for IL-5 further supports the evidence that the inflammatory response is orchestrated by T-H2-type T cells. Peripheral blood eosinophils and total serum IgE levels were increased in the absence of allergen and despite optimal treatment. The chemokine IL-8 may also be an aggravating factor in severe asthma; as well as being a potent chemotactic and activating factor for neutrophils, it may also be chemoattractant for eosinophils. We have recently detected increased levels of free IL-8 in the peripheral blood of patients with chronic severe asthma but not in healthy control subjects or in patients with mild asthma, even after allergen challenge. In patients with severe asthma there may be an imbalance between IL-8 production and the blocking capacity of IL-S autoantibodies. Higher levels of IL-8 complexed to IgA autoantibody and increased numbers of activated T cells were also found in patients with unstable asthma compared with patients who had severe but stable disease. We conclude that IL-8 may provide an additional marker of asthma severity and corticosteroid responsiveness.	MARTINI HOSP,NL-9728 NZ GRONINGEN,NETHERLANDS; ACAD HOSP,UTRECHT,NETHERLANDS; SOUTHAMPTON GEN HOSP,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND; DUTCH ASTHMA CTR,DAVOS,SWITZERLAND	Martini Hospital; University of Southampton			Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X; Djukanovic, Ratko/0000-0001-6039-5612				AALBERS R, 1993, CHEST, V103, P1178, DOI 10.1378/chest.103.4.1178; AALBERS R, 1993, AM REV RESPIR DIS, V147, P76, DOI 10.1164/ajrccm/147.1.76; ALEXANDER AG, 1994, THORAX, V49, P1231, DOI 10.1136/thx.49.12.1231; AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1016, DOI 10.1164/ajrccm/144.5.1016; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1026, DOI 10.1164/ajrccm/144.5.page; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; DJUKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669, DOI 10.1164/ajrccm/145.3.669; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; KERSTJENS HAM, 1992, NEW ENGL J MED, V327, P1413, DOI 10.1056/NEJM199211123272003; MARINI M, 1992, J ALLERGY CLIN IMMUN, V89, P1001, DOI 10.1016/0091-6749(92)90223-O; OHASHI Y, 1992, AM REV RESPIR DIS, V145, P1469, DOI 10.1164/ajrccm/145.6.1469; Redington A. E., 1993, Thorax, V48, P1081; ROBINSON D, 1993, AM REV RESPIR DIS, V148, P401, DOI 10.1164/ajrccm/148.2.401; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SCHLEIMER RP, 1990, AM REV RESPIR DIS, V141, pS59; SEARS MR, 1992, ASTHMA BASIC MECHANI, P1; SHUTE J, 1994, CLIN EXP ALLERGY, V24, P203, DOI 10.1111/j.1365-2222.1994.tb00220.x; SHUTE JK, 1993, RESPIR MED, V87, P650; SYLVESTER I, 1992, J CLIN INVEST, V90, P471, DOI 10.1172/JCI115883; vanVelzen E, 1996, THORAX, V51, P582, DOI 10.1136/thx.51.6.582; Vrugt B., 1994, European Respiratory Journal, V7, p239S; VRUGT B, 1994, AM J RESP CRIT CARE, V149, pA963; VRUGT B, 1994, AM J RESP CRIT CARE, V149, pA960; WALKER C, 1994, AM J RESP CRIT CARE, V150, P1038, DOI 10.1164/ajrccm.150.4.7921434; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; WIERENGA EA, 1990, J IMMUNOL, V144, P4651	29	10	10	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S22	S26		10.1016/S0091-6749(96)80125-4	http://dx.doi.org/10.1016/S0091-6749(96)80125-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939173				2022-12-18	WOS:A1996VW14000005
J	Liccardi, G; DAmato, M; DAmato, G				Liccardi, G; DAmato, M; DAmato, G			Oral allergy syndrome after ingestion of salami in a subject with monosensitization to mite allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											Liccardi, G (corresponding author), HOSP A CARDERELLI,DIV PNEUMOL & ALLERGOL,DEPT CHEST DIS,PIAZZA ARENELLA N 7-H,I-80128 NAPLES,ITALY.		D'Amato, Maria/H-3074-2012	D'Amato, Maria/0000-0002-5906-5701				AAS K, 1972, ACTA ALLERGOL, V27, P439; BRUIJNZEELKOOMEN C, 1995, ALLERGY, V50, P623, DOI 10.1111/j.1398-9995.1995.tb02579.x; DREBORG S, 1983, ALLERGY, V38, P161; LICCARDI G, 1994, J ALLERGY CLIN IMMUN, V94, P931, DOI 10.1016/0091-6749(94)90162-7; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; PASTORELLO EA, 1994, J ALLERGY CLIN IMMUN, V94, P699, DOI 10.1016/0091-6749(94)90177-5	6	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1996	98	4					850	852		10.1016/S0091-6749(96)70139-2	http://dx.doi.org/10.1016/S0091-6749(96)70139-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VM665	8876566				2022-12-18	WOS:A1996VM66500023
J	Dvorak, AM; Schroeder, JT; MacGlashan, DW; Bryan, KP; Morgan, ES; Lichtenstein, LM; MacDonald, SM				Dvorak, AM; Schroeder, JT; MacGlashan, DW; Bryan, KP; Morgan, ES; Lichtenstein, LM; MacDonald, SM			Comparative ultrastructural morphology of human basophils stimulated to release histamine by anti-lgE, recombinant IgE-dependent histamine-releasing factor, or monocyte chemotactic protein-1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						human basophil; secretion; electron microscopy; anti-IgE; recombinant IgE-dependent histamine-releasing factor; monocyte chemotactic protein-1; piecemeal degranulation; anaphylactic degranulation; motile structures; vesicle transport	ACTIVATING FACTOR MCAF; DE-GRANULATION; ACTIVITY HRA; MAST-CELLS; INDUCED DEGRANULATION; CYTOPLASMIC VESICLES; LEUKOCYTES; PURIFICATION; SECRETION; PIECEMEAL	An ultrastructural analysis of human basophils stimulated with anti-IgE, recombinant histamine-releasing factor (rHRF), or monocyte chemotactic protein-1 (MCP-1) (compared with unstimulated cells) was performed. Partially purified peripheral blood basophils were prepared for electron microscopy at time points known to precede histamine release and at half-maximum histamine release times for each secretagogue. Activation morphologies associated with stimulation included granule-vesicle attachments, piecemeal degranulation, anaphylactic degranulation, and uropod formation. These features were qualitatively similar in the stimulated samples. Quantitative differences were evident, however, when stimulated samples were compared with controls or at different time points after stimulation with a single agent or when individual secretagogues were compared. All stimulated samples differed quantitatively from the control samples. Rank orders for morphologic activation events revealed that the most effective trigger for anaphylactic degranulation was anti-IgE>MCP-1>rHRF, whereas the most effective trigger for uropod formation was rHRF>anti-IgE>MCP-1. Rank orders for piecemeal degranulation and granule-vesicle attachments were the same: MCP-1>anti-IgE>rHRF. Important relationships among these anatomic events reveal that the development of motile configurations is not associated with the development of secretion morphologies and that piecemeal degranulation precedes and is inversely related to anaphylactic degranulation in stimulated samples.	JOHNS HOPKINS ASTHMA & ALLERGY CTR,DIV CLIN IMMUNOL & ALLERGY,BALTIMORE,MD; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School	Dvorak, AM (corresponding author), BETH ISRAEL HOSP,DEPT PATHOL,330 BROOKLINE AVE,BOSTON,MA 02215, USA.				NIAID NIH HHS [AI-07290, AI-33372, AI-32651] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032651, R01AI033372, R29AI032651] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALAM R, 1992, J CLIN INVEST, V89, P723, DOI 10.1172/JCI115648; BISCHOFF SC, 1992, J EXP MED, V175, P1271, DOI 10.1084/jem.175.5.1271; DVORAK AM, 1976, J IMMUNOL, V116, P687; DVORAK AM, 1993, J LEUKOCYTE BIOL, V54, P465, DOI 10.1002/jlb.54.5.465; DVORAK AM, 1992, INT ARCH ALLERGY IMM, V99, P74, DOI 10.1159/000236338; DVORAK AM, 1984, CLIN IMMUNOL IMMUNOP, V32, P142, DOI 10.1016/0090-1229(84)90116-8; DVORAK AM, 1991, LAB INVEST, V64, P234; DVORAK AM, 1980, LAB INVEST, V43, P126; DVORAK AM, 1988, EOS-RIV IMMUNOL, V8, P50; DVORAK AM, 1989, LAB INVEST, V60, P557; DVORAK AM, 1994, BLOOD, V83, P3600; DVORAK AM, 1992, AM J PATHOL, V141, P1309; DVORAK AM, 1981, LAB INVEST, V44, P174; DVORAK AM, 1994, INT ARCH ALLERGY IMM, V105, P8, DOI 10.1159/000236796; DVORAK AM, 1981, J IMMUNOL, V126, P523; DVORAK AM, 1993, IMMUNOPHARMACOLOGY M, P153; DVORAK AM, 1995, FUND CLIN IMMUNOL, V3, P17; DVORAK AM, 1993, IMMUNOPHARMACOLOGY M, P89; Dvorak AM, 1992, GRANULOCYTE RESPONSE, P169; DVORAK AM, 1991, BLOOD CELL BIOCH, V4; DVORAK HF, 1975, CLIN HAEMATOL, V4, P651; DVORAK HF, 1970, J EXP MED, V132, P558, DOI 10.1084/jem.132.3.558; FINDLAY SR, 1981, J CLIN INVEST, V67, P1604, DOI 10.1172/JCI110195; FURUTANI Y, 1989, BIOCHEM BIOPH RES CO, V159, P249, DOI 10.1016/0006-291X(89)92430-3; GALLI SJ, 1981, J IMMUNOL, V126, P1066; KUNA P, 1992, J EXP MED, V175, P489, DOI 10.1084/jem.175.2.489; MACDONALD SM, 1989, J IMMUNOL, V142, P3527; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MACDONALD SM, 1993, ALLERGY PRINCIPLES P, P1; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; SCHROEDER JT, 1994, J IMMUNOL, V153, P1808; THUESON DO, 1979, J IMMUNOL, V123, P633; THUESON DO, 1979, J IMMUNOL, V123, P626; WARNER JA, 1989, J LEUKOCYTE BIOL, V45, P558, DOI 10.1002/jlb.45.6.558; YOSHIMURA T, 1989, J IMMUNOL, V142, P1956; ZACHARIAE COC, 1990, J EXP MED, V171, P2177, DOI 10.1084/jem.171.6.2177	37	10	14	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1996	98	2					355	370		10.1016/S0091-6749(96)70160-4	http://dx.doi.org/10.1016/S0091-6749(96)70160-4			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VC995	8757213				2022-12-18	WOS:A1996VC99500015
J	Lemiere, C; Malo, JL; McCants, M; Lehrer, S				Lemiere, C; Malo, JL; McCants, M; Lehrer, S			Occupational asthma caused by roasted coffee: Immunologic evidence that roasted coffee contains the same antigens as green coffee, but at a lower concentration	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HOP SACRE COEUR,DEPT CHEST MED,MONTREAL,PQ H4J 1C5,CANADA; TULANE UNIV,SCH MED,DEPT MED,NEW ORLEANS,LA 70118	Universite de Montreal; Tulane University								FIGLEY KD, 1950, J ALLERGY, V21, P545, DOI 10.1016/0021-8707(50)90106-7; KARR RM, 1979, J ALLERGY CLIN IMMUN, V64, P650, DOI 10.1016/0091-6749(79)90030-7; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; LEHRER SB, 1978, CLIN ALLERGY, V8, P217, DOI 10.1111/j.1365-2222.1978.tb03217.x; ZUSKIN E, 1981, THORAX, V36, P9, DOI 10.1136/thx.36.1.9	5	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1996	98	2					464	466		10.1016/S0091-6749(96)70173-2	http://dx.doi.org/10.1016/S0091-6749(96)70173-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VC995	8757226				2022-12-18	WOS:A1996VC99500028
J	Shanafelt, MC; Yssel, H; Soderberg, C; Steinman, L; Adelman, DC; Peltz, G; Lahesmaa, R				Shanafelt, MC; Yssel, H; Soderberg, C; Steinman, L; Adelman, DC; Peltz, G; Lahesmaa, R			CD45 isoforms on human CD4(+) T-cell subsets	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CD45 isoforms; T-cell subsets; costimulatory molecules	PROTEIN TYROSINE KINASE; LYMPHOCYTES-T; DIFFERENTIAL EXPRESSION; ADHESION MOLECULES; PHOSPHOTYROSINE PHOSPHATASE; ANTIGEN RECEPTOR; LYME ARTHRITIS; CLONES; ACTIVATION; MURINE	We have examined the level of surface expression and functional properties of leukocyte function associated antigen-1, very late antigen-4, and CD45 isoforms on a panel of human CD4(+) T-cell clones representative of TH0, TH1, and TH2 cells. There were no qualitative differences in the expression of these antigens among the three types of CD4(+) T-cell clones. However, CD45RB was the only CD45 isoform that provided a costimulatory signal in a solid-phase antibody-induced cellular proliferation assay. Additionally, the antigen-induced proliferative response of T-cell clones was inhibited by soluble anti-CD45RO and anti-CD45RB antibodies. Our results suggest that CD45 informs differentially provide costimulatory signals to T cells. However, the ability of each CD45 isoforms to provide a costimulatory signal does not differ among the Th-0, TH1, or TH2 T-cell populations.	SYNTEX RES CTR,DEPT LEUKOCYTE BIOL,PALO ALTO,CA; DNAX RES INST MOL & CELLULAR BIOL INC,DEPT HUMAN IMMUNOL,PALO ALTO,CA 94304; STANFORD UNIV,MED CTR,DEPT NEUROL & NEUROL SCI,STANFORD,CA 94305; UNIV CALIF SAN FRANCISCO,DEPT MED,DIV ALLERGY & IMMUNOL,SAN FRANCISCO,CA 94143	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Stanford University; University of California System; University of California San Francisco			Yssel, Hans/AFV-2907-2022; Yssel, Hans/C-6406-2009	Yssel, Hans/0000-0001-7454-1836; Yssel, Hans/0000-0001-7454-1836; Steinman, Lawrence/0000-0002-2437-2250				AKBAR AN, 1988, J IMMUNOL, V140, P2171; BOTTOMLY K, 1989, EUR J IMMUNOL, V19, P617, DOI 10.1002/eji.1830190407; BROD SA, 1989, J EXP MED, V170, P2147, DOI 10.1084/jem.170.6.2147; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; DAMLE NK, 1992, J IMMUNOL, V148, P1985; DAYNES RA, 1989, EUR J IMMUNOL, V19, P2319, DOI 10.1002/eji.1830191221; DIANZANI U, 1992, EUR J IMMUNOL, V22, P365, DOI 10.1002/eji.1830220212; DIANZANI U, 1990, EUR J IMMUNOL, V20, P2249, DOI 10.1002/eji.1830201014; FIRESTEIN GS, 1989, J IMMUNOL, V143, P518; HORGAN KJ, 1992, J IMMUNOL, V149, P4082; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; KANNER SB, 1992, IMMUNOLOGY, V75, P441; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; LAHESMAA R, 1993, J IMMUNOL, V150, P4125; LEDBETTER JA, 1988, P NATL ACAD SCI USA, V85, P8628, DOI 10.1073/pnas.85.22.8628; LEE WT, 1992, EUR J IMMUNOL, V22, P1455, DOI 10.1002/eji.1830220618; LUQMAN M, 1991, EUR J IMMUNOL, V21, P17, DOI 10.1002/eji.1830210104; MAGILAVY DB, 1989, J EXP MED, V170, P985, DOI 10.1084/jem.170.3.985; MOSSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; NOVAK TJ, 1990, P NATL ACAD SCI USA, V87, P9353, DOI 10.1073/pnas.87.23.9353; PELTZ G, 1991, IMMUNOL REV, V123, P23, DOI 10.1111/j.1600-065X.1991.tb00604.x; PICKER LJ, 1990, J IMMUNOL, V145, P3247; POWRIE F, 1989, J EXP MED, V169, P653, DOI 10.1084/jem.169.3.653; ROGERS PR, 1992, J IMMUNOL, V148, P4054; SALMON M, 1989, J IMMUNOL, V143, P907; SANDERS ME, 1988, J IMMUNOL, V140, P1401; STREET NE, 1991, FASEB J, V5, P171, DOI 10.1096/fasebj.5.2.1825981; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; YSSEL H, 1991, J EXP MED, V174, P593, DOI 10.1084/jem.174.3.593; YSSEL H, 1992, J IMMUNOL, V148, P738; YSSEL H, 1990, INT IMMUNOL, V2, P1081, DOI 10.1093/intimm/2.11.1081	34	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1996	98	2					433	440		10.1016/S0091-6749(96)70168-9	http://dx.doi.org/10.1016/S0091-6749(96)70168-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VC995	8757221				2022-12-18	WOS:A1996VC99500023
J	Yocum, MW; Gosselin, VA; Yunginger, JW				Yocum, MW; Gosselin, VA; Yunginger, JW			Safety and efficiency of an accelerated method for venom skin testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ALLERGY		MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905	Mayo Clinic								GEORGITIS JW, 1985, J ALLERGY CLIN IMMUN, V76, P803, DOI 10.1016/0091-6749(85)90752-3; HUNT KJ, 1976, ANN INTERN MED, V85, P56, DOI 10.7326/0003-4819-85-1-56; LICHTENSTEIN LM, 1979, J ALLERGY CLIN IMMUN, V64, P5, DOI 10.1016/0091-6749(79)90075-7; REISMAN RE, 1994, J ALLERGY CLIN IMMUN, V94, P651, DOI 10.1016/0091-6749(94)90167-8; SCHWARTZ HJ, 1981, J ALLERGY CLIN IMMUN, V67, P81, DOI 10.1016/0091-6749(81)90051-8	5	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1424	1425		10.1016/S0091-6749(96)70217-8	http://dx.doi.org/10.1016/S0091-6749(96)70217-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607	8648045				2022-12-18	WOS:A1996VD60700037
J	Foresi, A; Cavigioli, G; Pelucchi, A; Mastropasqua, B; Marazzini, L				Foresi, A; Cavigioli, G; Pelucchi, A; Mastropasqua, B; Marazzini, L			Effect of acetazolamide on cough induced by low-chloride-ion solutions in normal subjects: Comparison with furosemide	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						furosemide; acetazolamide; cough challenge	NEBULIZED DISTILLED WATER; DORSAL-ROOT-GANGLIA; GUINEA-PIG AIRWAYS; CARBONIC-ANHYDRASE; INHALED FUROSEMIDE; ASTHMATIC SUBJECTS; LOOP DIURETICS; BRONCHOCONSTRICTION; RESPONSES; TRANSPORT	Background: The antitussive activity of inhaled fuorsemide has been attributed to its blocking effect on the Na+-2Cl(-)-K+ cotransporter. It is likely that the antitussive activity of inhaled diuretics is more complex because amiloride, a diuretic that has no effect on the Na+-2Cl(-)-K+ cotransporter, also shows a significant effect against cough induced by low-chloride-ion solutions. Apart from pharmacokinetics of inhaled diuretics, this activity could also depend on the inhibition of carbonic anhydrase. Objectives: We therefore studied the effect of inhaled acetazolamide, a selective inhibitor of carbonic anhydrase activity, on cough induced by the inhalation of different chloride ion solutions in a group of normal subjects. This was compared with the antitussive effect of furosemide. In addition, we attempted to determine whether the effect of acetazolamide is dose-dependent. Methods: Cough challenge consisted of consecutive inhalations of four solutions having decreasing concentrations of chloride ions (150, 75, 37.5 and 0 mmol/L). Nine normal subjects underwent the cough challenge 5 minutes after the inhalation of saline placebo, azetazolamide (500 mg), and furosemide (30 mg) according to a randomized, double-blind study design. A group of six subjects were challenged according to the same procedure and study design, after the inhalation of saline placebo and of two doses of acetazolamide (250 mg and 500 mg). Results: Inhaled acetazolamide significantly reduced cough response to 37.5 and 0 mmol/L chloride solutions compared with placebo (p < 0.015 and p < 0.015, respectively). Furosemide showed a similar protective effect (p < 0.015 and p < 0.025, respectively). Acetazolamide provided a significantly better protective effect than furosemide (p < 0.025 and p < 0.015, respectively). The antitussive activity of the two doses of acetazolamide was not statistically different. Conclusion: These results demonstrate that inhaled acetazolamide, a selective inhibitor of carbonic anhydrase, attenuates cough induced by low-chloride-ion solutions in normal subjects. At the applied doses, its antitussive activity is slightly greater than furosemide. This finding suggests that the inhibition of carbonic anhydrase activity is likely involved in modulating changes caused by absence of a chloride ion in the airway microenvironment of human beings.			Foresi, A (corresponding author), OSPED CITTA SESTO SAN GIOVANNI,SERV FISIOPATOL RESP G CAMPARI,I-20099 SESTO SAN GIOVANN,ITALY.							BALLANYI K, 1985, J PHYSIOL-LONDON, V365, P41, DOI 10.1113/jphysiol.1985.sp015758; BIANCO S, 1993, EUR RESPIR J, V6, P130; BOGGS DF, 1982, J APPL PHYSIOL, V53, P455, DOI 10.1152/jappl.1982.53.2.455; BOUSHEY HA, 1974, J PHYSIOL-LONDON, V240, P153, DOI 10.1113/jphysiol.1974.sp010605; CAVIGIOLI G, 1993, EUR RESPIR J, V6, pS595; DROZ B, 1987, COMP BIOCHEM PHYS B, V88, P713, DOI 10.1016/0305-0491(87)90233-1; ELWOOD W, 1991, AM REV RESPIR DIS, V143, P1340, DOI 10.1164/ajrccm/143.6.1340; ESCHENBACHER WL, 1984, AM REV RESPIR DIS, V129, P211; FORESI A, 1986, CHEST, V90, P822, DOI 10.1378/chest.90.6.822; FORESI A, 1992, AM REV RESPIR DIS, V146, P364, DOI 10.1164/ajrccm/146.2.364; FORESI A, 1994, CLIN IMMUNOTHER, V1, P339; GALLAGHER JP, 1983, BRAIN RES, V267, P249, DOI 10.1016/0006-8993(83)90877-6; KARLSSON JA, 1988, J APPL PHYSIOL, V65, P1007, DOI 10.1152/jappl.1988.65.3.1007; OCONNOR BJ, 1992, THORAX, V47, pP234; ODONNELL WJ, 1992, AM REV RESPIR DIS, V146, P1518, DOI 10.1164/ajrccm/146.6.1518; PREISIG PA, 1987, RENAL PHYSIOL BIOCH, V10, P136; RILEY DA, 1988, BRAIN RES, V453, P79, DOI 10.1016/0006-8993(88)90145-X; ROBUSCHI M, 1990, PROG R RES, V24, P117; RUSSEL JM, 1983, J GEN PHYSIOL, V81, P908; SANTAMBROGIO FB, 1993, EUR RESPIR J, V6, P1151; SCLUE WR, 1988, CIBA FOUND S, V139, P47; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; STONE R A, 1991, American Review of Respiratory Disease, V143, pA548; STONE RA, 1993, EUR RESPIR J, V6, P862; STONE RA, 1994, THORAX, pP281; SUN J, 1993, AM REV RESPIR DIS, V148, P902, DOI 10.1164/ajrccm/148.4_Pt_1.902; SUZUKI AG, 1993, AM J PHYSIOL, V264, pG118, DOI 10.1152/ajpgi.1993.264.1.G118; SZABOLCS MJ, 1991, J HISTOCHEM CYTOCHEM, V39, P1617, DOI 10.1177/39.12.1719070; TESSIER GJ, 1990, AM J PHYSIOL, V259, pL459, DOI 10.1152/ajplung.1990.259.6.L459; VAGHI A, 1995, AM J RESP CRIT CARE, V151, pA178; VENTRESCA PG, 1990, AM REV RESPIR DIS, V142, P143, DOI 10.1164/ajrccm/142.1.143; VOGH BP, 1981, BRAIN RES, V221, P171, DOI 10.1016/0006-8993(81)91071-4; WELSH MJ, 1986, CLIN CHEST MED, V7, P273; WELSH MJ, 1987, PHYSIOL REV, V67, P1143, DOI 10.1152/physrev.1987.67.4.1143	34	10	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1996	97	5					1093	1099		10.1016/S0091-6749(96)70263-4	http://dx.doi.org/10.1016/S0091-6749(96)70263-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UL261	8626987				2022-12-18	WOS:A1996UL26100010
J	Park, CS; Ra, DJ; Lee, SM; Jeong, SW; Uh, S; Kim, HT; Kim, YH				Park, CS; Ra, DJ; Lee, SM; Jeong, SW; Uh, S; Kim, HT; Kim, YH			Interleukin-4 and low-affinity receptor for IgE on B cells in peripheral blood of patients with atopic bronchial asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						atopy; bronchial asthma; IgE; IL-4; CD23	INVITRO SYNTHESIS; INTERFERON-GAMMA; FC-RECEPTORS; LYMPHOCYTES; POPULATION; CLONES; SERUM; IL-4	Background: A greater frequency of type 2 helper cells producing IL-4 without interferon-gamma is thought to be responsible for the elevated IgE in serum of atopic subjects. However, the proportion of B cells responding to IL-4 by an increased synthesis of IgE is also higher in atopic subjects than in nonatopic subjects. Objective: Important questions are whether the elevated IgE in atopic subjects is due to overproduction of IL-4 by T cells, the enhanced sensitivity of B cells to IL-4, or both and whether functional alterations of T and B cells are related to the development of allergic diseases. Methods: Spontaneous and IL-4-induced CD23 expression on B cells was examined to evaluate the response of B cells to IL-4, and production of IL-4 by concanavalin-A-stimulated peripheral blood mononuclear cells (PBMCs) was measured to evaluate the T-cell function in nonatopic normal subjects, atopic normal subjects, and patients with symptomatic bronchial asthma. Results: IL-4-induced expression of CD23 on B cells was greater in normal atopic subjects and atopic patients with bronchial asthma than in normal nonatopic subjects. IL-4 generated by concanavalin A-stimulated PBMCs was also higher in normal atopic subjects and atopic patients with bronchial asthma than in normal non-atopic subjects. The expression of CD23 on B cells and IL-4 generation by concanavalin-A-stimulated PBMCs were not different between normal atopic subjects and atopic patients with bronchial asthma. Conclusions: Both B-cell and T-cell functions are enhanced in atopic subjects. However, neither enhanced B-cell nor T-cell function is a hallmark in development of allergic diseases.			Park, CS (corresponding author), SOONCHUNHYANG UNIV HOSP, DEPT INTERNAL MED, DIV ALLERGY & RESP MED, YOUNGSAN KU, HANNAM DONG, SEOUL 140743, SOUTH KOREA.							BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P106, DOI 10.1016/0091-6749(81)90167-6; BERG T, 1969, INT ARCH ALLER A IMM, V36, P219, DOI 10.1159/000230745; COCKCROFT DW, 1985, ANN ALLERGY, V55, P527; CONRAD DH, 1987, J IMMUNOL, V139, P2290; CONRAD DH, 1990, ANNU REV IMMUNOL, V8, P623, DOI 10.1146/annurev.immunol.8.1.623; FISER PM, 1979, J IMMUNOL, V123, P1788; HONG CS, 1992, KOREAN J ALLERGY, V4, P482; MAGGI E, 1988, EUR J IMMUNOL, V18, P1045, DOI 10.1002/eji.1830180712; MATSUMOTO T, 1991, CLIN EXP IMMUNOL, V85, P288; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; RICCI M, 1985, INT ARCH ALLER A IMM, V77, P32, DOI 10.1159/000233749; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SARFATI M, 1988, J IMMUNOL, V141, P2195; SPIEGELBERG HL, 1981, J CLIN INVEST, V68, P845, DOI 10.1172/JCI110339; SPIEGELBERG HL, 1979, J CLIN INVEST, V64, P714, DOI 10.1172/JCI109514; SPIEGELBERG HL, 1980, CLIN IMMUNOL IMMUNOP, V15, P424, DOI 10.1016/0090-1229(80)90054-9; TANG M, 1993, CLIN EXP IMMUNOL, V92, P120; TJIO AH, 1979, J IMMUNOL, V122, P2131; TURNER KJ, 1985, INT ARCH ALLER A IMM, V76, P308, DOI 10.1159/000233712; VERCELLI D, 1993, ALLERGY PRINCIPLES P, P93; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; WIERENGA EA, 1991, J IMMUNOL, V147, P2942; YOKOTA A, 1988, CELL, V55, P611, DOI 10.1016/0092-8674(88)90219-X; YUNGINGER JW, 1973, J ALLERGY CLIN IMMUN, V51, P174, DOI 10.1016/0091-6749(73)90022-5	24	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1996	97	5					1121	1128		10.1016/S0091-6749(96)70267-1	http://dx.doi.org/10.1016/S0091-6749(96)70267-1			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UL261	8626991				2022-12-18	WOS:A1996UL26100014
J	Barber, D; Pernas, M; Chamorro, MJ; Carreira, J; Arteaga, C; SanchezMonge, R; Polo, F; Salcedo, G				Barber, D; Pernas, M; Chamorro, MJ; Carreira, J; Arteaga, C; SanchezMonge, R; Polo, F; Salcedo, G			Specific depletion of the house dust mite allergen Der p 1 by cereal flour prolamins	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						dust mite allergen; Der p 1; cereal flour prolamins; proteolytic activity; allergenic exposure	PROTEINS	Background: Quantitation of Der 1 and Der 2 in dust samples by specific monoclonal antibodies is a method used increasingly to evaluate mite allergen exposure. The level of Der I has been proposed as a risk factor for sensitization Aim: We report a drastic deer-ease in the Der 1/Der 2 ratio when? dust samples are collected in bakeries. Methods: I Wheat pour and purified mites were extracted simultaneously: levels of Dei p 1 and Der p 2 and cysteine protease activity were determined by ELISA and inhibition experiments. Results: High titers of Der 2, but only, trace amounts of Der p 1, were detected in dust samples collected from bakeries. Both the level and proteolytic activity of Der p I appeared greatly decreased when mites and wheat flour were coextracted. Conclusions: Group 1 protein was found to be masked by flour components, resulting in an underestimation of the mite content in baker dust. This problem, was not found for group 2 allergen.	UNIV POLITECN MADRID,ETS INGN AGRON,DEPT BIOTECHNOL,UNIDAD BIOQUIM,MADRID,SPAIN	Universidad Politecnica de Madrid	Barber, D (corresponding author), ALERGIA & INMUNOL ABELLO,ALK ABELLO GRP,MIGUEL FLETA 19,E-28037 MADRID,SPAIN.		Barber, Domingo/Y-9516-2019; Pernas, Monica/G-3485-2015	Barber, Domingo/0000-0002-5488-5700; Pernas, Monica/0000-0002-6521-9164				ARAGONCILLO C, 1981, J EXP BOT, V32, P1279, DOI 10.1093/jxb/32.6.1279; BOUSQUET J, 1992, ALLERGY, V12, P61; FORD AW, 1985, INT ARCH ALLER A IMM, V76, P58, DOI 10.1159/000233662; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V80, P755, DOI 10.1016/S0091-6749(87)80261-0; SHEWRY PR, 1990, BIOCHEM J, V267, P1	5	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1996	97	4					963	965		10.1016/S0091-6749(96)80071-6	http://dx.doi.org/10.1016/S0091-6749(96)80071-6			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UG086	8655892				2022-12-18	WOS:A1996UG08600011
J	Jeebhay, MF; Prescott, R; Potter, PC; Ehrlich, RI				Jeebhay, MF; Prescott, R; Potter, PC; Ehrlich, RI			Occupational asthma caused by imbuia wood dust	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HEALTH		UNIV CAPE TOWN,SCH MED,ALLERGOL UNIT,RONDEBOSCH 7700,SOUTH AFRICA; UNIV CAPE TOWN,SCH MED,DEPT COMMUNITY HLTH,RONDEBOSCH 7700,SOUTH AFRICA	University of Cape Town; University of Cape Town	Jeebhay, MF (corresponding author), UNIV CAPE TOWN,IND HLTH RES GRP,PROTEM 1,SCH MED,PRIVATE BAG,RONDEBOSCH 7700,SOUTH AFRICA.		Jeebhay, Mohamed/AAR-8346-2021; Ehrlich, Rodney/M-5654-2014	Jeebhay, Mohamed/0000-0001-6656-9193; Ehrlich, Rodney/0000-0001-5736-9237				BUSH RK, 1983, CLIN ALLERGY, V13, P389, DOI 10.1111/j.1365-2222.1983.tb02613.x; CHANYEUNG M, 1987, J ALLERGY CLIN IMMUN, V79, P792, DOI 10.1016/0091-6749(87)90212-0; GANNON PFG, 1993, BRIT J IND MED, V50, P491; GOLDSMITH DF, 1988, SCAND J WORK ENV HEA, V14, P1; MALO JL, 1988, AM REV RESPIR DIS, V138, P807, DOI 10.1164/ajrccm/138.4.807	5	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1996	97	4					1025	1027		10.1016/S0091-6749(96)80079-0	http://dx.doi.org/10.1016/S0091-6749(96)80079-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UG086	8655879				2022-12-18	WOS:A1996UG08600019
J	MorenoAncillo, A; DiazPena, JM; Ferrer, A; MartinMunoz, F; MartinBarroso, JA; MartinEsteban, M; Ojeda, JA				MorenoAncillo, A; DiazPena, JM; Ferrer, A; MartinMunoz, F; MartinBarroso, JA; MartinEsteban, M; Ojeda, JA			Allergic bronchopulmonary cladosporiosis in a child	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASPERGILLOSIS; CURVULARIA; DIAGNOSIS; CRITERIA		HOSP LA PAZ,SERV CHILDHOOD ALLERGY,MADRID,SPAIN	Hospital Universitario La Paz				Ferrer, Angel/0000-0001-6567-053X				BENATAR SR, 1980, THORAX, V35, P515, DOI 10.1136/thx.35.7.515; CABALLERO T, 1995, J ALLERGY CLIN IMMUN, V95, P1004; GREENBERGER PA, 1986, ANN ALLERGY, V56, P444; HENDRICK DJ, 1982, AM REV RESPIR DIS, V126, P935; IMBEAU SA, 1977, AM J DIS CHILD, V131, P1127, DOI 10.1001/archpedi.1977.02120230073013; KIEFER TA, 1986, ANN ALLERGY, V56, P233; LEE TM, 1987, J ALLERGY CLIN IMMUN, V80, P816, DOI 10.1016/S0091-6749(87)80271-3; LIRSAC B, 1986, J ALLERGY CLIN IMMUN, V77, P167; MCALEER R, 1981, THORAX, V36, P338, DOI 10.1136/thx.36.5.338; MROUEH S, 1992, PEDIATR PULM, V12, P123, DOI 10.1002/ppul.1950120211; MUSCAT I, 1988, LANCET, V1, P1341; PATTERSON R, 1982, INT ARCH ALLER A IMM, V69, P30, DOI 10.1159/000233142; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405	13	10	10	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1996	97	2					714	715		10.1016/S0091-6749(96)70321-4	http://dx.doi.org/10.1016/S0091-6749(96)70321-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW087	8621861				2022-12-18	WOS:A1996TW08700021
J	Cabanas, R; Caballero, MT; Vega, A; MartinEsteban, M				Cabanas, R; Caballero, MT; Vega, A; MartinEsteban, M			Anaphylaxis to trimethoprim	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											Cabanas, R (corresponding author), HOSP LA PAZ,ALLERGY UNIT,AVDA EUROPA,4 PORTAL 2,1-C,E-28224 MADRID,SPAIN.		Caballero, Teresa/AAU-3982-2020; Caballero, Teresa/H-6454-2014	Caballero, Teresa/0000-0003-3005-9858; Caballero, Teresa/0000-0003-3005-9858				ALONSO MD, 1992, ALLERGY, V47, P340, DOI 10.1111/j.1398-9995.1992.tb02067.x; BRASO JV, 1993, REV ESP ALERGOL INMU, V8, P161; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; HARLE DG, 1987, CLIN ALLERGY, V17, P209, DOI 10.1111/j.1365-2222.1987.tb02005.x	4	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	1				137	138		10.1016/S0091-6749(96)70295-6	http://dx.doi.org/10.1016/S0091-6749(96)70295-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TR947	8568129				2022-12-18	WOS:A1996TR94700020
J	Miller, JD; Miller, A				Miller, JD; Miller, A			Ten minutes in a clothes dryer kills all mites in blankets	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				962	962						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600962
J	Ohkubo, K; Baraniuk, JN; Merida, M; Hausfeld, JN; Okada, H; Kaliner, MA				Ohkubo, K; Baraniuk, JN; Merida, M; Hausfeld, JN; Okada, H; Kaliner, MA			Human nasal mucosal carboxypeptidase: Activity, location, and release	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						carboxypeptidase; immunohistochemistry; nasal mucosa; nasal secretion; vascular permeability	KINASE CONVERSION FACTOR; PATHO-PHYSIOLOGY; HUMAN-PLASMA; SECRETIONS; RHINITIS; SUBUNITS; PROTEIN; PURIFICATION; BRADYKININ	Background: Carboxypeptidases (CPs), such as carboxypeptidase N (CPN) (kininase I, E.C.3.4.17.3), may regulate peptide-mediated vasodilation and vascular permeability in respiratory mucosa by degrading proinflammatory peptides such as bradykinin, anaphylatoxins, and neuropeptides during allergic and nonallergic inflammation. The sources of CP activity in human nasal secretions were investigated. Methods: Well-characterized human nasal provocation and secretion analysis methods were used. Potential sources of CPN in human nasal mucosa were identified by immunohistochemistry. CP activity was defined as DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid inhibitable Bz-Gly-Lys degradation. CP activity was measured in nasal mucosal homogenates and nasal lavage fluids induced by methacholine, histamine, and allergen nasal provocation. Results: CPN-immunoreactive material was localized to the glycocalyx of the epithelium, some vessels, and gland ducts near the epithelial basement membrane but not to submucosal gland cells. CP activity in human nasal lavage fluid after saline nasal provocation was 0.10 +/- 0.04 U/L. Histamine provoked secretion of significantly more CP activity (3.84 +/- 0.99 U/L; p<0.01 vs saline). Methacholine did not significantly increase secretion (0.54 +/- 0.22 U/L). After nasal allergen challenge, CP activity was at a maximum between 11 and 20 minutes, and CP activity correlated with IgG concentration (r = 0.91, p<0.01), a marker for proteins of plasma origin, suggesting that CP activity originated in plasma. Conclusions: These data suggest that plasma is the predominant source of CP activity secreted from human nasal mucosa and that plasma extravasation and interstitial fluid exudation across the epithelium are the primary processes regulating its appearance in nasal secretions.	WASHINGTON HOSP CTR, INST ASTHMA & ALLERGY, WASHINGTON, DC 20010 USA; NIPPON MED COLL, DEPT OTOLARYNGOL, TOKYO, JAPAN; GEORGETOWN UNIV, DIV RHEUMATOL ALLERGY & IMMUNOL, WASHINGTON, DC USA; GEORGETOWN UNIV, DEPT OTORHINOLARYNGOL, WASHINGTON, DC USA; GEORGETOWN UNIV, DEPT PEDIAT, WASHINGTON, DC 20057 USA; WASHINGTON HOSP CTR, DEPT FACIAL PLAST & RECONSTRUCT SURG, WASHINGTON, DC 20010 USA; NAGOYA CITY UNIV, SCH MED, DEPT BIOL MOLEC, NAGOYA, AICHI, JAPAN	MedStar Washington Hospital Center; Nippon Medical School; Georgetown University; Georgetown University; Georgetown University; MedStar Washington Hospital Center; Nagoya City University				Baraniuk, James Nicholas/0000-0002-1866-4177				BARANIUK JN, 1992, J APPL PHYSIOL, V73, P1867, DOI 10.1152/jappl.1992.73.5.1867; BARANIUK JN, 1990, AM REV RESPIR DIS, V141, P706, DOI 10.1164/ajrccm/141.3.706; BARNES PJ, 1992, THORAX, V47, P979, DOI 10.1136/thx.47.11.979; BOKISCH VA, 1970, J CLIN INVEST, V49, P2427, DOI 10.1172/JCI106462; CAMPBELL W, 1989, BIOCHEM BIOPH RES CO, V162, P933, DOI 10.1016/0006-291X(89)90762-6; EDWARDS RJ, 1984, BIOCHEM J, V221, P465, DOI 10.1042/bj2210465; Erdos E., 1979, HDB EXPT PHARM S, VXXV, P427; ERDOS EG, 1967, BIOCHEM PHARMACOL, V16, P1287, DOI 10.1016/0006-2952(67)90159-1; ERDOS EG, 1962, BIOCHEM PHARMACOL, V11, P585, DOI 10.1016/0006-2952(62)90119-3; ERDOS EG, 1964, BIOCHEM PHARMACOL, V13, P893, DOI 10.1016/0006-2952(64)90033-4; ERDOS EG, 1994, CL ALLER IM, V4, P313; FOLK JE, 1958, J BIOL CHEM, V231, P379; HAMAI K, 1990, CLIN CHIM ACTA, V188, P233, DOI 10.1016/0009-8981(90)90205-7; KLEINE R, 1969, ACTA BIOL MED GER, V22, P525; LEVIN Y, 1982, P NATL ACAD SCI-BIOL, V79, P4618, DOI 10.1073/pnas.79.15.4618; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEREDITH SD, 1989, J ALLERGY CLIN IMMUN, V84, P920, DOI 10.1016/0091-6749(89)90390-4; MICHELUTTI L, 1987, CLIN BIOCHEM, V20, P21, DOI 10.1016/S0009-9120(87)80093-0; NAGAE A, 1993, AM J RESP CELL MOL, V9, P221, DOI 10.1165/ajrcmb/9.2.221; OHKUBO K, 1993, AM J RESP CELL MOL, V9, P557, DOI 10.1165/ajrcmb/9.5.557; OHKUBO K, 1994, AM J RESP CELL MOL, V11, P173, DOI 10.1165/ajrcmb.11.2.8049077; OSHIMA G, 1975, ARCH BIOCHEM BIOPHYS, V170, P132, DOI 10.1016/0003-9861(75)90104-6; PLUMMER TH, 1981, BIOCHEM BIOPH RES CO, V98, P448, DOI 10.1016/0006-291X(81)90860-3; PROUD D, 1988, ANNU REV IMMUNOL, V6, P49, DOI 10.1146/annurev.iy.06.040188.000405; PROUD D, 1994, AM J RESP CELL MOL, V11, P57, DOI 10.1165/ajrcmb.11.1.7517143; PROUD D, 1987, J IMMUNOL, V138, P428; RAPHAEL GD, 1988, AM REV RESPIR DIS, V138, P413, DOI 10.1164/ajrccm/138.2.413; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V88, P33, DOI 10.1016/0091-6749(91)90298-3; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; RAPHAEL GD, 1989, AM REV RESPIR DIS, V139, P791, DOI 10.1164/ajrccm/139.3.791; SKIDGEL RA, 1989, J BIOL CHEM, V264, P2236; SKIDGEL RA, 1988, TRENDS PHARMACOL SCI, V9, P299, DOI 10.1016/0165-6147(88)90015-6; SKIDGEL RA, 1987, METHOD ENZYMAT AN, V5, P60; ZUHLKE H, 1975, CIBA F S, P183	34	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1995	96	6	1				924	931		10.1016/S0091-6749(95)70230-X	http://dx.doi.org/10.1016/S0091-6749(95)70230-X			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TN124	8543751				2022-12-18	WOS:A1995TN12400010
J	LEFLEIN, J; BROWN, E; HILL, M; KELLY, HW; LOFFERT, DT; NELSON, HS; SZEFLER, SJ				LEFLEIN, J; BROWN, E; HILL, M; KELLY, HW; LOFFERT, DT; NELSON, HS; SZEFLER, SJ			DELIVERY OF GLUCOCORTICOIDS BY JET NEBULIZATION - AEROSOL CHARACTERISTICS AND OUTPUT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						TRIAMCINOLONE ACETONIDE; GLUCOCORTICOIDS; LASER PARTICLE ANALYZER; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; CASCADE IMPACTOR	LUNG; PREDNISOLONE; NEBULIZERS; DEPOSITION; THERAPY; ASTHMA	Background: Since inflammation has been identified as a critical factor in the pathogenesis of asthma, use of inhaled glucocorticoids has increased. Because young children are often unable to coordinate properly the use of metered-dose inhalers and no glucocorticoids preparations for nebulization have been approved in the United States, parenteral and intranasal glucocorticoids preparations are occasionally administered by nebulization. Methods: We examined whether a parenteral preparation (triamcinolone acetonide [TAA]; Kenalog) could be delivered by nebulization. TAA, 1000 mu g (0.1 ml), was placed in the nebulizer bowl (MB5 [MeFar, Brescia, Italy] or Pari-Jet [Dura Pharmaceuticals, San Diego, Calif.]), then diluted with 2.9 ml normal saline solution for a total volume fill of 3 ml. Using a laser particle analyzer, high-performance liquid chromatography, and cascade impactor, we examined the percentage of aerosol volume produced with particles in the respirable range of 1 to 5 mu m in diameter actual TAA output (in micrograms) and concentration of TAA contained in the particles within the respirable range. Results: Laser particle analysis indicated that 34% +/- 3% (mean +/- SEM) (MB5) and 47 +/- 3% (Pari-Jet) of the total aerosol volume produced were within the respirable-range of 1 to 5 mu m in diameter, and this remained consistent throughout nebulization. The nebulizer was stopped serially for determination of TAA output with high-performance liquid chromatography. TAA output (1000 mu g less the amount in micrograms remaining after nebulization) was essentially complete after 2 minutes with the Pari-Jet and within 4 minutes with the MB5 and totaled 352 +/- 19 mu g and 367 +/- 9 mu g, respectively. Finally, cascade impactor studies confirmed that 33.4% of the TAA aerosol generated by the MB5 nebulizer was contained in particles in the respirable range. Conclusion: Approximately 35% (Pari-Jet) and 37% (MB5) of the initial 1000 mu g of TAA was delivered with the two nebulizers tested. The particles generated within the respirable range were limited to 34% (MB5) and 47% (Pari-Jet) of the amount delivered. TAA was equally distributed in the particles generated. The theoretic amount delivered in the respirable range was approximately 12.5% for the MB5 nebulizer on the basis of the cascade impactor and 16.5% for the Pari-Jet (assuming TAA distribution equivalence) of the TAA placed in each of the nebulizers. Additional clinical studies are needed to define efficacy and safely in view of the excipients used in preparing the parenteral preparation.	NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,IRA J & JACQUELINE NEIMARK LAB CLIN PHARMACOL PED,DENVER,CO 80206; NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,IRA J & JACQUELINE NEIMARK LAB CLIN PHARMACOL PED,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT MED,BOULDER,CO 80309; UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT,BOULDER,CO 80309; UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,BOULDER,CO 80309; UNIV NEW MEXICO,SCH MED,DEPT PEDIAT,ALBUQUERQUE,NM 87131; UNIV NEW MEXICO,SCH PHARM,ALBUQUERQUE,NM 87131	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of New Mexico; University of New Mexico								BARNES PJ, 1989, NEW ENGL J MED, V321, P1517; BENTON G, 1991, RESPIR CARE, V36, P1320; BRAIN JD, 1979, AM REV RESPIR DIS, V120, P1325; DOLOVICH M, 1981, CHEST, V80, P911; EVERARD ML, 1992, ARCH DIS CHILD, V67, P586, DOI 10.1136/adc.67.5.586; GREOS LS, 1991, AM REV RESPIR DIS, V144, P586, DOI 10.1164/ajrccm/144.3_Pt_1.586; HOLLIE MC, 1991, CHEST, V100, P1339, DOI 10.1378/chest.100.5.1339; KONIG P, 1992, PEDIATR PULM, V13, P209, DOI 10.1002/ppul.1950130407; LOFFERT DT, 1993, J ALLERGY CLIN IMMUN, V91, P167; LOURENCO RV, 1982, ARCH INTERN MED, V142, P2163, DOI 10.1001/archinte.142.12.2163; MALONE RA, 1993, CHEST, V104, P1114, DOI 10.1378/chest.104.4.1114; Morrow P. E., 1985, AEROSOLS MED PRINCIP, P149; RANDOLPH CC, 1992, AM J ASTHMA ALLERGY, V5, P143; ROCCI ML, 1981, J CHROMATOGR, V224, P221, DOI 10.1016/S0378-4347(00)80159-0; SUMMERS QA, 1991, CLIN EXP ALLERGY, V21, P259, DOI 10.1111/j.1365-2222.1991.tb01657.x; SWIFT DL, 1991, RADIAT PROT DOSIM, V38, P29; 1991, J ALLERGY CLIN IMMUN, V88, P425	17	10	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	1				944	949		10.1016/S0091-6749(95)70093-5	http://dx.doi.org/10.1016/S0091-6749(95)70093-5			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY917	7751514				2022-12-18	WOS:A1995QY91700004
J	MAGNUSSON, CGM				MAGNUSSON, CGM			MAJOR DIFFERENCES IN SPECIFICITY AMONG NATURALLY-OCCURRING HUMAN IGG-SUBCLASS ANTI-IGE AUTOANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ANTI-IGE; ASSAY; ATOPIC; AUTOANTIBODY; IGE; IGG4; IGG SUBCLASS; SPECIFICITY	NORMAL HUMAN-SERA; CARBOHYDRATE-SPECIFIC ANTIBODIES; ATOPIC-DERMATITIS; IMMUNE-COMPLEXES; MONOCLONAL-ANTIBODIES; BRONCHIAL-ASTHMA; IMMUNOGLOBULIN-E; RECOGNITION; DES); FAB	Background: The specificity of naturally occurring IgG-subclass anti-IgE autoantibodies (a-IgE Ab) was studied by ELISA inhibition assay with a highly purified IgE-DES myeloma protein as a solid-phase antigen. Because the IgG isotypes differ in effector functions, detailed specificity studies of IgG subclass anti-IgE antibodies might clarify their putative role. Methods: Selected sera containing a high concentration of a single IgG a-IgE Ab subclass were allowed io react with purified immunoglobulins of all five classes including five different IgE myeloma proteins and papain-derived Fab epsilon and Fc epsilon fragments of IgE-DES. Results: The inhibition results indicated that IgG1, IgG2, and IgG3 a-IgE Ab reacted in a low-affinity reaction with IgE myeloma protein-restricted determinants because only IgE-DES was inhibitory. Moreover the reacting epitopes were heat resistant (2 hours, 56 degrees C) and localized in the Fab epsilon-DES fragment. In sharp contrast, IgG4 a-IgE Ab reacted with high affinity to all five IgE myeloma proteins involving hear-susceptible epitopes confined to the Fc epsilon fragment. Conclusions: It seems that a majority of IgG a-IgE Ab have a specificity for nonisotypic myeloma-restricted determinants whereas IgG4 a-IgE Ab are mainly isotype specific. These findings ought to be taken into account in the consideration of physiologic implications of IgG a-IgE Ab and in the interpretation of previous investigations in which intact IgE myeloma proteins have been used to detect IgG a-IgE Ab.	KAROLINSKA INST, DEPT CLIN IMMUNOL, S-10401 STOCKHOLM, SWEDEN	Karolinska Institutet								AVRAMEAS S, 1969, IMMUNOCHEMISTRY, V6, P43, DOI 10.1016/0019-2791(69)90177-3; BAENZIGER JU, 1978, IMMEDIATE HYPERSENSI, P37; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; CARINI C, 1991, CLIN EXP ALLERGY, V21, P481, DOI 10.1111/j.1365-2222.1991.tb01689.x; CARINI C, 1992, INT ARCH ALLERGY IMM, V98, P227, DOI 10.1159/000236189; CARINI C, 1988, ANN ALLERGY, V60, P48; CARINI C, 1983, ANN ALLERGY, V51, P251; DORRINGTON KJ, 1973, J BIOL CHEM, V248, P8378; GEHA RS, 1983, J CLIN INVEST, V71, P46, DOI 10.1172/JCI110750; HAMMARSTROM L, 1986, MONOGR ALLERGY, V19, P122; INGANAS M, 1981, INT ARCH ALLER A IMM, V65, P51, DOI 10.1159/000232737; IWAMOTO I, 1989, INT ARCH ALLER A IMM, V90, P414, DOI 10.1159/000235064; JACKSON S, 1987, J IMMUNOL, V138, P2244; JEFFERIS R, 1985, IMMUNOL LETT, V10, P223, DOI 10.1016/0165-2478(85)90082-3; KEMENY DM, 1990, CLIN EXP ALLERGY, V20, P67, DOI 10.1111/j.1365-2222.1990.tb02777.x; KOIKE T, 1989, MONOGR ALLERGY, V26, P165; LALEZARI P, 1984, VOX SANG, V47, P146, DOI 10.1111/j.1423-0410.1984.tb01576.x; LALEZARI P, 1984, VOX SANG, V47, P133, DOI 10.1111/j.1423-0410.1984.tb01575.x; MAGNUSSON CGM, 1989, CLIN REV ALLERG, V7, P73; MAGNUSSON CGM, 1986, INT ARCH ALLER A IMM, V79, P157, DOI 10.1159/000233964; MAGNUSSON CGM, 1986, INT ARCH ALLER A IMM, V80, P329, DOI 10.1159/000234074; MAGNUSSON CGM, 1989, MONOGR ALLERGY, V26, P18; MAGNUSSON CGM, 1986, INT ARCH ALLER A IMM, V79, P149, DOI 10.1159/000233963; MARONE G, 1989, J INVEST DERMATOL, V93, P246, DOI 10.1111/1523-1747.ep12277582; NAWATA Y, 1984, CLIN EXP IMMUNOL, V58, P348; NAWATA Y, 1985, J IMMUNOL, V135, P478; PERSSELIN JE, 1985, J CLIN INVEST, V76, P723, DOI 10.1172/JCI112027; QUINTI I, 1986, J ALLERGY CLIN IMMUN, V77, P586, DOI 10.1016/0091-6749(86)90350-7; SCHEUER A, 1991, INT ARCH ALLER A IMM, V96, P271, DOI 10.1159/000235506; SHAKIB F, 1991, INT ARCH ALLER A IMM, V95, P102, DOI 10.1159/000235413; SHAKIB F, 1992, INT ARCH ALLERGY IMM, V97, P243, DOI 10.1159/000236127; SHAKIB F, 1990, ALLERGY, V45, P1, DOI 10.1111/j.1398-9995.1990.tb01077.x; STADLER BM, 1991, INT ARCH ALLER A IMM, V94, P83, DOI 10.1159/000235332; TWENA DM, 1989, CLIN IMMUNOL IMMUNOP, V53, P40, DOI 10.1016/0090-1229(89)90099-8; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; WILSON PB, 1989, MONOGR ALLERGY, V26, P176; [No title captured]	37	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	1				1011	1019		10.1016/S0091-6749(95)70102-8	http://dx.doi.org/10.1016/S0091-6749(95)70102-8			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY917	7538518				2022-12-18	WOS:A1995QY91700013
J	EMALA, CW; LEVINE, MA; ARYANA, A; MARGOLICK, JB; HIRSHMAN, CA				EMALA, CW; LEVINE, MA; ARYANA, A; MARGOLICK, JB; HIRSHMAN, CA			REDUCED ADENYLYL-CYCLASE ACTIVATION WITH NO DECREASE IN BETA-ADRENERGIC RECEPTORS IN BASENJI GREYHOUND LEUKOCYTES - RELEVANCE TO BETA-ADRENERGIC RESPONSES IN AIRWAY SMOOTH-MUSCLE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ADENYLYL CYCLASE; BETA-ADRENERGIC RECEPTORS; BASENJI GREYHOUND; MONONUCLEAR LEUKOCYTES; AIRWAY SMOOTH MUSCLE	BRONCHIAL-ASTHMA; HUMAN-LYMPHOCYTES; DOG-MODEL; ADRENOCEPTOR; DENSITY; HYPERRESPONSIVENESS; RESPONSIVENESS; SUBPOPULATIONS; IMPAIRMENT; HEART	Mononuclear leukocytes (MNLs) have been used as a model of beta-adrenergic responsiveness of airway smooth muscle, but the relevance of this model remains controversial. The basenji greyhound (BG) dog model of airway hyperresponsiveness shares some features with human asthma, and airway smooth muscle shows a selective impairment in isoproterenol-stimulated adenylyl cyclase activity. In this study, MNL membranes were obtained from these same dogs, and the beta-adrenergic receptor-adenylyl cyclase cascade function was compared with that in airway smooth muscle. beta-Adrenergic receptor numbers and affinities for iodine 125-cyanopindolol were similar in the two dog groups (receptor numbers [B-max] = 441 +/- 101 and 447 +/- 61 fmol/mg protein and dissociation constant [K-d] = 269 +/- 44 and 312 +/- 60 pmol/L for mongrel and BG MNLs, respectively). Quantities of the G(s) alpha protein were not different in the membranes as determined by immunoblotting. Stimulation of adenylyl cyclase by isoproterenol (100 mu mol/L) was impaired in MNL membranes of BG membranes (22% +/- 4% increase over guanosine triphosphate [10 mu mol/L]) compared with mongrel membranes (47% +/- 8.6% increase over guanosine triphosphate [10 mu mol/L] P < 0.05). Stimulation of adenylyl cyclase by prostaglandin E(1) (10 mu mol/L), NaF (10 mmol/L), or forskolin (10 mu mol/ L) did not differ in membranes from the two groups. No difference was found in the lymphocyte subsets in the two groups as determined by flow cytometry. These findings are qualitatively similar to studies of trachealis muscle membranes from these same dogs. We have found a selective impairment of isoproterenol stimulation of adenylyl cyclase in membranes prepared from MNLs of the BG dog, which was previously found in airway smooth muscle membranes despite no decrease in numbers of beta-adrenergic receptors.	JOHNS HOPKINS MED INST,DEPT ANESTHESIOL,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT ENVIRONM HLTH SCI,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine				Levine, Michael/0000-0003-0036-7809	NHLBI NIH HHS [HL 45794, HL 02693] Funding Source: Medline; NIEHS NIH HHS [ES 03819] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AARONS RD, 1982, J PHARMACOL EXP THER, V221, P439; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BRODDE OE, 1986, SCIENCE, V231, P1584, DOI 10.1126/science.3006250; BRODDE OE, 1981, LIFE SCI, V29, P2189, DOI 10.1016/0024-3205(81)90490-2; CHAN SC, 1985, J ALLERGY CLIN IMMUN, V76, P148, DOI 10.1016/0091-6749(85)90693-1; CHUNG MK, 1990, CIRC RES, V67, P753, DOI 10.1161/01.RES.67.3.753; CONOLLY ME, 1976, J CLIN INVEST, V58, P1307, DOI 10.1172/JCI108586; DAVIS PB, 1986, J ALLERGY CLIN IMMUN, V77, P871, DOI 10.1016/0091-6749(86)90386-6; EMALA C, 1993, AM J RESP CELL MOL, V8, P668, DOI 10.1165/ajrcmb/8.6.668; FRASER J, 1981, J CLIN INVEST, V67, P1777, DOI 10.1172/JCI110217; HAUCK RW, 1990, CHEST, V98, P376, DOI 10.1378/chest.98.2.376; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; KHAN MM, 1986, BIOCHEM PHARMACOL, V35, P1137, DOI 10.1016/0006-2952(86)90150-4; LANDMANN R, 1992, EUR J CLIN INVEST, V22, P30; LANDMANN RMA, 1984, J RECEPTOR RES, V4, P37, DOI 10.3109/10799898409042538; LEE TP, 1977, J ALLERGY CLIN IMMUN, V59, P408, DOI 10.1016/0091-6749(77)90002-1; MAISEL AS, 1989, CLIN PHARMACOL THER, V46, P429, DOI 10.1038/clpt.1989.161; MEURS H, 1985, INT ARCH ALLER A IMM, V76, P256, DOI 10.1159/000233701; MEURS H, 1982, J ALLERGY CLIN IMMUN, V70, P272, DOI 10.1016/0091-6749(82)90063-X; MEURS H, 1986, INT ARCH ALLER A IMM, V81, P224, DOI 10.1159/000234138; MOTULSKY HJ, 1982, NEW ENGL J MED, V307, P18, DOI 10.1056/NEJM198207013070104; NIELSON CP, 1992, J ALLERGY CLIN IMMUN, V90, P825, DOI 10.1016/0091-6749(92)90108-E; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; SILVERMAN HJ, 1990, CIRC SHOCK, V32, P293; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAKI F, 1986, AM REV RESPIR DIS, V133, P362; TAOUIS M, 1989, J PHARMACOL EXP THER, V250, P1061; TASHKIN DP, 1982, AM REV RESPIR DIS, V125, P185; VLEEMING W, 1989, CARDIOVASC RES, V23, P859; WANNER A, 1990, AM REV RESPIR DIS, V141, P253, DOI 10.1164/ajrccm/141.1.253; WILLSKARP M, 1993, AM J RESP CELL MOL, V8, P153, DOI 10.1165/ajrcmb/8.2.153	32	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1995	95	4					860	867		10.1016/S0091-6749(95)70130-3	http://dx.doi.org/10.1016/S0091-6749(95)70130-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QT468	7722167				2022-12-18	WOS:A1995QT46800012
J	JABARA, HH; VERCELLI, D; SCHNEIDER, LC; WILLIAMS, DP; GENBAUFFE, FS; POISSON, LR; WATERS, CA; GEHA, RS				JABARA, HH; VERCELLI, D; SCHNEIDER, LC; WILLIAMS, DP; GENBAUFFE, FS; POISSON, LR; WATERS, CA; GEHA, RS			INTERLEUKIN-4 RECEPTOR EXPRESSION BY HUMAN B-CELLS - FUNCTIONAL-ANALYSIS WITH A HUMAN INTERLEUKIN-4 TOXIN, DAB(389)IL-4	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						INTERLEUKIN-4; INTERLEUKIN-4 RECEPTORS; DIPHTHERIA FUSION TOXINS; IGE SYNTHESIS	HYPER-IGE SYNDROME; HUMAN-LYMPHOCYTES; IL-4; INDUCTION; REQUIREMENTS; GENERATION; ANTIBODIES; GAMMA; CD40	Background: Studies of hyman IgE-secreting B cells have proven difficult because of the small size of this population. We have used an interleukin-4 (IL-4) fusion toxin to detect functionally IL-4 receptor (IL-4R) expression on B cells involved in IgE synthesis. Methods: In diphtheria toxin IL-4 (DAB(389)IL-4) the receptor-binding domain of diphtheria toxin has been replaced with human IL-4. DAB(389)IL-4 cytotoxicity depends on IL-4R binding and internalization. Results: Addition of DAB(389)IL-4 inhibited IgE synthesis induced by IL-4(+) anti-CD40 monoclonal antibody or hydrocortisone. IgE inhibition resulted from DAB(389)IL-4 B-cell cytotoxicity because DAB(389)IL-4 inhibited IL-4-independent B-cell proliferation. Thus induction of human IgE synthesis involves IL-4R(+) cells. In contrast, terminally differentiated, IgE-producing B cells no longer express functional IL-4R because DAB(389)IL-4 only modestly inhibited ongoing IgE synthesis by B cells from patients with hyper-IgE states and only minimally affected IL-4-induced IgE synthesis in normal B cells when the toxin was added at day 7. Pokeweed mitogen-induced IgM synthesis was sensitive to early but not to late addition of DAB(389)IL-4. Thus the loss of functional IL-4R immunoglobulin-secreting B cells is independent of isotype switching. Conclusions: IgE-secreting B cells no longer express functional IL-4R. Therapies for allergic disease that target the IL-4R would not affect IgE-secreting B cells but may block the recruitment of B cells into the IgE-secreting pool. For optimal benefits this approach may be combined with therapies that target IL-4R-, IgE-secreting B cells.	CHILDRENS HOSP, DIV IMMUNOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; SERAGEN INC, HOPKINTON, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School					NIAID NIH HHS [AI-31136] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031136] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CLAASSEN JJ, 1991, J ALLERGY CLIN IMMUN, V88, P713, DOI 10.1016/0091-6749(91)90177-P; FINKELMAN FD, 1989, J IMMUNOL, V142, P403; FOXWELL BMJ, 1989, EUR J IMMUNOL, V19, P1637, DOI 10.1002/eji.1830190918; GASCAN H, 1991, J IMMUNOL, V147, P8; GRUBER MF, 1989, J IMMUNOL, V142, P4144; JABARA HH, 1991, J IMMUNOL, V147, P1557; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; JABARA HH, 1990, J IMMUNOL, V145, P3468; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; MOSS J, 1990, ADP RIBOSYLATING TOX, P141; SARFATI M, 1989, J EXP MED, V170, P1775, DOI 10.1084/jem.170.5.1775; SATO TA, 1993, J IMMUNOL, V150, P2717; SHAW JP, 1991, J BIOL CHEM, V266, P21118; THYPHRONITIS G, 1989, P NATL ACAD SCI USA, V86, P5580, DOI 10.1073/pnas.86.14.5580; UMETSU DT, 1985, J EXP MED, V162, P202, DOI 10.1084/jem.162.1.202; VERCELLI D, 1990, J CLIN INVEST, V85, P1666, DOI 10.1172/JCI114618; VERCELLI D, 1992, CURR OPIN IMMUNOL, V4, P794, DOI 10.1016/0952-7915(92)90064-L; WU CY, 1991, J CLIN INVEST, V87, P870, DOI 10.1172/JCI115092; ZHANG K, 1991, J IMMUNOL, V146, P1836; ZUBER CE, 1990, EUR J IMMUNOL, V20, P551, DOI 10.1002/eji.1830200314	21	10	12	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1995	95	4					893	900		10.1016/S0091-6749(95)70134-6	http://dx.doi.org/10.1016/S0091-6749(95)70134-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QT468	7722171				2022-12-18	WOS:A1995QT46800016
J	EBISAWA, M; SHICHIJO, M; MIURA, K; TACHIMOTO, H; KATSUNUMA, T; ONDA, T; IIKURA, Y; SAITO, H				EBISAWA, M; SHICHIJO, M; MIURA, K; TACHIMOTO, H; KATSUNUMA, T; ONDA, T; IIKURA, Y; SAITO, H			HUMAN MAST-CELLS PRODUCE TNF-ALPHA, MIP-1-ALPHA AND IL-5 FOLLOWING ACTIVATION THROUGH FC-EPSILON-RI	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NATL CHILDRENS MED RES CTR,DIV ALLERGY,TOKYO 154,JAPAN	National Center for Child Health & Development - Japan									0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				219	219						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400314
J	FROEHLICH, J; SCHOENHOFF, M; JARDIEU, P; RUPPEL, J; FEI, D; BUCKLEY, P; BUSH, R				FROEHLICH, J; SCHOENHOFF, M; JARDIEU, P; RUPPEL, J; FEI, D; BUCKLEY, P; BUSH, R			MULTIPLE DOSES OF A RECOMBINANT HUMANIZED MONOCLONAL ANTI IGE ANTIBODY ARE SAFELY TOLERATED AND DECREASE FREE SERUM IGE TO UNDETECTABLE LEVELS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				356	356						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400861
J	MCDOWALL, JE; MACKIE, AE; BYE, A; VENTRESCA, GP				MCDOWALL, JE; MACKIE, AE; BYE, A; VENTRESCA, GP			LOW SYSTEMIC EXPOSURE TO INTRANASAL FLUTICASONE PROPIONATE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				194	194						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400213
J	PFORTE, A; BRUNNER, A; GAIS, P; STROBEL, M; BURGER, G; BREYER, G; HAUSSINGER, K; ZIEGLERHEITBROCK, L				PFORTE, A; BRUNNER, A; GAIS, P; STROBEL, M; BURGER, G; BREYER, G; HAUSSINGER, K; ZIEGLERHEITBROCK, L			INCREASED LEVELS OF SOLUBLE SERUM INTERLEUKIN-2 RECEPTOR IN EXTRINSIC ALLERGIC ALVEOLITIS CORRELATE WITH INTERLEUKIN-2 RECEPTOR EXPRESSION ON ALVEOLAR MACROPHAGES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						EXTRINSIC ALLERGIC ALVEOLITIS; IL-2 RECEPTOR ALVEOLAR MACROPHAGES; LYMPHOCYTES; SSIL-2 RECEPTOR	T-CELLS; PULMONARY SARCOIDOSIS; HYPERSENSITIVITY PNEUMONITIS; BINDING-PROTEIN; BLOOD MONOCYTES; IL-2 RECEPTOR; B-CELLS; LYMPHOCYTES; GAMMA; GENE	In a group of 20 patients with extrinsic allergic alveolitis (10 with farmer's lung, 9 with bird-breeder's lung, and 1 with humidifier's lung), we observed increased levels of soluble serum interleukin-2 receptor (ssIL-2R) with an average of 75.2 pmol (control group average, 40.6 pmol). Analysis of bronchoalveolar lavage cells by immunocytochemistry with a CD25 antibody revealed only a slight increase to 4.2% IL-2R + cells among alveolar lymphocytes but a pronounced rise to 21.2% IL-2R + cells among alveolar macrophages. Furthermore, cytometry revealed a fourfold higher IL-2R expression on a per cell basis for alveolar macrophages as compared with alveolar lymphocytes. A clear-cut positive correlation (p = 0.006) was found for ssIL-2R and IL-2R + alveolar macrophages, but only a borderline correlation was found for sslL-2R and IL-2R + alveolar lymphocytes (p = 0.04). The finding of a concomitant decrease of IL-2R + alveolar macrophages and of sslL-2R on allergen avoidance further supports the notion that alveolar macrophages may be the main source of the increased sslL-2R in patients with extrinsic allergic alveolitis.	GESELL STRAHLEN & UMWELTFORSCH MBH,MUNICH,GERMANY; DEPT BIOMED IMAGE ANAL,MUNICH,GERMANY; UNIV MUNICH,INST IMMUNOL,W-8000 MUNICH,GERMANY; CENT HOSP GAUTING,MUNICH,GERMANY	University of Munich	PFORTE, A (corresponding author), UNIV MUNICH,KLINIKUM INNENSTADT,DEPT INTERNAL MED,ZIEMSSENSTR 1,W-8000 MUNICH 2,GERMANY.							AGOSTINI C, 1987, J CLIN IMMUNOL, V7, P64, DOI 10.1007/BF00915427; BRYNSKOV J, 1990, GUT, V31, P795, DOI 10.1136/gut.31.7.795; DUKOVICH M, 1987, NATURE, V327, P518, DOI 10.1038/327518a0; ERBER WN, 1984, LANCET, V1, P1042; GAIS P, 1987, CLIN CYTOMETRY HISTO, P36; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; HANCOCK WW, 1987, J IMMUNOL, V138, P185; HASLAM PL, 1990, CHEST, V97, P651, DOI 10.1378/chest.97.3.651; HERRMANN F, 1989, J IMMUNOL, V142, P139; HOLTER W, 1986, J IMMUNOL, V136, P2171; KEICHO N, 1990, CHEST, V98, P1125, DOI 10.1378/chest.98.5.1125; LAWRENCE EC, 1988, AM REV RESPIR DIS, V137, P759, DOI 10.1164/ajrccm/137.4.759; LOUGHNAN MS, 1989, NATURE, V340, P76, DOI 10.1038/340076a0; MALKOVSKY M, 1987, NATURE, V325, P262, DOI 10.1038/325262a0; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; MULLERQUERNHEIM J, 1989, AM REV RESPIR DIS, V140, P82; PEPYS J, 1965, THORAX, V20, P21, DOI 10.1136/thx.20.1.21; PFORTE A, 1990, J EXP MED, V171, P1163, DOI 10.1084/jem.171.4.1163; PINKSTON P, 1983, NEW ENGL J MED, V308, P793, DOI 10.1056/NEJM198304073081401; RAMBALDI A, 1987, EUR J IMMUNOL, V17, P153, DOI 10.1002/eji.1830170127; ROBB RJ, 1983, J EXP MED, V158, P1332, DOI 10.1084/jem.158.4.1332; RUBIN LA, 1990, ANN INTERN MED, V113, P619, DOI 10.7326/0003-4819-113-8-619; RUBIN LA, 1985, J IMMUNOL, V135, P3172; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SEMENZATO G, 1986, J IMMUNOL, V137, P1164; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Tebib J G, 1991, Eur Cytokine Netw, V2, P239; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; ZUBLER RH, 1984, J EXP MED, V160, P1170, DOI 10.1084/jem.160.4.1170	30	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1994	94	6	1				1057	1064		10.1016/0091-6749(94)90124-4	http://dx.doi.org/10.1016/0091-6749(94)90124-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PY230	7798538				2022-12-18	WOS:A1994PY23000014
J	SARLO, K; CLARK, ED; FERGUSON, J; ZEISS, CR; HATOUM, N				SARLO, K; CLARK, ED; FERGUSON, J; ZEISS, CR; HATOUM, N			INDUCTION OF TYPE-I HYPERSENSITIVITY IN GUINEA-PIGS AFTER INHALATION OF PHTHALIC-ANHYDRIDE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PHTHALIC ANHYDRIDE; SENSITIZATION; GUINEA PIGS	MOLECULAR-WEIGHT CHEMICALS; TRIMELLITIC ANHYDRIDE; SENSITIZATION; ASTHMA; IGE	Guinea pigs were exposed through inhalation to phthalic anhydride (PA) dust at 0.5, 1.0, and 5.0 mg/m(3), 3 hours/day for 5 consecutive days. Inhalation challenge with aerosolized phthalic anhydride-guinea pig serum albumin (PA-GPSA) conjugate elicited immediate-onset respiratory reactions in animals exposed to all three levels of dust. Inhalation challenge of a subgroup of animals with phthalic anhydride dust did not elicit an immediate response, as measured by changes in respiratory frequency and plethysmograph pressure. Serologic studies showed that these animals had allergic IgG1a antibody to PA-GPSA. There was a dose-dependent increase in specific IgG antibody activity, as measured by ELISA. Animals exposed to and challenged with 5.0 mg/m(3) PA dust had significant numbers of hemorrhagic lung foci. Those animals with the greatest number of foci had high IgG antibody activity to PA, as measured by ELISA. This study showed that exposure to levels of PA dust as low as 0.5 mg/m(3), below the current threshold limit value of 6.0 mg/m(3), can sensitize animals to produce allergic antibody.	IIT,RES INST,CHICAGO,IL 60616; NORTHWESTERN UNIV,SCH MED,CHICAGO,IL; LAKESIDE VET ADM MED CTR,CHICAGO,IL	Illinois Institute of Technology; Northwestern University	SARLO, K (corresponding author), PROCTER & GAMBLE CO,MIAMI VALLEY LABS,POB 398707,CINCINNATI,OH 45239, USA.							BERNSTEIN DI, 1984, J ALLERGY CLIN IMMUN, V74, P794, DOI 10.1016/0091-6749(84)90181-7; BOTHAM PA, 1988, TOXICOL LETT, V41, P159, DOI 10.1016/0378-4274(88)90089-6; DRAPOR NR, 1981, APPLIED REGRESSION A, P88; HOWE W, 1983, J ALLERGY CLIN IMMUN, V71, P5, DOI 10.1016/0091-6749(83)90539-0; KAROL MH, 1980, TOXICOL APPL PHARM, V53, P260, DOI 10.1016/0041-008X(80)90425-1; KERN RICHARD A., 1939, JOUR ALLERGY, V10, P164, DOI 10.1016/S0021-8707(39)90050-X; LEACH CL, 1988, AM REV RESPIR DIS, V137, P186, DOI 10.1164/ajrccm/137.1.186; LEACH CL, 1987, TOXICOL APPL PHARM, V87, P67, DOI 10.1016/0041-008X(87)90085-8; MACCIA CA, 1976, AM REV RESPIR DIS, V113, P701; NEILSEN J, 1988, J ALLERGY CLIN IMMUN, V82, P126; PATTERSON R, 1982, J ALLERGY CLIN IMMUN, V70, P19, DOI 10.1016/0091-6749(82)90196-8; SARLO K, 1992, FUND APPL TOXICOL, V18, P107, DOI 10.1016/0272-0590(92)90202-S; Snedecor GW., 1989, STAT METHODS, P217; SNYDER SL, 1975, ANAL BIOCHEM, V64, P289; TAO Y, 1991, INT ARCH ALLER A IMM, V96, P119, DOI 10.1159/000235482; VENABLES KM, 1989, BRIT J IND MED, V46, P222; WERNFORS M, 1986, INT ARCH ALLER A IMM, V79, P77, DOI 10.1159/000233946; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZEISS CR, 1983, ANN INTERN MED, V98, P8, DOI 10.7326/0003-4819-98-1-8; ZEISS CR, 1988, AM REV RESPIR DIS, V137, P191, DOI 10.1164/ajrccm/137.1.191; ZEISS CR, 1990, ALLERGY PROC, V11, P71, DOI 10.2500/108854190778993245; ZEISS CR, 1980, INT ARCH ALLER A IMM, V66, P332; 1990, THRESHOLD LIMIT VALU, P34	23	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1994	94	4					747	756		10.1016/0091-6749(94)90183-X	http://dx.doi.org/10.1016/0091-6749(94)90183-X			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PM273	7930309	Bronze			2022-12-18	WOS:A1994PM27300014
J	IGLESIASCADARSO, A; DIAZ, C; LAGUNA, JJ; HERNANDEZWEIGAND, P				IGLESIASCADARSO, A; DIAZ, C; LAGUNA, JJ; HERNANDEZWEIGAND, P			ALLERGIC CONTACT DERMATOMUCOSITIS TO BUDESONIDE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							NASAL SPRAY		HOSP PUERTA HIERRO,ALLERGY SERV,MADRID,SPAIN; HOSP UNIV SAN CARLOS,SERV OTORHINOLARYNGOL,MADRID,SPAIN	Hospital Puerta de Hierro-Majadahonda			Martinez, Jose Julio Laguna/L-6891-2017	Martinez, Jose Julio Laguna/0000-0001-5909-8979				DOOMSGOOSSENS A, 1992, CONTACT DERMATITIS, V26, P182, DOI 10.1111/j.1600-0536.1992.tb00290.x; DOOMSGOOSSENS A, 1991, EXOGENOUS DERMATOSES, P299; EDSBACKER S, 1985, EUR J CLIN PHARMACOL, V29, P477, DOI 10.1007/BF00613465; GAMBOA PM, 1991, CONTACT DERMATITIS, V24, P227, DOI 10.1111/j.1600-0536.1991.tb01707.x; Lauerma AI., 1992, AM J CONTACT DERMATI, V3, P112; MEDING B, 1986, CONTACT DERMATITIS, V14, P253, DOI 10.1111/j.1600-0536.1986.tb01241.x; PERISTORTAJADA A, 1991, J ALLERGY CLIN IMMUN, V87, P597, DOI 10.1016/0091-6749(91)90021-F; VANHECKE E, 1980, CONTACT DERMATITIS, V6, P509, DOI 10.1111/j.1600-0536.1980.tb05589.x	8	10	11	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1994	94	3	1				559	560		10.1016/0091-6749(94)90214-3	http://dx.doi.org/10.1016/0091-6749(94)90214-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG907	8083462				2022-12-18	WOS:A1994PG90700017
J	SELTZER, JM				SELTZER, JM			BIOLOGICAL CONTAMINANTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Symposium on Building-Related and Home-Related Complaints and Illnesses: Sick Building Syndrome	DEC 03-05, 1992	LAKE BUENA VISTA, FL			BIOLOGICAL CONTAMINANTS; FUNGUS; BACTERIA; VIRUS; ALLERGEN; HYPERSENSITIVITY PNEUMONITIS; ASTHMA; ALLERGIC RHINITIS; HUMIDIFIER FEVER; MYCOTOXIN	OUTBREAK; TUBERCULOSIS; MOLDS	''The potential economic impact of indoor air pollution is quite high and is estimated in the tens of billions of dollars per year. Such impacts includes direct medical costs and lost earnings due to major illness as well as increased employee sick days and lost productivity.'' The health consequences of biological contamination range from uncomfortable odors to end-stage lung disease to fatality. What factors predispose to biologic contamination? Which contaminants cause adverse health effects? What illnesses are associated with which contaminants, and how do these occur? This discussion will help answer these questions, leaving the discussion of environmental sampling, interpretation of sampling results, and remediation to other speakers who presented this information. A few interesting ideas for consideration regarding the implications of biological contamination will also be presented.	UNIV CALIF SAN DIEGO,SCH MED,SAN DIEGO,CA 92103; SAN DIEGO STATE UNIV,GRAD SCH PUBL HLTH,SAN DIEGO,CA 92182	University of California System; University of California San Diego; California State University System; San Diego State University								ARLETTE J, 1981, CONTACT DERMATITIS, V7, P129, DOI 10.1111/j.1600-0536.1981.tb04584.x; BARROWCLIFF DF, 1968, THORAX, V23, P490, DOI 10.1136/thx.23.5.490; BENEZRA C, 1985, PLANT CONTACT DERMAT; CONSTANTINE DG, 1967, PHS1617 PUBL; CROFT WA, 1986, ATMOS ENVIRON, V20, P549, DOI 10.1016/0004-6981(86)90096-X; DISTASIO AJ, 1990, MIL MED, V155, P347; GEHA RS, 1977, J ALLERGY CLIN IMMUN, V60, P357, DOI 10.1016/0091-6749(77)90066-5; KAMINSKI E, 1974, APPL MICROBIOL, V27, P1001, DOI 10.1128/AEM.27.6.1001-1004.1974; KOZAK PP, 1979, ANN ALLERGY, V43, P88; Kozak PP, 1985, INDOOR AIR HUMAN HLT, P149; Morey P. R., 1988, P IAQ 88 ENG SOL IND, P10; NOLAN CM, 1991, AM REV RESPIR DIS, V143, P257, DOI 10.1164/ajrccm/143.2.257; PEPYS J, 1969, MONOGR ALLERGY, V4, P69; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; RYLANDER R, 1984, CLIN ALLERGY, V14, P109, DOI 10.1111/j.1365-2222.1984.tb02197.x; RYLANDER R, 1985, AM REV RESPIR DIS, V131, P209; SEAL D, 1992, BRIT J OPHTHALMOL, V76, P424, DOI 10.1136/bjo.76.7.424; SPECTOR WG, 1969, J PATHOL, V98, P31, DOI 10.1002/path.1710980105; SPENDLOVE JC, 1983, PUBLIC HEALTH REP, V98, P229; WENZEL FJ, 1971, J ALLERGY CLIN IMMUN, V48, P224, DOI 10.1016/0091-6749(71)90069-8; 1992, INDOOR AIR B, V2, P1; 1989, FPA400189001A US EPA, pCH2; 1989, REPORT C INDOOR AIR, V2, pCH3; 1989, AM C GOVT IND HYGIEN; 1991, C RECORD        0222, pE592	25	10	11	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2	2				318	326		10.1053/ai.1994.v94.a56011	http://dx.doi.org/10.1053/ai.1994.v94.a56011			9	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG770	8077585				2022-12-18	WOS:A1994PG77000007
J	SPAUL, WA				SPAUL, WA			BUILDING-RELATED FACTORS TO CONSIDER IN INDOOR AIR-QUALITY EVALUATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Symposium on Building-Related and Home-Related Complaints and Illnesses: Sick Building Syndrome	DEC 03-05, 1992	LAKE BUENA VISTA, FL					Many factors should be considered in an indoor air quality (IAQ) evaluation, and many of these factors are interactive. This article identifies building-related factors that may contribute to IAQ problems. Sixty percent of IAQ problems are related to ventilation and 30% result from air contamination, 20% from inside the building and 10% from outside the building. The remaining 10% are due to miscellaneous other causes (ref. 1). Specific problem areas for each of these categories are discussed in this article. Elements of a proactive management style are also discussed, because management styles can influence how an IAQ episode is handled or prevented.			SPAUL, WA (corresponding author), SPAUL ENVIRONM INC,11279 KNIGHTS GRIFFIN RD,THONOTOSASSA,FL 33592, USA.							COTHERN CR, 1987, ENV RADON, P93; IMPERATO PJ, 1981, B NEW YORK ACAD MED, V57, P922; MAKOFSKE WJ, 1988, RADON ENV, P18; Melius J., 1984, ANN AM C GOVT IND HY, V10, P3; SAMET JM, 1991, INDOOR AIR POLLUTION, P307; SPAUL WA, 1992, 1ST P ANN IND AIR QU, V1, P222; SPAUL WA, 1988, UNPUB; SPAUL WA, 1993, 1993 P IND AIR HELS, V2, P705	8	10	10	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2	2				385	389						5	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG770	8077595				2022-12-18	WOS:A1994PG77000017
J	VERLEDEN, GM; PYPE, JL; DEMEDTS, MM				VERLEDEN, GM; PYPE, JL; DEMEDTS, MM			KETOTIFEN MODULATES NONCHOLINERGIC CONTRACTION IN GUINEA-PIG AIRWAYS IN-VITRO BY A PREJUNCTIONAL NONHISTAMINE RECEPTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						KETOTIFEN; NONCHOLINERGIC CONTRACTION; NEUROPEPTIDES; SENSORY NERVES	SMOOTH-MUSCLE; ASTHMA; HISTAMINE; BRONCHOCONSTRICTION; INHIBITION; 5-HYDROXYTRYPTAMINE; INNERVATION; CETIRIZINE; INVITRO; NERVES	In guinea pig airways, electrical field stimulation (50 V, 0.5 msec, 8 Hz for 20 seconds) produces a rapid contraction, which is followed by a long-lasting contraction, at least in the lower part of the trachea and in the bronchi. The latter contraction is due to the release of neuropeptides from airway sensory nerves. Ketotifen fumarate has been demonstrated to inhibit the noncholinergic contraction in guinea pig airways in vitro, but no attempt has been made to identify the receptor type. Therefore we have performed an in vitro study to investigate which receptor is responsible for the inhibitory effects of ketotifen on noncholinergic contraction in guinea pig airways. Ketotifen (3 to 100 mu mol/L) produced a concentration-dependent inhibition of the noncholinergic contraction, with a maximum inhibition of 74% +/- 7% at 8 Hz stimulation (p < 0.001; n = 5). Pretreatment of the tissues with either cimetidine (10 mu mol/L) or thioperamide (10 mu mol/L) or phentolamine (10 mu mol/L) did not prevent the inhibitory effect of ketotifen (10 mu mol/L). Cetirizine (10 mu mol/L), on the other hand, produced no inhibition of the noncholinergic contraction at all. Metitepine (0.1 mu mol/L) and methysergide (1 mu mol/L) both 5-HT1 antagonists, attenuated the inhibitory effect of ketotifen (10 mu mol/L). Ketanserin (a 5-HT2 antagonist, 10 mu mol/L) and tropisetron (a 5-HT3 antagonist 1 mu mol/L) had no effect Ketotifen (100 mu mol/L) did not affect the cumulative dose-response relationship to exogenous substance P (0.01 mu mol/L to 10 mmol/L). These results indicate that ketotifen may modulate the release of neuropeptides from airway sensory nerves by a prejunctional mechanism, the exact receptor of which seems to be a nonhistamine receptor, probably a 5-HT1 receptor.	CATHOLIC UNIV LEUVEN, PNEUMOL LAB, B-3000 LOUVAIN, BELGIUM	KU Leuven								AIKAWA T, 1990, BRIT J PHARMACOL, V101, P13, DOI 10.1111/j.1476-5381.1990.tb12080.x; AIZAWA H, 1990, J ALLERGY CLIN IMMUN, V86, P171, DOI 10.1016/S0091-6749(05)80062-4; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; ARRUZAZABALA MDL, 1984, RESPIRATION, V45, P50, DOI 10.1159/000194597; BARNES PJ, 1989, NEW ENGL J MED, V321, P1517; BARNES PJ, 1986, LANCET, V1, P242; BARNETT A, 1991, AGENT ACTION SUPPL, V33, P181; BROBERGER U, 1986, CLIN ALLERGY, V16, P119, DOI 10.1111/j.1365-2222.1986.tb00755.x; CHAND N, 1978, AGENTS ACTIONS, V8, P191, DOI 10.1007/BF01966602; CHUN GL, 1991, BRIT J PHARMACOL, V102, P91, DOI 10.1111/j.1476-5381.1991.tb12137.x; COLERIDGE JCG, 1984, REV PHYSIOL BIOCH P, V99, P1, DOI 10.1007/BFb0027715; CRAPS LP, 1984, RESPIRATION, V45, P411, DOI 10.1159/000194648; DUNLOP LS, 1977, BRIT J PHARMACOL, V59, pP475; FADEL R, 1987, CLIN ALLERGY, V17, P373, DOI 10.1111/j.1365-2222.1987.tb02027.x; GRANT SM, 1990, DRUGS, V40, P412, DOI 10.2165/00003495-199040030-00006; GRUNDSTROM N, 1981, ACTA PHARMACOL TOX, V49, P150; GUC MO, 1988, ARCH INT PHARMACOD T, V296, P57; GUSHCHIN IS, 1986, AGENTS ACTIONS, V18, P92, DOI 10.1007/BF01987992; ICHINOSE M, 1989, EUR J PHARMACOL, V174, P49, DOI 10.1016/0014-2999(89)90872-8; KAMIKAWA Y, 1989, ANN ALLERGY, V63, P59; LEPREVOST C, 1988, INT ARCH ALLER A IMM, V87, P9, DOI 10.1159/000234641; LISBOA C, 1985, BRIT J DIS CHEST, V79, P235, DOI 10.1016/S0007-0971(85)80024-3; LOFTUS BG, 1985, CLIN ALLERGY, V15, P465, DOI 10.1111/j.1365-2222.1985.tb02296.x; LUNDBERG JM, 1984, CELL TISSUE RES, V235, P251; MACDONALD GF, 1986, IMMUNOL ALLERGY PRAC, V8, P46; MARTIN U, 1978, ARZNEIMITTELFORSCH, V28-1, P770; MARTLING CR, 1984, N-S ARCH PHARMACOL, V325, P343, DOI 10.1007/BF00504379; MATRAN R, 1989, EUR J PHARMACOL, V163, P15, DOI 10.1016/0014-2999(89)90390-7; OKPAKO DT, 1978, J PHARM PHARMACOL, V30, P181, DOI 10.1111/j.2042-7158.1978.tb13193.x; POLSON JB, 1982, IMMUNOPHARMACOLOGY, V4, P69, DOI 10.1016/0162-3109(82)90026-1; PYPE JL, 1993, EUR RESPIR J, V6, P117; RACKHAM A, 1989, J ALLERGY CLIN IMMUN, V84, P286, DOI 10.1016/0091-6749(89)90410-7; RICHARDSON BP, 1990, SEROTONIN, P265; SNOWMAN AM, 1990, J ALLERGY CLIN IMMUN, V86, P1025, DOI 10.1016/S0091-6749(05)80248-9; TINKELMAN DG, 1986, ANN ALLERGY, V56, P213; WAHN U, 1983, PEDIATR PHARMACOL, V3, P287; WARD JK, 1993, AM REV RESPIR DIS, V147, pA814; WATTS AD, 1981, J PHARM PHARMACOL, V33, P515, DOI 10.1111/j.2042-7158.1981.tb13850.x; WHITE MP, 1988, J INT MED RES, V16, P107, DOI 10.1177/030006058801600205	39	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2					207	214		10.1016/0091-6749(94)90042-6	http://dx.doi.org/10.1016/0091-6749(94)90042-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC926	8064073	Bronze			2022-12-18	WOS:A1994PC92600011
J	TAKAMIZAWA, M; IWATA, T; WATANABE, K; HAYAKAWA, H; TAKAHASHI, T; FURUE, M; FUKUDA, T; JUJI, T; MINAMI, M				TAKAMIZAWA, M; IWATA, T; WATANABE, K; HAYAKAWA, H; TAKAHASHI, T; FURUE, M; FUKUDA, T; JUJI, T; MINAMI, M			ELEVATED PRODUCTION OF INTERLEUKIN-4 AND INTERLEUKIN-5 BY T-CELLS IN A CHILD WITH IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							GAMMA; INTERFERON; ALPHA		TOKYO UNIV HOSP,DEPT PEDIAT,TOKYO,JAPAN; TOKYO UNIV HOSP,DEPT DERMATOL,TOKYO,JAPAN; DOKKYO MED COLL,DEPT ALLERGY,UTSUNOMIYA,JAPAN; TOKYO UNIV HOSP,BLOOD TRANSFUS UNIT,TOKYO,JAPAN	University of Tokyo; University of Tokyo; Dokkyo Medical University; University of Tokyo								CAMPBELL HD, 1987, P NATL ACAD SCI USA, V84, P6629, DOI 10.1073/pnas.84.19.6629; CHRETIEN I, 1989, J IMMUNOL METHODS, V117, P67, DOI 10.1016/0022-1759(89)90120-8; DELPRETE G, 1989, J CLIN INVEST, V84, P1830, DOI 10.1172/JCI114368; FUKUDA Y, 1991, J IMMUNOL METHODS, V143, P89, DOI 10.1016/0022-1759(91)90276-L; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; OWEN WF, 1989, J EXP MED, V170, P343, DOI 10.1084/jem.170.1.343; PALIARD X, 1988, J IMMUNOL, V141, P849; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; SPRY CJF, 1988, EOSINOPHILS COMPREHE, P263	9	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1994	93	6					1076	1078		10.1016/S0091-6749(94)70060-5	http://dx.doi.org/10.1016/S0091-6749(94)70060-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NT172	8006315				2022-12-18	WOS:A1994NT17200020
J	MATZ, J; WILLIAMS, J; ROSENWASSER, LJ; BORISH, LC				MATZ, J; WILLIAMS, J; ROSENWASSER, LJ; BORISH, LC			GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES MACROPHAGES TO RESPOND TO IGE VIA THE LOW-AFFINITY IGE RECEPTOR (CD23)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF); INTERLEUKIN-4; LOW AFFINITY IGE RECEPTORS (FC-EPSILON-RII OR CD23); BRONCHOALVEOLAR LAVAGE; MONOCYTES; INTERLEUKIN-1	EPIDERMAL LANGERHANS CELLS; HUMAN RECOMBINANT INTERLEUKIN-4; ALVEOLAR MACROPHAGES; ATOPIC-DERMATITIS; MONONUCLEAR PHAGOCYTES; HUMAN-LYMPHOCYTES; FC-RECEPTORS; B-CELLS; ANTIGEN; ASTHMA	We have found increased concentrations of granulocyte-macrophage colony-stimulating factor (GM-CSF) in the bronchoalveolar lavage fluid of 11 patients with nocturnal asthma (15.3 +/- 4.6 pg/ml) compared with normal subjects (2.3 +/- 61 pg/ml) (p = 0.03). In contrast to patients with asthma, low affinity IgE receptors (FcepsilonRII or CD23) are not expressed on monocytes obtained from healthy nonatopic donors. FcepsilonRII expression was induced by the cytokines GM-CSF and interleukin (IL)-4 either alone or in combination. As assessed by flow cytometry, the combination of IL-4 and GM-CSF was found to be synergistic, inducing up to 54.8% +/- 4.6% FcepsilonRII-positive monocytes compared with a maximum of 274% +/- 5.0% and 30.0% +/- 4.0% with IL-4 and GM-CSF alone, respectively (p < 0.05 compared with either cytokine alone). Human monocytes from the peripheral blood of seven normal subjects were cultured for 24 hours with and without IL-4 or GM-CSF. With IL-4, addition of IgE/anti-IgE complexes failed to induce IL-1 secretion and inhibited IL-1 secretion induced by lipopolysaccharides. The addition of GM-CSF or IgE immune complexes alone resulted in no additional IL-1 secretion in supernatants of the untreated monocytes, whereas the IgE complexes did stimulate IL-1 secretion by monocytes cultured in GM-CSF, as measured by ELISA (from 0.7 +/- 0.2 ng/ml to 2.3 +/- 0.5 ng/ml; p < 0.01). This could be confirmed to represent an FcepsilonRII-dependent process insofar as blocking of the FcepsilonRII receptors abrogated the capacity of the IgE complexes to induce IL-1beta (1.0 +/- 0.4 ng/ml IL-1; p = NS in comparison with untreated monocytes). We conclude that GM-CSF is increased in the bronchoalveolar lavage fluid of patients with asthma and may be important in macrophage activation via induction of the low affinity IgE receptor, thereby making cells susceptible to IgE-dependent activation.	UNIV COLORADO,HLTH SCI CTR,NATL JEWISH CTR IMMUNOL & RESP MED,1400 JACKSON ST,DENVER,CO 80262	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI024848] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36577] Funding Source: Medline; NIAID NIH HHS [AI24848] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARNES PJ, 1989, NEW ENGL J MED, V321, P1517; BIEBER T, 1989, J EXP MED, V170, P309, DOI 10.1084/jem.170.1.309; BORISH L, 1992, J IMMUNOL, V149, P3078; BORISH L, 1991, J IMMUNOL, V146, P63; BORISH L, 1992, CLIN EXP ALLERGY, V22, P984, DOI 10.1111/j.1365-2222.1992.tb03025.x; BROIDE DH, 1991, J CLIN INVEST, V88, P1048, DOI 10.1172/JCI115366; BRUYNZEELKOOMEN C, 1988, CLIN EXP IMMUNOL, V74, P137; BRUYNZEELKOOMEN C, 1986, ARCH DERMATOL RES, V278, P199, DOI 10.1007/BF00412924; CASTEN LA, 1988, J IMMUNOL, V140, P404; DEFRANCE T, 1987, J EXP MED, V165, P1459, DOI 10.1084/jem.165.6.1459; ESSNER R, 1989, J IMMUNOL, V142, P3857; FONTAINE S, 1989, LYMPHOKINE RES, V8, P129; GALILI U, 1974, J IMMUNOL, V112, P1628; GODARD P, 1982, J ALLERGY CLIN IMMUN, V70, P88, DOI 10.1016/0091-6749(82)90234-2; GONZALEZMOLINA A, 1977, J CLIN INVEST, V59, P616, DOI 10.1172/JCI108679; GORDON J, 1989, IMMUNOL TODAY, V10, P153, DOI 10.1016/0167-5699(89)90171-0; GOSSET P, 1991, J ALLERGY CLIN IMMUN, V88, P561, DOI 10.1016/0091-6749(91)90149-I; JEFFREY DL, 1990, J LEUKOCYTE BIOL, V47, P475; JOSEPH M, 1983, J CLIN INVEST, V71, P221, DOI 10.1172/JCI110762; KAKIUCHI T, 1983, J IMMUNOL, V131, P109; KEHRY MR, 1989, P NATL ACAD SCI USA, V86, P7556, DOI 10.1073/pnas.86.19.7556; MARTIN RJ, 1991, AM REV RESPIR DIS, V143, P351, DOI 10.1164/ajrccm/143.2.351; MELEWICZ FM, 1982, CLIN EXP IMMUNOL, V49, P364; MIETTINEN HM, 1989, CELL, V58, P317, DOI 10.1016/0092-8674(89)90846-5; MUDDE GC, 1990, IMMUNOL TODAY, V11, P440, DOI 10.1016/0167-5699(90)90172-6; MUDDE GC, 1990, IMMUNOLOGY, V69, P335; RANKIN JA, 1982, NATURE, V297, P329, DOI 10.1038/297329a0; ROBINSON DS, 1992, J ALLERGY CLIN IMMUN, V89, P212; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; ROSENWASSER LJ, 1986, MANUAL CLIN LABORATO, P321; SPIEGELBERG HL, 1980, CLIN IMMUNOL IMMUNOP, V15, P424, DOI 10.1016/0090-1229(80)90054-9; THIELE DL, 1985, J IMMUNOL, V134, P786; TONY HP, 1985, J EXP MED, V162, P1695, DOI 10.1084/jem.162.5.1695; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343; WEINBERG DS, 1981, J IMMUNOL, V126, P794; WILLIAMS J, 1992, J IMMUNOL, V149, P2823; YING S, 1991, Clinical and Experimental Allergy, V21, P745, DOI 10.1111/j.1365-2222.1991.tb03205.x; YUKAWA K, 1987, J IMMUNOL, V138, P2576; YUKOTA A, 1988, CELL, V55, P611; 1962, AM REV RESPIR DIS, V85, P762	40	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1994	93	3					650	657		10.1016/S0091-6749(94)70077-X	http://dx.doi.org/10.1016/S0091-6749(94)70077-X			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ND140	8151065				2022-12-18	WOS:A1994ND14000012
J	COSTA, JJ; DEMETRI, GD; HARRIST, TJ; DVORAK, AM; HAYES, DF; MERICA, EA; MENCHACA, DM; GRINGERI, AJ; GALLI, SJ				COSTA, JJ; DEMETRI, GD; HARRIST, TJ; DVORAK, AM; HAYES, DF; MERICA, EA; MENCHACA, DM; GRINGERI, AJ; GALLI, SJ			RECOMBINANT HUMAN STEM-CELL FACTOR (RHSCF) INDUCES CUTANEOUS MAST-CELL ACTIVATION AND HYPERPLASIA, AND HYPERPIGMENTATION IN HUMANS IN-VIVO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Hayes, Daniel/ABE-1129-2020						0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				225	225						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700375
J	HOWLAND, W; SEGAL, A; GLASS, M; MINKWITZ, MC				HOWLAND, W; SEGAL, A; GLASS, M; MINKWITZ, MC			6-WEEK THERAPY WITH THE ORAL LEUKOTRIENE-RECEPTOR ANTAGONIST, ICI-204,219, IN THE TREATMENT OF ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									HEALTHQUEST RES,AUSTIN,TX; ALLERGY ASSOCIATES,DALLAS,TX; ZENECA PHARMACEUT GRP,WILMINGTON,DE										0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				259	259						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700580
J	LEMANSKE, R; DUNN, K; GALANT, S; HAMPEL, F; LUMRY, W; MCCAIN, F; NOONAN, M; PEARLMAN, D; RANSOM, J; SOUTHERN, L; ROGENES, P; FIELD, E; WISNIEWSKI, M; SCOTT, C				LEMANSKE, R; DUNN, K; GALANT, S; HAMPEL, F; LUMRY, W; MCCAIN, F; NOONAN, M; PEARLMAN, D; RANSOM, J; SOUTHERN, L; ROGENES, P; FIELD, E; WISNIEWSKI, M; SCOTT, C			FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY IS MORE EFFECTIVE THAN ASTEMIZOLE IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				165	165						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700015
J	NORDLEE, JA; TAYLOR, SL; TOWNSEND, JA; THOMAS, LA				NORDLEE, JA; TAYLOR, SL; TOWNSEND, JA; THOMAS, LA			HIGH METHIONINE BRAZIL NUT PROTEIN BINDS HUMAN IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Taylor, Steve L./V-1341-2019						0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				209	209						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700276
J	CHANEZ, P; VAGO, P; DEMOLY, P; CORNILLAC, L; GODARD, P; BUREAU, JP; MICHEL, FB; BOUSQUET, J				CHANEZ, P; VAGO, P; DEMOLY, P; CORNILLAC, L; GODARD, P; BUREAU, JP; MICHEL, FB; BOUSQUET, J			AIRWAY MACROPHAGES FROM PATIENTS WITH ASTHMA DO NOT PROLIFERATE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						MACROPHAGES; ASTHMA; CELL CYCLE; DNA CONTENT; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY	MONOCLONAL-ANTIBODY KI-67; NUCLEAR ANTIGEN PCNA; S-PHASE CELLS; ALVEOLAR MACROPHAGES; FLOW-CYTOMETRY; BONE-MARROW; BRONCHIAL-ASTHMA; IMMUNOGLOBULIN-E; DNA HISTOGRAMS; LUNG	Background. Macrophages are involved in asthma, but their pulmonary turnover is unknown. We compared the ability of bronchoalveolar lavage (BAL) and bronchial macrophages to proliferate in normal subjects and patients with asthma. Methods: BAL cells from eight patients with asthma and eight normal volunteers were separated with a discontinuous Percoll gradient (Pharmacia Fine Chemicals, Uppsala, Sweden). In a first experiment, nuclei of each alveolar macrophage (AM) fraction, stained with propidium iodide, were analyzed for DNA content with a flow cytometer, and the proportions of cells in the G0/G1, S, and G2 + M phases were determined. In a second experiment, expression of Ki-67-related antigen was sought on AMs by immunocytochemistry. Macrophages from 10 patients with asthma and 10 normal volunteers were studied in biopsy specimens by means of immunohistochemistry with a panmacrophage monoclonal antibody (HAM-56) and a monoclonal antibody against proliferating cell nuclear antigen. Results: The proportions of BAL AMs in the different phases of the cell cycle were similar in normal subjects and patients with asthma for all fractions, and the percentage of cells in S and G2 +/- M phases ranged from 7.3% to 11.3%. Under 1% of BAL AMs expressed Ki-67-related antigen. None of the macrophages present in the biopsy specimens expressed proliferating cell nuclear antigen. Conclusions: This study does not indicate that an important source of airway macrophages is local proliferation.	INSERM, 9210, MALADIES RESP & CONTRAT JEUNE FORMAT CLIN, F-34100 MONTPELLIER, FRANCE; CHR MONTPELLIER, CYTOL CLIN & CYTOGENET LAB, MONTPELLIER, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier			Demoly, Pascal/Y-9938-2019; Bousquet, Jean/O-4221-2019	Demoly, Pascal/0000-0001-7827-7964; VAGO, Philippe/0000-0001-7055-1295; chanez, pascal/0000-0003-4059-0917				AAS K, 1981, ALLERGY, V36, P3, DOI 10.1111/j.1398-9995.1981.tb01818.x; ADAMS CWM, 1989, J NEUROL SCI, V92, P291, DOI 10.1016/0022-510X(89)90144-5; ALBLAS ABV, 1981, J EXP MED, V154, P235, DOI 10.1084/jem.154.2.235; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; ARNOUX A, 1983, SARCOIDOSIS OTHER GR, P50; ARNOUX B, 1987, B EUR PHYSIOPATH RES, V23, P119; BAISCH H, 1982, CELL TISSUE KINET, V15, P235, DOI 10.1111/j.1365-2184.1982.tb01043.x; BALTER MS, 1988, AM REV RESPIR DIS, V138, P1134, DOI 10.1164/ajrccm/138.5.1134; BASERGA R, 1985, BIOL CELL REPRODUCTI; BITTERMAN PB, 1984, J CLIN INVEST, V74, P460, DOI 10.1172/JCI111443; BLUSSEVANOUDALBLAS A, 1979, J EXP MED, V149, P1504, DOI 10.1084/jem.149.6.1504; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BRANDES ME, 1990, TOXICOL LETT, V54, P3, DOI 10.1016/0378-4274(90)90050-V; CARROLL MP, 1989, HUMAN MONOCYTES, P493; CHANEZ P, 1991, AM REV RESPIR DIS, V144, P923, DOI 10.1164/ajrccm/144.4.923; CLUZEL M, 1987, J ALLERGY CLIN IMMUN, V80, P195, DOI 10.1016/0091-6749(87)90129-1; COGGLE JE, 1984, J LEUKOCYTE BIOL, V35, P317; COLRERA MD, 1990, J HISTOCHEM CYTOCHEM, V39, P23; DANOVA M, 1988, BIOL CELL, V64, P23, DOI 10.1016/0248-4900(88)90089-5; DIXON WJ, 1969, PROBABILITY ACCEPTIN; ERBER WN, 1986, LANCET, V1, P761; FISH JE, 1990, RHINITIS ASTHMA SIMI, P222; FUKUDA T, 1985, AM REV RESPIR DIS, V132, P981; GALAND P, 1989, CELL TISSUE KINET, V22, P383, DOI 10.1111/j.1365-2184.1989.tb00223.x; GERDES J, 1984, J IMMUNOL, V133, P1710; GIORDANO M, 1991, LEUKEMIA RES, V15, P965, DOI 10.1016/0145-2126(91)90101-X; GODARD P, 1982, J ALLERGY CLIN IMMUN, V70, P88, DOI 10.1016/0091-6749(82)90234-2; GODARD P, 1987, HIGHLIGHTS ASTHMOLOG, P186; GOLDE DW, 1974, NATURE, V247, P373, DOI 10.1038/247373a0; GOWN AM, 1986, AM J PATHOL, V125, P191; HAAG D, 1987, CYTOMETRY, V8, P377, DOI 10.1002/cyto.990080406; HULETTE CM, 1992, AM J SURG PATHOL, V16, P493, DOI 10.1097/00000478-199205000-00008; ISOLA JJ, 1990, CANCER, V65, P1180, DOI 10.1002/1097-0142(19900301)65:5<1180::AID-CNCR2820650525>3.0.CO;2-7; JOSEPH M, 1980, CLIN EXP IMMUNOL, V40, P416; JOSEPH M, 1983, J CLIN INVEST, V71, P221, DOI 10.1172/JCI110762; KIEFER G, 1976, BEITR PATHOL, V158, P332; KREIPE H, 1990, LAB INVEST, V62, P697; METZGER WJ, 1987, AM REV RESPIR DIS, V135, P433; ORAZI A, 1992, BLOOD, V79, P2610; POSTON RN, 1992, AM REV RESPIR DIS, V145, P918, DOI 10.1164/ajrccm/145.4_Pt_1.918; POULTER LW, 1990, EUR RESPIR J, V3, P792; RANKIN JA, 1989, J ALLERGY CLIN IMMUN, V83, P722, DOI 10.1016/0091-6749(89)90005-5; RANKIN JA, 1992, AM REV RESPIR DIS, V145, P928, DOI 10.1164/ajrccm/145.4_Pt_1.928; RAZA A, 1985, CYTOMETRY, V6, P445, DOI 10.1002/cyto.990060509; RONOT X, 1986, BIOL CELL, V58, P113, DOI 10.1111/j.1768-322X.1986.tb00493.x; SAWYER RT, 1986, J LEUKOCYTE BIOL, V39, P77, DOI 10.1002/jlb.39.1.77; SHAPIRO HM, 1989, ARCH PATHOL LAB MED, V113, P591; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; SIMONY J, 1990, CANCER RES, V50, P4382; TARLING JD, 1982, CELL TISSUE KINET, V15, P577, DOI 10.1111/j.1365-2184.1982.tb01064.x; TONNEL AB, 1983, LANCET, V1, P1406; VANFURTH R, 1988, INFLAMMATION BASIC P, P281; VANFURTH R, 1980, MONONUCLEAR PHAGOCYT, P279; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; VOLKMAN A, 1976, J RETICULOENDOTH SOC, V19, P249; WARNOCK ML, 1987, AM J PATHOL, V128, P171; WILKINS BS, 1992, J PATHOL, V166, P45, DOI 10.1002/path.1711660108; YONEMURA Y, 1990, CANCER, V65, P1130, DOI 10.1002/1097-0142(19900301)65:5<1130::AID-CNCR2820650516>3.0.CO;2-A	58	10	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1993	92	6					869	877		10.1016/0091-6749(93)90065-N	http://dx.doi.org/10.1016/0091-6749(93)90065-N			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ML893	8258621	Bronze			2022-12-18	WOS:A1993ML89300013
J	JOHNSTON, SL; PRICE, JN; LAU, LCK; WALLS, AF; WALTERS, C; FEATHER, IH; HOLGATE, ST; HOWARTH, PH				JOHNSTON, SL; PRICE, JN; LAU, LCK; WALLS, AF; WALTERS, C; FEATHER, IH; HOLGATE, ST; HOWARTH, PH			THE EFFECT OF LOCAL HYPERTHERMIA ON ALLERGEN-INDUCED NASAL CONGESTION AND MEDIATOR RELEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						RHINITIS; VASCULAR LEAKAGE; NASAL BLOCKAGE; LOCAL HYPERTHERMIA; TRYPTASE	HEAT-SHOCK PROTEINS; ELEVATED-TEMPERATURE; BRADYKININ; RESPONSES; RHINITIS; LYMPHOCYTES; VOLUNTEERS; INTERFERON; HISTAMINE; ANTIGEN	Background: Local hyperthermia reduces mast cell degranulation, the severity of acute lung injury, and exercise-induced asthma and decreases symptoms of rhinitis. We have investigated the effect of local hyperthermia on mast cell degranulation and symptom generation in allergic rhinitis to assess its effect and mechanism of action within the nose. Methods: In a randomized, double-blind, placebo-controlled, crossover study, 10 subjects with rhinitis were treated for 30 minutes with local hyperthermia or placebo, which was followed 30 minutes later by nasal allergen challenge. During the first two visits nasal lavages were performed to assess vascular leakage and mediator release. During the last two visits nasal airway resistance, the number of sneezes, and mucus secretion were monitored. Results: Local hyperthermia significantly reduced both nasal airway resistance (p < 0.05) and vascular leakage (p < 0.02) but had no significant effect on the number of sneezes, on mucus secretion, or on tryptase release. Conclusion: Local hyperthermia reduces allergen provoked nasal blockage and vascular leakage but has no effect on sneezing, rhinorrhea, or tryptase release. Nasal blockage occurs predominantly via newly formed lipid mediators and kinins, whereas sneezing and rhinorrhea occur predominantly via preformed mediators. We propose that local hyperthermia inhibits newly formed mediator production or release or reduces the sensitivity of the vasculature to inflammatory mediators in general. Further investigation into the mechanisms and potential uses of local hyperthermia is warranted.			JOHNSTON, SL (corresponding author), UNIV MED SOUTHAMPTON,SOUTHAMPTON GEN HOSP,LEVEL D,CTR BLOCK,TREMONA RD,SOUTHAMPTON SO9 4XY,ENGLAND.		Johnston, Sebastian Lennox/I-2423-2012	Johnston, Sebastian Lennox/0000-0003-3009-9200; Howarth, Peter/0000-0003-0619-7927				BORN W, 1990, IMMUNOL TODAY, V11, P40; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASTELLS M, 1988, J ALLERGY CLIN IMMUN, V82, P348, DOI 10.1016/0091-6749(88)90005-X; CHEVANCE LG, 1983, CR ACAD SCI III-VIE, V296, P499; DINARELLO CA, 1986, CANCER RES, V46, P6236; DOWNING JF, 1987, J INTERFERON RES, V7, P185, DOI 10.1089/jir.1987.7.185; DOYLE WJ, 1990, J ALLERGY CLIN IMMUN, V86, P924, DOI 10.1016/S0091-6749(05)80156-3; GROSSMAN J, 1988, J ALLERGY CLIN IMMUN, V81, P175, DOI 10.1016/0091-6749(88)90263-1; HERON I, 1978, NATURE, V274, P508, DOI 10.1038/274508a0; HOWARTH PH, 1989, RESP MED, V83, P179, DOI 10.1016/S0954-6111(89)80029-0; HOWARTH PH, 1984, BRIT J CLIN PHARMACO, V18, P1; JOHNSTON SL, 1992, THORAX, V47, P592, DOI 10.1136/thx.47.8.592; JUNIPER EF, 1990, J ALLERGY CLIN IMMUN, V86, P380, DOI 10.1016/S0091-6749(05)80101-0; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; KNAPP HR, 1990, NEW ENGL J MED, V323, P1745, DOI 10.1056/NEJM199012203232506; MCLEAN JA, 1983, J ALLERGY CLIN IMMUN, V72, P187, DOI 10.1016/0091-6749(83)90528-6; MIDDLETON E, 1960, J ALLERGY, V31, P448, DOI 10.1016/0021-8707(60)90008-3; MONGAR JL, 1957, J PHYSIOL-LONDON, V135, P320, DOI 10.1113/jphysiol.1957.sp005713; MONTGOMERYSMITH J, 1993, ALLERGIC NONALLERGIC, P15; MORIMOTO R, 1984, J CELL BIOL, V99, P1316, DOI 10.1083/jcb.99.4.1316; MOTA I, 1960, BRIT J PHARM CHEMOTH, V15, P82, DOI 10.1111/j.1476-5381.1960.tb01213.x; NACLERIO RM, 1986, CLIN ALLERGY, V16, P101, DOI 10.1111/j.1365-2222.1986.tb00753.x; NACLERIO RM, 1988, PEDIATR INFECT DIS J, V7, P219; OPHIR D, 1988, ANN OTO RHINOL LARYN, V97, P259, DOI 10.1177/000348948809700309; OPHIR D, 1987, AM J OTOLARYNG, V3, P149; PLAUT M, 1990, J IMMUNOL, V144, P4497; RAJAKULASINGAM K, 1993, THORAX, V48, P324, DOI 10.1136/thx.48.4.324; RAJAKULASINGAM K, 1991, J PHYSIOL-LONDON, V437, P557; RAJAKULASINGAM K, 1992, CLIN EXP ALLERGY, V22, P717, DOI 10.1111/j.1365-2222.1992.tb00196.x; RON Y, 1984, J IMMUNOL, V133, P2037; TYRRELL D, 1989, BRIT MED J, V298, P1280, DOI 10.1136/bmj.298.6683.1280; VARNEY VA, 1991, BRIT MED J, V302, P265, DOI 10.1136/bmj.302.6771.265; VILLAR J, 1990, AM REV RESPIR DIS, V144, pA541; WALLS AF, 1990, CLIN EXP ALLERGY, V20, P581, DOI 10.1111/j.1365-2222.1990.tb03153.x; WEEKE B, 1973, SCAND J IMMUNOL, V2, P37, DOI 10.1111/j.1365-3083.1973.tb03777.x; YERUSHALMI A, 1982, P NATL ACAD SCI-BIOL, V79, P4766, DOI 10.1073/pnas.79.15.4766; YERUSHALMI A, 1980, CR ACAD SCI D NAT, V291, P957	37	10	12	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1993	92	6					850	856		10.1016/0091-6749(93)90063-L	http://dx.doi.org/10.1016/0091-6749(93)90063-L			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ML893	8258620	Bronze			2022-12-18	WOS:A1993ML89300011
J	POLOSA, R; DJUKANOVIC, R; RAJAKULASINGAM, K; PALERMO, F; HOLGATE, ST				POLOSA, R; DJUKANOVIC, R; RAJAKULASINGAM, K; PALERMO, F; HOLGATE, ST			SKIN-RESPONSES TO BRADYKININ, KALLIDIN, AND [DESARG(9)]-BRADYKININ IN NONATOPIC AND ATOPIC VOLUNTEERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SKIN; WHEAL; FLARE; BRADYKININ; KALLIDIN; [DESARG(9)]-BRADYKININ; TERFENADINE	MAST-CELLS; HISTAMINE-RELEASE; RECEPTORS; PRICK; PHARMACOLOGY; INFLAMMATION; FIBROBLASTS; ANTAGONISTS; STIMULATION; CAPSAICIN	Background: Kinins are potent vasoactive oligopeptides that may act as mediators in a variety of inflammatory diseases of the skin by interacting with specific receptors designated B1 and B2 In this study we have investigated the structure-activity relationship of intradermally injected bradykinin, kallidin (lysine-bradykinin), and [desArg9]-bradykinin in atopic (n = 8) and nonatopic (n = 8) subjects. Methods: On two separate occasions, each separated by a week, subjects randomly underwent intradermal challenge with incremental doses (0.5, 5, and 50 nmol) of either the B1-agonist [desArg9]-bradykinin, the B2-agonists bradykinin or kallidin, or vehicle placebo. In a separate randomized double-blind study we have also examined the effect of an orally administered antihistamine, terfenadine, on kinin-induced wheal and flare responses and their repeatability in a group of nine volunteers. The skin responses were monitored objectively by measurement of wheal and flare areas. Results: Both bradykinin and kallidin induced a dose-dependent increase in wheal and flare areas in all subjects studied. Although the effects of the two lowest doses (0.5 and 5 nmol) of [desArg9]-bradykinin on skin responses were indistinguishable from those of placebo, this kinin at the highest dose administered (50 nmol) caused a significant increase in wheal and flare areas in all subjects studied. No difference could be identified in the skin responses to kinins between atopic and nonatopic subjects. In addition kinin-induced cutaneous responses were not altered by pretreatment with terfenadine. Conclusions: These in vivo structure activity studies suggest that in human beings the skin responses to kinins may be compatible with the stimulation of B2 receptors, which is unrelated to histamine release from cutaneous mast cells.	SOUTHAMPTON GEN HOSP,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND	University of Southampton				Djukanovic, Ratko/0000-0001-6039-5612				AAS K, 1978, ALLERGY, V33, P130, DOI 10.1111/j.1398-9995.1978.tb01522.x; ADINOFF AD, 1989, J ALLERGY CLIN IMMUN, V84, P168, DOI 10.1016/0091-6749(89)90321-7; BARANIUK JN, 1990, AM REV RESPIR DIS, V141, P706, DOI 10.1164/ajrccm/141.3.706; BASRAN GS, 1982, LANCET, V1, P935; BRICKMAN CM, 1983, INT J DERMATOL, V22, P141, DOI 10.1111/j.1365-4362.1983.tb03351.x; CONKLIN BR, 1988, J PHARMACOL EXP THER, V244, P646; CRIMI N, 1992, CLIN EXP ALLERGY, V22, P933, DOI 10.1111/j.1365-2222.1992.tb02067.x; CROSSMAN DC, 1988, BRIT J CLIN PHARMACO, V26, P113, DOI 10.1111/j.1365-2125.1988.tb03375.x; DEMOLY P, 1991, J ALLERGY CLIN IMMUN, V88, P758, DOI 10.1016/0091-6749(91)90183-O; DROUIN JN, 1979, CAN J PHYSIOL PHARM, V57, P375, DOI 10.1139/y79-056; FAUSSNER A, 1991, J BIOL CHEM, V266, P9442; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; HOVELL CJ, 1987, CLIN ALLERGY, V17, P469, DOI 10.1111/j.1365-2222.1987.tb02041.x; HUTHER KJ, 1977, EUR J CLIN PHARMACOL, V12, P95; ISHIZAKA T, 1985, J IMMUNOL, V134, P1880; JOHNSON AR, 1973, P SOC EXP BIOL MED, V142, P1252; KAPLAN AP, 1989, CLIN IMMUNOL IMMUNOP, V50, pS41, DOI 10.1016/0090-1229(89)90112-8; LAWRENCE ID, 1989, BIOCHEM PHARMACOL, V38, P227, DOI 10.1016/0006-2952(89)90031-2; LEE PY, 1990, AGENTS ACTIONS, V30, P67, DOI 10.1007/BF01969000; MARCEAU F, 1983, GEN PHARMACOL, V14, P209, DOI 10.1016/0306-3623(83)90001-0; POLOSA R, 1990, AM REV RESPIR DIS, V142, P1367, DOI 10.1164/ajrccm/142.6_Pt_1.1367; PROUD D, 1990, J ALLERGY CLIN IMMUN, V85, P896, DOI 10.1016/0091-6749(90)90075-F; RAJAKULASINGAM K, 1991, Journal of Physiology (Cambridge), V437, P577; RANGACHARI PK, 1988, REGUL PEPTIDES, V21, P237, DOI 10.1016/0167-0115(88)90006-7; REGOLI D, 1980, PHARMACOL REV, V32, P1; ROSSONI G, 1980, PROSTAGLANDINS, V20, P547, DOI 10.1016/0090-6980(80)90042-8; SARIA A, 1988, AM REV RESPIR DIS, V137, P1330, DOI 10.1164/ajrccm/137.6.1330; SHALL L, 1988, BRIT J DERMATOL, V119, P525, DOI 10.1111/j.1365-2133.1988.tb03257.x; TAUDORF E, 1985, ALLERGY, V40, P344, DOI 10.1111/j.1398-9995.1985.tb00245.x; VANARMAN C, 1961, J PHARMACOL EXP THER, V131, P366; VAVREK RJ, 1985, PEPTIDES, V6, P161, DOI 10.1016/0196-9781(85)90033-6; WHALLEY ET, 1987, N-S ARCH PHARMACOL, V336, P652, DOI 10.1007/BF00165756; WILHELM DL, 1971, ANNU REV MED, V22, P63, DOI 10.1146/annurev.me.22.020171.000431	33	10	10	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1993	92	5					683	689		10.1016/0091-6749(93)90011-4	http://dx.doi.org/10.1016/0091-6749(93)90011-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MG982	8227859				2022-12-18	WOS:A1993MG98200009
J	SHERWOOD, JE; HUTT, DA; KREUTNER, W; MORTON, JB; CHAPMAN, RW				SHERWOOD, JE; HUTT, DA; KREUTNER, W; MORTON, JB; CHAPMAN, RW			A MAGNETIC-RESONANCE-IMAGING EVALUATION OF HISTAMINE-MEDIATED ALLERGIC RESPONSE IN THE GUINEA-PIG NASOPHARYNX	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						MAGNETIC RESONANCE IMAGING; NASOPHARYNX; MUCOSA; GUINEA PIG; ANTIGEN; HISTAMINE; LORATADINE	NON-SEDATING ANTIHISTAMINE; POSITIVE AIRWAY PRESSURE; PARA-NASAL SINUSES; RHINITIS; NOSE; LORATADINE; FERRETS	Background: Magnetic resonance imaging (MRI) is a powerful technique for visualizing tissues with a high water content. In this study we used MRI to evaluate the effect of antigen and mediators of allergic responses on the nasopharyngeal airway of guinea pigs. Methods and Results: Longitudinal relaxation time-weighted transverse images of the nasopharyngeal airway revealed a clearly defined airway lumen and mucosa. Topical administration of ovalbumin (0.00006% to 0.06%) to the nasopharyngeal airway of sensitized guinea pigs caused a concentration-dependent reduction (34% +/- 1%, maximum) in airway luminal volume and a corresponding increase (28% +/- 3%, maximum) in the volume of the airway mucosa. These effects were duplicated by histamine (10(-5) to 10(-3) mol/L), but not by methacholine (10(-3) mol/L). The antigen-induced changes in airway and mucosal volumes were dose-dependently inhibited by the H-1-antagonist loratadine (0.3 to 3 mg/kg, administered orally). On the other hand, topical administration of a decongestant drug, oxymetazoline (250 mug per guinea pig), had no effect on the response to antigen. Conclusions: These results indicate that MRI is a useful technique to measure allergic responses in the airways and identify that histamine is an important mediator of the obstruction that occurs in the nasopharyngeal airway of guinea pigs after antigen challenge.	SCHERING PLOUGH CORP, RES INST, 2015 GALLOPING HILL RD, KENILWORTH, NJ 07033 USA; UMDNJ, ROBERT WOOD JOHNSON MED SCH, DIV PULM & CRIT CARE MED, NEW BRUNSWICK, NJ USA; LAURIE IMAGING CTR, NEW BRUNSWICK, NJ USA	Merck & Company; Schering Plough Corporation; Rutgers State University New Brunswick; Rutgers State University Medical Center								ABBEY NC, 1989, AM REV RESPIR DIS, V140, P717, DOI 10.1164/ajrccm/140.3.717; ABELLI L, 1992, PULM PHARMACOL, V5, P137, DOI 10.1016/0952-0600(92)90032-C; AELLIG WH, 1990, BRIT J CLIN PHARMACO, V29, P157, DOI 10.1111/j.1365-2125.1990.tb03615.x; Cole P., 1989, AM J RHINOL, V3, P63, DOI [10.2500/105065889782009804, DOI 10.2500/105065889782009804]; COLLIER HOJ, 1967, BRIT J PHARM CHEMOTH, V30, P283, DOI 10.1111/j.1476-5381.1967.tb02135.x; CONNER BL, 1989, ANN ALLERGY, V62, P457; CORRADO OJ, 1987, BRIT J CLIN PHARMACO, V24, P283, DOI 10.1111/j.1365-2125.1987.tb03171.x; GAWIN AZ, 1991, J APPL PHYSIOL, V71, P2460, DOI 10.1152/jappl.1991.71.6.2460; HOLMBERG K, 1989, ALLERGY, V44, P281, DOI 10.1111/j.1398-9995.1989.tb01070.x; IRANDER K, 1990, ALLERGY, V45, P86, DOI 10.1111/j.1398-9995.1990.tb00463.x; JULIUSSON S, 1987, CLIN ALLERGY, V17, P301, DOI 10.1111/j.1365-2222.1987.tb02018.x; KELEMEN G, 1950, AMA ARCH OTOLARYNGOL, V52, P579; KREUTNER W, 1987, ALLERGY, V42, P57, DOI 10.1111/j.1398-9995.1987.tb02188.x; LLOYD GAS, 1989, J ROY SOC MED, V82, P84, DOI 10.1177/014107688908200209; MISAWA M, 1990, JPN J PHARMACOL, V54, P217, DOI 10.1254/jjp.54.217; MIZUNO H, 1991, JPN J PHARMACOL, V55, P321, DOI 10.1254/jjp.55.321; MOORE J, 1986, LARYNGOSCOPE, V96, P267; MYGIND N, 1984, CLIN REV ALLERG, V2, P173; Mygind N, 1987, Eur J Respir Dis Suppl, V153, P26; NORMAN PS, 1985, J ALLERGY CLIN IMMUN, V75, P531, DOI 10.1016/0091-6749(85)90024-7; PASTOR LM, 1990, ACTA ANAT, V139, P254; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V87, P457, DOI 10.1016/0091-6749(91)90001-5; REO NV, 1992, MAGNET RESON MED, V27, P34, DOI 10.1002/mrm.1910270105; REO NV, 1992, MAGN RESON MED, V27, P21, DOI 10.1002/mrm.1910270104; ROBINSON MK, 1992, J ALLERGY CLIN IMMUN, V89, P302; RUDIN M, 1991, TRENDS PHARMACOL SCI, V12, P416, DOI 10.1016/0165-6147(91)90620-8; RYAN CF, 1991, AM REV RESPIR DIS, V144, P939, DOI 10.1164/ajrccm/144.4.939; SPECTOR SL, 1980, J ALLERGY CLIN IMMUN, V66, P129, DOI 10.1016/0091-6749(80)90060-3; SVENSSON C, 1992, CLIN EXP ALLERGY, V22, P411, DOI 10.1111/j.1365-2222.1992.tb03103.x; WASICKO MJ, 1990, AM REV RESPIR DIS, V141, P1569, DOI 10.1164/ajrccm/141.6.1569; ZAWISZA E, 1977, ANN ALLERGY, V39, P355; ZINREICH SJ, 1988, LARYNGOSCOPE, V98, P928	32	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1993	92	3					435	441		10.1016/0091-6749(93)90122-V	http://dx.doi.org/10.1016/0091-6749(93)90122-V			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LX309	8360394				2022-12-18	WOS:A1993LX30900009
J	JOSEPH, M; TSICOPOULOS, A; TONNEL, AB; CAPRON, A				JOSEPH, M; TSICOPOULOS, A; TONNEL, AB; CAPRON, A			MODULATION BY NEDOCROMIL SODIUM OF IMMUNOLOGICAL AND NONIMMUNOLOGICAL ACTIVATION OF MONOCYTES, MACROPHAGES, AND PLATELETS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HUMAN ALVEOLAR MACROPHAGES; IMMUNOGLOBULIN-E; ASTHMATIC-PATIENTS; BRONCHIAL-ASTHMA; HIGH-AFFINITY; IGE; RECEPTOR; ALLERGY; MANAGEMENT; PARASITES	Human monocytes, alveolar macrophages, and blood platelets were used in vitro to investigate the effects of nedocromil sodium on their IgE-dependent stimulation. The drug induced a significant inhibition of the IgE-mediated generation of cytotoxic mediators in both cell populations. This was evidenced by a strong inhibition of the killing of schistosome larvae and decreased free radical production, as demonstrated by chemiluminescence. Nedocromil sodium also produced a significant inhibition of lysosomal enzyme release and synthesis in alveolar macrophages. These effects reached a maximum between 10(-9) and 10(-7) mol/L nedocromil sodium. The 50% inhibition concentration was 10 times lower. The drug was also tested on IgE-activated rat peritoneal macrophages and blood platelets with similar results. Finally nedocromil sodium was shown to inhibit the abnormal response to aspirin of platelets, both in vitro and er vivo, from aspirin-sensitive asthma patients.			JOSEPH, M (corresponding author), INST PASTEUR,CTR IMMUNOL & BIOL PARASITAIRE,INSERM,CJF 9006,BP 245,F-59019 LILLE,FRANCE.		Tsicopoulos, Anne/C-2260-2019	Tsicopoulos, Anne/0000-0002-1579-2763				AMEISEN JC, 1986, ANN INST PASTEUR IMM, VD137, P141; AMEISEN JC, 1985, INT ARCH ALLER A IMM, V78, P438, DOI 10.1159/000233927; BAIRD B, 1989, INT ARCH ALLER A IMM, V88, P23, DOI 10.1159/000234742; CAPRON A, 1986, IMMUNOL TODAY, V7, P15, DOI 10.1016/0167-5699(86)90184-2; CAPRON A, 1982, PROG ALLERGY, V31, P234; CAPRON A, 1985, ANNU REV IMMUNOL, V3, P445; FAIRFAX AJ, 1986, EUR J RESPIR DIS, V69, P320; GOSSET P, 1984, J ALLERGY CLIN IMMUN, V74, P827, DOI 10.1016/0091-6749(84)90186-6; JOSEPH M, 1981, AGENTS ACTIONS, V11, P619, DOI 10.1007/BF01978766; JOSEPH M, 1980, CLIN EXP IMMUNOL, V40, P416; JOSEPH M, 1983, NATURE, V303, P810, DOI 10.1038/303810a0; JOSEPH M, 1982, CLIN IMMUNOL ALLERGY, V2, P567; JOSEPH M, 1983, J CLIN INVEST, V71, P221, DOI 10.1172/JCI110762; JOSEPH M, 1986, EUR J IMMUNOL, V16, P306, DOI 10.1002/eji.1830160318; KALINER M, 1989, J ALLERGY CLIN IMMUN, V83, P510, DOI 10.1016/0091-6749(89)90031-6; KAY AB, 1988, IMMUNOL INVEST, V17, P679, DOI 10.3109/08820138809089018; LAL S, 1984, THORAX, V39, P809, DOI 10.1136/thx.39.11.809; MARQUETTE CH, 1990, BRIT J CLIN PHARMACO, V29, P525, DOI 10.1111/j.1365-2125.1990.tb03675.x; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; MORLEY J, 1985, TRIANGLE, V24, P59; THOREL T, 1987, American Review of Respiratory Disease, V135, pA398; THOREL T, 1988, INT ARCH ALLER A IMM, V85, P227, DOI 10.1159/000234507; THOREL T, 1988, INT ARCH ALLER A IMM, V85, P232, DOI 10.1159/000234508; WHITEHEAD TP, 1983, NATURE, V305, P158, DOI 10.1038/305158a0	24	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	2				165	170		10.1016/0091-6749(93)90100-T	http://dx.doi.org/10.1016/0091-6749(93)90100-T			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ354	8393022				2022-12-18	WOS:A1993LQ35400006
J	HAMILOS, DL; OPPENHEIMER, JJ; NELSON, HS; WENZEL, S; DRISCOLL, S; LOCKEY, RF; GOLDEN, DBK; FAN, L; SANKS, RJ; BOCK, SA; YUNGINGER, JW; STEVENSON, D; SULLIVAN, T; CORBRIDGE, T				HAMILOS, DL; OPPENHEIMER, JJ; NELSON, HS; WENZEL, S; DRISCOLL, S; LOCKEY, RF; GOLDEN, DBK; FAN, L; SANKS, RJ; BOCK, SA; YUNGINGER, JW; STEVENSON, D; SULLIVAN, T; CORBRIDGE, T			ROSTRUM - SUGGESTED APPROACHES FOR RESEARCH PROTOCOLS INVOLVING THE POTENTIAL FOR LIFE-THREATENING REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DERMATOPHAGOIDES-PTERONYSSINUS EXTRACT; ALLERGEN IMMUNOTHERAPY; SYSTEMIC REACTIONS; VENOM IMMUNOTHERAPY; DOUBLE-BLIND; ANAPHYLAXIS; ASTHMA; SAFETY				HAMILOS, DL (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED,1400 JACKSON ST,DENVER,CO 80206, USA.							BERNSTEIN DI, 1989, J ALLERGY CLIN IMMUN, V84, P951, DOI 10.1016/0091-6749(89)90394-1; BLEECKER ER, 1991, J ALLERGY CLIN IMMUN, V88, P808; BOCK SA, 1989, J ALLERGY CLIN IMMUN, V83, P900, DOI 10.1016/0091-6749(89)90103-6; BOCK SA, 1988, J ALLERGY CLIN IMMUN, V82, P986; BOCK SA, 1990, J PEDIATR-US, V117, P561, DOI 10.1016/S0022-3476(05)80689-4; BOUSQUET J, 1989, J ALLERGY CLIN IMMUN, V83, P797, DOI 10.1016/0091-6749(89)90017-1; CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P823, DOI 10.1016/0091-6749(89)90346-1; DOHI M, 1991, J ALLERGY CLIN IMMUN, V87, P34, DOI 10.1016/0091-6749(91)90210-F; GOLDEN DBK, 1980, ANN INTERN MED, V92, P620, DOI 10.7326/0003-4819-92-5-620; GREENBERG MA, 1986, J ALLERGY CLIN IMMUN, V77, P865, DOI 10.1016/0091-6749(86)90385-4; HEJJAOUI A, 1990, J ALLERGY CLIN IMMUN, V85, P473, DOI 10.1016/0091-6749(90)90157-Y; HEPNER MJ, 1990, J ALLERGY CLIN IMMUN, V86, P407, DOI 10.1016/S0091-6749(05)80105-8; JACOBS RL, 1981, J ALLERGY CLIN IMMUN, V68, P125, DOI 10.1016/0091-6749(81)90170-6; LIEBERMAN P, 1990, J ALLERGY CLIN IMMUN, V86, P684, DOI 10.1016/S0091-6749(05)80241-6; LOCKEY RF, 1987, J ALLERGY CLIN IMMUN, V79, P660, DOI 10.1016/S0091-6749(87)80164-1; NORMAN PS, 1989, J ALLERGY CLIN IMMUN, V84, P438, DOI 10.1016/0091-6749(89)90355-2; NORMAN PS, 1990, J ALLERGY CLIN IMMUN, V85, P522, DOI 10.1016/0091-6749(90)90165-Z; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; REID MJ, 1991, J ALLERGY CLIN IMMUN, V85, P80; SPECTOR S, 1985, BRONCHIAL ASTHMA MEC, P360; STARK BJ, 1986, J ALLERGY CLIN IMMUN, V78, P76, DOI 10.1016/0091-6749(86)90117-X; VANDERZWAN JC, 1983, BRIT MED J, V287, P1329, DOI 10.1136/bmj.287.6402.1329; 1990, J ALLERGY CLIN IMMUN, V85, P526; 1989, LANCET          0204, P259	24	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1993	91	6					1101	1109		10.1016/0091-6749(93)90312-4	http://dx.doi.org/10.1016/0091-6749(93)90312-4			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LG740	8509573	Bronze			2022-12-18	WOS:A1993LG74000001
J	CRIMI, N; OLIVERI, R; POLOSA, R; PALERMO, F; MISTRETTA, A				CRIMI, N; OLIVERI, R; POLOSA, R; PALERMO, F; MISTRETTA, A			THE EFFECT OF ORAL TERFENADINE ON NEUROKININ-A-INDUCED BRONCHOCONSTRICTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note											CRIMI, N (corresponding author), UNIV CATANIA,IST MALATTIE APPARATO RESP,VIA PASSO GRAVINIA 187,I-95125 CATANIA,ITALY.		Crimi, Nunzio/AAL-2994-2020	Crimi, Nunzio/0000-0002-8591-4535				BARNES PJ, 1991, AM REV RESPIR DIS, V144, P1187, DOI 10.1164/ajrccm/144.5.1187; BRAUNSTEIN G, 1991, AM REV RESPIR DIS, V144, P630, DOI 10.1164/ajrccm/144.3_Pt_1.630; CRIMI N, 1990, ANN ALLERGY, V65, P115; CRIMI N, 1992, CLIN EXP ALLERGY, V22, P75, DOI 10.1111/j.1365-2222.1992.tb00117.x; JOOS GF, 1989, J ALLERGY CLIN IMMUN, V83, P663, DOI 10.1016/0091-6749(89)90080-8; LOWMAN MA, 1988, BRIT J PHARMACOL, V95, P121, DOI 10.1111/j.1476-5381.1988.tb16555.x; PAUWELS R, 1988, AM REV RESPIR DIS, V137, pA212	7	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1993	91	5					1096	1098		10.1016/0091-6749(93)90225-5	http://dx.doi.org/10.1016/0091-6749(93)90225-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LC978	8388006	Bronze			2022-12-18	WOS:A1993LC97800019
J	MEKORI, YA; BARAM, D; GOLDBERG, A; HERSHKOVIZ, R; RESHEF, T; SREDNI, D				MEKORI, YA; BARAM, D; GOLDBERG, A; HERSHKOVIZ, R; RESHEF, T; SREDNI, D			NEDOCROMIL SODIUM INHIBITS T-CELL FUNCTION-INVITRO AND INVIVO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NEDOCROMIL SODIUM; T-LYMPHOCYTES; IL-2; TNF-ALPHA; EXTRACELLULAR MATRIX; CONTACT SENSITIVITY	MAST-CELLS; CONTACT SENSITIVITY; LYMPHOCYTES-T; FREE CALCIUM; EOSINOPHILS; ASTHMA; HYPERSENSITIVITY; IDENTIFICATION; EXPRESSION; RESPONSES	Nedocromil sodium, a topical antiinflammatory agent recommended as a prophylactic regimen for asthma, is known to inhibit both allergic and nonallergic inflammatory processes in which an essential role for T cells has been implicated. Therefore the direct effects of this drug on several aspects of T-cell activity were analyzed in the present study. By using murine lymphocytes we found that NS at concentrations of 10(-8) to 10(-6) mol/L inhibited the mitogen- or antigen-induced proliferative responses of these cells. It is interesting to note that higher concentrations were ineffective. Preincubation of immune lymph node cells from contact sensitized mice with the drug abrogated their ability to transfer contact sensitivity to naive recipients, an effect that was found to be specific for the treated cells. Nedocromil sodium also interfered with the mitogen-induced interleukin-2 and tumor necrosis factor production by T cells and with their ability to adhere to the bound protein components of the extracellular matrix laminin and fibronectin. All these effects may be attributed to the inhibition of the increase of cytosolic calcium, which accompanies the early phase of T-cell activation and which is an essential step in inducing the aforementioned phenomena.	MEIR HOSP,ALLERGY IMMUNOL UNIT,IL-44281 KEFAR SAVA,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,TEL AVIV,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	MEKORI, YA (corresponding author), MEIR HOSP,DEPT MED B,IL-44281 KEFAR SAVA,ISRAEL.							AALBERS R, 1991, J ALLERGY CLIN IMMUN, V87, P993, DOI 10.1016/0091-6749(91)90422-K; AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; BARNES PJ, 1989, NEW ENGL J MED, V321, P1517; BUSSE WW, 1989, DRUGS S, V1, P1; CHURCH MK, 1989, DRUGS, V37, P101, DOI 10.2165/00003495-198900371-00018; DAHL R, 1986, EUR J RESPIR DIS, V69, P263; FERGUSON TA, 1991, P NATL ACAD SCI USA, V88, P8072, DOI 10.1073/pnas.88.18.8072; FONG TAT, 1989, J IMMUNOL, V143, P2887; FREW AJ, 1990, AM REV RESPIR DIS, V141, P407, DOI 10.1164/ajrccm/141.2.407; FREW AJ, 1988, J IMMUNOL, V141, P4158; GALLILY R, 1989, CELL IMMUNOL, V121, P146, DOI 10.1016/0008-8749(89)90012-9; HERSHKOVIZ R, 1992, EUR J IMMUNOL, V22, P7, DOI 10.1002/eji.1830220103; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; LEUNG KBP, 1986, EUR J RESPIR DIS, V69, P223; MEKORI YA, 1985, J EXP MED, V162, P1935, DOI 10.1084/jem.162.6.1935; METZGER WJ, 1985, CLIN REV ALLERG, V3, P145, DOI 10.1007/BF02992980; MILLS GB, 1985, J IMMUNOL, V134, P1640; MOORHEAD JW, 1978, J IMMUNOL, V120, P137; MOQBEL R, 1908, DRUGS S, V1, P19; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; OHEHIR RE, 1989, DRUGS S, V1, P23; PEARCE FL, 1989, DRUGS, V37, P37, DOI 10.2165/00003495-198900371-00009; RINK TJ, 1985, CELL CALCIUM, V6, P133, DOI 10.1016/0143-4160(85)90040-5; ROBINSONDS, 1992, NEW ENGL J MED, V362, P298; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; SEELDRAYERS PA, 1989, J NEUROIMMUNOL, V25, P221, DOI 10.1016/0165-5728(89)90140-9; SHAPIRO DN, 1985, J IMMUNOL, V135, P2256; SHIMIZU Y, 1991, FASEB J, V5, P2292, DOI 10.1096/fasebj.5.9.1860621; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STADLER BM, 1981, J IMMUNOL, V127, P1936; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; WHITE MV, 1991, J ALLERGY CLIN IMMUN, V87, P812, DOI 10.1016/0091-6749(91)90127-A; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767	36	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1993	91	3					817	824		10.1016/0091-6749(93)90202-Q	http://dx.doi.org/10.1016/0091-6749(93)90202-Q			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KU203	8384227				2022-12-18	WOS:A1993KU20300015
J	PRETOLANI, M; LEFORT, J; VARGAFTIG, BB				PRETOLANI, M; LEFORT, J; VARGAFTIG, BB			INHIBITION BY NEDOCROMIL SODIUM OF RECOMBINANT HUMAN INTERLEUKIN-5-INDUCED LUNG HYPERRESPONSIVENESS TO PLATELET-ACTIVATING-FACTOR IN ACTIVELY SENSITIZED GUINEA-PIGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						INTERLEUKIN-5; PLATELET-ACTIVATING FACTOR; NEDOCROMIL SODIUM; LUNG HYPERRESPONSIVENESS; GUINEA PIG; EOSINOPHILS; BRONCHOALVEOLAR LAVAGE	COLONY-STIMULATING FACTOR; HUMAN BASOPHILS; ALLERGEN CHALLENGE; HISTAMINE-RELEASE; HUMAN-NEUTROPHILS; LEUKOTRIENE; ASTHMA; CROMOGLYCATE; EOSINOPHILS; RESPONSES	Background: The intratracheal instillation of recombinant human interleukin-5 (rhIL-5) into isolated lungs from sensitized and antigen-boosted guinea pigs is followed by enhanced responses to platelet-activating factor (PAF). Methods: Modulation by nedocromil sodium of rhIL-5-dependent hyperresponsiveness to PAF was investigated. Perfused lungs from guinea pigs actively sensitized to ovalbumin were injected intratracheally with 300 ng rhIL-5 followed by PAF (10 and 100 ng intraarterially). Results: No inhibition of rhIL-5-induced increased bronchoconstriction and release of thromboxane (TX)B, and histamine by PAF was observed when nedocromil sodium (10 mumol/L) was perfused into the lungs. In contrast, when guinea pigs were treated for 2 days (30 mg/kg twice a day), eosinophil recruitment into the bronchoalveolar lavage fluid and hyperresponsiveness to PAF were markedly reduced (100% [p < 0.001]; around 70% [p < 0.05] and around 90% [p < 0.001] inhibition for bronchoconstriction, TXB2 and histamine release, repectively). Conclusion: Our results indicate that nedocromil sodium prevents the rhIL-5-induced lung hyperresponsiveness to PAF and the eosinophil migration into the airways only when it is administered in vivo. It is thus suggested that nedocromil sodium interferes with the development of airway inflammation by inhibiting the recruitment in the lung of a target on which PAF and IL-5 interact.			PRETOLANI, M (corresponding author), INST PASTEUR,INSERM,U285,UNITE PHARMACOL CELLULAIRE,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE.		Vargaftig, Bernardo Boris B.B.J./C-3323-2013; Pretolani, Marina/G-6643-2017					ABRAHAM WM, 1989, DRUGS, V37, P78, DOI 10.2165/00003495-198900371-00015; AUTY RM, 1990, ALLERGY ASTHMA NEW T, P171; BEAUVAIS F, 1989, DRUGS, V37, P4, DOI 10.2165/00003495-198900371-00003; BISCHOFF SC, 1990, P NATL ACAD SCI USA, V87, P6813, DOI 10.1073/pnas.87.17.6813; BISCHOFF SC, 1990, J EXP MED, V172, P1577, DOI 10.1084/jem.172.6.1577; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BRUIJNZEEL PLB, 1990, BRIT J PHARMACOL, V99, P798, DOI 10.1111/j.1476-5381.1990.tb13009.x; BRUIJNZEEL PLB, 1989, BRIT J PHARMACOL, V96, P631, DOI 10.1111/j.1476-5381.1989.tb11862.x; CHAND N, 1992, EUR J PHARMACOL, V211, P121, DOI 10.1016/0014-2999(92)90273-7; CHURCH MK, 1989, DRUGS, V37, P101, DOI 10.2165/00003495-198900371-00018; COEFFIER E, 1991, J IMMUNOL, V147, P2595; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; COLUMBO M, 1990, J IMMUNOL, V145, P3855; DAHINDEN CA, 1988, J EXP MED, V167, P1281, DOI 10.1084/jem.167.4.1281; DAMON M, 1989, EUR RESPIR J, V2, P202; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; FREW AJ, 1990, AM REV RESPIR DIS, V141, P407, DOI 10.1164/ajrccm/141.2.407; FUJISAWA T, 1990, J IMMUNOL, V144, P642; GONZALEZ MC, 1987, AM REV RESPIR DIS, V136, P600, DOI 10.1164/ajrccm/136.3.600; GULBENKIAN AR, 1992, AM REV RESPIR DIS, V146, P263, DOI 10.1164/ajrccm/146.1.263; HIRAI K, 1990, J EXP MED, V172, P1525, DOI 10.1084/jem.172.5.1525; HUTSON PA, 1988, AM REV RESPIR DIS, V138, P1157, DOI 10.1164/ajrccm/138.5.1157; KAPP A, 1991, BRIT J DERMATOL, V125, P108, DOI 10.1111/j.1365-2133.1991.tb06056.x; KIMURA I, 1975, Clinical Allergy, V5, P95, DOI 10.1111/j.1365-2222.1975.tb01840.x; LEBEL B, 1983, ANAL BIOCHEM, V133, P16, DOI 10.1016/0003-2697(83)90217-8; LEFORT J, 1984, BRIT J PHARMACOL, V82, P565, DOI 10.1111/j.1476-5381.1984.tb10795.x; LEUNG KBP, 1988, THORAX, V43, P756, DOI 10.1136/thx.43.10.756; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; MIYAJIMA A, 1988, FASEB J, V2, P2462, DOI 10.1096/fasebj.2.9.2836253; MOQBEL R, 1989, DRUGS, V37, P19, DOI 10.2165/00003495-198900371-00005; NAKAJIMA H, 1992, AM REV RESPIR DIS, V146, P374, DOI 10.1164/ajrccm/146.2.374; PRETOLANI M, 1988, AM REV RESPIR DIS, V138, P1572, DOI 10.1164/ajrccm/138.6.1572; PRETOLANI M, 1990, AM REV RESPIR DIS, V141, P1259, DOI 10.1164/ajrccm/141.5_Pt_1.1259; PRETOLANI M, 1992, BRIT J PHARMACOL, V106, P677, DOI 10.1111/j.1476-5381.1992.tb14394.x; RESLER B, 1992, J ALLERGY CLIN IMMUN, V89, pA362; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SCHELLENBERG RR, 1991, BRIT J PHARMACOL, V103, P1842, DOI 10.1111/j.1476-5381.1991.tb12339.x; SEDGWICK JB, 1992, J ALLERGY CLIN IMMUN, V90, P202, DOI 10.1016/0091-6749(92)90072-A; SEHMI R, 1991, INT C ICOI INFLAMMAT, P133; SILBERSTEIN DS, 1986, J IMMUNOL, V137, P3290; SILVA JRL, 1992, AM REV RESPIR DIS, V145, pA39; SORS H, 1978, PROSTAGLANDINS, V16, P277, DOI 10.1016/0090-6980(78)90030-8; TERADA N, 1992, J ALLERGY CLIN IMMUN, V90, P160, DOI 10.1016/0091-6749(92)90067-C; WANG JM, 1989, EUR J IMMUNOL, V19, P701, DOI 10.1002/eji.1830190420	44	10	10	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1993	91	3					809	816		10.1016/0091-6749(93)90201-P	http://dx.doi.org/10.1016/0091-6749(93)90201-P			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KU203	7681072				2022-12-18	WOS:A1993KU20300014
J	GARIBALDI, E; LABLANCE, G; HIBBETT, A; WALL, L				GARIBALDI, E; LABLANCE, G; HIBBETT, A; WALL, L			EXERCISE-INDUCED PARADOXICAL VOCAL CORD DYSFUNCTION - DIAGNOSIS WITH VIDEOSTROBOSCOPIC ENDOSCOPY AND TREATMENT WITH CLOSTRIDIUM TOXIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				200	200						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100236
J	JACOBSON, RS; HOFFMAN, DR				JACOBSON, RS; HOFFMAN, DR			CHARACTERIZATION OF BUMBLEBEE VENOM ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	12	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				187	187						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100185
J	YUNGINGER, JW; JONES, RT; FRANSWAY, AF; KELSO, JM; WARNER, MA; HUNT, LW; REED, CE				YUNGINGER, JW; JONES, RT; FRANSWAY, AF; KELSO, JM; WARNER, MA; HUNT, LW; REED, CE			LATEX ALLERGEN CONTENTS OF MEDICAL AND CONSUMER RUBBER PRODUCTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				241	241						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100403
J	KALINER, MA				KALINER, MA			THE PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE PARASYMPATHETIC NERVOUS-SYSTEM IN NASAL DISEASE - AN OVERVIEW	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	CONF ON INTRANASAL ANTICHOLINERGIC TREATMENT OF NASAL DISORDERS	MAR   06, 1991	SAN FRANCISCO, CA	BOEHRINGER INGELHEIM PHARM			SECRETIONS; RHINITIS				KALINER, MA (corresponding author), NIAID,ALLERG DIS SECT,BLDG 10,ROOM 11C205,BETHESDA,MD 20892, USA.							BARANIUK JN, 1991, AM J PHYSIOL, V261, pL223, DOI 10.1152/ajplung.1991.261.4.L223; IGARASHI Y, IN PRESS J ALLERGY C; KALINER MA, 1991, AM REV RESPIR DIS, V144, pS52, DOI 10.1164/ajrccm/144.3_pt_2.S52; OKAYAMA M, IN PRESS AM J RESPIR; RAPHAEL G, 1989, J ALLERGY CLIN IMMUN, V83, P110, DOI 10.1016/0091-6749(89)90484-3; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V88, P33, DOI 10.1016/0091-6749(91)90298-3; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V87, P457, DOI 10.1016/0091-6749(91)90001-5; RAPHAEL GD, 1991, RHINITIS, P135	8	10	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1992	90	6	2	S			1044	1045		10.1016/0091-6749(92)90120-Q	http://dx.doi.org/10.1016/0091-6749(92)90120-Q			2	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD635	1460205				2022-12-18	WOS:A1992KD63500003
J	SPECTOR, SL				SPECTOR, SL			THE PLACEBO-EFFECT IS NOTHING TO SNEEZE AT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	CONF ON INTRANASAL ANTICHOLINERGIC TREATMENT OF NASAL DISORDERS	MAR   06, 1991	SAN FRANCISCO, CA	BOEHRINGER INGELHEIM PHARM					ALLERGY RES FDN,LOS ANGELES,CA		SPECTOR, SL (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,ALLERGY MED CLIN,LOS ANGELES,CA 90024, USA.							DEWEESE DE, 1973, TXB OTOLARYNGOLOGY, P214; JONES LM, 1979, ANN ALLERGY, V42, P139; SCHULZ JI, 1978, CLIN ALLERGY, V8, P313, DOI 10.1111/j.1365-2222.1978.tb00466.x; SPECTOR SL, 1982, CLIN ALLERGY, V12, P187, DOI 10.1111/j.1365-2222.1982.tb01638.x	4	10	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1992	90	6	2	S			1042	1043		10.1016/0091-6749(92)90119-M	http://dx.doi.org/10.1016/0091-6749(92)90119-M			2	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD635	1460204	Bronze			2022-12-18	WOS:A1992KD63500002
J	AIZAWA, T; KAKUTA, Y; YAMAUCHI, K; OHKAWARA, Y; MARUYAMA, N; NITTA, Y; TAMURA, G; SASAKI, H; TAKISHIMA, T				AIZAWA, T; KAKUTA, Y; YAMAUCHI, K; OHKAWARA, Y; MARUYAMA, N; NITTA, Y; TAMURA, G; SASAKI, H; TAKISHIMA, T			INDUCTION OF GRANULE RELEASE BY INTRACELLULAR APPLICATION OF CALCIUM AND GUANOSINE-5'-O-(3-THIOTRIPHOSPHATE) IN HUMAN EOSINOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HUMAN EOSINOPHILS; PATCH-CLAMP TECHNIQUE; DEGRANULATION; GUANINE NUCLEOTIDE BINDING PROTEINS; BRONCHIAL ASTHMA	CELLS; PROTEINS	The roles of Ca and G proteins in granule release from human eosinophils were examined by use of a patch-clamp technique in single cells. The morphologic changes and the release of eosinophil peroxidase (EPO) from single cells were simultaneously observed. In addition, the expression of small molecular weight guanine nucleotide binding protein (small G protein) mRNA (smg p25A [rab 3] and smg p21 [rab 1]) was investigated. The intracellular application of Ca, 10 mumol/L, and guanosine-5'-O-(3-thiotriphosphate) (GTP-gamma-S), 100 mumol/L, induced fusion of EPO containing granules with the surface membrane, which was associated with a marked increase in membrane capacitance. Ca alone caused a rapid granule release at an early stage of cell dialysis, but most granules still remained in a cluster. GTP-gamma-S alone caused a gradual degranulation. Northern blot analysis revealed the definite expression of smg p21 mRNA with no appreciable expression of smg p25A. These results provide direct evidence of granule fusion by intracellular application of Ca and GTP-gamma-S. In addition, Ca dependent proteins and G proteins act cooperatively in granule release, and these proteins likely regulate the different processes of degranulation. Furthermore, a protein, encoded by smg p21, may be involved in the granule release process in human eosinophils.	TOHOKU UNIV, DEPT INTERNAL MED 1, 1-1 SEIRYO MACHI, AOBA KU, SENDAI, MIYAGI 980, JAPAN	Tohoku University			Yamauchi, Kohei/N-2749-2016					AIZAWA T, 1990, AM REV RESPIR DIS, V142, P133, DOI 10.1164/ajrccm/142.1.133; BAILLY E, 1991, NATURE, V350, P715, DOI 10.1038/350715a0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARZAGHI G, 1989, J PHARMACOL EXP THER, V248, P559; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; DEBOER M, 1986, J IMMUNOL, V136, P3447; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; GOMPERTS BD, 1990, ANNU REV PHYSIOL, V52, P591; KAKUTA Y, 1988, J ALLERGY CLIN IMMUN, V81, P460, DOI 10.1016/0091-6749(88)90918-9; KAKUTA Y, 1984, PFLUG ARCH EUR J PHY, V400, P72, DOI 10.1007/BF00670539; KAWATA M, 1988, J BIOL CHEM, V263, P18965; KROEGEL C, 1989, FEBS LETT, V243, P41, DOI 10.1016/0014-5793(89)81214-1; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; NUSSE O, 1990, J EXP MED, V171, P775, DOI 10.1084/jem.171.3.775; OHKAWARA Y, IN PRESS AM J RESPIR; OHNO I, 1990, IMMUNOLOGY, V70, P88; SAITO H, 1989, J IMMUNOL, V143, P250; SANO K, 1989, BIOCHEM BIOPH RES CO, V158, P377, DOI 10.1016/S0006-291X(89)80058-0; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; VENGE P, 1990, THORAX, V45, P161, DOI 10.1136/thx.45.3.161; 1962, AM REV RESPIR DIS, V852, P762	21	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1992	90	5					789	795		10.1016/0091-6749(92)90103-9	http://dx.doi.org/10.1016/0091-6749(92)90103-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JZ319	1430704				2022-12-18	WOS:A1992JZ31900009
J	SEDGWICK, JB; BJORNSDOTTIR, U; GEIGER, KM; BUSSE, WW				SEDGWICK, JB; BJORNSDOTTIR, U; GEIGER, KM; BUSSE, WW			INHIBITION OF EOSINOPHIL DENSITY CHANGE AND LEUKOTRIENE-C(4) GENERATION BY NEDOCROMIL SODIUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						EOSINOPHIL; LEUKOTRIENES; NEDOCROMIL SODIUM; CELL DENSITY; ASTHMA; SUPEROXIDE GENERATION	COLONY-STIMULATING FACTOR; PLATELET-ACTIVATING FACTOR; HYPODENSE EOSINOPHILS; FUNCTIONAL-PROPERTIES; ASTHMATIC REACTIONS; ANTIGEN CHALLENGE; ENDOTHELIAL-CELLS; 3T3 FIBROBLASTS; CYTO-TOXICITY; DOUBLE-BLIND	Nedocromil sodium (NS) has been shown to inhibit the late asthma response to inhaled antigen and to control symptoms in chronic asthma; in both processes the eosinophil is thought to be an important contributor. To understand the antiinflammatory actions of NS in asthma, its effects on three eosinophil functions were evaluated: (1) change in cell density during in vitro culture, (2) synthesis of leukotriene C4 (LTC4), and (3) generation of superoxide anion. In these studies normal density (> 1.095 gm/ml) purified human peripheral blood eosinophils were cultured for 24 hours in 50% conditioned medium from cow pulmonary arterial endothelial cells. After incubation, 45.2% +/- 8.0% of the eosinophils had a density less than 1.085 gm/ml. In the presence of NS (10-mu-mol/L), only 32.0% +/- 7.3% became less dense (p = 0.0393). In contrast, NS had no effect on changes in cell density after a 20-minute exposure of eosinophils to functional activators N-formyl-methionyl-leucyl-phenylalanine (0.1-mu-mol/L) or platelet activating factor (0.1-mu-mol/L). Furthermore, calcium ionophore-activated LTC4 secretion was found to be significantly inhibited by NS (3.8 +/- 0.6 ng/ml vs 2.4 +/- 0.3 ng/ml with 1-mu-mol/L NS or 1.7 +/- 0.6 ng/ml with 10-mu-mol/L NS, p < 0.025). However, NS did not significantly alter eosinophil superoxide anion generation. The effects of NS on eosinophil function suggest a mechanism by which this medication may be effective in asthma, particularly in the regulation of the late asthmatic response. Furthermore, the selective regulatory effects of NS may also provide insight into the biologic activities of eosinophils.	UNIV WISCONSIN,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023181] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 23181] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AALBERS R, 1991, J ALLERGY CLIN IMMUN, V87, P993, DOI 10.1016/0091-6749(91)90422-K; BRADFORD PG, 1986, EUR J RESPIR DIS, V69, P238; BRUIJNZEEL PLB, 1990, BRIT J PHARMACOL, V99, P798, DOI 10.1111/j.1476-5381.1990.tb13009.x; BRUIJNZEEL PLB, 1989, BRIT J PHARMACOL, V96, P631, DOI 10.1111/j.1476-5381.1989.tb11862.x; BURKE LA, 1990, J ALLERGY CLIN IMMUN, V85, P26, DOI 10.1016/0091-6749(90)90217-R; CRIMI E, 1989, J ALLERGY CLIN IMMUN, V83, P985, DOI 10.1016/0091-6749(89)90116-4; CRIMI E, 1987, CLIN ALLERGY, V17, P135, DOI 10.1111/j.1365-2222.1987.tb02331.x; DAHL R, 1986, EUR J RESPIR DIS, V69, P263; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DIAZ P, 1989, AM REV RESPIR DIS, V139, P1383, DOI 10.1164/ajrccm/139.6.1383; FRICK WE, 1989, AM REV RESPIR DIS, V139, P1401, DOI 10.1164/ajrccm/139.6.1401; GREIF J, 1989, CHEST, V96, P583, DOI 10.1378/chest.96.3.583; HENRIKSEN JM, 1988, ALLERGY, V43, P449, DOI 10.1111/j.1398-9995.1988.tb00917.x; JOUBERT JR, 1986, B EUR PHYSIOPATHO S8, V22, P720; LAMAS AM, 1991, J IMMUNOL, V147, P254; LAMAS AM, 1989, J IMMUNOL, V142, P3978; LEWIS SL, 1986, AM J NEPHROL, V6, P34, DOI 10.1159/000167050; MOQBEL R, 1989, DRUGS, V37, P19, DOI 10.2165/00003495-198900371-00005; MOQBEL R, 1986, EUR J RESPIR DIS, V69, P227; MOQBEL R, 1988, ALLERGY, V43, P268, DOI 10.1111/j.1398-9995.1988.tb00899.x; OWEN WF, 1987, J EXP MED, V166, P129, DOI 10.1084/jem.166.1.129; PEMBER SO, 1983, BLOOD, V61, P1105; PHILLIPS MJ, 1989, DRUGS, V37, P56, DOI 10.2165/00003495-198900371-00012; PINCUS SH, 1981, BLOOD, V58, P1175; RAND TH, 1988, INT ARCH ALLER A IMM, V87, P151, DOI 10.1159/000234665; ROTHENBERG ME, 1989, J IMMUNOL, V143, P2311; ROTHENBERG ME, 1987, SCIENCE, V237, P645, DOI 10.1126/science.3110954; ROTHENBERG ME, 1988, J CLIN INVEST, V81, P1986, DOI 10.1172/JCI113547; SEDGWICK JB, 1988, J ALLERGY CLIN IMMUN, V81, P876, DOI 10.1016/0091-6749(88)90945-1; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; SHAW RJ, 1985, BRIT J DIS CHEST, V79, P385, DOI 10.1016/0007-0971(85)90073-7; TAI PC, 1991, CLIN EXP IMMUNOL, V85, P312; WILHELMS OH, 1990, INT J TISSUE REACT, V12, P101; YUKAWA T, 1989, IMMUNOLOGY, V68, P140	34	10	10	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1992	90	2					202	209		10.1016/0091-6749(92)90072-A	http://dx.doi.org/10.1016/0091-6749(92)90072-A			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ423	1323588				2022-12-18	WOS:A1992JJ42300009
J	KAULBACH, HC; IGARASHI, Y; MULLOL, J; WHITE, MV; KALINER, MA				KAULBACH, HC; IGARASHI, Y; MULLOL, J; WHITE, MV; KALINER, MA			EFFECTS OF NEDOCROMIL SODIUM ON ALLERGEN-INDUCED RHINITIS IN HUMANS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NEDOCROMIL SODIUM; NASAL SECRETIONS; ALLERGEN CHALLENGE	1-PERCENT NASAL SOLUTION; PATHO-PHYSIOLOGY; CROMOLYN SODIUM; SECRETIONS; HISTAMINE; PLACEBO; RADIOIMMUNOASSAY; PROVOCATION; PROTEIN	Sixteen patients with allergic rhinitis were recruited into a double-blind crossover protocol studying the immediate effect of nedocromil sodium (NS) on the pattern of nasal symptoms and secretions after allergen challenge. After pretreatment with placebo or NS, allergen challenge resulted in pruritus, rhinorrhea, nasal congestion, and/or sneezing within 10 minutes in 12 of 16 subjects. Prostaglandin D2 (PGD2), a marker of mast cell degranulation, increased proportionately with symptom scores, remaining above the 95% confidence interval for 120 minutes after both pretreatments. No difference in PGD2 between the NS-treatment and placebo-treatment days was observed. Protein markers extravasated through the vasculature (albumin and IgG) or secreted by mucosal glands (lactoferrin) were assayed. Total protein, albumin, IgG, and lactoferrin all remained > 95% confidence interval for 100 minutes after allergen challenge in the placebo-pretreated group and 120 minutes in the NS-pretreated group. Although there appeared to be a trend for lower secretion of PGD2, albumin, and IgG in the NS-treated group, the overall differences did not achieve statistical significance. This protocol revealed that two topical 130-mu-l doses of a 1% solution of NS failed to significantly reduce allergen-induced symptoms, PGD2 generation, or secretion of albumin, IgG, or lactoferrin when NS was compared with placebo. The anti-inflammatory and mast cell-stabilizing effects of NS may require more prolonged pretreatment before provocation to be effective.	NIAID, CLIN INVEST LAB,ALLERG DIS SECT,BLDG 10, ROOM 11C205, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								ABRAHAM WM, 1987, CHEST, V92, P913, DOI 10.1378/chest.92.5.913; BELLIONI P, 1988, Rhinology (Utrecht), V26, P281; CLAGUE JE, 1987, B EUR PHYSIOPATH RES, V23, pS374; CORRADO OJ, 1987, J ALLERGY CLIN IMMUN, V80, P218, DOI 10.1016/0091-6749(87)90132-1; DAHLEN SE, 1989, DRUGS, V37, P63, DOI 10.2165/00003495-198900371-00013; DRUCE HM, 1990, ANN ALLERGY, V65, P212; EADY RP, 1985, BRIT J PHARMACOL, V85, P323, DOI 10.1111/j.1476-5381.1985.tb08864.x; FREI W, 1987, REV ESP ALLERGOL IMM, V2, P322; Granstrom E, 1978, Adv Prostaglandin Thromboxane Res, V5, P119; JUUL N, 1987, IMMUNOBIOLOGY HISTOP, P485; LINDSAYMILLER ACM, 1987, IMMUNOBIOLOGY HISTOP, P481; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LOZEWICZ S, 1990, J ALLERGY CLIN IMMUN, V85, P125, DOI 10.1016/0091-6749(90)90233-T; MCBRIDE P, 1988, J ALLERGY CLIN IMMUN, V82, P638, DOI 10.1016/0091-6749(88)90977-3; MEREDITH SD, 1989, J ALLERGY CLIN IMMUN, V84, P920, DOI 10.1016/0091-6749(89)90390-4; MYERS G, 1981, J ALLERGY CLIN IMMUN, V67, P305, DOI 10.1016/0091-6749(81)90026-9; RAPHAEL GD, 1988, AM REV RESPIR DIS, V138, P413, DOI 10.1164/ajrccm/138.2.413; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V88, P33, DOI 10.1016/0091-6749(91)90298-3; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; RAPHAEL GD, 1989, AM REV RESPIR DIS, V139, P791, DOI 10.1164/ajrccm/139.3.791; RUGGIERI F, 1989, European Respiratory Journal, V2, p568S; RUHNO J, 1988, J ALLERGY CLIN IMMUN, V81, P557, DOI 10.1016/0091-6749(88)90196-0; RUHNO J, 1986, J ALLERGY CLIN IMMUN, V77, P137; SCHULLER DE, 1990, J ALLERGY CLIN IMMUN, V86, P554, DOI 10.1016/S0091-6749(05)80212-X; SCHWARTZ HJ, 1987, J ALLERGY CLIN IMMUN, V79, P186; SIPILA P, 1987, CLIN OTOLARYNGOL, V12, P365, DOI 10.1111/j.1365-2273.1987.tb00218.x	26	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1992	89	2					599	610		10.1016/0091-6749(92)90328-Y	http://dx.doi.org/10.1016/0091-6749(92)90328-Y			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD753	1311008				2022-12-18	WOS:A1992HD75300013
J	AMORNMARN, L; BERNARD, L; KUMAR, N; BIELORY, L				AMORNMARN, L; BERNARD, L; KUMAR, N; BIELORY, L			ANAPHYLAXIS ADMISSIONS TO A UNIVERSITY HOSPITAL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				349	349						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000769
J	JARISCH, R; PIRKER, C; MOSLINGER, T; GOTZ, M				JARISCH, R; PIRKER, C; MOSLINGER, T; GOTZ, M			THE ROLE OF HISTAMINE IN WINE INTOLERANCE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV VIENNA,DERMATOL & PEDIAT ALLERGY CLIN,A-1010 VIENNA,AUSTRIA; UNIV VIENNA,DEPT PEDIAT,A-1010 VIENNA,AUSTRIA	University of Vienna; University of Vienna			Moeslinger, Thomas/C-2769-2009	Moeslinger, Thomas/0000-0002-8730-4001					0	10	10	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				197	197						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000162
J	FINE, SR				FINE, SR			POSSIBLE REACTIONS TO SOYA LECITHIN IN AEROSOLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											FINE, SR (corresponding author), FLUSHING HOSP MED CTR,37-31 149TH ST,FLUSHING,NY 11354, USA.							CONNOLLY CK, 1982, BRIT MED J, V285, P934, DOI 10.1136/bmj.285.6346.934	1	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1991	87	2					600	600		10.1016/0091-6749(91)90025-J	http://dx.doi.org/10.1016/0091-6749(91)90025-J			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EX987	1825215				2022-12-18	WOS:A1991EX98700024
J	KATZ, SI				KATZ, SI			MECHANISMS INVOLVED IN ALLERGIC CONTACT-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	MEETING ON HISTAMINE AND DISEASE : A FORUM ON CURRENT AND FUTURE MANAGEMENT	AUG 25-26, 1989	CARLSBAD, CA	MERRELL DOW PHARM														BRAATHEN LR, 1980, SCAND J IMMUNOL, V11, P401, DOI 10.1111/j.1365-3083.1980.tb00006.x; Cronin E., 1980, CONTACT DERMATITIS; DVORAK HF, 1972, J EXP MED, V135, P235, DOI 10.1084/jem.135.2.235; Fisher A. A., 1986, CONTACT DERMATITIS; SAUDER DN, 1984, J INVEST DERMATOL, V82, P605, DOI 10.1111/1523-1747.ep12261439; STINGL G, 1978, J IMMUNOL, V121, P2005; STINGL G, 1980, IMMUNOL REV, V53, P149, DOI 10.1111/j.1600-065X.1980.tb01043.x	7	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	2	S			670	672		10.1016/S0091-6749(05)80238-6	http://dx.doi.org/10.1016/S0091-6749(05)80238-6			3	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EH093	2229833				2022-12-18	WOS:A1990EH09300019
J	ROCK, MJ; DESPOT, J; LEMANSKE, RF				ROCK, MJ; DESPOT, J; LEMANSKE, RF			MAST-CELL GRANULES MODULATE ALVEOLAR MACROPHAGE RESPIRATORY-BURST ACTIVITY AND EICOSANOID METABOLISM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,SCH MED,DEPT MED,MADISON,WI 53706; UNIV WISCONSIN,SCH MED,DEPT PEDIAT,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NHLBI NIH HHS [1-K08-HL01147-01] Funding Source: Medline; NIAID NIH HHS [AI10404-16] Funding Source: Medline; PHS HHS [MCJ-009072] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL001147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI010404] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAN RC, 1972, BIOCHEM BIOPH RES CO, V47, P679; ALLEN RC, 1976, BIOCHEM BIOPH RES CO, V69, P245, DOI 10.1016/S0006-291X(76)80299-9; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; BROWN BW, 1977, STATISTICS BIOMEDICA; CHANDLER DB, 1987, J IMMUNOL, V139, P893; CHEUNG K, 1983, J IMMUNOL, V130, P2324; CHOCK SP, 1988, BIOCHEM BIOPH RES CO, V156, P1308, DOI 10.1016/S0006-291X(88)80775-7; CHUNG KF, 1986, THORAX, V41, P657, DOI 10.1136/thx.41.9.657; CLUZEL M, 1987, J ALLERGY CLIN IMMUN, V80, P195, DOI 10.1016/0091-6749(87)90129-1; DECHATELET LR, 1982, J IMMUNOL, V129, P1589; DESPOT J, 1988, J LAB CLIN MED, V111, P348; DIAZ P, 1979, NATURE, V278, P454, DOI 10.1038/278454a0; DILEEPAN KN, 1987, FASEB J, V46, P936; DILEEPAN KN, 1989, BIOCHEM ARCH, V5, P153; FALCK P, 1987, Allergie und Immunologie (Leipzig), V33, P45; FANTOZZI R, 1985, AGENTS ACTIONS, V16, P260, DOI 10.1007/BF01983155; GODARD P, 1982, J ALLERGY CLIN IMMUN, V70, P88, DOI 10.1016/0091-6749(82)90234-2; GOSSET P, 1984, J ALLERGY CLIN IMMUN, V74, P827, DOI 10.1016/0091-6749(84)90186-6; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HENDERSON WR, 1979, J IMMUNOL, V122, P1322; HENDERSON WR, 1978, J CLIN INVEST, V61, P187, DOI 10.1172/JCI108917; HOIDAL JR, 1978, J LAB CLIN MED, V92, P787; HUNNINGHAKE GW, 1978, AM REV RESPIR DIS, V117, P15; Jakschik B A, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17A, P180; Jakschik B A, 1986, Adv Prostaglandin Thromboxane Leukot Res, V16, P141; KALINER M, 1985, CHEST, V87, pS2, DOI 10.1378/chest.87.1_Supplement.2S; KALINER M, 1987, CHEST, V91, pS171, DOI 10.1378/chest.91.6.171S; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; LOWRY OH, 1951, J BIOL CHEM, V193, P265; METZGER WJ, 1987, AM REV RESPIR DIS, V135, P433; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; RAPHAEL GD, 1978, EXP CELL RES, V115, P428, DOI 10.1016/0014-4827(78)90300-2; SALARI H, 1989, J IMMUNOL, V142, P2821; Saugstad O D, 1985, Pediatr Pulmonol, V1, P167, DOI 10.1002/ppul.1950010308; Scholmerich J., 1987, BIOLUMINESCENCE CHEM, P555; SCHULMAN E S, 1989, American Review of Respiratory Disease, V139, pA117; SEVERNS C, 1986, J LAB CLIN MED, V107, P29; SMITH RL, 1980, BIOCHEM BIOPH RES CO, V97, P973, DOI 10.1016/0006-291X(80)91472-2; SULLIVAN TJ, 1975, J IMMUNOL, V114, P1473; Thorpe GHG, 1987, BIOLUMINESCENCE CHEM, P199; WEI YF, 1986, J IMMUNOL, V137, P1993; WELCH WD, 1980, J RETICULOENDOTH SOC, V28, P275; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed	43	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	1				452	461		10.1016/S0091-6749(05)80199-X	http://dx.doi.org/10.1016/S0091-6749(05)80199-X			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EG454	2172347				2022-12-18	WOS:A1990EG45400003
J	SZEFLER, SJ				SZEFLER, SJ			MEASURING THE RESPONSE TO GLUCOCORTICOIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	SZEFLER, SJ (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,1400 JACKSON ST,DENVER,CO 80206, USA.							ALVAREZ J, 1990, Journal of Allergy and Clinical Immunology, V85, P195; BARTOSZEK M, 1987, CLIN PHARMACOL THER, V42, P424, DOI 10.1038/clpt.1987.173; BOUDINOT FD, 1986, J PHARMACOKINET BIOP, V14, P469, DOI 10.1007/BF01059656; BRAUDE AC, 1983, LANCET, V2, P995; GREOS L S, 1990, Journal of Allergy and Clinical Immunology, V85, P195; GREOS LS, 1989, NOV AM COLL ALL IMM; MAROM Z, 1989, NOV AM COLL ALL IMM; MENDOZA GR, 1983, J ALLERGY CLIN IMMUN, V71, P135, DOI 10.1016/0091-6749(83)90310-X; ONG KS, 1978, J ALLERGY CLIN IMMUN, V62, P115, DOI 10.1016/0091-6749(78)90088-X; REISS WG, 1990, J ALLERGY CLIN IMMUN, V85, P1058, DOI 10.1016/0091-6749(90)90051-5; SUEZ D, 1986, J ALLERGY CLIN IMMUN, V77, P330, DOI 10.1016/S0091-6749(86)80113-0; SZEFLER SJ, 1986, EUR J CLIN PHARMACOL, V30, P323, DOI 10.1007/BF00541537; SZEFLER SJ, 1982, J ALLERGY CLIN IMMUN, V69, P455, DOI 10.1016/0091-6749(82)90121-X; SZEFLER SJ, 1989, ANTIINFLAMMATORY STE, P353; TOOGOOD JH, 1989, J ALLERGY CLIN IMMUN, V84, P688, DOI 10.1016/0091-6749(89)90297-2; VICHYANOND P, 1989, J ALLERGY CLIN IMMUN, V84, P867, DOI 10.1016/0091-6749(89)90381-3	16	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1990	85	6					985	987		10.1016/0091-6749(90)90041-2	http://dx.doi.org/10.1016/0091-6749(90)90041-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DK509	2355157				2022-12-18	WOS:A1990DK50900002
J	YOSHIE, Y; IIZUKA, K; NAKAZAWA, T				YOSHIE, Y; IIZUKA, K; NAKAZAWA, T			THE INHIBITORY EFFECT OF A SELECTIVE ALPHA-2-ADRENERGIC RECEPTOR ANTAGONIST ON MODERATE-TYPE TO SEVERE-TYPE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									GUNMA UNIV, COLL MED CARE & TECHNOL, MAEBASHI, GUNMA 371, JAPAN	Gunma University	YOSHIE, Y (corresponding author), GUNMA UNIV, SCH MED, DEPT INTERNAL MED 1, 3-39-15 SHOWA MACHI, MAEBASHI, GUNMA 371, JAPAN.							BARNES PJ, 1983, MOL PHARMACOL, V23, P570; BERNSTEIN L, 1983, ALLERGY PRINCIPLES P, V2, P927; BROWN J K, 1981, American Review of Respiratory Disease, V123, P51; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; FLEISCH JH, 1970, AM J PHYSIOL, V218, P596, DOI 10.1152/ajplegacy.1970.218.2.596; GADDIE J, 1972, British Journal of Diseases of the Chest, V66, P141, DOI 10.1016/S0007-0971(72)80036-6; GALANT SP, 1980, AM REV RESPIR DIS, V122, P231; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; GROSS GN, 1974, CHEST, V66, P397, DOI 10.1378/chest.66.4.397; IIZUKA K, 1987, Japanese Journal of Allergology, V36, P909; IIZUKA K, 1986, Japanese Journal of Allergology, V35, P387; KAMEDA K, 1982, ACTA ENDOCRINOL-COP, V99, P410, DOI 10.1530/acta.0.0990410; KAMEDA KY, 1981, BIOCHIM BIOPHYS ACTA, V677, P263; KAWAZU S, 1987, DIABETES, V36, P216, DOI 10.2337/diabetes.36.2.216; KERR JW, 1970, BMJ-BRIT MED J, V2, P139, DOI 10.1136/bmj.2.5702.139; LEFF AR, 1981, J PHARMACOL EXP THER, V217, P530; MAKINO S, 1977, J ALLERGY CLIN IMMUN, V59, P348, DOI 10.1016/0091-6749(77)90016-1; MEAD J, 1960, J APPL PHYSIOL, V15, P325, DOI 10.1152/jappl.1960.15.3.325; MURAYAMA T, 1983, J BIOL CHEM, V258, P3319; ONO S, 1987, EFFECT MIDAGLIZOLE A, P312; RICH KA, 1984, J BIOL CHEM, V259, P7893; SIMONSSON BG, 1972, SCAND J RESPIR DIS, V53, P227; Starke K, 1981, Rev Physiol Biochem Pharmacol, V88, P199, DOI 10.1007/BFb0034538; SZENTIVANYI A, 1979, ANN NY ACAD SCI, V322, P295; YAMANAKA K, 1984, EUR J PHARMACOL, V106, P625, DOI 10.1016/0014-2999(84)90068-2; YOSHIE Y, 1988, Japanese Journal of Allergology, V37, P1077; YOSHIE Y, 1988, J ASTHMA, V25, P321, DOI 10.3109/02770908809071373	27	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1989	84	5	1				747	752		10.1016/0091-6749(89)90304-7	http://dx.doi.org/10.1016/0091-6749(89)90304-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CA314	2572618				2022-12-18	WOS:A1989CA31400013
J	GALOPPIN, L; NOIROT, C; WASTIAUX, JP; SCHEINMANN, P; PAUPE, J; BURTIN, C				GALOPPIN, L; NOIROT, C; WASTIAUX, JP; SCHEINMANN, P; PAUPE, J; BURTIN, C			COMPARISON BETWEEN NUMBER OF BASOPHILS, BLOOD HISTAMINE, AND HISTAMINE-RELEASE IN CANCER AND NONCANCER PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											GALOPPIN, L (corresponding author), FAC NECKER ENFANTS MALAD,U200,156 RUE VAUGIRARD,F-75730 PARIS 15,FRANCE.							ALDERSON M, 1974, LANCET, V2, P1475; ALLEGRA J, 1976, CANCER RES, V36, P74; ASBOEHANSEN G, 1968, B NEW YORK ACAD MED, V44, P1048; BEESON PB, 1977, MAJOR PROBLEMS INTER, V14, P99; BURTIN C, 1983, BRIT J CANCER, V47, P367, DOI 10.1038/bjc.1983.55; BURTIN C, 1982, BRIT J CANCER, V45, P54, DOI 10.1038/bjc.1982.7; BURTIN C, 1986, J ALLERGY CLIN IMMUN, V78, P83, DOI 10.1016/0091-6749(86)90118-1; BURTIN C, 1985, J NATL CANCER I, V74, P671; CAMUSSI G, 1981, LAB INVEST, V44, P241; DVORAK AM, 1979, J IMMUNOL, V122, P2447; EGIDO J, 1980, ANN RHEUM DIS, V39, P312, DOI 10.1136/ard.39.4.312; FARRAM E, 1980, CELL IMMUNOL, V55, P294, DOI 10.1016/0008-8749(80)90162-8; FISHERMAN EW, 1960, J ALLERGY, V31, P74, DOI 10.1016/0021-8707(60)90026-5; HARTVEIT F, 1981, J PATHOL, V134, P7, DOI 10.1002/path.1711340103; JUHLIN L, 1963, ACTA MED SCAND, V174, P249; LEBEL B, 1983, ANAL BIOCHEM, V133, P16, DOI 10.1016/0003-2697(83)90217-8; LEONARD EJ, 1985, J ALLERGY CLIN IMMUN, V76, P556, DOI 10.1016/0091-6749(85)90775-4; LEVI FA, 1985, J IMMUNOL, V134, P217; LYNCH NR, 1978, CANCER IMMUNOL IMMUN, V4, P223; MACKAY WD, 1966, BRIT J CANCER, V20, P434, DOI 10.1038/bjc.1966.52; MEERS PD, 1973, LANCET, V1, P884; PIROTZKY E, 1982, LANCET, V13, P358; SAAVEDRADELGADO AMP, 1980, J ALLERGY CLIN IMMUN, V66, P464, DOI 10.1016/0091-6749(80)90007-X; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; SIMU G, 1972, ACTA MORPHOL HUNG, V20, P327; SIRAGANIAN RP, 1976, J ALLERGY CLIN IMMUN, V57, P525, DOI 10.1016/0091-6749(76)90003-8; TANOOKA H, 1982, J NATL CANCER I, V69, P1305; URE DM, 1969, SCOTT MED J, V74, P51; ZUCKERFRANKLIN D, 1983, HEMATOLOGY, P828; [No title captured]	30	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1989	84	4	1				501	506		10.1016/0091-6749(89)90363-1	http://dx.doi.org/10.1016/0091-6749(89)90363-1			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW760	2477430				2022-12-18	WOS:A1989AW76000011
J	PRICE, JA; LONGBOTTOM, JL				PRICE, JA; LONGBOTTOM, JL			IGG ANTIBODIES IN RELATION TO EXPOSURE TO LABORATORY-ANIMAL ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PRICE, JA (corresponding author), BROMPTON HOSP,DEPT PEDIAT,FULHAM RD,LONDON SW3 6HP,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHAPMAN MD, 1980, J IMMUNOL, V125, P587; LEE D, 1982, INT ARCH ALLER A IMM, V69, P363, DOI 10.1159/000233201; LICHTENSTEIN LM, 1971, ANN INTERN MED, V75, P663, DOI 10.7326/0003-4819-75-5-663; LINCOLN TA, 1974, J OCCUP ENVIRON MED, V16, P465; LONGBOTTOM JL, 1987, J ALLERGY CLIN IMMUN, V80, P243, DOI 10.1016/0091-6749(87)90026-1; LONGBOTTOM JL, 1980, ADV ALLERGOLOGY APPL, P483; LUTSKY II, 1975, ANN ALLERGY, V35, P201; PLATTSMILLS TAE, 1986, J ALLERGY CLIN IMMUN, V77, P850, DOI 10.1016/0091-6749(86)90383-0; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V79, P505, DOI 10.1016/0091-6749(87)90369-1; PRICE JA, 1988, CLIN ALLERGY, V18, P95, DOI 10.1111/j.1365-2222.1988.tb02848.x; PRICE JA, 1987, CLIN ALLERGY, V17, P43, DOI 10.1111/j.1365-2222.1987.tb02318.x; PRICE JA, 1988, ALLERGY, V43, P39, DOI 10.1111/j.1398-9995.1988.tb02042.x; SCHUMACHER MJ, 1980, MOL IMMUNOL, V17, P1087, DOI 10.1016/0161-5890(80)90105-4; SWANSON MC, 1985, J ALLERGY CLIN IMMUN, V76, P724, DOI 10.1016/0091-6749(85)90678-5; TSE KS, 1973, J ALLERGY CLIN IMMUN, V51, P208, DOI 10.1016/0091-6749(73)90140-1	15	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1989	84	4	1				520	528		10.1016/0091-6749(89)90366-7	http://dx.doi.org/10.1016/0091-6749(89)90366-7			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW760	2794295				2022-12-18	WOS:A1989AW76000014
J	ONEIL, CE; LEHRER, SB; GUTMAN, AA				ONEIL, CE; LEHRER, SB; GUTMAN, AA			ANAPHYLAXIS APPARENTLY CAUSED BY A COTTONSEED-CONTAINING CANDY INGESTED ON A COMMERCIAL AIRLINER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											ONEIL, CE (corresponding author), TULANE UNIV,MED CTR,1700 PERDIDO ST,NEW ORLEANS,LA 70112, USA.							BUTCHER BT, 1976, J ALLERGY CLIN IMMUN, V58, P89, DOI 10.1016/0091-6749(76)90110-X; HORNER WE, 1988, J ALLERGY CLIN IMMUN, V82, P978, DOI 10.1016/0091-6749(88)90134-0	2	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1989	84	3					407	407		10.1016/0091-6749(89)90429-6	http://dx.doi.org/10.1016/0091-6749(89)90429-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AR199	2778246				2022-12-18	WOS:A1989AR19900022
J	MOFFITT, JE; GUILL, MF; LEFFELL, MS; ADES, EW; BUREK, CL; LOBEL, SA; HOFFMAN, WH				MOFFITT, JE; GUILL, MF; LEFFELL, MS; ADES, EW; BUREK, CL; LOBEL, SA; HOFFMAN, WH			TYPE-I DIABETES IN AN ADOLESCENT WITH COMMON VARIABLE IMMUNODEFICIENCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL GEORGIA,ALLERGY IMMUNOL SECT,CJ141,AUGUSTA,GA 30912; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,BALTIMORE,MD 21218	University System of Georgia; Augusta University; Johns Hopkins University								ASHERSON GL, 1980, DIAGNOSIS TREATMENT, P37; BARBOSA J, 1982, DIABETES, V31, P585, DOI 10.2337/diab.31.7.585; BARRETTCONNOR E, 1985, REV INFECT DIS, V7, P207; CAHILL GF, 1981, NEW ENGL J MED, V304, P1454, DOI 10.1056/NEJM198106113042403; COLLE E, 1986, DIABETES, V35, P454, DOI 10.2337/diabetes.35.4.454; CONLEY ME, 1986, J PEDIATR-US, V108, P915, DOI 10.1016/S0022-3476(86)80927-1; CROSTI F, 1986, DIABETES, V35, P1053, DOI 10.2337/diabetes.35.9.1053; DEAN BM, 1987, CLIN EXP IMMUNOL, V69, P308; DELACONCHA EG, 1977, CLIN EXP IMMUNOL, V27, P208; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; ELDER ME, 1983, J IMMUNOL, V130, P1723; FRIEDMAN JM, 1977, CLIN EXP IMMUNOL, V28, P375; Gamble D R, 1980, Epidemiol Rev, V2, P49; GUPTA S, 1980, SEMIN HEMATOL, V17, P1; HERMANS PE, 1976, AM J MED, V61, P221, DOI 10.1016/0002-9343(76)90173-X; HODDINOTT S, 1982, DIABETOLOGIA, V23, P326; HOMME JLP, 1973, CLIN IMMUNOL IMMUNOP, V1, P241; JACKSON R, 1983, METABOLISM, V32, P83, DOI 10.1016/S0026-0495(83)80017-1; Kanakoudi-Tsakalidis F, 1984, Acta Endocrinol Suppl (Copenh), V265, P29; LEDERMAN MM, 1981, J IMMUNOL, V127, P2051; LIIKE AA, 1982, SCIENCE, V216, P644; MOFFITT JE, 1988, ANN ALLERGY, V61, P424; MOFFITT JE, 1987, CLIN IMMUNOL NEWSL, V8, P100; MORALES JP, 1987, DIABETES METAB REV, V3, P725; NEUFELD M, 1980, DIABETES, V29, P589, DOI 10.2337/diabetes.29.8.589; OLIVE D, 1978, ARCH FR PEDIATR, V35, P646; PROVISOR AJ, 1975, NEW ENGL J MED, V293, P62, DOI 10.1056/NEJM197507102930202; PURTILO D T, 1975, Lancet, V1, P935; QUINIOUDEBRIE MC, 1985, DIABETES, V34, P373, DOI 10.2337/diabetes.34.4.373; ROSSINI AA, 1984, J CLIN INVEST, V74, P39, DOI 10.1172/JCI111416; SAIKI O, 1982, P NATL ACAD SCI-BIOL, V79, P6008, DOI 10.1073/pnas.79.19.6008; SCHWARTZ SA, 1976, J CLIN INVEST, V50, P1176; SEIGAL FP, 1976, J CLIN INVEST, V58, P109; SEIGEL FP, 1977, CLIN HAEMATOL, V6, P355; SMITH WI, 1978, DIABETES, V27, P1092, DOI 10.2337/diabetes.27.11.1092; SRIKANTA S, 1986, DIABETES, V35, P139, DOI 10.2337/diabetes.35.2.139; TIWARI JL, 1985, HLA DISEASE ASS, P185; TIWARI JL, 1985, HLA DIEASE ASS, P428; TOGUCHI Y, 1985, DIABETES, V34, P855, DOI 10.2337/diabetes.34.9.855; WALDMANN TA, 1974, LANCET, V2, P609; WEBSTER ADB, 1974, CLIN EXP IMMUNOL, V18, P499; YOUNG RJ, 1981, BRIT MED J, V282, P1668, DOI 10.1136/bmj.282.6277.1668	42	10	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1989	84	2					191	196		10.1016/0091-6749(89)90324-2	http://dx.doi.org/10.1016/0091-6749(89)90324-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AL836	2527261				2022-12-18	WOS:A1989AL83600009
J	NOMA, T; YOSHIZAWA, I; MAEDA, K; ICHIKAWA, K; BABA, M; YATA, J				NOMA, T; YOSHIZAWA, I; MAEDA, K; ICHIKAWA, K; BABA, M; YATA, J			ALLERGEN-SPECIFIC INDUCTION OF INTERLEUKIN-2 (IL-2) RESPONSIVENESS IN LYMPHOCYTES FROM CHILDREN WITH ASTHMA .2. REGULATION OF IL-2 RESPONSIVENESS BY SUPERNATANTS OF NORMAL LYMPHOCYTES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									DOAI MEM HOSP,TOKYO,JAPAN; TOKYO MED & DENT UNIV,TOKYO 113,JAPAN	Tokyo Medical & Dental University (TMDU)	NOMA, T (corresponding author), SAITAMA MED SCH,DEPT PEDIAT,38 MOROHONGO,MORIYAMA,SAITAMA 35004,JAPAN.							ASHERSON G, 1977, CELL IMMUNOL, V33, P1878; BONNARD GD, 1979, J IMMUNOL, V123, P2704; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P51; CHALLACOMBE SJ, 1980, J EXP MED, V152, P1459, DOI 10.1084/jem.152.6.1459; GILLIS S, 1978, J IMMUNOL, V120, P2127; KURNICK JT, 1979, J IMMUNOL, V122, P1255; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; MATSUSHITA S, 1987, J IMMUNOL, V138, P109; MATTINGLY JA, 1978, J IMMUNOL, V121, P1878; MIYAMOTO T, 1974, J ALLERGY CLIN IMMUN, V53, P9, DOI 10.1016/0091-6749(74)90094-3; NGAN J, 1978, J IMMUNOL, V120, P861; NOMA T, 1987, J IMMUNOL, V138, P2929; NOMA T, 1985, EUR J IMMUNOL, V15, P833, DOI 10.1002/eji.1830150817; NOMA T, 1987, JPN J ALLERGOL, V36, P37; NOMA T, IN PRESS ANN ALLERGY; PAWLY LJ, 1982, J IMMUNOL METHODS, V50, P173; RICHMAN LK, 1978, J IMMUNOL, V121, P2429; RUSCETTI F, 1977, J IMMUNOL, V119, P31; SCHREIER MH, 1980, IMMUNOL REV, V51, P315, DOI 10.1111/j.1600-065X.1980.tb00326.x; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; Smith K A, 1979, Ann N Y Acad Sci, V332, P423, DOI 10.1111/j.1749-6632.1979.tb47136.x; SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x	22	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1989	84	2					255	262		10.1016/0091-6749(89)90333-3	http://dx.doi.org/10.1016/0091-6749(89)90333-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AL836	2788180				2022-12-18	WOS:A1989AL83600018
J	WEDNER, HJ; WILSON, P; LEWIS, WH				WEDNER, HJ; WILSON, P; LEWIS, WH			ALLERGIC REACTIVITY TO PARTHENIUM-HYSTEROPHORUS POLLEN - AN ELISA STUDY OF 582 SERA FROM THE UNITED-STATES GULF-COAST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WASHINGTON UNIV,DEPT BIOL,ST LOUIS,MO 63130	Washington University (WUSTL)	WEDNER, HJ (corresponding author), WASHINGTON UNIV,SCH MED,DEPT MED,DIV IMMUNOL,BOX 8122,660 S EUCLID ST,ST LOUIS,MO 63110, USA.							BAPAT BN, 1978, INDIAN J MED RES, V68, P1007; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BURRY JN, 1982, CONTACT DERMATITIS, V8, P410, DOI 10.1111/j.1600-0536.1982.tb04268.x; CHODIRKER WB, 1977, CAN MED ASSOC J, V116, P1254; HAZRA AK, 1984, ANAL BIOCHEM, V137, P437, DOI 10.1016/0003-2697(84)90110-6; KAHN IS, 1936, TEX STATE MED J, V32, P284; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIFERMAN KM, 1976, J ALLERGY CLIN IMMUN, V58, P140, DOI 10.1016/0091-6749(76)90149-4; LEWIS WH, 1987, J PALYNOLOGY, P23; LOPEZ M, 1985, CLIN REV ALLERG, V3, P183, DOI 10.1007/BF02992982; NARASIMHAN TR, 1977, EXPERIENTIA, V33, P1358, DOI 10.1007/BF01920179; PAGGIARO PL, 1986, CLIN ALLERGY, V16, P49, DOI 10.1111/j.1365-2222.1986.tb01953.x; RAO M, 1985, CLIN ALLERGY, V15, P449, DOI 10.1111/j.1365-2222.1985.tb02294.x; RODRIGUEZ E, 1976, EXPERIENTIA, V32, P236, DOI 10.1007/BF01937785; SCHEPPEGRELL WAM, 1922, HAY FEVER ASTHMA CAR, P54; SEETHARAMIAH AM, 1981, ANN ALLERGY, V47, P192; SIDDIQUI MA, 1978, INDIAN J MED RES, V68, P481; SMALL JK, 1913, FLORA SE US, P1247; SOHI AS, 1979, CONTACT DERMATITIS, V5, P133, DOI 10.1111/j.1600-0536.1979.tb04823.x; Wedner H J, 1987, Experientia Suppl, V51, P125; WEDNER HJ, 1987, INT ARCH ALLER A IMM, V84, P116; WODEHOUSE RP, 1971, HAY FEVER PLANTS, P155	22	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1989	84	2					263	271		10.1016/0091-6749(89)90334-5	http://dx.doi.org/10.1016/0091-6749(89)90334-5			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AL836	2474593	Bronze			2022-12-18	WOS:A1989AL83600019
J	HOWLAND, WC; SIMON, RA				HOWLAND, WC; SIMON, RA			SULFITE-TREATED LETTUCE CHALLENGES IN SULFITE-SENSITIVE SUBJECTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SCRIPPS CLIN & RES FDN,DIV ALLERGY & IMMUNOL,DEPT BASIC & CLIN RES,LA JOLLA,CA 92037	Scripps Research Institute					NCRR NIH HHS [RR00833] Funding Source: Medline; NIAID NIH HHS [AI10386] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI010386] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BUSH RK, 1986, AM J MED, V81, P816, DOI 10.1016/0002-9343(86)90351-7; BUSH RK, 1986, J FOOD PROTECT, V49, P126; PRENNER BM, 1976, ANN ALLERGY, V37, P180; SIMON R A, 1982, Journal of Allergy and Clinical Immunology, V69, P118; STEVENSON DD, 1981, J ALLERGY CLIN IMMUN, V68, P26, DOI 10.1016/0091-6749(81)90119-6; TAYLOR SL, 1986, J ALLERGY CLIN IMMUN, V77, P159; 1986, FED REGISTER, V51, P25012	7	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1989	83	6					1079	1082		10.1016/0091-6749(89)90449-1	http://dx.doi.org/10.1016/0091-6749(89)90449-1			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC235	2732408				2022-12-18	WOS:A1989AC23500010
J	HARTNELL, A; WALSH, GM; MOQBEL, R; KAY, AB				HARTNELL, A; WALSH, GM; MOQBEL, R; KAY, AB			PHENOTYPIC MARKERS ON HUMAN EOSINOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Walsh, Garry/D-4869-2013	Walsh, Garry/0000-0002-7138-4078					0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					192	192						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900103
J	MCDONALD, B; KUO, M; OHMAN, JL; ROSENWASSER, LJ				MCDONALD, B; KUO, M; OHMAN, JL; ROSENWASSER, LJ			A-29 AMINO-ACID PEPTIDE DERIVED FROM RAT ALPHA-2 UGLOBULIN (RA2UG) TRIGGERS MURINE ALLERGEN SPECIFIC HUMAN T-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					251	251						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900339
J	OLSON, GC; VAUGHAN, TR; LEDOUX, R; KOSSOY, AE; WILLIAMS, B; SELNER, JC; WEBER, RW				OLSON, GC; VAUGHAN, TR; LEDOUX, R; KOSSOY, AE; WILLIAMS, B; SELNER, JC; WEBER, RW			FOOD INDUCED MIGRAINE - SEARCH FOR IMMUNOLOGICAL MECHANISMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					238	238						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900289
J	DEGARMO, C; CERNY, F; CONBOY, K; ELLIS, EF				DEGARMO, C; CERNY, F; CONBOY, K; ELLIS, EF			INVIVO EFFECTS OF THEOPHYLLINE ON DIAPHRAGM, BICEP, AND QUADRICEP STRENGTH AND FATIGABILITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY BUFFALO,CHILDRENS HOSP,DEPT PHYS THERAPY & EXERCISE SCI,411 KIMBALL TOWER,BUFFALO,NY 14214; SUNY BUFFALO,CHILDRENS HOSP,DEPT PHYS THERAPY & EXERCISE SCI & PEDIAT,BUFFALO,NY 14214; SUNY BUFFALO,CHILDRENS HOSP,DEPT PEDIAT,BUFFALO,NY 14214; SUNY BUFFALO,CHILDRENS HOSP,DIV ALLERGY,BUFFALO,NY 14214	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								AUBIER M, 1983, J APPL PHYSIOL, V54, P460, DOI 10.1152/jappl.1983.54.2.460; AUBIER M, 1981, NEW ENGL J MED, V305, P249, DOI 10.1056/NEJM198107303050503; AUBIER M, 1983, AM REV RESPIR DIS, V127, P148; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; BRECKENR.BM, 1967, P NATL ACAD SCI USA, V57, P1893, DOI 10.1073/pnas.57.6.1893; CAMPNEY HK, 1965, RES QUART, V36, P403, DOI 10.1080/10671188.1965.10614712; Clarke H., 1966, MUSCULAR STRENGTH EN; DIMARCO AF, 1985, AM REV RESPIR DIS, V132, P800; DUBOIS AB, 1956, J CLIN INVEST, V35, P322, DOI 10.1172/JCI103281; EFTHIMIOU J, 1986, THORAX, V41, P122, DOI 10.1136/thx.41.2.122; FERGUSON GA, 1976, STATISTICAL ANAL PSY; GANDEVIA SC, 1983, RESP PHYSIOL, V53, P47, DOI 10.1016/0034-5687(83)90015-4; HOWELL S, 1984, AM REV RESPIR DIS, V129, P118; HUIDOBRO F, 1945, J PHARMACOL EXP THER, V84, P82; JONES DA, 1982, CLIN SCI, V63, P161, DOI 10.1042/cs0630161; LEWIS MI, 1986, AM REV RESPIR DIS, V133, P672; MOXHAM J, 1985, THORAX, V40, P288, DOI 10.1136/thx.40.4.288; MURCIANO D, 1984, NEW ENGL J MED, V311, P349, DOI 10.1056/NEJM198408093110601; MURCIANO D, 1987, J APPL PHYSIOL, V63, P51, DOI 10.1152/jappl.1987.63.1.51; SIGRIST S, 1982, AM REV RESPIR DIS, V126, P46; SINGH M, 1966, J APPL PHYSIOL, V21, P1435, DOI 10.1152/jappl.1966.21.4.1435; SUPINSKI GS, 1984, AM REV RESPIR DIS, V130, P429; WILES CM, 1983, CLIN SCI, V64, P547, DOI 10.1042/cs0640547	23	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1988	82	6					1041	1046		10.1016/0091-6749(88)90142-X	http://dx.doi.org/10.1016/0091-6749(88)90142-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R6311	3204250				2022-12-18	WOS:A1988R631100013
J	SELNER, JC				SELNER, JC			VISUALIZATION TECHNIQUES IN THE NASAL AIRWAY - THEIR ROLE IN THE DIAGNOSIS OF UPPER AIRWAY DISEASE AND MEASUREMENT OF THERAPEUTIC RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	SELNER, JC (corresponding author), ALLERGY RESP INST COLORADO,DENVER,CO, USA.							SELNER JC, 1985, ANN ALLERGY, V54, P479; SELNER JC, IN PRESS CLIN REV AL	2	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1988	82	5	2	S			909	916		10.1016/0091-6749(88)90033-4	http://dx.doi.org/10.1016/0091-6749(88)90033-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R2353	3057043	Bronze			2022-12-18	WOS:A1988R235300004
J	DEGENHART, HJ; VANDERMAAREL, JWM; JONGKIND, H; RAATGEEP, HC; NEIJENS, HJ				DEGENHART, HJ; VANDERMAAREL, JWM; JONGKIND, H; RAATGEEP, HC; NEIJENS, HJ			PROPERTIES OF HUMAN BASOPHILS ISOLATED BY FLUORESCENCE-ACTIVATED CELL SORTING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ERASMUS UNIV,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam	DEGENHART, HJ (corresponding author), ERASMUS UNIV ROTTERDAM,SOPHIA CHILDRENS HOSP,DEPT PEDIAT,GORDELWEG 160,3038 GE ROTTERDAM,NETHERLANDS.							BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; DEBOER M, 1986, J IMMUNOL, V136, P3447; DEGENHART HJ, 1986, B EUR PHYSIOPATH RES, V22, P100; DEGENHART HJ, UNPUB MEMBRANE POTEN; DEJONGSTE JC, 1987, EUR J RESPIR DIS, V71, P23; FUKUDA T, 1985, AM REV RESPIR DIS, V132, P981; GADDY JN, 1986, AM REV RESPIR DIS, V134, P969, DOI 10.1164/arrd.1986.134.5.969; GALLIN EK, 1986, J LEUKOCYTE BIOL, V39, P241, DOI 10.1002/jlb.39.3.241; GARTNER I, 1980, IMMUNOLOGY, V40, P133; GILBERT HS, 1975, BLOOD, V46, P279; HANDA T, 1983, CHEM PHARM BULL, V31, P1132; HOLGATE ST, 1986, J ALLERGY CLIN IMMUN, V77, P274, DOI 10.1016/S0091-6749(86)80104-X; KAUFFMAN HF, 1983, J IMMUNOL METHODS, V57, P1, DOI 10.1016/0022-1759(83)90058-3; KAUFFMANN F, 1984, B EUR PHYSIOPATH RES, V20, P163; KORCHAK HM, 1978, P NATL ACAD SCI USA, V75, P3818, DOI 10.1073/pnas.75.8.3818; LEONARD EJ, 1984, J LEUKOCYTE BIOL, V35, P169; MACGLASHAN DW, 1980, J IMMUNOL, V124, P2519; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; NEIJENS HJ, 1980, CLIN ALLERGY, V10, P535, DOI 10.1111/j.1365-2222.1980.tb02134.x; NEIJENS HJ, 1984, AM REV RESPIR DIS, V130, P744; PRUZANSKY JJ, 1981, J IMMUNOL METHODS, V44, P183, DOI 10.1016/0022-1759(81)90345-8; RAGHUPRASAD PK, 1982, J IMMUNOL, V129, P2128; ROBERTS RL, 1985, BLOOD, V65, P433; TOLL JBC, 1981, ALLERGY, V36, P411, DOI 10.1111/j.1398-9995.1981.tb01847.x; TUNG R, 1982, J IMMUNOL, V128, P2067; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; WEIL GJ, 1983, J IMMUNOL METHODS, V58, P359, DOI 10.1016/0022-1759(83)90363-0; 1962, AM REV RESPIR DIS, V85, P762; 1983, LANCET, V2, P829	29	10	10	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1988	82	3	1				455	461		10.1016/0091-6749(88)90019-X	http://dx.doi.org/10.1016/0091-6749(88)90019-X			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q3229	2459176				2022-12-18	WOS:A1988Q322900020
J	GILLES, JGG; MARESCHAL, JCP; SAINTREMY, JMR				GILLES, JGG; MARESCHAL, JCP; SAINTREMY, JMR			LATEX ALLERGOSORBENT TEST (LAST) - A NEW IMMUNOASSAY FOR SPECIFIC IGE WITH LATEX-PARTICLES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CATHOLIC UNIV LOUVAIN,INST CELLULAR & MOLEC PATHOL,EXPTL MED UNIT,ICP 7430,B-1200 BRUSSELS,BELGIUM; ACADE DIAGNOST SYST SA,BRUSSELS,BELGIUM	Universite Catholique Louvain								CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; GLEICH GJ, 1975, J ALLERGY CLIN IMMUN, V55, P334, DOI 10.1016/0091-6749(75)90005-6; HOFFMAN DR, 1980, ANN ALLERGY, V45, P343; JOHANSSON SGO, 1986, J ALLERGY CLIN IMMUN, V77, P555, DOI 10.1016/0091-6749(86)90344-1; JOHANSSON SGO, 1983, 12 P C EUR AC ALL CL, P67; MAGNUSSON CGM, 1986, INT ARCH ALLER A IMM, V80, P329, DOI 10.1159/000234074; MAGNUSSON CGM, 1981, CLIN ALLERGY, V11, P453, DOI 10.1111/j.1365-2222.1981.tb01619.x; MAGNUSSON CGM, 1982, J ALLERGY CLIN IMMUN, V70, P326, DOI 10.1016/0091-6749(82)90021-5; MAGNUSSON CGM, 1985, J ALLERGY CLIN IMMUN, V75, P513, DOI 10.1016/S0091-6749(85)80026-9; Masson P L, 1981, Methods Enzymol, V74 Pt C, P106; MCCONAHEY PJ, 1966, INT ARCH ALLER A IMM, V29, P185, DOI 10.1159/000229699; SAINTREMY JMR, IN PRESS ALLERGY; SELZER J, 1985, ANN ALLERGY, V54, P25; WIDE L, 1967, LANCET, V2, P1105; ZEISS CR, 1981, J ALLERGY CLIN IMMUN, V67, P105, DOI 10.1016/0091-6749(81)90004-X; ZEISS CR, 1978, J ALLERGY CLIN IMMUN, V62, P83, DOI 10.1016/0091-6749(78)90083-0	16	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1988	82	1					35	39		10.1016/0091-6749(88)90048-6	http://dx.doi.org/10.1016/0091-6749(88)90048-6			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P4004	2455743				2022-12-18	WOS:A1988P400400007
J	SCHUBERTH, KC; KWITEROVICH, KA; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; VALENTINE, MD				SCHUBERTH, KC; KWITEROVICH, KA; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; VALENTINE, MD			STARTING AND STOPPING VENOM IMMUNOTHERAPY (VIT) IN CHILDREN WITH INSECT ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					200	200		10.1016/0091-6749(88)90364-8	http://dx.doi.org/10.1016/0091-6749(88)90364-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400151
J	WALDEN, SM; PROUD, D; LICHTENSTEIN, LM; KAGEYSOBOTKA, A; NORMAN, PS; NACLERIO, RM				WALDEN, SM; PROUD, D; LICHTENSTEIN, LM; KAGEYSOBOTKA, A; NORMAN, PS; NACLERIO, RM			NASAL CHALLENGE WITH ANTIGEN (AG) LEADS TO INCREASED SENSITIVITY TO HISTAMINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					282	282		10.1016/0091-6749(88)90690-2	http://dx.doi.org/10.1016/0091-6749(88)90690-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400477
J	ROBERTS, JA; RODGER, IW; THOMSON, NC				ROBERTS, JA; RODGER, IW; THOMSON, NC			INVIVO AND INVITRO HUMAN AIRWAY RESPONSIVENESS TO LEUKOTRIENE-D4 IN PATIENTS WITHOUT ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WESTERN INFIRM,DEPT RESP MED,GLASGOW G11 6NT,SCOTLAND; UNIV STRATHCLYDE,DEPT PHYSIOL & PHARMACOL,GLASGOW G1 1XW,SCOTLAND	University of Strathclyde				Thomson, Neil/0000-0003-1632-6630				ARMOUR CL, 1984, AM REV RESPIR DIS, V129, P907; ARMOUR CL, 1984, RESP PHYSIOL, V58, P223, DOI 10.1016/0034-5687(84)90150-6; BARNES NC, 1984, THORAX, V39, P500, DOI 10.1136/thx.39.7.500; BISGAARD H, 1985, BRIT MED J, V290, P1468, DOI 10.1136/bmj.290.6480.1468; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; CLARK AJ, 1926, J PHYSL, V61, P545; COTES JE, 1975, LUNG FUNCTION PRINCI; CRETICOS PS, 1984, NEW ENGL J MED, V310, P1626, DOI 10.1056/NEJM198406213102502; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAHLEN SE, 1983, P NATL ACAD SCI-BIOL, V80, P1712, DOI 10.1073/pnas.80.6.1712; DUBOIS AB, 1956, J CLIN INVEST, V35, P227; DUNNILL MS, 1969, THORAX, V24, P176, DOI 10.1136/thx.24.2.176; GRIFFIN M, 1983, NEW ENGL J MED, V308, P436, DOI 10.1056/NEJM198302243080807; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HEARD BE, 1973, J PATHOL, V110, P319, DOI 10.1002/path.1711100406; HOLTZMAN MJ, 1983, AM REV RESPIR DIS, V127, P686; LEWIS RA, 1984, J CLIN INVEST, V73, P889, DOI 10.1172/JCI111312; LEWIS RA, 1980, P NATL ACAD SCI US, V77, P5710; Lillie R D, 1954, HISTOPATHOLOGICAL TE; MULLEN JBM, 1986, AM REV RESPIR DIS, V133, P120, DOI 10.1164/arrd.1986.133.1.120; OGALVIE CM, 1957, J CLIN INVEST, V36, P1; OPPENHEIMER EA, 1968, LANCET, V1, P552; Orange R P, 1969, Adv Immunol, V10, P105, DOI 10.1016/S0065-2776(08)60416-2; RAMSDELL JW, 1982, AM REV RESPIR DIS, V126, P829; ROBERTS JA, 1986, THORAX, V41, P12, DOI 10.1136/thx.41.1.12; ROBERTS JA, 1986, BRIT J DIS CHEST, V80, P218; ROBERTS JA, 1985, THORAX, V40, P261, DOI 10.1136/thx.40.4.261; ROBERTS JA, 1984, THORAX, V39, P837, DOI 10.1136/thx.39.11.837; SMITH LJ, 1985, AM REV RESPIR DIS, V131, P368; TAKIZAWA T, 1971, AM REV RESPIR DIS, V104, P331, DOI 10.1164/arrd.1971.104.3.331; TAKIZAWA T, 1971, AM REV RESPIR DIS, V103, P774; TAYLOR SM, 1985, AM REV RESPIR DIS, V132, P30; THOMSON NC, 1983, EUR J RESPIR DIS, V64, P206; VINCENC KS, 1983, AM REV RESPIR DIS, V128, P875; WEISS JW, 1983, JAMA-J AM MED ASSOC, V249, P2814, DOI 10.1001/jama.249.20.2814	35	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1987	80	5					688	694		10.1016/0091-6749(87)90288-0	http://dx.doi.org/10.1016/0091-6749(87)90288-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K9930	3680812	Bronze			2022-12-18	WOS:A1987K993000008
J	GARTY, BZ; CONLEY, ME; DOUGLAS, SD; KOLSKI, GB				GARTY, BZ; CONLEY, ME; DOUGLAS, SD; KOLSKI, GB			RECURRENT INFECTIONS AND STAPHYLOCOCCAL LIVER-ABSCESS IN A CHILD WITH C1R DEFICIENCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											GARTY, BZ (corresponding author), UNIV PENN,CHILDRENS HOSP,SCH MED,DIV ALLERGY & IMMUNOL,34TH & CIVIC CTR BLVD,PHILADELPHIA,PA 19104, USA.							BILFINGER TV, 1986, SOUTHERN MED J, V79, P37, DOI 10.1097/00007611-198601000-00012; CECH P, 1979, AM J MED, V66, P149, DOI 10.1016/0002-9343(79)90507-2; CHASE PH, 1976, ANN R COLL PHYSICIAN, V9, P81; CHUSID MJ, 1978, PEDIATRICS, V62, P554; DAY NK, 1972, J CLIN INVEST, V51, P1102, DOI 10.1172/JCI106902; GEWURZ A, 1978, ARTHRITIS RHEUM, V21, P28, DOI 10.1002/art.1780210106; LEE SL, 1978, ARTHRITIS RHEUM, V21, P958, DOI 10.1002/art.1780210813; MITTAL KK, 1976, TISSUE ANTIGENS, V7, P97; MONCADA B, 1972, NEW ENGL J MED, V286, P689, DOI 10.1056/NEJM197203302861304; PICKERING RJ, 1971, J PEDIATR-US, V78, P30, DOI 10.1016/S0022-3476(71)80261-5; PICKERING RJ, 1970, J EXP MED, V141, P803; PONDMAN KW, 1968, J IMMUNOL, V101, P811; PREIMESBERGER KF, 1974, RADIOLOGY, V110, P147, DOI 10.1148/110.1.147; RICH KC, 1979, CLIN IMMUNOL IMMUNOP, V13, P77, DOI 10.1016/0090-1229(79)90022-9; ROSS SC, 1984, MEDICINE, V63, P243, DOI 10.1097/00005792-198409000-00001; TAM PKH, 1983, ARCH DIS CHILD, V58, P828, DOI 10.1136/adc.58.10.828; TAPPEINER G, 1982, INT J DERMATOL, V21, P175, DOI 10.1111/j.1365-4362.1982.tb02069.x; VERHOEF J, 1977, IMMUNOLOGY, V33, P191; 1986, LANCET, V1, P953	19	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1987	80	4					631	635		10.1016/0091-6749(87)90018-2	http://dx.doi.org/10.1016/0091-6749(87)90018-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5224	3312373	Bronze			2022-12-18	WOS:A1987K522400018
J	YOUNGER, RE; HERROD, HG; LIEBERMAN, PL; VALENSKI, WR; TROUY, RL; CRAWFORD, LV				YOUNGER, RE; HERROD, HG; LIEBERMAN, PL; VALENSKI, WR; TROUY, RL; CRAWFORD, LV			CHARACTERIZATION OF MONONUCLEAR CELL DERIVED HISTAMINE-RELEASE ENHANCING FACTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									BAPTIST MEM HOSP,DEPT CHEM,MEMPHIS,TN 38146; LEBONHEUR CHILDRENS MED CTR,MEMPHIS,TN	Baptist Memorial Hospital Memphis	YOUNGER, RE (corresponding author), UNIV TENNESSEE,HLTH SCI CTR,DEPT PEDIAT,ALLERGY IMMUNOL SECT,960 E 3RD ST,SUITE 306,CHATTANOOGA,TN 37403, USA.							ALUM R, 1984, ANN ALLERGY, V53, P66; BAMZAI AK, 1978, J ALLERGY CLIN IMMUN, V62, P137, DOI 10.1016/0091-6749(78)90097-0; BEAVEN MA, 1972, CLIN CHIM ACTA, V37, P91, DOI 10.1016/0009-8981(72)90419-6; BEER DJ, 1984, J ALLERGY CLIN IMMUN, V73, P439, DOI 10.1016/0091-6749(84)90353-1; BONNARD GD, 1979, J IMMUNOL, V123, P2704; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; FAGNANI R, 1980, J IMMUNOL METHODS, V33, P313, DOI 10.1016/0022-1759(80)90002-2; GAROVOY MR, 1983, J IMMUNOL, V130, P357; GERBER PS, 1983, J CLIN IMMUNOL, V3, P222, DOI 10.1007/BF00915346; GOODWIN JS, 1977, J EXP MED, V146, P1417; IDA S, 1977, J EXP MED, V145, P892, DOI 10.1084/jem.145.4.892; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; KILLIAN D, 1976, CLIN ALLERGY, V6, P219, DOI 10.1111/j.1365-2222.1976.tb01900.x; LETTBROWN MA, 1984, CELL IMMUNOL, V87, P445, DOI 10.1016/0008-8749(84)90013-3; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; PEPYS J, 1975, POSTGRAD MED J, V51, P42; PETERS SP, 1981, NATURE, V292, P455, DOI 10.1038/292455a0; PETERS SP, 1982, T ASS AM PHYSICIANS, V45, P221; POOTHULLIL J, 1976, J ALLERGY CLIN IMMUN, V57, P164, DOI 10.1016/0091-6749(76)90035-X; REINHERZ EL, 1980, NEW ENGL J MED, V303, P370, DOI 10.1056/NEJM198008143030704; ROCKLIN RE, 1977, J IMMUNOL, V118, P1734; ROCKLIN RE, 1974, J CLIN INVEST, V53, P735, DOI 10.1172/JCI107612; SANAL SO, 1978, J CLIN INVEST, V61, P1, DOI 10.1172/JCI108907; SUBRAMANIAN N, 1987, J IMMUNOL, V138, P271; THUESON DO, 1979, J IMMUNOL, V123, P626; YOUNGER RE, 1986, J ALLERGY CLIN IMMUN, V77, P94, DOI 10.1016/0091-6749(86)90329-5	26	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1987	80	4					547	557		10.1016/0091-6749(87)90006-6	http://dx.doi.org/10.1016/0091-6749(87)90006-6			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5224	2444637				2022-12-18	WOS:A1987K522400006
J	GOLDEN, DBK; ADDISON, BI; BLAKE, K; KAGEYSOBOTKA, A; VALENTINE, MD; LICHTENSTEIN, LM				GOLDEN, DBK; ADDISON, BI; BLAKE, K; KAGEYSOBOTKA, A; VALENTINE, MD; LICHTENSTEIN, LM			DISCONTINUING VENOM IMMUNOTHERAPY (VIT) - IMMUNOLOGICAL AND CLINICAL-CRITERIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					126	126						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000029
J	MICHEL, FB; BOUSQUET, J; DANNAEUS, A; HAMBURGER, RN; BELLANTI, JA; BUSINCO, ML; SOOTHILL, J				MICHEL, FB; BOUSQUET, J; DANNAEUS, A; HAMBURGER, RN; BELLANTI, JA; BUSINCO, ML; SOOTHILL, J			PREVENTIVE MEASURES IN EARLY-CHILDHOOD ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV UPPSALA,DEPT PEDIAT,S-75105 UPPSALA,SWEDEN; UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093; INST CHILD HLTH,DEPT IMMUNOL,LONDON WC1N 1EH,ENGLAND; GEORGETOWN UNIV,SCH MED,WASHINGTON,DC; UNIV ROME,PRIMA CLIN PEDIAT,I-00100 ROME,ITALY	Uppsala University; University of California System; University of California San Diego; University of London; University College London; Georgetown University; Sapienza University Rome	MICHEL, FB (corresponding author), HOP AIGUELONGUE,MALAD RESP CLIN,AVE MAJOR FLANDRE,F-34059 MONTPELLIER,FRANCE.			Bellanti, Joseph/0000-0002-5038-7202				ANDRE C, 1975, J EXP MED, V142, P1509, DOI 10.1084/jem.142.6.1509; BACKMAN A, 1984, ALLERGY, V39, P309, DOI 10.1111/j.1398-9995.1984.tb00867.x; BAHNA SL, 1977, PEDIATR RES, V11, P484, DOI 10.1203/00006450-197704000-00686; BAHNA SL, 1983, ANN ALLERGY, V51, P574; BAHNA SL, 1980, ALLERGIES MILK; BIENENSTOCK J, 1982, CLIN IMMUNOL ALLERGY, V2, P5; BJORKSTEN B, 1983, IMMUNOL TODAY, V4, P215, DOI 10.1016/0167-5699(83)90029-4; BJORKSTEN F, 1978, LANCET, V2, P624; BJORKSTEN F, 1983, 11TH P INT C ALL CLI, P145; BOUSQUET J, 1986, J ALLERGY CLIN IMMUN, V78, P1019, DOI 10.1016/0091-6749(86)90296-4; BUSINCO L, 1983, CLIN ALLERGY, V13, P503, DOI 10.1111/j.1365-2222.1983.tb02631.x; CHANDRA RK, 1979, ACTA PAEDIATR SCAND, V68, P691, DOI 10.1111/j.1651-2227.1979.tb18439.x; CHANDRA RK, 1983, LANCET, V2, P1393; CRUZ JR, 1981, J PEDIATR-US, V99, P600, DOI 10.1016/S0022-3476(81)80269-7; DANNAEUS A, 1981, CLIN ALLERGY, V11, P533, DOI 10.1111/j.1365-2222.1981.tb02171.x; DANNAEUS A, 1978, ACTA PAEDIATR SCAND, V67, P497, DOI 10.1111/j.1651-2227.1978.tb16360.x; Donnally HH, 1930, J IMMUNOL, V19, P15; DUCHATEAU J, 1983, LANCET, V1, P413; EASTHAM EJ, 1978, J PEDIATR-US, V93, P561, DOI 10.1016/S0022-3476(78)80888-9; FERGUSSON DM, 1981, CLIN ALLERGY, V11, P325; FIRER MA, 1981, BRIT MED J, V283, P693, DOI 10.1136/bmj.283.6293.693; FRICK OL, 1979, J ALLERGY CLIN IMMUN, V63, P228, DOI 10.1016/0091-6749(79)90106-4; GERRARD JW, 1979, ANN ALLERGY, V42, P69; GERRARD JW, 1983, ANN ALLERGY, V51, P300; GLOVSKY MM, 1983, J ALLERGY CLIN IMMUN, V71, P92, DOI 10.1016/0091-6749(83)90138-0; GOGSWELL JJ, 1982, LANCET, V1, P910; GOLDING J, 1982, LANCET, V1, P623; GORDON RR, 1982, LANCET, V1, P72; GRUSKAY FL, 1955, PEDIATRICS, V16, P763; GRUSKAY FL, 1982, CLIN PEDIATR, V21, P486, DOI 10.1177/000992288202100807; HALPERN SR, 1973, J ALLERGY CLIN IMMUN, V51, P139, DOI 10.1016/0091-6749(73)90019-5; HAMBURGER RN, 1983, ANN ALLERGY, V51, P281; HANSON LA, 1982, IMMUNOL TODAY, V3, P168, DOI 10.1016/0167-5699(82)90108-6; HAYWARD AR, 1981, IMMUNOL REV, V57, P39, DOI 10.1111/j.1600-065X.1981.tb00441.x; HEMMINGS WA, 1978, LANCET, V2, P575; HIDE DW, 1981, ARCH DIS CHILD, V56, P172, DOI 10.1136/adc.56.3.172; JACOBSSON I, 1978, LANCET, V2, P437; JARRETT EEE, 1977, LANCET, V2, P223; JARRETT EEE, 1981, EUR J IMMUNOL, V11, P520, DOI 10.1002/eji.1830110615; JARRETT EEE, 1983, IMMUNOLOGY, V48, P49; JOHNSTONE DE, 1953, J ALLERGY, V24, P434, DOI 10.1016/0021-8707(53)90043-4; JOHNSTONE DE, 1980, ALLERGIC DISEASES IN, P346; JUTO P, 1982, CLIN ALLERGY, V12, P409, DOI 10.1111/j.1365-2222.1982.tb02546.x; KAJOSAARI M, 1983, ACTA PAEDIATR SCAND, V72, P411, DOI 10.1111/j.1651-2227.1983.tb09738.x; KAPLAN MS, 1979, J ALLERGY CLIN IMMUN, V64, P122, DOI 10.1016/0091-6749(79)90045-9; KATZ DH, 1978, IMMUNOL REV, V41, P77, DOI 10.1111/j.1600-065X.1978.tb01461.x; KAUFMAN H S, 1971, Clinical Allergy, V1, P363, DOI 10.1111/j.1365-2222.1971.tb00787.x; KAUFMAN HS, 1979, LANCET, V2, P163; KEMP AS, 1979, MED J AUSTRALIA, V1, P263, DOI 10.5694/j.1326-5377.1979.tb112072.x; KJELLMAN NIM, 1981, LANCET, V1, P993; KJELLMAN NIM, 1979, CLIN ALLERGY, V9, P347, DOI 10.1111/j.1365-2222.1979.tb02493.x; KJELLMAN NIM, 1982, ALLERGY, V67, P463; KLEINMAN RE, 1983, ANN ALLERGY, V51, P222; KRAMER MS, 1981, J PEDIATR-US, V98, P546, DOI 10.1016/S0022-3476(81)80757-3; KUHNS WJ, 1965, P SOC EXP BIOL MED, V118, P377, DOI 10.3181/00379727-118-29848; KUROUME T, 1976, ANN ALLERGY, V37, P41; LEVIN S, 1971, PEDIATR RES, V5, P87, DOI 10.1203/00006450-197102000-00028; MATTHEW DJ, 1977, LANCET, V1, P321; MATTHEWS THJ, 1976, LANCET, V2, P1387; MICHEL FB, 1980, J ALLERGY CLIN IMMUN, V65, P422, DOI 10.1016/0091-6749(80)90234-1; MILLER DL, 1973, J ALLERGY CLIN IMMUN, V65, P422; MIYAWAKI T, 1981, IMMUNOL REV, V57, P61, DOI 10.1111/j.1600-065X.1981.tb00442.x; MORRISONSMITH J, 1971, CLIN ALLERGY, V1, P57; MUNOZ JJ, 1977, BORDETELLA PERTUSSIS, P238; PAUWELS R, 1983, ALLERGY, V38, P239, DOI 10.1111/j.1398-9995.1983.tb01617.x; PEARSON DJ, 1977, CLIN ALLERGY, V7, P29, DOI 10.1111/j.1365-2222.1977.tb01421.x; PERELMUTTER L, 1978, ANN ALLERGY, V41, P159; REINHARDT MC, 1983, ANN ALLERGY, V51, P311; ROBERT J, 1979, REV FR ALLERGOL, V19, P153, DOI 10.1016/S0335-7457(79)80021-0; ROBERTS SA, 1982, ARCH DIS CHILD, V57, P127, DOI 10.1136/adc.57.2.127; SAARINEN UM, 1979, LANCET, V2, P163; SAARINEN UM, 1980, LANCET, V1, P166; SAARINEN UM, 1982, ALLERGY, V37, P345, DOI 10.1111/j.1398-9995.1982.tb01920.x; SLEIGH G, 1975, LANCET, V1, P753; SMITH JM, 1979, CLIN ALLERGY, V9, P153, DOI 10.1111/j.1365-2222.1979.tb01536.x; SOOTHILL JF, 1983, ANN ALLERGY, V51, P229; SOOTHILL JF, 1976, CLIN ALLERGY, V6, P305, DOI 10.1111/j.1365-2222.1976.tb01911.x; SUONIEMI I, 1981, ALLERGY, V36, P263, DOI 10.1111/j.1398-9995.1981.tb01573.x; TOMS GL, 1980, ARCH DIS CHILD, V55, P161; UNANDER AM, 1981, J IMMUNOL, V127, P1182; VANASPEREN PP, 1983, ARCH DIS CHILD, V58, P253, DOI 10.1136/adc.58.4.253; WALKER WA, 1982, CLIN IMMUNOL ALLERGY, V2, P15; WARNER JO, 1980, CLIN ALLERGY, V10, P133, DOI 10.1111/j.1365-2222.1980.tb02090.x; WELLIVER RC, 1980, NEW ENGL J MED, V303, P1198, DOI 10.1056/NEJM198011203032103; WELSH JK, 1979, J PEDIATR-US, V94, P1, DOI 10.1016/S0022-3476(79)80340-6; [No title captured]	86	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			1022	1027		10.1016/0091-6749(86)90297-6	http://dx.doi.org/10.1016/0091-6749(86)90297-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	3537086				2022-12-18	WOS:A1986E971900018
J	REED, CE; SWANSON, MC; YUNGINGER, JW				REED, CE; SWANSON, MC; YUNGINGER, JW			MEASUREMENT OF ALLERGEN CONCENTRATION IN THE AIR AS AN AID IN CONTROLLING EXPOSURE TO AEROALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO MED SCH,DEPT MED,DIV ALLERG DIS,ROCHESTER,MN 55901; MAYO MED SCH,DEPT PEDIAT,ROCHESTER,MN 55901	Mayo Clinic; Mayo Clinic	REED, CE (corresponding author), MAYO CLIN & MAYO FDN,DEPT MED,DIV ALLERG DIS,ROCHESTER,MN 55905, USA.				NIAID NIH HHS [AI 11483] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011483] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGARWAL MK, 1983, J ALLERGY CLIN IMMUN, V72, P40, DOI 10.1016/0091-6749(83)90050-7; AGARWAL MK, 1984, J ALLERGY CLIN IMMUN, V73, P137; EDWARDS RG, 1983, LAB ANIM, V17, P235, DOI 10.1258/002367783781070696; FORD AM, 1983, J ALLERGY CLIN IMMUN, V72, P40; SWANSON MC, 1984, AM REV RESPIR DIS, V129, P844, DOI 10.1164/arrd.1984.129.5.844; TWIGGS JT, 1982, J ALLERGY CLIN IMMUN, V69, P522, DOI 10.1016/0091-6749(82)90177-4	6	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			1028	1030		10.1016/0091-6749(86)90298-8	http://dx.doi.org/10.1016/0091-6749(86)90298-8			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	3782663				2022-12-18	WOS:A1986E971900019
J	LESKO, LJ				LESKO, LJ			DOSE-DEPENDENT KINETICS OF THEOPHYLLINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											LESKO, LJ (corresponding author), UNIV MARYLAND,SCH PHARM,20 N PINE ST,BALTIMORE,MD 21201, USA.							BACHMANN K, 1985, PHARMACOLOGY, V30, P136, DOI 10.1159/000138062; EFTHIMIOU H, 1984, BRIT J CLIN PHARMACO, V17, P525, DOI 10.1111/j.1365-2125.1984.tb02385.x; JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349; KADLEC GJ, 1978, ANN ALLERGY, V41, P337; KAUMEIER HS, 1983, INT J CLIN PHARM TH, V21, P339; LESKO LJ, 1978, IMMUNOL ALLERGY PRAC, V3, P48; LESKO LJ, 1986, WORLD C CLIN PHARM; LEVY G, 1976, J CLIN PHARMACOL, V16, P329, DOI 10.1002/j.1552-4604.1976.tb01528.x; MARLIN GE, 1980, BRIT J CLIN PHARMACO, V10, P265, DOI 10.1111/j.1365-2125.1980.tb01754.x; MILAVETZ G, 1984, PHARMACOTHERAPY, V4, P216; MILLER CA, 1985, J CLIN INVEST, V75, P1415, DOI 10.1172/JCI111843; RAMSAY LE, 1980, BRIT J CLIN PHARMACO, V10, P101, DOI 10.1111/j.1365-2125.1980.tb01725.x; ROVEI V, 1982, BRIT J CLIN PHARMACO, V14, P769, DOI 10.1111/j.1365-2125.1982.tb02035.x; SARRAZIN E, 1980, J PEDIATR-US, V97, P825, DOI 10.1016/S0022-3476(80)80280-0; SEDMAN AJ, 1974, J PHARMACOKINET BIOP, V2, P149, DOI 10.1007/BF01061505; SHEN DD, 1978, J PHARM SCI, V67, P916, DOI 10.1002/jps.2600670711; TANGLIU DD, 1981, THESIS ANN ARBOR; TANGLIU DDS, 1982, CLIN PHARMACOL THER, V31, P358, DOI 10.1038/clpt.1982.46; VOZEH S, 1980, EUR J CLIN PHARMACOL, V18, P473, DOI 10.1007/BF00874658; WEINBERGER M, 1977, J PEDIATR-US, V91, P820, DOI 10.1016/S0022-3476(77)81051-2	20	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	2				723	727		10.1016/0091-6749(86)90052-7	http://dx.doi.org/10.1016/0091-6749(86)90052-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5684	3534053	Bronze			2022-12-18	WOS:A1986E568400010
J	DAVIS, PB				DAVIS, PB			PUPILLARY RESPONSES AND AIRWAY REACTIVITY IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM MED CTR,DEPT MED,CLEVELAND,OH 44106	US Department of Veterans Affairs; Veterans Health Administration (VHA)					NHLBI NIH HHS [HL 28386] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028386] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARNES PJ, 1983, AM REV RESPIR DIS, V127, P758; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; Colton T., 1974, STAT MED, V1; DAVIS PB, 1983, J CLIN INVEST, V71, P1787, DOI 10.1172/JCI110934; DAVIS PB, 1980, NEW ENGL J MED, V302, P1453, DOI 10.1056/NEJM198006263022605; DAVIS PB, 1984, AM REV RESPIR DIS, V129, P911; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; HENDERSON WR, 1979, NEW ENGL J MED, V300, P642, DOI 10.1056/NEJM197903223001203; HOLTZMAN MJ, 1983, J APPL PHYSIOL, V54, P134, DOI 10.1152/jappl.1983.54.1.134; KALINER M, 1982, ANN INTERN MED, V96, P349, DOI 10.7326/0003-4819-96-3-349; KALINER M, 1976, J ALLERGY CLIN IMMUN, V58, P308, DOI 10.1016/0091-6749(76)90136-6; KALINER M, 1972, J EXP MED, V136, P5556; LEMANSKE RF, 1980, AM REV RESPIR DIS, V122, P213; OHNO Y, 1981, ARCH INT PHARMACOD T, V251, P205; OREHEK J, 1977, AM REV RESPIR DIS, V115, P937; PATEL KR, 1973, CLIN ALLERGY, V3, P439, DOI 10.1111/j.1365-2222.1973.tb01351.x; SHELHAMER JH, 1980, J CLIN INVEST, V66, P1400, DOI 10.1172/JCI109993; SHEPPARD D, 1983, AM REV RESPIR DIS, V127, P691; SMITH LJ, 1980, J ALLERGY CLIN IMMUN, V66, P374, DOI 10.1016/0091-6749(80)90116-5; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TIFFENEAU R, 1955, PRESSE MED, V63, P227	22	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1986	77	5					667	673		10.1016/0091-6749(86)90406-9	http://dx.doi.org/10.1016/0091-6749(86)90406-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	C3903	3700888				2022-12-18	WOS:A1986C390300004
J	BOSCHETTO, P; ZOCCA, E; MILANI, GF; LICATA, B; PIVIROTTO, F; MAPP, CE; FABBRI, LM				BOSCHETTO, P; ZOCCA, E; MILANI, GF; LICATA, B; PIVIROTTO, F; MAPP, CE; FABBRI, LM			BRONCHOALVEOLAR NEUTROPHILIA DURING LATE, BUT NOT EARLY, ASTHMATIC REACTIONS INDUCED BY TOLUENE DIISOCYANATE (TDI)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Boschetto, Piera/AAM-3247-2020; Fabbri, Leonardo M/I-4055-2012	Boschetto, Piera/0000-0003-3889-1681; Fabbri, Leonardo M/0000-0001-8894-1689					0	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			244	244						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800492
J	FIREMAN, P				FIREMAN, P			EUSTACHIAN-TUBE OBSTRUCTION AND ALLERGY - A ROLE IN OTITIS-MEDIA WITH EFFUSION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											FIREMAN, P (corresponding author), UNIV PITTSBURGH,CHILDRENS HOSP,SCH MED,125 DESOTO ST,PITTSBURGH,PA 15213, USA.				NCRR NIH HHS [M01-RR00084] Funding Source: Medline; NIAID NIH HHS [R01 AI19262] Funding Source: Medline; NINDS NIH HHS [P01 NS 16337] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016337] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKERMAN MN, 1984, J ALLERGY CLIN IMMUN, V73, P604, DOI 10.1016/0091-6749(84)90519-0; BERNSTEIN JM, 1983, AM J OTOL, V5, P66; BLUESTONE CD, 1977, LARYNGOSCOPE, V87, P493; BLUESTONE CD, 1980, CLIN IMPEDANCE AUDIO, P83; BLUESTONE CD, 1983, ALLERGY PRINCIPLES P, V2, P1023; BLUESTONE CD, 1983, PEDIATRIC OTOLARYNGO, V1, P356; CANTEKIN EI, 1984, RECENT ADV OTITIS ME, P45; COOK DA, 1980, J ALLERGY CLIN IMMUN, V65, P215; DOYLE WJ, 1980, ANN OTO RHINOL LARYN, V89, P41, DOI 10.1177/00034894800890S312; DOYLE WJ, 1984, ARCH OTOLARYNGOL, V110, P508; DOYLE WJ, J ALLERGY CLIN IMMUN; DRAPER WL, 1967, LARYNGOSCOPE, V77, P636, DOI 10.1288/00005537-196704000-00016; FIREMAN P, 1983, J ALLERGY CLIN IMMUN, V71, P155, DOI 10.1016/0091-6749(83)90390-1; FRIEDMAN PA, 1983, J ALLERGY CLIN IMMUN, V71, P442; GOLD S, 1985, J ALLERGY CLIN IMMUN, V75, P111, DOI 10.1016/0091-6749(85)90160-5; PHILLIPS MJ, 1974, LANCET, V2, P1176; REISMAN RE, 1975, PEDIATR CLIN N AM, V22, P251; SADE J, 1966, ARCHIV OTOLARYNGOL, V84, P137; SKONER D, 1985, J ALLERGY CLIN IMMUN, V75, P111, DOI 10.1016/0091-6749(85)90161-7; SLOYER JL, 1980, ANN OTO RHINOL LARYN, V89, P133, DOI 10.1177/00034894800890S334; STILLWAGON P, 1985, J ALLERGY CLIN IMMUN, V75, P154, DOI 10.1016/0091-6749(85)90332-X; WALKER SB, 1985, J ALLERGY CLIN IMMUN, V76, P158, DOI 10.1016/0091-6749(85)90694-3	22	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	2					137	140		10.1016/0091-6749(85)90690-6	http://dx.doi.org/10.1016/0091-6749(85)90690-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	APE88	4019946				2022-12-18	WOS:A1985APE8800002
J	GRAMMER, LC; SHAUGHNESSY, MA; SHAUGHNESSY, JJ; PATTERSON, R				GRAMMER, LC; SHAUGHNESSY, MA; SHAUGHNESSY, JJ; PATTERSON, R			BRIEF REPORT - EVALUATION OF POLYMERIZED RAGWEED EXTRACTS BY INTRADERMAL END-POINT TITRATION, RAST INHIBITION, AND PARALLEL LINE BIOASSAY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									HOPE COLL,DEPT PSYCHOL,HOLLAND,MI 49423	Hope College	GRAMMER, LC (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,303 E CHICAGO AVE,CHICAGO,IL 60611, USA.			Grammer, Leslie/0000-0001-6860-2014	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON MC, 1981, RAST INHIBITION PROC; BJORKSTEN F, 1984, J ALLERGY CLIN IMMUN, V73, P324, DOI 10.1016/0091-6749(84)90404-4; Cochran W.G, 1957, STAT METHODS, V6th ed; GRAMMER LC, 1983, J ALLERGY CLIN IMMUN, V72, P160, DOI 10.1016/0091-6749(83)90524-9; GRAMMER LC, 1982, J ALLERGY CLIN IMMUN, V69, P494, DOI 10.1016/0091-6749(82)90173-7; HENDRIX SG, 1980, J ALLERGY CLIN IMMUN, V66, P486, DOI 10.1016/0091-6749(80)90010-X; NORMAN PS, 1982, J ALLERGY CLIN IMMUN, V69, P1, DOI 10.1016/0091-6749(82)90079-3; PATTERSON R, 1978, J ALLERGY CLIN IMMUN, V61, P28, DOI 10.1016/0091-6749(78)90470-0; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9; YUNGINGER JW, 1984, J ALLERGY CLIN IMMUN, V73, P316, DOI 10.1016/0091-6749(84)90402-0; 1981, UNPUB FED REG	11	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	1					123	127		10.1016/0091-6749(85)90815-2	http://dx.doi.org/10.1016/0091-6749(85)90815-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AMV84	4008810	Bronze			2022-12-18	WOS:A1985AMV8400018
J	ISLES, AF; NEWTH, CJL				ISLES, AF; NEWTH, CJL			PHARMACOKINETICS OF A SUSTAINED-RELEASE THEOPHYLLINE PREPARATION IN INFANTS AND PRESCHOOL-CHILDREN WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HOSP SICK CHILDREN,DIV CHEST DIS,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Isles, Alan F/B-3268-2011					GINCHANSKY E, 1977, J PEDIATR-US, V91, P655, DOI 10.1016/S0022-3476(77)80527-1; HENDELES L, 1978, AM J DIS CHILD, V132, P876; HENDELES L, 1983, PHARMACOTHERAPY, V3, P2; LESKO LJ, 1981, IMMUNOL ALLERG PRACT, V3, P15; NEWTH CJL, 1982, J ASTHMA, V19, P145, DOI 10.3109/02770908209104750; OGILVIE RI, 1978, CLIN PHARMACOKINET, V3, P267, DOI 10.2165/00003088-197803040-00002; TABACHNIK E, 1982, J PEDIATR-US, V100, P489, DOI 10.1016/S0022-3476(82)80467-8; WEINBERGER M, 1981, J PEDIATR-US, V99, P145, DOI 10.1016/S0022-3476(81)80982-1; WEINBERGER M, 1978, NEW ENGL J MED, V299, P852, DOI 10.1056/NEJM197810192991603	9	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	3					377	381		10.1016/0091-6749(85)90075-2	http://dx.doi.org/10.1016/0091-6749(85)90075-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AEB46	3973312	Bronze			2022-12-18	WOS:A1985AEB4600009
J	MEKORI, YA; BENDER, EM; ZAPATASIRVENT, R; HANSBROUGH, JF; CLAMAN, HN				MEKORI, YA; BENDER, EM; ZAPATASIRVENT, R; HANSBROUGH, JF; CLAMAN, HN			THE EFFECT OF HISTAMINE-RECEPTOR ANTAGONISTS ON SPECIFIC AND NONSPECIFIC SUPPRESSION OF EXPERIMENTAL CONTACT SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO,SCH MED,DEPT MED,DIV CLIN IMMUNOL B164,4200 E 9TH AVE,DENVER,CO 80262; UNIV COLORADO,SCH MED,DEPT SURG,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012685] Funding Source: NIH RePORTER; NIAID NIH HHS [5 RO1 AI-12685] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Askenase P W, 1977, Prog Allergy, V23, P199, DOI 10.1159/000314242; AVELLA J, 1978, LANCET, V1, P624; BAKER CC, 1979, J TRAUMA, V19, P641, DOI 10.1097/00005373-197909000-00001; BEER DJ, 1984, J ALLERGY CLIN IMMUN, V73, P439, DOI 10.1016/0091-6749(84)90353-1; BEER DJ, 1982, CELL IMMUNOL, V69, P101, DOI 10.1016/0008-8749(82)90054-5; BRITTAIN RT, 1981, SCAND J GASTROENTE S, V69, P1; Casson P, 1966, Surg Forum, V17, P268; CAVAGNARO J, 1983, BIOTECHNIQUES, V1, P30; CAVANAGH RL, 1983, J PHARMACOL EXP THER, V224, P171; Claman H N, 1980, Adv Immunol, V30, P121, DOI 10.1016/S0065-2776(08)60195-9; CLAMAN HN, 1980, IMMUNOL REV, V50, P105, DOI 10.1111/j.1600-065X.1980.tb00309.x; DAMLE NK, 1981, J CLIN IMMUNOL, V1, P241, DOI 10.1007/BF00915143; DESCOTES J, 1983, IMMUNOPHARMACOLOGY, V6, P31, DOI 10.1016/0162-3109(83)90014-0; FALLAH HA, 1975, ANN INST PASTEUR IMM, VC126, P669; GALLI SJ, 1984, LAB INVEST, V50, P365; GAROVOY MR, 1983, J IMMUNOL, V130, P357; GRISWOLD DE, 1984, J IMMUNOL, V132, P3054; HANSBROUGH JF, 1983, SURGERY, V93, P415; HEGGERS JP, 1980, J SURG RES, V28, P110, DOI 10.1016/0022-4804(80)90153-5; JOHNSSON MB, 1963, MED EXP, V8, P251; LICHTENSTEIN LM, 1973, NATURE, V244, P287, DOI 10.1038/244287a0; LIM AM, 1981, CELL IMMUNOL, V64, P324; LIPSMEYER EA, 1980, CLIN IMMUNOL IMMUNOP, V16, P166, DOI 10.1016/0090-1229(80)90200-7; MILLER SD, 1977, EUR J IMMUNOL, V7, P165, DOI 10.1002/eji.1830070310; OLAFSSON JH, 1983, INT ARCH ALLER A IMM, V70, P174, DOI 10.1159/000233318; PEDEN NR, 1982, GUT, V23, P398, DOI 10.1136/gut.23.5.398; PHANUPHAK P, 1974, J IMMUNOL, V113, P1230; PLAUT M, 1982, PHARM HISTAMINE RECE, P392; ROCKLIN RE, 1979, CELL IMMUNOL, V44, P404, DOI 10.1016/0008-8749(79)90015-7; ROCKLIN RE, 1976, J CLIN INVEST, V57, P1051, DOI 10.1172/JCI108347; ROCKLIN RE, 1980, CELL IMMUNOL, V51, P226, DOI 10.1016/0008-8749(80)90255-5; SCHWARTZ A, 1980, IMMUNOPHARMACOLOGY, V2, P179, DOI 10.1016/0162-3109(80)90048-X; SY MS, 1977, J IMMUNOL, V119, P240; THOMAS Y, 1981, CELL IMMUNOL, V59, P268, DOI 10.1016/0008-8749(81)90408-1; WANG SR, 1978, CELL IMMUNOL, V36, P28, DOI 10.1016/0008-8749(78)90247-2; WOLFE JD, 1979, J ALLERGY CLIN IMMUN, V63, P208	36	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	1					90	96		10.1016/0091-6749(85)90809-7	http://dx.doi.org/10.1016/0091-6749(85)90809-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AMV84	3159783				2022-12-18	WOS:A1985AMV8400012
J	SCHACHTER, EN; BUCK, MG; MERRILL, WW; ASKENASE, P; WITEK, TJ				SCHACHTER, EN; BUCK, MG; MERRILL, WW; ASKENASE, P; WITEK, TJ			SKIN TESTING WITH AN AQUEOUS EXTRACT OF COTTON BRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									YALE UNIV,SCH MED,DEPT INTERNAL MED,PULM SECT,NEW HAVEN,CT 06510	Yale University								AINSWORTH SK, 1982, AM REV RESPIR DIS, V124, P280; BECK GJ, 1982, ANN INTERN MED, V97, P645, DOI 10.7326/0003-4819-97-5-645; BOUHUYS A, 1976, LUNG, V154, P3, DOI 10.1007/BF02713514; BOUHUYS A, 1969, J CLIN INVEST, V48, P1159, DOI 10.1172/JCI106073; BUCK MG, 1980, LUNG, V158, P25, DOI 10.1007/BF02713699; BUCK MG, 1983, 7TH P SPEC SESS COTT, P22; BUCK MG, 1980, CHEST, V79, P435; CAYTON HR, 1952, BRIT J IND MED, V9, P186; DESHAZO RD, 1983, ANN ALLERGY, V51, P166; DESHAZO RD, 1979, J IMMUNOL, V122, P692; DOR PJ, 1983, J ALLERGY CLIN IMMUN, V71, P363, DOI 10.1016/0091-6749(83)90063-5; ELISSALDE MH, 1979, AM IND HYG ASSOC J, V40, P1067, DOI 10.1080/15298667991430712; GODFREY H P, 1981, Journal of Histotechnology, V4, P80; HITCHCOCK M, 1973, ARCH ENVIRON HEALTH, V26, P177, DOI 10.1080/00039896.1973.10666252; JAMES MP, 1981, J INVEST DERMATOL, V78, P406; KUTZ SA, 1979, ENVIRON RES, V19, P405, DOI 10.1016/0013-9351(79)90065-3; LEMANSKE RF, 1983, J IMMUNOL, V131, P929; McKERROW C B, 1958, Br J Ind Med, V15, P75; Merchant J A, 1973, J Occup Med, V15, P222; MERRILL WW, 1983, AM REV RESPIR DIS, V127, P156; MITCHELL EB, 1982, LANCET, V1, P127; PETRONIO L, 1983, BRIT J IND MED, V40, P39; RICHERSON HB, 1979, J ALLERGY CLIN IMMUN, V64, P67, DOI 10.1016/0091-6749(79)90085-X; SCHACHTER EN, 1981, CHEST S, V79, P73; SCHILLING RSF, 1956, LANCET, V2, P261; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; VIRGULTO J, 1973, J APPL PHYSIOL, V35, P145, DOI 10.1152/jappl.1973.35.1.145	27	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	3					481	487		10.1016/0091-6749(85)90731-6	http://dx.doi.org/10.1016/0091-6749(85)90731-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ARC09	4031319				2022-12-18	WOS:A1985ARC0900011
J	SCHUYLER, MR; SCHMITT, D				SCHUYLER, MR; SCHMITT, D			ALVEOLAR MACROPHAGE CATABOLISM OF MICROPOLYSPORA-FAENI	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM MED CTR,CLEVELAND,OH 44106	US Department of Veterans Affairs; Veterans Health Administration (VHA)	SCHUYLER, MR (corresponding author), CASE WESTERN RESERVE UNIV,DEPT MED,10701 E BLVD,CLEVELAND,OH 44106, USA.				NIOSH CDC HHS [OH-00992] Funding Source: Medline	NIOSH CDC HHS		ALLEN PM, 1984, J IMMUNOL, V132, P323; BASELER MW, 1983, INFLAMMATION, V7, P387, DOI 10.1007/BF00916303; CASHNER FM, 1979, CLIN EXP IMMUNOL, V36, P266; COHN Z, 1963, J EXP MED, V188, P991; DELUSTRO F, 1982, J RETICULOENDOTH SOC, V31, P295; FINK JN, 1972, CHEST, V62, P277, DOI 10.1378/chest.62.3.277; GOLDSTEIN A, 1964, BIOSTATISTICS INTRO, P144; HARRIS JO, 1976, AM REV RESPIR DIS, V114, P29; HUNTER W, 1962, NATURE, V1, P499; JOHNSON HM, 1984, J IMMUNOL, V132, P413; JUERS JA, 1976, J CLIN INVEST, V58, P271, DOI 10.1172/JCI108468; KARNOVSKY ML, 1978, J IMMUNOL, V121, P809; KAWAI T, 1973, CLIN EXP IMMUNOL, V15, P123; KAWAI T, 1972, J ALLERGY CLIN IMMUN, V50, P276, DOI 10.1016/0091-6749(72)90026-7; KELLER RH, 1982, J CLIN IMMUNOL, V2, P46, DOI 10.1007/BF00915978; KELLER RH, 1982, J IMMUNOL, V128, P116; MCSHARRY C, 1983, CLIN ALLERGY, V13, P293, DOI 10.1111/j.1365-2222.1983.tb02603.x; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; RICHERSON HB, 1978, AM REV RESPIR DIS, V117, P5; RICHERSON HB, 1982, AM J PATHOL, V106, P409; SALVAGGIO J, 1975, J ALLERGY CLIN IMMUN, V56, P364, DOI 10.1016/0091-6749(75)90130-X; SCHUYLER M, 1984, SEMIN RESPIR MED, V5, P246, DOI 10.1055/s-2007-1011459; SCHUYLER M, 1984, EXP LUNG RES, V6, P159, DOI 10.3109/01902148409087903; SCHUYLER M, 1984, CONNECT TISSUE RES, V12, P87, DOI 10.3109/03008208408992774; SCHUYLER MR, 1981, AM REV RESPIR DIS, V123, P53; SCHUYLER MR, 1982, J LAB CLIN MED, V100, P932; SCHUYLER MR, 1983, AM REV RESPIR DIS, V128, P1071; SCHUYLER MR, 1984, AM REV RESPIR DIS, V130, P772; STANKUS RP, 1978, J IMMUNOL, V120, P685; WANNER A, 1977, AM REV RESPIR DIS, V116, P73; WEINSTOCK JV, 1983, J IMMUNOL, V130, P423; WEISSMANN G, 1980, NEW ENGL J MED, V303, P27; WERB Z, 1975, J EXP MED, V142, P361, DOI 10.1084/jem.142.2.361; WILLOUGHBY JB, 1977, J IMMUNOL, V119, P2137; WILSON BD, 1982, CELL IMMUNOL, V67, P90, DOI 10.1016/0008-8749(82)90201-5	35	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	4					614	622		10.1016/0091-6749(85)90784-5	http://dx.doi.org/10.1016/0091-6749(85)90784-5			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ATH66	4056249				2022-12-18	WOS:A1985ATH6600015
J	ACKLAND, J; STEWART, GA				ACKLAND, J; STEWART, GA			QUANTITATION AND THERMAL-STABILITY OF THE MITE ALLERGEN DPT-12 IN WHOLE MITE EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									COMMONWEALTH SERUM LABS,PARKVILLE,VIC 3052,AUSTRALIA		ACKLAND, J (corresponding author), PRINCESS MARGARET HOSP,CLIN IMMUNOL RES UNIT,PERTH 6008,WA,AUSTRALIA.							AGARWAL MK, 1982, J ALLERGY CLIN IMMUN, V70, P432, DOI 10.1016/0091-6749(82)90005-7; ANDERSON MC, 1982, J ALLERGY CLIN IMMUN, V69, P3, DOI 10.1016/0091-6749(82)90080-X; BAER H, 1980, J ALLERGY CLIN IMMUN, V66, P281, DOI 10.1016/0091-6749(80)90022-6; BAER H, 1974, J ALLERGY CLIN IMMUN, V54, P157, DOI 10.1016/0091-6749(74)90052-9; BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; BOUSQUET J, 1980, ANN ALLERGY, V45, P316; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; CHAPMAN MD, 1983, 11TH P INT C ALL CLI, P531; FORD AW, J ALLERGY CLIN IMMUN; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; HEARN MTW, 1981, J CHROMATOGR, V218, P483, DOI 10.1016/S0021-9673(00)82074-9; HIATT CW, 1977, J BIOL STAND, V5, P39, DOI 10.1016/0092-1157(77)90017-8; LAMAO J, 1983, J ALLERGY CLIN IMMUN, V71, P588; LIND P, 1980, ALLERGY, V35, P227, DOI 10.1111/j.1398-9995.1980.tb01756.x; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; STEWART GA, 1980, AUST J EXP BIOL MED, V58, P259, DOI 10.1038/icb.1980.26; STEWART GA, 1982, INT ARCH ALLER A IMM, V69, P224, DOI 10.1159/000233175; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; TURNER KJ, 1980, CLIN ALLERGY, V10, P441, DOI 10.1111/j.1365-2222.1980.tb02127.x; WEEKE B, 1973, SCAND J IMMUNOL, V2, P149, DOI 10.1111/j.1365-3083.1973.tb03796.x; WIDE L, 1967, LANCET, V2, P1105	22	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	6					848	854		10.1016/0091-6749(84)90189-1	http://dx.doi.org/10.1016/0091-6749(84)90189-1			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW418	6438211	Bronze			2022-12-18	WOS:A1984TW41800014
J	BLOCH, KJ; PERRY, RP; BLOCH, M; WALKER, WA				BLOCH, KJ; PERRY, RP; BLOCH, M; WALKER, WA			FEEDING OF ANTIGEN REDUCES ANTIGEN-BINDING ACTIVITY AND BLUNTS THE SECONDARY RESPONSE OF ACTIVELY IMMUNIZED RATS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MASSACHUSETTS GEN HOSP, GEN MED SERV, CLIN IMMUNOL UNIT, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, GEN MED SERV, ALLERGY UNIT, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, CHILDRENS SERV, PEDIAT GASTROINTESTINAL & NUTR UNIT, BOSTON, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital					NIADDK NIH HHS [AM-21505, AM-23099, AM-33506] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM021505] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDRE C, 1974, EUR J IMMUNOL, V4, P701, DOI 10.1002/eji.1830041013; BIERME SJ, 1982, RH HEMOLYTIC DISEASE, P249; BLOCH KJ, 1979, GASTROENTEROLOGY, V77, P1039; DAVID MF, 1979, J ALLERGY CLIN IMMUN, V64, P164, DOI 10.1016/0091-6749(79)90091-5; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HANSON DG, 1979, J IMMUNOL, V122, P2261; HERBART WJ, 1978, HDB EXPT IMMUNOLOGY; LAFONT S, 1982, J EXP MED, V155, P1573, DOI 10.1084/jem.155.5.1573; MINDEN P, 1978, HDB EXPT IMMUNOLOGY; SULLIVAN TJ, 1982, J ALLERGY CLIN IMMUN, V69, P275, DOI 10.1016/S0091-6749(82)80004-3; TOMASI TB, 1980, TRANSPLANTATION, V29, P353, DOI 10.1097/00007890-198005000-00001; WILLIAMS CA, 1967, METHODS IMMUNOLOGY I, V1, P201	12	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	4					482	488		10.1016/0091-6749(84)90382-8	http://dx.doi.org/10.1016/0091-6749(84)90382-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TN620	6491093				2022-12-18	WOS:A1984TN62000004
J	JACOBS, RL; LUX, GK; SPIELVOGEL, RL; EICHBERG, JW; GLEISER, CA				JACOBS, RL; LUX, GK; SPIELVOGEL, RL; EICHBERG, JW; GLEISER, CA			NASAL POLYPOSIS IN A CHIMPANZEE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WILFORD HALL USAF MED CTR, DIV MED, DEPT DERMATOL, LACKLAND AFB, TX 78236 USA; SW FDN RES & EDUC, DEPT MICROBIOL & INFECT DIS, SAN ANTONIO, TX 78284 USA; SW FDN RES & EDUC, DEPT LAB ANIM RESOURCES, SAN ANTONIO, TX 78284 USA	United States Department of Defense; United States Air Force; Texas Biomedical Research Institute; Texas Biomedical Research Institute	JACOBS, RL (corresponding author), WILFORD HALL USAF MED CTR, DIV MED, DEPT ALLERGY & IMMUNOL, LACKLAND AFB, TX 78236 USA.							BLOOD DC, 1974, VET MED, P179; BUSUTTIL A, 1978, J LARYNGOL OTOL, V92, P477, DOI 10.1017/S0022215100085649; ENGLISH GM, 1978, ALLERGY PRINCIPLES P, P977; JACOBS RL, 1983, ANN ALLERGY, V51, P500; MARX GF, 1973, ANESTHESIOLOGY, V39, P54, DOI 10.1097/00000542-197307000-00010; MOHAGHEGHPOUR N, 1969, COMP BIOCHEM PHYSIOL, V31, P437, DOI 10.1016/0010-406X(69)90025-5; MYERS D, 1974, LARYNGOSCOPE, V84, P833, DOI 10.1288/00005537-197405000-00014; NICHOLS RE, 1939, J AM VET MED ASSOC, V47, P56; SANTAGNESE PAD, 1979, AM J MED, V66, P121, DOI 10.1016/0002-9343(79)90491-1; SETTIPANE GA, 1977, J ALLERGY CLIN IMMUN, V59, P17, DOI 10.1016/0091-6749(77)90171-3; SIEGAL S, 1956, ARCH INTERN MED, V97, P431, DOI 10.1001/archinte.1956.00250220051005; SMALL P, 1981, ANN ALLERGY, V46, P317; SMITH HA, 1972, VET PATHOL, P1093; SPECTOR SL, 1979, J ALLERGY CLIN IMMUN, V64, P500, DOI 10.1016/0091-6749(79)90059-9; STICKLE RL, 1976, VET MED SM ANIM CLIN, V71, P1453; TURNER JAP, 1981, PEDIATRICS, V67, P805	16	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	1					61	63		10.1016/0091-6749(84)90087-3	http://dx.doi.org/10.1016/0091-6749(84)90087-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SZ648	6736484				2022-12-18	WOS:A1984SZ64800008
J	CUMMINGS, NP; MORRIS, HG; STRUNK, RC				CUMMINGS, NP; MORRIS, HG; STRUNK, RC			FAILURE OF CHILDREN WITH ASTHMA TO RESPOND TO DAILY ASPIRIN THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO,DENVER,CO 80202; NATL JEWISH HOSP & RES CTR,NATL ASTHMA CTR,DEPT MED,DENVER,CO 80206	University of Colorado System; University of Colorado Denver; National Jewish Health	CUMMINGS, NP (corresponding author), NATL JEWISH HOSP & RES CTR,NATL ASTHMA CTR,DEPT PEDIAT,DENVER,CO 80206, USA.							CLARKE CA, 1979, BR MED J, V256; DASILVA AM, 1976, PROSTAGLANDINS, V11, P71; FRIEDLAENDER S, 1947, ANN INTERN MED, V26, P734, DOI 10.7326/0003-4819-26-5-734; HUME M, 1977, SCAND J RESPIR DIS, V58, P284; KARIM SMM, 1967, BRIT J PHARM CHEMOTH, V31, P340, DOI 10.1111/j.1476-5381.1967.tb02003.x; KIMBERLY RP, 1979, ARTHRITIS RHEUM, V22, P281, DOI 10.1002/art.1780220311; KORDANSKY D, 1978, ANN INTERN MED, V88, P508, DOI 10.7326/0003-4819-88-4-508; LOCKEY RF, 1978, HOSP PRACT, V13, P129, DOI 10.1080/21548331.1978.11707389; LOCKEY RF, 1973, ANN INTERN MED, V78, P57, DOI 10.7326/0003-4819-78-1-57; MATHE AA, 1975, AM REV RESPIR DIS, V111, P313; MORRIS HG, 1981, PROSTAGLANDINS, V21, P771, DOI 10.1016/0090-6980(81)90234-3; MORRIS HG, 1980, ADV PROSTAGLANDIN TH, V80, P1759; OGORMAN T, 1977, GASTROENTEROLOGY, V72, P726; PEARSON RSB, 1963, SALICYLATES INT S, P170; RACHELEFSKY GS, 1975, PEDIATRICS, V56, P443; RUDOLF M, 1975, LANCET, V1, P450; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; SCHACHTER EN, 1978, ANN INTERN MED, V89, P287, DOI 10.7326/0003-4819-89-2-287_2; SETTIPANE GA, 1975, J ALLERGY CLIN IMMUN, V56, P215, DOI 10.1016/0091-6749(75)90092-5; SMITH AP, 1975, LANCET, V1, P39; SMITH AP, 1976, ADV PROSTAG THROMB R, V1, P449; SPECTOR SL, 1981, CHEST, V80, P676, DOI 10.1378/chest.80.6.676; STENIUS BSM, 1976, CLIN ALLERGY, V6, P119, DOI 10.1111/j.1365-2222.1976.tb01889.x; SZCZEKLIK A, 1978, THORAX, V33, P664, DOI 10.1136/thx.33.5.664; VEDANTHAN PK, 1977, J ALLERGY CLIN IMMUN, V60, P8, DOI 10.1016/0091-6749(77)90077-X; WEINBERGER M, 1978, NEW ENGL J MED, V299, P852, DOI 10.1056/NEJM197810192991603; YUNGINGER JW, 1973, J PEDIATR-US, V82, P218, DOI 10.1016/S0022-3476(73)80157-X	27	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	2					245	249		10.1016/0091-6749(83)90106-9	http://dx.doi.org/10.1016/0091-6749(83)90106-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QC188	6337200	Bronze			2022-12-18	WOS:A1983QC18800011
J	PAUWELS, RAR; VANDERSTRAETEN, MERP				PAUWELS, RAR; VANDERSTRAETEN, MERP			THE INVIVO BRONCHOCONSTRICTORY EFFECT OF ADENOSINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					103	103		10.1016/0091-6749(83)90182-3	http://dx.doi.org/10.1016/0091-6749(83)90182-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200059
J	PEERLESS, AG; RACHELEFSKY, GS; MICKEY, MR; KATZ, RM; SIEGEL, SC				PEERLESS, AG; RACHELEFSKY, GS; MICKEY, MR; KATZ, RM; SIEGEL, SC			BRONCHODILATOR CHARACTERISTICS OF NEBULIZED METAPROTERENOL SULFATE, ISOETHARINE, AND ATROPINE IN CHRONIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,DIV ALLERGY IMMUNOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA								ANDERSON SD, 1975, BRIT J DIS CHEST, V69, P1; BECK GJ, 1980, ANN ALLERGY, V44, P19; CAVANAUGH MJ, 1976, AM REV RESPIR DIS, V114, P517; CHEN WY, 1981, CHEST, V79, P653; CHERVINSKY P, 1977, ANN ALLERGY, V38, P107; CONNOLLY ME, 1971, BRIT J PHARMACOL, V43, P389; CROPP GJA, 1975, AM REV RESPIR DIS, V112, P599; DIXON WJ, 1981, BMDP STATISTICAL SOF; DUNN OJ, 1974, APPLIED STATISTICS; EMIRGIL C, 1976, CURR THER RES CLIN E, V19, P371; FAIRSHTER RD, 1980, CHEST, V78, P44, DOI 10.1378/chest.78.1.44; FISH JE, 1971, AM REV RESPIR DIS, V115, P371; HARRIS WS, 1973, ARCH INTERN MED, V131, P162, DOI 10.1001/archinte.131.1.162; HEMSTREET MPB, 1980, ANN ALLERGY, V4, P138; HOWARD LA, 1967, ANN ALLERGY, V25, P512; ITKIN IH, 1970, J ALLERGY, V45, P178, DOI 10.1016/0021-8707(70)90126-7; KEIGHLEY JF, 1966, ANN INTERN MED, V65, P985, DOI 10.7326/0003-4819-65-5-985; KLOCK LE, 1975, AM REV RESPIR DIS, V112, P371; LEIFER KN, 1975, ANN ALLERGY, V35, P69; MARINI JJ, 1980, CHEST, V77, P591, DOI 10.1378/chest.77.5.591; PAK CCF, 1982, AM REV RESPIR DIS, V125, P331; REILLY EB, 1974, CURR THER RES CLIN E, V16, P759; RIKER JB, 1980, CHEST, V78, P723, DOI 10.1378/chest.78.5.723; SCHOEFFEL RE, 1981, ANN ALLERGY, V46, P273; SHENFIELD GM, 1973, AM REV RESPIR DIS, V108, P501; SIEGEL S, 1979, CURRENT PROBLEMS PED, V9, P9; SIMONSSON BG, 1967, J CLIN INVEST, V46, P812; SLY RM, 1967, J ALLERGY, V40, P93, DOI 10.1016/0021-8707(67)90102-5; SOBOL BJ, 1974, ANN ALLERGY, V32, P137; SWARTS CL, 1976, CHEST, V70, P617, DOI 10.1378/chest.70.5.617; TINKELMAN DG, 1976, AM REV RESPIR DIS, V114, P87; WERNER N, 1980, PHARMACOL BASIS THER, P138; YU DYC, 1972, J APPL PHYSIOL, V32, P823, DOI 10.1152/jappl.1972.32.6.823; 1962, AM REV RESPIR DIS, V85, P762	34	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	6					702	708		10.1016/0091-6749(83)90633-4	http://dx.doi.org/10.1016/0091-6749(83)90633-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RW048	6358329				2022-12-18	WOS:A1983RW04800012
J	COUTURIER, P; BOUSQUET, J				COUTURIER, P; BOUSQUET, J			OCCUPATIONAL ALLERGY SECONDARY TO INHALATION OF GARLIC DUST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											COUTURIER, P (corresponding author), VALENCE & CHEST CLIN,ALLERGY CLIN,MONTPELLIER,FRANCE.							BENVENISTE J, 1981, CLIN ALLERGY, V11, P1, DOI 10.1111/j.1365-2222.1981.tb01559.x; COUTURIER P, 1980, REV FR ALLERGOL, V20, P145, DOI 10.1016/S0335-7457(80)80006-2; FALLERONI AE, 1981, J ALLERGY CLIN IMMUN, V68, P156, DOI 10.1016/0091-6749(81)90173-1	3	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	2					145	145		10.1016/0091-6749(82)90246-9	http://dx.doi.org/10.1016/0091-6749(82)90246-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PB591	7096823				2022-12-18	WOS:A1982PB59100014
J	PRYJMA, JR; MIKLASZEWSKA, J; HALUSZKA, J; SCISLICKI, A				PRYJMA, JR; MIKLASZEWSKA, J; HALUSZKA, J; SCISLICKI, A			DECREASE OF COMPLEMENT HEMOLYTIC-ACTIVITY AFTER AN ALLERGEN HOUSE DUST BRONCHIAL PROVOCATION TEST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL RES INST MOTHER & CHILD,RABKA,POLAND									ARROYAVE CM, 1977, CLIN ALLERGY, V7, P173, DOI 10.1111/j.1365-2222.1977.tb01439.x; BERRENS L, 1976, IMMUNOCHEMISTRY, V13, P367, DOI 10.1016/0019-2791(76)90369-4; BERRENS L, 1973, INT ARCH ALLER A IMM, V45, P30, DOI 10.1159/000230996; BOACKLE RJ, 1974, IMMUNOCHEMISTRY, V11, P543, DOI 10.1016/0019-2791(74)90245-6; BRUZDZINSKI H, 1976, OZNACZANIE POZIOMU I, V28, P377; COLLERAME ML, 1972, NEW ENGL J MED, V284, P459; GRANT JA, 1975, J IMMUNOL, V114, P1101; HALPRIN GM, 1973, AM REV RESPIR DIS, V108, P343; HALUSZA J, 1978, ALLERGOL IMMUNOPATH, V6, P163; HOOK WA, 1975, J IMMUNOL, V114, P1185; KAY AB, 1974, LANCET, V2, P916; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; ORIE NGM, 1973, P SPECIAL SECTIONAL; STEVENS E, 1979, MAST CELL ITS ROLE H, P296; THOMAS LL, 1979, J IMMUNOL, V123, P1468; THOMAS LL, 1979, J IMMUNOL, V123, P1462; TOPILSKY M, 1976, LANCET, V1, P813; 1962, AM REV RESPIR DIS, V85, P762	18	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	4					306	312		10.1016/0091-6749(82)90067-7	http://dx.doi.org/10.1016/0091-6749(82)90067-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PL151	6811647				2022-12-18	WOS:A1982PL15100011
J	HENDRIX, SG; PATTERSON, R; ZEISS, CR; SUSZKO, IM				HENDRIX, SG; PATTERSON, R; ZEISS, CR; SUSZKO, IM			FURTHER-STUDIES ON THE SAFETY OF POLYMERIZED ANTIGENS FOR IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611	Northwestern University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BACAL E, 1978, J ALLERGY CLIN IMMUN, V62, P289, DOI 10.1016/0091-6749(78)90160-4; HENDRIX S, 1980, J ALLERGY CLIN IMMUN, V65, P57, DOI 10.1016/0091-6749(80)90177-3; HENDRIX SG, 1980, J ALLERGY CLIN IMMUN, V66, P486, DOI 10.1016/0091-6749(80)90010-X; MELAM H, 1972, ALLERGIC DISEASES, P293; NORMAN PS, 1980, J ALLERGY CLIN IMMUN, V65, P87, DOI 10.1016/0091-6749(80)90191-8; PATTERSON R, 1978, J ALLERGY CLIN IMMUN, V61, P28, DOI 10.1016/0091-6749(78)90470-0; PATTERSON R, 1979, J ALLERGY CLIN IMMUN, V64, P155, DOI 10.1016/0091-6749(79)90089-7; PATTERSON R, 1977, J ALLERGY CLIN IMMUN, V59, P314, DOI 10.1016/0091-6749(77)90053-7; PATTERSON R, 1973, J IMMUNOL, V110, P1402; PATTERSON R, 1973, J IMMUNOL, V110, P1413; PATTERSON R, 1978, ALLERGY PRINCIPLES P, P877; PATTERSON R, 1976, 9TH P INT C ALL BUEN	12	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	2					124	128		10.1016/0091-6749(81)90007-5	http://dx.doi.org/10.1016/0091-6749(81)90007-5			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LB947	7451779				2022-12-18	WOS:A1981LB94700007
J	HENDELES, L; WEINBERGER, M				HENDELES, L; WEINBERGER, M			A TIME TO ABANDON THE USE OF IODIDES IN THE MANAGEMENT OF PULMONARY-DISEASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									UNIV IOWA, COLL PHARM, IOWA CITY, IA 52242 USA; UNIV IOWA, DIV PEDIAT ALLERGY & PULM, IOWA CITY, IA 52242 USA	University of Iowa; University of Iowa			Weinberger, Miles/H-6743-2019					BEGG TB, 1963, Q J MED, V32, P351; CARLSWEL.F, 1970, LANCET, V1, P1241; DOLAN TF, 1971, J PEDIATR-US, V79, P684; EKWO E, 1978, J ALLERGY CLIN IMMUN, V61, P240, DOI 10.1016/0091-6749(78)90198-7; FALLIERS CJ, 1966, J ALLERGY, V38, P183, DOI 10.1016/0021-8707(66)90041-4; GALINA MP, 1962, NEW ENGL J MED, V267, P1124, DOI 10.1056/NEJM196211292672205; MENEELY GR, 1962, AM REV RESPIR DIS, V85, P762; OSLER W, 1901, PRINCIPLES PRACTICE, P632; SEGAL S, 1964, J ALLERGY CLIN IMMUN, V35, P252; SHURE N, 1962, J ALLERGY, V33, P479, DOI 10.1016/0021-8707(62)90013-8; SIMON SW, 1961, J ALLERGY, V32, P493, DOI 10.1016/0021-8707(61)90003-X; WOLFF J, 1969, AM J MED, V47, P101, DOI 10.1016/0002-9343(69)90245-9; 1976, PEDIATRICS, V57, P272	13	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	3					177	178		10.1016/0091-6749(80)90035-4	http://dx.doi.org/10.1016/0091-6749(80)90035-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KH358	7410741				2022-12-18	WOS:A1980KH35800001
J	MUE, S; SHIBAHARA, S; SUZUKI, S; TAKAHASHI, M; HIDA, W; YAMAUCHI, K; OHMI, T; SASAKI, T; TAKISHIMA, T				MUE, S; SHIBAHARA, S; SUZUKI, S; TAKAHASHI, M; HIDA, W; YAMAUCHI, K; OHMI, T; SASAKI, T; TAKISHIMA, T			BRONCHIAL RESPONSE TO METHACHOLINE AND HISTAMINE IN MONKEYS WITH BETA-ADRENERGIC-BLOCKADE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MUE, S (corresponding author), TOHOKU UNIV, SCH MED, DEPT INTERNAL MED 1, SENDAI, MIYAGI 980, JAPAN.		Yamauchi, Kohei/N-2749-2016; Shibahara, Shigeki/M-3644-2014					COOKSON DU, 1963, AM REV RESPIR DIS, V88, P636; DAIN DS, 1975, J APPL PHYSIOL, V38, P1045, DOI 10.1152/jappl.1975.38.6.1045; DELAMATA RC, 1961, J PHARMACOL EXP THER, V135, P197; ISHIZAKA T, 1970, J IMMUNOL, V104, P854; KOELLE GB, 1975, PHARMACOL BASIS THER, P467; MCNEIL SR, 1964, AM J CARDIOL, V18, P473; MEAD J, 1960, J APPL PHYSIOL, V15, P325, DOI 10.1152/jappl.1960.15.3.325; MIDDLETON E, 1968, J ALLERGY, V42, P288, DOI 10.1016/0021-8707(68)90022-1; MUE S, 1975, TOHOKU J EXP MED, V117, P135, DOI 10.1620/tjem.117.135; MUE S, 1975, TOHOKU J EXP MED, V117, P125, DOI 10.1620/tjem.117.125; MUE S, 1975, TOHOKU J EXP MED, V115, P395, DOI 10.1620/tjem.115.395; NICOLAESCU V, 1972, RESPIRATION, V29, P139, DOI 10.1159/000192867; OREHEK J, 1975, J ALLERGY CLIN IMMUN, V55, P164, DOI 10.1016/0091-6749(75)90012-3; PATTERSON R, 1969, PROG ALLERGY, V13, P332, DOI 10.1159/000287510; PATTERSON R, 1976, J LAB CLIN MED, V87, P65; PATTERSON R, 1974, ANNU REV MED, V25, P53, DOI 10.1146/annurev.me.25.020174.000413; RADERMECKER M, 1972, Clinical Allergy, V2, P247, DOI 10.1111/j.1365-2222.1972.tb01289.x; REED CE, 1974, J ALLERGY CLIN IMMUN, V53, P34, DOI 10.1016/0091-6749(74)90097-9; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TSAI MJ, 1977, J APPL PHYSIOL, V43, P322, DOI 10.1152/jappl.1977.43.2.322; VIRTUE RW, 1967, ANESTHESIOLOGY, V28, P823, DOI 10.1097/00000542-196709000-00008; ZAID G, 1966, NEW ENGL J MED, V275, P580, DOI 10.1056/NEJM196609152751103	22	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	5					338	345		10.1016/0091-6749(80)90210-9	http://dx.doi.org/10.1016/0091-6749(80)90210-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JV955	6103013				2022-12-18	WOS:A1980JV95500004
J	PATTERSON, R; SUSZKO, IM; HENDRIX, S; ZEISS, CR; PRUZANSKY, JJ				PATTERSON, R; SUSZKO, IM; HENDRIX, S; ZEISS, CR; PRUZANSKY, JJ			POLYMERIZED INSOLUBLE BEE VENOM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PATTERSON, R (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,CHICAGO,IL 60611, USA.							BACAL E, 1978, J ALLERGY CLIN IMMUN, V62, P289, DOI 10.1016/0091-6749(78)90160-4; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; HENDRIX S, UNPUBLISHED; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; ILEA V, 1975, J ALLERGY CLIN IMMUN, V55, P74; LIDD D, 1962, J ALLERGY, V33, P45, DOI 10.1016/0021-8707(62)90062-X; METZGER WJ, 1976, NEW ENGL J MED, V295, P1160, DOI 10.1056/NEJM197611182952103; PATTERSON R, 1977, J ALLERGY CLIN IMMUN, V59, P314, DOI 10.1016/0091-6749(77)90053-7; PATTERSON R, 1973, J IMMUNOL, V110, P1402; PATTERSON R, 1973, J IMMUNOL, V110, P1413; PATTERSON R, UNPUBLISHED; REISMAN RE, 1978, ALLERGY PRINCIPLES P; SOBOTKA A, 1974, J ALLERGY CLIN IMMUN, V53, P103; ZEISS CR, 1977, CLIN EXP IMMUNOL, V28, P250	14	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	6					495	499		10.1016/0091-6749(80)90011-1	http://dx.doi.org/10.1016/0091-6749(80)90011-1			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KV363	7430506				2022-12-18	WOS:A1980KV36300010
J	GOLDEN, D; VALENTINE, MD; SOBOTKA, AK; LICHTENSTEIN, LM				GOLDEN, D; VALENTINE, MD; SOBOTKA, AK; LICHTENSTEIN, LM			REGIMENS OF HYMENOPTERA VENOM IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					180	180						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400155
J	KLEIN, GL; ONG, KS; UNDERWOOD, SB				KLEIN, GL; ONG, KS; UNDERWOOD, SB			THEOPHYLLINE SUPPRESSION OF LYMPHOCYTES-T BEARING FC RECEPTORS FOR IGM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					144	144						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400032
J	NORMAN, PS; MARSH, DG; LICHTENSTEIN, LM				NORMAN, PS; MARSH, DG; LICHTENSTEIN, LM			LONG-TERM IMMUNOTHERAPY WITH RAGWEED ALLERGEN AND ALLERGOID	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					167	167						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400108
J	ZEISS, CR; UNGS, CJ; LEVITZ, D; SUSZKO, IM; PATTERSON, R				ZEISS, CR; UNGS, CJ; LEVITZ, D; SUSZKO, IM; PATTERSON, R			IMMUNE-RESPONSE OF PATIENTS WITH RAGWEED HAY-FEVER TREATED WITH POLYMERIZED RAGWEED ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611	Northwestern University								BACAL E, 1978, J ALLERGY CLIN IMMUN, V62, P289, DOI 10.1016/0091-6749(78)90160-4; KING TP, 1976, ADV IMMUNOL, V23, P77, DOI 10.1016/S0065-2776(08)60319-3; METZGER WJ, 1976, NEW ENGL J MED, V295, P1160, DOI 10.1056/NEJM197611182952103; PATTERSON R, 1978, J ALLERGY CLIN IMMUN, V61, P28, DOI 10.1016/0091-6749(78)90470-0; PATTERSON R, 1974, INT ARCH ALLER A IMM, V46, P150, DOI 10.1159/000231119; PATTERSON R, 1973, J IMMUNOL, V110, P1402; PATTERSON R, 1973, J IMMUNOL, V110, P1413	7	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	4					273	275		10.1016/0091-6749(79)90112-X	http://dx.doi.org/10.1016/0091-6749(79)90112-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GR842	429704				2022-12-18	WOS:A1979GR84200008
J	ALLEN, DH; MATHISON, DA; WAGNER, PD; ARROYAVE, CM; PLOW, E; TAN, EM				ALLEN, DH; MATHISON, DA; WAGNER, PD; ARROYAVE, CM; PLOW, E; TAN, EM			MEDIATOR RELEASE DURING METHACHOLINE-INDUCED BRONCHOCONSTRICTION IN ASTHMATIC-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					140	140		10.1016/0091-6749(78)90279-8	http://dx.doi.org/10.1016/0091-6749(78)90279-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300040
J	MURANAKA, M; SUZUKI, S; KOIZUMI, K; IGARASHI, H; OKUMURA, H; TAKEDA, K; TADOKORO, K; HORIUCHI, Y				MURANAKA, M; SUZUKI, S; KOIZUMI, K; IGARASHI, H; OKUMURA, H; TAKEDA, K; TADOKORO, K; HORIUCHI, Y			BENZYLPENICILLIN PREPARATIONS CAN EVOKE A SYSTEMIC ANAPHYLACTIC REACTION IN GUINEA-PIGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MURANAKA, M (corresponding author), UNIV TOKYO,FAC MED,DEPT MED & PHYS THERAPY,TOKYO 113,JAPAN.							BANACERRAF B, 1963, J EXP MED, V117, P937; BATCHELOR FR, 1967, LANCET, V1, P1175; BROCKELHURST WE, 1967, HDB EXPT IMMUNOLOGY, P1152; BUTCHER BT, 1970, PENICILLIN ALLERGY C, P111; CASTILLO JC, 1947, J PHARMACOL EXP THER, V90, P104; IGARASHI H, 1978, INT ARCH ALLER A IMM, V57, P341, DOI 10.1159/000232123; KOIZUMI K, 1973, JAP J ALLERGY, V22, P627; KRAKOWKA S, 1975, TRANSPLANTATION, V20, P519, DOI 10.1097/00007890-197512000-00013; LEVINE BB, 1968, J CLIN INVEST, V47, P556, DOI 10.1172/JCI105752; LEVINE BB, 1971, J IMMUNOL, V106, P29; LEVINE BB, 1964, IMMUNOLOGY, V7, P527; LEVINE BB, 1962, J MED PHARMACEUT CH, V5, P1025, DOI 10.1021/jm01240a016; MURANAKA M, 1974, J ALLERGY CLIN IMMUN, V54, P329, DOI 10.1016/0091-6749(74)90023-2; MURANAKA M, 1976, 4TH P C JAP SOC CLIN, P160; OVARY Z, 1960, J IMMUNOL, V84, P409; OVARY Z, 1964, IMMUNOLOGICAL METHOD, P259; PERINI A, 1972, IMMUNOLOGY, V22, P915; STEWART GT, 1967, LANCET, V1, P1177; STEWART GT, 1967, ANTIMICROB AGENTS CH, P543; STREJAN G, 1967, J IMMUNOL, V98, P893; TADOKORO J, 1976, JAP J ALLERGOL, V25, P304; WECK ALD, 1968, INT ARCH ALLERGY, V33, P535; WESTON R, 1967, ANTIMICROB AGENTS CH, P553	23	10	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	62	5					276	282		10.1016/0091-6749(78)90158-6	http://dx.doi.org/10.1016/0091-6749(78)90158-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FW432	701662				2022-12-18	WOS:A1978FW43200004
J	PEPYS, J				PEPYS, J			ANTIGENS AND HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PEPYS, J (corresponding author), CARDIOTHORAC INST,LONDON SW3 6HP,ENGLAND.								0	10	10	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					201	203		10.1016/0091-6749(78)90178-1	http://dx.doi.org/10.1016/0091-6749(78)90178-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	147280				2022-12-18	WOS:A1978EV08000003
J	PLAUT, M; BERMAN, IJ				PLAUT, M; BERMAN, IJ			HISTAMINE RECEPTORS ON HUMAN AND MOUSE LYMPHOCYTES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					132	133		10.1016/0091-6749(78)90252-X	http://dx.doi.org/10.1016/0091-6749(78)90252-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173		Bronze			2022-12-18	WOS:A1978ES17300013
J	LEE, TP				LEE, TP			EFFECTS OF HISTAMINE-SENSITIZING FACTOR AND CORTISOL ON LYMPHOCYTE ADENYL-CYCLASE RESPONSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,DEPT MED,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison								BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BROWN BL, 1971, BIOCHEM J, V121, P561, DOI 10.1042/bj1210561; LEE TP, 1974, J ALLERGY CLIN IMMUN, V53, P283, DOI 10.1016/0091-6749(74)90107-9; LEE TP, 1975, ADV CYCLIC NUCLEOTID, V5, P815; LEHRER SB, 1974, J IMMUNOL, V113, P18; LEHRER SB, 1975, J IMMUNOL, V114, P34; MENDELSOHN J, 1973, J CLIN INVEST, V52, P2129, DOI 10.1172/JCI107397; MORSE SI, 1967, J EXP MED, V125, P619, DOI 10.1084/jem.125.4.619; MUNOZ J, 1963, J IMMUNOL, V90, P132; MUNOZ J, 1968, BACTERIOL REV, V32, P103, DOI 10.1128/MMBR.32.2.103-126.1968; OKUYAMA S, 1970, P SOC EXP BIOL MED, V133, P723, DOI 10.3181/00379727-133-34552; PARKER CW, 1973, J EXP MED, V137, P1078, DOI 10.1084/jem.137.4.1078; REED CE, 1972, J ALLERGY CLIN IMMUN, V49, P174, DOI 10.1016/0091-6749(72)90111-X; SATO Y, 1972, INFECT IMMUN, V6, P899, DOI 10.1128/IAI.6.6.899-904.1972; SATO Y, 1973, INFECT IMMUN, V7, P992, DOI 10.1128/IAI.7.6.992-999.1973; STRONK MG, 1955, J INFECT DIS, V96, P152, DOI 10.1093/infdis/96.2.152; SZENTIVANYI A, 1963, J INFECT DIS, V113, P86, DOI 10.1093/infdis/113.2.86; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2	18	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	1					79	82		10.1016/0091-6749(77)90181-6	http://dx.doi.org/10.1016/0091-6749(77)90181-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CS828	833377				2022-12-18	WOS:A1977CS82800013
J	LAMKIN, N; LIEBERMAN, P; SHEREFF, R; ROSENBERG, EW; ROBINSON, H				LAMKIN, N; LIEBERMAN, P; SHEREFF, R; ROSENBERG, EW; ROBINSON, H			EFFECT OF BETA-ADRENERGIC STIMULATION AND BLOCKADE ON CUTANEOUS REACTIVITY TO HISTAMINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV TENNESSEE,DEPT PREVENT & COMMUNITY MED,MEMPHIS,TN 38163; UNIV TENNESSEE,DEPT MED,DIV DERMATOL,ALLERGY IMMUNOL SECT,MEMPHIS,TN 38163	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center								ICHIKAWA A, 1972, BIOCHEM PHARMACOL, V21, P317, DOI 10.1016/0006-2952(72)90343-7; ICHIKAWA A, 1972, BIOCHEM PHARMACOL, V21, P2615, DOI 10.1016/0006-2952(72)90229-8; ISHIZAKA T, 1971, J IMMUNOL, V106, P1267; KALZ F, 1950, ARCH DERMATOL SYPH, V61, P772, DOI 10.1001/archderm.1950.01530120063005; LICHTENSTEIN LM, 1971, INT ARCH ALLER A IMM, V41, P56, DOI 10.1159/000230488; LUGNIER C, 1972, EUR J PHARMACOL, V19, P134, DOI 10.1016/0014-2999(72)90090-8; PERPER RJ, 1972, INT ARCH ALLER A IMM, V43, P837, DOI 10.1159/000230901; REED CE, 1974, MED CLIN N AM, V58, P55, DOI 10.1016/S0025-7125(16)32176-9; SHEREFF RH, 1973, J ALLERGY CLIN IMMUN, V52, P328, DOI 10.1016/0091-6749(73)90091-2; TRINER L, 1971, ANN NY ACAD SCI, V185, P458; YAMAMOTO S, 1973, IMMUNOLOGY, V24, P77	11	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	5					449	453		10.1016/0091-6749(76)90060-9	http://dx.doi.org/10.1016/0091-6749(76)90060-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BR201	4484				2022-12-18	WOS:A1976BR20100008
J	OKAZAKI, T; VERVLOET, D; ATTALLAH, A; LEE, JB; ARBESMAN, CE				OKAZAKI, T; VERVLOET, D; ATTALLAH, A; LEE, JB; ARBESMAN, CE			PROSTAGLANDINS AND ASTHMA - USE OF BLOOD COMPONENTS FOR METABOLIC STUDIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY, DEPT MICROBIOL, BUFFALO, NY 14222 USA; BUFFALO GEN HOSP, ALLERGY RES LAB, 100 HIGH ST, BUFFALO, NY 14203 USA; SUNY, DEPT MED, BUFFALO, NY 14222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College; Buffalo General Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College								ANGGARD E, 1966, ACTA PHYSIOL SCAND, V66, P509, DOI 10.1111/j.1748-1716.1966.tb03231.x; ANGGARD E, 1967, PROSTAGLANDINS, P97; BRUMMER HC, 1972, PROSTAGL, V2, P185, DOI 10.1016/S0090-6980(72)80022-4; BURKE G, 1973, PROSTAGLANDINS, V3, P291, DOI 10.1016/0090-6980(73)90067-1; CALDWELL BV, 1971, J CLIN ENDOCR METAB, V33, P171, DOI 10.1210/jcem-33-2-171; CERNOSEK RM, 1972, PROSTAGL, V1, P71, DOI 10.1016/0090-6980(72)90066-4; COLLIER HOJ, 1968, NATURE, V219, P864, DOI 10.1038/219864a0; COLLIER HOJ, 1971, NATURE, V232, P17, DOI 10.1038/232017a0; HAMPRECH.B, 1973, FEBS LETT, V36, P193, DOI 10.1016/0014-5793(73)80367-9; HEDQVIST P, 1973, 8 INT C ALL TOK, P95; HIGGINS CB, 1972, AM J MED, V53, P92, DOI 10.1016/0002-9343(72)90119-2; HIGGS GA, 1972, BRIT J PHARMACOL, V44, pP330; HORTON EW, 1965, BRIT J PHARM CHEMOTH, V24, P470, DOI 10.1111/j.1476-5381.1965.tb01736.x; JAFFE BM, 1973, J CLIN INVEST, V52, P398, DOI 10.1172/JCI107196; JAFFE BM, 1973, ADV BIOSCI, V9, P179; LICHTENSTEIN L M, 1973, P91; MATHE AA, 1973, BRIT MED J, V1, P193, DOI 10.1136/bmj.1.5847.193; MATHE AA, 1973, PROSTAGLANDINS, V4, P877, DOI 10.1016/0090-6980(73)90123-8; MATHE AA, 1973, ADV BIOSCI, V9, P241; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; MCDONALDGIBSON WJ, 1972, PROSTAGL, V2, P251, DOI 10.1016/S0090-6980(72)80013-3; NEEDLEMAN P, 1974, J PHARMACOL EXP THER, V188, P453; PACEASCIAK C, 1968, BIOCHIM BIOPHYS ACTA, V152, P784, DOI 10.1016/0005-2760(68)90126-4; PIPER P, 1971, ANN NY ACAD SCI, V180, P363, DOI 10.1111/j.1749-6632.1971.tb53205.x; RAMWELL PW, 1973, PERSPECTIVES PROSTAG, P8; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; SHEARD P, 1968, J PHARM PHARMACOL, V20, P232, DOI 10.1111/j.2042-7158.1968.tb09728.x; SILVER MJ, 1972, PROSTAGL, V1, P429, DOI 10.1016/0090-6980(72)90011-1; SILVER MJ, 1973, PROSTAGLANDINS, V4, P863, DOI 10.1016/0090-6980(73)90121-4; SMITH JB, 1970, BRIT J PHARMACOL, V40, pP545; SWEATMAN WJ, 1968, NATURE, V217, P69, DOI 10.1038/217069a0; TAUBER AI, 1973, J IMMUNOL, V111, P27; VANE J R, 1972, Hospital Practice, V7, P61; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0	34	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	2					124	133		10.1016/0091-6749(76)90031-2	http://dx.doi.org/10.1016/0091-6749(76)90031-2			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BE952	55427				2022-12-18	WOS:A1976BE95200004
J	DAVID, MF				DAVID, MF			PREVENTION OF HOMOCYTOTROPIC ANTIBODY-FORMATION AND ANAPHYLAXIS IN RATS BY PREFEEDING ANTIGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					135	135						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800161
J	DAVIS, RH; BERAN, AV; GALANT, SP				DAVIS, RH; BERAN, AV; GALANT, SP			CAPILLARY PH AND BLOOD-GAS DETERMINATIONS IN ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF,DEPT PEDIAT,IRVINE,CA 92664	University of California System; University of California Irvine								Abramson DI, 1942, AM HEART J, V23, P817, DOI 10.1016/S0002-8703(42)90683-5; ANDERSON LJ, 1968, CANCER, V21, P289, DOI 10.1002/1097-0142(196802)21:2&lt;289::AID-CNCR2820210219&gt;3.0.CO;2-C; BANNISTER A, 1969, ARCH DIS CHILDHOOD, V44, P726; DAVIS RH, 1974, J ALLERGY CLIN IMMUN, V53, P110; HUNT CE, 1973, PEDIATRICS, V51, P501; LAUGHLIN DE, 1964, J LAB CLIN MED, V64, P300; MACINTYRE J, 1968, BMJ-BRIT MED J, V3, P640, DOI 10.1136/bmj.3.5619.640; MORTENSEN JD, 1967, CIRCULATION, V35, P118; SIMPSON H, 1968, BRIT MED J, V3, P460, DOI 10.1136/bmj.3.5616.460; STRAUSS J, 1972, J APPL PHYSIOL, V33, P238, DOI 10.1152/jappl.1972.33.2.238	10	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	1					33	38		10.1016/0091-6749(75)90032-9	http://dx.doi.org/10.1016/0091-6749(75)90032-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AH615	237035	Green Submitted			2022-12-18	WOS:A1975AH61500004
J	DUNAND, P; CHAI, H; WELTMAN, D; SPAULDING, H; MELTZER, G				DUNAND, P; CHAI, H; WELTMAN, D; SPAULDING, H; MELTZER, G			POSTERIOR POLAR CATARACTS AND STEROID-THERAPY IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					123	123						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800134
J	KATZ, DH; STECHSCHULTE, DJ; BENACERRAF, B				KATZ, DH; STECHSCHULTE, DJ; BENACERRAF, B			INDUCTION OF IMMUNOLOGICAL-TOLERANCE IN IMMUNOGLOBULIN E B LYMPHOCYTES IN RATS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ROBERT B BRIGHAM HOSP,DEPT MED,BOSTON,MA; HARVARD UNIV,MED SCH,DEPT PATHOL,25 SHATTUCK ST,BOSTON,MA 02115	Harvard University; Harvard Medical School								AULT KA, 1974, P NATL ACAD SCI USA, V71, P3111, DOI 10.1073/pnas.71.8.3111; BENACERRAF B, 1962, J EXP MED, V115, P1023, DOI 10.1084/jem.115.5.1023; BINAGHI RA, 1964, J IMMUNOL, V92, P920; BOREL Y, 1971, NATURE-NEW BIOL, V230, P180, DOI 10.1038/newbio230180a0; ESHHAR Z, 1975, J IMMUNOL, V114, P872; FARR RS, 1958, J INFECT DIS, V103, P329; FIDLER JM, 1973, J EXP MED, V137, P42, DOI 10.1084/jem.137.1.42; GOLAN DT, 1971, J EXP MED, V134, P1046, DOI 10.1084/jem.134.4.1046; HAMAOKA T, 1974, J EXP MED, V139, P1446, DOI 10.1084/jem.139.6.1446; HAMILTON JA, 1973, EUR J IMMUNOL, V3, P457, DOI 10.1002/eji.1830030716; HAVAS HF, 1969, IMMUNOLOGY, V17, P819; KATZ DH, 1972, J EXP MED, V136, P1404, DOI 10.1084/jem.136.6.1404; KATZ DH, 1970, J EXP MED, V132, P261, DOI 10.1084/jem.132.2.261; KATZ DH, 1973, P NATL ACAD SCI USA, V70, P2776, DOI 10.1073/pnas.70.10.2776; KATZ DH, 1971, J EXP MED, V134, P201, DOI 10.1084/jem.134.1.201; KATZ DH, 1974, IMMUNOLOGICAL TOLERA, P189; NOSSAL GJV, 1973, J EXP MED, V138, P312, DOI 10.1084/jem.138.1.312; STECHSCHULTE DJ, 1973, INT ARCH ALLER A IMM, V45, P110, DOI 10.1159/000231012; STECHSCHULTE DJ, 1970, J IMMUNOL, V105, P1082; STECHSCHULTE DJ, 1967, J EXP MED, V125, P1271; WILSON RJM, 1968, J IMMUNOL, V100, P622	21	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	6					403	410		10.1016/0091-6749(75)90079-2	http://dx.doi.org/10.1016/0091-6749(75)90079-2			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AE593	48523	Bronze			2022-12-18	WOS:A1975AE59300007
J	RIEGER, CHL; KRAFT, SC; ROTHBERG, RM				RIEGER, CHL; KRAFT, SC; ROTHBERG, RM			ALTERATION OF T-CELL FUNCTION IN HEALTHY PERSONS WITH A HISTORY OF THYMIC X-IRRADIATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CHICAGO,PRITZKER SCH MED,DEPT PEDIAT,POB 244,950 E 59TH ST,CHICAGO,IL 60637; UNIV CHICAGO,PRITZKER SCH MED,DEPT MED,CHICAGO,IL 60637	University of Chicago; University of Chicago								ALFORD RH, 1973, P SOC EXP BIOL MED, V144, P826, DOI 10.3181/00379727-144-37691; ASQUITH P, 1973, GASTROENTEROLOGY, V65, P1; BLACKBURN WR, 1967, LAB INVEST, V16, P833; DAVID JR, 1973, NEW ENGL J MED, V288, P143; DEGROOT L, 1973, JAMA-J AM MED ASSOC, V225, P487, DOI 10.1001/jama.225.5.487; Doniach I, 1970, Monogr Neoplast Dis Var Sites, V6, P55; DUFFY BJ, 1950, CANCER, V3, P1018, DOI 10.1002/1097-0142(1950)3:6<1018::AID-CNCR2820030611>3.0.CO;2-H; FARR RS, 1958, J INFECT DIS, V103, P239, DOI 10.1093/infdis/103.3.239; HEMPELMANN LH, 1974, RADIAT RES, V58, P122, DOI 10.2307/3573955; KARCHER KH, 1973, STRAHLENTHER ONKOL, V145, P203; KIRKPATRICK CH, 1971, ANN INTERN MED, V74, P955, DOI 10.7326/0003-4819-74-6-955; LAWLOR GJ, 1973, J ALLERGY CLIN IMMUN, V52, P31, DOI 10.1016/0091-6749(73)90118-8; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MEUWISSEN HJ, 1968, J PEDIATR-US, V72, P177, DOI 10.1016/S0022-3476(68)80306-3; Miller J F, 1966, Clin Exp Immunol, V1, P61; MONTES LF, 1972, J AMER MED ASSOC, V222, P1619, DOI 10.1001/jama.222.13.1619; PACHMAN LM, 1970, J IMMUNOL, V105, P898; PIFER JW, 1963, J NATL CANCER I, V31, P1333; ROWE DS, 1970, INT ARCH ALLER A IMM, V39, P1; SCHNYDER T, 1969, STRAHLENTHER ONKOL, V137, P578; SHANNON DC, 1966, NEW ENGL J MED, V275, P690, DOI 10.1056/NEJM196609292751302; VALDIMARSSON H, 1973, CELL IMMUNOL, V6, P348, DOI 10.1016/0008-8749(73)90035-X	22	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	4					273	281		10.1016/0091-6749(75)90101-3	http://dx.doi.org/10.1016/0091-6749(75)90101-3			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AS523	126252				2022-12-18	WOS:A1975AS52300004
J	ROSENBERG, GL; ROSENTHAL, RR; NORMAN, PS				ROSENBERG, GL; ROSENTHAL, RR; NORMAN, PS			INHALATIONAL CHALLENGE WITH RAGWEED POLLEN IN RAGWEED-SENSITIVE ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					126	127						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800142
J	CLAMAN, HN; KARR, RM; KOHLER, PF; MASS, MF; MCINTOSH, RM; SAMS, WM; SMALL, P; STANFORD, RE; THORNE, EG				CLAMAN, HN; KARR, RM; KOHLER, PF; MASS, MF; MCINTOSH, RM; SAMS, WM; SMALL, P; STANFORD, RE; THORNE, EG			SYSTEMIC ALLERGIC VASCULITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO,DEPT PEDIAT,DENVER,CO 80220; UNIV COLORADO,DEPT MED,DIV CLIN IMMUNOL,DENVER,CO 80220; UNIV COLORADO,DEPT PATHOL,DIV DERMATOL,DENVER,CO 80220	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Denver								Braverman IM, 1970, SKIN SIGNS SYSTEMIC; CHURG J, 1951, AM J PATHOL, V27, P277; COCHRANE CG, 1971, J EXP MED, V134, pS75; COCHRANE CG, 1973, ADV IMMUNOL, V16, P186; DIXON FJ, 1958, ARCH PATHOL, V65, P18; GOCKE DJ, 1970, LANCET, V2, P1149; KOHLER PF, 1973, MEDICINE, V52, P419, DOI 10.1097/00005792-197309000-00006; LOWANCE DC, 1973, KIDNEY INT, V3, P167, DOI 10.1038/ki.1973.25; MCINTOSH RM, 1971, Q J MED, V40, P385; O'DUFFY JOHN D., 1965, CLEVELAND CLIN QUART, V32, P87; PIRQUET CFV, 1951, SERUM SICKNESS; VALDES AJ, 1968, FED PROC, V27, P246; ZIFF M, 1971, ANN INTERN MED, V75, P951, DOI 10.7326/0003-4819-75-6-951	13	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	54	1					54	64		10.1016/S0091-6749(74)80008-4	http://dx.doi.org/10.1016/S0091-6749(74)80008-4			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T5232	4275730				2022-12-18	WOS:A1974T523200007
J	FONTANA, VJ; INDYK, L; ZANJANIAN, M				FONTANA, VJ; INDYK, L; ZANJANIAN, M			RAGWEED POLLEN CHALLENGES IN A CONTROLLED ENVIRONMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ST VINCENTS HOSP & MED CTR, DEPT PEDIAT & PEDIAT ALLERGY, NEW YORK, NY USA	Saint Vincents Hospital Manhattan								BLUMSTEIN GI, 1937, J ALLERGY, V8, P321; CONNELL JT, 1968, J ALLERGY, V41, P123, DOI 10.1016/0021-8707(68)90053-1; CONNELL JT, 1969, J ALLERGY, V43, P33, DOI 10.1016/0021-8707(69)90018-5; FEINBERG SAMUEL M., 1933, JOUR ALLERGY, V5, P19, DOI 10.1016/S0021-8707(33)90166-5; FONTANA VJ, 1966, NEW YORK STATE J MED, V66, P2913; FONTANA VJ, 1969, J ALLERGY, V43, P16, DOI 10.1016/0021-8707(69)90016-1; MOCK DC, 1963, J ALLERGY, V34, P432, DOI 10.1016/0021-8707(63)90008-X; OGDEN EC, 1967, J ALLERGY, V40, P1, DOI 10.1016/0021-8707(67)90053-6; SHELDON JM, 1957, ATMOSPHERIC POLLUTIO; SOLOMON WR, 1969, J ALLERGY, V43, P181; TUFT L, 1950, J ALLERGY, V21, P326, DOI 10.1016/0021-8707(50)90066-9	11	10	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	54	4					235	243		10.1016/0091-6749(74)90066-9	http://dx.doi.org/10.1016/0091-6749(74)90066-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U3236	4415465				2022-12-18	WOS:A1974U323600006
J	HUBSCHER, T; BOOTELLO, A; EISEN, AH				HUBSCHER, T; BOOTELLO, A; EISEN, AH			HUMAN SKIN TARGET-CELLS - NATURE AND FATE IN IMMEDIATE HYPERSENSITIVITY REACTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MCGILL UNIV, MONTREAL CHILDRENS HOSP,RES INST, ANNIE & NATHAN STEINBERG LAB ALLERGY & IMMUNOL, DEPT, MONTREAL 108, QUEBEC, CANADA	McGill University								BOREUS LO, 1960, ACTA PHYSIOL SCAND, V48, P431, DOI 10.1111/j.1748-1716.1960.tb01876.x; HUBSCHER T, 1972, J ALLERGY CLIN IMMUN, V49, P91; HUBSCHER T, 1970, J IMMUNOL, V104, P1196; HUBSCHER T, 1970, J IMMUNOL, V104, P1187; ISHIZAKA T, 1971, J IMMUNOL, V106, P705; ISHIZAKA T, 1970, J IMMUNOL, V104, P854; KELLER R, 1964, INT ARCH ALLER A IMM, V24, P255, DOI 10.1159/000229465; KELLER R, 1966, MONOGRAPHS ALLERGY, V2; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; MCCONAHEY PJ, 1966, INT ARCH ALLER A IMM, V29, P185, DOI 10.1159/000229699; MOTA I, 1960, NATURE, V186, P245, DOI 10.1038/186245a0; PATTERSON R, 1971, J IMMUNOL, V106, P1274; PROUVOSTDANON A, 1970, IMMUNOLOGY, V18, P749; STUART EG, 1952, ANAT REC, V112, P394; TAICHMAN NS, 1971, INT ARCH ALLER A IMM, V40, P334; TOMIOKA H, 1971, J IMMUNOL, V107, P971; UNDERDOWN BJ, 1969, BIOCHEMISTRY-US, V8, P980, DOI 10.1021/bi00831a031; WOFSY L, 1969, J IMMUNOL, V103, P380	18	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	3					150	157		10.1016/0091-6749(74)90003-7	http://dx.doi.org/10.1016/0091-6749(74)90003-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S3550	4130685				2022-12-18	WOS:A1974S355000003
J	MAUR, KV; ADKINSON, NF; VANMETRE, TE; MARSH, DG; NORMAN, PS				MAUR, KV; ADKINSON, NF; VANMETRE, TE; MARSH, DG; NORMAN, PS			ASPIRIN INTOLERANCE IN A FAMILY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									JOHNS HOPKINS UNIV,SCH MED,CLIN IMMUNOL DIV,BALTIMORE,MD; JOHNS HOPKINS HOSP,ALLERGY CLIN,BALTIMORE,MD; GOOD SAMARITAN HOSP,CLIN IMMUNOL DIV,5601 LOCH RAVEN BLVD,BALTIMORE,MD 21239	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine								AMOS DB, 1969, TRANSPLANTATION, V7, P220, DOI 10.1097/00007890-196903000-00023; BENACERR.B, 1972, SCIENCE, V175, P273, DOI 10.1126/science.175.4019.273; BIAS WB, 1973, AM J HUM GENET, V25, pA16; BIAS WB, TO BE PUBLISHED; BLUMENTHAL M, 1974, Journal of Allergy and Clinical Immunology, V53, P93; BRUCEPEARSON RS, 1963, SALICYLATES, P170; Cooke RA, 1919, J AMER MED ASSOC, V73, P759, DOI 10.1001/jama.1919.02610360029008; CUTHBERT NS, 1972, PROSTAGLANDINS PHARM, P251; DEWECK AL, 1971, INT ARCH ALLER A IMM, V41, P393, DOI 10.1159/000230534; Dysart BR, 1933, J AMER MED ASSOC, V101, P446, DOI 10.1001/jama.1933.27430310002009a; FALLIERS CJ, 1973, J ALLERGY CLIN IMMUN, V52, P141, DOI 10.1016/0091-6749(73)90030-4; FARR RS, 1970, J ALLERGY, V45, P321, DOI 10.1016/0021-8707(70)90040-7; Francis N, 1935, J ALLERGY, V6, P504; FRIEDLAENDER S, 1947, ANN INTERN MED, V26, P734, DOI 10.7326/0003-4819-26-5-734; GILMAN A, 1964, AM J MED, V36, P167, DOI 10.1016/0002-9343(64)90080-4; GIRALDO B, 1969, ANN INTERN MED, V71, P479, DOI 10.7326/0003-4819-71-3-479; GIRARD JP, 1969, HELV MED ACTA, V35, P56; GLENN EM, 1972, P SOC EXP BIOL MED, V139, P290; HAWKINS D, 1969, J CLIN INVEST, V48, P536, DOI 10.1172/JCI106011; HEDQVIST P, 1971, ACTA PHYSIOL SCAND, V82, pA29, DOI 10.1111/j.1748-1716.1971.tb05033.x; HIRSCHBERG, 1902, DEUT MED WOCHENSCHR, V28, P416; HOFFMAN DR, 1970, J IMMUNOL, V104, P582; IDSOE O, 1968, B WORLD HEALTH ORGAN, V38, P159; ISHIZAKA K, 1970, J IMMUNOL, V105, P1459; LEVINE BB, 1972, SCIENCE, V178, P1201, DOI 10.1126/science.178.4066.1201; LEVINE R, 1971, ANN NY ACAD SCI, V180, P336, DOI 10.1111/j.1749-6632.1971.tb53202.x; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; LOCKEY RF, 1973, ANN INTERN MED, V78, P57, DOI 10.7326/0003-4819-78-1-57; Maresh MM, 1940, AM J DIS CHILD, V60, P841, DOI 10.1001/archpedi.1940.02000040060005; MARSH DG, 1972, IMMUNOLOGY, V22, P1013; MARSH DG, 1974, SEP P NAT AC SCI; MARSH DG, 1974, 8 P INT C ALL AMST; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; MCDEVITT HO, 1972, AM J MED, V52, P1, DOI 10.1016/0002-9343(72)90002-2; MCDEVITT HO, 1972, GENETIC CONTROL IMMU; MCDONALD JR, 1972, J ALLERGY CLIN IMMUN, V50, P198, DOI 10.1016/0091-6749(72)90014-0; MILLER FF, 1971, ANN ALLERGY, V29, P263; MINDEN P, 1967, ARTHRITIS RHEUM, V10, P299; PINCKARD RN, 1968, NATURE, V219, P68, DOI 10.1038/219068a0; PIPER P, 1971, ANN NY ACAD SCI, V180, P363, DOI 10.1111/j.1749-6632.1971.tb53205.x; PIPER PJ, 1969, NATURE, V223, P29, DOI 10.1038/223029a0; PIPER PJ, 1969, PROSTAGLANDINS PEPTI, P15; Prickman LE, 1937, J AMER MED ASSOC, V108, P445, DOI 10.1001/jama.1937.02780060011004; PRICKMAN LE, 1937, JAMA-J AM MED ASSOC, V108, P455; ROSENTHALE ME, 1972, J PHARM PHARMACOL, V24, P149, DOI 10.1111/j.2042-7158.1972.tb08948.x; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; SAMTER M, 1967, J ALLERGY, V40, P281, DOI 10.1016/0021-8707(67)90076-7; SAMTER M, 1973, HOSP PRACT, V8, P85; SMITH MJH, 1966, SALICYLATES, P235; SNIDER D E, 1973, Clinical Research, V21, P819; STARR WR, 1971, ANN ALLERGY, V29, P498; VANDERVEER A, 1920, NY MED J, V112, P392; VANE J R, 1972, Hospital Practice, V7, P61; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VANLEEUWEN WS, 1928, MUCH MED WOECHENSCHR, V75, P1588; VANSELOW NA, 1967, ANN INTERN MED, V66, P568, DOI 10.7326/0003-4819-66-3-568; WEINER LM, 1963, J IMMUNOL, V90, P788; WIJNJA L, 1966, LANCET, V2, P768; WILMER GD, 1968, J CLIN INVEST, V47, P2616; YUNGINGER JW, 1973, J PEDIATR-US, V82, P218, DOI 10.1016/S0022-3476(73)80157-X; YURCHAK AM, 1970, J ALLERGY, V46, P245, DOI 10.1016/0021-8707(70)90028-6; ZIMMERMAN HJ, 1974, N ENGL J MED, V80, P103; 1968, JAMA, V203, P31	63	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	54	6					380	395						16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U9288					2022-12-18	WOS:A1974U928800006
J	BAER, RL				BAER, RL			ALLERGIC CONTACT SENSITIZATION TO IRON	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NYU,MED CTR,DEPT DERMATOL,NEW YORK,NY 10016	New York University								BAER RL, 1964, ARCH DERMATOL, V89, P3, DOI 10.1001/archderm.1964.01590250009003; BURNET FM, 1961, SCIENCE, V133, P307, DOI 10.1126/science.133.3449.307; Fregert S, 1969, Trans St Johns Hosp Dermatol Soc, V55, P17; HARPER HA, 1967, REVIEW PHYSIOLOGICAL; MEDAWAR PB, 1961, SCIENCE, V133, P303, DOI 10.1126/science.133.3449.303; NATER J P, 1960, Hautarzt, V11, P223; RUDZKI E, 1970, BRIT J DERMATOL, V83, P543, DOI 10.1111/j.1365-2133.1970.tb15738.x; WEST ES, 1966, TEXTBOOK BIOCHEMISTR	8	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	1					35	38		10.1016/0091-6749(73)90006-7	http://dx.doi.org/10.1016/0091-6749(73)90006-7			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O5651	4264567	Bronze			2022-12-18	WOS:A1973O565100005
J	BRASHER, GW; HALL, FF; BOURLAND, PD				BRASHER, GW; HALL, FF; BOURLAND, PD			SERUM IGD CONCENTRATIONS IN CHILDREN WITH ATOPIC DISEASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SCOTT & WHITE MEM HOSP,SCOTT SHERWOOD & BRINDLEY FDN,SCOTT & WHITE CLIN,DEPT ALLERGY & IMMUNOL,TEMPLE,TX 76501; SCOTT & WHITE MEM HOSP,SCOTT SHERWOOD & BRINDLEY FDN,SCOTT & WHITE CLIN,DEPT PHYS,TEMPLE,TX 76501; SCOTT WHITE MEM HOSP,SCOTT SHERWOOD & BRINDLEY FDN,SCOTT & WHITE CLIN,DEPT CLIN PATHOL,SECT,TEMPLE,TX 76501	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center								BERG T, 1969, INT ARCH ALLER A IMM, V36, P219, DOI 10.1159/000230745; BERG T, 1969, ACTA PAEDIATR SCAND, V58, P513, DOI 10.1111/j.1651-2227.1969.tb04753.x; BRASHER GW, 1969, J PEDIATR, V74, P784, DOI 10.1016/S0022-3476(69)80143-5; BRASHER GW, 1971, ANN ALLERGY, V29, P422; BRASHER GW, 1972, ANN ALLERGY, V30, P241; FISHKIN BG, 1970, AM J CLIN PATHOL, V53, P209; GLEICH GJ, 1969, SCIENCE, V165, P606, DOI 10.1126/science.165.3893.606; HARTLEY TF, 1966, ARCH NEUROL-CHICAGO, V15, P472, DOI 10.1001/archneur.1966.00470170026003; ISHIZAKA K, 1966, J ALLERGY, V37, P336, DOI 10.1016/0021-8707(66)90133-X; ISHIZAKA K, 1970, CLIN EXP IMMUNOL, V6, P25; JOHANSSO.SG, 1968, ACTA PATHOL MIC SC, V74, P519; JOHANSSO.SG, 1967, LANCET, V2, P951; KANTOR GL, 1970, CLIN EXP IMMUNOL, V6, P951; KAUFMAN HS, 1970, LANCET, V2, P1061; KOHLER PF, 1967, J ALLERGY, V39, P311, DOI 10.1016/0021-8707(67)90095-0; MERRILL D, 1967, J LAB CLIN MED, V69, P151; PERELMUTTER L, 1966, INT ARCH ALLER A IMM, V29, P364, DOI 10.1159/000229717; RITCHIE RF, 1968, ARTHRITIS RHEUM, V11, P506; ROWE DS, 1965, J EXP MED, V121, P171, DOI 10.1084/jem.121.1.171; SALVAGGIO JE, 1970, J ALLERGY, V46, P326, DOI 10.1016/0021-8707(70)90083-3	20	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	3					167	171		10.1016/0091-6749(73)90033-X	http://dx.doi.org/10.1016/0091-6749(73)90033-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q7045	4199035				2022-12-18	WOS:A1973Q704500005
J	GUIRGIS, HA; TOWNLEY, RG				GUIRGIS, HA; TOWNLEY, RG			BIOCHEMICAL STUDY ON SPUTUM IN ASTHMA AND EMPHYSEMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					86	86		10.1016/S0091-6749(73)80020-X	http://dx.doi.org/10.1016/S0091-6749(73)80020-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300020
J	SMITH, RS; SHERMAN, NA; MIDDLETON, E				SMITH, RS; SHERMAN, NA; MIDDLETON, E			EFFECT OF HYDROCORTISONE AND ISOPROTERENOL ON IMMUNOGLOBULIN-SYNTHESIS BY PERIPHERAL-BLOOD LYMPHOCYTES OF PATIENTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHILDRENS ASTHMA RES INST & HOSP, DENVER, CO 80204 USA									BERNSTEIN RA, 1972, J ALLERGY CLIN IMMUN, V49, P86, DOI 10.1016/0091-6749(72)90060-7; BLISS CI, 1967, STATISTICS BIOLOGY; FARR RS, 1958, J INFECT DIS, V103, P239, DOI 10.1093/infdis/103.3.239; Hadden J W, 1970, Cell Immunol, V1, P583, DOI 10.1016/0008-8749(70)90024-9; ISHIZAKA K, 1971, BIOCHEMISTRY ACUTE A; JUJI F, 1972, J ALLERGY CLIN IMMUN, V49, P90; KUMAR L, 1971, PEDIATRICS, V47, P848; MIDDLETON E, IN PRESS; NELSON HS, 1972, J ALLERGY CLIN IMMUN, V49, P105; REED C, 1970, 7 P INT C ALL AMST; SHERMAN NA, TO BE PUBLISHED; SMITH R S, 1970, Journal of Immunology, V104, P367; SMITH RF, TO BE PUBLISHED; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TADA T, 1970, Journal of Immunology, V104, P377; TOWNLEY RG, 1972, J ALLERGY CLIN IMMUN, V49, P88	16	10	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	6					328	334		10.1016/0091-6749(73)90071-7	http://dx.doi.org/10.1016/0091-6749(73)90071-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P8319		Bronze			2022-12-18	WOS:A1973P831900002
J	PATTERSON, R; SLAVIN, R; ZEISS, CR; FINK, JN; PRUZANSKY, JJ; ROBERTS, M; REED, C				PATTERSON, R; SLAVIN, R; ZEISS, CR; FINK, JN; PRUZANSKY, JJ; ROBERTS, M; REED, C			SERUM IMMUNOGLOBULIN E IN PULMONARY ALLERGIC ASPERGILLOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		GLEICH GJ, 1971, J LAB CLIN MED, V77, P690	1	10	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					98	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700030
J	WICHER, V; DOLOVICH, J				WICHER, V; DOLOVICH, J			PROTEINASE-DEPENDENT FALSE POSITIVE PRECIPITIN TESTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note																		BELIN L, 1970, LANCET, V2, P1153; DOLOVICH J, 1972, J ALLERGY CLIN IMMUN, V49, P43, DOI 10.1016/0091-6749(72)90122-4; DOLOVICH J, 1971, J LAB CLIN MED, V77, P951; FLINDT MLH, 1969, LANCET, V1, P1177; FORSGREN A, 1966, J IMMUNOL, V97, P822; FRANZ T, 1971, J ALLERGY, V47, P170, DOI 10.1016/S0091-6749(71)80295-6; GOCKE DJ, 1970, J IMMUNOL, V104, P1031; KUNIN CM, 1970, P SOC EXP BIOL MED, V133, P858; LONGBOTTOM JL, 1964, J PATHOL BACTERIOL, V88, P141, DOI 10.1002/path.1700880119; MORSE JH, 1968, IMMUNOLOGY, V14, P713; NIECE JL, 1963, NATURE, V197, P1021, DOI 10.1038/1971021a0; PITNEY WR, 1970, BRIT J HAEMATOL, V19, P67, DOI 10.1111/j.1365-2141.1970.tb01602.x; POLGAR L, 1968, BIOCHEM, V6, P1344; SLAVIN RG, 1971, J ALLERGY, V47, P97; VANOSS CJ, 1971, PREP BIOCHEM, V1, P163, DOI 10.1080/00327487108081937; WICHER V, 1971, INT ARCH ALLER A IMM, V40, P779, DOI 10.1159/000230462	16	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	1					59	&		10.1016/0091-6749(72)90124-8	http://dx.doi.org/10.1016/0091-6749(72)90124-8			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L3388	4621375				2022-12-18	WOS:A1972L338800008
J	SMITH, JM				SMITH, JM			LONG-TERM EFFECT OF MOVING ON PATIENTS WITH ASTHMA AND HAY FEVER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BRODER I, 1962, J ALLERGY, V33, P524, DOI 10.1016/0021-8707(62)90020-5; Cooke RA, 1947, ALLERGY THEORY PRACT; FINE AJ, 1960, J ALLERGY, V31, P375, DOI 10.1016/0021-8707(60)90074-5; HAGY GW, 1969, J ALLERGY, V44, P323, DOI 10.1016/0021-8707(69)90024-0; MATERNOWSKI CJ, 1962, J ALLERGY, V33, P130; PINESS G, 1928, J ALLERGY, V1, P117; RACKEMANN FM, 1952, NEW ENGL J MED, V246, P815, DOI 10.1056/NEJM195205222462104	7	10	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	4					191	&		10.1016/0091-6749(71)90065-0	http://dx.doi.org/10.1016/0091-6749(71)90065-0			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5566	5285771				2022-12-18	WOS:A1971K556600001
J	Yang, L; Fu, JR; Han, X; Zhang, CY; Xia, L; Zhu, RH; Huang, SH; Xiao, WF; Yu, HM; Gao, YJ; Liang, QY; Li, W; Zhou, YF				Yang, Lan; Fu, Jinrong; Han, Xiao; Zhang, Caiyan; Xia, Li; Zhu, Ronghui; Huang, Saihua; Xiao, Wenfeng; Yu, Hongmiao; Gao, Yajing; Liang, Qiuyan; Li, Wei; Zhou, Yufeng			Hsa_circ_0004287 inhibits macrophagemediated inflammation in an N-6-methyladenosine-dependent manner in atopic dermatitis and psoriasis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Circular RNA; atopic dermatitis; psoriasis; macrophage activation; N-6-methyladenosine	MESSENGER-RNA; EXPRESSION	Background: Circular RNA (circRNA) has been implicated in various diseases; however, its role in atopic dermatitis (AD) or psoriasis remains unclear. Objective: We sought to determine the differential expression profiles of circRNAs in peripheral blood mononuclear cells between healthy controls and AD patients, and explore the mechanisms underlying the effects of circRNAs on the pathogenesis of AD. Methods: The differential expression profiles of circRNAs were analyzed by circRNA microarray. In vitro function and mechanisms by which circRNAs regulate macrophage-mediated inflammation were detected by reverse transcription quantitative PCR, Western blot analysis, RNA stability assay, immunoprecipitation, ELISA, and methylated RNA immunoprecipitation assay. In vivo roles of circRNAs were determined in 2,4-dinitrochlorobenzene (DNCB)-induced dermatitis and imiquimod (IMQ)-induced psoriasis mouse model. Results: We identified a functional unknown circRNA hsa_circ_0004287 from 88750 circRNAs, which was upregulated in peripheral blood mononuclear cells of both AD and psoriasis patients, and was mainly expressed by macrophages under inflammatory conditions. Hsa_circ_0004287 inhibited M1 macrophage activation in vitro, and macrophage-specific overexpression of hsa_circ_0004287 alleviated skin inflammation in both AD- and psoriasis-like mice. Mechanistically, hsa_circ_0004287 reduced the stability of its host gene metastasis associated lung adenocarcinoma transcript 1 (MALAT1) by competitively binding to IGF2BP3 with MALAT1 in an N-6-methyladenosine (m(6)A)-dependent manner. Lower levels of MALAT1 promoted the ubiquitination degradation of S100A8/S100A9, thereby impeding p38/mitogen-activated protein kinase phosphorylation and macrophagemediated inflammation. Conclusion: hsa_circ_0004287 inhibits M1 macrophage activation in an m(6)A-dependent manner in AD and psoriasis, and may serve as a general therapeutic candidate for AD and psoriasis.	[Yang, Lan; Fu, Jinrong; Han, Xiao; Zhang, Caiyan; Xia, Li; Huang, Saihua; Xiao, Wenfeng; Yu, Hongmiao; Gao, Yajing; Liang, Qiuyan; Zhou, Yufeng] Fudan Univ, Inst Pediat, Childrens Hosp, Natl Childrens Med Ctr, Shanghai, Peoples R China; [Yang, Lan; Fu, Jinrong; Han, Xiao; Zhang, Caiyan; Xia, Li; Huang, Saihua; Xiao, Wenfeng; Yu, Hongmiao; Gao, Yajing; Liang, Qiuyan; Zhou, Yufeng] Fudan Univ, Shanghai Key Lab Med Epigenet, Int Colab Med Epigenet & Metab, Minist Sci & Technol,Inst Biomed Sci, Shanghai, Peoples R China; [Yang, Lan; Han, Xiao; Xia, Li; Huang, Saihua; Xiao, Wenfeng; Yu, Hongmiao; Gao, Yajing; Liang, Qiuyan; Zhou, Yufeng] Fudan Univ, Natl Hlth Commiss Key Lab Neonatal Dis, Shanghai, Peoples R China; [Fu, Jinrong] Fudan Univ, Childrens Hosp, Dept Gen Med, Shanghai, Peoples R China; [Zhang, Caiyan] Fudan Univ, Childrens Hosp, Dept Crit Care Med, Shanghai, Peoples R China; [Zhu, Ronghui; Li, Wei] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Zhou, YF (corresponding author), 399 Wanyuan Rd, Shanghai 201102, Peoples R China.; Li, W (corresponding author), 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	liweiderma@fudan.edu.cn; yfzhou1@fudan.edu.cn		zhou, Yufeng/0000-0002-6050-4951	National Key Research and Development Program of China [2021YFC2701800, 2021YFC2701802, 2016YFC1305102]; National Natural Science Foundation of China [81974248, 81671561, 81900751, 82100033, 82003349]; International Joint Laboratory Program of National Children's Medical Center [EK1125180109]; Program for Outstanding Medical Academic Leader [2019LJ19]; Shanghai Municipal Planning Commission of Science and Research Fund [201740065, 20174Y0079]; Shanghai Pujiang Program [16PJ1401600]; Shanghai Committee of Science and Technology [21140902400, 21ZR1410000, 19ZR1406400, 20ZR1408300]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Joint Laboratory Program of National Children's Medical Center; Program for Outstanding Medical Academic Leader; Shanghai Municipal Planning Commission of Science and Research Fund; Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by grants from the National Key Research and Development Program of China (2021YFC2701800, 2021YFC2701802, and 2016YFC1305102 to Y.Z.) , the National Natural Science Foundation of China (81974248, 81671561 to Y.Z., 81900751 to X.H., 82100033 to S.H., 82003349 to W.L.) , the International Joint Laboratory Program of National Children?s Medical Center (EK1125180109 to Y.Z.) , the Program for Outstanding Medical Academic Leader (2019LJ19 to Y.Z.) , the Shanghai Municipal Planning Commission of Science and Research Fund (201740065 to Y.Z. and 20174Y0079 to X.H.) , the Shanghai Pujiang Program (16PJ1401600 to J.F.) , and the Shanghai Committee of Science and Technology (21140902400 to Y.Z., 21ZR1410000, 19ZR1406400 to J.F., 20ZR1408300 to X.H.) .	Boothe WD, 2017, ADV EXP MED BIOL, V1027, P21, DOI 10.1007/978-3-319-64804-0_3; Chen YG, 2017, MOL CELL, V67, P228, DOI 10.1016/j.molcel.2017.05.022; Cremer S, 2019, CIRCULATION, V139, P1320, DOI 10.1161/CIRCULATIONAHA.117.029015; Cui HC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124522; Errichelli L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14741; Ghosh D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02727; Hong SH, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01097; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Kasraie S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/942375; Le HN, 2018, INT J MOL MED, V41, P888, DOI 10.3892/ijmm.2017.3296; Lee DH, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107046; Lee SB, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176205; Li L, 2020, LIFE SCI, V243, DOI 10.1016/j.lfs.2019.117231; Li SF, 2018, CANCER SCI, V109, P1346, DOI 10.1111/cas.13587; Lim JM, 2018, INT IMMUNOPHARMACOL, V56, P135, DOI 10.1016/j.intimp.2018.01.025; Liu NA, 2017, NUCLEIC ACIDS RES, V45, P6051, DOI 10.1093/nar/gkx141; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Liu PH, 2020, AGING-US, V12, P5280, DOI 10.18632/aging.102950; Lu CH, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3523642; Luo F, 2016, BBA-MOL BASIS DIS, V1862, P1685, DOI 10.1016/j.bbadis.2016.06.004; Matsunaga Y, 2021, J DERMATOL, V48, P1518, DOI 10.1111/1346-8138.16032; Mayba JN, 2017, J CUTAN MED SURG, V21, P227, DOI 10.1177/1203475416685077; Mobus L, 2020, J ALLERGY CLIN IMMUN, V145, P1049, DOI 10.1016/j.jaci.2019.10.015; Nakajima S, 2019, J ALLERGY CLIN IMMUN, V143, P13, DOI 10.1016/j.jaci.2018.11.014; Patop IL, 2019, EMBO J, V38, DOI 10.15252/embj.2018100836; Rojahn TB, 2020, J ALLERGY CLIN IMMUN, V146, P1056, DOI 10.1016/j.jaci.2020.03.041; Sakaguchi M, 2016, J INVEST DERMATOL, V136, P2240, DOI 10.1016/j.jid.2016.06.617; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Spiniello M, 2018, J PROTEOME RES, V17, P3022, DOI 10.1021/acs.jproteome.8b00189; VANDENOORD JJ, 1994, BRIT J DERMATOL, V130, P589; Wang RJ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0911-0; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Xiong L, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa065; Zeng D, 2021, LIFE SCI, V266, DOI 10.1016/j.lfs.2020.118906; Zhang CY, 2020, THERANOSTICS, V10, P10908, DOI 10.7150/thno.48264; Zhao JL, 2020, LAB INVEST, V100, P751, DOI 10.1038/s41374-020-0371-1; Zhou KI, 2016, J MOL BIOL, V428, P822, DOI 10.1016/j.jmb.2015.08.021	40	9	9	10	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2021	2033		10.1016/j.jaci.2021.11.024	http://dx.doi.org/10.1016/j.jaci.2021.11.024			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	34953789				2022-12-18	WOS:000833525500025
J	Bjorkander, S; Du, LK; Zuo, FL; Ekstrom, S; Wang, YT; Wan, H; Sherina, N; Schoutens, L; Andrell, J; Andersson, N; Georgelis, A; Bergstrom, A; Marcotte, H; Kull, I; Hammarstrom, L; Melen, E; Pan-Hammarstrom, Q				Bjorkander, Sophia; Du, Likun; Zuo, Fanglei; Ekstrom, Sandra; Wang, Yating; Wan, Hui; Sherina, Natalia; Schoutens, Lisanne; Andrell, Juni; Andersson, Niklas; Georgelis, Antonios; Bergstrom, Anna; Marcotte, Harold; Kull, Inger; Hammarstrom, Lennart; Melen, Erik; Pan-Hammarstrom, Qiang		BAMSE COVID-19 Study Grp	SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SARS-CoV-2; COVID-19 disease; IgM; IgA; IgG; mem-ory T cells; memory B cells; young adults; population-based cohort; asthma; risk factors		Background: Young adults are now considered major spreaders of coronavirus disease 2019 (COVID-19) disease. Although most young individuals experience mild to moderate disease, there are concerns of long-term adverse health effects. The impact of COVID-19 disease and to which extent population-level immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exists in young adults remain unclear. Objective: We conducted a population-based study on humoral and cellular immunity to SARS-CoV-2 and explored COVID-19 disease characteristics in young adults. Methods: We invited participants from the Swedish BAMSE (Barn [Children], Allergy Milieu, Stockholm, Epidemiology) birth cohort (age 24-27 years) to take part in a COVID-19 followup. From 980 participants (October 2020 to June 2021), we here present data on SARS-CoV-2 receptor-binding domain-specific IgM, IgA, and IgG titers measured by ELISA and on symptoms and epidemiologic factors associated with seropositivity. Further, SARS-CoV-2-specific memory B-and T-cell responses were detected for a subpopulation (n 5 108) by ELISpot and FluoroSpot. Results: A total of 28.4% of subjects were seropositive, of whom 18.4% were IgM single positive. One in 7 seropositive subjects was asymptomatic. Seropositivity was associated with use of public transport, but not with sex, asthma, rhinitis, IgE sensitization, smoking, or body mass index. In a subset of representative samples, 20.7% and 35.0% had detectable SARSCoV-2 specific B-and T-cell responses, respectively. B-and T-cell memory responses were clearly associated with seropositivity, but T-cell responses were also detected in 17.2% of seronegative subjects. Conclusions: Assessment of IgM and T-cell responses may improve population-based estimations of SARS-CoV-2 infection. The pronounced surge of both symptomatic and asymptomatic infections among young adults indicates that the large-scale vaccination campaign should be continued. (J Allergy Clin Immunol 2022;149:65-75.)	[Bjorkander, Sophia; Kull, Inger; Melen, Erik] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Du, Likun; Zuo, Fanglei; Wang, Yating; Wan, Hui; Sherina, Natalia; Schoutens, Lisanne; Hammarstrom, Lennart; Pan-Hammarstrom, Qiang] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Ekstrom, Sandra; Andersson, Niklas; Georgelis, Antonios; Bergstrom, Anna; Melen, Erik] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Ekstrom, Sandra; Georgelis, Antonios; Bergstrom, Anna] Reg Stockholm, Ctr Occupat & Environm Med, Stockholm, Sweden; [Andrell, Juni] Stockholm Univ, Sci Life Lab, Dept Biochem & Biophys, Stockholm, Sweden; [Marcotte, Harold] Karolinska Inst, Dept Lab Med, Div Clin Immunol & Transfus Med, Stockholm, Sweden; [Marcotte, Harold] Karolinska Univ Hosp, Stockholm, Sweden; [Kull, Inger; Melen, Erik] Soder Sjukhuset, Sachs Children & Youth Hosp, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital	Melen, E (corresponding author), Sodersjukhuset S1, Dept Clin Sci & Educ, S-11883 Stockholm, Sweden.; Pan-Hammarstrom, Q (corresponding author), Karolinska Inst, Dept Biosci & Nutr H2, S-17177 Stockholm, Sweden.	erik.melen@ki.se; qiang.pan-hammarstrom@ki.se		Wan, Hui/0000-0002-4368-8672; Bjorkander, Sophia/0000-0002-4600-2883; Sherina, Natalia/0000-0001-6044-172X; Zuo, Fanglei/0000-0002-4545-1265	Swedish Research Council; Swedish Heart-Lung Foundation; European Union's Horizon 2020 research and innovation program (ATAC) [101003650]; European Union's Horizon 2020 research and innovation program (ERC) [757919 TRIBAL]; Karolinska Institutet; Region Stockholm (ALF project)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); European Union's Horizon 2020 research and innovation program (ATAC); European Union's Horizon 2020 research and innovation program (ERC); Karolinska Institutet(Karolinska Institutet); Region Stockholm (ALF project)	The study was funded by the Swedish Research Council, the Swedish Heart-Lung Foundation, the European Union's Horizon 2020 research and innovation program (ATAC, 101003650 and ERC no. 757919 TRIBAL), the Karolinska Institutet, and Region Stockholm (ALF project, and for cohort and database maintenance).	Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652; Ekstrom S, 2022, SCAND J PUBLIC HEALT, V50, P85, DOI 10.1177/14034948211025425; Melen E, 2020, CLIN TRANSL ALLERGY, V10, DOI 10.1186/s13601-020-00319-w; Wang G, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.02120-2020	4	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					65	+		10.1016/j.jaci.2021.10.014	http://dx.doi.org/10.1016/j.jaci.2021.10.014			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YJ5AM	34695490	Green Published, hybrid			2022-12-18	WOS:000744544500014
J	Dimitrova, D; Nademi, Z; Maccari, ME; Ehl, S; Uzel, G; Tomoda, T; Okano, T; Imai, K; Carpenter, B; Ip, W; Rao, K; Worth, AJJ; Laberko, A; Mukhina, A; Neven, B; Moshous, D; Speckmann, C; Warnatz, K; Wehr, C; Abolhassani, H; Aghamohammadi, A; Bleesing, JJ; Dara, J; Dvorak, CC; Ghosh, S; Kang, HJ; Markelj, G; Modi, A; Bayer, DK; Notarangelo, LD; Schulz, A; Garcia-Prat, M; Soler-Palacin, P; Karakukcu, M; Yilmaz, E; Gambineri, E; Menconi, M; Masmas, TN; Holm, M; Bonfim, C; Prando, C; Hughes, S; Jolles, S; Morris, EC; Kapoor, N; Koltan, S; Paneesha, S; Steward, C; Wynn, R; Duffner, U; Gennery, AR; Lankester, AC; Slatter, M; Kanakry, JA				Dimitrova, Dimana; Nademi, Zohreh; Maccari, Maria Elena; Ehl, Stephan; Uzel, Gulbu; Tomoda, Takahiro; Okano, Tsubasa; Imai, Kohsuke; Carpenter, Benjamin; Ip, Winnie; Rao, Kanchan; Worth, Austen J. J.; Laberko, Alexandra; Mukhina, Anna; Neven, Benedicte; Moshous, Despina; Speckmann, Carsten; Warnatz, Klaus; Wehr, Claudia; Abolhassani, Hassan; Aghamohammadi, Asghar; Bleesing, Jacob J.; Dara, Jasmeen; Dvorak, Christopher C.; Ghosh, Sujal; Kang, Hyoung Jin; Markelj, Gasper; Modi, Arunkumar; Bayer, Diana K.; Notarangelo, Luigi D.; Schulz, Ansgar; Garcia-Prat, Marina; Soler-Palacin, Pere; Karakukcu, Musa; Yilmaz, Ebru; Gambineri, Eleonora; Menconi, Mariacristina; Masmas, Tania N.; Holm, Mette; Bonfim, Carmem; Prando, Carolina; Hughes, Stephen; Jolles, Stephen; Morris, Emma C.; Kapoor, Neena; Koltan, Sylwia; Paneesha, Shankara; Steward, Colin; Wynn, Robert; Duffner, Ulrich; Gennery, Andrew R.; Lankester, Arjan C.; Slatter, Mary; Kanakry, Jennifer A.			International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Primary immunodeficiency; activated phosphoinositide 3-kinase delta syndrome; lymphoproliferation; allogeneic hemato-poietic cell transplantation; graft failure; mTOR inhibitor; serotherapy	3-KINASE DELTA SYNDROME; HUMAN IMMUNODEFICIENCY; MUTATIONS; DISEASE; PIK3CD	Background: Activated phosphoinositide 3-kinase delta syndrome (APDS) is a combined immunodeficiency with a heterogeneous phenotype considered reversible by allogeneic hematopoietic cell transplantation (HCT). Objectives: This study sought to characterize HCT outcomes in APDS. Methods: Retrospective data were collected on 57 patients with APDS1/2 (median age, 13 years; range, 2-66 years) who underwent HCT. Results: Pre-HCT comorbidities such as lung, gastrointestinal, and liver pathology were common, with hematologic malignancy in 26%. With median follow-up of 2.3 years, 2-year overall and graft failure-free survival probabilities were 86% and 68%, respectively, and did not differ significantly by APDS1 versus APDS2, donor type, or conditioning intensity. The 2-year cumulative incidence of graft failure following first HCT was 17% overall but 42% if mammalian target of rapamycin inhibitor(s) (mTORi) were used in the first year post-HCT, compared with 9% without mTORi. Similarly, 2-year cumulative incidence of unplanned donor cell infusion was overall 28%, but 65% in the context of mTORi receipt and 23% without. Phenotype reversal occurred in 96% of evaluable patients, of whom 17% had mixed chimerism. Vulnerability to renal complications continued post-HCT, adding new insights into potential nonimmunologic roles of phosphoinositide 3-kinase not correctable through HCT. Conclusions: Graft failure, graft instability, and poor graft function requiring unplanned donor cell infusion were major barriers to successful HCT. Post-HCT mTORi use may confer an advantage to residual host cells, promoting graft instability. Longer-term post-HCT follow-up of more patients is needed to elucidate the kinetics of immune reconstitution and donor chimerism, establish approaches that reduce graft instability, and assess the completeness of phenotype reversal over time.	[Dimitrova, Dimana; Kanakry, Jennifer A.] NCI, Expt Transplantat & Immunotherapy Branch, NIH, 10 Ctr Dr,Bldg 10 CRC,Room 3-3330, Bethesda, MD 20892 USA; [Uzel, Gulbu; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Nademi, Zohreh; Gennery, Andrew R.; Slatter, Mary] Great North Childrens Hosp, Childrens Bone Marrow Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Nademi, Zohreh; Gennery, Andrew R.; Slatter, Mary] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Maccari, Maria Elena; Ehl, Stephan; Speckmann, Carsten] Univ Freiburg, Fac Med, Med Ctr, Ctr Pediat,Dept Pediat Hematol & Oncol, Freiburg, Germany; [Maccari, Maria Elena; Ehl, Stephan; Speckmann, Carsten; Warnatz, Klaus; Wehr, Claudia] Univ Freiburg, Fac Med, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Wehr, Claudia] Univ Freiburg, Fac Med, Med Ctr, Dept Med 1, Freiburg, Germany; [Tomoda, Takahiro; Okano, Tsubasa] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo, Japan; [Imai, Kohsuke] Tokyo Med & Dent Univ, Dept Community Pediat Perinatal & Maternal Med, Tokyo, Japan; [Carpenter, Benjamin] Univ Coll Hosp Natl Hlth Serv Trust, Dept Haematol, London, England; [Ip, Winnie; Worth, Austen J. J.] Great Ormond St Hosp Children Natl Hlth Serv Fdn, Dept Immunol, London, England; [Rao, Kanchan] Great Ormond St Hosp Children Natl Hlth Serv Fdn, Dept Bone Marrow Transplantat, London, England; [Ip, Winnie; Worth, Austen J. J.] UCL, Great Ormond St Inst Child Hlth, London, England; [Laberko, Alexandra; Mukhina, Anna] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol O, Dept Immunol, Moscow, Russia; [Neven, Benedicte; Moshous, Despina] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Unite Immunohematol Pediat, Paris, France; [Neven, Benedicte; Moshous, Despina] Univ Paris, Paris, France; [Neven, Benedicte; Moshous, Despina] Inst Imagine, Paris, France; [Abolhassani, Hassan] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden; [Abolhassani, Hassan; Aghamohammadi, Asghar] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Childrens Med Ctr, Tehran, Iran; [Bleesing, Jacob J.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immunodeficiency, Cincinnati, OH 45229 USA; [Dara, Jasmeen; Dvorak, Christopher C.] Univ Calif San Francisco, Dept Pediat, Div Allergy Immunol Blood & Marrow Transplantat, Benioff Childrens Hosp, San Francisco, CA USA; [Ghosh, Sujal] Univ Hosp Dusseldorf, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Kang, Hyoung Jin] Seoul Natl Univ, Coll Med, Dept Pediat, Canc Res Inst,Wide River Inst Immunol, Seoul, South Korea; [Markelj, Gasper] Univ Childrens Hosp, Univ Med Ctr, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia; [Modi, Arunkumar] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Bayer, Diana K.] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA USA; [Schulz, Ansgar] Univ Med Ctr Ulm, Dept Pediat, Ulm, Germany; [Garcia-Prat, Marina; Soler-Palacin, Pere] Hosp Univ Vall dHebron, Pediat Infect Dis & Immunodeficiencies Unit, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain; [Karakukcu, Musa; Yilmaz, Ebru] Erciyes Univ, Dept Pediat Hematol & Oncol, Kayseri, Turkey; [Gambineri, Eleonora] Univ Florence, Sect Childs Hlth, Dept NEUROFARBA, Florence, Italy; [Gambineri, Eleonora] Anna Meyer Childrens Hosp, BMT Unit, Dept Haematol Oncol, Florence, Italy; [Menconi, Mariacristina] Azienda Osped Univ Pisana Santa Chiara, Unita Operat Oncoematol Pediat, Pisa, Italy; [Masmas, Tania N.] Copenhagen Univ Hosp, Child & Adolescent Clin, Pediat Hematopoiet Stem Cell Transplantat & Immun, Copenhagen, Denmark; [Holm, Mette] Aarhus Univ Hosp, Dept Pediat & Adolescent Med, Aarhus, Denmark; [Bonfim, Carmem] Hosp Pequeno Principe, Dept Immunol, Curitiba, Parana, Brazil; [Prando, Carolina] Inst Pesquisa Pele Pequeno Principe, Fac Pequeno Principe, Curitiba, Parana, Brazil; [Hughes, Stephen; Wynn, Robert] Royal Manchester Childrens Hosp, Dept Paediat Immunol, Manchester, Lancs, England; [Jolles, Stephen] Univ Hosp Wales, Immunodeficiency Ctr Wales, Cardiff, Wales; [Morris, Emma C.] UCL, Inst Immun & Transplantat, London, England; [Kapoor, Neena] Univ Southern Calif, Canc & Blood Dis Inst, Keck Sch Med, Los Angeles, CA 90007 USA; [Koltan, Sylwia] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Pediat Hematol & Oncol, Torun, Poland; [Paneesha, Shankara] Birmingham Heartlands Hosp, Dept Haematol & Stem Cell Transplantat, Birmingham, W Midlands, England; [Steward, Colin] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Duffner, Ulrich] Helen DeVos Childrens Hosp, Blood & Bone Marrow Transplantat, Grand Rapids, MI USA; [Duffner, Ulrich] Spectrum Hlth, Dept Pediat & Human Dev, Grand Rapids, MI USA; [Duffner, Ulrich] Michigan State Univ, Grand Rapids, MI USA; [Lankester, Arjan C.] Leiden Univ Med Ctr, Willem Alexander Childrens Hosp, Dept Pediat, Leiden, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Newcastle University - UK; University of Freiburg; University of Freiburg; University of Freiburg; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital; Tehran University of Medical Sciences; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Seoul National University (SNU); University Medical Centre Ljubljana; University of Arkansas System; University of Arkansas Medical Sciences; University of Iowa; Ulm University; Hospital Universitari Vall d'Hebron; Erciyes University; University of Florence; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Copenhagen; Aarhus University; Hospital Pequeno Principe; Hospital Pequeno Principe; Royal Manchester Children's Hospital; Cardiff University; University of London; University College London; University of Southern California; Nicolaus Copernicus University; Heart of England NHS Foundation Trust; University of Birmingham; University of Bristol; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Leiden University; Leiden University Medical Center (LUMC)	Kanakry, JA (corresponding author), NCI, Expt Transplantat & Immunotherapy Branch, NIH, 10 Ctr Dr,Bldg 10 CRC,Room 3-3330, Bethesda, MD 20892 USA.	dimana.dimitrova@nih.gov; jennifer.kanakry@nih.gov	Gambineri, Eleonora/J-8747-2016; Modi, Arunkumar/AAO-8206-2021; Abolhassani, Hassan/B-3465-2014; Koltan, Sylwia/B-4557-2018; paneesha, shankara/GPK-0660-2022	Gambineri, Eleonora/0000-0002-4676-6541; Modi, Arunkumar/0000-0002-9323-8979; Abolhassani, Hassan/0000-0002-4838-0407; Koltan, Sylwia/0000-0001-7663-6580; paneesha, shankara/0000-0002-7446-011X; Morris, Emma/0000-0003-4834-1130; Karakukcu, Musa/0000-0003-2015-3541; Dvorak, Christopher/0000-0002-6146-3952; Maccari, Maria Elena/0000-0001-6488-7622	Intramural Program of the National Cancer Institute, National Institutes of Health	Intramural Program of the National Cancer Institute, National Institutes of Health	This research was funded in part from the Intramural Program of the National Cancer Institute, National Institutes of Health. The funding source had no involvement in study design; collection, analysis, and interpretation of data; writing of the report; or in the decision to submit the article for publication.	Acevedo MJ, 2019, BIOL BLOOD MARROW TR, V25, P1666, DOI 10.1016/j.bbmt.2019.04.008; Ahmed S, 2019, BIOL BLOOD MARROW TR, V25, P1859, DOI 10.1016/j.bbmt.2019.05.025; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Bertaina A, 2014, BLOOD, V124, P822, DOI 10.1182/blood-2014-03-563817; Brettig T, 2019, J CLIN IMMUNOL, V39, P505, DOI 10.1007/s10875-019-00648-x; Burroughs LM, 2008, BIOL BLOOD MARROW TR, V14, P1279, DOI 10.1016/j.bbmt.2008.08.014; Carreras E., 2019, EBMT HDB HEMATOPOIET, V7th; Coulter TI, 2017, J ALLERGY CLIN IMMUN, V139, P597, DOI 10.1016/j.jaci.2016.06.021; Crank MC, 2014, J CLIN IMMUNOL, V34, P272, DOI 10.1007/s10875-014-0012-9; de Koning C, 2016, BLOOD, V128, P2607, DOI 10.1182/blood-2016-06-724005; De Santis MC, 2017, CANCERS, V9, DOI 10.3390/cancers9040030; Deau MC, 2014, J CLIN INVEST, V124, P3923, DOI 10.1172/JCI75746; Dimitrova D, 2020, BIOL BLOOD MARROW TR, V26, P94, DOI 10.1016/j.bbmt.2019.08.018; Dreger P, 2019, BLOOD ADV, V3, P360, DOI 10.1182/bloodadvances.2018027748; Edwards ESJ, 2019, J ALLERGY CLIN IMMUN, V143, P276, DOI 10.1016/j.jaci.2018.04.030; Elgizouli M, 2016, CLIN EXP IMMUNOL, V183, P221, DOI 10.1111/cei.12706; Elkaim E, 2016, J ALLERGY CLIN IMMUN, V138, P210, DOI 10.1016/j.jaci.2016.03.022; Ewertowska M, 2020, ALLERGY ASTHMA CL IM, V16, DOI 10.1186/s13223-020-00420-6; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fox TA, 2018, BLOOD, V131, P917, DOI 10.1182/blood-2017-09-807487; Garner KL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22233-9; Guo HF, 2015, J GENET GENOMICS, V42, P343, DOI 10.1016/j.jgg.2015.03.003; Hong CR, 2019, J ALLER CL IMM-PRACT, V7, P1034, DOI 10.1016/j.jaip.2018.05.029; Jagasia MH, 2015, BIOL BLOOD MARROW TR, V21, P389, DOI 10.1016/j.bbmt.2014.12.001; Jamee M, 2020, CLIN REV ALLERG IMMU, V59, P323, DOI 10.1007/s12016-019-08738-9; JONES RJ, 1987, TRANSPLANTATION, V44, P778, DOI 10.1097/00007890-198712000-00011; Kanate AS, 2016, BLOOD, V127, P938, DOI 10.1182/blood-2015-09-671834; Klein OR, 2016, BIOL BLOOD MARROW TR, V22, P895, DOI 10.1016/j.bbmt.2016.02.001; Laberko A, 2019, BLOOD, V134, P1755, DOI 10.1182/blood.2019001757; Ljungman P, 2019, LANCET INFECT DIS, V19, pE260, DOI 10.1016/S1473-3099(19)30107-0; Lucas CL, 2016, NAT REV IMMUNOL, V16, P702, DOI 10.1038/nri.2016.93; Lucas CL, 2014, J EXP MED, V211, P2537, DOI 10.1084/jem.20141759; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Maccari ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00543; Melendez-Munoz R, 2019, BIOL BLOOD MARROW TR, V25, P577, DOI 10.1016/j.bbmt.2018.10.011; Nademi Z, 2017, J ALLERGY CLIN IMMUN, V139, P1046, DOI 10.1016/j.jaci.2016.09.040; Notarangelo LD, 2019, J ALLERGY CLIN IMMUN, V143, P91, DOI 10.1016/j.jaci.2018.08.039; Okano T, 2019, J ALLERGY CLIN IMMUN, V143, P266, DOI 10.1016/j.jaci.2018.04.032; Rao VK, 2017, BLOOD, V130, P2307, DOI 10.1182/blood-2017-08-801191; Rastogi N, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26783; Ruiz-Garcia R, 2018, J ALLERGY CLIN IMMUN, V142, P605, DOI 10.1016/j.jaci.2017.11.042; Shah RM, 2018, J ALLERGY CLIN IMMUN, V141, P1417, DOI 10.1016/j.jaci.2017.07.008; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Takeda AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1152, DOI 10.1016/j.jaci.2017.03.026; Tsujita Y, 2016, J ALLERGY CLIN IMMUN, V138, P1672, DOI 10.1016/j.jaci.2016.03.055; Wang Y, 2018, J CLIN IMMUNOL, V38, P854, DOI 10.1007/s10875-018-0568-x	47	9	10	5	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					410	+		10.1016/j.jaci.2021.04.036	http://dx.doi.org/10.1016/j.jaci.2021.04.036			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	34033842	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000747922700010
J	Jee, H; Huang, ZP; Baxter, S; Huang, YL; Taylor, ML; Henderson, LA; Rosenzweig, S; Sharma, A; Chambers, EP; Hershfield, MS; Zhou, Q; Dedeoglu, F; Aksentijevich, I; Nigrovic, PA; O'Donnell-Luria, A; Lee, PY				Jee, Hyuk; Huang, Zhengping; Baxter, Samantha; Huang, Yuelong; Taylor, Maria L.; Henderson, Lauren A.; Rosenzweig, Sofia; Sharma, Aman; Chambers, Eugene P.; Hershfield, Michael S.; Zhou, Qing; Dedeoglu, Fatma; Aksentijevich, Ivona; Nigrovic, Peter A.; O'Donnell-Luria, Anne; Lee, Pui Y.			Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Adenosine deaminase 2; DADA2; ADA2 variants; carrier frequency; disease prevalence	ADENOSINE-DEAMINASE 2; POLYARTERITIS-NODOSA; DEFICIENCY; PHENOTYPE; PREVALENCE; GENOTYPE; DISEASE	Background: Deficiency of adenosine deaminase 2 (DADA2) is an autoinflammatory disease caused by deleterious ADA2 variants. The frequency of these variants in the general population, and hence the expected disease prevalence, remain unknown. Objective: We aimed to characterize the functional impact and carrier frequency of ADA2 variants. Methods: We performed functional studies and in silico analysis on 163 ADA2 variants, including DADA2-associated variants and population variants identified in the Genome Aggregation Database. We estimated the carrier rate using the aggregate frequency of deleterious variants. Results: Functional studies of ADA2 variants revealed that 77 (91 %) of 85 of DADA2-associated variants reduced ADA2 enzymatic function by >75%. Analysis of 100 ADA2 variants in the database showed a full spectrum of impact on ADA2 function, rather than a dichotomy of benign versus deleterious variants. We found several in silico algorithms that effectively predicted the impact of ADA2 variants with high sensitivity and specificity, and confirmed a correlation between the residual function of ADA2 variants in vitro and the plasma ADA2 activity of individuals carrying these variants (n = 45; r = 0.649; P < .0001). Using <25% residual enzymatic activity as the cutoff to define potential pathogenicity, integration of our results with the database population data revealed an estimated carrier frequency of at least 1 in 236 individuals, corresponding to an expected DADA2 disease prevalence of similar to 1 in 222,000 individuals. Conclusions: Functional annotation guides the interpretation of ADA2 variants to create a framework that enables estimation of DADA2 carrier frequency and disease prevalence.	[Jee, Hyuk; Taylor, Maria L.; Henderson, Lauren A.; Dedeoglu, Fatma; Nigrovic, Peter A.; Lee, Pui Y.] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Huang, Zhengping] Guangdong Second Prov Gen Hosp, Dept Rheumatol & Immunol, Guangzhou, Peoples R China; [Huang, Zhengping; Huang, Yuelong; Nigrovic, Peter A.; Lee, Pui Y.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA 02115 USA; [Baxter, Samantha; O'Donnell-Luria, Anne] Broad Inst MIT & Harvard, Ctr Mendelian Genom, Cambridge, MA 02142 USA; [Rosenzweig, Sofia; Aksentijevich, Ivona] NHGRI, Inflammatory Dis Sect, Bethesda, MD 20892 USA; [Sharma, Aman] Postgrad Inst Med Educ & Res, Dept Internal Med, Clin Immunol & Rheumatol Serv, Chandigarh, India; [Chambers, Eugene P.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN USA; [Chambers, Eugene P.] DADA2 Fdn, Nashville, TN USA; [Hershfield, Michael S.] Duke Univ, Dept Med & Biochem, Sch Med, Durham, NC USA; [Zhou, Qing] Zhejiang Univ, Life Sci Inst, Hangzhou, Zhejiang, Peoples R China; [O'Donnell-Luria, Anne] Harvard Med Sch, Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Vanderbilt University; Duke University; Zhejiang University; Harvard University; Boston Children's Hospital; Harvard Medical School	Lee, PY (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	pui.lee@childrens.harvard.edu		O'Donnell-Luria, Anne/0000-0001-6418-9592; Huang, Zhengping/0000-0002-2955-7385	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01-AR065538, R01-AR073201, R01-AR075906, P30-AR070253, K08-AR074562]; Rheumatology Research Foundation Investigator Award; Boston Children's Hospital Faculty Career Development Award; Chan Zuckerberg Initiative	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatology Research Foundation Investigator Award; Boston Children's Hospital Faculty Career Development Award; Chan Zuckerberg Initiative	Supported by National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grants R01-AR065538, R01-AR073201, R01-AR075906, P30-AR070253 (P.A.N.), and K08-AR074562 (P.Y.L.), the Rheumatology Research Foundation Investigator Award (P.Y.L.), the Boston Children's Hospital Faculty Career Development Award (P.Y.L.), and the Chan Zuckerberg Initiative to the Rare Genomes Projects (S.B. and A.O.L.).	Brnich SE, 2019, GENOME MED, V12, DOI 10.1186/s13073-019-0690-2; Caorsi R, 2017, ANN RHEUM DIS, V76, P1648, DOI 10.1136/annrheumdis-2016-210802; Carmona-Rivera C, 2019, BLOOD, V134, P395, DOI 10.1182/blood.2018892752; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Cooray S, 2021, RHEUMATOLOGY, V60, P4373, DOI 10.1093/rheumatology/keaa837; de Menthiere CS, 2003, NUCLEIC ACIDS RES, V31, P282, DOI 10.1093/nar/gkg031; Dhanwani R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba3688; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Greiner-Tollersrud OK, 2020, BIORXIV2020062116299; Hanany M, 2020, P NATL ACAD SCI USA, V117, P2710, DOI 10.1073/pnas.1913179117; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Keer N, 2016, RHEUMATOLOGY, V55, P1145, DOI 10.1093/rheumatology/kew050; Lee PY, 2020, J ALLERGY CLIN IMMUN, V145, P1664, DOI [10.1016/j.jaci.2019.12908, 10.1016/j.jaci.2019.12.908]; Lee PY, 2020, ANN RHEUM DIS, V79, P225, DOI 10.1136/annrheumdis-2019-216030; Lee PY, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00282; Lee PY, 2018, J ALLERGY CLIN IMMUN, V142, P1363, DOI 10.1016/j.jaci.2018.05.038; Liu W, 2019, GENET MED, V21, P2512, DOI 10.1038/s41436-019-0544-8; Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777; Meyts I, 2018, J CLIN IMMUNOL, V38, P569, DOI 10.1007/s10875-018-0525-8; Nanthapisal S, 2016, ARTHRITIS RHEUMATOL, V68, P2314, DOI 10.1002/art.39699; Nigrovic PA, 2020, J ALLERGY CLIN IMMUN, V146, P925, DOI 10.1016/j.jaci.2020.08.017; Ozen S, 2020, J RHEUMATOL, V47, P117, DOI 10.3899/jrheum.181384; Petty RE, 2016, WEDDERBURN LRBT T PR; Rama M, 2018, EUR J HUM GENET, V26, P960, DOI 10.1038/s41431-018-0130-6; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; SCHRADER WP, 1978, P NATL ACAD SCI USA, V75, P446, DOI 10.1073/pnas.75.1.446; Schrodi SJ, 2015, HUM GENET, V134, P659, DOI 10.1007/s00439-015-1551-8; Sharma A, 2021, ARTHRITIS RHEUMATOL, V73, P276, DOI 10.1002/art.41500; Sullivan KE, 2021, J ALLERGY CLIN IMMUN, V147, P492, DOI 10.1016/j.jaci.2020.06.011; Trotta L, 2018, J ALLERGY CLIN IMMUN, V141, P1534, DOI 10.1016/j.jaci.2018.01.012; Wang W, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.565099; Zavialov AV, 2010, J BIOL CHEM, V285, P12367, DOI 10.1074/jbc.M109.083527; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361	33	9	9	4	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					379	387		10.1016/j.jaci.2021.04.034	http://dx.doi.org/10.1016/j.jaci.2021.04.034			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	34004258				2022-12-18	WOS:000747922700007
J	Zhang, M; Yu, QY; Tang, W; Wu, YJ; Lv, JJ; Sun, L; Shi, GC; Wu, M; Qu, JM; Di, CX; Xia, ZW				Zhang, Meng; Yu, Qianying; Tang, Wei; Wu, Yujiao; Lv, JiaJia; Sun, Lin; Shi, Guochao; Wu, Min; Qu, Jieming; Di, Caixia; Xia, Zhenwei			Epithelial exosomal contactin-1 promotes monocyte-derived dendritic cell-dominant T-cell responses in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; epithelial cells; dendritic cells; exosomes; contactin-1; Notch2	F3/CONTACTIN ACTS; SECRETION; NOTCH; BIOGENESIS; EXPRESSION; IMMUNITY	Background: Exosomes have emerged as a vital player in cell cell communication; however, whether airway epithelial cell (AEC)-generated exosomes participate in asthma development remains unknown. Objective: Our aims were to characterize the AEC-secreted exosomes and the potentially functional protein(s) that may contribute to the proinflammatory effects of AEC exosomes in the dendritic cell (DC)-dominant airway allergic models and to confirm their clinical significance in patients with asthma. Methods: Mice were treated with exosomes derived from house dust mite (HDM)-stimulated AECs (HDM-AEC-EXOs) or monocyte-derived DCs primed by HDM and/or contactin-1 (CNTN1). The numbers of DCs in the lung were determined by flow cytometry. Proteomic analysis of purified HDM-AEC EXOs was performed. CNTN1 small interfering RNA was designed to probe its role in airway allergy, and gamma-secretase inhibitor was used to determine involvement of the Notch pathway. Results: HDM-AEC-EXOs facilitate the recruitment, proliferation, migration, and activation of monocyte-derived DCs in cell culture and in mice. CNTN1 in exosomes is a critical player in asthma pathology. RNA interference-mediated silencing and pharmaceutical inhibitors characterize Notch2 receptor as necessary for relaying the CNTN1 signal to activate TH2 cell/TH17 cell immune response. Studies of patients with asthma also support existence of the CNTN1-Notch2 axis that has been observed in cell and mouse models. Conclusion: This study's findings reveal a novel role for CNTN1 in asthma pathogenesis mediated through exosome secretion, indicating a potential strategy for the treatment of allergic airway inflammation.	[Zhang, Meng; Yu, Qianying; Wu, Yujiao; Lv, JiaJia; Xia, Zhenwei] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pediat, Sch Med, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China; [Tang, Wei; Sun, Lin; Shi, Guochao; Qu, Jieming; Di, Caixia] Shanghai Jiao Tong Univ, Shanghai Key Discipline Resp Dis, Dept Resp & Crit Care Med, Inst Resp Dis,Sch Med,Ruijin Hosp, Shanghai, Peoples R China; [Wu, Min] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of North Dakota Grand Forks	Xia, ZW (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pediat, Sch Med, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	xzw10484@rjh.com.cn			National Natural Science Foundation of China [91542202, 81600021, 81970021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the National Natural Science Foundation of China (grants 91542202 [to Z.W.X.] , 81600021 [to C.X.D.] , and 81970021 [to Z.W.X.] ) .	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Bizzoca A, 2012, DEV BIOL, V365, P133, DOI 10.1016/j.ydbio.2012.02.011; Cho BS, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0939-5; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Du YM, 2018, EXP CELL RES, V363, P114, DOI 10.1016/j.yexcr.2017.12.021; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Falk J, 2002, BIOL CELL, V94, P327, DOI 10.1016/S0248-4900(02)00006-0; Gabryelska A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00692; Haenisch C, 2005, MOL CELL NEUROSCI, V28, P361, DOI 10.1016/j.mcn.2004.04.013; Haj-Salem I, 2018, ALLERGY, V73, P178, DOI 10.1111/all.13234; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kaur R, 2019, J ALLERGY CLIN IMMUN, V144, P1, DOI 10.1016/j.jaci.2019.05.031; Ko HJ, 2014, J IMMUNOL, V192, P2202, DOI 10.4049/jimmunol.1302040; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kulshreshtha A, 2013, J ALLERGY CLIN IMMUN, V131, P1194, DOI 10.1016/j.jaci.2012.12.1565; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lasser C, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0927-4; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liang YS, 2019, J ALLERGY CLIN IMMUN, V144, P1025, DOI 10.1016/j.jaci.2019.06.011; Lin XL, 2017, ALLERGY, V72, P1972, DOI 10.1111/all.13216; Liu J, 2019, IMMUNITY, V50, P600, DOI 10.1016/j.immuni.2019.01.021; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Martinez-Bravo MJ, 2017, J ALLERGY CLIN IMMUN, V139, P1186, DOI 10.1016/j.jaci.2016.05.051; Mazzeo C, 2015, J ALLERGY CLIN IMMUN, V135, P1603, DOI 10.1016/j.jaci.2014.11.026; Miura Y, 2015, BRAIN, V138, P1484, DOI 10.1093/brain/awv054; Moon HG, 2018, IMMUNITY, V49, P275, DOI 10.1016/j.immuni.2018.06.009; Nocera AL, 2017, LARYNGOSCOPE, V127, pE295, DOI 10.1002/lary.26614; Park JA, 2012, J ALLERGY CLIN IMMUN, V130, P1375, DOI 10.1016/j.jaci.2012.05.031; Pelaia G, 2012, NAT REV DRUG DISCOV, V11, P958, DOI 10.1038/nrd3792; Perez-Cabezas B, 2011, J IMMUNOL, V186, P7006, DOI 10.4049/jimmunol.1100203; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Qian GJ, 2018, J EXP MED, V215, P2397, DOI 10.1084/jem.20172225; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rivera A, 2016, NAT IMMUNOL, V17, P356, DOI 10.1038/ni.3375; Sharma P, 2019, P NATL ACAD SCI USA, V116, P16086, DOI 10.1073/pnas.1902513116; Shen C, 2016, CLIN IMMUNOL, V168, P37, DOI 10.1016/j.clim.2016.04.013; Sinclair C, 2017, SCIENCE, V357, P1014, DOI 10.1126/science.aaj2155; Tjota MY, 2014, CURR OPIN IMMUNOL, V31, P44, DOI 10.1016/j.coi.2014.09.006; Wu HM, 2012, MOL MED REP, V6, P265, DOI 10.3892/mmr.2012.910; Xia MC, 2018, J ALLERGY CLIN IMMUN, V142, P1243, DOI 10.1016/j.jaci.2018.03.009; Xia MC, 2015, J ALLERGY CLIN IMMUN, V136, P441, DOI 10.1016/j.jaci.2015.02.014	46	9	10	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1545	1558		10.1016/j.jaci.2021.04.025	http://dx.doi.org/10.1016/j.jaci.2021.04.025		DEC 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM7UO	33957164	hybrid			2022-12-18	WOS:000729027300003
J	Patel, N; Chong, KW; Yip, AYG; Ierodiakonou, D; Bartra, J; Boyle, RJ; Turner, PJ				Patel, Nandinee; Chong, Kok Wee; Yip, Alexander Y. G.; Ierodiakonou, Despo; Bartra, Joan; Boyle, Robert J.; Turner, Paul J.			Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Epinephrine; allergic reaction; anaphylaxis; autoinjector device; refractory anaphylaxis	ORAL FOOD CHALLENGES; EMERGENCY-DEPARTMENT; BIPHASIC REACTIONS; PEDIATRIC ANAPHYLAXIS; ALLERGIC REACTIONS; RISK-FACTORS; CLINICAL PREDICTORS; NUT ALLERGY; CHILDREN; MANAGEMENT	Background: Regulatory bodies recommend that all patients at risk of anaphylaxis be prescribed 2 epinephrine autoinjectors, which they should carry at all times. This is in contrast to some guidelines. The proportion of anaphylaxis reactions that are treated with multiple doses of epinephrine has not been systematically evaluated. Objective: Our aim was to undertake a systematic review and meta-analysis of published studies reporting epinephrine treatment for anaphylaxis in which data relating to the number of doses administered were available. Methods: We searched the Medline, Embase, and Cochrane databases for relevant studies reporting at least 10 anaphylaxis events (due to food or venom) from 1946 until January 2020. Data were extracted in duplicate for the meta-analysis, and the risk of bias was assessed. The study was registered under the PROSPERO identifier CRD42017069109. Results: A total of 86 studies (36,557 anaphylaxis events) met the inclusion criteria (20 of the studies [23%] were prospective studies; 64 [74%] reported reactions in the community, and 22 [26%] included food challenge data). Risk of bias was assessed as low in 50 studies. Overall, 7.7% of anaphylaxis events from any cause (95% CI = 6.4-9.1) were treated with multiple doses of epinephrine. When only epinephrine-treated reactions for which subsequent doses were administered by a health care professional were considered, 11.1% of food-induced reactions (95% CI = 9.4-13.2) and 17.1% of venom-induced reactions (95% CI = 11.3-25.0) were treated with more than 1 epinephrine dose. Heterogeneity was moderate to high in the meta-analyses, but at sensitivity analysis this estimate was not affected by study design or anaphylaxis definition. Conclusion: Around 1 in 10 anaphylaxis reactions are treated with more than 1 dose of epinephrine.	[Patel, Nandinee; Boyle, Robert J.; Turner, Paul J.] Imperial Coll London, Natl Heart & Lung Inst, Norfolk Pl, London W2 1PG, England; [Chong, Kok Wee] KK Womens & Childrens Hosp, Dept Paediat Med, Allergy Serv, Singapore, Singapore; [Yip, Alexander Y. G.] Imperial Coll London, Sch Med, London, England; [Ierodiakonou, Despo] Univ Nicosia, Dept Primary Care & Populat Hlth, Med Sch, Nicosia, Cyprus; [Bartra, Joan] Hosp Clin Barcelona, Barcelona, Spain	Imperial College London; KK Women's & Children's Hospital; Imperial College London; University of Nicosia; University of Barcelona; Hospital Clinic de Barcelona	Turner, PJ (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Norfolk Pl, London W2 1PG, England.	p.turner@imperial.ac.uk		Ierodiakonou, Despo/0000-0002-7862-2016; Turner, Paul/0000-0001-9862-5161	UK Medical Research Council Clinician Scientist award [MR/K010468/1]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare National Health Service (NHS) Trust and Imperial Col-lege London	UK Medical Research Council Clinician Scientist award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare National Health Service (NHS) Trust and Imperial Col-lege London	This research was funded by a UK Medical Research Council Clinician Scientist award to P.J.T. (reference MR/K010468/1) . N.P., R.J.B., and P.J.T. are supported through the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare National Health Service (NHS) Trust and Imperial Col-lege London. The views expressed in this article are those of the author (s) and do not necessarily reflect those of the NHS, NIHR, or the Department of Health.	Abrams EM, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0215-8; Coutinho IA, 2018, ALLERGY, V73, P352; Alqurashi W, 2015, ANN ALLERG ASTHMA IM, V115, P217, DOI 10.1016/j.anai.2015.05.013; [Anonymous], PREFERRED REPORTING; Anvari S, 2019, J ALLER CL IMM-PRACT, V7, P1696, DOI 10.1016/j.jaip.2018.12.013; Arana N, 2009, ALLERGY, V64, P493; Arkwright PD, 2009, J ALLERGY CLIN IMMUN, V123, P267, DOI 10.1016/j.jaci.2008.08.035; Asaumi T, 2016, PEDIAT ALLERG IMM-UK, V27, P44, DOI 10.1111/pai.12489; Banerji A, 2010, ALLERGY ASTHMA PROC, V31, P308, DOI 10.2500/aap.2010.31.3375; Ben-Shoshan M, 2013, J ALLERGY CLIN IMMUN, V132, P739, DOI 10.1016/j.jaci.2013.06.016; Brennan AK, 2013, J ALLERGY CLIN IMMUN, V131, pAB86, DOI 10.1016/j.jaci.2012.12.974; Brough HA, 2020, J ALLERGY CLIN IMMUN, V145, P1231, DOI 10.1016/j.jaci.2019.09.036; Brown SGA, 2013, J ALLERGY CLIN IMMUN, V132, P1141, DOI 10.1016/j.jaci.2013.06.015; Campbell RL, 2015, J ALLER CL IMM-PRACT, V3, P576, DOI 10.1016/j.jaip.2015.04.009; Campbell RL, 2014, ANN ALLERG ASTHMA IM, V113, P599, DOI 10.1016/j.anai.2014.10.007; Capps JA, 2010, RESUSCITATION, V81, P653, DOI 10.1016/j.resuscitation.2010.01.021; Capucilli P, J ALLERGY CLIN IMMUN, V145, P219; Capucilli P, 2019, J ALLER CL IMM-PRACT, V7, P1662, DOI 10.1016/j.jaip.2018.11.021; Cardona V, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100472; Cardona V, 2017, INT ARCH ALLERGY IMM, V173, P171, DOI 10.1159/000477566; Chatelier J, 2019, INTERN MED J, V49, P18; Chung T, 2014, RESUSCITATION, V85, P1077, DOI 10.1016/j.resuscitation.2014.04.004; Clark AT, 2008, J ALLERGY CLIN IMMUN, V122, P286, DOI 10.1016/j.jaci.2008.05.015; Cohen N, 2019, J ALLER CL IMM-PRACT, V7, P2882, DOI 10.1016/j.jaip.2019.04.038; Coutinho IA, 2020, EUR ANN ALLERGY CLIN, V52, P23, DOI 10.23822/EurAnnACI.1764-1489.98; De Swert LFA, 2008, EUR J PEDIATR, V167, P1251, DOI 10.1007/s00431-007-0661-2; Dibs S D, 1997, Pediatrics, V99, pE7, DOI 10.1542/peds.99.1.e7; Dogru M, 2017, GUNCEL PEDIATRI, V15, P12, DOI 10.4274/jcp.58070; Dribin TE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211949; Elizur A, 2018, ALLERGY, V73, P593, DOI 10.1111/all.13353; Ellis AK, 2007, ANN ALLERG ASTHMA IM, V98, P64, DOI 10.1016/S1081-1206(10)60861-7; European Medicines Agency, EP AUT BETT TRAIN TO; Ewan P, 2016, CLIN EXP ALLERGY, V46, P1258, DOI 10.1111/cea.12788; Ewan PW, 2005, CLIN EXP ALLERGY, V35, P751, DOI 10.1111/j.1365-2222.2005.02266.x; Ewan PW, 2001, LANCET, V357, P111, DOI 10.1016/S0140-6736(00)03543-1; Aquino EGF, 2013, ALLERGY, V68, P449; Gabrielli S, 2019, J ALLER CL IMM-PRACT, V7, P2232, DOI 10.1016/j.jaip.2019.04.018; Giclas HE, 2019, J ALLERGY CLIN IMMUN, V143, pAB164, DOI 10.1016/j.jaci.2018.12.498; Goh SH, 2018, INT ARCH ALLERGY IMM, V175, P91, DOI 10.1159/000485127; Gold MS, 2000, J ALLERGY CLIN IMMUN, V106, P171, DOI 10.1067/mai.2000.106041; Grabenhenrich LB, 2018, J ALLER CL IMM-PRACT, V6, P1898, DOI 10.1016/j.jaip.2018.02.026; Hamilton DK, 2019, J ALLERGY CLIN IMMUN, V143, pAB265, DOI 10.1016/j.jaci.2018.12.810; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Hsiao KC, 2014, INTERN MED J, V44, P11; Huang F, 2012, J ALLERGY CLIN IMMUN, V129, P162, DOI 10.1016/j.jaci.2011.09.018; Inoue N, 2013, ASIA PAC ALLERGY, V3, P106, DOI 10.5415/apallergy.2013.3.2.106; Itazawa T, 2013, ALLERGY, V68, P40; Jarvinen KM, 2008, J ALLERGY CLIN IMMUN, V122, P133, DOI 10.1016/j.jaci.2008.04.031; Jarvinen KM, 2009, J ALLERGY CLIN IMMUN, V124, P1267, DOI 10.1016/j.jaci.2009.10.006; Johnson J, 2014, ACTA PAEDIATR, V103, P862, DOI 10.1111/apa.12687; Joint Task Force on Practice Parameters, 2005, J Allergy Clin Immunol, V115, pS483; Kahveci M, 2020, PEDIAT ALLERG IMM-UK, DOI 10.1111/pai.13320; Kim MY, 2018, KOREAN J INTERN MED, V33, P1008, DOI 10.3904/kjim.2016.024; Kondo Akihiko, 2018, Air Med J, V37, P259, DOI 10.1016/j.amj.2018.02.005; Lee J, 2013, ALLERGY ASTHMA PROC, V34, P220, DOI 10.2500/aap.2013.34.3669; Lee M, 2015, J ALLERGY CLIN IMMUN; Lee S, 2017, J ALLER CL IMM-PRACT, V5, P1295, DOI 10.1016/j.jaip.2017.07.020; Liu XW, 2020, J ALLER CL IMM-PRACT, V8, P1230, DOI 10.1016/j.jaip.2019.10.027; Manivannan V, 2014, AM J EMERG MED, V32, P1097, DOI 10.1016/j.ajem.2014.05.014; Manivannan V, 2009, ANN ALLERG ASTHMA IM, V103, P395, DOI 10.1016/S1081-1206(10)60358-4; Maris I, 2015, ALLERGY, V70, P296; Mehr S, 2009, CLIN EXP ALLERGY, V39, P1390, DOI 10.1111/j.1365-2222.2009.03276.x; Mulligan K, 2014, INTERN MED J, V44, P19; Muramatsu K, 2022, J EPIDEMIOL, V32, P163, DOI 10.2188/jea.JE20200309; Muraro A, 2014, ALLERGY, V69, P1026, DOI 10.1111/all.12437; Murata MA, 2021, AM J EMERG MED, V46, P499, DOI 10.1016/j.ajem.2020.10.060; Nagakura K, 2018, INT ARCH ALLERGY IMM, V175, P181, DOI 10.1159/000486310; Nogic C, 2016, J PAEDIATR CHILD H, V52, P487, DOI 10.1111/jpc.13173; Noimark L, 2012, CLIN EXP ALLERGY, V42, P284, DOI 10.1111/j.1365-2222.2011.03912.x; Noone S, 2015, J ALLER CL IMM-PRACT, V3, P424, DOI 10.1016/j.jaip.2014.10.008; Olabarri M, 2019, EUR J EMERG MED, V26, P163, DOI 10.1097/MEJ.0000000000000515; Oren E, 2007, ANN ALLERG ASTHMA IM, V99, P429, DOI 10.1016/S1081-1206(10)60568-6; Oya S, 2020, J EMERG MED, V59, P812, DOI 10.1016/j.jemermed.2020.07.004; Guevara LVP, 2018, J INVEST ALLERG CLIN, V28, P246, DOI 10.18176/jiaci.0243; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; rainor JL, PEDIATR EMERG CARE, DOI [10.1097/PEC.0000000000002146, DOI 10.1097/PEC.0000000000002146]; Rudders SA, 2012, J ALLERGY CLIN IMMUN, V130, P1216, DOI 10.1016/j.jaci.2012.08.029; Rudders SA, 2010, ANN ALLERG ASTHMA IM, V105, P85, DOI 10.1016/j.anai.2010.05.004; Rueter K, 2018, J ALLER CL IMM-PRACT, V6, P1545, DOI 10.1016/j.jaip.2017.11.038; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Shaker M, 2021, J ALLER CL IMM-PRACT, V9, P2440, DOI 10.1016/j.jaip.2021.01.007; Soller L, 2019, J ALLER CL IMM-PRACT, V7, P693, DOI 10.1016/j.jaip.2018.09.025; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sundquist BK, 2019, ALLERGY ASTHMA PROC, V40, P41, DOI 10.2500/aap.2019.40.4189; Tiyyagura GK, 2014, PREHOSP EMERG CARE, V18, P46, DOI 10.3109/10903127.2013.825352; Topal E, 2014, PEDIATR NEONATOL, V55, P320, DOI 10.1016/j.pedneo.2013.10.002; Tsuang A, 2018, ANN ALLERG ASTHMA IM, V121, P469, DOI 10.1016/j.anai.2018.06.015; Turner PJ, 2013, PEDIAT ALLERG IMM-UK, V24, P450, DOI 10.1111/pai.12093; Tyquin B, 2017, INTERN MED J, V47, P20, DOI 10.1111/imj.51_13578; Uguz A, 2005, CLIN EXP ALLERGY, V35, P746, DOI 10.1111/j.1365-2222.2005.02257.x; van der Valk JPM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151055; Vijaykumar A, 2017, CLIN EXP ALLERGY, V47, P1711; Villafana-Soto K, 2011, INTERN MED J, V41, P5; Webb LM, 2006, ANN ALLERG ASTHMA IM, V97, P39, DOI 10.1016/S1081-1206(10)61367-1; White MV, 2015, ALLERGY ASTHMA PROC, V36, P306, DOI 10.2500/aap.2015.36.3859; Yanagida N, 2018, PEDIAT ALLERG IMM-UK, V29, P417, DOI 10.1111/pai.12896; Yanagida N, 2017, INT ARCH ALLERGY IMM, V172, P173, DOI 10.1159/000458724; Zubrinich C, 2019, INTERN MED J, V49, P135, DOI 10.1111/imj.14181	98	9	9	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1307	1315		10.1016/j.jaci.2021.03.042	http://dx.doi.org/10.1016/j.jaci.2021.03.042		NOV 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV8FQ	33862009	Green Published, hybrid			2022-12-18	WOS:000717466600001
J	Ravi, A; Goorsenberg, AWM; Dijkhuis, A; Dierdorp, BS; Dekker, T; van Weeghel, M; Sabogal, YS; Shah, PL; ten Hacken, NHT; Annema, JT; Sterk, PJ; Vaz, FM; Bonta, PI; Lutter, R				Ravi, Abilash; Goorsenberg, Annika W. M.; Dijkhuis, Annemiek; Dierdorp, Barbara S.; Dekker, Tamara; van Weeghel, Michel; Sabogal, Yanaika S.; Shah, Pallav L.; ten Hacken, Nick H. T.; Annema, Jouke T.; Sterk, Peter J.; Vaz, Frederic M.; Bonta, Peter I.; Lutter, Rene			Metabolic differences between bronchial epithelium from healthy individuals and patients with asthma and the effect of bronchial thermoplasty	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Bronchial epithelium; metabolism; thermoplasty	OXIDATIVE-PHOSPHORYLATION; INFLAMMATION; DYSFUNCTION; EXPRESSION; SEVERITY	Background: Asthma is a heterogeneous disease with differences in onset, severity, and inflammation. Bronchial epithelial cells (BECs) contribute to asthma pathophysiology. Objective: We determined whether transcriptomes of BECs reflect heterogeneity in inflammation and severity in asthma, and whether this was affected in BECs from patients with severe asthma after their regeneration by bronchial thermoplasty. Methods: RNA sequencing was performed on BECs obtained by bronchoscopy from healthy controls (n = 16), patients with mild asthma (n = 17), patients with moderate asthma (n = 5), and patients with severe asthma (n = 17), as well as on BECs from treated and untreated airways of the latter (also 6 months after bronchial thermoplasty) (n = 23). Lipidome and metabolome analyses were performed on cultured BECs from healthy controls (n = 7); patients with severe asthma (n = 9); and, for comparison, patients with chronic obstructive pulmonary disease (n = 7). Results: Transcriptome analysis of BECs from patients showed a reduced expression of oxidative phosphorylation (OXPHOS) genes, most profoundly in patients with severe asthma but less profoundly and more heterogeneously in patients with mild asthma. Genes related to fatty acid metabolism were significantly upregulated in asthma. Lipidomics revealed enhanced levels of lipid species (phosphatidylcholines, lysophosphatidylcholines. and bis(monoacylglycerol)phosphate), whereas levels of OXPHOS metabolites were reduced in BECs from patients with severe asthma. BECs from patients with mild asthma characterized by hyperresponsive production of mediators implicated in neutrophilic inflammation had decreased expression of OXPHOS genes compared with that in BECs from patients with mild asthma with normoresponsive production. BECs obtained after thermoplasty had significantly increased expression of OXPHOS genes and decreased expression of fatty acid metabolism genes compared with BECs obtained from untreated airways. Conclusion: BECs in patients with asthma are metabolically different from those in healthy individuals. These differences are linked with inflammation and asthma severity, and they can be reversed by bronchial thermoplasty.	[Ravi, Abilash; Goorsenberg, Annika W. M.; Sabogal, Yanaika S.; Annema, Jouke T.; Sterk, Peter J.; Bonta, Peter I.; Lutter, Rene] Univ Amsterdam, Dept Resp Med, Amsterdam, Netherlands; [Ravi, Abilash; Dijkhuis, Annemiek; Dierdorp, Barbara S.; Dekker, Tamara; Sabogal, Yanaika S.; Lutter, Rene] Univ Amsterdam, Amsterdam Infect & Immun Inst, Dept Expt Immunol, Amsterdam, Netherlands; [van Weeghel, Michel; Vaz, Frederic M.] Univ Amsterdam, Med Ctr, Dept Clin Chem, Core Facil Metabol,Lab Genet Metab Dis, Amsterdam, Netherlands; [Shah, Pallav L.] Royal Brompton Hosp, London, England; [Shah, Pallav L.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Shah, Pallav L.] Chelsea & Westminster Hosp, London, England; [ten Hacken, Nick H. T.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Royal Brompton Hospital; Imperial College London; Imperial College London; University of Groningen	Ravi, A (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, Albinusdreef 2,B02-075, NL-2333 ZA Leiden, Netherlands.; Lutter, R (corresponding author), Univ Amsterdam, Med Ctr, Dept Resp Med & Expt Immunol, Meibergdreef 9,K0-150, NL-1105 AZ Amsterdam, Netherlands.	a.ravi@lumc.nl; r.lutter@amsterdamumc.nl		Shah, Pallav/0000-0002-9052-4638; Vaz, Frederic/0000-0002-9048-1041; Bonta, Peter/0000-0002-0429-4988	Lung Foundation [3.2.10.069, 3.2.07.012, 3.2.06.031]; GSK [CRT 114696]; Stichting Astma Bestrijding [2013_009]; Medimmune (Gaithersburg, Md); Netherlands Lung Foundation [5.2.13.064JO]; Netherlands Organization for Health Research and Development (ZonMw) [90713477]; Boston Scientific Corporation	Lung Foundation; GSK(GlaxoSmithKline); Stichting Astma Bestrijding; Medimmune (Gaithersburg, Md)(AstraZenecaMedimmune); Netherlands Lung Foundation; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Boston Scientific Corporation(Boston Scientific)	Supported by the Netherlands Asthma Foundation (currently the Lung Foundation [projects 3.2.10.069, 3.2.07.012, and 3.2.06.031]), GSK (CRT 114696), and Stichting Astma Bestrijding (project 2013_009). The explorative trial RILCO (Role of Innate Lymphoid Cells in COPD) was supported in part by Medimmune (Gaithersburg, Md). The TASMA (Unravelling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma) trial is funded by the Netherlands Lung Foundation (grant 5.2.13.064JO), The Netherlands Organization for Health Research and Development (ZonMw grant 90713477), and Boston Scientific Corporation.	Bel EH, 2011, THORAX, V66, P910, DOI 10.1136/thx.2010.153643; Bonser LR, 2016, J CLIN INVEST, V126, P2367, DOI 10.1172/JCI84910; Bonta PI, 2018, RESPIRATION, V95, P289, DOI 10.1159/000488291; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; Brandsma J, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1412-2; Button B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003755; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; Carrascoso I, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00174-17; Cruickshank-Quinn CI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35372-w; d'Hooghe JNS, 2018, PHARMACOL THERAPEUT, V181, P101, DOI 10.1016/j.pharmthera.2017.07.015; d'Hooghe JNS, 2019, CLIN EXP ALLERGY, V49, P541, DOI 10.1111/cea.13365; D'Hooghe JNS, 2017, EUR RESPIR J, V50, DOI 10.1183/1393003.congress-2017.PA3027; d'Hooghe JNS, 2017, RESPIRATION, V93, P58, DOI 10.1159/000452478; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Foer D, 2019, AM J RESP CRIT CARE, V199; Goorsenberg AWM, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1313-6; Goorsenberg AWM, 2018, RESPIRATION, V96, P564, DOI 10.1159/000491676; Gras D, 2012, J ALLERGY CLIN IMMUN, V129, P1259, DOI 10.1016/j.jaci.2012.01.073; Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje; Herzog K, 2018, J INHERIT METAB DIS, V41, P479, DOI 10.1007/s10545-017-0076-9; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; HOLTZMAN MJ, 1992, ANNU REV PHYSIOL, V54, P303; Hoogsteden HC, 1999, CLIN EXP ALLERGY, V29, P116, DOI 10.1046/j.1365-2222.1999.00020.x; Ingram JL, 2006, CURR MOL MED, V6, P409, DOI 10.2174/156652406777435426; Isquierdo JM, 2006, BIOCHEM BIOPH RES CO, V348, P703, DOI 10.1016/j.bbrc.2006.7.114; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kuerschner L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031342; Kuo CHS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02135-2016; Kuo CHS, 2017, AM J RESP CRIT CARE, V195, P443, DOI 10.1164/rccm.201512-2452OC; Lapperre TS, 2017, RESPIROLOGY, V22, P31; Liao SY, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00123-2018; Lodhi IJ, 2015, CELL METAB, V21, P51, DOI 10.1016/j.cmet.2014.12.002; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moheimani F, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0434-4; Pilette C, 2007, EUR RESPIR J, V29, P914, DOI 10.1183/09031936.00073005; Pineros YSS, 2019, AM J RESP CRIT CARE, V199, P508, DOI 10.1164/rccm.201803-0461OC; Pretolani M, 2014, AM J RESP CRIT CARE, V190, P1452, DOI 10.1164/rccm.201407-1374LE; Qian X, 2018, J ALLERGY CLIN IMMUN, V142, P435, DOI 10.1016/j.jaci.2017.08.043; Ravi A, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00547-2019; Ravi A, 2019, J ALLERGY CLIN IMMUN, V143, P442, DOI 10.1016/j.jaci.2018.09.016; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Schamberger A, 2016, EUR RESPIR J, V48; Schofield JPR, 2019, J ALLERGY CLIN IMMUN, V144, P70, DOI 10.1016/j.jaci.2019.03.013; Sweerus K, 2017, J ALLERGY CLIN IMMUN, V139, P72, DOI 10.1016/j.jaci.2016.02.035; Thomas B, 2010, J ALLERGY CLIN IMMUN, V126, P722, DOI 10.1016/j.jaci.2010.05.046; van der Sluijs KF, 2013, THORAX, V68, P1122, DOI 10.1136/thoraxjnl-2013-203728; Wenzel SE, 1997, PHARMACOTHERAPY, V17, pS3; Wiegman CH, 2015, J ALLERGY CLIN IMMUN, V136, P769, DOI 10.1016/j.jaci.2015.01.046	50	9	9	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1236	1248		10.1016/j.jaci.2020.12.653	http://dx.doi.org/10.1016/j.jaci.2020.12.653		NOV 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV7LX	33556463	Green Published, hybrid			2022-12-18	WOS:000717415000022
J	Choi, S; Sohn, KH; Jung, JW; Kang, MG; Yang, MS; Kim, S; Choi, JH; Cho, SH; Kang, HR; Yi, HN				Choi, Sungmi; Sohn, Kyoung-Hee; Jung, Jae-Woo; Kang, Min-Gyu; Yang, Min-Suk; Kim, Sujeong; Choi, Jeong-Hee; Cho, Sang-Heon; Kang, Hye-Ryun; Yi, Hana			Lung virome: New potential biomarkers for asthma severity and exacerbation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; herpesvirus; CMV; EBV; virome; metagenomics; microbiome	RISK-FACTORS; AGE	Background: Although some respiratory virus infections are known to contribute to the development and exacerbation of asthma, commensal viromes in airway have not been extensively studied due to technical challenges. Objectives: This study investigated the characteristics of the virome in asthmatic airways. Methods: Both the bacteriome and virome profiles in sputum from 12 healthy individuals, 15 patients with nonsevere asthma, and 15 patients with severe asthma were analyzed and assessed for the association with clinical characteristics such as severity, exacerbation, Asthma Control Test (ACT), and lung function. Results: While analysis of the 16S ribosomal RNA bacteriome in the airway showed no differences, clear contrasts in the diversity and composition of airway viromes were observed between healthy controls and patients with asthma. Herpesviruses were the most abundant type of virus in the asthma group (44.6 +/- 4.6%), mainly with cytomegalovirus (CMV) and EBV accounting for 24.5 +/- 3.3% and 16.9 +/- 3.5%, respectively, in contrast to those in the healthy controls (5.4 +/- 2.5% and 7.1 +/- 3.0%, respectively). CMV and EBV were more abundant in patients with asthma who experienced exacerbation, and their abundance showed correlation with more severe asthma, lower ACT score, and lower lung function. On the contrary, bacteriophage that is abundant in healthy controls was severely reduced in patients with asthma in the order of nonsevere and severe asthma and presented significant positive correlation with ACT and FEV1/forced vital capacity. Conclusions: Lung viromes, especially, CMV, EBV, and bacteriophage may be potential biomarkers of asthma severity and exacerbation.	[Choi, Sungmi; Yi, Hana] Korea Univ, Inst Biomat, Seoul, South Korea; [Choi, Sungmi; Yi, Hana] Korea Univ, Interdisciplinary Program Precis Publ Hlth, Seoul, South Korea; [Yi, Hana] Korea Univ, Sch Biosyst & Biomed Sci, 145 Anam Ro, Seoul 02841, South Korea; [Sohn, Kyoung-Hee; Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ, Coll Med, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Sohn, Kyoung-Hee] Kyung Hee Univ Hosp, Dept Internal Med, Seoul, South Korea; [Jung, Jae-Woo] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Min-Gyu] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Internal Med, Coll Med, Cheongju, South Korea; [Yang, Min-Suk] Seoul Natl Univ, Dept Internal Med, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Kim, Sujeong] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea; [Choi, Jeong-Hee] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Pulmonol & Allergy, Hwaseong, South Korea; [Choi, Jeong-Hee] Hallym Univ, Coll Med, Allergy & Clin Immunol Res Ctr, Chunchon, South Korea; [Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Korea University; Korea University; Korea University; Seoul National University (SNU); Kyung Hee University; Kyung Hee University Hospital; Chung Ang University; Chung Ang University Hospital; Chungbuk National University; Chungbuk National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Kyungpook National University; Kyungpook National University Hospital; Hallym University; Hallym University; Seoul National University (SNU); Seoul National University Hospital	Yi, HN (corresponding author), Korea Univ, Sch Biosyst & Biomed Sci, 145 Anam Ro, Seoul 02841, South Korea.; Kang, HR (corresponding author), Seoul Natl Univ Hosp, 101 Daehak Ro, Seoul 110744, South Korea.	helenmed@snu.ac.kr; hanayi@korea.ac.kr		Sohn, Kyoung-Hee/0000-0001-8407-8080; Kang, Hye-Ryun/0000-0002-2317-4201	Research of Korea Centers for Disease Control and Prevention [2016ER670400, 2017ER670100]	Research of Korea Centers for Disease Control and Prevention	This research was supported by a fund (2016ER670400 and 2017ER670100) from the Research of Korea Centers for Disease Control and Prevention.	Adriaenssens EM, 2018, MSYSTEMS, V3, DOI [10.1128/msystems.00025-18, 10.1128/mSystems.00025-18]; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Beasley R, 2015, LANCET, V386, P1075, DOI 10.1016/S0140-6736(15)00156-7; Bloomfield SF, 2006, CLIN EXP ALLERGY, V36, P402, DOI 10.1111/j.1365-2222.2006.02463.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boppana SB, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P795; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Cadwell K, 2015, IMMUNITY, V42, P805, DOI 10.1016/j.immuni.2015.05.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Dreyfus DH, 2013, J ALLERGY CLIN IMMUN, V132, P1278, DOI 10.1016/j.jaci.2013.02.039; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Esteban-Vasallo MD, 2014, HUM VACC IMMUNOTHER, V10, P1650, DOI 10.4161/hv.28620; Garmaeva S, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0704-y; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Illumina, 16S MET SEQ LIB PREP; Kowalski ML, 2017, ALLERGY, V72, P2035, DOI 10.1111/all.13233; Krishnamurthy SR, 2017, VIRUS RES, V239, P136, DOI 10.1016/j.virusres.2017.02.002; Kwon HJ, 2016, J ALLERGY CLIN IMMUN, V137, P1406, DOI 10.1016/j.jaci.2015.10.032; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Nenna R, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00062-2020; Popgeorgiev N, 2013, INTERVIROLOGY, V56, P395, DOI 10.1159/000354561; Rantala A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027912; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Reuter S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007595; RexSoft, 2018, REX EXC BAS STAT AN; Romero-Espinoza JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192878; Sawant A, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00111-2017; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schneeberger PHH, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0755-x; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sehrawat S, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00177; Sun HM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3345-9; van Rijn AL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223952; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Zarate S, 2017, ARCH MED RES, V48, P701, DOI 10.1016/j.arcmed.2018.01.005; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zheng XY, 2018, ARCH VIROL, V163, P845, DOI 10.1007/s00705-017-3700-y; Zuhair M, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2034	43	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					1007	+		10.1016/j.jaci.2021.03.017	http://dx.doi.org/10.1016/j.jaci.2021.03.017		OCT 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	33757721				2022-12-18	WOS:000705023300011
J	Rodriguez-Rosales, YA; Langereis, JD; Gorris, MAJ; van den Reek, JMPA; Fasse, E; Netea, MG; de Vries, IJM; Gomez-Munoz, L; van Cranenbroek, B; Korber, A; Sondermann, W; Joosten, Iw; de Jong, EMGJ; Koenen, HJPM				Rodriguez-Rosales, Yessica A.; Langereis, Jeroen D.; Gorris, Mark A. J.; van den Reek, Juul M. P. A.; Fasse, Esther; Netea, Mihai G.; de Vries, I. Jolanda M.; Gomez-Munoz, Laia; van Cranenbroek, Bram; Korber, Andreas; Sondermann, Wiebke; Joosten, Irma; de Jong, Elke M. G. J.; Koenen, Hans J. P. M.			Immunomodulatory aged neutrophils are augmented in blood and skin of psoriasis patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Neutrophil heterogeneity; aged neutrophils; psoriasis; inflammatory disease; neutrophil maturation; neutrophils in psoriatic skin; antibody therapy; IL-17; neutrophil extracellular traps; netosis	CELLS; DIFFERENTIATION; PATHOGENESIS; INFLAMMATION; INNATE	Background: Neutrophil accumulation in the skin is a hallmark of psoriasis. Novel insights on neutrophil phenotypic and functional heterogeneity raise the question to what extent these cells contribute to the sustained inflammatory skin reaction. Objective: We sought to examine the phenotype and functional properties of neutrophils in blood and skin of patients with psoriasis, and the effect of TNF-alpha and p40(IL-12/IL-23) antibody therapy on circulating neutrophils. Methods: Thirty-two patients with psoriasis were enrolled in an observational study performed in 2 university hospitals. We evaluated neutrophil phenotype and function using in vitro (co) culture stimulation assays, flow cytometry, multiplex immunohistochemistry, and multispectral imaging of patientderived blood and skin samples. Results: Cluster of differentiation (CD)10(pos) and CD10(neg) neutrophils were increased in peripheral blood of patients with psoriasis. In CD10(neg) neutrophils, different maturation stages were observed, including a subset resembling aged neutrophils that was 3 times more abundant than in healthy individuals. These aged neutrophils displayed suboptimal canonical neutrophil functions and induced IL-17 and IFN-gamma production by T cells in vitro, mediated by neutrophil extracellular trap formation. Also, mature and aged neutrophils were present in psoriatic skin and were found in the vicinity of T cells. Upon antibody therapy, numbers of these cells in circulation decreased. Conclusions: Patients with psoriasis reveal a unique neutrophil profile in circulation, and 2 distinct neutrophil subsets are present in psoriatic skin. Targeted biological treatment may aid in the containment of sustained neutrophil-mediated inflammation.	[Rodriguez-Rosales, Yessica A.; Langereis, Jeroen D.; Fasse, Esther; Gomez-Munoz, Laia; van Cranenbroek, Bram; Joosten, Irma; Koenen, Hans J. P. M.] Radboudumc, Dept Lab Med, Lab Med Immunol, Nijmegen, Netherlands; [Gorris, Mark A. J.; de Vries, I. Jolanda M.] Radboudumc, Dept Tumor Immunol, Nijmegen, Netherlands; [van den Reek, Juul M. P. A.; de Jong, Elke M. G. J.] Radboudumc, Dept Dermatol, Nijmegen, Netherlands; [Netea, Mihai G.] Radboudumc, Dept Internal Med, Nijmegen, Netherlands; [Netea, Mihai G.] Radboudumc, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Netea, Mihai G.] Univ Bonn, Dept Genom & Immunoregulat, Life & Med Sci Inst LIMES, Bonn, Germany; [Korber, Andreas; Sondermann, Wiebke] Univ Hosp Essen, Dept Dermatol, Essen, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Bonn; University of Duisburg Essen	Koenen, HJPM (corresponding author), Radboud Univ Nijmegen, Dept Lab Med, Lab Med Immunol, Med Ctr, Geert Grootepl Zuid 10,Route 469, NL-6500 HB Nijmegen, Netherlands.	Hans.Koenen@radboudumc.nl	Joosten, Irma/N-4418-2013; Langereis, Jeroen/H-1042-2013; de Jong, Elke M. G. J./L-4418-2015; Gorris, Mark/D-9700-2016; van den Reek, Juul M.P.A./O-8624-2015	Joosten, Irma/0000-0003-2950-4977; Langereis, Jeroen/0000-0001-5317-3202; de Jong, Elke M. G. J./0000-0003-3872-5704; Gorris, Mark/0000-0003-3621-226X; van den Reek, Juul M.P.A./0000-0002-3642-2673; Gomez Munoz, Laia/0000-0001-9640-6213	Mobility Postgraduate program of the Mexican National Council for Science and Technology (CONACyT) [270218]; European Research Council (ERC) [833247]; Spinoza grant of the Netherlands Organisation for Scientific Research; National Psoriasis Foundation/USA	Mobility Postgraduate program of the Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); European Research Council (ERC)(European Research Council (ERC)European Commission); Spinoza grant of the Netherlands Organisation for Scientific Research; National Psoriasis Foundation/USA	The study and Y.A.R.-R. were supported by the Mobility Postgraduate program of the Mexican National Council for Science and Technology (CONACyT) (grant no. 270218). M.G.N. was supported by an European Research Council (ERC) advanced grant (grant no. 833247) and a Spinoza grant of the Netherlands Organisation for Scientific Research. J.M.P.A.vdR. received funding from the National Psoriasis Foundation/USA for this study.	Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002; Aguirre-Gamboa R, 2016, CELL REP, V17, P2474, DOI 10.1016/j.celrep.2016.10.053; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Brodmerkel C, 2019, J ALLERGY CLIN IMMUN, V143, P1965, DOI 10.1016/j.jaci.2019.01.017; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chamilos G, 2012, BLOOD, V120, P3699, DOI 10.1182/blood-2012-01-401364; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Di Meglio P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015354; Ella K, 2016, BRAIN BEHAV IMMUN, V57, P209, DOI 10.1016/j.bbi.2016.04.016; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Gorris MAJ, 2017, J IMMUNOL, V12; Grieshaber-Bouyer R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00346; Grozdev I, 2014, CLIN DERMATOL, V32, P343, DOI 10.1016/j.clindermatol.2013.11.001; Hawkes JE, 2017, J ALLERGY CLIN IMMUN, V140, P645, DOI 10.1016/j.jaci.2017.07.004; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Johnson K. S, 2020, PHENOPTR INFORM HELP; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Krueger JG, 2019, J ALLERGY CLIN IMMUN, V144, P750, DOI 10.1016/j.jaci.2019.04.029; Lambert S, 2019, J INVEST DERMATOL, V139, P1245, DOI 10.1016/j.jid.2018.11.021; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Marini O, 2017, BLOOD, V129, P1343, DOI 10.1182/blood-2016-04-713206; Matsushima H, 2013, BLOOD, V121, P1677, DOI 10.1182/blood-2012-07-445189; Meng W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/149560; Moorlag SJCFM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108387; Nagl S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1127494; Niu HT, 2013, BLOOD, V121, P1986, DOI 10.1182/blood-2012-05-433755; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Rodriguez-Rosales YA, 2019, SHOCK, V51, P678, DOI 10.1097/SHK.0000000000001222; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Scapini P, 2016, IMMUNOL REV, V273, P48, DOI 10.1111/imr.12448; Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10; Strohbuecker L, 2019, PSORIASIS-TARGETS TH, V9, P7, DOI 10.2147/PTT.S190507; Sweeney CM, 2011, ARCH DERMATOL RES, V303, P691, DOI 10.1007/s00403-011-1169-1; Tillack K, 2012, J IMMUNOL, V188, P3150, DOI 10.4049/jimmunol.1103414; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Wolberink EAW, 2014, EXP DERMATOL, V23, P184, DOI 10.1111/exd.12345; Zhou GX, 2018, GUT, V67, P1052, DOI 10.1136/gutjnl-2016-313535	41	9	9	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					1030	1040		10.1016/j.jaci.2021.02.041	http://dx.doi.org/10.1016/j.jaci.2021.02.041		OCT 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	33745888	hybrid, Green Published			2022-12-18	WOS:000705023300013
J	Konnikova, L; Robinson, TO; Owings, AH; Shirley, JF; Davis, E; Tang, Y; Wall, S; Li, J; Hasan, MH; Gharaibeh, RZ; Alvarez, LBM; Ryan, LK; Doty, A; Chovanec, JF; O'Connell, MP; Grunes, DE; Daley, WP; Mayer, E; Chang, L; Liu, JL; Snapper, SB; Milner, JD; Glover, SC; Lyons, JJ				Konnikova, Liza; Robinson, Tanya O.; Owings, Anna H.; Shirley, James F.; Davis, Elisabeth; Tang, Ying; Wall, Sarah; Li, Jian; Hasan, Mohammad H.; Gharaibeh, Raad Z.; Alvarez, Lybil B. Mendoza; Ryan, Lisa K.; Doty, Andria; Chovanec, Jack F.; O'Connell, Michael P.; Grunes, Dianne E.; Daley, William P.; Mayer, Emeran; Chang, Lin; Liu, Julia; Snapper, Scott B.; Milner, Joshua D.; Glover, Sarah C.; Lyons, Jonathan J.			Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mast cells; pyroptosis; mast cell activation; hereditary alpha-tryptasemia; small intestine; memory B cells; CyTOF; double-negative T cells	MAST-CELLS; DISEASE; COLON; ILEUM	Background: Hereditary alpha-tryptasemia (H alpha T) is characterized by elevated basal serum tryptase due to increased copies of the TPSAB1 gene. Individuals with H alpha T frequently present with multisystem complaints, including anaphylaxis and seemingly functional gastrointestinal (GI) symptoms. Objective: We sought to determine the prevalence of H alpha T in an irritable bowel syndrome cohort and associated immunologic characteristics that may distinguish patients with HaT from patients without H alpha T. Methods: Tryptase genotyping by droplet digital PCR, flow cytometry, cytometry by time-of-flight, immunohistochemistry, and other molecular biology techniques was used. Results: H alpha T prevalence in a large irritable bowel syndrome cohort was 5% (N = 8/158). Immunophenotyping of H alpha T PBMCs (N >= 27) revealed increased total and class-switched memory B cells. In the small bowel, expansion of tissue mast cells with expression of CD203c, HLA-DR, and Fc epsilon RI, higher intestinal epithelial cell pyroptosis, and increased class-switched memory B cells were observed. IgG profiles in sera from individuals with HaT (N = 21) significantly differed from those in individuals with quiescent Crohn disease (N = 20) and non-H alpha T controls (N = 19), with increased antibodies directed against GI-associated proteins identified in individuals with H alpha T. Conclusions: Increased mast cell number and intestinal epithelial cell pyroptosis in the small intestine, and class-switched memory B cells in both the gut and peripheral blood associated with IgG reactive to GI-related proteins, distinguish H alpha T from functional GI disease. These innate and adaptive immunologic findings identified in association with H alpha T are suggestive of subclinical intestinal inflammation in symptomatic individuals.	[Konnikova, Liza] Boston Childrens Hosp, Div Newborn Med, Boston, MA USA; [Konnikova, Liza] Childrens Hosp UPMC, Dept Pediat, Pittsburgh, PA USA; [Konnikova, Liza] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Robinson, Tanya O.; Owings, Anna H.; Hasan, Mohammad H.; Glover, Sarah C.] Univ Mississippi, Med Ctr, Dept Med, Div Digest Dis, 2500 North State St, Jackson, MS 39206 USA; [Shirley, James F.; Tang, Ying; Li, Jian; Gharaibeh, Raad Z.; Glover, Sarah C.] Univ Florida, Dept Med, Div Gastroenterol, Gainesville, FL USA; [Davis, Elisabeth] Univ Arkansas Med Sci, Dept Med, Div Gastroenterol, Little Rock, AR 72205 USA; [Tang, Ying; Wall, Sarah; Snapper, Scott B.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Alvarez, Lybil B. Mendoza] Univ Florida, Dept Pediat, Div Pediat Gastroenterol, Gainesville, FL USA; [Ryan, Lisa K.] Univ Florida, Dept Med, Div Infect Dis, Gainesville, FL USA; [Doty, Andria] Univ Florida, Cytometry Core, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Chovanec, Jack F.; O'Connell, Michael P.; Lyons, Jonathan J.] NIH, NIAID, Lab Allerg Dis, 9000 Rockville Pike,Bldg 29B,Rm 5NN18,MSC 1889, Bethesda, MD 20892 USA; [Grunes, Dianne E.; Daley, William P.] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Mayer, Emeran; Chang, Lin] Univ Calif Los Angeles, Dept Med, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90024 USA; [Liu, Julia] Morehouse Sch Med, Atlanta, GA 30310 USA; [Milner, Joshua D.] Columbia Univ, Med Ctr, Div Allergy Immunol & Rheumatol, New York, NY USA	Harvard University; Boston Children's Hospital; Yale University; University of Mississippi; University of Mississippi Medical Center; State University System of Florida; University of Florida; University of Arkansas System; University of Arkansas Medical Sciences; Harvard University; Boston Children's Hospital; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Mississippi; University of Mississippi Medical Center; University of California System; University of California Los Angeles; Morehouse School of Medicine; Columbia University	Glover, SC (corresponding author), Univ Mississippi, Med Ctr, Dept Med, Div Digest Dis, 2500 North State St, Jackson, MS 39206 USA.; Lyons, JJ (corresponding author), NIH, NIAID, Lab Allerg Dis, 9000 Rockville Pike,Bldg 29B,Rm 5NN18,MSC 1889, Bethesda, MD 20892 USA.	scglover@umc.edu; jonathan.lyons@nih.gov		/0000-0002-4357-0690; Konnikova, Yelizaveta/0000-0003-4804-5497; Glover, Sarah/0000-0002-9899-0473	Gatorade Trust through University of Florida, Department of Medicine [1R21TR002639-01A1]; Crohn's & Colitis Foundation of America [CDA 422348]; National Institutes of Health (NIH) via the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; UF Health Cancer Center funds	Gatorade Trust through University of Florida, Department of Medicine; Crohn's & Colitis Foundation of America; National Institutes of Health (NIH) via the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; UF Health Cancer Center funds	This work was supported by the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine, a generous donation from the Mary Parker Foundation to the University of Florida, extramural funding to Drs Konnikova and Glover (grant no. 1R21TR002639-01A1) , Crohn's & Colitis Foundation ofAmerica funding to Dr Konnikova (grant no. CDA 422348) , and intramural National Institutes of Health (NIH) funding to Dr Lyons via the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. R.Z.G. is sup-ported by UF Health Cancer Center funds.	Bannert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042066; Carrasco A, 2016, J CROHNS COLITIS, V10, P1042, DOI 10.1093/ecco-jcc/jjw066; Chang SG, 1989, METHODS MOL BIOL, P47; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Ford AC, 2017, NEW ENGL J MED, V376, P2566, DOI 10.1056/NEJMra1607547; Gelbmann CM, 1999, GUT, V45, P210, DOI 10.1136/gut.45.2.210; Greiner G, 2021, BLOOD, V137, P238, DOI 10.1182/blood.2020006157; Hamilton MJ, 2021, AM J SURG PATHOL, V45, P997, DOI 10.1097/PAS.0000000000001676; Han GJ, 2018, NAT PROTOC, V13, P2121, DOI 10.1038/s41596-018-0016-7; Hartmann FJ, 2019, METHODS MOL BIOL, V1989, P55, DOI 10.1007/978-1-4939-9454-0_5; Infantino M, 2017, MINERVA GASTROENTERO, V63, P1, DOI 10.23736/S1121-421X.16.02351-5; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Jakate S, 2006, ARCH PATHOL LAB MED, V130, P362; KAGNOFF MF, 1993, GASTROENTEROLOGY, V105, P1275, DOI 10.1016/0016-5085(93)90128-Y; Konnikova L, 2018, MUCOSAL IMMUNOL, V11, P1684, DOI 10.1038/s41385-018-0047-y; Kulinski JM, 2020, J ALLER CL IMM-PRACT, V8, P292, DOI 10.1016/j.jaip.2019.07.004; Li J, 2016, CELL IMMUNOL, V304, P63, DOI 10.1016/j.cellimm.2016.05.001; Liu JJ, 2016, DIGEST DIS SCI, V61, P1895, DOI 10.1007/s10620-016-4154-x; Liu JJ, 2013, INFLAMM BOWEL DIS, V19, P912, DOI 10.1097/MIB.0b013e3182807600; Lyons JJ, 2021, J ALLERGY CLIN IMMUN, V147, P622, DOI 10.1016/j.jaci.2020.06.035; Lyons JJ, 2018, IMMUNOL ALLERGY CLIN, V38, P483, DOI 10.1016/j.iac.2018.04.003; Lyons JJ, 2018, GENET MED, V20, P503, DOI 10.1038/gim.2017.136; Lyons JJ, 2016, NAT GENET, V48, P1564, DOI 10.1038/ng.3696; Lyons JJ, 2014, J ALLERGY CLIN IMMUN, V133, P1471, DOI 10.1016/j.jaci.2013.11.039; Maun HR, 2019, CELL, V179, P417, DOI 10.1016/j.cell.2019.09.009; Mitsialis V, 2020, GASTROENTEROLOGY, V159, P591, DOI 10.1053/j.gastro.2020.04.074; Nojkov B, 2020, AM J GASTROENTEROL, V115, P1891, DOI 10.14309/ajg.0000000000000827; Osterman MT, INFLAMM BOWEL DIS, V27, P677; Le QT, 2019, J EXP MED, V216, P2348, DOI 10.1084/jem.20190701; Rabe H, 2019, CLIN EXP IMMUNOL, V197, P111, DOI 10.1111/cei.13294; Robey RC, 2020, J ALLER CL IMM-PRACT, V8, P3549, DOI 10.1016/j.jaip.2020.05.057; Rubin SJS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10387-7; Saitta S, 2006, COMBINING 2 DATA MIN; Sboner A, 2009, J PROTEOME RES, V8, P5451, DOI 10.1021/pr900412k; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Tornai T, 2017, WORLD J GASTROENTERO, V23, P5412, DOI 10.3748/wjg.v23.i29.5412; Tsuchiya K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09753-2; Valent P, 2019, J ALLER CL IMM-PRACT, V7, P81, DOI 10.1016/j.jaip.2018.09.024; Valent P, 2010, BEST PRACT RES CL HA, V23, P369, DOI 10.1016/j.beha.2010.07.003; Vivinus-Nebot M, 2014, GUT, V63, P744, DOI 10.1136/gutjnl-2012-304066; Volta U, 2012, J CLIN GASTROENTEROL, V46, P680, DOI 10.1097/MCG.0b013e3182372541; Wosen JE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02144	42	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					813	+		10.1016/j.jaci.2021.04.004	http://dx.doi.org/10.1016/j.jaci.2021.04.004		SEP 2021	16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	33865872	Green Accepted			2022-12-18	WOS:000695242900030
J	Krings, JG; Goss, CW; Lew, D; Samant, M; McGregor, MC; Boomer, J; Bacharier, LB; Sheshadri, A; Hall, C; Brownell, J; Schechtman, KB; Peterson, S; McEleney, S; Mauger, DT; Fahy, JV; Fain, SB; Denlinger, LC; Israel, E; Washko, G; Hoffman, E; Wenzel, SE; Castro, M				Krings, James G.; Goss, Charles W.; Lew, Daphne; Samant, Maanasi; McGregor, Mary Clare; Boomer, Jonathan; Bacharier, Leonard B.; Sheshadri, Ajay; Hall, Chase; Brownell, Joshua; Schechtman, Ken B.; Peterson, Samuel; McEleney, Stephen; Mauger, David T.; V. Fahy, John; Fain, Sean B.; Denlinger, Loren C.; Israel, Elliot; Washko, George; Hoffman, Eric; Wenzel, Sally E.; Castro, Mario		Natl Heart Lung Blood Inst Severe	Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: Results from SARP-3	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; severe asthma; CT imaging; asthma morbidity; asthma exacerbations; longitudinal; lung function	AIR-FLOW LIMITATION; COMPUTED-TOMOGRAPHY; RISK-FACTORS; COPD PHENOTYPES; WALL THICKNESS; EMPHYSEMA; DISEASE; BIOMARKER; PROGRESSION; SMOKERS	Background: Currently, there is limited knowledge regarding which imaging assessments of asthma are associated with accelerated longitudinal decline in lung function. Objectives: We aimed to assess whether quantitative computed tomography (qCT) metrics are associated with longitudinal decline in lung function and morbidity in asthma. Methods: We analyzed 205 qCT scans of adult patients with asthma and calculated baseline markers of airway remodeling, lung density, and pointwise regional change in lung volume (Jacobian measures) for each participant. Using multivariable regression models, we then assessed the association of qCT measurements with the outcomes of future change in lung function, future exacerbation rate, and changes in validated measurements of morbidity. Results: Greater baseline wall area percent (13 = -0.15 [95% CI = -0.26 to -0.05]; P < .01), hyperinflation percent (13 = -0.25 [95% CI = -0.41 to -0.09]; P < .01), and Jacobian gradient measurements (cranial-caudal 13 = 10.64 [95% CI = 3.7917.49]; P <.01; posterior-anterior 13 = -9.14, [95% CI = -15.49 to -2.78]; P <.01) were associated with more severe future lung function decline. Additionally, greater wall area percent (rate ratio = 1.06 [95% CI = 1.01-1.10]; P = .02) and air trapping percent (rate ratio =1.01 [95% CI = 1.00-1.02]; P = .03), as well as lower decline in the Jacobian determinant mean (rate ratio = 0.58 [95% CI = 0.41-0.82]; P <.01) and Jacobian determinant standard deviation (rate ratio = 0.52 [95% CI = 0.32-0.85]; P = .01), were associated with a greater rate of future exacerbations. However, imaging metrics were not associated with clinically meaningful changes in scores on validated asthma morbidity questionnaires. Conclusions: Baseline qCT measures of more severe airway remodeling, more small airway disease and hyperinflation, and less pointwise regional change in lung volumes were associated with future lung function decline and asthma exacerbations.	[Krings, James G.; Samant, Maanasi; McGregor, Mary Clare] Washington Univ St Louis Sch Med, Div Pulm & Crit Care Med, Dept Med, Washington, DC USA; [Goss, Charles W.; Lew, Daphne; Schechtman, Ken B.] Washington Univ St Louis Sch Med, Div Biostat, Washington, DC USA; [Boomer, Jonathan; Hall, Chase; Castro, Mario] Univ Kansas Sch Med, Div Pulm Crit Care & Sleep Med, Dept Med, 3901 Rainbow Blvd, Kansas City, KS 66103 USA; [Bacharier, Leonard B.] Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN USA; [Sheshadri, Ajay] Univ Texas MD Anderson Canc Ctr, Dept Med, Div Pulm & Crit Care Med, Houston, TX 77030 USA; [Brownell, Joshua; Denlinger, Loren C.] Univ Wisconsin, Dept Med, Div Allergy Pulm & Crit Care Med, Madison, WI USA; [Peterson, Samuel; McEleney, Stephen] VIDA Diagnost, Coralville, IA USA; [Mauger, David T.] Penn State Univ, Dept Publ Hlth Sci, Div Stat & Bioinformat, Hershey, PA USA; [V. Fahy, John] Univ Calif San Francisco, Div Pulm & Crit Care Med, Dept ofMedicine, San Francisco, CA 94143 USA; [Fain, Sean B.] Univ Wisconsin, Dept Radiol & Biomed Engn, Madison, WI 53706 USA; [Israel, Elliot; Washko, George] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA USA; [Hoffman, Eric] Univ Iowa, Dept Radiol Biomed Engn & Med, Iowa City, IA USA; [Wenzel, Sally E.] Univ Pittsburgh, Div Pulm Allergy & Crit Care, Dept Med, Pittsburgh, PA 15260 USA	Washington University (WUSTL); Washington University (WUSTL); University of Kansas; University of Kansas Medical Center; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Brigham & Women's Hospital; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Castro, M (corresponding author), Univ Kansas Sch Med, Div Pulm Crit Care & Sleep Med, Dept Med, 3901 Rainbow Blvd, Kansas City, KS 66103 USA.	mcastro2@kumc.edu	Goss, Charles W/R-7296-2019; Fain, Sean/K-4260-2016	Sheshadri, Ajay/0000-0002-8091-0180; Fain, Sean/0000-0001-5461-0646; Hoffman, Eric/0000-0001-8456-9437	National Heart, Lung, and Blood Institute [U10 HL109086-04, U10 HL109146, U10 HL109168, U10 HL109172, U10 HL109152, U10 HL109257]; Washington University Institutional Training Award from the National Heart, Lung, and Blood Institute [2T32HL007317-41]; National Center for Advancing Translational Science [UL1 TR000427, UL1 TR001102, UL1TR002345]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Washington University Institutional Training Award from the National Heart, Lung, and Blood Institute; National Center for Advancing Translational Science	Funded by grants from the National Heart, Lung, and Blood Institute to the Severe Asthma Research Program's (SARP's) principal investigators, clinical centers, and data coordinating center, including grants U10 HL109086-04 (to D.T.M.), U10 HL109146 (to J.V.F.), U10 HL109168 (to L.C.D.), U10 HL109172 (to G.W.), U10 HL109152 (to S.E.W.), and U10 HL109257 (to M.C.). Support for SARP visits occurring beyond the third year of follow-up was provided in part by SARP's partnerships with AstraZeneca, Boehringer-Ingelheim, Genentech, GSK, Sanofi-GenzymeRegeneron, and TEVA. In addition, this study was supported by aWashington University Institutional Training Award (2T32HL007317-41) from the National Heart, Lung, and Blood Institute, as well as by support from the following National Center for Advancing Translational Science awards: UL1 TR000427 (University of Wisconsin), UL1 TR001102 (Harvard University), UL1TR002345 (Washington University).	Amelon R, 2011, J BIOMECH, V44, P2489, DOI 10.1016/j.jbiomech.2011.06.009; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bai TR, 2007, EUR RESPIR J, V30, P452, DOI 10.1183/09031936.00165106; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; Bell AJ, 2019, J ALLERGY CLIN IMMUN, V144, P83, DOI 10.1016/j.jaci.2019.01.014; Belloli EA, 2017, AM J RESP CRIT CARE, V195, P942, DOI 10.1164/rccm.201604-0732OC; Bhatt SP, 2017, AM J RESP CRIT CARE, V196, P569, DOI 10.1164/rccm.201701-0050OC; Bhatt SP, 2016, AM J RESP CRIT CARE, V194, P178, DOI 10.1164/rccm.201511-2219OC; Bodduluri S, 2017, THORAX, V72, P409, DOI 10.1136/thoraxjnl-2016-209544; Bodduluri S, 2013, ACAD RADIOL, V20, P527, DOI 10.1016/j.acra.2013.01.019; Boulet LP, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00598-2019; Boulet LP, 2009, CURR ALLERGY ASTHM R, V9, P168, DOI 10.1007/s11882-009-0025-2; Brumpton BM, 2016, AM J EPIDEMIOL, V183, P739, DOI 10.1093/aje/kwv243; Bui DS, 2020, ANN AM THORAC SOC, V17, P302, DOI 10.1513/AnnalsATS.201904-329OC; Castro M, 2011, J ALLERGY CLIN IMMUN, V128, P467, DOI 10.1016/j.jaci.2011.04.051; Choi S, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2017-000252; Choi S, 2017, J ALLERGY CLIN IMMUN, V140, P690, DOI 10.1016/j.jaci.2016.11.053; Choi S, 2013, J APPL PHYSIOL, V115, P730, DOI 10.1152/japplphysiol.00113.2013; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Coumou H, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01785-2017; Covar RA, 2004, AM J RESP CRIT CARE, V170, P234, DOI 10.1164/rccm.200308-1174OC; Fitzpatrick AM, 2019, AM THOR SOC 2019 INT; Galban CJ, 2014, BIOL BLOOD MARROW TR, V20, P1592, DOI 10.1016/j.bbmt.2014.06.014; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Gono H, 2003, EUR RESPIR J, V22, P965, DOI 10.1183/09031936.03.00085302; Gupta S, 2014, J ALLERGY CLIN IMMUN, V133, P729, DOI 10.1016/j.jaci.2013.09.039; Harmanci E, 2002, RESPIRATION, V69, P420, DOI 10.1159/000064018; Herth FJF, 2018, RESPIRATION, V95, P8, DOI 10.1159/000480435; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; Jacob J, 2018, AM J RESP CRIT CARE, V198, P767, DOI 10.1164/rccm.201711-2174OC; Jacob J, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0739-7; Jacobt J, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00869-2018; Jahani N, 2017, J BIOMECH, V56, P102, DOI 10.1016/j.jbiomech.2017.03.012; Jahani N, 2014, J BIOMECH, V47, P1626, DOI 10.1016/j.jbiomech.2014.02.040; Juniper Elizabeth F, 2005, Health Qual Life Outcomes, V3, P58, DOI 10.1186/1477-7525-3-58; Kirby M, 2017, RESPIRATION, V94, P336, DOI 10.1159/000478865; Krings JG, 2019, J ALLER CL IMM-PRACT, V7, P1379, DOI 10.1016/j.jaip.2019.03.008; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Matsunaga K, 2015, J ALLER CL IMM-PRACT, V3, P759, DOI 10.1016/j.jaip.2015.05.005; Matsunaga K, 2013, RESP MED, V107, P355, DOI 10.1016/j.rmed.2012.11.014; McGregor MC, 2019, AM J RESP CRIT CARE, V199, P433, DOI 10.1164/rccm.201810-1944CI; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Newell JD, 2013, J THORAC IMAG, V28, P266, DOI 10.1097/RTI.0b013e31829f6796; Niimi A, 2000, AM J RESP CRIT CARE, V162, P1518, DOI 10.1164/ajrccm.162.4.9909044; Ortega H, 2018, J ALLER CL IMM-PRACT, V6, P980, DOI 10.1016/j.jaip.2017.12.019; Ostridge K, 2019, ANN AM THORAC SOC, V16, P990, DOI 10.1513/AnnalsATS.201810-669OC; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; PEAT JK, 1987, EUR J RESPIR DIS, V70, P171; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Shaw D., 2018, EUR RESPIR J, P51; Shifren A, 2012, J ALLERGY, V2012, P1, DOI DOI 10.1155/2012/316049; Sieren JP, 2016, AM J RESP CRIT CARE, V194, P794, DOI 10.1164/rccm.201506-1208PP; Subramanian DR, 2016, EUR RESPIR J, V48, P92, DOI 10.1183/13993003.01878-2015; Teague WG, 2018, J ALLER CL IMM-PRACT, V6, P545, DOI 10.1016/j.jaip.2017.05.032; ten Brinke A, 2001, AM J RESP CRIT CARE, V164, P744, DOI 10.1164/ajrccm.164.5.2011026; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Trivedi A, 2017, J ALLERGY CLIN IMMUN, V139, P1, DOI 10.1016/j.jaci.2016.11.009; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vonk JM, 2003, THORAX, V58, P322, DOI 10.1136/thorax.58.4.322; Wang M, 2019, JAMA-J AM MED ASSOC, V322, P546, DOI 10.1001/jama.2019.10255; Washko GR, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01570-2018; Witt CA, 2014, ACAD RADIOL, V21, P986, DOI 10.1016/j.acra.2014.05.001; Young HM, 2019, CLIN BIOMECH, V66, P107, DOI 10.1016/j.clinbiomech.2017.09.016	64	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					752	762		10.1016/j.jaci.2021.01.029	http://dx.doi.org/10.1016/j.jaci.2021.01.029		SEP 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	33577895	Green Accepted			2022-12-18	WOS:000695242900024
J	Macchiaverni, P; Rekima, A; van den Elsen, L; Renz, H; Verhasselt, V				Macchiaverni, Patricia; Rekima, Akila; van den Elsen, Lieke; Renz, Harald; Verhasselt, Valerie			Allergen shedding in human milk: Could it be key for immune system education and allergy prevention?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Allergy; primary prevention; oral tolerance; breast milk; allergen	HUMAN BREAST-MILK; NEONATAL FC-RECEPTOR; HOUSE-DUST MITE; BOVINE BETA-LACTOGLOBULIN; VITAMIN-A; PEANUT ALLERGENS; ORAL TOLERANCE; EGG CONSUMPTION; MATERNAL INTAKE; FOOD ALLERGEN	In addition to being a source of nutrients for the developing newborn, human milk contains thousands of bioactive compounds, which influence infant health in the short-term as exemplified by its major benefits on infectious disease prevention. Many of the human milk compounds also have the required characteristics to instruct immune development and guide long-term health. Prebiotics, probiotics, and varied antimicrobial molecules all have the potential to shape the composition and function of the establishing gut microbiota, which is known to be a major determinant of immune function. Another and less explored way human milk can instruct long-term immunity is through antigen shedding. Here, we will review the evidence that antigens from maternal environment and more specifically from allergen sources are found in human milk. We will discuss data from rodent models and birth cohorts showing that allergen shedding in breast milk may influence long-term allergy risk. We will uncover the variables that may underlie heterogeneity in oral tolerance induction and allergy prevention in children breast-fed by allergen-exposed mothers. We will focus on the parameters that control antigen transfer to breast milk, on the unique biological characteristics of allergens in breast milk, and on the milk bioactive compounds that were found to influence immune response in offspring. We propose this understanding is fundamental to guide maternal interventions leading to lifelong allergen tolerance.	[Macchiaverni, Patricia; Rekima, Akila; van den Elsen, Lieke; Verhasselt, Valerie] Univ Western Australia, Sch Med & Biomed Sci, Nedlands, WA, Australia; [Macchiaverni, Patricia; Rekima, Akila; van den Elsen, Lieke; Verhasselt, Valerie] Telethon Kids Inst, Perth, WA, Australia; [Renz, Harald] Philipps Univ Marburg, Inst Lab Med, Marburg, Germany; [Renz, Harald] Univ Giessen & Marburg Lung Cen ter UGMLC, Marburg, Germany; [Renz, Harald] German Ctr Lung Res DZL, Marburg, Germany; [Renz, Harald; Verhasselt, Valerie] Worldwide Univ Network WUN, West New York, NJ USA	University of Western Australia; Telethon Kids Institute; Philipps University Marburg	Verhasselt, V (corresponding author), Telethon Kids Inst, 15 Hosp Ave, Nedlands, WA 6009, Australia.	valerie.verhasselt@uwa.edu.au	; Macchiaverni, Patricia/K-8507-2018	verhasselt, valerie/0000-0002-5732-9048; van den Elsen, Lieke/0000-0002-9366-6631; Rekima, Akila/0000-0003-2323-6334; Macchiaverni, Patricia/0000-0002-1897-9013	University of Western Australia; Larsson-Rosenquist Foundation; German Center of Lung Research (DZL); MIRACUM network of the medical informatics initiative in Germany; network University Medicine COVID-19	University of Western Australia; Larsson-Rosenquist Foundation; German Center of Lung Research (DZL); MIRACUM network of the medical informatics initiative in Germany; network University Medicine COVID-19	This work was supported by funding from the University of Western Australia and the Larsson-Rosenquist Foundation. H.R. is funded by the German Center of Lung Research (DZL) , the MIRACUM network of the medical informatics initiative in Germany, and the network University Medicine COVID-19.	Aage S, 2015, ALLERGY, V70, P985, DOI 10.1111/all.12641; Adel-Patient K, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01545; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Al Nabhani Z, 2020, MUCOSAL IMMUNOL, V13, P183, DOI 10.1038/s41385-020-0257-y; AXELSSON I, 1986, ACTA PAEDIATR SCAND, V75, P702, DOI 10.1111/j.1651-2227.1986.tb10277.x; Baban B, 2018, JAMA PEDIATR, V172, P594, DOI 10.1001/jamapediatrics.2018.0148; Baiz N, 2017, J ALLERGY CLIN IMMUN, V139, P369, DOI 10.1016/j.jaci.2016.07.021; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bedin AS, 2019, PEDIAT ALLERG IMM-UK, V30, P479, DOI 10.1111/pai.13037; Bellach J, 2017, J ALLERGY CLIN IMMUN, V139, P1591, DOI 10.1016/j.jaci.2016.06.045; Bernard H, 2014, ALLERGY, V69, P888, DOI 10.1111/all.12411; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; Cabinian A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156762; CANT A, 1985, BRIT MED J, V291, P932, DOI 10.1136/bmj.291.6500.932; Chirdo FG, 1998, SCAND J GASTROENTERO, V33, P1186, DOI 10.1080/00365529850172557; Cianga P, 1999, EUR J IMMUNOL, V29, P2515, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2515::AID-IMMU2515&gt;3.0.CO;2-D; Dallas David C, 2012, J Nutr Disord Ther, V2, P112; Dawod B, 2020, J ALLERGY CLIN IMMUN, V146, P631, DOI 10.1016/j.jaci.2020.01.049; de Silva D, 2020, PEDIAT ALLERG IMM-UK, V31, P813, DOI 10.1111/pai.13273; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Ferranti P, 2004, J DAIRY RES, V71, P74, DOI 10.1017/S0022029903006599; Fukushima Y, 1997, AM J CLIN NUTR, V65, P30, DOI 10.1093/ajcn/65.1.30; Fusaro AE, 2007, IMMUNOLOGY, V122, P107, DOI 10.1111/j.1365-2567.2007.02618.x; Greer FR, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2019-0281; Halken S, 2021, PEDIAT ALLERG IMM-UK, V32, P843, DOI 10.1111/pai.13496; HANSON DG, 1981, J IMMUNOL, V127, P1518; Hassiotou F, 2013, J HUM LACT, V29, P171, DOI 10.1177/0890334413477242; Hirose J, 2001, BIOSCI BIOTECH BIOCH, V65, P1438, DOI 10.1271/bbb.65.1438; HOST A, 1990, CLIN EXP ALLERGY, V20, P383, DOI 10.1111/j.1365-2222.1990.tb02798.x; Ichikawa M, 2003, IMMUNOLOGY, V108, P189, DOI 10.1046/j.1365-2567.2003.01572.x; Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x; Jarvinen KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143855; Jarvinen KM, 2019, ANN ALLERG ASTHMA IM, V123, P133, DOI 10.1016/j.anai.2019.04.022; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khaleva E, 2019, CLIN EXP ALLERGY, V49, P1201, DOI 10.1111/cea.13409; KILSHAW PJ, 1984, INT ARCH ALLER A IMM, V75, P8, DOI 10.1159/000233582; KOMATSU T, 1988, J IMMUNOL, V141, P2895; Korotkova M, 2004, CLIN EXP IMMUNOL, V137, P237, DOI 10.1111/j.1365-2249.2004.02527.x; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lopez-Exposito I, 2009, J ALLERGY CLIN IMMUN, V124, P1039, DOI 10.1016/j.jaci.2009.08.024; Macchiaverni P, 2014, ALLERGY, V69, P395, DOI 10.1111/all.12332; Macchiaverni P, 2020, PEDIAT ALLERG IMM-UK, DOI 10.1111/pai.13311; Macchiaverni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139064; Matangkasombut P, 2017, PAEDIATR INT CHILD H, V37, P199, DOI 10.1080/20469047.2017.1289310; Metcalfe JR, 2016, CLIN EXP ALLERGY, V46, P1605, DOI 10.1111/cea.12806; Moles JP, 2018, PEDIAT ALLERG IMM-UK, V29, P133, DOI 10.1111/pai.12841; Mosconi E, 2010, MUCOSAL IMMUNOL, V3, P461, DOI 10.1038/mi.2010.23; Natsume O, 2017, LANCET, V389, P276, DOI 10.1016/S0140-6736(16)31418-0; Nielsen SD, 2017, J MAMMARY GLAND BIOL, V22, P251, DOI 10.1007/s10911-018-9388-0; O'Reilly D, 2021, ADV NUTR, V12, P59, DOI 10.1093/advances/nmaa094; Ohsaki A, 2018, J EXP MED, V215, P91, DOI 10.1084/jem.20171163; OLSON JA, 1984, AM J CLIN NUTR, V39, P903, DOI 10.1093/ajcn/39.6.903; Palmer DJ, 2008, CLIN EXP ALLERGY, V38, P1186, DOI 10.1111/j.1365-2222.2008.03014.x; Palmer DJ, 2017, J ALLERGY CLIN IMMUN, V139, P1600, DOI 10.1016/j.jaci.2016.06.052; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Palmer DJ, 2005, CLIN EXP ALLERGY, V35, P173, DOI 10.1111/j.1365-2222.2005.02170.x; Paredes PT, 2014, ALLERGY, V69, P463, DOI 10.1111/all.12357; Pawankar R, 2013, WHITE BOOK ALLERGY U; PENG HJ, 1990, CLIN EXP IMMUNOL, V81, P510; Penttila IA, 1998, PEDIATR RES, V44, P524, DOI 10.1203/00006450-199810000-00010; Picariello G, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00025; Prokesova L, 2006, PEDIAT ALLERG IMM-UK, V17, P175, DOI 10.1111/j.1399-3038.2006.00395.x; Ramanan D, 2020, CELL, V181, P1276, DOI 10.1016/j.cell.2020.04.030; Rekima A, 2017, CLIN EXP ALLERGY, V47, P565, DOI 10.1111/cea.12864; Rekima A, 2020, J ALLERGY CLIN IMMUN, V145, P1416, DOI 10.1016/j.jaci.2019.12.912; Renz H, 2018, J ALLERGY CLIN IMMUN, V141, P1212, DOI 10.1016/j.jaci.2017.11.019; Rodriguez JM, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020606; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; SCHNORR KL, 1984, J REPROD IMMUNOL, V6, P329, DOI 10.1016/0165-0378(84)90031-7; Schocker F, 2017, INT ARCH ALLERGY IMM, V174, P17, DOI 10.1159/000479388; SHENAI JP, 1981, J PEDIATR-US, V99, P302, DOI 10.1016/S0022-3476(81)80484-2; SORVA R, 1994, J ALLERGY CLIN IMMUN, V93, P787, DOI 10.1016/0091-6749(94)90259-3; STROBEL S, 1984, PEDIATR RES, V18, P588, DOI 10.1203/00006450-198407000-00004; Strobel S, 2001, P NUTR SOC, V60, P437, DOI 10.1079/PNS2001119; TRONCONE R, 1987, ACTA PAEDIATR SCAND, V76, P453, DOI 10.1111/j.1651-2227.1987.tb10498.x; Tulic MK, 2016, GUT, V65, P757, DOI 10.1136/gutjnl-2015-310523; Turfkruyer M, 2016, MUCOSAL IMMUNOL, V9, P479, DOI 10.1038/mi.2015.114; Turfkruyer M, 2015, CURR OPIN INFECT DIS, V28, P199, DOI 10.1097/QCO.0000000000000165; Untersmayr E, 2015, ALLERGO J INT, V24, P303, DOI DOI 10.1007/s40629-015-0085-x; Vadas P, 2001, JAMA-J AM MED ASSOC, V285, P1746, DOI 10.1001/jama.285.13.1746; van den Elsen LWJ, 2019, NESTLE NUTR WORKS SE, V90, P137, DOI 10.1159/000490301; van den Elsen LWJ, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00047; van Herwijnen MJC, 2016, MOL CELL PROTEOMICS, V15, P3412, DOI 10.1074/mcp.M116.060426; Vance GHS, 2005, CLIN EXP ALLERGY, V35, P1318, DOI 10.1111/j.1365-2222.2005.02346.x; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Verhasselt V, 2020, ALLERGY, V75, P1463, DOI 10.1111/all.14142; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WILLOUGHBY JB, 1977, J IMMUNOL, V119, P2137; Witkowska-Zimny M, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0042-4; Yamamoto T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/721085	92	9	9	2	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					679	688		10.1016/j.jaci.2021.07.012	http://dx.doi.org/10.1016/j.jaci.2021.07.012		SEP 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	34310930	hybrid			2022-12-18	WOS:000695242900007
J	Pellefigues, C; Naidoo, K; Mehta, P; Schmidt, AJ; Jagot, F; Roussel, E; Cait, A; Yumnam, B; Chappell, S; Meijlink, K; Camberis, M; Jiang, JX; Painter, G; Filbey, K; Uluckan, O; Gasser, O; Le Gros, G				Pellefigues, Christophe; Naidoo, Karmella; Mehta, Palak; Schmidt, Alfonso J.; Jagot, Ferdinand; Roussel, Elsa; Cait, Alissa; Yumnam, Bibek; Chappell, Sally; Meijlink, Kimberley; Camberis, Mali; Jiang, Jean X.; Painter, Gavin; Filbey, Kara; Uluckan, Ozge; Gasser, Olivier; Le Gros, Graham			Basophils promote barrier dysfunction and resolution in the skin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; basophils; M2; macrophages; efferocytosis; type 2 inflammation; resolution; IL-4; M-CSF	THYMIC STROMAL LYMPHOPOIETIN; TISSUE-REPAIR; ATOPIC-DERMATITIS; MACROPHAGES; INFLAMMATION; RESPONSES; CELLS; KERATINOCYTES; DISRUPTION; EXPRESSION	Background: The type 2 cytokines IL-4 and IL-13 promote not only atopic dermatitis (AD) but also the resolution of inflammation. How type 2 cytokines participate in the resolution of AD is poorly known. Objective: Our aim was to determine the mechanisms and cell types governing skin inflammation, barrier dysfunction, and resolution of inflammation in a model of AD. Methods: Mice that exhibit expression of IL-4, IL-13, and MCPT8 or that could be depleted of basophils or eosinophils, be deficient in IL-4 or MHC class II molecules, or have basophils lacking macrophage colony-stimulating factor (M-CSF) were treated with calcipotriol (MC903) as an acute model of AD. Kinetics of the disease; keratinocyte differentiation; and leukocyte accumulation, phenotype, function, and cytokine production were measured by transepidermal water loss, histopathology, molecular biology, or unbiased analysis of spectral flow cytometry. Results: In this model of AD, basophils were activated systemically and were the initial and main source of IL-4 in the skin. Basophils and IL-4 promoted epidermal hyperplasia and skin barrier dysfunction by acting on keratinocyte differentiation during inflammation. Basophils, IL-4, and basophil-derived M-CSF inhibited the accumulation of proinflammatory cells in the skin while promoting the expansion and function of proresolution M2-like macrophages and the expression of probarrier genes. Basophils kept their proresolution properties during AD resolution. Conclusion: Basophils can display both beneficial and detrimental type 2 functions simultaneously during atopic inflammation. (J Allergy Clin Immunol 2021;148:799-812.)	[Pellefigues, Christophe; Naidoo, Karmella; Mehta, Palak; Schmidt, Alfonso J.; Jagot, Ferdinand; Cait, Alissa; Yumnam, Bibek; Chappell, Sally; Meijlink, Kimberley; Camberis, Mali; Filbey, Kara; Gasser, Olivier; Le Gros, Graham] Victoria Univ, Malaghan Inst Med Res, Wellington, New Zealand; [Pellefigues, Christophe] Univ Paris, Inflamex, Ctr Rech Inflammat, INSERM,UMR1149,CNRS ERL8252, F-75018 Paris, France; [Roussel, Elsa; Uluckan, Ozge] Novartis, Novartis Inst Biomed Res NIBR, Basel, Switzerland; [Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA; [Painter, Gavin] Victoria Univ, Ferrier Res Inst, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Novartis; University of Texas System; University of Texas Health San Antonio; Victoria University Wellington	Pellefigues, C (corresponding author), Univ Paris, Inflamex, Ctr Rech Inflammat, INSERM,UMR1149,CNRS ERL8252, F-75018 Paris, France.	Christophe.pellefigues@inserm.fr		Filbey, Kara/0000-0001-5758-5730; Naidoo, Karmella/0000-0002-2505-5222; Pellefigues, Christophe/0000-0001-7036-0763	Health Research Council of New Zealand; Marjorie Barclay Trust; National Institutes of Health [AG045040]; Welch Foundation [AQ-1507]	Health Research Council of New Zealand(Health Research Council of New Zealand); Marjorie Barclay Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation)	Funded by an independent research organization grant from the Health Research Council of New Zealand and by the Marjorie Barclay Trust (to G.L.G.) , as well as by the Na-tional Institutes of Health (grant AG045040) and Welch Foundation (grant AQ-1507 [to J.X.J.] ) .	A-Gonzalez N, 2017, J EXP MED, V214, P1281, DOI 10.1084/jem.20161375; Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Borriello F, 2014, J INVEST DERMATOL, V134, P1202, DOI 10.1038/jid.2014.16; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Brunner PM, 2018, J ALLERGY CLIN IMMUN, V141, P2094, DOI 10.1016/j.jaci.2018.02.040; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Cheng LE, 2015, J EXP MED, V212, P513, DOI 10.1084/jem.20141671; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Ferrer-Font Laura, 2020, Curr Protoc Cytom, V92, pe70, DOI 10.1002/cpcy.70; Flohr C, 2004, J ALLERGY CLIN IMMUN, V114, P150, DOI 10.1016/j.jaci.2004.04.027; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Hamilton TA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00554; Harb H, 2020, CLIN EXP ALLERGY, V50, P5, DOI 10.1111/cea.13491; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Hashimoto T, 2015, J IMMUNOL, V194, P4631, DOI 10.4049/jimmunol.1401032; Hayes MD, 2020, ELIFE, V9, DOI 10.7554/eLife.51862; Hendricks AJ, 2020, BRIT J DERMATOL, V183, P16, DOI 10.1111/bjd.18781; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hill DA, 2018, ANN ALLERG ASTHMA IM, V120, P131, DOI 10.1016/j.anai.2017.10.037; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Hussain M, 2018, J ALLERGY CLIN IMMUN, V141, P223, DOI 10.1016/j.jaci.2017.02.035; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Isobe Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00270; Jacobsen EA, 2014, ALLERGY, V69, P315, DOI 10.1111/all.12321; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Junttila IS, 2013, J ALLERGY CLIN IMMUN, V132, P704, DOI 10.1016/j.jaci.2013.03.033; Karasuyama H, 2018, J ALLERGY CLIN IMMUN, V142, P370, DOI 10.1016/j.jaci.2017.10.042; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lee SH, 2018, J EXP MED, V215, P357, DOI 10.1084/jem.20171389; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Leyva-Castillo JM, 2013, J INVEST DERMATOL, V133, P154, DOI 10.1038/jid.2012.239; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Naidoo K, 2018, J INVEST DERMATOL, V138, P2606, DOI 10.1016/j.jid.2018.06.168; Nakashima C, 2014, J ALLERGY CLIN IMMUN, V134, P100, DOI 10.1016/j.jaci.2014.02.026; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, P1390, DOI 10.1016/j.jaci.2014.01.021; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Ochiai S, 2018, P NATL ACAD SCI USA, V115, P1033, DOI 10.1073/pnas.1714348115; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Omori-Miyake M, 2014, J INVEST DERMATOL, V134, P1342, DOI 10.1038/jid.2013.503; Pellefigues C, 2020, ANTIBODIES, V9, DOI 10.3390/antib9030047; Pellefigues C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02143; Pellefigues C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03129-8; Pellerin L, 2013, J ALLERGY CLIN IMMUN, V131, P1094, DOI 10.1016/j.jaci.2012.12.1566; Proto JD, 2018, IMMUNITY, V49, P666, DOI 10.1016/j.immuni.2018.07.015; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Saunders SP, 2016, J ALLERGY CLIN IMMUN, V137, P482, DOI 10.1016/j.jaci.2015.06.045; Schiechl G, 2016, AM J TRANSPLANT, V16, P2574, DOI 10.1111/ajt.13764; Schmidt AJ, 2019, CURR PROTOC CYTOM, V91, P64; Schwartz C, 2016, J ALLERGY CLIN IMMUN, V138, P1443, DOI 10.1016/j.jaci.2016.04.031; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Simpson EL, 2019, J AM ACAD DERMATOL, V80, P1013, DOI 10.1016/j.jaad.2018.11.059; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Voehringer D, 2012, EUR J IMMUNOL, V42, P2544, DOI 10.1002/eji.201142318; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Zeng MY, 2013, BLOOD, V121, P3473, DOI 10.1182/blood-2012-10-461913	71	9	9	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					799	+		10.1016/j.jaci.2021.02.018	http://dx.doi.org/10.1016/j.jaci.2021.02.018		SEP 2021	24	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	33662369	Green Accepted			2022-12-18	WOS:000695242900029
J	Hu, C; van Meel, ER; Medina-Gomez, C; Kraaij, R; Barroso, M; Kiefte-de Jong, J; Radjabzadeh, D; Pasmans, SGMA; de Jong, NW; de Jongste, JC; Moll, HA; Nijsten, T; Rivadeneira, F; Pardo, LM; Duijts, L				Hu, Chen; van Meel, Evelien R.; Medina-Gomez, Carolina; Kraaij, Robert; Barroso, Monica; Kiefte-de Jong, Jessica; Radjabzadeh, Djawad; Pasmans, Suzanne G. M. A.; de Jong, Nicolette W.; de Jongste, Johan C.; Moll, Henriette A.; Nijsten, Tamar; Rivadeneira, Fernando; Pardo, Luba M.; Duijts, Liesbeth			A population-based study on associations of stool microbiota with atopic diseases in school-age children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cohort; microbiome; atopic dermatitis; allergy; asthma; lung function	EARLY-LIFE; LUNG-FUNCTION; ASTHMA	Background: Infants with less diverse gut microbiota seem to have higher risks of atopic diseases in early life, but any associations at school age are unclear. Objectives: This study sought to examine the associations of diversity, relative abundance, and functional pathways of stool microbiota with atopic diseases in school-age children. Methods: We performed a cross-sectional study within an existing population-based prospective cohort among 1440 children 10 years of age. On stool samples, 16S ribosomal RNA gene sequencing was performed, and taxonomic and functional tables were produced. Physician-diagnosed eczema, allergy, and asthma were measured by questionnaires, allergic sensitization by skin prick tests, and lung function by spirometry. Results: The alpha-diversity of stool microbiota was associated with a decreased risk of eczema (odds ratio [OR], 0.98; 95% CI, 0.97, 1.00), and beta-diversity was associated with physician-diagnosed inhalant allergy (R-2 = 0.001; P = .047). Lachnospiraceae, Ruminococcaceae_UCG-005, and Christensenellaceae_R-7_group species were associated with decreased risks of eczema, inhalant allergic sensitization, and physician-diagnosed inhalant allergy (OR range, 0.88-0.94; 95% CI range, 0.79-0.96 to 0.88-0.98), while Agathobacter species were associated with an increased risk of physician-diagnosed inhalant allergy (OR, 1.23; 95% CI, 1.08-1.42). Functional pathways related to heme and terpenoid biosynthesis were associated with decreased risks of physician-diagnosed inhalant allergy and asthma (OR range, 0.89-0.86; 95% CI range, 0.80-0.99 to 0.73-1.02). No associations of stool microbiota with lung function were observed. Conclusions: The diversity, relative abundance and functional pathways of stool microbiota were most consistently associated with physician-diagnosed inhalant allergy in school-age children and less consistently with other atopic diseases.	[Hu, Chen; van Meel, Evelien R.] Univ Med Ctr Rotterdam, Generat R Study Grp, Erasmus MC, Rotterdam, Netherlands; [Hu, Chen; Pasmans, Suzanne G. M. A.; Nijsten, Tamar; Pardo, Luba M.] Univ Med Ctr Rotterdam, Dept Dermatol, Erasmus MC, Rotterdam, Netherlands; [van Meel, Evelien R.; de Jongste, Johan C.; Duijts, Liesbeth] Univ Med Ctr Rotterdam, Dept Pediat, Div Resp Med & Allergol, Erasmus MC, Rotterdam, Netherlands; [Medina-Gomez, Carolina; Kraaij, Robert; Radjabzadeh, Djawad; Rivadeneira, Fernando] Univ Med Ctr Rotterdam, Dept Internal Med, Erasmus MC, Rotterdam, Netherlands; [Barroso, Monica; Kiefte-de Jong, Jessica] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands; [Kiefte-de Jong, Jessica; Moll, Henriette A.] Univ Med Ctr Rotterdam, Dept Pediat, Erasmus MC, Rotterdam, Netherlands; [de Jong, Nicolette W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Divison Allergy & Clin Immunol, Rotterdam, Netherlands; [Duijts, Liesbeth] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, Div Neonatol, Rotterdam, Netherlands; [Kiefte-de Jong, Jessica] Leiden Univ Med Ctr, Dept Publ Hlth & Primary Care, Leiden Univ Med Ctr Campus Hague, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC)	Duijts, L (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC Sophia, Sp-3435,POB 2060, NL-3000 CB Rotterdam, Netherlands.	l.duijts@erasmusmc.nl	Barroso, Monica/GRO-3422-2022; Kiefte-de Jong, Jessica/GLV-3216-2022	Kiefte-de Jong, Jessica/0000-0002-8136-0918	Erasmus MC, Rotterdam; Erasmus University Rotterdam; Netherlands Organisation for Health Research and Development; European Union's Horizon 2020 research and innovation program (LIFECYCLE) [733206, 824989, 874583]	Erasmus MC, Rotterdam; Erasmus University Rotterdam; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); European Union's Horizon 2020 research and innovation program (LIFECYCLE)	The Generation R Study is made possible by financial support from the Erasmus MC, Rotterdam, the Erasmus University Rotterdam, and the Netherlands Organisation for Health Research and Development. L.D. received funding from the European Union's Horizon 2020 research and innovation program (LIFECYCLE, grant agreement no. 733206, 2016; EUCAN-Connect grant agreement no. 824989; Advancing Tools for Human Early Lifecourse Exposome Research and Translation (ATHLETE), grant agreement no. 874583). The study sponsors had no role in the study design, data analysis, interpretation of data, or writing of this report.	Anto JM, 2017, J ALLERGY CLIN IMMUN, V139, P388, DOI 10.1016/j.jaci.2016.12.940; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Belgrave DCM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001748; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935; Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Elbert NJ, 2017, ALLERGY, V72, P1936, DOI 10.1111/all.13195; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Hu C, 2020, CLIN TRANSL ALLERGY, V10, DOI 10.1186/s13601-020-0310-7; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kemter AM, 2019, J CLIN INVEST, V129, P1483, DOI 10.1172/JCI124610; Kim T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062187; Kirino M, 2008, J ALLERGY CLIN IMMUN, V122, P290, DOI 10.1016/j.jaci.2008.05.031; Kitada O, 2001, CLIN EXP ALLERGY, V31, P1470, DOI 10.1046/j.1365-2222.2001.01179.x; Lahti L., 2017, TOOLS MICROBIOME ANA; Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Oksanen J., **DATA OBJECT**; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; R Core Team, 2021, R LANG ENV STAT COMP; Radjabzadeh D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57734-z; Reddel S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41149-6; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Roth-Walter F, 2017, METALLOMICS, V9, P1676, DOI [10.1039/c7mt00241f, 10.1039/C7MT00241F]; Salem I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01459; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Shade KTC, 2020, NATURE, V582, P265, DOI 10.1038/s41586-020-2311-z; Silverberg JI, 2015, BRIT J DERMATOL, V173, P1400, DOI 10.1111/bjd.14031; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Stinson LF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01427; Tran MM, 2018, J ALLERGY CLIN IMMUN, V141, P601, DOI 10.1016/j.jaci.2017.08.024; van der Valk JPM, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0092-0; van Meel ER, 2018, THORAX, V73, P167, DOI 10.1136/thoraxjnl-2017-210149; von Kobyletzki LB, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-11; Wang J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0479-3; Yagi Y, 2020, BIOCHEM BIOPH RES CO, V530, P355, DOI 10.1016/j.bbrc.2020.08.009; Zeki AA, 2009, AM J RESP CRIT CARE, V180, P731, DOI 10.1164/rccm.200901-0018OC; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zimmermann P, 2019, J ALLERGY CLIN IMMUN, V143, P467, DOI 10.1016/j.jaci.2018.09.025	52	9	10	2	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					612	620		10.1016/j.jaci.2021.04.001	http://dx.doi.org/10.1016/j.jaci.2021.04.001		AUG 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	33862008	hybrid, Green Published			2022-12-18	WOS:000687104900012
J	Selb, J; Rijavec, M; Erzen, R; Zidarn, M; Kopac, P; Skerget, M; Bajrovic, N; Luzar, AD; Park, YH; Liu, YH; Serbec, VC; Zver, S; Kosnik, M; Lyons, JJ; Korosec, P				Selb, Julij; Rijavec, Matija; Erzen, Renato; Zidarn, Mihaela; Kopac, Peter; Skerget, Matevz; Bajrovic, Nissera; Luzar, Ajda Demsar; Park, Young Hwan; Liu, Yihui; Serbec, Vladka Curin; Zver, Samo; Kosnik, Mitja; Lyons, Jonathan J.; Korosec, Peter			Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Anaphylaxis; venom; tryptase; mast cells; KIT p.D816V; hereditary alpha-tryptasemia	SYSTEMIC MASTOCYTOSIS; D816V MUTATION; VENOM ALLERGY; SERUM; UPDATE	Background: Clonal mast cell disorders and elevated basal serum tryptase (BST) levels with unknown cause(s) are associated with severe Hymenoptera venom-triggered anaphylaxis (HVA). However, some individuals with clonal disease have a normal BST level (<11.4 ng/mL). Objective: Our aim was to evaluate whether screening for KIT p.D816V in the blood is a useful clinical tool to risk-stratify patients with venom allergy. Methods: We prospectively recruited 374 patients with Hymenoptera allergy and no overt signs of mastocytosis who were referred to our center during the years 2018 and 2019. KIT p.D816V was determined in their peripheral blood by quantitative PCR, and tryptase genotyping was performed by droplet digital PCR. Results: In all, 351 patients (93.9%) had normal levels of BST, and KIT p.D816V was detected in 8% of patients (28 of 351), predominantly in patients with the most severe Mueller grade IV anaphylaxis (18.2% [24 of 132] vs 1.8% in patients with lower grades [4 of 88 with grade III and 0 of 131 with other grades]; P < .001). In grade IV patients with a normal BST level, KIT p.D816V was associated with more severe symptoms, including a significantly higher frequency of loss of consciousness (58.3% [14 of 24] vs 34.3% [37 of 108]; P = .03) and absence of skin symptoms (41.7% [10 of 24] vs 15.7% [17 of 108]; P = .004). Among patients with a normal BST level, KIT p.D816V (OR = 10.25 [95% CI = 3.75-36.14]; P < .0001) was the major risk factor associated with severe HVA. Hereditary alpha-tryptasemia (H alpha T) due to increased germline copies of TPSAB1 encoding alpha-tryptase was the most common cause (65.2% [15 of 23]) of elevated BST level in patients with HVA, and together with KIT p.D816V, it accounted for 90% of BST level elevations (20 of 23) in patients with HVA. Conclusion: These results indicate that routine KIT p.D816V screening identifies clonal disease in high-risk patients with HVA who are regularly missed when BST level is used alone.	[Selb, Julij; Rijavec, Matija; Erzen, Renato; Zidarn, Mihaela; Kopac, Peter; Bajrovic, Nissera; Luzar, Ajda Demsar; Kosnik, Mitja; Korosec, Peter] Univ Clin Resp & Allerg Dis, Golnik, Slovenia; [Selb, Julij; Erzen, Renato; Zidarn, Mihaela; Kopac, Peter; Skerget, Matevz; Bajrovic, Nissera; Zver, Samo; Kosnik, Mitja] Univ Ljubljana, Med Fac, Ljubljana, Slovenia; [Rijavec, Matija] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Skerget, Matevz; Zver, Samo] Univ Med Ctr Ljubljana, Dept Hematol, Ljubljana, Slovenia; [Park, Young Hwan; Liu, Yihui; Lyons, Jonathan J.] NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Serbec, Vladka Curin] Blood Transfus Ctr Slovenia, Dept Res & Dev, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; University Medical Centre Ljubljana; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Korosec, P (corresponding author), Univ Clin Resp & Allerg Dis Golnik, Goln 36, Golnik 4204, Slovenia.	peter.korosec@klinika-golnik.si		Selb, Julij/0000-0001-9499-6504	Slovenian Research Agency [P3-0360]; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, Na-tional Institutes of Health	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, Na-tional Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by the Slovenian Research Agency (P3-0360) and by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, Na-tional Institutes of Health.	Dolle-Bierke S, 2019, J ALLERGY CLIN IMMUN, V144, P1448, DOI 10.1016/j.jaci.2019.07.037; Francuzik W, 2021, J ALLERGY CLIN IMMUN, V147, P653, DOI 10.1016/j.jaci.2020.06.008; Giannetti MP, 2021, J ALLERGY CLIN IMMUN, V147, P1497, DOI 10.1016/j.jaci.2020.11.017; Golden DBK, 2017, ANN ALLERG ASTHMA IM, V118, P28, DOI 10.1016/j.anai.2016.10.031; Greiner G, 2021, BLOOD, V137, P238, DOI 10.1182/blood.2020006157; Greiner G, 2018, CLIN CHEM, V64, P547, DOI 10.1373/clinchem.2017.277897; Hartmann K, 2016, J ALLERGY CLIN IMMUN, V137, P35, DOI 10.1016/j.jaci.2015.08.034; Kristensen T, 2014, AM J HEMATOL, V89, P493, DOI 10.1002/ajh.23672; Kristensen T, 2011, J MOL DIAGN, V13, P180, DOI 10.1016/j.jmoldx.2010.10.004; Lyons JJ, 2021, J ALLERGY CLIN IMMUN, V147, P622, DOI 10.1016/j.jaci.2020.06.035; Lyons JJ, 2016, NAT GENET, V48, P1564, DOI 10.1038/ng.3696; Lyons JJ, 2014, J ALLERGY CLIN IMMUN, V133, P1471, DOI 10.1016/j.jaci.2013.11.039; Mueller UR., 1990, INSECT STING ALLERGY, P183; Pardanani A, 2019, AM J HEMATOL, V94, P363, DOI 10.1002/ajh.25371; Robey RC, 2020, J ALLER CL IMM-PRACT, V8, P3549, DOI 10.1016/j.jaip.2020.05.057; Rueff F, 2009, J ALLERGY CLIN IMMUN, V124, P1047, DOI 10.1016/j.jaci.2009.08.027; Sabato V, 2018, J CLIN IMMUNOL, V38, P457, DOI 10.1007/s10875-018-0506-y; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; Ulrich R, 1990, INSECT STING ALLERGY, P183; Valent P, 2019, J ALLER CL IMM-PRACT, V7, P1125, DOI 10.1016/j.jaip.2019.01.006; Valent P, 2017, BLOOD, V129, P1420, DOI 10.1182/blood-2016-09-731893; Worm M, 2018, ALLERGY, V73, P1322, DOI 10.1111/all.13380; Zanotti R, 2015, J ALLERGY CLIN IMMUN, V136, P135, DOI 10.1016/j.jaci.2014.11.035	23	9	9	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					621	+		10.1016/j.jaci.2021.02.043	http://dx.doi.org/10.1016/j.jaci.2021.02.043		AUG 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	33753098				2022-12-18	WOS:000687104900013
J	Ruiter, B; Smith, NP; Fleming, E; Patil, SU; Hurlburt, BK; Maleki, SJ; Shreffler, WG				Ruiter, Bert; Smith, Neal P.; Fleming, Elizabeth; Patil, Sarita U.; Hurlburt, Barry K.; Maleki, Soheila J.; Shreffler, Wayne G.			Peanut protein acts as a T(H)2 adjuvant by inducing RALDH2 in human antigen-presenting cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Peanut allergy; peanut; dendritic cells; monocytes; RALDH2; TLR2; retinoic acid; T(H)2; IL-5; integrin alpha(4)beta(7)	HUMAN DENDRITIC CELLS; REGULATORY T-CELLS; RETINOIC-ACID; VITAMIN-A; RESPONSES; RECEPTOR; ALLERGY; FOOD; CONSUMPTION; EXPRESSION	Background: Peanut is a potent inducer of proallergenic T(H)2 responses in susceptible individuals. Antigen-presenting cells (APCs) including dendritic cells and monocytes instruct naive T cells to differentiate into various effector cells, determining immune responses such as allergy and tolerance. Objective: We sought to detect peanut protein (PN)-induced changes in gene expression in human myeloid dendritic cells (mDCs) and monocytes, identify signaling receptors that mediate these changes, and assess how PN-induced genes in mDCs impact their ability to promote T-cell differentiation. Methods: mDCs, monocytes, and naive CD4(+) T cells were isolated from blood bank donors and peanut-allergic patients. APCs were incubated with PN and other stimulants, and gene expression was measured using microarray and RT quantitative PCR. To assess T-cell differentiation, mDCs were cocultured with naive T-H cells. Results: PN induced a unique gene expression profile in mDCs, including the gene that encodes retinaldehyde dehydrogenase 2 (RALDH2), a rate-limiting enzyme in the retinoic acid (RA)-producing pathway. Stimulation of mDCs with PN also induced a 7-fold increase in the enzymatic activity of RALDH2. Blocking antibodies against Toll-like receptor (TLR)1/TLR2, as well as small interfering RNA targeting TLR1/TLR2, reduced the expression of RALDH2 in PN-stimulated APCs by 70%. Naive TH cells cocultured with PN-stimulated mDCs showed an RA-dependent 4-fold increase in production of IL-5 and expression of integrin alpha(4)beta(7). Conclusions: PN induces RALDH2 in human APCs by signaling through the TLR1/TLR2 heterodimer. This leads to production of RA, which acts on TH cells to induce IL-5 and gut-homing integrin. RALDH2 induction by PN in APCs and RA-promoted T(H)2 differentiation could be an important factor determining allergic responses to peanut.	[Ruiter, Bert; Smith, Neal P.; Fleming, Elizabeth; Patil, Sarita U.; Shreffler, Wayne G.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Rm 8-409,149 13th St, Boston, MA 02114 USA; [Ruiter, Bert; Patil, Sarita U.; Shreffler, Wayne G.] Harvard Med Sch, Boston, MA 02115 USA; [Patil, Sarita U.; Shreffler, Wayne G.] Massachusetts Gen Hosp, Food Allergy Ctr, Boston, MA 02114 USA; [Hurlburt, Barry K.; Maleki, Soheila J.] USDA, Agr Res Serv, New Orleans, LA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; United States Department of Agriculture (USDA)	Ruiter, B (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Rm 8-409,149 13th St, Boston, MA 02114 USA.	bruiter@mgh.harvard.edu		Ruiter, Bert/0000-0003-3945-3202	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [K08 AI067722, K08 AI067722-03S1, U19 AI095261]; U.S. Department of Agriculture, Agricultural Research Service [USDA-ARS-6054-43440-046-00D]; Food Allergy Science Initiative; Massachusetts General Hospital	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Food Allergy Science Initiative; Massachusetts General Hospital(General Electric)	This work was supported by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (grant nos. K08 AI067722 and K08 AI067722-03S1 to W.G.S., and grant no. U19 AI095261 to W.G.S. and Andrew D. Luster), the U.S. Department of Agriculture, Agricultural Research Service (grant no. USDA-ARS-6054-43440-046-00D to B.K.H. and S.J.M.), the Food Allergy Science Initiative, and institutional funds from Massachusetts General Hospital.	Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Bock SA, 2007, J ALLERGY CLIN IMMUN, V119, P1016, DOI 10.1016/j.jaci.2006.12.622; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002883; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P867, DOI 10.1016/j.jaci.2014.08.011; Brown CC, 2015, IMMUNITY, V42, P499, DOI 10.1016/j.immuni.2015.02.003; Chiang D, 2018, J ALLERGY CLIN IMMUN, V141, P2107, DOI 10.1016/j.jaci.2017.11.060; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Correale J, 2013, J IMMUNOL, V191, P3827, DOI 10.4049/jimmunol.1301110; Dawson HD, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-27; DEMEURE CE, 1995, EUR J IMMUNOL, V25, P2722, DOI 10.1002/eji.1830250950; Dolence JJ, 2018, J ALLERGY CLIN IMMUN, V142, P1144, DOI 10.1016/j.jaci.2017.11.020; Dorner JW, 2008, FOOD ADDIT CONTAM A, V25, P203, DOI 10.1080/02652030701658357; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Fox AT, 2009, J ALLERGY CLIN IMMUN, V123, P417, DOI 10.1016/j.jaci.2008.12.014; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gupta RS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.5630; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hamilton RG, 2010, IMMUNOL RES, V47, P273, DOI 10.1007/s12026-009-8160-3; Harris NL, 2017, IMMUNITY, V47, P1024, DOI 10.1016/j.immuni.2017.11.015; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; Hirata H, 2019, CLIN EXP ALLERGY, V49, P474, DOI 10.1111/cea.13313; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lamhamedi-Cherradi SE, 2008, J IMMUNOL, V180, P6000, DOI 10.4049/jimmunol.180.9.6000; Larange A, 2016, ANNU REV IMMUNOL, V34, P369, DOI 10.1146/annurev-immunol-041015-055427; Lovett-Racke AE, 2002, CELL IMMUNOL, V215, P54, DOI 10.1016/S0008-8749(02)00013-8; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mueller GA, 2013, ALLERGY, V68, P1546, DOI 10.1111/all.12261; Ozias-Akins P, 2019, ALLERGY, V74, P888, DOI 10.1111/all.13719; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; R Core Team, 2021, R LANG ENV STAT COMP; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; Ruiter B, 2015, CLIN EXP ALLERGY, V45, P1214, DOI 10.1111/cea.12568; Ruiter B, 2020, J ALLERGY CLIN IMMUN, V145, P270, DOI 10.1016/j.jaci.2019.09.033; Ruiter B, 2012, SEMIN IMMUNOPATHOL, V34, P617, DOI 10.1007/s00281-012-0334-8; Sanders TJ, 2014, GASTROENTEROLOGY, V146, P1278, DOI 10.1053/j.gastro.2014.01.057; Sato T, 2013, J IMMUNOL, V191, P3152, DOI 10.4049/jimmunol.1203517; Schuijs MJ, 2019, TRENDS IMMUNOL, V40, P22, DOI 10.1016/j.it.2018.11.001; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Smeekens JM, 2019, CLIN EXP ALLERGY, V49, P1500, DOI 10.1111/cea.13486; Spiegl N, 2008, BLOOD, V112, P3762, DOI 10.1182/blood-2008-01-135251; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Tordesillas L, 2018, CLIN REV ALLERG IMMU, V55, P107, DOI 10.1007/s12016-018-8680-5; Tordesillas L, 2014, J CLIN INVEST, V124, P4965, DOI 10.1172/JCI75660; Turcanu V, 2003, J CLIN INVEST, V111, P1065, DOI 10.1172/JCI200316142; Vicente-Suarez I, 2015, MUCOSAL IMMUNOL, V8, P141, DOI 10.1038/mi.2014.51; Villablanca EJ, 2011, GASTROENTEROLOGY, V141, P176, DOI 10.1053/j.gastro.2011.04.010; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Wansley Daniel L, 2013, Clin Mol Allergy, V11, P4, DOI 10.1186/1476-7961-11-4; Xi JL, 2008, GENE EXPR PATTERNS, V8, P438, DOI 10.1016/j.gep.2008.04.003; Yamanaka KI, 2008, J ALLERGY CLIN IMMUN, V121, P148, DOI 10.1016/j.jaci.2007.08.014; Yoshie O, 2015, INT IMMUNOL, V27, P11, DOI 10.1093/intimm/dxu079; Zimmer A, 2011, J IMMUNOL, V186, P3966, DOI 10.4049/jimmunol.1003184	66	9	9	4	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					182	+		10.1016/j.jaci.2020.11.047	http://dx.doi.org/10.1016/j.jaci.2020.11.047		JUL 2021	17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IE	33378690	Green Accepted			2022-12-18	WOS:000669906700026
J	Bachert, C; Maurer, M; Palomares, O; Busse, WW				Bachert, Claus; Maurer, Marcus; Palomares, Oscar; Busse, William W.			What is the contribution of IgE to nasal polyposis?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CRS with nasal polyps; IgE; biologicals; anti-IgE; omalizumab; type 2 inflammation; T2 inflammation; Staphylococcus aureus	ENDOSCOPIC SINUS SURGERY; STAPHYLOCOCCUS-AUREUS ENTEROTOXINS; EXACERBATED RESPIRATORY-DISEASE; CHRONIC SPONTANEOUS URTICARIA; QUALITY-OF-LIFE; CHRONIC RHINOSINUSITIS; ANTI-IGE; IMMUNOGLOBULIN-E; ALLERGIC RHINITIS; MAST-CELLS	Taking a novel approach, this narrative review collates knowledge about nasal polyposis and the biological functions of IgE in several diseases (allergic rhinitis, allergic asthma, nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease, and chronic spontaneous urticaria) to consider which IgE-mediated mechanisms are relevant to nasal polyposis pathology. A type 2 eosinophil-dominated inflammatory signature is typical in nasal polyp tissue of European patients with nasal polyposis, with a shift toward this endotype observed in Asian populations in recent years. Elevated polyclonal IgE is present in the nasal tissue of patients with and without allergy. It is derived from many different B-cell clones and, importantly, is functional (proinflammatory). Staphylococcus aureus enterotoxins are thought to act as superantigens, inducing production of polyclonal IgE via B-cell and T-cell activation, and triggering release of inflammatory mediators. In some patients, exposure to antigens/triggers leads to production of high levels of antigen-specific IgE, which mediates cross-linking of the high-affinity IgE receptor on various cells, causing release of inflammatory mediators. The efficacy of omalizumab confirms IgE as an important inflammatory mediator in nasal polyposis. By blocking IgE, omalizumab targets the T2 inflammation in nasal polyposis, reduces nasal polyp score and improves symptoms.	[Bachert, Claus] Univ Ghent, Upper Airways Res Lab, De Pintelaan 185, B-9000 Ghent, Belgium; [Bachert, Claus] Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden; [Maurer, Marcus] Charite Univ Med Berlin, Dept Dermatol & Allergy, Allergie Ctr Charite, Dermatol Allergol, Berlin, Germany; [Palomares, Oscar] Univ Complutense Madrid, Sch Chem, Dept Biochem & Mol Biol, Madrid, Spain; [Busse, William W.] Univ Wisconsin, Sch Med & Publ Hlth, Div Allergy Pulm & Crit Care Med, Dept Med, Madison, WI USA	Ghent University; Ghent University Hospital; Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Complutense University of Madrid; University of Wisconsin System; University of Wisconsin Madison	Bachert, C (corresponding author), Univ Ghent, Upper Airways Res Lab, De Pintelaan 185, B-9000 Ghent, Belgium.	Claus.Bachert@UGent.be	Maurer, Marcus/ABG-2174-2020; Bachert, Claus/J-8825-2012	Maurer, Marcus/0000-0002-4121-481X; 				Adelroth E, 2000, J ALLERGY CLIN IMMUN, V106, P253, DOI 10.1067/mai.2000.108310; Alsharif S, 2019, LARYNGOSCOPE, V129, P1286, DOI 10.1002/lary.27815; Altrichter S, 2018, ALLERGY, V73, P1497, DOI 10.1111/all.13381; Altrichter S, 2020, ALLERGY, V75, P3208, DOI 10.1111/all.14412; Altrichter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014794; Anvari S, 2019, CLIN REV ALLERG IMMU, V57, P244, DOI 10.1007/s12016-018-8710-3; Bachert C, 2018, J PROTEOMICS, V180, P53, DOI 10.1016/j.jprot.2017.12.003; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Bachert C, 2003, J ALLERGY CLIN IMMUN, V111, P1131, DOI 10.1016/S0091-6749(03)70044-X; Bachert C, 1997, J ALLERGY CLIN IMMUN, V99, P837, DOI 10.1016/S0091-6749(97)80019-X; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Bachert C, 2021, J ALLERGY CLIN IMMUN, V147, P29, DOI 10.1016/j.jaci.2020.11.013; Bachert C, 2020, J ALLERGY CLIN IMMUN, V145, P725, DOI 10.1016/j.jaci.2020.01.020; Bachert C, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01592-2019; Bachert C, 2019, LANCET, V394, P1638, DOI 10.1016/S0140-6736(19)31881-1; Bachert C, 2018, J ALLERGY CLIN IMMUN, V141, pAB90; Bachert C, 2017, J ALLERGY CLIN IMMUN, V140, P1024, DOI 10.1016/j.jaci.2017.05.044; Bachert C, 2015, J ALLERGY CLIN IMMUN, V136, P1431, DOI 10.1016/j.jaci.2015.10.010; Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Batra PS, 2013, LARYNGOSCOPE, V123, pS1, DOI 10.1002/lary.24418; Belliveau Paul P, 2005, MedGenMed, V7, P27; Berings M, 2018, CLIN EXP ALLERGY, V48, P970, DOI 10.1111/cea.13157; Bonfils P, 2015, EUR ANN OTORHINOLARY, V132, P119, DOI 10.1016/j.anorl.2015.03.008; Buchheit KM, 2018, J ALLERGY CLIN IMMUN, V141, pAB204, DOI 10.1016/j.jaci.2017.12.645; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Busse WW, 2020, AM J RESP CRIT CARE, V201, P1459, DOI 10.1164/rccm.202003-0783ED; Busse WW, 2020, ANN ALLERG ASTHMA IM, V124, P190, DOI 10.1016/j.anai.2019.11.016; Cahill KN, 2017, J ALLERGY CLIN IMMUN, V139, P764, DOI 10.1016/j.jaci.2016.09.025; Calus L, 2016, CLIN EXP ALLERGY, V46, P555, DOI 10.1111/cea.12687; Calus L, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0269-4; Casale TB, 2001, JAMA-J AM MED ASSOC, V286, P2956, DOI 10.1001/jama.286.23.2956; Chairakaki AD, 2018, J ALLERGY CLIN IMMUN, V142, P542, DOI 10.1016/j.jaci.2017.08.032; Chan Marcia A, 2013, Clin Transl Allergy, V3, P29, DOI 10.1186/2045-7022-3-29; Chervinsky P, 2003, ANN ALLERG ASTHMA IM, V91, P160, DOI 10.1016/S1081-1206(10)62171-0; Chinthrajah RS, 2021, J ALLERGY CLIN IMMUN, V147, P1207, DOI 10.1016/j.jaci.2020.10.033; Chung JH, 2015, ANN OTO RHINOL LARYN, V124, P663, DOI 10.1177/0003489415576181; Church MK, 2018, IMMUNOL REV, V282, P232, DOI 10.1111/imr.12632; Corriveau MN, 2009, AM J RHINOL ALLERGY, V23, P461, DOI 10.2500/ajra.2009.23.3367; Cugno M, 2018, ALLERGY, V73, P2408, DOI 10.1111/all.13587; De Schryver E, 2016, J ALLERGY CLIN IMMUN, V138, P893, DOI 10.1016/j.jaci.2016.03.040; De Schryver E, 2015, ALLERGY ASTHMA IMMUN, V7, P321, DOI 10.4168/aair.2015.7.4.321; DeConde AS, 2017, LARYNGOSCOPE, V127, P550, DOI 10.1002/lary.26391; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Ertas R, 2018, ALLERGY, V73, P705, DOI 10.1111/all.13345; European Medicines Agency (EMA), 2020, OM XOL SUMM PROD CHA; European Medicines Agency (EMA), 2019, DUP SUMM OP; Forster-Ruhrmann U, 2020, RHINOLOGY, V58, P226, DOI [10.4193/Rhin19318, 10.4193/Rhin19.318]; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Food and Drug Administration (FDA), HIGHL PRESCR INF XOL; Garcia G, 2012, EUR RESPIR J, V40, p856S; Gasser P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13815-w; Gericke J, 2017, J ALLERGY CLIN IMMUN, V139, P1059, DOI 10.1016/j.jaci.2016.07.047; Gevaert E, 2017, J ALLERGY CLIN IMMUN, V139, P1849, DOI 10.1016/j.jaci.2017.01.019; Gevaert P, 2013, ALLERGY, V68, P55, DOI 10.1111/all.12054; Gevaert P, 2020, ANN ALLERGY ASTHMA I, V125; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Gevaert P, 2020, J ALLERGY CLIN IMMUN, V146, P595, DOI 10.1016/j.jaci.2020.05.032; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Hatada Y, 2013, INT ARCH ALLERGY IMM, V161, P154, DOI 10.1159/000350388; Hayashi H, 2020, AM J RESP CRIT CARE, V201, P1488, DOI 10.1164/rccm.201906-1215OC; Hayashi H, 2016, J ALLERGY CLIN IMMUN, V137, P1585, DOI 10.1016/j.jaci.2015.09.034; Hedman J, 1999, INT J EPIDEMIOL, V28, P717, DOI 10.1093/ije/28.4.717; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Holgate ST, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-17; Hopkins C, 2020, EUR RESPIR J, V56; Hopkins C, 2019, NEW ENGL J MED, V381, P55, DOI 10.1056/NEJMcp1800215; Jessen M, 1997, ALLERGY, V52, P3, DOI 10.1111/j.1398-9995.1997.tb04876.x; Johansson L, 2003, ANN OTO RHINOL LARYN, V112, P625, DOI 10.1177/000348940311200709; Johns CB, 2014, AM J RHINOL ALLERGY, V28, P287, DOI 10.2500/ajra.2014.28.4054; Kaplan AP, 2017, ALLERGY, V72, P519, DOI 10.1111/all.13083; Katotomichelakis M, 2013, AM J RHINOL ALLERGY, V27, P354, DOI 10.2500/ajra.2013.27.3922; Kilmon MA, 2004, J IMMUNOL, V172, P1065, DOI 10.4049/jimmunol.172.2.1065; Kim JY, 2019, JAMA OTOLARYNGOL, V145, P313, DOI 10.1001/jamaoto.2018.4103; Klossek JM, 2005, ALLERGY, V60, P233, DOI 10.1111/j.1398-9995.2005.00688.x; Kolkhir P, 2017, J ALLERGY CLIN IMMUN, V139, P1772, DOI 10.1016/j.jaci.2016.08.050; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubota T, 2006, J IMMUNOL, V176, P7008, DOI 10.4049/jimmunol.176.11.7008; Lakin E, 2019, THERANOSTICS, V9, P829, DOI 10.7150/thno.29902; Lang DM, 2018, ANN ALLERG ASTHMA IM, V121, P98, DOI 10.1016/j.anai.2018.05.007; Langdon C, 2016, J ASTHMA ALLERGY, V9, P45, DOI 10.2147/JAA.S86251; Larsen K, 1996, ALLERGY ASTHMA PROC, V17, P243, DOI 10.2500/108854196778662255; Ledford D, 2017, J ALLERGY CLIN IMMUN, V140, P162, DOI 10.1016/j.jaci.2016.08.054; Leynaert B, 1999, J ALLERGY CLIN IMMUN, V104, P301, DOI 10.1016/S0091-6749(99)70370-2; Lopez-Abente J, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.00751-2020; Lopez-Abente J, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.congress-2019.OA3803; Loureiro CC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3254094; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Masieri S, 2016, EUR REV MED PHARMACO, V20, P5249; Massanari M, 2010, RESP MED, V104, P188, DOI 10.1016/j.rmed.2009.09.011; Maurer M, 2020, INT ARCH ALLERGY IMM, V181, P321, DOI 10.1159/000507218; Maurer M, 2013, NEW ENGL J MED, V368, P924, DOI 10.1056/NEJMoa1215372; Maurer M, 2011, J ALLERGY CLIN IMMUN, V128, P202, DOI 10.1016/j.jaci.2011.04.038; Mechtcheriakova D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025611; Mellor EA, 2002, J EXP MED, V195, P583, DOI 10.1084/jem.20020044; Messingham KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107725; Metz M, 2019, ALLERGY, V74, P141, DOI 10.1111/all.13547; Metz M, 2017, THERANOSTICS, V7, P1266, DOI 10.7150/thno.18304; Mitchell PD, 2017, HANDB EXP PHARMACOL, V237, P131, DOI 10.1007/164_2016_65; Niven RM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011857; Noga O, 2003, INT ARCH ALLERGY IMM, V131, P46, DOI 10.1159/000070434; Okubo K, 2020, J ALLER CL IMM-PRACT, V8, P3130, DOI 10.1016/j.jaip.2020.04.068; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS3, DOI 10.1002/alr.21694; Palaniyandi S, 2015, MUCOSAL IMMUNOL, V8, P1262, DOI 10.1038/mi.2015.16; Palomares O, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061328; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Pawankar R, 2011, ASIA PAC ALLERGY, V1, P157, DOI 10.5415/apallergy.2011.1.3.157; Payet ME, 1999, J IMMUNOL, V163, P217; Perez-Novo CA, 2004, INT ARCH ALLERGY IMM, V133, P255, DOI 10.1159/000076832; Persson EK, 2019, SCIENCE, V364, P751, DOI 10.1126/science.aaw4295; Pharmaceuticals and Medical Devices Agency, NEW DRUGS APPR FY 20; Philpott CM, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0823-y; Pillai P, 2011, ISRN ALLERGY, V2011, DOI DOI 10.5402/2011/195846; Pillai P, 2016, EUR RESPIR J, V48, P1593, DOI 10.1183/13993003.01501-2015; Rabe KF, 2011, ALLERGY, V66, P1142, DOI 10.1111/j.1398-9995.2011.02617.x; Russian Federal Service for Surveillance in Healthcare (Roszdravnadzor), 2020, INSTR MED US XOL; Sahlstrand-Johnson P, 2017, RHINOLOGY, V55, P251, DOI [10.4193/Rhino16126, 10.4193/Rhino16.126]; Sakalar EG, 2017, EUR ARCH OTO-RHINO-L, V274, P1291, DOI 10.1007/s00405-016-4273-1; Scheerens H, 2019, J ALLERGY CLIN IMMUN, V143, P805, DOI 10.1016/j.jaci.2018.10.011; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Schmetzer O, 2018, J ALLERGY CLIN IMMUN, V142, P876, DOI 10.1016/j.jaci.2017.10.035; Schmidt F, 2017, J PROTEOMICS, V155, P31, DOI 10.1016/j.jprot.2017.01.008; Settipane RA, 2013, AM J RHINOL ALLERGY, V27, pS56, DOI 10.2500/ajra.2013.27.3929; Shamji MH, 2019, J ALLERGY CLIN IMMUN, V143, P2086, DOI 10.1016/j.jaci.2019.02.001; Shen Y, 2019, ASIAN PAC J ALLERGY, V37, P220, DOI 10.12932/AP-120417-0072; Sintobin I, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00198-2019; SMALL P, 1985, ANN ALLERGY, V55, P736; Song WJ, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0880-4; Stevens WW, 2016, J ALLER CL IMM-PRACT, V4, P565, DOI 10.1016/j.jaip.2016.04.012; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Tabatabaian F, 2018, J ASTHMA ALLERGY, V11, P53, DOI 10.2147/JAA.S107982; Takabayashi T, 2020, J ALLERGY CLIN IMMUN, V145, P740, DOI 10.1016/j.jaci.2020.01.027; Tan BK, 2013, J ALLERGY CLIN IMMUN, V131, P1350, DOI 10.1016/j.jaci.2013.02.002; Taniguchi M, 2019, ALLERGOL INT, V68, P289, DOI 10.1016/j.alit.2019.05.001; Teufelberger AR, 2019, TRENDS MOL MED, V25, P696, DOI 10.1016/j.molmed.2019.05.003; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Tripathi A, 2004, LARYNGOSCOPE, V114, P1822, DOI 10.1097/00005537-200410000-00027; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; We J, 2015, AM J RHINOL ALLERGY, V29, pE24, DOI 10.2500/ajra.2015.29.4131; Wegrzyn AS, 2015, J ALLERGY CLIN IMMUN, V136, P194, DOI 10.1016/j.jaci.2014.12.1866; Weller K, 2018, ALLERGY, V73, P2406, DOI 10.1111/all.13586; Workman AD, 2018, IMMUNOL ALLERGY CLIN, V38, P679, DOI 10.1016/j.iac.2018.06.006; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Yoo HS, 2013, INT ARCH ALLERGY IMM, V162, P340, DOI 10.1159/000353976; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	151	9	11	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					1997	2008		10.1016/j.jaci.2021.03.016	http://dx.doi.org/10.1016/j.jaci.2021.03.016		JUN 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33757720				2022-12-18	WOS:000657814800002
J	Wang, LF; Sharif, H; Vora, SM; Zheng, YM; Wu, H				Wang, Longfei; Sharif, Humayun; Vora, Setu M.; Zheng, Yumei; Wu, Hao			Structures and functions of the inflammasome engine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Inflammasome; NLRP3; NLRP1; NLRC4; pyroptosis; IL-1; caspase-1	INNATE IMMUNE DETECTION; NLRP1 INFLAMMASOME; GASDERMIN-D; BACTERIAL FLAGELLIN; CRYO-EM; NEK7; ACTIVATION; SECRETION; RECOGNITION; NLRC4	Inflammasomes are molecular machines that carry out inflammatory responses on challenges by pathogens and endogenous dangers. Dysregulation of inflammasome assembly and regulation is associated with numerous human diseases from autoimmunity to cancer. In recent years, significant advances have been made in understanding the mechanism of inflammasome signaling using structural approaches. Here, we review inflammasomes formed by the NLRP1, NLRP3, and NLRC4 sensors, which are well characterized structurally, and discuss the structural and functional diversity among them.	[Wang, Longfei; Sharif, Humayun; Vora, Setu M.; Zheng, Yumei; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Longfei; Sharif, Humayun; Vora, Setu M.; Zheng, Yumei; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA.	wu@crystal.harvard.edu		, Hao/0000-0002-7281-8579	National Institutes of Health [R13HL149440]; National Institutes of Health Office of Research on Women's Health; US Food AMP; Drug Administration Office of Women's Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); US Food AMP; Drug Administration Office of Women's Health	This study was supported by the National Institutes of Health (grant/award no. R13HL149440 to C.C.) , the National Institutes of Health Office of Research on Women's Health, and the US Food & Drug Administration Office of Women's Health. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Bauernfried S, 2021, SCIENCE, V371, P482, DOI 10.1126/science.abd0811; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Case CL, 2011, MBIO, V2, DOI 10.1128/mBio.00117-11; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Diebolder CA, 2015, STRUCTURE, V23, P2349, DOI 10.1016/j.str.2015.10.001; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Gai K, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1817-5; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Gong Q, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20319-5; Grandemange S, 2017, ANN RHEUM DIS, V76, P1191, DOI 10.1136/annrheumdis-2016-210021; Griswold AR, 2019, ACS CHEM BIOL, V14, P2424, DOI 10.1021/acschembio.9b00462; Griswold AR, 2019, CELL CHEM BIOL, V26, P901, DOI 10.1016/j.chembiol.2019.03.007; Haloupek N, 2019, METHOD ENZYMOL, V625, P177, DOI 10.1016/bs.mie.2019.04.030; Haq T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9771; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Hollingsworth LR, 2021, NATURE, V592, P778, DOI 10.1038/s41586-021-03350-4; Hollingsworth LR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20320-y; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Huang MH, 2021, NATURE, V592, P773, DOI 10.1038/s41586-021-03320-w; Janssens S, 2012, CELL DEATH DIFFER, V19, P13, DOI 10.1038/cdd.2011.162; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kim S, 2007, BIOCHEM BIOPH RES CO, V360, P56, DOI 10.1016/j.bbrc.2007.05.206; Kim S, 2011, J CELL SCI, V124, P3760, DOI 10.1242/jcs.078089; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kortmann J, 2015, J IMMUNOL, V195, P815, DOI 10.4049/jimmunol.1403100; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15986; Li Y, 2018, P NATL ACAD SCI USA, V115, P10845, DOI 10.1073/pnas.1810524115; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Magupalli VG, 2020, SCIENCE, V369, P1448, DOI 10.1126/science.aas8995; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mitchell PS, 2019, CURR OPIN IMMUNOL, V60, P37, DOI 10.1016/j.coi.2019.04.015; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Okondo MC, 2018, CELL CHEM BIOL, V25, P262, DOI 10.1016/j.chembiol.2017.12.013; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Ravotti F, 2016, BIOMOL NMR ASSIGN, V10, P107, DOI 10.1007/s12104-015-9647-6; Rayamajhi M, 2013, J IMMUNOL, V191, P3986, DOI 10.4049/jimmunol.1301549; Regue L, 2011, J BIOL CHEM, V286, P18118, DOI 10.1074/jbc.M110.209080; Robinson KS, 2020, SCIENCE, V370, P1182, DOI 10.1126/science.aay2002; Ross B, 2018, P NATL ACAD SCI USA, V115, pE1437, DOI 10.1073/pnas.1717565115; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Sborgi L, 2015, P NATL ACAD SCI USA, V112, P13237, DOI 10.1073/pnas.1507579112; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Sdelci S, 2012, CURR BIOL, V22, P1516, DOI 10.1016/j.cub.2012.06.027; Sdelci S, 2011, CELL CYCLE, V10, P3816, DOI 10.4161/cc.10.22.18226; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; SHI HX, 2016, NAT IMMUNOL, V17, P250, DOI DOI 10.1038/NI.3333; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Taabazuing CY, 2020, IMMUNOL REV, V297, P13, DOI 10.1111/imr.12884; Tenthorey JL, 2017, SCIENCE, V358, P888, DOI 10.1126/science.aao1140; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Tsu BV, 2021, ELIFE, V10, DOI 10.7554/eLife.60609; Vance RE, 2015, CURR OPIN IMMUNOL, V32, P84, DOI 10.1016/j.coi.2015.01.010; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Xu J, 2016, ACTA BIOCH BIOPH SIN, V48, P966, DOI 10.1093/abbs/gmw080; Yang XR, 2018, CELL RES, V28, P35, DOI 10.1038/cr.2017.148; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhang LM, 2018, CELL RES, V28, P141, DOI 10.1038/cr.2018.5; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhong FL, 2018, J BIOL CHEM, V293, P18864, DOI 10.1074/jbc.RA118.004350; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001	83	9	9	0	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2021	2029		10.1016/j.jaci.2021.04.018	http://dx.doi.org/10.1016/j.jaci.2021.04.018		JUN 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	34092352	Green Accepted			2022-12-18	WOS:000657814800004
J	Bloom, CI; Franklin, C; Bush, A; Saglani, S; Quint, JK				Bloom, Chloe I.; Franklin, Courtney; Bush, Andrew; Saglani, Sejal; Quint, Jennifer K.			Burden of preschool wheeze and progression to asthma in the UK: Population-based cohort 2007 to 2017	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Preschool; wheeze; children; asthma; rhinovirus; month	RESPIRATORY-SYNCYTIAL-VIRUS; 1ST 6 YEARS; CHILDHOOD ASTHMA; EARLY-LIFE; RHINOVIRUS ILLNESSES; PRETERM INFANTS; CHILDREN; RISK; ALLERGY; EXACERBATIONS	Background: Wheeze is one of the most common symptoms of preschool children (age 1-5 years), yet we have little understanding of the burden in the United Kingdom. Objectives: We sought to determine prevalence and pattern of physician-confirmed preschool wheeze, related health care utilization, and factors associated with progression to school-age asthma. Methods: We used nationally representative primary and secondary care electronic medical records between 2007 and 2017 to identify preschool children with wheeze. Factors associated with asthma progression were identified in a nested cohort of children with follow-up from age 1 to 2 years, until at least age 8 years. Results: From 1,021,624 preschool children, 69,261 were identified with wheeze. Prevalence of preschool wheeze was 7.7% in 2017. Wheeze events were lowest in August and highest in late-autumn/early-winter. During median follow-up of 2 years (interquartile range, 1.2-4.0 years), 15.8% attended an emergency department, and 13.9% had a hospital admission, for a respiratory disorder. The nested cohort with prolonged follow-up identified 15,085 children; 35.5% progressed to asthma between age 5 and 8 years. Of children with preschool wheeze, without an asthma diagnosis, 34.9% were prescribed inhaled corticosteroids and 15.6% oral corticosteroids. The factors most strongly associated with progression to asthma were wheeze frequency and severity, atopy, prematurity, maternal asthma severity, and first reported wheeze event occurring in September. Conclusions: Preschool wheeze causes considerable health care burden, and a large number of children are prescribed asthma medication and have unplanned secondary care visits. Multiple factors influence progression to asthma, including first wheeze event occurring in September. (J Allergy Clin Immunol 2021;147:1949-58.)	[Bloom, Chloe I.; Bush, Andrew; Saglani, Sejal; Quint, Jennifer K.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Franklin, Courtney] London Sch Hyg & Trop Med, London, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Bloom, CI (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Airways Dis Sect, Cale St,Guy Scadding Bldg, London, England.	chloe.bloom06@imperial.ac.uk	quint, jennifer/ABE-3384-2020	Bloom, Chloe/0000-0003-1285-7602	NIHR Biomedical Research Centre at Imperial College	NIHR Biomedical Research Centre at Imperial College	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Supported by the the NIHR Biomedical Research Centre at Imperial College.	Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Belgrave DCM, 2018, LANCET RESP MED, V6, P526, DOI 10.1016/S2213-2600(18)30099-7; Bloom CI, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02130-2018; Bloom CI, 2018, THORAX, V73, P313, DOI 10.1136/thoraxjnl-2017-210650; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; British Thoraric Society, 2019, BTS SIGN BRIT GUID M; Bush A, 2020, ALLERGY, V75, P2711, DOI 10.1111/all.14172; Bush A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g15; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Carlos E, 2017, J ASTHMA ALLERGY, V10, P83, DOI 10.2147/JAA.S128319; Carroll KN, 2017, J ALLERGY CLIN IMMUN, V139, P66, DOI 10.1016/j.jaci.2016.01.055; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2016, PEDIATR PULM, V51, P868, DOI 10.1002/ppul.23429; Caudri D, 2009, J ALLERGY CLIN IMMUN, V124, P903, DOI 10.1016/j.jaci.2009.06.045; Davies G, 2008, ARCH DIS CHILD, V93, P952, DOI 10.1136/adc.2007.133868; DCLG (Department for Communities and Local Government), 2010, ENGL IND DEPR 2010; Douros K, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00218; Driscoll AJ, 2020, VACCINE, V38, P2435, DOI 10.1016/j.vaccine.2020.01.020; Fleming DM, 2000, THORAX, V55, P662, DOI 10.1136/thorax.55.8.662; Garty BZ, 1998, ANN ALLERG ASTHMA IM, V81, P563, DOI 10.1016/S1081-1206(10)62707-X; Glanville N, 2015, CURR OPIN VIROL, V11, P83, DOI 10.1016/j.coviro.2015.03.004; Griffiths LJ, 2018, BMJ OPEN RESPIR RES, V5, DOI 10.1136/bmjresp-2017-000260; Guilbert Theresa W, 2010, Expert Rev Respir Med, V4, P71, DOI 10.1586/ers.09.60; Guilbert TW, 2014, J ALLER CL IMM-PRACT, V2, P664, DOI 10.1016/j.jaip.2014.09.010; Harcourt SE, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000542, 10.1017/s0950268819000542]; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Higgins D, 2021, J ASTHMA, V58, P770, DOI 10.1080/02770903.2020.1734023; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Johnston NW, 2006, THORAX, V61, P722, DOI 10.1136/thx.2005.045161; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Korppi M, 2004, PEDIATR PULM, V38, P155, DOI 10.1002/ppul.20058; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Larsen K, 2016, ANN AM THORAC SOC, V13, P231, DOI 10.1513/AnnalsATS.201508-545OC; Lebold KM, 2020, J LEUKOCYTE BIOL, V108, P113, DOI 10.1002/JLB.3MR1219-338R; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lister S, 2001, AUST NZ J PUBL HEAL, V25, P514, DOI 10.1111/j.1467-842X.2001.tb00315.x; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; Liu XQ, 2018, J ALLERGY CLIN IMMUN, V141, P886, DOI 10.1016/j.jaci.2017.05.016; Lukkarinen M, 2017, J ALLERGY CLIN IMMUN, V140, P988, DOI 10.1016/j.jaci.2016.12.991; Martel MJ, 2009, EUR RESPIR J, V34, P579, DOI 10.1183/09031936.00074608; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Minassian C, 2019, PHARMACOEPIDEM DR S, V28, P923, DOI 10.1002/pds.4811; Mochizuki H, 2017, AM J RESP CRIT CARE, V196, P29, DOI [10.1164/rccm.201609-1812OC, 10.1164/rccm.201609-1812oc]; Nissen F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017474; Papadopoulos NG, 2017, J ALLERGY CLIN IMMUN, V140, P921, DOI 10.1016/j.jaci.2017.07.001; Perry R, 2019, PHARMACOECONOMICS, V37, P155, DOI 10.1007/s40273-018-0726-2; Rohde GGU, 2011, EUR RESPIR J, V37, P3, DOI 10.1183/09031936.00136510; Scheltema NM, 2018, LANCET RESP MED, V6, P257, DOI 10.1016/S2213-2600(18)30055-9; Selby A, 2018, THORAX, V73, P1049, DOI 10.1136/thoraxjnl-2016-209429; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Smit HA, 2015, LANCET RESP MED, V3, P973, DOI 10.1016/S2213-2600(15)00428-2; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P131, DOI 10.1016/j.jaci.2008.10.042; Stevens CA, 2003, EUR RESPIR J, V21, P1000, DOI 10.1183/09031936.03.00057002; Uphoff Eleonora P, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00150-2016; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC	59	9	10	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1949	1958		10.1016/j.jaci.2020.12.643	http://dx.doi.org/10.1016/j.jaci.2020.12.643		MAY 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZE	33453287	Bronze, Green Submitted			2022-12-18	WOS:000651594000003
J	Ghaedi, M; Takei, F				Ghaedi, Maryam; Takei, Fumio			Innate lymphoid cell development	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Innate lymphoid cells; ILCs; development; transcription factors; progenitors	NATURAL-KILLER-CELL; TRANSCRIPTION FACTOR GATA3; ARYL-HYDROCARBON RECEPTOR; TISSUE-INDUCER CELL; T-CELL; LINEAGE COMMITMENT; IL-33 PROMOTES; FACTOR BCL11B; HELPER-CELLS; STEM-CELL	Innate lymphoid cells (ILCs) mainly reside at barrier surfaces and regulate tissue homeostasis and immunity. ILCs are divided into 3 groups, group 1 ILCs, group 2 ILCs, and group 3 ILC3, on the basis of their similar effector programs to T cells. The development of ILCs from lymphoid progenitors in adult mouse bone marrow has been studied in detail, and multiple ILC progenitors have been characterized. ILCs are mostly tissue-resident cells that develop in the perinatal period. More recently, ILC progenitors have also been identified in peripheral tissues. In this review, we discuss the stepwise transcription factor-directed differentiation of mouse ILC progenitors into mature ILCs, the critical time windows in ILC development, and the contribution of bone marrow versus tissue ILC progenitors to the pool of mature ILCs in tissues. (J Allergy Clin Immunol 2021;147:1549-60.)	[Ghaedi, Maryam] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Takei, Fumio] Univ British Columbia UBC, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Takei, Fumio] BC Canc, Terry Fox Lab, Vancouver, BC, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of British Columbia	Takei, F (corresponding author), BC Canc Res Ctr, Terry Fox Lab, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ftakei@bccrc.ca			Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institute of Health Research.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Bal SM, 2020, NAT REV IMMUNOL, V20, P552, DOI 10.1038/s41577-020-0282-9; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Bernink JH, 2019, NAT IMMUNOL, V20, P992, DOI 10.1038/s41590-019-0423-0; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bhandoola A, 2006, NAT REV IMMUNOL, V6, P117, DOI 10.1038/nri1778; Bielecki P, NATURE; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Branzk N, 2018, IMMUNOL REV, V286, P86, DOI 10.1111/imr.12718; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Cella M, 2019, NAT IMMUNOL, V20, P980, DOI 10.1038/s41590-019-0425-y; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen LX, 2018, IMMUNITY, V49, P464, DOI 10.1016/j.immuni.2018.08.010; Christianson CA, 2015, J ALLERGY CLIN IMMUN, V136, P59, DOI 10.1016/j.jaci.2014.11.037; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2016, IMMUNOL LETT, V179, P19, DOI 10.1016/j.imlet.2016.07.005; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Diefenbach A, 2015, NAT IMMUNOL, V16, P222, DOI 10.1038/ni.3107; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dogra P, 2020, CELL, V180, P749, DOI 10.1016/j.cell.2020.01.022; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Ferreira ACF, 2021, NAT IMMUNOL, V22, P166, DOI 10.1038/s41590-020-00833-w; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Geiger TL, 2016, CURR OPIN IMMUNOL, V39, P82, DOI 10.1016/j.coi.2016.01.007; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Ghaedi M, 2020, J EXP MED, V217, DOI 10.1084/jem.20182293; Ghaedi M, 2016, CELL REP, V15, P471, DOI 10.1016/j.celrep.2016.03.039; Gluck J, 2012, INFLAMM RES, V61, P547, DOI 10.1007/s00011-012-0443-9; Golebski K, 2021, IMMUNITY, V54, P291, DOI 10.1016/j.immuni.2020.12.013; Golebski K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09883-7; Gronke K, 2016, IMMUNOL LETT, V179, P9, DOI 10.1016/j.imlet.2016.07.004; Gronke K, 2015, NATURE, V528, P488, DOI 10.1038/nature16325; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Harly C, 2018, J EXP MED, V215, P249, DOI 10.1084/jem.20170832; Held W, 1999, IMMUNITY, V11, P433, DOI 10.1016/S1074-7613(00)80118-1; Held W, 2003, EUR J IMMUNOL, V33, P1393, DOI 10.1002/eji.200323840; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Hochdorfer T, 2019, EUR J IMMUNOL, V49, P884, DOI 10.1002/eji.201848006; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Jaradat M, 2006, AM J RESP CRIT CARE, V174, P1299, DOI 10.1164/rccm.200510-1672OC; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Karta MR, 2018, J ALLERGY CLIN IMMUN, V141, P329, DOI 10.1016/j.jaci.2017.03.010; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kiss EA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00124; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2010, IMMUNOL REV, V238, P37, DOI 10.1111/j.1600-065X.2010.00963.x; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Krabbendam L, 2021, CURR OPIN IMMUNOL, V68, P28, DOI 10.1016/j.coi.2020.08.007; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Levanon D, 2014, MOL CELL BIOL, V34, P1158, DOI 10.1128/MCB.01202-13; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lim AI, 2019, EUR J IMMUNOL, V49, P11, DOI 10.1002/eji.201747294; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Lo BC, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8864; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Matsuyama Y, 2010, J RHEUMATOL, V37, P18, DOI 10.3899/jrheum.090492; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nagasawa M, 2019, J EXP MED, V216, P1762, DOI 10.1084/jem.20190490; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oherle K, 2020, IMMUNITY, V52, P275, DOI [10.1016/j.immuni.7020.01.005, 10.1016/j.immuni.2020.01.005]; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Parker ME, 2020, J EXP MED, V217, DOI 10.1084/jem.20191030; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2018, MUCOSAL IMMUNOL, V11, P50, DOI 10.1038/mi.2017.38; Robinette ML, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14601; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Scoville SD, 2019, CURR OPIN IMMUNOL, V56, P100, DOI 10.1016/j.coi.2018.11.003; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Seehus CR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02023-z; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shin SB, 2020, BLOOD ADV, V4, P5362, DOI 10.1182/bloodadvances.2020002758; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Smith SG, 2016, J ALLERGY CLIN IMMUN, V137, P75, DOI 10.1016/j.jaci.2015.05.037; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Steer CA, 2017, J ALLERGY CLIN IMMUN, V140, P593, DOI 10.1016/j.jaci.2016.12.984; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Stokic-Trtica V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00813; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; Tamagawa-Mineoka R, 2014, J AM ACAD DERMATOL, V70, P882, DOI 10.1016/j.jaad.2014.01.867; Tizian C, 2020, ELIFE, V9, DOI 10.7554/eLife.52549; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Veinotte LL, 2006, BLOOD, V107, P2673, DOI 10.1182/blood-2005-07-2797; Veinotte LL, 2003, CRIT REV IMMUNOL, V23, P251, DOI 10.1615/CritRevImmunol.v23.i4.10; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Wang LH, 2015, DEV CELL, V35, P269, DOI 10.1016/j.devcel.2015.10.019; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wei H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1388; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Williams TC, CELL RES; Winkler C, 2019, J ALLERGY CLIN IMMUN, V144, P61, DOI 10.1016/j.jaci.2019.01.027; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Wong WF, 2011, IMMUNOLOGY, V132, P157, DOI 10.1111/j.1365-2567.2010.03381.x; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yu X, 2014, ELIFE, V3, P1; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318; Yudanin NA, 2019, IMMUNITY, V50, P505, DOI 10.1016/j.immuni.2019.01.012; Zeis P, 2020, IMMUNITY, V53, P775, DOI 10.1016/j.immuni.2020.09.002; Zhong C, 2020, IMMUNITY, V52, P83, DOI 10.1016/j.immuni.2019.12.001; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318; Zhu J, 2018, NAT IMMUNOL, V19, P2; Zook EC, 2016, J EXP MED, V213, P687, DOI 10.1084/jem.20150851	169	9	9	3	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1549	1560		10.1016/j.jaci.2021.03.009	http://dx.doi.org/10.1016/j.jaci.2021.03.009		MAY 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33965092				2022-12-18	WOS:000647680800002
J	Ribo, P; Guo, YR; Aranda, J; Ainsua-Enrich, E; Navines-Ferrer, A; Guerrero, M; Pascal, M; de la Cruz, C; Orozco, M; Munoz-Cano, R; Martin, M				Ribo, Pau; Guo, Yanru; Aranda, Juan; Ainsua-Enrich, Erola; Navines-Ferrer, Arnau; Guerrero, Mario; Pascal, Mariona; de la Cruz, Cinthia; Orozco, Modesto; Munoz-Cano, Rosa; Martin, Margarita			Mutation in KARS: A novel mechanism for severe anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Anaphylaxis; lysyl-tRNA synthetase (LysRS); KARS; microphthalmia transcription factor; mast cells	TRANSFER-RNA-SYNTHETASE; POSTMORTEM DIAGNOSIS; PROSTAGLANDIN D-2; MAST-CELLS; MITF; PARAMETERS; MANAGEMENT; PHENOTYPE; PROTEINS; MOLECULE	Background: Anaphylaxis is a severe allergic reaction that can be lethal if not treated adequately. The underlying molecular mechanisms responsible for the severity are mostly unknown. Objective: This study is based on a clinical case of a patient with extremely severe anaphylaxis to paper wasp venom. This patient has a mutation in the KARS gene, which encodes lysyl-tRNA synthetase (LysRS), a moonlight protein with a canonical function in protein synthesis and a noncanonical function in antigen dependent-FceRI activation in mast cells. In this study, the objective was to characterize the mutation at the molecular level. Methods: Analysis of the KARS mutation was carried out using biochemical and functional approaches, cell transfection, Western blot, confocal microscopy, cell degranulation, prostaglandin D-2 secretion, and proteases gene transcription. Structural analysis using molecular dynamics simulations and well-tempered metadynamics was also performed. Results: The mutation found, P542R (proline was replaced by arginine at aminoacid 542), affects the location of the protein as we show in biochemical and structural analyses. The mutation resembles active LysRS and causes a constitutive activation of the microphthalmia transcription factor, which is involved in critical mast cell functions such as synthesis of mediators and granule biogenesis. Moreover, the structural analysis provides insights into how LysRS works in mast cell activation. Conclusions: A link between the aberrant LysRS-P542R function and mast cell-exacerbated activation with increase in proinflammatory mediator release after antigen-IgE-dependent response could be established.	[Ribo, Pau; Guo, Yanru; Ainsua-Enrich, Erola; Navines-Ferrer, Arnau; Guerrero, Mario; Martin, Margarita] Univ Barcelona, Fac Med, Biomed Dept, Biochem & Mol Biol Unit, Barcelona, Spain; [Guo, Yanru; Ainsua-Enrich, Erola; Navines-Ferrer, Arnau; Pascal, Mariona; de la Cruz, Cinthia; Munoz-Cano, Rosa; Martin, Margarita] Inst Investigac Biomed August Pi & Sunyer, Clin & Expt Resp Immunoallergy IRCE, Barcelona, Spain; [Aranda, Juan; Orozco, Modesto] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Pascal, Mariona] Univ Barcelona, Hosp Clin, Ctr Diagnost Biomed, Immunol Dept, Barcelona, Spain; [Pascal, Mariona; Munoz-Cano, Rosa; Martin, Margarita] Inst Salud Carlos III, ARADyAL, Madrid, Spain; [de la Cruz, Cinthia; Munoz-Cano, Rosa] Hosp Clin Barcelona, Pneumol Dept, Allergy Sect, Barcelona, Spain; [Orozco, Modesto] Univ Barcelona, Biochem & Biomed Dept, Fac Biol, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Martin, M (corresponding author), Univ Barcelona, Biomed Dept, Fac Med, Biochem Unit, Carrer Casanova 143, E-08036 Barcelona, Spain.	martin_andorra@ub.edu	Moratalla, Juan Aranda/A-6888-2016; Moratalla, Juan Aranda/G-3376-2017; Pascal, Mariona/HCG-9380-2022; Ferrer, Arnau Navinés/AAC-2875-2021; Andorra, Margarita Martin/H-2025-2015; Munoz Cano, Rosa/K-9413-2014; Ainsua Enrich, Erola/D-3582-2019	Moratalla, Juan Aranda/0000-0001-9385-4651; Moratalla, Juan Aranda/0000-0001-9385-4651; Ferrer, Arnau Navinés/0000-0002-3806-4021; Andorra, Margarita Martin/0000-0002-9245-4899; Munoz Cano, Rosa/0000-0001-8566-8285; Guerrero, Mario/0000-0002-9912-661X; Ainsua Enrich, Erola/0000-0001-7901-5798	Spanish Ministry of Science and Innovation; European Regional Development Fund/European Social Fund "Investing in your future'' [RTI2018-096915-B100]; Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional for the Thematic Networks and Co-operative Research Centres: ARADyAL [RD16/0006/0007]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund/European Social Fund "Investing in your future''; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional for the Thematic Networks and Co-operative Research Centres: ARADyAL	This study has been funded by grants of the Spanish Ministry of Science and Innovation and European Regional Development Fund/European Social Fund ``Investing in your future'' (grant no. RTI2018-096915-B100) and a grant issued by the Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional for the Thematic Networks and Co-operative Research Centres: ARADyAL (grant no. RD16/0006/0007).	Ainsua-Enrich E, 2015, J IMMUNOL, V194, P4309, DOI 10.4049/jimmunol.1402887; Airas RK, 1996, EUR J BIOCHEM, V240, P223, DOI 10.1111/j.1432-1033.1996.0223h.x; Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; Alvarez-Twose I, 2010, J ALLERGY CLIN IMMUN, V125, P1269, DOI 10.1016/j.jaci.2010.02.019; Ardissone A, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0788-4; Beck SC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00494; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Case D.A., 2019, AMBER 2018; Castells M, 2017, J ALLERGY CLIN IMMUN, V140, P321, DOI 10.1016/j.jaci.2017.06.012; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Desogus G, 2000, BIOCHEMISTRY-US, V39, P8418, DOI 10.1021/bi0006722; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; Faloon PW, 2012, PROBE REPORTS NIH MO; Hei ZF, 2019, J BIOL CHEM, V294, P4775, DOI 10.1074/jbc.RA118.006356; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679; Kristensen T, 2011, J MOL DIAGN, V13, P180, DOI 10.1016/j.jmoldx.2010.10.004; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Lee YN, 2011, BLOOD, V117, P3629, DOI 10.1182/blood-2010-07-293548; Li YP, 2018, J ALLERGY CLIN IMMUN, V142, P1173, DOI 10.1016/j.jaci.2017.10.043; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; Lu S, 2010, J CUTAN PATHOL, V37, P26, DOI 10.1111/j.1600-0560.2010.01504.x; Ma PL, 2011, BLOOD, V118, P3459, DOI 10.1182/blood-2011-04-351809; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Martin M, 2005, J IMMUNOL, V174, P5977, DOI 10.4049/jimmunol.174.10.5977; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; McMillan HJ, 2015, J CHILD NEUROL, V30, P1037, DOI 10.1177/0883073814553272; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; MOORE KJ, 1995, TRENDS GENET, V11, P442, DOI 10.1016/S0168-9525(00)89143-X; Morii E, 2004, J BIOL CHEM, V279, P48923, DOI 10.1074/jbc.M407026200; Nechushtan H, 2002, MOL IMMUNOL, V38, P1177, DOI 10.1016/S0161-5890(02)00059-7; Nishio H, 2005, INT J LEGAL MED, V119, P331, DOI 10.1007/s00414-005-0524-1; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Oliver-Vila I, 2008, MOL IMMUNOL, V45, P2138, DOI 10.1016/j.molimm.2007.12.006; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Osawa Motoki, 2008, Legal Medicine, V10, P143, DOI 10.1016/j.legalmed.2007.10.002; Panesar SS, 2013, ALLERGY, V68, P1353, DOI 10.1111/all.12272; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serrano-Candelas E, 2016, CLIN EXP ALLERGY, V46, P92, DOI 10.1111/cea.12668; Simons FER, 2010, J ALLERGY CLIN IMMUN, V125, pS161, DOI 10.1016/j.jaci.2009.12.981; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; van Kampen V, 2013, ALLERGY, V68, P580, DOI 10.1111/all.12120; WAHAB SZ, 1985, J BIOL CHEM, V260, P5286; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019	55	9	9	2	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1855	+		10.1016/j.jaci.2020.12.637	http://dx.doi.org/10.1016/j.jaci.2020.12.637		MAY 2021	19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZH	33385443				2022-12-18	WOS:000651594300006
J	Silverwood, RJ; Mansfield, KE; Mulick, A; Wong, AYS; Schmidt, SAJ; Roberts, A; Smeeth, L; Abuabara, K; Langan, SM				Silverwood, Richard J.; Mansfield, Kathryn E.; Mulick, Amy; Wong, Angel Y. S.; Schmidt, Sigrun A. J.; Roberts, Amanda; Smeeth, Liam; Abuabara, Katrina; Langan, Sinead M.			Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Activity; atopic eczema; cohort study; electronic health care records; mortality; population-based; primary care; severity; United Kingdom	CHRONIC KIDNEY-DISEASE; INCREASED RISK; PREVALENT EXPOSURES; PSORIASIS; DERMATITIS; INCIDENT; SEVERITY	Background: Atopic eczema affects up to 10% of adults and is becoming more common globally. Few studies have assessed whether atopic eczema increases the risk of death. Objective: We aimed to determine whether adults with atopic eczema were at increased risk of death overall and by specific causes and to assess whether the risk varied by atopic eczema severity and activity. Methods: The study was a population-based matched cohort study using UK primary care electronic health care records from the Clinical Practice Research Datalink with linked hospitalization data from Hospital Episode Statistics and mortality data from the Office for National Statistics from 1998 to 2016. Results: A total of 526,736 patients with atopic eczema were matched to 2,567,872 individuals without atopic eczema. The median age at entry was 41.8 years, and the median follow-up time was 4.5 years. There was limited evidence of increased hazard for all-cause mortality in those with atopic eczema (hazard ratio = 1.04; 99% CI = 1.03-1.06), but there were somewhat stronger associations (8%-14% increased hazard) for deaths due to infectious, digestive, and genitourinary causes. Differences on the absolute scale were modest owing to low overall mortality rates. Mortality risk increased markedly with eczema severity and activity. For example, patients with severe atopic eczema had a 62% increased hazard (hazard ratio = 1.62; 99% CI = 1.54-1.71) for mortality compared with those without eczema, with the strongest associations for infectious, respiratory, and genitourinary causes. Conclusion: The increased hazards for all-cause and cause-specific mortality were largely restricted to those with the most severe or predominantly active atopic eczema. Understanding the reasons for these increased hazards for mortality is an urgent priority.	[Silverwood, Richard J.; Mansfield, Kathryn E.; Mulick, Amy; Wong, Angel Y. S.; Smeeth, Liam; Langan, Sinead M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England; [Silverwood, Richard J.] UCL, Social Res Inst, Ctr Longitudinal Studies, London, England; [Schmidt, Sigrun A. J.] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Schmidt, Sigrun A. J.] Aarhus Univ Hosp, Dept Dermatol, Aarhus, Denmark; [Roberts, Amanda] Nottingham Support Grp Carers Children Eczema, Nottingham, England; [Abuabara, Katrina] Univ Calif San Francisco, San Francisco Sch Med, Dept Dermatol, San Francisco, CA USA; [Langan, Sinead M.] Hlth Data Res UK, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Institute of Education; Aarhus University; Aarhus University; University of California System; University of California San Francisco	Langan, SM (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	Sinead.Langan@lshtm.ac.uk	Smeeth, Liam/X-5862-2018; Silverwood, Richard/A-1249-2014	Smeeth, Liam/0000-0002-9168-6022; Schmidt, Sigrun/0000-0001-5527-0698; Mulick, Amy/0000-0002-4009-2080; Silverwood, Richard/0000-0002-2744-1194; Langan, Sinead/0000-0002-7022-7441	Wellcome senior research fellowship in clinical science [205039/Z/16/Z]; Health Data Research UK [LOND1]; UK Medical Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation; Wellcome Trust	Wellcome senior research fellowship in clinical science; Health Data Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This article presents independent research supported by a Wellcome senior research fellowship in clinical science to S.M.L. (205039/Z/16/Z) . This work was also supported by Health Data Research UK (grant LOND1) , which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England) , Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government) , Public Health Agency (Northern Ireland) , British Heart Foundation, and Wellcome Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the article. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funders.	Abdel-Hafez M, 2009, AM J KIDNEY DIS, V54, P945, DOI 10.1053/j.ajkd.2009.03.019; Abuabara K, 2017, J INVEST DERMATOL; Abuabara K, 2019, ANN INTERN MED, V170, P354, DOI 10.7326/M18-2246; Alcabes P, 1997, AM J EPIDEMIOL, V146, P543, DOI 10.1093/oxfordjournals.aje.a009312; [Anonymous], 2016, DEATHS QUALITY ASSUR; Ascott A, 2019, J ALLERGY CLIN IMMUN, V143, P1821, DOI 10.1016/j.jaci.2018.11.030; Barbarot S, 2018, ALLERGY, V73, P1284, DOI 10.1111/all.13401; Berghea Elena Camelia, 2017, Maedica (Bucur), V12, P55; Chi CC, 2015, J DERMATOL SCI, V78, P232, DOI 10.1016/j.jdermsci.2015.03.012; Chiu HY, 2015, BRIT J DERMATOL, V173, P146, DOI 10.1111/bjd.13599; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Egeberg A, 2017, J AM ACAD DERMATOL, V76, P98, DOI 10.1016/j.jaad.2016.06.021; Eyerich K, 2018, J EUR ACAD DERMATOL, V32, P692, DOI 10.1111/jdv.14673; Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2015, PHARMACOEPIDEM DR S, V24, P586; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Kim MJ, 2010, J KOREAN MED SCI, V25, P1828, DOI 10.3346/jkms.2010.25.12.1828; Langan SM, 2017, J INVEST DERMATOL, V137, P1375, DOI 10.1016/j.jid.2017.01.030; Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Ramirez FD, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2019.0025; Sandhu JK, 2019, JAMA DERMATOL, V155, P178, DOI 10.1001/jamadermatol.2018.4566; Serrano L, 2019, J AM ACAD DERMATOL, V80, P904, DOI 10.1016/j.jaad.2018.11.028; Silverberg JI, 2018, J ALLER CL IMM-PRACT, V6, P1306, DOI 10.1016/j.jaip.2017.10.005; Silverberg JI, 2017, DERMATOL CLIN, V35, P283, DOI 10.1016/j.det.2017.02.002; Silverberg JI, 2014, DERMATITIS, V25, P107, DOI 10.1097/DER.0000000000000034; Silverwood RJ, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1786; Strom MA, 2016, J PEDIATR-US, V174, P247, DOI 10.1016/j.jpeds.2016.03.063; Thyssen JP, 2018, J AM ACAD DERMATOL, V78, P506, DOI 10.1016/j.jaad.2017.10.032; Vandenbroucke J, 2015, AM J EPIDEMIOL, V182, P826, DOI 10.1093/aje/kwv225; Vandenbroucke J, 2015, AM J EPIDEMIOL, V182, P846, DOI 10.1093/aje/kwv219; Wan J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5961; Wei CC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002586; Wei CC, 2014, PEDIATR NEPHROL, V29, P2157, DOI 10.1007/s00467-014-2835-2	37	9	9	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1753	1763		10.1016/j.jaci.2020.12.001	http://dx.doi.org/10.1016/j.jaci.2020.12.001		MAY 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33516523	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000647680800024
J	Utrero-Rico, A; Ruiz-Hornillos, J; Gonzalez-Cuadrado, C; Rita, CG; Almoguera, B; Minguez, P; Herrero-Gonzalez, A; Fernandez-Ruiz, M; Carretero, O; Taracido-Fernandez, JC; Lopez-Rodriguez, R; Corton, M; Aguado, JM; Villar, LM; Ayuso-Garcia, C; Paz-Artal, E; Laguna-Goya, R				Utrero-Rico, Alberto; Ruiz-Hornillos, Javier; Gonzalez-Cuadrado, Cecilia; Rita, Claudia Geraldine; Almoguera, Berta; Minguez, Pablo; Herrero-Gonzalez, Antonio; Fernandez-Ruiz, Mario; Carretero, Octavio; Carlos Taracido-Fernandez, Juan; Lopez-Rodriguez, Rosario; Corton, Marta; Maria Aguado, Jose; Maria Villar, Luisa; Ayuso-Garcia, Carmen; Paz-Artal, Estela; Laguna-Goya, Rocio			IL-6-based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						COVID-19; IL-6; mortality risk; predictive model; second wave; external validation	RISK	Background: Coronavirus disease 2019 (COVID-19) is a highly variable condition. Validated tools to assist in the early detection of patients at high risk of mortality can help guide medical decisions. Objective: We sought to validate externally, as well as in patients from the second pandemic wave in Europe, our previously developed mortality prediction model for hospitalized COVID-19 patients. Methods: Three validation cohorts were generated: 2 external with 185 and 730 patients from the first wave and 1 internal with 119 patients from the second wave. The probability of death was calculated for all subjects using our prediction model, which includes peripheral blood oxygen saturation/fraction of inspired oxygen ratio, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, IL-6, and age. Discrimination and calibration were evaluated in the validation cohorts. The prediction model was updated by reestimating individual risk factor effects in the overall cohort (N = 1477). Results: The mortality prediction model showed good performance in the external validation cohorts 1 and 2, and in the second wave validation cohort 3 (area under the receiver operating characteristic curve, 0.94, 0.86, and 0.86, respectively), with excellent calibration (calibration slope, 0.86, 0.94, and 0.79; intercept, 0.05, 0.03, and 0.10, respectively). The updated model accurately predicted mortality in the overall cohort (area under the receiver-operating characteristic curve, 0.91), which included patients from both the first and second COVID-19 waves. The updated model was also useful to predict fatal outcome in patients without respiratory distress at the time of evaluation. Conclusions: This is the first COVID-19 mortality prediction model validated in patients from the first and second pandemic waves. The COR112 online calculator is freely available to facilitate its implementation (https://utrero-rico.shinyapps.io/COR12_Score/).	[Utrero-Rico, Alberto; Gonzalez-Cuadrado, Cecilia; Paz-Artal, Estela; Laguna-Goya, Rocio] Hosp Univ 12 Octubre, Dept Immunol, Madrid, Spain; [Utrero-Rico, Alberto; Gonzalez-Cuadrado, Cecilia; Fernandez-Ruiz, Mario; Carretero, Octavio; Paz-Artal, Estela; Laguna-Goya, Rocio] Inst Invest Sanitaria Hosp 12 Octubre Imas12, Madrid, Spain; [Ruiz-Hornillos, Javier] Hosp Infanta Elena, Allergy Unit, Madrid, Spain; [Ruiz-Hornillos, Javier] Univ Autonoma Madrid IIS FJD, Inst Invest Sanitaria Fdn Jimenez Diaz Univ Hosp, UAM, Madrid, Spain; [Ruiz-Hornillos, Javier] Univ Francisco Vitoria, Fac Med, Madrid, Spain; [Rita, Claudia Geraldine; Maria Villar, Luisa] Hosp Ramon & Cajal, Dept Immunol, IRYCIS, Madrid, Spain; [Almoguera, Berta; Minguez, Pablo; Lopez-Rodriguez, Rosario; Corton, Marta; Maria Aguado, Jose; Ayuso-Garcia, Carmen] Univ Autonoma Madrid IIS FJD, Inst Invest Sanitaria Fdn Jimenez Diaz Univ Hosp, Dept Genet & Genom, UAM, Madrid, Spain; [Almoguera, Berta; Minguez, Pablo; Lopez-Rodriguez, Rosario; Corton, Marta; Ayuso-Garcia, Carmen] Inst Salud Carlos III, Ctr Biomed Network Res Rare Dis CIBERER, Madrid 28029, Spain; [Herrero-Gonzalez, Antonio; Carlos Taracido-Fernandez, Juan] Univ Autonoma Madrid IIS FJD, Inst Invest Sanitaria Fdn Jimenez Diaz Univ Hosp, Data Anal Dept, UAM, Madrid, Spain; [Fernandez-Ruiz, Mario; Carretero, Octavio; Maria Aguado, Jose] Hosp Univ 12 Octubre, Unit Infect Dis, Madrid, Spain; [Maria Aguado, Jose] Univ Complutense Madrid, Dept Med, Madrid, Spain; [Paz-Artal, Estela] Univ Complutense Madrid, Dept Immunol Ophthalmol & ENT, Madrid, Spain	Hospital Universitario 12 de Octubre; Autonomous University of Madrid; Universidad Francisco de Vitoria; Hospital Universitario Ramon y Cajal; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Complutense University of Madrid	Laguna-Goya, R (corresponding author), Hosp 12 Octubre, Serv Inmunol, Avda Cordoba S-N, Madrid 28041, Spain.	rocio.laguna@salud.madrid.org	Miguez, Pablo/D-4822-2013; Lopez-Rodriguez, Rosario/M-3381-2014; López-Rodríguez, Rosario/AAB-2290-2022	Miguez, Pablo/0000-0003-4099-9421; Lopez-Rodriguez, Rosario/0000-0002-4713-0633; López-Rodríguez, Rosario/0000-0002-4713-0633; Rita, Claudia Geraldine/0000-0003-2103-0973; Corton, Marta/0000-0003-0087-1626; Utrero-Rico, Alberto/0000-0001-8814-8410	Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (COVID-19 research call) - European Development Regional Fund "A way to achieve Europe" [COV20/00181]; Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation [CM19/00120, JR17/00020, CP18/00073, CP16/00116, CP17/00006]; IIS Fundacion Jimenez Diaz UAM Genomic Medicine Chair	Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (COVID-19 research call) - European Development Regional Fund "A way to achieve Europe"; Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); IIS Fundacion Jimenez Diaz UAM Genomic Medicine Chair	This study was supported by the Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (COVID-19 research call COV20/00181) -cofinanced by the European Development Regional Fund "A way to achieve Europe."R.L.-G. holds a research contract "Rio Hortega" (CM19/00120) , B.A. a research contract "Juan Rodes" (JR17/00020) , and M.F.-R., P.M., and M.C. a research contract "Miguel Servet" (CP18/00073, CP16/00116, and CP17/00006, respectively) , all from the Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation. R.L.-R. is sponsored by the IIS Fundacion Jimenez Diaz UAM Genomic Medicine Chair.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; Borras-Bermejo B, 2020, EMERG INFECT DIS, V26, P2281, DOI 10.3201/eid2609.202603; Cacciapaglia G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72611-5; Clift AK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3731; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1101/2020.05.28.20115758, 10.1038/s41591-020-1051-9]; Jin C, 2020, NAT COMMUN, V11; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Laguna-Goya R, 2020, J ALLERGY CLIN IMMUN, V146, P799, DOI 10.1016/j.jaci.2020.07.009; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Moons KGM, 2015, ADV ANAT PATHOL, V22, P303, DOI 10.1097/PAP.0000000000000072; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Pastor-Barriuso R, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4509; Patel MC, 2020, CLIN INFECT DIS, V71, P2920, DOI 10.1093/cid/ciaa763; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rice TW, 2007, CHEST, V132, P410, DOI 10.1378/chest.07-0617; Siregar S, 2019, INTERACT CARDIOV TH, V28, P333, DOI 10.1093/icvts/ivy338; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	19	9	11	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1652	+		10.1016/j.jaci.2021.02.021	http://dx.doi.org/10.1016/j.jaci.2021.02.021		MAY 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33662370	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000647680800015
J	Wang, H; Hu, DQ; Xiao, Q; Liu, YB; Song, J; Liang, YX; Ruan, JW; Wang, ZZ; Li, JX; Pan, L; Wang, MC; Zeng, M; Shi, LL; Xu, K; Ning, Q; Zhen, GH; Yu, D; Wang, DY; Wenzel, SE; Liu, Z				Wang, Hai; Hu, Dan-Qing; Xiao, Qiao; Liu, Yi-Bo; Song, Jia; Liang, Yuxia; Ruan, Jian-Wen; Wang, Zhe-Zheng; Li, Jing-Xian; Pan, Li; Wang, Meng-Chen; Zeng, Ming; Shi, Li-Li; Xu, Kai; Ning, Qin; Zhen, Guohua; Yu, Di; Wang, De-Yun; Wenzel, Sally E.; Liu, Zheng			Defective STING expression potentiates IL-13 signaling in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chemokine (C-C motif) ligand 26; interleukin 13; nasal polyp; stimulator of interferon genes; suppressor of cytokine signaling 1; signal transducer and activator of transcription 6	PHOSPHORYLATION; DIFFERENTIATION; INFLAMMATION; ACTIVATION; ADAPTER; SENSOR; STAT6	Background: Stimulator of interferon genes (STING) activation favors effective innate immune responses against viral infections. Its role in chronic rhinosinusitis with nasal polyps (CRSwNP) remains unknown. Objective: Our aim was to explore the expression, regulation, and function of STING in CRSwNP. Methods: STING expression in sinonasal mucosal samples was analyzed by means of quantitative RT-PCR, immunohistochemistry, flow cytometry, and Western blotting. Regulation and function of STING expression were explored by using cultured primary human nasal epithelial cells (HNECs) and cells of the line BEAS-2B in vitro. Results: STING expression was reduced in eosinophilic nasal polyps compared with that in noneosinophilic nasal polyps and control tissues. STING was predominantly expressed by epithelial cells in nasal tissue and was downregulated by IL-4 and IL-13 in a signal transducer and activator of transcription 6 (STAT6)-dependent manner. HNECs derived from eosinophilic polyps displayed compromised STING-dependent type I interferon production but heightened IL-13-induced STAT6 activation and CCL26 production as compared with HNECs from noneosinophilic polyps and control tissues, which were rescued by exogenous STING overexpression. Knocking down or overexpressing STING decreased or enhanced expression of suppressor of cytokine signaling 1 (SOCS1) in BEAS-2B cells, respectively, independent of the canonic STING pathway elements TBK1 and IRF3. Knocking down SOCS1 abolished the inhibitory effect of STING on IL-13 signaling in BEAS-2B cells. STING expression was positively correlated with SOCS1 expression but negatively correlated with CCL26 expression in nasal epithelial cells from patients with CRSwNP. Conclusions: Reduced STING expression caused by the type 2 milieu not only impairs STING-dependent type I interferon production but also amplifies IL-13 signaling by decreasing SOCS1 expression in nasal epithelial cells in eosinophilic CRSwNP. (J Allergy Clin Immunol 2021;147:1692-703.)	[Wang, Hai; Xiao, Qiao; Liu, Yi-Bo; Song, Jia; Ruan, Jian-Wen; Wang, Zhe-Zheng; Li, Jing-Xian; Pan, Li; Wang, Meng-Chen; Zeng, Ming; Shi, Li-Li; Xu, Kai; Liu, Zheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, 1095 Jiefang Ave, Wuhan 430030, Peoples R China; [Hu, Dan-Qing; Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Infect Dis,Dept Infect Dis, Wuhan, Peoples R China; [Liang, Yuxia; Zhen, Guohua] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med,Div Pulm & Crit Care Med, Wuhan, Peoples R China; [Liang, Yuxia; Zhen, Guohua] Minist Hlth, Key Lab Resp Dis, Wuhan, Peoples R China; [Yu, Di] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia; [Wang, De-Yun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Otolaryngol, Singapore, Singapore; [Wenzel, Sally E.] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA 15260 USA; [Wenzel, Sally E.] Univ Pittsburgh, Med Ctr, Dept Environm & Occupat Hlth, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Australian National University; John Curtin School of Medical Research; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, Z (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	zhengliuent@hotmail.com	Zhen, Guohua/HHC-2805-2022	Yu, Di/0000-0003-1721-8922	National Natural Science Foundation of China [81630024, 81920108011, 81900925, 81702687, 81670019]; Natural Science Foundation of Hubei Province of China [2017CFA016, 2018CFB602]; Australian National Healthand Medical Research Council Fellowship [GNT1085509]; BellberryViertel Senior Medical Research Fellowship	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Australian National Healthand Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia); BellberryViertel Senior Medical Research Fellowship	Supported by the National Natural Science Foundation of China (grants 81630024 and 81920108011 [to Z.L.] ) , 81900925 [to J.S.] , 81702687 [to K.X.] , and 81670019 [to G.Z.] ) , the Natural Science Foundation of Hubei Province of China (grants 2017CFA016 [to Z.L.] and 2018CFB602 [to M.Z.] ) , and an Australian National Healthand Medical Research Council Fellowship (GNT1085509) and BellberryViertel Senior Medical Research Fellowship (to D.Y.) .	Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Cerboni S, 2017, J EXP MED, V214, P1769, DOI 10.1084/jem.20161674; Dong GJ, 2015, MOL CELLS, V38, P441, DOI 10.14348/molcells.2015.2359; Doran E, 2016, EUR RESPIR J, V48, P715, DOI 10.1183/13993003.00400-2015; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gries CM, 2016, INFECT IMMUN, V84, P3564, DOI 10.1128/IAI.00447-16; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Hoggard M, 2017, CLIN MICROBIOL REV, V30, P321, DOI 10.1128/CMR.00060-16; Hwang JW, 2019, J ALLERGY CLIN IMMUN, V144, P1551, DOI 10.1016/j.jaci.2019.08.010; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Lan F, 2016, ALLERGY, V71, P1381, DOI 10.1111/all.12934; Lan F, 2016, RHINOLOGY, V54, P141, DOI [10.4193/Rhin15.213, 10.4193/Rhino15.213]; Li Y, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0159-2; Li ZP, 2019, J ALLERGY CLIN IMMUN, V144, P1228, DOI 10.1016/j.jaci.2019.06.037; Liao B, 2018, ALLERGY, V73, P1459, DOI 10.1111/all.13411; Liao B, 2015, ALLERGY, V70, P1169, DOI 10.1111/all.12667; Liu JX, 2020, J ALLERGY CLIN IMMUN, V145, P160, DOI 10.1016/j.jaci.2019.07.009; Luo PH, 2018, AUTOPHAGY, V14, P2155, DOI 10.1080/15548627.2018.1501134; Min JY, 2017, J ALLERGY CLIN IMMUN, V139, P130, DOI 10.1016/j.jaci.2016.07.020; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS3, DOI 10.1002/alr.21694; Pesu M, 2000, BLOOD, V95, P494, DOI 10.1182/blood.V95.2.494; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Sharma S, 2015, P NATL ACAD SCI USA, V112, pE710, DOI 10.1073/pnas.1420217112; Soler ZM, 2010, OTOLARYNG HEAD NECK, V142, P64, DOI 10.1016/j.otohns.2009.10.005; Song J, 2018, J ALLERGY CLIN IMMUN, V141, P927, DOI 10.1016/j.jaci.2017.10.014; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tan KS, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0693-2; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wang BF, 2017, ALLERGY, V72, P1384, DOI 10.1111/all.13153; Wang H, 2018, J ALLERGY CLIN IMMUN, V141, P1646, DOI 10.1016/j.jaci.2017.12.972; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Wang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039875; Wu JJ, 2019, J EXP MED, V216, P867, DOI 10.1084/jem.20182192; Zhai GT, 2018, J ALLERGY CLIN IMMUN; Zhang CX, 2019, CELL DEATH DIFFER; Zhang XH, 2012, AM J RESP CRIT CARE, V185, P140, DOI 10.1164/rccm.201103-0456OC; Zhao BY, 2019, NATURE, V569, P718, DOI 10.1038/s41586-019-1228-x; Zhao QL, 2019, GUT, V68, P1827, DOI 10.1136/gutjnl-2018-317098	45	9	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1692	1703		10.1016/j.jaci.2020.12.623	http://dx.doi.org/10.1016/j.jaci.2020.12.623		MAY 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33340608				2022-12-18	WOS:000647680800019
J	Van de Walle, I; Silence, K; Budding, K; Van de Ven, L; Dijkxhoorn, K; de Zeeuw, E; Yildiz, C; Gabriels, S; Percier, JM; Wildemann, J; Meeldijk, J; Simons, PJ; Boon, L; Cox, L; Holgate, R; Urbanus, R; Otten, HG; Leusen, JHW; Blanchetot, C; de Haard, H; Hack, CE; Boross, P				Van de Walle, Inge; Silence, Karen; Budding, Kevin; Van de Ven, Liesbeth; Dijkxhoorn, Kim; de Zeeuw, Elisabeth; Yildiz, Cafer; Gabriels, Sofie; Percier, Jean-Michel; Wildemann, Johanna; Meeldijk, Jan; Simons, Peter J.; Boon, Louis; Cox, Linda; Holgate, Rob; Urbanus, Rolf; Otten, Henny G.; Leusen, Jeanette H. W.; Blanchetot, Christophe; de Haard, Hans; Hack, C. Erik; Boross, Peter			ARGX-117, a therapeutic complement inhibiting antibody targeting C2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Complement system; C2; monoclonal antibody; complement inhibitor	HEREDITARY ANGIOEDEMA; ECULIZUMAB; MODALITY; DISEASE; BINDING; C1	Background: Activation of the classical and lectin pathway of complement may contribute to tissue damage and organ dysfunction of antibody-mediated diseases and ischemia-reperfusion conditions. Complement factors are being considered as targets for therapeutic intervention. Objective: We sought to characterize ARGX-117, a humanized inhibitory monoclonal antibody against complement C2. Methods: The mode-of-action and binding characteristics of ARGX-117 were investigated in detail. Furthermore, its efficacy was analyzed in in vitro complement cytotoxicity assays. Finally, a pharmacokinetic/pharmacodynamic study was conducted in cynomolgus monkeys. Results: Through binding to the Sushi-2 domain of C2, ARGX-117 prevents the formation of the C3 proconvertase and inhibits classical and lectin pathway activation upstream of C3 activation. As ARGX-117 does not inhibit the alternative pathway, it is expected not to affect the antimicrobial activity of this complement pathway. ARGX-117 prevents complement-mediated cytotoxicity in in vitro models for autoimmune hemolytic anemia and antibody-mediated rejection of organ transplants. ARGX-117 exhibits pH- and calcium-dependent target binding and is Fc-engineered to increase affinity at acidic pH to the neonatal Fc receptor, and to reduce effector functions. In cynomolgus monkeys, ARGX-117 dose-dependently reduces free C2 levels and classical pathway activity. A 2-dose regimen of 80 and 20 mg/kg separated by a week, resulted in profound reduction of classical pathway activity lasting for at least 7 weeks. Conclusions: ARGX-117 is a promising new complement inhibitor that is uniquely positioned to target both the classical and lectin pathways while leaving the alternative pathway intact.	[Van de Walle, Inge; Silence, Karen; Van de Ven, Liesbeth; Gabriels, Sofie; Percier, Jean-Michel; Blanchetot, Christophe; de Haard, Hans] Argenx BVBA, Zwijnaarde, Belgium; [Budding, Kevin; Dijkxhoorn, Kim; de Zeeuw, Elisabeth; Yildiz, Cafer; Wildemann, Johanna; Meeldijk, Jan; Otten, Henny G.; Leusen, Jeanette H. W.; Hack, C. Erik; Boross, Peter] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Utrecht, Netherlands; [Urbanus, Rolf] Univ Utrecht, Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Urbanus, Rolf] Univ Utrecht, Univ Med Ctr Utrecht, Van Creveldklin, Utrecht, Netherlands; [Hack, C. Erik; Boross, Peter] Prothix BV, Warmonderweg 23, NL-2334 AB Leiden, Netherlands; [Simons, Peter J.; Boon, Louis; Cox, Linda] Bioceros BV, Utrecht, Netherlands; [Holgate, Rob] Antitope Ltd, Cambridge, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Bioceros B.V.	Boross, P (corresponding author), Prothix BV, Warmonderweg 23, NL-2334 AB Leiden, Netherlands.; Van de Walle, I (corresponding author), Argenx, Ind Pk Zwijnaarde 7, B-9052 Zwijnaarde, Belgium.	ivandewalle@argenx.com; peterboross@gmail.com	Boon, Laurence/HCI-3629-2022; Boross, Peter/AAD-8928-2022; Urbanus, Rolf/AAG-7933-2020	Urbanus, Rolf/0000-0002-1601-9393; Boon, Louis/0000-0002-0937-9171	LSH Impuls Programme grant from The Life Science and Health-Topconsortium for Knowledge and Innovation [40-43100-98-013]; Dutch Kidney Foundation	LSH Impuls Programme grant from The Life Science and Health-Topconsortium for Knowledge and Innovation; Dutch Kidney Foundation	This work was supported by an LSH Impuls Programme grant from The Life Science and Health-Topconsortium for Knowledge and Innovation and project 40-43100-98-013 from the Dutch Kidney Foundation.	Bartko J, 2018, CLIN PHARMACOL THER, V104, P655, DOI 10.1002/cpt.1111; Berentsen S, 2015, TRANSFUS MED HEMOTH, V42, P303, DOI 10.1159/000438964; Bernstein JA, 2010, ANN ALLERG ASTHMA IM, V105, P149, DOI 10.1016/j.anai.2010.06.005; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875; Fukuzawa T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01087-7; GADEK JE, 1980, NEW ENGL J MED, V302, P542, DOI 10.1056/NEJM198003063021002; Gao T., 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962; Gloor J, 2010, NAT REV NEPHROL, V6, P297, DOI 10.1038/nrneph.2010.34; Glovsky MM, 2004, ANN ALLERG ASTHMA IM, V93, P513, DOI 10.1016/S1081-1206(10)61257-4; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hironiwa N, 2016, MABS-AUSTIN, V8, P65, DOI 10.1080/19420862.2015.1110660; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Holgate RGE, 2009, IDRUGS, V12, P233; Igawa T, 2016, IMMUNOL REV, V270, P132, DOI 10.1111/imr.12392; Lansita JA, 2017, INT J TOXICOL, V36, P449, DOI 10.1177/1091581817740873; Macedo ACL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00055; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; Mastaglio S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108450; Mastellos DC, 2019, NAT REV DRUG DISCOV, V18, P707, DOI 10.1038/s41573-019-0031-6; McNamara LA, 2017, MMWR-MORBID MORTAL W, V66, P734, DOI 10.15585/mmwr.mm6627e1; Ramadass M, 2014, J IMMUNOL, V192, P1220, DOI 10.4049/jimmunol.1302288; Reis ES, 2019, NAT REV IMMUNOL, V19, P503, DOI 10.1038/s41577-019-0168-x; Ricklin D, 2018, NAT REV NEPHROL, V14, P26, DOI 10.1038/nrneph.2017.156; Risitano AM, 2009, BLOOD, V113, P4094, DOI 10.1182/blood-2008-11-189944; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Shi J, 2014, BLOOD, V123, P4015, DOI 10.1182/blood-2014-02-556027; Tange CE, 2018, CLIN CHEM LAB MED, V56, P1498, DOI 10.1515/cclm-2017-1068; TENNER AJ, 1986, J IMMUNOL, V137, P625; Vaccaro C, 2006, P NATL ACAD SCI USA, V103, P18709, DOI 10.1073/pnas.0606304103; WOLBINK GJ, 1993, J IMMUNOL METHODS, V163, P67, DOI 10.1016/0022-1759(93)90240-8	31	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1420	+		10.1016/j.jaci.2020.08.028	http://dx.doi.org/10.1016/j.jaci.2020.08.028		APR 2021	17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RX3VK	32926878	hybrid, Green Published			2022-12-18	WOS:000647154500007
J	Lee, MK; Wyss, AB; Carnes, MU; Richards, M; Parks, CG; Freeman, LEB; Thorne, PS; Umbach, DM; Azcarate-Peril, MA; Peddada, SD; London, SJ				Lee, Mi Kyeong; Wyss, Annah B.; Carnes, Megan U.; Richards, Marie; Parks, Christine G.; Freeman, Laura E. Beane; Thorne, Peter S.; Umbach, David M.; Azcarate-Peril, M. Andrea; Peddada, Shyamal D.; London, Stephanie J.			House dust microbiota in relation to adult asthma and atopy in a US farming population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Bacteria; microbiome; host microbial interactions; asthma; allergy and immunology	ENDOTOXIN EXPOSURE; RISK; EPIDEMIOLOGY; DIVERSITY; AGE	Background: Bacterial exposure from house dust has been associated with asthma and atopy in children but whether these relationships are present in adults remains unclear. Objective: We sought to examine associations of house dust microbiota with adult asthma, atopy, and hay fever. Methods: Vacuumed bedroom dust samples from the homes of 879 participants (average age, 62 years) in the Agricultural Lung Health Study, a case-control study of asthma nested within a farming cohort, were subjected to 16S rRNA amplicon sequencing to characterize bacterial communities. We defined current asthma and hay fever using questionnaires and current atopy by blood specific IgE level > 0.70 IU/mL to 1 or more of 10 common allergens. We used linear regression to examine whether overall within-sample bacterial diversity differed by outcome, microbiome regression-based kernel association test to evaluate whether between-sample bacterial community compositions differed by outcome, and analysis of composition of microbiomes to identify differentially abundant bacterial taxa. Results: Overall diversity of bacterial communities in house dust was similar by asthma status but was lower (P < .05) with atopy or hay fever. Many individual bacterial taxa were differentially abundant (false-discovery rate, <0.05) by asthma, atopy, or hay fever. Several taxa from Cyanobacteria, Bacteroidetes, and Fusobacteria were more abundant with asthma, atopy, or hay fever. In contrast, several taxa from Firmicutes were more abundant in homes of individuals with adequately controlled asthma (vs inadequately controlled asthma), individuals without atopy, or individuals without hay fever. Conclusions: Microbial composition of house dust may influence allergic outcomes in adults. (J Allergy Clin Immunol 2021;147:910-20.)	[Lee, Mi Kyeong; Wyss, Annah B.; Parks, Christine G.; London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, DHHS, Res Triangle Pk, NC 27709 USA; [Carnes, Megan U.] RTI Int, Genom Publ Hlth & Med Ctr, Biostat & Epidemiol Div, Res Triangle Pk, NC USA; [Richards, Marie] Westat Corp, Durham, NC USA; [Freeman, Laura E. Beane] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Rockville, MD USA; [Thorne, Peter S.] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA; [Umbach, David M.] NIEHS, Biostat & Computat Biol Branch, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Azcarate-Peril, M. Andrea] Univ N Carolina, Dept Med & Microbiome Core, Ctr Gastrointestinal Biol & Dis, Sch Med, Chapel Hill, NC 27515 USA; [Peddada, Shyamal D.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Research Triangle Institute; Westat; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	London, SJ (corresponding author), NIEHS, POB 12233,Mail Drop A3-05, Res Triangle Pk, NC 27709 USA.	london2@niehs.nih.gov	Azcarate-Peril, M. Andrea/AAA-9056-2022; Lee, Mi Kyeong/C-3046-2017; Core, UNC Microbiome/AAB-3304-2022; Azcarate-Peril, M. Andrea/AFO-7157-2022	Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Lee, Mi Kyeong/0000-0002-3036-3684; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Carnes, Megan/0000-0002-7270-132X	National Institutes of Health (NIH), the National Institute of Environmental Health Sciences [Z01 ES043012, Z01-ES049030, Z01-ES102385, HHSN273201600003I]; National Cancer Institute [Z01CP010119B]; American Recovery and Reinvestment Act funds; NIH, National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK34987]; University of Iowa [PHR-SUPS2-S-1000179]; NIH [P30 ES005605]	National Institutes of Health (NIH), the National Institute of Environmental Health Sciences; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Recovery and Reinvestment Act funds; NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Iowa; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), the National Institute of Environmental Health Sciences (grant nos. Z01 ES043012, Z01-ES049030 and Z01-ES102385 and for A.B.W. contract no. HHSN273201600003I) and the National Cancer Institute (grant no. Z01CP010119B) and by American Recovery and Reinvestment Act funds. The Microbiome Core Facility at the University of North Carolina is supported in part by the NIH, National Institute of Diabetes and Digestive and Kidney Diseases (grant no. P30 DK34987). P.S.T. was supported by the University of Iowa (PHR-SUPS2-S-1000179) and the NIH (grant no. P30 ES005605).	Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Arbes SJ, 2013, CLIN EXP ALLERGY, V43, P544, DOI 10.1111/cea.12069; Arbes SJ, 2003, J ALLERGY CLIN IMMUN, V112, P339, DOI 10.1067/mai.2003.1597; Barberan A, 2015, P ROY SOC B-BIOL SCI, V282, P212, DOI 10.1098/rspb.2015.1139; Birzele LT, 2017, ALLERGY, V72, P109, DOI 10.1111/all.13002; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carnes MU, 2017, ANN AM THORAC SOC, V14, P324, DOI 10.1513/AnnalsATS.201611-861OC; Dannemiller KC, 2016, J ALLERGY CLIN IMMUN, V138, P76, DOI 10.1016/j.jaci.2015.11.027; de Nijs SB, 2013, EUR RESPIR REV, V22, P193, DOI 10.1183/09059180.50007112; Dharmage SC, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00246; Durack J, 2017, J ALLERGY CLIN IMMUN, V140, P63, DOI 10.1016/j.jaci.2016.08.055; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ege MJ, 2017, ANN AM THORAC SOC, V14, pS348, DOI 10.1513/AnnalsATS.201702-139AW; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; House JS, 2017, J ALLERGY CLIN IMMUN, V140, P249, DOI 10.1016/j.jaci.2016.09.036; Jari Oksanen G.B., 2020, R PACKAGE VERSION; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Karvonen AM, 2019, J ALLERGY CLIN IMMUN, V144, P1402, DOI 10.1016/j.jaci.2019.07.035; Kim MH, 2017, ALLERGY ASTHMA IMMUN, V9, P453, DOI 10.4168/aair.2017.9.5.453; Kirjavainen PV, 2019, NAT MED, V25, P1089, DOI 10.1038/s41591-019-0469-4; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lear G, 2018, NEW ZEAL J ECOL, V42, P10, DOI 10.20417/nzjecol.42.9; Lee MK, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP3145; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lin H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17041-7; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Mahmoudi N, 2011, CAN J MICROBIOL, V57, P623, DOI [10.1139/W11-049, 10.1139/w11-049]; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Morton JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10656-5; Myles IA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86955; National Health Interview Survey National Center for Health Statistics CDC., 2017, NATL HLTH INTERVIEW; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nylund L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-12; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Pekkanen J, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01241-2017; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smit LAM, 2008, EUR RESPIR J, V31, P1241, DOI 10.1183/09031936.00090607; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stephens B, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00083-16; Stewart Ian, 2006, Environ Health, V5, P7, DOI 10.1186/1476-069X-5-7; Thorne PS, 2015, AM J RESP CRIT CARE, V192, P1287, DOI 10.1164/rccm.201502-0251OC; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; Valkonen M, 2018, INDOOR AIR, V28, P16, DOI 10.1111/ina.12427; Valkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131594; Van Hoeyveld E, 2015, CLIN CHIM ACTA, V450, P46, DOI 10.1016/j.cca.2015.07.023; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Williams LK, 2005, ANN ALLERG ASTHMA IM, V94, P323, DOI 10.1016/S1081-1206(10)60983-0; Zhao N, 2015, AM J HUM GENET, V96, P797, DOI 10.1016/j.ajhg.2015.04.003	59	9	9	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					910	920		10.1016/j.jaci.2020.06.013	http://dx.doi.org/10.1016/j.jaci.2020.06.013		MAR 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RA9TV	32615170	Green Accepted, hybrid			2022-12-18	WOS:000631762400013
J	Li, C; Xu, M; Coyne, J; Wang, WB; Davila, ML; Wang, Y; Xiong, N				Li, Chao; Xu, Ming; Coyne, James; Wang, Wei-Bei; Davila, Micha L.; Wang, Yong; Xiong, Na			Psoriasis-associated impairment of CCL27/CCR10-derived regulation leads to IL-17A/IL-22-producing skin T-cell overactivation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CCR10		[Li, Chao; Wang, Wei-Bei; Xiong, Na] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA; [Li, Chao; Xu, Ming; Wang, Wei-Bei; Davila, Micha L.; Xiong, Na] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Li, Chao] China Med Univ, Div Pneumoconiosis, Sch Publ Hlth, Shenyang, Peoples R China; [Coyne, James; Wang, Yong] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; China Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Xiong, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA.; Xiong, N (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.; Wang, Y (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.	yxw30@psu.edu; xiongn@uthscsa.edu		Li, Chao/0000-0001-5723-1414	NIH [AR064831, R01AR070887, R01AR073364]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grants AR064831 and R01AR070887 (to N.X.) and R01AR073364 (to Y.W.).	Coyne J, 2017, ACS BIOMATER SCI ENG, V3, P3395, DOI 10.1021/acsbiomaterials.7b00718; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Jin Y, 2010, J IMMUNOL, V185, P5723, DOI 10.4049/jimmunol.1001612; Riis JL, 2011, EXP DERMATOL, V20, P789, DOI 10.1111/j.1600-0625.2011.01323.x; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Xia MC, 2014, J ALLERGY CLIN IMMUN, V134, P634, DOI 10.1016/j.jaci.2014.03.010; Xiong N, 2012, PROTEIN CELL, V3, P571, DOI 10.1007/s13238-012-2927-3; Yang J, 2016, NAT IMMUNOL, V17, P48, DOI 10.1038/ni.3312	9	9	9	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					759	+		10.1016/j.jaci.2020.05.044	http://dx.doi.org/10.1016/j.jaci.2020.05.044		FEB 2021	6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32533971	Bronze, Green Accepted			2022-12-18	WOS:000616665800044
J	Budu-Aggrey, A; Watkins, SH; Brumpton, B; Loset, M; Tyrrell, J; Modalsli, EH; Vie, GA; Palmer, T; Fritsche, LG; Nielsen, JB; Romundstad, PR; Smith, GD; Asvold, BO; Paternoster, L; Brown, SJ				Budu-Aggrey, Ashley; Watkins, Sarah H.; Brumpton, Ben; Loset, Mari; Tyrrell, Jess; Modalsli, Ellen H.; Vie, Gunnhild Aberge; Palmer, Tom; Fritsche, Lars G.; Nielsen, Jonas Bille; Romundstad, Pal Richard; Smith, George Davey; Asvold, Bjorn Olav; Paternoster, Lavinia; Brown, Sara J.			Assessment of a causal relationship between body mass index and atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; OBESITY; LOCI		[Budu-Aggrey, Ashley; Watkins, Sarah H.; Brumpton, Ben; Palmer, Tom; Smith, George Davey; Paternoster, Lavinia] Univ Bristol, Bristol Med Sch, Med Res Council Integrat Epidemiol Unit, Bristol, Avon, England; [Budu-Aggrey, Ashley; Watkins, Sarah H.; Palmer, Tom; Smith, George Davey; Paternoster, Lavinia] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Brumpton, Ben; Loset, Mari; Fritsche, Lars G.; Nielsen, Jonas Bille; Asvold, Bjorn Olav] Norwegian Univ Sci & Technol, NTNU, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway; [Modalsli, Ellen H.; Vie, Gunnhild Aberge; Romundstad, Pal Richard] Norwegian Univ Sci & Technol, NTNU, Dept Publ Hlth & Nursing, Trondheim, Norway; [Modalsli, Ellen H.] Norwegian Univ Sci & Technol, NTNU, Dept Clin & Mol Med, Trondheim, Norway; [Brumpton, Ben] Univ Trondheim Hosp, St Olavs Hosp, Dept Thorac & Occupat Med, Trondheim, Norway; [Loset, Mari; Modalsli, Ellen H.] Univ Trondheim Hosp, St Olavs Hosp, Dept Dermatol, Trondheim, Norway; [Asvold, Bjorn Olav] Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [Tyrrell, Jess] Univ Exeter, Genet Complex Traits, Inst Biomed & Clin Sci, Med Sch,Royal Devon & Exeter Hosp, Exeter, Devon, England; [Nielsen, Jonas Bille] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Brown, Sara J.] Univ Dundee, Sch Med, Skin Res Grp, Dundee, Scotland; [Brown, Sara J.] Ninewells Hosp & Med Sch, Dept Dermatol, Dundee, Scotland	University of Bristol; University of Bristol; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Exeter; University of Michigan System; University of Michigan; University of Dundee; University of Dundee	Brown, SJ (corresponding author), Univ Dundee, Sch Med, Skin Res Grp, Dundee, Scotland.; Brown, SJ (corresponding author), Ninewells Hosp & Med Sch, Dept Dermatol, Dundee, Scotland.	s.j.brown@dundee.ac.uk	Davey Smith, George/A-7407-2013; Fritsche, Lars G/AAF-9387-2019	Davey Smith, George/0000-0002-1407-8314; Fritsche, Lars G/0000-0002-2110-1690; Loset, Mari/0000-0003-3736-6551; Budu-Aggrey, Ashley/0000-0002-8911-2492; Watkins, Sarah/0000-0002-8034-8095; Palmer, Tom/0000-0003-4655-4511	British Skin Foundation [8010]; UK Medical Research Council [MC_UU_00011/1]; Stiftelsen Kristian Gerhard Jebsen, Faculty of Medicine and Health Sciences, NTNU; Liaison Committee for Education, Research, and Innovation in Central Norway; St. Olav's Hospital; Faculty of Medicine and Health Sciences, NTNU; Academy of Medical Sciences Springboard award; Academy of Medical Sciences; Wellcome Trust; GCRF; Government Department of Business, Energy and Industrial strategy; British Heart Foundation; Diabetes UK; Liaison Committee for Education, Research and Innovation in Central Norway; Norwegian Research Council [250335]; Danish Heart Foundation; Lundbeck Foundation; Government Department for Business, Energy and Industrial Strategy; Global Challenges Research Fund; British Heart Foundation [SBF003/1094]; Wellcome Trust Senior Research Fellowship in Clinical Science [106865/Z/15/Z]; British Skin Foundation large project grant; National Institutes of Health; University of Michigan; Research Council of Norway; MRC [MC_UU_00011/1] Funding Source: UKRI	British Skin Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stiftelsen Kristian Gerhard Jebsen, Faculty of Medicine and Health Sciences, NTNU; Liaison Committee for Education, Research, and Innovation in Central Norway; St. Olav's Hospital; Faculty of Medicine and Health Sciences, NTNU; Academy of Medical Sciences Springboard award; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome TrustEuropean Commission); GCRF; Government Department of Business, Energy and Industrial strategy; British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); Liaison Committee for Education, Research and Innovation in Central Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission); Danish Heart Foundation; Lundbeck Foundation(Lundbeckfonden); Government Department for Business, Energy and Industrial Strategy; Global Challenges Research Fund; British Heart Foundation(British Heart Foundation); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); British Skin Foundation large project grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); Research Council of Norway(Research Council of Norway); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A.B-A. is funded by a grant awarded to L.P. by the British Skin Foundation (8010 Innovative Project). A.B-A, L.P., S.W., and G.D.S. work in a research unit funded by the UK Medical Research Council (MC_UU_00011/1). B.B., M.L., L.G.F., and B.O.A. work in a research unit funded by Stiftelsen Kristian Gerhard Jebsen, Faculty of Medicine and Health Sciences, NTNU; The Liaison Committee for Education, Research, and Innovation in Central Norway; and the Joint Research Committee between St. Olav's Hospital and the Faculty of Medicine and Health Sciences, NTNU. J.T. is supported by an Academy of Medical Sciences Springboard award, which is supported by the Academy of Medical Sciences, the Wellcome Trust, GCRF, the Government Department of Business, Energy and Industrial strategy, the British Heart Foundation, and Diabetes UK. E.H.M. was supported by a research grant from the Liaison Committee for Education, Research and Innovation in Central Norway. G.A.V. is supported by a research grant from the Norwegian Research Council (grant 250335). M.L. is supported by research grants from the Liaison Committee for Education, Research and Innovation in Central Norway. J.B.N. was supported by grants from the Danish Heart Foundation and the Lundbeck Foundation. L.P. is supported by an Academy of Medical Sciences Springboard Award, which is supported by the Wellcome Trust, the Government Department for Business, Energy and Industrial Strategy, the Global Challenges Research Fund, and the British Heart Foundation [SBF003/1094]. S.J.B. holds a Wellcome Trust Senior Research Fellowship in Clinical Science (106865/Z/15/Z) and a British Skin Foundation large project grant. The genotyping in HUNTwas financed by the National Institutes of Health; the University of Michigan; the Research Council of Norway; the Liaison Committee for Education, Research, and Innovation in Central Norway; and the Joint Research Committee between St. Olav's Hospital and the Faculty of Medicine and Health Sciences, NTNU. The funders had no influence on study design, data collection and analysis, decision to publish, or preparation of the article.	Budu-Aggrey A, 2019, PLOS MED, V16, DOI [10.1371/journal., 10.1371/journal.pmed.1002739]; Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Nakamizo S, 2017, TRENDS IMMUNOTHER, V1, P67; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Yosipovitch G, 2007, J AM ACAD DERMATOL, V56, P901, DOI 10.1016/j.jaad.2006.12.004	9	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					400	403		10.1016/j.jaci.2020.04.050	http://dx.doi.org/10.1016/j.jaci.2020.04.050		JAN 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	32433920	Green Accepted, hybrid, Green Published			2022-12-18	WOS:000607781700017
J	Longo, VD; Cortellino, S				Longo, Valter D.; Cortellino, Salvatore			Fasting, dietary restriction, and immunosenescence	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hematopoietic stem cell; exhausted T cell; inflammation; metabolism; dietary intervention	REGENERATION		[Longo, Valter D.] Univ Southern Calif, Longev Inst, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Longo, Valter D.; Cortellino, Salvatore] FIRC Inst Mol Oncol, IFOM, Milan, Italy	University of Southern California; IFOM - FIRC Institute of Molecular Oncology	Longo, VD (corresponding author), Univ Southern Calif, Longev Inst, Sch Gerontol, Dept Biol Sci, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	vlongo@usc.edu; valter.longo@ifom.eu	Cortellino, Salvatore/GPW-6929-2022	CORTELLINO, Salvatore/0000-0001-8331-3800	Associazione Italiana per la Ricerca sul Cancro [17605]; Cariplo [2018-054]; National Institutes of Health [AG034906, AG20642]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Cariplo(Fondazione Cariplo); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the Associazione Italiana per la Ricerca sul Cancro (grant no. IG#17605) and in part by Cariplo (grant no. 2018-054) and National Institutes of Health (grant nos. AG034906 and AG20642).	Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Rangan P, 2019, CELL REP, V26, P2704, DOI 10.1016/j.celrep.2019.02.019; Suez J, 2019, NAT MED, V25, P716, DOI 10.1038/s41591-019-0439-x; Vasto S, 2014, GERONTOLOGY, V60, P508, DOI 10.1159/000363060	10	9	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					1002	1004		10.1016/j.jaci.2020.07.035	http://dx.doi.org/10.1016/j.jaci.2020.07.035			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	32853639	Bronze			2022-12-18	WOS:000588153700001
J	Rigoni, R; Fontana, E; Dobbs, K; Marrella, V; Taverniti, V; Maina, V; Facoetti, A; D'Amico, G; Al-Herz, W; Cruz-Munoz, ME; Schuetz, C; Gennery, AR; Garabedian, EK; Giliani, S; Draper, D; Dbaibo, G; Geha, RS; Meyts, I; Tousseyn, T; Neven, B; Moshous, D; Fischer, A; Schulz, A; Finocchi, A; Kuhns, DB; Fink, DL; Lionakis, MS; Swamydas, M; Guglielmetti, S; Alejo, J; Myles, IA; Pittaluga, S; Notarangelo, LD; Villa, A; Cassani, B				Rigoni, Rosita; Fontana, Elena; Dobbs, Kerry; Marrella, Veronica; Taverniti, Valentina; Maina, Virginia; Facoetti, Amanda; D'Amico, Giovanna; Al-Herz, Waleed; Cruz-Munoz, Mario Ernesto; Schuetz, Catharina; Gennery, Andrew R.; Garabedian, Elizabeth K.; Giliani, Silvia; Draper, Deborah; Dbaibo, Ghassan; Geha, Raif S.; Meyts, Isabelle; Tousseyn, Thomas; Neven, Benedicte; Moshous, Despina; Fischer, Alain; Schulz, Ansgar; Finocchi, Andrea; Kuhns, Douglas B.; Fink, Danielle L.; Lionakis, Michail S.; Swamydas, Muthulekha; Guglielmetti, Simone; Alejo, Julie; Myles, Ian A.; Pittaluga, Stefania; Notarangelo, Luigi D.; Villa, Anna; Cassani, Barbara			Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						RAG; T cells; skin inflammation; erythroderma; immune-mediated disease; cytokines; chemokines; gut-skin axis; LPS; dysbiosis	INTESTINAL BACTERIAL OVERGROWTH; MEMORY T-CELLS; CHEMOKINE RECEPTORS; LYMPHOCYTE ANTIGEN; TH17 CELLS; MANIFESTATIONS; KERATINOCYTES; ERYTHRODERMA; TRAFFICKING; MECHANISMS	Background: Severe early-onset erythroderma and gut inflammation, with massive tissue infiltration of oligoclonal activated T cells are the hallmark of Omenn syndrome (OS). Objective: The impact of altered gut homeostasis in the cutaneous manifestations of OS remains to be clarified. Methods: We analyzed a cohort of 15 patients with OS and the 129Sv/C57BL/6 knock-in Rag2(R229Q/R229Q) (Rag2(R229Q)) mouse model. Homing phenotypes of circulating lymphocytes were analyzed by flow cytometry. Inflammatory cytokines and chemokines were examined in the sera by ELISA and in skin biopsies by immunohistochemistry and in situ RNA hybridization. Experimental colitis was induced in mice by dextran sulfate sodium salt. Results: We show that memory/activated T cells from patients with OS and from the Rag2(R229Q) mouse model of OS abundantly express the skin homing receptors cutaneous lymphocyte associated antigen and CCR4 (Ccr4), associated with high levels of chemokine C-C motif ligands 17 and 22. Serum levels of LPS are also elevated. A broad T(H)1/T(H)2/T(H)17 inflammatory signature is detected in the periphery and in the skin. Increased Tlr4 expression in the skin of Rag2(R229Q) mice is associated with enhanced cutaneous inflammation on local and systemic administration of LPS. Likewise, boosting colitis in Rag2(R229Q) mice results in increased frequency of Ccr4(+) splenic T cells and worsening of skin inflammation, as indicated by epidermal thickening, enhanced epithelial cell activation, and dermal infiltration by T(H)1 effector T cells. Conclusions: These results support the existence of an interplay between gut and skin that can sustain skin inflammation in OS.	[Rigoni, Rosita; Marrella, Veronica; Maina, Virginia; Villa, Anna; Cassani, Barbara] Natl Res Council CNR, Milan Unit, Inst Genet & Biomed Res IRGB, Via Manzoni 113, I-20089 Milan, Italy; [Rigoni, Rosita; Fontana, Elena; Marrella, Veronica; Maina, Virginia; Facoetti, Amanda; Cassani, Barbara] Humanitas Clin & Res Ctr IRCCS, Milan, Italy; [Dobbs, Kerry; Draper, Deborah; Myles, Ian A.; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Taverniti, Valentina; Guglielmetti, Simone] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy; [Facoetti, Amanda] Humanitas Univ, Milan, Italy; [D'Amico, Giovanna] Univ Milano Bicocca, Ctr Ric Tettamanti, Clin Pediat, Monza, Italy; [Al-Herz, Waleed] Kuwait Univ, Fac Med, Dept Pediat, Kuwait, Kuwait; [Al-Herz, Waleed] Al Sabah Hosp, Pediat Dept, Allergy & Clin Immunol Unit, Kuwait, Kuwait; [Cruz-Munoz, Mario Ernesto] Univ Autonoma Estado Morelos, Fac Med, Cuernavaca, Morelos, Mexico; [Schuetz, Catharina] Tech Univ Dresden, Dept Pediat, Med Fak Carl Gustav Carus, Dresden, Germany; [Gennery, Andrew R.] Great North Childrens Hosp, Clin Resource Bldg, Newcastle Upon Tyne, Tyne & Wear, England; [Gennery, Andrew R.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Garabedian, Elizabeth K.] NHGRI, NIH, Bethesda, MD 20892 USA; [Giliani, Silvia] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Giliani, Silvia] Spedali Civili Hosp, A Nocivelli Inst Mol Med, Cytogenet & Med Genet Unit, Brescia, Italy; [Dbaibo, Ghassan] Amer Univ, Dept Pediat & Adolescent Med, Beirut Med Ctr, Beirut, Lebanon; [Geha, Raif S.] Harvard Med Sch, Div Immunol, Boston Childrens Hosp, Boston, MA 02115 USA; [Meyts, Isabelle] Univ Ziekenhuis Leuven, Univ Hosp Leuven, Dept Pediat, Leuven, Belgium; [Meyts, Isabelle] Katholieke Univ Leuven, Dept Immunol Microbiol & Transplantat, Lab Inborn Errors Immun, Leuven, Belgium; [Tousseyn, Thomas] Katholieke Univ Leuven, Dept Imaging & Pathol, Lab Translat Cell & Tissue Res, Leuven, Belgium; [Neven, Benedicte; Moshous, Despina; Fischer, Alain] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Paris, France; [Neven, Benedicte; Moshous, Despina; Fischer, Alain] Necker Children Hosp, AP HP, Pediat Immunohematol Unit, Paris, France; [Schulz, Ansgar] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany; [Finocchi, Andrea] Childrens Hosp Bambino Gesu, Dept Pediat, Rome, Italy; [Kuhns, Douglas B.; Fink, Danielle L.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Neutrophil Monitoring Lab, Frederick, MD USA; [Lionakis, Michail S.; Swamydas, Muthulekha] NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol, Bethesda, MD 20892 USA; [Alejo, Julie; Pittaluga, Stefania] NCI, Lab Pathol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Villa, Anna] IRCCS San Raffaele Sci Inst, Telethon Inst Gene Therapy, Div Regenerat Med Stem Cells & Gene Therapy, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Milan; Humanitas University; University of Milano-Bicocca; Kuwait University; Al Sabah Hospital; Universidad Autonoma del Estado de Morelos; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Brescia; Hospital Spedali Civili Brescia; American University of Beirut; Beirut Medical Center; Harvard University; Boston Children's Hospital; Harvard Medical School; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Ulm University; IRCCS Bambino Gesu; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fondazione Telethon; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Cassani, B (corresponding author), Natl Res Council CNR, Milan Unit, Inst Genet & Biomed Res IRGB, Via Manzoni 113, I-20089 Milan, Italy.; Villa, A (corresponding author), San Raffaele Telethon Inst Gene Therapy SR Tiget, Via Olgettina 60, I-20132 Milan, Italy.; Notarangelo, LD (corresponding author), NIAID, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	luigi.notarangelo2@nih.gov; villa.anna@hsr.it; barbara.cassani@humanitasresearch.it	Marrella, Veronica/ABI-1285-2020; Facoetti, Amanda/ABI-1297-2020; Finocchi, Andrea/K-5926-2016; Lionakis, Michail/J-8840-2017; Dbaibo, Ghassan S./X-2978-2019; Elena, Fontana/K-3845-2016; Guglielmetti, Simone/K-2507-2018	Marrella, Veronica/0000-0003-4035-8106; Facoetti, Amanda/0000-0002-5396-8344; Finocchi, Andrea/0000-0003-0958-8536; Lionakis, Michail/0000-0003-4994-9500; Elena, Fontana/0000-0001-8853-3335; Dobbs, Kerry/0000-0002-3432-3137; Guglielmetti, Simone/0000-0002-8673-8190; D'Amico, Giovanna/0000-0001-7809-7269; Tousseyn, Thomas/0000-0002-0397-1086	Italian Ministry of Health [GR-2011-02349759, PE-2016_02363691]; Italian Fondazione Telethon; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health	Italian Ministry of Health(Ministry of Health, Italy); Italian Fondazione Telethon(Fondazione Telethon); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by grants from the Italian Ministry of Health (GR-2011-02349759 to B. Cassani; PE-2016_02363691 to A. Villa, E. Fontana, and L.D. Notarangelo) and the Italian Fondazione Telethon (TIGET E2 Core grant). L.D. Notarangelo is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Albanesi C, 2001, J LEUKOCYTE BIOL, V70, P617; Andrew DP, 2001, J IMMUNOL, V166, P103, DOI 10.4049/jimmunol.166.1.103; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; Biedermann T, 2002, EUR J IMMUNOL, V32, P3171, DOI 10.1002/1521-4141(200211)32:11<3171::AID-IMMU3171>3.0.CO;2-4; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Di Cesare A, 2008, J INVEST DERMATOL, V128, P2569, DOI 10.1038/jid.2008.283; Elias PM, 2007, SEMIN IMMUNOPATHOL, V29, P3, DOI 10.1007/s00281-007-0060-9; Fierro MT, 2006, DERMATOLOGY, V213, P284, DOI 10.1159/000096191; Forno Erick, 2008, Clin Mol Allergy, V6, P11, DOI 10.1186/1476-7961-6-11; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Hart AL, 2010, INFLAMM BOWEL DIS, V16, P1969, DOI 10.1002/ibd.21304; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Huang BL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00013; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Leffler DA, 2015, NAT REV GASTRO HEPAT, V12, P561, DOI 10.1038/nrgastro.2015.131; Lehman H, 2014, CLIN REV ALLERG IMMU, V46, P112, DOI 10.1007/s12016-013-8377-8; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Lonsdorf AS, 2009, J INVEST DERMATOL, V129, P2552, DOI 10.1038/jid.2009.122; Maina V, 2013, J LEUKOCYTE BIOL, V94, P1221, DOI 10.1189/jlb.0713365; Marrella V, 2007, J CLIN INVEST, V117, P1260, DOI 10.1172/JCI30928; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Mora JR, 2006, CURR TOP MICROBIOL, V308, P83; Myles IA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86955; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; NESTLE FO, 1994, J CLIN INVEST, V94, P202, DOI 10.1172/JCI117308; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nizza ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091054; Notarangelo LD, 2016, NAT REV IMMUNOL, V16, P234, DOI 10.1038/nri.2016.28; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Orange Jordan S, 2005, Pediatr Crit Care Med, V6, pS99, DOI 10.1097/01.PCC.0000164488.19810.DB; Oyoshi MK, 2011, J CLIN INVEST, V121, P2210, DOI 10.1172/JCI43586; Parodi A, 2008, CLIN GASTROENTEROL H, V6, P759, DOI 10.1016/j.cgh.2008.02.054; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Randolph GJ, 2017, ANNU REV IMMUNOL, V35, P31, DOI 10.1146/annurev-immunol-041015-055354; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Rigoni R, 2016, GUT MICROBES, V7, P503, DOI 10.1080/19490976.2016.1228517; Rigoni R, 2016, J EXP MED, V213, P355, DOI 10.1084/jem.20151116; Scheimberg I, 2001, PEDIATR DEVEL PATHOL, V4, P237, DOI 10.1007/s100240010171; Schwarz A, 2017, J INVEST DERMATOL, V137, P855, DOI 10.1016/j.jid.2016.11.014; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smith PD, 2013, SOC MUCOSAL IMMUNOLO; Song PI, 2002, J INVEST DERMATOL, V119, P424, DOI 10.1046/j.1523-1747.2002.01847.x; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Subramaniam JM, 2012, DRUGS, V72, P1293, DOI 10.2165/11631090-000000000-00000; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Weinstock LB, 2013, J AM ACAD DERMATOL, V68, P875, DOI 10.1016/j.jaad.2012.11.038; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424; Zhang L.Y., 2019, NAT COMMUN, V10, P1, DOI DOI 10.1007/s00294019-00994-8	57	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					1165	+		10.1016/j.jaci.2020.04.005	http://dx.doi.org/10.1016/j.jaci.2020.04.005			26	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	32311393	hybrid, Green Published			2022-12-18	WOS:000588153700019
J	Thomas, ZRM; Leuppi-Taegtmeyer, A; Jamiolkowski, D; Steveling-Klein, E; Bellutti-Enders, F; Hofmeier, KS; Hartmann, K				Thomas, Zita-Rose Manjaly; Leuppi-Taegtmeyer, Anne; Jamiolkowski, Dagmar; Steveling-Klein, Esther; Bellutti-Enders, Felicitas; Hofmeier, Kathrin Scherer; Hartmann, Karin			Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Acute respiratory syndrome; adverse drug reactions; coronavirus; COVID-19; drug allergy; drug hypersensitivity; remdesivir; SARS-CoV-2			[Thomas, Zita-Rose Manjaly; Steveling-Klein, Esther; Hofmeier, Kathrin Scherer; Hartmann, Karin] Univ Hosp Basel, Dept Dermatol, Div Allergy, Basel, Switzerland; [Thomas, Zita-Rose Manjaly; Jamiolkowski, Dagmar; Steveling-Klein, Esther; Bellutti-Enders, Felicitas; Hofmeier, Kathrin Scherer; Hartmann, Karin] Univ Hosp Basel, Dept Biomed, Basel, Switzerland; Univ Basel, Basel, Switzerland; [Leuppi-Taegtmeyer, Anne] Univ Hosp Basel, Dept Clin Pharmacol & Toxicol, Reg Pharmacovigilance Ctr, Basel, Switzerland; [Leuppi-Taegtmeyer, Anne] Univ Hosp Basel, Dept Pharmaceut Sci, Basel, Switzerland; [Jamiolkowski, Dagmar] Univ Hosp Basel, Dept Dermatol, Basel, Switzerland; [Bellutti-Enders, Felicitas] Univ Childrens Hosp Basel, Allergy Unit, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Hartmann, K (corresponding author), Univ Basel, Dept Dermatol, Div Allergy, Petersgraben 4, CH-4031 Basel, Switzerland.	karin.hartmann@usb.ch	Hartmann, Karin/N-4865-2015	Hartmann, Karin/0000-0002-4595-8226; Scherer, Kathrin/0000-0002-5235-2556				Fernandez-Nieto D, 2020, J AM ACAD DERMATOL, V83, pE61, DOI 10.1016/j.jaad.2020.04.093; Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163; Hedou M, 2020, J EUR ACAD DERMATOL, V34, pE299, DOI 10.1111/jdv.16519; Lagziel T, 2020, CUREUS, V12, DOI 10.7759/cureus.8198; Pichler WJ, 2019, ALLERGY, V74, P1457, DOI 10.1111/all.13765; Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; Torres-Navarro I, 2020, J EUR ACAD DERMATOL, V34, pE537, DOI 10.1111/jdv.16664; Uppsala Monitoring Centre, WHO COLL CTR INT DRU; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X	10	9	9	2	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2020	146	4					786	789		10.1016/j.jaci.2020.07.008	http://dx.doi.org/10.1016/j.jaci.2020.07.008			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OH2JO	32710973	Bronze, Green Published			2022-12-18	WOS:000582395800008
J	Chen, CL; Yao, Y; Pan, L; Hu, ST; Ma, J; Wang, ZC; Kern, RC; Schleimer, RP; Liu, Z				Chen, Cai-Ling; Yao, Yin; Pan, Li; Hu, Si-Tao; Ma, Jin; Wang, Zhi-Chao; Kern, Robert C.; Schleimer, Robert P.; Liu, Zheng			Common fibrin deposition and tissue plasminogen activator downregulation in nasal polyps with distinct inflammatory endotypes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CHRONIC RHINOSINUSITIS		[Chen, Cai-Ling; Yao, Yin; Pan, Li; Hu, Si-Tao; Ma, Jin; Wang, Zhi-Chao; Liu, Zheng] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Otolaryngol Head & Neck Surg, Tongji Med Coll, Wuhan, Peoples R China; [Kern, Robert C.] Northwestern Univ, Feinberg Sch Med, Deprtment Otolaryngol, Chicago, IL 60611 USA; [Schleimer, Robert P.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL 60611 USA	Huazhong University of Science & Technology; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Liu, Z (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Otolaryngol Head & Neck Surg, Tongji Med Coll, Wuhan, Peoples R China.	zhengliuent@hotmail.com		Yin, Yao/0000-0002-5833-5263; Liu, Zheng/0000-0002-4168-6702	National Natural Science Foundation of China [81630024, 81570899, 8192010801]; Hubei Province Natural Science Foundation [2017CFA016]; National Key RAMP;D Program of China [2018YFC0116805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Natural Science Foundation(Natural Science Foundation of Hubei Province); National Key RAMP;D Program of China	Supported by the National Natural Science Foundation of China (grants 81630024, 81570899, and 8192010801 [to Z.L.]), Hubei Province Natural Science Foundation (grant 2017CFA016 [to Z.L.]), the National Key R&D Program of China (grant 2018YFC0116805 [to Z.L.]).	Al-Afif A, 2015, J ALLERGY CLIN IMMUN, V136, P1346, DOI 10.1016/j.jaci.2015.01.042; Bachert C, 2000, AM J RHINOL, V14, P279, DOI 10.2500/105065800781329573; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Enoksson M, 2011, J INNATE IMMUN, V3, P142, DOI 10.1159/000321933; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Imoto Y, 2019, J ALLERGY CLIN IMMUN, V144, P1566, DOI 10.1016/j.jaci.2019.08.040; Portales-Cervantes L, 2017, J INNATE IMMUN, V9, P94, DOI 10.1159/000450576; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Shimizu S, 2011, AM J RHINOL ALLERGY, V25, P7, DOI 10.2500/ajra.2011.25.3535; Slaine PD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050272; Takabayashi T, 2017, ALLERGOL INT, V66, P594, DOI 10.1016/j.alit.2017.03.007; Takabayashi T, 2013, AM J RESP CRIT CARE, V187, P49, DOI 10.1164/rccm.201207-1292OC; Tan BK, 2017, J ALLERGY CLIN IMMUN, V139, P699, DOI 10.1016/j.jaci.2016.06.063; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041	14	9	9	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2020	146	3					677	+		10.1016/j.jaci.2020.02.010	http://dx.doi.org/10.1016/j.jaci.2020.02.010			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NN7PN	32112792	Green Accepted, Bronze			2022-12-18	WOS:000568978400006
J	Chou, J; Alazami, AM; Jaber, F; Hoyos-Bachiloglu, R; Jones, J; Weeks, S; Alosaimi, MF; Bainter, W; Cangemi, B; Badran, YR; Mohammed, R; Alroqi, F; Almutairi, A; Al-Onazi, N; AlAjaji, S; Al-Saud, B; Arnaout, R; Elkins, M; Devana, S; Imperial, J; Li, B; Drexhage, L; Rahman, AMA; Jacob, M; Haddad, H; Hanna-Wakim, R; Dbaibo, G; Massaad, MJ; Dasouki, M; Mikhael, R; Baz, Z; Geha, RS; Al-Mousa, H				Chou, Janet; Alazami, Anas M.; Jaber, Faris; Hoyos-Bachiloglu, Rodrigo; Jones, Jennifer; Weeks, Sabrina; Alosaimi, Mohammed F.; Bainter, Wayne; Cangemi, Brittney; Badran, Yousef R.; Mohammed, Reem; Alroqi, Fayhan; Almutairi, Abduarahman; Al-Onazi, Noufa; AlAjaji, Sulaiman; Al-Saud, Bander; Arnaout, Rand; Elkins, Megan; Devana, Sridevi; Imperial, Juliet; Li, Betty; Drexhage, Linnea; Rahman, Anas M. Abdel; Jacob, Minnie; Haddad, Hadi; Hanna-Wakim, Rima; Dbaibo, Ghassan; Massaad, Michel J.; Dasouki, Majed; Mikhael, Raymond; Baz, Zeina; Geha, Raif S.; Al-Mousa, Hamoud			Hypomorphic variants in AK2 reveal the contribution of mitochondrial function to B-cell activation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						AK2; adenylate kinase 2; hypogammaglobulinemia; mitochondria; oxidative phosphorylation; primary immunodeficiencies; B cells; common variable immunodeficiency	ADENYLATE KINASE; METABOLISM; MOTIONS	Background: The gene AK2 encodes the phosphotransferase adenylate kinase 2 (AK2). Human variants in AK2 cause reticular dysgenesis, a severe combined immunodeficiency with agranulocytosis, lymphopenia, and sensorineural deafness that requires hematopoietic stem cell transplantation for survival. Objective: We investigated the mechanisms underlying recurrent sinopulmonary infections and hypogammaglobulinemia in 15 patients, ranging from 3 to 34 years of age, from 9 kindreds. Only 2 patients, both of whom had mildly impaired T-cell proliferation, each had a single clinically significant opportunistic infection. Methods: Patient cells were studied with next-generation DNA sequencing, tandem mass spectrometry, and assays of lymphocyte and mitochondrial function. Results: We identified 2 different homozygous variants in AK2. AK2(G100S) and AK2(A182D) permit residual protein expression, enzymatic activity, and normal numbers of neutrophils and lymphocytes. All but 1 patient had intact hearing. The patients' B cells had severely impaired proliferation and in vitro immunoglobulin secretion. With activation, the patients' B cells exhibited defective mitochondrial respiration and impaired regulation of mitochondrial membrane potential and quality. Although activated T cells from the patients with opportunistic infections demonstrated impaired mitochondrial function, the mitochondrial quality in T cells was preserved. Consistent with the capacity of activated T cells to utilize nonmitochondrial metabolism, these findings revealed a less strict cellular dependence of T-cell function on AK2 activity. Chemical inhibition of ATP synthesis in control T and B cells similarly demonstrated the greater dependency of B cells on mitochondrial function. Conclusions: Our patients demonstrate the in vivo sequelae of the cell-specific requirements for the functions of AK2 and mitochondria, particularly in B-cell activation and antibody production.	[Chou, Janet; Jaber, Faris; Hoyos-Bachiloglu, Rodrigo; Jones, Jennifer; Weeks, Sabrina; Alosaimi, Mohammed F.; Bainter, Wayne; Cangemi, Brittney; Badran, Yousef R.; Almutairi, Abduarahman; Elkins, Megan; Drexhage, Linnea; Massaad, Michel J.; Geha, Raif S.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Devana, Sridevi; Imperial, Juliet; Li, Betty] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Alazami, Anas M.; Rahman, Anas M. Abdel; Jacob, Minnie; Dasouki, Majed; Al-Mousa, Hamoud] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Mohammed, Reem; Al-Saud, Bander; Arnaout, Rand; Al-Mousa, Hamoud] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Allergy & Immunol Sect, Riyadh, Saudi Arabia; [Alosaimi, Mohammed F.] King Saud Univ, Dept Pediat, Riyadh, Saudi Arabia; [Alroqi, Fayhan; AlAjaji, Sulaiman] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Al-Onazi, Noufa] Prince Sultan Mil Med City, Dept Pediat, Riyadh, Saudi Arabia; [Rahman, Anas M. Abdel; Al-Mousa, Hamoud] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Rahman, Anas M. Abdel] Mem Univ Newfoundland, Dept Chem, St John, NF, Canada; [Jacob, Minnie] James Cook Univ, Dept Mol & Cell Biol, Div Trop Hlth, Townsville, Qld, Australia; [Haddad, Hadi] Lebanese Amer Univ, Med Ctr, Rizk Hosp, Beirut, Lebanon; [Hanna-Wakim, Rima; Dbaibo, Ghassan] Amer Univ Beirut, Div Pediat Infect Dis, Beirut, Lebanon; [Mikhael, Raymond] St Joseph Univ, Hotel Dieu France Univ Hosp, Dept Pediat, Beirut, Lebanon; [Baz, Zeina] St George Hosp, Univ Med Ctr, Beirut, Lebanon; [Massaad, Michel J.] Amer Univ Beirut, Fac Med, Beirut, Lebanon	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Prince Sultan Military Medical City; Alfaisal University; Memorial University Newfoundland; James Cook University; Lebanese American University; American University of Beirut; American University of Beirut; American University of Beirut	Chou, J (corresponding author), Boston Childrens Hosp, 1 Blackfan Circle,Karp 10127, Boston, MA 02115 USA.	Janet.Chou@childrens.harvard.edu	Dbaibo, Ghassan S./X-2978-2019; Alosaimi, Mohammed F/AAY-5814-2021; Abdel Rahman, Anas/AEC-1515-2022	Alosaimi, Mohammed F/0000-0002-8025-3491; Abdel Rahman, Anas/0000-0002-9527-9424; Jaber, Faris/0000-0002-8483-6934; Drexhage, Linnea Zoe/0000-0001-7679-4466; Mohammed, Reem Walid/0000-0002-5166-438X	Perkin Fund [5K08AI116979-04, 1R01AI139633-01]; National Science, Technology and Innovation Plan program of Saudi Arabia [KACST 13-BIO-755-2]; Saudi Human Genome Program	Perkin Fund; National Science, Technology and Innovation Plan program of Saudi Arabia; Saudi Human Genome Program	Supported by grant 5K08AI116979-04 (to J.C.), grant 1R01AI139633-01 (to R.S.G.), the Perkin Fund (to R.S.G.), the National Science, Technology and Innovation Plan program of Saudi Arabia (grant KACST 13-BIO-755-2 to M.J.D. and H.A.A.), and the Saudi Human Genome Program.	Al-Mousa H, 2016, J ALLERGY CLIN IMMUN, V137, P1780, DOI 10.1016/j.jaci.2015.12.1310; Alosaimi MF, 2019, J ALLERGY CLIN IMMUN, V144, P306, DOI 10.1016/j.jaci.2019.02.020; Ashmore J, 2002, BRIT MED BULL, V63, P59, DOI 10.1093/bmb/63.1.59; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/NCHEMBIO.610, 10.1038/nchembio.610]; Castagnoli R, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00295; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; CHOU JTY, 1971, ARCH KLIN EXP OHR, V200, P300, DOI 10.1007/BF00373312; Daily MD, 2010, J MOL BIOL, V400, P618, DOI 10.1016/j.jmb.2010.05.015; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Henderson LA, 2013, J ALLERGY CLIN IMMUN, V131, P1227, DOI 10.1016/j.jaci.2012.07.045; Hoenig M, 2017, BLOOD, V129, P2928, DOI 10.1182/blood-2016-11-745638; Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; Marsh RA, 2018, J ALLERGY CLIN IMMUN, V142, P2004, DOI 10.1016/j.jaci.2018.08.010; McFadden K, 2016, P NATL ACAD SCI USA, V113, pE782, DOI 10.1073/pnas.1517141113; Menk AV, 2018, CELL REP, V22, P1509, DOI 10.1016/j.celrep.2018.01.040; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Nicholas DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176793; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Price MJ, 2018, CELL REP, V23, P3152, DOI 10.1016/j.celrep.2018.05.053; Rissone A, 2015, J EXP MED, V212, P1185, DOI 10.1084/jem.20141286; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Six E, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.211; Swan DJ, 2019, HAEMATOLOGICA, V104, pE483, DOI 10.3324/haematol.2018.208397; Tanimura A, 2018, CELL PHYSIOL BIOCHEM, V47, P1936, DOI 10.1159/000491464; Tanimura A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089916; Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005	32	9	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2020	146	1					192	202		10.1016/j.jaci.2019.12.004	http://dx.doi.org/10.1016/j.jaci.2019.12.004			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OC5BB	31862378	Bronze			2022-12-18	WOS:000579170500028
J	Matsumoto, K; Iikura, K; Morita, H; Saito, H				Matsumoto, Kenji; Iikura, Katsuhito; Morita, Hideaki; Saito, Hirohisa			Barrier dysfunction in the atopic march-how does atopic dermatitis lead to asthma in children?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Atopic dermatitis; asthma; antiviral IFNs; atopic march	INFECTIONS; ASSOCIATION		[Matsumoto, Kenji; Morita, Hideaki; Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan; [Iikura, Katsuhito] Natl Hosp Org Nishisaitama Chuo Natl Hosp, Dept Pediat, Saitama, Japan	National Center for Child Health & Development - Japan	Matsumoto, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	Matsumoto-k@ncchd.go.jp	Morita, Hideaki/S-2214-2016; Morita, Hideaki/ADL-2008-2022	Morita, Hideaki/0000-0003-0928-8322; Saito, Hirohisa/0000-0002-6630-8337	National Center for Child Health and Development, Japan [2020B-4]	National Center for Child Health and Development, Japan	This work was supported in part by a grant from the National Center for Child Health and Development, Japan (grant no. 2020B-4 to K.M.).	Bonnelykke K, 2015, J ALLERGY CLIN IMMUN, V136, P81, DOI 10.1016/j.jaci.2015.02.024; Castro-Rodriguez JA, 2010, J ALLERGY CLIN IMMUN, V126, P212, DOI 10.1016/j.jaci.2010.06.032; Edwards MR, 2017, J ALLERGY CLIN IMMUN, V140, P909, DOI 10.1016/j.jaci.2017.07.025; Gill MA, 2018, J ALLERGY CLIN IMMUN, V141, P1735, DOI 10.1016/j.jaci.2017.07.035; Guttman-Yassky E, 2019, J ALLERGY CLIN IMMUN, V144, P362, DOI 10.1016/j.jaci.2019.03.021; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Lynch JP, 2016, J ALLERGY CLIN IMMUN, V138, P1326, DOI 10.1016/j.jaci.2016.02.039; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Strom MA, 2017, BRIT J DERMATOL, V176, P495, DOI 10.1111/bjd.14708; Wu Q, 2013, VIROLOGY, V446, P199, DOI 10.1016/j.virol.2013.08.005	10	9	9	3	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2020	145	6					1551	1553		10.1016/j.jaci.2020.04.014	http://dx.doi.org/10.1016/j.jaci.2020.04.014			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LW4ZZ	32344057	Bronze			2022-12-18	WOS:000539157800007
J	Park, HK; Choi, Y; Lee, DH; Kim, S; Lee, JM; Choi, SW; Lee, HR; Rho, M; Park, HS				Park, Han-Ki; Choi, Youngwoo; Lee, Dong-Hyun; Kim, Sujeong; Lee, Jong-Myung; Choi, Sae Won; Lee, Hee-Ra; Rho, Mina; Park, Hae-Sim			Altered gut microbiota by azithromycin attenuates airway inflammation in allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ANTIBIOTICS; LIFE		[Park, Han-Ki; Kim, Sujeong; Lee, Jong-Myung] Kyungpook Natl Univ, Sch Med, Dept Allergy & Clin Immunol, Daegu, South Korea; [Choi, Youngwoo; Lee, Dong-Hyun; Park, Hae-Sim] Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon, South Korea; [Choi, Sae Won] Seoul Natl Univ Hosp, Off Hosp Informat, Seoul, South Korea; [Lee, Hee-Ra] MD Healthcare Inc, Seoul, South Korea; [Rho, Mina] Hanyang Univ, Dept Comp Sci & Engn, Seoul, South Korea	Kyungpook National University; Ajou University; Seoul National University (SNU); Seoul National University Hospital; Hanyang University	Park, HS (corresponding author), Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon, South Korea.	hspark@ajou.ac.kr	Park, Han-Ki/AAY-3102-2020	Park, Hae-Sim/0000-0003-2614-0303; Park, Han-Ki/0000-0002-5460-9917	Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea [HI16C0992]; Basic Science Research Program through the National Research Foundation, Republic of Korea - Ministry of Education [2018R1D1A1B07050941]	Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation, Republic of Korea - Ministry of Education	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (grant no. HI16C0992). This research was also supported by the Basic Science Research Program through the National Research Foundation, Republic of Korea funded by the Ministry of Education (grant no. 2018R1D1A1B07050941).	Gibson PG, 2017, LANCET, V390, P659, DOI 10.1016/S0140-6736(17)31281-3; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Ianiro G, 2016, GUT, V65, P1906, DOI 10.1136/gutjnl-2016-312297; Kim DH, 2018, ALLERGY ASTHMA IMMUN, V10, P457, DOI 10.4168/aair.2018.10.5.457; Ottman N, 2019, J ALLERGY CLIN IMMUN, V143, P1198, DOI 10.1016/j.jaci.2018.06.024; Qian L, 2019, ALLERGOL IMMUNOPATH, V47, P2, DOI 10.1016/j.aller.2018.05.004; Roduit C, 2019, ALLERGY, V74, P799, DOI 10.1111/all.13660; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Theiler A, 2019, J ALLERGY CLIN IMMUN, V144, P764, DOI 10.1016/j.jaci.2019.05.002	9	9	9	4	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1466	+		10.1016/j.jaci.2020.01.044	http://dx.doi.org/10.1016/j.jaci.2020.01.044			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	32035985	Bronze			2022-12-18	WOS:000531063400019
J	Borek, I; Koffel, R; Feichtinger, J; Spies, M; Glitzner-Zeis, E; Hochgerner, M; Sconocchia, T; Krump, C; Tam-Amersdorfer, C; Passegger, C; Benezeder, T; Tittes, J; Redl, A; Painsi, C; Thallinger, GG; Wolf, P; Stary, G; Sibilia, M; Strobl, H				Borek, Izabela; Koeffel, Rene; Feichtinger, Julia; Spies, Melanie; Glitzner-Zeis, Elisabeth; Hochgerner, Mathias; Sconocchia, Tommaso; Krump, Corinna; Tam-Amersdorfer, Carmen; Passegger, Christina; Benezeder, Theresa; Tittes, Julia; Redl, Anna; Painsi, Clemens; Thallinger, Gerhard G.; Wolf, Peter; Stary, Georg; Sibilia, Maria; Strobl, Herbert			BMP7 aberrantly induced in the psoriatic epidermis instructs inflammation-associated Langerhans cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						BMP7; Langerhans cells; psoriasis; TGF-beta signaling	DENDRITIC CELLS; TGF-BETA; STEADY-STATE; AUTOCRINE/PARACRINE TGF-BETA-1; SKIN-RESIDENT; NOTCH LIGAND; EXPRESSION; RECEPTORS; MAINTAIN; ACTIVATION	Background: Epidermal hyperplasia represents a morphologic hallmark of psoriatic skin lesions. Langerhans cells (LCs) in the psoriatic epidermis engage with keratinocytes (KCs) in tight physical interactions; moreover, they induce T-cell-mediated immune responses critical to psoriasis. Objective: This study sought to improve the understanding of epidermal factors in psoriasis pathogenesis. Methods: BMP7-LCs versus TGF-beta 1-LCs were phenotypically characterized and their functional properties were analyzed using flow cytometry, cell kinetic studies, co-culture with CD4 T cells, and cytokine measurements. Furthermore, immunohistology of healthy and psoriatic skin was performed. Additionally, in vivo experiments with Jun(f/f) JunB(f/f) K5cre-ERT mice were carried out to assess the role of bone morphogenetic protein (BMP) signaling in psoriatic skin inflammation. Results: This study identified a KC-derived signal (ie, BMP signaling) to promote epidermal changes in psoriasis. Whereas BMP7 is strictly confined to the basal KC layer in the healthy skin, it is expressed at high levels throughout the lesional psoriatic epidermis. BMP7 instructs precursor cells to differentiate into LCs that phenotypically resemble psoriatic LCs. These BMP7-LCs exhibit proliferative activity and increased sensitivity to bacterial stimulation. Moreover, aberrant high BMP signaling in the lesional epidermis is mediated by a KC intrinsic mechanism, as suggested from murine data and clinical outcome after topical antipsoriatic treatment in human patients. Conclusions: These data indicate that available TGF-beta family members within the lesional psoriatic epidermis preferentially signal through the canonical BMP signaling cascade to instruct inflammatory-type LCs and to promote psoriatic epidermal changes. Targeting BMP signaling might allow to therapeutically interfere with cutaneous psoriatic manifestations.	[Borek, Izabela; Spies, Melanie; Sconocchia, Tommaso; Krump, Corinna; Tam-Amersdorfer, Carmen; Passegger, Christina; Strobl, Herbert] Med Univ Graz, Chair Immunol & Pathophysiol, Otto Loewi Res Ctr, Heinrichstr 31a, A-8010 Graz, Austria; [Koeffel, Rene] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Div Cell Biol Histol & Embryol, Graz, Austria; [Feichtinger, Julia] Med Univ Graz, Dept Dermatol, Graz, Austria; [Glitzner-Zeis, Elisabeth; Hochgerner, Mathias; Sibilia, Maria] Univ Bern, Inst Anat, Bern, Switzerland; [Benezeder, Theresa; Wolf, Peter] Med Univ Vienna, Dept Internal Med 1, Inst Canc Res, Vienna, Austria; [Tittes, Julia; Redl, Anna; Stary, Georg] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Painsi, Clemens] State Hosp Klagenfurt, Dept Dermatol, Klagenfurt, Austria; [Thallinger, Gerhard G.] Graz Univ Technol, Inst Computat Biotechnol, Graz, Austria; [Thallinger, Gerhard G.] Omics Ctr Graz, BioTechMed Graz, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Bern; Medical University of Vienna; Medical University of Vienna; Graz University of Technology	Strobl, H (corresponding author), Med Univ Graz, Chair Immunol & Pathophysiol, Otto Loewi Res Ctr, Heinrichstr 31a, A-8010 Graz, Austria.	herbert.strobl@medunigraz.at	Sconocchia, Tommaso/ABB-8372-2020; Köffel, René/ABI-2028-2020; Sconocchia, Tommaso/ABD-3570-2020; Stary, Georg/M-8978-2014	Sconocchia, Tommaso/0000-0001-8735-7958; Köffel, René/0000-0001-9477-4282; Sconocchia, Tommaso/0000-0001-8735-7958; Benezeder, Theresa/0000-0001-6218-2792; Borek, Izabela/0000-0002-2527-6199; Sibilia, Maria/0000-0001-6129-5613; Stary, Georg/0000-0003-1746-4250; Strobl, Herbert/0000-0002-8070-4977; Glitzner, Elisabeth/0000-0002-1541-4076; Feichtinger, Julia/0000-0002-3667-5857; Tam-Amersdorfer, Carmen/0000-0003-3123-6342	Austrian Science Fund FWF (Fonds zur F_orderung der Wissenschaftlichen Forschung) [W1241]; Medical University of Graz through the PhD Program Molecular Fundamentals of Inflammation (DK-MOLIN, Doktoratskolleg Molecular Fundamentals of Inflammation); FWF PhD program [W1212]; FWF [W1212, P2572]; BioTechMed Graz; Austrian Ministry of Science, Research and Economy (HSRSM); Austrian Ministry of Science, Research and Economy (Omics Center Graz)	Austrian Science Fund FWF (Fonds zur F_orderung der Wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Medical University of Graz through the PhD Program Molecular Fundamentals of Inflammation (DK-MOLIN, Doktoratskolleg Molecular Fundamentals of Inflammation); FWF PhD program; FWF(Austrian Science Fund (FWF)); BioTechMed Graz; Austrian Ministry of Science, Research and Economy (HSRSM); Austrian Ministry of Science, Research and Economy (Omics Center Graz)	This work was supported by the Austrian Science Fund FWF (Fonds zur F_orderung der Wissenschaftlichen Forschung; W1241) and the Medical University of Graz through the PhD Program Molecular Fundamentals of Inflammation (DK-MOLIN, Doktoratskolleg Molecular Fundamentals of Inflammation, to H.S.). Additional funding was obtained by FWF PhD program W1212 (to H.S.), FWF project P2572 (to H.S.), BioTechMed Graz (project ``secretome,'' to H.S.), and by the Austrian Ministry of Science, Research and Economy (HSRSM, Hochschulraum Strukturmittel, grant Omics Center Graz, to G.G.T.).	Aliahmadi E, 2009, EUR J IMMUNOL, V39, P1221, DOI 10.1002/eji.200838742; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Capucha T, 2018, J EXP MED, V215, P481, DOI 10.1084/jem.20171508; Capucha T, 2015, IMMUNITY, V43, P369, DOI 10.1016/j.immuni.2015.06.017; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Caux C, 1999, J LEUKOCYTE BIOL, V66, P781, DOI 10.1002/jlb.66.5.781; Chopin M, 2013, J EXP MED, V210, P2967, DOI 10.1084/jem.20130930; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Di Fusco D, 2017, BRIT J DERMATOL, V177, P1633, DOI 10.1111/bjd.15703; Dijkstra D, 2008, J INVEST DERMATOL, V128, P1696, DOI 10.1038/sj.jid.5701250; Doi H, 2003, J DERMATOL SCI, V33, P7, DOI 10.1016/S0923-1811(03)00107-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eidsmo L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00300; Flacher V, 2006, J IMMUNOL, V177, P7959, DOI 10.4049/jimmunol.177.11.7959; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Glitzner E, 2014, EMBO MOL MED, V6, P1312, DOI 10.15252/emmm.201404114; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guttman-Yassky E, 2019, J ALLERGY CLIN IMMUN, VS0091-6749, P30474; Hatakeyama M, 2017, J IMMUNOL, V199, P2937, DOI 10.4049/jimmunol.1601681; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Holstein J, 2017, J DERMATOL SCI, V87, P236, DOI 10.1016/j.jdermsci.2017.06.007; Hoshino N, 2005, J LEUKOCYTE BIOL, V78, P921, DOI 10.1189/jlb.1204746; Hovav AH, 2018, TRENDS IMMUNOL, V39, P788, DOI 10.1016/j.it.2018.08.007; Jiang M, 2017, J INVEST DERMATOL, V137, P2177, DOI 10.1016/j.jid.2017.06.005; Jiang S, 2016, J IMMUNOL, V196, P3834, DOI 10.4049/jimmunol.1502599; Jurkin J, 2017, J ALLERGY CLIN IMMUN, V139, P1873, DOI 10.1016/j.jaci.2016.09.018; Kanitakis J, 2011, EXP DERMATOL, V20, P145, DOI 10.1111/j.1600-0625.2010.01146.x; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kel JM, 2010, J IMMUNOL, V185, P3248, DOI 10.4049/jimmunol.1000981; Kim JH, 2016, NAT IMMUNOL, V17, P1159, DOI 10.1038/ni.3523; Kitashima DY, 2018, EBIOMEDICINE, V27, P293, DOI 10.1016/j.ebiom.2017.12.022; Korenfeld D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96101; Larregina AT, 2001, NAT IMMUNOL, V2, P1151, DOI 10.1038/ni731; Lee J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11278; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Luo YC, 2014, P NATL ACAD SCI USA, V111, P15178, DOI 10.1073/pnas.1416714111; Martinez-Cingolani C, 2014, BLOOD, V124, P2411, DOI 10.1182/blood-2014-04-568311; Martini E, 2017, J INVEST DERMATOL, V137, P865, DOI 10.1016/j.jid.2016.11.033; Mc Dermott R, 2002, MOL BIOL CELL, V13, P317, DOI 10.1091/mbc.01-06-0300; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Mende I, 2006, BLOOD, V107, P1383, DOI 10.1182/blood-2005-05-1878; Milne P, 2015, BLOOD, V125, P470, DOI 10.1182/blood-2014-08-593582; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nagashima H, 2019, CURR TOP MICROBIOL, V421, P139, DOI 10.1007/978-3-030-15138-6_6; Novak N, 2002, J INVEST DERMATOL, V119, P842, DOI 10.1046/j.1523-1747.2002.00102.x; Oosting M, 2014, P NATL ACAD SCI USA, V111, pE4478, DOI 10.1073/pnas.1410293111; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Peiser M, 2008, J LEUKOCYTE BIOL, V83, P1118, DOI 10.1189/jlb.0807567; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Platzer B, 2004, BLOOD, V104, P3655, DOI 10.1182/blood-2004-02-0412; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schuster C, 2014, DEVELOPMENT, V141, P807, DOI 10.1242/dev.102699; Schuster C, 2009, J EXP MED, V206, P169, DOI 10.1084/jem.20081747; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sere K, 2012, IMMUNITY, V37, P905, DOI 10.1016/j.immuni.2012.07.019; Singh TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13581; Stockl J, 1999, J CLIN INVEST, V104, P957, DOI 10.1172/JCI7255; Strobl H, 1996, J IMMUNOL, V157, P1499; Strobl H, 2018, SEMIN CELL DEV BIOL, VS1084-9521, P30350; Terhorst D, 2015, J IMMUNOL, V195, P4953, DOI 10.4049/jimmunol.1500551; van der Aar AMG, 2007, J IMMUNOL, V178, P1986, DOI 10.4049/jimmunol.178.4.1986; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; WatayaKaneda M, 1996, J DERMATOL SCI, V11, P183, DOI 10.1016/0923-1811(95)00438-6; Wollenberg A, 2002, J INVEST DERMATOL, V118, P327, DOI 10.1046/j.0022-202x.2001.01665.x; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Yasmin N, 2013, J EXP MED, V210, P2597, DOI 10.1084/jem.20130275; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963	73	9	9	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1194	+		10.1016/j.jaci.2019.12.011	http://dx.doi.org/10.1016/j.jaci.2019.12.011			25	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	31870764	Green Published, Bronze			2022-12-18	WOS:000523633400016
J	Mauracher, AA; Eekels, JJM; Woytschak, J; van Drogen, A; Bosch, A; Prader, S; Felber, M; Heeg, M; Opitz, L; Truck, J; Schroeder, S; Adank, E; Klocperk, A; Haralambieva, E; Zimmermann, D; Tantou, S; Kotsonis, K; Stergiou, A; Kanariou, MG; Ehl, S; Boyman, O; Sediva, A; Renella, R; Schmugge, M; Vavassori, S; Schmid, JP				Mauracher, Andrea A.; Eekels, Julia J. M.; Woytschak, Janine; van Drogen, Audrey; Bosch, Alessandra; Prader, Seraina; Felber, Matthias; Heeg, Maximillian; Opitz, Lennart; Trueck, Johannes; Schroeder, Silke; Adank, Eva; Klocperk, Adam; Haralambieva, Eugenia; Zimmermann, Dieter; Tantou, Sofia; Kotsonis, Kosmas; Stergiou, Aikaterini; Kanariou, Maria G.; Ehl, Stephan; Boyman, Onur; Sediva, Anna; Renella, Raffaele; Schmugge, Markus; Vavassori, Stefano; Schmid, Jana Pachlopnik			Erythropoiesis defect observed in STAT3 GOF patients with severe anemia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MULTIPLE IMPUTATION		[Mauracher, Andrea A.; Prader, Seraina; Felber, Matthias; Opitz, Lennart; Trueck, Johannes; Vavassori, Stefano; Schmid, Jana Pachlopnik] Univ Childrens Hosp Zurich, Div Immunol, Zurich, Switzerland; [Mauracher, Andrea A.; Prader, Seraina; Felber, Matthias; Opitz, Lennart; Trueck, Johannes; Vavassori, Stefano; Schmid, Jana Pachlopnik] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Eekels, Julia J. M.; Bosch, Alessandra; Felber, Matthias; Schmugge, Markus] Univ Childrens Hosp Zurich, Div Haematol, Zurich, Switzerland; [Woytschak, Janine; Boyman, Onur] Univ Zurich, Univ Hosp Zurich, Dept Immunol, Zurich, Switzerland; [van Drogen, Audrey] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Heeg, Maximillian; Ehl, Stephan] Univ Med Ctr, Inst Immunodeficiency, Freiburg, Germany; [Heeg, Maximillian; Ehl, Stephan] Univ Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Opitz, Lennart] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Trueck, Johannes; Schmid, Jana Pachlopnik] Univ Zurich, Zurich, Switzerland; [Schroeder, Silke; Adank, Eva] Univ Childrens Hosp Zurich, Div Rheumatol, Zurich, Switzerland; [Klocperk, Adam] Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic; [Klocperk, Adam] Univ Hosp Motol, Prague, Czech Republic; [Haralambieva, Eugenia; Zimmermann, Dieter] Dept Pathol Univ, Zurich, Switzerland; [Haralambieva, Eugenia; Zimmermann, Dieter] Univ Hosp Zurich, Zurich, Switzerland; [Tantou, Sofia; Kotsonis, Kosmas; Stergiou, Aikaterini; Kanariou, Maria G.] Aghia Sophia Childrens Hosp, Dept Paediat 1, Athens, Greece; [Sediva, Anna; Renella, Raffaele] Lausanne Univ Hosp, Div Pediat, Pediat Hematol Oncol Unit, Lausanne, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; University of Freiburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University Children's Hospital Zurich; Charles University Prague; Motol University Hospital; University of Zurich; University Zurich Hospital; The Aghia Sophia Children's Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Schmid, JP (corresponding author), Univ Childrens Hosp Zurich, Div Immunol, Zurich, Switzerland.; Schmid, JP (corresponding author), Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland.; Schmid, JP (corresponding author), Univ Zurich, Zurich, Switzerland.	jana.pachlopnikr@kispi.uzh.ch	Sediva, Anna/AAE-2774-2019; Klocperk, Adam/L-6185-2017; Renella, Raffaele/AAO-1729-2020; Trück, Johannes/E-3459-2012; Vavassori, Stefano/AAI-9606-2020; Ehl, Stephan/AAM-6006-2020	Sediva, Anna/0000-0001-7730-2304; Klocperk, Adam/0000-0002-1526-4557; Trück, Johannes/0000-0002-0418-7381; Vavassori, Stefano/0000-0002-7452-7978; Mauracher, Andrea/0000-0001-6847-9984; Bosch, Alessandra/0000-0001-8888-7205; Boyman, Onur/0000-0001-8279-5545; Ehl, Stephan/0000-0002-9265-2721; Renella, Raffaele/0000-0002-5041-2308; Schmugge, Markus/0000-0003-4745-8572	Clinical Research Priority Program (CRPP Zurich initiative on novel cytokine-directed treatments for immune dysregulation [CYTIMM-Z]) of the University of Zurich; Beatrice Ederer-Weber; Helmut Horten Foundation; Ulrich M_uller Gierok Stiftung; University of Zurich Forschungskredit programme; Children's Research Centre of the University Children's Hospital of Zurich grant; Centre for Integrative Biological Signalling Studies (CIBSS)-EXC 2189 excellence cluster; Swiss National Science Foundation [310030-172978, PZ00P3_161147]	Clinical Research Priority Program (CRPP Zurich initiative on novel cytokine-directed treatments for immune dysregulation [CYTIMM-Z]) of the University of Zurich; Beatrice Ederer-Weber; Helmut Horten Foundation; Ulrich M_uller Gierok Stiftung; University of Zurich Forschungskredit programme; Children's Research Centre of the University Children's Hospital of Zurich grant; Centre for Integrative Biological Signalling Studies (CIBSS)-EXC 2189 excellence cluster; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by grants from the Clinical Research Priority Program (CRPP Zurich initiative on novel cytokine-directed treatments for immune dysregulation [CYTIMM-Z]) of the University of Zurich (to J.P.S.), the Beatrice Ederer-Weber, and the Helmut Horten Foundation (to S.V. and J.P.S.), the Ulrich M_uller Gierok Stiftung, the University of Zurich Forschungskredit programme, the Children's Research Centre of the University Children's Hospital of Zurich grant (to A.A.M.), Swiss National Science Foundation grant (310030-172978 to O.B.), and Ambizione-SCORE grant of the Swiss National Science Foundation (PZ00P3_161147; PZ00P3_161147 to J.T.). S.E. was supported by the Centre for Integrative Biological Signalling Studies (CIBSS)-EXC 2189 excellence cluster.	Center for Disease Control and Prevention, 2016, NAT HLTH NUTR EX SUR; Fabre A, 2019, J ALLER CL IMM-PRACT, V7, P1958, DOI 10.1016/j.jaip.2019.02.018; Forbes LR, 2018, J ALLERGY CLIN IMMUN, V142, P1665, DOI 10.1016/j.jaci.2018.07.020; Kim AR, 2017, CELL, V168, P1053, DOI 10.1016/j.cell.2017.02.026; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Liu BM, 2016, STAT MED, V35, P5170, DOI 10.1002/sim.7049; Liu Yang, 2015, Int J Stat Med Res, V4, P287; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763; Porpiglia E, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001383; Rubin D.B., 2004, MULTIPLE IMPUTATION; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schafer JL, 1998, P SURV RES METH SECT; Sediva H, 2017, HORM RES PAEDIAT, V88, P160, DOI 10.1159/000456544; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828	16	9	9	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1297	+		10.1016/j.jaci.2019.11.042	http://dx.doi.org/10.1016/j.jaci.2019.11.042			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	31857100	Bronze			2022-12-18	WOS:000523633400028
J	Perez-Portilla, A; Moraru, M; Blazquez-Moreno, A; Kolb, P; Garcia-Morato, MB; Ranganath, T; Esteso, G; Gianelli, C; Rodriguez-Pena, R; Lozano-Rodriguez, R; Torres-Canizales, JM; Blish, CA; Vales-Gomez, M; Hengel, H; Vilches, C; Lopez-Granados, E; Reyburn, HT				Perez-Portilla, A.; Moraru, M.; Blazquez-Moreno, Alfonso; Kolb, Philipp; Bravo Garcia-Morato, Maria; Ranganath, Thanmayi; Esteso, Gloria; Gianelli, Carla; Rodriguez-Pena, Rebeca; Lozano-Rodriguez, Roberto; Manuel Torres-Canizales, Juan; Blish, Catherine A.; Vales-Gomez, Mar; Hengel, Hartmut; Vilches, Carlos; Lopez-Granados, Eduardo; Reyburn, Hugh T.			Identification of the first cases of complete CD16A deficiency: Association with persistent EBV infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; RECEPTOR; IGG		[Perez-Portilla, A.; Blazquez-Moreno, Alfonso; Esteso, Gloria; Lozano-Rodriguez, Roberto; Vales-Gomez, Mar; Reyburn, Hugh T.] CSIC, CNB, Dept Immunol & Oncol, Madrid, Spain; [Moraru, M.; Vilches, Carlos] Hosp Univ Puerta Hierro Majadahonda, Dept Immunol, Madrid, Spain; [Kolb, Philipp; Hengel, Hartmut] Univ Freiburg, Fac Med, Med Ctr, Inst Virol, Freiburg, Germany; [Bravo Garcia-Morato, Maria; Gianelli, Carla; Rodriguez-Pena, Rebeca; Manuel Torres-Canizales, Juan; Lopez-Granados, Eduardo] Univ Hosp La Paz, Clin Immunol Dept, Madrid, Spain; [Bravo Garcia-Morato, Maria; Gianelli, Carla; Rodriguez-Pena, Rebeca; Manuel Torres-Canizales, Juan; Lopez-Granados, Eduardo] IdiPAZ Inst Hlth Res, Lymphocyte Pathophysiol Immunodeficiencies Grp, Madrid, Spain; [Ranganath, Thanmayi; Blish, Catherine A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Puerta de Hierro-Majadahonda; University of Freiburg; Hospital Universitario La Paz; Stanford University	Vilches, C (corresponding author), Hosp Univ Puerta Hierro Majadahonda, Dept Immunol, Madrid, Spain.	carlos.vilches@yahoo.com; elgranados@salud.madrid.org; htreyburn@cnb.csic.es	Vilches, Carlos/G-1471-2012; Kolb, Philipp/AAE-4007-2021; Valés-Gómez, Mar/F-5351-2012; Ranganath, Thanmayi/N-8616-2019; Vilches, Carlos/AAG-9203-2021; Vales-Gomez, Mar/ABG-7808-2020	Vilches, Carlos/0000-0002-0300-9225; Kolb, Philipp/0000-0001-7935-217X; Valés-Gómez, Mar/0000-0001-7424-3206; Ranganath, Thanmayi/0000-0001-9865-2119; Vales-Gomez, Mar/0000-0001-7424-3206; Lozano-Rodriguez, Roberto/0000-0003-0093-9707; Blish, Catherine/0000-0001-6946-7627; Torres Canizales, Juan/0000-0002-7138-5732; Moraru, Manuela/0000-0001-5394-4521; Esteso Tornero, Gloria/0000-0001-6162-013X	Spanish Science agency/European Regional Development Fund, European Union, AEI/FEDER, EU [SAF2014-58752-R, SAF2017-83265-R, SAF2016-80363-C2-2-R]; Spanish Ministry of Science and Innovation [RTC-2017-6379-1, RTI2018-093569-B-I00]; regional government of Madrid [S2017/BMD3733-2]; Spanish Ministry of Science [RED2018-102411-T]; National Secretary of Higher Education, Science, Technology and Innovation (SENESCYT, Ecuador); Spanish Ministry of Economy and Competitivity (MINECO) [SVP-2014068263]; Fundacion de la Asociacion Espanola contra el Cancer [GCB15152947MELE]; Infect-ERA grant TANKACY; BMBF [031L0090]; German Research Foundation (DFG) [HE2526/9-1]; Spanish Association Against Cancer (AECC); Carlos III Health Institute [PI16/01605]; National Institutes of Health [DP2AI11219301]	Spanish Science agency/European Regional Development Fund, European Union, AEI/FEDER, EU; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); regional government of Madrid; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Secretary of Higher Education, Science, Technology and Innovation (SENESCYT, Ecuador); Spanish Ministry of Economy and Competitivity (MINECO)(Spanish Government); Fundacion de la Asociacion Espanola contra el Cancer; Infect-ERA grant TANKACY; BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Spanish Association Against Cancer (AECC); Carlos III Health Institute(Instituto de Salud Carlos III); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants SAF2014-58752-R and SAF2017-83265-R to H.T.R. and grant SAF2016-80363-C2-2-R to C.V. (Spanish Science agency/European Regional Development Fund, European Union, AEI/FEDER, EU). The group of M.V.-G. has also received funding from the Spanish Ministry of Science and Innovation (grant nos. RTC-2017-6379-1 and RTI2018-093569-B-I00 [MCIU/AEI/FEDER, EU]) and the regional government of Madrid (grant no. S2017/BMD3733-2). The group of M.V.-G. also belongs to the research network TENTACLES (RED2018-102411-T) funded by the Spanish Ministry of Science. A.P.P. and A.B.M. acknowledge PhD studentships funded by the National Secretary of Higher Education, Science, Technology and Innovation (SENESCYT, Ecuador) and Spanish Ministry of Economy and Competitivity (MINECO), respectively (SVP-2014068263). M.M. was supported by grant GCB15152947MELE from Fundaci~on de la Asociaci~on Espa~nola contra el C~ancer. Work in the laboratory of H.H. is supported by Infect-ERA grant TANKACY, BMBF 031L0090, and German Research Foundation (DFG) grant HE2526/9-1. E.L.G. has grants from the Spanish Association Against Cancer (AECC) and Carlos III Health Institute (grant no. PI16/01605). C.A.B. acknowledges support from the National Institutes of Health (grant no. DP2AI11219301). The agencies who provided financial support for the conduct of the research and preparation of the article played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The rest of the authors declare that they have no relevant conflicts of interest.	Azzi T, 2014, BLOOD, V124, P2533, DOI 10.1182/blood-2014-01-553024; Corrales-Aguilar E, 2013, J IMMUNOL METHODS, V387, P21, DOI 10.1016/j.jim.2012.09.006; Grier JT, 2012, J CLIN INVEST, V122, P3769, DOI 10.1172/JCI64837; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hargreaves CE, 2015, IMMUNOL REV, V268, P6, DOI 10.1111/imr.12341; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; PERUSSIA B, 1984, J IMMUNOL, V133, P180; Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x	9	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1288	+		10.1016/j.jaci.2019.11.049	http://dx.doi.org/10.1016/j.jaci.2019.11.049			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	31953104	Bronze, Green Accepted			2022-12-18	WOS:000523633400025
J	Turner, PJ; Fleming, L; Saglani, S; Southern, J; Andrews, NJ; Miller, E				Turner, Paul J.; Fleming, Louise; Saglani, Sejal; Southern, Jo; Andrews, Nick J.; Miller, Elizabeth		SNIFFLE-4 Study Investigators	Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; children; immunization; influenza; live attenuated influenza vaccine	POSTMARKETING EVALUATION; ADVISORY-COMMITTEE; YOUNG-CHILDREN; EFFICACY; RECOMMENDATIONS; EXACERBATIONS; INTRANASAL; PREVENTION; FREQUENCY	Background: Live attenuated influenza vaccine (LAIV) is recommended for annual influenza vaccination in children from age 2 years. However, some guidelines recommend against its use in children with asthma or recurrent wheeze due to concerns over its potential to induce wheezing. Objective: We sought to assess the safety of LAIV in children with moderate to severe asthma, and in preschool children with recurrent wheeze. Methods: Prospective, multicenter, open-label, phase IV intervention study in 14 specialist UK clinics. LAIV was administered under medical supervision, with follow-up of asthma symptoms 72 hours and 4 weeks late, using validated questionnaires. Results: A total of 478 young people (median, 9.3; range, 2-18 years) with physician-diagnosed asthma or recurrent wheeze were recruited, including 208 (44%) prescribed high-dose inhaled corticosteroids and 122 (31%) with severe asthma. There was no significant change in asthma symptoms in the 4 weeks after administration (median change, 0; P=.26, McNemar test), with no impact of level of baseline asthma control/symptoms in predicting either a worsening of asthma or exacerbation after LAIV using a regression model. A total of 47 subjects (14.7%; 95% CI, 11%-19.1%) reported a severe asthma exacerbation in the 4 weeks after immunization, requiring a short course of systemic corticosteroids; in 4 cases, this occurred within 72 hours of vaccination. No association with asthma severity, baseline lung function, or asthma control was identified. Conclusions: LAIV appears to be well tolerated in the vast majority of children with asthma or recurrent wheeze, including those whose asthma is categorized as severe or poorly controlled.	[Turner, Paul J.; Fleming, Louise; Saglani, Sejal] Imperial Coll London, Natl Heart & Lung Inst, Sect Inflammat Repair & Dev, London, England; [Turner, Paul J.; Southern, Jo; Andrews, Nick J.; Miller, Elizabeth] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England	Imperial College London; Public Health England	Turner, PJ (corresponding author), St Marys Hosp, Childrens Clin Res Facil, 2nd Floor,Cambridge Wing,Praed St, London W2 1NY, England.	p.turner@imperial.ac.uk	Fleming, Louise/ABD-7452-2020	Seddon, Paul/0000-0003-2136-958X; Fleming, Louise/0000-0002-7268-7433; Roberts, Graham/0000-0003-2252-1248; Turner, Paul/0000-0001-9862-5161; Erlewyn-Lajeunesse, Michel/0000-0003-1982-1397; Murray, Clare/0000-0002-8961-8055	National Institute for Health Research (NIHR) Policy Research Programme (National Vaccine Evaluation Consortium Phase II) [039/0031]; UK Medical Research Council [MR/K010468/1]; Department of Health through the NIHR comprehensive Biomedical Research Centre; MRC [MR/K010468/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Policy Research Programme (National Vaccine Evaluation Consortium Phase II); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health through the NIHR comprehensive Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is independent research funded by the National Institute for Health Research (NIHR) Policy Research Programme (National Vaccine Evaluation Consortium Phase II, 039/0031). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. P.J.T. was supported by a Clinician Scientist award funded by the UK Medical Research Council (reference MR/K010468/1), and has received research support from the Department of Health through the NIHR comprehensive Biomedical Research Centre award to Imperial College London Healthcare NHS Trust. The study received additional local support through the NIHR Clinical Research Networks. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The study design and data collection were performed independently of the funder; data analysis was performed in conjunction with Public Health England, who also contributed to the writing of this report.	Ambrose CS, 2012, EUR J CLIN MICROBIOL, V31, P2549, DOI 10.1007/s10096-012-1595-9; Ambrose CS, 2012, VACCINE, V30, P886, DOI 10.1016/j.vaccine.2011.11.104; Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P389, DOI 10.1111/j.1750-2659.2011.00243.x; Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Baxter R, 2012, VACCINE, V30, P2989, DOI 10.1016/j.vaccine.2012.02.039; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Bergen R, 2004, PEDIATR INFECT DIS J, V23, P138, DOI 10.1097/01.inf.0000109392.96411.4f; Bime C, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.75; Bloom CI, 2019, EUR RESPIR J, V53; British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2014, BRIT GUID MAN ASTHM; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2019, BRIT GID MAN ASTHM N; Caspard H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023118; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Department of Health and Social Care Public Health England and NHS England, NAT FLU IMM PROGR; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gaglani MJ, 2008, PEDIATR INFECT DIS J, V27, P444, DOI 10.1097/INF.0b013e3181660c2e; Grohskopf LA, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6803a1; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Nordin JD, 2019, VACCINE, V37, P4055, DOI 10.1016/j.vaccine.2019.05.081; Pebody RG, 2020, VACCINE, V38, P489, DOI 10.1016/j.vaccine.2019.10.071; Public Health England, IMM INF DIS; Ray GT, 2017, VACCINE, V35, P2668, DOI 10.1016/j.vaccine.2017.03.082; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Tennis P, 2012, VACCINE, V30, P6099, DOI 10.1016/j.vaccine.2012.07.031; Tennis P, 2011, VACCINE, V29, P4947, DOI 10.1016/j.vaccine.2011.04.113; Turner PJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6291; Vesikari T, 2006, PEDIATR INFECT DIS J, V25, P590, DOI 10.1097/01.inf.0000220229.51531.47; Zeiger RS, 2011, J ALLERGY CLIN IMMUN, V128, P983, DOI 10.1016/j.jaci.2011.08.010	30	9	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1157	+		10.1016/j.jaci.2019.12.010	http://dx.doi.org/10.1016/j.jaci.2019.12.010			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	31863808	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000523633400012
J	Spertini, F				Spertini, Francois			Metabolomics and allergy: Opening Pandora's box	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Metabolomics; food allergy; asthma; sphingolipid; biliary salts; tryptophan; NKT cells	CELLS		[Spertini, Francois] CHU Vaudois, Div Immunol & Allergy, Rue Bugnon 46, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Spertini, F (corresponding author), CHU Vaudois, Div Immunol & Allergy, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	francois.spertini@chuv.ch						Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; An DD, 2011, P NATL ACAD SCI USA, V108, P4666, DOI 10.1073/pnas.1001501107; Crestani E, 2020, J ALLERGY CLIN IMMUN, V145, P897, DOI 10.1016/j.jaci.2019.10.014; Ghosh D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02727; Izawa K, 2014, J ALLERGY CLIN IMMUN, V133, P270, DOI 10.1016/j.jaci.2013.08.008; James B, 2019, J ALLERGY CLIN IMMUN, V144, P634, DOI 10.1016/j.jaci.2019.07.023; Jyonouchi S, 2011, J ALLERGY CLIN IMMUN, V128, P102, DOI 10.1016/j.jaci.2011.02.026; Lee-Sarwar K, 2018, J ALLERGY CLIN IMMUN, V142, P335, DOI 10.1016/j.jaci.2018.04.016; Obeso D, 2018, ALLERGY, V73, P2137, DOI 10.1111/all.13563; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678	10	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					782	784		10.1016/j.jaci.2020.01.012	http://dx.doi.org/10.1016/j.jaci.2020.01.012			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31981625	Bronze			2022-12-18	WOS:000518756700014
J	Tsuda, T; Nishide, M; Maeda, Y; Hayama, Y; Koyama, S; Nojima, S; Takamatsu, H; Okuzaki, D; Morita, T; Nakatani, T; Kato, Y; Nakanishi, Y; Futami, Y; Suga, Y; Naito, Y; Konaka, H; Satoh, S; Naito, M; Izumi, M; Obata, S; Nakatani, A; Shikina, T; Takeda, K; Hayama, M; Inohara, H; Kumanogoh, A				Tsuda, Takeshi; Nishide, Masayuki; Maeda, Yohei; Hayama, Yoshitomo; Koyama, Shohei; Nojima, Satoshi; Takamatsu, Hyota; Okuzaki, Daisuke; Morita, Takayoshi; Nakatani, Takeshi; Kato, Yasuhiro; Nakanishi, Yoshimitsu; Futami, Yu; Suga, Yasuhiko; Naito, Yujiro; Konaka, Hachiro; Satoh, Shingo; Naito, Maiko; Izumi, Mayuko; Obata, Sho; Nakatani, Ayaka; Shikina, Takashi; Takeda, Kazuya; Hayama, Masaki; Inohara, Hidenori; Kumanogoh, Atsushi			Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Semaphorin4D; SEMA4D; ECRS	BLOOD-BRAIN-BARRIER; NASAL POLYPS; SYSTEM; CD100; PATHOGENESIS; CONTRIBUTES; LYMPHOCYTES; ACTIVATION; RESPONSES; ANTIBODY	Background: Eosinophilic chronic rhinosinusitis (ECRS) is a subtype of chronic rhinosinusitis. Clinical markers for ECRS disease activity and treatment strategies have not been sufficiently established. Although semaphorins are originally identified as neuronal guidance factors, it is becoming clear that they play key roles in immune regulation and inflammatory diseases. Objective: We sought to investigate the pathological functions and therapeutic potential of semaphorin 4D (SEMA4D) in ECRS. Methods: Serum soluble SEMA4D levels in patients with paranasal sinus diseases were measured by ELISA. The expression of SEMA4D in blood cells and nasal polyp tissues was assessed by flow cytometry and immunohistochemistry, respectively. Generation of soluble SEMA4D was evaluated in matrix metalloproteinase-treated eosinophils. Endothelial cells were stimulated with recombinant SEMA4D, followed by eosinophil transendothelial migration assays. Allergic chronic rhinosinusitis was induced in mice using Aspergillus protease with ovalbumin. The efficacy of treatment with anti-SEMA4D antibody was evaluated histologically and by nasal lavage fluid analysis. Results: Serum soluble SEMA4D levels were elevated in patients with ECRS and positively correlated with disease severity. Tissue-infiltrated eosinophils in nasal polyps from patients with ECRS stained strongly with anti-SEMA4D antibody. Cell surface expression of SEMA4D on eosinophils from patients with ECRS was reduced, which was due to matrix metalloproteinase-9-mediated cleavage of membrane SEMA4D. Soluble SEMA4D induced eosinophil transendothelial migration. Treatment with anti-SEMA4D antibody ameliorated eosinophilic infiltration in sinus tissues and nasal lavage fluid in the ECRS animal model. Conclusions: Eosinophil-derived SEMA4D aggravates ECRS. Levels of serum SEMA4D reflect disease severity, and anti-SEMA4D antibody has therapeutic potential as a treatment for ECRS.	[Tsuda, Takeshi; Maeda, Yohei; Obata, Sho; Nakatani, Ayaka; Shikina, Takashi; Hayama, Masaki; Inohara, Hidenori] Osaka Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Suita, Osaka, Japan; [Tsuda, Takeshi; Nishide, Masayuki; Koyama, Shohei; Takamatsu, Hyota; Morita, Takayoshi; Nakatani, Takeshi; Kato, Yasuhiro; Nakanishi, Yoshimitsu; Futami, Yu; Suga, Yasuhiko; Naito, Yujiro; Konaka, Hachiro; Satoh, Shingo; Naito, Maiko; Izumi, Mayuko; Obata, Sho; Kumanogoh, Atsushi] Osaka Univ, Dept Resp Med & Clin Immunol, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan; [Tsuda, Takeshi; Nishide, Masayuki; Koyama, Shohei; Nojima, Satoshi; Takamatsu, Hyota; Morita, Takayoshi; Nakatani, Takeshi; Kato, Yasuhiro; Nakanishi, Yoshimitsu; Futami, Yu; Suga, Yasuhiko; Naito, Yujiro; Konaka, Hachiro; Satoh, Shingo; Naito, Maiko; Izumi, Mayuko; Obata, Sho; Kumanogoh, Atsushi] World Premier Int Immunol Frontier Res Ctr, Lab Immunopathol, Suita, Osaka, Japan; [Hayama, Yoshitomo] Kinki Cent Hosp, Dept Resp Med, Itami, Hyogo, Japan; [Nojima, Satoshi] Osaka Univ, Dept Pathol, Grad Sch Med, Suita, Osaka, Japan; [Okuzaki, Daisuke] Osaka Univ, Res Inst Microbial Dis, Genome Informat Res Ctr, Suita, Osaka, Japan; [Shikina, Takashi] Ikeda Municipal Hosp, Dept Otolaryngol, Ikeda, Osaka, Japan; [Takeda, Kazuya] Osaka City Gen Hosp, Dept Otolaryngol, Osaka, Osaka, Japan; [Kumanogoh, Atsushi] Inst Open & Transdisciplinary Res Initiat, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka City General Hospital	Nishide, M; Kumanogoh, A (corresponding author), Osaka Univ, Dept Resp Med & Clin Immunol, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.; Kumanogoh, A (corresponding author), Osaka Univ, Osaka Univ Grad Sch Med, Dept Resp Med & Clin Immunol, Immunol Frontier Res Ctr IFReC,Lab Immunopathol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	nishide@imed3.med.osaka-u.ac.jp; kumanogo@imed3.med.osaka-u.ac.jp	Koyama, Shohei/AAU-4113-2021; Morita, Takayoshi/AAW-2706-2021; Okuzaki, Daisuke/AAN-5641-2020; Morita, Takayoshi/AAZ-4112-2021; Nishide, Masayuki/AHE-4839-2022	Koyama, Shohei/0000-0002-6897-9417; Okuzaki, Daisuke/0000-0002-4552-783X; Morita, Takayoshi/0000-0002-7111-9506; Tsuda, Takeshi/0000-0002-6861-1700; Nishide, Masayuki/0000-0001-6060-1228; Hayama, Masaki/0000-0002-7952-0206	Japan Agency for Medical Research and Development -Core Research for Evolutional Science and Technology (AMED-CREST); AMED [18059042, JP19ek0109307]; Center of Innovation (COI) stream and Sports Research Innovation Project (SRIP) grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; SENSHIN Medical Research Foundation; MEXT/Japan Society for the Promotion of Science (JSPS) KAKENHI [JP18H05282, 18K16146, 16H06958]	Japan Agency for Medical Research and Development -Core Research for Evolutional Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); AMED; Center of Innovation (COI) stream and Sports Research Innovation Project (SRIP) grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); MEXT/Japan Society for the Promotion of Science (JSPS) KAKENHI	This work was supported by research grants from Japan Agency for Medical Research and Development -Core Research for Evolutional Science and Technology (AMED-CREST) and AMED (grant no. 18059042 and JP19ek0109307 to A.K.); Center of Innovation (COI) stream and Sports Research Innovation Project (SRIP) grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to A.K.); grants from SENSHIN Medical Research Foundation (to M.N.) and from MEXT/Japan Society for the Promotion of Science (JSPS) KAKENHI (grant no. JP18H05282 to A.K., grant no. 18K16146 to M.N., and grant no. 16H06958 to T.T.).	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Bachert C, 2018, J ALLERGY CLIN IMMUN, V141, P1543, DOI 10.1016/j.jaci.2018.03.004; Besliu A, 2011, AUTOIMMUNITY, V44, P427, DOI 10.3109/08916934.2010.541171; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Kataoka TR, 2010, J IMMUNOL, V184, P2468, DOI 10.4049/jimmunol.0902450; Ke Y, 2017, J INVEST DERMATOL, V137, P2396, DOI 10.1016/j.jid.2017.07.818; Kim JH, 2014, AM J RHINOL ALLERGY, V28, P465, DOI 10.2500/ajra.2014.28.4100; Kinehara Y, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123093; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; La Flamme AC, 2000, J IMMUNOL, V164, P2419, DOI 10.4049/jimmunol.164.5.2419; LaGanke C, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000367; Lee CH, 1999, ANN OTO RHINOL LARYN, V108, P594, DOI 10.1177/000348949910800612; Liao B, 2015, ALLERGY, V70, P1169, DOI 10.1111/all.12667; Meltzer EO, 2006, J ALLERGY CLIN IMMUN, V118, pS17, DOI 10.1016/j.jaci.2006.09.005; Meyer JE, 2005, AM J RHINOL, V19, P15, DOI 10.1177/194589240501900103; Nishide M, 2017, ANN RHEUM DIS, V76, P1440, DOI 10.1136/annrheumdis-2016-210706; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Olze H, 2006, RHINOLOGY, V44, P145; Patnaik A, 2016, CLIN CANCER RES, V22, P827, DOI 10.1158/1078-0432.CCR-15-0431; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Shanks K, 2013, MOL IMMUNOL, V56, P480, DOI 10.1016/j.molimm.2013.05.228; Shen SX, 2018, J INVEST DERMATOL, V138, P588, DOI 10.1016/j.jid.2017.09.037; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Shin SH, 2017, AM J RHINOL ALLERGY, V31, P168, DOI 10.2500/ajra.2017.31.4423; Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602; Smith EP, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-30; Smith ES, 2015, NEUROBIOL DIS, V73, P254, DOI 10.1016/j.nbd.2014.10.008; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Tokunaga T, 2015, ALLERGY, V70, P995, DOI 10.1111/all.12644; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Tsuda T, 2019, INT IMMUNOL, V31, P33, DOI 10.1093/intimm/dxy061; Turner JH, 2018, J ALLERGY CLIN IMMUN, V141, P1895, DOI 10.1016/j.jaci.2018.02.002; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; WARDLAW AJ, 1986, J CLIN INVEST, V78, P1701, DOI 10.1172/JCI112765; Yoshida Y, 2015, ARTHRITIS RHEUMATOL, V67, P1481, DOI 10.1002/art.39086; Zhou H, 2014, ANGIOGENESIS, V17, P261, DOI 10.1007/s10456-013-9395-0; Zhou YF, 2018, FASEB J, V32, P2181, DOI 10.1096/fj.201700786RR; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104	42	9	10	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					843	+		10.1016/j.jaci.2019.12.893	http://dx.doi.org/10.1016/j.jaci.2019.12.893			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	32035658				2022-12-18	WOS:000518756700022
J	Klaver, D; Posch, B; Geisler, A; Hermann, M; Reider, N; Heufler, C				Klaver, Dominik; Posch, Beate; Geisler, Anita; Hermann, Martin; Reider, Norbert; Heufler, Christine			Peptides from allergenic lipocalins bind to formyl peptide receptor 3 in human dendritic cells to mediate T(H)2 immunity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Lipocalin allergens; formyl peptide receptor 3; human monocyte-derived dendritic cells; T(H)2 polarization; antagonistic peptide	T-CELLS; IN-VIVO; INDUCTION; POLARIZATION; GENERATION; MATURATION; PROTEIN; IDENTIFICATION; DEPLETION; RESPONSES	Background: How T(H)2-mediated allergic immune responses are induced is still under investigation. Objective: In an in vitro system we compared the effect of lipocalin allergens and nonallergenic homologues on human monocyte-derived dendritic cells (DCs) to investigate how they polarize naive CD4(+) T-H cells. Microarray data gained with these DCs showed a significant difference in expression of formyl peptide receptors (FPRs). Activation of FPR3 in human monocyte-derived DCs leads to inhibition of IL-12 production. Low concentrations of IL-12 during T-cell priming biases immune responses toward T(H)2. We hypothesize that binding of allergenic lipocalins to FPR3 might be a mechanism for induction of allergic immune responses. Methods: We examined whether lipocalins and FPR3 colocalize within the cells by using confocal microscopy. With calcium mobilization assays of FPR3-transfected HEK 293 cells, we measured FPR3 signaling in response to allergenic and nonallergenic lipocalins. Silencing of FPR3 in DCs and pretreatment with an antagonistic peptide were used to assess the function of FPR3 in T(H)2 induction. Results: FPR3 and lipocalins colocalize in the same vesicles in DCs. Cathepsin S-digested allergenic lipocalins, but not digestion products of nonallergenic homologues, activate FPR3 signaling. FPR3 silencing in DCs or pretreatment with an antagonistic peptide restores IL-12 and induces IL-10 expression by DCs treated with lipocalin allergens, attenuating the T(H)2 bias and inducing IL-10 production in cocultured T-H cells. Conclusion: We describe a novel molecular mechanism for induction of T(H)2-mediated allergic immune responses.	[Klaver, Dominik; Posch, Beate; Geisler, Anita; Reider, Norbert; Heufler, Christine] Med Univ Innsbruck, Dept Dermatol, Innsbruck, Austria; [Hermann, Martin] Med Univ Innsbruck, Dept Anaesthesiol & Crit Care Med, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Heufler, C (corresponding author), Med Univ Innsbruck, Dept Dermatol Venerol & Allergol, Anichstr 35, A-6020 Innsbruck, Austria.	Christine.heufler@i-med.ac.at		Heufler, Christine/0000-0003-1963-4217; Klaver, Dominik/0000-0002-3367-0823	Austrian Science Fund (FWF) [P27543]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Supported by the Austrian Science Fund (FWF; project no. P27543 to C.H.).	Al-Ghouleh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033929; Bae YS, 2004, J IMMUNOL, V173, P607, DOI 10.4049/jimmunol.173.1.607; Bourque J, 2018, CRIT REV IMMUNOL, V38, P379, DOI 10.1615/CritRevImmunol.2018026790; Calzada D, 2018, CURR MED CHEM, V25, P2215, DOI 10.2174/0929867325666171201114353; Cervi L, 2004, J IMMUNOL, V172, P2016, DOI 10.4049/jimmunol.172.4.2016; Chen KQ, 2017, J AUTOIMMUN, V85, P64, DOI 10.1016/j.jaut.2017.06.012; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Comi M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00682; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Domogalla MP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01764; Ebner S, 2001, J IMMUNOL METHODS, V252, P93, DOI 10.1016/S0022-1759(01)00337-4; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017278; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Freier R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12707; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Glimcher LH, 2000, GENE DEV, V14, P1693; Guery L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/314620; Guha S, 2008, INDIAN J BIOCHEM BIO, V45, P75; Hoernes TP, 2016, NUCLEIC ACIDS RES, V44, P852, DOI 10.1093/nar/gkv1182; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kang HK, 2005, J IMMUNOL, V175, P685, DOI 10.4049/jimmunol.175.2.685; Kanof ME, 2016, CURR PROTOC IMMUNOL, V112; Lau JL, 2018, BIOORGAN MED CHEM, V26, P2700, DOI 10.1016/j.bmc.2017.06.052; Lee HY, 2018, BIOCHEM BIOPH RES CO, V497, P226, DOI 10.1016/j.bbrc.2018.02.060; Lutz MB, 2016, IMMUNE NETW, V16, P13, DOI 10.4110/in.2016.16.1.13; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Pfeiffer IA, 2013, IMMUNOBIOLOGY, V218, P1392, DOI 10.1016/j.imbio.2013.07.005; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Pilette C, 2013, ALLERGY, V68, P312, DOI 10.1111/all.12090; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; Posch B, 2015, J CELL MOL MED, V19, P2375, DOI 10.1111/jcmm.12616; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Raabe CA, 2019, BBA-MOL CELL RES, V1866, P305, DOI 10.1016/j.bbamcr.2018.11.015; Rabiet MJ, 2011, J BIOL CHEM, V286, P26718, DOI 10.1074/jbc.M111.244590; Reider N, 2002, J ALLERGY CLIN IMMUN, V109, P89, DOI 10.1067/mai.2002.120556; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Schmitt N, 2015, CURR OPIN IMMUNOL, V34, P130, DOI 10.1016/j.coi.2015.03.007; Schulke S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00455; Schuurhuis DH, 2006, INT ARCH ALLERGY IMM, V140, P53, DOI 10.1159/000092002; Shin EH, 2006, BIOCHEM BIOPH RES CO, V341, P1317, DOI 10.1016/j.bbrc.2006.01.098; SIMONS K, 1993, NEURON, V11, P789, DOI 10.1016/0896-6273(93)90109-5; Skvortsov SS, 2017, BIOCHEMISTRY-MOSCOW+, V82, P426, DOI 10.1134/S0006297917040034; Tae YM, 2012, J IMMUNOL, V188, P1799, DOI 10.4049/jimmunol.1102481; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Walker JA, 2018, NAT REV IMMUNOL, V18, P121, DOI 10.1038/nri.2017.118; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Yang D, 2002, J LEUKOCYTE BIOL, V72, P598	51	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					654	665		10.1016/j.jaci.2019.07.008	http://dx.doi.org/10.1016/j.jaci.2019.07.008			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31330220	hybrid, Green Accepted			2022-12-18	WOS:000512887400027
J	Yu, Y; Kumar, MNK; Wu, MX				Yu, Yang; Kumar, Mudnakudu Nagaraju Kiran; Wu, Mei X.			Delivery of allergen powder for safe and effective epicutaneous immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Epicutaneous immunotherapy; tolerogenic adjuvant; powdered peanut allergens; immunoregulatory macrophages; dissolvable microneedle arrays; regulatory T cells	REGULATORY T-CELLS; FOOD ALLERGY; CD127 EXPRESSION; DENDRITIC CELLS; DRUG-DELIVERY; D-3 PROMOTES; MURINE MODEL; INTACT SKIN; ACCEPTABILITY; ANAPHYLAXIS	Background: More effective and safer immunotherapies to manage peanut allergy are in great demand despite extensive investigation of sublingual/oral immunotherapy and epicutaneous immunotherapy (EPIT) currently in the clinics. Objective: We sought to develop a powder-laden, dissolvable microneedle array (PLD-MNA) for epidermal delivery of powdered allergens and to evaluate the efficacy of this novel EPIT in peanut-sensitized mice. Methods: PLD-MNA was packaged with a mixture of powdered peanut allergen (PNA), 1,25-dihydroxyvitamin D-3 (VD3), and CpG. Its epidermal delivery and therapeutic efficacy were evaluated alongside PNA-specific forkhead box P3-positive regulatory T cells and IL-10(+) and TGF-beta 1(+) skin-resident macrophages. Results: PLD-MNAwas successfully laden with PNA/VD3/CpG powder and capable of epidermal delivery of most of its content 1 hour after application onto intact mouse skin concomitant with no significant leakage into the circulation or skin irritation. PLD-MNA-mediated EPIT substantially reduced clinical allergy scores to 1 from 3.5 in sham control mice (P <.001) after 6 treatments accompanied by lower levels of PNA-specific IgE and intestinal mucosal mast cells and eosinophils over sham treatments. Moreover, in comparison with allergens administered intradermally, powdered allergens delivered by means of PLD-MNA preferentially attracted immunoregulatory macrophages and stimulated the cells to produce IL-10, TGF-beta, or both at the immunization site, which might account for increased numbers of regulatory T-like cells in lymph tissues in association with systemic tolerance. PNA/VD3/CpG-laden PLD-MNA was safe and required only 6 treatments and one fifth of the PNA adjuvant dose, with improved outcomes when compared with 12 conventional intradermal immunotherapies. Conclusions: PLD-MNA holds great promise as a novel, safe, effective, and self-applicable modality to manage IgE-mediated allergies.	[Yu, Yang; Kumar, Mudnakudu Nagaraju Kiran; Wu, Mei X.] Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02115 USA; [Kumar, Mudnakudu Nagaraju Kiran] JSS Acad Higher Educ & Res, Div Biotechnol & Bioinformat, Fac Life Sci, Mysuru, India	Harvard University; Harvard Medical School; Massachusetts General Hospital; JSS Academy of Higher Education & Research	Wu, MX (corresponding author), 50 Blossom St,EDW222, Boston, MA 02114 USA.	mwu5@mgh.harvard.edu	Nagaraju, Kiran Kumar Mudnakudu/AAV-4509-2020	Nagaraju, Kiran Kumar Mudnakudu/0000-0002-0048-6384	National Institute of Health [AI135233, AI113458, AI089779]; Wellman Center Discretionary Fund	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellman Center Discretionary Fund	This work is supported by National Institute of Health grants AI135233, AI113458, and AI089779 and the Wellman Center Discretionary Fund (to M.X.W.).	Arya J, 2017, BIOMATERIALS, V128, P1, DOI 10.1016/j.biomaterials.2017.02.040; Bauer RN, 2015, J ALLERGY CLIN IMMUN, V135, P312, DOI 10.1016/j.jaci.2014.12.1908; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Cao Y, 2017, J CONTROL RELEASE, V249, P94, DOI 10.1016/j.jconrel.2017.01.030; Chen F, 2017, J CONTROL RELEASE, V255, P36, DOI 10.1016/j.jconrel.2017.03.397; Chen XW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008598; Chen XY, 2014, J CONTROL RELEASE, V192, P310, DOI 10.1016/j.jconrel.2014.08.006; Chen XY, 2012, J CONTROL RELEASE, V159, P43, DOI 10.1016/j.jconrel.2012.01.002; DeMuth PC, 2013, NAT MATER, V12, P367, DOI [10.1038/nmat3550, 10.1038/NMAT3550]; Dhami S, 2017, ALLERGY, V72, P1825, DOI 10.1111/all.13208; Dioszeghy V, 2017, CELL MOL IMMUNOL, V14, P770, DOI 10.1038/cmi.2016.14; Dioszeghy V, 2011, J IMMUNOL, V186, P5629, DOI 10.4049/jimmunol.1003134; Greenhawt MJ, 2013, ALLERGY ASTHMA PROC, V34, P197, DOI 10.2500/aap.2013.34.3661; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Heine G, 2014, J IMMUNOL, V193, P1017, DOI 10.4049/jimmunol.1301656; Hessenberger M, 2013, VACCINE, V31, P3427, DOI 10.1016/j.vaccine.2012.09.086; Hofmann AM, 2009, J ALLERGY CLIN IMMUN, V124, P286, DOI 10.1016/j.jaci.2009.03.045; Jones SM, 2016, J ALLERGY CLIN IMMUN, V137, P1258, DOI 10.1016/j.jaci.2016.01.008; Kang SW, 2012, J IMMUNOL, V188, P5276, DOI 10.4049/jimmunol.1101211; Kumar MNK, 2016, J CONTROL RELEASE, V235, P82, DOI 10.1016/j.jconrel.2016.05.057; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Lifshitz GV, 2016, AUTOIMMUNITY, V49, P388, DOI 10.1080/08916934.2016.1199020; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Majewska-Szczepanik M, 2016, J ALLERGY CLIN IMMUN, V138, pe6; Manstein D, 2004, LASER SURG MED, V34, P426, DOI 10.1002/lsm.20048; Mondoulet L, 2019, ALLERGY, V74, P152, DOI 10.1111/all.13479; Mondoulet L, 2010, CLIN EXP ALLERGY, V40, P659, DOI 10.1111/j.1365-2222.2009.03430.x; Mondoulet L, 2015, J ALLERGY CLIN IMMUN, V135, P1546, DOI 10.1016/j.jaci.2014.11.028; Mondoulet Lucie, 2012, Clin Transl Allergy, V2, P22, DOI 10.1186/2045-7022-2-22; Mondoulet L, 2011, INT ARCH ALLERGY IMM, V154, P299, DOI 10.1159/000321822; Nagaraju KKM, 2016, EUR J IMMUNOL, V46, P1727, DOI 10.1002/eji.201545918; Nikolic T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00113; Norman JJ, 2014, VACCINE, V32, P1856, DOI 10.1016/j.vaccine.2014.01.076; Nurmatov U, 2017, ALLERGY, V72, P1133, DOI 10.1111/all.13124; O'Neill ASG, 2013, IMMUNOLOGY, V138, P198, DOI 10.1111/imm.12042; Oun AA, 2015, CARBOHYD POLYM, V127, P101, DOI 10.1016/j.carbpol.2015.03.073; Pajno GB, 2018, ALLERGY, V73, P799, DOI 10.1111/all.13319; Rani M, 2014, J BURN CARE RES, V35, P46, DOI 10.1097/01.bcr.0000440705.91099.cc; Sampson HA, 2017, JAMA-J AM MED ASSOC, V318, P1798, DOI 10.1001/jama.2017.16591; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Senti G, 2015, ALLERGY, V70, P707, DOI 10.1111/all.12600; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Sindher S, 2016, IMMUNOL ALLERGY CLIN, V36, P39, DOI 10.1016/j.iac.2015.08.008; Spina L, 2015, INT ARCH ALLERGY IMM, V167, P103, DOI 10.1159/000434681; Tordesillas L, 2017, J ALLERGY CLIN IMMUN, V139, P189, DOI 10.1016/j.jaci.2016.03.057; Varshney P, 2009, J ALLERGY CLIN IMMUN, V124, P1351, DOI 10.1016/j.jaci.2009.09.042; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Wang J, 2015, P NATL ACAD SCI USA, V112, P5005, DOI 10.1073/pnas.1500408112; Wang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5447; Yasuda T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167952	52	9	9	3	26	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					597	609		10.1016/j.jaci.2019.11.022	http://dx.doi.org/10.1016/j.jaci.2019.11.022			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31783055	Green Accepted, Bronze			2022-12-18	WOS:000512887400022
J	Fitzpatrick, AM; Szefler, SJ; Mauger, DT; Phillips, BR; Denlinger, LC; Moore, WC; Sorkness, RL; Wenzel, SE; Gergen, PJ; Bleecker, ER; Castro, M; Erzurum, SC; Fahy, JV; Gaston, BM; Israel, E; Levy, BD; Meyers, DA; Teague, WG; Bacharier, LB; Ly, NP; Phipatanakul, W; Ross, KR; Zein, J; Jarjour, NN				Fitzpatrick, Anne M.; Szefler, Stanley J.; Mauger, David T.; Phillips, Brenda R.; Denlinger, Loren C.; Moore, Wendy C.; Sorkness, Ronald L.; Wenzel, Sally E.; Gergen, Peter J.; Bleecker, Eugene R.; Castro, Mario; Erzurum, Serpil C.; Fahy, John, V; Gaston, Benjamin M.; Israel, Elliot; Levy, Bruce D.; Meyers, Deborah A.; Teague, W. Gerald; Bacharier, Leonard B.; Ly, Ngoc P.; Phipatanakul, Wanda; Ross, Kristie R.; Zein, Joe; Jarjour, Nizar N.			Development and initial validation of the Asthma Severity Scoring System (ASSESS)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma control; asthma severity classification; severe asthma; psychometric testing; tool development	HEALTH-RELATED QUALITY; CORTICOSTEROID RESPONSES; OF-LIFE; CHILDREN; OUTCOMES; RELIABILITY; CRITERION; FEATURES; BURDEN; COHORT	Background: Tools for quantification of asthma severity are limited. Objective: We sought to develop a continuous measure of asthma severity, the Asthma Severity Scoring System (ASSESS), for adolescents and adults, incorporating domains of asthma control, lung function, medications, and exacerbations. Methods: Baseline and 36-month longitudinal data from participants in phase 3 of the Severe Asthma Research Program (NCT01606826) were used. Scale properties, responsiveness, and a minimally important difference were determined. External replication was performed in participants enrolled in the Severe Asthma Research Program phase 1/2. The utility of ASSESS for detecting treatment response was explored in participants undergoing corticosteroid responsiveness testing with intramuscular triamcinolone and participants receiving biologics. Results: ASSESS scores ranged from 0 to 20 (8.78 +/- 3.9; greater scores reflect worse severity) and differed among 5 phenotypic groups. Measurement properties were acceptable. ASSESS was responsive to changes in quality of life with a minimally important difference of 2, with good specificity for outcomes of asthma improvement and worsening but poor sensitivity. Replication analyses yielded similar results, with a 2-point decrease (improvement) associated with improvements in quality of life. Participants with a 2-point or greater decrease (improvement) in ASSESS scores also had greater improvement in lung function and asthma control after triamcinolone, but these differences were limited to phenotypic clusters 3, 4, and 5. Participants treated with biologics also had a 2-point or greater decrease (improvement) in ASSESS scores overall. Conclusions: The ASSESS tool is an objective measure that might be useful in epidemiologic and clinical research studies for quantification of treatment response in individual patients and phenotypic groups. However, validation studies are warranted.	[Fitzpatrick, Anne M.] Emory Univ, Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA; [Fitzpatrick, Anne M.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Szefler, Stanley J.] Childrens Hosp Colorado, Aurora, CO USA; [Szefler, Stanley J.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA; [Mauger, David T.; Phillips, Brenda R.] Penn State Univ, Dept Publ Hlth Sci, Hershey, PA USA; [Denlinger, Loren C.; Sorkness, Ronald L.; Jarjour, Nizar N.] Univ Wisconsin, Dept Med, Madison, WI USA; [Moore, Wendy C.] Wake Forest Univ, Dept Internal Med, Winston Salem, NC 27101 USA; [Wenzel, Sally E.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Gergen, Peter J.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bleecker, Eugene R.; Meyers, Deborah A.] Univ Arizona, Coll Med, Tucson, AZ USA; [Castro, Mario] Washington Univ, Dept Internal Med, St Louis, MO 63110 USA; [Erzurum, Serpil C.; Zein, Joe] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Fahy, John, V] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ly, Ngoc P.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Gaston, Benjamin M.; Ross, Kristie R.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Israel, Elliot; Levy, Bruce D.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Teague, W. Gerald] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Bacharier, Leonard B.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Phipatanakul, Wanda] Boston Childrens Hosp, Div Immunol, Boston, MA USA	Emory University; Children's Healthcare of Atlanta (CHOA); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Wisconsin System; University of Wisconsin Madison; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Arizona; Washington University (WUSTL); Cleveland Clinic Foundation; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Virginia; Washington University (WUSTL); Harvard University; Boston Children's Hospital	Fitzpatrick, AM (corresponding author), Emory Univ, Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	anne.fitzpatrick@emory.edu		Wenzel, Sally/0000-0002-4242-0164; Bacharier, Leonard/0000-0003-0432-2704	National Heart, Lung, and Blood Institute's the Severe Asthma Research Program (SARP) [U10 HL109086, U10 HL109146, U10 HL109152, U10 HL109164, U10 HL109168, U10 HL109172, U10 HL109250, U10 HL109257]; National Institutes of Health National Center for Advancing Translational Sciences [UL1 TR001420, UL1 TR000427, UL1 TR001102, UL1 TR002378]	National Heart, Lung, and Blood Institute's the Severe Asthma Research Program (SARP); National Institutes of Health National Center for Advancing Translational Sciences	Supported by the National Heart, Lung, and Blood Institute's the Severe Asthma Research Program (SARP): U10 HL109086, U10 HL109146, U10 HL109152, U10 HL109164, U10 HL109168, U10 HL109172, U10 HL109250, and U10 HL109257. In addition, this program is supported through the following National Institutes of Health National Center for Advancing Translational Sciences awards: UL1 TR001420 (Wake Forest University), UL1 TR000427 (University of Wisconsin), UL1 TR001102 (Harvard University), and UL1 TR002378 (Emory University).	Barry LE, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0614-x; Braido F, 2017, PULM PHARMACOL THER, V44, P83, DOI 10.1016/j.pupt.2017.03.013; BRAND PLP, 1992, THORAX, V47, P429, DOI 10.1136/thx.47.6.429; Brunner M, 2005, EDUC PSYCHOL MEAS, V65, P227, DOI 10.1177/0013164404268669; Calciano L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177538; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Crespo-Lessmann A, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2017-000189; Denlinger LC, 2017, AM J RESP CRIT CARE, V195, P302, DOI 10.1164/rccm.201602-0419OC; Farber HJ, 2017, PEDIATRICS, V139; Fitzpatrick AM, 2017, J ALLER CL IMM-PRACT, V5, P410, DOI 10.1016/j.jaip.2016.08.001; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Garcia E, 2015, J ALLERGY CLIN IMMUN, V136, P610, DOI 10.1016/j.jaci.2015.01.030; Gillis RME, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/s41533-017-0027-9; Global Iniative for asthma, 2020, GLOB STRAT ASTHM MAN; Israel E, 2017, NEW ENGL J MED, V377, P965, DOI 10.1056/NEJMra1608969; Jayadevappa R, 2017, J CLIN EPIDEMIOL, V89, P188, DOI 10.1016/j.jclinepi.2017.06.009; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper Elizabeth F, 2004, Prim Care Respir J, V13, P181, DOI 10.1016/j.pcrj.2004.04.003; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Krouse RZ, 2017, J ALLERGY CLIN IMMUN, V139, P1052, DOI 10.1016/j.jaci.2016.08.041; Malhotra K, 2014, J ASTHMA, V51, P913, DOI 10.3109/02770903.2014.930479; Menzies-Gow A, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/s41533-017-0050-x; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Newby C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102987; Nordon C, 2018, RESP MED, V144, P42, DOI 10.1016/j.rmed.2018.10.002; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Norman GR, 2001, MED CARE, V39, P1039, DOI 10.1097/00005650-200110000-00002; Okupa AY, 2013, CHEST, V143, P993, DOI 10.1378/chest.12-1055; Patel M, 2014, J ALLER CL IMM-PRACT, V2, P751, DOI 10.1016/j.jaip.2014.06.001; Phipatanakul W, 2017, AM J RESP CRIT CARE, V195, P1439, DOI 10.1164/rccm.201607-1453OC; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Silkoff PE, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0360-5; Sullivan PW, 2015, J ASTHMA, V52, P669, DOI 10.3109/02770903.2015.1004683; Sullivan PW, 2015, ANN ALLERG ASTHMA IM, V114, P462, DOI 10.1016/j.anai.2015.03.019; Sweeney J, 2014, PRIM CARE RESP J, V23, P74, DOI 10.4104/pcrj.2014.00007; Szefler SJ, 2018, J ALLERGY CLIN IMMUN, V142, P773, DOI 10.1016/j.jaci.2018.03.010; Tabatabaian F, 2017, IMMUNOL ALLERGY CLIN, V37, P329, DOI 10.1016/j.iac.2017.01.007; Taylor DR, 2008, EUR RESPIR J, V32, P545, DOI 10.1183/09031936.00155307; Teague WG, 2018, J ALLER CL IMM-PRACT, V6, P545, DOI 10.1016/j.jaip.2017.05.032; Urrutia I, 2013, J ASTHMA, V50, P877, DOI 10.3109/02770903.2013.819886; Ward H, 2015, CHEST, V148, P877, DOI 10.1378/chest.14-2413; Wildfire JJ, 2012, J ALLERGY CLIN IMMUN, V129, P694, DOI 10.1016/j.jaci.2011.12.962; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2; Zaihra T, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0232-2	46	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					127	139		10.1016/j.jaci.2019.09.018	http://dx.doi.org/10.1016/j.jaci.2019.09.018			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31604088	Bronze, Green Accepted			2022-12-18	WOS:000505590800020
J	Macia, L; Mackay, CR				Macia, Laurence; Mackay, Charles R.			Dysfunctional microbiota with reduced capacity to produce butyrate as a basis for allergic diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Gut microbiota; butyrate; CAZymes; allergy; dietary fiber	DIETARY FIBER; RISK		[Macia, Laurence] Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney, NSW, Australia; [Macia, Laurence] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Sydney, NSW, Australia; [Mackay, Charles R.] Monash Univ, Fac Med Nursing & Hlth Sci, Biomed Discovery Inst, Dept Microbiol, Bldg 77,Clayton Campus,Wellington Rd, Clayton, Vic 3800, Australia; [Mackay, Charles R.] Shandong Acad Sci, Qilu Univ Technol, Shandong Anal & Test Ctr, Lab Immunol Environm & Hlth, Jinan, Shandong, Peoples R China	University of Sydney; University of Sydney; Monash University; Qilu University of Technology	Mackay, CR (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Biomed Discovery Inst, Dept Microbiol, Bldg 77,Clayton Campus,Wellington Rd, Clayton, Vic 3800, Australia.	charles.mackay@monash.edu	Mackay, Charles R/A-9673-2008; Macia, Loreto/AAN-2021-2021; Macia, laurence/D-5983-2016	Mackay, Charles R/0000-0002-6338-7340; Macia, Loreto/0000-0002-1801-7607; Macia, laurence/0000-0003-0835-851X				Cait A, 2019, J ALLERGY CLIN IMMUN, V144; Johnson CC, 2005, J ALLERGY CLIN IMMUN, V115, P1218, DOI 10.1016/j.jaci.2005.04.020; McKenzie C, 2017, IMMUNOL REV, V278, P277, DOI 10.1111/imr.12556; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444	10	9	9	4	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1513	1515		10.1016/j.jaci.2019.10.009	http://dx.doi.org/10.1016/j.jaci.2019.10.009			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31654650	Bronze			2022-12-18	WOS:000500694900007
J	Voorheis, P; Bell, S; Cornelsen, L; Quaife, M; Logan, K; Marrs, T; Radulovic, S; Craven, J; Flohr, C; Lack, G; Perkin, MR; Young, L; Offord, V; DeSousa, M; Cullen, J; Taylor, K; Tseng, A; Raji, B; Byrom, S; Regis, G; Bigwood, C; Stedman, C; Tonner, S; Kahnum, Y; Babic, R; Stockwell, B; Thompson, E; Wheatley, L; Patkunam, D; Richards, K; Pietraszewicz, E; Stephens, A; Sudra, A; Turcanu, V				Voorheis, Paula; Bell, Sadie; Cornelsen, Laura; Quaife, Matthew; Logan, Kirsty; Marrs, Tom; Radulovic, Suzana; Craven, Joanna; Flohr, Carsten; Lack, Gideon; Perkin, Michael R.; Young, Louise; Offord, Victoria; DeSousa, Mary; Cullen, Jason; Taylor, Katherine; Tseng, Anna; Raji, Bunmi; Byrom, Sarah; Regis, Gillian; Bigwood, Charlie; Stedman, Charlotte; Tonner, Sharon; Kahnum, Yasmin; Babic, Rachel; Stockwell, Ben; Thompson, Erin; Wheatley, Lorna; Patkunam, Devi; Richards, Kerry; Pietraszewicz, Ewa; Stephens, Alick; Sudra, Asha; Turcanu, Victor		EAT Study Team	Challenges experienced with early introduction and sustained consumption of allergenic foods in the Enquiring About Tolerance (EAT) study: A qualitative analysis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; diet; allergens; infancy; breastfeeding; randomized controlled trial; adherence; qualitative	INFANTS; RISK; PREVENTION; SOCIETY; ECZEMA; TRIAL	Background: The early introduction group participants of the Enquiring About Tolerance study were asked to undertake a proscriptive regimen of early introduction and sustained consumption of 6 allergenic foods. It was envisaged that this might be challenging, and early introduction group families were presented with an open-text question to express any problems they were experiencing with the regimen in recurring online questionnaires. Objective: We sought to analyze these open-text questionnaire responses with the aim of identifying challenges associated with the introduction and regular consumption of allergenic foods. Methods: Three combinations of interim questionnaire responses were selected for analysis, representing the early period (4, 5, and 6 months), middle period (8 and 12 months), and late period (24 and 36 months) of participation in the Enquiring About Tolerance study. Responses were assigned a code to describe their content and subsequently grouped into themes to portray key messages. A thematic content analysis allowed for conversion of qualitative codes into quantitative summaries. Results: Three main challenges to allergenic food consumption were identified. First, some children refused the allergenic food, causing a sense of defeat among caregivers. Second, caregivers were concerned that allergenic foods might be causing a reaction, triggering a need for reassurance. Third, practical problems associated with the regimen compromised caregivers' capacity to persist. Conclusion: Understanding the challenges experienced with allergenic food introduction and sustained consumption is the necessary precursor to developing specific communication and support strategies that could be used by caregivers, practitioners, policymakers, and key stakeholders to address these problems.	[Voorheis, Paula] London Sch Hyg & Trop Med, Execut Off, London, England; [Voorheis, Paula; Bell, Sadie; Cornelsen, Laura; Quaife, Matthew] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Logan, Kirsty; Marrs, Tom; Radulovic, Suzana; Craven, Joanna; Lack, Gideon] Kings Coll London, Sch Life Course Sci, Dept Women & Childrens Hlth, Paediat Allergy Res Grp, London, England; [Flohr, Carsten] Kings Coll London, Fac Life Sci & Med, Unit Populat Based Dermatol Res, Sch Basic & Med Biosci,St Johns Inst Dermatol, London, England; [Perkin, Michael R.] St Georges Univ London, Populat Hlth Res Inst, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of London; King's College London; St Georges University London	Perkin, MR (corresponding author), St Georges Univ London, Populat Hlth Res Inst, Paediat Allergy & Reader Clin Epidemiol, Room 1-27,1st Floor,Jenner Wing,Cranmer Terrace, London SW17 0RE, England.	m.perkin@sgul.ac.uk	Perkin, Michael/AID-7491-2022	Quaife, Matthew/0000-0001-9291-1511; Tonner, Sharon/0000-0002-7775-9926; Lack, Gideon/0000-0001-7350-4021; Bell, Sadie/0000-0003-4381-0030; Perkin, Michael/0000-0001-9272-2585	UK Food Standards Agency (FSA) [T07051]; Medical Research Council (MRC) [MC_G1001205]; UK National Institute for Health Research (NIHR); NIHR Clinician Scientist Award [NIHRCS/01/2008/009]; FSA [FS101178]; MRC [MC_G1001205] Funding Source: UKRI	UK Food Standards Agency (FSA); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Clinician Scientist Award; FSA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The main components of the Enquiring About Tolerance (EAT) study were jointly funded by the UK Food Standards Agency (FSA; contract code T07051) and the Medical Research Council (MRC; grant MC_G1001205). Additionally, we would like to thank the Davis Foundation. The skin-related aspects of the EAT study were supported by the UK National Institute for Health Research (NIHR). C.F. held an NIHR Clinician Scientist Award (NIHRCS/01/2008/009). The analyses presented in this article were supported by a subsequent grant from the FSA (contract code FS101178). The views expressed in this publication are those of the authors and not necessarily those of the FSA, MRC, National Health Service, NIHR, or UK Department of Health.	Abrams EM, 2019, J ALLER CL IMM-PRACT, V7, P681, DOI 10.1016/j.jaip.2018.07.035; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Fewtrell M, 2017, J PEDIATR GASTR NUTR, V64, P119, DOI 10.1097/MPG.0000000000001454; Greenhawt M, 2018, ANN ALLERG ASTHMA IM, V120, P620, DOI 10.1016/j.anai.2018.03.001; Gupta R, 2013, JAMA PEDIATR, V167, P1026, DOI 10.1001/jamapediatrics.2013.2376; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Joshi PA, 2019, MED J AUSTRALIA, V210, P89, DOI 10.5694/mja2.12102; Levy MB, 2012, ISR MED ASSOC J, V14, P29; Matvienko-Sikar K, 2018, OBES REV, V19, P501, DOI 10.1111/obr.12653; McAndrew A. F., 2012, INFANT FEEDING SURVE; Natsume O, 2017, LANCET, V389, P276, DOI 10.1016/S0140-6736(16)31418-0; Palmer DJ, 2017, J ALLERGY CLIN IMMUN, V139, P1600, DOI 10.1016/j.jaci.2016.06.052; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Perkin MR, 2019, J ALLERGY CLIN IMMUN, V144, P1595, DOI 10.1016/j.jaci.2019.06.046; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Scientific Advisory Committee on Nutrition Public Health England UK, 2018, FEED 1 YEAR LIF; Tan JWL, 2017, J ALLERGY CLIN IMMUN, V139, P1621, DOI 10.1016/j.jaci.2016.08.035; Tey D, 2014, J ALLERGY CLIN IMMUN, V133, P476, DOI 10.1016/j.jaci.2013.11.019; Togias A, 2017, ANN ALLERG ASTHMA IM, V118, P166, DOI 10.1016/j.anai.2016.10.004; van den Engel-Hoek L, 2014, INFANT BEHAV DEV, V37, P187, DOI 10.1016/j.infbeh.2014.01.008; Ventura AK, 2013, CURR BIOL, V23, pR401, DOI 10.1016/j.cub.2013.02.037	23	9	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1615	1623		10.1016/j.jaci.2019.09.004	http://dx.doi.org/10.1016/j.jaci.2019.09.004			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31812185	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000500694900019
J	Warren, CM; Aktas, ON; Gupta, RS; Davis, CM				Warren, Christopher M.; Aktas, Ozge N.; Gupta, Ruchi S.; Davis, Carla M.			Prevalence and characteristics of adult shellfish allergy in the United States	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SEAFOOD ALLERGY; RNA		[Warren, Christopher M.; Gupta, Ruchi S.] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Chicago, IL 60611 USA; [Aktas, Ozge N.] Univ Illinois, Coll Med, Dept Pediat, Chicago, IL USA; [Gupta, Ruchi S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Gupta, Ruchi S.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Gupta, Ruchi S.] Ann & Robert H Lurie Childrens Hosp Chicago, Mary Ann & J Milburn Smith Child Hlth Res Outreac, Chicago, IL 60611 USA; [Davis, Carla M.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Immunol Allergy Rheumatol & Retrovirol, Houston, TX 77030 USA	Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Baylor College of Medicine	Gupta, RS (corresponding author), Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Chicago, IL 60611 USA.; Gupta, RS (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.; Gupta, RS (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.; Gupta, RS (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Mary Ann & J Milburn Smith Child Hlth Res Outreac, Chicago, IL 60611 USA.	r-gupta@northwestern.edu		Davis, Carla/0000-0003-0866-7822	National Institute of Allergy and Infectious Diseases, "US Prevalence, Distribution and Determinants of Adult and Childhood Food Allergy'' [R21AI135702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI135702] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, "US Prevalence, Distribution and Determinants of Adult and Childhood Food Allergy''; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institute of Allergy and Infectious Diseases, "US Prevalence, Distribution and Determinants of Adult and Childhood Food Allergy'' (grant no. R21AI135702-PI: R.S.G.).	Gupta RS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.5630; Gupta RS, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1235; Leung NYH, 2014, CLIN REV ALLERG IMMU, V46, P180, DOI 10.1007/s12016-012-8336-9; Moonesinghe H, 2016, ANN ALLERG ASTHMA IM, V117, P264, DOI 10.1016/j.anai.2016.07.015; National Academies of Sciences Engineering and Medicine, 2017, FINDING PATH SAFETY, DOI [10.17226/23658, DOI 10.17226/23658]; NOAA Office for Coastal Management, 2017, COAST COUNT DEF; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rosales SL, 2018, METHODS MOL BIOL, V1799, P275, DOI 10.1007/978-1-4939-7896-0_21; Seumois G, 2014, NAT IMMUNOL, V15, P777, DOI 10.1038/ni.2937; Seumois G, 2012, AM J CLIN EXP IMMUNO, V1, P70; Shek LPC, 2010, J ALLERGY CLIN IMMUN, V126, P324, DOI 10.1016/j.jaci.2010.06.003; Sicherer SH, 2004, J ALLERGY CLIN IMMUN, V114, P159, DOI 10.1016/j.jaci.2004.04.018; Steinke M, 2007, INT ARCH ALLERGY IMM, V143, P290, DOI 10.1159/000100575	13	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1435	+		10.1016/j.jaci.2019.07.031	http://dx.doi.org/10.1016/j.jaci.2019.07.031			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31401288	Bronze, Green Accepted			2022-12-18	WOS:000495004700039
J	Klein, O; Krier-Burris, RA; Lazki-Hagenbach, P; Gorzalczany, Y; Mei, Y; Ji, P; Bochner, BS; Sagi-Eisenberg, R				Klein, Ofir; Krier-Burris, Rebecca A.; Lazki-Hagenbach, Pia; Gorzalczany, Yaara; Mei, Yang; Ji, Peng; Bochner, Bruce S.; Sagi-Eisenberg, Ronit			Mammalian diaphanous-related formin 1 (mDia1) coordinates mast cell migration and secretion through its actin-nucleating activity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mast cells; actin; mammalian diaphanous-related formin 1; chemotaxis; exocytosis	SMALL GTPASE; HUMAN LUNG; CXCR1; ACTIVATION; RECEPTOR; PROTEIN; DEGRANULATION; EXOCYTOSIS; ADHESION; RHO	Background: Actin remodeling is a key regulator of mast cell ( MC) migration and secretion. However, the precise mechanism underlying the coordination of these processes has remained obscure. Objective: We sought to characterize the actin rearrangements that occur during MC secretion or chemotactic migration and identify the underlying mechanism of their coordination. Methods: Using high-resolution microscopy, we analyzed the dynamics of actin rearrangements in MCs triggered to migration by IL-8 or prostaglandin E-2 or to Fc epsilon URI-stimulated secretion. Results: We show that a major feature of the actin skeleton in MCs stimulated to migration is the buildup of pericentral actin clusters that prevent cell flattening and converge the secretory granules (SGs) in the cell center. This migratory phenotype is replaced on encounter of an IgE cross-linking antigen that stimulates secretion through a secretory phenotype characterized by cell flattening, reduction of actin mesh density, ruffling of cortical actin, and mobilization of SGs. Furthermore, we show that knockdown of mammalian diaphanous-related formin 1 (mDia1) inhibits chemotactic migration and its typical actin rearrangements, whereas expression of an active mDia1 mutant recapitulates the migratory actin phenotype and enhances cell migration while inhibiting Fc epsilon RI-triggered secretion. However, mice deficient in mDia1 appear to have normal numbers of MCs in various organs at baseline. Conclusion: Our results demonstrate a unique role of actin rearrangements in clustering the SGs and inhibiting their secretion during MC migration. We identify mDia1 as a novel regulator of MC response that coordinates MC chemotaxis and secretion through its actin-nucleating activity.	[Klein, Ofir; Lazki-Hagenbach, Pia; Gorzalczany, Yaara; Sagi-Eisenberg, Ronit] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Krier-Burris, Rebecca A.; Bochner, Bruce S.] Northwestern Univ, Dept Med, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Mei, Yang; Ji, Peng] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Tel Aviv University; Sackler Faculty of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Sagi-Eisenberg, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	histol3@tauex.tau.ac.il		Lazki-Hagenbach, Pia/0000-0003-0521-7981; Krier-Burris, Rebecca/0000-0001-9722-215X	Israel Science Foundation [933/15]; United States-Israel Binational Science Foundation [2013263]; Constantiner Institute; Ministry of Aliyah and Integration; Department of Defense [CA140119]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105839, U19AI136443] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Constantiner Institute; Ministry of Aliyah and Integration; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grant 933/15 from the Israel Science Foundation founded by the Israel Academy for Sciences (to R.S.-E.) and by the United States-Israel Binational Science Foundation (grant 2013263 to R.S.-E.). This work was supported in part by a travel grant from the Constantiner Institute (to O.K.) and a scholarship from the Ministry of Aliyah and Integration (to P.L.-H.). P.J. is a scholar of the Leukemia and Lymphoma Society. This work is partially supported by the Department of Defense (CA140119; to P.J.).	Azouz NP, 2014, J IMMUNOL, V192, P4043, DOI 10.4049/jimmunol.1302196; Azouz NP, 2012, J IMMUNOL, V189, P2169, DOI 10.4049/jimmunol.1200542; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Benhamou M, 2010, FEBS LETT, V584, P4941, DOI 10.1016/j.febslet.2010.09.023; BISCHOFF SC, 1992, J EXP MED, V175, P237, DOI 10.1084/jem.175.1.237; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Blank U, 2011, ADV EXP MED BIOL, V716, P107, DOI 10.1007/978-1-4419-9533-9_7; Brightling CE, 2005, J LEUKOCYTE BIOL, V77, P759, DOI 10.1189/jlb.0904511; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Chan CY, 2012, CURR OPIN MICROBIOL, V15, P78, DOI 10.1016/j.mib.2011.10.007; Cheng LN, 2011, DEV CELL, V20, P342, DOI 10.1016/j.devcel.2011.01.008; Daou P, 2014, MOL BIOL CELL, V25, P658, DOI 10.1091/mbc.E13-08-0482; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Efergan A, 2016, J IMMUNOL, V196, P1091, DOI 10.4049/jimmunol.1500731; Falcone FH, 2018, IMMUNOL REV, V282, P47, DOI 10.1111/imr.12628; Feniger-Barish R, 2003, BIOCHEMISTRY-US, V42, P2874, DOI 10.1021/bi026783d; Frigeri L, 1999, J IMMUNOL, V162, P2243; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Halova I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00119; Higashio H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22539; Hsu HT, 2016, J CELL BIOL, V215, P875, DOI 10.1083/jcb.201604136; Jung ID, 2009, CELL SIGNAL, V21, P1698, DOI 10.1016/j.cellsig.2009.07.008; Juremalm M, 2005, CHEM IMMUNOL ALLERGY, V87, P130, DOI 10.1159/000087640; Keerthivasan G, 2014, BLOOD, V124, P780, DOI 10.1182/blood-2014-01-552463; Klein O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15047-8; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Kuehn HS, 2010, J CELL SCI, V123, P2576, DOI 10.1242/jcs.071043; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lippert U, 1998, J IMMUNOL, V161, P2600; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Matityahu E, 2002, EUR J IMMUNOL, V32, P3525, DOI 10.1002/1521-4141(200212)32:12<3525::AID-IMMU3525>3.0.CO;2-1; Mei Y, 2017, BLOOD ADV, V1, P1650, DOI 10.1182/bloodadvances.2017007906; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Mukai K, 2018, IMMUNOL REV, V282, P121, DOI 10.1111/imr.12634; Mukai K, 2016, SEMIN IMMUNOPATHOL, V38, P581, DOI 10.1007/s00281-016-0565-1; Munoz I, 2016, J CELL BIOL, V215, P203, DOI 10.1083/jcb.201605073; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Porat-Shliom N, 2013, CELL MOL LIFE SCI, V70, P2099, DOI 10.1007/s00018-012-1156-5; Raghuwanshi SK, 2012, J IMMUNOL, V189, P2824, DOI 10.4049/jimmunol.1201114; Ramirez-Valadez KA, 2017, EUR J IMMUNOL, V47, P1305, DOI 10.1002/eji.201646876; Redegeld FA, 2018, IMMUNOL REV, V282, P87, DOI 10.1111/imr.12629; Richardson RM, 2003, J IMMUNOL, V170, P2904, DOI 10.4049/jimmunol.170.6.2904; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Sen B, 2014, J BONE MINER RES, V29, P78, DOI 10.1002/jbmr.2031; Sheshachalam A, 2017, J LEUKOCYTE BIOL, V102, P71, DOI 10.1189/jlb.2A0616-279RRR; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Singh V, 2014, J IMMUNOL, V192, P2186, DOI 10.4049/jimmunol.1301875; Smith AJ, 2003, TRAFFIC, V4, P302, DOI 10.1034/j.1600-0854.2003.00084.x; Smrz D, 2013, EUR J IMMUNOL, V43, P1873, DOI 10.1002/eji.201243214; Tanizaki H, 2010, BLOOD, V116, P5875, DOI 10.1182/blood-2010-01-264150; TAUB D, 1995, J IMMUNOL, V154, P2393; Toda M, 2004, J BIOL CHEM, V279, P48443, DOI 10.1074/jbc.M408725200; Towns WL, 2009, CELL MOTIL CYTOSKEL, V66, P80, DOI 10.1002/cm.20327; Tumova M, 2010, EUR J IMMUNOL, V40, P3235, DOI 10.1002/eji.201040403; Vicente-Manzanares M, 2003, J IMMUNOL, V171, P1023, DOI 10.4049/jimmunol.171.2.1023; Vosseller K, 1997, MOL BIOL CELL, V8, P909, DOI 10.1091/mbc.8.5.909; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wilson JD, 2016, TRAFFIC, V17, P1027, DOI 10.1111/tra.12418; Yu M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01745-4	69	9	9	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					1074	1090		10.1016/j.jaci.2019.06.028	http://dx.doi.org/10.1016/j.jaci.2019.06.028			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31279009	Bronze, Green Accepted			2022-12-18	WOS:000488803900022
J	Brandt, EB; Lewkowich, IP				Brandt, Eric B.; Lewkowich, Ian P.			RAGE-induced asthma: A role for the receptor for advanced glycation end-products in promoting allergic airway disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; receptor for advanced glycation end-products; high-mobility group box 1 protein; S100A8; S100A9; calprotectin; T(H)2; IL-4; IL-13; signal transducer and activator of transcription 6			[Brandt, Eric B.; Lewkowich, Ian P.] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45221 USA; [Brandt, Eric B.] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA; [Lewkowich, Ian P.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Brandt, EB (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA.	Eric.Brandt@cchmc.org		Brandt, Eric/0000-0003-0617-4100	National Institute of Allergy and Infectious Diseases [2U19AI70235]; National Heart, Lung, and Blood Institute [R01 HL122300]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institute of Allergy and Infectious Diseases grant 2U19AI70235 (to E.B.B.) and National Heart, Lung, and Blood Institute grant R01 HL122300 (to I.P.L.).	Di Candia L, 2017, J ALLERGY CLIN IMMUN, V140, P584, DOI 10.1016/j.jaci.2016.11.049; Hirakawa S, 2011, J IMMUNOL, V186, P4762, DOI 10.4049/jimmunol.1000791; Imbalzano Egidio, 2017, Clin Mol Allergy, V15, P12, DOI 10.1186/s12948-017-0068-1; Kumar V, 2017, NUCLEIC ACIDS RES, V45, P10595, DOI 10.1093/nar/gkx705; Manni ML, 2019, AM J RESP CELL MOL B; Oczypok EA, 2017, PAEDIATR RESPIR REV, V23, P40, DOI 10.1016/j.prrv.2017.03.012; Oczypok EA, 2015, J ALLERGY CLIN IMMUN, V136, P747, DOI 10.1016/j.jaci.2015.03.011; Ojo OO, 2015, AM J PHYSIOL-LUNG C, V309, pL1354, DOI 10.1152/ajplung.00054.2015; Perkins TN, 2019, J ALLERGY CLIN IMMUN, V144, P796, DOI 10.1016/j.jaci.2019.03.019; Ullah MA, 2014, J ALLERGY CLIN IMMUN, V134, P440, DOI 10.1016/j.jaci.2013.12.1035	10	9	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					651	653		10.1016/j.jaci.2019.06.012	http://dx.doi.org/10.1016/j.jaci.2019.06.012			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IW8CV	31251951				2022-12-18	WOS:000485222300005
J	Wang, YQ; Nakahashi-Oda, C; Okayama, Y; Shibuya, A				Wang, Yaqiu; Nakahashi-Oda, Chigusa; Okayama, Yoshimichi; Shibuya, Akira			Autonomous regulation of IgE-mediated mast cell degranulation and immediate hypersensitivity reaction by an inhibitory receptor CD300a	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PHOSPHATIDYLSERINE; EXPOSURE		[Wang, Yaqiu] Univ Tsukuba, Sch Integrat & Global Majors, PhD Program Human Biol, Tsukuba, Ibaraki, Japan; [Wang, Yaqiu; Nakahashi-Oda, Chigusa; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan; [Wang, Yaqiu; Shibuya, Akira] Univ Tsukuba, TARA, Life Sci Ctr Survival Dynam, Tsukuba, Ibaraki, Japan; [Okayama, Yoshimichi] Nihon Univ, Sch Med, Allergy & Immunol Project Team, Ctr Inst Res & Med Educ,Itabashi Ku, Tokyo, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Nihon University	Nakahashi-Oda, C (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan.	chigusano@md.tsukuba.ac.jp; ashibuya@md.tsukuba.ac.jp	Okayama, Yoshimichi/AAG-4352-2021	Wang, Yaqiu/0000-0002-6827-5495	Japan Society for the Promotion of Science (KAKENHI) [16H06387, 18H05022, 16H05350, 17H05495]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants provided by the Japan Society for the Promotion of Science (KAKENHI) (grant nos. 16H06387 and 18H05022 to A.S. and grant nos. 16H05350 and 17H05495 to C.N.-O.).	Elliott JI, 2006, BLOOD, V108, P1611, DOI 10.1182/blood-2005-11-012328; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; Joulia R, 2017, J ALLERGY CLIN IMMUN, V140, P497, DOI 10.1016/j.jaci.2016.09.049; Lee H, 2013, ARTHRITIS RHEUM-US, V65, P109, DOI 10.1002/art.37741; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Martin S, 2000, INT ARCH ALLERGY IMM, V123, P249, DOI 10.1159/000024451; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Nakahashi-Oda C, 2012, BIOCHEM BIOPH RES CO, V417, P646, DOI 10.1016/j.bbrc.2011.12.025; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	14	9	9	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					323	+		10.1016/j.jaci.2019.03.005	http://dx.doi.org/10.1016/j.jaci.2019.03.005			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	31155312	Green Submitted, hybrid			2022-12-18	WOS:000473432800038
J	Cheminant, M; Mahlaoui, N; Desconclois, C; Canioni, D; Ysebaert, L; Dupre, L; Vasconcelos, Z; Malphettes, M; Moshous, D; Neven, B; Rohrlich, PS; Bernard, M; Bertrand, Y; Fischer, A; Suarez, F				Cheminant, Morgane; Mahlaoui, Nizar; Desconclois, Celine; Canioni, Danielle; Ysebaert, Loic; Dupre, Loic; Vasconcelos, Zilton; Malphettes, Marion; Moshous, Despina; Neven, Benedicte; Rohrlich, Pierre-Simon; Bernard, Marc; Bertrand, Yves; Fischer, Alain; Suarez, Felipe			Lymphoproliferative disease in patients with Wiskott-Aldrich syndrome: Analysis of the French Registry of Primary Immunodeficiencies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MUTATIONS; WASP		[Cheminant, Morgane; Suarez, Felipe] Necker Univ Hosp, AP HP, Clin Hematol, Paris, France; [Cheminant, Morgane; Canioni, Danielle; Moshous, Despina; Neven, Benedicte; Fischer, Alain; Suarez, Felipe] Sorbonne Paris Cite Univ, Paris Descartes Univ, Imagine Inst, Paris, France; [Cheminant, Morgane; Suarez, Felipe] INSERM, UMR1163, Paris, France; [Cheminant, Morgane; Suarez, Felipe] CNRS, URL 8254, Lab Cellular & Mol Mech Hematol Disorders & Thera, Paris, France; [Cheminant, Morgane; Mahlaoui, Nizar; Moshous, Despina; Neven, Benedicte; Fischer, Alain; Suarez, Felipe] Necker Univ Hosp, AP HP, French Natl Reference Ctr Primary Immune Deficien, Paris, France; [Mahlaoui, Nizar; Moshous, Despina; Neven, Benedicte; Fischer, Alain] Necker Univ Hosp, AP HP, Pediat Immunohematol & Rheumatol Unit, Paris, France; [Canioni, Danielle] Necker Univ Hosp, AP HP, Dept Pathol, Paris, France; [Desconclois, Celine] Kremlin Bicetre Univ Hosp, AP HP, Biol Hematol, Paris, France; [Ysebaert, Loic] Inst Univ Canc Toulouse Oncopole, Clin Hematol, Toulouse, France; [Dupre, Loic; Vasconcelos, Zilton] INSERM, UMR1043, Ctr Pathophysiol Toulouse Purpan, Toulouse, France; [Dupre, Loic; Vasconcelos, Zilton] Paul Sabatier Univ, CNRS, UMR5282, Toulouse, France; [Vasconcelos, Zilton] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil; [Malphettes, Marion] St Louis Univ Hosp, AP HP, Dept Immunol, Paris, France; [Rohrlich, Pierre-Simon] Univ Cote Azur, Nice Univ Hosp, Nice, France; [Bernard, Marc] Pontchaillou Univ Hosp, Clin Hematol, Rennes, France; [Bertrand, Yves] Claude Bernard Univ, IHOP, Dept Immunohematopediat, Lyon, France; [Fischer, Alain] Coll France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Fundacao Oswaldo Cruz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Rennes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; PSL Research University Paris; College de France	Suarez, F (corresponding author), Necker Univ Hosp, AP HP, Clin Hematol, Paris, France.; Suarez, F (corresponding author), Sorbonne Paris Cite Univ, Paris Descartes Univ, Imagine Inst, Paris, France.; Suarez, F (corresponding author), INSERM, UMR1163, Paris, France.; Suarez, F (corresponding author), CNRS, URL 8254, Lab Cellular & Mol Mech Hematol Disorders & Thera, Paris, France.; Suarez, F (corresponding author), Necker Univ Hosp, AP HP, French Natl Reference Ctr Primary Immune Deficien, Paris, France.	felipe.suarez@aphp.fr	MAHLAOUI, Nizar/AAH-6103-2020; Vasconcelos, Zilton/AAD-5784-2019; Ysebaert, Loic/H-1554-2016; dupre, loic/L-8174-2014	MAHLAOUI, Nizar/0000-0002-0030-8094; Vasconcelos, Zilton/0000-0002-2193-2224; Ysebaert, Loic/0000-0001-8478-5623; dupre, loic/0000-0002-7278-6503	French Association of Patients with Primary Immuno-deficiencies (IRIS); French Ministry of Health; LFB; GlaxoSmithKline; CSL Behring; Baxalta; Octapharma; Binding Site; AT-Europe; Trophee Guillaume	French Association of Patients with Primary Immuno-deficiencies (IRIS); French Ministry of Health; LFB; GlaxoSmithKline(GlaxoSmithKline); CSL Behring; Baxalta; Octapharma; Binding Site; AT-Europe; Trophee Guillaume	CEREDIH is supported by the French Association of Patients with Primary Immuno-deficiencies (IRIS) and is funded by the French Ministry of Health. It additionally received unrestricted educational grants from LFB, GlaxoSmithKline, CSL Behring, Baxalta, Octapharma, the Binding Site, and the patient associations AT-Europe and Trophee Guillaume. The ESID (European Society for Immune Deficiencies) Online Registry Database was used for collecting data for the CEREDIH Registry.	Albert MH, 2018, ASH ANN M SAN DIEG C; Albert MH, 2010, BLOOD, V115, P3231, DOI 10.1182/blood-2009-09-239087; Beaute J, 2010, CLIN IMMUNOL, V135, P264, DOI 10.1016/j.clim.2010.02.021; Candotti F, 2018, J CLIN IMMUNOL, V38, P13, DOI 10.1007/s10875-017-0453-z; COTELINGAM JD, 1985, CANCER INVEST, V3, P515, DOI 10.3109/07357908509039813; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Moratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569	10	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2311	+		10.1016/j.jaci.2019.01.046	http://dx.doi.org/10.1016/j.jaci.2019.01.046			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30796981	Bronze			2022-12-18	WOS:000470113200042
J	Hardman, C; Chen, WT; Luo, J; Batty, P; Chen, YL; Nahler, J; Wu, YQ; Pavord, ID; Erpenbeck, VJ; Sandham, DA; Xue, LZ; Ogg, G				Hardman, Clare; Chen, Wentao; Luo, Jian; Batty, Paul; Chen, Yi-Ling; Nahler, Janina; Wu, Yanqiu; Pavord, Ian D.; Erpenbeck, Veit J.; Sandham, David A.; Xue, Luzheng; Ogg, Graham			Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA		[Hardman, Clare; Chen, Yi-Ling; Nahler, Janina; Ogg, Graham] Univ Oxford, MRC Human Immunol Unit, Oxford, England; [Hardman, Clare; Chen, Yi-Ling; Nahler, Janina; Ogg, Graham] Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford, England; [Chen, Wentao; Luo, Jian; Batty, Paul; Wu, Yanqiu; Pavord, Ian D.; Xue, Luzheng] Univ Oxford, Resp Med Unit, Oxford, England; [Chen, Wentao; Luo, Jian; Batty, Paul; Wu, Yanqiu; Pavord, Ian D.; Xue, Luzheng] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Erpenbeck, Veit J.] Novartis Pharma AG, Basel, Switzerland; [Sandham, David A.] Novartis Inst Biomed Res, Cambridge, MA USA	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Novartis; Novartis	Ogg, G (corresponding author), Univ Oxford, MRC Human Immunol Unit, Oxford, England.; Ogg, G (corresponding author), Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford, England.	graham.ogg@ndm.ox.ac.uk	; Chen, Wentao/P-5076-2018	Luo, Jian/0000-0001-9009-065X; Batty, Paul/0000-0002-9807-5099; Hardman, Clare/0000-0002-1127-6446; Chen, Yi-Ling/0000-0003-3758-0638; Chen, Wentao/0000-0003-1705-2299; Ogg, Graham/0000-0002-3097-045X	Novartis; MRC [MC_UU_12010/5, G116/150, MC_PC_14131, MC_UU_00008/5, MC_PC_14103, MC_U137881017, G0701693] Funding Source: UKRI	Novartis(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a research grant to G.O. and L.X. from Novartis administered through the University of Oxford. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute of Health Research (NIHR), or the Department of Health.	Bateman ED, 2017, EUR RESPIR J, V50; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Gonem S, 2016, LANCET RESP MED, V4, P699, DOI 10.1016/S2213-2600(16)30179-5; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hilvering B, 2018, MUCOSAL IMMUNOL, V11, P1408, DOI 10.1038/s41385-018-0049-9; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Nagakumar P, 2016, J ALLERGY CLIN IMMUN, V137, P624, DOI 10.1016/j.jaci.2015.06.038; Sandham DA, 2017, ACS MED CHEM LETT, V8, P582, DOI 10.1021/acsmedchemlett.7b00157; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056	9	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2329	+		10.1016/j.jaci.2019.02.015	http://dx.doi.org/10.1016/j.jaci.2019.02.015			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30825466	Bronze, Green Submitted			2022-12-18	WOS:000470113200047
J	Skinner, OP; Jurczyluk, J; Baker, PJ; Masters, SL; Wilks, AGR; Clearwater, MS; Robertson, AAB; Schroder, K; Mehr, S; Munoz, MA; Rogers, MJ				Skinner, Oliver P.; Jurczyluk, Julie; Baker, Paul J.; Masters, Seth L.; Wilks, Alicia G. Rios; Clearwater, Misaki S.; Robertson, Avril A. B.; Schroder, Kate; Mehr, Sam; Munoz, Marcia A.; Rogers, Michael J.			Lack of protein prenylation promotes NLRP3 inflammasome assembly in human monocytes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ACTIVATION		[Skinner, Oliver P.; Jurczyluk, Julie; Wilks, Alicia G. Rios; Clearwater, Misaki S.; Munoz, Marcia A.; Rogers, Michael J.] Garvan Inst Med Res, Bone Biol, Sydney, NSW, Australia; [Skinner, Oliver P.; Jurczyluk, Julie; Wilks, Alicia G. Rios; Clearwater, Misaki S.; Munoz, Marcia A.; Rogers, Michael J.] UNSW Sydney, St Vincents Clin Sch, Sydney, NSW, Australia; [Baker, Paul J.; Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Melbourne, Vic, Australia; [Robertson, Avril A. B.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Schroder, Kate] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Mehr, Sam] Royal Childrens Hosp, Dept Allergy Immunol, Melbourne, Vic, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Queensland; University of Queensland; Royal Children's Hospital Melbourne	Rogers, MJ (corresponding author), Garvan Inst Med Res, Bone Biol, Sydney, NSW, Australia.; Rogers, MJ (corresponding author), UNSW Sydney, St Vincents Clin Sch, Sydney, NSW, Australia.	m.rogers@garvan.org.au	Masters, Seth L/N-2886-2013; Robertson, Avril/A-4043-2012; Schroder, Kate/C-6132-2008	Masters, Seth L/0000-0003-4763-576X; Robertson, Avril/0000-0002-9652-8357; Schroder, Kate/0000-0001-9261-3805; Munoz, Marcia/0000-0001-7603-0351; Rogers, Michael/0000-0002-1818-9249; Skinner, Oliver/0000-0003-0898-4131	NHMRC [APP1139644]; Allergy and Immunology Foundation of Australasia; Mrs Janice Gibson and the Ernest Heine Family Foundation; Marian AMP; E.H. Flack Trust	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Allergy and Immunology Foundation of Australasia; Mrs Janice Gibson and the Ernest Heine Family Foundation; Marian AMP; E.H. Flack Trust	Supported in part by NHMRC project grant APP1139644 (to M.J.R.), a grant from the Allergy and Immunology Foundation of Australasia (to M.A.M. and M.J.R.), Mrs Janice Gibson and the Ernest Heine Family Foundation, and the Marian & E.H. Flack Trust.	Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Guo CS, 2018, IMMUNITY, V49, P842, DOI 10.1016/j.immuni.2018.08.021; Jurczyluk J, 2016, IMMUNOL CELL BIOL, V94, P994, DOI 10.1038/icb.2016.58; Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194; Munoz MA, 2017, J ALLERGY CLIN IMMUN, V140, P873, DOI 10.1016/j.jaci.2017.02.033; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Stoffels M, 2015, RHEUMATOLOGY, V54, P363, DOI 10.1093/rheumatology/keu341	9	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2315	+		10.1016/j.jaci.2019.02.013	http://dx.doi.org/10.1016/j.jaci.2019.02.013			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30797829	hybrid			2022-12-18	WOS:000470113200043
J	Kercsmar, CM; Sorkness, CA; Calatroni, A; Gergen, PJ; Bloomberg, GR; Gruchalla, RS; Kattan, M; Liu, AH; O'Connor, GT; Pongracic, JA; Szefler, SJ; Teach, SJ; Wildfire, JJ; Wood, RA; Zoratti, EM; Busse, WW				Kercsmar, Carolyn M.; Sorkness, Christine A.; Calatroni, Agustin; Gergen, Peter J.; Bloomberg, Gordon R.; Gruchalla, Rebecca S.; Kattan, Meyer; Liu, Andrew H.; O'Connor, George T.; Pongracic, Jacqueline A.; Szefler, Stanley J.; Teach, Stephen J.; Wildfire, Jeremy J.; Wood, Robert A.; Zoratti, Edward M.; Busse, William W.		Natl Inst Allergy Infect Dis	A computerized decision support tool to implement asthma guidelines for children and adolescents	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma guidelines; asthma control; decision support; inner-city asthma	MEDICATION USE; CARE; ADHERENCE; MANAGEMENT; SPECIALISTS; OMALIZUMAB; SYSTEM; TRIAL	Background: Multicenter randomized controlled trials (RCTs) for asthma management that incorporate usual-care regimens could benefit from standardized application of evidence-based guidelines. Objective: We sought to evaluate performance of a computerized decision support tool, the Asthma Control Evaluation and Treatment (ACET) Program, to standardize usual-care regimens for asthma management in RCTs. Methods: Children and adolescents with persistent uncontrolled asthma living in urban census tracts were recruited into 3 multicenter RCTs (each with a usual-care arm) between 2004 and 2014. A computerized decision support tool scored asthma control and assigned an appropriate treatment step based on published guidelines. Control-level determinants (symptoms, rescue medication use, pulmonary function measure, and adherence estimates) were collected at visits and entered into the ACET Program. Changes in control levels and treatment steps were examined during the trials. Results: At screening, more than half of the participants were rated as having symptoms that were not controlled or poorly controlled. The proportion of participants who gained good control between screening and randomization increased significantly in all 3 trials. Between 51% and 70% had symptoms that were well controlled by randomization. The proportion of well-controlled participants remained constant or improved slightly from randomization until the last posttreatment visit. Nighttime symptoms were the most common control-level determinant; there were few (< 1%) instances of complete overlap of factors. FEV1 was the driver of control-level assignment in 30% of determinations. Conclusion: The ACET Program decision support tool facilitated standardized asthma assessment and treatment in multicenter RCTs and was associated with attaining and maintaining good asthma control in most participants.	[Kercsmar, Carolyn M.] Univ Cincinnati, Coll Med, Dept Pediat, Div Pulm Med,Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Sorkness, Christine A.; Busse, William W.] Univ Wisconsin, Dept Med, Div Allergy & Immunol, Sch Med & Publ Hlth, Madison, WI USA; [Calatroni, Agustin; Wildfire, Jeremy J.] Rho Fed Syst Div, Chapel Hill, NC USA; [Gergen, Peter J.] NIH, Div Allergy Immunol & Transplantat, Bldg 10, Bethesda, MD 20892 USA; [Bloomberg, Gordon R.] Washington Univ, Sch Med, Dept Pediat, Div Pediat Allergy Immunol & Pulm Med, St Louis, MO 63110 USA; [Gruchalla, Rebecca S.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Pediat, Div Allergy & Immunol, Dallas, TX 75390 USA; [Kattan, Meyer] Columbia Univ, Dept Pediat, Div Pediat Pulmonol, Coll Phys & Surg, New York, NY 10027 USA; [Liu, Andrew H.] Childrens Hosp Colorado, Div Pulm Med, Dept Pediat, Aurora, CO USA; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Div Pulm Allergy Sleep & Crit Care Med, Boston, MA 02118 USA; [Pongracic, Jacqueline A.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Allergy & Immunol, Chicago, IL 60611 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Div Pulm Med, Dept Pediat, Denver, CO USA; [Szefler, Stanley J.] Univ Colorado, Denver Sch Med, Denver, CO 80202 USA; [Teach, Stephen J.] Childrens Natl Med Ctr, Dept Pediat, Div Emergency Med & Trauma Serv, Washington, DC 20010 USA; [Wood, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Baltimore, MD 21205 USA; [Zoratti, Edward M.] Henry Ford Hlth Syst, Div Allergy & Immunol, Dept Pediat, Detroit, MI USA; [Zoratti, Edward M.] Wayne State Univ, Sch Med, Detroit, MI USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; Children's Hospital Colorado; Boston University; Ann & Robert H. Lurie Children's Hospital of Chicago; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's National Health System; Johns Hopkins University; Henry Ford Health System; Henry Ford Hospital; Wayne State University	Kercsmar, CM (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 7041, Cincinnati, OH 45229 USA.	carolyn.kercsmar@cchmc.org			National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [NO1-AI-25496, NO1-AI-25482, HHSN272200900052C, HHSN272201000052I, 1UM1AI114271-01, UM1AI109565, UM2AI117870]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [NCRR/NIH RR00052, M01RR00533, UL1RR025741, UL1TR000451, UL1RR024982, M01RR00071, 1UL1RR024156, 5M01RR020359-04, UL1RR031988, 1ULRR025771, 1UL1RR 025780, 1UL1RR031988, UL1TR000150, UL1TR000077-04]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [5R01AI098077];  [UL1TR001105];  [1UL1RR025780];  [UL1TR000154];  [NCATS/NIH UL1TR001082];  [UL1TR000040];  [UL1TR000075]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075, UL1TR001422, UL1TR001105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI109565, UM1AI114271, UM2AI117870] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract numbers NO1-AI-25496, NO1-AI-25482, HHSN272200900052C, HHSN272201000052I, 1UM1AI114271-01, UM1AI109565, and UM2AI117870. Additional support was provided by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health under grants NCRR/NIH RR00052, M01RR00533, UL1RR025741, UL1TR000451, UL1RR024982, M01RR00071, 1UL1RR024156, 5M01RR020359-04, UL1RR031988, 1ULRR025771, 1UL1RR 025780, 1UL1RR031988, UL1TR000150, UL1TR000077-04, UL1TR001105, 1UL1RR025780, UL1TR000154, NCATS/NIH UL1TR001082, UL1TR000040, UL1TR000075, and National Institutes of Health/National Institute of Allergy and Infectious Diseases 5R01AI098077. The authors gratefully acknowledge receiving donated product for these studies from Lincoln Diagnostics (skin testing materials), GlaxoSmithKline (study drug), Novartis Pharmaceuticals (study drug and EpiPens), SC Johnson (household pest control), Mylan (EpiPens), and BF Ascher & Co (Ayr nasal rinse).	Akinbami Lara J, 2011, Natl Health Stat Report, P1; [Anonymous], 2015, GLOB STRAT ASTHM MAN; Asthma and Allergy Foundation of America, ASTHM FACTS FIG; Backer V, 2006, ANN ALLERG ASTHMA IM, V97, P490, DOI 10.1016/S1081-1206(10)60940-4; Beck AF, 2014, PEDIATRICS, V133, P431, DOI 10.1542/peds.2013-2437; Busse WW, 2007, J ALLERGY CLIN IMMUN, V119, P43, DOI 10.1016/j.jaci.2006.10.021; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Butz AM, 2006, PEDIATRICS, V118, P2504, DOI 10.1542/peds.2006-1630; Cloutier MM, 2016, CURR OPIN ALLERGY CL, V16, P142, DOI 10.1097/ACI.0000000000000242; Dexheimer JW, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-82; Dexheimer JW, 2015, KNOWLEDGE MANAGEMENT, V7, P353; Evans R, 1999, J PEDIATR-US, V135, P332, DOI 10.1016/S0022-3476(99)70130-7; Fuhlbrigge A, 2009, ALLERGY ASTHMA PROC, V30, P529, DOI 10.2500/aap.2009.30.3276; Halterman JS, 2000, PEDIATRICS, V105, P272; Hoeksema LJ, 2011, J AM MED INFORM ASSN, V18, P243, DOI 10.1136/amiajnl-2010-000063; Janson S, 2004, J ASTHMA, V41, P343, DOI 10.1081/JAS-120026093; Kit BK, 2012, PEDIATRICS, V129, P62, DOI 10.1542/peds.2011-1513; Kuhn L, 2015, J AM BOARD FAM MED, V28, P382, DOI 10.3122/jabfm.2015.03.140248; Larsson J., VERSION 1 0 0 EULERR; Lomotan EA, 2012, INT J MED INFORM, V81, P157, DOI 10.1016/j.ijmedinf.2011.11.004; National Institutes of Health. Heart Lung and Blood Institute, 2007, 3 NAT I HLTH HEART L; Navaratnam P, 2008, ANN ALLERG ASTHMA IM, V100, P216, DOI 10.1016/S1081-1206(10)60445-0; Okelo SO, 2013, PEDIATRICS, V132, P517, DOI 10.1542/peds.2013-0779; Rand CS, 2008, J ALLERGY CLIN IMMUN, V122, P319, DOI 10.1016/j.jaci.2008.07.004; Sarkar D, 2008, USE R, P1; Slejko JF, 2014, J ALLERGY CLIN IMMUN, V133, P1579, DOI 10.1016/j.jaci.2013.10.028; Sullivan PW, 2014, J ASTHMA, V51, P769, DOI 10.3109/02770903.2014.906607; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; Wisnivesky JP, 2008, ANN ALLERG ASTHMA IM, V101, P264, DOI 10.1016/S1081-1206(10)60491-7	30	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1760	1768		10.1016/j.jaci.2018.10.060	http://dx.doi.org/10.1016/j.jaci.2018.10.060			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30529451	Bronze, Green Accepted			2022-12-18	WOS:000466784600012
J	Thakur, N; Borrell, LN; Ye, M; Oh, SS; Eng, C; Meade, K; Avila, PC; Farber, HJ; Serebrisky, D; Brigino-Buenaventura, E; Rodriguez-Cintron, W; Kumar, R; Bibbins-Domingo, K; Thyne, S; Sen, S; Rodriguez-Santana, JR; Burchard, EG				Thakur, Neeta; Borrell, Luisa N.; Ye, Morgan; Oh, Sam S.; Eng, Celeste; Meade, Kelley; Avila, Pedro C.; Farber, Harold J.; Serebrisky, Denise; Brigino-Buenaventura, Emerita; Rodriguez-Cintron, William; Kumar, Rajesh; Bibbins-Domingo, Kirsten; Thyne, Shannon; Sen, Saunak; Rodriguez-Santana, Jose R.; Burchard, Esteban G.			Acculturation is associated with asthma burden and pulmonary function in Latino youth: The GALA II study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Latino; asthma; acculturation; pediatric; health disparities; social determinants of health	LOW-BIRTH-WEIGHT; CHILDHOOD ASTHMA; UNITED-STATES; LUNG-FUNCTION; BRONCHODILATOR RESPONSE; RESPIRATORY HEALTH; MATERNAL SMOKING; GENETIC ANCESTRY; CHILDREN; US	Background: Acculturation is an important predictor of asthma in Latino youth, specifically Mexican Americans. Less is known about acculturation and pulmonary function measures. Objective: We sought to estimate the association of acculturation measures with asthma and pulmonary function in Latino youth and determine whether this association varies across Latino subgroups. Methods: We included 1849 Latinos (302 Caribbean Spanish, 193 Central or South Americans, 1136 Mexican Americans, and 218 other Latino children) aged 8 to 21 years from 4 urban regions in the United States. Acculturation measures include nativity status, age of immigration, language of preference, and generation in the United States. We used multivariable logistic and linear regression models to quantify the association of acculturation factors with the presence of asthma (case-control study) and pulmonary function (case-only study), adjusting for demographic, socioenvironmental, and clinical variables. Results: For all acculturation measures (nativity status, age of immigration, language of preference, and generation in the United States), greater levels of acculturation were associated with greater odds of asthma. Among cases, high (English preference) and medium (equal preference for Spanish and English) levels of language acculturation were associated with decreased bronchodilator response compared with low (Spanish preference) levels (P = .009 and .02, respectively). Similarly, high language acculturation was associated with increased FEV1 compared with low language acculturation (P = .02). There was insufficient evidence of heterogeneity for associations across Latino subgroups. Conclusions: Acculturation was associated with diagnosed asthma and pulmonary function in Latino children and is an important factor to consider in the management of Latino youth with asthma.	[Thakur, Neeta; Ye, Morgan; Oh, Sam S.; Eng, Celeste; Bibbins-Domingo, Kirsten; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, 550 16th St,2nd Floor, San Francisco, CA 94143 USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Borrell, Luisa N.] CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Meade, Kelley] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Avila, Pedro C.] Allergy ENT & Associates, The Woodlands, TX USA; [Farber, Harold J.] Baylor Coll Med, Dept Pediat, Sect Pulmonol, Houston, TX 77030 USA; [Farber, Harold J.] Texas Childrens Hosp, Houston, TX 77030 USA; [Serebrisky, Denise] Jacobi Med Ctr, Pediat Pulm Div, Bronx, NY USA; [Brigino-Buenaventura, Emerita] Kaiser Permanente Vallejo Med Ctr, Dept Allergy & Immunol, Vallejo, CA USA; [Rodriguez-Cintron, William] Vet Caribbean Hlth Care Syst, San Juan, PR USA; [Kumar, Rajesh] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Thyne, Shannon] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Sen, Saunak] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Rodriguez-Santana, Jose R.] Ctr Neumol Pediat, San Juan, PR USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; City University of New York (CUNY) System; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Baylor College of Medicine; Baylor College of Medicine; Jacobi Medical Center; Kaiser Permanente; Ann & Robert H. Lurie Children's Hospital of Chicago; University of California System; University of California Los Angeles; University of Tennessee System; University of Tennessee Health Science Center	Thakur, N (corresponding author), Univ Calif San Francisco, Dept Med, 550 16th St,2nd Floor, San Francisco, CA 94143 USA.	Neeta.Thakur@ucsf.edu	Borrell, Luisa N./G-8753-2018	Borrell, Luisa N./0000-0002-0560-4853; Kumar, Rajesh/0000-0002-1962-7108	Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II; National Heart, Lung, and Blood Institute [1R01HL117004, R01Hl128439, R01HL135156, 1X01HL134589, K12-HL119997, K23-HL125551-01A1]; National Institute of Health and Environmental Health Sciences [R01ES015794, R21ES24844]; National Institute on Minority Health and Health Disparities [1P60MD006902, U54MD009523, 1R01MD010443]; Tobacco-Related Disease Research Program [24RT-0025]; National Institute of General Medical Sciences [T32-GM007546]; Parker B. Francis Fellowship Program; American Thoracic Society;  [M01-RR00188]	Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Health and Environmental Health Sciences; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Tobacco-Related Disease Research Program(University of California System); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Parker B. Francis Fellowship Program; American Thoracic Society; 	Supported in part by the Sandler Family Foundation, the American Asthma Foundation, the RWJF Amos Medical Faculty Development Program, the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II, the National Heart, Lung, and Blood Institute (1R01HL117004, R01Hl128439, R01HL135156, and 1X01HL134589), the National Institute of Health and Environmental Health Sciences (R01ES015794 and R21ES24844), the National Institute on Minority Health and Health Disparities (1P60MD006902, U54MD009523, and 1R01MD010443), and the Tobacco-Related Disease Research Program (award no. 24RT-0025). Grant M01-RR00188 went to H.J.F., and N.T. was supported by an institutional training grant from the National Institute of General Medical Sciences (T32-GM007546) and career development awards from the National Heart, Lung, and Blood Institute (K12-HL119997 and K23-HL125551-01A1), the Parker B. Francis Fellowship Program, and the American Thoracic Society. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abid Z, 2016, CLIN EXP ALLERGY, V46, P1398, DOI 10.1111/cea.12765; Abraido-Lanza AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI 10.2105/AJPH.89.10.1543; Acevedo-Garcia D, 2005, SOC SCI MED, V61, P1223, DOI 10.1016/j.socscimed.2005.01.027; Acevedo-Garcia D, 2008, LATINAS/OS IN THE UNITED STATES: CHANGING THE FACE OF AMERICA, P101, DOI 10.1007/978-0-387-71943-6_7; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bandoli G, 2015, J IMMIGR MINOR HEALT, V17, P1739, DOI 10.1007/s10903-015-0158-4; Barr RG, 2016, AM J RESP CRIT CARE, V193, P386, DOI 10.1164/rccm.201506-1211OC; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Brehm JM, 2015, AM J RESP CRIT CARE, V192, P47, DOI 10.1164/rccm.201501-0037OC; Brooks AM, 2001, ARCH PEDIAT ADOL MED, V155, P401, DOI 10.1001/archpedi.155.3.401; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Cabieses B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105347; Callister LC, 2002, J PERINAT NEONAT NUR, V16, P22, DOI 10.1097/00005237-200212000-00005; Chan KS, 2005, ARCH PEDIAT ADOL MED, V159, P283, DOI 10.1001/archpedi.159.3.283; Chavez-Payan Paola, 2015, Hisp Health Care Int, V13, P119, DOI 10.1891/1540-4153.13.3.119; Clark LP, 2017, ENV HLTH PERSPECT, P125; Coker TR, 2012, HEALTH SERV RES, V47, P431, DOI 10.1111/j.1475-6773.2011.01339.x; Crespo NC, 2011, J CHILD HEALTH CARE, V15, P358, DOI 10.1177/1367493510397680; Devoe JE, 2012, J PEDIATR HEALTH CAR, V26, pE25, DOI 10.1016/j.pedhc.2011.01.003; Dumanovsky T, 2007, J ASTHMA, V44, P297, DOI 10.1080/02770900701344140; Eldeirawi K, 2005, J ALLERGY CLIN IMMUN, V116, P42, DOI 10.1016/j.jaci.2005.03.041; Eldeirawi K, 2009, J ASTHMA, V46, P796, DOI 10.3109/02770900903114572; Farah CS, 2012, RESPIROLOGY, V17, P412, DOI 10.1111/j.1440-1843.2011.02080.x; Forno E, 2009, CURR OPIN ALLERGY CL, V9, P154, DOI 10.1097/ACI.0b013e3283292207; Gallo LC, 2009, J PERS, V77, P1707, DOI 10.1111/j.1467-6494.2009.00598.x; Gent JF, 2012, ENVIRON RES, V118, P86, DOI 10.1016/j.envres.2012.07.005; Gibson MV, 2005, BIRTH-ISS PERINAT C, V32, P93, DOI 10.1111/j.0730-7659.2005.00351.x; Gilliland FD, 2003, AM J RESP CRIT CARE, V167, P917, DOI 10.1164/rccm.200206-616OC; Gilliland FD, 2001, AM J RESP CRIT CARE, V163, P429, DOI 10.1164/ajrccm.163.2.2006009; Grineski SE, 2016, J PUBLIC HEALTH-UK, V38, P441, DOI 10.1093/pubmed/fdv086; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Heffler E, 2016, RESP MED, V112, P45, DOI 10.1016/j.rmed.2016.01.012; Holguin F, 2005, AM J RESP CRIT CARE, V171, P103, DOI 10.1164/rccm.200402-143OC; Huh J, 2008, J IMMIGR MINOR HEALT, V10, P103, DOI 10.1007/s10903-007-9065-7; Iqbal S, 2014, AM J PUBLIC HEALTH, V104, pS175, DOI 10.2105/AJPH.2013.301509; Jacobs DE, 2011, AM J PUBLIC HEALTH, V101, pS115, DOI 10.2105/AJPH.2010.300058; Jerschow E, 2017, AM J PREV MED, V52, P579, DOI 10.1016/j.amepre.2016.12.018; Kandula NR, 2004, HEALTH SERV RES, V39, P1509, DOI 10.1111/j.1475-6773.2004.00301.x; Klinnert MD, 2003, PEDIATRICS, V112, P49, DOI 10.1542/peds.112.1.49; Koinis-Mitchell D, 2011, J PEDIATR PSYCHOL, V36, P1130, DOI 10.1093/jpepsy/jsr041; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lara M, 2006, PEDIATRICS, V117, P43, DOI 10.1542/peds.2004-1714; Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615; Martin MA, 2007, AM J PUBLIC HEALTH, V97, P1290, DOI 10.2105/AJPH.2006.092239; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; Morales LS, 2002, J HEALTH CARE POOR U, V13, P477, DOI 10.1177/104920802237532; Motel S, 2012, 10 LARGEST HISPANIC; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; Oh SS, 2012, J ALLERGY CLIN IMMUN, V129, P1478, DOI 10.1016/j.jaci.2012.03.017; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; RCore Team, 2016, R LANG ENV STAT COMP; RODE A, 1994, RESPIRATION, V61, P187; Rudmin F, 2009, INT J INTERCULT REL, V33, P106, DOI 10.1016/j.ijintrel.2008.12.001; Saad NJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178962; Salam MT, 2015, PLOS ONE, V10, P1; Sianez M, 2018, J IMMIGR MINOR HEALT, V20, P884, DOI 10.1007/s10903-017-0627-z; Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8; Sundquist J, 2000, INT J EPIDEMIOL, V29, P470, DOI 10.1093/ije/29.3.470; Svarstad BL, 1999, PATIENT EDUC COUNS, V37, P113, DOI 10.1016/S0738-3991(98)00107-4; Svendsen ER, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-55; Thakur N, 2013, AM J RESP CRIT CARE, V188, P1202, DOI 10.1164/rccm.201306-1016OC; Turra CM, 2007, J GERONTOL B-PSYCHOL, V62, pS184, DOI 10.1093/geronb/62.3.S184; Villamor E, 2009, AM J EPIDEMIOL, V169, P1337, DOI 10.1093/aje/kwp054; Wardlaw TM, 2004, LOW BIRTHW COUNTR RE; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Wisnivesky JP, 2009, MED CARE, V47, P243, DOI 10.1097/MLR.0b013e3181847606; Zahran HS, 2018, MMWR-MORBID MORTAL W, V67, P149, DOI 10.15585/mmwr.mm6705e1; 2016, ANN REV PUBLIC HLTH, V37, P219; 2006, AM J PUBLIC HLTH, V96, P1342	70	9	9	3	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1914	1922		10.1016/j.jaci.2018.12.1015	http://dx.doi.org/10.1016/j.jaci.2018.12.1015			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	HW6FP	30682453	Green Accepted, Bronze			2022-12-18	WOS:000466784600026
J	Greenberger, PA				Greenberger, Paul A.			Hypersensitivity pneumonitis: A fibrosing alveolitis produced by inhalation of diverse antigens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hypersensitivity; pneumonitis; avian; restrictive; lymphocytes; precipitins; granulomas; thermophilic	T-CELLS; LUNG; DIAGNOSIS	Hypersensitivity pneumonitis (HP) is a TH1 lymphocyte-biased fibrosing alveolitis caused by antigens ranging from avian excreta, fungi, thermophilic bacteria, and protozoa to reactive chemicals found in the workplace. Mimicking a viral syndrome, acute exposures to inciting antigens cause abrupt onset of nonproductive cough, dyspnea, and chills with arthralgias or malaise usually from 4 to 8 hours later so that the temporal relationship between antigen exposure and symptoms might be unsuspected. The histology of HP reveals prominent lymphocyte infiltrates that thicken the alveolar septa with poorly formed granulomas or giant cells. Bronchoalveolar lavage fluid demonstrates greater than 20% lymphocytes in nearly all patients. Abnormalities on high-resolution computed tomographic examinations range from nodular centrilobular opacities in acute/ subacute disease to increased reticular markings and honeycombing fibrosis, which typically are predominant in the upper lobes, in patients with advanced disease. Descriptors include "mosaic" attenuation and groundglass opacities. Repeated episodes can result in nodular pulmonary infiltrates and suspected nonspecific interstitial pneumonia or idiopathic pulmonary fibrosis. Clinicians require a high level of suspicion to make an early diagnosis of HP before extensive pulmonary fibrosis or restrictive lung disease has occurred.	[Greenberger, Paul A.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine	Greenberger, PA (corresponding author), 211 E Ontario St,1000, Chicago, IL 60611 USA.	p-greenberger@northwestern.edu	Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498	Ernest S. Bazley Grant; Northwestern Memorial Hospital	Ernest S. Bazley Grant; Northwestern Memorial Hospital	Supported by the Ernest S. Bazley Grant to Northwestern University and Northwestern Memorial Hospital.	Agostini C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-20; Andrews KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058816; Baumer I, 1998, Eur J Med Res, V3, P288; Bertelsen RJ, 2016, ENVIRON RES, V148, P491, DOI 10.1016/j.envres.2016.04.033; Burge PS, 2017, THORAX, V72, P280, DOI 10.1136/thoraxjnl-2016-208776; Chung JH, 2017, ANN AM THORAC SOC, V14, P1533, DOI 10.1513/AnnalsATS.201701-035OC; Churg A, 2018, ARCH PATHOL LAB MED, V142, P109, DOI 10.5858/arpa.2017-0173-RA; Greenberger PA, 2004, ALLERGY ASTHMA PROC, V25, P219; Higashino-Kameda M, 2016, INFLAMM RES, V65, P235, DOI 10.1007/s00011-015-0910-1; KELLER RH, 1982, J IMMUNOL, V128, P116; Korosec P, 2007, CHEST, V132, P1291, DOI 10.1378/chest.07-0128; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Millon L, 2016, J ALLERGY CLIN IMMUN, V138, P1738, DOI 10.1016/j.jaci.2016.06.037; Molyneaux PL, 2017, AM J RESP CRIT CARE, V196, P655, DOI 10.1164/rccm.201707-1439ED; Mooney JJ, 2017, ANN AM THORAC SOC, V14, P1506, DOI 10.1513/AnnalsATS.201707-590ED; MOORE VL, 1974, J ALLERGY CLIN IMMUN, V53, P319, DOI 10.1016/0091-6749(74)90115-8; Moran JV, 2002, ALLERGY ASTHMA PROC, V23, P265; Morell F, 2008, MEDICINE, V87, P110, DOI 10.1097/MD.0b013e31816d1dda; Morisset J, 2018, AM J RESP CRIT CARE, V197, P1036, DOI 10.1164/rccm.201710-1986OC; NAKAZAWA T, 1989, CHEST, V95, P1149, DOI 10.1378/chest.95.5.1149; Salisbury ML, 2017, AM J RESP CRIT CARE, V196, P690, DOI 10.1164/rccm.201608-1675PP; Vasakova M, 2017, AM J RESP CRIT CARE, V196, P680, DOI 10.1164/rccm.201611-2201PP; Villar A, 2014, RESPIROLOGY, V19, P891, DOI 10.1111/resp.12323; Xu JF, 2014, CLIN RESPIR J, V8, P297, DOI 10.1111/crj.12071; Yu BQ, 2017, BOSNIAN J BASIC MED, V17, P17, DOI 10.17305/bjbms.2016.1233	25	9	9	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1295	1301		10.1016/j.jaci.2018.09.040	http://dx.doi.org/10.1016/j.jaci.2018.09.040			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30448501	Bronze			2022-12-18	WOS:000463348900003
J	Lan, F; Zhong, H; Zhang, N; Johnston, SL; Wen, WP; Papadopoulos, N; Zhang, L; Bachert, C				Lan, Feng; Zhong, Hua; Zhang, Nan; Johnston, Sebastian L.; Wen, Weiping; Papadopoulos, Nikos; Zhang, Luo; Bachert, Claus			IFN-lambda 1 enhances Staphylococcus aureus clearance in healthy nasal mucosa but not in nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis with nasal polyps; IFN-lambda 1; Staphylococcus aureus; antibacterial activity; macrophages	INTERFERON-LAMBDA; CHRONIC RHINOSINUSITIS; CELLS; ENTEROTOXINS; COLONIZATION; MACROPHAGES; DEFENSE; BARRIER; PROTEIN; INNATE	Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by TH2-skewed inflammation and increased colonization by Staphylococcus aureus. IFN-lambda 1 is known for its antiviral activity, but there is little information on its antibacterial role. Objective: We sought to determine the expression and release of IFN-lambda 1 from nasal mucosal tissue of healthy subjects and patients with CRSwNP on exposure to S aureus and assess its potential role in antibacterial defense mechanisms. Methods: Nasal tissue from healthy subjects and patients with CRSwNP was exposed to S aureus, and we assessed expression of IFN-lambda 1, MUC5AC, and MUC5B. THP1-derived macrophages incubated with or without IFN-lambda 1 were assessed for uptake and killing of S aureus and expression of lysosomal-associated membrane protein 1 and intracellular reactive oxidase substrate (ROS), the IFN-lambda 1 receptor IL-28 receptor (IL-28R), and the Janus kinase/signal transducer and activator of transcription (STAT) 1 pathway by means of immunofluorescence staining. Results: S aureus infection increased IFN-lambda 1 expression in tissue from patients with CRSwNP. IFN-lambda 1 (10 ng/mL) significantly decreased the number of S aureus colony-forming units in healthy control tissue but not in tissue from patients with CRSwNP and upregulated MUC5AC and MUC5B expression in control tissue on S aureus infection. IFN-lambda 1 stimulation increased intracellular killing of S aureus in THP1-derived macrophages and substantially increased lysosomal-associated membrane protein 1, IL-28R, ROS, and STAT signaling in macrophages incubated with S aureus. All of these effects were attenuated by blocking IL-28R and ROS activities. Conclusions: IFN-lambda 1 favors clearance of S aureus in healthy nasal mucosa and enhances antibacterial function of macrophages through IFN-lambda 1-IL-28R-ROS-Janus kinase-STAT signaling pathways.	[Lan, Feng; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Beijing Inst Otolaryngol, Dept Otolaryngol Head & Neck Surg, 17 HouGouHuTong, Beijing 100730, Peoples R China; [Lan, Feng; Zhong, Hua; Zhang, Nan; Bachert, Claus] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium; [Johnston, Sebastian L.] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Infect Sect, London, England; [Zhong, Hua; Wen, Weiping] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou, Guangdong, Peoples R China; [Papadopoulos, Nikos] Univ Manchester, Inst Human Dev, Ctr Pediat & Child Hlth, Manchester, Lancs, England; [Bachert, Claus] Karolinska Inst, Clintec, Div ENT Dis, Stockholm, Sweden	Capital Medical University; Ghent University; Ghent University Hospital; Imperial College London; Sun Yat Sen University; University of Manchester; Karolinska Institutet	Zhang, L (corresponding author), Capital Med Univ, Beijing TongRen Hosp, Beijing Inst Otolaryngol, Dept Otolaryngol Head & Neck Surg, 17 HouGouHuTong, Beijing 100730, Peoples R China.; Bachert, C (corresponding author), Univ Ghent, ENT Dept, Upper Airways Res Lab, Pintelaan 185, B-9000 Ghent, Belgium.	dr.luozhang@139.com; claus.bachert@ugent.be	温, 家琦/GYV-3177-2022; Zhang, Nan/AAQ-3944-2020; Johnston, Sebastian Lennox/I-2423-2012; Bachert, Claus/J-8825-2012	Johnston, Sebastian Lennox/0000-0003-3009-9200; Zhang, Luo/0000-0002-0910-9884; Zhong, Hua/0000-0002-9120-2323	European Commission's Seventh Framework programme [260895]; Flemish Scientific Research Board (FWO) [1841713N, G. 039412N, G. 067512N, BOF14/GOA/019]; Interuniversity Attraction Poles Program-Belgian State Belgian Science Policy [IAP P7/30]; Program for Changjiang Scholars and Innovative Research Team [IRT13082]; 12th five-year science and technology support project [2014BAI07B04]; National Natural Science Foundation of China [81630023, 81420108009, 81700887]	European Commission's Seventh Framework programme; Flemish Scientific Research Board (FWO)(FWO); Interuniversity Attraction Poles Program-Belgian State Belgian Science Policy(Belgian Federal Science Policy Office); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 12th five-year science and technology support project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by grants to C.B. from the European Commission's Seventh Framework programme under grant agreement no. 260895 (PREDICTA); from the Flemish Scientific Research Board (FWO), projects 1841713N, G. 039412N, and G. 067512N; BOF14/GOA/019 and the Interuniversity Attraction Poles Program-Belgian State Belgian Science Policy, no. IAP P7/30; to L.Z. from the Program for Changjiang Scholars and Innovative Research Team (IRT13082), the 12th five-year science and technology support project (2014BAI07B04), and the National Natural Science Foundation of China (81630023 and 81420108009); to F.L. from the National Natural Science Foundation of China (81700887).	Altunbulakli C, 2018, J ALLERGY CLIN IMMUN, V142, P665, DOI 10.1016/j.jaci.2018.01.046; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Bylund J, 2010, FREE RADICAL BIO MED, V49, P1834, DOI 10.1016/j.freeradbiomed.2010.09.016; Cohen TS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003682; Edwards MR, 2011, EMBO MOL MED, V3, P306, DOI 10.1002/emmm.201100143; Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51; Satorres SE, 2009, IMMUNOL LETT, V123, P185, DOI 10.1016/j.imlet.2009.03.003; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; France MM, 2017, J CELL SCI, V130, P307, DOI 10.1242/jcs.193482; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kim JJ, 2013, PATHOGENS, V2, P55, DOI 10.3390/pathogens2010055; Krysko O, 2011, ALLERGY, V66, P396, DOI 10.1111/j.1398-9995.2010.02498.x; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lan F, 2016, ALLERGY, V71, P1381, DOI 10.1111/all.12934; Lan F, 2018, AM J RESP CRIT CARE, V198, P452, DOI 10.1164/rccm.201710-2112OC; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Livraghi-Butrico A, 2017, MUCOSAL IMMUNOL, V10, P395, DOI 10.1038/mi.2016.63; Okai B, 2015, INFECT IMMUN, V83, P1523, DOI 10.1128/IAI.02917-14; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Planet PJ, 2016, MBIO, V7, DOI 10.1128/mBio.01939-15; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Wang X-Q., 2012, INT J CLIN MED, V3, P319, DOI DOI 10.4236/IJCM.2012.35063; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang Y, 2015, ALLERGY ASTHMA IMMUN, V7, P367, DOI 10.4168/aair.2015.7.4.367	30	9	10	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1416	+		10.1016/j.jaci.2018.09.041	http://dx.doi.org/10.1016/j.jaci.2018.09.041			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30508540	Bronze			2022-12-18	WOS:000463348900018
J	Bublin, M; Kostadinova, M; Radauer, C; Varga, EM; Hafner, C; Schmidthaler, K; Saidova, A; Maleki, SJ; Szepfalusi, Z; Eiwegger, T; Breiteneder, H				Bublin, Merima; Kostadinova, Maria; Radauer, Christian; Varga, Eva-Maria; Hafner, Christine; Schmidthaler, Klara; Saidova, Aziza; Maleki, Soheila J.; Szepfalusi, Zsolt; Eiwegger, Thomas; Breiteneder, Heimo			Engineering of structural variants of the major peanut allergens Ara h 2 and Ara h 6 for allergen-specific immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							BODY-MASS INDEX; EXPIRATORY FLOW VARIABILITY; INCIDENT ASTHMA; OBESITY; RISK; OVERWEIGHT; CHILDREN; AGE; PREVALENCE; ONSET		[Bublin, Merima; Kostadinova, Maria; Radauer, Christian; Breiteneder, Heimo] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Varga, Eva-Maria] Med Univ Graz, Dept Pediat, Resp & Allerg Dis Div, Graz, Austria; [Hafner, Christine] Karl Landsteiner Univ Hlth Sci, Univ Hosp St Poelten, Dept Dermatol, St Polten, Austria; [Hafner, Christine] Karl Landsteiner Inst Dermatol Res, St Polten, Austria; [Schmidthaler, Klara; Saidova, Aziza; Szepfalusi, Zsolt; Eiwegger, Thomas] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Maleki, Soheila J.] ARS, USDA, Southern Reg Res Ctr, New Orleans, LA USA; [Eiwegger, Thomas] Hosp Sick Children, Dept Paediat, Div Immunol & Allergy, Food Allergy & Anaphylaxis Program, Toronto, ON, Canada; [Eiwegger, Thomas] Hosp Sick Children, Res Inst, Translat Med Program, Toronto, ON, Canada; [Eiwegger, Thomas] Univ Toronto, Dept Immunol, Toronto, ON, Canada	Medical University of Vienna; Medical University of Graz; Medical University of Vienna; United States Department of Agriculture (USDA); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Eiwegger, T (corresponding author), Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria.; Eiwegger, T (corresponding author), Hosp Sick Children, Dept Paediat, Div Immunol & Allergy, Food Allergy & Anaphylaxis Program, Toronto, ON, Canada.; Eiwegger, T (corresponding author), Hosp Sick Children, Res Inst, Translat Med Program, Toronto, ON, Canada.; Eiwegger, T (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	thomas.eiwegger@sickkids.ca	Saidova, Aziza/AAP-3485-2020; Radauer, Christian/AAN-6260-2021	Saidova, Aziza/0000-0002-3089-4151; Radauer, Christian/0000-0001-9920-4449; Schmidthaler, Klara/0000-0003-1979-4798; Eiwegger, Thomas/0000-0002-2914-7829; Szepfalusi, Zsolt/0000-0003-4852-3102	Austrian Research Promotion Agency (FFG) [820127]; Medical Scientific Fund of the Mayor of the City of Vienna [11013]; HSBC Bank Canada Catalyst Research Grant from The Hospital for Sick Children; Innovation Fund Denmark [6159-00005A]	Austrian Research Promotion Agency (FFG); Medical Scientific Fund of the Mayor of the City of Vienna; HSBC Bank Canada Catalyst Research Grant from The Hospital for Sick Children; Innovation Fund Denmark	This work was funded by the Austrian Research Promotion Agency (FFG; the BRIDGE grant no. 820127 to H.B.), the Medical Scientific Fund of the Mayor of the City of Vienna (grant no. 11013), an HSBC Bank Canada Catalyst Research Grant from The Hospital for Sick Children, and the Innovation Fund Denmark (grant no. 6159-00005A to T.E.).	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bannon GA, 2001, INT ARCH ALLERGY IMM, V124, P70, DOI 10.1159/000053672; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Bird JA, 2018, J ALLER CL IMM-PRACT, V6, P476, DOI 10.1016/j.jaip.2017.09.016; Black MH, 2012, OBESITY, V20, P1041, DOI 10.1038/oby.2012.5; Brown H., 1999, APPL MIXED MODELS ME; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Castro-Rodriguez LA, 2001, AM J RESP CRIT CARE, V163, P1344, DOI 10.1164/ajrccm.163.6.2006140; Chen YC, 2013, OBES REV, V14, P222, DOI 10.1111/j.1467-789X.2012.01055.x; Chen ZH, 2017, AM J RESP CRIT CARE, V195, P1181, DOI 10.1164/rccm.201608-1691OC; Chinn S, 2001, THORAX, V56, P845, DOI 10.1136/thorax.56.11.845; Egan KB, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-121; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Flinterman AE, 2010, CLIN EXP ALLERGY, V40, P590, DOI 10.1111/j.1365-2222.2009.03431.x; Frey U, 2015, ALLERGY, V70, P26, DOI 10.1111/all.12525; Gilliland FD, 2003, AM J EPIDEMIOL, V158, P406, DOI 10.1093/aje/kwg175; Glaspole IN, 2005, ALLERGY, V60, P35, DOI 10.1111/j.1398-9995.2004.00608.x; Global Initiative for Asthma (GINA) NHLaBI National Institutes of Health, GINA REP GLOB STRAT; Gold DR, 2003, PEDIATR PULM, V36, P514, DOI 10.1002/ppul.10376; Gonzalez JR, 2014, AM J HUM GENET, V94, P361, DOI 10.1016/j.ajhg.2014.01.015; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Guerra S, 2002, CHEST, V122, P1256, DOI 10.1378/chest.122.4.1256; Guerra S, 2013, THORAX, V68, P1021, DOI 10.1136/thoraxjnl-2013-203538; Guibas GV, 2013, ALLERGY, V68, P1298, DOI 10.1111/all.12245; Gump A, 2001, J APPL PHYSIOL, V90, P2306, DOI 10.1152/jappl.2001.90.6.2306; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P1235, DOI 10.1016/j.jaci.2005.09.016; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; HIGGINS BG, 1992, AM REV RESPIR DIS, V145, P588, DOI 10.1164/ajrccm/145.3.588; Huovinen E, 2003, RESP MED, V97, P273, DOI 10.1053/rmed.2003.1419; Jindal SL, 2002, J ASTHMA, V39, P363, DOI 10.1081/JAS-120004029; Kuczmarski R.J., 2000, CDC GROWTH CHARTS US; Litonjua AA, 2008, J ALLERGY CLIN IMMUN, V121, P85, DOI [DOI 10.1016/HACI.2008.03.005, 10.1016/j.jaci.2008.03.005]; Litonjua AA, 2008, J ALLERGY CLIN IMMUN, V121, P1075, DOI 10.1016/j.jaci.2008.03.005; Luder E, 2004, RESP MED, V98, P29, DOI 10.1016/j.rmed.2003.08.004; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Otsu K, 2015, CLIN EXP ALLERGY, V45, P471, DOI 10.1111/cea.12407; Permaul P, 2014, ANN ALLERG ASTHMA IM, V113, P244, DOI 10.1016/j.anai.2014.07.001; Ponce M, 2016, ALLERGY, V71, P1393, DOI 10.1111/all.12953; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; SIERSTED HC, 1994, AM J RESP CRIT CARE, V149, P598, DOI 10.1164/ajrccm.149.3.8118624; Starkl P, 2012, CLIN EXP ALLERGY, V42, P1801, DOI 10.1111/cea.12031; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Strine TW, 2007, J ASTHMA, V44, P651, DOI 10.1080/02770900701554896; TAUSSIG LM, 1989, AM J EPIDEMIOL, V129, P1219, DOI 10.1093/oxfordjournals.aje.a115242; van Hoffen E, 2014, CLIN EXP ALLERGY, V44, P1558, DOI 10.1111/cea.12319; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537; Willeboordse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077574; Wood RA, 2013, ALLERGY, V68, P803, DOI 10.1111/all.12158; Yao TC, 2011, J ASTHMA, V48, P503, DOI 10.3109/02770903.2011.576743	49	9	9	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1226	+		10.1016/j.jaci.2018.10.039	http://dx.doi.org/10.1016/j.jaci.2018.10.039			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30414861	Bronze			2022-12-18	WOS:000460272900045
J	Schwartz, JT; Morris, DW; Collins, MH; Rothenberg, ME; Fulkerson, PC				Schwartz, Justin T.; Morris, David W.; Collins, Margaret H.; Rothenberg, Marc E.; Fulkerson, Patricia C.			Eosinophil progenitor levels correlate with tissue pathology in pediatric eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Schwartz, Justin T.; Morris, David W.; Rothenberg, Marc E.; Fulkerson, Patricia C.] Univ Cincinnati, Coll Med, Dept Pediat, Div Allergy & Immunol,Cincinnati Childrens Hosp M, Cincinnati, OH 45221 USA; [Collins, Margaret H.] Univ Cincinnati, Coll Med, Dept Pediat, Div Pathol & Lab Med,Cincinnati Childrens Hosp Me, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Fulkerson, PC (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Div Allergy & Immunol,Cincinnati Childrens Hosp M, Cincinnati, OH 45221 USA.	Patricia.Fulkerson@cchmc.org		Schwartz, Justin/0000-0001-6472-5877	National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI130033, T32 AI60515]; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) [U54 AI117804]; NIAID; National Institute of Diabetes and Digestive and Kidney Diseases; NCATS; APFED CURED; EFC; National Institutes of Health of the Digestive Disease Research Core Center in Cincinnati [P30 DK078392]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130033, U54AI117804, T32AI060515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); APFED CURED; EFC; National Institutes of Health of the Digestive Disease Research Core Center in Cincinnati; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (grant/award nos. R01 AI130033 and T32 AI60515) and the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR; grant no. U54 AI117804). CEGIR is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Diseases Research, the National Center for Advancing Translational Sciences (NCATS), and is funded through collaboration between the NIAID, the National Institute of Diabetes and Digestive and Kidney Diseases, and the NCATS. CEGIR is also supported by patient advocacy groups including APFED CURED and EFC. This project was also supported in part by the National Institutes of Health (grant no. P30 DK078392: Research Flow Cytometry Cores) of the Digestive Disease Research Core Center in Cincinnati.	Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Cameron L, 2000, J IMMUNOL, V164, P1538, DOI 10.4049/jimmunol.164.3.1538; Collins MH, 2017, DIS ESOPHAGUS, V30, DOI 10.1111/dote.12470; Kim YK, 1999, AM J RESP CELL MOL, V20, P388, DOI 10.1165/ajrcmb.20.3.3060; Koppelman SJ, 2016, FOOD CHEM TOXICOL, V91, P82, DOI 10.1016/j.fct.2016.02.016; Levine A, 2009, DIGEST DIS, V27, P212, DOI 10.1159/000228552; Min SB, 2017, J CLIN GASTROENTEROL, V51, P127, DOI 10.1097/MCG.0000000000000621; Morris DW, 2016, J ALLERGY CLIN IMMUN, V138, P915, DOI 10.1016/j.jaci.2016.03.027; Sampson HA, 2017, JAMA-J AM MED ASSOC, V318, P1798, DOI 10.1001/jama.2017.16591; Sehmi R, 2016, CLIN EXP ALLERGY, V46, P793, DOI 10.1111/cea.12695; Shoda T, 2018, LANCET GASTROENTEROL, V3, P477, DOI 10.1016/S2468-1253(18)30096-7	11	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1221	+		10.1016/j.jaci.2018.10.036	http://dx.doi.org/10.1016/j.jaci.2018.10.036			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30414854	Green Accepted, Bronze			2022-12-18	WOS:000460272900043
J	Shiratori-Hayashi, M; Hasegawa, A; Toyonaga, H; Andoh, T; Nakahara, T; Kido-Nakahara, M; Furue, M; Kuraishi, Y; Inoue, K; Dong, XZ; Tsuda, M				Shiratori-Hayashi, Miho; Hasegawa, Ayumi; Toyonaga, Honami; Andoh, Tsugunobu; Nakahara, Takeshi; Kido-Nakahara, Makiko; Furue, Masutaka; Kuraishi, Yasushi; Inoue, Kazuhide; Dong, Xinzhong; Tsuda, Makoto			Role of P2X3 receptors in scratching behavior in mouse models	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INVOLVEMENT; ITCH; PAIN; MICE		[Shiratori-Hayashi, Miho; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka, Fukuoka, Japan; [Hasegawa, Ayumi; Toyonaga, Honami; Inoue, Kazuhide] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka, Fukuoka, Japan; [Andoh, Tsugunobu; Kuraishi, Yasushi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, Toyama, Japan; [Nakahara, Takeshi; Kido-Nakahara, Makiko; Furue, Masutaka] Kyushu Univ, Grad Sch Med, Dept Dermatol, Fukuoka, Fukuoka, Japan; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD USA	Kyushu University; Kyushu University; University of Toyama; Kyushu University; Johns Hopkins University; Johns Hopkins University	Tsuda, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka, Fukuoka, Japan.	tsuda@phar.kyushu-u.ac.jp	Shiratori-Hayashi, Miho/ABD-6887-2021; Tsuda, Makoto/AAE-7256-2020		Japan Society for the Promotion of Science (JSPS KAKENHI) [JP15H02522]; Core Research for Evolutional Science and Technology program from Japan Agency for Medical Research and Development (AMED) [JP17gm0910006]; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED [JP17ek0410034]; JSPS; Astellas Foundation for Research on Metabolic Disorders; AMED [JP18am0101091]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology program from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; AMED; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI; grant no. JP15H02522 to M.T.), the Core Research for Evolutional Science and Technology program from Japan Agency for Medical Research and Development (AMED; grant no. JP17gm0910006 to M.T.), the Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED (grant no. JP17ek0410034 to M.T.), the Bilateral Collaborations (Joint Research Projects and Seminars) from JSPS (to M.T.), Astellas Foundation for Research on Metabolic Disorders, and Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research) from AMED (grant no. JP18am0101091 to M.T.).	Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Akiyama T, 2010, ACTA DERM-VENEREOL, V90, P575, DOI 10.2340/00015555-0962; Bader M, 2014, PHARMACOL REV, V66, P1080, DOI 10.1124/pr.113.008136; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Fu K, 2014, NEUROSCI LETT, V579, P190, DOI 10.1016/j.neulet.2014.03.062; Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Han L, 2018, NAT NEUROSCI, V21, P324, DOI 10.1038/s41593-018-0074-8; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Horak F, 2009, J ALLERGY CLIN IMMUN, V124, P471, DOI 10.1016/j.jaci.2009.06.006; Inagaki N, 2002, EUR J PHARMACOL, V448, P175, DOI 10.1016/S0014-2999(02)01933-7; Kamei J, 2006, EUR J PHARMACOL, V547, P160, DOI 10.1016/j.ejphar.2006.07.034; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Miller G, 2007, SCIENCE, V318, P188, DOI 10.1126/science.318.5848.188; Ohmura T, 2004, EUR J PHARMACOL, V491, P191, DOI 10.1016/j.ejphar.2004.03.047; Pfaar O, 2017, ALLERGY, V72, P1035, DOI 10.1111/all.13133; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Shiratori-Hayashi M, 2015, NAT MED, V21, P927, DOI 10.1038/nm.3912; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Takahashi T, 2013, J INVEST DERMATOL, V133, P2407, DOI 10.1038/jid.2013.163; Takano N, 2003, EUR J PHARMACOL, V471, P223, DOI 10.1016/S0014-2999(03)01828-4; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Yamashita T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165189	30	9	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1252	+		10.1016/j.jaci.2018.10.053	http://dx.doi.org/10.1016/j.jaci.2018.10.053			25	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30452925	Green Accepted, Bronze			2022-12-18	WOS:000460272900054
J	Wu, TD; Perzanowski, M; Peng, RD; Wise, RA; Balcer-Whaley, S; Newman, M; Cunningham, A; Phipatanakul, W; Matsui, EC; McCormack, MC				Wu, Tianshi David; Perzanowski, Matthew; Peng, Roger D.; Wise, Robert A.; Balcer-Whaley, Susan; Newman, Michelle; Cunningham, Amparito; Phipatanakul, Wanda; Matsui, Elizabeth C.; McCormack, Meredith C.			Validation of the maximum symptom day among children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							URBAN CHILDREN; INTERVENTION; ADOLESCENTS; MANAGEMENT; GUIDELINE		[Wu, Tianshi David; Wise, Robert A.; McCormack, Meredith C.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA; [Perzanowski, Matthew] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Peng, Roger D.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Balcer-Whaley, Susan; Newman, Michelle] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD USA; [Cunningham, Amparito; Phipatanakul, Wanda] Harvard Med Sch, Div Pediat Allergy & Immunol, Boston, MA USA; [Cunningham, Amparito; Phipatanakul, Wanda] Boston Childrens Hosp, Boston, MA USA; [Matsui, Elizabeth C.] Univ Texas Austin, Dell Med Sch, Dept Populat Hlth, Austin, TX 78712 USA	Johns Hopkins University; Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Texas System; University of Texas Austin	McCormack, MC (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA.	mmccor16@jhmi.edu		Koehl, Rachelle/0000-0002-7797-7456; Wise, Robert/0000-0002-8353-2349; McCormack, Meredith/0000-0003-1702-3201; Pham, Hewlett/0000-0003-0330-6104; Matsui, Elizabeth/0000-0001-8134-5593	National Institute of Allergy and Infectious Diseases [U01Al083238, K24 AI114769, K24 AI106822]; National Institute of Environmental Health Sciences [F32 ES028578, P50 ES018176, R01 ES023447, R01 ES026170]; EPA [83615201]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI106822, K24AI114769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES028578, R01ES023447, P30ES009089, P50ES018176, R01ES026170] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EPA(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants U01Al083238, K24 AI114769, and K24 AI106822 from the National Institute of Allergy and Infectious Diseases; grants F32 ES028578, P50 ES018176, R01 ES023447, and R01 ES026170 from the National Institute of Environmental Health Sciences; and EPA Agreement Number 83615201.	Bime C, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.75; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; Diette GB, 2009, PATIENT, V2, P233, DOI 10.2165/11313820-000000000-00000; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Kennedy J, 2007, PEDIATRICS, V120, pS132; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Krishnan JA, 2012, J ALLERGY CLIN IMMUN, V129, pS124, DOI 10.1016/j.jaci.2011.12.981; Leas BF, 2018, J ALLERGY CLIN IMMUN, V141, P1854, DOI 10.1016/j.jaci.2018.02.001; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Lu KD, 2013, J ALLERGY CLIN IMMUN, V131, P1017, DOI 10.1016/j.jaci.2012.12.1570; Matsui EC, 2017, JAMA-J AM MED ASSOC, V317, P1027, DOI 10.1001/jama.2016.21048; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Pongracic JA, 2010, J ALLERGY CLIN IMMUN, V125, P593, DOI 10.1016/j.jaci.2009.10.036; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Sheehan WJ, 2017, JAMA PEDIATR, V171, P31, DOI 10.1001/jamapediatrics.2016.2543; Shelef DQ, 2016, J ALLERGY CLIN IMMUN, V138, P1512, DOI 10.1016/j.jaci.2016.10.001; Skinner Elizabeth A, 2004, Dis Manag, V7, P305, DOI 10.1089/dis.2004.7.305; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Wildfire JJ, 2012, J ALLERGY CLIN IMMUN, V129, P694, DOI 10.1016/j.jaci.2011.12.962	23	9	9	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					803	+		10.1016/j.jaci.2018.10.008	http://dx.doi.org/10.1016/j.jaci.2018.10.008			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30342891	Bronze, Green Accepted			2022-12-18	WOS:000457718700047
J	Notarangelo, LD				Notarangelo, Luigi D.			Hematopoietic stem cell transplantation for activated phosphoinositide 3-kinase delta syndrome: Who, when, and how?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Activated phosphoinositide 3-kinase delta syndrome; hematopoietic stem cell transplantation; immune dysregulation; lymphocyte metabolism	PI3K-DELTA		[Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, Bldg 10,Rm 5-3950,10 Ctr Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Notarangelo, LD (corresponding author), NIAID, Lab Clin Immunol & Microbiol, NIH, Bldg 10,Rm 5-3950,10 Ctr Dr, Bethesda, MD 20892 USA.	luigi.notarangelo2@nih.gov			Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001222] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Compagno M, 2017, NATURE, V542, P489, DOI 10.1038/nature21406; Coulter TI, 2017, J ALLERGY CLIN IMMUN, V139, P597, DOI 10.1016/j.jaci.2016.06.021; Elkaim E, 2016, J ALLERGY CLIN IMMUN, V138, P210, DOI 10.1016/j.jaci.2016.03.022; Lucas CL, 2016, NAT REV IMMUNOL, V16, P702, DOI 10.1038/nri.2016.93; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Maccari ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00543; Michalovich D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00369; Nademi Z, 2017, J ALLERGY CLIN IMMUN, V139, P1046, DOI 10.1016/j.jaci.2016.09.040; Okano T, 2019, J ALLERGY CLIN IMMUN, V143, P266, DOI 10.1016/j.jaci.2018.04.032; Rao VK, 2017, BLOOD, V130, P2307, DOI 10.1182/blood-2017-08-801191	10	9	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					91	93		10.1016/j.jaci.2018.08.039	http://dx.doi.org/10.1016/j.jaci.2018.08.039			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30218677	Green Accepted, Bronze			2022-12-18	WOS:000454918300013
J	Wilson, JM; Platts-Mills, TAE				Wilson, Jeffrey M.; Platts-Mills, Thomas A. E.			IgE to galactose-alpha-1,3-galactose and the a-Gal syndrome: Insights from basophil activation testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Galactose-alpha-1,3-galactose; alpha-Gal; basophil activation; IgE	PREVALENCE		[Wilson, Jeffrey M.; Platts-Mills, Thomas A. E.] Univ Virginia, Div Allergy & Clin Immunol, Charlottesville, VA USA	University of Virginia	Platts-Mills, TAE (corresponding author), Univ Virginia, Asthma & Allerg Dis Ctr, POB 801355, Charlottesville, VA 22908 USA.	tap2z@virginia.edu	Wilson, JM/AAD-6421-2020	Wilson, JM/0000-0002-5975-1760; Platts-Mills, Thomas/0000-0002-1263-329X	National Institutes of Health (NIH) [T32-AI-007496]; NIH [R37-AI-20565]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020565, T32AI007496] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.M.W. is supported by National Institutes of Health (NIH) grant T32-AI-007496, and T.A.E.P.-M. is supported by NIH grant R37-AI-20565.	Bahri R, 2018, J ALLERGY CLIN IMMUN, V142, P485, DOI 10.1016/j.jaci.2018.01.043; Carter MC, 2018, ALLERGY, V73, P1131, DOI 10.1111/all.13366; Commins SP, 2014, J ALLERGY CLIN IMMUN, V134, P108, DOI 10.1016/j.jaci.2014.01.024; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Fischer J, 2017, ALLERGY, V72, P1540, DOI 10.1111/all.13156; MacGlashan DW, 2013, J ALLERGY CLIN IMMUN, V132, P777, DOI 10.1016/j.jaci.2013.06.038; Mehlich J, 2019, J ALLERGY CLIN IMMUN, V143, P182, DOI 10.1016/j.jaci.2018.06.049; Villalta D, 2016, CLIN EXP ALLERGY, V46, P377, DOI 10.1111/cea.12655; Wilson JM, 2018, ARTERIOSCL THROM VAS, V38, P1665, DOI 10.1161/ATVBAHA.118.311222; Wilson JM, 2018, EMJ ALLERGY IMMUNOL, V3, P89	10	9	9	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					101	103		10.1016/j.jaci.2018.10.029	http://dx.doi.org/10.1016/j.jaci.2018.10.029			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30395890	Green Accepted, Bronze			2022-12-18	WOS:000454918300016
J	De Bruyne, M; Bogaert, DJ; Venken, K; Van den Bossche, L; Bonroy, C; Roels, L; Tavernier, SJ; van de Vijver, E; Driessen, A; van Gijn, M; Gamez-Diaz, L; Elewaut, D; Grimbacher, B; Haerynck, F; Moes, N; Dullaers, M				De Bruyne, Marieke; Bogaert, Delfien J.; Venken, Koen; Van den Bossche, Lien; Bonroy, Carolien; Roels, Lisa; Tavernier, Simon J.; van de Vijver, Els; Driessen, Ann; van Gijn, Marielle; Gamez-Diaz, Laura; Elewaut, Dirk; Grimbacher, Bodo; Haerynck, Filomeen; Moes, Nicolette; Dullaers, Melissa			A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive T(H)17 immunity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DYSREGULATION; DEFICIENCY; ENTEROPATHY		[De Bruyne, Marieke; Bogaert, Delfien J.; Van den Bossche, Lien; Roels, Lisa; Tavernier, Simon J.; Haerynck, Filomeen; Dullaers, Melissa] Ghent Univ Hosp, Clin Immunol Res Lab, Dept Pulm Med, Ghent, Belgium; [De Bruyne, Marieke; Bogaert, Delfien J.; Van den Bossche, Lien; Bonroy, Carolien; Roels, Lisa; Tavernier, Simon J.; Haerynck, Filomeen; Dullaers, Melissa] Ghent Univ Hosp, Jeffrey Modell Diag & Res Ctr, Ctr Primary Immunodeficiency, Ghent, Belgium; [De Bruyne, Marieke; Bogaert, Delfien J.] Univ Ghent, Ctr Med Genet, Ghent, Belgium; [De Bruyne, Marieke; Bogaert, Delfien J.] Ghent Univ Hosp, Ghent, Belgium; [De Bruyne, Marieke; Bogaert, Delfien J.; Haerynck, Filomeen] Ghent Univ Hosp, Dept Pediat, Div Pediat Immunol & Pulmonol, Ghent, Belgium; [Bogaert, Delfien J.; Tavernier, Simon J.; Dullaers, Melissa] VIB UGent Inflammat Res Ctr, Immunoregulat Lab, Ghent, Belgium; [Venken, Koen; Elewaut, Dirk] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium; [Venken, Koen; Elewaut, Dirk] VIB UGent Inflammat Res Ctr, Unit Mol Immunol & Inflammat, Ghent, Belgium; [Bonroy, Carolien] Ghent Univ Hosp, Dept Lab Med, Ghent, Belgium; [van de Vijver, Els; Moes, Nicolette] Antwerp Univ Hosp, Dept Pediat Gastroenterol, Edegem, Belgium; [van de Vijver, Els; Moes, Nicolette] Univ Antwerp, Fac Med & Hlth Sci, Lab Expt Med & Pediat, Antwerp, Belgium; [Driessen, Ann] Antwerp Univ Hosp, Dept Pathol, Edegem, Belgium; [Driessen, Ann] Univ Antwerp, Fac Med & Healthcare Sci, MIPRO, Antwerp, Belgium; [van Gijn, Marielle] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Gamez-Diaz, Laura; Grimbacher, Bodo] Univ Freiburg, Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Dullaers, Melissa] Univ Ghent, Dept Internal Med, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; Utrecht University; Utrecht University Medical Center; University of Freiburg; Ghent University	Moes, N (corresponding author), Antwerp Univ Hosp, Dept Pediat Gastroenterol, Edegem, Belgium.; Moes, N (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Lab Expt Med & Pediat, Antwerp, Belgium.	Nicolette.Moes@uza.be	Driessen, Ann/D-3768-2017; Moes, Nicolette/GXN-4667-2022; Tavernier, Simon/L-9949-2019; Haerynck, Filomeen/AAD-6761-2020; Bogaert, Delfien/AAF-5977-2021; van de vijver, els/ABB-5840-2020	Driessen, Ann/0000-0003-4148-610X; Tavernier, Simon/0000-0003-2514-5655; Bonroy, Carolien/0000-0002-9170-4200; Roels, Lisa/0000-0002-0443-1233; /0000-0002-4268-5461; Elewaut, Dirk/0000-0002-7468-974X; De Bruyne, Marieke/0000-0001-6636-5537; Haerynck, Filomeen/0000-0001-9161-7361; Venken, Koen/0000-0002-4950-386X	Ghent University Hospital Spearhead Initiative for Immunology Research; Jeffrey Modell Foundation; Research Foundation Flanders (FWO); research council of Ghent University	Ghent University Hospital Spearhead Initiative for Immunology Research; Jeffrey Modell Foundation; Research Foundation Flanders (FWO)(FWO); research council of Ghent University(Ghent University)	This study was supported by the Ghent University Hospital Spearhead Initiative for Immunology Research (to M.D.B., M.D. and F.H.) and the Jeffrey Modell Foundation (to F.H.), the Research Foundation Flanders (FWO) (to D.J.B., D.E. and K.V.), and the research council of Ghent University (to D.E., F.H., and K.V.).	Alangari A, 2012, J ALLERGY CLIN IMMUN, V130, P481, DOI 10.1016/j.jaci.2012.05.043; Alkhairy OK, 2016, J CLIN IMMUNOL, V36, P33, DOI 10.1007/s10875-015-0224-7; Alroqi FJ, 2018, J ALLERGY CLIN IMMUN, V141, P1050, DOI 10.1016/j.jaci.2017.05.022; Azizi G, 2017, EUR ANN ALLERGY CLIN, V49, P235, DOI 10.23822/EurAnnACI.1764-1489.22; Charbonnier LM, 2015, J ALLERGY CLIN IMMUN, V135, P217, DOI 10.1016/j.jaci.2014.10.019; Gamez-Diaz L, 2016, J ALLERGY CLIN IMMUN, V137, P223, DOI 10.1016/j.jaci.2015.09.025; Hou TZ, 2017, BLOOD, V129, P1458, DOI 10.1182/blood-2016-10-745174; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Lopez-Herrera G, 2012, AM J HUM GENET, V90, P986, DOI 10.1016/j.ajhg.2012.04.015	9	9	9	0	18	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1968	1971		10.1016/j.jaci.2018.08.026	http://dx.doi.org/10.1016/j.jaci.2018.08.026			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30193839	Bronze			2022-12-18	WOS:000452315800029
J	Cassard, L; Sperber, K; Buivan, TP; Cotillard, A; Bourdet-Sicard, R; Albert, ML; Mottez, E; Laurent, J; Guinnepain, MT; Daeron, M				Cassard, Lydie; Sperber, Katia; Buivan, Tan-Phut; Cotillard, Aurelie; Bourdet-Sicard, Raphaelle; Albert, Matthew L.; Mottez, Estelle; Laurent, Jerome; Guinnepain, Marie-Therese; Daeron, Marc			Basophils from allergic patients are neither hyperresponsive to activation signals nor hyporesponsive to inhibition signals	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Anaphylaxis; asthma; atopic dermatitis; basophil activation; chronic urticaria; Fc epsilon RI; Fc gamma RIIB; lactobacilli; negative regulation; rhinitis	FC-GAMMA-RIIB; AFFINITY IGE RECEPTOR; HISTAMINE-RELEASE; CELLS; IMMUNOTHERAPY; MANAGEMENT; URTICARIA; AUTOANTIBODIES; RECRUITMENT; PREVENTION	Background: Basophil activation contributes to inflammatory reactions, especially in allergy. It is controlled, both positively and negatively, by several mechanisms. High-affinity IgE receptors (Fc epsilon RI) generate a mixture of activation and inhibition signals when aggregated, the ratio of which depends on the concentration of allergen recognized by receptor-bound IgE. Low-affinity IgG receptors (Fc gamma RIIA/B) generate inhibition signals when coengaged with Fc epsilon RI by allergen-antibody immune complexes. Commensal and probiotic bacteria, such as Lactobacillus paracasei, generate inhibition signals through still unclear mechanisms. Objective: We sought to investigate whether mechanisms that control, both positively and negatively, basophil activation, which were unraveled and studied in basophils from healthy donors, are functional in allergic patients. Methods: Fc epsilon RI and Fc gamma RIIA/B expression, Fc epsilon RI-dependent activation, FceRI-dependent inhibition, and Fc gamma RIIB-dependent inhibition were examined in blood basophils incubated overnight with or without L paracasei and challenged under 10 experimental conditions. Basophils from healthy donors were compared with basophils from patients who consulted an allergology outpatient clinic over a period of 3 months with respiratory allergy, anaphylaxis antecedents, chronic urticaria, and/or atopic dermatitis. Results: Patients' basophils expressed neither more Fc epsilon RI nor less Fc gamma RIIB than basophils from healthy donors. They were neither hyperreactive to positive regulation nor hyporeactive to negative regulation, irrespective of the receptors or mechanisms involved and the allergic manifestations of the patients. Conclusion: Regulatory mechanisms that control basophil activation are fully functional in allergic patients. Intrinsic defects in these mechanisms do not explain allergic manifestations. Based on these mechanisms, immune checkpoint modifiers can be developed as novel therapeutic tools for allergy.	[Cassard, Lydie; Sperber, Katia; Buivan, Tan-Phut; Albert, Matthew L.; Mottez, Estelle; Daeron, Marc] Inst Pasteur, Ctr Immunol Humaine, Dept Immunol, Paris, France; [Cassard, Lydie; Sperber, Katia; Buivan, Tan-Phut; Albert, Matthew L.; Mottez, Estelle] INSERM, Inst Pasteur, UMS 20, Paris, France; [Cotillard, Aurelie] Soladis, Lyon, France; [Bourdet-Sicard, Raphaelle] Danone Res, Palaiseau, France; [Laurent, Jerome; Guinnepain, Marie-Therese] Inst Pasteur, Ctr Med, Paris, France; [Daeron, Marc] Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM, Marseille, France; [Cassard, Lydie] Gustave Roussy Canc Campus, Lab Immunomonitoring Oncol, Villejuif, France; [Sperber, Katia] Lab Virbac, Preclin & Clin Unit, Carros, France; [Buivan, Tan-Phut] Inst Pasteur, Ctr Rech Translat, Paris, France; [Albert, Matthew L.] Inst Pasteur, Dept Immunol, Inserm U818, Unite Immunobiol Cellules Dendrit, Paris, France; [Laurent, Jerome] Hop Europeen Georges Pompidou, Serv Immunol, Paris, France; [Guinnepain, Marie-Therese] Hop Foch, Suresnes, France; [Daeron, Marc] Inst Pasteur, Direct Dev, Grant Off, Paris, France; [Daeron, Marc] Ctr Immunol Marseille Luminy, Marseille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Danone Nutricia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Gustave Roussy; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Daeron, M (corresponding author), Inst Pasteur, Direct Dev, Grant Off, Paris, France.; Daeron, M (corresponding author), Ctr Immunol Marseille Luminy, Marseille, France.; Daeron, M (corresponding author), Inst Pasteur, 28 Rue Docteur Roux, F-5015 Paris, France.	marc.daeron@pasteur.fr			Danone Research [WO2009068997]	Danone Research(Danone Nutricia)	L. Cassard has received personal fees from Danone Research; has a patent (WO2009068997; "Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation'') issued; and has a patent ("Methods of inhibiting biological responses induced by a receptor that uses pi3k to signal in a cell'') pending. A. Cotillard reports fees from Danone Research to her company for her consulting work. R. Bourdet-Sicard is an employee of Danone Research and has a patent (WO2009068997; "Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation''). M. L. Albert is an employee of Genentech. M. Daeron has received a grant, personal fees, and nonfinancial support from Danone Research; has a patent (WO2009068997; "Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation'') issued; and has a patent ("Methods of inhibiting biological responses induced by a receptor that uses pi3k to signal in a cell'') pending. The rest of the authors declare that they have no relevant conflicts of interest.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bruhns P, 2000, J BIOL CHEM, V275, P37357, DOI 10.1074/jbc.M003518200; Burton OT, 2014, J ALLERGY CLIN IMMUN, V134, P1310, DOI 10.1016/j.jaci.2014.05.042; Carver DJ, 2000, BLOOD, V96, P1449, DOI 10.1182/blood.V96.4.1449.h8001449_1449_1456; Cassard L, 2012, J IMMUNOL, V189, P2995, DOI 10.4049/jimmunol.1200968; Chiossone L, 2017, SEMIN IMMUNOL, V31, P55, DOI 10.1016/j.smim.2017.08.003; Chu SY, 2012, J ALLERGY CLIN IMMUN, V129, P1102, DOI 10.1016/j.jaci.2011.11.029; CONRAD DH, 1983, J IMMUNOL, V130, P327; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Dema B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090424; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Gimborn K, 2005, J IMMUNOL, V174, P507, DOI 10.4049/jimmunol.174.1.507; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; MALVEAUX FJ, 1978, J CLIN INVEST, V62, P176, DOI 10.1172/JCI109103; Meknache N, 2009, J IMMUNOL, V182, P2542, DOI 10.4049/jimmunol.0801665; Mimoto F, 2013, PROTEIN ENG DES SEL, V26, P589, DOI 10.1093/protein/gzt022; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Nakashima C, 2014, J ALLERGY CLIN IMMUN, V134, P100, DOI 10.1016/j.jaci.2014.02.026; Noon L, 1911, LANCET, V1, P1572; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Schiffer C, 2011, J IMMUNOL, V187, P2646, DOI 10.4049/jimmunol.1002415; Sheikh J, 2005, CURR OPIN ALLERGY CL, V5, P403, DOI 10.1097/01.all.0000182540.45348.bc; Sterba PM, 2015, J INVEST DERMATOL, V135, P1454, DOI 10.1038/jid.2015.13; STONE SP, 1973, ARCH DERMATOL, V108, P806, DOI 10.1001/archderm.108.6.806; Tam SW, 2004, ALLERGY, V59, P772, DOI 10.1111/j.1398-9995.2004.00332.x; Uermosi C, 2010, J ALLERGY CLIN IMMUN, V126, P375, DOI 10.1016/j.jaci.2010.05.040; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518; Zuberbier T, 2014, ALLERGY, V69, P868, DOI 10.1111/all.12313	37	9	9	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1548	1557		10.1016/j.jaci.2017.11.053	http://dx.doi.org/10.1016/j.jaci.2017.11.053			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	29366701	Bronze			2022-12-18	WOS:000449429800018
J	Leffler, J; Jones, AC; Hollams, EM; Prastanti, F; Le Souef, PN; Holt, PG; Bosco, A; Laing, IA; Strickland, DH				Leffler, Jonatan; Jones, Anya C.; Hollams, Elysia M.; Prastanti, Franciska; Le Souef, Peter N.; Holt, Patrick G.; Bosco, Anthony; Laing, Ingrid A.; Strickland, Deborah H.			Basophil counts in PBMC populations during childhood acute wheeze/asthma are associated with future exacerbations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MOLECULAR-WEIGHT KININOGEN; ANGIOEDEMA; DISEASE; ASTHMA; PLASMA		[Leffler, Jonatan; Jones, Anya C.; Hollams, Elysia M.; Le Souef, Peter N.; Holt, Patrick G.; Bosco, Anthony; Laing, Ingrid A.; Strickland, Deborah H.] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia; [Jones, Anya C.; Le Souef, Peter N.] Univ Western Australia, Div Paediat, Crawley, Australia; [Prastanti, Franciska; Laing, Ingrid A.] Univ Western Australia, Sch Biomed Sci, Crawley, Australia; [Holt, Patrick G.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Queensland	Leffler, J (corresponding author), Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia.	Jonatan.Leffler@telethonkids.org.au	Bosco, Anthony/AAC-6900-2022; Laing, Ingrid/I-7092-2013; Jones, Anya/AAE-8029-2021; Leffler, Jonatan/A-8748-2018; Strickland, Deborah/AGV-6937-2022; Le Souef, Peter N/H-5256-2014; Holt, Patrick/H-1548-2011	Laing, Ingrid/0000-0002-1641-9899; Jones, Anya/0000-0002-6649-4977; Leffler, Jonatan/0000-0001-5674-8462; Strickland, Deborah/0000-0003-0114-4201; Hollams, Elysia/0000-0002-3481-6396; Bosco, Anthony/0000-0002-4335-615X; Le Souef, Peter/0000-0003-0930-1654; Holt, Patrick/0000-0003-1193-0935	National Health and Medical Research Council; Royal Physiographic Society in Lund; Swedish Society for Medical Research; University of Western Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Royal Physiographic Society in Lund; Swedish Society for Medical Research; University of Western Australia	Supported by the National Health and Medical Research Council, Royal Physiographic Society in Lund, Swedish Society for Medical Research, and University of Western Australia.	Banerji A, 2017, NEW ENGL J MED, V376, P717, DOI 10.1056/NEJMoa1605767; Cyr MM, 2001, CURR OPIN IMMUNOL, V13, P727, DOI 10.1016/S0952-7915(01)00286-2; Dijkstra D, 2014, CYTOM PART A, V85A, P580, DOI 10.1002/cyto.a.22472; Hofman ZLM, 2017, J ALLERGY CLIN IMMUN, V140, P1700, DOI 10.1016/j.jaci.2017.07.012; Karasuyama H, 2014, CURR OPIN IMMUNOL, V31, P1, DOI 10.1016/j.coi.2014.07.004; Koga T, 2006, RESP MED, V100, P273, DOI 10.1016/j.rmed.2005.05.017; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Rodrigo GJ, 2004, CHEST, V125, P1081, DOI 10.1378/chest.125.3.1081; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Suffritti C, 2014, CLIN EXP ALLERGY, V44, P1503, DOI 10.1111/cea.12293; Suzuki Y, 2017, ALLERGY, V72, P1532, DOI 10.1111/all.13197; Ygberg S, 2012, ACTA PAEDIATR, V101, P120, DOI 10.1111/j.1651-2227.2011.02494.x; Zhang GD, 2017, BIOANALYSIS, V9, P1477, DOI 10.4155/bio-2017-0105	13	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1639	+		10.1016/j.jaci.2018.07.003	http://dx.doi.org/10.1016/j.jaci.2018.07.003			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	30036597	Bronze			2022-12-18	WOS:000449429800028
J	Bernstein, DI; Lummus, ZL; Kesavalu, B; Yao, JB; Kottyan, L; Miller, D; Cartier, A; Cruz, MJ; Lemiere, C; Munoz, X; Quirce, S; Tarlo, S; Sastre, J; Boulet, LP; Weirauch, MT; Kaufman, K				Bernstein, David I.; Lummus, Zana L.; Kesavalu, Banu; Yao, Jianbo; Kottyan, Leah; Miller, Daniel; Cartier, Andre; Cruz, Maria-Jesus; Lemiere, Catherine; Munoz, Xavier; Quirce, Santiago; Tarlo, Susan; Sastre, Joaquin; Boulet, Louis Philippe; Weirauch, Matthew T.; Kaufman, Kenneth			Genetic variants with gene regulatory effects are associated with diisocyanate-induced asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; bioinformatics; diisocyanate; electrophoretic mobility shift assay; functional genomics; gene regulation; genetic; his tone; isocyanate; luciferase assay; next-generation sequencing; occupational asthma; oligonucleotide; single nucleotide polymorphism	GENOME-WIDE ASSOCIATION; TOLUENE DIISOCYANATE; TRACHEAL HYPERREACTIVITY; ATF3; PATHOGENESIS; DISEASE; CTNNA3; ALPHA; WORK; POLYMORPHISMS	Background: Isocyanates are major causes of occupational asthma, but susceptibility and mechanisms of diisocyanate-induced asthma (DA) remain uncertain. Objective: The aim of this study was to identify DA-associated functional genetic variants through next-generation sequencing (NGS), bioinformatics, and functional assays. Methods: NGS was performed in 91 workers with DA. Fourteen loci with known DA-associated single nucleotide polymorphisms (SNPs) were sequenced and compared with data from 238 unexposed subjects. Ranking of DA-associated SNPs based on their likelihood to affect gene regulatory mechanisms in the lung yielded 21 prioritized SNPs. Risk and nonrisk oligonucleotides were tested for binding of nuclear extracts from A549, BEAS-2B, and IMR-90 lung cell lines by using electrophoretic mobility shift assays. DNA constructs were cloned into a pGL3 promoter vector for luciferase gene reporter assays. Results: NGS detected 130 risk variants associated with DA (3.1 x 10-6 to 6.21 X 10-i), 129 of which were located in noncoding regions. The 21 SNPs prioritized by using functional genomic data sets were in or proximal to 5 genes: cadherin 17 (CDH17; n = 10), activating transcription factor 3 (ATF3; n = 7), family with sequence similarity, member A (FAM71A; n = 2), tachykinin receptor 1 (TACR1; n = 1), and zinc finger and BTB domain-containing protein 16 (ZBTB16; n = 1). Electrophoretic mobility shift assays detected allele-dependent nuclear protein binding in A549 cells for 8 of 21 variants. In the luciferase assay 4 of the 21 SNPs exhibited allele-dependent changes in gene expression. DNA affinity precipitation and mass spectroscopy of rs147978008 revealed allele-dependent binding of H1 histones, which was confirmed by using Western blotting. Conclusions: We identified 5 DA-associated potential regulatory SNPs. Four variants exhibited effects on gene regulation (ATF rs11571537, CDH17 rs2446824 and rs2513789, and TACR1 rs2287231). A fifth variant (FAM71A rs147978008) showed nonrisk allele preferential binding to H1 histones. These results demonstrate that many DA-associated genetic variants likely act by modulating gene regulation.	[Bernstein, David I.; Lummus, Zana L.; Kesavalu, Banu] Univ Cincinnati, Coll Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Kottyan, Leah; Weirauch, Matthew T.; Kaufman, Kenneth] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Yao, Jianbo] West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV USA; [Miller, Daniel; Weirauch, Matthew T.; Kaufman, Kenneth] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat & Dev Biol, Cincinnati, OH 45229 USA; [Cartier, Andre; Lemiere, Catherine] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Cartier, Andre; Lemiere, Catherine] Hop Sacre Coeur Montreal, Div Resp, Montreal, PQ, Canada; [Cruz, Maria-Jesus; Munoz, Xavier] Hosp Valle De Hebron, Resp Dept, Barcelona, Spain; [Cruz, Maria-Jesus; Munoz, Xavier] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Quirce, Santiago] Hosp La Paz, IdiPAZ, Dept Allergy, Madrid, Spain; [Quirce, Santiago; Sastre, Joaquin] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Tarlo, Susan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Sastre, Joaquin] Fdn Jimenez Diaz, Dept Allergy, Madrid, Spain; CIBERES, Madrid, Spain; [Boulet, Louis Philippe] Univ Laval, Hop Laval, Inst Univ Cardiol & Pneumol Quebec, Ste Foy, PQ, Canada; [Kaufman, Kenneth] Cincinnati VA Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; West Virginia University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Universite de Montreal; Universite de Montreal; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Toronto; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Laval University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Bernstein, DI (corresponding author), Univ Cincinnati, Dept Internal Med, Div Immunol Allergy & Rheumatol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	bernstdd@ucmail.uc.edu	Weirauch, Matthew/M-5459-2019; s, q/AAD-7171-2020	Kottyan, Leah/0000-0003-3979-2220; Tarlo, Susan/0000-0002-4746-5310; Munoz, Xavier/0000-0002-8693-022X	National Institute for Occupational Safety and Health (NIOSH)/Centers for Disease Control and Prevention (CDC) grant [OH008795]; National Institutes of Health (NIH) shared instrumentation grant [S10 RR027015-01]; NIH [P30 AR070549, R21 HG008186]; Cincinnati Children's Hospital Medical Center CpG Award [53553]; Lupus Research Institute "Novel Approaches" Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG008186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR070549] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health (NIOSH)/Centers for Disease Control and Prevention (CDC) grant; National Institutes of Health (NIH) shared instrumentation grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Hospital Medical Center CpG Award; Lupus Research Institute "Novel Approaches" Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by National Institute for Occupational Safety and Health (NIOSH)/Centers for Disease Control and Prevention (CDC) grant OH008795 (PI: D. I. Bernstein); a National Institutes of Health (NIH) shared instrumentation grant (S10 RR027015-01; PI: K. D. Greis); NIH grant P30 AR070549 for Cincinnati Children's Hospital Medical Center Functional Genomics Core; Cincinnati Children's Hospital Medical Center CpG Award 53553 (PI: M. T. Weirauch); a Lupus Research Institute "Novel Approaches" Award (PI: M. T. Weirauch); and NIH grant R21 HG008186 (PI: M. T. Weirauch).	Aizawa M, 2015, J BIOL CHEM, V290, P22250, DOI 10.1074/jbc.M115.669242; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bednar J, 2016, BBA-GENE REGUL MECH, V1859, P436, DOI 10.1016/j.bbagrm.2015.10.012; Bernstein DI, 2013, TOXICOL SCI, V131, P242, DOI 10.1093/toxsci/kfs272; Bernstein DI, 2011, J ALLERGY CLIN IMMUN, V128, P418, DOI 10.1016/j.jaci.2011.03.007; Bernstein DI, 1999, AM J IND MED, V36, P459, DOI 10.1002/(SICI)1097-0274(199910)36:4<459::AID-AJIM7>3.0.CO;2-W; Booth K, 2009, J OCCUP ENVIRON HYG, V6, P228, DOI 10.1080/15459620902724060; Campo P, 2004, CURR OPIN PULM MED, V10, P142, DOI 10.1097/00063198-200403000-00009; Carino M, 1997, RESPIRATION, V64, P111, DOI 10.1159/000196653; Cartier A, 1999, ASTHMA WORKPLACE, P211; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Cui HM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7752; De Nardo D, 2015, CYTOKINE, V74, P181, DOI 10.1016/j.cyto.2015.02.025; Douglas SD, 2011, ANN NY ACAD SCI, V1217, P83, DOI 10.1111/j.1749-6632.2010.05826.x; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Griffon A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1280; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Handstad T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-372; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hergeth SP, 2015, EMBO REP, V16, P1439, DOI 10.15252/embr.201540749; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; Holden NS, 2011, J PHARMACOL TOX MET, V63, P7, DOI 10.1016/j.vascn.2010.03.002; Jajosky R A, 1999, MMWR CDC Surveill Summ, V48, P1; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Kim SH, 2009, CLIN EXP ALLERGY, V39, P203, DOI 10.1111/j.1365-2222.2008.03117.x; Kwon JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14470; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lummus ZL, 2011, IMMUNOL ALLERGY CLIN, V31, P699, DOI 10.1016/j.iac.2011.07.008; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mapp CE, 1998, AM J RESP CRIT CARE, V158, P263, DOI 10.1164/ajrccm.158.1.9704061; Mapp CE, 2003, EUR RESPIR J, V22, P173, DOI 10.1183/09031936.03.00011003; McGeachie MJ, 2015, J ALLERGY CLIN IMMUN, V136, P1503, DOI 10.1016/j.jaci.2015.04.039; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983; Meyer JD, 2001, OCCUP MED-OXFORD, V51, P204, DOI 10.1093/occmed/51.3.204; Miller DE, 2016, JOVE-J VIS EXP, DOI 10.3791/54093; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; PAGGIARO PL, 1986, THORAX, V41, P279, DOI 10.1136/thx.41.4.279; Piirila PL, 2005, J OCCUP HEALTH, V47, P112, DOI 10.1539/joh.47.112; Ribeiro M, 2014, J OCCUP ENVIRON MED, V56, P1001, DOI 10.1097/JOM.0000000000000220; Roussel L, 2011, J ALLERGY CLIN IMMUN, V127, P1632, DOI 10.1016/j.jaci.2011.03.034; Sastre J, 2003, EUR RESPIR J, V22, P364, DOI 10.1183/09031936.03.00045103; Sastre J, 2003, CHEST, V123, P1276, DOI 10.1378/chest.123.4.1276; Scheerens H, 1996, BRIT J PHARMACOL, V119, P1665, DOI 10.1111/j.1476-5381.1996.tb16087.x; Scheerens H, 1996, AM J RESP CRIT CARE, V154, P858, DOI 10.1164/ajrccm.154.4.8887575; Shan YX, 2015, ANTIOXID REDOX SIGN, V22, P651, DOI 10.1089/ars.2014.5987; Tarlo SM, 2008, CHEST, V134, p1S, DOI 10.1378/chest.08-0201; Vandenplas O, 2013, ASTHMA WORKPLACE, P133; Wijeratne AB, 2013, J PROTEOME RES, V12, P4268, DOI 10.1021/pr400835k; Wisnewski AV, 2012, ANN OCCUP HYG, V56, P901, DOI 10.1093/annhyg/mes024; Yucesoy B, 2015, J OCCUP ENVIRON MED, V57, P1331, DOI 10.1097/JOM.0000000000000561; Yucesoy B, 2016, J IMMUNOTOXICOL, V13, P119, DOI 10.3109/1547691X.2015.1017061; Yucesoy B, 2015, TOXICOL SCI, V146, P192, DOI 10.1093/toxsci/kfv084; Yucesoy B, 2014, J OCCUP ENVIRON MED, V56, P382, DOI 10.1097/JOM.0000000000000138; Yucesoy B, 2012, TOXICOL SCI, V129, P166, DOI 10.1093/toxsci/kfs183; Zhao J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2664-8	59	9	9	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					959	969		10.1016/j.jaci.2018.06.022	http://dx.doi.org/10.1016/j.jaci.2018.06.022			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29969634	Bronze			2022-12-18	WOS:000443726500027
J	Shamji, MH; Temblay, JN; Cheng, W; Byrne, SM; Macfarlane, E; Switzer, AR; Francisco, NDC; Olexandra, F; Jacubczik, F; Durham, SR; Ashton-Rickardt, PG				Shamji, Mohamed H.; Temblay, Jeff N.; Cheng, Wei; Byrne, Susan M.; Macfarlane, Ellen; Switzer, Amy R.; Francisco, Natalia D. C.; Olexandra, Fedina; Jacubczik, Fabian; Durham, Stephen R.; Ashton-Rickardt, Philip G.			Antiapoptotic serine protease inhibitors contribute to survival of allergenic T(H)2 cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T(H)2 cells; apoptosis; memory; grass pollen allergy	CD4(+) T-CELLS; INNATE LYMPHOID-CELLS; MEDIATED APOPTOSIS; AIRWAY INFLAMMATION; CARCINOMA ANTIGEN-2; ATOPIC-DERMATITIS; MEMORY CELLS; CATHEPSIN-G; TH2 MEMORY; SERPIN	Background: The mechanisms that regulate maintenance of persistent T(H)2 cells and potentiate allergic inflammation are not well understood. Objective: The function of serine protease inhibitor 2A (Spi2A) was studied in mouse T(H)2 cells, and the serine protease inhibitor B3 (SERPINB3) and SERPINB4 genes were studied in T(H)2 cells from patients with grass pollen allergy. Methods: Spi2A-deficient T-H 2 cells were studied in in vitro culture or in vivo after challenge of Spi2A knockout mice with ovalbumin in alum. Expression of SERPINB3 and SERPINB4 mRNA was measured in in vitro-cultured T(H)2 cells and in ex vivo CD27(-)CD4(+) cells and innate lymphoid cell (ILC) 2 from patients with grass pollen allergy by using quantitative PCR. SERPINB3 and SERPINB4 mRNA levels were knocked down in cultured CD27 2 CD4 1 cells with small hairpin RNA. Results: There were lower levels of in vitro-polarized T(H)2 cells from Spi2A knockout mice (P<.005) and in vivo after ovalbumin challenge (P<.05), higher levels of apoptosis (Annexin V positivity, P<.005), and less lung allergic inflammation (number of lung eosinophils, P <.005). In vitro-polarized T(H)2 cells from patients with grass pollen allergy expressed higher levels of both SERPINB3 and SERPINB4 mRNA (both P<.05) compared with unpolarized CD4 T cells. CD27(-)CD4(+) from patients with grass pollen allergy expressed higher levels of both SERPINB3 and SERPINB4 mRNA (both P<. 0005) compared with CD27(-)CD4(+) cells. ILC2 expressed higher levels of both SERPINB3 and SERPINB4 mRNA (both P<.0005) compared with ILC1. Knockdown of either SERPINB3 or SERPINB4 mRNA (both P<.005) levels resulted in decreased viability of CD27(-)CD4(+) compared with control transduced cells. Conclusion: The Serpins Spi2A in mice and SERPINB3 and SERPINB4 in allergic patients control the viability of T(H)2 cells. This provides proof of principle for a therapeutic approach for allergic disease through ablation of allergic memory T(H)2 cells through SERPINB3 and SERPINB4 mRNA downregulation.	[Shamji, Mohamed H.; Macfarlane, Ellen; Switzer, Amy R.; Francisco, Natalia D. C.; Olexandra, Fedina; Durham, Stephen R.] Imperial Coll London, Immunomodulat & Tolerance Grp, Natl Heart & Lung Inst, London, England; [Shamji, Mohamed H.; Macfarlane, Ellen; Switzer, Amy R.; Francisco, Natalia D. C.; Durham, Stephen R.] Imperial Coll London, Allergy & Clin Immunol Inflammat Repair & Dev, Natl Heart & Lung Inst, London, England; MRC & Asthma UK Ctr Allerg Mech Asthma, London, England; [Temblay, Jeff N.; Cheng, Wei; Byrne, Susan M.; Jacubczik, Fabian; Ashton-Rickardt, Philip G.] Imperial Coll London, Immunobiol Sect, Div Inflammat & Immunol, Dept Med,Fac Med, Norfolk Pl, London W21PG, England	Imperial College London; Imperial College London; University of London; King's College London; Imperial College London	Ashton-Rickardt, PG (corresponding author), Imperial Coll London, Immunobiol Sect, Div Inflammat & Immunol, Dept Med,Fac Med, Norfolk Pl, London W21PG, England.	p.ashton-rickardt@imperial.ac.uk	Shamji, Mohamed/AAU-8811-2020; Shamji, Mohamed/AAD-1788-2019; Switzer, Amy/AEP-0843-2022	Shamji, Mohamed/0000-0003-3425-3463; 	Wellcome Trust; Immune Tolerance Network (National Institutes of Health) at the University of California San Francisco [N01 AI15416]; National Institute of Allergy and Infectious Diseases; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416, R01AI045108] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Immune Tolerance Network (National Institutes of Health) at the University of California San Francisco; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the Wellcome Trust and the Immune Tolerance Network (National Institutes of Health contract no. N01 AI15416), an international clinical research consortium headquartered at the University of California San Francisco, the National Institute of Allergy and Infectious Diseases, and the Juvenile Diabetes Research Foundation.	Akdis M, 2003, FASEB J, V17, P1026, DOI 10.1096/fj.02-1070com; Akkoc T, 2008, J ALLERGY CLIN IMMUN, V121, P652, DOI 10.1016/j.jaci.2007.12.1171; Ashton-Rickardt PG, 2013, IMMUNOL LETT, V152, P65, DOI 10.1016/j.imlet.2013.04.004; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bateman EAL, 2006, J ALLERGY CLIN IMMUN, V118, P1350, DOI 10.1016/j.jaci.2006.07.040; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Byrne SM, 2012, J IMMUNOL, V189, P1133, DOI 10.4049/jimmunol.1003406; Chechlinska M, 2010, TUMOR BIOL, V31, P559, DOI 10.1007/s13277-010-0069-x; Chu HH, 2009, P NATL ACAD SCI USA, V106, P11241, DOI 10.1073/pnas.0902015106; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498; Dev A, 2013, J EXP MED, V210, P225, DOI 10.1084/jem.20121762; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Hamerman JA, 2002, J IMMUNOL, V168, P2415, DOI 10.4049/jimmunol.168.5.2415; Hampson L, 2001, Hematol J, V2, P150, DOI 10.1038/sj.thj.6200102; Hartwig C, 2008, EXP TOXICOL PATHOL, V60, P425, DOI 10.1016/j.etp.2008.05.010; Hashimoto K, 2005, TUMOR BIOL, V26, P165, DOI 10.1159/000086949; Holt P, 2004, CHEM IMMUNOL, V84, P102; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Katagiri C, 2006, J CELL BIOL, V172, P983, DOI 10.1083/jcb.200508064; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Lamb JP, 2005, EUR RESPIR J, V26, P265, DOI 10.1183/09031936.05.00144304; Landais E, 2009, J IMMUNOL, V183, P7949, DOI 10.4049/jimmunol.0902493; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Liu N, 2004, FEBS LETT, V569, P49, DOI 10.1016/j.febslet.2004.05.061; Liu N, 2003, EMBO J, V22, P5313, DOI 10.1093/emboj/cdg510; Liu N, 2004, NAT IMMUNOL, V5, P919, DOI 10.1038/ni1107; Lloyd CM, 2001, J IMMUNOL, V166, P2033, DOI 10.4049/jimmunol.166.3.2033; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; McGettrick AF, 2001, EUR J BIOCHEM, V268, P5868, DOI 10.1046/j.0014-2956.2001.02535.x; Meisel C, 2001, J IMMUNOL, V166, P3143, DOI 10.4049/jimmunol.166.5.3143; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mitsuishi K, 2005, CLIN EXP ALLERGY, V35, P1327, DOI 10.1111/j.1365-2222.2005.02353.x; Mojtabavi N, 2002, J IMMUNOL, V169, P4788, DOI 10.4049/jimmunol.169.9.4788; Murakami A, 2001, BRIT J CANCER, V84, P851, DOI 10.1054/bjoc.2000.1683; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Noma T, 2002, J ASTHMA, V39, P591, DOI 10.1081/JAS-120014923; Ogawa N, 2003, EUR J PHARMACOL, V474, P273, DOI 10.1016/S0014-2999(03)01998-8; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; Serre K, 2010, MOL IMMUNOL, V47, P1914, DOI 10.1016/j.molimm.2010.03.010; Shamji MH, 2015, J ALLERGY CLIN IMMUN, V135, P913, DOI 10.1016/j.jaci.2014.09.049; Sivaprasad U, 2011, J ALLERGY CLIN IMMUN, V127, P254, DOI 10.1016/j.jaci.2010.10.009; SWAIN SL, 1994, IMMUNITY, V1, P543, DOI 10.1016/1074-7613(94)90044-2; Takeda A, 2002, BIOL CHEM, V383, P1231, DOI 10.1515/BC.2002.136; vanReijsen FC, 1997, J INVEST DERMATOL, V108, P530, DOI 10.1111/1523-1747.ep12291799; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837	55	9	9	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					569	+		10.1016/j.jaci.2017.07.055	http://dx.doi.org/10.1016/j.jaci.2017.07.055			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29106998	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000440664400024
J	Uller, L; Persson, C				Uller, Lena; Persson, Carl			Viral induced overproduction of epithelial TSLP: Role in exacerbations of asthma and COPD?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Uller, Lena] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Persson, Carl] Univ Hosp Lund, Lab Med, Lund, Sweden	Lund University; Lund University; Skane University Hospital	Persson, C (corresponding author), Univ Hosp Lund, Lab Med, Lund, Sweden.	carl.persson@med.lu.se		Uller, Lena/0000-0003-1842-148X	Swedish Medical Research Council; Heart and Lung Foundation; VINNOVA-Sweden's Innovation Agency	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Heart and Lung Foundation(Swedish Heart-Lung Foundation); VINNOVA-Sweden's Innovation Agency(Vinnova)	L. Uller and C. Persson have received grants from the Swedish Medical Research Council, Heart and Lung Foundation, and VINNOVA-Sweden's Innovation Agency.	Calven J, 2012, J INNATE IMMUN, V4, P86, DOI 10.1159/000329131; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Edwards MR, 2017, J ALLERGY CLIN IMMUN, V140, P909, DOI 10.1016/j.jaci.2017.07.025; Mahmutovic-Persson I, 2014, ALLERGY, V69, P348, DOI 10.1111/all.12329; Minton K, 2013, NAT REV IMMUNOL, V13, P391, DOI 10.1038/nri3462; Redhu NS, 2012, CLIN EXP ALLERGY, V42, P994, DOI 10.1111/j.1365-2222.2011.03919.x; Uller L, 2010, THORAX, V65, P59	7	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					712	712		10.1016/j.jaci.2018.01.051	http://dx.doi.org/10.1016/j.jaci.2018.01.051			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29628119	Bronze			2022-12-18	WOS:000440664400047
J	Garcia-Morato, MB; Santos, FJA; Briones, AC; Moreno, AB; Mate, AD; Dominguez-Soto, A; Merino, MJB; Molina, LD; Canizales, JT; Marin, AV; Garcia, EV; Rodriguez, MF; Sabando, DPL; Jimenez-Reinoso, A; del Castillo, YM; Santaeufemia, FJS; de Lucas-Laguna, R; Cardenas, PP; Polo, LC; Diaz, MC; Vales-Gomez, M; Santiago, ER; Cerdan, AF; Blanco, JN; Corbi, AL; Reyburn, HT; Regueiro, JR; Lopez-Granados, E; Pena, RR				Bravo Garcia-Morato, Maria; Aracil Santos, Francisco Javier; Contreras Briones, Alejandro; Blazquez Moreno, Alfonso; del Pozo Mate, Angela; Dominguez-Soto, Angeles; Beato Merino, Maria Jose; del Pino Molina, Lucia; Torres Canizales, Juan; Victoria Marin, Ana; Vallespin Garcia, Elena; Feito Rodriguez, Marta; Lopez Sabando, Diego Plaza; Jimenez-Reinoso, Anais; Mozo del Castillo, Yasmina; Sanz Santaeufemia, Francisco Jose; de Lucas-Laguna, Raul; Cardenas, Paula P.; Casamayor Polo, Laura; Coronel Diaz, Maria; Vales-Gomez, Mar; Roldan Santiago, Ernesto; Ferreira Cerdan, Antonio; Nevado Blanco, Julian; Corbi, Angel L.; Reyburn, Hugh T.; Ramon Regueiro, Jose; Lopez-Granados, Eduardo; Rodriguez Pena, Rebeca			New human combined immunodeficiency caused by interferon regulatory factor 4 (IRF4) deficiency inherited by uniparental isodisomy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR IRF4; DISOMY; CHROMOSOME-6; CROSSROADS; ROLES; IUGR		[Bravo Garcia-Morato, Maria; del Pino Molina, Lucia; Torres Canizales, Juan; Casamayor Polo, Laura; Coronel Diaz, Maria; Ferreira Cerdan, Antonio; Lopez-Granados, Eduardo; Rodriguez Pena, Rebeca] Hosp Univ La Paz, Dept Immunol, Madrid, Spain; [Aracil Santos, Francisco Javier] Hosp Univ La Paz, Dept Pediat, Madrid, Spain; [Beato Merino, Maria Jose] Hosp Univ La Paz, Dept Pathol Anat, Madrid, Spain; [Feito Rodriguez, Marta] Hosp Univ La Paz, Dept Dermatol, Madrid, Spain; [Lopez Sabando, Diego Plaza; Mozo del Castillo, Yasmina] Hosp Univ La Paz, Dept Pediat Hematol Oncol, Madrid, Spain; [Bravo Garcia-Morato, Maria; del Pino Molina, Lucia; Torres Canizales, Juan; Ferreira Cerdan, Antonio; Lopez-Granados, Eduardo; Rodriguez Pena, Rebeca] IdiPAZ, Lymphocyte Pathophysiol Grp, La Paz Inst Biomed Res, Madrid, Spain; [Contreras Briones, Alejandro; Victoria Marin, Ana; Jimenez-Reinoso, Anais; Cardenas, Paula P.; Ramon Regueiro, Jose] Univ Complutense Madrid, Dept Microbiol Immunol 1, Sch Med, Octubre Hlth Res Inst Imas12 12, Madrid, Spain; [Blazquez Moreno, Alfonso; Vales-Gomez, Mar; Reyburn, Hugh T.] CSIC, Dept Immunol & Oncol, Ctr Nacl Biotecnol, Madrid, Spain; [del Pozo Mate, Angela; Vallespin Garcia, Elena; Nevado Blanco, Julian] Inst Med & Mol Genet INGEMM, Madrid, Spain; [Dominguez-Soto, Angeles; Corbi, Angel L.] CSIC, Myeloid Cell Lab, Ctr Invest Biol, Madrid, Spain; [Sanz Santaeufemia, Francisco Jose] Hosp Univ Nino Jesus, Dept Pediat, Madrid, Spain; [de Lucas-Laguna, Raul; Roldan Santiago, Ernesto] Hosp Univ Ramon y Cajal, Dept Immunol, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario Ramon y Cajal	Garcia-Morato, MB (corresponding author), Hosp Univ La Paz, Dept Immunol, Madrid, Spain.; Garcia-Morato, MB (corresponding author), IdiPAZ, Lymphocyte Pathophysiol Grp, La Paz Inst Biomed Res, Madrid, Spain.	maria.bravo@salud.madrid.org	Cardenas, Paula P/I-2395-2017; Jiménez Reinoso, Anaïs/K-2453-2014; Vallespin, Elena/E-5277-2018; MORENO, ALFONSO BLAZQUEZ/L-8150-2019; Corbi, Angel/B-7194-2011; Vales-Gomez, Mar/ABG-7808-2020; DOMINGUEZ-SOTO, ANGELES/K-5937-2014; nevado, julian/ADX-5844-2022; Valés-Gómez, Mar/F-5351-2012; Corbí, Angel L./ABC-8146-2020; Marin, Ana V./K-2446-2014; Regueiro, Jose/B-5499-2014	Cardenas, Paula P/0000-0001-9054-8130; Jiménez Reinoso, Anaïs/0000-0001-8229-1881; Vallespin, Elena/0000-0002-8080-8629; Corbi, Angel/0000-0003-1980-5733; Vales-Gomez, Mar/0000-0001-7424-3206; nevado, julian/0000-0001-5611-2659; Valés-Gómez, Mar/0000-0001-7424-3206; Corbí, Angel L./0000-0003-1980-5733; Marin, Ana V./0000-0002-7541-3729; Dominguez Soto, Angeles/0000-0003-1299-5992; Regueiro, Jose/0000-0001-8442-7762; Torres Canizales, Juan/0000-0002-7138-5732; DEL PINO MOLINA, LUCIA/0000-0003-2392-097X	Spanish MINECO [SVP-2014-068263]; MINECO [FPI BES-2012-055054, 152JA19262, SAF2014-58752-R, SAF2015-69169-R, SAF2014-54708-R]; Comunidad de Madrid [CAM S2010/BMD-2316]; Complutense University [CT46/15-Harvard Univ, CT28/16]; Spanish Association Against Cancer (AECC); Carlos III Health Institute [PI16/01605]	Spanish MINECO(Spanish Government); MINECO(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Complutense University; Spanish Association Against Cancer (AECC); Carlos III Health Institute(Instituto de Salud Carlos III)	A.B.M. received a fellowship from the Spanish MINECO (SVP-2014-068263). A.J.-R. was supported by the MINECO (FPI BES-2012-055054). A.V.M. was supported by the Comunidad de Madrid (CAM S2010/BMD-2316) and the Complutense University (CT46/15-Harvard Univ). A.B.C. was supported by the Complutense University (CT28/16). P.C. was supported by the MINECO (152JA19262). This work was supported by grants from the Spanish Association Against Cancer (AECC) and Carlos III Health Institute PI16/01605) to E.L.-G. and the MINECO SAF2014-58752-R to H.T.R., SAF2015-69169-R to M.V.G., and SAF2014-54708-R to J.R.R.).	De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; Huber M, 2014, EUR J IMMUNOL, V44, P1886, DOI 10.1002/eji.201344279; JOLLIFF CR, 1982, CLIN CHEM, V28, P126; Kearney HM, 2011, CLIN LAB MED, V31, P595, DOI 10.1016/j.cll.2011.08.003; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Knudsen NH, 2014, DIABETES, V63, P1838, DOI 10.2337/db14-0273; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Lazier J, 2016, AM J MED GENET A, V170, P3227, DOI 10.1002/ajmg.a.37876; Leung WC, 2017, J OBSTET GYNAECOL, V37, P113, DOI 10.1080/01443615.2016.1242558; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Mace EM, 2017, J CLIN INVEST, V127, P306, DOI 10.1172/JCI86276; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Pathak S, 2008, MOL CELL BIOL, V28, P2815, DOI 10.1128/MCB.01946-07; Picard C, 2015, J CLIN IMMUNOL, V35, P696, DOI 10.1007/s10875-015-0201-1; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schatorje EJH, 2011, SCAND J IMMUNOL, V74, P502, DOI 10.1111/j.1365-3083.2011.02609.x; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Takashima T, 2017, J CLIN IMMUNOL, V37, P486, DOI 10.1007/s10875-017-0405-7; Temple IK, 2002, J MED GENET, V39, P872, DOI 10.1136/jmg.39.12.872; van Gent R, 2009, CLIN IMMUNOL, V133, P95, DOI 10.1016/j.clim.2009.05.020; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	25	9	9	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1924	+		10.1016/j.jaci.2017.12.995	http://dx.doi.org/10.1016/j.jaci.2017.12.995			27	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29408330	Bronze			2022-12-18	WOS:000432148200047
